PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Chen, M; Edwards, SR; Reutens, DC				Chen, Min; Edwards, Stephen R.; Reutens, David C.			Complement in the Development of Post-Traumatic Epilepsy: Prospects for Drug Repurposing	JOURNAL OF NEUROTRAUMA			English	Article						complement system; drug repurposing; epilepsy; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MANNOSE-BINDING LECTIN; CONTROLLED CORTICAL IMPACT; MEMBRANE ATTACK COMPLEX; INTRAVENOUS IMMUNOGLOBULIN; RAT MODEL; MICROGLIAL ACTIVATION; BARRIER DISRUPTION; INHIBITION; SYSTEM	Targeting neuroinflammation is a novel frontier in the prevention and treatment of epilepsy. A substantial body of evidence supports a key role for neuroinflammation in epileptogenesis, the pathological process that leads to the development and progression of spontaneous recurrent epileptic seizures. It is also well recognized that traumatic brain injury (TBI) induces a vigorous neuroinflammatory response and that a significant proportion of patients with TBI suffer from debilitating post-traumatic epilepsy. The complement system is a potent effector of innate immunity and a significant contributor to secondary tissue damage and to epileptogenesis following central nervous system injury. Several therapeutic agents targeting the complement system are already on the market to treat other central nervous system disorders or are well advanced in their development. The purpose of this review is to summarize findings on complement activation in experimental TBI and epilepsy models, highlighting the potential of drug repurposing in the development of therapeutics to ameliorate post-traumatic epileptogenesis.	[Chen, Min; Edwards, Stephen R.; Reutens, David C.] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia		Reutens, DC (corresponding author), Univ Queensland, Res Rd,Bldg 57, St Lucia, Qld 4072, Australia.	d.reutens@uq.edu.au	Chen, Min/A-1134-2014	Edwards, Stephen/0000-0002-4253-4655	Department of Defense Office of the Congressionally Directed Medical Research Programs (CDMRP) [W81XWH-17-1-0670]	W81XWH-17-1-0670, Department of Defense Office of the Congressionally Directed Medical Research Programs (CDMRP).	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; ALBERTWEISSENBERGE, 2014, FRONT CELL NEUROSCI, V0008, DOI DOI 10.3389/FNCEL.2014.00269; Andrade P, 2018, J NEUROSCI METH, V307, P37, DOI 10.1016/j.jneumeth.2018.06.015; Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Basta M, 2008, MOL IMMUNOL, V45, P4073, DOI 10.1016/j.molimm.2008.07.012; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Benson MJ, 2015, EPILEPSIA, V56, P895, DOI 10.1111/epi.12960; Benson MJ, 2015, NEUROBIOL DIS, V76, P87, DOI 10.1016/j.nbd.2015.02.004; Bhandare AM, 2017, NEUROSCIENCE, V350, P23, DOI 10.1016/j.neuroscience.2017.03.012; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Boone DR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214741; Bosco DB, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0376-5; Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Brilland B, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2019.102424; Carpanini SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00362; Chen M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40528; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Dalle Lucca Jurandir J, 2012, J Neurol Sci, V318, P146, DOI 10.1016/j.jns.2012.02.002; Davis AE, 2010, THROMB HAEMOSTASIS, V104, P886, DOI 10.1160/TH10-01-0073; De Blasio D, 2017, J CEREBR BLOOD F MET, V37, P938, DOI 10.1177/0271678X16647397; Dong XW, 2018, THERANOSTICS, V8, P1481, DOI 10.7150/thno.21254; Eadon MT, 2014, IMMUNOLOGY, V143, P363, DOI 10.1111/imm.12314; Eyo UB, 2017, GLIA, V65, P5, DOI 10.1002/glia.23006; Falope I A, 1991, West Afr J Med, V10, P187; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Frank MM, 2000, IMMUNOL RES, V22, P137, DOI 10.1385/IR:22:2-3:137; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; He F, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160290; HEYES MP, 1992, BIOCHEM J, V283, P633, DOI 10.1042/bj2830633; Hicks RR, 2002, J NEUROTRAUM, V19, P705, DOI 10.1089/08977150260139093; Hillman Y, 2016, J IMMUNOL, V196, P5156, DOI 10.4049/jimmunol.1502701; Holtman L, 2011, NEUROSCIENCE, V188, P109, DOI 10.1016/j.neuroscience.2011.05.003; Iacobas DA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24013-x; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jayne D, 2019, NEPHROL THER, V15, P409, DOI 10.1016/j.nephro.2019.04.001; Jeong S, 2014, J NEUROIMMUNOL, V276, P112, DOI 10.1016/j.jneuroim.2014.08.626; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; Kaminski RM, 2014, NEUROTHERAPEUTICS, V11, P385, DOI 10.1007/s13311-014-0266-1; Kassimatis T, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1972-x; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2014, BRAIN STRUCT FUNCT, V219, P683, DOI 10.1007/s00429-013-0528-4; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Kwon YS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-30; Lansita JA, 2017, INT J TOXICOL, V36, P449, DOI 10.1177/1091581817740873; Lee JD, 2019, SEMIN IMMUNOL, V45, DOI 10.1016/j.smim.2019.101340; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Libbey JE, 2010, J VIROL, V84, P6452, DOI 10.1128/JVI.00422-10; Longhi L, 2008, ACTA NEUROCHIR SUPPL, V102, P381, DOI 10.1007/978-3-211-85578-2_73; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Loscher W., 2019, NEUROPHARMACOLOGY; Ma YY, 2013, EPILEPSIA, V54, P1232, DOI 10.1111/epi.12195; Mansor NI, 2019, CURR DRUG DELIV, V16, P698, DOI 10.2174/1567201816666190828153017; Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Nomaru H, 2014, GLIA, V62, P1284, DOI 10.1002/glia.22680; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Ostergard T, 2016, J NEUROSCI METH, V272, P50, DOI 10.1016/j.jneumeth.2016.03.023; Pardridge WM, 2017, BIODRUGS, V31, P503, DOI 10.1007/s40259-017-0248-z; Pillay NS, 2007, BRAIN RES, V1153, P158, DOI 10.1016/j.brainres.2007.03.056; Pillay NS, 2005, ANN NY ACAD SCI, V1056, P450, DOI 10.1196/annals.1352.021; Presumey J, 2017, ADV IMMUNOL, V135, P53, DOI 10.1016/bs.ai.2017.06.004; Rana A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1192-7; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Ravizza Teresa, 2018, Epilepsia Open, V3, P133, DOI 10.1002/epi4.12242; Rich MC, 2016, NEUROSCI LETT, V617, P188, DOI 10.1016/j.neulet.2016.02.025; Ricklin D, 2018, NAT REV NEPHROL, V14, P26, DOI 10.1038/nrneph.2017.156; Roselli F, 2018, J NEUROTRAUM, V35, P226, DOI 10.1089/neu.2017.5168; Rostami E, 2013, J NEUROTRAUM, V30, P1954, DOI 10.1089/neu.2012.2583; ROZOVSKY I, 1994, NEUROSCIENCE, V62, P741, DOI 10.1016/0306-4522(94)90473-1; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Schartz ND, 2019, PHYSIOL BEHAV, V212, DOI 10.1016/j.physbeh.2019.112705; Schartz ND, 2018, NEUROBIOL DIS, V109, P163, DOI 10.1016/j.nbd.2017.10.012; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Stahel PF, 1997, MOL BRAIN RES, V50, P205, DOI 10.1016/S0169-328X(97)00189-7; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Stavarache M, 2019, J NEUROSURG, V130, P989, DOI 10.3171/2017.8.JNS17790; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tamamis P, 2010, PROTEINS, V78, P2655, DOI 10.1002/prot.22780; Tieng QM, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa8069; Tieng QM, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026018; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2014, NEUROBIOL DIS, V63, P74, DOI 10.1016/j.nbd.2013.11.019; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Wang N, 2015, NEUROSCIENCE, V287, P144, DOI 10.1016/j.neuroscience.2014.12.021; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Whitelaw BS, 2018, J NEUROPHYSIOL, V119, P1, DOI 10.1152/jn.00021.2017; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com; Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014; Woodruff TM, 2008, J IMMUNOL, V181, P8727, DOI 10.4049/jimmunol.181.12.8727; Xiong ZQ, 2003, J NEUROSCI, V23, P955; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Zelek WM, 2019, MOL IMMUNOL, V114, P341, DOI 10.1016/j.molimm.2019.07.030; Zhou YM, 2019, BRAIN RES, V1724, DOI 10.1016/j.brainres.2019.146442; Zhou YQ, 2018, J CONTROL RELEASE, V270, P290, DOI 10.1016/j.jconrel.2017.12.015	115	2	2	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2020	37	5					692	705		10.1089/neu.2019.6942			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LD0OA	WOS:000525731200003	32000582				2022-02-06	
J	Cole, PA; Dugarte, AJ; Talbot, M; Routt, ML				Cole, Peter A.; Dugarte, Anthony J.; Talbot, Max; Routt, Milton L. (Chip)			Early resection of ectopic bone in patients with heterotopic ossification about the hip after trauma	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Heterotopic ossification; HO; Early resection; Ectopic bone; Trauma; Hip; Recurrence	SPINAL-CORD-INJURY; EARLY EXCISION; ACETABULAR FRACTURE; SURGICAL EXCISION; ELBOW; IRRADIATION; SURGERY; BURNS; RISK	Objectives: Heterotopic ossification (HO) is a common complication in patients who have sustained high-energy trauma to the hip region. Traditionally, resection is performed after ectopic bone maturation. We hypothesized that early HO resection in patients with hip ankylosis after trauma can be performed with little chance of recurrence. Design: Retrospective clinical cohort. Setting: Level I Trauma Center Patients/participants: 14 patients with resection of HO about the hip performed by the senior author during a six-year period. Intervention: Early resection of Brooker Class III or IV HO. Main outcome measurements: The original injuries, risk factors for HO, post-traumatic clinical course including the workup for HO, times from fixation to resection, surgical approach, and complications were recorded. Records were reviewed to document pre and postoperative hip motions. Pre and post-operative x-rays and CT scans were reviewed to classify the HO and localize the ectopic mass. Results: Mean injury to resection interval was 6.8-months. Nine of 14 (64%) patients were followed for a mean of 32.9-months post-resection. Indications for resection included pain, stiffness, and evolving sciatic nerve lesions. Risk factors were male gender, brain injury, and extended iliofemoral and Kocher-Langenbeck surgical approaches. Complications included gluteal vein laceration, draining wounds, and recurrence. Mean flexion-extension arc of motion was 18 degrees (range = 0-70 degrees) preoperatively, 100 degrees (range = 85-125 degrees) intra-operatively, and 94 degrees (range = 20-110 degrees) at final follow-up. HO recurred in nine patients; functionally significant in one. Conclusion: Early resection of HO around the hip may be performed with little chance of symptomatic recurrence. (C) 2020 Published by Elsevier Ltd.	[Cole, Peter A.; Dugarte, Anthony J.] Univ Minnesota, Dept Orthopaed Surg, Reg Hosp, St Paul, MN 55108 USA; [Routt, Milton L. (Chip)] UT Hlth McGovern Med Sch, Dept Orthopaed Surg, Houston, TX USA; [Talbot, Max] Canadian Armed Forces, Canadian Field Hosp 1, 147 Flanders Row, Garrison Petawawa, ON K8H 2X3, Canada		Cole, PA (corresponding author), Univ Minnesota, Dept Orthopaed Surg, Reg Hosp, St Paul, MN 55108 USA.	Peter.A.Cole@healthpartners.com; Milton.L.Routt@uth.tmc.edu		Cole, Peter/0000-0001-6217-5103			Beingessner DM, 2000, J HAND SURG-AM, V25A, P483, DOI 10.1053/jhsu.2000.6922; Burd TA, 2003, J BONE JOINT SURG BR, V85B, P700, DOI 10.1302/0301-620X.85B5.13970; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; Chen S, 2015, J SHOULDER ELB SURG, V24, P1165, DOI 10.1016/j.jse.2015.05.044; Cobb TK, 1999, CLIN ORTHOP RELAT R, P131; Daum W J, 1992, J Orthop Trauma, V6, P427, DOI 10.1097/00005131-199212000-00006; Davis TA, 2011, J BONE JOINT SURG AM, V93A, P1122, DOI [10.2106/JBJS.J.01417, 10.2106/JBJSJ.01417]; Freebourn TM, 1999, SPINAL CORD, V37, P50, DOI 10.1038/sj.sc.3100719; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GHALAMBOR N, 1994, CLIN ORTHOP RELAT R, P96; HASTINGS H, 1994, HAND CLIN, V10, P417; HSU JD, 1975, CLIN ORTHOP RELAT R, P165; Iorio Richard, 2002, J Am Acad Orthop Surg, V10, P409; Kaempffe F A, 1991, J Orthop Trauma, V5, P439, DOI 10.1097/00005131-199112000-00009; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; LETOURNEL E, 1993, CLIN ORTHOP RELAT R, P62; MATTA JM, 1986, CLIN ORTHOP RELAT R, P241; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; MOED BR, 1994, J BONE JOINT SURG BR, V76B, P895, DOI 10.1302/0301-620X.76B6.7983114; Moritomo H, 2001, J SHOULDER ELB SURG, V10, P164, DOI 10.1067/mse.2001.112055; MUNSTER AM, 1972, J TRAUMA, V12, P1071, DOI 10.1097/00005373-197212000-00008; Neal B, 2002, ANZ J SURG, V72, P808, DOI 10.1046/j.1445-2197.2002.02549.x; PENNAL GF, 1980, CLIN ORTHOP RELAT R, P115; PETERS W J, 1990, Journal of Burn Care and Rehabilitation, V11, P318, DOI 10.1097/00004630-199007000-00009; Rath EMS, 2002, INJURY, V33, P751, DOI 10.1016/S0020-1383(01)00194-2; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; SAWYER JR, 1991, CALCIFIED TISSUE INT, V49, P208, DOI 10.1007/BF02556120; STOVER SL, 1976, J BONE JOINT SURG AM, V58, P683, DOI 10.2106/00004623-197658050-00019; Takemoto RC, 2011, J ORTHOP TRAUMA, V25, pE77, DOI 10.1097/BOT.0b013e3181f981e1; TIBONE J, 1978, J BONE JOINT SURG AM, V60, P769, DOI 10.2106/00004623-197860060-00007; Tsionos I, 2004, J BONE JOINT SURG BR, V86B, P396, DOI 10.1302/0301-620X.86B3.14480; Viola RW, 1999, J HAND SURG-AM, V24A, P370; WARREN SB, 1992, J BONE JOINT SURG AM, V74A, P201, DOI 10.2106/00004623-199274020-00006; WHARTON GW, 1975, CLIN ORTHOP RELAT R, P142; Wick M, 1999, ARCH ORTHOP TRAUM SU, V119, P151, DOI 10.1007/s004020050379; Wu XB, 2014, INJURY, V45, P1604, DOI 10.1016/j.injury.2014.05.018	39	2	2	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAR	2020	51	3					705	710		10.1016/j.injury.2020.01.021			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	LB2IS	WOS:000524458500024	32035630				2022-02-06	
J	Coreno, A; Ciccia, AH				Coreno, Alyssa; Ciccia, Angela H.			Supporting Students with TBI: A Clinically Focused Tutorial for Speech-Language Pathologists	SEMINARS IN SPEECH AND LANGUAGE			English	Article						childhood; adolescence; teen; brain injury; TBI; speech-language pathology	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; UNITED-STATES; HEAD-INJURY; HIGH-SCHOOL; SHORT-TERM; CHILDREN; CONCUSSIONS; YOUTH; INTERVENTION	Attention to pediatric traumatic brain injury (TBI) has grown in recent years, likely due to the increased awareness of mild TBI (mTBI) in contact sports. With this increased attention, along with an increased diagnosis of injury, more students with TBI need services, especially as they return to the classroom environment and progress through school. Support of students with TBI of all severities requires an interdisciplinary team with the school-based speech-language pathologist playing a critical role. The purpose of this tutorial is to provide a clinically focused summary of the complexities that exist for students with TBI of all severities and practical steps that can be implemented in clinical practice to enhance service provision for students with TBI.	[Coreno, Alyssa; Ciccia, Angela H.] Case Western Reserve Univ, Dept Psychol Sci, Commun Sci Program, Cleveland, OH 44106 USA		Ciccia, AH (corresponding author), Case Western Reserve Univ, Dept Psychol Sci, Commun Sci Program, Cleveland, OH 44106 USA.	Angela.ciccia@case.edu					5 College of Audiologists and Speech-Language Pathologists of Ontario (CASLPO), 2015, PRACT STAND GUID ACQ; American Speech-Language-Hearing Association, 2005, ROL SPEECH LANG PATH; American Speech-Language-Hearing Association, 2016, SCOP PRACT SPEECH LA; American Speech-Language-Hearing Association, 2004, PREF PRACT PATT PROF; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Asarnow R, 1995, TRAUMATIC BRAIN INJU, P117; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Brehaut JC, 2003, PEDIATRICS, V111, P262, DOI 10.1542/peds.111.2.262; Brown J, 2019, AM J SPEECH-LANG PAT, V28, P1363, DOI 10.1044/2019_AJSLP-18-0296; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Carrow-Woolfolk E, 2017, CASL 2; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention (CDC), 2010, RAT TBI REL HOSP AG; Chan DYK, 2011, DISABIL REHABIL, V33, P2023, DOI 10.3109/09638288.2011.556207; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Dexheimer JW, 2017, INT J MED INFORM, V97, P163, DOI 10.1016/j.ijmedinf.2016.10.007; Dise-Lewis JE, 2009, J HEAD TRAUMA REHAB, V24, P166, DOI 10.1097/HTR.0b013e3181a7ecb0; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gioia G. A., 2015, BRIEF; Glang A, 2008, NEUROREHABILITATION, V23, P477; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Laatsch L, 2020, NEUROPSYCHOL REHABIL, V30, P130, DOI 10.1080/09602011.2019.1678490; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; MacDonald S, 2013, STUDENT FAVRES; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Manasco H, 2017, INTRO NEUROGENIC COM, P7; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; Turkstra LS, 2015, DEV MED CHILD NEUROL, V57, P217, DOI 10.1111/dmcn.12600; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; WHO, 2002, WORLD HLTH REP; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	48	2	2	1	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	MAR	2020	41	2					161	169		10.1055/s-0040-1701684			9	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	LE5NF	WOS:000526765100003	32155651				2022-02-06	
J	Correa, DJ; Milano, L; Kwon, CS; Jette, N; Dlugos, D; Harte-Hargrove, L; Pugh, MJ; Smith, JK; Moshe, SL				Correa, Daniel Jose; Milano, Lindsey; Kwon, Churl-Su; Jette, Nathalie; Dlugos, Dennis; Harte-Hargrove, Lauren; Pugh, Mary Jo; Smith, Jessica K.; Moshe, Solomon L.			Quantitative readability analysis of websites providing information on traumatic brain injury and epilepsy: A need for clear communication	EPILEPSIA			English	Article						community health; health literacy; plain language; posttraumatic epilepsy; readability	SPECTRUM PROMOTING-HEALTH; ONLINE INFORMATION; QUALITY; CONCUSSION; LITERACY; WRITTEN	Objective The use of the Internet for health-related questions is increasing, but it is not clear whether individuals can understand the information available online. Most health organizations recommend that health educational materials (HEMs) be written below the sixth grade reading level. This study was designed to evaluate the readability level of available online HEMs pertaining to traumatic brain injury (TBI), epilepsy, and posttraumatic epilepsy (PTE). Methods This cross-sectional readability assessment included HEMs from TBI and epilepsy stakeholder organizations and those obtained from four Internet searches. The search strategy was designed to replicate a nonmedical individual's keyword searches. Each HEM was assessed with an online automated readability tool using three indices (Flesch Reading Ease Score, Flesch-Kincaid Grade Level, and Simple Measure of Gobbledygook). Findings were compared as a function of organization type (journalistic news or health organization), targeted medical condition (TBI, epilepsy, or PTE), or content topic (patient health education, clinical research education, or both). Results Readability analysis of 405 identified HEMs revealed scores above the sixth grade reading level recommendation. Only 6.2% of individual HEMs met the sixth grade recommendation. Journalistic news organizations' HEMs had similar readability levels to health organizations' HEMs. PTE-related HEMs required the highest readability level, >11th grade (P < .001). There were significant differences in the readability scores (P < .01 for all indices) among HEMs with information on health education, research education, or both topics. The highest required readability level (>12 grade level) was for HEMs that included both health and research education. Significance The majority of TBI-, epilepsy-, and PTE-related online HEMs do not meet the sixth grade reading recommendation. Improving the readability of HEMs may advance health literacy around TBI, epilepsy, and PTE, leading to more effective participant recruitment/retention strategies for future antiepileptogenesis trials in persons with TBI and perhaps better patient-centered outcomes.	[Correa, Daniel Jose] Albert Einstein Coll Med, Saul R Korey Dept Neurol, 1410 Pelham Pkwy South,K-312, Bronx, NY 10461 USA; [Correa, Daniel Jose] Montefiore Med Ctr, 1410 Pelham Pkwy South,K-312, Bronx, NY 10461 USA; [Milano, Lindsey] Univ North Carolina Wilmington, Wilmington, NC USA; [Kwon, Churl-Su; Jette, Nathalie] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Dlugos, Dennis] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Harte-Hargrove, Lauren] Citizens United Res Epilepsy, Chicago, IL USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Pugh, Mary Jo] Univ Utah, Sch Med, Salt Lake City, UT USA; [Smith, Jessica K.] Living Well Epilepsy, Philadelphia, PA USA; [Moshe, Solomon L.] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Moshe, Solomon L.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Moshe, Solomon L.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA		Correa, DJ (corresponding author), Albert Einstein Coll Med, Saul R Korey Dept Neurol, 1410 Pelham Pkwy South,K-312, Bronx, NY 10461 USA.; Correa, DJ (corresponding author), Montefiore Med Ctr, 1410 Pelham Pkwy South,K-312, Bronx, NY 10461 USA.	daniel.correa@einsteinmed.org	Correa, Daniel/AAU-9441-2020; Correa, Daniel Jose/U-8633-2019	Correa, Daniel Jose/0000-0002-6490-9331	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001073, UL1 TR002556] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS043209, R37 NS043209, U54 NS100064, U24 NS107201] Funding Source: Medline		Abel GA, 2015, CANCER EPIDEM BIOMAR, V24, P1629, DOI 10.1158/1055-9965.EPI-15-0274; Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Aikia M, 1995, EPILEPSY RES, V22, P157; Arif N, 2018, BREAST, V37, P6, DOI 10.1016/j.breast.2017.10.004; Baur C, 2017, STUD HEALTH TECHNOL, V240, P186, DOI 10.3233/978-1-61499-790-0-186; Beaunoyer E, 2017, PATIENT EDUC COUNS, V100, P183, DOI 10.1016/j.pec.2016.08.028; Brigo F, 2015, EPILEPSY BEHAV, V44, P35, DOI 10.1016/j.yebeh.2014.12.029; Correa DJ, 2019, NEUROBIOL DIS, V123, P137, DOI 10.1016/j.nbd.2018.07.007; Cutilli CC, 2010, ORTHOP NURS, V29, P214, DOI 10.1097/NOR.0b013e3181db5471; Doak CC., 1995, TEACHING PATIENTS LO, V2; Elliott JO, 2007, EPILEPSY BEHAV, V11, P525, DOI 10.1016/j.yebeh.2007.08.021; Elliott JO, 2009, SEIZURE-EUR J EPILEP, V18, P434, DOI 10.1016/j.seizure.2009.04.003; Engel J, 2019, NEUROBIOL DIS, V123, P3, DOI 10.1016/j.nbd.2018.04.002; England MJ, 2012, EPILEPSY CURR, V12, P245, DOI 10.5698/1535-7511-12.6.245; Fitzsimmons PR, 2010, J ROY COLL PHYS EDIN, V40, P292, DOI 10.4997/JRCPE.2010.401; Flesch R, WRITE PLAIN ENGLISH; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Fox S., 2011, SOCIAL LIFE HLTH INF; Fox S., HLTH ONLINE 2013; Friedman DB, 2014, CONTEMP CLIN TRIALS, V38, P275, DOI 10.1016/j.cct.2014.05.004; Gill PS, 2012, INT J GEN MED, V5, P923, DOI 10.2147/IJGM.S37110; Hesdorffer DC, 2013, EPILEPSIA, V54, P207, DOI 10.1111/epi.12056; Kincaid J, 1975, TRAINING CONT; Klingbeil C, 2018, J PEDIATR NURS, V42, P81, DOI 10.1016/j.pedn.2018.06.002; Leonard K, 2017, J CONS HLTH INTERNET, V21, P87, DOI 10.1080/15398285.2017.1280347; Ley P., 1996, PSYCHOL HEALTH MED, V1, P7, DOI DOI 10.1080/13548509608400003; McLaughlin GH, 1969, J READING, V12, P5; Moccia M, 2016, J CLIN NEUROSCI, V25, P167, DOI 10.1016/j.jocn.2015.10.003; Mollayeva T, 2019, NEUROSCI BIOBEHAV R, V99, P198, DOI 10.1016/j.neubiorev.2019.01.011; Mozafarpour S, 2018, WORLD J UROL, V36, P985, DOI 10.1007/s00345-018-2179-9; National Institutes of Health, PLAIN LANG NIH; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Paquette-Lemieux E, 2019, THER INNOV REGUL SCI, V53, P340, DOI 10.1177/2168479018786481; Parker RM, 1999, JAMA-J AM MED ASSOC, V281, P552; Plain Language Action and Information Network, FED PLAIN LANG GUID; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Prins E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130257; Purcell Kristen, 2012, SEARCH ENGINE USE 20; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Rosales A, 2007, NATL SURVEY MED GUID; Sanders JB, 2011, AM J GERIAT PSYCHIAT, V19, P664, DOI 10.1097/JGP.0b013e3181f7d8e9; Sobolewski J, 2019, J VET INTERN MED, V33, P350, DOI 10.1111/jvim.15462; Somers Rita, 2017, AJOB Empir Bioeth, V8, P277, DOI 10.1080/23294515.2017.1401563; Walsh TM, 2008, RESP CARE, V53, P1310; Wang LW, 2013, RES SOC ADMIN PHARM, V9, P503, DOI 10.1016/j.sapharm.2012.05.009; Wang SW, 2009, J HAND SURG-AM, V34A, P1308, DOI 10.1016/j.jhsa.2009.04.008; Weih M, 2008, INT PSYCHOGERIATR, V20, P1116, DOI 10.1017/S1041610208007576; Yoo SGK, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.005251	48	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	MAR	2020	61	3					528	538		10.1111/epi.16446			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KV6TM	WOS:000520614800016	32096225	Green Accepted			2022-02-06	
J	Daugherty, J; DePadilla, L; Sarmiento, K; Breiding, MJ				Daugherty, Jill; DePadilla, Lara; Sarmiento, Kelly; Breiding, Matthew J.			Self-Reported Lifetime Concussion Among Adults: Comparison of 3 Different Survey Questions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; injury prevention; survey methodology	TRAUMATIC BRAIN-INJURY; HISTORY; POPULATION; DEFINITION; PREVALENCE	Objective: Because of limitations in current national data sets, respondent self-report may be critical to obtaining concussion prevalence estimates. We examined whether self-report of lifetime concussion among adults varies with the provision of a concussion definition and by the content of that definition. Setting and Participants: A convenience sample of 6427 American adults who participated in the 2018 Porter Novelli SpringStyles survey. Design: Cross-sectional. Main Measures: Frequency of self-reported concussion by variation in concussion definition. Results: A quarter of respondents (28.9%) reported experiencing a concussion in their lifetime. While concussion prevalence varied by demographic characteristics, it did not vary significantly by concussion definition. Variation in concussion definition did not result in differences related to recency of last concussion, mechanism of injury, or respondent activity engaged in during which they sustained their most recent concussion. Conclusion: The current study suggested that in this sample of adults, the percentage reporting a concussion did not significantly vary by whether a concussion definition was provided or by the content of the definition. However, research suggests that prompting about mechanism of injury, listing symptoms individually, and considering only athletic populations may affect estimates and these factors should be included in future question comparisons.	[Daugherty, Jill; DePadilla, Lara; Sarmiento, Kelly; Breiding, Matthew J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 4770 Buford Hwy NE, Atlanta, GA 30341 USA		Daugherty, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 4770 Buford Hwy NE, Atlanta, GA 30341 USA.	JDaugherty@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Alosco ML, 2017, BRAIN INJURY, V31, P1116, DOI 10.1080/02699052.2017.1294709; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dawson R, 2011, J STAT EDUC, V19, DOI 10.1080/10691898.2011.11889610; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	15	2	2	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		E136	E143		10.1097/HTR.0000000000000534			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500012	31479084	Green Accepted			2022-02-06	
J	Dengler, BA; Plaza-Wuthrich, S; Chick, RC; Muir, MT; Bartanusz, V				Dengler, Bradley A.; Plaza-Wuthrich, Sonia; Chick, Robert C.; Muir, Mark T.; Bartanusz, Viktor			Secondary Overtriage in Patients with Complicated Mild Traumatic Brain Injury: An Observational Study and Socioeconomic Analysis of 1447 Hospitalizations	NEUROSURGERY			English	Article						Complicated mild traumatic brain injury; Hospitalization costs; Injury severity score; Secondary overtriage; Trauma injury severity score	INTRACRANIAL HEMORRHAGE; LEVEL III; TRANSFERS; HELICOPTER; PROTOCOL; OUTCOMES	BACKGROUND: Secondary overtriage is a problematic phenomenon because it creates unnecessary expense and potentially results in the mismanagement of healthcare resources. The rates of secondary overtriage among patients with complicated mild traumatic brain injury (cmTBI) are unknown. OBJECTIVE: To determine the rate of secondary overtriage among patients with cmTBI using the institutional trauma registry. METHODS: An observational study using retrospective analysis of 1447 hospitalizations including all consecutive patients with cmTBI between 2004 and 2013. Data on age, sex, race/ethnicity, insurance status, GCS, Injury Severity Score (ISS), Trauma Injury Severity Score, transfer mode, overall length of stay (LOS), LOS within intensive care unit, and total charges were collected and analyzed. RESULTS: Overall, the rate of secondary overtriage among patients with cmTBI was 17.2%. These patients tended to be younger (median: 41 vs 60.5 yr; P < .001), have a lower ISS (9 vs 16; P < .001), and were more likely to be discharged home or leave against medical advice. CONCLUSION: Our findings provide evidence to the growing body of literature suggesting that not all patients with cmTBI need to be transferred to a tertiary care center. In our study, these transfers ultimately incurred a total cost of $13 294 ($1337 transfer cost) per patient.	[Dengler, Bradley A.] Walter Reed Natl Mil Med Ctr, Dept Neurosurg, Bethesda, MD USA; [Plaza-Wuthrich, Sonia] CHU Vaudois, Div Spine Surg, Lausanne, Switzerland; [Chick, Robert C.] Brooke Army Med Ctr, Dept Surg, San Antonio, TX USA; [Muir, Mark T.] Univ Texas Hlth San Antonio, Dept Surg, San Antonio, TX 78229 USA; [Bartanusz, Viktor] Univ Texas Hlth San Antonio, Dept Neurosurg, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA		Bartanusz, V (corresponding author), Univ Texas Hlth San Antonio, Dept Neurosurg, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	bartanusz@uthscsa.edu	Dengler, Bradley/AAN-7688-2021; Chick, Robert/AAD-8310-2021; Chick, Robert Connor/AAD-7548-2021	Chick, Robert/0000-0001-5912-0902			Bekelis K, 2015, ANN SURG, V262, P9, DOI 10.1097/SLA.0000000000001239; Brouwers HB, 2014, JAMA NEUROL, V71, P158, DOI 10.1001/jamaneurol.2013.5433; Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P319, DOI 10.1097/TA.0b013e3182572bee; Ciesla DJ, 2008, J AM COLL SURGEONS, V206, P131, DOI 10.1016/j.jamcollsurg.2007.06.285; Elswick CM, 2018, J PEDIATR SURG, V53, P1795, DOI 10.1016/j.jpedsurg.2018.04.032; Kreitzer N, 2017, AM J EMERG MED, V35, P875, DOI 10.1016/j.ajem.2017.01.051; Latifi R, 2018, WORLD NEUROSURG, V112, pE747, DOI 10.1016/j.wneu.2018.01.146; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Lynch KT, 2016, J SURG RES, V204, P460, DOI 10.1016/j.jss.2016.05.035; Madiraju SK, 2017, J SURG RES, V218, P261, DOI 10.1016/j.jss.2017.05.102; Martin GE, 2018, J TRAUMA ACUTE CARE, V84, P483, DOI 10.1097/TA.0000000000001767; Medford-Davis LN, 2018, AM J EMERG MED, V36, P797, DOI 10.1016/j.ajem.2017.10.024; Menchine MD, 2008, ACAD EMERG MED, V15, P329, DOI 10.1111/j.1553-2712.2008.00071.x; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Rao MB, 2010, ACAD EMERG MED, V17, P1374, DOI 10.1111/j.1553-2712.2010.00927.x; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Vercruysse GA, 2015, J TRAUMA ACUTE CARE, V78, P510, DOI 10.1097/TA.0000000000000553; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	18	2	2	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2020	86	3					374	381		10.1093/neuros/nyz092			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LS6AA	WOS:000536463300037	30953054				2022-02-06	
J	Feary, N; McKinlay, A				Feary, Natalie; McKinlay, Audrey			Impact of mild traumatic brain injury understanding on intended help-seeking behaviour	JOURNAL OF CHILD HEALTH CARE			English	Article						Health education; health knowledge; parents; post-concussive symptoms; mild traumatic brain injury	SPORT CONCUSSION; KNOWLEDGE; PARENTS; ADOLESCENTS; CHILDREN; INTERVENTION; STATEMENT; PRESCHOOL	Children do not always receive adequate medical attention following a mild traumatic brain injury (mTBI), despite the necessity of this treatment. Adult mTBI knowledge may be one factor that affects if a child receives medical attention, but little is known about association between mTBI knowledge and help-seeking behaviour. Participants were 212 females and 58 males, including 84 parents, with a mean age of 35.57 years (standard deviation = 10.96). A questionnaire evaluated participants' understanding of mTBI and vignettes to evaluate behavioural intentions regarding help-seeking behaviour after an mTBI. Only 40.0% of participants were able to recall an adequate number of mTBI symptoms (5+). Surprisingly, mTBI history was not associated with better mTBI knowledge, t(df, 268) = 1.29, p = .20. Similarly, knowing a close friend or family member with mTBI was not associated with higher mTBI knowledge, t(df = 268) = .81, p = .4. Further, neither mTBI symptom knowledge nor vignette child age (young = 5 years, older = 15 years) significantly predicted participants' cited intentions to perform help-seeking behaviour. Consistent with the existing research, the current study demonstrates a continued lack of mTBI knowledge in the general population. However, this may not be a factor that influences an adult's decision to take a child to hospital following mTBI. Future research should investigate the association between help-seeking intentions and actual behaviour in relation to paediatric mTBI.	[Feary, Natalie; McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3010, Australia		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514			Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; BASS LW, 1982, PEDIATRICS, V70, P870; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Centers for Disease Control and Prevention, 2016, WHAT AR SIGNS SYMPT; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Elliott BA, 2004, J ADOLESCENT HEALTH, V35, P303, DOI [10.1016/S1054-139X(03)00534-2, 10.1016/j.jadohealth.2003.09.015]; Fieldston ES, 2013, PEDIATR EMERG CARE, V29, P331, DOI 10.1097/PEC.0b013e31828512c7; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Rowe BH, 2006, ACAD EMERG MED, V13, P848, DOI 10.1197/j.aem.2006.01.028; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Sharma V, 2000, PEDIATRICS, V106, P1031, DOI 10.1542/peds.106.5.1031; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; The Royal Children's Hospital Melbourne, KIDS HLTH INF HEAD I; Weber M, 2012, ARCH CLIN NEUROPSYCH, V27, P355, DOI 10.1093/arclin/acs029	29	2	2	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1367-4935	1741-2889		J CHILD HEALTH CARE	J. Child Health Care	MAR	2020	24	1					78	91		10.1177/1367493518799617			14	Nursing; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Pediatrics	LA2QH	WOS:000523796800007	30213191				2022-02-06	
J	Filley, CM				Filley, Christopher M.			Social Cognition and White Matter: Connectivity and Cooperation	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						social cognition; white matter; connectivity; cooperation	VON ECONOMO NEURONS; UNCINATE FASCICULUS; BRAIN; MICROSTRUCTURE; EVOLUTION; INTEGRITY; DISCONNECTION; ABNORMALITIES; NEUROANATOMY; NEUROSCIENCE	Humans are highly social animals whose survival and well-being depend on their capacity to cooperate in complex social settings. Advances in anthropology and psychology have demonstrated the importance of cooperation for enhancing social cohesion and minimizing conflict. The understanding of social behavior is informed by the notion of social cognition, a set of mental operations including emotion perception, mentalizing, and empathy. The social brain hypothesis posits that the mammalian brain has enlarged over evolution to meet the challenges of social life, culminating in a large human brain well adapted for social cognition. The structures subserving social cognition are mainly located in the frontal and temporal lobes, and although gray matter is critical, social cognition also requires white matter. Whereas the social brain hypothesis assumes that brain enlargement has been driven by neocortical expansion, cerebral white matter has expanded even more robustly than the neocortex, coinciding with the emergence of social cognition. White matter expansion is most evident in the frontal and temporal lobes, where it enhances connectivity between regions critical for social cognition. Myelination has, in turn, conferred adaptive social advantages by enabling prompt empathic concern for offspring and by strengthening networks that support cooperation and the related capacities of altruism and morality. Social cognition deficits related to myelinated tract involvement occur in many disorders, including stroke, Binswanger disease, traumatic brain injury, multiple sclerosis, glioma, and behavioral variant frontotemporal dementia. The contribution of white matter to social cognition can be conceptualized as the enhancement of cooperation through brain connectivity.	[Filley, Christopher M.] Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect,Marcus Inst Brain Hlth, Aurora, CO USA; [Filley, Christopher M.] Univ Colorado, Sch Med, Dept Psychiat, Behav Neurol Sect,Marcus Inst Brain Hlth, Aurora, CO USA		Filley, CM (corresponding author), Behav Neurol Sect, 12469 East 17th Pl, Aurora, CO 80045 USA.	christopher.filley@ucdenver.edu					Allman JM, 2011, ANN NY ACAD SCI, V1225, P59, DOI 10.1111/j.1749-6632.2011.06011.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arciniegas D. B., 2013, BEHAV NEUROLOGY NEUR, P266; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Batista S, 2017, NEUROLOGY, V89, P38, DOI 10.1212/WNL.0000000000004060; Baumgartner T, 2015, NEUROIMAGE, V122, P345, DOI 10.1016/j.neuroimage.2015.08.011; Bickart KC, 2014, NEUROPSYCHOLOGIA, V63, P235, DOI 10.1016/j.neuropsychologia.2014.08.013; Cacioppo JT, 2014, WORLD PSYCHIATRY, V13, P131, DOI 10.1002/wps.20118; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Chalah MA, 2017, J INT NEUROPSYCH SOC, V23, P266, DOI 10.1017/S1355617716001156; Cobos I, 2015, CEREB CORTEX, V25, P213, DOI 10.1093/cercor/bht219; Cotter J, 2018, NEUROSCI BIOBEHAV R, V84, P92, DOI 10.1016/j.neubiorev.2017.11.014; de Waal FBM, 2017, NAT REV NEUROSCI, V18, P498, DOI 10.1038/nrn.2017.72; de Waal FBM, 2012, SCIENCE, V336, P874, DOI 10.1126/science.1220999; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Dicke U, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0180; Downey LE, 2015, NEUROIMAGE-CLIN, V8, P640, DOI 10.1016/j.nicl.2015.06.005; Dunbar RIM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0244; Dunbar RIM, 2009, ANN HUM BIOL, V36, P562, DOI 10.1080/03014460902960289; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.3.CO;2-P; Filley CM, 2016, J NEUROPHYSIOL, V116, P2093, DOI 10.1152/jn.00221.2016; Filley CM, 2010, NEUROPSYCHOL REV, V20, P158, DOI 10.1007/s11065-010-9127-9; Filley CM, 2012, BEHAV NEUROLOGY WHIT, V2nd; Filley CM, 2016, WHITE MATTER DEMENTI; Filley CM, 1988, NEUROPSY NEUROPSY BE, V1, P239; Gainotti G, 1972, Cortex, V8, P41; Genetti Gatfield Melanie, 2019, Front Neurol Neurosci, V44, P15, DOI 10.1159/000494946; Giazkoulidou A, 2019, HELL J NUCL MED, V22, P102; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; Hallett M, 2016, HAND CLINIC, V139, P61, DOI 10.1016/B978-0-12-801772-2.00006-0; Hampton WH, 2016, SOC COGN AFFECT NEUR, V11, P721, DOI 10.1093/scan/nsv153; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; Hare B, 2017, ANNU REV PSYCHOL, V68, P155, DOI 10.1146/annurev-psych-010416-044201; Haroutunian V, 2014, GLIA, V62, P1856, DOI 10.1002/glia.22716; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; HEILMAN KM, 1975, J NEUROL NEUROSUR PS, V38, P69, DOI 10.1136/jnnp.38.1.69; Heilman KM, 1985, CLIN NEUROPSYCHOLOGY, P377; Herbet G, 2014, BRAIN, V137, P944, DOI 10.1093/brain/awt370; Highley JR, 2002, CEREB CORTEX, V12, P1218, DOI 10.1093/cercor/12.11.1218; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kim EJ, 2012, CEREB CORTEX, V22, P251, DOI 10.1093/cercor/bhr004; Kynast J, 2018, J CEREBR BLOOD F MET, V38, P996, DOI 10.1177/0271678X17719380; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Leigh R, 2013, BRAIN, V136, P2539, DOI 10.1093/brain/awt177; Li HL, 2016, BRAIN RES, V1641, P111, DOI 10.1016/j.brainres.2015.10.013; Lindquist KA, 2016, CEREB CORTEX, V26, P1910, DOI 10.1093/cercor/bhv001; McDonald S, 2019, BRAIN IMAGING BEHAV, V13, P819, DOI 10.1007/s11682-018-9906-0; McDonald S, 2017, J INT NEUROPSYCH SOC, V23, P719, DOI 10.1017/S1355617717000844; Mendez MF, 2011, SOC NEUROSCI-UK, V6, P415, DOI 10.1080/17470919.2011.624806; Mendez MF, 2009, CNS SPECTRUMS, V14, P608, DOI 10.1017/S1092852900023853; Mesulam M.-M., 2000, PRINC BEHAV COGN NEU, V2, P1, DOI [DOI 10.1017/9781108164320.002, 10.1017/9781108164320.002]; Multani N, 2017, NEUROIMAGE-CLIN, V16, P447, DOI 10.1016/j.nicl.2017.08.020; Nakajima R, 2018, NEUROPSYCHOLOGIA, V115, P179, DOI 10.1016/j.neuropsychologia.2018.01.024; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Niznikiewicz MA, 2013, ADV COGN PSYCHOL, V9, P173, DOI [10.2478/v10053-008-0145-6, 10.5709/acp-0145-6]; Noonan MP, 2018, BEHAV BRAIN RES, V355, P12, DOI 10.1016/j.bbr.2018.02.019; Nunez PL, 2015, CLIN NEUROPHYSIOL, V126, P110, DOI 10.1016/j.clinph.2014.04.003; Oishi K, 2015, ANN NEUROL, V77, P68, DOI 10.1002/ana.24300; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Parkinson C, 2014, CEREB CORTEX, V24, P614, DOI 10.1093/cercor/bhs347; Parvizi J, 2009, TRENDS COGN SCI, V13, P354, DOI 10.1016/j.tics.2009.04.008; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Redhead G, 2013, EVOL PSYCHOL-US, V11, P845, DOI 10.1177/147470491301100409; Rilling JK, 2018, BRAIN BEHAV EVOLUT, V91, P170, DOI 10.1159/000488886; Rilling JK, 1999, J HUM EVOL, V37, P191, DOI 10.1006/jhev.1999.0313; ROSS ED, 1979, ARCH NEUROL-CHICAGO, V36, P144, DOI 10.1001/archneur.1979.00500390062006; Rule NO, 2012, PERCEPTION, V41, P687, DOI 10.1068/p7023; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shultz S, 2010, P NATL ACAD SCI USA, V107, P21582, DOI 10.1073/pnas.1005246107; SILBERMAN EK, 1986, BRAIN COGNITION, V5, P322, DOI 10.1016/0278-2626(86)90035-7; Smaers JB, 2011, BRAIN BEHAV EVOLUT, V77, P67, DOI 10.1159/000323671; Sonne JWH, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00575; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; Tattersall I, 2010, THEOR BIOSCI, V129, P193, DOI 10.1007/s12064-010-0093-9; Tomassy GS, 2016, TRENDS CELL BIOL, V26, P135, DOI 10.1016/j.tcb.2015.09.002; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; van Horn JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037454; Vermeij A, 2018, NEUROPSYCHOLOGY, V32, P735, DOI 10.1037/neu0000448; Waller R, 2017, NEUROIMAGE-CLIN, V14, P201, DOI 10.1016/j.nicl.2017.01.014; Wang Y, 2018, NEUROSCI BIOBEHAV R, V90, P350, DOI 10.1016/j.neubiorev.2018.04.015; Wang Y, 2018, TRENDS COGN SCI, V22, P504, DOI 10.1016/j.tics.2018.03.005; Wittmann MK, 2018, ANNU REV NEUROSCI, V41, P99, DOI 10.1146/annurev-neuro-080317-061450; Wolf RC, 2015, HUM BRAIN MAPP, V36, P4202, DOI 10.1002/hbm.22911; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	93	2	2	5	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	MAR	2020	33	1					67	75		10.1097/WNN.0000000000000223			9	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	LB3DH	WOS:000524517600008	32132405				2022-02-06	
J	Fischer, VE; Boulter, JH; Bell, RS; Ikeda, DS				Fischer, Victoria E.; Boulter, Jason H.; Bell, Randy S.; Ikeda, Daniel S.			Paradoxical Contralateral Herniation Detected by Pupillometry in Acute Syndrome of the Trephined	MILITARY MEDICINE			English	Article							INFRARED PUPILLOMETRY; BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; PUPIL; RELIABILITY; DEVICE	Severe traumatic brain injury has historically been a non-survivable injury. Recent advances in neurosurgical care, however, have demonstrated that these patients not only can survive, but they also can recover functionally when they undergo appropriate cerebral decompression within hours of injury. At the present, general surgeons are deployed further forward than neurosurgeons (Role 2 compared to Role 3) and have been provided with guidelines that stipulate conditions where they may have to perform decompressive craniectomies. Unfortunately, Role 2 medical facilities do not have access to computed tomography imaging or intracranial pressure monitoring capabilities rendering the decision to proceed with craniectomy based solely on exam findings. Utilizing a case transferred from downrange to our institution, we demonstrate the utility of a small, highly portable quantitative pupillometer to obtain reliable and reproducible data about a patient's intracranial pressures. Following the case presentation, the literature supporting quantitative pupillometry for surgical decision-making is reviewed.	[Fischer, Victoria E.] Univ Texas Hlth Sci Ctr San Antonio, Div Neurosurg, 7703 Floyd Curl Dr,MC 7843, San Antonio, TX 78229 USA; [Boulter, Jason H.; Bell, Randy S.; Ikeda, Daniel S.] Walter Reed Natl Mil Med Ctr, Div Neurosurg, 8901 Rockville Pike, Bethesda, MD 20814 USA		Fischer, VE (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Neurosurg, 7703 Floyd Curl Dr,MC 7843, San Antonio, TX 78229 USA.						Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; ANDREWS BT, 1989, SURG NEUROL, V32, P434, DOI 10.1016/0090-3019(89)90006-2; [Anonymous], 2004, ROL MED CAR US, P17; Aoun SG, 2019, WORLD NEUROSURG, V121, pE475, DOI 10.1016/j.wneu.2018.09.140; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Bell R, 2018, JOINT TRAUMA SYSTEM; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chen JW, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-548; Choi JJ, 2011, J CRANIOFAC SURG, V22, P2163, DOI 10.1097/SCS.0b013e3182323fd5; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Emelifeonwu JA, 2018, BRAIN INJURY, V32, P675, DOI 10.1080/02699052.2018.1429021; Fountas KN, 2006, NEUROCRIT CARE, V5, P55, DOI 10.1385/NCC:5:1:55; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Kim HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208259; Larkin MB, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.9.FOCUS18359; Larson MD, 1997, ANESTHESIOLOGY, V87, P849, DOI 10.1097/00000542-199710000-00019; Larson MD, 2015, ANESTH ANALG, V120, P1242, DOI 10.1213/ANE.0000000000000314; Lee Bruce, 2005, NeuroRx, V2, P372; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Lubillo S, 2009, MED INTENSIVA, V33, P74, DOI 10.1016/S0210-5691(09)70685-0; Manley GT, 2002, J NEUROSURG ANESTH, V14, P223, DOI 10.1097/00008506-200207000-00009; MARSHALL LF, 1983, J NEUROSURG, V58, P566, DOI 10.3171/jns.1983.58.4.0566; McNett M, 2018, J NEUROSCI NURS, V50, P357, DOI 10.1097/JNN.0000000000000401; McNett M, 2017, J NEUROSCI NURS, V49, P229, DOI 10.1097/JNN.0000000000000290; Mease L, 2018, MIL MED, V183, pE291, DOI 10.1093/milmed/usy011; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Natzeder S, 2019, J NEUROSURG ANESTH, V31, P428, DOI 10.1097/ANA.0000000000000553; Oddo M, 2018, INTENS CARE MED, V44, P2102, DOI 10.1007/s00134-018-5448-6; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Osman M, 2019, J STROKE CEREBROVASC, V28, P1902, DOI 10.1016/j.jstrokecerebrovasdis.2019.03.055; Papangelou A, 2018, MIL MED, V183, pE113, DOI 10.1093/milmed/usx018; Phillips SS, 2019, NEUROCRIT CARE, V31, P142, DOI 10.1007/s12028-018-0645-2; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; Rollins MD, 2014, ANESTHESIOLOGY, V121, P1037, DOI 10.1097/ALN.0000000000000384; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Shackelford SA, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.9.FOCUS18404; Stevens AR, 2019, BRAIN INJURY, V33, P1032, DOI 10.1080/02699052.2019.1605621; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Vinciguerra L, 2017, NEUROCRIT CARE, V27, P122, DOI 10.1007/s12028-016-0361-8; Wachler BSB, 1999, OPHTHALMOLOGY, V106, P319; Zhao WD, 2016, J CLIN NEUROSCI, V33, P79, DOI 10.1016/j.jocn.2016.01.039	44	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2020	185	3-4					532	536		10.1093/milmed/usz409			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LR7HU	WOS:000535866100067	32236451	hybrid			2022-02-06	
J	Goldschmidt, E; Deng, HS; Puccio, AM; Okonkwo, DO				Goldschmidt, Ezequiel; Deng, Hansen; Puccio, Ava M.; Okonkwo, David O.			Post-traumatic hydrocephalus following decompressive hemicraniectomy: Incidence and risk factors in a prospective cohort of severe TBI patients	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Post-traumatic hydrocephalus; Decompressive hemicraniectomy; Traumatic brain injury; Intracranial pressure; Ventriculoperitoneal shunt	INTERHEMISPHERIC HYGROMA; BRAIN-INJURY; CRANIECTOMY	Background: In severe traumatic brain injury (TBI) patients undergoing decompressive hemicraniectomy (DHC), the rate of post-traumatic hydrocephalus (PTH) is high at 12-36%. Early diagnosis and shunt placement can improve outcomes. Herein, we examined the incidence of and predictors of PTH after craniectomy. Methods: A retrospective analysis of prospectively collected database of severe TBI patients at a single U.S. Level 1 trauma center from May 2000 to July 2014 was performed. Demographics, Injury Severity Score (ISS), Glasgow Coma Scale (GCS), bleeding pattern and time-to-cranioplasty were analyzed. Glasgow Outcome Scale (GOS) scores at 6 and 12-months were studied. Statistical significance was assessed at p < 0.05. Results: A total of 402 patients were enrolled and 105 patients had DHC. Twenty-two (21.0%) of 105 required ventriculoperitoneal shunt (VPS), compared to 18 (6%) of 297 patients without DHC. There was increased odds ratio for shunting after DHC at 3.62 (95%CI:1.62-8.07; p < 0.01). Mean age at time of DHC was 43.8 +/- 17.7 years old, and 81.9% were male. Subdural hematoma (SDH) was most common at 57.1%. Median time from admission to cranioplasty was 63 days. Patients who experienced PTH after DHC were younger (35.5 +/- 17.7 versus 46.0 +/- 17.7 years, p < 0.01) and had higher ISS scores (35 versus 26, p = 0.04) compared to patients without shunt after DHC. Conclusions: After severe TBI requiring hemicraniectomy, shunt-dependent hydrocephalus was 21%. Younger patients and higher ISS score were associated with PTH. Shunt-dependent patients achieved similar 6- and 12-month outcomes as those without PTH. Early diagnosis and shunt placement can enhance long-term neurological recovery. (C) 2020 Elsevier Ltd. All rights reserved.	[Goldschmidt, Ezequiel; Deng, Hansen; Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Neurotrauma Clin Trials Ctr, Med Ctr, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA		Okonkwo, DO (corresponding author), Univ Pittsburgh, Med Ctr, UPMC Enterprises, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	Goldschmidted@upmc.edu; dengh3@upmc.edu; Puccioam@upmc.edu; OkonkwoDO@upmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R00 NR13176]; NIH/NNR	This study was supported by the grants NIH/NNR and R00 NR13176 from the National Institutes of Health.	Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Dandy WE, 1932, PRACTICE SURG, P306; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Hu QX, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00337; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Wilkins TE, 2019, J NEUROTRAUM, V36, P3158, DOI 10.1089/neu.2018.6153	19	2	2	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAR	2020	73						85	88		10.1016/j.jocn.2020.01.027			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LF3GN	WOS:000527309400015	31987632				2022-02-06	
J	Goldsmith, L; Neal, N; Briggs, J; Tapping, C; Boardman, P; Turney, B; Reynard, J				Goldsmith, Louise; Neal, Naomi; Briggs, James; Tapping, Charles; Boardman, Phil; Turney, Ben; Reynard, John			Percutaneous cystolitholapaxy: A safe and effective alternative to open stone surgery for the management of complex bladder stones in patients with no urethral access	JOURNAL OF CLINICAL UROLOGY			English	Article						Lithotripsy; urinary bladder calculi; urinary diversion	RISK	Objectives: Bladder stone management in patients with reconstructed bladders drained by Mitrofanoff catheterizable channels, with no urethral access, generates multiple challenges. Trans-Mitrofanoff access limits the size of endoscopic stone fragmenting devices, risking prolonged procedures, incomplete stone clearance and damage to the continent conduit. Access through previous surgical access sites risks bowel injury. This case series reports outcomes in patients undergoing percutaneous cystolitholapaxy (PCCL), using ultrasound-guided access and direct track closure, thereby limiting radiation exposure and avoiding suprapubic catheters (SPCs). Patients and methods: Seven PCCL procedures were performed in five patients with closed urethras. Average age 32 years, primary diagnoses: spina bifida, vertebrae, anus, trachea, esophagus, renal (VATER) syndrome, bladder exstrophy and traumatic brain injury. Four used Mitrofanoff stomas and one an SPC. Average largest stone was 18.57 mm (range 10-30 mm). Five procedures were for multiple stones (range 2-30 stones). Results: Each PCCL achieved complete stone clearance. Average operative time: 146 min (range 72-250 min). No intraoperative blood loss or bladder perforation. Postoperative median length of stay was 2 days. Conclusion: PCCL is a safe, minimally invasive alternative to open surgery for large and multiple bladder stones in individuals with complex lower urinary tract anatomy, specifically reconstructed bladders drained by Mitrofanoff catheterizable channels with no urethral access.	[Goldsmith, Louise; Neal, Naomi; Turney, Ben; Reynard, John] Churchill Hosp, Dept Urol, Oxford, England; [Briggs, James] Royal Berkshire Hosp, Dept Radiol, Reading, Berks, England; [Tapping, Charles; Boardman, Phil] Churchill Hosp, Dept Radiol, Oxford, England		Goldsmith, L (corresponding author), Oxford Univ Hosp, Churchill Hosp, Dept Urol, 4 Galpin Close, Oxford OX4 1PR, England.	louisegoldsmith@doctors.org.uk		Goldsmith, Louise/0000-0002-4300-2554			Breda A, 2019, J UROLOGY, V183, P1989; DeFoor W, 2004, J UROLOGY, V172, P1964, DOI 10.1097/01.ju.0000140911.43898.15; Demirel F, 2006, J ENDOUROL, V20, P429, DOI 10.1089/end.2006.20.429; Ord J, 2003, J UROLOGY, V170, P1734, DOI 10.1097/01.ju.0000091780.59573.fa; Tan YK, 2014, J ENDOUROL, V28, P61, DOI 10.1089/end.2013.0127	5	2	2	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2051-4158	2051-4166		J CLIN UROL	J. Clin. Urol.	MAR	2020	13	2					106	109		10.1177/2051415819830191			4	Urology & Nephrology	Emerging Sources Citation Index (ESCI)	Urology & Nephrology	LA3HL	WOS:000523841400004					2022-02-06	
J	Gonda, DD; Huang, M; Briceno, V; Lam, SK; Luerssen, TG; Jea, A				Gonda, David D.; Huang, Meng; Briceno, Valentina; Lam, Sandi K.; Luerssen, Thomas G.; Jea, Andrew			Protecting Against Postoperative Dyspnea and Dysphagia After Occipitocervical Fusion	OPERATIVE NEUROSURGERY			English	Article						Clival-axial angle; Dysphagia; Dyspnea; Occipitocervical fusion	COMPLICATIONS; ANGLE	BACKGROUND: Upper airway obstruction leading to dyspnea and dysphagia after occipitocervical fusion is a rare complication that has significant morbidity. OBJECTIVE: To estimate the frequency of postoperative dyspnea and dysphagia in children after occipitocervical fusion and to identify variables associated with its occurrence. METHODS: We retrospectively reviewed outcomes from all pediatric occipitocervical fusions at our institution between 2007 and 2014. Pre- and postoperative computed tomography (CT) scans were compared to determine differences in the clivoaxial (OC2) angles. RESULTS: Sixty-seven pediatric patients underwent occipitocervical fusions. Median age was 9.6 yr (range 6 mo-18 yr). Fifty-six of 62 patients (90.3%) with at least 1 yr of follow-up had successful fusions. Eleven had pre-existing symptoms or otherwise compromised examination (eg, severe traumatic brain injury). None of 15 patients placed in extension (>2 degrees) relative to preoperative CT in Situ position developed new dyspnea or dysphagia. Nine of forty patients (23%) kept in Situ or flexed position developed new symptoms of dyspnea or dysphagia. Dysphagia in patients fused in the in Situ position was milder and resolved within a few weeks. No patient under age 5 (n = 20) developed symptoms of dyspnea or dysphagia regardless of head position. There were 3 cases of infection, 1 clinically silent vertebral artery injury, and 3 deaths at last follow-up. CONCLUSION: Positioning of the child's head prior to occipitocervical fusion has considerable impact on outcomes, especially in older children. Careful measurements of the OC2 angle during surgery to ensure optimal head positioning in Situ or slightly extended position may prevent postoperative dysphagia or dyspnea.	[Gonda, David D.] Univ Calif San Diego, Rady Childrens Hosp, Dept Neurosurg, Div Pediat Neurosurg, San Diego, CA 92103 USA; [Huang, Meng; Briceno, Valentina; Lam, Sandi K.; Luerssen, Thomas G.] Texas Childrens Hosp, Baylor Coll Med, Dept Neurosurg, Div Pediat Neurosurg, Houston, TX 77030 USA; [Jea, Andrew] Indiana Univ Sch Med, Riley Hosp Children, Sect Pediat Neurosurg, Indianapolis, IN 46202 USA		Jea, A (corresponding author), Indiana Univ Sch Med, Riley Hosp Children, MSA Surg, 575 Riley Hosp Dr,2nd Floor, Indianapolis, IN 46202 USA.	ajea@goodmancampbell.com		Lam, Sandi/0000-0003-3294-6637			Bagley CA, 2009, J SPINAL DISORD TECH, V22, P170, DOI 10.1097/BSD.0b013e318168be6f; Hankinson TC, 2010, J NEUROSURG-PEDIATR, V5, P380, DOI 10.3171/2009.10.PEDS09296; Huang M, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14810; Hwang SW, 2012, J NEUROSURG-PEDIATR, V9, P586, DOI 10.3171/2012.2.PEDS11497; Izeki M, 2013, SPINE, V38, pE513, DOI 10.1097/BRS.0b013e31828b26df; Lall R, 2010, NEUROSURGERY, V67, P1396, DOI 10.1227/NEU.0b013e3181f1ec73; Matsunaga S, 2001, SPINE, V26, P161, DOI 10.1097/00007632-200101150-00010; Mazur MD, 2014, J NEUROSURG-PEDIATR, V14, P465, DOI 10.3171/2014.7.PEDS1432; MCGRAW BL, 1990, ARCH OTOLARYNGOL, V116, P41; Miyata M, 2009, SPINE, V34, P184, DOI [10.1097/BRS.0b013e31818ff64e, 10.1097/BRS.0b013e3181ab3ce8]; Ota M, 2011, SPINE, V36, pE720, DOI 10.1097/BRS.0b013e3181f9f714; Revelle W., 2015, Psych: Procedures for Personality and Psychological Research; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5	13	2	3	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	MAR	2020	18	3					254	260		10.1093/ons/opz122			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KY8XT	WOS:000522860100019	31214708				2022-02-06	
J	Grujicic, M; Ramaswami, S; Snipes, JS; Dudt, P				Grujicic, M.; Ramaswami, S.; Snipes, J. S.; Dudt, P.			Potential improvement in helmet blast-protection via the use of a polyurea external coating: Combined experimental/computational analyses	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART L-JOURNAL OF MATERIALS-DESIGN AND APPLICATIONS			English	Article						Traumatic brain injury; advanced combat helmet; polyurea; helmet augmentation	TRAUMATIC BRAIN-INJURY; EQUILIBRIUM MATERIAL MODEL; STRESS-STRAIN BEHAVIOR; COMPUTATIONAL ASSESSMENT; MITIGATION EFFICACY; LEVEL ANALYSIS; DEFORMATION; IMPACT; WAVE; PARAMETERIZATION	The Advanced Combat Helmet (ACH) currently in use is designed for maximum protection against ballistic impacts and hard-surface collisions. It has been well-established now that the ACH provides relatively little protection against blast, and that a significant fraction of the soldiers returning from the recent conflicts suffer from traumatic brain injury (TBI). In the present work, an augmentation of the ACH, which involves the use of a polyurea (a nano-segregated elastomeric copolymer)-based external coating for improved blast protection is considered. To test the utility of this approach, blast experiments are carried out on instrumented head-mannequins. Three configurations of the head-mannequins are investigated: (i) unprotected; (ii) protected using a standard ACH; and (iii) protected using an augmented ACH. To provide additional insight into the problem of blast-wave interaction with a head-mannequin, a series of complementary combined Eulerian/Lagrangian transient non-linear dynamics computational fluid/solid interaction finite-element analyses is carried out. The results obtained clearly demonstrated that the use of the augmented ACH affects (generally in a beneficial way) head-mannequin dynamic loading and kinematic response as quantified by the intra-cranial pressure, impulse, acceleration, and jolt.	[Grujicic, M.; Ramaswami, S.; Snipes, J. S.] Clemson Univ, Dept Mech Engn, Clemson, SC USA; [Dudt, P.] Naval Surface Warfare Ctr, Carderock Div, West Bethesda, MD USA		Grujicic, M (corresponding author), Clemson Univ, 241 Engn Innovat Bldg, Clemson, SC 29634 USA.	gmica@clemson.edu					Altair Engineering Inc, 2010, HYP HYPERWORKS 10 0; Amini MR, 2010, MECH MATER, V42, P615, DOI 10.1016/j.mechmat.2009.09.009; Amini MR, 2010, MECH MATER, V42, P628, DOI 10.1016/j.mechmat.2009.09.008; Amirkhizi AV, 2006, PHILOS MAG, V86, P5847, DOI 10.1080/14786430600833198; Bartyczak S, 2014, J PHYS CONF SER, V500, DOI 10.1088/1742-6596/500/18/182003; Bogoslovov RB, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2745212; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cho H, 2013, POLYMER, V54, P5952, DOI 10.1016/j.polymer.2013.08.012; Cho H, 2013, SOFT MATTER, V9, P6319, DOI 10.1039/c3sm27125k; Choi T, 2012, MACROMOLECULES, V45, P3581, DOI 10.1021/ma300128d; Christou GA, 2010, THESIS; Cui ZW, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022602; Dassault Systemes, 2014, ABAQUS VERS 6 14EF 1; El Sayed T, 2009, COMPUT MECH, V43, P525, DOI 10.1007/s00466-008-0327-6; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Goel R, 2011, THESIS; Greer AD, 2006, THESIS; Grujicic A, 2012, J MATER ENG PERFORM, V21, P1562, DOI 10.1007/s11665-011-0065-3; Grujicic A., 2013, REV BIOINFORMATICS B, V2, P45; Grujicic M, 2013, MULTIDISCIP MODEL MA, V9, P214, DOI 10.1108/MMMS-04-2013-0029; Grujicic M, 2012, MULTIDISCIP MODEL MA, V8, P213, DOI 10.1108/15736101211251220; Grujicic M, 2012, MULTIDISCIP MODEL MA, V8, P297, DOI 10.1108/15736101211269122; Grujicic M, 2013, J MATER ENG PERFORM, V22, P1964, DOI 10.1007/s11665-013-0485-3; Grujicic M, 2012, MULTIDISCIP MODEL MA, V8, P524, DOI 10.1108/15736101211281632; Grujicic M, 2013, P I MECH ENG L-J MAT, V227, P124, DOI 10.1177/1464420712470356; Grujicic M, 2011, MULTIDISCIP MODEL MA, V7, P96, DOI 10.1108/15736101111157064; Grujicic M, 2012, J MATER ENG PERFORM, V21, P2024, DOI 10.1007/s11665-011-0117-8; Grujicic M, 2012, J MATER SCI, V47, P8197, DOI 10.1007/s10853-012-6716-4; Grujicic M, 2010, MULTIDISCIP MODEL MA, V6, P335, DOI 10.1108/15736101011080097; Grujicic M, 2012, J MATER SCI, V47, P3876, DOI 10.1007/s10853-011-6243-8; Grujicic M, 2011, P I MECH ENG L-J MAT, V225, P182, DOI 10.1177/0954420711401959; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Grujicic M, 2012, J MATER ENG PERFORM, V21, P2, DOI 10.1007/s11665-011-9875-6; Grujicic M, 2011, MAT SCI ENG A-STRUCT, V528, P3799, DOI 10.1016/j.msea.2011.01.081; Grujicic M, 2010, MAT SCI ENG A-STRUCT, V527, P7741, DOI 10.1016/j.msea.2010.08.042; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Grujicic M, 2014, AIMS MATER SCI, V1, P15, DOI 10.3934/matersci.2014.1.15; Grujicic M, 2013, MULTIDISCIP MODEL MA, V9, P548, DOI 10.1108/MMMS-10-2012-0014; Grujicic M, 2014, J MATER ENG PERFORM, V23, P357, DOI 10.1007/s11665-013-0769-7; Grujicic M, 2014, J MATER ENG PERFORM, V23, P49, DOI 10.1007/s11665-013-0760-3; Grujicic M, 2011, J MATER SCI, V46, P1767, DOI 10.1007/s10853-010-4998-y; Hirsch AE, 1966, HEAD INJURY C P, P37; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hyde DW, 1988, 58551 TM USA ENG WAT; Ivancevic VG, 2009, COGN NEURODYNAMICS, V3, P281, DOI 10.1007/s11571-008-9070-0; Littlestone A, 2010, NSWCCD66TR201036; Lockhart P, 2011, J TRAUMA, V70, pE29, DOI 10.1097/TA.0b013e3181de3f4b; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Mock W, 2009, AIP CONF PROC, V1195, P1241; Moss W.C., 2009, J ACOUST SOC AM, V125, P2650; Nyein MK, 2013, THESIS; Qiao J, 2011, MECH MATER, V43, P598, DOI 10.1016/j.mechmat.2011.06.012; Roberts JC, 2012, J BIOMECH, V45, P2899, DOI 10.1016/j.jbiomech.2012.07.027; Roland CM, 2007, POLYMER, V48, P5747, DOI 10.1016/j.polymer.2007.07.017; Roland CM, 2007, POLYMER, V48, P574, DOI 10.1016/j.polymer.2006.11.051; Roland CM, 2010, COMPOS STRUCT, V92, P1059, DOI 10.1016/j.compstruct.2009.09.057; Samiee A, 2013, MECH MATER, V64, P1, DOI 10.1016/j.mechmat.2013.03.008; Sarva SS, 2007, POLYMER, V48, P2208, DOI 10.1016/j.polymer.2007.02.058; Sharma S, 2011, OH STAT U INJ BIOM S; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Walsh S. M., 2005, ARLTR3700; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Xue L, 2010, MECH MATER, V42, P981, DOI 10.1016/j.mechmat.2010.08.004; Yi J, 2006, POLYMER, V47, P319, DOI 10.1016/j.polymer.2005.10.107; Youssef G, 2012, MECH TIME-DEPEND MAT, V16, P317, DOI 10.1007/s11043-011-9164-7; Youssef G, 2012, J MATER RES, V27, P494, DOI 10.1557/jmr.2011.405; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	69	2	3	3	14	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1464-4207	2041-3076		P I MECH ENG L-J MAT	Proc. Inst. Mech. Eng. Pt. L-J. Mater.-Design Appl.	MAR	2020	234	3					337	367		10.1177/1464420716644472			31	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	LA9FV	WOS:000524246700001					2022-02-06	
J	Hajiaghamemar, M; Kilbaugh, T; Arbogast, KB; Master, CL; Margulies, SS				Hajiaghamemar, Marzieh; Kilbaugh, Todd; Arbogast, Kristy B.; Master, Christina L.; Margulies, Susan S.			Using Serum Amino Acids to Predict Traumatic Brain Injury: A Systematic Approach to Utilize Multiple Biomarkers	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						head injury; diagnostics; trauma; data science; biomarker; multivariate metrics	CEREBROSPINAL-FLUID; GLUTAMATE; CLASSIFICATION; HEMORRHAGE; CHILDREN; TAURINE	Traumatic brain injury (TBI) can cause biochemical and metabolomic alterations in the brain tissue and serum. These alterations can be used for diagnosis and prognosis of TBI. Here, the serum concentrations of seventeen amino acids (AA) were studied for their potential utility as biomarkers of TBI. Twenty-five female, 4-week-old piglets received diffuse (n = 13) or focal (n = 12) TBI. Blood samples were obtained both pre-injury and at either 24-h or 4-days post-TBI. To find a robust panel of biomarkers, the results of focal and diffuse TBIs were combined and multivariate logistic regression analysis, coupled with the best subset selection technique and repeated k-fold cross-validation method, was used to perform a thorough search of all possible subsets of AAs. The combination of serum glycine, taurine, and ornithine was optimal for TBI diagnosis, with 80% sensitivity and 86% overall prediction rate, and showed excellent TBI diagnostic performance, with 100% sensitivity and 78% overall prediction rate, on a separate validation dataset including four uninjured and five injured animals. We found that combinations of biomarkers outperformed any single biomarker. We propose this 3-AA serum biomarker panel to diagnose mild-to-moderate focal/diffuse TBI. The systematic approaches implemented herein can be used for combining parameters from various TBI assessments to develop/evaluate optimal multi-factorial diagnostic/prognostic TBI metrics.	[Hajiaghamemar, Marzieh; Margulies, Susan S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Hajiaghamemar, Marzieh; Margulies, Susan S.] Emory Univ, Atlanta, GA 30322 USA; [Kilbaugh, Todd; Arbogast, Kristy B.; Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.; Master, Christina L.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA		Hajiaghamemar, M (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.; Hajiaghamemar, M (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	memar@gatech.edu; kilbaugh@email.chop.edu; arbogast@email.chop.edu; masterc@email.chop.edu; susan.margulies@gatech.edu		Hajiaghamemar, Marzieh/0000-0002-0232-2447; Arbogast, Kristy/0000-0002-1694-4562; Master, Christina/0000-0002-6717-4270	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097549]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS069545]	This research was funded by the National Institutes of Health (NIH) grant R01NS097549 and National Institute of Neurological Disorders and Stroke (NINDS) grant U01NS069545.	Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Azar S, 2017, METHODS MOL BIOL, V1598, P45, DOI 10.1007/978-1-4939-6952-4_3; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1044-3; Beckonert O, 2003, ANAL CHIM ACTA, V490, P3, DOI 10.1016/S0003-2670(03)00060-6; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Da Rosa R.C., 2018, THESIS; Dash PK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00036; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Dziak JJ, 2020, BRIEF BIOINFORM, V21, P553, DOI 10.1093/bib/bbz016; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; El Idrissi A, 2008, AMINO ACIDS, V34, P321, DOI 10.1007/s00726-006-0396-9; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Hajiaghamemar M, 2020, BIOMECH MODEL MECHAN, V19, P1109, DOI 10.1007/s10237-019-01273-8; Hajiaghamemar M, 2019, J NEUROTRAUM, V36, pA109; Hajiaghamemar M, 2019, EXP NEUROL, V318, P101, DOI 10.1016/j.expneurol.2019.04.019; Hajiaghamemar M, 2017, J NEUROTRAUM, V34, pA25; Hastie T, 2009, ELEMENTS STAT LEARNI, V2nd, DOI 10.1007/978-0-387-84858-7; Heo G, 2011, PATTERN RECOGN, V44, P716, DOI 10.1016/j.patcog.2010.10.007; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; HOSMER DW, 1989, BIOMETRICS, V45, P1265, DOI 10.2307/2531779; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Jung CS, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/560305; Kilbaugh TJ, 2016, MITOCHONDRION, V26, P19, DOI 10.1016/j.mito.2015.11.001; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Ko J, 2018, LAB CHIP, V18, P3617, DOI 10.1039/c8lc00672e; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Koza L, 2019, NEURAL REGEN RES, V14, P1701, DOI 10.4103/1673-5374.257520; Kurbat MN, 2009, NEUROCHEM J+, V3, P23, DOI 10.1134/S1819712409010036; Lieberman H., 1999, ROLE PROTEIN AMINO A; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; Lou DD, 2018, MOL NEUROBIOL, V55, P4928, DOI 10.1007/s12035-017-0687-z; Louin G, 2007, NITRIC OXIDE-BIOL CH, V17, P91, DOI 10.1016/j.niox.2007.05.006; Manzano S, 2016, EMERG MED J, V33, P42, DOI 10.1136/emermed-2014-204513; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Newell DW, 1997, EXP NEUROL, V145, P235, DOI 10.1006/exnr.1997.6463; Nissim I, 2014, J BIOL CHEM, V289, P9710, DOI 10.1074/jbc.M113.544726; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Otori T, 2004, J NEUROTRAUM, V21, P707, DOI 10.1089/0897715041269623; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Pohar M., 2004, METODOLOSKI ZVEZKI, V1, P143; Qureshi AI, 2003, CRIT CARE MED, V31, P1482, DOI 10.1097/01.CCM.0000063047.63862.99; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Seki Y, 2005, NEUROCHEM RES, V30, P123, DOI 10.1007/s11064-004-9693-4; Stefani MA, 2017, ANN CLIN TRANSL NEUR, V4, P392, DOI 10.1002/acn3.416; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yi LZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21320; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.35; Zhao D, 2018, BIOCHEM BIOPH RES CO, V501, P85, DOI 10.1016/j.bbrc.2018.04.171	56	2	2	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	MAR	2020	21	5							1786	10.3390/ijms21051786			21	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	LB8VL	WOS:000524908500237	32150890	gold, Green Published			2022-02-06	
J	Hartley, RL; Lam, J; Kinlin, C; Hulin, K; Temple-Oberle, C; Harrop, AR; Fraulin, FOG				Hartley, Rebecca L.; Lam, Josh; Kinlin, Ceilidh; Hulin, Karen; Temple-Oberle, Claire; Harrop, A. Robertson; Fraulin, Frankie O. G.			Surgical and Nonsurgical Pediatric Hand Fractures: A Cohort Study	PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN			English	Article							INJURIES; CHILDREN; EPIDEMIOLOGY; ADOLESCENTS; SURGERY	Background: Pediatric hand fractures are common and approximately 10% require surgery. Methods: This retrospective cohort study reports on hand fractures in a large pediatric population and identifies the characteristics and patterns of fractures that required surgical correction. A chi(2) analysis was done to evaluate the association between individual fracture variables and surgery. The STROBE checklist was applied. Results: One thousand one-hundred seventy-three hand fractures were reviewed. Peak age was 16 years for boys and 14 years for girls. Most fractures were closed (96.0%) and nonrotated (91.3%), and had no concomitant soft tissue injury (72.7%). More than half (56.3%) were nonepiphyseal plate fractures; yet as a single diagnosis, Salter-Harris II fractures were most common (30.2%). The following variables were significantly associated with surgery: open fractures, rotational deformity, distal phalangeal fracture location, multiple fractures, oblique pattern, comminution, displacement >2mm, intra-articular involvement, and angulation >15 degrees. Most fractures required only immobilization and early range of motion (64.3%). Closed reduction was required in 22.7%. Minor surgery by the primary provider was performed in 3.2% of fractures. Surgery by a hand surgeon was performed in 9.8%. The most common patterns requiring surgery were proximal or middle phalanx head or neck fractures (38.2%) and metacarpal midshaft fractures (20.9%). The most common operation was open reduction internal fixation (52.2%). Conclusions: Pediatric hand fractures are common, but 90.2% do not require surgery and, as such, primary providers play a key role in management. Certain fracture variables and patterns are more likely to lead to surgery.	[Hartley, Rebecca L.; Temple-Oberle, Claire; Harrop, A. Robertson; Fraulin, Frankie O. G.] Univ Calgary, Sect Plast Surg, Dept Surg, Calgary, AB, Canada; [Lam, Josh] Univ Calgary, Calgary, AB, Canada; [Kinlin, Ceilidh] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Hulin, Karen] Alberta Childrens Prov Gen Hosp, Dept Rehabil, Calgary, AB, Canada; [Harrop, A. Robertson; Fraulin, Frankie O. G.] Alberta Childrens Prov Gen Hosp, Sect Pediat Surg, Dept Surg, Calgary, AB, Canada		Fraulin, FOG (corresponding author), Alberta Childrens Prov Gen Hosp, 28 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	Frankie.fraulin@albertahealthservices.ca					Ablove RH, 1998, PEDIATR CLIN N AM, V45, P1507, DOI 10.1016/S0031-3955(05)70101-2; Al-Jasser FS, 2015, SAUDI MED J, V36, P587, DOI 10.15537/smj.2015.5.10527; Al-Qattan MM, 2015, INJURY, V46, P935, DOI 10.1016/j.injury.2015.02.018; Anzarut A, 2007, PLAST RECONSTR SURG, V119, P1933, DOI 10.1097/01.prs.0000259209.56609.83; BHENDE MS, 1993, ANN EMERG MED, V22, P1519, DOI 10.1016/S0196-0644(05)81251-X; Chew EM, 2012, J HAND SURG-AM, V37A, P1684, DOI 10.1016/j.jhsa.2012.05.010; Cooper C, 2004, J BONE MINER RES, V19, P1976, DOI 10.1359/JBMR.040902; DAVIS TRC, 1990, J HAND SURG-BRIT EUR, V15B, P299, DOI 10.1016/0266-7681(90)90008-R; Fetter-Zarzeka A, 2002, PEDIATR EMERG CARE, V18, P341, DOI 10.1097/00006565-200210000-00003; Hartley RL, 2019, PLAST SURG-CHIR PLAS, V27, P340, DOI 10.1177/2292550319876659; HASTINGS H, 1984, CLIN ORTHOP RELAT R, P120; Hill C, 1998, J HAND SURG-BRIT EUR, V23B, P196, DOI 10.1016/S0266-7681(98)80174-5; LANDIN LA, 1983, ACTA ORTHOP SCAND, V54, P1; Larsen CF, 2004, EUR J EPIDEMIOL, V19, P323, DOI 10.1023/B:EJEP.0000024662.32024.e3; LEONARD MH, 1970, CLIN ORTHOP RELAT R, P160; Lindley SG, 2006, HAND CLIN, V22, P253, DOI 10.1016/j.hcl.2006.05.002; Liu EH, 2014, PEDIATR EMERG CARE, V30, P299, DOI 10.1097/PEC.0000000000000118; Mahabir RC, 2001, PEDIATR EMERG CARE, V17, P153, DOI 10.1097/00006565-200106000-00001; Mirdad T, 2001, J R SOC PROMO HEALTH, V121, P47, DOI 10.1177/146642400112100110; Rajesh A, 2001, CLIN RADIOL, V56, P667, DOI 10.1053/crad.2001.0753; Stanton JS, 2007, J HAND SURG-EUR VOL, V32E, P626, DOI 10.1016/j.jhse.2007.06.017; USAL H, 1992, Health Bulletin (Edinburgh), V50, P285; Vadivelu R, 2006, J PEDIATR ORTHOPED, V26, P29, DOI 10.1097/01.bpo.0000189970.37037.59; Valencia J, 2005, CLIN ORTHOP RELAT R, P77, DOI 10.1097/01.blo.0000155376.88317.b7; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Weber DM, 2009, PEDIATR EMERG CARE, V25, P547, DOI 10.1097/PEC.0b013e3181b4f471; Worlock PH, 1985, J HAND SURG, P198; Young K, 2013, J HAND SURG-EUR VOL, V38, P898, DOI 10.1177/1753193412475045	28	2	3	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2169-7574			PRS-GLOB OPEN	PRS-GLOB. OPEN	MAR	2020	8	3							e2703	10.1097/GOX.0000000000002703			7	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	LY2FY	WOS:000540337200041	32537358	gold, Green Published			2022-02-06	
J	Hosseini, H; Rangchian, A; Prins, ML; Giza, CC; Ruberti, JW; Kavehpour, HP				Hosseini, H.; Rangchian, A.; Prins, M. L.; Giza, C. C.; Ruberti, J. W.; Kavehpour, H. P.			Probing Flow-Induced Biomolecular Interactions With Micro-Extensional Rheology: Tau Protein Aggregation	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							TRAUMATIC BRAIN-INJURY; PINCH-OFF DYNAMICS; INDUCED CRYSTALLIZATION; POLYMER-SOLUTIONS; RELAXATION-TIMES; DILUTE	Biomolecules in solutions subjected to extensional strain can form aggregates, which may be important for our understanding of pathologies involving insoluble protein structures where mechanical forces are thought to be causative (e.g., tau fibers in chronic traumatic encephalopathy (CTE)). To examine the behavior of biomolecules in solution under mechanical strains requires applying rheological methods, often to very small sample volumes. There were two primary objectives in this investigation: (1) To probe flow-induced aggregation of proteins in microliter-sized samples and (2) To test the hypothesis that tau protein aggregates under extensional flow. Tau protein (isoform:3R 0 N; 36.7 kDa) was divided into 10 mu l droplets and subjected to extensional strain in a modified tensiometer. Sixteen independent tests were performed where one test on a single droplet comprised three extensional events. To assess the rheological performance of the fluid/tau mixture, the diameter of the filament that formed during extension was tracked as function of time and analyzed for signs of aggregation (i.e., increased relaxation time). The results were compared to two molecules of similar and greater size (Polyethylene Oxide: PEO35, 35 kDa and PEO100, 100 kDa). Analysis showed that the tau protein solution and PEO35 are likely to have formed aggregates, albeit at relatively high extensional strain rates (similar to 10 kHz). The investigation demonstrates an extensional rheological method capable of determining the properties of protein solutions in mu l volumes and that tau protein can aggregate when exposed to a single extensional strain with potentially significant biological implications.	[Hosseini, H.] Univ Tehran Med Sci, Sch Med, Tehran 1416753955, Iran; [Rangchian, A.; Kavehpour, H. P.] Univ Calif Los Angeles, Mech & Aerosp Engn & Bioengn, Los Angeles, CA 90095 USA; [Prins, M. L.; Giza, C. C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Pediat, Los Angeles, CA 90095 USA; [Prins, M. L.; Giza, C. C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA; [Prins, M. L.; Giza, C. C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Bioengn, Los Angeles, CA 90095 USA; [Ruberti, J. W.] Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA		Kavehpour, HP (corresponding author), Univ Calif Los Angeles, Mech & Aerosp Engn & Bioengn, Los Angeles, CA 90095 USA.; Ruberti, JW (corresponding author), Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA.			Hosseini, Helia/0000-0001-5553-1069			Blair LJ, 2013, J CLIN INVEST, V123, P4158, DOI 10.1172/JCI69003; Clasen C, 2006, J RHEOL, V50, P883, DOI 10.1122/1.2357190; Del Giudice F, 2017, J RHEOL, V61, P327, DOI 10.1122/1.4975933; Dinic J, 2017, J POLYM SCI POL PHYS, V55, P1692, DOI 10.1002/polb.24388; Dinic J, 2017, LAB CHIP, V17, P460, DOI 10.1039/c6lc01155a; Dinic J, 2015, ACS MACRO LETT, V4, P804, DOI 10.1021/acsmacrolett.5b00393; Dobson J, 2017, P NATL ACAD SCI USA, V114, P4673, DOI 10.1073/pnas.1702724114; Dunstan DE, 2009, PROTEIN ENG DES SEL, V22, P741, DOI 10.1093/protein/gzp059; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; HAAS TW, 1969, POLYM ENG SCI, V9, P225, DOI 10.1002/pen.760090402; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hill EK, 2006, BIOMACROMOLECULES, V7, P10, DOI 10.1021/bm0505078; Jho YS, 2010, BIOPHYS J, V99, P2387, DOI 10.1016/j.bpj.2010.06.056; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Keller A., 1997, PROCESSING POLYM, P187; Kojic N, 2006, J EXP BIOL, V209, P4355, DOI 10.1242/jeb.02516; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Larson R.G., 1999, STRUCTURE RHEOLOGY C; Liu CL, 2011, ADV PROTEIN CHEM STR, V84, P1, DOI 10.1016/B978-0-12-386483-3.00005-7; MACKLEY MR, 1975, PHILOS T R SOC A, V278, P29, DOI 10.1098/rsta.1975.0020; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Paten JA, 2016, ACS NANO, V10, P5027, DOI 10.1021/acsnano.5b07756; Rao IJ, 2001, INT J SOLIDS STRUCT, V38, P1149, DOI 10.1016/S0020-7683(00)00079-2; Schliwa M, 2002, NAT REV MOL CELL BIO, V3, P291, DOI 10.1038/nrm781; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WILSON DM, 1995, J BIOL CHEM, V270, P24306, DOI 10.1074/jbc.270.41.24306; YING QC, 1987, MACROMOLECULES, V20, P362, DOI 10.1021/ma00168a023; Young JE, 2015, SOFT MATTER, V11, P3618, DOI 10.1039/c5sm00429b; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	29	2	2	1	7	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	MAR	2020	142	3			SI				034501	10.1115/1.4046330			5	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	KS8JM	WOS:000518552900012	34043752				2022-02-06	
J	Hu, HT; Zhao, Q; Liu, XX; Yan, T				Hu, Haotian; Zhao, Qiang; Liu, Xiaoxuan; Yan, Tao			Human umbilical cord blood cells rescued traumatic brain injury-induced cardiac and neurological deficits	ANNALS OF TRANSLATIONAL MEDICINE			English	Article						Traumatic brain injury (TBI); human umbilical cord blood cells (HUCBCs); cardiac dysfunction; neurological deficit	MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-BETA; HEART INTERACTION; RAT MODEL; STROKE; CONTRIBUTES; DYSFUNCTION; PROTECTION; THERAPY; NOX2	Background: Traumatic brain injury (TBI) evokes neurological deficits and induces cardiac dysfunction. Treatment with human umbilical cord blood cells (HUCBCs) represents a potential therapeutic strategy for TBI-induced neurological deficits. The present study aimed to determine whether HUCBCs could ameliorate the cardiac dysfunction and neurological deficits induced by TBI. Methods: Adult male C57BL/6J mice were subjected to controlled cortical impact (CCI)-induced TBI and were treated with either HUCBCs (1x10(6)) or phosphate-buffered saline (PBS), via tail vein injections, 3 days after TBI. Neurological and cognitive functions were subsequently evaluated at multiple time points after TBI and cardiac function was assessed by echocardiography 3 and 30 days after TBI. Brain and heart tissues were paraffin-embedded 30 days after TBI. Hematoxylin and eosin (H&E) staining was performed on brain tissue sections to calculate the brain damage volume, and Picro Sirius Red (PSR) staining was performed on heart tissue sections to evaluate myocardial fibrosis. Terminal deoxynucleotide transferase dUTP nick end labeling (TUNEL) staining was employed to assess cell apoptosis 30 days after TBI. Transforming growth factor-beta (TGF-beta) and NADPH oxidase-2 (NOX2) levels were assessed to evaluate inflammation and oxidative stress levels 30 days after TBI. Results: TBI elicited acute and chronic cardiac deficits, identified by decreased left ventricular ejection fraction (LVEF) and fractional shortening (LVFS) values 3 and 30 days after TBI, in addition to neurological and cognitive deficits. TBI mice treated with HUCBCs exhibited enhanced LVEF and FS values 30 days after TBI compared with untreated TBI controls. HUCBC treatment significantly improved neurological and cognitive functions and reduced cardiomyocyte apoptosis, inflammatory response, oxidative stress, and cardiac fibrosis in heart tissues 30 days after TBI. Conclusions: TBI induced both neurological deficits and cardiac dysfunction in mice, which were ameliorated by HUCBC treatment. The anti-inflammatory activities of HUCBCs may contribute to these observed therapeutic effects.	[Hu, Haotian; Zhao, Qiang; Liu, Xiaoxuan; Yan, Tao] Tianjin Med Univ, Key Lab Postneurotrauma Neurorepair & Regenerat C, Minist Educ & Tianjin City, Gen Hosp,Tianjin Neurol Inst,Dept Neurol, Tianjin 300052, Peoples R China		Yan, T (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurol, 154 Anshan Rd, Tianjin 300052, Peoples R China.	taoyan@tmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671144, 91746205]; Tianjin Natural Science Foundation Grant [17JCZDJC36100]	This work was supported by the National Natural Science Foundation of China, Grant Numbers: 81671144, 91746205; Tianjin Natural Science Foundation Grant, Grant/Award Number: 17JCZDJC36100.	Braunersreuther V, 2013, J MOL CELL CARDIOL, V64, P99, DOI 10.1016/j.yjmcc.2013.09.007; Chen JL, 2017, TRANSL STROKE RES, V8, P374, DOI 10.1007/s12975-017-0520-z; Chen JL, 2016, STEM CELLS, V34, P102, DOI 10.1002/stem.2193; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; Cui X, 2016, STROKE, V47, P214, DOI 10.1161/STROKEAHA.115.011046; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finsterer J, 2014, J NEUROL SCI, V345, P8, DOI 10.1016/j.jns.2014.07.003; Gincberg G, 2018, CYTOTHERAPY, V20, P245, DOI 10.1016/j.jcyt.2017.11.008; GREENHOO.JH, 1969, J NEUROSURG, V30, P521, DOI 10.3171/jns.1969.30.5.0521; Henning RJ, 2007, CELL TRANSPLANT, V16, P907, DOI 10.3727/096368907783338299; Henning RJ, 2008, STEM CELLS DEV, V17, P1207, DOI 10.1089/scd.2008.0023; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Liraz-Zaltsman S, 2011, SYNAPSE, V65, P634, DOI 10.1002/syn.20889; Liu GW, 2017, EXP THER MED, V13, P2123, DOI 10.3892/etm.2017.4246; Liu YQ, 2015, INT J CLIN EXP PATHO, V8, P10908; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mito S, 2008, HYPERTENSION, V51, P1570, DOI 10.1161/HYPERTENSIONAHA.107.102566; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; SABBAH HN, 1995, MOL CELL BIOCHEM, V147, P29, DOI 10.1007/BF00944780; Sirker A, 2011, BASIC RES CARDIOL, V106, P735, DOI 10.1007/s00395-011-0190-z; Son M, 2017, BRAIN BEHAV IMMUN, V66, P347, DOI 10.1016/j.bbi.2017.07.158; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Tanai E, 2016, COMPR PHYSIOL, V6, P187, DOI 10.1002/cphy.c140055; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Venkat P, 2018, STEM CELL TRANSL MED, V7, P451, DOI 10.1002/sctm.18-0014; Venkat P, 2017, NEUROBIOL AGING, V50, P96, DOI 10.1016/j.neurobiolaging.2016.11.002; Wang ZC, 2019, STEM CELLS DEV, V28, P1384, DOI 10.1089/scd.2019.0115; Xiong Y, 2010, DISCOV MED, V10, P434; Yan T, 2018, J CEREB BLOOD FLOW M; Yan T, 2015, STROKE, V46, P2599, DOI 10.1161/STROKEAHA.115.009870; Yan T, 2014, CNS NEUROSCI THER, V20, P935, DOI 10.1111/cns.12307; Zhao JJ, 2012, NEURAL REGEN RES, V7, P741, DOI 10.3969/j.issn.1673-5374.2012.10.004; Zhao Q, 2019, J NEUROTRAUM, V36, P619, DOI 10.1089/neu.2018.5766	41	2	2	2	4	AME PUBL CO	SHATIN	FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA	2305-5839	2305-5847		ANN TRANSL MED	ANN. TRANSL. MED.	MAR	2020	8	6							278	10.21037/atm.2020.03.52			10	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	KY7WZ	WOS:000522784900021	32355722	Green Published, gold			2022-02-06	
J	Jezierska-Wozniak, K; Sinderewicz, E; Czelejewska, W; Wojtacha, P; Barczewska, M; Maksymowicz, W				Jezierska-Wozniak, Katarzyna; Sinderewicz, Emilia; Czelejewska, Wioleta; Wojtacha, Pawel; Barczewska, Monika; Maksymowicz, Wojciech			Influence of Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Oxidative Stress Intensity in Minimally Conscious State Patients	JOURNAL OF CLINICAL MEDICINE			English	Article						minimally conscious state; mesenchymal stem cells; oxidative stress; traumatic brain injury	AMYOTROPHIC-LATERAL-SCLEROSIS; LONG-TERM POTENTIATION; CEREBROSPINAL-FLUID; SUPEROXIDE-DISMUTASE; ASCORBIC-ACID; VITAMIN-C; MONONUCLEAR-CELLS; MITOCHONDRIAL DYSFUNCTION; NEUROLOGICAL DISEASES; NEUROTROPHIC FACTORS	Neurological disorders, including minimally conscious state (MCS), may be associated with the presence of high concentrations of reactive oxygen species within the central nervous system. Regarding the documented role of mesenchymal stem cells (MSCs) in oxidative stress neutralization, the aim of this study is to evaluate the effect of bone marrow-derived MSC (BM-MSC) transplantation on selected markers of oxidative stress in MCS patients. Antioxidant capacity was measured in cerebrospinal fluid (CSF) and plasma collected from nine patients aged between 19 and 45 years, remaining in MCS for 3 to 14 months. Total antioxidant capacity, ascorbic acid and ascorbate concentrations, superoxide dismutase, catalase, and peroxidase activity were analyzed and the presence of tested antioxidants in the CSF and plasma was confirmed. Higher ascorbic acid (AA) content and catalase (CAT) activity were noted in CSF relative to plasma, whereas superoxide dismutase (SOD) activity and total antioxidant capacity were higher in plasma relative to CSF. Total antioxidant capacity measured in CSF was greater after BM-MSC transplantations. The content of ascorbates was lower and CAT activity was higher both in CSF and plasma after the administration of BM-MSC. The above results suggest that MSCs modulate oxidative stress intensity in MCS patients, mainly via ascorbates and CAT activity.	[Jezierska-Wozniak, Katarzyna; Sinderewicz, Emilia; Czelejewska, Wioleta] Univ Warmia & Mazury, Sch Med, Dept Neurosurg, Lab Regenerat Med,Coll Med, Warszawska 30 Str, PL-10082 Olsztyn, Poland; [Jezierska-Wozniak, Katarzyna; Sinderewicz, Emilia; Czelejewska, Wioleta; Barczewska, Monika; Maksymowicz, Wojciech] Univ Warmia & Mazury, Sch Med, Dept Neurosurg, Coll Med, Warszawska 30 Str, PL-10082 Olsztyn, Poland; [Wojtacha, Pawel] Univ Warmia & Mazury, Fac Food Sci, Dept Ind & Food Microbiol, Plac Cieszynski 1 Str, PL-10726 Olsztyn, Poland		Jezierska-Wozniak, K (corresponding author), Univ Warmia & Mazury, Sch Med, Dept Neurosurg, Lab Regenerat Med,Coll Med, Warszawska 30 Str, PL-10082 Olsztyn, Poland.; Jezierska-Wozniak, K (corresponding author), Univ Warmia & Mazury, Sch Med, Dept Neurosurg, Coll Med, Warszawska 30 Str, PL-10082 Olsztyn, Poland.	katarzyna.jezierska@uwm.edu.pl; emilia.sinderewicz@uwm.edu.pl; wioleta.czelejewska@uwm.edu.pl; pawel.wojtacha@uwm.edu.pl; monika.barczewska@uwm.edu.pl; maksymowicz@interia.pl	; SINDEREWICZ, Emilia/H-7245-2017	Czelejewska, Wioleta/0000-0002-7529-7465; Wojtacha, Pawel/0000-0002-2557-5770; SINDEREWICZ, Emilia/0000-0001-8259-3441; Jezierska-Wozniak, Katarzyna/0000-0002-0571-8877	National Centre for Research and Development [STRATEGMED I/234261/2/2014]	This research was funded by the National Centre for Research and Development (No: STRATEGMED I/234261/2/2014).	Alhazzani A, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120250; Alho H, 1998, RESTOR NEUROL NEUROS, V12, P159; Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964; Angelow S, 2003, BRAIN RES, V988, P105, DOI 10.1016/S0006-8993(03)03350-X; Arlt S, 2002, DRUG DEVELOP RES, V56, P452, DOI 10.1002/ddr.10107; Arlt S, 2002, NEUROBIOL DIS, V10, P150, DOI 10.1006/nbdi.2002.0496; Arlt S, 2012, NEUROCHEM RES, V37, P2706, DOI 10.1007/s11064-012-0860-8; Astuya A, 2005, J NEUROSCI RES, V79, P146, DOI 10.1002/jnr.20326; Aygul R, 2006, J INT MED RES, V34, P413, DOI 10.1177/147323000603400411; Bao XJ, 2011, EUR J NEUROSCI, V34, P87, DOI 10.1111/j.1460-9568.2011.07733.x; Baud O, 2004, J NEUROSCI, V24, P1531, DOI 10.1523/JNEUROSCI.3989-03.2004; Bayir A, 2011, J HEAD TRAUMA REHAB, V26, P406; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025; Bowman GL, 2009, J ALZHEIMERS DIS, V16, P93, DOI 10.3233/JAD-2009-0923; BRAU RH, 1984, NEUROSURGERY, V14, P142, DOI 10.1227/00006123-198402000-00004; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Buhmann C, 2004, NEUROBIOL DIS, V15, P160, DOI 10.1016/j.nbd.2003.10.003; Carvalho AN, 2017, CURR DRUG TARGETS, V18, P705, DOI 10.2174/1389450117666160401120514; Castro MA, 2007, J NEUROCHEM, V102, P773, DOI 10.1111/j.1471-4159.2007.04631.x; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chen F, 2017, CELL TRANSPLANT, V26, P1483, DOI 10.1177/0963689717735407; Chen MF, 2006, INT J RADIAT ONCOL, V66, P244, DOI 10.1016/j.ijrobp.2006.03.062; Cisternas P, 2014, J NEUROCHEM, V129, P663, DOI 10.1111/jnc.12663; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; de Menezes CC, 2009, NEUROCHEM RES, V34, P1255, DOI 10.1007/s11064-008-9903-6; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; ENGLARD S, 1986, ANNU REV NUTR, V6, P365, DOI 10.1146/annurev.nu.06.070186.002053; Farbstein D, 2010, MOLECULES, V15, P8098, DOI 10.3390/molecules15118098; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Gebicka L, 2019, J INORG BIOCHEM, V197, DOI 10.1016/j.jinorgbio.2019.110699; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goncalves FD, 2017, BIOTECHNOL LETT, V39, P613, DOI 10.1007/s10529-016-2272-3; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Grisendi G, 2010, CYTOTHERAPY, V12, P466, DOI 10.3109/14653241003649510; GRUENER N, 1994, LIFE SCI, V54, P711, DOI 10.1016/0024-3205(94)90159-7; Islam MT, 2017, NEUROL RES, V39, P73, DOI 10.1080/01616412.2016.1251711; Jacobsson J, 2001, BRAIN, V124, P1461, DOI 10.1093/brain/124.7.1461; Karanth S, 2000, P NATL ACAD SCI USA, V97, P1891, DOI 10.1073/pnas.97.4.1891; Kaynar MY, 2005, NEUROL RES, V27, P562, DOI 10.1179/016164105X17288; Kemp K, 2010, J NEUROCHEM, V114, P1569, DOI 10.1111/j.1471-4159.2009.06553.x; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; Kodydkova J, 2014, FOLIA BIOL-PRAGUE, V60, P153; Kohen R, 2000, FREE RADICAL BIO MED, V28, P871, DOI 10.1016/S0891-5849(00)00191-X; Kohen R, 1999, METHOD ENZYMOL, V300, P285; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lagowska-Lenard M., 2008, POLSKI MERKURIUSZ LE, V147, P205; Lanza C, 2009, J NEUROCHEM, V110, P1674, DOI 10.1111/j.1471-4159.2009.06268.x; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; Liu JT, 2008, ACT NEUR S, V101, P71; Ludwig L, 2016, HAND CLINIC, V139, P313, DOI 10.1016/B978-0-12-801772-2.00028-X; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; May James M, 2012, Subcell Biochem, V56, P85, DOI 10.1007/978-94-007-2199-9_6; Nayak C, 2006, CLIN CHEM LAB MED, V44, P460, DOI 10.1515/CCLM.2006.068; Nissanka N, 2018, FEBS LETT, V592, P728, DOI 10.1002/1873-3468.12956; Nualart Francisco, 2014, J Stem Cell Res Ther, V4, P209; Nualart F, 2012, BIOL RES, V45, P243, DOI 10.4067/S0716-97602012000300006; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; Paraskevas GP, 1997, ACTA NEUROL SCAND, V96, P88; Pastor P, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00119; Pignat JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156882; Pincherle A, 2019, ANN NEUROL, V85, P443, DOI 10.1002/ana.25417; Polidori MC, 2001, STROKE, V32, P898, DOI 10.1161/01.STR.32.4.898; Prasad R, 2012, PEDIATR INFECT DIS J, V31, P1012, DOI 10.1097/INF.0b013e31825cf1d7; Qiu S, 2007, J NEUROSCI RES, V85, P1046, DOI 10.1002/jnr.21204; REBEC GV, 1994, PROG NEUROBIOL, V43, P537, DOI 10.1016/0301-0082(94)90052-3; REIBER H, 1993, CLIN CHIM ACTA, V217, P163, DOI 10.1016/0009-8981(93)90162-W; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Rice ME, 1998, NEUROSCIENCE, V82, P1213; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Ryu JM, 2015, INT J STEM CELLS, V8, P24, DOI 10.15283/ijsc.2015.8.1.24; Salim S, 2017, J PHARMACOL EXP THER, V360, P201, DOI 10.1124/jpet.116.237503; Sapoynikova N., 2012, ANTIOXIDANT ENZYME; Saso L, 2014, CURR DRUG TARGETS, V15, P1177, DOI 10.2174/1389450115666141024113925; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schippling S, 2000, FREE RADICAL BIO MED, V28, P351, DOI 10.1016/S0891-5849(99)00247-6; SHANNON LM, 1966, J BIOL CHEM, V241, P2166; Sharma S, 2010, J NEUROSCI RES, V88, P2869, DOI 10.1002/jnr.22452; Singhal A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.362; SPECTOR R, 1973, AM J PHYSIOL, V225, P757, DOI 10.1152/ajplegacy.1973.225.4.757; SPECTOR R, 1977, AM J PHYSIOL, V232, pR73, DOI 10.1152/ajpregu.1977.232.3.R73; Spector R, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-3; Spranger M, 1997, STROKE, V28, P2425, DOI 10.1161/01.STR.28.12.2425; STRAND T, 1992, STROKE, V23, P515, DOI 10.1161/01.STR.23.4.515; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; TALLAKSEN CME, 1992, AM J CLIN NUTR, V56, P559, DOI 10.1093/ajcn/56.3.559; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Traub SJ, 2016, EMERG MED CLIN N AM, V34, P777, DOI 10.1016/j.emc.2016.06.017; Urao N, 2013, FREE RADICAL BIO MED, V54, P26, DOI 10.1016/j.freeradbiomed.2012.10.532; Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Voigt K, 2002, FREE RADICAL RES, V36, P735, DOI 10.1080/10715760290032557; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; Whone AL, 2012, BRAIN RES, V1431, P86, DOI 10.1016/j.brainres.2011.10.038; Wijdicks Eelco F M, 2010, Pract Neurol, V10, P51, DOI 10.1136/jnnp.2009.200097; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Xu JF, 2014, SCI CHINA LIFE SCI, V57, P989, DOI 10.1007/s11427-014-4725-z; Yokokawa K, 2019, J ALZHEIMERS DIS, V72, P867, DOI 10.3233/JAD-190817; Yoo DY, 2016, NEUROCHEM RES, V41, P3300, DOI 10.1007/s11064-016-2062-2; YOSHIDA E, 1994, J NEUROL SCI, V124, P25, DOI 10.1016/0022-510X(94)90006-X; Younus H, 2018, INT J HEALTH SCI-IJH, V12, P88; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	110	2	2	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	MAR	2020	9	3							683	10.3390/jcm9030683			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LF2UT	WOS:000527278800072	32138308	gold, Green Published			2022-02-06	
J	Khademi, E; Mahabadi, VP; Ahmadvand, H; Akbari, E; Khalatbary, AR				Khademi, Emad; Mahabadi, Vahid Pirhajati; Ahmadvand, Hassan; Akbari, Esmaeil; Khalatbary, Ali Reza			Anti-inflammatory and anti-apoptotic effects of hyperbaric oxygen preconditioning in a rat model of cisplatin-induced peripheral neuropathy	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Apoptosis; Cisplatin; Hyperbaric oxygen; Inflammation; Neuropathy	SPINAL-CORD-INJURY; ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; ROOT GANGLION NEURONS; NITRIC-OXIDE; IN-VITRO; THERAPY; PAIN; NEUROPROTECTION; PATHWAY	Objective(s): Cisplatin-induced peripheral neuropathy is a debilitating side effect in patients receiving this drug. Recent studies suggest hyperbaric oxygen (HBO) therapy as a new treatment approach for models of neural injury. The aim of the current study was to determine the protective effects of HBO preconditioning against peripheral neuropathy induced by Cisplatin (CDDP). Materials and Methods: The present study was conducted on 4 groups of rats: Sham group; HBO group (60 min/d); Control group (CDDP 2 mg/kg/d); Precondition group (HBO+CDDP). Mechanical threshold testing was weekly carried out using von Frey filament. Sciatic nerve and associated ganglia were removed five weeks after the first CDDP injection for biochemical evaluation of malondialdehyde (MDA) content and myeloperoxidase (MPO) activity, immunohistochemistry of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), TNF-alpha, caspase-3 and iNOS, and transmission electron microscopic (TEM) assessments. Results: MDA levels and MPO activities were significantly decreased in preconditioned rats. Attenuated TUNEL reaction along with attenuated caspase-3, TNF-alpha, and iNOS expression could be significantly detected in preconditioned rats. Also, HBO preconditioning improved the nociceptive threshold. Conclusion: The results suggest that HBO preconditioning can attenuate peripheral neuropathy caused by cisplatin in rats.	[Khademi, Emad; Khalatbary, Ali Reza] Mazandaran Univ Med Sci, Fac Med, Mol & Cell Biol Res Ctr, Dept Anat, Sari, Iran; [Mahabadi, Vahid Pirhajati] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran; [Mahabadi, Vahid Pirhajati] Iran Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Ahmadvand, Hassan] Lorestan Univ Med Sci, Fac Med, Dept Biochem, Khorramabad, Iran; [Ahmadvand, Hassan] Lorestan Univ Med Sci, Razi Herbal Res Ctr, Khorramabad, Iran; [Akbari, Esmaeil] Mazandaran Univ Med Sci, Fac Med, Immunogenet Res Ctr, Sari, Iran; [Akbari, Esmaeil] Mazandaran Univ Med Sci, Fac Med, Dept Physiol & Pharmacol, Sari, Iran		Khalatbary, AR (corresponding author), Mazandaran Univ Med Sci, Fac Med, Mol & Cell Biol Res Ctr, Dept Anat, Sari, Iran.	khalat90@yahoo.com	khalatbary, ali reza/A-4950-2014		Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran	This work was supported financially by Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. The results presented in this paper were part of a student thesis.	Agthong S, 2015, EXP NEUROBIOL, V24, P139, DOI 10.5607/en.2015.24.2.139; Areti A, 2014, REDOX BIOL, V2, P289, DOI 10.1016/j.redox.2014.01.006; Atasoyu E, 2005, ARCH TOXICOL, V79, P289, DOI 10.1007/s00204-004-0627-3; Aydinoz S, 2007, RENAL FAILURE, V29, P257, DOI 10.1080/08860220601166487; Bianchi R, 2006, CLIN CANCER RES, V12, P2607, DOI 10.1158/1078-0432.CCR-05-2177; Bianchi R, 2007, EUR J CANCER, V43, P710, DOI 10.1016/j.ejca.2006.09.028; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; CAVALETTI G, 1992, ACTA NEUROPATHOL, V84, P364; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chazalviel L, 2016, MED GAS RES, V6, P64, DOI 10.4103/2045-9912.184713; Chen XY, 2016, NEUROCHEM RES, V41, P3032, DOI 10.1007/s11064-016-2022-x; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; Cobanoglu HB, 2019, CLIN EXP OTORHINOLAR, V12, P66, DOI 10.21053/ceo.2017.01704; Ding YY, 2018, MOL PAIN, V14, DOI 10.1177/1744806918765837; Ding YY, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0760-z; Fu HQ, 2017, SCAND J PAIN, V17, P330, DOI 10.1016/j.sjpain.2017.08.014; Gilardini A, 2012, NEUROTOXICOLOGY, V33, P1, DOI 10.1016/j.neuro.2011.10.010; Gill JS, 1998, J CLIN INVEST, V101, P2842, DOI 10.1172/JCI1130; Han G, 2013, PAIN RES MANAG, V18, P137, DOI 10.1155/2013/147043; Hu Q, 2015, EUR J PAIN, V19, P920, DOI 10.1002/ejp.618; Hu Q, 2016, MED GAS RES, V6, P20, DOI 10.4103/2045-9912.179337; Huang H, 2013, INT J CLIN EXP PATHO, V6, P1337; Jensen TS, 2003, PAIN, V102, P1, DOI 10.1016/S0304-3959(03)00006-X; Kanat O, 2017, WORLD J CLIN ONCOL, V8, P329, DOI 10.5306/wjco.v8.i4.329; Kato N, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-1; Khalil Z, 2001, FREE RADICAL BIO MED, V31, P430, DOI 10.1016/S0891-5849(01)00597-4; Li FH, 2011, ANESTH ANALG, V113, P626, DOI 10.1213/ANE.0b013e31821f9544; Li JS, 2009, NEUROSCIENCE, V159, P1309, DOI 10.1016/j.neuroscience.2009.01.011; Li JS, 2008, BRAIN RES, V1210, P223, DOI 10.1016/j.brainres.2008.03.007; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu XH, 2015, SPINE, V40, pE1276, DOI 10.1097/BRS.0000000000001056; Liu YD, 2019, J PAIN RES, V12, P443, DOI 10.2147/JPR.S189353; Long Y, 2014, INT J CLIN EXP MED, V7, P4073; Lou M, 2006, BRAIN RES BULL, V69, P109, DOI 10.1016/j.brainresbull.2005.11.009; Low PA, 1997, DIABETES, V46, pS38, DOI 10.2337/diab.46.2.S38; Lu PG, 2013, J NEUROSURG SCI, V57, P253; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; McDonald ES, 2005, NEUROBIOL DIS, V18, P305, DOI 10.1016/j.nbd.2004.09.013; Melli G, 2008, EXP NEUROL, V214, P276, DOI 10.1016/j.expneurol.2008.08.013; Miao T, 2019, OPEN ACCESS LIB J, V6, pe5339; Mullane K, 1989, Prog Clin Biol Res, V301, P39; Ostrowski RP, 2008, NEUROBIOL DIS, V29, P1, DOI 10.1016/j.nbd.2007.07.020; Pan XR, 2015, NEUROSCI LETT, V600, P220, DOI 10.1016/j.neulet.2015.06.030; Podratz JL, 2011, NEUROBIOL DIS, V41, P661, DOI 10.1016/j.nbd.2010.11.017; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Camara-Lemarroy CR, 2010, NEUROIMMUNOMODULAT, V17, P314, DOI 10.1159/000292020; Shams Z, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-1004-1; Starobova H, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00174; Sugimoto T, 2001, NEUROREPORT, V12, P137, DOI 10.1097/00001756-200101220-00035; Sunami K, 2000, CRIT CARE MED, V28, P2831, DOI 10.1097/00003246-200008000-00025; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Xiao WH, 2012, PAIN, V153, P704, DOI 10.1016/j.pain.2011.12.011; Xu JJ, 2014, J NEUROTRAUM, V31, P1343, DOI 10.1089/neu.2013.3222; Yang LM, 2015, BRAIN RES, V1627, P21, DOI 10.1016/j.brainres.2015.08.011; Yang ZJ, 2010, EUR J APPL PHYSIOL, V108, P513, DOI 10.1007/s00421-009-1229-9; Yassuda CC, 2008, ACTA CIR BRAS, V23, P72, DOI 10.1590/S0102-86502008000700013; Zhao BS, 2014, J MOL NEUROSCI, V53, P251, DOI 10.1007/s12031-013-0213-3; Zhao BS, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-016-0713-y; Zhao BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134984; Zhou BC, 2016, NEURAL REGEN RES, V11, P1445, DOI 10.4103/1673-5374.191218; Zhou Y, 2013, CHINESE MED J-PEKING, V126, P3897, DOI 10.3760/cma.j.issn.0366-6999.20130571	62	2	2	1	7	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	MAR	2020	23	3					321	328		10.22038/IJBMS.2019.40095.9504			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	KD6WK	WOS:000508005600007	32440318				2022-02-06	
J	Martin-Rodriguez, F; Lopez-Izquierdo, R; Mohedano-Moriano, A; Polonio-Lopez, B; Miquel, CM; Vinuela, A; Fernandez, CD; Correas, JG; Marques, G; Martin-Conty, JL				Martin-Rodriguez, Francisco; Lopez-Izquierdo, Raul; Mohedano-Moriano, Alicia; Polonio-Lopez, Begona; Maestre Miquel, Clara; Vinuela, Antonio; Durantez Fernandez, Carlos; Gomez Correas, Jesus; Marques, Goncalo; Luis Martin-Conty, Jose			Identification of Serious Adverse Events in Patients with Traumatic Brain Injuries, from Prehospital Care to Intensive-Care Unit, Using Early Warning Scores	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						early warning score; emergency medical services; patient safety; medical decision-making; critical care	PROGNOSTIC VALUE; SCORING SYSTEM; BLOOD-PRESSURE; MORTALITY; HYPOTENSION; VALIDATION; HYPOXIA; IMPACT	Traumatic brain injuries are complex situations in which the emergency medical services must quickly determine the risk of deterioration using minimal diagnostic methods. The aim of this study is to analyze whether the use of early warning scores can help with decision-making in these dynamic situations by determining the patients who need the intensive care unit. A prospective, multicentric cohort study without intervention was carried out on traumatic brain injury patients aged over 18 given advanced life support and taken to the hospital. Our study included a total of 209 cases. The total number of intensive-care unit admissions was 50 cases (23.9%). Of the scores analyzed, the National Early Warning Score2 was the best result presented with an area under the curve of 0.888 (0.81-0.94; p < 0.001) and an odds ratio of 25.4 (95% confidence interval (CI):11.2-57.5). The use of early warning scores (and specifically National Early Warning Score2) can help the emergency medical services to differentiate traumatic brain injury patients with a high risk of deterioration. The emergency medical services should use the early warning scores routinely in all cases for the early detection of high-risk situations.	[Martin-Rodriguez, Francisco] Univ Valladolid, Sch Med, Adv Clin Simulat Ctr, E-47005 Valladolid, Spain; [Martin-Rodriguez, Francisco] Emergency Med Serv, Adv Life Support Unit, Valladolid 47006, Spain; [Lopez-Izquierdo, Raul] Hosp Univ Rio Hortega, Emergency Dept, Valladolid 47012, Spain; [Mohedano-Moriano, Alicia; Polonio-Lopez, Begona; Maestre Miquel, Clara; Vinuela, Antonio; Durantez Fernandez, Carlos; Gomez Correas, Jesus; Luis Martin-Conty, Jose] Univ Castilla La Mancha, Fac Hlth Sci, Talavera De La Reina 45600, Spain; [Marques, Goncalo] Univ Beira Interior, Inst Telecomunicac, P-6200001 Covilha, Portugal		Lopez-Izquierdo, R (corresponding author), Hosp Univ Rio Hortega, Emergency Dept, Valladolid 47012, Spain.	fmartin@saludcastillayleon.es; rlopeziz@saludcastillayleon.es; Alicia.Mohedano@uclm.es; Begona.polonio@uclm.es; Clara.maestre@uclm.es; Antonio.vinuela@uclm.es; Carlos.durantez@uclm.es; jesus.gomez@uclm.es; goncalosantosmarques@gmail.com; JoseLuis.MartinConty@uclm.es	Durantez, Carlos/AAW-9193-2020; Polonio-Lopez, Begona/D-3878-2009; Marques, Goncalo/N-1805-2018; Durantez-Fernandez, Carlos/AAZ-4354-2021; Martin-Conty, Jose Luis/AAI-1118-2020; Vinuela, antonio/S-1128-2019; Martin-Rodriguez, Francisco/R-3599-2018; Mohedano-Moriano, Alicia/L-1121-2016	Durantez, Carlos/0000-0002-9388-8074; Polonio-Lopez, Begona/0000-0003-2922-7519; Marques, Goncalo/0000-0001-5834-6571; Martin-Conty, Jose Luis/0000-0001-8579-2323; Vinuela, antonio/0000-0003-4306-1607; Martin-Rodriguez, Francisco/0000-0002-1773-2860; Mohedano-Moriano, Alicia/0000-0003-4904-6774; Lopez-Izquierdo, Raul/0000-0001-5092-4138	Gerencia Regional de Salud de Castilla y Leon (Spain) [GRS 1678/A/18]; Consejeria de Sanidad de Castilla y Leon (Spain) [INT/E/02/19]	This research was funded by Gerencia Regional de Salud de Castilla y Leon (Spain), grant number GRS 1678/A/18 and Consejeria de Sanidad de Castilla y Leon (Spain), grant number INT/E/02/19.	Ahmed WA, 2020, SPINAL CORD, V58, P165, DOI 10.1038/s41393-019-0330-0; Barker RO, 2020, AGE AGEING, V49, P141, DOI 10.1093/ageing/afz130; Bendinelli C, 2020, EUR J TRAUMA EMERG S, V46, P873, DOI 10.1007/s00068-019-01139-9; Bossuyt PM, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2016.02.06; Burger D, 2017, J CLIN NURS, V26, P2794, DOI 10.1111/jocn.13852; Chou R, 2017, ANN EMERG MED, V70, P143, DOI 10.1016/j.annemergmed.2016.11.032; da Rocha TF, 2016, REV BRAS ENFERM, V69, P850, DOI 10.1590/0034-7167-2015-0145; de Grooth HJ, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1609-1; Denninghoff KR, 2017, PREHOSP EMERG CARE, V21, P539, DOI 10.1080/10903127.2017.1315201; Ehara J, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000018475; Faisal M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031596; Farenden S, 2017, BRIT J HOSP MED, V78, P132, DOI 10.12968/hmed.2017.78.3.132; Gamberini Lorenzo, 2019, Air Med J, V38, P366, DOI 10.1016/j.amj.2019.06.001; Gang MC, 2019, CLIN EXP EMERG MED, V6, P152, DOI 10.15441/ceem.18.027; Garvin R, 2017, NEUROCRIT CARE, V27, pS159, DOI 10.1007/s12028-017-0461-0; Gok RGY, 2019, INT EMERG NURS, V43, P9, DOI 10.1016/j.ienj.2018.06.002; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Hoikka M, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0514-1; Jeong H, 2020, AM J EMERG MED, V38, P2277, DOI 10.1016/j.ajem.2019.09.021; Jiang XB, 2019, PEERJ, V7, DOI 10.7717/peerj.7227; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P698, DOI 10.1097/TA.0000000000000584; Juelsgaard J, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0534-x; Kavi T, 2019, CUREUS, V11, DOI 10.7759/cureus.5677; Kramer AA, 2019, J TRAUMA ACUTE CARE, V87, pS67, DOI 10.1097/TA.0000000000002197; Lee SB, 2020, AM J EMERG MED, V38, P203, DOI 10.1016/j.ajem.2019.02.004; Manoochehry S, 2019, ARCH ACAD EMERG MED, V7; Marehbian J, 2017, NEUROCRIT CARE, V27, P430, DOI 10.1007/s12028-017-0408-5; Martin-Rodriguez F, 2019, INTERN EMERG MED, V14, P581, DOI 10.1007/s11739-019-02026-2; Meizoso JP, 2015, J TRAUMA ACUTE CARE, V79, P227, DOI 10.1097/TA.0000000000000748; Najafi Z, 2018, INT EMERG NURS, V36, P27, DOI 10.1016/j.ienj.2017.08.003; Negrin LL, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7320158; Ortega Zufiria Jose Manuel, 2018, Surg Neurol Int, V9, pS16, DOI 10.4103/sni.sni_371_17; Pakkanen T, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0590-x; Panday RSN, 2017, EUR J INTERN MED, V45, P20, DOI 10.1016/j.ejim.2017.09.027; Pargaonkar R, 2019, J CLIN NEUROSCI, V66, P100, DOI 10.1016/j.jocn.2019.05.011; Patel R, 2018, RESUSCITATION, V132, P101, DOI 10.1016/j.resuscitation.2018.08.028; Pelieu Iris, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7010012; Pimentel MAF, 2019, RESUSCITATION, V134, P147, DOI 10.1016/j.resuscitation.2018.09.026; Pirneskoski J, 2019, ACTA ANAESTH SCAND, V63, P676, DOI 10.1111/aas.13310; Pourahmad S, 2019, J RES MED SCI, V24, DOI 10.4103/jrms.JRMS_89_18; Prabhakaran K, 2017, J SURG RES, V219, P66, DOI 10.1016/j.jss.2017.05.103; Ram Kodanda, 2019, World Neurosurg X, V2, P100020, DOI 10.1016/j.wnsx.2019.100020; Royal College of Physicians, 2017, NATL EARLY WARNING S; Scheetz LJ, 2018, INT EMERG NURS, V37, P29, DOI 10.1016/j.ienj.2016.11.003; Silcock DJ, 2015, RESUSCITATION, V89, P31, DOI 10.1016/j.resuscitation.2014.12.029; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stanley A, 2019, CAN J RURAL MED, V24, P83, DOI 10.4103/CJRM.CJRM_17_18; Strnad M, 2017, WIEN KLIN WOCHENSCHR, V129, P110, DOI 10.1007/s00508-016-0974-0; Teuben M, 2020, EUR J TRAUMA EMERG S, V46, P1321, DOI 10.1007/s00068-019-01141-1; Tirkkonen J, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0691-6; Torun G, 2019, ANN ITAL CHIR, V90, P152; Valentin G, 2019, INT J TECHNOL ASSESS, V35, P27, DOI 10.1017/S0266462318003616; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wijayatilake DS, 2015, CURR OPIN ANESTHESIO, V28, P517, DOI 10.1097/ACO.0000000000000233	56	2	2	1	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR	2020	17	5							1504	10.3390/ijerph17051504			14	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	KY2GJ	WOS:000522389200044	32110959	Green Published, gold			2022-02-06	
J	Morriss, NJ; Conley, GM; Ospina, SM; Meehan, WP; Qiu, JH; Mannix, R				Morriss, Nicholas J.; Conley, Grace M.; Ospina, Sara M.; Meehan, William P., III; Qiu, Jianhua; Mannix, Rebekah			Automated Quantification of Immunohistochemical Staining of Large Animal Brain Tissue Using QuPath Software	NEUROSCIENCE			English	Article						QuPath; immunohistochemistry; automated analysis; traumatic brain injury; phosphorylated tau	IMAGE-ANALYSIS; TAU; PATHOLOGY; LOCALIZATION; MORPHOLOGY; TANGLES	Large scale unbiased quantification of immunohistochemistry (IHC) is time consuming, expensive, and/or limited in scope. Heterogeneous tissue types such as brain tissue have presented a further challenge to the development of automated analysis, as differing cellular morphologies result in either limited applicability or require large amounts of training tissue for machine-learning methods. Here we present the use of QuPath, a free and open source software, to quantify whole-brain sections stained with the immunohistochemical markers IBA1 and AT8, for microglia and phosphorylated tau respectively. The pixel-based method of analysis herein allows for statistical comparison of global protein expression between brains and generates heat-maps of stain intensity, visualizing stain signal across whole sections and permitting more specific investigation of regions of interest. This method is fast, automated, unbiased, and easily replicable. We compared swine brains that had undergone a closed head traumatic brain injury with brains of sham animals, and found a global increase in both microglial signal expression and phosphorylated tau. We discuss the IHC methods necessary to utilize this analysis and provide detailed instruction on the use of QuPath in the pixel-based analysis of whole-slide images. (C) 2020 IBRO. Published by Elsevier Ltd. All rights reserved.	[Morriss, Nicholas J.; Conley, Grace M.; Ospina, Sara M.; Qiu, Jianhua; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA; [Meehan, William P., III] Boston Childrens Hosp, Dept Orthoped, Boston, MA 02115 USA; [Meehan, William P., III] Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P., III; Qiu, Jianhua; Mannix, Rebekah] Harvard Med Sch, Boston, MA 02115 USA; [Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	Rebekah.Mannix@childrens.harvard.edu		Mannix, Rebekah/0000-0003-3608-2792	CHB IDDRC; National Football League through the Prospective, LONGitudinal, and Translational Study for Formal NFL Players grant	This work was supported in part by funding from the CHB IDDRC and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and the National Football League. Further support was provided by funding from the National Football League through the Prospective, LONGitudinal, and Translational Study for Formal NFL Players grant under Dr. Meehan.	Albarqouni S, 2016, IEEE T MED IMAGING, V35, P1313, DOI 10.1109/TMI.2016.2528120; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Brown DL, 2017, J TOXICOL PATHOL, V30, P183, DOI 10.1293/tox.2017-0013; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chen ZF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088744, 10.1371/journal.pone.0094493]; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Chu PG, 2009, MODERN IMMUNOHISTOCH; Farris AB, 2017, ARCH PATHOL LAB MED, V141, P542, DOI 10.5858/arpa.2016-0265-SA; Gadegbeku CA, 2013, KIDNEY INT, V83, P749, DOI 10.1038/ki.2012.428; Rojo MG, 2006, INT J SURG PATHOL, V14, P285, DOI 10.1177/1066896906292274; Golub VM, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00196, 10.3389/fnagi.2015.00196]; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Isse K, 2012, AM J TRANSPLANT, V12, P27, DOI 10.1111/j.1600-6143.2011.03797.x; Jaraj SJ, 2009, VIRCHOWS ARCH, V455, P375, DOI 10.1007/s00428-009-0833-8; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kempf M, 1996, J NEUROSCI, V16, P5583; Korzhevskii DE, 2013, MORFOLOGIIA, V142, P30; KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lopez Carlos, 2012, Stud Health Technol Inform, V179, P155; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Madabhushi A, 2016, MED IMAGE ANAL, V33, P170, DOI 10.1016/j.media.2016.06.037; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; Pantanowitz L, 2010, J PATHOL INFORM, V1; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; Rizzardi AE, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-42; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI [10.1146/annurev-bioeng-071516-044442, 10.1146/annurev-bioeng-071516044442]; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	36	2	2	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	MAR 1	2020	429						235	244		10.1016/j.neuroscience.2020.01.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KM6CA	WOS:000514225000020	31982467				2022-02-06	
J	Nagai, T; Schilaty, ND; Krause, DA; Crowley, EM; Hewett, TE				Nagai, Takashi; Schilaty, Nathan D.; Krause, David A.; Crowley, Eric M.; Hewett, Timothy E.			Sex Differences in Ultrasound-Based Muscle Size and Mechanical Properties of the Cervical-Flexor and -Extensor Muscles	JOURNAL OF ATHLETIC TRAINING			English	Article						cervical spine; neck pain; stiffness	SHEAR-WAVE ELASTOGRAPHY; CHRONIC NECK PAIN; SEMISPINALIS CERVICIS; SPLENIUS CAPITIS; HEAD; ACTIVATION; STIFFNESS; RELIABILITY; THICKNESS; STRENGTH	Context: Neck pain (NP), neck injuries, and concussions are more prevalent in female athletes than in their male counterparts. Females exhibit less neck girth, strength, and stiffness against a perturbation. As part of the clinical examination for individuals with NP, ultrasound (US)-based imaging of the cervical muscles has become common. Muscle size or thickness and stiffness can be measured with US-based B-mode and shear-wave elastography (SWE), respectively. Information on reliability, normative values, and sex differences based on US-based muscle size or thickness and stiffness in young and athletic individuals is limited. Objective: To evaluate sex differences in US-based muscle size or thickness and biomechanical properties of the cervical-flexor and -extensor muscles. Design: Cross-sectional study. Setting: Laboratory. Patients or Other Participants: A total of 13 women (age = 23.7 +/- 1.9 years, height = 167.1 +/- 6.1 cm, mass = 63.8 +/- 5.6 kg) and 11 men (age = 25.6 +/- 4.9 years, height = 178.7 +/- 8.3 cm, mass = 78.9 +/- 12.0 kg). Main Outcome Measure(s): The same examiner collected all measures, using US B-mode to scan the cross-sectional area and thickness of the longus colli (LC), sternocleidomastoid (SCM), cervical-extensor muscles, and upper trapezius (UT) muscle. The US SWE-mode was used to measure the stiffness of the SCM and UT. Independent t tests or Mann-Whitney U tests were calculated to determine sex differences. The intraclass correlation coefficient (ICC) measured intrarater test-retest reliability. Results: Men had thicker SCMs than women (P = .01). No sex differences were present for longus colli cross-sectional area, cervical-extensor muscle thickness, or UT thickness (P > .05). In addition, no sex differences were evident for SCM (P = .302) or UT (P= .703) SWE stiffness. Reliability was good to excellent (ICC = 0.715-0.890) except for SCM SWE stiffness (ICC = 0.554). Conclusions: The only sex difference was in SCM thickness. However, smaller SCMs in women did not result in less SCM SWE stiffness. We provided normative values for US-based imaging of the cervical-flexor and -extensor muscles in young and athletic men and women.	[Nagai, Takashi; Schilaty, Nathan D.; Crowley, Eric M.; Hewett, Timothy E.] Mayo Clin, Dept Orthoped Surg, Biomech Labs, Rochester, MN 55905 USA; [Nagai, Takashi; Schilaty, Nathan D.; Crowley, Eric M.; Hewett, Timothy E.] Mayo Clin, Sports Med Ctr, Rochester, MN 55905 USA; [Schilaty, Nathan D.; Krause, David A.; Hewett, Timothy E.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Hewett, Timothy E.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA		Nagai, T (corresponding author), Mayo Clin, Biomech Labs, 200 First St SW, Rochester, MN 55905 USA.	nagai.takashi@mayo.edu	Schilaty, Nathan/M-8606-2019	Schilaty, Nathan/0000-0002-6038-7126; Nagai, Takashi/0000-0002-1597-4399	NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [L30 AR070273] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD065987] Funding Source: Medline		Cagnie B, 2009, MANUAL THER, V14, P421, DOI 10.1016/j.math.2008.07.007; Dieterich AV, 2017, EUR J APPL PHYSIOL, V117, P171, DOI 10.1007/s00421-016-3509-5; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Elliott J, 2008, MANUAL THER, V13, P258, DOI 10.1016/j.math.2007.01.012; Goodarzi F, 2018, J MANIP PHYSIOL THER, V41, P34, DOI 10.1016/j.jmpt.2017.07.012; Herman J, 2017, BIOMED PAP, V161, P320, DOI 10.5507/bp.2017.024; Hoy D, 2014, ANN RHEUM DIS, V73, P1309, DOI 10.1136/annrheumdis-2013-204431; Jafari M, 2018, J BODYW MOV THER, V22, P374, DOI 10.1016/j.jbmt.2017.06.019; Javanshir K, 2015, J BACK MUSCULOSKELET, V28, P833, DOI 10.3233/BMR-150593; Javanshir K, 2011, AM J PHYS MED REHAB, V90, P293, DOI 10.1097/PHM.0b013e31820173e5; Jin X, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037399; Jull GA, 2000, J MUSCULOSKELET PAIN, V8, P143, DOI 10.1300/J094v08n01_12; Karimi N, 2016, MANUAL THER, V22, P174, DOI 10.1016/j.math.2015.12.004; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Koppenhaver SL, 2009, ARCH PHYS MED REHAB, V90, P87, DOI 10.1016/j.apmr.2008.06.022; Kristjansson E, 2004, MANUAL THER, V9, P83, DOI 10.1016/S1356-689X(03)00059-6; Kuo WH, 2013, ULTRASOUND MED BIOL, V39, P1356, DOI 10.1016/j.ultrasmedbio.2012.11.015; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Flao E, 2018, SPORTS MED, V48, P2641, DOI 10.1007/s40279-018-0984-3; Linek P, 2017, J ULTRAS MED, V36, P775, DOI 10.7863/ultra.16.03086; Noormohammadpour P, 2018, ASIAN SPINE J, V12, P1146, DOI 10.31616/asj.2018.12.6.1146; Overas CK, 2017, CHIROPR MAN THER, V25, DOI 10.1186/s12998-016-0132-9; Rankin G, 2005, MANUAL THER, V10, P108, DOI 10.1016/j.math.2004.08.004; Rezasoltani A, 2013, J BODYW MOV THER, V17, P200, DOI 10.1016/j.jbmt.2012.07.001; Rivard J, 2017, MUSCULOSKEL SCI PRAC, V30, P56, DOI 10.1016/j.msksp.2017.05.007; Schomacher J, 2015, MANUAL THER, V20, P694, DOI 10.1016/j.math.2015.04.010; Schomacher J, 2013, MANUAL THER, V18, P360, DOI 10.1016/j.math.2013.05.009; Simmons MM, 2017, J ATHL TRAINING, V52, P776, DOI 10.4085/1062-6050-52.4.03; Stemper BD, 2016, J ORTHOP SPORT PHYS, V46, P834, DOI 10.2519/jospt.2016.6846; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA	31	2	2	0	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAR	2020	55	3					282	288		10.4085/1062-6050-482-18			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KX2RC	WOS:000521726900009	31967864	gold, Green Published			2022-02-06	
J	Pape, MM; Kodosky, PN; Hoover, P				Pape, Marcy M.; Kodosky, Paula N.; Hoover, Peter			The Community Balance and Mobility Scale: Detecting Impairments in Military Service Members With Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; WALKING SPEED; GAIT; RELIABILITY; VALIDITY; RECOMMENDATIONS; INDIVIDUALS; CHECKLIST; SYMPTOMS	Introduction The objective of this study was to determine the utility of the Community Balance and Mobility scale (CB&M) among service members presenting with mild traumatic brain injury (mTBI), to compare the results against well-established balance assessments, and to find a new military-specific CB&M cut score to help differentiate those with and without mTBI. Materials and Methods The setting was a 4-week, intensive-outpatient, interdisciplinary program for active duty service members with mTBI. This was a nonrandomized, cross-sectional design that compared multiple measures between two groups: active duty service members with (n = 45) and without (n = 45) mTBI. The assessments, including the Activities-Specific Balance Confidence Scale, gait speed (comfortable and fast), the Functional Gait Assessment, and the CB&M, were provided to both sample groups. Results The mTBI group performed significantly worse (P <= 0.01) across all measures. A higher cut score for the CB&M of 81.5 is suggested. The CB&M demonstrated the best sensitivity (78%) and specificity (91%) ratio, as well as the largest effect size and area under the curve(0.92). Conclusion All objective measures distinguish participants with mTBI from controls, ranging from fair to excellent. The recommended CB &M cut score of 81.5 allows for good variance, standard deviation, and reduced risk of ceiling or floor effects. Further examination of the recommended CB &M cut score is warranted for use in the mTBI civilian populations.	[Pape, Marcy M.; Kodosky, Paula N.; Hoover, Peter] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA		Pape, MM (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA.						Balasubramanian CK, 2015, J GERIATR PHYS THER, V38, P78, DOI 10.1519/JPT.0000000000000024; Balasubramanian CK, 2012, J GERIATR PHYS THER, V36, pS1; Beninato M, 2016, PHYS THER, V96, P456, DOI 10.2522/ptj.20150167; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Center. DaVBI, DOD WORLDW NUMB TRAU; Chan K, 2017, SPINAL CORD, V55, P294, DOI 10.1038/sc.2016.140; Ciufredda KJ, 2009, OPTOM VIS DEV, V40, P16; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Danna-Dos-Santos A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22825-5; Dean S, 2000, PSYCHOL REP, V86, P653, DOI 10.2466/pr0.2000.86.2.653; Epidemiology Program Post-Deployment Health Group OoPH VsHA Department of Veterans Affairs, 2014, REP VA FAC SPEC OP E, P10; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; King JE, 2018, MIL MED, V183, P237, DOI 10.1093/milmed/usx170; Kline Mangione Kathleen, 2008, Physiother Can, V60, P10, DOI 10.3138/physio/60/1/10; Knorr S, 2010, ARCH PHYS MED REHAB, V91, P890, DOI 10.1016/j.apmr.2010.02.010; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Leland Azadeh, 2017, Mater Sociomed, V29, P251, DOI 10.5455/msm.2017.29.251-256; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Marchetti GF, 2014, J NEUROL PHYS THER, V38, P119, DOI 10.1097/NPT.0000000000000015; Martelli L, 2018, J CARDIOPULM REHABIL, V38, P100, DOI 10.1097/HCR.0000000000000277; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Pape MM, 2016, J HEAD TRAUMA REHAB, V31, P339, DOI 10.1097/HTR.0000000000000179; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Perry SB, 2014, J HEAD TRAUMA REHAB, V29, P117, DOI 10.1097/HTR.0b013e3182864f2f; Portney L. G., 2000, FDN CLIN RES APPL PR, V2; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rocque R, 2005, PHYSIOTHER CAN, V57, P285; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Takacs J, 2014, PHYS THER REHABIL J, V94, P866, DOI 10.2522/ptj.20130385; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Walker ML, 2007, PHYS THER, V87, P1468, DOI 10.2522/ptj.20060344; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Ward Irene, 2014, Arch Phys Med Rehabil, V95, P2229; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Wright FV, 2010, BRAIN INJURY, V24, P1585, DOI 10.3109/02699052.2010.523045; Wrisley DM, 2010, PHYS THER, V90, P761, DOI 10.2522/ptj.20090069	45	2	2	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2020	185	3-4					428	435		10.1093/milmed/usz265			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LR7HU	WOS:000535866100053	31621858	hybrid			2022-02-06	
J	Park, CH; Kim, SH; Jung, HY				Park, Chan-Hyuk; Kim, Su-Hong; Jung, Han-Young			Diffusion-Tensor-Tractography-Based Diagnosis for Injury of Corticospinal Tract in a Patient with Hemiplegia Following Traumatic Brain Injury	DIAGNOSTICS			English	Article						traumatic brain injury; diffusion tensor imaging; traumatic axonal injury; corticospinal tract; hemiplegia	SPINOTHALAMIC TRACT	This paper reports a mechanism for corticospinal tract injury in a patient with hemiplegia following traumatic brain injury (TBI) based on diffusion tensor tractography (DTT) finding. A 73-year-old male with TBI resulting from a fall, without medical history, was diagnosed as having left convexity epidural hematoma (EDH). He underwent craniotomy and suffered motor weakness on the right side of the body. Two weeks after onset, he was transferred to a rehabilitation department with an alerted level of consciousness. Four weeks after onset, his motor functions were grade 1 by the Medical Research Council's (MRC) standards in the right-side limbs and grade 4 in the left-side limbs. The result of DTT using the different regions of interest (ROIs) showed that most of the right corticospinal tract (CST) did not reach the cerebral cortex around where the EDH was located, and when the ROI was placed on upper pons, a disconnection of the CST was shown and a connection of the CST in ROI with the middle pons appeared. However, the right CST was connected to the cerebral cortex below the pons regardless of ROI. This study is the first report to use DTT to detect that the discontinuation of the left CST in the cerebral cortex and injury lesions below the lower pons and between the upper and lower pons are responsible for motor weakness in a patient.	[Park, Chan-Hyuk; Kim, Su-Hong; Jung, Han-Young] Inha Univ, Inha Univ Hosp, Dept Phys & Amp, Sch Med, Incheon 22332, South Korea		Jung, HY (corresponding author), Inha Univ, Inha Univ Hosp, Dept Phys & Amp, Sch Med, Incheon 22332, South Korea.	chanhyuk@gmail.com; suhong1207@gmail.com; rmjung@inha.ac.kr		Jung, Han-Young/0000-0003-1428-9821; Park, Chan hyuk/0000-0002-0664-9922	Inha University	This study was supported by a research grant from Inha University.	Jang SH, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9040155; Jang SH, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00787; Jang SH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013315; Jang SH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00057; Jang SH, 2017, NEURAL REGEN RES, V12, P2021, DOI 10.4103/1673-5374.221159; Jang SH, 2016, NEURAL REGEN RES, V11, P1527, DOI 10.4103/1673-5374.191230; Jang SH, 2016, J NEUROTRAUM, V33, P1790, DOI 10.1089/neu.2015.4298; Jang SH, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0434-x; Jang SH, 2015, SOMATOSENS MOT RES, V32, P67, DOI 10.3109/08990220.2014.966899; Jaspers E, 2016, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00112; Kim JH, 2015, NEURAL REGEN RES, V10, P2054, DOI 10.4103/1673-5374.172326; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; O'Donnell LJ, 2011, NEUROSURG CLIN N AM, V22, P185, DOI 10.1016/j.nec.2010.12.004; Santillo AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066932; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin HE, 2017, ANN REHABIL MED-ARM, V41, P153, DOI 10.5535/arm.2017.41.1.153	17	2	2	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	MAR	2020	10	3							156	10.3390/diagnostics10030156			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA9XR	WOS:000524293700052	32183086	gold, Green Published			2022-02-06	
J	Renaud, MI; Lambregts, SAM; van de Port, IGL; Catsman-Berrevoets, CE; van Heugten, CM				Renaud, M. Irene; Lambregts, Suzanne A. M.; van de Port, Ingrid G. L.; Catsman-Berrevoets, Coriene E.; van Heugten, Caroline M.			Predictors of activities and participation six months after mild traumatic brain injury in children and adolescents	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Mild traumatic brain injury; Predictors; Activities and participation; Children	POST-CONCUSSIVE SYMPTOMS; POSTCONCUSSION SYNDROME; PRE-INJURY; OUTCOMES; VALIDATION; VERSION; DETERMINANTS; DEPRESSION; RECOVERY; FATIGUE	Objective: This study aimed to identify predictors of long-term consequences for activities and participation in children and adolescents with mild traumatic brain injury (mTBI). Methods: A multicentre prospective longitudinal cohort study was conducted. The primary outcome measure was activities and participation measured with the Child and Adolescent Scale of Participation - CASP and completed by children (N = 156) and caregivers (N = 231) six months post-mTBI. The CASP items were categorized into home, community, school, and environment. Predictors were categorized according to the International Classification of Functioning, Disability and Health for Children and Youth. Predictors included pre-injury personal- and environmental factors, injury-related factors, symptoms, and resumption of activities in the first two weeks after mTBI. Univariate and multivariate logistic regression analyses were used to determine the predictive value of these factors. Results: Results show that predictors differ across settings and perspectives (child or caregiver). Decreased activities and participation in children with mTBI can be predicted by adverse pre-injury behavioral functioning of the child (p < .000 - p = .038), adverse pre-injury family functioning (p = .001), lower parental SES (p = .038), more stress symptoms post-injury (p = .017 - p = .032), more post-concussive symptoms (p = .016 - p = .028) and less resumption of activities (p = .006 - p = .045). Discussion: Pre-injury factors, more symptoms post-injury and less resumption of activities should be considered when children are screened for unfavorable outcomes. Additional factors may add to the prediction, but injury-related factors do not. It is recommended that future research explores psychosocial factors, such as coping styles, emotion-regulation, personality traits, social support, and other comorbid problems of both children and caregivers. (C) 2019 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Renaud, M. Irene; Lambregts, Suzanne A. M.; van de Port, Ingrid G. L.] Revant Rehabil Ctr, Breda, Netherlands; [Renaud, M. Irene; van Heugten, Caroline M.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands; [Renaud, M. Irene; van Heugten, Caroline M.] Limburg Brain Injury Ctr, Maastricht, Netherlands; [Lambregts, Suzanne A. M.] Erasmus Univ Hosp, Dept Rehabil Med, Sophia Childrens Hosp, Rotterdam, Netherlands; [Catsman-Berrevoets, Coriene E.] Erasmus Univ Hosp, Dept Paediat Neurol, Sophia Childrens Hosp, Rotterdam, Netherlands; [van Heugten, Caroline M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Med Ctr, Maastricht, Netherlands		van Heugten, CM (corresponding author), Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	caroline.vanheugten@maastrichtuniversity.nl			Johanna Kinderfonds [2012/0040-1552]; Revalidatiefonds [R2012175]	The study was funded by the Johanna Kinderfonds (Award Number 2012/0040-1552) and the Revalidatiefonds (Award Number R2012175).	Achenbach TM, 2008, J CHILD PSYCHOL PSYC, V49, P251, DOI 10.1111/j.1469-7610.2007.01867.x; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babcock L, 2013, PEDIATR EMERG CARE, V29, P458, DOI 10.1097/PEC.0b013e31828a202d; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Bohnert AM, 2007, J RES ADOLESCENCE, V17, P221, DOI 10.1111/j.1532-7795.2007.00520.x; Bult MK, 2010, CLIN REHABIL, V24, P843, DOI 10.1177/0269215510367545; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; de Buy Wenniger W.F. Maillette, 1995, TIJDSCHR PSYCHIAT, V37; de Kloet AJ, 2015, BRAIN INJURY, V29, P1135, DOI 10.3109/02699052.2015.1034178; de Kloet AJ, 2015, DEV NEUROREHABIL, V18, P357, DOI 10.3109/17518423.2013.850749; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Durish CL, 2019, J INT NEUROPSYCH SOC, V25, P346, DOI 10.1017/S1355617718001169; Foo WS, 2012, DEV NEUROREHABIL, V15, P1, DOI 10.3109/17518423.2011.623142; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Golos A, 2018, DEV NEUROREHABIL, V21, P431, DOI 10.1080/17518423.2017.1342711; Gordijn MS, 2011, QUAL LIFE RES, V20, P1103, DOI 10.1007/s11136-010-9836-9; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; Imms Christine, 2008, Phys Occup Ther Pediatr, V28, P389, DOI 10.1080/01942630802307135; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; La Torre G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-22; Mansfield AK, 2015, FAM PROCESS, V54, P82, DOI 10.1111/famp.12080; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDougall J, 2013, CHILD CARE HLTH DEV, V39, P512, DOI 10.1111/cch.12050; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moulaert VRMP, 2010, J REHABIL MED, V42, P553, DOI 10.2340/16501977-0547; Renaud MI, 2018, CLIN REHABIL, V32, P1440, DOI 10.1177/0269215518785418; Renaud MI, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1357-6; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Seagly KS, 2018, BRAIN INJURY, V32, P78, DOI 10.1080/02699052.2017.1374467; Smyth K, 2014, DEV MED CHILD NEUROL, V56, P73, DOI 10.1111/dmcn.12263; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; van der Horn HJ, 2020, J NEUROL, V267, P2497, DOI 10.1007/s00415-019-09335-8; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; van Heugten Caroline, 2017, Concussion, V2, pCNC38, DOI 10.2217/cnc-2016-0030; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; World Health Organization, 2007, INT CLASS FUNCT DIS	47	2	2	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	MAR	2020	25						145	156		10.1016/j.ejpn.2019.11.008			12	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	LH1HC	WOS:000528539300022	31831269	Green Published			2022-02-06	
J	Robinson, D; Khoury, JC; Kleindorfer, D				Robinson, David; Khoury, Jane C.; Kleindorfer, Dawn			Regional Variation in the Management of Nontraumatic Subdural Hematomas Across the United States	WORLD NEUROSURGERY			English	Article						Epidemiology; Subdural hematomas; Surgical decision-making	TRAUMATIC BRAIN-INJURY; ASSOCIATION; EVACUATION; MORTALITY; ADMISSION; DIAGNOSIS; RATES; SCORE	BACKGOUND: Nontraumatic subdural hematomas are a common indication for inpatient hospitalization in the United States, yet there is little high-quality evidence regarding which patients should receive surgical or medical treatment. We sought to assess variation in surgical management and medical treatment with steroids for nontraumatic subdural hematomas across the United States. METHODS: Using the Premier database, we analyzed patients with a primary discharge diagnosis of nontraumatic subdural hematoma in 2014. international Classification of Diseases, Ninth Revision, procedure codes were used to identify patients who underwent surgical management, and pharmacy data were used to identify patients treated with dexamethasone. Univariable and multivariable analyses were used to examine the association of age, race, sex, academic versus nonacademic center, and regions of the United States with conservative or surgical management. RESULTS: There were 3915 inpatient hospitalizations for nontraumatic subdural hematomas in 2014 in the Premier database, of whom 1860 (47.5%) underwent surgery, and 360 (9.2%) underwent treatment with dexamethasone, either as a primary treatment or as an adjuvant to surgery. Older age, female sex, and being managed outside of the Western U.S. region were associated with a lower likelihood of undergoing surgical management on multivariable analysis; only younger age was associated with a greater likelihood of being treated with dexamethasone. CONCLUSIONS: There is considerable variability in surgical management of nontraumatic subdural hematomas across the United States based on age, sex, and region. Future studies should explore the reasons for the variability and attempt to better clarify indications for surgical management of subdural hematomas.	[Robinson, David; Kleindorfer, Dawn] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH 45221 USA; [Khoury, Jane C.] Cincinnati Childrens Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA; [Khoury, Jane C.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA		Robinson, D (corresponding author), Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH 45221 USA.	robin2dv@ucmail.uc.edu		Robinson, David/0000-0003-3221-3599	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS047996-13]	Funded by National Institute of Neurological Disorders and Stroke (T32NS047996-13).	Balser D, 2015, J NEUROSURG, V123, P1209, DOI 10.3171/2014.9.JNS141550; Birkmeyer JD, 2013, LANCET, V382, P1121, DOI 10.1016/S0140-6736(13)61215-5; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Busl KM, 2013, J NEUROSURG, V119, P1296, DOI 10.3171/2013.4.JNS122236; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Franko LR, 2018, J NEUROSURG, V129, P1008, DOI 10.3171/2017.6.JNS17188; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Gaist D, 2017, JAMA-J AM MED ASSOC, V317, P836, DOI 10.1001/jama.2017.0639; Gernsback JE, 2018, WORLD NEUROSURG, V120, pE414, DOI 10.1016/j.wneu.2018.08.095; Glancz LJ, 2019, NEUROSURGERY, V85, P486, DOI 10.1093/neuros/nyy366; Hotta K, 2017, WORLD NEUROSURG, V105, P47, DOI 10.1016/j.wneu.2017.05.105; Jiang RC, 2018, JAMA NEUROL, V75, P1338, DOI 10.1001/jamaneurol.2018.2030; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Karlson EW, 1997, AM J MED, V102, P524; Kleindorfer D, 2008, STROKE, V39, P924, DOI 10.1161/STROKEAHA.107.490375; Kocak A, 2009, TURK NEUROSURG, V19, P333; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Marion DW, 2006, NEUROSURGERY, V58, P655; Mehta V, 2018, J CLIN NEUROSCI, V50, P7, DOI 10.1016/j.jocn.2018.01.050; Miah IP, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2945-4; Missios S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092057; Morris NA, 2016, NEUROCRIT CARE, V24, P226, DOI 10.1007/s12028-015-0178-x; Patel PV, 2009, ARCH NEUROL-CHICAGO, V66, P79, DOI 10.1001/archneur.66.1.79; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Poulsen FR, 2016, PHARMACOEPIDEM DR S, V25, P1253, DOI 10.1002/pds.4058; Reichman J, 2012, NEUROSURGERY, V71, P74, DOI 10.1227/NEU.0b013e3182517938; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; THOMAS TPL, 1984, GERONTOLOGY, V30, P60, DOI 10.1159/000212608; Van Essen TA, 2018, J NEUROTRAUM, V35, pA184; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; WONG CW, 1995, ACTA NEUROCHIR, V135, P38, DOI 10.1007/BF02307412; Yang WY, 2017, NEUROSURG CLIN N AM, V28, P205, DOI 10.1016/j.nec.2016.11.002; Yao Z, 2017, ACTA NEUROCHIR, V159, P2037, DOI 10.1007/s00701-017-3309-7	34	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2020	135									10.1016/j.wneu.2019.12.011			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KR7GS	WOS:000517784600048	31862343	Green Accepted			2022-02-06	
J	Roy, D; Peters, ME; Everett, AD; Leoutsakos, JMS; Yan, HJ; Rao, V; Bechtold, KT; Sair, HI; Van Meter, T; Falk, H; Vassila, A; Hall, A; Ofoche, U; Akbari, F; Lyketsos, C; Korley, F				Roy, Durga; Peters, Matthew E.; Everett, Allen D.; Leoutsakos, Jeannie-Marie Sheppard; Yan, Haijuan; Rao, Vani; Bechtold, Kathleen T.; Sair, Haris I.; Van Meter, Tim; Falk, Hayley; Vassila, Alexandra; Hall, Anna; Ofoche, Uju; Akbari, Freshta; Lyketsos, Constantine; Korley, Frederick			Loss of Consciousness and Altered Mental State as Predictors of Functional Recovery Within 6 Months Following Mild Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							QUALITY-OF-LIFE; HEAD-INJURY; RECOMMENDATIONS	Objective: The authors tested the hypothesis that a combination of loss of consciousness (LOC) and altered mental state (AMS) predicts the highest risk of incomplete functional recovery within 6 months after mild traumatic brain injury (mTBI), compared with either condition alone, and that LOC alone is more strongly associated with incomplete recovery, compared with AMS alone. Methods: Data were analyzed from 407 patients with mTBI from Head injury Serum Markers for Assessing Response to Trauma (HeadSMART), a prospective cohort study of TBI patients presenting to two urban emergency departments. Four patient subgroups were constructed based on information documented at the time of injury: neither LOC nor AMS, LOC only, AMS only, and both. Logistic regression models assessed LOC and AMS as predictors of functional recovery at 1, 3, and 6 months. Results: A gradient of risk of incomplete functional recovery at 1, 3, and 6 months postinjury was noted, moving from neither LOC nor AMS, to LOC or AMS alone, to both. LOC was associated with incomplete functional recovery at 1 and 3 months (odds ratio=2.17, SE=0.46, p<0.001; and odds ratio=1.80, SE=0.40, p=0.008, respectively). AMS was associated with incomplete functional recovery at 1 month only (odds ratio=1.77, SE=0.37 p=0.007). No association was found between AMS and functional recovery in patients with no LOC. Neither LOC nor AMS was predictive of functional recovery at later times. Conclusions: These findings highlight the need to include symptom-focused clinical variables that pertain to the injury itself when assessing who might be at highest risk of incomplete functional recovery post-mTBI.	[Roy, Durga; Peters, Matthew E.; Leoutsakos, Jeannie-Marie Sheppard; Yan, Haijuan; Rao, Vani; Lyketsos, Constantine] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Everett, Allen D.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Bechtold, Kathleen T.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Sair, Haris I.] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA; [Van Meter, Tim] ImmunArray USA, Program Neurol Dis, Richmond, VA USA; [Falk, Hayley; Korley, Frederick] Univ Michigan, Med Sch, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Vassila, Alexandra] Theradex Syst, Princeton, NJ USA; [Hall, Anna] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Ofoche, Uju] Drexel Univ, Coll Med, Dept Forens Sci, Philadelphia, PA 19104 USA; [Akbari, Freshta] Univ Maryland, Dept Cardiac Surg, Baltimore, MD 21201 USA		Roy, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.	droy4@jhmi.edu			ImmunArray USA	HeadSMART and this study were funded by ImmunArray USA.	Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll L, 2014, BRAIN INJ S, V95, pS152; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kerr Zachary Y, 2014, N C Med J, V75, P8; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Kreutzer JS, 2001, J HEAD TRAUMA REHAB, V16, pV, DOI 10.1097/00001199-200108000-00001; Kristman VL, 2014, ARCH PHYS MED REH S3, V95, pS266; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; National Hospital Discharge Survey [NHDS], 2010, NAT HOSP AMB MED CAR; ONeil ME, 2013, EVIDENCE BASED SYNTH; Peters ME, 2017, BRAIN INJURY, V31, P370, DOI 10.1080/02699052.2016.1231344; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086	37	2	2	0	1	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2020	32	2					132	138		10.1176/appi.neuropsych.18120379			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	MV7WG	WOS:000556562500004	31530119	Bronze			2022-02-06	
J	Sun, DL; Jiang, B; Ru, XJ; Sun, HX; Fu, J; Wu, SP; Wang, LH; Wang, LM; Zhang, M; Liu, BY; Wang, WZ				Sun, Dongling; Jiang, Bin; Ru, Xiaojuan; Sun, Haixin; Fu, Jie; Wu, Shengping; Wang, Linhong; Wang, Limin; Zhang, Mei; Liu, Baiyun; Wang, Wenzhi		NESS-China Investigators	Prevalence and Altered Causes of Traumatic Brain Injury in China: A Nationwide Survey in 2013	NEUROEPIDEMIOLOGY			English	Article						Neuroepidemiology; Population-based studies; Prevalence; Risk factors; Traumatic brain injury	POPULATION; EPIDEMIOLOGY	Background: Traumatic brain injury (TBI) is one of the leading causes of death and disability annually worldwide. However, the epidemiology of TBI had not been established in China. We conducted a nationally representative door-to-door survey in the general population across all age groups in 31 provinces in mainland China in 2013. Methods: All participants were reviewed for a history of physician-diagnosed TBI by trained investigators using a structured questionnaire. TBI survivors were considered as prevalent cases at the prevalent time. The present study also examined the odds of TBI as a function of sex, age, and other demographical variables using logistic regression model. Results: Of 583,870 participants, 2,673 individuals had suffered from a TBI during their past life, yielding a weighted prevalence of being 442.4 (95% CI 342.2-542.6) per 100,000 person. The TBI prevalence increased with increasing age. The present study observed the multiadjusted ORs of TBI were 1.9 (95% CI 1.8-2.1) for the male, 1.9 (95% CI 1.2-3.1) for the farmers, 1.9 (95% CI 1.2-3.3) for the retiree or homemakers, 3.4 (95% CI 1.5-7.7), and 2.8 (95% CI 1.1-6.6) for those whose education were primary school and high school, respectively. The most common external cause was road traffic accidents among those who were aged 18-34 years old and those whose educational levels were middle school in both genders. Conclusions: Our results indicate TBI was substantially prevalent among Chinese population and underscore the need to develop national strategies to improve the safe education on road and traffic of TBI in rural residents and some subgroup population.	[Sun, Dongling; Jiang, Bin; Ru, Xiaojuan; Sun, Haixin; Fu, Jie; Wu, Shengping; Wang, Wenzhi] Capital Med Univ, Beijing Neurosurg Inst, Dept Neuroepidemiol, 119 S 4th Ring West Rd, Beijing 100070, Peoples R China; [Sun, Dongling; Jiang, Bin; Ru, Xiaojuan; Sun, Haixin; Fu, Jie; Wu, Shengping; Wang, Wenzhi] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Wang, Linhong; Wang, Limin; Zhang, Mei] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Liu, Baiyun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, 119 S 4th Ring West Rd, Beijing 100070, Peoples R China		Wang, WZ (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Neuroepidemiol, 119 S 4th Ring West Rd, Beijing 100070, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, 119 S 4th Ring West Rd, Beijing 100070, Peoples R China.	liuhaiyun1212@163.com; qgnfbwwz@163.com	Sun, HX/G-4628-2010		Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2011BAI08B01]	This study was funded by the Ministry of Science and Technology of China (reference number 2011BAI08B01).	[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Asbridge M, 2010, ACCIDENT ANAL PREV, V42, P1408, DOI 10.1016/j.aap.2010.03.005; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Kessaram T, 2016, DRUG ALCOHOL REV, V35, P412, DOI 10.1111/dar.12328; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Massenburg BB, 2017, NEUROL INDIA, V65, P305, DOI 10.4103/neuroindia.NI_719_16; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McCrea PLaM, 2015, TRANSLATIONAL RES TR; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Paci M, 2017, CAN J NEUROL SCI, V44, P518, DOI 10.1017/cjn.2017.43; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Riesch SK, 2013, INT J NURS STUD, V50, P1067, DOI 10.1016/j.ijnurstu.2012.10.012; Wang WZ, 2017, CIRCULATION, V135, P759, DOI 10.1161/CIRCULATIONAHA.116.025250; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Zhao YD, 2001, WORLD J SURG, V25, P1202	24	2	2	2	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology	MAR	2020	54	2					106	113		10.1159/000501911			8	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Neurosciences & Neurology	KX8FV	WOS:000522111700003	31851999				2022-02-06	
J	Sylvia, L; West, E; Blackburn, AM; Gupta, C; Bui, E; Mahoney, T; Duncan, G; Wright, EC; Lejeune, S; Spencer, TJ				Sylvia, Louisa; West, Emerson; Blackburn, Allyson M.; Gupta, Carina; Bui, Eric; Mahoney, Tara; Duncan, Geraldine; Wright, Edward C.; Lejeune, Simon; Spencer, Thomas J.			Acceptability of an adjunct equine-assisted activities and therapies program for veterans with posttraumatic stress disorder and/or traumatic brain injury	JOURNAL OF INTEGRATIVE MEDICINE-JIM			English	Article						Posttraumatic stress disorder; Military personnel; Traumatic brain injury; Complementary and alternative medicine; Equine-assisted therapy	PSYCHOTHERAPY	Objective: Equine-assisted activities and therapies (EAATs) have been a growing adjunctive integrative health modality, as they allow participants to practice mindfulness, emotional regulation, and self-mastery or self-esteem building skills. Preliminary evidence suggests that these programs may be helpful in reducing posttraumatic stress disorder (PTSD), anxiety, and depressive symptoms. The current study examines the acceptability of integrating an EAAT program as part of a two-week, intensive clinical program for veterans with PTSD and/or traumatic brain injury (TBI). Methods: A family member or support person could accompany veterans and participate in the program. One hundred and six participants (veteran n = 62, family n = 44) left the urban environment in an intensive outpatient program (IOP) to attend a two-day, weekend EAAT in rural New Hampshire. Satisfaction surveys were conducted on the last day of the program and examined using thematic analysis. Results: The following themes were reported in the surveys: ability of horses to catalyze emotional rehabilitation, effectiveness of immersion in equine-assisted activities, program's ability to foster interpersonal relationships and necessity of education about PTSD for staff. Participants also reported enjoying the program as highlighted by qualitative feedback, a mean score of 9.76 (standard deviation [SD] = 0.61) as reported by veterans and a mean score of 9.91 (SD = 0.29) as reported by family members on a 10-point visual analog scale with higher scores indicating a greater overall experience. Conclusion: These data offer preliminary evidence that an adjunct EAAT program is acceptable for veterans with PTSD and/or TBI participating in an IOP. (C) 2020 Shanghai Changhai Hospital. Published by Elsevier B.V. All rights reserved.	[Sylvia, Louisa; West, Emerson; Blackburn, Allyson M.; Gupta, Carina; Bui, Eric; Wright, Edward C.; Lejeune, Simon; Spencer, Thomas J.] Massachusetts Gen Hosp, Home Base, Charlestown, MA 02129 USA; [Sylvia, Louisa; Bui, Eric; Wright, Edward C.; Lejeune, Simon; Spencer, Thomas J.] Harvard Med Sch, Boston, MA 02115 USA; [Sylvia, Louisa] Massachusetts Gen Hosp, Dauten Family Ctr Bipolar Treatment Innovat, Boston, MA 02114 USA; [Mahoney, Tara; Duncan, Geraldine] Equine Immers Programs, Long Valley, NJ USA; [Spencer, Thomas J.] Massachusetts Gen Hosp, Pediat Psychopharmacol & Adult ADHD Program, Boston, MA 02114 USA		Sylvia, L (corresponding author), Home Base, One Constitut Wharf, Charlestown, MA 02129 USA.	lsylvia2@mgh.harvard.edu	Blackburn, Allyson M./AAT-8097-2020	Blackburn, Allyson M./0000-0002-7678-4505	Home Base: A Red Sox Foundation; Massachusetts General Hospital Program	This work was made possible in part by the Wounded Warrior Project (WWP) and departmental funds from Home Base: A Red Sox Foundation and Massachusetts General Hospital Program. WWP maintains no involvement in study design, collection, analysis, interpretation of data or the decision to publish this work. Home Base pays Touchstone Farms for patient participation in EAATs, as part of routine clinical care in Home Base's Intensive Clinical Program.	Anestis MD, 2014, J CLIN PSYCHOL, V70, P1115, DOI 10.1002/jclp.22113; Bachi K, 2013, J CONTEMP PSYCHOTHER, V43, P187, DOI 10.1007/s10879-013-9232-1; Bachi K, 2012, CLIN CHILD PSYCHOL P, V17, P298, DOI 10.1177/1359104511404177; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Chen Q, 2016, COMPUT HUM BEHAV, V54, P34, DOI 10.1016/j.chb.2015.07.047; Earles JL, 2015, J TRAUMA STRESS, V28, P149, DOI 10.1002/jts.21990; Ferruolo DM, 2016, SOC WORK, V61, P53, DOI 10.1093/sw/swv054; Harvey MM, 2019, COGN BEHAV PRACT, V26, P323; Hruschka D., 2004, FIELD METHOD, V16, P184, DOI DOI 10.1177/1525822X03262663; Lanning BA, 2013, J REHABIL RES DEV, V50, pXV, DOI 10.1682/JRRD.2013.07.0159; MacLean B, 2011, J REHABIL RES DEV, V48, pIX, DOI 10.1682/JRRD.2011.05.0085; Mahoney T, 2018, VIRT EQ SERV HER C; Masini A, 2010, J PSYCHOSOC NURS MEN, V48, P30, DOI 10.3928/02793695-20100831-08; Ohye BY, 2015, PROF PSYCHOL-RES PR, V46, P97, DOI 10.1037/a0037735; Romaniuk M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203943; Saha S, 2008, J NATL MED ASSOC, V100, P1275, DOI 10.1016/S0027-9684(15)31505-4; Sylvia LG, 2013, J CLIN PSYCHOPHARM, V33, P343, DOI 10.1097/JCP.0b013e3182900c6f; Ward A. F., 2017, J ASS CONSUM RES, V2, P140, DOI [10.1086/691462, DOI 10.1086/691462]	18	2	2	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2095-4964			J INTEGR MED-JIM	J. Integr. Med.-JIM	MAR	2020	18	2					169	173		10.1016/j.joim.2020.01.005			5	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Integrative & Complementary Medicine	KU8WN	WOS:000519993900009	31996299	Bronze			2022-02-06	
J	Wiseman-Hakes, C; Kakonge, L; Doherty, M; Beauchamp, M				Wiseman-Hakes, Catherine; Kakonge, Lisa; Doherty, Meghan; Beauchamp, Miriam			A Conceptual Framework of Social Communication: Clinical Applications to Pediatric Traumatic Brain Injury	SEMINARS IN SPEECH AND LANGUAGE			English	Article						social communication; pediatrics; TBI; communication; pragmatics	YOUNG-CHILDREN; NEURAL BASIS; PRAGMATIC LANGUAGE; JOINT ATTENTION; ADOLESCENTS; SKILLS; COMPETENCE; NEUROSCIENCE; PREDICTORS; COGNITION	Social communication impairments are common following pediatric traumatic brain injury (TBI) and can lead to social isolation, and poor social outcomes. Social communication has been documented as a persistent area of need in terms of proper assessment and intervention; however, this is not consistently addressed in clinical practice. While there is a body of evidence regarding social communication impairments and pediatric TBI, this area is not yet fully understood and remains underrecognized. To meet this gap, we provide a conceptual framework of social communication from a neurodevelopmental perspective, which can be applied to better understand the social communication impairments associated with pediatric TBI. We propose a general model of social communication with component constructs and consideration of internal factors such as sex and gender. These can inform considerations, clinical applications, and future research in assessment and evidence-based interventions within the domain of social communication.	[Wiseman-Hakes, Catherine] McMaster Univ, Dept Speech Language Pathol, Hamilton, ON, Canada; [Kakonge, Lisa] Holland Bloorview Kids Rehabil Hosp, Dept Speech Language Pathol, Toronto, ON, Canada; [Doherty, Meghan] Five Counties Childrens Ctr, Dept Speech Language Pathol, Lindsay, ON, Canada; [Beauchamp, Miriam] Univ Montreal, Dept Dev Neuropsychol, Canada Res Chair Pediat Traumat Brain Injury, Montreal, PQ, Canada; [Wiseman-Hakes, Catherine] KITE UHN Toronto Rehab Inst, Toronto, ON, Canada		Wiseman-Hakes, C (corresponding author), McMaster Univ, Dept Speech Language Pathol, Sch Rehabil Sci, Inst Appl Hlth Sci, Room 403,1400 Main St West, Hamilton, ON L8S 1C7, Canada.	wisemc1@mcmaster.ca	Wiseman-Hakes, Catherine/AAC-8303-2021	Wiseman-Hakes, Catherine/0000-0001-8441-884X; Doherty, Meghan/0000-0001-8999-642X; Kakonge, Lisa/0000-0003-4164-6716; Beauchamp, Miriam/0000-0002-8637-6361			Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Agnihotri S, 2014, DEV NEUROREHABIL, V17, P44, DOI 10.3109/17518423.2013.844739; Agnihotri S, 2012, DEV NEUROREHABIL, V15, P284, DOI 10.3109/17518423.2012.673178; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; [Anonymous], 2019, SOC COMM DIS INT; Ashton R, 2018, APPL NEUROPSYCH-CHIL, V7, P175, DOI 10.1080/21622965.2016.1261701; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Beauchamp MH, 2019, BRAIN INJURY, V33, P32, DOI 10.1080/02699052.2018.1531307; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp MH, 2017, NEUROPSYCHOLOGY, V31, P981, DOI 10.1037/neu0000395; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beaudoin C, 2020, HDB PEDIAT NEUROLOGY; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Bishop D.V.M., 2006, CHILDRENS COMMUNICAT; Byom L, 2014, BRAIN BEHAV COGNITIO, P368; Canadian Institutes of Health Research, 2010, GEND SEX HLTH RES GU; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; CAVELL TA, 1990, J CLIN CHILD PSYCHOL, V19, P111, DOI 10.1207/s15374424jccp1902_2; Ciccia A, 2011, ENCY CLIN NEUROPSYCH, P1994; Ciccia AH, 2018, NEUROREHABILITATION, V42, P331, DOI 10.3233/NRE-172384; Code, 2014, SOCIAL COMMUNICATION, P1; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Deighton S, 2019, J HEAD TRAUMA REHAB, P29; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P230, DOI 10.1017/S135561771300009X; DeRosier ME, 2010, READ WRIT Q, V27, P25, DOI 10.1080/10573569.2011.532710; Douglas JM, 2010, BRAIN IMPAIR, V11, P171, DOI 10.1375/brim.11.2.171; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Elleseff T, 2018, ASSESSING SOCIAL PRA; Eunson B, 2012, COMMUNICATING 21 CEN, P74; Ewing-Cobbs L, 2013, J INT NEUROPSYCH SOC, V19, P497, DOI 10.1017/S1355617713000210; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Genova HM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00850; Greenaway K, 2017, OXFORD RES ENCY COMM, P1; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hartup WW, 1999, CURR DIR PSYCHOL SCI, V8, P76, DOI 10.1111/1467-8721.00018; Heverly-Fitt S, 2016, J PEDIATR PSYCHOL, V41, P235, DOI 10.1093/jpepsy/jsv085; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kuhnert RL, 2017, J EXP CHILD PSYCHOL, V154, P13, DOI 10.1016/j.jecp.2016.10.001; Landry SH, 2004, DEV NEUROPSYCHOL, V26, P707, DOI 10.1207/s15326942dn2603_4; Letteri A M, 2018, COGNITIVE REHABILITA, P190; Levey S, 2019, INTRO LANGUAGE DEV, P1; Linden MA, 2020, DISABIL REHABIL, V42, P2422, DOI 10.1080/09638288.2019.1629699; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Lundine JP, 2018, AM J SPEECH-LANG PAT, V27, P247, DOI 10.1044/2017_AJSLP-16-0131; MacDonald S, 2013, J INT NEUROPSYCHOL S; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Matthews D, 2018, LANG LEARN DEV, V14, P186, DOI 10.1080/15475441.2018.1455584; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P528, DOI 10.1017/S1355617713000039; Mesa-Gresa P, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082486; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moran LM, 2015, BRAIN INJURY, V29, P1682, DOI 10.3109/02699052.2015.1075140; Mundy P, 2018, EUR J NEUROSCI, V47, P497, DOI 10.1111/ejn.13720; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; O'Neill DK, 2007, J SPEECH LANG HEAR R, V50, P214, DOI 10.1044/1092-4388(2007/017); Orpinas P, 2010, SOCIAL COMPETENCE; Poulin V, 2019, BRAIN INJURY, V33, P120; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shaw JA, 2017, CONSCIOUS COGN, V51, P268, DOI 10.1016/j.concog.2017.02.012; Shin MS, 2012, J EARLY CHILD RES, V10, P309, DOI 10.1177/1476718X12443023; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Sohlberg MM, 2019, INT J SPEECH-LANG PA, V21, P115, DOI 10.1080/17549507.2019.1583280; Steel J, 2019, BRAIN INJURY, V33, P48, DOI 10.1080/02699052.2018.1531304; Struchen M A, 2006, FILLING GAPS IMPORTA; Sullivan JR, 2010, APPL NEUROPSYCHOL, V17, P93, DOI 10.1080/09084281003708852; Thompson EJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016633; Tlustos SJ, 2016, REHABIL PSYCHOL, V61, P347, DOI 10.1037/rep0000098; Togher L, 2014, BRAIN BEHAV COGNITIO, P89; Togher L, 2014, BRAIN BEHAV COGNITIO, P336; Tomasello M., 1992, SOC DEV, V1, P67, DOI [DOI 10.1111/J.1467-9507.1992.TB00135.X, 10.1111/j.1467-9507.1992.tb00135.x]; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2015, DEV MED CHILD NEUROL, V57, P217, DOI 10.1111/dmcn.12600; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2018, REHABIL PSYCHOL, V63, P327, DOI 10.1037/rep0000187; Wiseman-Hakes C, 1998, J HEAD TRAUMA REHAB, V13, P23, DOI 10.1097/00001199-199812000-00005; Wiseman-Hakes C, 2018, COGNITIVE REHABILITA, P122; Wiseman-Hakes C, 2020, DISABIL REHABIL, V42, P3559, DOI 10.1080/09638288.2019.1597180; Wood RL, 2013, J HEAD TRAUMA REHAB, V28, P98, DOI 10.1097/HTR.0b013e3182426029; Yeates G, 2016, NEUROREHABILITATION, V38, P299, DOI 10.3233/NRE-161321; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P493, DOI 10.1017/S1355617713000398; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891; Yuan SNV, 2018, LONDON J PRIM CARE, V10, P110, DOI 10.1080/17571472.2018.1483000; Zamani A, 2019, EXP NEUROL, V314, P34, DOI 10.1016/j.expneurol.2019.01.007	99	2	2	0	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	MAR	2020	41	2					143	160		10.1055/s-0040-1701683			18	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	LE5NF	WOS:000526765100002	32155650				2022-02-06	
J	Hill, E; Claessen, M; Whitworth, A; Boyes, M				Hill, Elizabeth; Claessen, Mary; Whitworth, Anne; Boyes, Mark			Profiling variability and development of spoken discourse in mainstream adolescents	CLINICAL LINGUISTICS & PHONETICS			English	Article						Discourse; adolescent; language; assessment	TRAUMATIC BRAIN-INJURY; EXPOSITORY DISCOURSE; LANGUAGE PRODUCTION; ELICITATION TASK; CHILDREN; NARRATIVES; COHESION; ADULTS; CHILDHOOD; COHERENCE	Competence in spoken discourse is an important consideration during assessment and intervention planning for adolescents with communication difficulties. Currently, a lack of age-appropriate protocols and reference data against which to interpret performance, are barriers when working with this population, particularly those that assess a range of genre and language features. Using a new assessment tool, the Curtin University Discourse Protocol-Adolescent (CUDP-A), this study aimed to collect and describe spoken discourse samples from a large group of adolescents (n = 160), aged 12 to 15 years, recruited to represent a mainstream academic cohort. For each participant, samples of recount (n = 3), expository (n = 3), persuasive (n = 3), and narrative (n = 2) discourse were described using theoretically supported measurements sensitive to micro-linguistic, micro-structural, macro-structural, and super-structural discourse features. Participants also completed a standardized assessment of oral language. Variability was found in micro-linguistic and micro-structural features, with stability seen in macro-structural and super-structural features. Few age- and gender-related differences were observed, while multiple significant correlations between spoken discourse and oral language variables were revealed across the sample. The CUDP-A was successful in eliciting spoken discourse across genres relevant to social and academic contexts, enabling an in-depth description of adolescent discourse. This tool, supported by the reference data, provides a new opportunity to assess spoken discourse skills in adolescents from clinical populations, e.g., acquired brain injury or developmental disorders. Further research is needed to examine factors influencing discourse ability, such as those that may be related to genre, or contextual factors related to the presence of communication partners, with novel tools such as the CUDP-A facilitating this.	[Hill, Elizabeth; Claessen, Mary; Whitworth, Anne] Curtin Univ, Sch Occupat Therapy Social Work & Speech Pathol, Perth, Australia; [Boyes, Mark] Curtin Univ, Sch Psychol, Perth, WA, Australia		Hill, E (corresponding author), Curtin Univ, Perth, WA, Australia.	elizabeth.j.hill@postgrad.curtin.edu.au	Whitworth, Anne/AAX-4888-2020; Hill, Elizabeth/AAL-7790-2020; Boyes, Mark/G-9680-2014	Whitworth, Anne/0000-0002-4653-0782; Claessen, Mary/0000-0002-1087-5041; Boyes, Mark/0000-0001-5420-8606; Hill, Elizabeth/0000-0003-4363-4962	Curtin University School of Occupational Therapy, Social Work, and Speech Pathology, an Australian Postgraduate Award; Curtin University Postgraduate Scholarship	The authors declare that they have no conflicts of interest. This work was funded through the Curtin University School of Occupational Therapy, Social Work, and Speech Pathology, an Australian Postgraduate Award, and Curtin University Postgraduate Scholarship.	Beales A, 2018, INT J SPEECH-LANG PA, V20, P361, DOI 10.1080/17549507.2018.1442498; Berman RA, 2007, DISCOURSE PROCESS, V43, P79, DOI 10.1207/s15326950dp4302_1; Bishop DVM, 2005, BRIT J DEV PSYCHOL, V23, P25, DOI 10.1348/026151004X20685; Bornstein MH, 2014, CHILD DEV, V85, P1346, DOI 10.1111/cdev.12192; Bryant L, 2017, APHASIOLOGY, V31, P1105, DOI 10.1080/02687038.2016.1239013; CANNIZZARO MS, 2019, CLIN ARCH COMMUN DIS, V0004, P00010, DOI DOI 10.21849/CACD.2019.00017; Capilouto G, 2005, J COMMUN DISORD, V38, P431, DOI 10.1016/j.jcomdis.2005.03.005; Channell MM, 2018, AM J SPEECH-LANG PAT, V27, P123, DOI 10.1044/2017_AJSLP-17-0046; Channell MM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00283; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Colozzo P, 2011, J SPEECH LANG HEAR R, V54, P1609, DOI 10.1044/1092-4388(2011/10-0247); Daniel, 1999, BIOSTATISTICS FDN AN; Ebert KD, 2014, LANG SPEECH HEAR SER, V45, P337, DOI 10.1044/2014_LSHSS-14-0034; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; FREDERIKSEN CH, 1993, NARRATIVE DISCOURSE; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Heilmann J, 2014, LANG SPEECH HEAR SER, V45, P277, DOI 10.1044/2014_LSHSS-13-0050; Heilmann J, 2010, LANG SPEECH HEAR SER, V41, P393, DOI 10.1044/0161-1461(2009/09-0023); HOLLAND A, 1990, RES S COMM SCI DIS A, DOI DOI 10.1099/00221287-136-2-327; Jakobson R., 1980, FRAMEWORK LANGUAGE, P93; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Le K., 2011, ASHA LEADER, V16, P18, DOI [10.1044/leader.FTR4.16022011.18, DOI 10.1044/LEADER.FTR4.16022011.18, DOI 10.1044/leader.FTR4.16022011.18]; LILES BZ, 1985, J SPEECH HEAR RES, V28, P123, DOI 10.1044/jshr.2801.123; Loban Walter, 1976, LANGUAGE DEV KINDERG; Lundine JP, 2018, LANG SPEECH HEAR SER, V49, P551, DOI 10.1044/2018_LSHSS-17-0105; Makinen L, 2014, FIRST LANG, V34, P24, DOI 10.1177/0142723713511000; Matsuoka K, 2012, BRAIN INJURY, V26, P1723, DOI 10.3109/02699052.2012.698789; McMahon S., 2005, ADV SPEECH LANGUAGE, V7, P113, DOI [10.1080/, DOI 10.1080/14417040500125251]; Miller, 2004, ADV SPEECH LANGUAGE, V6, P195, DOI [10.1080/14417040400010140, DOI 10.1080/14417040400010140]; Miller J.F., 2012, SYSTEMATIC ANAL LANG; Miller JF, 2016, LANG SPEECH HEAR SER, V47, P99, DOI 10.1044/2015_LSHSS-15-0051; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Nippold M., 1998, LATER LANGUAGE DEV S; Nippold M. A., 2007, LATER LANGUAGE DEV S; Nippold M. A, 2010, LANGUAGE SAMPLING AD; Nippold MA, 2005, J SPEECH LANG HEAR R, V48, P1048, DOI 10.1044/1092-4388(2005/073); NIPPOLD MA, 2010, NEW DIRECTIONS COMMU, P00001; Nippold MA, 2008, AM J SPEECH-LANG PAT, V17, P356, DOI 10.1044/1058-0360(2008/07-0049); Nippold MA, 2017, AM J SPEECH-LANG PAT, V26, P908, DOI 10.1044/2017_AJSLP-16-0181; Nippold MA, 2015, J SPEECH LANG HEAR R, V58, P325, DOI 10.1044/2015_JSLHR-L-14-0129; Norbury CF, 2003, INT J LANG COMM DIS, V38, P287, DOI 10.1080/136820310000108133; O'Kearney R, 2007, APPL COGNITIVE PSYCH, V21, P821, DOI 10.1002/acp.1294; PAUL R, 2011, LANGUAGE DISORDERS I; Pimentel-Gomes F, 1985, CURSO ESTATISTICA EX; Reese E, 2011, J COGN DEV, V12, P424, DOI 10.1080/15248372.2011.587854; ROCKWELL N, 1953, YOUNG LADY SHINER; ROCKWELL N, 1958, THE RUNAWAY; *SCH CURR STAND AU, 2016, ENGL SCOP SEQ P 10 V; Scott CM, 2000, J SPEECH LANG HEAR R, V43, P324, DOI 10.1044/jslhr.4302.324; Scott KS, 2014, INT J LANG COMM DIS, V49, P75, DOI 10.1111/1460-6984.12048; Semel E., 2003, CLIN EVALUATION LANG; Snow PC, 2005, PSYCHOL CRIME LAW, V11, P239, DOI 10.1080/1068316042000209323; Solomon O, 2004, DISCOURSE STUD, V6, P253, DOI 10.1177/1461445604041770; Steel J, 2019, BRAIN INJURY, V33, P48, DOI 10.1080/02699052.2018.1531304; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Tabachnik BG, 2007, USING MULTIVARIATE S; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Westerveld MF, 2016, INT J SPEECH-LANG PA, V18, P288, DOI 10.3109/17549507.2016.1159332; Westerveld MF, 2011, LANG SPEECH HEAR SER, V42, P182, DOI 10.1044/0161-1461(2010/10-0044); WHITWORTH A, 2018, APHASIOLOGY, V32, P246, DOI DOI 10.1080/02687038.2018.1493427; Whitworth A, 2015, CLIN LINGUIST PHONET, V29, P455, DOI 10.3109/02699206.2015.1020450; World Health Organization, 2007, INT CLASS FUNCT DIS; Zelazo PD, 2012, CHILD DEV PERSPECT, V6, P354, DOI 10.1111/j.1750-8606.2012.00246.x	67	2	2	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.	FEB 1	2021	35	2					117	137		10.1080/02699206.2020.1731607		FEB 2020	21	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	PO2MH	WOS:000518334400001	32126850				2022-02-06	
J	Rushby, JA; De Blasio, FM; Logan, JA; Wearne, T; Kornfeld, E; Wilson, EJ; Loo, C; Martin, D; McDonald, S				Rushby, Jacqueline A.; De Blasio, Frances M.; Logan, Jodie A.; Wearne, Travis; Kornfeld, Emma; Wilson, Emily Jane; Loo, Colleen; Martin, Donel; McDonald, Skye			tDCS effects on task-related activation and working memory performance in traumatic brain injury: A within group randomized controlled trial	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Transcranial direct current stimulation (tDCS); Traumatic brain injury (TBI); Working memory; Treatment; Arousal	DIRECT-CURRENT STIMULATION; COGNITIVE REHABILITATION; HOSPITAL ANXIETY; MOTOR CORTEX; AROUSAL; DEPRESSION; ATTENTION; VALIDITY; EMPATHY; NEUROSTIMULATION	Non-invasive transcranial direct current stimulation (tDCS) has been reported to facilitate working memory in normal adults. There is some evidence in people with Traumatic Brain Injury (TBI) but overall evidence is mixed. This study aimed to address shortcomings of prior study designs in TBI to examine whether a single dose of tDCS would lead to benefits in working memory. Thirty people with severe, chronic TBI were administered a single session of either anodal tDCS (2 mA for 20 min) or sham tDCS (2 mA for 30 s), in a counterbalanced order, over the left parietal cortex while performing 1-back and 2-back working memory tasks. Skin conductance levels were examined as a measure of task activated arousal, a possible functional analogue of cortical excitability. We found that tDCS led to no improvements in accuracy on the working memory tasks. A slight increase in variability and reaction time with tDCS was related to decreased task activated arousal. Overall, this study yielded no evidence that a single session of tDCS can facilitate working memory for people with TBI.	[Rushby, Jacqueline A.; De Blasio, Frances M.; Logan, Jodie A.; Wearne, Travis; Kornfeld, Emma; Wilson, Emily Jane; McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Loo, Colleen; Martin, Donel] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Loo, Colleen; Martin, Donel] Univ New South Wales, Black Dog Inst, Sydney, NSW, Australia		Rushby, JA (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	De Blasio, Frances M./D-9158-2019; McDonald, Skye/G-4118-2014	De Blasio, Frances M./0000-0003-1442-9820; Wilson, Emily/0000-0002-1949-7657; Wearne, Travis/0000-0002-7565-9163; McDonald, Skye/0000-0003-0723-6094; Logan, Jodie/0000-0003-1198-487X	Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [1081923]	This work was supported by the Australian National Health and Medical Research Council (NHMRC) [grant number 1081923].	Arciniega H, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00057; Barry RJ, 2005, CLIN NEUROPHYSIOL, V116, P2693, DOI 10.1016/j.clinph.2005.08.008; Barry RJ, 2005, J PSYCHOPHYSIOL, V19, P91, DOI 10.1027/0269-8803.19.2.91; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Berryhill ME, 2010, NEUROSCI LETT, V479, P312, DOI 10.1016/j.neulet.2010.05.087; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Buchsbaum BR, 2008, J COGNITIVE NEUROSCI, V20, P762, DOI 10.1162/jocn.2008.20501; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Dhaliwal SK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00119; Fisher AC, 2015, CLIN NEUROPHYSIOL, V126, P314, DOI 10.1016/j.clinph.2014.05.033; Franke LM, 2016, INT J PSYCHOPHYSIOL, V106, P21, DOI 10.1016/j.ijpsycho.2016.05.010; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gonzalez PC, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00416; Heimrath K, 2012, Front Psychiatry, V3, P56, DOI 10.3389/fpsyt.2012.00056; Heinen K, 2016, NEUROPSYCHOLOGIA, V87, P35, DOI 10.1016/j.neuropsychologia.2016.04.028; Imburgio MJ, 2018, NEUROPSYCHOLOGIA, V117, P156, DOI 10.1016/j.neuropsychologia.2018.04.022; Jones KT, 2017, BRAIN RES, V1667, P28, DOI 10.1016/j.brainres.2017.05.005; Jones KT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121904; Jones KT, 2015, NEUROIMAGE, V105, P238, DOI 10.1016/j.neuroimage.2014.11.012; Jones KT, 2014, EXP BRAIN RES, V232, P4043, DOI 10.1007/s00221-014-4090-y; Jones Kevin T, 2012, Front Psychiatry, V3, P81, DOI 10.3389/fpsyt.2012.00081; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Loo CK, 2011, INT J NEUROPSYCHOPH, V14, P425, DOI 10.1017/S1461145710001197; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martin DM, 2018, NEUROSCI BIOBEHAV R, V90, P137, DOI 10.1016/j.neubiorev.2018.04.008; Martin DM, 2014, EXP BRAIN RES, V232, P3345, DOI 10.1007/s00221-014-4022-x; Martin DM, 2013, INT J NEUROPSYCHOPH, V16, P1927, DOI 10.1017/S1461145713000539; McDonald S, 2019, BRAIN IMAGING BEHAV, V13, P819, DOI 10.1007/s11682-018-9906-0; McDonald S, 2011, INT J PSYCHOPHYSIOL, V82, P124, DOI 10.1016/j.ijpsycho.2011.01.014; Medina J, 2017, CORTEX, V94, P131, DOI 10.1016/j.cortex.2017.06.021; Nikolin S, 2019, FRONT INTEGR NEUROSC, V12, DOI 10.3389/fnint.2018.00064; Nilsson J, 2017, PSYCHOL SCI, V28, P907, DOI 10.1177/0956797617698139; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Olson IR, 2009, NEUROBIOL LEARN MEM, V91, P155, DOI 10.1016/j.nlm.2008.09.006; Parkin BL, 2015, NEURON, V87, P932, DOI 10.1016/j.neuron.2015.07.032; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Rae CD, 2013, INT J NEUROPSYCHOPH, V16, P1695, DOI 10.1017/S1461145713000084; Reitan RM, 1992, TRAIL MAKING TEST; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; ROSE JE, 1991, PHARMACOL BIOCHEM BE, V38, P333, DOI 10.1016/0091-3057(91)90287-C; Rushby J. A., INVESTIGATION UNPUB; Rushby JA, 2016, NEUROIMAGE-CLIN, V12, P607, DOI 10.1016/j.nicl.2016.09.017; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P460, DOI 10.1016/j.ijpsycho.2013.05.009; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P466, DOI 10.1016/j.ijpsycho.2013.06.013; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00057; Smith A., 2007, SYMBOL DIGITS MODALI; Stephens JA, 2016, BRAIN STIMUL, V9, P555, DOI 10.1016/j.brs.2016.04.001; Terry PC, 1999, J SPORT SCI, V17, P861, DOI 10.1080/026404199365425; Terry PC, 2003, PSYCHOL SPORT EXERC, V4, P125, DOI 10.1016/S1469-0292(01)00035-8; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; VaezMousavi SM, 2007, ACTA NEUROBIOL EXP, V67, P461; VaezMousavi SM, 2007, ACTA NEUROBIOL EXP, V67, P179; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wagner T, 2007, NEUROIMAGE, V35, P1113, DOI 10.1016/j.neuroimage.2007.01.027; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	68	2	2	2	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 28	2021	31	5					814	836		10.1080/09602011.2020.1733620		FEB 2020	23	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	RW6NE	WOS:000518256200001	32114899				2022-02-06	
J	Lei, SS; He, Y; Zhu, ZT; Liu, ZR; Lin, YW; He, YH; Du, S; Chen, X; Xu, PY; Zhu, XQ				Lei, Shuisheng; He, Yan; Zhu, Ziting; Liu, Zhongrui; Lin, Yuwan; He, Yuehua; Du, Sheng; Chen, Xiang; Xu, Pingyi; Zhu, Xiaoqin			Inhibition of NMDA Receptors Downregulates Astrocytic AQP4 to Suppress Seizures	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Seizures; NMDAR; NR2A; Aquaporin 4; Inflammation; NF-kappa B	TRAUMATIC BRAIN-INJURY; AQUAPORIN 4 EXPRESSION; SUBUNIT COMPOSITION; LOBE EPILEPSY; EDEMA; INFLAMMATION; HIPPOCAMPUS; ACTIVATION	Aquaporin 4 (AQP4), a water-specific channel protein locating on the astrocyte membrane, has been found to be antagonist, agonist and undergone closely related to epilepsy. Our previous study showed that inhibition of an N-methyl-d-aspartate receptor (NMDAR) subunit NR2A can suppress epileptic seizures, suggesting that AQP4 is potentially involved in NR2A-mediated epilepsy treatment. In this study, we aimed to explore the relevance of AQP4 in NR2A-mediated seizures treatment in pentylenetetrazol (PTZ)-induced rat models. We performed electroencephalogram (EEG) recording and examined AQP4 expression at mRNA and protein levels, and the downstream molecules of AQP4 as well. It showed that AQP4 expression was increased after the induction of seizures. Lateral ventricle pretreatment of NR2A inhibitor could mitigate the PTZ-induced seizures severity and counterbalance the increase of AQP4 expression. In contrast, NR2A activator that resulted in seizures aggravation could further augment the seizure-related elevations of AQP4 expression. Pharmacological inhibition of AQP4 alone could also suppress the PTZ-induced seizure activities, with decreased expressions of NF-kappa B p65, interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-alpha in the brain. The results indicated that increased expression of AQP4 might be an important mechanism involved in NR2A of NMDAR-mediated treatment for epileptic seizures, enlightening a potentially new target for seizures treatment.	[Lei, Shuisheng; He, Yan; Zhu, Ziting; Liu, Zhongrui; Lin, Yuwan; He, Yuehua; Du, Sheng; Xu, Pingyi; Zhu, Xiaoqin] Guangzhou Med Univ, Key Lab Neurosci, Dept Physiol, Sch Basic Med Sci,Dept Dermatol,Affiliated Hosp 5, Guangzhou 511436, Peoples R China; [Zhu, Ziting; Lin, Yuwan; Chen, Xiang; Xu, Pingyi] Guangzhou Med Univ, Dept Neurol, Affiliated Hosp 1, Guangzhou 510120, Peoples R China		Xu, PY; Zhu, XQ (corresponding author), Guangzhou Med Univ, Key Lab Neurosci, Dept Physiol, Sch Basic Med Sci,Dept Dermatol,Affiliated Hosp 5, Guangzhou 511436, Peoples R China.; Xu, PY (corresponding author), Guangzhou Med Univ, Dept Neurol, Affiliated Hosp 1, Guangzhou 510120, Peoples R China.	pingyixu@sina.com; whzhuxiaoqin@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771401, 81870992, 81870856, 81603681, U1603281]; Natural Science Foundation of Guangdong Province of ChinaNational Natural Science Foundation of Guangdong Province [2020A1515010986]; Science and Technology Planning Project of Guangdong Province of China [2017ZC0234]; technology project of Guangzhou [2018-1202-SF-0019]	This work was supported by research grants from the National Natural Science Foundation of China (81771401, 81870992, 81870856, 81603681, U1603281), Natural Science Foundation of Guangdong Province of China (2020A1515010986), Science and Technology Planning Project of Guangdong Province of China (2017ZC0234), a technology project of Guangzhou (2018-1202-SF-0019).	Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Burfeind Kevin G, 2017, Alzheimers Dement (N Y), V3, P348, DOI 10.1016/j.trci.2017.05.001; Cai M, 2016, J ETHNOPHARMACOL, V181, P136, DOI 10.1016/j.jep.2016.01.026; Chen L, 2015, J HUAZHONG U SCI TEC, V05, P510; Chen LH, 2018, IRAN J BASIC MED SCI, V21, P1148, DOI 10.22038/IJBMS.2018.29135.7037; Chen Q, 2007, J NEUROSCI, V27, P542, DOI 10.1523/JNEUROSCI.3607-06.2007; Choi J, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-38; Dai WS, 2018, INT J MOL MED, V42, P1716, DOI 10.3892/ijmm.2018.3749; Das A, 2012, NEUROSCIENCE, V220, P237, DOI 10.1016/j.neuroscience.2012.06.002; Deng Z, 2014, EPILEPTICUS, V2, P168; Devinsky O, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.24; Duan L, 2017, MED SCI MONITOR, V23, P5818, DOI 10.12659/MSM.903855; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Mercado-Gomez OF, 2018, EPILEPSY RES, V148, P37, DOI 10.1016/j.eplepsyres.2018.09.012; Guo C, 2019, INFLAMMATION, V42, P1401, DOI 10.1007/s10753-019-01002-4; Han XJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010300; Hubbard JA, 2018, BRAIN RES BULL, V136, P118, DOI 10.1016/j.brainresbull.2017.02.011; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kouis P, 2014, EPILEPSY RES, V108, P1564, DOI 10.1016/j.eplepsyres.2014.08.001; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Li X, 2017, BEHAV BRAIN RES, V364, P403, DOI DOI 10.1016/j.bbr.2017.12.031; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Luo Tong, 2011, Front Biol (Beijing), V6, P468; Medici V, 2011, BRAIN RES, V1367, P330, DOI 10.1016/j.brainres.2010.10.005; Mei ZR, 2018, BEHAV BRAIN RES, V340, P195, DOI 10.1016/j.bbr.2017.04.017; Menezes FP, 2017, EPILEPSY RES, V135, P14, DOI 10.1016/j.eplepsyres.2017.05.009; Michel PP, 2016, NEURON, V90, P675, DOI 10.1016/j.neuron.2016.03.038; Ohnishi M, 2014, NEUROCHEM INT, V75, P32, DOI 10.1016/j.neuint.2014.05.007; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Patterson KP, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0034-15.2015; Paxinos G, 1996, RAT BRAIN STEREOTAXI; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Rozov A, 2016, CELL CALCIUM, V60, P407, DOI 10.1016/j.ceca.2016.09.005; Schrattenholz A, 2006, CURR TOP MED CHEM, V6, P663, DOI 10.2174/156802606776894519; Shi YB, 2018, MOL MED REP, V17, P5125, DOI 10.3892/mmr.2018.8485; Shin HJ, 2014, CELL DEATH DIFFER, V21, P1095, DOI 10.1038/cdd.2014.29; Skowronska K, 2019, NEUROTOX RES, V35, P271, DOI 10.1007/s12640-018-9958-3; Sun L, 2019, J NEUROTRAUM, V36, P421, DOI 10.1089/neu.2018.5642; Sun L, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1008-1; Szepetowski P, 2018, PRESSE MED, V47, P218, DOI 10.1016/j.lpm.2017.10.020; Tovar KR, 1999, J NEUROSCI, V19, P4180; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Verkman AS, 2017, EXPERT OPIN THER TAR, V21, P1161, DOI 10.1080/14728222.2017.1398236; Wang C, 2018, LIFE SCI, V193, P270, DOI 10.1016/j.lfs.2017.10.021; Wang XR, 2017, J STROKE CEREBROVASC, V26, P2199, DOI 10.1016/j.jstrokecerebrovasdis.2017.05.002; Wang XX, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00147; Wu X, 2017, NEUROPHARMACOLOGY, V112, P124, DOI 10.1016/j.neuropharm.2016.06.031; Xie YY, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00315; Yang Y, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau2357; Yin J, 2018, MED SCI MONITOR, V24, P1863, DOI 10.12659/MSM.907212; Yu H, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15039012; Yu H, 2015, J APOPLEXY NERV DIS, V08, P730; Zhou DS, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00121; Zhou Y, 2010, NEUROCHEM RES, V35, P2124, DOI 10.1007/s11064-010-0325-x	56	2	2	4	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2020	40	8					1283	1295		10.1007/s10571-020-00813-6		FEB 2020	13	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	NO3DI	WOS:000516959700003	32107753				2022-02-06	
J	Patchana, T; Wiginton, J; Brazdzionis, J; Ghanchi, H; Zampella, B; Toor, H; Dorkoski, R; Mannickarottu, A; Wacker, M; Sweiss, R; Miulli, DE				Patchana, Tye; Wiginton, James; Brazdzionis, James; Ghanchi, Hammad; Zampella, Bailey; Toor, Harjyot; Dorkoski, Ryan; Mannickarottu, Anjali; Wacker, Margaret; Sweiss, Raed; Miulli, Dan E.			Increased Brain Tissue Oxygen Monitoring Threshold to Improve Hospital Course in Traumatic Brain injury Patients	CUREUS			English	Article						cerebral tissue oxygenation; traumatic brain injury; pbto2; brain tissue oxygen monitoring; tbi		Introduction This article is a retrospective analysis of the neurosurgical census at our institution to determine an optimal threshold for brain tissue oxygenation (PbtO2). The use of brain tissue oxygen monitoring has been in place for approximately three decades but data suggesting optimal thresholds to improve outcomes have been lacking. Though there are multiple modalities to monitor cerebral oxygenation, the monitoring of brain tissue oxygen tension has been deemed the gold standard. Still, it is not clear exactly how reductions in PbtO2 should be treated or what appropriate thresholds to treat might be. The aim of our study was to determine if our threshold of 28 mmHg for a good functional outcome could be correlated to the Glasgow Coma Scale (GCS) and Glasgow Outcome Scale (GOS). Methods A retrospective analysis of the Arrowhead Regional Medical Center (ARMC) Neurosurgery Census was performed. Patients from 2017-2019 who had placement of Licox (R) cerebral oxygen monitoring sensors (Integra (R) Lifesciences, Plainsboro Township, New Jersey) were included in the analysis. Fifteen patients were consecutively identified, all of which presented with traumatic brain injury (TBI). Data on age, gender, days in the intensive care unit (ICU), days before discharge or end of medical care, admission GCS, hospital length of stay, GOS, maximum and minimum PbtO2 values for five days following insertion, minimum and maximum intracranial pressures (ICPs), and brain temperature were included for analysis. Patient data were separated into two groups; those with consistently higher PbtO2 scores (>= 28 mmHg; n = 7) and those with inconsistent/lower PbtO2 scores (< 28 mmHg; n = 8). Standard student t-tests were used to find potential statistical differences between the groups (alpha = 0.05). Results There were seven patients in the consistently high PbtO2 category (>= 28 mmHg) and eight patients in the inconsistent/low PbtO2 category (<28 mmHg). The average maximum and minimum PbtO2 for the group displaying worse outcomes (as defined by GCS/GOS) was 23.0 mmHg and 14 mmHg, respectively. Those with consistent Day 2 PbtO2 scores of >= 28 mmHg had significantly higher GCS scores at discharge/end of medical care (p < 0.05). Average GCS for the patient group with >28 mmHg PbtO2 averaged over Days 2-5 group was 11.4 (n=7). Average GCS for the <28 group was 7.0 (n=8). The GCS for the >28 group was 63% higher than found in the <28 group (p = 0.03). GOS scores were significantly higher in those with consistently higher PbtO2 (>= 28) than those with lower PbtO2 scores (< 28). The averages were 3.5 in the higher PbtO2 group as compared to 2 in the lower PbtO2 group. Conclusion Along with ICP monitors and monitoring in the assessment of CPP, brain tissue oxygenation allows yet another metric by which to optimize treatment in TBI patients. At our institution, a PbtO2 level of >= 28 mmHg is targeted in order to facilitate a good functional outcome in TBI patients. Keeping patients at this level improves GCS and GOS at discharge/end of medical treatment.	[Patchana, Tye; Wiginton, James; Brazdzionis, James; Ghanchi, Hammad; Zampella, Bailey; Toor, Harjyot; Sweiss, Raed; Miulli, Dan E.] Riverside Univ Hlth Syst, Med Ctr, Neurosurg, Moreno Valley, CA 92555 USA; [Dorkoski, Ryan] Ohio Univ, Environm & Plant Sci, Athens, OH 45701 USA; [Mannickarottu, Anjali; Wacker, Margaret] Arrowhead Reg Med Ctr, Neurosurg, Colton, CA USA		Patchana, T (corresponding author), Riverside Univ Hlth Syst, Med Ctr, Neurosurg, Moreno Valley, CA 92555 USA.	tyepatchana@gmail.com		Brazdzionis, James/0000-0002-1336-4810			[Anonymous], 2019, INTEGRA LICOX BRAIN; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Craven CL, 2019, J NEUROL NEUROSUR PS, V90, pE2, DOI 10.1136/jnnp-2019-ABN.4; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Doppenberg EMR, 1998, ACT NEUR S, V71, P166; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; Hirschi R, 2019, J NEUROSURG, V131, P1216, DOI 10.3171/2018.4.JNS172604; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pinggera D, 2018, WORLD NEUROSURG, V117, P62, DOI 10.1016/j.wneu.2018.05.154; Siddiqi J, 2017, NEUROSURGICAL INTENS; Smythe Paul R, 2002, Anesthesiol Clin North Am, V20, P293, DOI 10.1016/S0889-8537(01)00003-7; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278	15	2	3	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	FEB 27	2020	12	2							e7115	10.7759/cureus.7115			20	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	KR4AP	WOS:000517560700005	32257661	Green Published, gold			2022-02-06	
J	Ghroubi, S; Alila, S; Elleuch, W; Ben Ayed, H; Mhiri, C; Elleuch, MH				Ghroubi, Sameh; Alila, Samar; Elleuch, Wafa; Ben Ayed, Houda; Mhiri, Chokri; Elleuch, Mohamed Habib			Efficacy of botulinum toxin A for the treatment of hemiparesis in adults upper limb spasticity	PAN AFRICAN MEDICAL JOURNAL			English	Article						Botulinum toxin-A; function; stroke; upper limb	DOUBLE-BLIND; CEREBRAL-PALSY; STROKE; REHABILITATION; SAFETY	Introduction: this study aimed to evaluate the effectiveness of botulinum toxin A (BoNT-A) injection in hemiparetic patients with chronic spasticity in the upper limb resulting from stroke or traumatic brain injury. Methods: we conducted a retrospective study including 45 patients seen, in our department of Physical Medicine and Rehabilitation, between January 2014 and December 2016. All patients received an injection of BoNT-A (Dysport, 100 U/ml). Affected upper-extremity muscles could be injected as per the investigator's discretion to a maximum total dose of 1000 U. We evaluated muscle tone using Modified Ashworth Scale (MAS) [1]. Functional disability was assessed using Modified Frenchay Scale (MFS), Nine Hole Peg Test (NHPT) and Barthel Index (BI). Quality of life (QoL) was assessed using the 36-Item Short Form Health Survey (SF-36). The achievement of treatment goal was assessed by the Goal Attainment Scaling (GAS). Results: patients decreased their MAS score over the first and the third months (p<0.05). MFS showed improvement at 1 month after injection with a median change from baseline of 8 (range: 1-16; p<0.001). The change from baseline ranged from 0 to 5 points for NHPT at 1 month after injection (p< 0.001). This functional improvement was maintained to 3 months. Improvements in Barthel Index was observed at 3 months with a median change from baseline of 5 points (range 0-15; p<0.001). The mean change from baseline of SF-36 score was 4.77 +/- 3.39 (p<0.001). The mean GAS T-score was 47.04 +/- 7.78 (median 50, IQR 7.7), giving a mean (SD) change from baseline of 25.36 +/- 8.46 (95% CI 22.82 to 27.90; p <0.001). Binary logistic regression was used to identify the independent factors predicting a favorable functional outcome of Bon-T treatment. It showed that neglect was independent predictive factor treatment failure (p=0.009, OR=3.2) while previous injection of BoNT-A was an independent predictive factors of treatment success (p=0.009, OR=0.3). Conclusion: our study showed a good response to BoNT-A injection delivered in the management of chronic upper limb spasticity resulting from stroke or traumatic brain injury. It demonstrated its outcome in improving muscle tone, function and QoL. It also showed that the majority of patients achieved their goal as defined at the start of the treatment, mainly for patients who received previous injection of BoNT-A.	[Ghroubi, Sameh; Alila, Samar; Elleuch, Wafa; Elleuch, Mohamed Habib] Univ Hosp Hbib Bourguiba, Dept Phys Med & Rehabil, Sfax, Tunisia; [Ben Ayed, Houda] Univ Hosp Hedi Cheker Sfax, Dept Epidemiol & Community Med, Sfax, Tunisia; [Mhiri, Chokri] Univ Hosp Hbib Bourguiba, Dept Neurol, Sfax, Tunisia		Elleuch, MH (corresponding author), Univ Hosp Hbib Bourguiba, Dept Phys Med & Rehabil, Sfax, Tunisia.						Ada L, 2006, DISABIL REHABIL, V28, P891, DOI 10.1080/09638280500535165; Bakheit AMO, 2001, EUR J NEUROL, V8, P559, DOI 10.1046/j.1468-1331.2001.00277.x; Cardillo JE., 1994, GOAL ATTAINMENT SCAL; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Ferrapie A.-L., 2005, Annales de Readaptation et de Medecine Physique, V48, P172, DOI 10.1016/j.annrmp.2004.10.007; Feve A, 2003, NEUROCHIRURGIE, V49, P265; Garces K, 2015, BOTULINUM TOXIN UPPE; Gracies JM, 2010, EUR J PHYS REHAB MED, V46, P411; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Guermazi M., 2012, Annals of Physical and Rehabilitation Medicine, V55, P388, DOI 10.1016/j.rehab.2012.05.003; Hesse S, 1998, CLIN REHABIL, V12, P381, DOI 10.1191/026921598668275996; Intiso D., 2013, J NEUROL NEUROPHYSIO, V4, P1; Jahangir A W, 2007, Med J Malaysia, V62, P319; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Levy CE, 2001, AM J PHYS MED REHAB, V80, P4, DOI 10.1097/00002060-200101000-00003; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; Montecucco C, 2005, CURR OPIN PHARMACOL, V5, P274, DOI 10.1016/j.coph.2004.12.006; Ostensjo S, 2008, DEV NEUROREHABIL, V11, P252, DOI 10.1080/17518420802525500; Page SJ, 2003, AM J PHYS MED REHAB, V82, P76, DOI 10.1097/00002060-200301000-00014; Pandyan AD, 1999, CLIN REHABIL, V13, P373, DOI 10.1191/026921599677595404; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Reiter F, 1996, J NEUROL REHABIL, V10, P47; Rousseaux M, 2002, J NEUROL, V249, P76, DOI 10.1007/PL00007851; Rousseaux M., 2003, Annales de Readaptation et de Medecine Physique, V46, P286, DOI 10.1016/S0168-6054(03)00112-0; Royal College of Physicians British Society of Rehabilitation Medicine Chartered Society of Physiotherapy, 2009, SPAST AD MAN US BOT; Rychlik R, 2015, HEALTH ECON REV, V6, P27; Santamato A, 2010, BRAIN INJURY, V24, P1108, DOI 10.3109/02699052.2010.494591; Shaw LC, 2011, STROKE, V42, P1371, DOI 10.1161/STROKEAHA.110.582197; Slawek J, 2005, NEUROL SCI, V26, P32, DOI 10.1007/s10072-005-0379-8; Steenbeek D, 2005, CLIN REHABIL, V19, P274, DOI 10.1191/0269215505cr859oa; Suputtitada A, 2005, DISABIL REHABIL, V27, P176, DOI 10.1080/09638280400009360; Turner-Stokes L, 2013, BR MED J OPEN, V3, P6; Turner- Stokes LK, 2013, PM R S1, V5; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742	34	2	2	0	1	AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET	KAMPALA	PO BOX 12874, KAMPALA, 00000, UGANDA	1937-8688			PAN AFR MED J	Pan Afr. Med. J.	FEB 25	2020	35								55	10.11604/pamj.2020.35.55.16091			11	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	LH2EZ	WOS:000528601600001	32523646	gold, Green Published			2022-02-06	
J	Kunker, K; Peters, DM; Mohapatra, S				Kunker, Katrina; Peters, Denise M.; Mohapatra, Sambit			Long-term impact of mild traumatic brain injury on postural stability and executive function	NEUROLOGICAL SCIENCES			English	Article						Brain injury; Balance; Cognition; Posture	SPORT-RELATED CONCUSSION; CORPUS-CALLOSUM; BIMANUAL COORDINATION; PERFORMANCE; DIAGNOSIS; CHILDREN; HISTORY; ADULTS; MOTOR	Objective A substantial number of individuals present with prolonged symptoms after a mild traumatic brain injury (mTBI) or concussion. This has warranted the development of assessment tools that can reliably detect prolonged symptoms after an mTBI. At present, a gold standard diagnostic tool for accurately identifying such prolonged symptoms is not available. The purpose of this study is to utilize specific measures of standing balance, cognitive function, and bimanual coordination to examine persisting long-term deficits in individuals with mTBI. Methods A total of 18 (medically diagnosed with an mTBI within the last year) and 14 (healthy age-matched controls) individuals participated in the study. Assessment tools included NIH Toolbox Cognition Battery (NIHTB-CB), TEMPA, and Purdue pegboard (bimanual coordination) and standing balance on a force platform. Results Individuals with mTBI demonstrated lower scores in all measures of cognition with statistically significant difference (p = 0.03) in executive function. The clinical tests of bimanual coordination did not show any statistically significant differences between groups. Postural stability was significantly reduced (p = 0.039) in the mTBI group. Conclusion Our results show long-term performance deficits (cognition and postural stability) that persist in individuals with mTBI. In addition, to the best of our knowledge, this is the first study to identify cognitive deficits in individuals with mTBI by utilizing NIHTB-CB. Knowledge gained from this study might affect decisions of return-to-play or return-to-learn in individuals with a history of mTBI(s).	[Kunker, Katrina; Peters, Denise M.; Mohapatra, Sambit] Univ Vermont, Dept Rehabil & Movement Sci, Burlington, VT 05405 USA		Mohapatra, S (corresponding author), Univ Vermont, Dept Rehabil & Movement Sci, Burlington, VT 05405 USA.	sambit.mohapatra@med.uvm.edu	Mohapatra, Sambit/AAJ-6657-2021	Mohapatra, Sambit/0000-0001-7714-5281	University of Vermont, Office of the Vice President for Research, Express Grant program	The authors would like to thank the University of Vermont, Office of the Vice President for Research, Express Grant program (PI: Mohapatra) Grant Program, for funding this study.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; [Anonymous], 2015, NIH PUBL, V15-2478; [Anonymous], 2016, VA DOD CLIN PRACTICE; Baracks J, 2018, J ATHL TRAINING, V53, P597, DOI 10.4085/1062-6050-174-17; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Buzzini SRR, 2006, CURR OPIN PEDIAT; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Caplain S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00666; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; DESROSIERS J, 1995, DISABIL REHABIL, V17, P217, DOI 10.3109/09638289509166638; DVBIC, 2016, DOD WORLDW NUMB TBI; Gerberding JLBS, 2003, CTR DIS CONTR PREV, P9; Ghawami H, 2017, APPL NEUROPSYCH-ADUL, V24, P299, DOI 10.1080/23279095.2016.1157078; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jantzen KJ, 2004, AM J NEURORADIOL; jcoleman@ncaa.org, 2014, CONC DIAGN MAN BEST; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Korman C, 2017, NFLS CONCUSSION PROT; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Kumar S, 2013, CLIN NEUROL NEUROSUR, V115, P1326, DOI 10.1016/j.clineuro.2012.12.038; Lange RT, 2011, NATO SCI PEACE SEC, V86, P171, DOI 10.3233/978-1-60750-797-0-171; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Michael Hurley CB, 2017, HURLEY TOM SAVAGE BE; Moseley AM, 2003, J HEAD TRAUMA REHAB, V18, P526, DOI 10.1097/00001199-200311000-00006; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; Platz T, 2001, ARCH PHYS MED REHAB, V82, P961, DOI 10.1053/apmr.2001.23982; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Serrien DJ, 2001, EUR J NEUROSCI, V14, P1897, DOI 10.1046/j.0953-816x.2001.01798.x; Thompson LA, 2017, SPORTS, V5, DOI 10.3390/sports5040086; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wortzel HS, 2012, CURR TREAT OPTION NE, V14, P493, DOI 10.1007/s11940-012-0193-6	45	2	3	0	4	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUL	2020	41	7					1899	1907		10.1007/s10072-020-04300-0		FEB 2020	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MJ2EG	WOS:000516375400002	32095948				2022-02-06	
J	White, H; Venkatesh, B; Jones, M; Kruger, PS; Walsham, J; Fuentes, H				White, Hayden; Venkatesh, Balasubramanian; Jones, Mark; Kruger, Peter S.; Walsham, James; Fuentes, Hesly			Inducing ketogenesis via an enteral formulation in patients with acute brain injury:a phase II study	NEUROLOGICAL RESEARCH			English	Article						Ketones; acute brain injury; traumatic brain injury; beta-hydroxybutyrate; stroke; subarachnoid hemorrhage	FUNCTION IMPROVING AGENT; KETONE-BODY METABOLISM; BETA-HYDROXYBUTYRATE; DIET; INCREASES; HYPOXIA; DISEASE; PLASMA; BODIES	Objective: Although extensively studied in children, the safety and tolerability of ketone supplementation in adults is unclear, particularly in the acute brain injury population. The purpose of this study was to examine the feasibility and safety of inducing ketosis using an enteric ketogenic formulation and determine its impact on intracranial and cerebral perfusion pressures and metabolic parameters. Methods: Prospective interventional Phase II trial of ventilated critically ill patients with acute brain injury administered a ketogenic feed over a 6 day period. Results: 20 patients were recruited, 5 females and 15 males, 3 with stroke, 2 with subarachnoid haemorrhage and 15 with traumatic brain injury. Feeds were well tolerated with 19 patients completing study. There was a significant increase in both plasma beta-hydroxybutyrate and acetoacetate from 0.24 +/- 0.31 mmol/l and 0.19 +/- 0.16 mmol/l to 0.61 +/- 0.53 mmol/l (p =0.0005) and 0.52 +/- 0.40 mmol/l (p<0.0001) respectively over the 6 day period. Total daily Ketocal (R) caloric intake was positively correlated with plasma beta-hydroxybutyrate concentrations (p=0.0011). There was no significant correlation between the cerebral hypertension and cerebral hypoperfusion indices and plasma ketone concentrations. In 95% of patients there were no clinically significant changes in acid/base status over the 6 days with pH remaining within normal range. Conclusion: In patients with acute brain injury, an enterally administered ketogenic formulation increased plasma ketone concentrations, was well tolerated, did not impact on cerebral hemodynamics and can be safely administered. Clinical trial registered at the Australian New Zealand Clinical Trials Registry (ACTRN12616000332426)	[White, Hayden] Griffiths Univ, Logan Hosp, Dept Intens Care, Crit Care Med, Logan, Qld 4131, Australia; [Venkatesh, Balasubramanian] Univ Queensland, Crit Care Med, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Venkatesh, Balasubramanian] Univ Queensland, Crit Care Med, Wesley Hosp, Brisbane, Qld, Australia; [Jones, Mark] Univ Queensland, Fac Med & Biomed Sci, Sch Publ Hlth, Brisbane, Qld, Australia; [Kruger, Peter S.] Univ Queensland, Princess Alexandra Hosp, Crit Care Med, Brisbane, Qld, Australia; [Walsham, James] Princess Alexandra Hosp, Dept Intensive Care Med, Brisbane, Qld, Australia; [Fuentes, Hesly] Princess Alexandra Hosp, Dept Intens Care, Brisbane, Qld, Australia		White, H (corresponding author), Griffiths Univ, Logan Hosp, Dept Intens Care, Crit Care Med, Logan, Qld 4131, Australia.	hayden.white@health.qld.gov.au		Venkatesh, Bala/0000-0002-3234-5244			Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Cahill George F Jr, 2003, Trans Am Clin Climatol Assoc, V114, P149; Cardinali S, 2006, EPILEPSY RES, V69, P129, DOI 10.1016/j.eplepsyres.2006.01.007; Cervenka MC, 2017, NEUROLOGY, V88, P938, DOI [10.1212/wnl.0000000000003690, 10.1212/WNL.0000000000003690]; Freeman JM, 1998, PEDIATRICS, V102, P1358, DOI 10.1542/peds.102.6.1358; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Gasior M, 2006, BEHAV PHARMACOL, V17, P431, DOI 10.1097/00008877-200609000-00009; Gilbert DL, 2000, J CHILD NEUROL, V15, P787, DOI 10.1177/088307380001501203; Gomez-Arbelaez D, 2017, ENDOCRINE, V58, P81, DOI 10.1007/s12020-017-1405-3; Henderson ST, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-31; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kossoff EH, 2013, J CHILD NEUROL, V28, P1049, DOI 10.1177/0883073813487601; Kossoff EH, 2009, EPILEPSIA, V50, P304, DOI 10.1111/j.1528-1167.2008.01765.x; Krebs H A, 1969, Adv Enzyme Regul, V7, P397, DOI 10.1016/0065-2571(69)90030-2; Krentz AJ, 1996, METABOLISM, V45, P1214, DOI 10.1016/S0026-0495(96)90238-3; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Nehlig A, 2004, PROSTAG LEUKOTR ESS, V70, P265, DOI 10.1016/j.plefa.2003.07.006; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Payne NE, 2011, EPILEPSIA, V52, P1941, DOI 10.1111/j.1528-1167.2011.03287.x; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; RISING CL, 1989, STROKE, V20, P1219, DOI 10.1161/01.STR.20.9.1219; Ritter AM, 1996, J NEUROTRAUM, V13, P473, DOI 10.1089/neu.1996.13.473; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Schwartz K, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0129-1; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Van Hove JLK, 2003, LANCET, V361, P1433, DOI 10.1016/S0140-6736(03)13105-4; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Veech RL, 2001, IUBMB LIFE, V51, P241; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7; White H, 2017, J NEUROL NEUROSCI, V8, P188, DOI [10.21767/21716625.1000188, DOI 10.21767/2171-6625.1000188, 10.21767/2171-6625.1000188]; White H, 2013, INTENS CARE MED, V39, P727, DOI 10.1007/s00134-012-2790-y; White H, 2011, CRIT CARE, V15, DOI 10.1186/cc10020; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Ziegler DR, 2003, NEUROCHEM RES, V28, P1793, DOI 10.1023/A:1026107405399; 2007, J NEUROTRAUMA S1, V24, P1	43	2	2	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR 2	2020	42	4					275	285		10.1080/01616412.2019.1709743		FEB 2020	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU8VV	WOS:000516912700001	32098578				2022-02-06	
J	Carlson, JM; Kangas, KJ; Susa, TR; Fang, L; Moore, MT				Carlson, Joshua M.; Kangas, Keara J.; Susa, Taylor R.; Fang, Lin; Moore, Marguerite T.			Sport-related concussion is associated with elevated anxiety, but not attentional bias to threat	BRAIN INJURY			English	Article						mTBI; attentional bias; anxiety; threat bias; collegiate athletes; concussion	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; POSTCONCUSSION SYMPTOMS; FACIAL EXPRESSIONS; EPIDEMIOLOGY; DEFICITS; FEARFUL	Primary Objective: Symptoms following concussion commonly include deficits in attentional processing and elevated anxiety. Prioritized allocation of attentional resources to threat-related information is referred to as attentional bias to threat, which is a cardinal symptom - and in some cases a causal factor in the development - of anxiety. Here, we aimed to assess two possibilities regarding the relationship between attentional bias and anxiety in the post-concussive phase of sport-related concussion: (1) attentional bias mediates the relationship between concussion and anxiety or (2) attentional bias and concussion are uniquely associated with anxiety. Research Design: A cross-sectional between-groups design was used to assess differences in anxiety and attentional bias to threat between collegiate athletes with a recent sport-related concussion and a matched control group. Methods and Procedures: Forty-two collegiate athletes, 21 with a sport-related concussion and 21 matched controls, completed the dot-probe task of attentional bias and an anxiety questionnaire. Main Outcomes and Results: Anxiety, but not attentional bias, is elevated in concussion. Additionally, concussion and attentional bias to threat appear to be uniquely associated with anxiety symptoms. Conclusions: Unique treatment/rehabilitation strategies should be considered for individuals with elevated anxiety following concussion.	[Carlson, Joshua M.; Kangas, Keara J.; Susa, Taylor R.; Fang, Lin] Northern Michigan Univ, Dept Psychol Sci, 1401 Presque Isle Ave, Marquette, MI 49855 USA; [Moore, Marguerite T.] Northern Michigan Univ, Sch Hlth & Human Performance, Marquette, MI USA		Carlson, JM (corresponding author), Northern Michigan Univ, Dept Psychol Sci, 1401 Presque Isle Ave, Marquette, MI 49855 USA.	joshcarl@nmu.edu		Zuidema, Taylor/0000-0002-5722-0560			Aday J, 2017, MED HYPOTHESES, V109, P6, DOI 10.1016/j.mehy.2017.09.002; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bardel MH, 2012, RES Q EXERCISE SPORT, V83, P597; Beard C, 2012, BEHAV THER, V43, P724, DOI 10.1016/j.beth.2012.01.002; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Carlson JM, 2015, J NONVERBAL BEHAV, V39, P69, DOI 10.1007/s10919-014-0185-1; Carlson JM, 2014, COGNITION EMOTION, V28, P1398, DOI 10.1080/02699931.2014.885410; Carlson JM, 2009, EVOL PSYCHOL, V7, P534, DOI 10.1177/147470490900700404; Chan RCK, 2001, BRAIN INJURY, V15, P71, DOI 10.1080/02699050150209156; Comstock D, 2012, EPIDEMIOLOGY PREVENT; Fox E, 2002, COGN AFFECT BEHAV NE, V2, P52, DOI 10.3758/CABN.2.1.52; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Hakamata Y, 2010, BIOL PSYCHIAT, V68, P982, DOI 10.1016/j.biopsych.2010.07.021; Hallion LS, 2011, PSYCHOL BULL, V137, P940, DOI 10.1037/a0024355; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Hayes, 2018, INTRO MEDIATION MODE; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Lundqvist D., 1998, CD ROM DEP CLIN NEUR, DOI DOI 10.1017/S0048577299971664; MACLEOD C, 1988, Q J EXP PSYCHOL-A, V40, P653, DOI 10.1080/14640748808402292; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518; McCrory P, 2013, NAT REV NEUROL, V9, P361, DOI 10.1038/nrneurol.2013.88; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; MOGG K, 1995, BRIT J CLIN PSYCHOL, V34, P17, DOI 10.1111/j.2044-8260.1995.tb01434.x; Mogg K, 2002, BEHAV RES THER, V40, P1403, DOI 10.1016/S0005-7967(02)00017-7; Mogg K, 2017, CLIN PSYCHOL SCI, V5, P698, DOI 10.1177/2167702617696359; Mogoase C, 2014, J CLIN PSYCHOL, V70, P1133, DOI 10.1002/jclp.22081; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; National Collegiate Athletic Association, 2017, INT CONS DOC MENT HL; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Riegler KE, 2020, NEUROPSYCHOLOGY, V34, P63, DOI 10.1037/neu0000582; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Torrence RD, 2017, J NONVERBAL BEHAV, V41, P139, DOI 10.1007/s10919-016-0247-7; Van Bockstaele B, 2014, PSYCHOL BULL, V140, P682, DOI 10.1037/a0034834; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Zhou Zheng, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P217	45	2	2	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2020	34	3					363	368		10.1080/02699052.2020.1723698			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8UO	WOS:000519287300008	32050803				2022-02-06	
J	Zhang, BW; Wang, QJ; Guo, JH; Pei, MJ; Wang, HY; Jiang, S; Shin, EY; Noh, YY; Tsukagoshi, K; Shi, Y; Li, Y				Zhang, Bowen; Wang, Qijing; Guo, Jianhang; Pei, Mengjiao; Wang, Hengyuan; Jiang, Sai; Shin, Eul-Yong; Noh, Yong-Young; Tsukagoshi, Kazuhito; Shi, Yi; Li, Yun			Solution-processed organic single-crystalline semiconductors with a fence-like shape via ultrasound concussion	JOURNAL OF MATERIALS CHEMISTRY C			English	Article							FIELD-EFFECT TRANSISTORS; HIGH-PERFORMANCE; LARGE-AREA; CHARGE-TRANSPORT; SURFACE	Well-aligned organic single-crystalline semiconductors are essential for practical applications in electronic devices. Here, we demonstrated dioctylbenzothienobenzothiophene (C-8-BTBT) single crystals via an ultrasound concussion-assisted solution-processing method. Organic crystalline semiconductors with a fence-like shape were achieved, where rod-like crystals were joined together along a crystalline backbone up to millimeter length, which can allow the deposited crystals to combine the features of well-aligned orientation and desirable deposition. Organic field-effect transistors (OFETs) were fabricated using the C-8-BTBT single crystals, yielding a high field-effect hole mobility up to 6.0 cm(2) V-1 s(-1). Therefore, the ultrasound-assisted solution process can provide a general guide for the integration of functional materials into high performance devices.	[Zhang, Bowen; Wang, Qijing; Guo, Jianhang; Pei, Mengjiao; Wang, Hengyuan; Jiang, Sai; Shi, Yi; Li, Yun] Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Sch Elect Sci & Engn, Natl Lab Solid State Microstruct, Nanjing 210093, Jiangsu, Peoples R China; [Shin, Eul-Yong; Noh, Yong-Young] Pohang Univ Sci & Technol, Dept Chem Engn, 77 Cheongam Ro, Pohang 37673, South Korea; [Tsukagoshi, Kazuhito] NIMS, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan		Wang, QJ; Li, Y (corresponding author), Nanjing Univ, Collaborat Innovat Ctr Adv Microstruct, Sch Elect Sci & Engn, Natl Lab Solid State Microstruct, Nanjing 210093, Jiangsu, Peoples R China.	qijingwang@nju.edu.cn; yli@nju.edu.cn	TSUKAGOSHI, Kazuhito/H-2688-2011; Li, Yun/D-5437-2011	TSUKAGOSHI, Kazuhito/0000-0001-9710-2692; Li, Yun/0000-0003-1753-7317	NSFJS [BK20170075]; NSFCNational Natural Science Foundation of China (NSFC) [61774080, 61574074, 51861145202]; China Postdoctoral Innovation Program; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2019M651782]	Y. L. and Q. W. conceived the idea, and initiated and supervised the work. B. Z. and Q. W. designed, implemented, and optimized the growth of C<INF>8</INF>-BTBT crystals and device fabrication. B. Z., J. G., K. T., and S. J. contributed to electrical measurements. H. W. and M. P. contributed to AFM measurements and analysis. E. S. and Y. N. contributed to GIXD measurements. All authors contributed to the writing of the manuscript. This work was supported by NSFJS under Grant. No. BK20170075, NSFC under Grant No. 61774080, 61574074, and 51861145202, China Postdoctoral Innovation Program, and China Postdoctoral Science Foundation under Grant No. 2019M651782.	Blulle B, 2014, PHYS REV APPL, V1, DOI 10.1103/PhysRevApplied.1.034006; Crone B, 2000, NATURE, V403, P521, DOI 10.1038/35000530; Deng W, 2019, MATER TODAY, V24, P17, DOI 10.1016/j.mattod.2018.07.018; Dimitrakopoulos CD, 2002, ADV MATER, V14, P99, DOI 10.1002/1521-4095(20020116)14:2<99::AID-ADMA99>3.0.CO;2-9; Ebata H, 2007, J AM CHEM SOC, V129, P15732, DOI 10.1021/ja074841i; He DW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701186; Izawa T, 2008, ADV MATER, V20, P3388, DOI 10.1002/adma.200800799; Jiang S, 2018, J PHYS CHEM LETT, V9, P6755, DOI 10.1021/acs.jpclett.8b03108; Khim DY, 2013, ADV MATER, V25, P4302, DOI 10.1002/adma.201205330; Kumatani A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00393; Lee J, 2013, ADV MATER, V25, P5886, DOI 10.1002/adma.201301257; Li H, 2006, ULTRASON SONOCHEM, V13, P359, DOI 10.1016/j.ultsonch.2006.01.002; Li HY, 2012, J AM CHEM SOC, V134, P2760, DOI 10.1021/ja210430b; Li Y, 2013, AIP ADV, V3, DOI 10.1063/1.4807669; Li Y, 2011, AIP ADV, V1, DOI 10.1063/1.3608793; Liu C, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201901700; Liu C, 2012, J MATER CHEM, V22, P8462, DOI 10.1039/c2jm15747k; Liu CA, 2011, ADV MATER, V23, P523, DOI 10.1002/adma.201002682; Minari T, 2012, ADV MATER, V24, P299, DOI 10.1002/adma.201102554; Mullin JW., 2001, CRYSTALLIZATION; Nakayama K, 2011, ADV MATER, V23, P1626, DOI 10.1002/adma.201004387; Sirringhaus H, 2014, ADV MATER, V26, P1319, DOI 10.1002/adma.201304346; Sundar VC, 2004, SCIENCE, V303, P1644, DOI 10.1126/science.1094196; Takeya J, 2003, J APPL PHYS, V94, P5800, DOI 10.1063/1.1618919; Wang QJ, 2016, ADV FUNCT MATER, V26, P3191, DOI 10.1002/adfm.201600304; Yilmaz M, 2015, ADV FUNCT MATER, V25, P5669, DOI 10.1002/adfm.201502151; Zhao WQ, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201902494; Zhou Y, 2010, ADV MATER, V22, P1484, DOI 10.1002/adma.200904171	28	2	2	2	15	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-7526	2050-7534		J MATER CHEM C	J. Mater. Chem. C	FEB 21	2020	8	7					2589	2593		10.1039/c9tc06635g			5	Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Physics	KQ9RM	WOS:000517258900039					2022-02-06	
J	Ho, RA; Hall, GB; Noseworthy, MD; DeMatteo, C				Ho, Rachelle A.; Hall, Geoffrey B.; Noseworthy, Michael D.; DeMatteo, Carol			Post-concussive depression: evaluating depressive symptoms following concussion in adolescents and its effects on executive function	BRAIN INJURY			English	Article						Concussion; adolescents; depression; post-concussive depression; symptoms; cognition	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; SPORT CONCUSSION; PREVALENCE; ANXIETY; IMPACT; INVENTORY; YOUTH; RISK; RELIABILITY	Background: Post-concussive depression describes an elevation of depressive symptoms following concussion that occurs in conjunction with other symptoms of concussion. Children with concussion are more likely to diagnosed with depression. The overlapping symptoms between clinical depression and concussion make the diagnosis of depression difficult. The purpose of this study is to explore how post-concussive depression relates to post-concussion symptoms and cognition by investigating symptom-reporting in youth with post-concussive depression and executive function. Methods: Adolescents (age 10-17 years) diagnosed with concussion were divided into two groups based on depression scores on the Children's Depression Inventory (post-concussion depression; non-depression groups). Symptom reporting on the Post-Concussion Symptom Inventory and performance on Immediate Post-concussion Assessment and Cognitive Testing (ImPACT) were compared. Results: Participants with post-concussive depression had heightened emotionality, irritability, and nervousness. Sadness and fatigue were reported by both groups. ImPACT was unable to distinguish between groups but the group overall demonstrated severe neurocognitive deficits. Conclusion: Reports of greater emotionality, irritability, and nervousness on concussion symptom scales may be indicators of post-concussion depression. It is important for clinicians to take note when an adolescent with concussion scores high on these three emotional symptoms as they may be indicative of greater emotional distress.	[Ho, Rachelle A.; Hall, Geoffrey B.] McMaster Univ, Dept Psychol Neurosci & Behav, 1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Ho, Rachelle A.; DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Noseworthy, Michael D.] St Josephs Healthcare, Imaging Res Ctr, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, McMaster Sch Biomed Engn, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Elect & Comp Engn, Hamilton, ON, Canada; [Noseworthy, Michael D.] McMaster Univ, Dept Radiol, Hamilton, ON, Canada		Ho, RA (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, 1280 Main St West, Hamilton, ON L8S 4K1, Canada.	homr@mcmaster.ca		/0000-0002-3398-6692	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [312571]	This work was supported by the Canadian Institutes of Health Research [312571].	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chrisman SPD, 2019, J PEDIATR-US, V207, P176, DOI 10.1016/j.jpeds.2018.11.003; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Fergusson DM, 2005, ARCH GEN PSYCHIAT, V62, P66, DOI 10.1001/archpsyc.62.1.66; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Haarasilta L, 2001, PSYCHOL MED, V31, P1169, DOI 10.1017/S0033291701004573; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kovacs M, 2011, CDI2 CHILDRENS DEPRE; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Massey JS, 2015, NEUROPSYCHOLOGY, V29, P530, DOI 10.1037/neu0000192; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McLeod GFH, 2016, PSYCHOL MED, V46, P1401, DOI 10.1017/S0033291715002950; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Pryor James, 2016, J Lifestyle Med, V6, P7, DOI 10.15280/jlm.2016.6.1.7; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Richardson LP, 2010, ACAD PEDIATR, V10, P36, DOI 10.1016/j.acap.2009.09.011; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; SAYLOR CF, 1984, J CONSULT CLIN PSYCH, V52, P955, DOI 10.1037/0022-006X.52.6.955; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tavitian LR, 2014, EUR CHILD ADOLES PSY, V23, P659, DOI 10.1007/s00787-013-0492-9; Timbremont B, 2004, J CLIN CHILD ADOLESC, V33, P149, DOI 10.1207/S15374424JCCP3301_14; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499	44	2	2	4	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 20	2020	34	4					520	527		10.1080/02699052.2020.1725841		FEB 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8TS	WOS:000514497800001	32064943				2022-02-06	
J	Stubberud, J; Holthe, IL; Lovstad, M; Schanke, AK; Brandt, A; Finnanger, T				Stubberud, Jan; Holthe, Ingvil L.; Lovstad, Marianne; Schanke, Anne-Kristine; Brandt, Anne; Finnanger, Torun			The feasibility and acceptability of goal management training of executive functions in children with spina bifida and acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Executive functioning; Cognitive rehabilitation; Brain injury; Goal management; Child	COGNITIVE REHABILITATION; EMOTIONAL REGULATION; INTERVENTIONS; HEALTH; QUESTIONNAIRE; DYSFUNCTION; PREDICTORS; CHILDHOOD; ATTENTION	Executive dysfunction causes significant real-life disability for children with spina bifida (SB) and acquired brain injury (ABI), and efficient interventions are needed. Goal Management Training (GMT) is a cognitive rehabilitation intervention for improving executive function (EF) that has received empirical support in studies of adults with SB and ABI. The purpose of this study was to determine the feasibility and acceptability of a newly developed pediatric GMT protocol (pGMT). Thirteen children (7 boys, 10-16 years) with SB (n = 4), traumatic brain injury (n = 8), and encephalitis (n = 1) were included, based upon the presence of EF problems as described by parents. The participants received 21 h of pGMT, using inpatient intervention periods, followed by 4 h of pGMT outpatient guidance over 8 weeks. Notably, pGMT was found to be both feasible and acceptable, with satisfactory compliance for the children, parents and teachers, in addition to being considered acceptable by all participants. Furthermore, a reliable change in daily life EF was reported by the parents for 2 children. And, some children obtained scores below clinical cut-off on a measure of parent reported real-life EF after intervention. Hence, findings suggest that a randomized controlled trial of pGMT, with a larger sample size, should be conducted.	[Stubberud, Jan] TRS Natl Resource Ctr Rare Disorders, Nesoddtangen, Norway; [Stubberud, Jan] Lovisenberg Diaconal Hosp, Dept Res, Oslo, Norway; [Stubberud, Jan; Lovstad, Marianne; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, POB 1094, N-0317 Oslo, Norway; [Holthe, Ingvil L.; Lovstad, Marianne; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Brandt, Anne; Finnanger, Torun] Trondheim Reg & Univ Hosp, St Olavs Hosp, Childrens Clin, Trondheim, Norway		Stubberud, J (corresponding author), Univ Oslo, Dept Psychol, POB 1094, N-0317 Oslo, Norway.	Jan.stubberud@psykologi.uio.no	Stubberud, Jan/ABE-6922-2021				Adnan A, 2017, NEUROREHAB NEURAL RE, V31, P910, DOI 10.1177/1545968317728580; Anderson V, 2009, DEV NEUROREHABIL, V12, P253, DOI 10.3109/17518420903086899; Angold A, 1995, INT J METHOD PSYCH, V5, P237; Bellin MH, 2010, J PEDIATR PSYCHOL, V35, P778, DOI 10.1093/jpepsy/jsp094; Bjorklund DF, 2018, CHILD DEV, V89, P2288, DOI 10.1111/cdev.13019; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Catroppa C, 2009, DEV NEUROREHABIL, V12, P53, DOI 10.1080/17518420802634476; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; CHRISTENSEN L, 1986, BEHAV THER, V17, P305, DOI 10.1016/S0005-7894(86)80060-0; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2012, ARCH PHYS MED REHAB, V93, P188, DOI 10.1016/j.apmr.2011.12.003; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Conners CK, 2000, CONNERS CPT 2 CONTIN; Copp AJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.7; Daviss WB, 2006, J CHILD PSYCHOL PSYC, V47, P927, DOI 10.1111/j.1469-7610.2006.01646.x; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2010, DEV DISABIL RES REV, V16, P31, DOI 10.1002/ddrr.89; DuPaul G.J., 1998, ADHD RATING SCALE 4; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Gioia GA IP, 2000, BEHAV RATING INVENTO; Haskins E.C., 2012, COGNITIVE REHABILITA; Jacobs R, 2011, CORTEX, V47, P808, DOI 10.1016/j.cortex.2010.06.002; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Knight RT., 2013, PRINCIPLES FRONTAL L; Krasny-Pacini A, 2014, J HEAD TRAUMA REHAB, V29, pE49, DOI 10.1097/HTR.0000000000000015; Krasny-Pacini A, 2014, DISABIL REHABIL, V36, P105, DOI 10.3109/09638288.2013.777807; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Levaux M-N, 2012, Case Rep Psychiatry, V2012, P503023, DOI 10.1155/2012/503023; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Limond J, 2014, CLIN NEUROPSYCHOL, V28, P181, DOI 10.1080/13854046.2013.873083; Linden M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011020.pub2; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Michaeli O, 2014, PEDIATRICS, V133, pE546, DOI 10.1542/peds.2013-3010; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Robinson KE, 2014, J PEDIATR PSYCHOL, V39, P846, DOI 10.1093/jpepsy/jsu031; Rothbart MK, 2011, EMOT REV, V3, P207, DOI 10.1177/1754073910387943; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Spencer-Smith M, 2009, DEV NEUROREHABIL, V12, P279, DOI 10.3109/17518420903090701; Stamenova V, 2019, NEUROPSYCHOL REHABIL, V29, P1569, DOI 10.1080/09602011.2018.1438294; Stubberud J., 2016, 60 ANN M SOC RES HYD; Stubberud J, 2015, REHABIL PSYCHOL, V60, P1, DOI 10.1037/rep0000018; Stubberud J, 2013, J INT NEUROPSYCH SOC, V19, P672, DOI 10.1017/S1355617713000209; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Tal G, 2013, PEDIATR NEUROL, V48, P424, DOI 10.1016/j.pediatrneurol.2012.11.008; Tamm L, 2015, ADHD-ATTEND DEFICIT, V7, P183, DOI 10.1007/s12402-014-0162-x; Tamm L, 2014, J ATTEN DISORD, V18, P551, DOI 10.1177/1087054712445782; Timmerman L, 2015, AM J TRANSPLANT, V15, P508, DOI 10.1111/ajt.13046; Tornas S, 2016, ARCH PHYS MED REHAB, V97, P1841, DOI 10.1016/j.apmr.2016.06.014; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Varni J., 2004, PEDSQL 4 0 MEASUREME; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Wade SL, 2019, J INT NEUROPSYCH SOC, V25, P941, DOI 10.1017/S1355617719000778; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1999, MANUAL WECHSLER ABBR; Worthington A. D., 2005, HDB CLIN NEUROPSYCHO, P322; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Zukerman JM, 2011, J PEDIATR PSYCHOL, V36, P265, DOI 10.1093/jpepsy/jsq075	69	2	2	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 21	2021	31	4					601	620		10.1080/09602011.2020.1723649		FEB 2020	20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	RN0PC	WOS:000514440000001	32065032				2022-02-06	
J	Op 't Eyndee, J; Yu, AW; Eckersley, CP; Bass, CR				Op 't Eynde, Joost; Yu, Allen W.; Eckersley, Christopher P.; Bass, Cameron R.			Primary blast wave protection in combat helmet design: A historical comparison between present day and World War I	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; RISK-ASSESSMENT; SHELL SHOCK	Since World War I, helmets have been used to protect the head in warfare, designed primarily for protection against artillery shrapnel. More recently, helmet requirements have included ballistic and blunt trauma protection, but neurotrauma from primary blast has never been a key concern in helmet design. Only in recent years has the threat of direct blast wave impingement on the head-separate from penetrating trauma-been appreciated. This study compares the blast protective effect of historical (World War I) and current combat helmets, against each other and 'no helmet' or bare head, for realistic shock wave impingement on the helmet crown. Helmets included World War I variants from the United Kingdom/United States (Brodie), France (Adrian), Germany (Stahlhelm), and a current United States combat variant (Advanced Combat Helmet). Helmets were mounted on a dummy head and neck and aligned along the crown of the head with a cylindrical shock tube to simulate an overhead blast. Primary blast waves of different magnitudes were generated based on estimated blast conditions from historical shells. Peak reflected overpressure at the open end of the blast tube was compared to peak overpressure measured at several head locations. All helmets provided significant pressure attenuation compared to the no helmet case. The modern variant did not provide more pressure attenuation than the historical helmets, and some historical helmets performed better at certain measurement locations. The study demonstrates that both historical and current helmets have some primary blast protective capabilities, and that simple design features may improve these capabilities for future helmet systems.	[Op 't Eynde, Joost; Yu, Allen W.; Eckersley, Christopher P.; Bass, Cameron R.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA		Op 't Eyndee, J (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.	joost.opteynde@duke.edu		Eckersley, Christopher/0000-0001-5467-0358; Op 't Eynde, Joost/0000-0002-3021-4312	Josiah Charles Trent Memorial Foundation Endowment Fund at Duke University	aWe would like to gratefully acknowledge funding and support from the Josiah Charles Trent Memorial Foundation Endowment Fund at Duke University for directly funding this research. There is no particular grant associated with the work and funding was not provided to a particular member of the research group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalric A, 2008, GRANDE GUERRE CHRONO; Arnold C., 1997, STEEL POTS HIST AM S; Baer L, 1985, HIST GERMAN STEEL HE; Bajaj P, 1997, INDIAN J FIBRE TEXT, V22, P274; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bull S, 2000, WORLD WAR ONE GERMAN; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; COOPER GJ, 1991, J BIOMECH, V24, P273, DOI 10.1016/0021-9290(91)90346-O; Coune F, 2012, COIFFURES MILITAIRES; Cullis I G, 2001, J R Army Med Corps, V147, P16; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Dean B., 1920, HELMETS BODY ARMOR M; Dunstan S, 1984, FLAK JACKETS 20 CENT; Facon P, 2007, ATLAS PREMIERE GUERR; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Great Britain War Office, 1916, NOT GERM SHELLS; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holmes Richard, 2001, OXFORD COMPANION MIL; Hooker DR, 1924, AM J PHYSIOL, V67, P219; Jacobs MJN, 2001, J MATER SCI, V36, P3137, DOI 10.1023/A:1017922000090; Jager Herbert, 2001, GERMAN ARTILLERY WOR; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Jouineau A, 2009, OFFICERS SOLDIERS FR; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MELLOR SG, 1992, WORLD J SURG, V16, P893, DOI 10.1007/BF02066988; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mott DR, 2008, BLAST INDUCED PRESSU; Mott DR, 2014, 52 AER SCI M; Mott F W, 1917, Br Med J, V2, P612; Myers CS, 1915, LANCET, V1, P316; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer MB, 2010, PERS ARM SYST S QUEB; Rafaels KA, 2010, PERS ARM SYST S QUEB; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Richmond D R, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P35; Richmond DR., 1968, ESTIMATE MANS TOLERA; Roshchupkin VV, 2017, HIGH TEMP+, V55, P938, DOI 10.1134/S0018151X17060165; Sarvghad-Moghaddam H, 2017, INT J NUMER METHOD B, V33; Shridharani J, 2012, PERS ARM SYST S NUR; Wilson C, IMPROVISED EXPLOSIVE; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wood GW, 2013, INJURY PREV, V19, P19, DOI 10.1136/injuryprev-2011-040277; Yu AW, 2014, PERS ARM SYST S CAMB; Zhang Timothy G, 2013, P ASME 2013 INT MECH; Zuckerman S, 1940, LANCET, V2, P219	49	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2020	15	2							e0228802	10.1371/journal.pone.0228802			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ7SH	WOS:000535198700057	32053658	Green Published, gold			2022-02-06	
J	Sercy, E; Orlando, A; Carrick, M; Lieser, M; Madayag, R; Vasquez, D; Tanner, A; Rubin, B; Bar-Or, D				Sercy, Erica; Orlando, Alessandro; Carrick, Matthew; Lieser, Mark; Madayag, Robert; Vasquez, Donald; Tanner, Allen, II; Rubin, Benjamin; Bar-Or, David			Long-term mortality and causes of death among patients with mild traumatic brain injury: a 5-year multicenter study	BRAIN INJURY			English	Article						Traumatic brain injury; long-term mortality; neurodegenerative diseases		Objective: Undergoing mild traumatic brain injury (mTBI) increases mortality risk, but it is unclear what drives this finding. This study explored associations with mortality in patients with mTBI. Methods: This was a retrospective study of patients with mTBI and controls admitted to six level 1 trauma centers in 1/1/2009-12/31/2013. Mortality data were from the CDC National Death Index. Patients with mTBI were identified by ICD-9 code, Glasgow Coma Scale 13-15, Injury Severity Score (ISS) <16, and loss of consciousness <= 1 hour. Controls had hospital length of stay <= 24 hours, ISS<16, and no head injury. Results: This study included 964 patients with mTBI and 5,567 controls. mTBI was associated with a 47% increased 5-year mortality risk (HR = 1.47, 95% CL 1.08-2.01). Patients with mTBI were more likely to die of a neurodegenerative disease (17% vs 11%, P = .119). Cardiovascular (HR = 1.80, 95% CL 1.17-2.77), neurological (HR = 3.33, 95% CL 2.07-5.38), and respiratory (HR = 1.70, 95% CL 1.01-2.86) comorbidities were associated with mortality in patients with mTBI. Conclusions: Patients with mTBI are at increased mortality risk in the 5 years post-injury. Mortality in patients with mTBI was most influenced by preexisting conditions.	[Sercy, Erica; Orlando, Alessandro; Bar-Or, David] Swedish Med Ctr, Trauma Res Dept, 501 E Hampden Ave, Englewood, CO 80113 USA; [Sercy, Erica; Orlando, Alessandro; Bar-Or, David] St Anthony Hosp, Trauma Res Dept, Lakewood, CO USA; [Sercy, Erica; Orlando, Alessandro; Bar-Or, David] Penrose Community Hosp, Trauma Res Dept, Colorado Springs, CO USA; [Sercy, Erica; Orlando, Alessandro; Bar-Or, David] Med City Plano, Trauma Res Dept, Plano, TX USA; [Sercy, Erica; Orlando, Alessandro; Bar-Or, David] Res Med Ctr, Trauma Res Dept, Kansas City, MO USA; [Sercy, Erica; Orlando, Alessandro; Bar-Or, David] Wesley Med Ctr, Trauma Res Dept, Wichita, KS USA; [Carrick, Matthew] Med City Plano, Trauma Serv Dept, Plano, TX USA; [Lieser, Mark] Res Med Ctr, Trauma Serv Dept, Kansas City, MO USA; [Madayag, Robert] St Anthony Hosp, Trauma Serv Dept, Lakewood, CO USA; [Vasquez, Donald] Wesley Med Ctr, Trauma Serv Dept, Wichita, KS USA; [Tanner, Allen, II] Penrose Community Hosp, Trauma Serv Dept, Colorado Springs, CO USA; [Rubin, Benjamin] Swedish Med Ctr, Trauma Serv Dept, Englewood, CO USA; [Bar-Or, David] Kaiser Permanente, Neurosurg Dept, Denver, CO USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Dept, 501 E Hampden Ave, Englewood, CO 80113 USA.	davidbme49@gmail.com		Sercy, Erica/0000-0002-7975-8601			Ahmadi N, 2015, BRAIN INJURY, V29, P1635, DOI 10.3109/02699052.2015.1075149; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Centers for Disease Control and Prevention, 2019, TBI REL EM DEP VIS H; Cheng PL, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-7; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; National Center for Health Statistics, 2018, UND MULT CAUS DEATH; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Spitz G, 2015, J NEUROTRAUM, V32, P1272, DOI 10.1089/neu.2014.3814; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Vaaramo K, 2015, J NEUROTRAUM, V32, P1579, DOI 10.1089/neu.2014.3757; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289	24	2	3	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 20	2020	34	4					556	566		10.1080/02699052.2020.1725981		FEB 2020	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8TS	WOS:000513750100001	32050811				2022-02-06	
J	Shapiro, JS; Silk, T; Takagi, M; Anderson, N; Clarke, C; Davis, GA; Dunne, K; Hearps, SJC; Ignjatovic, V; Rausa, V; Seal, M; Babl, FE; Anderson, V				Shapiro, Jesse S.; Silk, Tim; Takagi, Michael; Anderson, Nicholas; Clarke, Cathriona; Davis, Gavin A.; Dunne, Kevin; Hearps, Stephen J. C.; Ignjatovic, Vera; Rausa, Vanessa; Seal, Marc; Babl, Franz E.; Anderson, Vicki			Examining Microstructural White Matter Differences between Children with Typical and Those with Delayed Recovery Two Weeks Post-Concussion	JOURNAL OF NEUROTRAUMA			English	Article						Bayesian analysis; mild traumatic brain injury; pediatric concussion; pediatric neuroimaging; post-concussion syndrome	SPORTS-RELATED CONCUSSION; DIFFUSION TENSOR; BRAIN-INJURY; ABNORMALITIES; EPIDEMIOLOGY	Delayed recovery from concussion can dramatically affect a child's social, emotional, and educational development, yet little is known about what causes some children to recover faster than others. The contribution of white matter disruption in children with delayed recovery has been hypothesized, but findings are limited by methodological issues such as: small heterogeneous samples, bias toward children with delayed recovery, and inconsistencies in timing of brain imaging, both within and between studies. The aim of the present study was to assess diffusion neuroimaging correlates of delayed recovery post-concussion in children. A prospective, longitudinal, observational cohort study was conducted at a statewide tertiary pediatric hospital. Forty-three children who presented to the emergency department (ED) with concussion (defined according to the Zurich/Berlin Consensus Statement on Concussion in Sport) underwent magnetic resonance imaging (MRI) at a 2 weeks post-injury and were classified as either normally recovering (n = 26) or delayed recovering (n = 17). Diffusion imaging comparison using voxelwise tract-based spatial statistics (TBSS) analysis found no difference between the groups in fractional anisotropy, axial diffusion, radial diffusion, or mean diffusivity metrics (p > 0.05 threshold-free cluster enhancement [TFCE] corrected). Post-hoc tract-based Bayesian analysis found evidence for the null in 11 unique white matter tracts (Bayes factor >3). These findings indicate that delayed recovery from post-concussive symptoms in children is unlikely to be caused by white matter microstructural damage.	[Shapiro, Jesse S.; Silk, Tim; Takagi, Michael; Anderson, Nicholas; Clarke, Cathriona; Davis, Gavin A.; Dunne, Kevin; Hearps, Stephen J. C.; Ignjatovic, Vera; Rausa, Vanessa; Seal, Marc; Babl, Franz E.; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Shapiro, Jesse S.; Silk, Tim; Takagi, Michael; Anderson, Vicki] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Dunne, Kevin; Ignjatovic, Vera; Seal, Marc; Babl, Franz E.; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Silk, Tim] Deakin Univ, Sch Psychol, Melbourne, Vic, Australia; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia		Babl, FE (corresponding author), Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia.; Babl, FE (corresponding author), Murdoch Childrens Res Inst, Emergency Med Res, 4 West,50 Flemington Rd, Parkville, Vic 3052, Australia.	franz.babl@rch.org.au	Silk, Tim/K-4295-2019	Seal, Marc/0000-0002-8396-140X; Takagi, Michael/0000-0003-2903-7598; Hearps, Stephen/0000-0003-2984-1172; Shapiro, Jesse/0000-0002-9328-4633; Silk, Tim/0000-0002-7290-512X	Royal Children's Hospital Foundation, Melbourne, Australia [2014-370]; Clinical Sciences Theme, MCRI; Royal Children's Hospital Research Foundation; NHMRCNational Health and Medical Research Council of Australia [GNT 1127542, GNT 1079478]; Melbourne Campus Clinician Scientist Fellowship	The study is funded by a project grant from Royal Children's Hospital Foundation, Melbourne, Australia (2014-370) and nearmiss funding from the Clinical Sciences Theme, MCRI. Dr. Babl was funded by the Royal Children's Hospital Research Foundation, an NHMRC Practitioner Fellowship GNT 1127542, and a Melbourne Campus Clinician Scientist Fellowship; and Dr. Anderson was funded by an NHMRC Senior Practitioner Fellowship GNT 1079478. The funding organizations did not have a role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Anderson PJ., 2000, CLIN NEUROPSYCHOL AS, V1, P247; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Gornall M.A., J NEUROTRAUMA, V37, P163; Hearps S.J., 2017, PEDIATRICS, pii; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McElreath R., 2018, STAT RETHINKING BAYE; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nichols TE, 2017, NAT NEUROSCI, V20, P299, DOI 10.1038/nn.4500; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Takagi M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022098; Truss K, 2017, J NEUROTRAUM, V34, P2272, DOI 10.1089/neu.2016.4842; Van Beek L, 2015, J NEUROTRAUM, V32, P1567, DOI 10.1089/neu.2014.3809; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wechsler D, 2003, WECHSLER INTELLIGENC; WHO, 1992, INT STAT CLASS DIS R; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x	39	2	2	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2020	37	11					1300	1305		10.1089/neu.2019.6768		FEB 2020	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LT0OT	WOS:000513852700001	31856681	Bronze			2022-02-06	
J	McAllister-Deitrick, J; Trbovich, AM; Broglio, SP; McCrea, M; McAllister, TW; Kontos, AP				McAllister-Deitrick, Jamie; Trbovich, Alicia M.; Broglio, Steven P.; McCrea, Michael; McAllister, Thomas W.; Kontos, Anthony P.			Effect of Diagnosed Sleep Disorders on Baseline Concussion Symptom, Cognitive, and Balance Assessments in Collegiate Athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; sleep; balance; symptoms; cognitive; college	NEUROCOGNITIVE PERFORMANCE; SPORTS; QUALITY; IMPACT; SPECIFICITY; SENSITIVITY; DISTURBANCE; IMPAIRMENT; EDUCATION; PATTERNS	Background: Symptoms, cognition, balance, and other domains are commonly assessed at baseline testing as part of comprehensive preseason evaluations among collegiate student-athletes. Although approximately 27% of college students have at least 1 sleep disorder, researchers have yet to examine the role of a preexisting sleep disorder on preinjury baseline performance. Purpose: To compare athletes with and without a reported history of diagnosed sleep disorders on commonly used baseline concussion assessments. Study Design: Cross-sectional study; Level of evidence, 3. Methods: A total of 666 National Collegiate Athletic Association student-athletes completed baseline measures including the Balance Error Scoring System (BESS), Brief Symptom Inventory-18 (BSI-18), Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), Post-Concussion Symptom Scale (PCSS), Sport Concussion Assessment Tool-5th Edition (SCAT5), and Standardized Assessment of Concussion (SAC). There were 333 athletes with a history of diagnosed sleep disorders who were matched on age, sex, sport, and concussion history to 333 athletes with no history of diagnosed sleep disorders. Participants in both groups had a mean age of 19.89 +/- 1.36 years and included 182 (54.7%) male athletes, and 126 (37.8%) reported a history of >= 1 concussions. Results: A series of 1-way analyses of covariance with Bonferroni corrections revealed significant group differences on the BESS (F-1,F-559 = 8.88; P < .01); BSI-18 somatization (F-1,F-640 = 18.48; P < .01), depression (F-1,F-640 = 18.78; P < .01), anxiety (F-1,F-640 = 19.42; P < .01), and global severity index (F-1,F-640 = 27.18; P < .01); PCSS (F-1,F-424 = 29.42; P < .01); SCAT5 symptom number (F-1,F-634 = 28.79; P < .01) and symptom severity (F-1,F-634 = 31.74; P < .01); and SAC (F-1,F-578 = 4.36; P = .037). Specifically, while the sleep disorder group did perform better on the BESS, they also reported higher symptoms on the BSI-18, PCSS, and SCAT5 and performed worse on the SAC. There were no group differences on ImPACT performance. Conclusion: Collegiate student-athletes with diagnosed sleep disorders reported elevated affective and concussion symptoms at baseline that could affect the interpretation of postinjury impairments and symptoms. Based on the small effect sizes of our findings, however, the magnitude of these differences is of questionable clinical significance. Still, clinicians should consider diagnosed sleep disorders as reported during preparticipation sports physical examinations when interpreting baseline and postinjury concussion assessments.	[Trbovich, Alicia M.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Trbovich, Alicia M.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [McAllister-Deitrick, Jamie] Coastal Carolina Univ, Dept Kinesiol, Williams Brice 111,POB 261954, Conway, SC 29528 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		McAllister-Deitrick, J (corresponding author), Coastal Carolina Univ, Dept Kinesiol, Williams Brice 111,POB 261954, Conway, SC 29528 USA.	jdeitrick@coastal.edu			Grand Alliance CARE Consortium - National Collegiate Athletic Association; US Department of DefenseUnited States Department of Defense; US Army Medical Research Acquisition Activity, Fort Detrick, Maryland, USA; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program [W81XWH-14-2-0151]	This publication was made possible, in part, with support from the Grand Alliance CARE Consortium, funded by the National Collegiate Athletic Association and the US Department of Defense. The US Army Medical Research Acquisition Activity, Fort Detrick, Maryland, USA, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program under Award No. W81XWH-14-2-0151. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Arnett PA, CONCUSSIONS ATHLETIC, V2014, P35; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Cortese S, 2009, J AM ACAD CHILD PSY, V48, P894, DOI 10.1097/CHI.0b013e3181ac09c9; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; FARNILL D, 1990, AUST PSYCHOL, V25, P178, DOI 10.1080/00050069008260010; Fietze I, 2009, CHRONOBIOL INT, V26, P1249, DOI 10.1080/07420520903221319; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Frederick AR, COMP SLEEP DEPRIVATI; Gaultney JF, 2010, J AM COLL HEALTH, V59, P91, DOI 10.1080/07448481.2010.483708; Hausswirth C, 2014, MED SCI SPORT EXER, V46, P1036, DOI 10.1249/MSS.0000000000000177; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Iverson G, IMMEDIATE POSTCONCUS; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jones NS, 2014, CLIN J SPORT MED, V24, P284, DOI 10.1097/JSM.0000000000000031; Juliff LE, 2015, J SCI MED SPORT, V18, P13, DOI 10.1016/j.jsams.2014.02.007; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kelman L, 2005, HEADACHE, V45, P904, DOI 10.1111/j.1526-4610.2005.05159.x; Lateef T, 2011, CEPHALALGIA, V31, P648, DOI 10.1177/0333102410390395; Leeder J, 2012, J SPORT SCI, V30, P541, DOI 10.1080/02640414.2012.660188; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Millman RP, 2005, PEDIATRICS, V115, P1774, DOI 10.1542/peds.2005-0772; MOUGIN F, 1991, EUR J APPL PHYSIOL O, V63, P77, DOI 10.1007/BF00235173; Odegard SS, 2010, J HEADACHE PAIN, V11, P197, DOI 10.1007/s10194-010-0201-8; Ott S, 2014, ARCH CLIN NEUROPSYCH, V29, P152, DOI 10.1093/arclin/act091; Owens JA, 2005, J DEV BEHAV PEDIATR, V26, P312, DOI 10.1097/00004703-200508000-00011; Owens JA, 2000, ARCH PEDIAT ADOL MED, V154, P549, DOI 10.1001/archpedi.154.6.549; REILLY T, 1994, ERGONOMICS, V37, P1; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Seidel S, 2009, CEPHALALGIA, V29, P662, DOI 10.1111/j.1468-2982.2008.01784.x; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401	39	2	2	2	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2020	48	4					991	999	0363546520902701	10.1177/0363546520902701		FEB 2020	9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	LA3KS	WOS:000513328500001	32049571	Bronze			2022-02-06	
J	Stockbridge, MD; Newman, RS; Zukowski, A; Slawson, KK; Doran, A; Ratner, NB				Stockbridge, Melissa D.; Newman, Rochelle S.; Zukowski, Andrea; Slawson, Kristin K.; Doran, Anthony; Ratner, Nan Bernstein			Language profiles in children with concussion	BRAIN INJURY			English	Article						Concussion; language; pediatric	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; SPORTS-RELATED CONCUSSION; PROGRESSIVE MATRICES; HIGH-SCHOOL; MILD; CHILDHOOD; LONG; PERCEPTION; DISCOURSE	Primary Objective: Inform the production of a screening tool for language in children with concussion. The authors predicted that children with a recent concussion would perform the cognitive-linguistic tasks more poorly, but some tasks may be more sensitive to concussion than others. Methods & Procedures: 22 elementary school aged children within 30 days of a concussion and age-matched peers with no history of concussion were assessed on a battery of novel language and cognitive-linguistic tasks. They also completed an auditory attention task and the Raven's Colored Progressive Matrices. Main Outcomes & Results: Children with a recent concussion scored significantly more poorly in novel tasks targeting category identification, grammaticality judgments, and recognizing target words presented in a short story than their age-matched peers with no such injury history. All observed effects had moderate sizes. Inclusion of these three tasks significantly improved prediction of concussion status over symptom score when controlling for the age of participants. Conclusions: The finding supports continued investigation of targeted linguistic tasks in children following concussion, particularly in the domains of semantic and syntactic access and verbal working memory. Future work developing brief language assessments specifically targeting children in this age range may provide a valuable addition to the existing tools for identifying the effects of concussion.	[Stockbridge, Melissa D.; Newman, Rochelle S.; Slawson, Kristin K.; Ratner, Nan Bernstein] Univ Maryland, Dept Hearing & Speech Sci, College Pk, MD 20742 USA; [Zukowski, Andrea] Univ Maryland, Dept Linguist, College Pk, MD 20742 USA; [Doran, Anthony] Head First Sports Injury & Concuss Care, Waugh Chapel, MD USA		Stockbridge, MD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 600 N Wolfe St,Phipps 4,Suite 446, Baltimore, MD 21287 USA.	md.stockbridge@jhmi.edu	Stockbridge, Melissa/AAP-7382-2020	Stockbridge, Melissa/0000-0001-9069-1236			Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baldo JV, 2005, BRAIN LANG, V92, P240, DOI 10.1016/j.bandl.2004.06.103; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Blanchet S, 2009, BRAIN INJURY, V23, P111, DOI 10.1080/02699050802649688; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Brungart DS, 2001, J ACOUST SOC AM, V110, P2527, DOI 10.1121/1.1408946; Brungart DS, 2001, J ACOUST SOC AM, V109, P1101, DOI 10.1121/1.1345696; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Christy EM, 2005, BRAIN LANG, V95, P195, DOI 10.1016/j.bandl.2005.07.104; COCKRELL J L, 1992, Brain Injury, V6, P261, DOI 10.3109/02699059209029667; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 2000, APHASIOLOGY, V14, P391, DOI 10.1080/026870300401423; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Haarbauer-Krupa J, 2019, J HEAD TRAUMA REHAB, V34, P111, DOI 10.1097/HTR.0000000000000414; Iverson GL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218997; JORDAN FM, 1991, J SPEECH HEAR RES, V34, P572, DOI 10.1044/jshr.3403.572; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; MARTIN AW, 1954, J CONSULT PSYCHOL, V18, P143, DOI DOI 10.1037/H0055913; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mellor D, 2014, J PEDIATR PSYCHOL, V39, P369, DOI 10.1093/jpepsy/jst079; Musiek Frank E, 2004, J Am Acad Audiol, V15, P117, DOI 10.3766/jaaa.15.2.3; Pueyo R, 2008, J INTELL DISABIL RES, V52, P437, DOI 10.1111/j.1365-2788.2008.01045.x; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Raven J, 1998, MANUAL RAVENS PROGR; Sacco K, 2008, J COGN SCI, V9, P111; Schechter J, 2015, ARCH CLIN NEUROPSYCH, V30, P559; Stockbridge MD, 2017, THESIS, DOI [10.13016/M2DN3ZX6N, DOI 10.13016/M2DN3ZX6N]; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Werff KRV, 2017, EAR HEARING, V38, pE200, DOI 10.1097/AUD.0000000000000411; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375	44	2	2	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 20	2020	34	4					567	574		10.1080/02699052.2020.1725836		FEB 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8TS	WOS:000513750800001	32050797				2022-02-06	
J	Sauter, TC; Ronz, K; Hirschi, T; Lehmann, B; Hutt, C; Exadaktylos, AK; Muller, M				Sauter, Thomas C.; Ronz, Katharina; Hirschi, Trevor; Lehmann, Beat; Huett, Christopher; Exadaktylos, Aristomenis K.; Mueller, Martin			Intubation in acute alcohol intoxications at the emergency department	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Alcoholic intoxication; Drug overdoses; Unconsciousness; Glasgow coma scale; Intratracheal intubation; Airway management	GLASGOW COMA SCALE; INJURY; MANAGEMENT	Background Guidelines recommend endotracheal intubation in trauma patients with a Glasgow coma scale (GCS) < 9 because of the loss of airway reflexes and consequential risk of airway obstruction. However, in patients with acute alcohol intoxication guidelines are not clear. Thus, we aimed to determine the proportional incidence of intubation in alcohol intoxication and compare the clinical characteristics of intubated and non-intubated patients, as well as reasons for intubation in all patients and in the subgroup of patients with reduced GCS (< 9) but without traumatic brain injury. Methods We performed a retrospective analysis of all consultations to an urban ED in Switzerland that presented with an acute alcohol intoxication between 1st June 2012 and 31th Mai 2017. Patient and emergency consultations' characteristics, related injuries, intubation and reason for intubations were extracted. As a subgroup analysis, we analysed the patients with a GCS < 9 without a traumatic brain injury. Results Of 3003 consultations included from 01.06.2012 to 31.05.2017, 68 were intubated, leading to a proportional incidence of 2.3% intubations in alcohol-intoxication. Intubated patients had a lower blood alcohol concentration (1.3 g/kg [IQR 1.0-2.2] vs. 1.6 g/kg [IQR1.1-2.2], p = 0.034) and less often suffered from chronic alcohol abuse (1183 [39.4%] patients vs. 14 [20.6%], p = 0.001) than non-intubated patients. Patients with trauma were intubated more often (33 patients [48.5%] vs. 742 [25.3%], p < 0.001). In subgroup analysis, 110/145 patients (74.3%) were not intubated; again, more intubated patients had a history of trauma (9 patients [25.7%] vs. 10 [9.1%], p = 0.011). Conclusions Intubation in alcohol-intoxicated patients is rare and, among intoxicated patients with GCS < 9, more than two thirds were not intubated in our study - without severe complications. Trauma in general, independent of the history of a traumatic brain injury, and a missing history of chronic alcohol abuse are associated with intubation, but not with blood alcohol concentration. Special caution is required for intoxicated patients with trauma or other additional intoxications or diseases.	[Sauter, Thomas C.; Ronz, Katharina; Lehmann, Beat; Exadaktylos, Aristomenis K.; Mueller, Martin] Univ Bern, Univ Hosp Bern, Inselspital, Dept Emergency Med, Freiburgstr 8, CH-3010 Bern, Switzerland; [Sauter, Thomas C.] Charite Med Sch Berlin, Med Skills Lab, Berlin, Germany; [Ronz, Katharina] Hop Cantonal Fribourg, Dept Anaesthesiol, Fribourg, Switzerland; [Hirschi, Trevor] Univ Bern, Bern Univ Hosp, Dept Anaesthesiol, Inselspital, Bern, Switzerland; [Huett, Christopher; Mueller, Martin] Univ Hosp Bonn, Dept Anaesthesiol & Intens Care, Bonn, Germany		Sauter, TC (corresponding author), Univ Bern, Univ Hosp Bern, Inselspital, Dept Emergency Med, Freiburgstr 8, CH-3010 Bern, Switzerland.; Sauter, TC (corresponding author), Charite Med Sch Berlin, Med Skills Lab, Berlin, Germany.	thomas.sauter@insel.ch		Sauter, Thomas C/0000-0002-6646-5789	Gottfried and Julia Bangerter-Rhyner-Foundation; Swiss Academy of Medical Sciences [TCR 14/17]; Boehringer IngelheimBoehringer Ingelheim; Daiichi-SankyoDaiichi Sankyo Company Limited; BayerBayer AG	MM was funded by the Gottfried and Julia Bangerter-Rhyner-Foundation and the Swiss Academy of Medical Sciences through the "Young Talents in Clinical research" grant (TCR 14/17). TCS has received research grants or lecture fees from Bayer, Boehringer Ingelheim, and Daiichi-Sankyo and Gottfried and Julia Bangerter-Rhyner-Foundation.	Albrecht JS, 2018, AM J EPIDEMIOL, V187, P233, DOI 10.1093/aje/kwx254; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chan Betty, 1993, Journal of Emergency Medicine, V11, P579, DOI 10.1016/0736-4679(93)90312-U; Cherpitel CJ, 2005, ADDICTION, V100, P1840, DOI 10.1111/j.1360-0443.2005.01257.x; Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026; Eizadi-Mood N, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.08.008; Exadaktylos AHW, 2015, ICU MANAG, V15, P160; Gmel G, 2006, ALCOHOL CLIN EXP RES, V30, P501, DOI 10.1111/j.1530-0277.2006.00054.x; Haberkern M, 2010, EMERG MED J, V27, P199, DOI 10.1136/emj.2008.065482; Heard K, 2004, HUM EXP TOXICOL, V23, P197, DOI 10.1191/0960327104ht436oa; Hua A, 2017, J EMERG MED, V52, P59, DOI 10.1016/j.jemermed.2016.07.114; Isbister GK, 2004, CRIT CARE MED, V32, P88, DOI 10.1097/01.CCM.0000104207.42729.E4; JURKOVICH GJ, 1992, ANN EMERG MED, V21, P704, DOI 10.1016/S0196-0644(05)82783-0; Lynd LD, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-5; MOULTON C, 1991, BRIT MED J, V303, P1240, DOI 10.1136/bmj.303.6812.1240; MOULTON C, 1994, LANCET, V343, P1261, DOI 10.1016/S0140-6736(94)92155-5; Nielsen K, 2012, EMERG MED J, V29, P887, DOI 10.1136/emermed-2011-200119; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Rajajee V, 2017, NEUROCRIT CARE, V27, pS4, DOI 10.1007/s12028-017-0451-2; Ronning P, 2015, BRAIN INJURY, V29, P1648, DOI 10.3109/02699052.2015.1075154; Rotheray KR, 2012, RESUSCITATION, V83, P86, DOI 10.1016/j.resuscitation.2011.07.017; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Vonghia L, 2008, EUR J INTERN MED, V19, P561, DOI 10.1016/j.ejim.2007.06.033; WHO Collaborating Centre for Drug Statistics Methodology, 2018, ATC DDD IND	24	2	2	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	FEB 10	2020	28	1							11	10.1186/s13049-020-0707-2			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KV4IH	WOS:000520445400001	32041639	Green Published, gold			2022-02-06	
J	Schomann, T; Iljas, JD; Que, I; Li, YD; Suidgeest, E; Cruz, LJ; Frijns, JHM; Chan, A; Lowik, CMWG; Huisman, MA; Mezzanotte, L				Schomann, Timo; Iljas, Juvita D.; Que, Ivo; Li, Yuedan; Suidgeest, Ernst; Cruz, Luis J.; Frijns, Johan H. M.; Chan, Alan; Lowik, Clemens M. W. G.; Huisman, Margriet A.; Mezzanotte, Laura			Multimodal imaging of hair follicle bulge-derived stem cells in a mouse model of traumatic brain injury	CELL AND TISSUE RESEARCH			English	Article						Hair follicle bulge-derived stem cells; Bioluminescence imaging; Magnetic resonance imaging; Brain injury; Stem cell treatment; Tracking	IN-VITRO; FERUMOXYTOL; DIFFERENTIATION; FIBRONECTIN; TRACKING; STROKE; NANOCOMPLEXES; PROTAMINE; HEPARIN; LAMININ	Traumatic brain injury (TBI) is a devastating event for which current therapies are limited. Stem cell transplantation may lead to recovery of function via different mechanisms, such as cell replacement through differentiation, stimulation of angiogenesis and support to the microenvironment. Adult hair follicle bulge-derived stem cells (HFBSCs) possess neuronal differentiation capacity, are easy to harvest and are relatively immune-privileged, which makes them potential candidates for autologous stem cell-based therapy. In this study, we apply in vivo multimodal, optical and magnetic resonance imaging techniques to investigate the behavior of mouse HFBSCs in a mouse model of TBI. HFBSCs expressed Luc2 and copGFP and were examined for their differentiation capacity in vitro. Subsequently, transduced HFBSCs, preloaded with ferumoxytol, were transplanted next to the TBI lesion (cortical region) in nude mice, 2 days after injury. Brains were fixed for immunohistochemistry 58 days after transplantation. Luc2- and copGFP-expressing, ferumoxytol-loaded HFBSCs showed adequate neuronal differentiation potential in vitro. Bioluminescence of the lesioned brain revealed survival of HFBSCs and magnetic resonance imaging identified their localization in the area of transplantation. Immunohistochemistry showed that transplanted cells stained for nestin and neurofilament protein (NF-Pan). Cells also expressed laminin and fibronectin but extracellular matrix masses were not detected. After 58 days, ferumoxytol could be detected in HFBSCs in brain tissue sections. These results show that HFBSCs are able to survive after brain transplantation and suggest that cells may undergo differentiation towards a neuronal cell lineage, which supports their potential use for cell-based therapy for TBI.	[Schomann, Timo; Frijns, Johan H. M.; Huisman, Margriet A.] Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands; [Schomann, Timo; Iljas, Juvita D.; Li, Yuedan; Chan, Alan] Percuros BV, Leiden, Netherlands; [Iljas, Juvita D.] Max Planck Inst Metab Res, Cologne, Germany; [Que, Ivo; Li, Yuedan; Cruz, Luis J.] Med Ctr, Dept Radiol, Translat Nanobiomat & Imaging, Leiden, Netherlands; [Suidgeest, Ernst; Chan, Alan] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Frijns, Johan H. M.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Lowik, Clemens M. W. G.; Mezzanotte, Laura] Erasmus MC, Dept Radiol & Nucl Med, Opt Mol Imaging, Rotterdam, Netherlands; [Lowik, Clemens M. W. G.; Mezzanotte, Laura] Erasmus MC, Dept Mol Genet, Rotterdam, Netherlands; [Huisman, Margriet A.] Hair Sci Inst, Maastricht, Netherlands		Mezzanotte, L (corresponding author), Erasmus MC, Dept Radiol & Nucl Med, Opt Mol Imaging, Rotterdam, Netherlands.; Mezzanotte, L (corresponding author), Erasmus MC, Dept Mol Genet, Rotterdam, Netherlands.	l.mezzanotte@erasmusmc.nl	Frijns, Johan H.M. HM/H-6249-2011; Suidgeest, Ernst/ABG-4795-2021	Frijns, Johan H.M. HM/0000-0002-1180-3314; Suidgeest, Ernst/0000-0001-8015-9238; Chan, Alan/0000-0001-6949-9274; Mezzanotte, Laura/0000-0001-5592-8904	FP7 European Union Marie Curie IAPP Program, BRAINPATH [612360]; H2020-MSCA-RISE PRISAR grant [644373]; MED-EL (Innsbruck, Austria) [FK0151/MEDELI001]; Stichting Het Heinsius-Houbolt Fonds, the NetherlandsNetherlands Government	This work was supported by the FP7 European Union Marie Curie IAPP Program, BRAINPATH, under grant number 612360, the project grant H2020-MSCA-RISE PRISAR grant number 644373 and by a grant from MED-EL (Innsbruck, Austria) grant number FK0151/MEDELI001.This project is financially supported by grants from Stichting Het Heinsius-Houbolt Fonds, the Netherlands. Timo Schomann received funding from MED-EL (Innsbruck, Austria).	Alexanian AR, 2008, STEM CELLS DEV, V17, P1123, DOI 10.1089/scd.2007.0212; Bang OY, 2016, J STROKE, V18, P256, DOI 10.5853/jos.2016.01263; Boehm-Sturm P, 2014, BIOMATERIALS, V35, P2218, DOI 10.1016/j.biomaterials.2013.11.085; Bryant LH, 2017, NANOMED-NANOTECHNOL, V13, P503, DOI 10.1016/j.nano.2016.07.011; Caplan AI, 2017, STEM CELL TRANSL MED, V6, P1445, DOI 10.1002/sctm.17-0051; Cox C, 2006, SAFETY AUTOLOGOUS ST; Cox C, 2012, TREATMENT SEVERE ADU; Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]; El Seady R, 2008, BIOCHEM BIOPH RES CO, V376, P358, DOI 10.1016/j.bbrc.2008.08.166; Evans AR, 2007, DEV NEUROBIOL, V67, P1721, DOI 10.1002/dneu.20540; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Gho CG, 2016, CYTOTECHNOLOGY, V68, P1849, DOI 10.1007/s10616-015-9938-x; Grigoriadis N, 2011, EXP NEUROL, V230, P78, DOI 10.1016/j.expneurol.2011.02.021; Gutova M, 2013, STEM CELL TRANSL MED, V2, P766, DOI 10.5966/sctm.2013-0049; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419; Hu YF, 2010, STEM CELL REV REP, V6, P186, DOI 10.1007/s12015-010-9152-3; Jendelova P, 2016, EXPERT OPIN BIOL TH, V16, P43, DOI 10.1517/14712598.2016.1094457; Khurana A, 2013, NANOMEDICINE-UK, V8, P1969, DOI 10.2217/nnm.12.198; Khurana A, 2012, RADIOLOGY, V264, P803, DOI 10.1148/radiol.12112393; Kiasatdolatabadi A, 2017, MOL NEUROBIOL, V54, P4963, DOI 10.1007/s12035-016-0030-0; Ladewig J, 2008, STEM CELLS, V26, P1705, DOI 10.1634/stemcells.2008-0007; Lemmens R, 2013, CURR OPIN NEUROL, V26, P617, DOI 10.1097/WCO.0000000000000023; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Low K, 2010, GENE THER, V17, P577, DOI 10.1038/gt.2010.14; Meguro R, 2007, ARCH HISTOL CYTOL, V70, P1, DOI 10.1679/aohc.70.1; Mezzanotte L, 2017, TRENDS BIOTECHNOL, V35, P640, DOI 10.1016/j.tibtech.2017.03.012; Mezzanotte L, 2013, CONTRAST MEDIA MOL I, V8, P505, DOI 10.1002/cmmi.1549; Mezzanotte L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019277; Mishra SK, 2018, STEM CELL REV REP, V14, P888, DOI 10.1007/s12015-018-9828-7; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; Ngen EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13628; Paus R, 2005, TRENDS IMMUNOL, V26, P32, DOI 10.1016/j.it.2004.09.014; Pirko Istvan, 2005, NeuroRx, V2, P250, DOI 10.1602/neurorx.2.2.250; SanBio, 2016, STUD MOD STEM CELLS; Schieda N, 2013, INSIGHTS IMAGING, V4, P509, DOI 10.1007/s13244-013-0262-8; Schomann T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187183; Schomann T, 2016, CONTRAST MEDIA MOL I, V11, P550, DOI 10.1002/cmmi.1717; Seppen J, 2000, J VIROL, V74, P7642, DOI 10.1128/JVI.74.16.7642-7645.2000; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Sieber-Blum Maya, 2004, Birth Defects Res C Embryo Today, V72, P162, DOI 10.1002/bdrc.20008; Smith BA, 2012, ACS CHEM NEUROSCI, V3, P530, DOI 10.1021/cn3000197; Strachan LR, 2008, EXP CELL RES, V314, P441, DOI 10.1016/j.yexcr.2007.10.016; Tate CC, 2007, J NEUROTRAUM, V24, P226, DOI 10.1089/neu.2006.0043; Techawattanawisal W, 2007, BIOCHEM BIOPH RES CO, V357, P917, DOI 10.1016/j.bbrc.2007.04.031; Tennstaedt A, 2015, BIOMATERIALS, V44, P143, DOI 10.1016/j.biomaterials.2014.12.038; Nguyen TD, 2013, BIOL CHEM, V394, P1623, DOI 10.1515/hsz-2013-0191; Thu MS, 2012, NAT MED, V18, P463, DOI 10.1038/nm.2666; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zhang ZG, 2019, NAT REV NEUROL, V15, P193, DOI 10.1038/s41582-018-0126-4; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310; Zheng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep14055	53	2	2	1	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	JUL	2020	381	1					55	69		10.1007/s00441-020-03173-1		FEB 2020	15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	LZ6QA	WOS:000515984300001	32036485	Green Published, hybrid			2022-02-06	
J	Asken, BM; Houck, ZM; Schmidt, JD; Bauer, RM; Broglio, SP; McCrea, MA; McAllister, TW; Clugston, JR				Asken, Breton M.; Houck, Zachary M.; Schmidt, Julianne D.; Bauer, Russell M.; Broglio, Steven P.; McCrea, Michael A.; McAllister, Thomas W.; Clugston, James R.		Care Consortium Investigators	A Normative Reference vs. Baseline Testing Compromise for ImPACT: The CARE Consortium Multiple Variable Prediction (CARE-MVP) Norms	SPORTS MEDICINE			English	Article							PREMORBID INTELLIGENCE; CONCUSSION; PERFORMANCE; DISORDERS; EDUCATION	Background Sports medicine clinicians routinely use computerized neurocognitive testing in sport-related concussion management programs. Debates continue regarding the appropriateness of normative reference comparisons versus obtaining individual baseline assessments, particularly for populations with greater likelihood of having below- or above-average cognitive abilities. Improving normative reference methods could offer alternatives to perceived logistical and financial burdens imposed by universal baseline testing. Objectives To develop and validate the Concussion Assessment, Research, and Education (CARE) Consortium Multiple Variable Prediction (MVP) norms for the Immediate Postconcussion Assessment and Cognitive Testing (ImPACT). Methods We developed the CARE-MVP norms for ImPACT composite scores using regression-based equations. Predictor variables included sex, race (white/Caucasian, black/African American, Asian, or Multiple Races), medical history [attention-deficit/hyperactivity disorder (ADHD), learning disorder (LD), prior concussion(s), prior psychiatric diagnosis], and an estimate of premorbid intellect (Wechsler Test of Adult Reading). CARE-MVP norms were first validated in an independent sample of healthy collegiate athletes by comparing predicted and actual baseline test scores using independent-samples t-tests and Cohen's d effect sizes. We then evaluated base rates of low scores in athletes self-reporting ADHD/LD (vs. non-ADHD/LD) and black/African American race (vs. white/Caucasian) across multiple normative reference methods (Chi square, Cramer's V effect size). Lastly, we validated the CARE-MVP norms in a concussed sample (dependent samples t test, Cohen's d effect size). Results A total of 5233 collegiate athletes (18.8 +/- 1.2 years, 70.5% white/Caucasian, 39.1% female) contributed to the CARE-MVP norms (development N = 2616; internal validation N = 2617). Race and WTAR score were the strongest and most consistent ImPACT score predictors. There were negligible mean differences between observed and predicted (CARE-MVP) baseline scores (Cohen's d < 0.1) for all ImPACT composite scores except Reaction Time (predicted 20 ms faster than observed, d = - 0.28). Low score base rates were similar for athletes across subpopulations when using CARE-MVP norms (ADHD/LD, V = 0.017-0.028; black/African American, V = 0.043-0.053); while, other normative reference methods resulted in disproportionately higher rates of low scores (ADHD/LD, V = 0.062-0.101; black/African American race, V = 0.163-0.221). Acute (24-48 h) postconcussion ImPACT scores were significantly worse than CARE-MVP norms but notably varied as a function of concussion symptom severity. Conclusions Results support CARE-MVP norm use in populations typically underrepresented or not adjusted for in traditional normative reference samples, such as those self-reporting ADHD/LD or black/African American race. CARE-MVP norms improve upon prior normative methods and may offer a practical, simple alternative for collegiate institutions concerned about logistical and financial burden associated with baseline testing. An automated scoring program is provided.	[Asken, Breton M.] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA; [Asken, Breton M.; Houck, Zachary M.; Bauer, Russell M.] Univ Florida, Dept Clin & Hlth Psychol, HSC POB 100165, Gainesville, FL 32610 USA; [Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Sch Kinesiol, Ann Arbor, MI 48109 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg & Neurol, Milwaukee, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Clugston, James R.] Univ Florida, Univ Athlet Assoc, Dept Community Hlth & Family Med, Gainesville, FL USA		Asken, BM (corresponding author), Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA.; Asken, BM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, HSC POB 100165, Gainesville, FL 32610 USA.	breton.asken@ucsf.edu		Asken, Breton/0000-0001-8419-142X; Clugston, James/0000-0002-2103-1039	Grand Alliance Concussion Assessment, Research, and Education Consortium from the National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	BMA, ZMH, JDS, RMB, SPB, MAM, TWM, and JRC declare no conflicts of interest related to the content of this study. This publication was supported in part by the Grand Alliance Concussion Assessment, Research, and Education Consortium, which receives funding from the National Collegiate Athletic Association and the Department of Defense. The US Army Medical Research Acquisition Activity is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program (award W81XWH-14-2-0151). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (Defense Health Program funds).	Arnett P, 2016, SPORTS MED ARTHROSC, V24, P116, DOI 10.1097/JSA.0000000000000123; Asken BM, 2020, CLIN NEUROPSYCHOL, V34, P919, DOI 10.1080/13854046.2019.1680735; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Bright P, 2020, NEUROPSYCHOL REHABIL, V30, P1, DOI 10.1080/09602011.2018.1445650; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Brooks BL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P893, DOI 10.1007/978-0-387-76978-3_31; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P793, DOI 10.1016/0191-8869(89)90126-8; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Duff K, 2019, ARCH CLIN NEUROPSYCH, V34, P395, DOI 10.1093/arclin/acy050; Duff K, 2010, APPL NEUROPSYCHOL, V17, P278, DOI 10.1080/09084282.2010.525113; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Garcia GGP, 2019, J NEUROTRAUMA; Haran FJ, 2016, BRAIN INJURY, V30, P280, DOI 10.3109/02699052.2015.1118766; Hinton-Bayre AD, 2015, BRAIN IMPAIR, V16, P80, DOI 10.1017/BrImp.2015.14; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Houck ZM, 2019, J INT NEUROPSYCH SOC, V25, P961, DOI 10.1017/S1355617719000729; Houck ZM, 2019, CLIN NEUROPSYCHOL; ImPACT Applications I, 2016, IMPACT APPL 1 IMPACT; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P1429, DOI 10.1001/jama.2018.1536; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2012, REHABIL RES PRACT, V2012; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Manly JJ, 2007, ARCH CLIN NEUROPSYCH, V22, P319, DOI 10.1016/j.acn.2007.01.006; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; McCrory P., 2017, BRIT J SPORT MED; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Steward KA, 2017, ARCH CLIN NEUROPSYCH, V32, P98, DOI 10.1093/arclin/acw081; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Weber ML, 2018, AM J SPORT MED, V46, P1742, DOI 10.1177/0363546518765145; Wechsler D, 2001, WTAR WECHSLER TEST A; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	46	2	2	1	4	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	AUG	2020	50	8					1533	1547		10.1007/s40279-020-01263-2		FEB 2020	15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	MN8VX	WOS:000515963400002	32034702				2022-02-06	
J	Oginska-Bulik, N; Michalska, P				Oginska-Bulik, Nina; Michalska, Paulina			The Mediating Role of Cognitive Processing in the Relationship Between Negative and Positive Effects of Trauma Among Female Victims of Domestic Violence	JOURNAL OF INTERPERSONAL VIOLENCE			English	Article						cognitive processing of trauma; domestic violence; posttraumatic growth; posttraumatic stress symptoms; women	INTIMATE PARTNER-VIOLENCE; POSTTRAUMATIC-STRESS-DISORDER; BRAIN-INJURY; WOMENS HEALTH; MENTAL-HEALTH; GROWTH; SURVIVORS; SYMPTOMS; PTSD; THERAPY	Exposure to domestic violence may lead not only to negative but also positive consequences of trauma. Negative effects are indicated by posttraumatic stress symptoms (PTSSs), and positive effects by posttraumatic growth (PTG) changes. PTG has been conceptualized to follow experiences of PTSSs. Therefore, the positive and negative effects of trauma appear to be related to one another. The cognitive processing may play a special role in determining whether the positive and negative consequences of trauma exposure are experienced. The aim of the study was to establish the mediating role of multiple patterns of cognitive processing, reflected by the cognitive strategies used to cope with trauma, in the relationship between negative and positive posttraumatic changes in women following domestic violence. Data were obtained from 63 Polish women who had experienced domestic violence. The age of the respondents ranged from 19 to 71 years (M = 42.25, SD = 14.81). The Polish versions of the following standardized tools were used: the Posttraumatic Stress Disorder Checklist (PCL-5), the Posttraumatic Growth Inventory (PTGI), and the Cognitive Processing of Trauma Scale (CPOTS). PTSS severity appeared to be negatively related to that of PTG. Negative coping strategies were positively related to the PTSS severity but negatively to PTG, while positive strategies were negatively related to the PTSS severity but positively to PTG. Cognitive strategies for coping with trauma, such as resolution/acceptance, downward comparison, and regret, appeared to play a mediating role in the relationship between PTSS severity and PTG. Positive coping strategies strengthen the occurrence of positive posttraumatic changes while strategy of regret weakens the PTG changes occurrence. The process of adaptation and human development among people who have experienced traumatic events is favored by the use of more frequent positive and less frequent negative strategies of dealing with trauma.	[Oginska-Bulik, Nina] Univ Lodz, Hlth Psychol Dept, Inst Psychol, Lodz, Poland; [Michalska, Paulina] Univ Lodz, Psychol, Lodz, Poland		Michalska, P (corresponding author), Univ Lodz, Inst Psychol, Dept Hlth Psychol, Smugowa 10-12, PL-91433 Lodz, Poland.	paulina.michalska@uni.lodz.pl		Michalska, Paulina/0000-0003-2179-0307; Oginska-Bulik, Janina/0000-0001-8868-407X			Albrecht JS, 2017, J HEAD TRAUMA REHAB, V32, P178, DOI 10.1097/HTR.0000000000000266; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arandia AMH, 2018, J INTERPERS VIOLENCE, V33, P2849, DOI 10.1177/0886260516632354; Bear M., 2016, NEUROSCIENCE EXPLORI; Becker KD, 2010, J INTERPERS VIOLENCE, V25, P1699, DOI 10.1177/0886260509354578; Bernard NK, 2019, VIOLENCE VICTIMS, V34, P522, DOI 10.1891/0886-6708.VV-D-18-00095; Black M C., 2011, NATL INTIMATE PARTNE; Brown JR, 2005, J INTERPERS VIOLENCE, V20, P1478, DOI 10.1177/0886260505278604; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Calhoun L.G., 2010, POSTTRAUMATIC GROWTH, P1, DOI DOI 10.1002/9781118270028.CH1; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Cann A, 2010, J LOSS TRAUMA, V15, P151, DOI 10.1080/15325020903375826; Cobb AR, 2006, J TRAUMA STRESS, V19, P895, DOI 10.1002/jts.20171; Coker AL, 2009, J WOMENS HEALTH, V18, P1179, DOI 10.1089/jwh.2008.1048; Crowell NA, 1996, UNDERSTANDING VIOLEN; Dbkowska M., 2009, ALKOHOL NARKOM, V22, P11; DeJonghe ES, 2008, J POSTGRAD MED, V54, P294, DOI 10.4103/0022-3859.41435; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Dillon Gina, 2013, Int J Family Med, V2013, P313909, DOI 10.1155/2013/313909; Draucker C B, 2001, Health Care Women Int, V22, P67, DOI 10.1080/073993301300003081; Dutton MA, 2006, J INTERPERS VIOLENCE, V21, P955, DOI 10.1177/0886260506289178; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Elderton A, 2017, TRAUMA VIOLENCE ABUS, V18, P223, DOI 10.1177/1524838015611672; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; Griffing S, 2006, J INTERPERS VIOLENCE, V21, P936, DOI 10.1177/0886260506288938; Gul E, 2017, J TRAUMA STRESS, V30, P54, DOI 10.1002/jts.22161; Hagenaars MA, 2010, J TRAUMA STRESS, V23, P504, DOI 10.1002/jts.20551; Hall BJ, 2008, J TRAUMA STRESS, V21, P22, DOI 10.1002/jts.20301; Hegarty KL, 2013, J INTERPERS VIOLENCE, V28, P273, DOI 10.1177/0886260512454722; Horowitz M. J., 1976, STRESS RESPONSE SYND; Iverson KM, 2015, BEHAV RES THER, V66, P49, DOI 10.1016/j.brat.2015.01.002; Johnson RJ, 2007, APPL PSYCHOL-INT REV, V56, P428, DOI 10.1111/j.1464-0597.2007.00296.x; Jones L., 2001, TRAUMA VIOLENCE ABUS, V2, P99, DOI [10.1177/1524838001002002001, DOI 10.1177/1524838001002002001]; Juczynski Z., 2010, PSYCHIATRIA, V7, P129, DOI [10.1002/cad.20376, DOI 10.1002/CAD.20376]; Juczynski Z, 2018, REV PSYCHOL, V61, P153; Juczynski Z, 2018, POSTEP PSYCHIATR NEU, V27, P318, DOI 10.5114/ppn.2018.80884; Kaysen D, 2013, PSYCHOL TRAUMA-US, V5, P184, DOI 10.1037/a0026053; Kunst MJJ, 2010, J TRAUMA STRESS, V23, P514, DOI 10.1002/jts.20556; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lechner SC, 2004, PSYCHOL INQ, V15, P35; Lev-Wiesel R, 2005, J LOSS TRAUMA, V10, P7, DOI 10.1080/15325020490890606; Levendosky Alytia A, 2012, Psychodyn Psychiatry, V40, P397; Levine SZ, 2008, J TRAUMA STRESS, V21, P492, DOI 10.1002/jts.20361; Lutwak N, 2018, J PSYCHOL, V152, P373, DOI 10.1080/00223980.2018.1447435; Mccaw B, 2007, WOMEN HEALTH, V45, P1, DOI 10.1300/J013v45n02_01; McLean CP, 2014, J FAM VIOLENCE, V29, P559, DOI 10.1007/s10896-014-9613-6; Meng ZY, 2018, INT J DISAST RISK RE, V27, P524, DOI 10.1016/j.ijdrr.2017.11.016; Monahan K, 2019, J AGGRESS MALTREAT T, V28, P807, DOI 10.1080/10926771.2019.1628154; Monson C. M., 2014, TREATING PTSD COGNIT; Morina N, 2014, CLIN PSYCHOL REV, V34, P249, DOI 10.1016/j.cpr.2014.03.002; Ogiska-Bulik N., 2018, REV PSYCHOL, V61, P281; Ogiska-Bulik N., 2013, FAMILY PEDAGOGY, V3, P89; Ogiska-Bulik N., 2015, 2 FACES TRAUMA NEGAT; Ogiska-Bulik N., 2019, J CLIN PSYCHOL MED S, DOI [10.1007/s10880-019-09606-6, DOI 10.1007/S10880-019-09606-6]; Ogiska-Bulik N., 2016, ANN PSYCHOL, V19, P643; Perez S, 2008, J INTERPERS VIOLENCE, V23, P635, DOI 10.1177/0886260507313528; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Saavedra, 2015, PHILIPPINE J PSYCHOL, V48, P3; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schnurr, 2013, PTSD CHECKLIST DSM 5; Scott ST, 2007, J INTERPERS VIOLENCE, V22, P932, DOI 10.1177/0886260507301226; Senter KE, 2002, CONTEMP FAM THER, V24, P543, DOI 10.1023/A:1021269028756; Smith S.G., 2017, NATL INTIMATE PARTNE; Solomon Z, 1999, J SOC CLIN PSYCHOL, V18, P419, DOI 10.1521/jscp.1999.18.4.419; Stockton H, 2011, J TRAUMA STRESS, V24, P85, DOI 10.1002/jts.20606; Swopes RM, 2017, J INTERPERS VIOLENCE, V32, P1143, DOI 10.1177/0886260515587668; Taylor S.E, 1989, POSITIVE ILLUSIONS C; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Trevillion K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051740; Ulloa E, 2016, J AGGRESS MALTREAT T, V25, P286, DOI 10.1080/10926771.2015.1079286; Valdez CE, 2015, J INTERPERS VIOLENCE, V30, P215, DOI 10.1177/0886260514533154; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Wijma K, 2000, J INTERPERS VIOLENCE, V15, P944, DOI 10.1177/088626000015009003; Williams RM, 2002, CLIN PSYCHOL PSYCHOT, V9, P349, DOI 10.1002/cpp.343; World Health Organization, 2013, GLOBAL REGIONAL ESTI; Yalch M. M., 2015, PARTNER VIOLENCE RIS, P113; Yalch MM, 2017, J INTERPERS VIOLENCE, V32, P3131, DOI 10.1177/0886260515596978	80	2	2	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0886-2605	1552-6518		J INTERPERS VIOLENCE	J. Interpers. Violence	DEC	2021	36	23-24					NP12898	NP12921	0886260520903141	10.1177/0886260520903141		FEB 2020	24	Criminology & Penology; Family Studies; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Family Studies; Psychology	XG9QD	WOS:000512275500001	32028810				2022-02-06	
J	Hickling, A; Mallory, KD; Wilson, KE; Del Fernandes, R; Fuselli, P; Reed, N; DeMatteo, C; Isaac, J; Macpherson, A; Pike, I; Shubat, T; Stringer, G; Stringer, K; Tator, C; Thompson, S; Bianchi, S; Chan, A; DiLeonardo, K; Kita, H; Yu, J; Barnes, K; Cowle, S; Ellis, MJ; Hung, R; Hunt, AW; Hutchison, MG; Kawasoe, B; Kay, G; Kourtis, G; Kraetschmer, N; Kroshus, E; Louis, R; MacPhee, J; Markham, C; Provvidenza, CF; Russell, K; Scratch, SE; Sheps, G; Tanenbaum, B; Weiser, P; Zemek, R				Hickling, Andrea; Mallory, Kylie D.; Wilson, Katherine E.; Del Fernandes, Rosephine; Fuselli, Pamela; Reed, Nick; DeMatteo, Carol; Isaac, Jonathan; Macpherson, Alison; Pike, Ian; Shubat, Tammy; Stringer, Gordon; Stringer, Kathleen; Tator, Charles; Thompson, Sue; Bianchi, Stefan; Chan, Alice; DiLeonardo, Kiera; Kita, Helena; Yu, Julianne; Barnes, Kathryn; Cowle, Stephanie; Ellis, Michael J.; Hung, Ryan; Hunt, Anne W.; Hutchison, Michael G.; Kawasoe, Barbara; Kay, Gina; Kourtis, George; Kraetschmer, Nancy; Kroshus, Emily; Louis, Richard; MacPhee, Jennifer; Markham, Chris; Provvidenza, Christine F.; Russell, Kelly; Scratch, Shannon E.; Sheps, Gideon; Tanenbaum, Brandy; Weiser, Paul; Zemek, Roger		Youth Concussion Awareness Network	The youth concussion awareness network (You-CAN) - a school-based peer-led intervention to improve concussion reporting and social support: the protocol for a cluster randomized trial	BMC PUBLIC HEALTH			English	Article						Concussion; School-based intervention; Peer education; Education; Adolescents; Brain injury	KNOWLEDGE; EDUCATION; PLAYERS; HOCKEY; BRAIN; PROGRAM; VIDEO	Background: Concussion prevalence is increasing in the pediatric population, and is a matter of public health concern. Concussion symptoms can be physical, cognitive, emotional and behavioural, and last longer in high school aged youth than adults. Concussions are underreported in youth due to their lack of knowledge, social environment, perceived outcomes of reporting, norms, and self-efficacy. The Youth Concussion Awareness Network (You-CAN) is a school-based peer-led program designed to increase high school students' intent to report a concussion, and provide social support to a peer. This study aims to investigate whether participation in You-CAN, a program grounded in service learning principles, impacts concussion knowledge, attitudes, intent to report a suspected concussion to an adult, and intent to provide social support to a peer. Secondary aims include assessing the implementation fidelity and acceptability of the intervention. Methods: This longitudinal study will use a cluster randomized trial design. Three high schools from six randomly selected Canadian school boards will participate and be randomized to three study arms: (1) You-CAN led by school staff; (2) You-CAN led by school staff and research team; and (3) untreated comparison group. Intervention arms 1 and 2 will deliver the You-CAN program and create a Concussion Council at their school. The Concussion Council will deliver a concussion awareness campaign and participate in an online showcase with other participating schools. In addition, arm 2 will have monthly video-calls with the research team. A survey based on the Theory of Planned Behaviour will be administered school-wide with all arms (1, 2, 3) at two time points (beginning {T-0} and end {T-1} of the school year). Exit interviews will be completed with the Concussion Councils and participating school staff. Discussion: This study will provide evidence of the effectiveness of a school-based peer-led concussion program on increasing concussion knowledge, attitudes, subjective norms, perceived behavioural control, intent to report a concussion to an adult, and intent to provide social support to a peer amongst Canadian high school students. It will also provide important information about the implementation and acceptability of the You-CAN program for high school students and staff.	[Hickling, Andrea; Mallory, Kylie D.; Wilson, Katherine E.; Del Fernandes, Rosephine; Reed, Nick; Hung, Ryan; Hunt, Anne W.; Provvidenza, Christine F.; Scratch, Shannon E.; Sheps, Gideon; Weiser, Paul] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Hickling, Andrea; Reed, Nick; Hunt, Anne W.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Fac Med, Toronto, ON, Canada; [Mallory, Kylie D.; Reed, Nick; Hunt, Anne W.; Scratch, Shannon E.] Univ Toronto, Rehabil Sci Inst, Fac Med, Toronto, ON, Canada; [Fuselli, Pamela; Cowle, Stephanie] Parachute, Toronto, ON, Canada; [Bianchi, Stefan; Chan, Alice; DiLeonardo, Kiera; Kita, Helena; Yu, Julianne] Bloorview Res Inst, Toronto, ON, Canada; [Barnes, Kathryn; Kawasoe, Barbara] Upper Canada Coll, Toronto, ON, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Pediat, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Neurosurg Sect, Winnipeg, MB, Canada; [Ellis, Michael J.] Pan Am Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.; Russell, Kelly] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Hung, Ryan] Univ Toronto, Div Dev Pediat, Dept Paediat, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, David L MacIntosh Sport Med Clin, Toronto, ON, Canada; [Hutchison, Michael G.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Kay, Gina] Crescent Sch, Toronto, ON, Canada; [Kourtis, George] Toronto Dist Sch Board, Toronto, ON, Canada; [Kraetschmer, Nancy] Toronto Cent Local Hlth Integrat Network, Toronto, ON, Canada; [Kraetschmer, Nancy] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Louis, Richard] NB Trauma Program, St John, NB, Canada; [MacPhee, Jennifer] Toronto Dist Sch Board, Toronto, ON, Canada; [Markham, Chris] Ontario Phys & Hlth Educ Assoc, Toronto, ON, Canada; [Russell, Kelly] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Scratch, Shannon E.] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Tanenbaum, Brandy] Sunnybrook Hlth Sci Ctr, Ctr Injury Prevent, Toronto, ON, Canada; [Zemek, Roger] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Pediat & Emergency Med, Ottawa, ON, Canada		Reed, N (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.; Reed, N (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, Fac Med, Toronto, ON, Canada.	nick.reed@utoronto.ca		Hickling, Andrea/0000-0001-6251-6369	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [153025]	This work is funded by the Canadian Institutes of Health Research (#153025) from 2017 to 2021. The Canadian Institutes of Health Research is Canada's federal funding agency for health research and located at 160 Elgin Street, 10th Floor, Address Locator 4809A, Ottawa ON K1A 0 W9, Canada. The study design; collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the report for publication development, are independednt of the Canadian Institutes of Health Research.	Ahmed OH, 2016, PHYS THER SPORT, V21, P82, DOI 10.1016/j.ptsp.2016.03.001; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2013, R LANG ENV STAT COMP; [Anonymous], 2017, IPARD FRAMEWORK; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Beitman C., 2015, INT J RES SERVICE LE, V3; Billig S. H., 2002, ED HORIZONS, V80, P184; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dobbie F, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7112-7; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Google, 2019, GOOGL AN; Henshaw MM, EVALUATING SERVICE L; IBM Corp, IBM SPSS STAT WIND V; Kindt KCM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-212; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Larsen T, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5241-z; Layzer C, 2014, J ADOLESCENT HEALTH, V54, pS70, DOI 10.1016/j.jadohealth.2013.12.023; Mallory KD, 2020, BRAIN INJURY, V34, P171, DOI 10.1080/02699052.2019.1692369; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; McNeely CA, 2002, J SCHOOL HEALTH, V72, P138, DOI 10.1111/j.1746-1561.2002.tb06533.x; Patel DR, 2017, TRANSL PEDIATR, V6, P114, DOI 10.21037/tp.2017.03.08; Rao DP, 2018, HEALTH PROMOT CHRON, V38, P147, DOI 10.24095/hpcdp.38.3.05; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sampasa-Kanyinga H, 2016, PREV MED, V87, P11, DOI 10.1016/j.ypmed.2016.02.010; Selmo L., 2015, INT J RES SERVICE LE, V3; Story M, 2002, J SCHOOL HEALTH, V72, P121, DOI 10.1111/j.1746-1561.2002.tb06529.x; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Taylor ME, 2017, J SCH NURS, V33, P73, DOI 10.1177/1059840515619683; Theye Fred, 2004, Clin Med Res, V2, P165; Volanen S-M, 2016, BMC PSYCHOL, V4, P1, DOI DOI 10.1186/s40359-016-0142-3; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	42	2	2	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	FEB 5	2020	20	1							186	10.1186/s12889-020-8244-5			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	KM1SB	WOS:000513899800003	32024506	gold, Green Published			2022-02-06	
J	Silver, IA; Province, K; Nedelec, JL				Silver, Ian A.; Province, Karli; Nedelec, Joseph L.			Self-reported traumatic brain injury during key developmental stages: examining its effect on co-occurring psychological symptoms in an adjudicated sample	BRAIN INJURY			English	Article						Key developmental stages; traumatic brain injury; co-occurring psychological symptoms; adverse psychological effects	POSTTRAUMATIC-STRESS-DISORDER; COMMUNITY INTEGRATION; MAJOR DEPRESSION; HEAD-INJURIES; ANXIETY; TERM; ENCEPHALOPATHY; EPIDEMIOLOGY; SATISFACTION; DELINQUENCY	Primary Objective: Prior research has demonstrated that traumatic brain injury (TBI) is associated with individual psychological symptoms. These findings, however, may not pertain to the influence of TBI during key developmental stages on the co-occurrence of negative psychological symptoms. Research Design: It was hypothesized that (H1) self-reported TBI is associated with adverse psychological effects, that (H2) self-reported TBI during adolescences is associated with both immediate and delayed adverse psychological effects, and finally, (H3) self-reported TBI during the early stages of adulthood is not associated with immediate psychological effects. Methods and Procedures: The current study employed a sample of adjudicated youth (N: 419 to 562) and structural equation modeling to estimate the association between self-reported TBI and subsequent adverse psychological effects. Results: Findings suggested that higher levels of self-reported TBI during adolescence were associated with higher levels of adverse psychological effects. These effects were both immediate and delayed. However, higher levels of self-reported TBI during adulthood were not associated with immediate adverse psychological effects. Conclusion: Overall, the findings suggest that deleterious outcomes related to self-reported TBI during key developmental stages include proximal and long-term adverse psychological effects.	[Silver, Ian A.; Province, Karli; Nedelec, Joseph L.] Univ Cincinnati, Sch Criminal Justice, Cincinnati, OH 45221 USA		Silver, IA (corresponding author), Univ Cincinnati, Sch Criminal Justice, Cincinnati, OH 45221 USA.	silveria@ucmail.uc.edu		Silver, Ian/0000-0001-8233-4378	Office of Juvenile Justice and Delinquency Prevention [2007-MU-FX-0002]; National Institute of Justice [2008-IJ-CX-0023]; John D. and Catherine T. MacArthur Foundation; William T. Grant Foundation; Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); William Penn Foundation; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA019697]; Pennsylvania Commission on Crime and Delinquency; Arizona Governor's Justice Commission; Center for Disease Control	The project described was supported by funds from the following: Office of Juvenile Justice and Delinquency Prevention (2007-MU-FX-0002), National Institute of Justice (2008-IJ-CX-0023), John D. and Catherine T. MacArthur Foundation, William T. Grant Foundation, Robert Wood Johnson Foundation, William Penn Foundation, Center for Disease Control, National Institute on Drug Abuse (R01DA019697), Pennsylvania Commission on Crime and Delinquency, and the Arizona Governor's Justice Commission. The content of the article is the sole responsibility of the authors and does not necessarily represent the official views of these agencies. We are grateful for their support, and any errors or omissions are ours alone. The current study did not receive any support from these grants.	Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bandura A, 1996, J PERS SOC PSYCHOL, V71, P364, DOI 10.1037/0022-3514.71.2.364; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Byrne B.M., 2016, STRUCTURAL EQUATION, V3rd; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chitsabesan P, 2015, J HEAD TRAUMA REHAB, V30, P106, DOI 10.1097/HTR.0000000000000129; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Daigle LE, 2018, J CRIM JUST, V58, P78, DOI 10.1016/j.jcrimjus.2018.07.005; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goodkind M, 2015, JAMA PSYCHIAT, V72, P305, DOI 10.1001/jamapsychiatry.2014.2206; Goodwin RD, 2004, AM J PSYCHIAT, V161, P88, DOI 10.1176/appi.ajp.161.1.88; GRAY JA, 1987, J RES PERS, V21, P493, DOI 10.1016/0092-6566(87)90036-5; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hux D, 1998, BRAIN INJURY, V12, P667; Jodis CA, 2018, CURR OPIN PSYCHIATR, P67; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; Kline RB., 2011, PRINCIPLES PRACTICE, V3; Kosson DS, 2003, HARE PSYCHOPATHY CHE; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Prigatano GP, 2003, INT REV PSYCHIATR, V15, P371, DOI 10.1080/09540260310001606755; Reed A, 1996, J Psychiatr Ment Health Nurs, V3, P249, DOI 10.1111/j.1365-2850.1996.tb00119.x; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rydon-Grange M, 2015, CNS SPECTRUMS, V20, P463, DOI 10.1017/S109285291500053X; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schubert Carol A, 2004, Youth Violence Juv Justice, V2, P237, DOI 10.1177/1541204004265875; Schwartz JA, 2018, J CRIM JUST, V56, P70, DOI 10.1016/j.jcrimjus.2017.08.004; Schwartz JA, 2017, J RES CRIME DELINQ, V54, P869, DOI 10.1177/0022427817710287; Selner-O'Hagan MB, 1998, J CHILD PSYCHOL PSYC, V39, P215, DOI 10.1017/S002196309700187X; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; WEINBERGER DA, 1990, J PERS, V58, P381, DOI 10.1111/j.1467-6494.1990.tb00235.x; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2	57	2	2	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2020	34	3					375	384		10.1080/02699052.2020.1723166		FEB 2020	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8UO	WOS:000512564700001	32013624				2022-02-06	
J	Latronico, N; Piva, S; Fagoni, N; Pinelli, L; Frigerio, M; Tintori, D; Berardino, M; Bottazzi, A; Carnevale, L; Casalicchio, T; Castioni, CA; Cavallo, S; Cerasti, D; Citerio, G; Fontanella, M; Galiberti, S; Girardini, A; Gritti, P; Manara, O; Maremmani, P; Mazzani, R; Natalini, G; Patassini, M; Perna, ME; Pesaresi, I; Radolovich, DK; Saini, M; Stefini, R; Minelli, C; Gasparotti, R; Rasulo, FA				Latronico, Nicola; Piva, Simone; Fagoni, Nazzareno; Pinelli, Lorenzo; Frigerio, Michele; Tintori, Davide; Berardino, Maurizio; Bottazzi, Andrea; Carnevale, Livio; Casalicchio, Tiziana; Castioni, Carlo Alberto; Cavallo, Simona; Cerasti, Davide; Citerio, Giuseppe; Fontanella, Marco; Galiberti, Serena; Girardini, Alan; Gritti, Paolo; Manara, Ornella; Maremmani, Paolo; Mazzani, Roberta; Natalini, Giuseppe; Patassini, Mirko; Perna, Maria Elena; Pesaresi, Ilaria; Radolovich, Danila Katia; Saini, Maurizio; Stefini, Roberto; Minelli, Cosetta; Gasparotti, Roberto; Rasulo, Francesco A.			Impact of a posttraumatic cerebral infarction on outcome in patients with TBI: the Italian multicenter cohort INCEPT study	CRITICAL CARE			English	Article						Traumatic brain injury; Posttraumatic cerebral infarction; Long term outcome; Disability	TRAUMATIC BRAIN-INJURY; COMA DATA-BANK; ARTERIAL TERRITORIES; PROGNOSIS; MODERATE; MODELS; CARE; CT	Background Post-traumatic cerebral infarction (PTCI) is common after traumatic brain injury (TBI). It is unclear what the occurrence of a PTCI is, how it impacts the long-term outcome, and whether it adds incremental prognostic value to established outcome predictors. Methods This was a prospective multicenter cohort study of moderate and severe TBI patients. The primary objective was to evaluate if PTCI was an independent risk factor for the 6-month outcome assessed with the Glasgow Outcome Scale (GOS). We also assessed the PTCI occurrence and if it adds incremental value to the International Mission for Prognosis and Clinical Trial design in TBI (IMPACT) core and extended models. Results We enrolled 143 patients, of whom 47 (32.9%) developed a PTCI. In the multiple ordered logistic regression, PTCI was retained in both the core and extended IMPACT models as an independent predictor of the GOS. The predictive performances increased significantly when PTCI was added to the IMPACT core model (AUC = 0.73, 95% C.I. 0.66-0.82; increased to AUC = 0.79, 95% CI 0.71-0.83, p = 0.0007) and extended model (AUC = 0.74, 95% C.I. 0.65-0.81 increased to AUC = 0.80, 95% C.I. 0.69-0.85; p = 0.00008). Patients with PTCI showed higher ICU mortality and 6-month mortality, whereas hospital mortality did not differ between the two groups. Conclusions PTCI is a common complication in patients suffering from a moderate or severe TBI and is an independent risk factor for long-term disability. The addition of PTCI to the IMPACT core and extended predictive models significantly increased their performance in predicting the GOS.	[Latronico, Nicola; Piva, Simone; Gasparotti, Roberto; Rasulo, Francesco A.] Univ Brescia, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth, Brescia, Italy; [Latronico, Nicola; Piva, Simone; Fagoni, Nazzareno; Tintori, Davide; Rasulo, Francesco A.] ASST Spedali Civili Univ Hosp, Dept Anesthesia Intens Care & Emergency, Piazzale Osped Civili 1, I-25121 Brescia, Italy; [Fagoni, Nazzareno; Gasparotti, Roberto] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Pinelli, Lorenzo; Frigerio, Michele] ASST Spedali Civili Univ Hosp, Dept Radiol, Neuroradiol Unit, Brescia, Italy; [Berardino, Maurizio; Cavallo, Simona] AOU Citta Salute & Sci, Presidio CTO, Anesthesia & Intens Care Unit, Turin, Italy; [Bottazzi, Andrea; Carnevale, Livio; Radolovich, Danila Katia] IRCCS Policlin San Matteo Pavia, Dept Anesthesia & Crit Care Med, Pavia, Italy; [Casalicchio, Tiziana; Castioni, Carlo Alberto] ASLTO2, Dept Anestesiol & Intens Care Med, S Giovanni Bosco Hosp, Turin, Italy; [Cerasti, Davide] Univ Parma, Dept Neuroradiol, Osped Maggiore, Parma, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Citerio, Giuseppe; Saini, Maurizio] ASST Monza, Unit Neurointens Care Med, Dept Anesthesia & Crit Care Med, Monza, Italy; [Fontanella, Marco] Univ Brescia, Dept Med & Surg Specialties, Div Neurosurg, Radiol Sci & Publ Hlth, Brescia, Italy; [Galiberti, Serena; Maremmani, Paolo] Azienda Osped Univ Pisana, Dept Anesthesia & Crit Care Med, Pisa, Italy; [Girardini, Alan; Natalini, Giuseppe] Fdn Poliambulanza Hosp, Dept Anesthesia & Intens Care, Brescia, Italy; [Gritti, Paolo] ASST Bergamo, Dept Anesthesia & Crit Care Med, Papa Giovanni XXIII Hosp, Bergamo, Italy; [Manara, Ornella] ASST Bergamo, Dept Neuroradiol, Papa Giovanni XXIII Hosp, Bergamo, Italy; [Mazzani, Roberta] Maggiore Univ Hosp, Dept Anesthesiol Crit Care & Pain Med, Parma, Italy; [Patassini, Mirko] ASST Monza, Sect Neuroradiol, Dept Radiol, Monza, Italy; [Perna, Maria Elena] ASLTO2, Dept Radiol, S Giovanni Bosco Hosp, Turin, Italy; [Pesaresi, Ilaria] Azienda Osped Univ Pisana, Dept Diag & Imaging, Neuroradiol, Pisa, Italy; [Stefini, Roberto] Legnano Gen Hosp, Dept Neurosci, Milan, Italy; [Minelli, Cosetta] Imperial Coll London, Natl Heart & Lung Inst, London, England		Piva, S (corresponding author), Univ Brescia, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth, Brescia, Italy.; Piva, S (corresponding author), ASST Spedali Civili Univ Hosp, Dept Anesthesia Intens Care & Emergency, Piazzale Osped Civili 1, I-25121 Brescia, Italy.	simone.piva@unibs.it	Fagoni, Nazzareno/I-1156-2016; FONTANELLA, Marco Maria/AAD-1160-2022; Castioni, Carlo Alberto/AAC-3167-2021; Natalini, Giuseppe/AAY-8223-2020; Piva, Simone/E-1902-2014; LATRONICO, Nicola/F-1557-2010	Fagoni, Nazzareno/0000-0002-7312-8174; FONTANELLA, Marco Maria/0000-0002-4023-1909; Castioni, Carlo Alberto/0000-0002-8895-425X; Natalini, Giuseppe/0000-0002-0408-1966; Piva, Simone/0000-0002-5483-8007; RASULO, Francesco Antonio/0000-0002-7187-5168; LATRONICO, Nicola/0000-0002-2521-5871; Gritti, Paolo/0000-0001-9870-1507			Alberti G, 2014, AUC ADJUST R FUNCTIO; Bae Dong-Hyeon, 2014, Korean J Neurotrauma, V10, P35, DOI 10.13004/kjnt.2014.10.2.35; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chen H, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.27463; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; Holloway RG, 2005, JAMA-J AM MED ASSOC, V294, P725; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; JENNETT B, 1975, LANCET, V1, P480; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu SW, 2015, ACTA NEUROCHIR, V157, P1697, DOI 10.1007/s00701-015-2559-5; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Marino R, 2006, NEUROLOGY, V67, P1165, DOI 10.1212/01.wnl.0000238081.35281.b5; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; National Institute for Health and Clinical, 2007, HEAD INJ TRIAG ASS I; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Rodgers H, 2008, BRIT MED J, V336, P337, DOI 10.1136/bmj.39456.470880.80; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; Tatu L, 1996, NEUROLOGY, V47, P1125, DOI 10.1212/WNL.47.5.1125; Tatu L, 2012, FRONT NEUROL NEUROSC, V30, P99, DOI 10.1159/000333602; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Zamperetti N, 2008, INTENS CARE MED, V34, P1330, DOI 10.1007/s00134-008-1096-6	30	2	3	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	FEB 3	2020	24	1							33	10.1186/s13054-020-2746-5			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KL8PU	WOS:000513681200002	32014041	Green Published, gold			2022-02-06	
J	Nishijima, DK; Gaona, SD; Faul, M; Tancredi, DJ; Waechter, T; Maloney, R; Bair, T; Blitz, A; Elms, AR; Farrales, RD; Howard, C; Montoya, J; Garzon, H; Holmes, JF				Nishijima, Daniel K.; Gaona, Samuel D.; Faul, Mark; Tancredi, Daniel J.; Waechter, Trent; Maloney, Ric; Bair, Troy; Blitz, Adam; Elms, Andrew R.; Farrales, Roel D.; Howard, Calvin; Montoya, James; Garzon, Hernando; Holmes, James F.		Sacramento Cty Prehosp Res	The Association of Trauma Center Transport and Long-term Functional Outcomes in Head-injured Older Adults Transported by Emergency Medical Services	ACADEMIC EMERGENCY MEDICINE			English	Article							BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; UNITED-STATES; LEVEL-I; MORTALITY; EPIDEMIOLOGY; DEATHS; SYSTEM; CARE	Objective It is unclear whether trauma center care is associated with improved outcomes in older adults with traumatic brain injury (TBI) compared to management at nontrauma centers. Our primary objectives were to describe the long-term outcomes of older adults with TBI and to evaluate the association of trauma center transport with long-term functional outcome. Methods This was a prospective, observational study at five emergency medical services (EMS) agencies and 11 hospitals representing all 9-1-1 transfers within a county. Older adults (>= 55 years) with TBI (defined as closed head injury associated with loss of consciousness and/or amnesia, abnormal Glasgow Coma Scale [GCS] score, or traumatic intracranial hemorrhage) and transported by EMS from August 2015 to September 2016 were eligible. EMS providers completed standardized data forms and emergency department (ED) and hospital data were abstracted. Functional outcomes were measured using the Extended Glasgow Outcome Scale (GOS-E) at 3- and 6-month intervals by telephone follow-up. Reasons for disabilities were coded as due to head injury, due to illness or injury to other part of body, or due to a mixture of both. To evaluate the association of trauma center transport and functional outcomes, we conducted multivariate ordinal logistic regression analyses on multiple imputed data for 1) all patients with TBI and 2) patients with traumatic intracranial hemorrhage. Results We enrolled 350 patients with TBI; the median (Q1, Q3) age was 70 (61, 84) years, 187 (53%) were male, and 91 patients (26%) had traumatic intracranial hemorrhage on initial ED cranial computed tomography (CT) imaging. A total of 257 patients (73%) were transported by EMS to a Level I or II trauma center. Sixty-nine patients (20%) did not complete follow-up at 3 or 6 months. Of the patients with follow-up, 119 of 260 patients (46%) had moderate disability or worse at 6 months, including 55 of 260 patients (21%) who were dead at 6-month follow-up. Death or severe disabilities were more commonly attributed to non-TBI causes while moderate disabilities or better were more commonly due to TBI. On adjusted analysis, an abnormal GCS score, higher Charlson Comorbidity Index scores, and the presence of traumatic intracranial hemorrhage on initial ED cranial imaging were associated with worse GOS-E scores at 6 months. Trauma center transport was not associated with GOS-E scores at 6 months for TBI patients and in patients with traumatic intracranial hemorrhage on initial ED CT imaging. Conclusions In older adults with TBI, moderate disability or worse is common 6 months after injury. Over one in five of older adults with TBI died by 6 months, usually due to nonhead causes. Patients with TBI or traumatic intracranial hemorrhage did not have improved functional outcomes with initial triage to a trauma center.	[Nishijima, Daniel K.; Gaona, Samuel D.; Tancredi, Daniel J.; Holmes, James F.] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Faul, Mark] Amer Coll Surg, Comm Trauma, Chicago, IL USA; [Waechter, Trent] City Sacramento Fire Dept, Sacramento, CA USA; [Maloney, Ric] Sacramento Metropolitan Fire Dept, Sacramento, CA USA; [Bair, Troy] Cosumnes Community Serv Dist Fire Dept, Elk Grove, CA USA; [Blitz, Adam] Amer Med Response, Greenwood Village, CO USA; [Elms, Andrew R.] Kaiser Permanente South Sacramento Med Ctr, Sacramento, CA USA; [Farrales, Roel D.] Mercy Gen Hosp, Sacramento, CA USA; [Howard, Calvin] City Folsom Fire Dept, Folsom, CA USA; [Montoya, James] Sutter Community Hosp, Sacramento, CA USA; [Garzon, Hernando] Kaiser Permanente Sacramento Med Ctr, Sacramento, CA USA		Nishijima, DK (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu	Tancredi, Daniel J/O-3381-2013	Tancredi, Daniel J/0000-0002-3884-7907; Faul, Mark/0000-0002-7683-0348	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002177]; Mentored Clinical Research Training Program Award from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1TR000002, KL2TR000134]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	DKN has received funding to serve as a grant reviewer for Pfizer. This work was funded by the Centers for Disease Control and Prevention (CDC), grant U01CE002177. The findings and conclusion of this research are those of the authors and do not represent the official views of the U.S. Department of Health and Human Services (DHHS) and the CDC. The inclusion of individuals, programs, or organizations in this article does not constitute endorsement by the US federal government, DHHS, or CDC. DKN was supported through Mentored Clinical Research Training Program Award (grant UL1TR000002 and linked award KL2TR000134) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Hon S, 2020, PREHOSP EMERG CARE, V24, P8, DOI 10.1080/10903127.2019.1597954; Katsoulis M, 2017, J INTERN MED, V281, P300, DOI 10.1111/joim.12586; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Mullins RJ, 1998, J TRAUMA, V44, P609, DOI 10.1097/00005373-199804000-00009; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nishijima DK, 2018, J NEUROTRAUM, V35, P750, DOI 10.1089/neu.2017.5232; Nishijima DK, 2017, ANN EMERG MED, V70, P127, DOI 10.1016/j.annemergmed.2016.12.018; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Perkins NJ, 2018, AM J EPIDEMIOL, V187, P568, DOI 10.1093/aje/kwx348; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Rubin D.B., 1987, MULTIPLE IMPUTATION; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolfe R., 1997, OMODEL STATA MODULES	37	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAR	2020	27	3					207	216		10.1111/acem.13915		FEB 2020	10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	NE4BJ	WOS:000510499200001	31917495				2022-02-06	
J	Allison, JR; Kearns, A; Banks, RJ				Allison, James R.; Kearns, Andrew; Banks, Robert J.			Predicting orbital fractures in head injury: a preliminary study of clinical findings	EMERGENCY RADIOLOGY			English	Article						Head trauma; Fracture; orbital; Signs and symptoms; X-ray computed tomography; Maxillofacial injuries	MAXILLOFACIAL COMPUTED-TOMOGRAPHY; FACIAL FRACTURES; TRAUMA; RADIOGRAPHY; CRITERIA; VALIDATION; DIAGNOSIS; SCANS; RULE	Purpose Patients presenting to emergency departments (EDs) following head injury often undergo computed tomography (CT) of the head to exclude traumatic brain injury. In many cases, this does not show the maxillofacial skeleton. A proportion of these patients also sustain facial fractures, and when fractures involve the orbits, CT imaging is useful in diagnosis and management; obtaining a second scan may cause delay, incur greater cost, and increase radiation dose. The aim of this preliminary study was to examine the value of signs and symptoms of orbital fractures in predicting a fracture on CT. Methods The clinical records of 47 patients who underwent CT of the face following facial trauma were retrospectively examined for the presence of signs and symptoms of orbital fractures. Sensitivity, specificity, negative predictive value (NPV) and positive predictive values (PPV) were then calculated for each sign and symptom for the presence of an orbital fracture on CT. We also described a clinical decision instrument and examined the predictive values of this. Results Change in the position of the globe, reduced visual acuity, subconjunctival haemorrhage and change in sensation in the maxillary division of the trigeminal nerve were the most specific signs and symptoms for orbital fracture. Our clinical decision instrument had 80.0% sensitivity, 75.0% specificity, 90.3% PPV and 56.3% NPV for predicting the presence of an orbital fracture on CT in this population. Conclusions Our results demonstrate that signs and symptoms of orbital fractures may be useful for predicting these injuries, and a decision instrument could be used in the ED to identify patients likely to benefit from extending the radiation field to include the orbits where CT of the head is already planned. This work is however exploratory; and further prospective validation is required before a robust instrument can be recommended for clinical use.	[Allison, James R.] Newcastle Univ, Sch Dent Sci, Oral Surg, Framlington Pl, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England; [Kearns, Andrew] Univ Manchester, Manchester, Lancs, England; [Banks, Robert J.] Sunderland Royal Hosp, Sunderland, England		Allison, JR (corresponding author), Newcastle Univ, Sch Dent Sci, Oral Surg, Framlington Pl, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England.	James.allison@newcastle.ac.uk	Allison, James R/AAH-3241-2020	Allison, James R/0000-0002-0562-4133			American College of Radiology, 2018, AM COLL RAD CT ACCR; Barry C, 2008, J ORAL MAXIL SURG, V66, P888, DOI 10.1016/j.joms.2008.01.005; dos Santos DT, 2007, J APPL ORAL SCI, V15, P135, DOI 10.1590/S1678-77572007000200012; Exadaktylos AK, 2005, J TRAUMA, V58, P336, DOI 10.1097/01.TA.0000141874.73520.A6; Harrington AW, 2018, J CRANIOFAC SURG, V29, pE167, DOI 10.1097/SCS.0000000000004240; Haworth S, 2017, J CRANIO MAXILL SURG, V45, P1333, DOI 10.1016/j.jcms.2017.05.016; Holmgren EP, 2005, J ORAL MAXIL SURG, V63, P651, DOI 10.1016/j.joms.2004.10.009; Huang LK, 2017, INJURY, V48, P1417, DOI 10.1016/j.injury.2017.04.046; Marinaro J, 2007, AM J EMERG MED, V25, P616, DOI 10.1016/j.ajem.2006.11.029; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Ng P, 1996, Australas Radiol, V40, P264, DOI 10.1111/j.1440-1673.1996.tb00400.x; NHS England, 2018, HOSP ACC EM ACT 2017; NICE, 2014, HEAD INJ ASS EARL MA; Oester AE, 2012, OPHTHAL PLAST RECONS, V28, P7, DOI 10.1097/IOP.0b013e31822672c4; Public Health England, 2011, ION RAD DOS COMP; Sammy IA, 2017, EMERG MED J, V34, P647, DOI 10.1136/emermed-2016-206167; Shrimpton PC, 2014, DOSES COMPUTED TOMOG; Silverman N, 2017, ORBIT, V36, P331, DOI 10.1080/01676830.2017.1337180; Sitzman TJ, 2015, J CRANIOFAC SURG, V26, P1199, DOI 10.1097/SCS.0000000000001712; Sitzman TJ, 2011, PLAST RECONSTR SURG, V127, P1270, DOI 10.1097/PRS.0b013e3182043ad8; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; Stiell IG, 1997, JAMA-J AM MED ASSOC, V278, P2075, DOI 10.1001/jama.1997.03550230051036; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Suzuki S, 2010, AM J NEURORADIOL, V31, P822, DOI 10.3174/ajnr.A1946; Timashpolsky A, 2016, PLAST SURG-CHIR PLAS, V24, P73, DOI 10.1177/229255031602400203; Yadav K, 2012, J TRAUMA ACUTE CARE, V73, P1313, DOI 10.1097/TA.0b013e318265cf61	26	2	2	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1070-3004	1438-1435		EMERG RADIOL	Emerg. Radiol.	FEB	2020	27	1					31	36		10.1007/s10140-019-01720-0			6	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	KJ2YX	WOS:000511925000005	31471701	Green Published, hybrid			2022-02-06	
J	Begum, G; Reddy, R; Yakoub, KM; Belli, A; Davies, DJ; Di Pietro, V				Begum, Ghazala; Reddy, Rahul; Yakoub, Kamal M.; Belli, Antonio; Davies, David J.; Di Pietro, Valentina			Differential Expression of Circulating Inflammatory Proteins Following Sport-Related Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						mild traumatic brain injury; concussion; neuroinflammation; FGF21; MCP-1	HEAD-INJURY; CHEMOKINE FRACTALKINE; MICROGLIA; DISEASE; CELLS; MCP-1; MILD; RISK; CONCUSSION; ACTIVATION	Sport-related traumatic brain injury (TBI) elicits a multifaceted inflammatory response leading to brain injury and morbidity. This response could be a predictive tool for the progression of TBI and to stratify the injury of which mild TBI is most prevalent. Therefore, we examined the differential expression of serum inflammatory markers overtime and identified novel markers in repetitively concussed athletes. Neuropsychological assessment by Wechsler Adult Intelligence Scale (WAIS) and Immediate Post Concussion Assessment and Cognitive Test (ImPACT) was performed on rugby players and serum was taken from healthy, concussed and repetitively concussed athletes. Serum was also obtained <1 week and >1 week after trauma and analyzed for 92 inflammatory protein markers. Fibroblast growth factor 21 (FGF21) and interleukin-7 (IL-7) differentiated repetitively concussed athletes. Macrophage chemotactic protein-1 (MCP-1), tumor necrosis factor superfamily member 14 (TNFSF14) were significantly reduced >1 week and chemokine (C-X3-C motif) ligand 1 (CX3CL1) upregulated <1 week after injury. FGF21 and MCP-1 negatively correlated with symptoms and their severity. We have identified dynamic changes in the inflammatory response overtime and in different classes of concussion correlating with disease progression. This data supports the use of inflammatory biomarkers as predictors of symptom development due to secondary complications of sport-related mTBI.	[Begum, Ghazala] Marker Diagnost Ltd, BioHub, Birmingham B15 2SQ, W Midlands, England; [Reddy, Rahul] Univ Illinois, Chicago, IL 60607 USA; [Yakoub, Kamal M.; Belli, Antonio; Davies, David J.; Di Pietro, Valentina] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Neurosci & Ophthalmol Res Grp, Birmingham B15 2TT, W Midlands, England; [Yakoub, Kamal M.; Belli, Antonio; Davies, David J.; Di Pietro, Valentina] Queen Elizabeth Hosp, Natl Inst Hlth Res Surg Reconstruct, Birmingham B15 2TH, W Midlands, England; [Yakoub, Kamal M.; Belli, Antonio; Davies, David J.; Di Pietro, Valentina] Queen Elizabeth Hosp, Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England		Davies, DJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Neurosci & Ophthalmol Res Grp, Birmingham B15 2TT, W Midlands, England.; Davies, DJ (corresponding author), Queen Elizabeth Hosp, Natl Inst Hlth Res Surg Reconstruct, Birmingham B15 2TH, W Midlands, England.; Davies, DJ (corresponding author), Queen Elizabeth Hosp, Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England.	gbegum@markerhealth.co; rahulr3@illinois.edu; K.Yakoub@bham.ac.uk; A.Belli@bham.ac.uk; D.J.Davies.1@bham.ac.uk; V.DiPietro@bham.ac.uk	Belli, Antonio/I-3799-2015	Belli, Antonio/0000-0002-3211-9933; Begum, Ghazala/0000-0002-8445-1815	National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC)	This research was funded by the National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; Berman JW, 1996, J IMMUNOL, V156, P3017; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Borlongan C., 2015, NEUROPSYCH DIS TREAT, P97, DOI [10.2147/NDT.S65815, DOI 10.2147/NDT.S65815]; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Echemendia R.J., 2017, BRIT J SPORT MED, V51, P84850; Furusho M, 2015, GLIA, V63, P1714, DOI 10.1002/glia.22838; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hill LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04722-5; Hsuchou H, 2007, PEPTIDES, V28, P2382, DOI 10.1016/j.peptides.2007.10.007; Huang WT, 2019, J PHARMACOL SCI, V140, P120, DOI 10.1016/j.jphs.2019.03.010; Jana M, 2014, IMMUNOLOGY, V141, P549, DOI 10.1111/imm.12214; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jernas M, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-32; Jin YC, 2017, WORLD NEUROSURG, V100, P351, DOI 10.1016/j.wneu.2017.01.033; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Kuroda M, 2017, J CLIN INVEST, V127, P3502, DOI 10.1172/JCI94337; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Raeber ME, 2018, IMMUNOL REV, V283, P176, DOI 10.1111/imr.12644; Rancan M, 2004, J CEREBR BLOOD F MET, V24, P1110, DOI 10.1097/01.WCB.0000133470.91843.72; Rhodes J, 2009, J TRAUMA, V66, P1591, DOI 10.1097/TA.0b013e31819a0344; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shaikh RB, 2001, J IMMUNOL, V167, P6330, DOI 10.4049/jimmunol.167.11.6330; Sheridan GK, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130181; Soroosh P, 2011, J EXP MED, V208, P797, DOI 10.1084/jem.20101562; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Takada K, 2016, BRAIN INJURY, V30, P1590, DOI 10.1080/02699052.2016.1199901; Tamada K, 2000, NAT MED, V6, P283; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Thoma RJ, 2018, COGENT PSYCHOL, V5, DOI 10.1080/23311908.2018.1430199; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yakoub KM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029883; Yang GA, 2011, BRAIN PATHOL, V21, P279, DOI 10.1111/j.1750-3639.2010.00445.x; Yi JY, 2013, CURR SPORT MED REP, V12, P28, DOI 10.1249/JSR.0b013e31827ec9e3; Yuan XC, 2019, BIOCHEM BIOPH RES CO, V514, P1023, DOI 10.1016/j.bbrc.2019.04.159; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00331	61	2	3	0	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	FEB	2020	21	4							1216	10.3390/ijms21041216			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Chemistry	KY4FE	WOS:000522524400043	32059364	gold, Green Published			2022-02-06	
J	Bonney, PA; Fujii, T; Jarvis, CA; Pham, MH; Giannotta, SL				Bonney, Phillip A.; Fujii, Tats; Jarvis, Casey A.; Pham, Martin H.; Giannotta, Steven L.			Surgical Closed Suction Drain Use After Craniotomy for Evacuation of Supratentorial Epidural Hematomas: A Case Series of Radiographic and Clinical Outcomes	WORLD NEUROSURGERY			English	Article						Craniotomy; Drain; Epidural hematoma; Neurosurgery; Surgical outcomes; Traumatic brain injury	RISK-FACTORS; HYPOTENSION; INFECTION	BACKGROUND: Surgical closed suction drain (SCSDs) are used in a variety of surgical disciplines to prevent postoperative fluid collections. Use of SCSDs has not been well studied in the neurosurgical literature. Practice patterns have varied within our institution with respect to SCSDs after craniotomies for neurotrauma. In this study we describe SCSD use for patients undergoing evacuation of supratentorial epidural hematomas (EDHs) and examine the effect on patient outcomes and length of hospital stay. METHODS: We performed a retrospective review of craniotomies for supratentorial EDH performed at our Level I trauma center between May 2015 and May 2018. Imaging and clinical data were obtained from chart review. RESULTS: Fifty-two patients with EDH received operations from 8 attending surgeons. The number of drains used was 0 or 1 in 36 cases and 2 or more in 16 cases. Drain location was subgaleal in 25 cases, epidural in 8 cases, and both subgaleal and epidural in 13 cases. Attending preference (P < 0.001) but not hematoma size was associated with use of an epidural drain and use of 2 or more drains. After controlling for age, initial neurologic exam, and presence of other injuries, use of more drains was associated with longer intensive care unit lengths of stay. Drain use pattern was not associated with patient outcome measures, and no return to the operating room was necessary for residual or recurrent EDH. CONCLUSIONS: Use of fewer SCSDs did not affect radiographic outcome after evacuation of epidural hematomas but was associated with decreased intensive care unit length of stay.	[Bonney, Phillip A.; Fujii, Tats; Jarvis, Casey A.; Giannotta, Steven L.] Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90007 USA; [Pham, Martin H.] Univ Calif San Diego, Dept Neurosurg, San Diego, CA 92103 USA		Bonney, PA (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90007 USA.	phil.alan.bonney@gmail.com		Jarvis, Casey/0000-0001-9598-6615			Chan KW, 2000, SURG NEUROL, V54, P444, DOI 10.1016/S0090-3019(00)00323-2; Choi H, 2013, J NEUROSURG-PEDIATR, V12, P181, DOI 10.3171/2013.4.PEDS12505; Choi Su Yong, 2015, J Cerebrovasc Endovasc Neurosurg, V17, P194, DOI 10.7461/jcen.2015.17.3.194; Fujii T, 2016, J CLIN NEUROSCI, V31, P152, DOI 10.1016/j.jocn.2016.03.007; JACKSON FE, 1971, SURGERY, V70, P578; Karamchandani K, 2006, BRIT J ANAESTH, V96, P608, DOI 10.1093/bja/ael063; Kim T, 2013, ACTA NEUROCHIR, V155, P2165, DOI 10.1007/s00701-013-1833-7; Krpata DM, 2017, J GASTROINTEST SURG, V21, P2083, DOI 10.1007/s11605-017-3601-0; Meguro T, 2007, NEUROL MED-CHIR, V47, P314, DOI 10.2176/nmc.47.314; Parker MJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001825.pub2; Schipmann S, 2016, WORLD NEUROSURG, V95, P178, DOI 10.1016/j.wneu.2016.07.093; TOLEDO E, 1980, ACTA NEUROCHIR, V52, P55, DOI 10.1007/BF01400947; Watanabe J, 2017, INT J COLORECTAL DIS, V32, P391, DOI 10.1007/s00384-016-2687-2; Zhang GM, 2009, SURG NEUROL, V72, P138, DOI 10.1016/j.surneu.2008.06.014; Zhang QY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011290	15	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2020	134						E460	E468		10.1016/j.wneu.2019.10.098			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KK6VS	WOS:000512878200055	31669243				2022-02-06	
J	Caldera, FE				Caldera, Franklin E.			Medical cannibus as an alternative for opioids for chronic pain: A case report	SAGE OPEN MEDICAL CASE REPORTS			English	Article						Orthopedics/rehabilitation/occupational therapy; anesthesia/pain; marijuana; opioid	RISK	Opioid medication-related deaths have increased to epidemic proportions in the last decade. This report describes a case of 43-year-old female with a traumatic brain injury who developed chronic pain and opioid dependence. The patient expressed concerns and wanted weaning off opioids. Recent legalization of medical marijuana in Pennsylvania allows us to try it as an alternative to opioids for chronic pain. Medical cannibus has risks associated with administration but is safer than opioids. Our patient was successfully weaned off her opioid medications with the help of medical cannibus and pain remained well controlled. More studies need to be done on using medical cannibus as an alternative to opioids.	[Caldera, Franklin E.] Hosp Univ Penn, 1800 Lombard St, Philadelphia, PA 19104 USA		Caldera, FE (corresponding author), Hosp Univ Penn, 1800 Lombard St, Philadelphia, PA 19104 USA.	Franklin.Caldera@uphs.upenn.edu		Caldera, Franlkin/0000-0002-2887-4629			Barnett ML, 2017, NEW ENGL J MED, V376, P663, DOI 10.1056/NEJMsa1610524; Bhattacharyya S, 2010, NEUROPSYCHOPHARMACOL, V35, P764, DOI 10.1038/npp.2009.184; Department of Health State of Pennsylvania (DOH), 2019, WHAT AR APPR SER MED; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6501e1; Dussy FE, 2005, FORENSIC SCI INT, V149, P3, DOI 10.1016/j.forsciint.2004.05.015; Hartman RL, 2013, CLIN CHEM, V59, P478, DOI 10.1373/clinchem.2012.194381; Hill KP, 2015, JAMA-J AM MED ASSOC, V313, P2474, DOI 10.1001/jama.2015.6199; Miller M, 2011, J AM GERIATR SOC, V59, P430, DOI 10.1111/j.1532-5415.2011.03318.x; Pertwee RG, 2006, BRIT J PHARMACOL, V147, pS163, DOI 10.1038/sj.bjp.0706406; Turner J., 2014, AHRQ PUBLICATION	10	2	2	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2050-313X			SAGE OPEN MED CASE R	SAGE Open Med. Case Rep.	FEB	2020	8								2050313X20907015	10.1177/2050313X20907015			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	KN2BA	WOS:000514644600001	32110409	Green Published, gold			2022-02-06	
J	Clark, JMR; Jak, AJ; Twamley, EW				Clark, Jillian M. R.; Jak, Amy J.; Twamley, Elizabeth W.			Cognition and Functional Capacity Following Traumatic Brain Injury in Veterans	REHABILITATION PSYCHOLOGY			English	Article						concussion; cognition; neuropsychological performance; functioning; activities of daily living	NEUROPSYCHOLOGICAL IMPAIRMENT; POSTCONCUSSIVE SYMPTOMS; OEF/OIF VETERANS; PERFORMANCE; RELIABILITY; VALIDITY; OUTCOMES; SCORES	Objective: Performance-based tests of functional capacity are rarely used in research on mild to moderate traumatic brain injury (TBI), but they may function as a link between cognitive impairment and real-world functioning. We sought to examine the relationship between cognitive functioning and performance-based functional capacity. as measured by the University of California San Diego Performance-Based Skills Assessment-Brief (UPSA-B), in Veterans with TBI histories. Research Method: A total of 50 unemployed Operation Enduring Freedom/Operation Iraqi Freedom Veterans with mild to moderate TBI histories completed assessments of neuropsychological performance and functional capacity (UPSA-B total. financial subscale. and communication subscale scores). All participants were impaired in at least 1 neuropsychological domain on a prior clinical neuropsychological evaluation. A global deficit score was calculated based on neuropsychological performance on assessments of attention/working memory, processing speed, learning, delayed recall. prospective memory, and executive functioning. Deficit scores were also calculated for the executive-functioning domain and the processing-speed domain. Neuropsychological deficit scores were then correlated with UPSA-B performances. Results: Correlation coefficients indicated that worse global neuropsychological performance was related to worse overall functional capacity (r(s)= -.28, p = .046) and communication capacity (r(s) = -.34, p = .016). Worse executive functioning was related to worse functional capacity, r = -.37, p = .008, particularly in the domain of communication, r = -.44, p <= .001. Processing-speed performance was not related to functional capacity. Conclusions: Executive functioning was moderately associated with both communication and overall everyday functioning capacity. Improvement in executive-functioning deficits may improve functional capacity, specifically in communication tasks.	[Clark, Jillian M. R.; Jak, Amy J.; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr 116A, San Diego, CA 92161 USA; [Clark, Jillian M. R.; Jak, Amy J.; Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, San Diego, CA USA		Twamley, EW (corresponding author), VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr 116A, San Diego, CA 92161 USA.	etwamley@ucsd.edu		Twamley, Elizabeth/0000-0002-8693-8782	Department of Defense AwardUnited States Department of Defense [W81XWH08-2-0193]; Center of Excellence for Stress and Mental Health, VA San Diego Health-care System; Office of Academic Affiliations, Center of Excellence for Stress and Mental Health Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs	This research was funded by Department of Defense Award W81XWH08-2-0193 to Elizabeth W. Twamley, with additional support from the Center of Excellence for Stress and Mental Health, VA San Diego Health-care System. The writing of this article was supported by the Office of Academic Affiliations, Center of Excellence for Stress and Mental Health Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs.	Axelrod BN, 2007, INT J NEUROSCI, V117, P1591, DOI 10.1080/00207450600941189; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hannah Fischer, 2015, GUIDE US MILITARY CA; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kongs S. K., 2000, WCST 64 WISCONSIN CA; Leifker FR, 2010, SCHIZOPHR RES, V119, P246, DOI 10.1016/j.schres.2010.03.021; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Mausbach BT, 2007, SCHIZOPHRENIA BULL, V33, P1364, DOI 10.1093/schbul/sbm014; Mausbach BT, 2010, BIPOLAR DISORD, V12, P45, DOI 10.1111/j.1399-5618.2009.00787.x; Parker HA, 2018, REHABIL PSYCHOL, V63, P595, DOI 10.1037/rep0000243; Raskin S, 2004, J INT NEUROPSYCHO S1, V10, P110, DOI DOI 10.1017/S1355617704040019; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Twamley EW, 2002, AM J PSYCHIAT, V159, P2013, DOI 10.1176/appi.ajp.159.12.2013; Vella L, 2017, PSYCHIAT RES, V256, P150, DOI 10.1016/j.psychres.2017.06.025; Verfaellie M, 2013, J INT NEUROPSYCH SOC, V19, P1, DOI 10.1017/S1355617712000902; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; Zakzanis KK, 2016, BRAIN INJURY, V30, P986, DOI 10.3109/02699052.2016.1147077	36	2	2	0	0	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2020	65	1					72	79		10.1037/rep0000294			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	KP9HV	WOS:000516542600008	31670546	Bronze			2022-02-06	
J	Huurnink, A; Fransz, DP; de Boode, VA; Kingma, I; van Dieen, JH				Huurnink, Arnold; Fransz, Duncan P.; de Boode, Vosse A.; Kingma, Idsart; van Dieen, Jaap H.			Age-Matched Z-Scores for Longitudinal Monitoring of Center of Pressure Speed in Single-Leg Stance Performance in Elite Male Youth Soccer Players	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						one-leg stance; minimal detectable difference; critical difference; reliability; sensorimotor control	CRUCIATE LIGAMENT RECONSTRUCTION; POSTURAL-CONTROL MEASURES; TALENT IDENTIFICATION; BALANCE ABILITIES; FORCE-PLATFORM; ANKLE INJURIES; STABILITY; RELIABILITY; YOUNG; SWAY	Huurnink, A, Fransz, DP, de Boode, VA, Kingma, I, and van Dieen, JH. Age-matched z-scores for longitudinal monitoring of center of pressure speed in single-leg stance performance in elite male youth soccer players. J Strength Cond Res 34(2): 495-505, 2020-Coordination of corrective motor actions is considered important for soccer performance and injury prevention. A single-leg stance (SLS) test assesses the integrity and proficiency of the sensorimotor control system, quantified by center of pressure averaged speed (COPspeed). We aimed to provide age-matched z-scores for COPspeed in elite male youth soccer players. Second, we assessed a threshold for abnormal long-term change in performance, i.e., critical difference (CD). In a youth academy program, 133 soccer players of 9-18 years were tested twice for both legs (2 repetitions), and one repetition follow-up was conducted at 5.8 months (SD 2.7). Linear regression between age and COPspeed was performed to provide age-matched z-scores. Variance of differences in z-scores at baseline and between sessions was used to estimate the CD up to 5 repetitions. Intraclass correlation coefficients (ICCs) were assessed within and between sessions. The age significantly affected COPspeed (p < 0.0001), with lower values in older players (95% confidence interval; 3.45-9.17 to 2.88-5.13 cm center dot s(-1), for 9 and 18 years, respectively). The z-score CD ranged from 1.72 (one repetition) to 1.34 (5 repetitions). The ICC of z-scores was 0.88 within session and 0.81 between sessions. In conclusion, the SLS performance in elite male youth soccer players improves with age. We determined age-matched z-scores of COPspeed, which reliably determined performance according to age. The CD allows for detection of abnormal variations in COPspeed to identify players with a (temporary) deterioration of sensorimotor function. This could be applied to concussion management, or to detect underlying physical impairments.	[Huurnink, Arnold; Fransz, Duncan P.; Kingma, Idsart; van Dieen, Jaap H.] Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands; [Huurnink, Arnold] Univ Amsterdam, Acad Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands; [Fransz, Duncan P.] Maastricht Univ, Dept Orthopaed Surg, Med Ctr, Maastricht, Netherlands; [de Boode, Vosse A.] AFC Ajax, Adidas MiCoach Performance Ctr, Amsterdam, Netherlands		Huurnink, A (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, Amsterdam Movement Sci, Amsterdam, Netherlands.; Huurnink, A (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.	a.huurnink@gmail.com	van Dieen, Jaap/B-3937-2013	van Dieen, Jaap/0000-0002-7719-5585; Fransz, Duncan/0000-0001-8616-1929			Ajrezo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081066; Assaiante C, 2012, NEUROPHYSIOL CLIN, V42, P43, DOI 10.1016/j.neucli.2011.09.002; Barozzi S, 2014, EUR ARCH OTO-RHINO-L, V271, P2069, DOI 10.1007/s00405-014-2930-9; Bruhn S, 2006, INT J SPORTS MED, V27, P401, DOI 10.1055/s-2005-865750; Clark JE, 2016, HUM PSYCHOPHARM CLIN, V31, P259, DOI 10.1002/hup.2528; Condon C, 2014, PHYSIOTHER RES INT, V19, P1, DOI 10.1002/pri.1549; DIBLEY MJ, 1987, AM J CLIN NUTR, V46, P736, DOI 10.1093/ajcn/46.5.736; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3; Fransz DP, 2016, GAIT POSTURE, V50, P137, DOI 10.1016/j.gaitpost.2016.09.002; Fransz DP, 2014, J BIOMECH, V47, P3248, DOI 10.1016/j.jbiomech.2014.06.019; Fraser CG, 2004, CLIN CHEM LAB MED, V42, P758, DOI 10.1515/CCLM.2004.128; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Hammami R, 2016, J STRENGTH COND RES, V30, P3278, DOI 10.1519/JSC.0000000000001425; Hertel J, 2006, J APPL BIOMECH, V22, P67, DOI 10.1123/jab.22.1.67; Honer O, 2016, J SPORT SCI, V34, P2269, DOI 10.1080/02640414.2016.1177658; Honer O, 2015, J SPORT SCI, V33, P145, DOI 10.1080/02640414.2014.928416; Hof AL, 2007, J BIOMECH, V40, P451, DOI 10.1016/j.jbiomech.2005.12.016; Holme E, 1999, SCAND J MED SCI SPOR, V9, P104; Hupperets MDW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2684; Huurnink A, 2014, CLIN BIOMECH, V29, P183, DOI 10.1016/j.clinbiomech.2013.11.014; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; Jakobsen MD, 2011, EUR J APPL PHYSIOL, V111, P521, DOI 10.1007/s00421-010-1669-2; Kiers H, 2013, SPORTS MED, V43, P1171, DOI 10.1007/s40279-013-0082-5; Knapp D, 2011, J ATHL TRAINING, V46, P257, DOI 10.4085/1062-6050-46.3.257; Kouvelioti V, 2015, RES SPORTS MED, V23, P151, DOI 10.1080/15438627.2015.1005292; Lago-Penas C, 2014, J HUM KINET, V40, P189, DOI 10.2478/hukin-2014-0021; Larsen LR, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-144; Le TT, 2006, VISION RES, V46, P3586, DOI 10.1016/j.visres.2006.06.018; Lin CF, 2011, AM J SPORT MED, V39, P1324, DOI 10.1177/0363546510393943; Linens SW, 2014, J ATHL TRAINING, V49, P15, DOI 10.4085/1062-6050-48.6.09; Mallau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013078; Matsuda S, 2010, PERCEPT MOTOR SKILL, V111, P167, DOI 10.2466/05.23.26.27.PMS.111.4.167-177; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; McKeon PO, 2008, MED SCI SPORT EXER, V40, P1810, DOI 10.1249/MSS.0b013e31817e0f92; Mirkov D, 2008, J STRENGTH COND RES, V22, P1046, DOI 10.1519/JSC.0b013e31816eb4af; Mohammadi F, 2012, KNEE SURG SPORT TR A, V20, P1603, DOI 10.1007/s00167-011-1806-4; Mudaliar V, 2013, J CLIN EXP RES, V1, P39; Negahban H, 2014, KNEE SURG SPORT TR A, V22, P1491, DOI 10.1007/s00167-013-2501-4; Nolan L, 2005, DEV MED CHILD NEUROL, V47, P449, DOI 10.1017/S0012162205000873; O'Connor D, 2016, EUR J SPORT SCI, V16, P837, DOI 10.1080/17461391.2016.1151945; Olivier I, 2008, EXP BRAIN RES, V185, P341, DOI 10.1007/s00221-008-1271-6; Olivier I, 2010, GAIT POSTURE, V32, P494, DOI 10.1016/j.gaitpost.2010.07.008; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/0363546510376053; Pau M, 2015, PHYS THER SPORT, V16, P236, DOI 10.1016/j.ptsp.2014.12.003; Pau M, 2014, RES SPORTS MED, V22, P355, DOI 10.1080/15438627.2014.944302; Pau M, 2014, J ATHL TRAINING, V49, P454, DOI 10.4085/1062-6050-49.2.12; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Read PJ, 2017, INT J SPORTS MED, V38, P902, DOI 10.1055/s-0043-114009; Read PJ, 2016, J STRENGTH COND RES, V30, P3304, DOI 10.1519/JSC.0000000000001438; Reeves NP, 2007, CLIN BIOMECH, V22, P266, DOI 10.1016/j.clinbiomech.2006.11.011; Ricotti L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077264; Riemann BL, 2012, INT J SPORTS PHYS TH, V7, P257; Ross SE, 2009, MED SCI SPORT EXER, V41, P399, DOI 10.1249/MSS.0b013e3181872d89; Sekulic D, 2013, J STRENGTH COND RES, V27, P802, DOI 10.1519/JSC.0b013e31825c2cb0; Teixeira LA, 2011, RES Q EXERCISE SPORT, V82, P21, DOI 10.1080/02701367.2011.10599718; TROPP H, 1984, MED SCI SPORT EXER, V16, P64; Unnithan V, 2012, J SPORT SCI, V30, P1719, DOI 10.1080/02640414.2012.731515; van der Sluis A, 2014, INT J SPORTS MED, V35, P351, DOI 10.1055/s-0033-1349874; van Dieen JH, 2010, GAIT POSTURE, V31, P42, DOI 10.1016/j.gaitpost.2009.08.242; Wikstrom EA, 2010, GAIT POSTURE, V32, P82, DOI 10.1016/j.gaitpost.2010.03.015; Witchalls J, 2012, BRIT J SPORT MED, V46, P515, DOI 10.1136/bjsports-2011-090137; Wu JH, 2009, EXP BRAIN RES, V196, P329, DOI 10.1007/s00221-009-1852-z	65	2	2	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	FEB	2020	34	2					495	505		10.1519/JSC.0000000000002765			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LB0YB	WOS:000524362300025	30052604	Green Published			2022-02-06	
J	Meyers, JE				Meyers, John E.			Long-Term Test-Retest Stability of ANAM in a Large Military Sample	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Head injury; Traumatic brain injury; Norms/normative studies	NEUROPSYCHOLOGICAL ASSESSMENT METRICS; PERFORMANCE; TBI; RELIABILITY; CONCUSSION; RECOVERY	Objective: This paper examines the long-term stability of the Automated Neuropsychological Assessment Metrics (ANAM) over 1-year, 3-year, and 5-year time periods. Methods: The sample was drawn from active duty military personnel. All individuals were administered the ANAM and were re-administered the ANAM a second time, either 1 year, 3 years, or 5 years later. All individuals had no reported cognitive problems or concussion or any traumatic brain injury between the first and second assessments and had no intervening contact with the ANAM. All were assessed using the military standard approach with trained proctors. Results: The results for (n = 19,997) individuals who were tested 1 year apart showed an intra-class correlation (ICC) of .6 for simple reaction time and simple reaction time repeat and .7 and above for all other scales. For the sample with 3 years between testings (n = 9,166), the ICC was similar to the 1-year sample. When the 5 year between testings data was examined (n = 2,270), the ICCs for all scales except the simple reaction time and simple reaction time repeat showed ICCs of .7 and .8. The simple reaction time and simple reaction time repeat showed ICCs of .596. Conclusions: These results indicate that the use of the ANAN baseline for comparison can be done even if the baseline is up to 5 years old.	[Meyers, John E.] Off Surg Gen Army, Chief Neurocognit Assessment Branch, Rehabil & Reintegrat Div, Dept Army, Room 3SW130C,7700 Arlington Blvd, Falls Church, VA 20042 USA		Meyers, JE (corresponding author), Off Surg Gen Army, Chief Neurocognit Assessment Branch, Rehabil & Reintegrat Div, Dept Army, Room 3SW130C,7700 Arlington Blvd, Falls Church, VA 20042 USA.	jmeyersneuro@yahoo.com					Abramson IS, 2000, J INT NEUROPSYCH SOC, V6, P365, DOI 10.1017/S1355617700633131; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cognitive Science Research Center, 2013, ANAM TECHN MAN; Cognitive Science Research Center, 2013, ANAM GNS BATT ADM MA; Cohen J., 2013, STAT POWER ANAL BEHA; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Dretsch M, 2015, APPL NEUROPSYCH-ADUL, V22, P304, DOI 10.1080/23279095.2014.926454; Haran FJ, 2016, J HEAD TRAUMA REHAB, V31, P329, DOI 10.1097/HTR.0000000000000172; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055; Schlegel RE, 2007, ARCH CLIN NEUROPSYCH, V22, pS49, DOI 10.1016/j.acn.2006.10.005; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Vincent AS, 2018, CLIN NEUROPSYCHOL, V32, P479, DOI 10.1080/13854046.2017.1368716	25	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2020	35	1					70	74		10.1093/arclin/acz062			5	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN8GI	WOS:000569024700007	31670778	Bronze			2022-02-06	
J	Newman, MA; Hirsch, MA; Peindl, RD; Habet, NA; Tsai, TJ; Runyon, MS; Huynh, T; Phillips, C; Zheng, N				Newman, Mark A.; Hirsch, Mark A.; Peindl, Richard D.; Habet, Nahir A.; Tsai, Tobias J.; Runyon, Michael S.; Toan Huynh; Phillips, Christian; Zheng, Nigel		Carolinas Trauma Network Res Grp	Use of an instrumented dual-task timed up and go test in children with traumatic brain injury	GAIT & POSTURE			English	Article						Traumatic brain injury; Cognitive-motor task; Inertial measurement unit; Gait-related mobility; Timed up and go test; Inpatient rehabilitation	GAIT; RELIABILITY; RECOVERY; VALIDITY; WALKING; MOTOR	Background: Wearable sensors have allowed researchers to instrument tests of gait-related mobility, including the widely used timed 'up-and-go' WA (TUG). Currently, there is a lack of instrumented WA data on whether children with moderate to severe traumatic brain injury (TBI) perform differently on the TUG compared to typically developed (TD) controls during a cognitive-motor task. Research Question: The aim was to explore the effects of a cognitive-motor task on TUG subcomponents among children with TBI compared to TD children. Methods: This observational cross-sectional study included 12 children with moderate to severe TBI (6 males and 6 females, age 10.5 +/- 1.5 years of age) and 10 age and sex-matched TD controls (5 males and 5 females, 10.4 +/- 1.3 years of age). Each participant completed 6 trials of the TUG wearing a single inertial measurement unit sensor at a self-selected walking pace while listening to an array of 10 randomly presented single digits during each TUG trial. Results: Total time to complete the TUG was not significantly different between groups. The cognitive-motor task led to significantly lower mean turn and peak turn angular velocity values during the turn-around-the-cone and turn-before-sitting TUG subcomponents in children with TBI compared to the TD controls (p <= 0.05). Additionally, the cognitive-motor task led to significantly lower values for maximum torso flexion to extension angle, peak flexion and extension angular velocity and peak vertical acceleration for the sit-to-stand subcomponent (p < 0.05). Peak flexion angular velocity during the stand-to-sit subcomponent was lower for the TBI group compared to the children with TD (p < 0.05). Significance: The study provides new insights into the performance of complex gait-related mobility tasks in the context of an instrumented TUG among children with moderate to severe TBI. Our results highlight the potential benefits of outfitting pediatric inpatients with an IMU while completing the TUG.	[Newman, Mark A.; Hirsch, Mark A.; Tsai, Tobias J.; Phillips, Christian] Carolinas Med Ctr, Dept Phys Med & Rehabil, Carolinas Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA; [Peindl, Richard D.; Habet, Nahir A.] Atrium Hlth Musculoskeletal Inst, 1000 Blythe Blvd, Charlotte, NC 28203 USA; [Runyon, Michael S.] Carolinas Med Ctr, Dept Emergency Med, 1000 Blythe Blvd, Charlotte, NC 28203 USA; [Toan Huynh] Carolinas Med Ctr, Dept Surg, Div Acute Care Surg, 1000 Blythe Blvd, Charlotte, NC 28203 USA; [Zheng, Nigel] Univ North Carolina Charlotte, Ctr Biomed Engn & Sci, 9201 Univ City Blvd, Charlotte, NC 28223 USA		Newman, MA (corresponding author), Carolinas Med Ctr, Dept Phys Med & Rehabil, Carolinas Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.	Mark.Newman@atriumhealth.org	Runyon, Michael/AAR-8899-2021	Runyon, Michael/0000-0002-1703-4317	Carolinas HealthCare System Trauma Center of Excellence	We thank D. Hamm for her contribution to the data collection, and the clinical and administrative staff in the Department of Physical Medicine and Rehabilitation at Levine Children's Hospital, Carolinas Medical Center for their support. We thank the participants and their families for their participation. This work was supported by a grant from Carolinas HealthCare System Trauma Center of Excellence to Dr. Mark A. Hirsch.	Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beretta E, 2018, DEV NEUROREHABIL, V21, P449, DOI 10.1080/17518423.2017.1360408; Cohen J., 2013, STAT POWER ANAL BEHA; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Huang Hsiang-Ju, 2003, Pediatr Phys Ther, V15, P105, DOI 10.1097/01.PEP.0000067886.96352.6B; Kahneman D., 1973, ATTENTION EFFORT; Katz-Leurer M, 2011, BRAIN INJURY, V25, P581, DOI 10.3109/02699052.2011.572943; Katz-Leurer Michal, 2008, Pediatr Phys Ther, V20, P254, DOI 10.1097/PEP.0b013e3181820dd8; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Leversen JSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038830; Li KZH, 2001, PSYCHOL SCI, V12, P230, DOI 10.1111/1467-9280.00341; Newman MA, 2018, GAIT POSTURE, V63, P248, DOI 10.1016/j.gaitpost.2018.05.014; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Parasuraman R., 1981, ATTENTION PERFORM, P493; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Schmidt R. A., 1988, MOTOR CONTROL LEARNI; Schoene D, 2013, J AM GERIATR SOC, V61, P202, DOI 10.1111/jgs.12106; Sivarajah L, 2018, PHYS OCCUP THER PEDI, V38, P280, DOI 10.1080/01942638.2017.1357066; Swart E., 2019, MICROTOTAL ANAL SYST; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	25	2	2	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	FEB	2020	76						193	197		10.1016/j.gaitpost.2019.12.001			5	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Orthopedics; Sport Sciences	KK8KG	WOS:000512984600030	31862669				2022-02-06	
J	Parsons, JT; Anderson, SA; Casa, DJ; Hainline, B				Parsons, John T.; Anderson, Scott A.; Casa, Douglas J.; Hainline, Brian			Preventing catastrophic injury and death in collegiate athletes: interassociation recommendations endorsed by 13 medical and sports medicine organisations	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							ASSOCIATION TASK-FORCE; SUDDEN CARDIAC-ARREST; HIGH-SCHOOL; TEAM RHABDOMYOLYSIS; AMERICAN FOOTBALL; NCAA FOOTBALL; FATALITIES	The Second Safety in College Football Summit resulted in interassociation consensus recommendations for three paramount safety issues in collegiate athletics: (1) independent medical care for collegiate athletes; (2) diagnosis and management of sport-related concussion; and (3) year-round football practice contact for collegiate athletes. This document, the fourth arising from the 2016 event, addresses the prevention of catastrophic injury, including traumatic and non-traumatic death, in collegiate athletes. The final recommendations in this document are the result of presentations and discussions on key items that occurred at the summit. After those presentations and discussions, endorsing organisation representatives agreed on 18 foundational statements that became the basis for this consensus paper that has been subsequently reviewed by relevant stakeholders and endorsing organisations. This is the final endorsed document for preventing catastrophic injury and death in collegiate athletes. This document is divided into the following components. (1) Background-this section provides an overview of catastrophic injury and death in collegiate athletes. (2) Interassociation recommendations: preventing catastrophic injury and death in collegiate athletes-this section provides the final recommendations of the medical organisations for preventing catastrophic injuries in collegiate athletes. (3) Interassociation recommendations: checklist-this section provides a checklist for each member school. The checklist statements stem from foundational statements voted on by representatives of medical organisations during the summit, and they serve as the primary vehicle for each member school to implement the prevention recommendations. (4) References-this section provides the relevant references for this document. (5) Appendices-this section lists the foundational statements, agenda, summit attendees and medical organisations that endorsed this document.	[Parsons, John T.; Hainline, Brian] NCAA, Sport Sci Inst, Indianapolis, IN USA; [Anderson, Scott A.] Univ Oklahoma, Athlet, Norman, OK 73019 USA; [Casa, Douglas J.] Univ Connecticut, Kinesiol, Storrs, CT USA		Hainline, B (corresponding author), NCAA, Indianapolis, IN 46206 USA.	bhainline@ncaa.org					Adams WM, 2016, J ATHL TRAINING, V51, P358, DOI 10.4085/1062-6050-51.4.14; Anderson S, 2017, J ATHL TRAINING, V52, P145, DOI 10.4085/1062-6050-52.3.02; Anderson SA, 2012, J STRENGTH COND RES, V26, P1179, DOI 10.1519/JSC.0b013e31824f2091; Andres K., 2018, 2018 2019 NCAA MENS; ASTM International, 2016, SPORTS EQ PLAYING SU, V15; Boden BP, 2013, AM J SPORT MED, V41, P1108, DOI 10.1177/0363546513478572; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Casa DJ, 2015, J ATHL TRAINING, V50, P986, DOI 10.4085/1062-6050-50.9.07; Casa DJ, 2012, J ATHL TRAINING, V47, P477, DOI 10.4085/1062-6050-47.4.08; Casa DJ, 2012, CURR SPORT MED REP, V11, P115, DOI 10.1249/JSR.0b013e31825615cc; Casa DJ, 2012, J ATHL TRAINING, V47, P96; Cooper ER, 2016, J ATHL TRAINING, V51, P593, DOI 10.4085/1062-6050-51.8.08; DeMartini JK, 2011, J STRENGTH COND RES, V25; Drezner JA, 2008, HEART RHYTHM, V5, P794, DOI 10.1016/j.hrthm.2008.03.001; Drezner JA, 2007, J ATHL TRAINING, V42, P143; Eichner ER, 2018, CURR SPORT MED REP, V17, P142, DOI 10.1249/JSR.0000000000000484; Eichner ER, 2016, CURR SPORT MED REP, V15, P378, DOI 10.1249/JSR.0000000000000311; Eichner ER, 2016, CURR SPORT MED REP, V15, P122, DOI 10.1249/JSR.0000000000000251; Garrett AT, 2011, SPORTS MED, V41, P757, DOI 10.2165/11587320-000000000-00000; Hainline B, 2016, J AM COLL CARDIOL, V67, P2981, DOI 10.1016/j.jacc.2016.03.527; Harmon KG, 2012, BRIT J SPORT MED, V46, P325, DOI 10.1136/bjsports-2011-090896; Harris KM, 2012, AM J CARDIOL, V110, P1185, DOI 10.1016/j.amjcard.2012.06.004; Hsu AC, 2012, MED SCI SPORT EXER, V44, P178, DOI 10.1249/MSS.0b013e318275044f; Hyland A., 2018, 2018 19 NCAA MENS BA; Institute of Medicine, 2015, STRATEGIES IMPROVE C; Kucera KL, 2018, ANN SURVEY FOOTBALL; Kucera KL, 2019, INJURY PREV, V25, P83, DOI 10.1136/injuryprev-2017-042642; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; McGrew CA, 2010, CURR SPORT MED REP, V9, P185, DOI 10.1249/JSR.0b013e3181e7c9c4; Mueller FO, 2001, J ATHL TRAINING, V36, P312; National Athletic Trainers' Association, CONS STAT SICKL CELL; National Operating Committee on Standards for Athletic Equipment, 2015, STAND PERF SPEC NEWL; National Operating Committee on Standards for Athletic Equipment, 2012, STAND PERF SPEC REC; Parsons JT, 2014, 2014 2015 NCAA SPORT; Redding R., 2018, 2017 NCAA FOOTBALL R; TORG JS, 1990, AM J SPORT MED, V18, P50, DOI 10.1177/036354659001800109; TORG JS, 1991, AM J SPORT MED, V19, P6, DOI 10.1177/036354659101900103; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; Yau R. K., 2018, CATASTROPHIC SPORTS	39	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2020	54	4					208	215		10.1136/bjsports-2019-101090			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KS3CW	WOS:000518188300008	31537549	Bronze			2022-02-06	
J	Pushchina, EV; Kapustyanov, IA; Varaksin, AA				Pushchina, Evgeniya, V; Kapustyanov, Ilya A.; Varaksin, Anatoly A.			Neural Stem Cells/Neuronal Precursor Cells and Postmitotic Neuroblasts in Constitutive Neurogenesis and After ,Traumatic Injury to the Mesencephalic Tegmentum of Juvenile Chum Salmon, Oncorhynchus keta	BRAIN SCIENCES			English	Article						traumatic brain injury; neuronal stem cells; cell's proliferation; neuronal precursor cells; postmitotic neuroblasts; mesencephalic tegmentum; chum salmon; nestin; vimentin; doublecortin	CENTRAL-NERVOUS-SYSTEM; ADULT NEUROGENESIS; PROLIFERATION ZONES; OLFACTORY-BULB; TELEOST FISH; MOLECULAR CHARACTERIZATION; NEURONAL REGENERATION; SUBVENTRICULAR ZONE; VENTRICULAR ZONE; BRAIN	The proliferation of neural stem cells (NSCs)/neuronal precursor cells (NPCs) and the occurrence of postmitotic neuroblasts in the mesencephalic tegmentum of intact juvenile chum salmon, Oncorhynchus keta, and at 3 days after a tegmental injury, were studied by immunohistochemical labeling. BrdU+ constitutive progenitor cells located both in the periventricular matrix zone and in deeper subventricular and parenchymal layers of the brain are revealed in the tegmentum of juvenile chum salmon. As a result of traumatic damage to the tegmentum, the proliferation of resident progenitor cells of the neuroepithelial type increases. Nestin-positive and vimentin-positive NPCs and granules located in the periventricular and subventricular matrix zones, as well as in the parenchymal regions of the tegmentum, are revealed in the mesencephalic tegmentum of juvenile chum salmon, which indicates a high level of constructive metabolism and constitutive neurogenesis. The expression of vimentin and nestin in the extracellular space, as well as additionally in the NSCs and NPCs of the neuroepithelial phenotype, which do not express nestin in the control animals, is enhanced during the traumatic process. As a result of the proliferation of such cells in the post-traumatic period, local Nes+ and Vim+ NPCs clusters are formed and become involved in the reparative response. Along with the primary traumatic lesion, which coincides with the injury zone, additional Nes+ and Vim+ secondary lesions are observed to form in the adjacent subventricular and parenchymal zones of the tegmentum. In the lateral tegmentum, the number of doublecortin-positive cells is higher compared to that in the medial tegmentum, which determines the different intensities and rates of neuronal differentiation in the sensory and motor regions of the tegmentum, respectively. In periventricular regions remote from the injury, the expression of doublecortin in single cells and their groups significantly increases compared to that in the damage zone.	[Pushchina, Evgeniya, V; Kapustyanov, Ilya A.; Varaksin, Anatoly A.] Russian Acad Sci, Zhirmunsky Natl Sci Ctr Marine Biol, Far East Branch, Vladivostok 690041, Russia; [Pushchina, Evgeniya, V] Natl Acad Sci Ukraine, Bogomoletz Inst Physiol, UA-01024 Kiev, Ukraine		Pushchina, EV (corresponding author), Russian Acad Sci, Zhirmunsky Natl Sci Ctr Marine Biol, Far East Branch, Vladivostok 690041, Russia.; Pushchina, EV (corresponding author), Natl Acad Sci Ukraine, Bogomoletz Inst Physiol, UA-01024 Kiev, Ukraine.	puschina@mail.ru; ilyaak9772@gmail.com; anvaraksin@mail.ru	Varaksin, Anatoliy/AAN-1585-2021; Pushchina, Evgeniya/P-9789-2015	Pushchina, Evgeniya/0000-0003-0388-3147	Russian FederationRussian Federation [MD-4318.2015.4]; Far East Branch of the Russian Academy of Sciences within the Program for Basic Research for 2015-2017 [15-I-6-116]	This work was supported by the President of the Russian Federation (grant No. MD-4318.2015.4; to EVP) and by the Far East Branch of the Russian Academy of Sciences within the Program for Basic Research for 2015-2017 (grant No. 15-I-6-116; section III; to A.A.V. and E.V.P.).	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Albright JE, 2016, NEUROSCI LETT, V615, P50, DOI 10.1016/j.neulet.2016.01.019; ALONSO JR, 1989, J ANAT, V163, P155; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Arochena M, 2004, J COMP NEUROL, V469, P413, DOI 10.1002/cne.11021; Barbosa JS, 2015, SCIENCE, V348, P789, DOI 10.1126/science.aaa2729; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Carmona IC, 2011, MICROSC RES TECHNIQ, V74, P148, DOI 10.1002/jemt.20884; Cerda J, 1998, EUR J CELL BIOL, V77, P175, DOI 10.1016/S0171-9335(98)80105-2; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; Chen M, 2018, MOL NEUROBIOL, V55, P5478, DOI 10.1007/s12035-017-0759-0; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; DAHL D, 1981, EUR J CELL BIOL, V24, P191; DOLBEARE F, 1995, HISTOCHEM J, V27, P339; Dong ZQ, 2012, NEURON, V74, P65, DOI 10.1016/j.neuron.2012.01.031; Ekstrom P, 2001, J COMP NEUROL, V436, P92, DOI 10.1002/cne.1056; ELMQUIST JK, 1994, J COMP NEUROL, V344, P283, DOI 10.1002/cne.903440209; Ferretti P, 2011, EUR J NEUROSCI, V34, P951, DOI 10.1111/j.1460-9568.2011.07833.x; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grandel H, 2013, DEV GENES EVOL, V223, P131, DOI 10.1007/s00427-012-0425-5; Hendrickson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018535; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; Kalman M, 1998, ANAT EMBRYOL, V198, P409, DOI 10.1007/s004290050193; Kalman M, 2002, J EXP ZOOL, V293, P395, DOI 10.1002/jez.10134; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kishimoto N, 2011, J COMP NEUROL, V519, P3549, DOI 10.1002/cne.22722; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kuroyanagi Y, 2010, BRAIN RES, V1323, P33, DOI 10.1016/j.brainres.2010.01.045; Lim Daniel A., 2008, V52, P175; Lyons DA, 2003, DEVELOPMENT, V130, P3427, DOI 10.1242/dev.00569; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Mahler J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-89; Margotta Vito, 2002, Italian Journal of Anatomy and Embryology, V107, P185; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Mueller T, 2009, BRAIN BEHAV EVOLUT, V74, P30, DOI 10.1159/000229011; Pushchina EV, 2019, RUSS J DEV BIOL+, V50, P59, DOI 10.1134/S106236041902005X; Pushchina E.V., 2017, NEUROCHEMICAL ORG AD, P267; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Takeda A, 2015, NEUROSCIENCE, V284, P134, DOI 10.1016/j.neuroscience.2014.09.066; Tozzini ET, 2012, AGING CELL, V11, P241, DOI 10.1111/j.1474-9726.2011.00781.x; Traniello IM, 2014, DEV NEUROBIOL, V74, P514, DOI 10.1002/dneu.22145; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wullimann MF, 1999, ANAT EMBRYOL, V199, P329, DOI 10.1007/s004290050232; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; ZUPANC GKH, 1995, J COMP NEUROL, V353, P213, DOI 10.1002/cne.903530205; Zupanc GKH, 1999, J EXP BIOL, V202, P1435; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569; Zupanc GKH, 2013, CURR TOP MICROBIOL, V367, P193, DOI 10.1007/82_2012_297; Zupanc GKH, 2011, EUR J NEUROSCI, V34, P917, DOI 10.1111/j.1460-9568.2011.07854.x	60	2	2	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	FEB	2020	10	2							65	10.3390/brainsci10020065			29	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KT8DY	WOS:000519243400010	31991815	Green Published, gold			2022-02-06	
J	Shandra, O; Robel, S				Shandra, Oleksii; Robel, Stefanie			Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Behavior; Issue 156; TBI; epilepsy; seizures; astrogliosis; EEG; mild TBI; concussion; diffuse TBI; posttraumatic epilepsy	RATS; EPILEPTOGENESIS; RISK	Traumatic brain injury (TBI) is a leading cause of acquired epilepsy. TBI can result in a focal or diffuse brain injury. Focal injury is a result of direct mechanical forces, sometimes penetrating through the cranium, creating a direct lesion in the brain tissue. These are visible during brain imaging as areas with contusion, laceration, and hemorrhage. Focal lesions induce neuronal death and glial scar formation and are present in 20% -25% of all people who incur a TBI. However, in the majority of TBI cases, injury is caused by acceleration-deceleration forces and subsequent tissue shearing, resulting in nonfocal, diffuse damage. A subpopulation of TBI patients continues to develop post-traumatic epilepsy (PTE) after a latency period of months or years. Currently, it is impossible to predict which patients will develop PTE, and seizures in PTE patients are challenging to control, necessitating further research. Until recently, the field was limited to only two animal/rodent models with validated spontaneous post-traumatic seizures, both presenting with large focal lesions with massive tissue loss in the cortex and sometimes subcortical structures. In contrast to these approaches, it was determined that diffuse TBI induced using a modified weight drop model is sufficient to initiate development of spontaneous convulsive and non-convulsive seizures, even in the absence of focal lesions or tissue loss. Similar to human patients with acquired post-traumatic epilepsy, this model presents with a latency period after injury before seizure onset. In this protocol, the community will be provided with a new model of post-traumatic epilepsy, detailing how to induce diffuse non-lesional TBI followed by continuous long-term video-electroencephalographic animal monitoring over the course of several months. This protocol will detail animal handling, the weight drop procedure, the electrode placement for two acquisition systems, and the frequent challenges encountered during each of the steps of surgery, postoperative monitoring, and data acquisition.	[Shandra, Oleksii; Robel, Stefanie] Virginia Tech Carilion, Fralin Biomed Res Inst, Roanoke, VA 24016 USA; [Robel, Stefanie] Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA; [Robel, Stefanie] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA		Robel, S (corresponding author), Virginia Tech Carilion, Fralin Biomed Res Inst, Roanoke, VA 24016 USA.; Robel, S (corresponding author), Virginia Tech, Sch Neurosci, Blacksburg, VA 24061 USA.; Robel, S (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	srobel@vt.edu	Shandra, Oleksii/AAD-2622-2020	Shandra, Oleksii/0000-0003-4447-3312; Robel, Stefanie/0000-0001-6716-3670	NINDS NIH HHS/United States [R01 NS105807/NS]; United States Army Medical Research and Materiel Command, Department of Defense (DoD), through the Psychological Health and Traumatic Brain Injury Research Program [W81XWH-15-2-0069]	This work was supported by R01 NS105807/NS/NINDS NIH HHS/United States and CURE based on a grant CURE received from the United States Army Medical Research and Materiel Command, Department of Defense (DoD), through the Psychological Health and Traumatic Brain Injury Research Program under Award No. W81XWH-15-2-0069. Ivan Zuidhoek is greatly appreciated for proofreading the manuscript.	Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gades NM, 2000, CONTEMP TOP LAB ANIM, V39, P8; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Ostergard T, 2016, J NEUROSCI METH, V272, P50, DOI 10.1016/j.jneumeth.2016.03.023; Paxinos G., 2007, MOUSE BRAIN STEREOTA; Piccenna Loretta, 2017, Epilepsia Open, V2, P123, DOI 10.1002/epi4.12049; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; Shandra O, 2019, J NEUROSCI, V39, P1944, DOI 10.1523/JNEUROSCI.1067-18.2018; Shandra O, 2019, METHODS MOL BIOL, V1938, P233, DOI 10.1007/978-1-4939-9068-9_16	17	2	2	0	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	FEB	2020		156							e60360	10.3791/60360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KS6FS	WOS:000518403300017	32090988				2022-02-06	
J	Thomas, I; Dickens, AM; Posti, JP; Mohammadian, M; Ledig, C; Takala, RSK; Hyotylainen, T; Tenovuo, O; Oresic, M				Thomas, Ilias; Dickens, Alex M.; Posti, Jussi P.; Mohammadian, Mehrbod; Ledig, Christian; Takala, Riikka S. K.; Hyotylainen, Tuulia; Tenovuo, Olli; Oresic, Matej			Integrative Analysis of Circulating Metabolite Profiles and Magnetic Resonance Imaging Metrics in Patients with Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						blood biomarkers; magnetic resonance imaging; mass spectrometry; metabolomics; traumatic brain injury	CENTER-TBI; SPECTROSCOPY; MYOINOSITOL; BIOMARKER; MODERATE; OUTCOMES; DAMAGE; SERUM; S100B; ACIDS	Recent evidence suggests that patients with traumatic brain injuries (TBIs) have a distinct circulating metabolic profile. However, it is unclear if this metabolomic profile corresponds to changes in brain morphology as observed by magnetic resonance imaging (MRI). The aim of this study was to explore how circulating serum metabolites, following TBI, relate to structural MRI (sMRI) findings. Serum samples were collected upon admission to the emergency department from patients suffering from acute TBI and metabolites were measured using mass spectrometry-based metabolomics. Most of these patients sustained a mild TBI. In the same patients, sMRIs were taken and volumetric data were extracted (138 metrics). From a pool of 203 eligible screened patients, 96 met the inclusion criteria for this study. Metabolites were summarized as eight clusters and sMRI data were reduced to 15 independent components (ICs). Partial correlation analysis showed that four metabolite clusters had significant associations with specific ICs, reflecting both the grey and white matter brain injury. Multiple machine learning approaches were then applied in order to investigate if circulating metabolites could distinguish between positive and negative sMRI findings. A logistic regression model was developed, comprised of two metabolic predictors (erythronic acid and myo-inositol), which, together with neurofilament light polypeptide (NF-L), discriminated positive and negative sMRI findings with an area under the curve of the receiver-operating characteristic of 0.85 (specificity = 0.89, sensitivity = 0.65). The results of this study show that metabolomic analysis of blood samples upon admission, either alone or in combination with protein biomarkers, can provide valuable information about the impact of TBI on brain structural changes.	[Thomas, Ilias; Oresic, Matej] Orebro Univ, Sch Med Sci, S-70281 Orebro, Sweden; [Dickens, Alex M.; Oresic, Matej] Univ Turku, Turku Biosci Ctr, FI-20520 Turku, Finland; [Dickens, Alex M.; Oresic, Matej] Abo Akad Univ, FI-20520 Turku, Finland; [Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, FI-20520 Turku, Finland; [Posti, Jussi P.] Turku Univ Hosp, Dept Rehabil, Div Clin Neurosci, FI-20520 Turku, Finland; [Posti, Jussi P.] Turku Univ Hosp, Dept Brain Trauma, Div Clin Neurosci, FI-20520 Turku, Finland; [Posti, Jussi P.; Mohammadian, Mehrbod; Takala, Riikka S. K.; Tenovuo, Olli] Turku Univ Hosp, Turku Brain Injury Ctr, FI-20520 Turku, Finland; [Posti, Jussi P.; Mohammadian, Mehrbod; Tenovuo, Olli] Univ Turku, Dept Clin Neurosci, FI-20520 Turku, Finland; [Ledig, Christian] Imperial Coll London, Dept Comp, London SW7 2AZ, England; [Takala, Riikka S. K.] Turku Univ Hosp, Perioperat Serv, Intens Care Med & Pain Management, FI-20520 Turku, Finland; [Takala, Riikka S. K.] Univ Turku, FI-20520 Turku, Finland; [Hyotylainen, Tuulia] Orebro Univ, Dept Chem, S-70281 Orebro, Sweden		Oresic, M (corresponding author), Orebro Univ, Sch Med Sci, S-70281 Orebro, Sweden.; Oresic, M (corresponding author), Univ Turku, Turku Biosci Ctr, FI-20520 Turku, Finland.; Oresic, M (corresponding author), Abo Akad Univ, FI-20520 Turku, Finland.	ilias.thomas@oru.se; alex.dickens@utu.fi; jussi.posti@utu.fi; mehmoh@utu.fi; ledig.christian@gmail.com; riikka.takala@gmail.com; tuulia.hyotylainen@oru.se; olli.Tenovuo@tyks.fi; matej.oresic@oru.se	Oresic, Matej/K-7673-2016; Posti, Jussi P./Y-2908-2019; Hyotylainen, Tuulia/AAP-6266-2020; Oresic, Matej/AAV-3978-2020; Dickens, Alex/F-8566-2013	Oresic, Matej/0000-0002-2856-9165; Posti, Jussi P./0000-0002-5925-5193; Hyotylainen, Tuulia/0000-0002-1389-8302; , ILIAS/0000-0002-5795-7677; Dickens, Alex/0000-0002-3178-8449	Swedish Research CouncilSwedish Research CouncilEuropean Commission [2018-02629]; EU FP7 project TBIcare [270259]; GE-NFL Head Health Challenge I Award [7620]; Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Emil Aaltonen Foundation; Finnish Brain Foundation; Maire Taponen Foundation	This study was supported by the Swedish Research Council (grant no. 2018-02629; to M.O.), the EU FP7 project TBIcare (grant no. 270259; to M.O., D.M., and O.T.), the GE-NFL Head Health Challenge I Award (grant no. 7620; to M.O. and T.H.), the Academy of Finland (grant no. 17379 to J.P.P.) Government's Special Financial Transfer tied to academic research in Health Sciences (to J.P.P), the Emil Aaltonen Foundation (to J.P.P.), the Finnish Brain Foundation and the Maire Taponen Foundation (to J.P.P.).	Ahonen L, 2019, METABOLITES, V9, DOI 10.3390/metabo9090184; Ala-Seppala H, 2016, BRAIN INJURY, V30, P1062, DOI 10.3109/02699052.2016.1170880; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Castillo S, 2011, ANAL CHEM, V83, P3058, DOI 10.1021/ac103308x; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Clausen F, 2011, ACTA NEUROCHIR, V153, P653, DOI 10.1007/s00701-010-0871-7; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Dickens AM, 2018, J NEUROTRAUM, V35, P2673, DOI 10.1089/neu.2017.5272; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Engelke UFH, 2010, BBA-MOL BASIS DIS, V1802, P1028, DOI 10.1016/j.bbadis.2010.06.007; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Harding JJ, 1999, CURR EYE RES, V19, P131, DOI 10.1076/ceyr.19.2.131.5334; Haris M, 2011, NEUROIMAGE, V54, P2079, DOI 10.1016/j.neuroimage.2010.10.017; Ho TK, 1995, P 3 INT C DOC AN REC; HOFFMANN GF, 1993, J CHROMATOGR-BIOMED, V617, P1, DOI 10.1016/0378-4347(93)80414-Y; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hyvarinen A., 2001, INDEPENDENT COMPONEN, V1, P11, DOI [10.1002/0471221317, DOI 10.1002/0471221317]; Jaeger C, 2015, AM J PATHOL, V185, P1699, DOI 10.1016/j.ajpath.2015.02.016; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mendez KM, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1612-4; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; National Institute for Health and Care Excellence, 2017, NICE GUID, DOI [10.1530/eje.0.1310385, DOI 10.1530/EJE.0.1310385]; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; Posti JP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00398; R Core Team, 2017, R LANG ENV STAT COMP; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	53	2	2	2	5	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	FEB	2020	21	4							1395	10.3390/ijms21041395			17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	KY4FE	WOS:000522524400222	32092929	Green Published, gold			2022-02-06	
J	Valier, ARS; Bliven, KCH; Gibson, A; Simon, J; Dompier, TP; Wasserman, EB; Rynard, KL; Kerr, ZY				Valier, Alison R. Snyder; Bliven, Kellie C. Huxel; Gibson, Amy; Simon, Janet; Dompier, Thomas P.; Wasserman, Erin B.; Rynard, Kelsi L.; Kerr, Zachary Y.			Non-Time-Loss and Time-Loss Softball Injuries in Secondary School Athletes: A Report From the National Athletic Treatment, Injury and Outcomes Network (NATION)	JOURNAL OF ATHLETIC TRAINING			English	Article						injury surveillance; females; athletes; epidemiology	UNITED-STATES; DESCRIPTIVE EPIDEMIOLOGY; SHOULDER INJURIES; SURVEILLANCE SYSTEM; BASEBALL INJURIES; ASSOCIATION; PATTERNS; SPORTS; CONCUSSIONS; TRAINERS	Context: Most studies of injury trends associated with softball focus on injuries requiring at least 24 hours of missed participation time (time-loss [TL] injuries), with little focus on those that do not (non-time-loss [NTL] injuries). A better understanding of injury trends associated with softball will improve athlete care. Objective: To describe NTL and TL injuries experienced by secondary school girls' softball players. Design: Descriptive epidemiology study. Setting: Secondary school athletic training clinics. Patients or Other Participants: Secondary school girls' softball players. Main Outcome Measure(s): Aggregate data were collected from schools participating in the National Athletic Treatment, Injury, and Outcomes Network surveillance program during the 2011-2012 through 2013-2014 academic years. Frequencies and rates of injuries (NTL and TL) according to time of season, event type, body part injured, and diagnosis were analyzed. Results: In total, 1059 injuries were reported during 140 073 athlete-exposures (AEs): overall injury rate = 7.56/1000 AEs. Of these injuries, 885 (83.6%) were NTL (NTL rate = 6.32/1000 AEs) and 174 (16.4%) were TL (TL rate = 1.24/1000 AEs). Of the NTL and TL injuries, the largest numbers occurred during the regular season (NTL: n = 443 [50.1%]; TL: n = 131 [75.3%]). Injuries sustained during practices accounted for the majority of NTL and TL injuries (NTL: n =631 [71.3%]; TL: n =104 [59.8%]). The NTL injuries occurred most often at the shoulder (n = 134 [15.1%]) and hand/fingers (n = 109 [12.3%]) and were diagnosed as contusions (n = 316 [35.7%]), strains (n = 157 [17.7%]), and abrasions (n = 151 [17.1%]). The largest numbers of TL injuries were to the head/face (n = 71 [40.8%]) and diagnosed as concussions (n = 50 [28.7%]) and strains (n = 28 [16.1%]). Conclusions: Secondary school softball players sustained a larger proportion of NTL injuries than TL injuries. Although NTL injuries may be less severe, they are numerous. Efforts are needed to ensure that injury-prevention programs are incorporated into the care of softball athletes to promote health and reduce injury occurrence.	[Valier, Alison R. Snyder; Bliven, Kellie C. Huxel; Gibson, Amy] AT Still Univ, Athlet Training Programs, 5850 E Still Circle, Mesa, AZ 85206 USA; [Valier, Alison R. Snyder; Bliven, Kellie C. Huxel; Gibson, Amy] AT Still Univ, Dept Interdisciplinary Hlth Sci, Mesa, AZ 85206 USA; [Valier, Alison R. Snyder] AT Still Univ, Sch Osteopath Med Arizona & Res Support, Mesa, AZ 85206 USA; [Simon, Janet] Ohio Univ, Dept Appl Hlth Sci & Wellness, Athens, OH 45701 USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Wasserman, Erin B.; Rynard, Kelsi L.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA; [Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC USA		Valier, ARS (corresponding author), AT Still Univ, Athlet Training Programs, 5850 E Still Circle, Mesa, AZ 85206 USA.	arsnyder@atsu.edu		Wasserman, Erin/0000-0001-5957-5878	National Athletic Trainers' Association Research & Education Foundation; Central Indiana Corporate Partnership Foundation (Indianapolis, IN); BioCrossroads (Indianapolis, IN)	The NATION data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. We thank the ATs who participate in the NATION data-collection process. Their time and effort contribute much to research investigating the safety of athletes who participate in secondary school athletics nationwide. We also thank Deborah Goggin for technical review of the paper. This project was funded by the National Athletic Trainers' Association Research & Education Foundation and the Central Indiana Corporate Partnership Foundation (Indianapolis, IN) in cooperation with BioCrossroads (Indianapolis, IN). The content of this report is solely the responsibility of the authors and does not necessarily reflect the views of the National Athletic Trainers' Association Research & Education Foundation, Central Indiana Corporate Partnership Foundation, or BioCrossroads.	[Anonymous], 2014 15 HIGH SCH ATH; Bonza JE, 2009, J ATHL TRAINING, V44, P76, DOI 10.4085/1062-6050-44.1.76; Briskin SM, 2012, CURR SPORT MED REP, V11, P265, DOI 10.1249/JSR.0b013e3182699489; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley PS, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117703944; Collins CL, 2008, PEDIATRICS, V121, P1181, DOI 10.1542/peds.2007-2572; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Dick R, 2007, J ATHL TRAINING, V42, P183; Dompier TP, 2015, J ATHL TRAINING, V50, P862, DOI 10.4085/1062-6050-50.5.04; Frollo J., SEE YOUR STATE STAND; Hill JL, 2004, J STRENGTH COND RES, V18, P426, DOI 10.1519/00124278-200408000-00006; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2015, J ATHL TRAINING, V50, P1310, DOI 10.4085/1062-6050-51.1.08; Knowles SB, 2010, BRIT J SPORT MED, V44, P38, DOI 10.1136/bjsm.2009.065763; Krajnik S, 2010, PEDIATRICS, V125, P497, DOI 10.1542/peds.2009-0961; Lawson BR, 2009, PEDIATRICS, V123, pE1028, DOI 10.1542/peds.2007-3796; LOOSLI AR, 1992, AM J SPORT MED, V20, P35, DOI 10.1177/036354659202000110; Malcom NL, 2006, J CONTEMP ETHNOGR, V35, P495, DOI 10.1177/0891241605283571; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall SW, 2007, J ATHL TRAINING, V42, P286; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mueller, 2012, ATHL TRAIN SPORTS HL, V4, P11, DOI DOI 10.3928/19425864-20110331-01; Post EG, 2017, AM J SPORT MED, V45, P1405, DOI 10.1177/0363546517690848; Powell JW, 2004, J ATHL TRAINING, V39, P56; Powell JW, 1999, J ATHL TRAINING, V34, P277; Powell JW, 2000, AM J SPORT MED, V28, P385, DOI 10.1177/03635465000280031801; Robinson TW, 2014, PEDIATRICS, V133, P272, DOI 10.1542/peds.2013-2279; Shanley E, 2011, J ATHL TRAINING, V46, P648; Soldatis JJ, 1997, J SHOULDER ELB SURG, V6, P265, DOI 10.1016/S1058-2746(97)90015-X; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537	30	2	2	0	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2020	55	2					188	194		10.4085/1062-6050-105-19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KM1GV	WOS:000513866900009	31913657	Green Published, gold			2022-02-06	
J	Valiuddin, H; Alam, A; Calice, M; Boehm, K; Millard, J; Laforest, D; Valiuddin, Y; Ricardi, R; Kaakaji, R; Koch, S; Oweis, T; Keyes, D				Valiuddin, Hisham; Alam, Ariful; Calice, Michael; Boehm, Kevin; Millard, John; Laforest, Daniel; Valiuddin, Yaser; Ricardi, Rick; Kaakaji, Rami; Koch, Spencer; Oweis, Thomas; Keyes, Daniel			UTILITY OF INR FOR PREDICTION OF DELAYED INTRACRANIAL HEMORRHAGE AMONG WARFARIN USERS WITH HEAD INJURY	JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Meeting of the Society-of-Academic-Emergency-Medicine	MAY 17, 2019	Las Vegas, NV	Soc Acad Emergency Med		anticoagulated; delayed intracranial hemorrhage; head injury; trauma; warfarin	TRAUMATIC BRAIN-INJURY; VITAMIN-K ANTAGONISTS; THERAPY; ANTICOAGULATION; TRENDS; RISK; CT	Background: Incidence of delayed intracranial hemorrhage (DICH) in patients on warfarin has been controversial. No previous literature has reported the utility of international normalized ratio (INR) in predicting traumatic DICH. Objectives: Utilizing INR to risk stratify head trauma patients who may be managed without repeat imaging. Methods: This was a retrospective study at a Level II trauma center. All patients on warfarin with head injuries from March 2014 to December 31, 2017 were included. Each patient underwent an initial head computed tomography scan (HCT) and subsequent repeat HCT 12 h after. Patients presenting > 12 h after head injury received only one HCT. Two blinded neuroradiologists reviewed each case of DICH. Statistical analysis evaluated Glasgow Coma Scale (GCS), Injury Severity Score (ISS), heart rate, systolic blood pressure (SBP), age, and platelet count. Results: There were 395 patients who qualified for the protocol; 238 were female. Average age was 79 years. Seventy-seven percent of patients underwent repeat HCT. Five resulted in DICH (INR 2.6-3.0), three of which might have been present on initial HCT; incidence rate of 0.51-1.27%. One patient required neurosurgical intervention. Among 80 patients with INR < 2, no DICH was identified, resulting in high sensitivity, but with a wide confidence interval; sensitivity of 100% (95% confidence interval [CI] 47.8-100), specificity 21% (95% CI 16.6-28.9). Correlation of factors: ISS (p = 0.039), GCS (p = 0.978), HR (p = 0.601), SBP (p = 0.198), age (p = 0.014), and platelets (p = 0.281). Conclusion: No patient with INR < 2 suffered DICH, suggesting that warfarin users presenting with INR < 2 may be managed without repeat HCT. For INR > 2, patients age and injury severity can be used for shared decision-making to discharge home with standard head injury precautions and no repeat HCT. (C) 2020 Elsevier Inc. All rights reserved.	[Valiuddin, Hisham; Calice, Michael; Keyes, Daniel] St Mary Mercy Hosp, Dept Emergency Med, 36475 Five Mile, Livonia, MI 48154 USA; [Alam, Ariful] St Mary Mercy Hosp, Dept Internal Med, Livonia, MI 48154 USA; [Boehm, Kevin] Broward Hlth Med Ctr, Dept Emergency Med, Ft Lauderdale, FL USA; [Millard, John; Ricardi, Rick; Oweis, Thomas] St Mary Mercy Hosp, Dept Trauma Surg, Livonia, MI 48154 USA; [Laforest, Daniel] Michigan State Univ, Sparrow Hosp, Dept Emergency Med, Lansing, MI USA; [Valiuddin, Yaser] Bluefield State Coll, Via Coll Osteopath Med, Blacksburg, VA USA; [Kaakaji, Rami; Koch, Spencer] St Mary Mercy Hosp, Dept Radiol, Livonia, MI 48154 USA		Keyes, D (corresponding author), St Mary Mercy Hosp, Dept Emergency Med, 36475 Five Mile, Livonia, MI 48154 USA.			Keyes, Daniel/0000-0002-8625-5703; Alam, Ariful/0000-0003-3161-1579			Barnes GD, 2015, AM J MED, V128, P1300, DOI 10.1016/j.amjmed.2015.05.044; Bauman ZM, 2017, AM SURGEON, V83, P429; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Centers for Disease Control and Prevention (CDC), 2014, RAT TBI REL EM DEP V; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; Cipriano A, 2018, INTERN EMERG MED, V13, P1077, DOI 10.1007/s11739-018-1806-1; Connolly BJ, 2014, STROKE, V45, P1672, DOI 10.1161/STROKEAHA.114.005430; Docimo S, 2014, AM SURGEON, V80, P610; Franschman G, 2011, J NEUROTRAUM, V29, P128; Ganetsky M, 2015, J EMERG MED, V49, P693, DOI 10.1016/j.jemermed.2015.04.028; George RL, 2018, BMC EMERG MED, V18, P16; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Li J, 2012, ANN EMERG MED, V59, P457, DOI 10.1016/j.annemergmed.2012.01.010; McCammack KC, 2015, WEST J EMERG MED, V16, P43, DOI 10.5811/westjem.2014.10.19488; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Miller J, 2015, J TRAUMA ACUTE CARE, V79, P310, DOI 10.1097/TA.0000000000000725; National Clinical Guideline Centre (NICE), 2014, HEAD INJURY; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Riccardi A, 2017, AM J EMERG MED, V35, P1317, DOI 10.1016/j.ajem.2017.03.072; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Verschoof MA, 2018, J NEUROL, V265, P315, DOI 10.1007/s00415-017-8701-y; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	27	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	FEB	2020	58	2					183	190		10.1016/j.jemermed.2020.01.003			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	LL3UR	WOS:000531481300017	32057543				2022-02-06	
J	Zuromski, KL; Bernecker, SL; Chu, C; Wilks, CR; Gutierrez, PM; Joiner, TE; Liu, H; Naifeh, JA; Nock, MK; Sampson, NA; Zaslaysky, AM; Stein, MB; Ursano, RJ; Kessler, RC; Heeringa, S; Wagner, J; Kessler, RC; Cox, K; Aliaga, PA; Benedek, DM; Campbell-Sills, L; Fullerton, CS; Gebler, N; Gifford, RK; House, M; Hurwitz, PE; Jain, S; Kao, TC; Lewandowski-Romps, L; Mash, HH; McCarroll, JE; Naifeh, JA; Ng, THH; Nock, MK; Sampson, NA; Santiago, P; Wynn, GH; Zaslaysky, AM				Zuromski, Kelly L.; Bernecker, Samantha L.; Chu, Carol; Wilks, Chelsey R.; Gutierrez, Peter M.; Joiner, Thomas E.; Liu, Howard; Naifeh, James A.; Nock, Matthew K.; Sampson, Nancy A.; Zaslaysky, Alan M.; Stein, Murray B.; Ursano, Robert J.; Kessler, Ronald C.; Heeringa, Steven; Wagner, James; Kessler, Ronald C.; Cox, Kenneth; Aliaga, Pablo A.; Benedek, David M.; Campbell-Sills, Laura; Fullerton, Carol S.; Gebler, Nancy; Gifford, Robert K.; House, Meredith; Hurwitz, Paul E.; Jain, Sonia; Kao, Tzu-Cheg; Lewandowski-Romps, Lisa; Mash, Holly Herberman; McCarroll, James E.; Naifeh, James A.; Ng, Tsz Hin Hinz; Nock, Matthew K.; Sampson, Nancy A.; Santiago, Patcho; Wynn, Gary H.; Zaslaysky, Alan M.		Site Principal Investigators; Army Liaison Consultant	Pre-deployment predictors of suicide attempt during and after combat deployment: Results from the Army Study to Assess Risk and Resilience in Servicemembers	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Deployment; Military personnel; Suicide; Predictive modeling; Risk factors	US MILITARY; SOLDIERS; BEHAVIORS; PERSONNEL; DESIGN	Background: Deployment-related experiences might be risk factors for soldier suicides, in which case identification of vulnerable soldiers before deployment could inform preventive efforts. We investigated this possibility by using pre-deployment survey and administrative data in a sample of US Army soldiers to develop a risk model for suicide attempt (SA) during and shortly after deployment. Methods: Data came from the Army Study to Assess Risk and Resilience in Servicemembers Pre-Post Deployment Survey (PPDS). Soldiers completed a baseline survey shortly before deploying to Afghanistan in 2011-2012. Survey measures were used to predict SAs, defined using administrative and subsequent survey data, through 30 months after deployment. Models were built using penalized regression and ensemble machine learning methods. Results: Significant pre-deployment risk factors were history of traumatic brain injury, 9 + mental health treatment visits in the 12 months before deployment, young age, female, previously married, and low relationship quality. Cross-validated AUC of the best penalized and ensemble models were .75-77. 21.3-40.4% of SAs occurred among the 5-10% of soldiers with highest predicted risk and positive predictive value (PPV) among these high-risk soldiers was 4.4-5.7%. Conclusions: SA can be predicted significantly from pre-deployment data, but intervention planning needs to take PPV into consideration.	[Zuromski, Kelly L.; Bernecker, Samantha L.; Chu, Carol; Wilks, Chelsey R.; Nock, Matthew K.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Zuromski, Kelly L.; Bernecker, Samantha L.; Chu, Carol; Wilks, Chelsey R.; Liu, Howard; Sampson, Nancy A.; Zaslaysky, Alan M.; Kessler, Ronald C.; Kessler, Ronald C.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Gutierrez, Peter M.] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO USA; [Gutierrez, Peter M.] Rocky Mt Reg Vet Affairs Med Ctr, Rocky Mt Mental Illness Res Educ & Clin Ctr, Aurora, CO USA; [Joiner, Thomas E.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Naifeh, James A.; Ursano, Robert J.] Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Sch Med, Dept Psychiat, Bethesda, MD USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Heeringa, Steven; Wagner, James; Gebler, Nancy; House, Meredith; Lewandowski-Romps, Lisa] Univ Michigan, Ann Arbor, MI 48109 USA; [Kessler, Ronald C.; Sampson, Nancy A.; Zaslaysky, Alan M.] Harvard Med Sch, Boston, MA 02115 USA; [Cox, Kenneth] US Army, Publ Hlth Ctr, Aberdeen Proving Ground, MD USA; [Aliaga, Pablo A.; Benedek, David M.; Fullerton, Carol S.; Gifford, Robert K.; Hurwitz, Paul E.; Kao, Tzu-Cheg; Mash, Holly Herberman; McCarroll, James E.; Naifeh, James A.; Ng, Tsz Hin Hinz; Santiago, Patcho; Wynn, Gary H.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Campbell-Sills, Laura; Jain, Sonia] Univ Calif San Diego, San Diego, CA 92103 USA; [Nock, Matthew K.] Harvard Univ, Cambridge, MA 02138 USA		Kessler, RC (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	kessler@hcp.med.harvard.edu	Ursano, Robert/ABE-6533-2020		Department of the Army; U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH) [U01MH087981]; Department of Defense (USUHS)United States Department of Defense [HU0001-15-2-0004]	The Army STARRS Team consists of Co-Principal Investigators: Robert J. Ursano, MD (Uniformed Services University of the Health Sciences) and Murray B. Stein, MD, MPH (University of California San Diego and VA San Diego Healthcare System). Army STARRS was sponsored by the Department of the Army and funded under cooperative agreement number U01MH087981 (2009-2015) with the U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH). Subsequently, STARRS-LS was sponsored and funded by the Department of Defense (USUHS grant number HU0001-15-2-0004). The contents are solely the responsibility of the authors and do not necessarily represent the views of the Department of Health and Human Services, NIMH, or the Department of the Army, or the Department of Defense.	Belsher BE, 2019, JAMA PSYCHIAT, V76, P642, DOI 10.1001/jamapsychiatry.2019.0174; Bembom O, 2007, STAT APPL GENET MOL, V6; Bernecker SL, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1656-4; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bryan CJ, 2018, SUICIDE LIFE-THREAT, V48, P413, DOI 10.1111/sltb.12370; Bryan CJ, 2015, SUICIDE LIFE-THREAT, V45, P633, DOI 10.1111/sltb.12163; Bryan CJ, 2014, J AFFECT DISORDERS, V159, P15, DOI 10.1016/j.jad.2014.02.021; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Franklin JC, 2017, PSYCHOL BULL, V143, P187, DOI 10.1037/bul0000084; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Fusar-Poli P, 2018, JAMA PSYCHIAT, V75, P1289, DOI 10.1001/jamapsychiatry.2018.2530; Gilman SE, 2014, PSYCHOL MED, V44, P2579, DOI 10.1017/S003329171400018X; Greden JF, 2010, ANN NY ACAD SCI, V1208, P90, DOI 10.1111/j.1749-6632.2010.05719.x; James G., 2017, SPRINGER TEXTS STAT, DOI [DOI 10.1007/978-1-4614-7138-7_8, 10.1007/978-1-4614-7138-7]; Kessler RC, 2015, PSYCHOL MED, V45, P3293, DOI 10.1017/S0033291715001294; Kessler RC, 2019, JAMA PSYCHIAT, V76, P777, DOI 10.1001/jamapsychiatry.2019.1238; Kessler RC, 2015, JAMA PSYCHIAT, V72, P49, DOI 10.1001/jamapsychiatry.2014.1754; Kessler RC, 2013, INT J METH PSYCH RES, V22, P267, DOI 10.1002/mpr.1401; Kessler RC, 2013, INT J METH PSYCH RES, V22, P288, DOI 10.1002/mpr.1399; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; Little R. J., 2019, STAT ANAL MISSING DA, V793; Matarazzo BB, 2019, JAMA PSYCHIAT, V76, P869, DOI 10.1001/jamapsychiatry.2019.1519; Niculescu AB, 2017, MOL PSYCHIATR, V22, P1250, DOI 10.1038/mp.2017.128; Nock MK, 2013, PSYCHIATRY, V76, P97, DOI 10.1521/psyc.2013.76.2.97; Nock MK, 2010, PSYCHOL SCI, V21, P511, DOI 10.1177/0956797610364762; O'Connor RC, 2014, LANCET PSYCHIAT, V1, P73, DOI 10.1016/S2215-0366(14)70222-6; Office of the Under Secretary of Defense for Personnel and Readiness, 2017, DEF SUIC PREV PROGR; Olfson M, 2017, JAMA PSYCHIAT, V74, P1095, DOI 10.1001/jamapsychiatry.2017.2582; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Reger MA, 2018, PERSPECT PSYCHOL SCI, V13, P688, DOI 10.1177/1745691618785366; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Rosellini AJ, 2016, PSYCHOL MED, V46, P303, DOI 10.1017/S0033291715001774; Rosellini AJ, 2018, DEPRESS ANXIETY, V35, P1073, DOI 10.1002/da.22807; Rosellini AJ, 2017, AM J PREV MED, V53, P661, DOI 10.1016/j.amepre.2017.06.022; SAS Institute Inc, 2010, SAS STATR SOFTW; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Shen YC, 2016, LANCET PSYCHIAT, V3, P1039, DOI 10.1016/S2215-0366(16)30304-2; Simon GE, 2019, JAMA PSYCHIAT, V76, P868, DOI 10.1001/jamapsychiatry.2019.1516; Smith GCS, 2014, AM J EPIDEMIOL, V180, P318, DOI 10.1093/aje/kwu140; Stein MB, 2017, AM J MED GENET B, V174, P786, DOI 10.1002/ajmg.b.32594; Street AE, 2015, PSYCHOL MED, V45, P717, DOI 10.1017/S003329171400258X; Street AE, 2016, CLIN PSYCHOL SCI, V4, P939, DOI 10.1177/2167702616639532; Torous J, 2019, JAMA PSYCHIAT, V76, P999, DOI 10.1001/jamapsychiatry.2019.1231; Ursano RJ, 2018, JAMA PSYCHIAT, V75, P596, DOI 10.1001/jamapsychiatry.2018.0296; Ursano RJ, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1350-y; Ursano RJ, 2016, JAMA PSYCHIAT, V73, P741, DOI 10.1001/jamapsychiatry.2016.0600; Ursano RJ, 2015, PSYCHIATRY, V78, P1, DOI 10.1080/00332747.2015.1006512; Wolter KM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-35099-8; Zuromski KL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0766	51	2	2	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	FEB	2020	121						214	221		10.1016/j.jpsychires.2019.12.003			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	KE7ZO	WOS:000508769800025	31865211	Green Accepted, Bronze			2022-02-06	
J	Grovola, MR; Paleologos, N; Wofford, KL; Harris, JP; Browne, KD; Johnson, V; Duda, JE; Wolf, JA; Cullen, DK				Grovola, Michael R.; Paleologos, Nicholas; Wofford, Kathryn L.; Harris, James P.; Browne, Kevin D.; Johnson, Victoria; Duda, John E.; Wolf, John A.; Cullen, D. Kacy			Mossy cell hypertrophy and synaptic changes in the hilus following mild diffuse traumatic brain injury in pigs	JOURNAL OF NEUROINFLAMMATION			English	Article						Mild traumatic brain injury; Concussion; Microglia; Hippocampus; Mossy cell	DENTATE GYRUS; AXONAL PATHOLOGY; CONTUSION INJURY; WHITE-MATTER; MODEL; MICROGLIA; NEURONS; DAMAGE; HYPEREXCITABILITY; INFLAMMATION	Background Each year in the USA, over 2.4 million people experience mild traumatic brain injury (TBI), which can induce long-term neurological deficits. The dentate gyrus of the hippocampus is notably susceptible to damage following TBI, as hilar mossy cell changes in particular may contribute to post-TBI dysfunction. Moreover, microglial activation after TBI may play a role in hippocampal circuit and/or synaptic remodeling; however, the potential effects of chronic microglial changes are currently unknown. The objective of the current study was to assess neuropathological and neuroinflammatory changes in subregions of the dentate gyrus at acute to chronic time points following mild TBI using an established model of closed-head rotational acceleration induced TBI in pigs. Methods This study utilized archival tissue of pigs which were subjected to sham conditions or rapid head rotation in the coronal plane to generate mild TBI. A quantitative assessment of neuropathological changes in the hippocampus was performed via immunohistochemical labeling of whole coronal tissue sections at 3 days post-injury (DPI), 7 DPI, 30 DPI, and 1 year post-injury (YPI), with a focus on mossy cell atrophy and synaptic reorganization, in context with microglial alterations (e.g., density, proximity to mossy cells) in the dentate gyrus. Results There were no changes in mossy cell density between sham and injured animals, indicating no frank loss of mossy cells at the mild injury level evaluated. However, we found significant mossy cell hypertrophy at 7 DPI and 30 DPI in anterior (> 16% increase in mean cell area at each time; p = < 0.001 each) and 30 DPI in posterior (8.3% increase; p = < 0.0001) hippocampus. We also found dramatic increases in synapsin staining around mossy cells at 7 DPI in both anterior (74.7% increase in synapsin labeling; p = < 0.0001) and posterior (82.7% increase; p = < 0.0001) hippocampus. Interestingly, these morphological and synaptic alterations correlated with a significant change in microglia in proximity to mossy cells at 7 DPI in anterior and at 30 DPI in the posterior hippocampus. For broader context, while we found that there were significant increases in microglia density in the granule cell layer at 30 DPI (anterior and posterior) and 1 YPI (posterior only) and in the molecular layer at 1 YPI (anterior only), we found no significant changes in overall microglial density in the hilus at any of the time points evaluated post-injury. Conclusions The alterations of mossy cell size and synaptic inputs paired with changes in microglia density around the cells demonstrate the susceptibility of hilar mossy cells after even mild TBI. This subtle hilar mossy cell pathology may play a role in aberrant hippocampal function post-TBI, although additional studies are needed to characterize potential physiological and cognitive alterations.	[Grovola, Michael R.; Paleologos, Nicholas; Wofford, Kathryn L.; Harris, James P.; Browne, Kevin D.; Duda, John E.; Wolf, John A.; Cullen, D. Kacy] Corporal Michael J Crescenz VA Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA 19104 USA; [Grovola, Michael R.; Paleologos, Nicholas; Wofford, Kathryn L.; Harris, James P.; Browne, Kevin D.; Johnson, Victoria; Wolf, John A.; Cullen, D. Kacy] Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, 105E Hayden Hall 3320 Smith Walk, Philadelphia, PA 19104 USA; [Wofford, Kathryn L.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Duda, John E.] Corporal Michael J Crescenz VA Med Ctr, Educ & Clin Ctr, Parkinsons Dis Res, Philadelphia, PA USA; [Duda, John E.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Cullen, D. Kacy] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, 105E Hayden Hall 3320 Smith Walk, Philadelphia, PA 19104 USA		Cullen, DK (corresponding author), Corporal Michael J Crescenz VA Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA 19104 USA.; Cullen, DK (corresponding author), Univ Penn, Ctr Brain Injury & Repair, Dept Neurosurg, 105E Hayden Hall 3320 Smith Walk, Philadelphia, PA 19104 USA.; Cullen, DK (corresponding author), Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, 105E Hayden Hall 3320 Smith Walk, Philadelphia, PA 19104 USA.	dkacy@pennmedicine.upenn.edu		Grovola, Michael/0000-0003-4125-9329; Paleologos, Nicholas/0000-0002-5110-9378; Harris, James/0000-0002-8458-5434	Department of Veterans AffairsUS Department of Veterans Affairs [I01-RX001097, I01-BX003748, IK2-RX001479]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS R01-NS-101108, NINDS T32-NS043126]; CURE Foundation; US Department of DefenseUnited States Department of Defense [W81XWH-16-1-0675]; National Science FoundationNational Science Foundation (NSF) [DGE-0947936]	This work was made possible through financial support provided by the Department of Veterans Affairs [RR&D Merit Review I01-RX001097 (Duda), BLR&D Merit Review I01-BX003748 (Cullen), and RR&D Career Development Award IK2-RX001479 (Wolf)], the National Institutes of Health (NINDS R01-NS-101108 (Wolf), NINDS T32-NS043126 (Harris)], the CURE Foundation [Taking Flight Award (Wolf)], the US Department of Defense [ERP CDMRP #W81XWH-16-1-0675 (Wolf)], and the National Science Foundation [STEMGK-12 program #DGE-0947936 (Wofford)]. None of the funding sources aided in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the paper for publication.	Abraham H, 2005, NEUROSCIENCE, V136, P231, DOI 10.1016/j.neuroscience.2005.07.030; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Aronica E, 2007, NEUROSCIENTIST, V13, P100, DOI 10.1177/1073858406295832; Bailey EL, 2009, STROKE, V40, pE451, DOI 10.1161/STROKEAHA.108.528430; Blumcke I, 2000, EPILEPSIA, V41, pS174, DOI 10.1111/j.1528-1157.2000.tb01577.x; BUCKMASTER PS, 1994, HIPPOCAMPUS, V4, P393, DOI 10.1002/hipo.450040402; Bui AD, 2018, SCIENCE, V359, P787, DOI 10.1126/science.aan4074; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Duffy AM, 2013, HIPPOCAMPUS, V23, P649, DOI 10.1002/hipo.22138; Eyo UB, 2017, GLIA, V65, P5, DOI 10.1002/glia.23006; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gorse KM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00778; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Howells DW, 2010, J CEREBR BLOOD F MET, V30, P1412, DOI 10.1038/jcbfm.2010.66; Jinde S, 2012, NEURON, V76, P1189, DOI 10.1016/j.neuron.2012.10.036; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pierce JP, 2005, EXP NEUROL, V196, P316, DOI 10.1016/j.expneurol.2005.08.007; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scharfman HE, 2016, NAT REV NEUROSCI, V17, P562, DOI 10.1038/nrn.2016.87; Scharfman HE, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00106; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Webb TS, 2015, BRAIN INJURY, V29, P430, DOI 10.3109/02699052.2014.989904; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Wofford KL, 2019, NEURAL REGEN RES, P1; Wolf JA, 2017, J NEUROTRAUM, V34, P2303, DOI 10.1089/neu.2016.4848; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Zhang W, 2015, HIPPOCAMPUS, V25, P594, DOI 10.1002/hipo.22396	54	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JAN 31	2020	17	1							44	10.1186/s12974-020-1720-0			18	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	KK3RN	WOS:000512663600001	32005260	Green Published, gold			2022-02-06	
J	Zheng, T; Yuan, Y; Yang, HX; Du, J; Wu, S; Jin, YL; Wang, ZQ; Liu, DF; Shi, QL; Wang, XH; Liu, LX				Zheng, Tao; Yuan, Yi; Yang, Haoxiang; Du, Juan; Wu, Shuo; Jin, Yinglan; Wang, Zhanqiu; Liu, Defeng; Shi, Qinglei; Wang, Xiaohan; Liu, Lanxiang			Evaluating the Therapeutic Effect of Low-Intensity Transcranial Ultrasound on Traumatic Brain Injury With Diffusion Kurtosis Imaging	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						traumatic brain injury; low-intensity transcranial ultrasound; diffusion kurtosis imaging	WHITE-MATTER; FOCUSED ULTRASOUND; PULSED ULTRASOUND; DYSFUNCTION; INTEGRITY; EPILEPSY; MODEL; LOBE	Background Low-intensity transcranial ultrasound (LITUS) has a therapeutic effect on traumatic brain injury (TBI). Diffusion kurtosis imaging (DKI) might be able to evaluate the effect changes of injured brain microstructure. Purpose To evaluate the therapeutic effect of LITUS in a moderate TBI rat model with DKI parameters. Study Type Prospective case-control animal study. Animal Model Forty-five rats were randomly divided into sham control, TBI, and LITUS treatment groups (n = 15). Field Strength/Sequence Single-shot spin echo echo-planar imaging and fast T2WI sequences at 3.0T. Assessment DKI parameters were obtained on days 1, 7, 14, 21, 28, 35, and 42 after TBI. Statistical Tests For the mean kurtosis (MK), axial kurtosis (Ka), and radial kurtosis (Kr) values, groups were compared using a two-way analysis of variance (ANOVA). Results LITUS inhibited TBI and caused MK values to increase significantly during the early stage (LITUS vs. TBI, day 7, adjusted P < 0.0001) and decrease during the late stage (LITUS vs. TBI, day 42, adjusted P = 0.0156) in the damaged cortex. In the thalamus, the MK value of the TBI group began to rise on day 7, with no change observed in the LITUS group. TBI increases Ka value during the early stage in the cortex and decreases during the late stage in the cortex and thalamus. LITUS inhibited these Ka changes (LITUS vs. TBI, day 7, adjusted P = 0.0014; LITUS vs. TBI, day 42, adjusted P = 0.0026 and 0.0478, respectively, for cortex and thalamus). The Kr value increased slightly during the early stage in the cortex (TBI vs. Sham, day 1, adjusted P = 0.0016). Data Conclusion The DKI parameter, particularly the MK value, evaluates primary cortical injury as well as the secondary brain injury that could not be detected by conventional T2WI. Technical Efficacy Stage: 4 J. Magn. Reson. Imaging 2020.	[Zheng, Tao; Du, Juan; Wu, Shuo; Wang, Zhanqiu; Liu, Defeng; Wang, Xiaohan; Liu, Lanxiang] Qinhuangdao Municipal 1 Hosp, Dept Magnet Resonance Imaging, 258 Wenhua Rd, Qinhuangdao 066000, Hebei, Peoples R China; [Yuan, Yi] Yanshan Univ, Inst Elect Engn, Qinhuangdao, Hebei, Peoples R China; [Yang, Haoxiang] Qinhuangdao Municipal 1 Hosp, Dept Cardiovasc Med, Qinhuangdao, Hebei, Peoples R China; [Jin, Yinglan] Peking Univ, Hlth Sci Ctr, Beijing, Peoples R China; [Shi, Qinglei] Siemens Ltd, Beijing, Peoples R China		Liu, LX (corresponding author), Qinhuangdao Municipal 1 Hosp, Dept Magnet Resonance Imaging, 258 Wenhua Rd, Qinhuangdao 066000, Hebei, Peoples R China.	liulanxiang66@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871029]	This research was supported by the National Natural Science Foundation of China (81871029).	Ai L, 2016, IEEE ENG MED BIO, P1758, DOI 10.1109/EMBC.2016.7591057; AXIOTIS CA, 1991, AM J PATHOL, V138, P799; Bystritsky A, 2011, BRAIN STIMUL, V4, P125, DOI 10.1016/j.brs.2011.03.007; Cheung JS, 2012, STROKE, V43, P2252, DOI 10.1161/STROKEAHA.112.661926; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Gao Y, 2012, NMR BIOMED, V25, P1369, DOI 10.1002/nbm.2809; Gatto R, 2015, RESTOR NEUROL NEUROS, V33, P927, DOI 10.3233/RNN-150577; Gatto RG, 2019, AMYOTROPH LAT SCL FR, V20, P549, DOI 10.1080/21678421.2019.1620285; Gatto RG, 2019, MAGN RESON MATER PHY, V32, P461, DOI 10.1007/s10334-019-00742-6; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hameroff S, 2013, BRAIN STIMUL, V6, P409, DOI 10.1016/j.brs.2012.05.002; Helpern JA, 2011, J MAGN RESON IMAGING, V33, P17, DOI 10.1002/jmri.22397; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Jordao JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010549; Legon W, 2014, NAT NEUROSCI, V17, P322, DOI 10.1038/nn.3620; Li WB, 2018, ANN CLIN TRANSL NEUR, V5, P552, DOI 10.1002/acn3.552; Liang YJ, 2016, COMMUN NONLINEAR SCI, V39, P529, DOI 10.1016/j.cnsns.2016.04.006; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Liu LX, 2020, MAGN RESON IMAGING, V67, P79, DOI 10.1016/j.mri.2019.06.013; Liu LX, 2019, BRAIN RES BULL, V146, P22, DOI 10.1016/j.brainresbull.2018.12.004; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Lu X, 2017, EXP THER MED, V13, P2247, DOI 10.3892/etm.2017.4283; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mukai S, 2005, ULTRASOUND MED BIOL, V31, P1713, DOI 10.1016/j.ultrasmedbio.2005.07.012; Munivenkatappa A, 2016, J NEUROSCI RURAL PRA, V7, pS76, DOI 10.4103/0976-3147.196468; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; Pan MX, 2018, CHIN J TRAUMATOL, V21, P224, DOI 10.1016/j.cjtee.2018.04.003; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Rogasch NC, 2017, NEUROIMAGE, V147, P934, DOI 10.1016/j.neuroimage.2016.10.031; Sasso V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0616-5; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shi RY, 2017, EUR RADIOL, V27, P4710, DOI 10.1007/s00330-017-4874-0; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Su WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15916-2; Su WS, 2017, BRAIN STIMUL, V10, P1032, DOI 10.1016/j.brs.2017.09.003; Su WS, 2015, ONCOTARGET, V6, P42290, DOI 10.18632/oncotarget.5978; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tsai SJ, 2016, MED SCI MONITOR, V22, P4026, DOI 10.12659/MSM.898041; Tsai SJ, 2015, MED HYPOTHESES, V84, P381, DOI 10.1016/j.mehy.2015.01.030; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yuan Y, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00562; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	47	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	AUG	2020	52	2					520	531		10.1002/jmri.27063		JAN 2020	12	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	ML4UW	WOS:000510055700001	31999388				2022-02-06	
J	Fouche, PF; Jennings, PA; Boyle, M; Bernard, S; Smith, K				Fouche, Pieter Francsois; Jennings, Paul Andrew; Boyle, Malcolm; Bernard, Stephen; Smith, Karen			The utility of the brain trauma evidence to inform paramedic rapid sequence intubation in out-of-hospital stroke	BMC EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Stroke; rapid sequence intubation; Paramedic	GENERAL-ANESTHESIA; SURVIVAL; INJURY	Background Rapid sequence intubation (RSI) is used to secure the airway of stroke patients. Randomized controlled trial evidence exists to support the use of paramedic RSI for traumatic brain injury (TBI), but cannot necessarily be applied to stroke RSI because of differences between the stroke and TBI patient. To understand if the TBI evidence can be used for stroke RSI, we analysed a retrospective cohort of TBI and strokes to compare how survival is impacted differently by RSI when comparing strokes and TBI. Methods This study was a retrospective analysis of 10 years of in-hospital and out-of-hospital data for all stroke and TBI patients attended by Ambulance Victoria, Australia. Logistic regression predicted the survival for ischemic and haemorrhagic strokes as well as TBI. The constituents of RSI, such a medications, intubation success and time intervals were analysed against survival using interactions to asses if RSI impacts survival differently for strokes compared to TBI. Results This analysis found significant interactions in the RSI-only group for age, number of intubation attempts, atropine, fentanyl, pulse rate and perhaps scene time and time- to-RSI. Such interactions imply that RSI impact survival differently for TBI versus strokes. Additionally, no significant difference in survival for TBI was found, with a - 0.7% lesser survival for RSI compared to no-RSI; OR 0.86 (95% CI 0.67 to 1.11; p = 0.25). Survival for haemorrhagic stroke was - 14.1% less for RSI versus no-RSI; OR 0.44 (95% CI 0.33 to 0.58; p = 0.01) and was - 4.3%; OR 0.67 (95% CI 0.49 to 0.91; p = 0.01) lesser for ischemic strokes. Conclusions Rapid sequence intubation and related factors interact with stroke and TBI, which suggests that RSI effects stroke survival in a different way from TBI. If RSI impact survival differently for strokes compared to TBI, then perhaps the TBI evidence cannot be used for stroke RSI.	[Fouche, Pieter Francsois; Smith, Karen] Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Melbourne, Vic, Australia; [Jennings, Paul Andrew] Ambulance Victoria, Doncaster, Australia; [Boyle, Malcolm] Griffith Univ, Sch Med, Gold Coast, Australia; [Bernard, Stephen; Smith, Karen] Ambulance Victoria, Res & Evaluat, Blackburn North, Australia; [Smith, Karen] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia		Fouche, PF (corresponding author), Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Melbourne, Vic, Australia.	Pieter.Fouche@monash.edu		Smith, Karen/0000-0002-9057-0685			Ambulance Victoria, 2016, CLIN PRACT GUID AMB, P2016; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; Fouche PF, 2019, EMERG MED AUSTRALAS, V31, P533, DOI 10.1111/1742-6723.13304; Fouche PF, 2019, EMERG MED J, V36, P416, DOI 10.1136/emermed-2019-208613; Fouche PF, 2017, PREHOSP EMERG CARE, V21, P700, DOI 10.1080/10903127.2017.1325952; Hosmer DW, 2013, WILEY SER PROBAB ST, P1; Jensen AG, 2010, ACTA ANAESTH SCAND, V54, P922, DOI 10.1111/j.1399-6576.2010.02277.x; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Lattanzi S, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.04; Lecky F, 2014, BRIT J ANAESTH, V113, P286, DOI 10.1093/bja/aeu242; Lee AH, 2003, MED J AUSTRALIA, V179, P289, DOI 10.5694/j.1326-5377.2003.tb05549.x; Mansour O, 2014, ACUTE ISCHEMIC STROK; Montgomery JM, 2018, AM J POLIT SCI, V62, P760, DOI 10.1111/ajps.12357; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Rothman KJ, 1998, MODERN EPIDEMIOLOGY; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Simonsen CZ, 2018, JAMA NEUROL, V75, P470, DOI 10.1001/jamaneurol.2017.4474; Sjoding MW, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0923-8; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5	21	2	2	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	JAN 28	2020	20	1							5	10.1186/s12873-020-0303-9			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KL7ZM	WOS:000513637100001	31992228	Green Published, gold			2022-02-06	
J	Gonzalez, MG; Brutus, RD; Garcia-Olloqui, A; Rosado, HGD; Alba, RB; Torres, IP				Genebat Gonzalez, Miguel; Dusseck Brutus, Reginald; Garcia-Olloqui, Angel; Garcia-Delgado Rosado, Horacio; Bellido Alba, Rafael; Perez Torres, Ignacio			Role of antiplatelet therapy in the development of intracranial bleeding after mild traumatic brain injury	MEDICINA CLINICA			Spanish	Article						Brain injury; Intracranial bleeding; Antiplatelet therapy	HEAD-INJURY; RISK	Introduction and objective: The use of antiplatelet agents is increasing, mainly in elderly patients in whom cranial trauma is a frequent reason for consultation to the emergency department. In this context, discordances have been described regarding the increased risk of post-traumatic injury that involves taking antiplatelet drugs. Therefore, the objective of this present study was to analyse factors associated with intracranial bleeding after mild brain trauma. Patients and methods: A retrospective study was designed that included all patients who had consulted the emergency department during 2016 because of mild brain trauma (Glasgow coma scale 14-15) and excluded patients under anticoagulant therapy. A logistic regression analysis was performed to analyse the variables associated with intracranial bleeding. Results: 566 patients were included in the study. 18% of them were taking antiplatelet drugs. Tomography showed haemorrhagic intracranial damage in 16.1%. Factors associated with intracranial bleeding were: advanced age, Glasgow coma scale < 15, high-energy trauma and antiplatelet therapy. Discussion: Antiplatelet therapy emerges as a risk factor for intracranial bleeding after mild head trauma, in addition to other known factors. (C) 2019 Elsevier Espaila, S.L.U. All rights reserved.	[Genebat Gonzalez, Miguel; Garcia-Olloqui, Angel; Perez Torres, Ignacio] Hosp Univ Virgen del Rocio, Serv Urgencias, Seville, Spain; [Dusseck Brutus, Reginald; Garcia-Delgado Rosado, Horacio; Bellido Alba, Rafael] Hosp Univ Virgen del Rocio, Unidad Cuidados Intens, Seville, Spain		Gonzalez, MG (corresponding author), Hosp Univ Virgen del Rocio, Serv Urgencias, Seville, Spain.	mgenebat@yahoo.es					Arboix A, 2007, J NEUROL NEUROSUR PS, V78, P1392, DOI 10.1136/jnnp.2007.119776; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Fabbri A, 2010, J NEUROL NEUROSUR PS, V81, P1275, DOI 10.1136/jnnp.2009.197467; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vedin T, 2018, EUR J TRAUMA EMERG S, DOI [10.1007/500068-018-0941-8., DOI 10.1007/500068-018-0941-8]	10	2	2	0	0	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0025-7753	1578-8989		MED CLIN-BARCELONA	Med. Clin.	JAN 24	2020	154	2					52	54		10.1016/j.medcli.2019.01.011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4OI	WOS:000530842100003	30857793				2022-02-06	
J	Allain, P; Hamon, M; Saout, V; Verny, C; Dinomais, M; Besnard, J				Allain, Philippe; Hamon, Martin; Saout, Virginie; Verny, Christophe; Dinomais, Mickael; Besnard, Jeremy			Theory of Mind Impairments Highlighted With an Ecological Performance-Based Test Indicate Behavioral Executive Deficits in Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						theory of mind; ecological assessment; behavioral dysexecutive disorders; traumatic brain injury; mentalizing abilities	SOCIAL COGNITION; EMOTION RECOGNITION; PREFRONTAL LESIONS; IMPAIRED THEORY; ADULTS; ASSOCIATION; DISTURBANCE; CONSTRUCTS; DISORDERS; OUTCOMES	Background: In view of the recent literature, the negative impact of traumatic brain injury (TBI) on social cognition remains a debated issue. On one hand, a considerable number of studies reported significant impairments in emotion recognition, empathy, moral reasoning, social problem solving, and mentalizing or theory of mind (ToM) abilities in patients with TBI. On the other hand, the ecological validity of social cognition tasks is still a matter of concern and debate for clinicians and researchers. Objectives: The objectives of the present study were 2-fold: (1) to assess social cognition in TBI with an ecological performance-based test which focuses on ToM ability, and (2) to study the relationship between performances on this task and behavioral disorders. To this end, 47 patients with moderate to severe TBI in the chronic stage were assessed with a ToM task, the Movie for the Assessment of Social Cognition (MASC), a film displaying social interactions in natural settings and asking for an evaluation of the emotions, thoughts, and intentions of the characters. Behavioral disorders were assessed with the Behavioral Dysexecutive Syndrome Inventory (BDSI), a structured interview of an informant in assessing changes compared with previous behavior in 12 domains. Results: Patients were significantly less accurate in mental state attribution than a demographically matched group of 38 healthy control subjects. Significant others of patients also reported more behavioral executive problems than controls' relatives on most of the domains of the BDSI. In addition, social cognition performance in the MASC was significantly correlated with behavioral dysexecutive problems rated by proxies on the BDSI. Conclusions: This study is the first to find association between impairments in mentalizing abilities in the MASC and behavioral impairments in patients with TBI, confirming the added value of this ecological task and that the recognition of social signals is a key element for adequate behavioral functioning.	[Allain, Philippe; Hamon, Martin; Besnard, Jeremy] Univ Angers, Lab Psychol Pays Loire, EA 4638, Angers, France; [Allain, Philippe; Verny, Christophe] Angers Univ Hosp, Dept Neurol, Angers, France; [Saout, Virginie] Arceau Anjou, Angers, France; [Dinomais, Mickael] Angers Univ Hosp, Dept Phys & Rehabil Med, Angers, France		Allain, P (corresponding author), Univ Angers, Lab Psychol Pays Loire, EA 4638, Angers, France.; Allain, P (corresponding author), Angers Univ Hosp, Dept Neurol, Angers, France.	philippe.allain@univ-angers.fr			University Hospital of Angers; International Foundation of Applied Disability Research (FIRAH)	This study was funded by a grant from the University Hospital of Angers and from the International Foundation of Applied Disability Research (FIRAH).	Achim AM, 2013, PSYCHOL ASSESSMENT, V25, P117, DOI 10.1037/a0029137; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Allain P, 2019, BRAIN INJURY, V33, P1, DOI 10.1080/02699052.2018.1533143; Allain P, 2011, NEUROPSYCHOLOGY, V25, P741, DOI 10.1037/a0024408; Azouvi P, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000169; Besnard J, 2018, NEUROPSYCHOL REHABIL, V28, P919, DOI 10.1080/09602011.2016.1209420; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bourseau T, 2019, J HEAD TRAUMA REHAB, V34, pE51, DOI 10.1097/HTR.0000000000000452; BROTHERS L, 1992, J COGNITIVE NEUROSCI, V4, P107, DOI 10.1162/jocn.1992.4.2.107; Buhlmann U, 2015, J ANXIETY DISORD, V34, P107, DOI 10.1016/j.janxdis.2015.06.003; Burgess P, 1996, BEHAV ASSESSMENT DYS; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Champagne-Lavau Maud, 2009, Cogn Neuropsychiatry, V14, P217, DOI 10.1080/13546800903004114; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan PW, 1997, PSYCHIATRY, V60, P309, DOI 10.1080/00332747.1997.11024809; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Dvash J, 2014, TOP LANG DISORD, V34, P282, DOI 10.1097/TLD.0000000000000040; Dziobek I, 2006, J AUTISM DEV DISORD, V36, P623, DOI 10.1007/s10803-006-0107-0; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Fretland RA, 2015, SCHIZOPHR RES, V162, P42, DOI 10.1016/j.schres.2015.01.024; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Guevara AB, 2016, J HEAD TRAUMA REHAB, V31, pE48, DOI 10.1097/HTR.0000000000000151; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Ivarsson A, 2013, PSYCHOL SPORT EXERC, V14, P97, DOI 10.1016/j.psychsport.2012.07.007; Kelly M, 2017, BRAIN IMPAIR, V18, P11, DOI 10.1017/BrImp.2016.34; Kilford EJ, 2016, NEUROSCI BIOBEHAV R, V70, P106, DOI 10.1016/j.neubiorev.2016.08.016; Kraemer M, 2013, CLIN NEUROL NEUROSUR, V115, P1016, DOI 10.1016/j.clineuro.2012.10.027; Laillier R, 2019, BRAIN COGNITION, V136, DOI 10.1016/j.bandc.2019.103588; Lecce S, 2019, AGING NEUROPSYCHOL C, V26, P541, DOI 10.1080/13825585.2018.1500996; Martinez G, 2017, SCHIZOPHR RES, V185, P161, DOI 10.1016/j.schres.2017.01.012; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Milders M, 2019, BRAIN INJURY, V33, P62, DOI 10.1080/02699052.2018.1531301; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Narme P, 2017, AGING NEUROPSYCHOL C, V24, P80, DOI 10.1080/13825585.2016.1171291; Narme P, 2013, NEUROPSYCHOLOGY, V27, P182, DOI 10.1037/a0031522; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; Njomboro P, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-18; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Perri R, 2018, NEUROPSYCHOLOGIA, V118, P12, DOI 10.1016/j.neuropsychologia.2018.01.039; Pottgen J, 2013, J NEUROL NEUROSUR PS, V84, P523, DOI 10.1136/jnnp-2012-304157; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Santangelo G, 2012, MOVEMENT DISORD, V27, P98, DOI 10.1002/mds.23949; Schilbach L, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00278; Sharp C, 2011, J AM ACAD CHILD PSY, V50, P563, DOI 10.1016/j.jaac.2011.01.017; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Turkstra LS, 2018, NEUROPSYCHOLOGIA, V111, P117, DOI 10.1016/j.neuropsychologia.2018.01.016; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; Urbach Mathieu, 2013, Front Psychiatry, V4, P30, DOI 10.3389/fpsyt.2013.00030; van der Hulst EJ, 2015, J NEUROL NEUROSUR PS, V86, P1208, DOI 10.1136/jnnp-2014-309290; Wolkenstein L, 2011, J AFFECT DISORDERS, V132, P104, DOI 10.1016/j.jad.2011.02.010	69	2	2	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 22	2020	10								1367	10.3389/fneur.2019.01367			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KI5BE	WOS:000511363900001	32038455	Green Published, gold			2022-02-06	
J	Miles, DK; Ponisio, MR; Colvin, R; Limbrick, D; Greenberg, JK; Brancato, C; Leonard, JR; Pineda, JA				Miles, Darryl K.; Ponisio, Maria R.; Colvin, Ryan; Limbrick, David; Greenberg, Jacob K.; Brancato, Celeste; Leonard, Jeffrey R.; Pineda, Jose A.			Predictors of intracranial hypertension in children undergoing ICP monitoring after severe traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Pediatric; Intracranial hypertension; CT imaging	PRESSURE; OUTCOMES; MORTALITY	Purpose Intracranial hypertension (ICH) is a common and treatable complication after severe traumatic brain injury (sTBI) in children. Describing the incidence and risk factors for developing ICH after sTBI could impact clinical practice. Methods Retrospective cohort study from 2006 to 2015 at two university-affiliated level I pediatric trauma centers of children admitted with accidental or abusive TBI, a post-resuscitation Glasgow Coma Score (GCS) of 8 or less, and an invasive intracranial pressure (ICP) monitor. Bivariate and multivariable logistic regression analysis were performed to identify demographic, injury, and imaging characteristics in patients who received ICP directed therapies for ICH (ICP > 20 mmHg). Results Eight to 5% (271/321) of monitored patients received ICP directed therapy for ICH during their PICU stay. Ninety-seven percent of patients had an abnormality on CT scan by either the Marshall or the Rotterdam score. Of the analyzed clinical and radiologic variables, only presence of hypoxia prior to PICU arrival, female sex, and a higher Injury Severity Score (ISS) were associated with increased risk of ICH (p < 0.05). Conclusions In this retrospective study of clinical practice of ICP monitoring in children after sTBI, the vast majority of children had an abnormal CT scan and experienced ICH requiring clinical intervention. Commonly measured clinical variables and radiologic classification scores did not significantly add to the prediction for developing of ICH and further efforts are needed to define low-risk populations that would not develop ICH.	[Miles, Darryl K.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Crit Care, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Ponisio, Maria R.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Colvin, Ryan; Brancato, Celeste; Pineda, Jose A.] Washington Univ, Sch Med, Dept Pediat, Div Crit Care Med, St Louis, MO 63110 USA; [Limbrick, David; Greenberg, Jacob K.; Leonard, Jeffrey R.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO USA		Miles, DK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Crit Care, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	darryl.miles@utsouthwestern.edu		Miles, Darryl/0000-0001-7855-5741	St. Louis Children's Hospital Foundation; Sean Glanvill Foundation; Robert Wood Johnson Foundation Harold Amos Medical Faculty Development ProgramRobert Wood Johnson Foundation (RWJF); Perot Brain and Nerve Injury Center	This study was supported by the St. Louis Children's Hospital Foundation, the Sean Glanvill Foundation, the Robert Wood Johnson Foundation Harold Amos Medical Faculty Development Program (JAP), and The Perot Brain and Nerve Injury Center (DKM).	Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alemayehu D, 2012, ACAD RADIOL, V19, P1457, DOI 10.1016/j.acra.2012.09.006; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Bailey BM, 2012, J TRAUMA ACUTE CARE, V72, P263, DOI 10.1097/TA.0b013e31822a9512; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Figaji AA, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E4; Forsyth RJ, 2008, PEDIATR CRIT CARE ME, V9, P8, DOI 10.1097/01.PCC.0000298759.78616.3A; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P280, DOI 10.1097/PCC.0000000000001736; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lemeshow S, 2000, APPL LOGISTIC REGRES; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Murphy S, 2017, J NEUROTRAUMA; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Roumeliotis N, 2015, CHILD NERV SYST, V31, P2011, DOI 10.1007/s00381-015-2837-9; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Slovis JC, 2018, PEDIATR CRIT CARE ME, V19, P353, DOI 10.1097/PCC.0000000000001490; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Tasker RC, 2014, SEMIN PEDIATR NEUROL, V21, P255, DOI 10.1016/j.spen.2014.10.004; Tasker RC, 2013, SEMIN PEDIATR SURG, V22, P168, DOI 10.1053/j.sempedsurg.2013.10.003; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	32	2	3	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2020	36	7					1453	1460		10.1007/s00381-020-04516-7		JAN 2020	8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	LY8TW	WOS:000508704600002	31970473				2022-02-06	
J	Humphries, TJ; Ingram, S; Sinha, S; Lecky, F; Dawson, J; Singh, R				Humphries, Thomas Jackson; Ingram, Sarah; Sinha, Saurabh; Lecky, Fiona; Dawson, Jeremy; Singh, Rajiv			The effect of socioeconomic deprivation on 12 month Traumatic Brain Injury (TBI) outcome	BRAIN INJURY			English	Article						Traumatic brain injury; global outcome; social deprivation; socio-economic status	HEAD-INJURY; EPIDEMIOLOGY; PREVALENCE; MORTALITY; CHILDREN; RECOVERY; IMPACT; COHORT; SCALE; INDEX	Objectives: To assess the impact of social deprivation on Traumatic Brain Injury (TBI) global outcome. Design: The study was a prospective observational study conducted using consecutive admissions with TBI. Subjects: 1322 consecutive adult patients with TBI were recruited into the study between 2010 and 2015. Methods: All patients were assessed by the TBI rehabilitation team at both six weeks and 12 months following TBI. Details of the injury and demographic data was collated at six weeks. This included age, gender and ZIP Code. Social deprivation was measured by the Indices of Multiple Deprivation (IMD) Score. The outcome measure used was the Extended Glasgow Outcome Score (GOSE) at 12 months. Univariate analysis was followed by a Multi-Ordinal Regression to evaluate predictor variables. Results: With regard to the representation of IMD deciles, the study population approximated to the general Sheffield population (p = .139). Within the univariate analysis, statistically significant relationships were noted between IMD and GOSE (p = <.001). The Ordinal Regression revealed a significant relationship between worse GOSE and IMD (p = .002), age (p = .001), GCS (p < .001), alcohol intoxication (p < .001) and Medical Comorbidity (p = .041). Conclusion: Increasing social deprivation is associated with poorer global TBI outcomes at 12 months.	[Humphries, Thomas Jackson; Ingram, Sarah] Univ Sheffield, Sheffield Inst Translat Neurosci Sitran, Sheffield, S Yorkshire, England; [Humphries, Thomas Jackson; Ingram, Sarah] Univ Sheffield, Med Sch, Sheffield, S Yorkshire, England; [Humphries, Thomas Jackson; Sinha, Saurabh] Sheffield Teaching Hosp, Dept Neurosurg, Sheffield, S Yorkshire, England; [Lecky, Fiona; Dawson, Jeremy; Singh, Rajiv] Univ Sheffield, Fac Med Dent & Hlth, Sch Hlth & Related Res Scharr, Hlth Serv Res, Sheffield, S Yorkshire, England; [Singh, Rajiv] Sheffield Teaching Hosp, Osborn Neurorehabil Unit, Dept Rehabil Med, Sheffield, S Yorkshire, England		Humphries, TJ (corresponding author), Univ Sheffield, Sheffield Inst Translat Neurosci Sitran, Sheffield, S Yorkshire, England.	thomas.j.humphries@doctors.org.uk		Humphries, Thomas/0000-0002-7165-6109; Sinha, Saurabh/0000-0001-7453-9576			Abel GA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012750; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Chaix B, 2007, EPIDEMIOLOGY, V18, P104, DOI 10.1097/01.ede.0000249573.22856.9a; De Guise E, 2009, BRAIN INJURY, V23, P853, DOI 10.1080/02699050903283221; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Deas I, 2003, ENVIRON PLANN C, V21, P883, DOI 10.1068/c0240; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Dunn L, 2003, J NEUROL NEUROSUR PS, V74, P1060, DOI 10.1136/jnnp.74.8.1060; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley C, 2013, INJURY, V44, P1855, DOI 10.1016/j.injury.2013.07.021; Hudon C, 2005, J CLIN EPIDEMIOL, V58, P603, DOI 10.1016/j.jclinepi.2004.10.017; Kingdom (UK), 2016, TOWNS CIT AN; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Niggebrugge A, 2005, SOC SCI MED, V60, P2743, DOI 10.1016/j.socscimed.2004.11.026; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Singh R, 2018, BRAIN INJURY, V32, P1122, DOI 10.1080/02699052.2018.1483028; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Spitz G, 2016, J NEUROL NEUROSUR PS, V87, P173, DOI 10.1136/jnnp-2014-309479; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	39	2	2	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2020	34	3					343	349		10.1080/02699052.2020.1715481		JAN 2020	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8UO	WOS:000507816200001	31951751	Green Accepted			2022-02-06	
J	Lubrini, G; Viejo-Sobera, R; Perianez, JA; Cicuendez, M; Castano, AM; Gonzalez-Marques, J; Lagares, A; Rios-Lago, M				Lubrini, Genny; Viejo-Sobera, Raquel; Perianez, Jose A.; Cicuendez, Marta; Castano, Ana M.; Gonzalez-Marques, Javier; Lagares, Alfonso; Rios-Lago, Marcos			Evolution of cognitive impairment after a traumatic brain injury: is there improvement after controlling the practice effect?	REVISTA DE NEUROLOGIA			English	Article						Cognitive performance; Evolution; Longitudinal design; Practice; Recovery; Traumatic brain injury	RECOVERY; MODERATE; PERFORMANCE; METAANALYSES	Introduction. The importance of knowing the pattern of evolution of cognitive deficits in the first months after a traumatic brain injury (TBI) has encouraged the development of numerous longitudinal studies. However, the results of most of them should be taken with caution due to the lack of adequate control of practice effects that can lead to overestimating the genuine recovery of cognitive processes. Aim. To describe the cognitive changes between the acute and subacute phases of the TBI controlling the effect of the practice. Patients and methods. Twenty-two patients were assessed in two different time points after TBI (immediately and after six months) using the following tests: Trail Making Test (A, B, B/A, B-A), Stroop Test (W, C, CW, interference), Digit Symbol-Coding, Symbol Search, Digits Forward and Backward, Verbal Fluency and Short-term Memory. To control for the practice effects, a transformation of the scores was performed applying the procedure proposed by Calamia et al. Results. Before controlling the practice effects, the scores of all tests improved (p > 0.001). However, afterward, the improvement remained only in the Trail Making Test-B, B/A and B-A, Digit Symbol-Coding, Symbol Search, Stroop CW and Digits Backward. Conclusions. The lack of control of practice effects in longitudinal studies can generate misleading interpretations about the evolution of cognitive deficits. The pattern of recovery after a TBI varies depending on the cognitive process.	[Lubrini, Genny] Univ Francisco Vitoria, Fac Educ & Psychol, Madrid, Spain; [Viejo-Sobera, Raquel] Univ Oberta Catalunya, Fac Hlth Sci, Cognit NeuroLab, Barcelona, Spain; [Perianez, Jose A.; Gonzalez-Marques, Javier] Univ Complutense Madrid, Dept Expt Psychol, Madrid, Spain; [Cicuendez, Marta] Hosp Univ Vall dHebron, Neurosurg Serv, Barcelona, Spain; [Castano, Ana M.; Lagares, Alfonso; Rios-Lago, Marcos] Hosp Univ 12 Octubre, Neurosurg Serv, Madrid, Spain; [Rios-Lago, Marcos] Univ Nacl Educ Distancia, Dept Basic Psychol 2, Juan del Rosal 10, E-28040 Madrid, Spain; [Rios-Lago, Marcos] Hosp Beata Maria Ana, Brain Injury Unit, Madrid, Spain		Rios-Lago, M (corresponding author), Univ Nacl Educ Distancia, Dept Basic Psychol 2, Juan del Rosal 10, E-28040 Madrid, Spain.	mrios@psi.uned.es	Rios-Lago, Marcos/P-6930-2019; Viejo-Sobera, Raquel/E-8728-2018; Rios-Lago, Marcos/C-9568-2012; Lubrini, Genny/AAP-2155-2021; Lagares, Alfonso/B-2969-2011; Perianez, Jose Antonio/AAI-3988-2021; Castano-Leon, Ana M/ABF-6322-2020	Rios-Lago, Marcos/0000-0003-0187-5047; Viejo-Sobera, Raquel/0000-0003-4672-1906; Rios-Lago, Marcos/0000-0003-0187-5047; Lagares, Alfonso/0000-0003-3996-0554; Perianez, Jose Antonio/0000-0003-4310-4021; Castano-Leon, Ana M/0000-0002-7918-5049			Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; BROOKS DN, 1987, NEUROBEHAVIORAL RECO, P57; Calamia M, 2013, CLIN NEUROPSYCHOL, V27, P1077, DOI 10.1080/13854046.2013.809795; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Griffen J., 2014, HDB NEUROPSYCHOLOGY, P25; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Jurado MA, 2000, BRAIN INJURY, V14, P789; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; Lezak MD, 2012, NEURO PSYCHOL ASSESS; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Novack TA, 2000, BRAIN INJURY, V14, P987; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schultz R, 2013, BRAIN IMPAIR, V14, P450, DOI 10.1017/BrImp.2013.24; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Van der Elst W, 2008, J INT NEUROPSYCH SOC, V14, P71, DOI 10.1017/S1355617708080028; Wechsler D., 1999, WAIS 3 ESCALA INTELI; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053	27	2	2	0	4	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JAN 16	2020	70	2					37	44		10.33588/rn.7002.2019233			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KS5XH	WOS:000518381100001	31930469	Green Submitted			2022-02-06	
J	Gonzalez, L; Jones, LE; Fakeh, M; Shah, N; Panchella, JA; Shendell, DG				Gonzalez, Lauren; Jones, Laura E.; Fakeh, Maryanne; Shah, Nimit; Panchella, Joseph A.; Shendell, Derek G.			Incidence reporting via online high school concussion surveillance by certified athletic trainers and school nurses, 2015-2018	INJURY EPIDEMIOLOGY			English	Article						Adolescent health; Athletic trainer; Brain injuries; Concussions; Epidemiology; Incidence; New Jersey; School nurse; Surveillance; Symptoms	SPORT-RELATED CONCUSSION; POSTCONCUSSION SYMPTOMS; UNITED-STATES; SERVICES	BackgroundThere is an increasing concern over adolescent concussions in sports due to risks of long-term negative effects. This study analyzed data over three school years on reported concussion incidence rates by season, high school grade levels and gender, and reported symptoms by school nurses versus athletic trainers, from New Jersey student-athlete concussion data available from an online school-based surveillance system.MethodsSchool nurses and athletic trainers reported 300 concussions within five days from when each occurred over three school years, 2015-2018, in team sports and physical education in New Jersey high schools. Analysis was further conducted on symptoms and number of symptoms reported by school nurses versus school athletic trainers for each documented student-athlete concussion. Estimated concussion incidence rates were calculated using state agency verified school enrollment data.FindingsConcussions most commonly occurred during fall, followed by spring, then winter. Concussion incidence rates ranged from 6.3/1000 (4.99, 7.55) - 9.1/1000 (7.27, 10.98) students over the three school years of the study. Athletic trainers completed 86% of the reports while nurses completed 11% (position or title of 3%, or n=7, were not disclosed); the values were similar when considering only fall pre-season and regular season sports (88, 10, 2%, respectively). On average, across the three school years, athletic trainers reported about 3.5 symptoms per report while nurses reported 2.7 (values in fall seasons only were 3.7 and 3.1, respectively.)ConclusionsCertified athletic trainers, compared to school nurses, more often completed concussion report forms and reported more symptoms per injured student, perhaps due partly to closer contact and immediate care provided after injury. Additionally, this study had a higher concussion incidence rate during fall sports seasons compared to winter and spring. Future research can further improve our understanding of concussions among adolescent student-athletes to better inform concussion identification, management and recovery protocols.	[Gonzalez, Lauren; Jones, Laura E.; Fakeh, Maryanne; Shah, Nimit; Shendell, Derek G.] Rutgers Sch Publ Hlth, New Jersey Safe Sch Program, 683 Hoes Lane West,3rd Floor SPH Bldg,Suite 399, Piscataway, NJ 08854 USA; [Jones, Laura E.; Shah, Nimit] Rutgers Sch Publ Hlth, Dept Biostat & Epidemiol, 683 Hoes Lane West, Piscataway, NJ 08854 USA; [Jones, Laura E.] Rutgers Sch Publ Hlth, Dept Urban Global Publ Hlth, One Riverfront Plaza,Suite 1020, Newark, NJ 07102 USA; [Panchella, Joseph A.] West Deptford High Sch Athlet Dept, 1600 Old Crown Point Rd, W Deptford, NJ 08093 USA; [Shendell, Derek G.] Rutgers Sch Publ Hlth, Dept Environm & Occupat Hlth, 683 Hoes Lane West, Piscataway, NJ 08854 USA; [Shendell, Derek G.] Rutgers State Univ, Environm & Occupat Hlth Sci Inst, 170 Freylinghuysen Rd, Piscataway, NJ 08854 USA; [Shendell, Derek G.] Brain Injury Alliance NJ Concuss Youth Sports Com, 825 Georges Rd, North Brunswick, NJ 08902 USA		Shendell, DG (corresponding author), Rutgers Sch Publ Hlth, New Jersey Safe Sch Program, 683 Hoes Lane West,3rd Floor SPH Bldg,Suite 399, Piscataway, NJ 08854 USA.; Shendell, DG (corresponding author), Rutgers Sch Publ Hlth, Dept Environm & Occupat Hlth, 683 Hoes Lane West, Piscataway, NJ 08854 USA.; Shendell, DG (corresponding author), Rutgers State Univ, Environm & Occupat Hlth Sci Inst, 170 Freylinghuysen Rd, Piscataway, NJ 08854 USA.	shendedg@sph.rutgers.edu		Shah, Nimit/0000-0002-7540-8444	Kessler Foundation	This project was funded by Kessler Foundation, Special Projects Program mechanism, with two rounds of funding during 2014-2017 (final report submitted winter 2018).	Adams WM, 2019, ATHL TRAIN SPORTS HL, V11, P206; American College of Emergency Physicians, 2008, DEC MAK AD MILD TRAU; [Anonymous], 2019, CHEER SAFE GET FACTS; Bruce JM, 2004, NEUROLOGY, V63, P1516; Centers for Disease Control and Prevention (CDC), 2018, NAT CONC SURV SYST; Centers for Disease Control and Prevention (CDC), 2015, HEADS ONL TRAIN HEAL; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lau Brian C., 2011, J SPORTS MED, V39, P1209, DOI [10.1177/0363546510392016, DOI 10.1177/0363546510392016]; Long Ashley S., 2018, ATHL TRAIN SPORT HLT, V11, P28, DOI [10.3928/19425864-20180430-01, DOI 10.3928/19425864-20180430-01]; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; N.J.S.A, 18A40414 NJSA; NEVINS D, 2018, ATHLETIC TRAINING SP, V11, P174, DOI DOI 10.3928/19425864-20180802-02; New Jersey Department of Education, 2018, DOE DAT FALL SURV CO; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Patel DR, 2010, PEDIATR CLIN N AM, V57, P649, DOI 10.1016/j.pcl.2010.03.006; Pike A, 2016, J ATHL TRAINING, V51, P717, DOI 10.4085/1062-6050-51.11.04c; Pike AM, 2017, J ATHL TRAINING, V52, P5, DOI 10.4085/1062-6050-51.11.15; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Shendell DG, 2019, J SCHOOL HEALTH, V89, P527, DOI 10.1111/josh.12775; Shendell DG, 2018, INT J ATHL THER TRAI, V23, P162, DOI 10.1123/ijatt.2017-0083; Taylor KM, 2018, AM J SPORT MED, V46, P3262, DOI 10.1177/0363546518798801; UCA, 2019, AB UN CHEERL ASS; UT Southwestern Medical Center, 2018, UTSW LEADS GROUNDBR	31	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2197-1714		INJURY EPIDEMIOL	Inj. Epidemiol.	JAN 13	2020	7	1							1	10.1186/s40621-019-0228-5			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	TD5FI	WOS:000669352300001		Green Published, gold			2022-02-06	
J	Pluck, G; Barajas, BM; Hernandez-Rodriguez, JL; Martinez, MA				Pluck, Graham; Barajas, Brittany M.; Hernandez-Rodriguez, Jose L.; Martinez, Maria A.			Language ability and adult homelessnesset al.	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						homelessness; socio-economic status; poverty; aphasia; language; cognitive impairment	SOCIOECONOMIC POSITION; COGNITIVE FUNCTION; HOSPITAL ANXIETY; PERFORMANCE; MORTALITY; APHASIA	Background People experiencing homelessness are at increased risk of neurological disorder due to multiple factors such as substance abuse, infection, and higher rates of serious mental illness and traumatic brain injury. This could affect cognitive and language skills. Indeed, past research has suggested that certain language-related skills tend to be lower in people experiencing homelessness. However, that research has compared homeless samples with age-matched normative samples and not with samples of people from similar socio-economic backgrounds. Therefore, it is unclear whether homelessness is even a relevant factor, or if adults who are homeless tend to have appropriate linguistic skills relative to their social and educational background. Aims To compare the language skills of a group of adults with histories of homelessness with an education-matched control group. It was hypothesized that participants with histories of homelessness would have worse language performance than their matched controls. Methods & Procedures A quasi-experimental design was employed involving 17 adults with histories of homelessness, mainly rough sleeping, in the city of Quito in Ecuador, and a sample of 16 adults who had never been homeless. All were assessed with measures of head injury, substance dependence, affective disorder and language skills. A paired-sample analysis was performed on homeless and control participants matched for educational background, used as an index of socio-economic background. Outcomes & Results The mean years of formal education was low in both the homeless sample (mean = 5.82 years) and the control sample (mean = 6.75 years). There were no differences between the groups for any demographic or clinical factors, nor for a measure of expected or 'premorbid' ability based on single-word reading, nor for current non-verbal cognitive functioning. In contrast, the homeless group scored significantly worse than the control group on measures of auditory comprehension and oral expression. Conclusions & Implications Adults with histories of homelessness may have worse language skills than would be expected based on their educational backgrounds and non-verbal cognitive abilities. It is possible that some of this lower language ability is pathological, in the form of either a developmental language disorder or an acquired impairment. As such, some adults who are homeless may benefit from therapy directed at clinical language disorders.	[Pluck, Graham; Hernandez-Rodriguez, Jose L.; Martinez, Maria A.] Univ San Francisco Quito, Inst Neurosci, Cumbaya, Ecuador; [Barajas, Brittany M.] Univ Illinois, Coll Appl Hlth Sci, Urbana, IL USA		Pluck, G (corresponding author), Univ San Francisco Quito, Coll Social Sci & Humanities, Diego de Robles & Via Interocean, Cumbaya, Ecuador.	g.c.pluck@gmail.com	Pluck, Graham/C-6482-2008	Pluck, Graham/0000-0002-0368-0051	Undergraduate Research Support Grant from the University of Illinois at Urbana-Champaign	This research was supported by an Undergraduate Research Support Grant from the University of Illinois at Urbana-Champaign to the second author. The authors thank Sarahi Ponton and Gonzalo Villa Villalba for assistance with data collection.	Aldridge RW, 2018, LANCET, V391, P241, DOI 10.1016/S0140-6736(17)31869-X; Barwick MA, 1996, J RES ADOLESCENCE, V6, P649; BOYLE GJ, 1991, PERS INDIV DIFFER, V12, P291, DOI 10.1016/0191-8869(91)90115-R; Bramley G, 2018, HOUSING STUD, V33, P96, DOI 10.1080/02673037.2017.1344957; BRIGGS SR, 1986, J PERS, V54, P106, DOI 10.1111/j.1467-6494.1986.tb00391.x; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Clegg J, 2015, J CHILD PSYCHOL PSYC, V56, P67, DOI 10.1111/jcpp.12281; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conroy P, 2009, INT J LANG COMM DIS, V44, P1036, DOI [10.3109/13682820802585975, 10.1080/13682820802585975]; Conti-Ramsden G., 2017, CHILD PSYCHOL PSYCHI; Conti-Ramsden G, 2018, INT J LANG COMM DIS, V53, P237, DOI 10.1111/1460-6984.12338; CRAWFORD JR, 1987, BRIT J CLIN PSYCHOL, V26, P313, DOI 10.1111/j.2044-8260.1987.tb01366.x; CRAWFORD JR, 1988, BRIT J CLIN PSYCHOL, V27, P181, DOI 10.1111/j.2044-8260.1988.tb00770.x; Davidson D, 2014, COMMUNITY MENT HLT J, V50, P548, DOI 10.1007/s10597-013-9664-9; DelSer T, 1997, BRAIN COGNITION, V33, P343, DOI 10.1006/brcg.1997.0877; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Glahn DC, 2006, J AFFECT DISORDERS, V92, P309, DOI 10.1016/j.jad.2006.01.025; Gonzalez-Saiz F, 1999, REV ESP DROGODEP, V24, P46; Goodglass H, 2001, TEST BOSTON DIAGNOST; Herrero MJ, 2003, GEN HOSP PSYCHIAT, V25, P277, DOI 10.1016/S0163-8343(03)00043-4; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Isen J, 2010, CLIN PSYCHOL REV, V30, P423, DOI 10.1016/j.cpr.2010.02.003; Katz R. C., 2001, LANGUAGE INTERVENTIO; Koegel P, 1995, AM J PUBLIC HEALTH, V85, P1642, DOI 10.2105/AJPH.85.12.1642; Kremen WS, 1996, NEUROPSYCHOLOGY, V10, P22, DOI 10.1037/0894-4105.10.1.22; Macchi L, 2019, J COMMUN DISORD, V81, DOI 10.1016/j.jcomdis.2019.05.002; McMillan TM, 2015, J NEUROTRAUM, V32, P116, DOI 10.1089/neu.2014.3387; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; O'Neil-Pirozzi TM, 2003, AM J SPEECH-LANG PAT, V12, P229, DOI 10.1044/1058-0360(2003/069); OCARROLL RE, 1987, BRIT J CLIN PSYCHOL, V26, P315, DOI 10.1111/j.2044-8260.1987.tb01367.x; Pluck G, 2015, East Asian Arch Psychiatry, V25, P122; Pluck G., 2017, REV ECUAT NEUROL, V26, P226; Pluck G., 2019, COGNITION BRAIN BEHA, V22, P175, DOI [10.24193/cbb.2018.22.12, DOI 10.24193/CBB.2018.22.12]; Pluck G, 2007, CAN MED ASSOC J, V176, P489, DOI 10.1503/cmaj.1060229; Pluck G, 2012, CAN J BEHAV SCI, V44, P9, DOI 10.1037/a0025382; Pluck G, 2011, BRIT J CLIN PSYCHOL, V50, P33, DOI 10.1348/014466510X490253; RAISTRICK D, 1994, ADDICTION, V89, P563, DOI 10.1111/j.1360-0443.1994.tb03332.x; ROSSELLI M, 1990, J CLIN EXP NEUROPSYC, V12, P313, DOI 10.1080/01688639008400977; Schretlen DJ, 2005, J INT NEUROPSYCH SOC, V11, P784, DOI 10.1017/S1355617705050939; Snowling MJ, 2019, CHILD DEV, V90, pE548, DOI 10.1111/cdev.13216; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Turrell G, 2002, J GERONTOL B-PSYCHOL, V57, pS43, DOI 10.1093/geronb/57.1.S43; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	MAY	2020	55	3					332	344		10.1111/1460-6984.12521		JAN 2020	13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	LH6VO	WOS:000506526300001	31925870				2022-02-06	
J	Cao, JH; Duan, YH; Liu, YZ; Liu, HX; Wei, CH; Wang, J; Qin, XM; Wang, XW; Li, ZY				Cao, Jianhua; Duan, Yahui; Liu, Yanzhi; Liu, Haixia; Wei, Chunhong; Wang, Jiang; Qin, Xuemei; Wang, Xuwen; Li, Zhenyu			Metabolomics coupled with SystemsDock reveal the protective effect and the potential active components of Naozhenning granule against traumatic brain injury	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Naozhenning granule; Cerebral concussion; Metabolomics; Molecular docking	OXIDATIVE STRESS; METABONOMICS; CONSTITUENTS; MECHANISM; MODEL; RADIX; TANG; MAZE	Ethnopharmacological relevance: Naozhenning granule (NZN), a widely traditional Chinese medicine (TCM) prescription with a long history of clinical, which is mainly used in the treatment of concussion, cerebral post-traumatic syndrome, consists of Di Huang (Radix of Rehmannia glutinosa (Gaertn.) DC.), Dang Gui (Radix of Angelica sinensis (Olio.) Diels), Chen Pi (Pericarpium of Citrus reticulata Blanco), Dan shen (Radix of Salvia Miltiorrhiza Bunge.), Di Long (Pheretima aspergillum (E. Perrier)), Mu Dan Pi (Cortex of Paeonia suffruticosa Andrews), Suan Zao Ren (Semen of Ziziphus jujuba Mill.), Chuan Xiong (Rhizoma of Ligusticum striatum DC.), Zhu Ru (Phyllostachys nigra (Lodd. Ex Lindl.) Munro), Bai Zi Ren (Semen of Platycladus orientalis (L.) Franco) and Fu Ling (sclerotium of Poria cocos (Schw.)Wolf). Aim of the study: This study aimed to unravel the mechanism and material basis of NZN against traumatic brain injury. Materials and methods: In this study, a H-1 nuclear magnetic resonance (NMR) based metabolomic approach combined with systemsDock was employed to study the protective effect of NZN against traumatic brain injury using a cerebral concussion rat model. The morris water maze test and biochemical indexes were used to evaluate the efficacy of NZN. Results: The results of morris water maze test suggested NZN can improve the spatial learning and memory of model rats, and the superoxide dismutas (SOD) and malonyldialdehyde (MDA) level indicated that the effect of NZN was related with the regulation of oxidative stress. Multivariate analysis revealed that the effect of NZN was related with regulation of 18 brain metabolites, and the corresponding metabolic pathways were further revealed by MetPA analysis. 13 serum absorbed components were found to hit the targets both related with the metabolic regulation and cerebral trauma through systemsDock-aided molecular docking experiments, and these compounds might be served as the active compounds in NZN against cerebral trauma. Conclusion: H-1-NMR based metabolomics and molecular docking provided the insights for the synergistic mechanisms and the potential active compounds of NZN in treating cerebral trauma. However, the bioactive compounds and their synergistic effect need to be further validated.	[Cao, Jianhua; Duan, Yahui; Qin, Xuemei; Li, Zhenyu] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan 030006, Shanxi, Peoples R China; [Cao, Jianhua; Duan, Yahui] Shanxi Univ, Coll Chem & Chem Engn, Taiyuan 030006, Shanxi, Peoples R China; [Liu, Yanzhi; Liu, Haixia; Wei, Chunhong; Wang, Jiang; Wang, Xuwen] Shanxi Zhendong Ante Biol Pharmaceut Co Ltd, Jinzhong 030600, Peoples R China		Li, ZY (corresponding author), Shanxi Univ, Modern Res Ctr Tradit Chinese Med, Taiyuan 030006, Shanxi, Peoples R China.; Wang, XW (corresponding author), Shanxi Zhendong Ante Biol Pharmaceut Co Ltd, Jinzhong 030600, Peoples R China.	wangxuwen@zdjt.com; lizhenyu@sxu.edu.cn			Program of Science and Technology of Shanxi Province [201603D3113003, 2106ZD0404]; Key Laboratory of Effective Substances Research and Utilization in TCM of Shanxi Province [201605D111004]; Science and technology innovation team of Shanxi Province [201605D131045-18]	This study was financially supported by the Program of Science and Technology of Shanxi Province (No. 201603D3113003, 2106ZD0404), Key Laboratory of Effective Substances Research and Utilization in TCM of Shanxi Province (201605D111004), and Science and technology innovation team of Shanxi Province (201605D131045-18). We also thank Scientific Instrument Center of Shanxi University for the NMR analysis.	Bibak B, 2019, BIOMED PHARMACOTHER, V111, P485, DOI 10.1016/j.biopha.2018.12.082; Cole PL, 2014, SOC WORK, V59, P261, DOI 10.1093/sw/swu015; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; El Idrissi A, 2008, AMINO ACIDS, V34, P321, DOI 10.1007/s00726-006-0396-9; Gao SY, 2015, J ETHNOPHARMACOL, V166, P323, DOI 10.1016/j.jep.2015.03.025; Gotz JM, 1997, GUT, V40, P591, DOI 10.1136/gut.40.5.591; Han L, 2018, INT IMMUNOPHARMACOL, V63, P43, DOI 10.1016/j.intimp.2018.06.045; Hsin KY, 2016, NUCLEIC ACIDS RES, V44, pW507, DOI 10.1093/nar/gkw335; Jia Y, 2017, CHIN J NAT MEDICINES, V15, P631, DOI [10.3724/SP.J.1009.2017.00631, 10.1016/S1875-5364(17)30091-2]; Jiao LJ, 2017, J AGR FOOD CHEM, V65, P4449, DOI 10.1021/acs.jafc.7b01486; Kim M, 2015, NEUROCHEM RES, V40, P1792, DOI 10.1007/s11064-015-1659-1; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Li SJ, 2015, J ETHNOPHARMACOL, V170, P175, DOI 10.1016/j.jep.2015.05.019; Li ZH, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/598412; [刘杰 Liu Jie], 2002, [军事医学科学院院刊, Bulletin of the Academy of Military Medical Sciences], V26, P182; Liu XJ, 2019, J ETHNOPHARMACOL, V235, P141, DOI 10.1016/j.jep.2019.01.018; Liu XW, 2018, J PHARMACEUT BIOMED, V159, P252, DOI 10.1016/j.jpba.2018.06.065; Liu YT, 2017, CHEMOMETR INTELL LAB, V164, P16, DOI 10.1016/j.chemolab.2017.03.005; Liu ZK, 2018, J ETHNOPHARMACOL, V217, P11, DOI 10.1016/j.jep.2018.02.004; Lu XY, 2015, CELL MOL NEUROBIOL, V35, P713, DOI 10.1007/s10571-015-0167-9; Luo L, 2016, J ETHNOPHARMACOL, V186, P257, DOI 10.1016/j.jep.2016.03.059; Mahesh R, 2012, PHYTOTHER RES, V26, P1211, DOI 10.1002/ptr.3705; McCann SK, 2013, BRAIN SCI, V3, P561, DOI 10.3390/brainsci3020561; Miyazaki I, 2019, CELLS, V221, P1; Nunez J, 2008, JOVE-J VIS EXP, P1; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wang X. J., 2017, CHIN J NEUROTRAUMA S, V3, P292; Wang XJ, 2012, ANAL CHEM, V84, P428, DOI 10.1021/ac202828r; Wei L, 2009, TOXICOL APPL PHARM, V234, P314, DOI 10.1016/j.taap.2008.11.010; Yang B, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1076-2; Yu Shu-ting, 2018, Yaoxue Xuebao, V53, P609, DOI 10.16438/j.0513-4870.2017-1190; Yu ST, 2019, J PHARMACEUT BIOMED, V166, P281, DOI 10.1016/j.jpba.2019.01.020; Zhang AH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/257909; Zhang LY, 2019, CHEMOSPHERE, V226, P817, DOI 10.1016/j.chemosphere.2019.04.007; Zhang M, 2018, NEUROCHEM RES, V43, P2435, DOI 10.1007/s11064-018-2671-z; Zhang MS, 1997, CHIN TRADIT PAT MED, V19, P33; Zhang WN, 2018, J PHARMACEUT BIOMED, V158, P128, DOI 10.1016/j.jpba.2018.05.045; Zhang ZZ, 2016, J PHARMACEUT BIOMED, V120, P1, DOI 10.1016/j.jpba.2015.12.001; Zheng XF, 2014, J ETHNOPHARMACOL, V151, P912, DOI 10.1016/j.jep.2013.12.001; Zhong YY, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8916938; Zhou Y, 2014, J NEURAL TRANSM, V121, P799, DOI 10.1007/s00702-014-1180-8	43	2	3	2	35	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741	1872-7573		J ETHNOPHARMACOL	J. Ethnopharmacol.	JAN 10	2020	246								112247	10.1016/j.jep.2019.112247			9	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	JI1FR	WOS:000493211800038	31542470				2022-02-06	
J	Eslami, M; Alizadeh, L; Morteza-Zadeh, P; Sayyah, M				Eslami, Mansoureh; Alizadeh, Leila; Morteza-Zadeh, Parastoo; Sayyah, Mohammad			The effect of Lipopolysaccharide (LPS) pretreatment on hippocampal apoptosis in traumatic rats	NEUROLOGICAL RESEARCH			English	Article						Controlled cortical injury; LPS preconditioning; Apoptosis; Caspase 3; Caspase7	KINDLING EPILEPTOGENESIS; BRAIN TRAUMA; ACTIVATION; SEIZURES; INJURY; NEUROPROTECTION; MICROGLIA	Objectives: Traumatic brain injury (TBI) is a serious medical problem that affects the quality of life. Apoptosis is a form of programmed cell death that happens after trauma. Effector caspases are responsible for initiating apoptosis. Methods: In the present study, we examined the effect of LPS preconditioning (0.1 and 0.5 mg/kg, ip; 5 days prior controlled cortical injury) on apoptosis, 4 and 12 hours after trauma. We investigated possible mechanisms on the expression of caspase3 and caspase7 in hippocampal CA1 and CA3 areas by using immunohistochemistry and Western blotting techniques and also TUNEL-positive cells. Results: Higher expression of caspase3 and caspase7 were accompanied by a higher number of dead neurons in traumatic rats 4 and 12 hours after trauma(P < 0.05). LPS preconditioning decreased caspase3 and caspase7over-expression and the number of dead neurons in the hippocampus(P < 0.05). Discussion: Our data indicate that LPS preconditioning inhibits neural damage and apoptosis induced by trauma in the hippocampus.	[Eslami, Mansoureh] Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Basic Sci, Tehran, Iran; [Alizadeh, Leila] Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Morteza-Zadeh, Parastoo] Kharazmi Univ, Fac Basic Sci, Dept Biol, Tehran, Iran; [Sayyah, Mohammad] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran		Eslami, M (corresponding author), Shahid Beheshti Univ Med Sci, Sch Allied Med Sci, Dept Basic Sci, Tehran, Iran.	eslami342@yahoo.com	alizadeh, leila/AAM-6213-2020		Shahid Beheshti University of Medical Sciences [8142]	This work was supported by the Shahid Beheshti University of Medical Sciences [8142].	Ahmadi A, 2013, EXP BRAIN RES, V226, P107, DOI 10.1007/s00221-013-3415-6; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Bingham D, 2011, BRAIN RES BULL, V85, P403, DOI 10.1016/j.brainresbull.2011.04.007; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Dmowska M, 2010, NEUROCHEM RES, V35, P262, DOI 10.1007/s11064-009-0050-5; Eslami M, 2016, NEUROL RES, V38, P269, DOI 10.1179/1743132815Y.0000000086; Eslami M, 2015, J NEUROIMMUNOL, V289, P143, DOI 10.1016/j.jneuroim.2015.11.003; Guo C, 2014, INFLAMMATION, V37, P621, DOI 10.1007/s10753-013-9778-9; Hayakawa K, 2014, J NEUROSCI RES, V92, P1647, DOI 10.1002/jnr.23448; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Jahan-Abad AJ, 2018, MOL NEUROBIOL, V55, P4225, DOI 10.1007/s12035-017-0642-z; Khodaie B, 2015, BEHAV BRAIN RES, V278, P55, DOI 10.1016/j.bbr.2014.09.034; Larochelle A, 2015, BRAIN BEHAV IMMUN, V46, P221, DOI 10.1016/j.bbi.2015.02.019; Li WC, 2014, INT J NEUROSCI, V124, P585, DOI 10.3109/00207454.2013.864289; Lin HY, 2009, PEDIATR RES, V66, P254, DOI 10.1203/PDR.0b013e3181b0d336; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Mirrione MM, 2010, NEUROBIOL DIS, V39, P85, DOI 10.1016/j.nbd.2010.04.001; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Sayyah M, 2003, EPILEPSY RES, V57, P175, DOI 10.1016/j.eplepsyres.2003.11.002; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Wang TH, 2017, MOL NEUROBIOL, V54, P7746, DOI 10.1007/s12035-016-0259-7; Yu JT, 2010, J NEUROL SCI, V296, P69, DOI 10.1016/j.jns.2010.06.004	26	2	2	2	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	FEB 1	2020	42	2					91	98		10.1080/01616412.2019.1709139		JAN 2020	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KH3QI	WOS:000506274700001	31914902				2022-02-06	
J	Juengst, SB; Nabasny, A; Terhorst, L				Juengst, Shannon B.; Nabasny, Andrew; Terhorst, Lauren			Cohort Differences in Neurobehavioral Symptoms in Chronic Mild to Severe Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; behavior; emotion; education; health disparities	ETHNIC DISPARITIES; CHALLENGING BEHAVIOR; OUTCOMES; REHABILITATION; DEPRESSION; PEOPLE; HEALTH; URBAN; TBI; RACE/ETHNICITY	Our understanding of neurobehavioral symptoms after traumatic brain injury (TBI) largely relies on data gathered in studies conducted at academic medical centers or large clinical centers with research infrastructure. Though this often provides a well-characterized clinical sample, it may also introduce bias based on geographic locations served by these institutions and personal factors associated with patient access to these institutions. We collected neurobehavioral symptoms via the self-reported Behavioral Assessment Screening Tool (BAST) in a National TBI Cohort (n = 263) and a Medical Center TBI Cohort (n = 218) of English-speaking community-dwelling adults with chronic TBI. The primary focus of the present study was to compare demographics and neurobehavioral symptom reporting across the two cohorts and to discuss the implications of any such differences on interpretation of symptom scores. Across all BAST subscales (Negative Affect, Fatigue, Executive Function, Impulsivity, and Substance Abuse), participants in the National TBI Cohort reported significantly more frequent symptoms than those in the Medical Center TBI Cohort (p's < 0.001). Participants in the National TBI Cohort were more likely to be non-White and Hispanic compared to the Medical Center TBI Cohort, and those with mild TBI in the National TBI Cohort were more likely to have less than a high school education than those with mild TBI in the Medical Center TBI Cohort. Individuals with TBI recruited through academic and clinical institutions may not be representative of individuals with TBI living across the United States.	[Juengst, Shannon B.; Nabasny, Andrew] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Terhorst, Lauren] Univ Pittsburgh, Dept Occupat Therapy, Pittsburgh, PA USA		Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA.	shannon.juengst@utsouthwestern.edu			National Institutes for Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD) [R03HD09445]; University of Pittsburgh Medical Center Rehabilitation Institute Pilot Grant Program [01140]; North Texas TBI Model Systems [90DPTB0013]; Texas Institute for Brain Injury and Repair as part of the Peter J. O'Donnell Brain Institute at The University of Texas Southwestern Medical Center	This work was funded in part by the National Institutes for Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD), Grant #: R03HD09445 (PI: Juengst); the University of Pittsburgh Medical Center Rehabilitation Institute Pilot Grant Program, Grant #: 01140 (PI: Juengst); the North Texas TBI Model Systems, Grant #: 90DPTB0013 (PI: Driver); and a grant from the Texas Institute for Brain Injury and Repair as part of the Peter J. O'Donnell Brain Institute at The University of Texas Southwestern Medical Center.	Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P814, DOI 10.3109/02699052.2012.655360; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P801, DOI 10.3109/02699052.2012.655368; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cruz-Flores S, 2011, STROKE, V42, P2091, DOI 10.1161/STR.0b013e3182213e24; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Desai A, 2012, J NEUROSURG, V117, P599, DOI 10.3171/2012.6.JNS111281; Diamantopoulou S, 2007, DEV NEUROPSYCHOL, V32, P521, DOI 10.1080/87565640701360981; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Driver S, 2019, CONT CLIN TRIAL COMM, V14, DOI 10.1016/j.conctc.2019.100328; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fuentes A, 2019, REHABIL PSYCHOL, V64, P229, DOI 10.1037/rep0000260; Gao SY, 2018, J HEAD TRAUMA REHAB, V33, pE40, DOI 10.1097/HTR.0000000000000338; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Guerra-Carrillo B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182276; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Juengst SB, 2020, DISABIL REHABIL, V42, P255, DOI 10.1080/09638288.2018.1496487; Juengst SB, 2019, DISABIL REHABIL, V41, P1200, DOI 10.1080/09638288.2017.1423403; Juengst SB, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01210; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Lequerica AH, 2018, ARCH PHYS MED REHAB, V99, P1811, DOI 10.1016/j.apmr.2018.03.023; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Lucke KT, 2013, QUAL HEALTH RES, V23, P218, DOI 10.1177/1049732312468062; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Perrin PB, 2014, ARCH PHYS MED REHAB, V95, P2288, DOI 10.1016/j.apmr.2014.07.409; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Riggio S, 2010, PSYCHIAT CLIN N AM, V33, P807, DOI 10.1016/j.psc.2010.08.004; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Whealin JM, 2014, PSYCHOL SERV, V11, P114, DOI 10.1037/a0032782	38	2	2	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 9	2020	10								1342	10.3389/fneur.2019.01342			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KE8YH	WOS:000508834800001	31998213	Green Published, gold			2022-02-06	
J	Zhang, YC; Zhang, YB; Kou, YH; Yin, XF; Wang, YH; Zhang, DY				Zhang, Yichong; Zhang, Yuanbo; Kou, Yuhui; Yin, Xiaofeng; Wang, Yanhua; Zhang, Dianying			Identification of biological pathways and genes associated with neurogenic heterotopic ossification by text mining	PEERJ			English	Article						Heterotopic ossification; Spinal cord injury; Traumatic brain injury adipogenesis; Text mining	LITERATURE-BASED DISCOVERY; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; SHOCK-WAVE THERAPY; CANDIDATE GENES; BITOLA SYSTEM; RECEPTOR; IDENTIFY; CALCIFICATION; PATHOGENESIS	Background: Neurogenic heterotopic ossification is a disorder of aberrant bone formation affecting one in five patients sustaining a spinal cord injury or traumatic brain injury (SCI-TBI-HO). However, the underlying mechanisms of SCI-TBI-HO have proven difficult to elucidate. The aim of the present study is to identify the most promising candidate genes and biological pathways for SCI-TBI-HO. Methods: In this study, we used text mining to generate potential explanations for SCI-TBI-HO. Moreover, we employed several additional datasets, including gene expression profile data, drug data and tissue-specific gene expression data, to explore promising genes that associated with SCI-TBI-HO. Results: We identified four SCI-TBI-HO-associated genes, including GDF15, LDLR, CCL2, and CLU. Finally, using enrichment analysis, we identified several pathways, including integrin signaling, insulin pathway, internalization of ErbB1, urokinase-type plasminogen activator and uPAR-mediated signaling, PDGFR-beta signaling pathway, EGF receptor (ErbB1) signaling pathway, and class I PI3K signaling events, which may be associated with SCI-TBI-HO. Conclusions: These results enhance our understanding of the molecular mechanisms of SCI-TBI-HO and offer new leads for researchers and innovative therapeutic strategies.	[Zhang, Yichong; Kou, Yuhui; Yin, Xiaofeng; Wang, Yanhua; Zhang, Dianying] Peking Univ, Peoples Hosp, Dept Trauma & Orthopaed Surg, Beijing, Peoples R China; [Zhang, Yuanbo] Harbin Med Univ, Affiliated Hosp 2, Dept Periodontol & Oral Mucosa, Harbin, Heilongjiang, Peoples R China		Zhang, DY (corresponding author), Peking Univ, Peoples Hosp, Dept Trauma & Orthopaed Surg, Beijing, Peoples R China.	zdy8016@163.com		Zhang, Dianying/0000-0001-8396-702X	National Natural Science FundNational Natural Science Foundation of China (NSFC) [31640045, 31671246]; National Key Research and Development Program [2016YFC1101604]	This work was funded by the National Natural Science Fund (Nos. 31640045 and 31671246), and the National Key Research and Development Program (2016YFC1101604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2018, BONE, V110, P221, DOI 10.1016/j.bone.2018.02.018; Anaraki PK, 2015, J BONE MINER RES, V30, P379, DOI 10.1002/jbmr.2350; Awan Z, 2011, ATHEROSCLEROSIS, V219, P455, DOI 10.1016/j.atherosclerosis.2011.08.035; Banovac K, 2004, SPINAL CORD, V42, P707, DOI 10.1038/sj.sc.3101628; Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; Betsholtz C, 2014, BRAIN PATHOL, V24, P387, DOI 10.1111/bpa.12158; Cheng X, 2017, ONCOTARGET, V8, P58494, DOI 10.18632/oncotarget.17028; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Convente MR, 2015, CURR OSTEOPOROS REP, V13, P116, DOI 10.1007/s11914-015-0258-z; Cullen N, 2009, J HEAD TRAUMA REHAB, V24, P69, DOI 10.1097/HTR.0b013e31819a8fcc; Davis AP, 2017, NUCLEIC ACIDS RES, V45, pD972, DOI 10.1093/nar/gkw838; Davis EL, 2016, J CELL BIOCHEM, V117, P1044, DOI 10.1002/jcb.25454; Debaud C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182454; Di Maggio N, 2017, SCI REP-UK, V7, DOI 10.1038/srep44398; Docheva D, 2014, BIRTH DEFECTS RES C, V102, P13, DOI 10.1002/bdrc.21059; Garciadiego-Cazares D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127166; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Gomara-Toldra N, 2014, J SPINAL CORD MED, V37, P371, DOI 10.1179/2045772314Y.0000000194; Henry S, 2017, J BIOMED INFORM, V74, P20, DOI 10.1016/j.jbi.2017.08.011; Hristovski D, 2005, INT J MED INFORM, V74, P289, DOI 10.1016/j.ijmedinf.2004.04.024; Hristovski Dimitar, 2006, AMIA Annu Symp Proc, P349; Hristovski Dimitar, 2013, Cardiovascular & Hematological Agents in Medicinal Chemistry, V11, P14; Hwang IK, 2006, NEUROSCI RES, V54, P319, DOI 10.1016/j.neures.2005.12.012; Kan LX, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/309287; Karic A, 2011, BOSNIAN J BASIC MED, V11, P185; Karic A, 2011, BIOCHEM MEDICA, V21, P174; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Liu YF, 2015, NUCLEIC ACIDS RES, V43, pW535, DOI 10.1093/nar/gkv383; Loeser RF, 2014, MATRIX BIOL, V39, P11, DOI 10.1016/j.matbio.2014.08.007; Luo Yu-jia, 2016, Fa Yi Xue Za Zhi, V32, P54; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Patel R, 2016, IMPLEMENT SCI, V11; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Reznik JE, 2017, BRAIN INJURY, V31, P526, DOI 10.1080/02699052.2017.1283059; Reznik JE, 2017, BRAIN INJURY, V31, P533, DOI 10.1080/02699052.2017.1283060; Reznik JE, 2014, J MUSCULOSKEL NEURON, V14, P19; Rousselet E, 2011, J LIPID RES, V52, P1383, DOI 10.1194/jlr.M014118; Ruschke K, 2012, CELL TISSUE RES, V347, P521, DOI 10.1007/s00441-011-1283-6; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Schindowski K, 2011, CELL TISSUE RES, V343, P399, DOI 10.1007/s00441-010-1090-5; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shehab D, 2002, J NUCL MED, V43, P346; Shekaran A, 2014, BONE, V68, P131, DOI 10.1016/j.bone.2014.08.008; Strelau J, 2003, J NEURAL TRANSM-SUPP, P197; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; SWANSON DR, 1988, PERSPECT BIOL MED, V31, P526; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; Torossian F, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96034; Troakes C, 2017, NEUROPATHOLOGY, V37, P12, DOI 10.1111/neup.12320; Uchiyama T, 2015, CANCER MED-US, V4, P1558, DOI 10.1002/cam4.502; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Weeber M, 2005, BRIEF BIOINFORM, V6, P277, DOI 10.1093/bib/6.3.277; Yan P, 1999, J NEUROSCI, V19, P9355; Yildiz N, 2010, TURK FIZ TIP REHAB D, V56, P81, DOI 10.4274/tftr.56.81; Zhan YB, 2017, BEHAV BRAIN RES, V320, P136, DOI 10.1016/j.bbr.2016.11.047; Zhan YB, 2014, J PERIODONTOL, V85, P1059, DOI 10.1902/jop.2014.130523; Zhang J, 2014, BIOMATERIALS, V35, P9322, DOI 10.1016/j.biomaterials.2014.07.056; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295; Zimmermann LL, 2017, CURR OPIN NEUROL, V30, P580, DOI 10.1097/WCO.0000000000000505	61	2	2	2	4	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	JAN 3	2020	8								e8276	10.7717/peerj.8276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KA1EV	WOS:000505543000006	31915578	Green Published, gold			2022-02-06	
J	Bomyea, J; Jurick, SM; Keller, AV; Hays, CC; Twamley, EW; Jak, AJ				Bomyea, Jessica; Jurick, Sarah M.; Keller, Amber, V; Hays, Chelsea C.; Twamley, Elizabeth W.; Jak, Amy J.			Neurobehavioral symptom validity and performance validity in veterans: Evidence for distinct outcomes across data types	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Effort; neuropsychology; PTSD; TBI; validity; veterans	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; RESPONSE BIAS SCALE; CLINICAL UTILITY; US MILITARY; SERVICE; STRESS; COMPLAINTS; MMPI-2; TESTS	Self-reported traumatic brain injury (TBI) is common in combat veterans, and identification of psychiatric and neuropsychological consequences following TBI has become a priority for veteran healthcare. Given the importance of accurately capturing symptoms potentially related to TBI in VA settings, validity metrics are frequently used to evaluate both neuropsychological testing validity and the validity of symptom self-reports. The Validity-10 of the Neurobehavioral Symptom Inventory is one such metric that was designed to evaluate symptom over-reporting and thus identify individuals who may produce inconclusive testing profiles. However, the Validity-10's ability to predict objective effort during neuropsychological testing has not been sufficiently explored in veterans. Clinical evaluation data were collected from 295 veterans seeking treatment in a VA TBI clinic. We examined whether the Validity-10 can predict invalid performance on a battery of neuropsychological tests. Validity-10 was a poor predictor of performance validity metrics. Results provide a conceptual replication of earlier work demonstrating that performance and symptom validity are divergent. As such, separate evaluation of these domains is warranted during evaluations conducted in veteran TBI populations.	[Bomyea, Jessica; Jurick, Sarah M.; Keller, Amber, V; Twamley, Elizabeth W.; Jak, Amy J.] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Bomyea, Jessica; Jurick, Sarah M.; Twamley, Elizabeth W.; Jak, Amy J.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Hays, Chelsea C.] SDSU UCSD Joint Doctoral Program Clin Psychol, San Diego, CA USA		Bomyea, J (corresponding author), VA San Diego Healthcare Syst, San Diego, CA 92161 USA.; Bomyea, J (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	jbomyea@ucsd.edu			Office of Academic AffiliationsUS Department of Veterans Affairs; VA Career Development Award [IK2CX001600]	This study was supported by the Office of Academic Affiliations and a VA Career Development Award (IK2CX001600) to J. Bomyea.	Armistead-Jehle P., 2016, ARCH CLIN NEUROPSYCH, V31, P584; Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Delis D.C., 1999, CALIFORNIA VERBAL LE, VSecond; Delis D. C., 2001, TECHNICAL MANUAL DEL; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Department of Veterans Affairs, 2016, MAN CONC MILD TRAUM; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Heinzelmann M, 2014, SLEEP MED, V15, P1565, DOI 10.1016/j.sleep.2014.08.004; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; King PR, 2014, J NERV MENT DIS, V202, P231, DOI 10.1097/NMD.0000000000000103; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lippa SM, 2017, APPL NEUROPSYCH-ADUL, V24, P73, DOI 10.1080/23279095.2015.1100617; Lo A, 2015, P NATL ACAD SCI USA, V112, P13892, DOI 10.1073/pnas.1518285112; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McCrea M., 2008, MILD TRAUMATIC BRAIN; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Osterrieth P A, 1944, ARCH PSYCHOL, V28, P1021; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Russo AC, 2017, ARCH CLIN NEUROPSYCH, V32, P184, DOI 10.1093/arclin/acw093; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Spencer RJ, 2017, BRAIN INJURY, V31, P32, DOI 10.1080/02699052.2016.1218546; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Veterans Health Administration, 2010, SCREEN EV POSS TRAUM; Waldron-Perrine B, 2012, MIL MED, V177, P1293, DOI 10.7205/MILMED-D-12-00169; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F. W., 1993, P INT SOC TRAUM STRE; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2008, WECHSLER ADULT INTEL; Whitney KA, 2013, ARCH CLIN NEUROPSYCH, V28, P222, DOI 10.1093/arclin/act012; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Williams Valerie F, 2017, MSMR, V24, P2	66	2	2	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 2	2020	27	1					62	72		10.1080/23279095.2018.1480484			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	JZ9JN	WOS:000505419800007	30183368				2022-02-06	
J	Goworowski, L; Vagt, D; Salazar, C; Mulligan, K; Webbe, F				Goworowski, Lauren; Vagt, Denise; Salazar, Carlos; Mulligan, Kevin; Webbe, Frank			Normative values of the Rey Word Recognition Test in college athletes	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Concussion; effort; performance validity test; Rey WRT; sports	SPORTS-RELATED CONCUSSION; FALSE-POSITIVE RATES; BASE-LINE; TEST-PERFORMANCE; IMPACT; MOTIVATION; UTILITY	Improved detection of sport-related concussions can be enhanced by performance validity tests, such as the Rey Word Recognition Test (WRT). The WRT is brief and in the public domain but no norms exist for healthy college-athletes. The present study identified such normative values in a large college-athlete sample. Participants included 1,147 college-athletes, and four measures were collected: total words correct, words correct of the first 8, total number of intrusions, and combination score. The WRT was administered individually during baseline evaluations. Means and standard deviations were as follows: total correct words recognized, 10.47 (SD = 2.12); number of correct words out of the first eight words presented, 6.01 (SD = 1.41); number of intrusions, 0.89 (SD = 1.09); combination score, 15.59 (SD = 3.55). Females scored significantly higher than males in total words correct, number correct of the first eight, and combination score, and significantly lower in intrusions. The WRT proved to be a quick, easily administer test in the baseline testing setting. Only 22 athletes recognized all 15 words, and close to a normal distribution of scores was obtained, suggesting that an expectation of optimum performance by college-athletes as an inference of effortful performance would be misplaced.	[Goworowski, Lauren; Vagt, Denise; Salazar, Carlos; Mulligan, Kevin; Webbe, Frank] Florida Inst Technol, Dept Psychol, 150 W Univ Blvd, Melbourne, FL 32901 USA		Webbe, F (corresponding author), Florida Inst Technol, Dept Psychol, 150 W Univ Blvd, Melbourne, FL 32901 USA.	Webbe@fit.edu		Webbe, Frank/0000-0002-4370-5698			Alfano K., 2007, ASSESSMENT FEIGNED C, P366; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bell-Sprinkel TL, 2013, CLIN NEUROPSYCHOL, V27, P516, DOI 10.1080/13854046.2012.744853; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Frederick R.I., 2003, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n03_01, DOI 10.1300/J151V02N03_01, https://doi.org/10.1300/J151v02n03_01]; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Love CM, 2014, ASSESSMENT, V21, P618, DOI 10.1177/1073191114528028; Lovell MR, 2007, IMPACT VERSION 6 0 C; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; National Collegiate Athletic Association, 2018, CONC TIM; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Reilly R., 2011, ESPN; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Salazar CL, 2017, DEV NEUROPSYCHOL, V42, P83, DOI 10.1080/87565641.2017.1303701; Schatz P, 2017, SPORT EXERC PERFORM, V6, P243, DOI 10.1037/spy0000100; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Zillmer E. A., 2011, HDB SPORT NEUROPSYCH, P295; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	25	2	2	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 2	2020	27	1					94	100		10.1080/23279095.2018.1488716			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	JZ9JN	WOS:000505419800011	30265571				2022-02-06	
J	Sweeney, JE; Slade, HP				Sweeney, James E.; Slade, Heather P.			Preliminary study of spatial cognition relating to nonimpact mTBI	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Diagnosis; etiology; neuropsychology; tests	HALSTEAD-REITAN; BRAIN-INJURY	Sweeney and Johnson found that individuals that sustained mild traumatic brain injury without impact to the head (Nonimpact) demonstrated significantly slower performance than participants that suffered mild traumatic brain injury with impact to the head and normal controls on the Tactile Form Recognition Test (TFR). The current study explored the spatial cognition of three groups of Nonimpact participants classified as Deficient, Perfectly Normal, and Normal on the basis of TFR response time. Dependent variables consisted of neuropsychological tests requiring tactile- and/or visual-spatial perception and memory. Univariate analysis of variance (ANOVAs) were carried out, with false positive findings controlled by adjusting p-values using the False Detection Rate. Deficient TFR individuals performed at significantly inefficient levels relative to both Perfectly Normal and Normal TFR patients on tactile-spatial tests requiring the perception and recognition of multiple geometric configurations with the left hand, tactile-spatial memory for these shapes, and identification of numbers traced on the fingertips of the right hand. TFR Deficiency appeared to negatively affect performance on visual-spatial tests involving memory for abstract concepts and rapid association of numbers and geometric shapes, but only in relation to Perfectly Normal participants.	[Sweeney, James E.; Slade, Heather P.] Neuropsychol Practice, 401-242 Rideau St, Ottawa, ON K1N 0B7, Canada		Sweeney, JE (corresponding author), Neuropsychol Practice, 401-242 Rideau St, Ottawa, ON K1N 0B7, Canada.	jsweeney@neuroinjury.com					Beaudry M, 2003, CAN J NEUROL SCI, V30, P320, DOI 10.1017/S0317167100003024; Belanger H. G., 2005, J INT NEUROPSYCH SOC, V11, P215227; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Butcher JN, 2001, MMPI 2 MANUAL ADM SC; Coolidge F. L., 1984, COOLIDGE AXIS 2 INVE; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hathaway SR, 1967, MINNESOTA MULTIPHASI; Henry G K, 2000, Appl Neuropsychol, V7, P65, DOI 10.1207/S15324826AN0702_1; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirmani M. N., 2016, INT J MED SCI, V3, P8; Kocer A, 2015, TURK J MED SCI, V45, P993, DOI 10.3906/sag-1403-100; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; McCrea M., 2008, MILD TRAUMATIC BRAIN; Morey, 1991, PERSONALITY ASSESSME; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; PARKER RS, 2001, CONCUSSIVE BRAIN TRA; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Reitan RM, 2001, ARCH CLIN NEUROPSYCH, V16, P215; ROSENHAN DL, 1973, SCIENCE, V179, P250, DOI 10.1126/science.179.4070.250; Spence JD, 2006, PREVENT YOUR STROKE; Sweeney J E, 1999, Appl Neuropsychol, V6, P79, DOI 10.1207/s15324826an0602_3; Sweeney JE, 2019, APPL NEUROPSYCH-ADUL, V26, P181, DOI 10.1080/23279095.2017.1392304; Sweeney JE, 2019, APPL NEUROPSYCH-ADUL, V26, P65, DOI 10.1080/23279095.2017.1359783; Sweeney JE, 2017, APPL NEUROPSYCH-ADUL, V24, P446, DOI 10.1080/23279095.2016.1198909; Sweeney JE, 2017, APPL NEUROPSYCH-ADUL, V24, P169, DOI 10.1080/23279095.2015.1119694; SWEENEY JE, 1992, CLIN NEUROPSYCHOL, V6, P443, DOI 10.1080/13854049208401870; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; UC Davis Health, 2017, VERT INS; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wolfson, 1993, HALSTEAD REITAN NEUR	37	2	2	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JAN 2	2020	27	1					35	43		10.1080/23279095.2018.1476867			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	JZ9JN	WOS:000505419800004	30183360				2022-02-06	
B	Agam, G; Levine, J		Gozes, I; Levine, J		Agam, Galila; Levine, Joseph			Neuroprotective effects of lithium in neuropsychiatric disorders	NEUROPROTECTION IN AUTISM, SCHIZOPHRENIA AND ALZHEIMER'S DISEASE			English	Article; Book Chapter							GLYCOGEN-SYNTHASE KINASE-3-BETA; AMYOTROPHIC-LATERAL-SCLEROSIS; MOOD STABILIZERS LITHIUM; MITOCHONDRIAL COMPLEX-I; MAGNETIC-RESONANCE-SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE; BIPOLAR DISORDER		[Agam, Galila] Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel; [Agam, Galila] Ben Gurion Univ Negev, Fac Hlth Sci, Psychiat Res Unit, Beer Sheva, Israel; [Agam, Galila] Beer Sheva Mental Hlth Ctr, Beer Sheva, Israel; [Levine, Joseph] Ben Gurion Univ Negev, Beer Sheva, Israel		Agam, G (corresponding author), Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel.; Agam, G (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Psychiat Res Unit, Beer Sheva, Israel.; Agam, G (corresponding author), Beer Sheva Mental Hlth Ctr, Beer Sheva, Israel.						ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Agam G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00267; Aggarwal SP, 2010, LANCET NEUROL, V9, P481, DOI 10.1016/S1474-4422(10)70068-5; Agrawal S, 2013, EXP GERONTOL, V48, P1285, DOI 10.1016/j.exger.2013.08.006; Ahn M, 2017, ANAT CELL BIOL, V50, P48, DOI 10.5115/acb.2017.50.1.48; Al Temaimi R, 2017, EXP MOL PATHOL, V103, P237, DOI 10.1016/j.yexmp.2017.11.004; Al-Azemi M, 2010, J ASSIST REPROD GEN, V27, P469, DOI 10.1007/s10815-010-9426-3; Al-Chalabi A, 2017, NAT REV NEUROL, V13, P96, DOI 10.1038/nrneurol.2016.182; Albayrak A, 2013, INT IMMUNOPHARMACOL, V16, P35, DOI 10.1016/j.intimp.2013.03.018; Allen C, 2013, LANCET NEUROL, V12, P339, DOI [10.1016/S1474-4422(13)700374, 10.1016/S1474-4422(13)70037-1]; Alural B, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00209; Alvarez G, 1999, FEBS LETT, V453, P260, DOI 10.1016/S0014-5793(99)00685-7; Amare AT, 2017, EPMA J, V8, P211, DOI 10.1007/s13167-017-0112-8; AMINOFF MJ, 1974, LANCET, V1, P107; Aminzadeh A, 2014, CELL MOL NEUROBIOL, V34, P1143, DOI 10.1007/s10571-014-0089-y; Atack JR, 1996, BRAIN RES REV, V22, P183; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250; Baban B, 2013, HYPERTENSION, V61, P95, DOI 10.1161/HYPERTENSIONAHA.111.00028; Bachmann RF, 2009, INT J NEUROPSYCHOPH, V12, P805, DOI 10.1017/S1461145708009802; Baethge C, 2004, J AFFECT DISORDERS, V79, P43, DOI 10.1016/S0165-0327(02)00354-3; BAKKER CE, 1994, CELL, V78, P23; Ballanger F, 2008, ARCH DERMATOL RES, V300, P215, DOI 10.1007/s00403-007-0824-z; Bazinet RP, 2006, BIOL PSYCHIAT, V59, P401, DOI 10.1016/j.biopsych.2005.07.024; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; Berger Z, 2005, HUM MOL GENET, V14, P3003, DOI 10.1093/hmg/ddi331; Berry-Kravis E, 2008, J DEV BEHAV PEDIATR, V29, P293, DOI 10.1097/DBP.0b013e31817dc447; Bersani G, 2016, HUM PSYCHOPHARM CLIN, V31, P19, DOI 10.1002/hup.2510; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Bosetti F, 2002, MOL PSYCHIATR, V7, P845, DOI 10.1038/sj.mp.4001111; Bothwell M, 2016, F1000RES, V5, P1885, DOI [DOI 10.12688/F1000RESEARCH.8434.1, 10.12688/f1000research.8434.1]; Boufidou F, 2004, J AFFECT DISORDERS, V82, P309, DOI 10.1016/j.jad.2004.01.007; Broeke JHP, 2010, BIOL CELL, V102, P479, DOI 10.1042/BC20100036; Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057; Cade JFJ, 2000, B WORLD HEALTH ORGAN, V78, P518; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Carmo C, 2018, ADV EXP MED BIOL, V1049, P59, DOI 10.1007/978-3-319-71779-1_3; Carter CJ, 2007, NEUROCHEM INT, V50, P461, DOI 10.1016/j.neuint.2006.11.009; Castren ML, 2014, NEUROPHARMACOLOGY, V76, P729, DOI 10.1016/j.neuropharm.2013.05.018; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Chang JW, 2011, J NEUROCHEM, V116, P659, DOI 10.1111/j.1471-4159.2010.07158.x; Chen G, 1999, J NEUROCHEM, V72, P879, DOI 10.1046/j.1471-4159.1999.720879.x; Chen G, 2004, FASEB J, V18, P1162, DOI 10.1096/fj.04-1551fje; Chen K, 2013, MOL VIS, V19, P1502; Cheng C, 2017, J CLIN PSYCHIAT, V78, pE139, DOI 10.4088/JCP.15m10304; Chio A, 2010, NEUROLOGY, V75, P619, DOI 10.1212/WNL.0b013e3181ed9e7c; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Chiu CT, 2011, NEUROPSYCHOPHARMACOL, V36, P2406, DOI 10.1038/npp.2011.128; Choi CH, 2010, BIOGERONTOLOGY, V11, P347, DOI 10.1007/s10522-009-9259-6; Citrome L, 2009, EXPERT REV NEUROTHER, V9, P55, DOI 10.1586/14737175.9.1.55; Coant N, 2011, J HEPATOL, V55, P784, DOI 10.1016/j.jhep.2010.12.039; COFFEY CE, 1984, CLIN NEUROPHARMACOL, V7, P223, DOI 10.1097/00002826-198409000-00003; Frota ERC, 2009, NEUROSCI LETT, V460, P130, DOI 10.1016/j.neulet.2009.05.057; Cotman SL, 2002, HUM MOL GENET, V11, P2709, DOI 10.1093/hmg/11.22.2709; Crawford DC, 2002, AM J MED GENET, V110, P226, DOI 10.1002/ajmg.10427; Criollo A, 2007, AUTOPHAGY, V3, P350, DOI 10.4161/auto.4077; Crotti A, 2015, TRENDS IMMUNOL, V36, P364, DOI 10.1016/j.it.2015.04.007; Cunha ABM, 2006, NEUROSCI LETT, V398, P215, DOI 10.1016/j.neulet.2005.12.085; Dahlhaus R, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00041; Damri O, 2015, EUR NEUROPSYCHOPHARM, V25, P425, DOI 10.1016/j.euroneuro.2014.06.012; Danivas V, 2013, INDIAN J PSYCHIAT, V55, P81, DOI 10.4103/0019-5545.105522; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Datta G, 2017, BRAIN, V140, P2927, DOI 10.1093/brain/awx228; De Sarno P, 2008, J IMMUNOL, V181, P338, DOI 10.4049/jimmunol.181.1.338; de Sousa RT, 2015, PSYCHOPHARMACOLOGY, V232, P245, DOI 10.1007/s00213-014-3655-6; de Sousa RT, 2011, NEUROSCI LETT, V494, P54, DOI 10.1016/j.neulet.2011.02.054; De-Paula VJ, 2016, CURR ALZHEIMER RES, V13, P848, DOI 10.2174/1567205013666160219112612; DELCAMPO ALG, 1991, COMP BIOCHEM PHYS A, V100, P943, DOI 10.1016/0300-9629(91)90319-8; Dell'Osso L, 2016, NEUROPSYCH DIS TREAT, V12, P1687, DOI 10.2147/NDT.S106479; Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006; Dunn N, 2005, ALZ DIS ASSOC DIS, V19, P20, DOI 10.1097/01.wad.0000155068.23937.9b; Dwivedi T, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00457; Elliott R, 2016, SOJ BIOCH, V2, P5; Emamghoreishi M, 2015, IRAN J BASIC MED SCI, V18, P240; Fan MY, 2015, BEHAV BRAIN RES, V291, P399, DOI 10.1016/j.bbr.2015.05.047; Fawcett JA, 2003, J CLIN PSYCHIAT, V64, P32; Feier G, 2013, PHARMACOL BIOCHEM BE, V103, P589, DOI 10.1016/j.pbb.2012.09.010; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ferrucci M, 2010, NEUROBIOL DIS, V37, P370, DOI 10.1016/j.nbd.2009.10.017; Forlenza OV, 2014, ACS CHEM NEUROSCI, V5, P443, DOI 10.1021/cn5000309; Forlenza OV, 2011, BRIT J PSYCHIAT, V198, P351, DOI 10.1192/bjp.bp.110.080044; Fornai F, 2008, AUTOPHAGY, V4, P527, DOI 10.4161/auto.5923; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Gao M, 2013, NEUROSCIENCE, V254, P301, DOI 10.1016/j.neuroscience.2013.09.033; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gideons ES, 2017, ELIFE, V6, DOI 10.7554/eLife.25480; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Gubellini P, 2015, REV NEUROL-FRANCE, V171, P750, DOI 10.1016/j.neurol.2015.07.011; Guloksuz S, 2010, J AFFECT DISORDERS, V126, P458, DOI 10.1016/j.jad.2010.04.027; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Hampel H, 2009, J CLIN PSYCHIAT, V70, P922, DOI 10.4088/JCP.08m04606; Hantson P, 2019, CLIN TOXICOL, V57, P1, DOI 10.1080/15563650.2018.1497172; Hashimoto R, 2002, NEUROPHARMACOLOGY, V43, P1173, DOI 10.1016/S0028-3908(02)00217-4; Hashioka S, 2007, EXP NEUROL, V206, P33, DOI 10.1016/j.expneurol.2007.03.022; Himmerich H, 2013, J PSYCHIATR RES, V47, P1751, DOI 10.1016/j.jpsychires.2013.07.026; HOLLENBACH K, 1984, HEALTH EDUC QUART, V11, P215, DOI 10.1177/109019818401100212; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Hull M, 2014, J CELL BIOCHEM, V115, P71, DOI 10.1002/jcb.24634; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ibarguen-Vargas Y, 2009, BEHAV BRAIN RES, V202, P245, DOI 10.1016/j.bbr.2009.03.040; Jakobsson E, 2017, J MEMBRANE BIOL, V250, P587, DOI 10.1007/s00232-017-9998-2; Jope RS, 2016, CEREBRUM; Jornada LK, 2010, J PSYCHIATR RES, V44, P506, DOI 10.1016/j.jpsychires.2009.11.002; JR TG, 2016, J NEUROL SCI, V368, P221; Kang K, 2012, NEUROL RES, V34, P447, DOI 10.1179/1743132812Y.0000000015; Karabiyik C, 2017, ESSAYS BIOCHEM, V61, P711, DOI 10.1042/EBC20170023; Keshavarz M, 2013, IRAN J MED SCI, V38, P255; Kessing LV, 2010, BIPOLAR DISORD, V12, P87, DOI 10.1111/j.1399-5618.2009.00788.x; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kim HK, 2016, J PSYCHIATR RES, V76, P59, DOI 10.1016/j.jpsychires.2016.02.001; King TD, 2001, BRAIN RES, V919, P106, DOI 10.1016/S0006-8993(01)03005-0; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Knijff EM, 2007, BIPOLAR DISORD, V9, P743, DOI 10.1111/j.1399-5618.2007.00444.x; KOHLSCHUTTER A, 1993, J INHERIT METAB DIS, V16, P241, DOI 10.1007/BF00710254; Koriyama Y, 2013, NEUROSCI RES, V77, P87, DOI 10.1016/j.neures.2013.07.001; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KUCHARZ EJ, 1993, IMMUNOPHARM IMMUNOT, V15, P515, DOI 10.3109/08923979309019728; Kusters CDJ, 2018, PARKINSONISM RELAT D, V47, P39, DOI 10.1016/j.parkreldis.2017.11.339; Kwon YJ, 2014, JOINT BONE SPINE, V81, P240, DOI 10.1016/j.jbspin.2013.09.006; Lazzara CA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00403; Leeds PR, 2014, ACS CHEM NEUROSCI, V5, P422, DOI 10.1021/cn500040g; Lei P, 2017, MOL PSYCHIATR, V22, P396, DOI 10.1038/mp.2016.96; LEONARD DP, 1975, AUST NZ J PSYCHIAT, V9, P115, DOI 10.3109/00048677509159834; Lepack AE, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu033; Leucht S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003834.pub2; Leucht S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003834.pub3; Leyhe T, 2009, J ALZHEIMERS DIS, V16, P649, DOI 10.3233/JAD-2009-1004; Li HF, 2011, J CEREBR BLOOD F MET, V31, P2106, DOI 10.1038/jcbfm.2011.75; Li Q, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.33; Li Q, 2017, CELL MOL NEUROBIOL, V37, P377, DOI 10.1007/s10571-016-0386-8; Li XZ, 2013, INT J NEUROSCI, V123, P73, DOI 10.3109/00207454.2012.729234; Liang PZ, 2015, NEUROSCI BULL, V31, P435, DOI 10.1007/s12264-015-1545-5; Lieu CA, 2014, BRAIN RES, V1591, P111, DOI 10.1016/j.brainres.2014.10.032; Linares GR, 2016, EXP NEUROL, V281, P81, DOI 10.1016/j.expneurol.2016.04.003; Liu J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01005; Liu KJ, 2011, J CELL PHYSIOL, V226, P424, DOI 10.1002/jcp.22348; Liu XL, 2018, INT J MOL MED, V41, P615, DOI 10.3892/ijmm.2017.3255; Liu ZH, 2014, ACS CHEM NEUROSCI, V5, P477, DOI 10.1021/cn500077p; Macdonald A, 2008, INT J GERIATR PSYCH, V23, P704, DOI 10.1002/gps.1964; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Machado-Vieira R, 2007, BIOL PSYCHIAT, V61, P142, DOI 10.1016/j.biopsych.2006.03.070; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; MAJ M, 1988, J AFFECT DISORDERS, V14, P129, DOI 10.1016/0165-0327(88)90055-9; Martin DDO, 2015, TRENDS NEUROSCI, V38, P26, DOI 10.1016/j.tins.2014.09.003; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; Martin LJ, 2010, J ALZHEIMERS DIS, V20, pS335, DOI 10.3233/JAD-2010-100348; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Matsebatlela T, 2012, BIOL TRACE ELEM RES, V149, P323, DOI 10.1007/s12011-012-9438-1; Matsunaga S, 2015, J ALZHEIMERS DIS, V48, P403, DOI 10.3233/JAD-150437; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Maurer IC, 2009, BIPOLAR DISORD, V11, P515, DOI 10.1111/j.1399-5618.2009.00729.x; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; MCCAUL JA, 1974, LANCET, V1, P1117; McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007; McQuillin A, 2007, PHARMACOGENET GENOM, V17, P605, DOI 10.1097/FPC.0b013e328011b5b2; Miller RG, 2011, NEUROLOGY, V77, P973, DOI 10.1212/WNL.0b013e31822dc7a5; Min WW, 2009, NEUROPHARMACOLOGY, V56, P463, DOI 10.1016/j.neuropharm.2008.09.017; Mohammadianinejad SE, 2014, CLIN NEUROPHARMACOL, V37, P73, DOI 10.1097/WNF.0000000000000028; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Morlet E, 2018, GERIATR PSYCHOL NEUR, V16, P78, DOI 10.1684/pnv.2017.0718; Morris G, 2016, CURR ALZHEIMER RES, V13, P853, DOI 10.2174/1567205013666160219113112; Motaghinejad M, 2016, NEUROTOXICOLOGY, V56, P40, DOI 10.1016/j.neuro.2016.06.010; Motoi Y, 2014, ACS CHEM NEUROSCI, V5, P434, DOI 10.1021/cn500056q; Muller-Oerlinghausen B, 2010, NEUROPSYCHOBIOLOGY, V62, P43, DOI 10.1159/000314309; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; MURPHY DL, 1971, AM J PSYCHIAT, V127, P1559, DOI 10.1176/ajp.127.11.1559; Nahman S, 2012, INNATE IMMUN-LONDON, V18, P447, DOI 10.1177/1753425911421512; Nascimento C, 2015, J NEURAL TRANSM, V122, P741, DOI 10.1007/s00702-014-1318-8; Nassar Ahmad, 2014, ACS Chem Neurosci, V5, P451, DOI 10.1021/cn500038f; Natsume H, 2011, MOL CELL ENDOCRINOL, V331, P66, DOI 10.1016/j.mce.2010.08.009; Nciri R, 2013, INT J NEUROPSYCHOPH, V16, P365, DOI 10.1017/S1461145712000132; Ngok-Ngam P, 2013, CELL MOL BIOL LETT, V18, P58, DOI 10.2478/s11658-012-0039-y; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Nonaka S, 1998, NEUROREPORT, V9, P2081, DOI 10.1097/00001756-199806220-00031; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Nunes MA, 2013, CURR ALZHEIMER RES, V10, P104; Nunes PV, 2007, BRIT J PSYCHIAT, V190, P359, DOI 10.1192/bjp.bp.106.029868; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Park HJ, 2009, HEARING RES, V257, P53, DOI 10.1016/j.heares.2009.08.001; Parker WF, 2018, JAMA PSYCHIAT, V75, P751, DOI 10.1001/jamapsychiatry.2018.1020; Patergnani S, 2017, INT REV CEL MOL BIO, V328, P49, DOI 10.1016/bs.ircmb.2016.08.003; Paterson A, 2017, INT CLIN PSYCHOPHARM, V32, P57, DOI 10.1097/YIC.0000000000000152; Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Post RM, 2007, J PSYCHIATR RES, V41, P979, DOI 10.1016/j.jpsychires.2006.09.009; Procaccini C, 2015, EUR J PHARMACOL, V759, P182, DOI 10.1016/j.ejphar.2015.03.042; Prosser JM, 2016, PROG NEURO-PSYCHOPH, V71, P39, DOI 10.1016/j.pnpbp.2016.06.006; Quartini A, 2016, NEURAL REGEN RES, V11, P1234, DOI 10.4103/1673-5374.189175; Quiroz JA, 2008, NEUROPSYCHOPHARMACOL, V33, P2551, DOI 10.1038/sj.npp.1301671; Radak D, 2017, CURR VASC PHARMACOL, V15, P115, DOI 10.2174/1570161115666161104095522; Radi E, 2014, J ALZHEIMERS DIS, V42, pS125, DOI 10.3233/JAD-132738; Ramesh N, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00263; Rapaport MH, 2001, BIOL PSYCHIAT, V50, P217, DOI 10.1016/S0006-3223(01)01144-1; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Rinker JR, 2013, MULT SCLER RELAT DIS, V2, P327, DOI 10.1016/j.msard.2013.03.004; Roux M, 2017, METALLOMICS, V9, P1326, DOI 10.1039/c7mt00203c; Rowe Michael K., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008385; ROWLAND LP, 1995, P NATL ACAD SCI USA, V92, P1251, DOI 10.1073/pnas.92.5.1251; Rowse AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052658; Rybakowski JK, 2014, ACS CHEM NEUROSCI, V5, P413, DOI 10.1021/cn5000277; Rybakowski JK, 2010, INT J NEUROPSYCHOPH, V13, P617, DOI 10.1017/S1461145710000404; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sade Y, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.217; Santos GL, 2016, J STROKE CEREBROVASC, V25, P2968, DOI 10.1016/j.jstrokecerebrovasdis.2016.08.014; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2006, AUTOPHAGY, V2, P132, DOI 10.4161/auto.2387; Scheuing L, 2014, INT J BIOL SCI, V10, P1024, DOI 10.7150/ijbs.9898; Schioldann J, 1999, ACTA PSYCHIAT SCAND, V100, P403; Scola G, 2014, PSYCHOPHARMACOLOGY, V231, P4189, DOI 10.1007/s00213-014-3565-7; Scrivo A, 2018, LANCET NEUROL, V17, P802, DOI 10.1016/S1474-4422(18)30238-2; Senatorov VV, 2004, MOL PSYCHIATR, V9, P371, DOI 10.1038/sj.mp.4001463; Serret S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0490-1; Shalbuyeva N, 2007, J BIOL CHEM, V282, P18057, DOI 10.1074/jbc.M702134200; Shin JH, 2007, MOL PHARMACOL, V71, P965, DOI 10.1124/mol.106.030676; Siegel M, 2014, J CHILD ADOL PSYCHOP, V24, P399, DOI 10.1089/cap.2014.0019; Silachev DN, 2015, CHEM-BIOL INTERACT, V237, P175, DOI 10.1016/j.cbi.2015.06.012; Smith Emma F, 1800, Neurosci Lett, V710, P132933, DOI 10.1016/j.neulet.2017.06.052; Soleimani Mitra, 2017, Avicenna Journal of Medical Biotechnology, V9, P176; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stapinski A, 1989, Przegl Dermatol, V76, P345; Straten G, 2011, CURR ALZHEIMER RES, V8, P853, DOI 10.2174/156720511798192754; Szuster-Ciesielska A, 2003, POL J PHARMACOL, V55, P353; Tam ZY, 2014, J GERONTOL A-BIOL, V69, P810, DOI 10.1093/gerona/glt210; Tan WF, 2010, CLIN EXP PHARMACOL P, V37, P1010, DOI 10.1111/j.1440-1681.2010.05433.x; Tanila H, 2017, NEUROBIOL DIS, V97, P114, DOI 10.1016/j.nbd.2016.05.008; Tanno M, 2014, J BIOL CHEM, V289, P29285, DOI 10.1074/jbc.M114.563924; Tay TF, 2012, TROP BIOMED, V29, P551; TaylorRobinson SD, 1996, MOVEMENT DISORD, V11, P167, DOI 10.1002/mds.870110209; Terao T, 2006, PROG NEURO-PSYCHOPH, V30, P1125, DOI 10.1016/j.pnpbp.2006.04.020; Toker L, 2014, ACS CHEM NEUROSCI, V5, P411, DOI 10.1021/cn5001149; Toker L, 2014, NEUROPSYCHOPHARMACOL, V39, P319, DOI 10.1038/npp.2013.194; Valenti D, 2014, NEUROSCI BIOBEHAV R, V46, P202, DOI 10.1016/j.neubiorev.2014.01.012; Valvassori SS, 2010, J PSYCHIATR RES, V44, P903, DOI 10.1016/j.jpsychires.2010.02.009; Van Damme P, 2017, DIS MODEL MECH, V10, P537, DOI 10.1242/dmm.029058; van den Ameele S, 2016, J AFFECT DISORDERS, V203, P364, DOI 10.1016/j.jad.2016.06.016; van Eijk RPA, 2017, NEUROLOGY, V89, P1915, DOI 10.1212/WNL.0000000000004606; Verstraete E, 2012, J NEUROL NEUROSUR PS, V83, P557, DOI 10.1136/jnnp-2011-302021; VESTERGAARD P, 1977, ACTA PSYCHIAT SCAND, V56, P183, DOI 10.1111/j.1600-0447.1977.tb03561.x; Victoratos P, 1997, CLIN EXP IMMUNOL, V109, P569, DOI 10.1046/j.1365-2249.1997.4631361.x; Vincze I, 2008, BIPOLAR DISORD, V10, P580, DOI 10.1111/j.1399-5618.2008.00603.x; Vines A, 2006, J BIOL CHEM, V281, P16985, DOI 10.1074/jbc.M602446200; Vivekanantham S, 2015, INT J NEUROSCI, V125, P717, DOI 10.3109/00207454.2014.982795; Wang HM, 2013, NEUROCHEM INT, V63, P345, DOI 10.1016/j.neuint.2013.07.003; Wang Y, 2017, NEUROCHEM RES, V42, P2363, DOI 10.1007/s11064-017-2256-2; Wei H, 2001, NEUROSCIENCE, V106, P603, DOI 10.1016/S0306-4522(01)00311-6; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Won E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122679; Wood NI, 2003, BRAIN RES BULL, V61, P375, DOI 10.1016/S0361-9230(03)00141-2; WU YY, 1991, P SOC EXP BIOL MED, V198, P620; Xilouri M, 2016, MOVEMENT DISORD, V31, P178, DOI 10.1002/mds.26477; Xu JH, 2003, STROKE, V34, P1287, DOI 10.1161/01.STR.0000066308.25088.64; Yan JQ, 2018, P NATL ACAD SCI USA, V115, pE9707, DOI 10.1073/pnas.1808247115; Yanez M, 2014, NEURODEGENER DIS, V13, P171, DOI 10.1159/000357281; Yang JL, 2018, REDOX BIOL, V16, P263, DOI 10.1016/j.redox.2018.03.002; Yang K, 2017, CELL PHYSIOL BIOCHEM, V44, P1445, DOI 10.1159/000485580; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; York JD, 2001, ADV ENZYME REGUL, V41, P57, DOI 10.1016/S0065-2571(00)00025-X; Youdim MBH, 2004, NEUROPHARMACOLOGY, V46, P1130, DOI 10.1016/j.neuropharm.2004.02.005; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Yuskaitis CJ, 2010, BIOCHEM PHARMACOL, V79, P632, DOI 10.1016/j.bcp.2009.09.023; Yuskaitis CJ, 2009, CELL SIGNAL, V21, P264, DOI 10.1016/j.cellsig.2008.10.014; Zeng ZW, 2016, PSYCHOPHARMACOLOGY, V233, P785, DOI 10.1007/s00213-015-4168-7; Zhang P, 2009, MOL IMMUNOL, V46, P677, DOI 10.1016/j.molimm.2008.08.281; Zhang X, 2011, J ALZHEIMERS DIS, V24, P739, DOI 10.3233/JAD-2011-101875; Zhao LD, 2011, EXP GERONTOL, V46, P1031, DOI 10.1016/j.exger.2011.09.002; Zhou X, 2016, NEUROCHEM RES, V41, P1993, DOI 10.1007/s11064-016-1909-x; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008; Zuccato Chiara, 2014, Handb Exp Pharmacol, V220, P357, DOI 10.1007/978-3-642-45106-5_14	285	2	2	0	0	ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD	LONDON	125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND			978-0-12-814038-3; 978-0-12-814037-6				2020							209	241		10.1016/B978-0-12-814037-6.00006-9			33	Neurosciences; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BR0ZK	WOS:000631379300010					2022-02-06	
J	Bancroft, E; Srinivasan, R; Shapiro, LA				Bancroft, Eric; Srinivasan, Rahul; Shapiro, Lee A.			Macrophage Migration Inhibitory Factor Alters Functional Properties of CA1 Hippocampal Neurons in Mouse Brain Slices	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						neuroinflammation; neurotrauma; traumatic brain injury (TBI); ischemic stroke; epilepsy; macrophage migration inhibitory factor (MIF)	TOLL-LIKE RECEPTORS; FACTOR MIF; ALZHEIMERS-DISEASE; IMMUNE-RESPONSES; REGULATORY ROLE; RAT-BRAIN; EXPRESSION; INNATE; INTERLEUKIN-1-BETA; ASTROCYTES	Neuroinflammation is implicated in a host of neurological insults, such as traumatic brain injury (TBI), ischemic stroke, Alzheimer's disease, Parkinson's disease, and epilepsy. The immune response to central nervous system (CNS) injury involves sequelae including the release of numerous cytokines and chemokines. Macrophage migration inhibitory factor (MIF), is one such cytokine that is elevated following CNS injury, and is associated with the prognosis of TBI, and ischemic stroke. MIF has been identified in astrocytes and neurons, and some of the trophic actions of MIF have been related to its direct and indirect actions on astrocytes. However, the potential modulation of CNS neuronal function by MIF has not yet been explored. This study tests the hypothesis that MIF can directly influence hippocampal neuronal function. MIF was microinjected into the hippocampus and the genetically encoded calcium indicator, GCaMP6f, was used to measure Ca2+ events in acute adult mouse brain hippocampal slices. Results demonstrated that a single injection of 200 ng MIF into the hippocampus significantly increased baseline calcium signals in CA1 pyramidal neuron somata, and altered calcium responses to N-methyl-d-aspartate (NMDA) + D-serine in pyramidal cell apical dendrites located in the stratum radiatum. These data are the first to show direct effects of MIF on hippocampal neurons and on NMDA receptor function. Considering that MIF is elevated after brain insults such as TBI, the data suggest that, in addition to the previously described role of MIF in astrocyte reactivity, elevated MIF can have significant effects on neuronal function in the hippocampus.	[Bancroft, Eric; Srinivasan, Rahul; Shapiro, Lee A.] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX 77807 USA		Srinivasan, R; Shapiro, LA (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX 77807 USA.	eric369@exchange.tamu.edu; rahul@tamu.edu; lshapiro@tamu.edu		Bancroft, Eric/0000-0002-5857-7625	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS104282] Funding Source: Medline		Alexander JK, 2012, EXP NEUROL, V236, P351, DOI 10.1016/j.expneurol.2012.04.018; Bacher M, 1998, MOL MED, V4, P217, DOI 10.1007/BF03401919; Bacher M, 2010, MOL MED, V16, P116, DOI 10.2119/molmed.2009.00123; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bowman CC, 2003, GLIA, V43, P281, DOI 10.1002/glia.10256; Choi SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092325; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; Faul M, 2010, TRAUMATIC BRAIN INJU; Ghoochani A, 2016, ONCOGENE, V35, P6246, DOI 10.1038/onc.2016.160; Grygorczuk S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0898-2; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; Harari O, 2014, BIOL PSYCHIAT, V75, P723, DOI 10.1016/j.biopsych.2013.11.032; HEBERKATZ E, 1982, J EXP MED, V155, P1086, DOI 10.1084/jem.155.4.1086; Huttl S, 2016, BIOCHEM J, V473, P1405, DOI 10.1042/BCJ20160156; Huttl S, 2015, J IMMUNOL, V195, P1548, DOI 10.4049/jimmunol.1403171; Iacobucci GJ, 2017, NAT REV NEUROSCI, V18, P236, DOI 10.1038/nrn.2017.24; Jankauskas SS, 2019, CELL SIGNAL, V57, P76, DOI 10.1016/j.cellsig.2019.01.006; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawahara Y, 2020, BRAIN DEV-JPN, V42, P185, DOI 10.1016/j.braindev.2019.11.002; Khaibullin T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00531; Kwan K, 2020, J NEUROSURG, V133, P1786, DOI 10.3171/2019.6.JNS19613; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lepennetier G, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1601-6; Li YS, 2017, INT J NEUROSCI, V127, P539, DOI 10.1080/00207454.2016.1211648; Maier M, 2008, SHOCK, V30, P344, DOI 10.1097/SHK.0b013e3181673eb4; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Murray CA, 1998, J NEUROSCI, V18, P2974; Niino M, 2000, J NEUROL SCI, V179, P127, DOI 10.1016/S0022-510X(00)00397-X; Ogata A, 1998, NEUROSCI LETT, V246, P173, DOI 10.1016/S0304-3940(98)00203-1; Oikonomidi A, 2017, J ALZHEIMERS DIS, V60, P273, DOI 10.3233/JAD-170335; OKAZAKI MM, 1995, J COMP NEUROL, V352, P515, DOI 10.1002/cne.903520404; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Ostergaard C, 2009, CRIT CARE, V13, DOI 10.1186/cc7933; PLATASALAMAN CR, 1994, EUR J PHARM-MOLEC PH, V266, P1, DOI 10.1016/0922-4106(94)90202-X; Popp J, 2009, J PSYCHIATR RES, V43, P749, DOI 10.1016/j.jpsychires.2008.10.006; Racca C, 2000, J NEUROSCI, V20, P2512; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Srinivasan R, 2015, NAT NEUROSCI, V18, P708, DOI 10.1038/nn.4001; Su Y, 2017, ONCOTARGET, V8, P2719, DOI 10.18632/oncotarget.13739; Sun CW, 2004, J NEUROSCI, V24, P9944, DOI 10.1523/JNEUROSCI.2856-04.2004; Sutula T, 1996, J NEUROSCI, V16, P7398; Svenningsen AF, 2017, CELL MOL LIFE SCI, V74, P4561, DOI 10.1007/s00018-017-2592-z; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Villalonga N, 2010, BIOCHEM PHARMACOL, V80, P858, DOI 10.1016/j.bcp.2010.05.012; Wang CW, 2019, CYTOKINE, V115, P8, DOI 10.1016/j.cyto.2018.11.029; Yang DB, 2017, CLIN CHIM ACTA, V469, P99, DOI 10.1016/j.cca.2017.03.030; Zhang S, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0508-x; Zhang YX, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1468-6; Zhou Y, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1297-z	54	2	2	0	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JAN 1	2020	21	1							276	10.3390/ijms21010276			13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	KO2KF	WOS:000515378000276	31906137	Green Published, gold			2022-02-06	
B	Bridel, W; Ventresca, M; Kelly, D; Viliunas, K; Schneider, K		Ventresca, M; McDonald, MG		Bridel, William; Ventresca, Matt; Kelly, Danika; Viliunas, Kevin; Schneider, Kathryn			"I Kinda' Lost My Sense of Who I Was" Foregrounding Youths' Experiences in Critical Conversations About Sport-Related Concussions	SOCIOCULTURAL EXAMINATIONS OF SPORTS CONCUSSIONS	Routledge Research in Sport and Exercise Science		English	Article; Book Chapter							MASCULINITY; HEALTH; CLINICIAN; LIFE; MEN		[Bridel, William; Ventresca, Matt; Kelly, Danika; Viliunas, Kevin; Schneider, Kathryn] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Schneider, Kathryn] Univ Calgary, Sport Injury Prevent Res Ctr SIPRC, Calgary, AB, Canada		Bridel, W (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.						Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Atkinson M, 2008, LEISURE STUD, V27, P165, DOI 10.1080/02614360801902216; Bale J., 2004, RUNNING CULTURES RAC; Bale J, 2005, ETHICS SPORT, P65; BENDELOW GA, 1995, SOCIOL HEALTH ILL, V17, P139, DOI 10.1111/1467-9566.ep10933376; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; Bridel W., 2013, Leisure/Loisir, V37, P37, DOI 10.1080/14927713.2013.776745; Bruhm Steven, 1994, GOTHIC BODIES POLITI; Burkitt I., 1999, BODIES THOUGHT EMBOD; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Cassilo D, 2019, COMMUN SPORT, V7, P678, DOI 10.1177/2167479518790039; Charlton J. I, 1998, NOTHING US US DISABI; Charmaz K., 2014, BROKERAGE CLOSURE IN; Ciskie Bruce, 2012, SB NATION       0120; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Dumas Alexandre, 2012, MEN MASCULINITIES IN, P32; Gough B, 2006, SOC SCI MED, V63, P2476, DOI 10.1016/j.socscimed.2006.06.004; Harris M, 2009, SOCIOL HEALTH ILL, V31, P1028, DOI 10.1111/j.1467-9566.2009.01172.x; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Kelly Danika, 2018, I DONT ACTUALLY KNOW; Kelly Emily, 2018, NEW YORK TIMES  0202; Leder Drew, 1990, ABSENT BODY; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; Loland S, 2005, ETHICS SPORT, P49; Malcolm D., 2017, SPORT MED HLTH MEDIC; Malcolm D, 2020, HEALTH-LONDON, V24, P366, DOI 10.1177/1363459318800142; Malcolm D, 2009, SOCIOL SPORT J, V26, P191, DOI 10.1123/ssj.26.2.191; Maloney T, 2016, HOW CANADIANS COMMUNICATE V: SPORTS, P195; Messner M. A., 1990, International Review for the Sociology of Sport, V25, P203, DOI 10.1177/101269029002500303; Morris D., 1991, CULTURE PAIN; Noe Francis, 1973, INT REV SPORT SOCIOL, V8, P47, DOI 10.1177/101269027300800204; Safai P, 2003, SOCIOL SPORT J, V20, P127, DOI 10.1123/ssj.20.2.127; Saldana J., 2003, LONGITUDINAL QUALITA; Scarry Elaine, 1985, BODY PAIN MAKING UNM; SCOTT JW, 1991, CRIT INQUIRY, V17, P773, DOI 10.1086/448612; Shakespeare T., 2014, DISABILITY RIGHTS WR; Shakespeare T., 2017, DISABILITY BASICS; Sveen U, 2016, DISABIL REHABIL, V38, P2296, DOI 10.3109/09638288.2015.1129445; Theberge N, 2008, SOCIOL SPORT J, V25, P206, DOI 10.1123/ssj.25.2.206; TSN Staff, 2018, FRANZENS WIFE DETAIL; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Waddington I, 2004, SPORTING BODIES DAMA, P287; Williams Simon J, 1998, LIVED BODY SOCIOLOGI; Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191; Young AA, 2004, PRINC STUD CULT, P1; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175	49	2	2	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-0-429-02817-5; 978-0-367-13450-1	ROUT RES SPORT EXERC			2020							97	115					19	Hospitality, Leisure, Sport & Tourism; Sociology; Sport Sciences	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Social Sciences - Other Topics; Sociology; Sport Sciences	BO8OT	WOS:000528901400006					2022-02-06	
J	Cao, W; Zhang, C; Chen, R; Wu, QQ; Xu, RH; Zhang, L; Zhang, XJ				Cao, Wen; Zhang, Cong; Chen, Rong; Wu, Qianqian; Xu, Renhao; Zhang, Lan; Zhang, Xiangjian			A Novel Cerebroprotein Hydrolysate, CH1, Ameliorates Chronic Focal Cerebral Ischemia Injury by Promoting White Matter Integrity via the Shh/Ptch-1/Gli-1 Signaling Pathway	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						ischemic stroke; cerebroprotein hydrolysate; axonal plasticity; white matter integrity; Shh pathway	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; DOUBLE-BLIND; CEREBROLYSIN; STROKE; RECOVERY; NEUROGENESIS; RESVERATROL; DISRUPTION; HEMORRHAGE	Purpose: Strokes are devastating as there are no current therapies to prevent long-term neurological deficits. Previous studies reported that cerebroprotein hydrolysate (CH) plays a role in neuronal protection in acute phase after ischemic stroke, while the long-term effects of CH upon brain plasticity and neurological outcomes after stroke are still uncertain. To address these gaps, we assessed the effect of a new cerebroprotein hydrolysate, CH1, on long-term gray and white matter integrity as well as axonal plasticity in the late phase after ischemic stroke and the potential mechanisms. Methods: Adult male mice were subjected to permanent distal middle cerebral artery occlusion (dMCAO), followed by daily intraperitoneal injection of CH1 for 14 days. Motor function was measured weekly through behavioral neurological evaluations. Gray matter intensity and white matter intensity were examined by immunofluorescence staining. The sonic hedgehog (Shh) inhibitor cyclopamine (CYC) was injected to determine the involvement of the Shh pathway in the therapeutic effects of CH1. Results: We found that intraperitoneal delivery of CH1, compared to vehicle administration, significantly improved long-term neurological outcomes at various times and promoted neuronal viability at 14 days but not at 28 days after stroke. Importantly, CH1 mitigated stroke-induced white matter injury and facilitated axonal plasticity in the late stage after stroke. Conclusion: These results unveil a previously unappreciated role for CH in the repair of white matter and brain plasticity after stroke.	[Cao, Wen; Zhang, Cong; Wu, Qianqian; Zhang, Lan; Zhang, Xiangjian] Hebei Med Univ, Dept Neurol, Hosp 2, 215 Hepingxi Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Chen, Rong; Xu, Renhao; Zhang, Xiangjian] Hebei Collaborat Innovat Ctr Cardiocerebrovasc Di, Shijiazhuang 050000, Hebei, Peoples R China; [Chen, Rong; Xu, Renhao; Zhang, Xiangjian] Hebei Vasc Homeostasis Key Lab Neurol, Shijiazhuang 050000, Hebei, Peoples R China		Zhang, XJ (corresponding author), Hebei Med Univ, Dept Neurol, Hosp 2, 215 Hepingxi Rd, Shijiazhuang 050000, Hebei, Peoples R China.	zhang666xj@sina.com		Zhang, Xiangjian/0000-0003-0114-1668	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81974184]; Health Commission of Hebei Province [20190061]	This work was generously supported by grants from the National Natural Science Foundation of China (grant No.81974184), and the Health Commission of Hebei Province (20190061).	Alvarez XA, 2011, EUR J NEUROL, V18, P59, DOI 10.1111/j.1468-1331.2010.03092.x; Amani H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42633-9; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Caballero-Garrido E, 2015, J NEUROSCI, V35, P12446, DOI 10.1523/JNEUROSCI.1641-15.2015; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Cheng W, 2015, CELL PHYSIOL BIOCHEM, V35, P2019, DOI 10.1159/000374009; Cui LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064684; Freret T, 2009, BEHAV NEUROSCI, V123, P224, DOI 10.1037/a0014157; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Gao X, 2020, BRAIN RES BULL, V154, P51, DOI 10.1016/j.brainresbull.2019.10.006; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; He WL, 2017, EXP CELL RES, V350, P83, DOI 10.1016/j.yexcr.2016.11.008; Heiss WD, 2012, STROKE, V43, P630, DOI 10.1161/STROKEAHA.111.628537; Ji H, 2012, NEUROSCI LETT, V506, P1, DOI 10.1016/j.neulet.2011.11.027; Kastrup A, 2008, STROKE, V39, P2385, DOI 10.1161/STROKEAHA.107.505420; Khalili H, 2017, CLIN NEUROL NEUROSUR, V152, P34, DOI 10.1016/j.clineuro.2016.11.011; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kissela B, 2009, STROKE, V40, P530, DOI 10.1161/STROKEAHA.108.521906; Oksala NKJ, 2009, J NEUROL NEUROSUR PS, V80, P762, DOI 10.1136/jnnp.2008.154104; Pu HJ, 2019, P NATL ACAD SCI USA, V116, P9115, DOI 10.1073/pnas.1821979116; Rost NS, 2018, J CEREBR BLOOD F MET, V38, P75, DOI 10.1177/0271678X17706449; Shi LG, 2018, J CEREBR BLOOD F MET, V38, P2073, DOI 10.1177/0271678X18798162; Shi YJ, 2017, P NATL ACAD SCI USA, V114, pE1243, DOI 10.1073/pnas.1621174114; Song DG, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1660-8; Stokowska A, 2017, BRAIN, V140, P353, DOI 10.1093/brain/aww314; Sullivan GM, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9342534; Wang RR, 2020, STROKE, V51, P975, DOI 10.1161/STROKEAHA.119.028398; Wang YM, 2016, NAT MED, V22, P1050, DOI 10.1038/nm.4154; Wooten DW, 2019, J NEUROTRAUM, V36, P3233, DOI 10.1089/neu.2018.6178; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Yang Y, 2016, NEUROCHEM RES, V41, P748, DOI 10.1007/s11064-015-1745-4; Yu PP, 2017, MOL NEUROBIOL, V54, P212, DOI 10.1007/s12035-015-9639-7; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495; Zhang L, 2019, J NEUROL SCI, V398, P22, DOI 10.1016/j.jns.2019.01.017; Zhang YL, 2018, J NEUROSURG, V129, P1295, DOI 10.3171/2017.6.JNS171007; Zhao HY, 2021, INT J NEUROSCI, V131, P264, DOI 10.1080/00207454.2020.1738431; Zhao L, 2018, J CEREBR BLOOD F MET, V38, P1299, DOI 10.1177/0271678X17728162; Ziganshina Liliya Eugenevna, 2020, Cochrane Database Syst Rev, V7, pCD007026, DOI 10.1002/14651858.CD007026.pub6	41	2	2	1	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2020	16						3209	3224		10.2147/NDT.S289990			16	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	PI0NX	WOS:000600798500002	33380798	Green Published, gold			2022-02-06	
J	Cao, YQ; Chen, Y; Wang, F; Wang, YG; Long, J				Cao, Yiqiang; Chen, Yu; Wang, Fei; Wang, Yonggang; Long, Jiang			PARP1 might enhance the therapeutic effect of tetrahydroxystilbene glucoside in traumatic brain injury via inhibition of Ras/JNK signalling pathway	FOLIA NEUROPATHOLOGICA			English	Article						PARP1; tetrahydroxystilbene glucoside; traumatic brain injury; Ras/JNK signalling pathway	NITRIC-OXIDE; ACTIVATION; APOPTOSIS; EXPRESSION; CATALASE; PROTEIN; IMPACT; MODEL; BCL-2	Trauma is the main cause of death for people aged 1-45, and among them, traumatic brain injury (TBI) is the major condition, which causes over 50,000 deaths each year and costs over 80 billion per year. Tetrahydroxystilbene glucoside (TSG) is the active ingredient of polygonum multiflorum, a traditional Chinese herbal medicine, which presented multiple pharmacological effects, including antioxidative, anti-inflammatory, reducing blood fat and neuroprotection effects. However, the effect of TSG in promoting the recovery of the nerve system after TBI is not fully understood. PARP1 is a key enzyme in repair of the damage in DNA, which is activated by binding to DNA breaks, initiating both single-strand and double-strand DNA break repair. And we thought that overexpression of TSG might enhance the effect of TSG in TBI treatment. In this study, we firstly detected the oxidative stress response related molecules in serum samples of TBI patients and a TBI mice model, and found that oxidative stress response was activated after TBI, and TSG would reduce this effect. We further noticed that inflammation related molecules presented a similar trend with oxidative stress response related molecules. These results indicated that inflammatory response and oxidative stress processes were both activated after TBI, and reduced after TSG treatment. We further detected that the apoptosis related proteins and anti-oxidative proteins were increased after TSG treatment, and these effects were enlarged after overexpression of PARP1. We further noticed that these effects might be mediated by inhibition of the Ras/JNK signalling pathway. Thus, we thought overexpression of PARP1 might enhance the therapeutic effect of TSG in TBI treatment.	[Cao, Yiqiang; Wang, Fei; Wang, Yonggang; Long, Jiang] Kunming Med Univ, Dept Neurosurg, Affiliated Hosp 1, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China; [Chen, Yu] Zhengzhou Univ, Dept Neurosurg, Affiliated Hosp 1, Zhengzhou, Peoples R China		Long, J (corresponding author), Kunming Med Univ, Dept Neurosurg, Affiliated Hosp 1, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China.	Jiang_long2528@outlook.com		Cao, Yiqiang/0000-0001-7385-6238			ALKHATIB HM, 1987, P NATL ACAD SCI USA, V84, P1224, DOI 10.1073/pnas.84.5.1224; Aravalli RN, 2013, ARCH TOXICOL, V87, P227, DOI 10.1007/s00204-012-0931-2; Ashkenazi A, 2017, NAT REV DRUG DISCOV, V16, P273, DOI 10.1038/nrd.2016.253; Baskaran Y, 2012, EMBO REP, V13, P653, DOI 10.1038/embor.2012.75; Caprioli Joseph, 2009, Trans Am Ophthalmol Soc, V107, P161; Chauhan D, 2003, J BIOL CHEM, V278, P17593, DOI 10.1074/jbc.C300076200; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Ewelina W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10307-z; Glorieux C, 2015, FREE RADICAL BIO MED, V87, P84, DOI 10.1016/j.freeradbiomed.2015.06.017; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hu W, 2018, FOLIA NEUROPATHOL, V56, P112, DOI 10.5114/fn.2018.76615; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kang JG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48130-3; Kodydkova J, 2014, FOLIA BIOL-PRAGUE, V60, P153; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Liu C, 2017, NUCLEIC ACIDS RES, V45, P8129, DOI 10.1093/nar/gkx565; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olczak M, 2019, FOLIA NEUROPATHOL, V57, P51, DOI 10.5114/fn.2019.83831; Park JH, 2015, J NEUROGASTROENTEROL, V21, P51, DOI 10.5056/jnm14008; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rakotoarisoa M, 2019, MOLECULES, V24, DOI 10.3390/molecules24173058; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Tanaka T, 2002, EMBO J, V21, P1695, DOI 10.1093/emboj/21.7.1695; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Tehrani HS, 2018, PROG BIOPHYS MOL BIO, V140, P5, DOI 10.1016/j.pbiomolbio.2018.03.001; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wang ZY, 2013, FREE RADICAL BIO MED, V65, P942, DOI 10.1016/j.freeradbiomed.2013.08.166; Xu JY, 2018, FOLIA NEUROPATHOL, V56, P179, DOI 10.5114/fn.2018.78697; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yu F, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3913981; Zhang M, 2014, CELL TRANSPLANT, V23, P1061, DOI 10.3727/096368913X666999; Ziaja M, 2007, J NEUROTRAUM, V24, P1845, DOI 10.1089/neu.2007.0303	41	2	2	0	0	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1641-4640	1509-572X		FOLIA NEUROPATHOL	Folia Neuropathol.		2020	58	1					45	56		10.5114/fn.2020.94006			12	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	KY6ZL	WOS:000522723000006	32337957	gold			2022-02-06	
J	Castro-Espicalsky, TL; Costa, ST; Santiago, BM; Freire, AR; Daruge, E; Prado, FB; Rossi, AC				Castro-Espicalsky, Talita Lima; Costa, Sarah Teixeira; Santiago, Bianca Marques; Freire, Alexandre Rodrigues; Daruge Junior, Eduardo; Prado, Felippe Bevilacqua; Rossi, Ana Claudia			Craniofacial injuries by firearms projectiles: An analysis of 868 deaths in the five regions of Brazil	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Gunshot wounds; Craniocerebral trauma; Brazil	GUNSHOT INJURIES; FATALITIES; WOUNDS; HEAD; HOMICIDES; DIRECTION; SUICIDE; BULLET; TURKEY; SITE	Firearms injuries have a legal and medico-legal importance, and are especially lethal when they reach the craniofacial regions of the victim. The present study aims to identify the characteristics of craniofacial lesions resulting from firearm projectiles, to register the most affected craniofacial regions by this type of injury and to verify the demographic profile of the victims. A retrospective study was carried out on the autopsy records produced in the first semester of 2015, in five Institutes of Legal Medicine in Porto Velho, situated in the cities of Joao Pessoa, Vitoria, Porto Alegre and Brasilia. Data extracted included sex, skin color and age of the victim, craniofacial region reached, shooting distance, shape and size of the injuries and manner of death (homicide, suicide or accident). Based on the 868 reports analyzed, it was possible to observe 1700 entrance lesions of firearm projectiles in craniofacial regions. Among cases of known manner of death, homicides were the most frequent (97.0%). It was observed a higher frequency of male victims (93.3%), mixed race (62.0%), between the ages of 12 and 29 years (59.4%). In all cases considered as suicide or accident there was only one entrance wound, but in 82.8% of the homicides there were multiple gunshot wounds. The craniofacial most affected regions were temporal (25.2%) and occipital (19.8%). The most common sites of projectiles exit were the temporal (25.3%) and parietal (16.1%). All cases of suicide were related to contact shot (69.2%) or close-range shot (30.8%), and among the homicides the distant range shots were more frequent (54.0%). The shape of entrance wounds was mostly circular (56.8%) and oval (31.3%), and among the exit injuries, the lesions were irregular (43.3%) and starry (24.1%). The entrance wounds showed smaller sizes than the exit lesions (p < 0.0001). The data obtained are useful for guiding research that takes into account craniofacial trauma caused by firearm projectiles, makes it possible to compare this data with those of other countries and can base investigative conclusions based on the analyzes discussed in the present work.	[Castro-Espicalsky, Talita Lima; Costa, Sarah Teixeira; Freire, Alexandre Rodrigues; Prado, Felippe Bevilacqua; Rossi, Ana Claudia] Univ Estadual Campinas, Sch Dent Piracicaba, Dept Morphol, Anat Div,UNICAMP, Campinas, Brazil; [Santiago, Bianca Marques] Univ Fed Paraiba, Dept Clin & Social Dent, Joao Pessoa, Paraiba, Brazil; [Daruge Junior, Eduardo] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Social Odontol, Forens Dent Div,UNICAMP, Campinas, Brazil		Rossi, AC (corresponding author), Univ Estadual Campinas, UNICAMP, Piracicaba Dent Sch, Anat Div,Dept Biosci, 901 Limeira Ave, BR-13414903 Piracicaba, SP, Brazil.	anarossi@unicamp.br	Rossi, Ana Claudia/F-2690-2012; Freire, Alexandre R/F-2697-2012	Rossi, Ana Claudia/0000-0002-8718-4898; Freire, Alexandre R/0000-0002-0175-0896; Lima de Castro-Espicalsky, Talita/0000-0002-4226-4464; daruge junior, eduardo daruge junior/0000-0001-6565-3203	Coordination for the Improvement of Higher Level or Education Personnel (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	The authors are thankful for the financial support granted by Coordination for the Improvement of Higher Level or Education Personnel (CAPES).	Al Madani OM, 2011, EGYPTIAN J FORENSIC, V1, P140, DOI DOI 10.1016/J.EJFS.2011.07.003; Amiri A, 2003, J Clin Forensic Med, V10, P159, DOI 10.1016/S1353-1131(03)00082-8; Azmak D, 1999, FORENSIC SCI INT, V101, P217, DOI 10.1016/S0379-0738(99)00032-8; Azmak D, 1998, FORENSIC SCI INT, V95, P231, DOI 10.1016/S0379-0738(98)00101-7; Chen YB, 2010, J BIOMECH, V43, P1131, DOI 10.1016/j.jbiomech.2009.12.009; Cina SJ, 1999, AM J FOREN MED PATH, V20, P109, DOI 10.1097/00000433-199906000-00001; Costa ST, 2017, J FORENSIC SCI, V62, P361, DOI 10.1111/1556-4029.13387; Costa ST, 2016, AUST J FORENSIC SCI, P1; de la Grandmaison GL, 2008, FORENSIC SCI INT, V177, P207, DOI 10.1016/j.forsciint.2008.01.002; Desinan L, 2005, FORENSIC SCI INT, V147, pS37, DOI 10.1016/j.forsciint.2004.09.089; Dorado-Fernandez E, 2017, J LEGAL MED, V43, P70, DOI [10.1016/j.remle.2017.04.002, DOI 10.1016/J.REMLE.2017.04.002]; Druid H, 1997, FORENSIC SCI INT, V88, P147, DOI 10.1016/S0379-0738(97)00104-7; Edirisinghe PAS, 2010, FORENSIC SCI MED PAT, V6, P93, DOI 10.1007/s12024-009-9139-z; Fedakar Recep, 2007, Legal Medicine, V9, P14, DOI 10.1016/j.legalmed.2006.09.002; Goren S, 2003, TOHOKU J EXP MED, V201, P139, DOI 10.1620/tjem.201.139; Hagras AM, 2012, EGYPT J FORENSIC SCI, V2, P1, DOI DOI 10.1016/J.EJFS.2012.01.002; Jeffery A, 2007, Forensic Sci Med Pathol, V3, P252, DOI 10.1007/s12024-007-0035-0; Karger B, 2002, INT J LEGAL MED, V116, P273, DOI 10.1007/s00414-002-0325-8; Karlsson T, 1999, FORENSIC SCI INT, V101, P131, DOI 10.1016/S0379-0738(99)00017-1; Kumar A, 2015, J FORENSIC SCI, V60, pS83, DOI 10.1111/1556-4029.12593; Maitre M, 2018, FORENSIC SCI INT, V292, P1, DOI 10.1016/j.forsciint.2018.08.036; Matoso RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111192; Myint S, 2014, J FORENSIC LEG MED, V28, P5, DOI 10.1016/j.jflm.2014.09.002; Norris O, 2015, J ORAL MAXIL SURG, V73, P1532, DOI 10.1016/j.joms.2015.03.019; Padosch SA, 2006, FORENSIC SCI INT, V158, P224, DOI 10.1016/j.forsciint.2005.05.024; Quatrehomme G, 1998, FORENSIC SCI INT, V94, P141, DOI 10.1016/S0379-0738(98)00056-5; Rancic N, 2013, J FORENSIC SCI, V58, P1549, DOI 10.1111/1556-4029.12217; RIDDICK L, 1993, AM J FOREN MED PATH, V14, P215, DOI 10.1097/00000433-199309000-00008; Rodrigues LL, 2019, AUST J FORENSIC SCI, V51, P446, DOI 10.1080/00450618.2017.1416173; ROUSE D, 1992, FORENSIC SCI INT, V56, P59, DOI 10.1016/0379-0738(92)90147-O; Solarino B, 2007, FORENSIC SCI INT, V168, P95, DOI 10.1016/j.forsciint.2007.01.023; Stefanopoulos PK, 2015, INT J ORAL MAX SURG, V44, P67, DOI 10.1016/j.ijom.2014.07.012; SUWANJUTHA T, 1988, FORENSIC SCI INT, V37, P223, DOI 10.1016/0379-0738(88)90188-0; Tholpady SS, 2014, J CRANIO MAXILL SURG, V42, P403, DOI 10.1016/j.jcms.2013.06.004; THOMSEN JL, 1991, MED SCI LAW, V31, P162, DOI 10.1177/002580249103100213; United Nations. Centro Regional de las Naciones Unidas para la Paz el Desarme y el Desarrollo en America Latina y el Caribe (UNLIREC), CTR REG NAC UN PAZ D, DOI [10.1016/j.joms.2015.03.019, DOI 10.1016/J.JOMS.2015.03.019]; Verzeletti A, 2009, J FORENSIC LEG MED, V16, P325, DOI 10.1016/j.jflm.2009.01.006	37	2	2	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	JAN	2020	69								101888	10.1016/j.jflm.2019.101888			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	KN0TO	WOS:000514552200004	32056805				2022-02-06	
J	Chen, KH; Shao, PL; Li, YC; Chiang, JY; Sung, PH; Chien, HW; Shih, FY; Lee, MS; Chen, WF; Yip, HK				Chen, Kuan-Hung; Shao, Pei-Lin; Li, Yi-Chen; Chiang, John Y.; Sung, Pei-Hsun; Chien, Hui-Wen; Shih, Fu-Yuan; Lee, Mel S.; Chen, Wu-Fu; Yip, Hon-Kan			Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Effectively Protected the Brain Architecture and Neurological Function in Rat After Acute Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article						traumatic brain injury; xenogeneic cell therapy; neurological function; inflammation; oxidative stress; apoptosis		Intracranial hemorrhage from stroke and head trauma elicits a cascade of inflammatory and immune reactions detrimental to neurological integrity and function at cellular and molecular levels. This study tested the hypothesis that human umbilical cord-derived mesenchymal stem cell (HUCDMSC) therapy effectively protected the brain integrity and neurological function in rat after acute traumatic brain injury (TBI). Adult male Sprague-Dawley rats (n= 30) were equally divided into group 1 (sham-operated control), group 2 (TBI), and group 3 [TBI + HUCDMSC (1.2 x 10(6)cells/intravenous injection at 3 h after TBI)] and euthanized by day 28 after TBI procedure. The results of corner test and inclined plane test showed the neurological function was significantly progressively improved from days 3, 7, 14, and 28 in groups 1 and 3 than in group 2, and group 1 than in group 3 (allP< 0.001). By day 28, brain magnetic resonance imaging brain ischemic volume was significantly increased in group 2 than in group 3 (P< 0.001). The protein expressions of apoptosis [mitochondrial-bax positive cells (Bax)/cleaved-caspase3/cleaved-poly(adenosine diphosphate (ADP)-ribose) polymerase], fibrosis (Smad3 positive cells (Smad3)/transforming growth factor-beta), oxidative stress (NADPH Oxidase 1 (NOX-1)/NADPH Oxidase 2 (NOX-2)/oxidized-protein/cytochrome b-245 alpha chain (p22phox)), and brain-edema/deoxyribonucleic acid (DNA)-damaged biomarkers (Aquaporin-4/gamma H2A histone family member X ( (gamma-H2AX)) displayed an identical pattern to neurological function among the three groups (allP< 0.0001), whereas the protein expressions of angiogenesis biomarkers (vascular endothelial growth factor/stromal cell-derived factor-1 alpha/C-X-C chemokine receptor type 4 (CXCR4)) significantly increased from groups 1 to 3 (allP< 0.0001). The cellular expressions of inflammatory biomarkers (cluster of differentiation 14 (+) cells (CD14+)/glial fibrillary acidic protein positive cells (GFAP+)/ a member of a new family of EGF-TM7 molecules positive cells (F4/80+)) and DNA-damaged parameter (gamma-H2AX) exhibited an identical pattern, whereas cellular expressions of neural integrity (hexaribonucleotide Binding Protein-3 positive cells (NeuN+)/nestin+/doublecortin+) exhibited an opposite pattern of neurological function among the three groups (allP< 0.0001). Xenogeneic HUCDMSC therapy was safe and it significantly preserved neurological function and brain architecture in rat after TBI.	[Chen, Kuan-Hung] Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung, Taiwan; [Chen, Kuan-Hung; Li, Yi-Chen; Sung, Pei-Hsun; Shih, Fu-Yuan; Lee, Mel S.; Chen, Wu-Fu; Yip, Hon-Kan] Chang Gung Univ, Coll Med, Kaohsiung 83301, Taiwan; [Shao, Pei-Lin; Chien, Hui-Wen; Yip, Hon-Kan] Asia Univ, Dept Nursing, Taichung, Taiwan; [Li, Yi-Chen; Sung, Pei-Hsun; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Chiang, John Y.] Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung, Taiwan; [Chiang, John Y.] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Shih, Fu-Yuan; Chen, Wu-Fu] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan; [Lee, Mel S.] Kaohsiung Chang Gung Mem Hosp, Dept Orthoped, Kaohsiung, Taiwan; [Chen, Wu-Fu] Xiamen Chang Gung Hosp, Dept Neurosurg, Xiamen, Fujian, Peoples R China; [Chen, Wu-Fu] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung, Taiwan; [Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Ctr Shockwave Med & Tissue Engn, Kaohsiung, Taiwan; [Yip, Hon-Kan] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yip, Hon-Kan] Xiamen Chang Gung Hosp, Dept Internal Med, Div Cardiol, Xiamen, Fujian, Peoples R China		Chen, WF; Yip, HK (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung 83301, Taiwan.; Yip, HK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.; Chen, WF (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan.	han.gung@msa.hinet.net; chaiht@mail.cgmh.org.tw		Yip, Hon-Kan/0000-0002-6305-5717; Sung, Pei-Hsun/0000-0002-1989-9752	Chang Gung Memorial Hospital, Chang Gung UniversityChang Gung Memorial Hospital [BMRP542]	The author(s) disclosed receipt of the following financial support for the research and/or authorship of this article: This study was supported by a program grant from Chang Gung Memorial Hospital, Chang Gung University (Grant No. BMRP542).	Bartolucci J, 2017, CIRC RES, V121, P1192, DOI 10.1161/CIRCRESAHA.117.310712; Chen KH, 2016, ONCOTARGET, V7, P74537, DOI 10.18632/oncotarget.12902; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; Chen YL, 2015, INT J CARDIOL, V201, P668, DOI 10.1016/j.ijcard.2015.03.137; Di Carlo A, 2009, AGE AGEING, V38, P4, DOI 10.1093/ageing/afn282; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Lambert APF, 2009, DIFFERENTIATION, V77, P221, DOI 10.1016/j.diff.2008.10.016; Hammadi AMA, 2019, EXP CLIN TRANSPLANT, V17, P239, DOI 10.6002/ect.MESOT2018.P102; HU HH, 1992, STROKE, V23, P1237, DOI 10.1161/01.STR.23.9.1237; HUNG T-P, 1988, Taiwan yixuehui zazhi, V87, P261; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Lee FY, 2017, ONCOTARGET, V8, P45626, DOI 10.18632/oncotarget.17320; Lee HS, 2015, J CELL BIOCHEM, V116, P310, DOI 10.1002/jcb.24969; Leu S, 2011, INT J CARDIOL, V150, P156, DOI 10.1016/j.ijcard.2010.03.007; Leu S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-63; Li YC, 2015, FRONT MED-PRC, V9, P20, DOI 10.1007/s11684-014-0371-x; MASDEU JC, 1984, NEUROLOGY, V34, P381, DOI 10.1212/WNL.34.3.381; Misra V, 2012, NEUROLOGY, V79, pS207, DOI 10.1212/WNL.0b013e31826959d2; Paolucci S, 2003, STROKE, V34, P2861, DOI 10.1161/01.STR.0000102902.39759.D3; Park EH, 2018, STEM CELL TRANSL MED, V7, P636, DOI 10.1002/sctm.18-0031; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Shahror RA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6422; Sheu JJ, 2019, AM J TRANSL RES, V11, P67; Testai FD, 2008, NEUROL CLIN, V26, P963, DOI 10.1016/j.ncl.2008.06.001; Vibhuti,, 2017, J NEUROCHEM, V143, P722, DOI 10.1111/jnc.14241; Wang YM, 2019, TURK NEUROSURG, V29, P750, DOI 10.5137/1019-5149.JTN.25463-18.2; Wu K, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1428-1; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yang B, 2013, STROKE, V44, P3463, DOI 10.1161/STROKEAHA.111.000821; Yip HK, 2017, ONCOTARGET, V8, P108692, DOI 10.18632/oncotarget.21433; Yuen CM, 2015, AM J TRANSL RES, V7, P976	35	2	2	3	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.	JAN-DEC	2020	29								0963689720929313	10.1177/0963689720929313			15	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	PQ5KJ	WOS:000606584100004	33169616	gold, Green Published			2022-02-06	
J	Clark, D; Joannides, A; Abdallah, OI; Adeleye, AO; Bajamal, AH; Bashford, T; Bhebhe, A; Biluts, H; Budohoska, N; Budohoski, K; Cherian, I; Marklund, N; Mendez, RF; Figaji, T; Gupta, DK; Iaccarino, C; Ilunga, A; Joseph, M; Khan, T; Laeke, T; Waran, V; Park, K; Rosseau, G; Rubiano, A; Saleh, Y; Shabani, HK; Smith, B; Sichizya, K; Tewari, M; Tirsit, A; Thu, M; Tripathi, M; Trivedi, R; Villar, S; Bhagavatula, ID; Servadei, F; Menon, D; Kolias, A; Hutchinson, P				Clark, David; Joannides, Alexis; Abdallah, Omar Ibrahim; Adeleye, Amos Olufemi; Bajamal, Abdul Hafid; Bashford, Tom; Bhebhe, Arnold; Biluts, Hagos; Budohoska, Natalia; Budohoski, Karol; Cherian, Iype; Marklund, Niklas; Mendez, Rocio Fernandez; Figaji, Tony; Gupta, Deepak Kumar; Iaccarino, Corrado; Ilunga, Ali; Joseph, Mathew; Khan, Tariq; Laeke, Tsegazeab; Waran, Vicknes; Park, Kee; Rosseau, Gail; Rubiano, Andres; Saleh, Youssuf; Shabani, Hamisi K.; Smith, Brandon; Sichizya, Kachinga; Tewari, Manoj; Tirsit, Abenezer; Thu, Myat; Tripathi, Manjul; Trivedi, Rikin; Villar, Sofia; Bhagavatula, Indira Devi; Servadei, Franco; Menon, David; Kolias, Angelos; Hutchinson, Peter		Global Neurotrauma Outcomes Study	Management and outcomes following emergency surgery for traumatic brain injury - A multi-centre, international, prospective cohort study (the Global Neurotrauma Outcomes Study)	INTERNATIONAL JOURNAL OF SURGERY PROTOCOLS			English	Article						Injuries; Brain injuries; Traumatic; Neurosurgery; Epidemiology; Global health	HEMATOMA; CRANIOTOMY; PROGNOSIS; CARE	Introduction: Traumatic brain injury (TBI) accounts for a significant amount of death and disability worldwide and the majority of this burden affects individuals in low-and-middle income countries. Despite this, considerable geographical differences have been reported in the care of TBI patients. On this background, we aim to provide a comprehensive international picture of the epidemiological characteristics, management and outcomes of patients undergoing emergency surgery for traumatic brain injury (TBI) worldwide. Methods and analysis: The Global Neurotrauma Outcomes Study (GNOS) is a multi-centre, international, prospective observational cohort study. Any unit performing emergency surgery for TBI worldwide will be eligible to participate. All TBI patients who receive emergency surgery in any given consecutive 30-day period beginning between 1st of November 2018 and 31st of December 2019 in a given participating unit will be included. Data will be collected via a secure online platform in anonymised form. The primary outcome measures for the study will be 14-day mortality (or survival to hospital discharge, whichever comes first). Final day of data collection for the primary outcome measure is February 13th. Secondary outcome measures include return to theatre and surgical site infection. Ethics and dissemination: This project will not affect clinical practice and has been classified as clinical audit following research ethics review. Access to source data will be made available to collaborators through national or international anonymised datasets on request and after review of the scientific validity of the proposed analysis by the central study team. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd.	[Clark, David; Joannides, Alexis; Adeleye, Amos Olufemi; Bajamal, Abdul Hafid; Bashford, Tom; Biluts, Hagos; Budohoska, Natalia; Budohoski, Karol; Figaji, Tony; Gupta, Deepak Kumar; Joseph, Mathew; Khan, Tariq; Laeke, Tsegazeab; Waran, Vicknes; Rubiano, Andres; Shabani, Hamisi K.; Smith, Brandon; Sichizya, Kachinga; Tewari, Manoj; Tirsit, Abenezer; Thu, Myat; Tripathi, Manjul; Trivedi, Rikin; Bhagavatula, Indira Devi; Menon, David; Kolias, Angelos; Hutchinson, Peter] Univ Cambridge, Natl Inst Hlth Res Global Hlth Res Grp Neurotraum, Cambridge CB2 0QQ, England; [Clark, David; Bhebhe, Arnold; Ilunga, Ali; Sichizya, Kachinga] Univ Teaching Hosp, Lusaka, Zambia; [Abdallah, Omar Ibrahim] Sohag Univ Hosp, Sohag, Egypt; [Adeleye, Amos Olufemi] Univ Coll Hosp Ibadan, Ibadan, Oyo, Nigeria; [Bajamal, Abdul Hafid] Dr Soetomo Hosp, Surabaya, Jawa Timur, Indonesia; [Bashford, Tom; Mendez, Rocio Fernandez] Univ Cambridge, Cambridge, Cambs, England; [Biluts, Hagos; Laeke, Tsegazeab] Addis Ababa Univ, Coll Hlth Sci, Surg Dept, Neurosurg Unit, Addis Ababa, Oromia, Ethiopia; [Cherian, Iype] Nobel Med Coll Teaching Hosp P Ltd, Morang, Nepal; [Marklund, Niklas] Lund Univ, Skane Univ Hosp, Lund, Sweden; [Figaji, Tony] Univ Cape Town, Rondebosch, Western Cape, South Africa; [Gupta, Deepak Kumar] All India Inst Med Sci, Delhi, India; [Iaccarino, Corrado] Univ Hosp Parma, Parma, Emilia Romagna, Italy; [Joseph, Mathew] Christian Med Coll Vellore Assoc, Vellore, Tamil Nadu, India; [Khan, Tariq] North West Gen Hosp & Res Ctr, Peshawar, Khyber Pakhtunk, Pakistan; [Waran, Vicknes] Univ Malaya, Med Ctr, Kuala Lumpur, Wilayah Perseku, Malaysia; [Park, Kee] Harvard Med Sch, Boston, MA 02115 USA; [Rosseau, Gail] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Rubiano, Andres] Univ El Bosque, Dept Neurosurg, Bogota, Colombia; [Saleh, Youssuf] Univ Oxford, Oxford, Oxon, England; [Shabani, Hamisi K.] Muhimbili Orthopaed Inst, Dar Es Salaam, Tanzania; [Shabani, Hamisi K.] Muhimbili Univ Coll Allied Hlth Sci, Dar Es Salaam, Tanzania; [Tewari, Manoj; Tripathi, Manjul] Post Grad Inst Med Educ & Res Chandigarh, Chandigarh, India; [Tirsit, Abenezer] Addis Ababa Univ, Tikur Anbessa Specialized Hosp, Addis Ababa, Oromia, Ethiopia; [Thu, Myat] Yangon Gen Hosp, Yangon, Yangon Region, Myanmar; [Villar, Sofia] MRC Biostat Unit, Cambridge, Cambs, England; [Bhagavatula, Indira Devi] Natl Inst Mental Hlth & Neurosci, Bangalore, Karnataka, India; [Servadei, Franco] Humanitas Univ & Res Hosp, Dept Neurosurg, Milan, Italy		Clark, D (corresponding author), Univ Cambridge, Div Neurosurg, Natl Inst Hlth Res Global Hlth Res Grp Neurotraum, Cambridge CB2 0QQ, England.	gnos@globalneurotrauma.com	Iaccarino, Corrado/L-3190-2013; Tripathi, Manjul/AAN-8701-2021; Bashford, Tom/H-9586-2019; Mathaneswaran, Vickneswaran/E-5180-2010	Iaccarino, Corrado/0000-0002-5133-6327; Bashford, Tom/0000-0003-0228-9779; Figaji, Anthony/0000-0002-3357-6490; Tripathi, Manjul/0000-0002-5679-3439; Kolias, Angelos/0000-0003-3992-0587	NIHR Global Health Research Group grant	This project has received support from a NIHR Global Health Research Group grant. The funder has not been involved in the drafting of this protocol or review of this manuscript.	Bhangu A, 2016, BRIT J SURG, V103, P971, DOI 10.1002/bjs.10151; Bhangu A, 2018, LANCET INFECT DIS, V18, P516, DOI 10.1016/S1473-3099(18)30101-4; Biccard BM, 2018, LANCET, V391, P1589, DOI [10.1016/S0140-6736(18)30001-1, 10.1016/s0140-6736(18)30001-1]; Botman M, 2015, WORLD J SURG, V39, P1335, DOI 10.1007/s00268-015-3057-x; Brennan Paul M, 2017, J Neurosurg, P1, DOI 10.3171/2016.8.JNS16134.test; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hauptman JS, 2011, J NEUROSURG, V115, P1262, DOI 10.3171/2011.8.JNS11857; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Mock CN, 2015, LANCET, V385, P2209, DOI 10.1016/S0140-6736(15)60091-5; Patel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161554; Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; WHO, 2015, CAUS SPEC MORT EST 2	20	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2468-3574			INT J SURG PROTOC	Int. J. Surg. Protocol.		2020	20						1	7		10.1016/j.isjp.2020.02.001			7	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	LD0WY	WOS:000525755400001	32211566	Green Published, gold			2022-02-06	
J	Clopton, ZD				Clopton, Zachary D.			MDL AS CATEGORY	CORNELL LAW REVIEW			English	Article							MULTIDISTRICT LITIGATION; AGGREGATE LITIGATION; PERSONAL JURISDICTION; PANEL ASSIGNMENT; CIVIL PROCEDURE; FEDERAL-COURTS; CHIEF-JUSTICE; ONE SIZE; LAW; LESSONS	Multidistrict litigation (MDL) dominates the federal civil docket. MDL has been used to consolidate hundreds of thousands of cases, including with respect to asbestos, the BP oil spill, Johnson & Johnson baby powder, NFL concussions, opioids, and more. In recent years, MDL has attracted the attention of reformers and scholars, who have offered proposals for rules or practices that would apply to all MDLs, and to only MDLs. These proposals are premised on a fundamental error about what MDL is. Using quantitative and qualitative data, case studies, and interviews with judges, this Article demonstrates that reformers and scholars have made a mistake about what defines the category "MDL." MDL is not a uniform category of large civil cases demanding one-size-fits-all procedure. Recent proposals for MDL-specific rules, therefore, are misguided. Indeed, because such proposals would create incentives for parties to "procedure shop" into or out of MDL, they imperil horizontal equity and invite abuse. Proposals for MDL-specific rules thus risk exacerbating existing problems in MDL and creating new problems that were not there before. That said, MDL is a coherent category with respect to the way MDLs are created. Every MDL is created by the Judicial Panel on Multidistrict Litigation (JPML), a group of seven judges hand picked by the Chief Justice, who have the nearly unconstrained authority to decide whether to consolidate cases and to which federal judge to assign them. Yet despite this unusual and highly consequential procedure, reformers and scholars have paid scant attention to the JPML. Having dispensed with the initial MDL categorization error, this Article also examines the understudied role of the JPML and offers suggestions for JPML reform consistent with a clearer description of what MDL is.	[Clopton, Zachary D.] Northwestern Pritzker Sch Law, Chicago, IL 60611 USA		Clopton, ZD (corresponding author), Northwestern Pritzker Sch Law, Chicago, IL 60611 USA.						[Anonymous], 2017, AUD TAP MDL PROBL P; [Anonymous], 2017, TABL C US DISTR COUR; [Anonymous], 2017, REQ RUL ADV COMM CIV, V481; Associated Press, 2017, ASS PRESS; BANE CHARLES A., 1973, ELECT EQUIPMENT CONS, P317; Bartley Lisa, 2017, ABC7; Bellon Tina, 2017, REUTERS; Bock JF, 2018, CALIF LAW REV, V106, P1657, DOI 10.15779/Z38BG2H979; BONE RG, 2008, OKLA L REV, V61, P319; Bone RG, 2014, GEORGE WASH LAW REV, V82, P651; Bookman PK, 2017, NEW YORK U LAW REV, V92, P767; Bookman PK, 2016, NOTRE DAME LAW REV, V92, P579; Bookman Pamela K., 2016, NOTRE DAME L REV, V92, P628; Bradt AD, 2019, GEORGETOWN LAW J, V108, P73; Bradt AD, 2018, FORDHAM LAW REV, V87, P87; Bradt AD, 2018, NORTHWEST U LAW REV, V112, P905; Bradt AD, 2017, CALIF LAW REV, V105, P1259, DOI 10.15779/Z388P5V874; Bradt AD, 2017, U PENN LAW REV, V165, P1711; Bradt AD, 2017, U PENN LAW REV, V165, P831; Bradt AD, 2012, NOTRE DAME LAW REV, V88, P759; Bradt Andrew D., 2018, BOSTON COLL LAW REV, V59, P1251; Bradt Andrew D., 2019, GEORGETOWN LAW J, V108, P88; Bradt Andrew D., 2018, B C L REV, V59, P1261; Bray SL, 2017, HARVARD LAW REV, V131, P417; Bray Samuel L., 2017, HARVARD LAW REV, V131, P457; Bui D, 2013, BMC CANCER, V13, P1, DOI DOI 10.1175/JAS-D-13-021.1; BURBANK SB, 1987, MICH LAW REV, V85, P1463, DOI 10.2307/1289061; BURBANK SB, 1982, U PENN LAW REV, V130, P1015, DOI 10.2307/3311804; Burbank Stephen, 1982, U PENN LAW REV, V130, P1018; Burbank SB, 2017, RIGHTS AND RETRENCHMENT: THE COUNTERREVOLUTION AGAINST FEDERAL LITIGATION, P65; Burch EC, 2014, LOUISIANA LAW REV, V73, P399; Burch EC, 2017, VANDERBILT LAW REV, V70, P67; Burch EC, 2015, NEW YORK U LAW REV, V90, P71; Burch Elizabeth Chamblee, 2017, U PENN LAW REV, V70, P77; Cabraser EJ, 2017, NEW YORK U LAW REV, V92, P846; Chamblee L. Elizabeth, 2004, LA LAW REV, V65, P158; Chamblee L. Elizabeth, 2004, LA LAW REV, V65, P157; Chilton AS, 2015, CORNELL LAW REV, V101, P1; Clopton ZD, 2019, CALIF LAW REV, V107, P1713, DOI 10.15779/Z38TT4FT52; Clopton ZD, 2018, CORNELL LAW REV, V104, P1; Clopton Zachary D., 2021, NW U L REV, V115; Clopton Zachary D., 2015, IND L J, V90, P1414; Cloptons ZD, 2015, INDIANA LAW J, V90, P1387; Coleman BD, 2016, WASH LAW REV, V91, P1005; Coleman Brooke D., 2018, NORTHWEST U LAW REV, V113, P52; Coleman Brooke D., 2018, NORTHWEST U LAW REV, V113, P62; Dobbins JC, 2010, MICH LAW REV, V108, P1453; Dodge Jaime, 2014, EMORY LJ, V64, P329; Dodge Jaime, 2014, EMORY LJ, V64, P332; Dodson S, 2019, MICH LAW REV, V117, P1463; DUKE LAW CTR, 2014, MDL STAND BEST PRACT; Engstrom NF, 2019, YALE LAW J, V129, P2; Engstrom NF, 2017, MICH LAW REV, V115, P639; Ewing J., 2018, NY TIMES; EWING JACK, 2017, FASTER HIGHER FARTHE, P1; Fallon Eldon E., 2008, TUL L REV, V82, P2354; Fallon Eldon E., 2008, TUL L REV, V82, P2328; Feinberg KR, 2012, COLUMBIA J LAW SOC P, V45, P481; Frost A, 2018, NEW YORK U LAW REV, V93, P1065; Frost Amanda, 2018, NEW YORK U LAW REV, V93, P1069; Galanter M., 2004, J EMPIR LEGAL STUD, V1, P459; Glover JM, 2018, FORDHAM LAW REV, V86, P2113; Gluck AR, 2017, U PENN LAW REV, V165, P1669; HART JR HENRY M., 1958, LEGAL PROCESS BASIC, P155; Hellerstein AK, 2012, CORNELL LAW REV, V98, P127; Hellerstein Alvin K, 2013, WASH U L REV, V90, P653; Hoffman Jan, 2018, NY TIMES; Hsu T., 2018, NY TIMES; Issacharoff S, 2004, VANDERBILT LAW REV, V57, P1571; Jack Downing Note, 2016, MO L REV, V81, P833; Jack Downing Note, 2016, MO L REV, V81, P831; Lahav AD, 2008, GEORGE WASH LAW REV, V76, P576; Lahav AD, 2018, VANDERBILT LAW REV, V71, P821; Land Clay D., 2019, GA L REV, V53, P1237; Land Clay D., 2019, GA L REV, V53, P1238; Langbein JH, 2012, YALE LAW J, V122, P522; LAWYERS FOR CIVIL JUSTICE, 2017, ADV COMM RUL CIV PRO; Lemos MH, 2012, HARVARD LAW REV, V126, P486; Lemos Margaret H., 2012, HARVARD LAW REV, V496-97; Levy MK, 2017, CORNELL LAW REV, V103, P65; Lingwall Jeff, 2018, MISS L J, V87, P132; Lingwall Jeff, 2018, MISS L J, V87, P131; Margaret S.Thomas, 2014, EMORY LJ, V63, P1339; McKenzie TA, 2012, NEW YORK U LAW REV, V87, P960; McKenzie Troy A., 2012, NEW YORK U LAW REV, V87, P980; Moore Patricia Hatamyar, 2013, UMKC L REV, V82, P175; Moore Patricia Hatamyar, 2013, UMKC L REV, V82, P133; Mueller Christopher B., 2017, KAN L REV, V65, P533; Mueller Christopher B., 2017, U KAN L REV, V65, P531; Mullenix LS, 2013, NORTHWEST U LAW REV, V107, P511; Mullenix LS, 2011, U CINCI LAW REV, V80, P389; Mullenix Linda S., 2011, U CIN L REV, V80, P390; Mullenix Linda S., 2015, NEV LJ, V15, P1455; Mullenix Linda S., 2015, NEV LJ, V15, P1469; Mulligan LN, 2012, UCLA LAW REV, V59, P1188; Mulligan Lumen N., 2012, UCLA LAW REV, V59, P1206; NEAL PC, 1964, AM BAR ASSOC J, V50, P621; Noll DL, 2019, MICH LAW REV, V118, P403; Pfander JE, 2007, CALIF LAW REV, V95, P1423; Pfander JE, 2013, NORTHWEST U LAW REV, V107, P1125; Pollis AS, 2011, FORDHAM LAW REV, V79, P1643; Ratner MA, 2017, WASH LAW REV, V92, P785; Ratner Morris A., 2017, WASH L REV, V92, P845; Ratner Morris A., 2018, REV LITIG, V37, P123; Redish MH, 2015, BOSTON U LAW REV, V95, P109; Redish Martin H., 1995, UC DAVIS L REV, V28, P917; Redish Martin H., 2015, BU L REV, V95, P111; Redish Martin H., 1995, UC DAVIS L REV, V28, P957; Redish MartinH., 1981, NORTHWEST U LAW REV, V75, P1113; REDISH MH, 1981, NORTHWEST U LAW REV, V75, P1112; Rensberger JL, 2018, WISC LAW REV, P847; Rensberger Jeffrey L., 2018, WISC LAW REV, P859; RESNIK J, 1982, HARVARD LAW REV, V96, P374, DOI 10.2307/1340797; RESNIK J, 1991, LAW CONTEMP PROBL, V54, P5, DOI 10.2307/1191922; Resnik J, 2017, U PENN LAW REV, V165, P1765; Resnik J, 2017, NEW YORK U LAW REV, V92, P1017; Resnik J, 2006, U PENN LAW REV, V154, P1575, DOI 10.2307/40041348; Resnik Judith, 2006, U PENN LAW REV, V154, P1585; ROBERTSON C, 2015, NY TIMES; Ruger Theodore W., 2004, U PA J CONST L, V7, P388; RUGER TW, 2004, U PA J CONST L, V0007, P00341; SAACK AL, 2017, LEWIS CLARK L REV, V21, P847; Sant'Ambrogio M, 2017, YALE LAW J, V126, P1634; Shapiro DL, 1998, NOTRE DAME LAW REV, V73, P913; Simard LS, 2018, VANDERBILT LAW REV, V71, P1919; Simard Linda Sandstrom, 2018, VANDERBILT LAW REV, V71, P1924; Spencer AB, 2019, UCLA LAW REV, V66, P654; Struve Catherine T., 2002, U PENN LAW REV, V150, P1103; Struve CT, 2002, U PENN LAW REV, V150, P1099, DOI 10.2307/3312995; Subrin SN, 2010, DENVER U LAW REV, V87, P377; Tidmarsh Jay, 2019, CALIF LAW REV, V51, P771; Tischbein Cory, 2013, U PA J CONST L, V16, P233; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; U.S. JUDICIAL PANEL ON MULTIDISTRICT LITIG, 2018, MDL STAT REPORT DOCK; U.S. JUDICIAL PANEL ON MULTIDISTRICT LITIG, 2017, MULT LIT TERM THROUG; U.S. JUDICIAL PANEL ON MULTIDISTRICT LITIG, 2018, MDL STAT REP DISTR P; WEINSTEIN JB, 1994, NORTHWEST U LAW REV, V88, P469; Williams MS, 2013, J EMPIR LEGAL STUD, V10, P424, DOI 10.1111/jels.12015; Williams Margaret S., 2019, GA L REV, V53, P1270; Williams Margaret S., 2012, J TORT L, V5, P157; Williams Margaret S., 2012, J TORT L, V5, P141; WILLIAMS MS, 2019, GA L REV, V53, P1245; Wolff Tobias B., 2013, WASH U L REV, V90, P1030; Wolff TB, 2017, U PENN LAW REV, V165, P1847; Wolff Tobias Barrington, 2017, UC DAVIS L REV, V165, P1883; WOOD DP, 1987, INDIANA LAW J, V62, P597; WRIGHT CHARLES ALAN, 2019, FEDERAL PRACTICE PRO, V3866; WRIGHT CHARLES ALAN, 2019, FEDERAL PRACTICE PRO, V8; Zimmerman AS, 2017, FORDHAM LAW REV, V85, P2275	149	2	2	0	0	CORNELL LAW REVIEW	ITHACA	CORNELL LAW SCHOOL, ITHACA, NY 14853-4901 USA	0010-8847			CORNELL LAW REV	Cornell Law Rev.		2020	105	5					1297	1342					46	Law	Social Science Citation Index (SSCI)	Government & Law	NT8WH	WOS:000573217100001					2022-02-06	
S	Conde, V; Siebner, HR		Ramsey, NF; Millan, JD		Conde, Virginia; Siebner, Hartwig Roman			Brain damage by trauma	BRAIN-COMPUTER INTERFACES	Handbook of Clinical Neurology		English	Article; Book Chapter							CONNECTIVITY PREDICTS; ATTENTION DEFICITS; NETWORK FUNCTION; STIMULATION; INJURY; NEUROFEEDBACK; PLASTICITY; REHABILITATION; CONSCIOUSNESS; INTERFACES	Traumatic brain injury (TBI) represents a major clinical and economic challenge for health systems worldwide, and it is considered one of the leading causes of disability in young adults. The recent development of brain-computer interface (BCI) tools to target cognitive and motor impairments has led to the exploration of these techniques as potential therapeutic tools in patients with TBI. However, little evidence has been gathered so far to support applicability and efficacy of BCIs for TBI in a clinical setting. In the present chapter, results from studies using BCI approaches in conscious patients with TBI or in animal models of TBI as well as an overview of future directions in the use of BCIs to treat cognitive symptoms in this patient population will be presented.	[Conde, Virginia; Siebner, Hartwig Roman] Univ Copenhagen, Danish Res Ctr Magnet Resonance, Hosp Hvidovre, DK-2650 Copenhagen, Denmark; [Conde, Virginia] Norwegian Univ Sci & Technol, Dept Psychol, Clin Neurosci Lab, Trondheim, Norway; [Siebner, Hartwig Roman] Univ Copenhagen, Bispebjerg Hosp, Dept Neurol, Copenhagen, Denmark		Siebner, HR (corresponding author), Univ Copenhagen, Danish Res Ctr Magnet Resonance, Hosp Hvidovre, DK-2650 Copenhagen, Denmark.	h.siebner@drcmr.dk		Conde, Virginia/0000-0002-0309-0393			Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Baliyan V, 2016, WORLD J RADIOL, V8, P785, DOI 10.4329/wjr.v8.i9.785; Bennett CN, 2018, CLIN EEG NEUROSCI; Bick SKB, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.3.FOCUS162; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Chaudhary U, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.1002593; Dancause N, 2011, PROG BRAIN RES, V192, P273, DOI 10.1016/B978-0-444-53355-5.00015-4; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Dhaliwal SK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00119; Groppa S, 2012, HUM BRAIN MAPP, V33, P419, DOI 10.1002/hbm.21221; Grosse-Wentrup M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025004; Guggenmos DJ, 2013, P NATL ACAD SCI USA, V110, P21177, DOI 10.1073/pnas.1316885110; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Hashim E, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00097; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Ito K, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3794029; Karabanov A, 2016, CURR OPIN NEUROL, V29, P397, DOI 10.1097/WCO.0000000000000342; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Krucoff MO, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00584; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lucchiari C, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00020; Mandonnet E, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00082; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Munivenkatappa A, 2014, NEUROREHABILITATION, V35, P481, DOI 10.3233/NRE-141140; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Olsen A, 2015, CEREB CORTEX, V25, P2170, DOI 10.1093/cercor/bhu023; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peters Matthew E, 2018, Concussion, V3, pCNC56, DOI 10.2217/cnc-2018-0001; Rebesco JM, 2011, PROG BRAIN RES, V192, P83, DOI 10.1016/B978-0-444-53355-5.00006-3; Rezai AR, 2016, NEUROSURGERY, V79, P204, DOI 10.1227/NEU.0000000000001190; Riccio A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045001; Rosanova M, 2012, BRAIN, V135, P1308, DOI 10.1093/brain/awr340; Rostami R, 2017, CHIN J TRAUMATOL, V20, P278, DOI 10.1016/j.cjtee.2016.11.007; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Ruffini G, 2014, NEUROIMAGE, V89, P216, DOI 10.1016/j.neuroimage.2013.12.002; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schiff ND, 2002, NEUROL RES, V24, P116, DOI 10.1179/016164102101199576; Schreuder M, 2013, ARTIF INTELL MED, V59, P71, DOI 10.1016/j.artmed.2013.07.005; Serruya MD, 2008, BEHAV BRAIN RES, V192, P149, DOI 10.1016/j.bbr.2008.04.007; Sharma M, 2016, J NEUROSURG SCI, V60, P242; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sophie Su Y, 2016, TRANSLATIONAL RES TR; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Surmeli T, 2017, CLIN EEG NEUROSCI, V48, P217, DOI 10.1177/1550059416654849; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Trojano L, 2009, J REHABIL MED, V41, P393, DOI 10.2340/16501977-0344; Turner DA, 2016, TRANSLATIONAL RES TR; Vallence AM, 2014, CORTEX, V58, P261, DOI 10.1016/j.cortex.2013.12.006; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Vincent C, 2010, CAN J OCCUP THER, V77, P101, DOI 10.2182/cjot.2010.77.2.6; Wheble JLC, 2016, J ROY ARMY MED CORPS, V162, P87, DOI 10.1136/jramc-2015-000472; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Zhang HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00392-5	71	2	2	1	2	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463933-2; 978-0-44-463934-9	HAND CLINIC			2020	168						39	49		10.1016/B978-0-444-63934-9.00005-6			11	Computer Science, Cybernetics; Engineering, Biomedical; Neurosciences; Rehabilitation	Book Citation Index – Science (BKCI-S)	Computer Science; Engineering; Neurosciences & Neurology; Rehabilitation	BR6QJ	WOS:000662859700006	32164867				2022-02-06	
J	Dean, NA; Bundon, A				Dean, Nikolaus A.; Bundon, Andrea			'You're only falling into water!': exploring surfers' understandings of concussion in Canadian surf culture	QUALITATIVE RESEARCH IN SPORT EXERCISE AND HEALTH			English	Article						Concussion; surfing; injury; gender; risk	SPORT	Over the last decade, a growing body of research has explored the linkages between sport and sport-related concussion (SRC). However, collectively, these studies have primarily focused on three commonalities: team sport, contact sport and mainstream sport, all the while ignoring the participants of individualised, non-contact, alternative sports such as surfing. Noting this gap within the existing literature, this qualitative, interview-driven study critically explored how twelve (n = 12), experienced surfers from the West Coast of Canada came to perceive, give meaning towards and manage sport-related concussion within the ethos of Canadian surfing subculture. The findings demonstrated that surfers expressed mixed and ambiguous understandings of and attitudes towards sport-related concussion. These, we argued, fuelled their headstrong attitudes and embodiments towards sport-related concussion. In addition, the findings revealed that both male and female surfers were willing to push through their concussive injuries as a way of showing one's commitment to the surfing subculture and found that surfers would return-to-surf following an SRC for three primary reasons 1) the wave conditions, 2) limited amount of time to surf and 3) pressures from others in the water. The findings from this study have the potential to inform surfers, surf instructors and surf organisations about the topic of sport-related concussion in surfing and importantly about the topic of head-related safety in surfing.	[Dean, Nikolaus A.; Bundon, Andrea] Univ British Columbia, Sch Kinesiol, 1924 West Mall, Vancouver, BC, Canada		Dean, NA (corresponding author), Univ British Columbia, Sch Kinesiol, 1924 West Mall, Vancouver, BC, Canada.	nik.dean@ubc.ca	Bundon, Andrea/I-8679-2016	Bundon, Andrea/0000-0002-6287-4788			Accident Compensation Corporation New Zealand (ACC), 2019, AM INJURED; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Atencio M, 2009, QUAL RES SPORT EXERC, V1, P3, DOI 10.1080/19398440802567907; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; Booth D., 2004, UNDERSTANDING LIFEST, P94; Braun V, 2016, ROUT INT HANDB, P191; Brayton S, 2019, COMMUN SPORT, V7, P110, DOI 10.1177/2167479517740342; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Charlesworth H, 2004, SPORTING BODIES DAMA, P163; Connell R.W., 2002, GENDER; Dant T, 2007, ANTHROPOL TODAY, V23, P8, DOI 10.1111/j.1467-8322.2007.00547.x; Dart J., 2018, TOFINO GUIDE; Dean NA, 2019, SOCIOL SPORT J, V36, P22, DOI 10.1123/ssj.2018-0033; Dumas A, 2009, LEISURE STUD, V28, P19, DOI 10.1080/02614360802334898; Emerson R.M., 2011, WRITING ETHNOGRAPHIC; Evers C., 2004, CULTURAL STUDIES REV, V10, P27, DOI [10.5130/csr.v10i1.3519, DOI 10.5130/csr.v10i1.3519, DOI 10.5130/CSR.V10I1.3519]; Evers C, 2006, J SPORT SOC ISSUES, V30, P229, DOI 10.1177/0193723506290394; Evers C, 2009, SOC CULT GEOGR, V10, P893, DOI 10.1080/14649360903305783; Ford N., 2006, SURFING SOCIAL THEOR; Furness J, 2015, AM J SPORT MED, V43, P1246, DOI 10.1177/0363546514567062; Geertz C., 1973, INTERPRETATION CULTU; Gilchrist P, 2017, INT J SPORT POLICY P, V9, P1, DOI 10.1080/19406940.2017.1293132; Gilchrist P, 2011, INT J SPORT POLICY P, V3, P109, DOI 10.1080/19406940.2010.547866; Hay CSM, 2009, WILD ENVIRON MED, V20, P335, DOI 10.1580/1080-6032-020.004.0335; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; HUNT JC, 1995, SYMB INTERACT, V18, P439, DOI 10.1525/si.1995.18.4.439; Kern L, 2014, SAFETY SCI, V62, P370, DOI 10.1016/j.ssci.2013.08.009; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Klick C, 2016, AM J EMERG MED, V34, P1491, DOI 10.1016/j.ajem.2016.05.008; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Liston K, 2018, INT REV SOCIOL SPORT, V53, P668, DOI 10.1177/1012690216679966; LYNG S, 1990, AM J SOCIOL, V95, P851, DOI 10.1086/229379; Lyng S., 2005, EDGEWORK SOCIOLOGY R; Malcolm D, 2018, SOCIOL SPORT J, V35, P141, DOI 10.1123/ssj.2017-0113; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; Nathanson A, 2002, AM J EMERG MED, V20, P155, DOI 10.1053/ajem.2002.32650; Nathanson A, 2007, AM J SPORT MED, V35, P113, DOI 10.1177/0363546506293702; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Nixon H. L. II, 1992, Journal of Sport and Social Issues, V16, P127, DOI 10.1177/019372359201600208; Olive R, 2015, SPORT EDUC SOC, V20, P258, DOI 10.1080/13573322.2012.754752; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosano M., 2016, CANADIAN GEOGRAPHIC; Rubin H.J., 2005, QUALITATIVE INTERVIE, V2nd; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Sayer A., 2019, HOW TOFINO BECAME CA; Shilling G, 2003, CEDAR SURF INFORMAL; Smith B, 2016, ROUT INT HANDB, P103; Stranger M., 1999, International Review for the Sociology of Sport, V34, P265, DOI 10.1177/101269099034003003; Stranger M., 2011, SURFING LIFE SURFACE; Swinney Christian, 2015, Hawaii J Med Public Health, V74, P403; Taylor DM, 2005, WILD ENVIRON MED, V16, P75, DOI 10.1580/1080-6032(2005)16[75:POSRRT]2.0.CO;2; Taylor DM, 2004, J SCI MED SPORT, V7, P429, DOI 10.1016/S1440-2440(04)80260-3; Ulkestad G.-E., 2016, OPEN SPORTS SCI J, V9, P153, DOI [10.2174/1875399X01609010153, DOI 10.2174/1875399X01609010153]; Ventresca M, 2019, COMMUN SPORT, V7, P135, DOI 10.1177/2167479518761636; Waitt G, 2008, SOC CULT GEOGR, V9, P75, DOI 10.1080/14649360701789600; Waitt G, 2007, INT STUD PHYS EDUC Y, P99; Wheaton B., 2002, Power games: a critical sociology of sport, P240; Wheaton B, 2017, ANN LEIS RES, V20, P96, DOI 10.1080/11745398.2016.1167610; Willis JW, 2007, FDN QUALITATIVE RES; Woodacre T, 2015, INJURY, V46, P162, DOI 10.1016/j.injury.2014.07.019; Young, 2004, SPORTING BODIES DAMA, P59; Young K., 1995, Journal of Sport and Social Issues, V19, P45, DOI 10.1177/019372395019001004; YOUNG K, 1994, SOCIOL SPORT J, V11, P175, DOI 10.1123/ssj.11.2.175; Young K, 2012, SPORT, VIOLENCE AND SOCIETY, P100	65	2	2	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2159-676X	2159-6778		QUAL RES SPORT EXERC	Qual. Res. Sport Exerc. Health		2020	12	4					579	596		10.1080/2159676X.2019.1657930			18	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	QE0TJ	WOS:000615920200008					2022-02-06	
J	Demirkiran, H; Uzunoglu, E; Erdivanli, B; Karadamar, U; KOc, S; Tomak, Y; Ozmen, M; Almali, N; Cagac, A; Comez, MS; Tuncer, M; Tokur, ME; Bayrakci, S; Binici, O; Bahadir, T; Tekeli, AE; Bahar, I; Karakas, B; Keskin, S; Oksuz, H				Demirkiran, Hilmi; Uzunoglu, Emine; Erdivanli, Basar; Karadamar, Ulas; KOc, Suna; Tomak, Yakup; Ozmen, Mustafa; Almali, Necat; Cagac, Aydin; Comez, Mehmet Selim; Tuncer, Mustafa; Tokur, Murat Emre; Bayrakci, Sinem; Binici, Orhan; Bahadir, Turkan; Tekeli, Arzu Esen; Bahar, Ilhan; Karakas, Bugra; Keskin, Siddik; Oksuz, Hafize			PREVALENCE AND CLINICAL FEATURES OF CHRONIC CRITICAL ILLNESS IN THE ELDERLY POPULATION IN TURKEY	TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI			English	Article						Chronic Disease; Critical Illness; Intensive Care Unit; Aged; Turkey	INTENSIVE-CARE UNITS; MORTALITY; EPIDEMIOLOGY; BURDEN	Objectives: The definition of chronic critical illness in the elderly has not yet been determined. The aim of the study is to determine the prevalence and clinical features of chronic critical illness in the elderly population in Turkey. Materials and Methods: Data from 16 intensive care units of public and private hospitals in Turkey were evaluated. Patients staying in the intensive care units for at least eight days between 2015 and 2017 and having at least one of the additional criteria were accepted as chronic critical illness and they were divided into two groups by age, those 65 and older and those under 65. Results: The chronic critical illness patient rate in the intensive care units was 10.7%. Of chronic critical illness patients in the intensive care units, 60.9% were 65 years of age and older, and the mortality rate of patients 65 years and older was 70%. The frequencies of ischemic stroke and sepsis, the number of patients with comorbidities, and the mortality rate were higher in patients over 65 years of age, while the frequency of traumatic brain injury, presence of a major wound, tracheostomy, length of hospital stay and cost of care were higher in patients under 65 years of age. Conclusion: We determined that prolonged mechanical ventilation, traumatic brain injury, tracheostomy and major wound presence in intensive care units patients 65 years and older increased hospital stay and costs. More work is needed to define chronic critical illness more clearly in elderly.	[Demirkiran, Hilmi; Tekeli, Arzu Esen] Yuzuncu Yil Univ, Dept Anesthesiol & Reanimat, Fac Med, Van, Turkey; [Uzunoglu, Emine] Istanbul Medipol Univ, Dept Anesthesiol & Reanimat, Mega Hosp Complex, Istanbul, Turkey; [Erdivanli, Basar] Recep Tayyip Erdogan Univ, Dept Anesthesiol & Reanimat, Fac Med, Rize, Turkey; [Karadamar, Ulas] Private OFM Antalya Hosp, Gen Intens Care Unit, Antalya, Turkey; [KOc, Suna; Bahadir, Turkan] Biruni Univ, Dept Anesthesiol & Reanimat, Fac Med, Istanbul, Turkey; [Tomak, Yakup] Sakarya Univ, Anesthesiol & Intens Care Unit, Fac Med, Sakarya, Turkey; [Ozmen, Mustafa] Private Corlu Vatan Hosp, Gen Intens Care Unit, Tekirdag, Turkey; [Almali, Necat] Van Yuzuncu Yil Univ, Dept Gen Surg, Fac Med, Van, Turkey; [Cagac, Aydin] Van Yuzuncu Yil Univ, Dept Neurol, Fac Med, Van, Turkey; [Comez, Mehmet Selim] Hatay Mustafa Kemal Univ, Dept Anesthesiol & Reanimat, Tayfur Ata Sokmen Fac Med, Antakya, Turkey; [Tuncer, Mustafa] Van Yuzuncu Yil Univ, Dept Cardiol, Fac Med, Van, Turkey; [Tokur, Murat Emre] Kutahya Hlth Sci Univ, Internal Med Crit Care Unit, Evliya Celebi Training & Res Hosp, Kutahya, Turkey; [Bayrakci, Sinem] Gaziantep Sehitkamil State Hosp, Gen Intens Care Unit, Gaziantep Prov Directorate Hlth, Gaziantep, Turkey; [Binici, Orhan] Harran Univ, Dept Anesthesiol & Reanimat, Fac Med, Sanliurfa, Turkey; [Bahar, Ilhan] Izmir Katip Celebi Univ, Internal Med Crit Care Unit, Ataturk Training & Res Hosp, Izmir, Turkey; [Karakas, Bugra] Van Hlth Sci Univ, Anesthesiol Intens Care Unit, Van Training & Res Hosp, Van, Turkey; [Keskin, Siddik] Van Yuzuncu Yil Univ, Dept Biostat, Fac Med, Van, Turkey; [Oksuz, Hafize] Kahramanmaras Sutcu Imam Univ, Dept Anesthesiol & Reanimat, Fac Med, Kahramanmaras, Turkey		Demirkiran, H (corresponding author), Yuzuncu Yil Univ, Dept Anesthesiol & Reanimat, Fac Med, Van, Turkey.	h.demirkiran@yyu.edu.tr	, Comez/AAD-1535-2021	, Comez/0000-0003-0821-5148			Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Boniatti MM, 2011, CLINICS, V66, P701, DOI 10.1590/S1807-59322011000400027; Carson SS, 2012, RESP CARE, V57, P848, DOI 10.4187/respcare.01736; Carson SS., 2012, RESP CARE, V57, P56; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Guidet B, 2017, JAMA-J AM MED ASSOC, V318, P1450, DOI 10.1001/jama.2017.13889; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Heyland D, 2015, CRIT CARE MED, V43, P1352, DOI 10.1097/CCM.0000000000001024; Iwashyna TJ, 2016, LANCET RESP MED, V4, P566, DOI 10.1016/S2213-2600(16)30098-4; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kwak SH, 2014, J KOREAN MED SCI, V29, P431, DOI 10.3346/jkms.2014.29.3.431; Laake JH, 2010, ACTA ANAESTH SCAND, V54, P479, DOI 10.1111/j.1399-6576.2009.02170.x; Milbrandt EB, 2010, AM J RESP CRIT CARE, V182, P995, DOI 10.1164/rccm.200904-0630CP; Nelson JE, 2004, CRIT CARE MED, V32, P1527, DOI 10.1097/01.CCM.0000129485.08835.5A; Polastri M, 2020, PULMONOLOGY, V26, P119, DOI 10.1016/j.pulmoe.2019.11.003; Rordorf G, 2000, CRIT CARE MED, V28, P1301, DOI 10.1097/00003246-200005000-00007; Stavem K, 2017, CLIN EPIDEMIOL, V9, P311, DOI 10.2147/CLEP.S133624; Vásquez-Revilla HR, 2017, Med. interna Méx., V33, P168; Westphal GA, 2012, REV PANAM SALUD PUBL, V31, P499, DOI 10.1590/S1020-49892012000600008	19	2	2	0	0	GUNES KITABEVI LTD STI	ANKARA	M RAUF INAN SOK NO 3, ANKARA, SIHHIYE 06410, TURKEY	1304-2947	1307-9948		TURK J GERIATR	Turk. J. Geriatr.		2020	23	4					501	508		10.31086/tjgeri.2020.188			8	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	PO7RE	WOS:000605365100011		gold			2022-02-06	
J	Dilogo, IH; Erwin, US; Hendriarto, A				Dilogo, Ismail Hadisoebroto; Erwin, Uno Surgery; Hendriarto, Andra			Posterior dislocation of left hip joint with closed fracture of left acetabulum Judet-Letournel type posterior wall, femoral head fracture, management and follow up: A case report	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Hip; Dislocation; Acetabular; Fracture; Posterior; Case report		INTRODUCTION: Traumatic dislocation of the hip is a very severe injury. Posterior hip dislocation can be associated with acetabular fracture, which can ultimately result in a higher incidence of complications. CASE PRESENTATION: We present a case report of 26-year-old men with a motor vehicle accident and suffered a posterior hip dislocation on left hip joint and acetabular fracture with Judet-Letournel type posterior wall and femoral head fracture. This patient was performed closed reduction, however, due to dynamic instability of hip joint, internal Fixation through Kocher Langenback Approach and insertion of Herbert screws for femoral head and acetabular posterior wall fracture and interfragmentary screw for trochanteric osteotomy. The patient was followed up for 2 years and have a painless hip with full hip range of motion. DISCUSSION: Posterior wall acetabular fractures sometimes occurs after posterior dislocation of the hip. Posterior wall fragment of the acetabular wall fracture can compromise the stability of the hip joint. The reduction can be maintained by closed means or by operative reduction if there is an obstacle to performed closed reduction or followed by sciatic nerve palsy after closed reduction. The complication of operative reduction is avascular necrosis which compromises the integrity of the femoral head and contributing to posttraumatic osteoarthritis. CONCLUSION: Careful examination of acetabular fracture in posterior hip dislocation is required and failed of closed reduction or instability of hip joint are indications to perform open reduction and internal fixation. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.	[Dilogo, Ismail Hadisoebroto] Univ Indonesia, Dept Orthopaed & Traumatol, Orthopaed Trauma & Reconstruct, Fac Med,Dr Cipto Mangunkusumo Hosp, Jakarta, Indonesia; [Erwin, Uno Surgery; Hendriarto, Andra] Univ Indonesia, Cipto Mangunkusumo Natl Cent Hosp, Dept Orthopaed & Traumatol, Jalan Diponegoro 71, Jakarta 10430, Indonesia; [Erwin, Uno Surgery; Hendriarto, Andra] Univ Indonesia, Fac Med, Jalan Diponegoro 71, Jakarta 10430, Indonesia		Erwin, US (corresponding author), Cipto Mangunkusumo Natl Cent Hosp, Dept Orthopaed & Traumatol, Jalan Diponegoro 71, Jakarta 10430, Indonesia.	unosurgery@gmail.com	Dilogo, Ismail Hadisoebroto/ABA-3073-2020	Dilogo, Ismail Hadisoebroto/0000-0003-4060-2260; Hdilogo, Ismail/0000-0002-6202-0918			Agha RA, 2018, INT J SURG, V60, P279, DOI 10.1016/j.ijsu.2018.10.031; Alonso JE, 2000, CLIN ORTHOP RELAT R, P32; Bhandari M, 2006, J BONE JOINT SURG BR, V88B, P1618, DOI 10.1302/0301-620X.88B12.17309; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Jamshidi MHT, 2014, ARCH BONE JT SURG-AB, V2, P75; Jauregui JJ, 2015, EXPERT REV MED DEVIC, V12, P287, DOI 10.1586/17434440.2015.1009828; Kellam P, 2016, J ORTHOP TRAUMA, V30, P10, DOI 10.1097/BOT.0000000000000419; Lawrence DA, 2013, AM J ROENTGENOL, V201, pW425, DOI 10.2214/AJR.12.10470; Qi BC, 2016, TECHNOL HEALTH CARE, V24, P281, DOI 10.3233/THC1111; Ziran N, 2019, PATIENT SAF SURG, V13, DOI 10.1186/s13037-019-0196-2	10	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.		2020	71						85	90		10.1016/j.ijscr.2020.04.009			6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	ME6BO	WOS:000544739100021	32446995	Green Published, gold			2022-02-06	
J	Dwivedi, A; Dwivedi, SS; Tariq, MR; Qiu, XM; Hong, SZ; Xin, Y				Dwivedi, Atul; Dwivedi, Shweta Shukla; Tariq, Muhammad Raheel; Qiu, Xiaoming; Hong, Suzhen; Xin, Yu			Traumatic Brain Injury and Stem Cell Therapy	JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE			English	Article						Traumatic brain injury; Mesenchymal stem cells; Stem cell therapy; Neural stem cells; Endothelial progenitor cells	TRANSPLANTATION; SEQUELAE; OUTCOMES	Traumatic brain injury is a major health issue globally. Recently, there is no effective treatment, which can improve functional recovery of the TBI patients. Recent studies conclude that stem cell therapy has got tremendous regenerative potential, which can cure CNS injuries. Experimental Success in stem cell therapy also raise a hope in researchers to investigate more. The therapeutic aspects of stem cell therapy are based on the potential to differentiate in to tissue specific cells and integrate in to host tissue to regenerate the lost cells or injured cells. This commentary reflects the role of variety of stem cells in treating TBI .	[Dwivedi, Atul; Hong, Suzhen; Xin, Yu] Hubei Polytech Univ HBPU Huangshi, Dept Clin & Basic Sci, Med Coll, Huangshi, Hubei, Peoples R China; [Dwivedi, Shweta Shukla] Dept Dent Surg, Jabalpur, Madhya Pradesh, India; [Tariq, Muhammad Raheel] North Sichuan Med Coll, Dept Internal Med, Affiliated Hosp, Nanchong, Sichuan, Peoples R China; [Qiu, Xiaoming] Hubei Polytech Univ HBPU, Dept Radiol, Huangshi Cent Hosp, Edong Hlth Care Grp, Huangshi, Hubei, Peoples R China		Dwivedi, SS (corresponding author), Dept Dent Surg, Jabalpur, Madhya Pradesh, India.	shweta0761@gmail.com					Baethmann A, 1998, Curr Opin Anaesthesiol, V11, P193, DOI 10.1097/00001503-199804000-00013; Clervius H, 2019, NEURAL REGEN RES, V14, P1699, DOI 10.4103/1673-5374.255620; Cox CS, 2018, PEDIATR RES, V83, P325, DOI 10.1038/pr.2017.253; Gill M, 2001, CIRC RES, V88, P167; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; KRAUS JF, 1987, PEDIATRICS, V79, P501; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McIntosh TK, 1996, LAB INVEST, V74, P315; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Rouhl RPW, 2008, STROKE, V39, P2158, DOI 10.1161/STROKEAHA.107.507251; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Xiong Y, 2008, BRAIN RES, V1230, P247, DOI 10.1016/j.brainres.2008.06.127	17	2	2	2	4	AMBER PUBLICATION	GUJARAT	402, PARIJAT APT, WALKESHWARI NAGAR, JAMNAGAR, GUJARAT, 361 008, INDIA	2347-2545	2347-2367		J RES MED DENT SCI	J. Res. Med. Dent. Sci.		2020	8	3					94	96					3	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	MJ5HK	WOS:000548121100015					2022-02-06	
J	Esterov, D; Lennon, RJ; Bergquist, T; Brown, A				Esterov, Dmitry; Lennon, Ryan J.; Bergquist, Thomas; Brown, Allen			Predictors of neurobehavioral symptom reporting in a community based sample with mild traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; TBI; mild traumatic brain injury; MTBI; concussion; post-concussion syndrome; PCS; neurobehavioral symptom inventory; NSI-22; neurobehavioral symptoms	PERSISTENT POSTCONCUSSIVE SYMPTOMS; PATIENT HEALTH QUESTIONNAIRE-9; POST-CONCUSSION SYNDROME; RISK-FACTORS; DEPRESSION; PREVALENCE; INVENTORY; STRESS; SATISFACTION; POPULATION	BACKGROUND: The Neurobehavioral Symptom Inventory (NSI-22) is a validated self-report measure designed to assess neurobehavioral symptoms (NBS) after mild TBI (MTBI). Psychological and behavioral factors have been shown to be predictors of persistent NBS reporting in veterans; however, there is still a gap in knowledge about these associations in a civilian population presenting for treatment. OBJECTIVE: This study seeks to identify the predictors of increased NBS reporting on the NSI-22 in a treatment-seeking population with MTBI. METHODS: Analysis of 80 treatment seeking participants admitted to an interdisciplinary outpatient rehabilitation program with a diagnosis of MTBI. NSI-22 was used to measure NBS reporting. Predictor variables identified by univariate analysis were entered into a multivariable regression model, which was adjusted for demographic variables. RESULTS: Higher NSI-22 scores correlated with increased level of depressive complaints (PHQ-9), higher disability (M2PI), lower satisfaction with life (SWLS), prior MTBI, fewer years of education, absence of motor vehicle collision (MVC), and unemployment at time of assessment. When those variables were used in a multivariable linear regression model, PHQ-9, M2PI, years of education, and absence of MVC remained statistically significant. CONCLUSION: Psychological factors and level of societal participation predicted increased NBS as compared with injury severity and time since injury.	[Esterov, Dmitry; Brown, Allen] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Bergquist, Thomas] Mayo Clin, Dept Psychiat & Psychol, Dept Phys Med & Rehabil, Rochester, MN USA; [Lennon, Ryan J.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA		Esterov, D (corresponding author), 200 First St SW, Rochester, MN 55905 USA.	Esterov.Dmitry@mayo.edu	Esterov, Dmitry/AAR-6991-2021				Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Amtmann D, 2019, ASSESSMENT, V26, P695, DOI 10.1177/1073191117693921; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Belanger HG, 2016, CLIN NEUROPSYCHOL, V30, P1063, DOI 10.1080/13854046.2016.1193632; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; de la Cour FLD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00103; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Delmonico R, 2017, ARCH PHYSMED REHAB, V98, pe96, DOI DOI 10.1016/J.APMR.2017.08.309; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Donders J, 2017, ARCH PHYS MED REHAB, V98, P2514, DOI 10.1016/j.apmr.2017.05.019; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Dretsch M, 2016, J HEAD TRAUMA REHAB, V31, P23, DOI 10.1097/HTR.0000000000000109; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kreitzer N, 2019, J HEAD TRAUMA REHAB, V34, pE47, DOI 10.1097/HTR.0000000000000439; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kruse RC, 2018, PM&R, V10, P898, DOI 10.1016/j.pmrj.2018.03.003; Kumar RG, 2014, AM J PHYS MED REHAB, V93, P687, DOI 10.1097/PHM.0000000000000077; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; McLean SA, 2005, PSYCHOSOM MED, V67, P783, DOI 10.1097/01.psy.0000181276.49204.bb; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Merz ZC, 2019, BRAIN INJURY, V33, P1003, DOI 10.1080/02699052.2019.1581949; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Nordhaug LH, 2016, CEPHALALGIA, V36, P1009, DOI 10.1177/0333102415618948; O'Rourke J, 2019, J HEAD TRAUMA REHAB, V34, P30, DOI 10.1097/HTR.0000000000000405; Perrin PB, 2014, ARCH PHYS MED REHAB, V95, P2288, DOI 10.1016/j.apmr.2014.07.409; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Powell MR, 2019, J CLIN PSYCHOL MED S, V26, P470, DOI 10.1007/s10880-019-09602-w; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Silverberg ND, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2076-9; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Staab JP, 2019, NEUROSENSORY DISORDERS IN MILD TRAUMATIC BRAIN INJURY, P99, DOI 10.1016/B978-0-12-812344-7.00008-X; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Terry DP, 2019, CLIN NEUROPSYCHOL, V33, P124, DOI 10.1080/13854046.2018.1459853; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wortzel HS, 2014, NEUROREHABILITATION, V34, P613, DOI 10.3233/NRE-141086; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	68	2	2	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	47	1					65	77		10.3233/NRE-203082			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NE7EM	WOS:000562764300007	32675426				2022-02-06	
J	Figueiredo, T; Harbert, CL; Pidoplichko, V; Almeida-Suhett, CP; Rossetti, K; Braga, MFM; Marini, AM				Figueiredo, Taiza; Harbert, Carolina L.; Pidoplichko, Volodymyr; Almeida-Suhett, Camila P.; Rossetti, Katia; Braga, Maria F. M.; Marini, Ann M.			The Recovery of GABAergic Function in the Hippocampus CA1 Region After mTBI	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Hippocampus; GABAergic interneurons; Hyperexcitability; NMDA receptors; memory impairment; Recovery	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INTEGRITY; HEAD-INJURY; MILD; CONCUSSION; MEMORY; PATHOPHYSIOLOGY; IMPAIRMENT; RETROGRADE; SYMPTOMS	Traumatic brain injury (TBI) is a major public health concern in the USA. There are approximately 2.5 million brain injuries annually, 90% of which may be classified as mild since these individuals do not display clear morphological abnormalities following injury on imaging. The majority of individuals develop neurocognitive deficits such as learning and memory impairment and recovery occurs over 3 to 6 months after mild TBI (mTBI). The hippocampus is highly susceptible to injury from mTBI due to the anatomic localization and has been implicated in the neurocognitive impairments after mTBI. Here, we investigated whether the mTBI-induced morphological and pathophysiological alterations of GABAergic interneurons in the CA1 subfield of the hippocampus recovers after 30 days in the controlled cortical impact (CCI) model of TBI. Design-based stereology shows a significant reduction in the number of GABAergic interneurons 7 days after CCI. However, the number of GABAergic interneurons is not significantly reduced at 30 days after CCI. The total number of neurons is not altered over the course of 30 days. GABAergic inhibitory currents in the CA1 subfield also show that, although there is a significant reduction in the CCI group at 7 days, the currents are not significantly different from sham controls at 30 days. We suggest that the recovery of GABAergic function in the CA1 subfield of the hippocampus observed 30 days after CCI is one of the mechanisms associated with the recovery of memory after mTBI.	[Figueiredo, Taiza; Pidoplichko, Volodymyr; Almeida-Suhett, Camila P.; Rossetti, Katia; Braga, Maria F. M.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Harbert, Carolina L.; Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Harbert, Carolina L.; Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Program Neurosci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Marini, AM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Marini, AM (corresponding author), Uniformed Serv Univ Hlth Sci, Program Neurosci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Ann.marini@usuhs.edu	Almeida-Suhett, Camila/I-8045-2016	Almeida-Suhett, Camila/0000-0002-7588-9487			Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; [Anonymous], 2006, MED SCI SPORT EXER, V38, P395, DOI 10.1249/01.mss.0000202025.48774.31; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Faul M, 2010, TRAUMATIC BRAIN INJU; Figueiredo TH, 2018, MOL NEUROBIOL, V55, P187, DOI 10.1007/s12035-017-0732-y; Gaines KD, 2016, APPL NEUROPSYCH-ADUL, V23, P115, DOI 10.1080/23279095.2015.1012762; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Miazaki S, 1989, INTRACRANIAL PRESSUR, P651; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Park K, 2007, BIOCHEM BIOPH RES CO, V361, P718, DOI 10.1016/j.bbrc.2007.07.064; Prager EM, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00038; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Tayim FM, 2016, J CLIN EXP NEUROPSYC, V38, P1005, DOI 10.1080/13803395.2016.1182968; Watson C., 2005, RAT BRAIN STEROTAXIC; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030	53	2	2	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2020	57	1			SI		23	31		10.1007/s12035-019-01753-z			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KV1HZ	WOS:000520176200003	31520315				2022-02-06	
J	Fokin, AA; Wycech, J; Shue, KC; Stalder, R; Crawford, M; Lozada, J; Puente, I				Fokin, Alexander A.; Wycech, Joanna; Shue, Kyle Chin; Stalder, Ryan; Crawford, Maggie; Lozada, Jose; Puente, Ivan			Early Versus Late Tracheostomy in Trauma Patients With Rib Fractures	JOURNAL OF SURGICAL RESEARCH			English	Article						Tracheostomy; Rib fractures; Early versus late tracheostomy; Tracheostomy timing; Blunt chest trauma; Thoracic trauma	RESOURCE UTILIZATION; INTUBATION; MORTALITY; TRACHEOTOMY; OUTCOMES; COHORT	Background: Patients with blunt chest trauma with multiple rib fractures (RF) may require tracheostomy. The goal was to compare early (<= 7 d) versus late (>7 d) tracheostomy patients and to analyze clinical outcomes, to determine which timing is more beneficial. Methods: This retrospective review included 124 patients with RF admitted to trauma ICU at two level 1 trauma centers who underwent tracheostomy. Analyzed variables included age, gender, injury severity score, Glasgow Coma Scale, number of ribs fractured, total fractures of the ribs, prevalence of bilateral RF, flail chest, maxillofacial injuries, cervical vertebrae trauma, traumatic brain injuries (TBI), coinjuries, epidural analgesia, surgical stabilization of RF, failure to extubate, hospital LOS, intensive care unit LOS (ICULOS), duration of mechanical ventilation, mortality, and timing and type of tracheostomy. Results: Mean number of RF in all tracheostomized patients with blunt chest trauma was 5.2 and 85% of patients had pulmonary co-injuries. Mean tracheostomy timing was 9.9 d. Early tracheostomy (ET) was correlated with statistically significant reduction in ICULOS and duration of mechanical ventilation. The dominant cause of mortality in all groups was TBI and it was more pronounced in the ET patients. Most deaths were encountered between 3 and 5 wk after admission. ET was more often performed in the operating room with an open technique, whereas late tracheostomy was more often implemented with percutaneous technique at bedside. Conclusions: ET could be beneficial in chest trauma patients with multiple RF as it reduces ICULOS and ventilation requirements. Mortality benefits are not correlated with tracheostomy timing. (C) 2019 Elsevier Inc. All rights reserved.	[Fokin, Alexander A.; Wycech, Joanna; Shue, Kyle Chin; Crawford, Maggie; Puente, Ivan] Delray Med Ctr, Div Trauma & Crit Care Serv, 5352 Linton Blvd, Delray Beach, FL 33484 USA; [Wycech, Joanna; Stalder, Ryan; Lozada, Jose; Puente, Ivan] Broward Hlth Med Ctr, Div Trauma & Crit Care Serv, Ft Lauderdale, FL USA; [Shue, Kyle Chin; Puente, Ivan] Florida Atlantic Univ, Dept Surg, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA; [Puente, Ivan] Florida Int Univ, Dept Surg, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Stalder, Ryan] Wake Forest Univ, Winston Salem, NC 27101 USA		Fokin, AA (corresponding author), Delray Med Ctr, Div Trauma & Crit Care Serv, 5352 Linton Blvd, Delray Beach, FL 33484 USA.	Alexander.Fokin@tenethealth.com	Wycech, Joanna/AAC-1162-2019	Wycech, Joanna/0000-0002-8869-8575			Angus DC, 2013, JAMA-J AM MED ASSOC, V309, P2163, DOI 10.1001/jama.2013.6014; Arabi Y, 2004, CRIT CARE, V8, pR347, DOI 10.1186/cc2924; Arabi YM, 2009, J CRIT CARE, V24, P435, DOI 10.1016/j.jcrc.2008.07.001; Banfi P, 2013, RESP CARE, V58, P1995, DOI 10.4187/respcare.02875; Battle CE, 2012, INJURY, V43, P8, DOI 10.1016/j.injury.2011.01.004; Cai SQ, 2017, INJURY, V48, P866, DOI 10.1016/j.injury.2017.02.023; Clum SR, 2007, CRIT CARE MED, V35, P963, DOI 10.1097/01.CCM.0000257467.84570.B5; Dunham CM, 2006, AM SURGEON, V72, P276; Elkbuli A, 2019, AM SURGEON, V85, P370; Flagel BT, 2005, SURGERY, V138, P717, DOI 10.1016/j.surg.2005.07.022; Flores-Funes D, 2018, EUR J TRAUMA EMERG S; Freeman BD, 2013, RESP CARE, V58, P1863, DOI 10.4187/respcare.02359; Goettler CE, 2006, J TRAUMA, V60, P991, DOI 10.1097/01.ta.0000217270.16860.32; Holevar M, 2009, J TRAUMA, V67, P870, DOI 10.1097/TA.0b013e3181b5a960; Hyde GA, 2015, INJURY, V46, P110, DOI 10.1016/j.injury.2014.08.049; Jones KM, 2011, AM J SURG, V202, P598, DOI 10.1016/j.amjsurg.2010.09.029; Kane T D, 1997, Respir Care Clin N Am, V3, P1; Kang BH, 2018, WORLD J SURG, V42, P1742, DOI 10.1007/s00268-018-4474-4; Liu CC, 2015, OTOLARYNG HEAD NECK, V152, P219, DOI 10.1177/0194599814561606; Mallick A, 2010, EUR J ANAESTH, V27, P676, DOI 10.1097/EJA.0b013e32833b1ba0; Manay Priyadarshini, 2017, J Emerg Trauma Shock, V10, P128, DOI 10.4103/JETS.JETS_131_16; McCredie V, 2017, NEUROCRIT CARE, V26, P14, DOI 10.1007/s12028-016-0297-z; Miller C, 2019, AM J SURG, V218, P51, DOI 10.1016/j.amjsurg.2019.01.027; Nathens AB, 2006, CRIT CARE MED, V34, P2919, DOI 10.1097/01.CCM.0000243800.28251.AE; Prunet Bertrand, 2019, J Intensive Care Soc, V20, P46, DOI 10.1177/1751143718767060; Romero Vazquez AM, 2016, J PATIENT SAF; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Shan L, 2013, RESP CARE, V58, P1856, DOI 10.4187/respcare.02413; Shulzhenko NO, 2017, SURGERY, V161, P1083, DOI 10.1016/j.surg.2016.10.018; Sirmali M, 2003, EUR J CARDIO-THORAC, V24, P133, DOI 10.1016/S1010-7940(03)00256-2; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154	31	2	3	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2020	245						72	80		10.1016/j.jss.2019.07.023			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JT4CK	WOS:000500939000009	31401250				2022-02-06	
J	Fremont, P; Schneider, K; Laroche, A; Emery, C; Yeates, K				Fremont, Pierre; Schneider, Kathryn; Laroche, Anne; Emery, Carolyn; Yeates, Keith			Could a massive open online course be part of the solution to sport-related concussion? Participation and impact among 8368 registrants	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						concussion; education; public health; sports & exercise medicine	KNOWLEDGE TRANSFER; EDUCATION; POLICY; MANAGEMENT	ObjectivesA massive open online course (MOOC) has the potential to help address the public health burden of concussion across all levels of sport and leisure activities. The main objectives of this study were to document the volume of participation and to estimate the impact of a MOOC on concussion protocol implementation.MethodsBetween April 2016 and October 2018, four editions of a French-language MOOC on concussion were presented. Each of the six modules contains a section presenting the main learning content and a section proposing a reflective process to support the implementation of a concussion protocol in the participant's environment. The proportion of registrants who achieved successful completion of the course was the main outcome. Surveys were also used to document the types of participants and their intent to implement or update a protocol.ResultsThirty per cent of 8368 registrants successfully completed the course. Of the 3061 participants who completed a survey about their background, 58.8% were healthcare professionals, 16.3% were sport or school stakeholders, and 10.1% were parents or persons who sustained a concussion. Of the 1471 participants who completed a survey about their intent to implement or update a concussion protocol in their environment, 39.4% answered positively.ConclusionThis study describes the first use of a MOOC to address the issue of concussion. The experience of a French-language MOOC shows promising results supporting the use of this innovative educational strategy as part of the solution to the public health issue of concussion.	[Fremont, Pierre] Laval Univ, Dept Rehabil, Quebec City, PQ, Canada; [Schneider, Kathryn; Emery, Carolyn] Univ Calgary, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Schneider, Kathryn; Emery, Carolyn] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Laroche, Anne] Laval Univ, Educ Support Off, Quebec City, PQ, Canada; [Yeates, Keith] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada		Fremont, P (corresponding author), Laval Univ, Dept Rehabil, Quebec City, PQ, Canada.	pierre.fremont@fmed.ulaval.ca	Yeates, Keith/AAJ-4223-2020	Fremont, Pierre/0000-0003-2810-8382			Canadian Concussion Collaborative, 2016, ROADM DEV IMPL CONCL; College of Family Physicians of Canada and Canadian Academy of Sport and Exercise Medicine, JOINT POS STAT ROL F; Fremont P, 2015, BRIT J SPORT MED, V49, P88, DOI 10.1136/bjsports-2014-093961; Goldberg LR, 2017, ADV MED EDUC PRACT, V8, P603, DOI 10.2147/AMEP.S115321; Goldberg LR, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0344-z; Gooding Ira, 2013, Front Public Health, V1, P59, DOI 10.3389/fpubh.2013.00059; Gostelow N, 2017, CLIN TEACH, V14, P390, DOI 10.1111/tct.12703; Griffin S, 2016, BRIT J SPORT MED, V50, P1101, DOI 10.1136/bjsports-2016-095986; Hachem LD, 2016, CAN J NEUROL SCI, V43, P554, DOI 10.1017/cjn.2016.41; Jordan K, 2014, INT REV RES OPEN DIS, V15, DOI 10.19173/irrodl.v15i1.1651; KANE AJ, 2015, J LAW HLTH, V28, P201; Karsenti T, 2015, INT J TECHNOL HIGH E, V12, P138; Laval University, 2020, NOS FORM LIGN GRAT; Legislative Assembly of the Province of Ontario, 2018, ROW LAW CONCL SAF; Liyanagunawardena TR, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3439; Lowrey Kerri McGowan, 2016, J Health Care Law Policy, V19, P99; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Ministry of Education of Ontario (Canada), 2014, 158 MIN ED ONT; Parachute, 2017, CAN GUID CONC SPORT; Pickering JD, 2017, MED TEACH, V39, P691, DOI 10.1080/0142159X.2017.1322189; Policy Surveillance Program at Temple University, YOUTH SPORS TRAUM BR; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Schneider K, 2019, FREE MOOC CONCUSSION; Statistics Canada, LANG HIGHL TABL 2016; Wikipedia, 2019, WORLD LANG; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	28	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2020	6	1							e000700	10.1136/bmjsem-2019-000700			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PF6OZ	WOS:000599172500001	32180994	Green Published, gold			2022-02-06	
J	Glaser, N; Chu, S; Hung, B; Fernandez, L; Wulff, H; Tancredi, D; ODonnell, ME				Glaser, Nicole; Chu, Steven; Hung, Benjamin; Fernandez, Luis; Wulff, Heike; Tancredi, Daniel; ODonnell, Martha E.			Acute and chronic neuroinflammation is triggered by diabetic ketoacidosis in a rat model	BMJ OPEN DIABETES RESEARCH & CARE			English	Article						diabetes mellitus; type 1; diabetic ketoacidosis; brain edema	TRAUMATIC BRAIN-INJURY; CEREBRAL EDEMA; MATRIX METALLOPROTEINASES; CYTOKINE RESPONSE; OXIDATIVE STRESS; RISK-FACTORS; CHILDREN; MICROGLIA; INFLAMMATION; BLOOD	Introduction Cognitive decline is common in patients with type 1 diabetes and has been attributed to the effects of chronic hyperglycemia and severe hypoglycemia. Diabetic ketoacidosis (DKA) has only recently been suspected to be involved in causing cognitive decline. We hypothesized that DKA triggers both acute and chronic neuroinflammation, contributing to brain injury. Research methods and design We measured concentrations of cytokines, chemokines and matrix metalloproteinases (MMP) in serum and brain tissue lysates in juvenile rats during and after DKA (during acute DKA, 24 hours and 7 days after DKA), and compared these to healthy controls and hyperglycemic controls. We also measured cytokine, chemokine and MMP concentrations in serum and brain tissue of adult rats (70 days) that had experienced DKA as juveniles and compared these measurements to those of adult diabetic rats without exposure to DKA. Results During acute DKA in the juvenile rats, serum concentrations of CCL3, tumor necrosis factor (TNF)-alpha, interleukin (IL)-1ss and MMP-9 were significantly increased. Serum concentrations of IL-2 and IL-17A increased 7 days after DKA recovery. In brain tissue lysates, concentrations of CCL3, CCL5, interferon (IFN)-gamma and MMP-9 were significantly elevated during acute DKA. In adult rats that had DKA as juveniles (28 days previously), serum concentrations of IL-1ss and brain concentrations of IL-10 and IL-12p70 were elevated in comparison to diabetic rats without prior DKA. Composite scores for highly correlated cytokines and chemokines (mean z-scores for IL-10, IL-1ss, TNF-alpha, IL-17A, IFN-gamma, CXCL-1 and CCL5) were also significantly elevated in adult rats with prior DKA. Conclusions These data confirm that DKA causes acute systemic inflammation and neuroinflammation in a rat model. Importantly, the neuroinflammatory response triggered by DKA is long-lasting, suggesting the possibility that DKA-induced chronic neuroinflammation could contribute to long-term cognitive decline in individuals with diabetes.	[Glaser, Nicole; Chu, Steven; Fernandez, Luis; Tancredi, Daniel] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Hung, Benjamin; ODonnell, Martha E.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Sacramento, CA 95817 USA; [Wulff, Heike] Univ Calif Davis, Sch Med, Dept Pharmacol, Sacramento, CA 95817 USA		Glaser, N (corresponding author), Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA.	nsglaser@ucdavis.edu	Tancredi, Daniel/O-3381-2013	Tancredi, Daniel/0000-0002-3884-7907	American Diabetes Association basic science grantAmerican Diabetes Association [1-17-IBS-186]	These studies were supported by American Diabetes Association basic science grant (grant number 1-17-IBS-186, awarded to NG).	Alonso GT, 2020, DIABETES CARE, V43, P117, DOI 10.2337/dc19-0428; Aye T, 2019, DIABETES CARE, V42, P443, DOI 10.2337/dc18-1405; Azizi G, 2014, AM J ALZHEIMERS DIS, V29, P415, DOI 10.1177/1533317513518651; Cameron FJ, 2015, PEDIATR CLIN N AM, V62, P911, DOI 10.1016/j.pcl.2015.04.003; Cameron FJ, 2014, DIABETES CARE, V37, P1554, DOI 10.2337/dc13-1904; Carcillo JA, 2017, PEDIATR CRIT CARE ME, V18, pS32, DOI 10.1097/PCC.0000000000001052; Cato MA, 2014, J INT NEUROPSYCH SOC, V20, P238, DOI 10.1017/S1355617713001434; Cengiz E, 2013, PEDIATR DIABETES, V14, P447, DOI 10.1111/pedi.12030; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chiu Kin, 2007, J Vis Exp, P269, DOI 10.3791/269; Close TE, 2013, MICROCIRCULATION, V20, P534, DOI 10.1111/micc.12053; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; Dabelea D, 2014, PEDIATRICS, V133, pE938, DOI 10.1542/peds.2013-2795; Eisenhut M, 2014, INT J INFLAMM, V2014, DOI 10.1155/2014/509707; Eisenhut M, 2011, PFLUG ARCH EUR J PHY, V461, P401, DOI 10.1007/s00424-010-0917-y; Garro A, 2017, PEDIATR DIABETES, V18, P95, DOI 10.1111/pedi.12359; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Ghetti S, 2010, J PEDIATR-US, V156, P109, DOI 10.1016/j.jpeds.2009.07.054; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; Glaser N, 2017, NEUROSCI LETT, V650, P161, DOI 10.1016/j.neulet.2017.04.035; Glaser N, 2017, PEDIATR DIABETES, V18, P356, DOI 10.1111/pedi.12396; Glaser N, 2012, NEUROSCI LETT, V510, P110, DOI 10.1016/j.neulet.2012.01.014; Glaser N, 2009, PEDIATR DIABETES, V10, P534, DOI 10.1111/j.1399-5448.2009.00511.x; Glaser NS, 2017, J PEDIATR-US, V180, P170, DOI 10.1016/j.jpeds.2016.09.003; Glaser NS, 2006, PEDIATR DIABETES, V7, P75, DOI 10.1111/j.1399-543X.2006.00156.x; Victoria ECG, 2017, CURR NEUROVASC RES, V14, P125, DOI 10.2174/1567202614666170313113056; Haskins M, 2016, NEUROSCI LETT, V610, P165, DOI 10.1016/j.neulet.2015.11.002; Hawkins BT, 2007, DIABETOLOGIA, V50, P202, DOI 10.1007/s00125-006-0485-z; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hulse RE, 2004, J NEUROSCI METH, V136, P87, DOI 10.1016/j.jneumeth.2003.12.023; Jacobson AM, 2011, DIABETOLOGIA, V54, P245, DOI 10.1007/s00125-010-1883-9; Karavanaki K, 2011, ENDOCR J, V58, P1045, DOI 10.1507/endocrj.EJ11-0024; Kempuraj D., 2016, J NEUROL NEUROSURG S, V1; Lam TL, 2005, DIABETES, V54, P510, DOI 10.2337/diabetes.54.2.510; Lanfranco MF, 2018, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00137; Li J, 2014, J DIABETES COMPLICAT, V28, P662, DOI 10.1016/j.jdiacomp.2014.06.008; Li T, 2017, NEUROMOL MED, V19, P541, DOI 10.1007/s12017-017-8468-4; Lo W, 2016, PEDIATR DIABETES, V17, P127, DOI 10.1111/pedi.12251; Louboutin JP, 2013, CNS NEUROL DISORD-DR, V12, P815, DOI 10.2174/18715273113126660173; Maahs DM, 2015, DIABETES CARE, V38, P1876, DOI 10.2337/dc15-0780; Mirabelli-Badenier M, 2011, THROMB HAEMOSTASIS, V105, P409, DOI 10.1160/TH10-10-0662; Omatsu T, 2014, AM J PHYSIOL-ENDOC M, V306, pE1077, DOI 10.1152/ajpendo.00659.2013; Ozer G, 2003, J PEDIATR ENDOCR MET, V16, P203; Raggi P, 2018, ATHEROSCLEROSIS, V276, P98, DOI 10.1016/j.atherosclerosis.2018.07.014; Raphael I, 2015, CYTOKINE, V74, P5, DOI 10.1016/j.cyto.2014.09.011; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; Shalimova A, 2019, J CLIN ENDOCR METAB, V104, P2239, DOI 10.1210/jc.2018-01315; Shukla V, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0774-5; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stentz FB, 2004, DIABETES, V53, P2079, DOI 10.2337/diabetes.53.8.2079; Takami S, 2001, J CEREBR BLOOD F MET, V21, P1430, DOI 10.1097/00004647-200112000-00007; Trivedi A, 2019, CELL MOL LIFE SCI, V76, P3141, DOI 10.1007/s00018-019-03176-4; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; Upperman JS, 2017, PEDIATR CRIT CARE ME, V18, pS58, DOI 10.1097/PCC.0000000000001051; Wootton-Gorges SL, 2007, AM J NEURORADIOL, V28, P895; Yang CJ, 2019, AM J PHYSIOL-CELL PH, V316, pC135, DOI 10.1152/ajpcell.00136.2018; Younger D, 2019, MOL NEUROBIOL, V56, P5202, DOI 10.1007/s12035-018-1428-7; Ziemka-Nalecz M, 2017, J NEUROPATH EXP NEUR, V76, P644, DOI 10.1093/jnen/nlx046	59	2	2	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		2052-4897		BMJ OPEN DIAB RES CA	BMJ Open Diab. Res. Care		2020	8	2							e001793	10.1136/bmjdrc-2020-001793			11	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	PH1SO	WOS:000600201600003	33318070				2022-02-06	
B	Goldberg, D		Ventresca, M; McDonald, MG		Goldberg, Daniel			What Does the Precautionary Principle Demand of Us? Ethics, Population Health Policy, and Sports-Related TBI	SOCIOCULTURAL EXAMINATIONS OF SPORTS CONCUSSIONS	Routledge Research in Sport and Exercise Science		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CONFLICTS-OF-INTEREST; YOUTH SPORTS; FOOTBALL		[Goldberg, Daniel] Univ Colorado Anschutz Med Campus, Ctr Bioeth & Humanities, Aurora, CO 80045 USA; [Goldberg, Daniel] Univ Colorado Anschutz Med Campus, CU Sch Med, Dept Family Med, Aurora, CO 80045 USA; [Goldberg, Daniel] Univ Colorado Anschutz Med Campus, CO Sch Publ Hlth, Dept Epidemiol, Aurora, CO 80045 USA		Goldberg, D (corresponding author), Univ Colorado Anschutz Med Campus, Ctr Bioeth & Humanities, Aurora, CO 80045 USA.; Goldberg, D (corresponding author), Univ Colorado Anschutz Med Campus, CU Sch Med, Dept Family Med, Aurora, CO 80045 USA.; Goldberg, D (corresponding author), Univ Colorado Anschutz Med Campus, CO Sch Publ Hlth, Dept Epidemiol, Aurora, CO 80045 USA.						Bachynski KE, 2018, INJURY PREV, V24, P180, DOI 10.1136/injuryprev-2017-042404; Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Chung J, 2018, MINNEAPOLIS STAR TRI; Dawson A., 2007, ETHICS PREVENTION PU; Domb BG, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114534824; Emery CA, 2019, JAMA PEDIATR, V173, P309, DOI 10.1001/jamapediatrics.2018.5498; Evans Randolph W., 2017, PRACT NEUROL; Fainaru-Wada M, 2018, DEBATE YOUTH TACKLE; Findler P, 2015, J PHILOS SPORT, V42, P443, DOI 10.1080/00948705.2015.1079132; Finkel AM, 2019, HUM ECOL RISK ASSESS, V25, P564, DOI 10.1080/10807039.2018.1456899; Frank Noah, 2018, MARYLAND INTRO BILL; Gardiner SM, 2006, J POLIT PHILOS, V14, P33, DOI 10.1111/j.1467-9760.2006.00237.x; GEERTZ C, 1972, DAEDALUS, P1; Goldberg D, 2016, KENNEDY INST ETHIC J, V26, P173, DOI 10.1353/ken.2016.0022; Goldberg DS, 2013, J LEGAL MED, V34, P157, DOI 10.1080/01947648.2013.800792; Goldberg DS, 2008, HEC FORUM, V20, P337, DOI 10.1007/s10730-008-9079-0; Golightly Yvonne M, 2011, LOWER EXTREMITY  OCT; Gostin LO, 2016, PUBLIC HEALTH LAW: POWER, DUTY, RESTRAINT, 3RD EDITION; Greenhalgh T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3725; Grossman J, 2005, PERSPECT BIOL MED, V48, P516, DOI 10.1353/pbm.2005.0092; Grossman Jason, 2008, SOC EPISTEMOL, V22, P333; Karte Ryan, 2018, ORANGE COUNTY R 0427; LACAZE A, 2008, SOC EPISTEMOL, V22, P353, DOI DOI 10.1080/02691720802559438; Michaels D., 2008, DOUBT IS THEIR PRODU; Munthe C, 2011, INT LIBR ETH LAW TEC, V6, P1, DOI 10.1007/978-94-007-1330-7; Nowinski C.J., 2018, FLAG FOOTBALL 14 ED; Paolini Mikayla, 2018, EMORY LAW J, V68, P607; Sadin Steve, 2018, CHICAGO TRIBUNE 0418; Shen Francis X., 2018, MINNEAPOLIS STA 0131; Steel D., 2015, PHILOS PRECAUTIONARY; Studdert DM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001848; Thompson DennisF., 2004, WHY DELIBERATIVE DEM; Tim Edgy, 2018, NBC SPORTS      0302; Tobbell DA, 2009, J HIST MED ALL SCI, V64, P429, DOI 10.1093/jhmas/jrp012; Tobbell Dominique A., 2011, PILLS POWER POLICY S, V23; Trouwborst A., 2002, EVOLUTION STATUS PRE; Vandenbroucke JP, 2016, INT J EPIDEMIOL, V45, P1776, DOI 10.1093/ije/dyv341; Weed DL, 2004, J MED PHILOS, V29, P313, DOI 10.1080/03605310490500527; Weed DL, 2010, ANN EPIDEMIOL, V20, P347, DOI 10.1016/j.annepidem.2010.02.001	40	2	2	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-0-429-02817-5; 978-0-367-13450-1	ROUT RES SPORT EXERC			2020							78	93					16	Hospitality, Leisure, Sport & Tourism; Sociology; Sport Sciences	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Social Sciences - Other Topics; Sociology; Sport Sciences	BO8OT	WOS:000528901400005					2022-02-06	
J	Graham, NSN; Zimmerman, KA; Bertolini, G; Magnoni, S; Oddo, M; Zetterberg, H; Moro, F; Novelli, D; Heslegrave, A; Chieregato, A; Fainardi, E; Fleming, JM; Garbero, E; Abed-Maillard, S; Gradisek, P; Bernini, A; Sharp, DJ				Graham, Neil Samuel Nyholm; Zimmerman, Karl A.; Bertolini, Guido; Magnoni, Sandra; Oddo, Mauro; Zetterberg, Henrik; Moro, Federico; Novelli, Deborah; Heslegrave, Amanda; Chieregato, Arturo; Fainardi, Enrico; Fleming, Joanne M.; Garbero, Elena; Abed-Maillard, Samia; Gradisek, Primoz; Bernini, Adriano; Sharp, David J.			Multicentre longitudinal study of fluid and neuroimaging BIOmarkers of AXonal injury after traumatic brain injury: the BIO-AX-TBI study protocol	BMJ OPEN			English	Article						trauma management; neurological injury; biochemistry; magnetic resonance imaging	NEUROFILAMENT LIGHT; HEAD-INJURY; YOUNG-PEOPLE; TAU; DISABILITY; ADULTS	Introduction and aims Traumatic brain injury (TBI) often results in persistent disability, due particularly to cognitive impairments. Outcomes remain difficult to predict but appear to relate to axonal injury. Several new approaches involving fluid and neuroimaging biomarkers show promise to sensitively quantify axonal injury. By assessing these longitudinally in a large cohort, we aim both to improve our understanding of the pathophysiology of TBI, and provide better tools to predict clinical outcome. Methods and analysis BIOmarkers of AXonal injury after TBI is a prospective longitudinal study of fluid and neuroimaging biomarkers of axonal injury after moderate-to-severe TBI, currently being conducted across multiple European centres. We will provide a detailed characterisation of axonal injury after TBI, using fluid (such as plasma/microdialysate neurofilament light) and neuroimaging biomarkers (including diffusion tensor MRI), which will then be related to detailed clinical, cognitive and functional outcome measures. We aim to recruit at least 250 patients, including 40 with cerebral microdialysis performed, with serial assessments performed twice in the first 10 days after injury, subacutely at 10 days to 6 weeks, at 6 and 12 months after injury. Ethics and dissemination The relevant ethical approvals have been granted by the following ethics committees: in London, by the Camberwell St Giles Research Ethics Committee; in Policlinico (Milan), by the Comitato Etico Milano Area 2; in Niguarda (Milan), by the Comitato Etico Milano Area 3; in Careggi (Florence), by the Comitato Etico Regionale per la Sperimentazione Clinica della Regione Toscana, Sezione area vasta centro; in Trento, by the Trento Comitato Etico per le Sperimentazioni Cliniche, Azienda Provinciale per i Servizi Sanitari della Provincia autonoma di Trento; in Lausanne, by the Commission cantonale d'ethique de la recherche sur l'etre humain; in Ljubljana, by the National Medical Ethics Committee at the Ministry of Health of the Republic of Slovenia. The study findings will be disseminated to patients, healthcare professionals, academics and policy-makers including through presentation at conferences and peer-reviewed publications. Data will be shared with approved researchers to provide further insights for patient benefit.	[Graham, Neil Samuel Nyholm; Zimmerman, Karl A.; Sharp, David J.] Imperial Coll London, Dept Brain Sci, London, England; [Graham, Neil Samuel Nyholm; Zimmerman, Karl A.; Sharp, David J.] UK DRI Ctr Care Res & Technol, London, England; [Bertolini, Guido; Moro, Federico; Novelli, Deborah; Fleming, Joanne M.; Garbero, Elena] IRCCS Mario Negri Inst Pharmacol Res, Publ Hlth, Ranica, Italy; [Magnoni, Sandra] Santa Chiara Hosp, Dept Anesthesia & Intens Care, Trento, Italy; [Oddo, Mauro; Abed-Maillard, Samia; Bernini, Adriano] CHUV Lausanne Univ Hosp, Dept Intens Care Med, Lausanne, Switzerland; [Zetterberg, Henrik] UCL Queen Sq Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Heslegrave, Amanda] UCL Queen Sq Inst Neurol, London, England; [Chieregato, Arturo] ASST Grande Osped Metropolitano Niguarda, Neurorianimaz, Milan, Italy; [Fainardi, Enrico] Univ Firenze, Careggi Univ Hosp, Dept Expt & Clin Sci, Florence, Italy; [Gradisek, Primoz] Univ Med Ctr, Clin Dept Anaesthesiol & Intens Therapy, Ljubljana, Slovenia		Sharp, DJ (corresponding author), Imperial Coll London, Dept Brain Sci, London, England.; Sharp, DJ (corresponding author), UK DRI Ctr Care Res & Technol, London, England.	david.sharp@imperial.ac.uk	moro, federico/K-5644-2016; Graham, Neil/AAN-2754-2021; Abed-Maillard, Samia/AAI-1052-2021; Bernini, Adriano/AAR-7408-2020; Moro, Federico/AAG-1731-2021; Novelli, Deborah/ABG-3179-2020; Magnoni, Sandra/AAC-7479-2022; Zimmerman, Karl/AAL-4988-2020	moro, federico/0000-0002-2682-5583; Graham, Neil/0000-0002-0183-3368; Bernini, Adriano/0000-0003-0207-0064; Moro, Federico/0000-0002-2682-5583; Novelli, Deborah/0000-0002-2749-304X; Magnoni, Sandra/0000-0002-1723-0844; Zimmerman, Karl/0000-0003-1239-3414; Garbero, Elena/0000-0003-4902-0144; Bertolini, Guido/0000-0002-3101-4259; Chieregato, Arturo/0000-0001-6690-8597	ERA-NET Neuron Cofund part of the European Research Projects on External Insults to the Nervous System call, within the Horizon 2020 funding framework [MR/R004528/1]; Alzheimer's Research UK Clinical Research Fellowship; UK Dementia Research Institute (DRI) Care Research and Technology Centre (NG/DJS); National Institute of Health Research (NIHR) ProfessorshipNational Institute for Health Research (NIHR) [NIHR-RP-011-048]; NIHR Clinical Research Facility and Biomedical Research Centre (BRC) at Imperial College Healthcare NHS Trust; Medical Research Council through a Clinician Scientist FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006, UKDRI-1003, MR/R004528/1] Funding Source: UKRI	The study is funded by the ERA-NET Neuron Cofund (grant MR/R004528/1), part of the European Research Projects on External Insults to the Nervous System call, within the Horizon 2020 funding framework. The work was supported by an Alzheimer's Research UK Clinical Research Fellowship awarded to NSNG, and by the UK Dementia Research Institute (DRI) Care Research and Technology Centre (NG/DJS), an National Institute of Health Research (NIHR) Professorship (NIHR-RP-011-048) awarded to DJS. and by the NIHR Clinical Research Facility and Biomedical Research Centre (BRC) at Imperial College Healthcare NHS Trust. The research was also supported the Medical Research Council through a Clinician Scientist Fellowship awarded to DJS.	Apolone G, 1992, Minerva Anestesiol, V58, P1297; Bernick C, 2018, J NEUROTRAUM, V35, P2351, DOI 10.1089/neu.2017.5553; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Escott-Price V, 2015, BRAIN, V138, P3673, DOI 10.1093/brain/awv268; Giorgi-Coll S, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6513; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; Jolly AE, BRAIN; Karayumak SC, 2019, NEUROIMAGE, V184, P180, DOI 10.1016/j.neuroimage.2018.08.073; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Monteiro M, 2020, LANCET DIGIT HEALTH, V2, pE314, DOI 10.1016/S2589-7500(20)30085-6; Oddo M, 2018, INTENS CARE MED, V44, P1945, DOI 10.1007/s00134-017-5031-6; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	31	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	11							e042093	10.1136/bmjopen-2020-042093			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OX7NZ	WOS:000593748200003	33172948	Green Published, gold			2022-02-06	
J	Heinemann, AW; Kisala, PA; Boulton, AJ; Sherer, M; Sander, AM; Chiaravalloti, N; Bushnik, T; Hanks, R; Roth, E; Tulsky, DS				Heinemann, Allen W.; Kisala, Pamela A.; Boulton, Aaron J.; Sherer, Mark; Sander, Angelle M.; Chiaravalloti, Nancy; Bushnik, Tamara; Hanks, Robin; Roth, Elliot; Tulsky, David S.			Development and Calibration of the TBI-QOL Ability to Participate in Social Roles and Activities and TBI-QOL Satisfaction With Social Roles and Activities Item Banks and Short Forms	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Patient reported outcome measures; Psychometrics; Quality of life; Rehabilitation; Social participation	TRAUMATIC BRAIN-INJURY; PATIENT-REPORTED OUTCOMES; QUALITY-OF-LIFE; SPINAL-CORD-INJURY; RESPONSE THEORY; NEURO-QOL; HEALTH; FIT; VALIDATION; HANDICAP	Objective: To develop traumatic brain injury (TBI)-optimized versions of the Quality of Life in Neurological Disorders (Neuro-QoL) Ability to Participate in Social Roles and Activities and Satisfaction with Social Roles and Activities item banks, evaluate the psychometric properties of the item banks developed for adults with TBI, develop short form and computer adaptive test (CAT) versions, and report information to facilitate research and clinical applications. Design: We used a mixed methods design to develop and evaluate Ability to Participate in Social Roles and Activities and Satisfaction with Social Roles and Activities items. Focus groups defined the constructs, cognitive interviews guided item revisions, and confirmatory factor analysis and item response theory methods helped calibrate item banks and evaluate differential item functioning related to demographic and injury characteristics. Setting: Five TBI Model Systems centers in the United States. Participants: Community-dwelling adults with TBI (N=556). Interventions: None. Outcome Measures: Traumatic Brain Injury-Quality of Life (TBI-QOL) Ability to Participate in Social Roles and Activities and TBI-QOL Satisfaction with Social Roles and Activities item banks. Results: Forty-five Ability to Participate in Social Roles and Activities and 41 Satisfaction with Social Roles and Activities items demonstrated good psychometric properties. Although some of the items are new, most were drawn from analogous banks in the Neuro-QoL measurement system. Consequently, the 2 TBI-QOL item banks were linked to the Neuro-QoL metric, and scores are comparable with the general population. All CAT and short forms correlated highly (>0.90) with the full item banks and demonstrate comparable construct coverage and measurement error. Conclusion: The TBI-QOL Ability to Participate in Social Roles and Activities and TBI-QOL Satisfaction with Social Roles and Activities item banks are TBI-optimized versions of the Neuro-QoL Ability to Participate in Social Roles and Activities and Satisfaction with Social Roles and Activities item banks and demonstrate excellent measurement properties in individuals with TBI. These measures, particularly in CAT or short form format, are suitable for efficient and precise measurement of social outcomes in clinical and research applications. (C) 2019 by the American Congress of Rehabilitation Medicine	[Heinemann, Allen W.; Roth, Elliot] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Heinemann, Allen W.; Roth, Elliot] Shirley Ryan AbilityLab, Chicago, IL USA; [Kisala, Pamela A.; Boulton, Aaron J.; Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, 100 Discovery Blvd, Newark, DE 19713 USA; [Sherer, Mark; Sander, Angelle M.] TIRR Mem Hermann, Houston, TX USA; [Sander, Angelle M.] Baylor Coll Med, Houston, TX 77030 USA; [Chiaravalloti, Nancy] Kessler Fdn, E Hanover, NJ USA; [Chiaravalloti, Nancy] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Bushnik, Tamara] NYU Langone Hlth, Rusk Rehabil, New York, NY USA; [Hanks, Robin] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, 100 Discovery Blvd, Newark, DE 19713 USA		Tulsky, DS (corresponding author), Univ Delaware, Ctr Hlth Assessment Res & Translat, 100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, 100 Discovery Blvd, Newark, DE 19713 USA.	dtulsky@udel.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Bushnik, Tamara/0000-0003-3328-257X; Tulsky, David/0000-0002-4335-4509; Chiaravalloti, Nancy/0000-0003-2943-7567	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, H133A70038]; NIDILRRUnited States Department of Health & Human Services [H133A120100]	Supported by grant numbers H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, and H133A70038 from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). Additional support for the preparation of this manuscript was provided by NIDILRR (grant no. H133A120100).	[Anonymous], PATIENT REPORTED OUT; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Caplan B, 2011, ENCY CLIN NEUROPSYCH; CARF International, 2018, QUAL STAND; Carlozzi NE, 2017, MOVEMENT DISORD, V32, P1096, DOI 10.1002/mds.27046; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Choi SW, 2011, J STAT SOFTW, V39, P1; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Erlebach R, 2017, MINERVA ANESTESIOL, V83, P1169, DOI 10.23736/S0375-9393.17.11837-7; Eton DT, 2007, LUNG CANCER, V57, P339, DOI 10.1016/j.lungcan.2007.03.021; Gershon R, 2010, QUAL LIFE RES, V19, P677, DOI 10.1007/s11136-010-9634-4; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Hahn EA, 2010, QUAL LIFE RES, V19, P1035, DOI 10.1007/s11136-010-9654-0; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Heinemann AW, 2011, ARCH PHYS MED REHAB, V92, P564, DOI 10.1016/j.apmr.2010.07.220; Heinemann AW, 2010, ARCH PHYS MED REHAB, V91, pS72, DOI 10.1016/j.apmr.2009.11.031; Heinemann AW, 2010, ARCH PHYS MED REHAB, V91, pS1, DOI 10.1016/j.apmr.2009.08.155; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kim SH, 2007, J EDUC MEAS, V44, P93, DOI 10.1111/j.1745-3984.2007.00029.x; Kisala Pamela A, 2010, J Appl Meas, V11, P315; Kostanjsek N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S3; Magasi S, 2018, ARCH PHYS MED REHAB, V99, P1, DOI 10.1016/j.apmr.2017.06.030; MetaMetrics, 1995, LEXILE FRAMEWORK REA; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; National Quality Forum, AS APPL PARTN FIND; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Orlando M, 2003, APPL PSYCH MEAS, V27, P289, DOI 10.1177/0146621603027004004; Reckase M. D, 1989, ED MEASUREMENT ISSUE, V8, P11; SAMEJIMA F, 1969, PSYCHOMETRIKA, V34, P1; Steiger J., 1980, ANN M PSYCH SOC IOW, V758; Steiger JH, 2016, STRUCT EQU MODELING, V23, P777, DOI 10.1080/10705511.2016.1217487; STOCKING ML, 1983, APPL PSYCH MEAS, V7, P201, DOI 10.1177/014662168300700208; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tulsky DS, 2019, J HEAD TRAUMA REHAB, V34, P281, DOI 10.1097/HTR.0000000000000531; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tulsky DS, 2015, J SPINAL CORD MED, V38, P257, DOI [10.1179/2045772315Y.0000000023, 10.1179/2045772315Y.0000000035]; Tulsky DS, 2011, ARCH PHYS MED REHAB, V92, pS44, DOI 10.1016/j.apmr.2011.04.024; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wong AWK, 2017, QUAL LIFE RES, V26, P2633, DOI 10.1007/s11136-017-1586-5; World Health Organization, 2001, INT CLASS FUNCT DIS	53	2	2	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2020	101	1					20	32		10.1016/j.apmr.2019.07.015			13	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	KA2PR	WOS:000505640300003	31473208				2022-02-06	
J	Helmich, I; Coenen, J; Henckert, S; Pardalis, E; Schupp, S; Lausberg, H				Helmich, I.; Coenen, J.; Henckert, S.; Pardalis, E.; Schupp, S.; Lausberg, H.			Reduced frontopolar brain activation characterizes concussed athletes with balance deficits	NEUROIMAGE-CLINICAL			English	Article						Sport-related concussions; fNIRS; Postural control; Brain oxygenation; Frontopolar cortex	NEAR-INFRARED SPECTROSCOPY; SPORTS-RELATED CONCUSSION; POSTURAL CONTROL; PREFRONTAL CORTEX; WORKING-MEMORY; CEREBRAL CONCUSSION; FOOTBALL PLAYERS; HEAD-INJURY; TASK; SYMPTOMS	Objectives: Athletes with sport-related concussions (SRC) often demonstrate deficits in postural stability. Lower cerebral blood flow in frontal cortices has been documented in athletes with symptoms after SRC, however, it is unclear if functional brain oxygenation during postural control tasks is reduced in symptomatic athletes after SRC in the same manner. We therefore compared brain oxygenation patterns in frontal cortices of symptomatic and asymptomatic athletes with SRC during postural control tasks with the hypothesis that symptomatic athletes are characterized by reduced functional brain oxygenation during postural control. Methods: 62 concussed athletes (n = 31 symptomatic, n = 31 asymptomatic) were investigated during four postural control tasks with eyes closed versus eyes opened conditions and stable vs. unstable surface conditions. Brain oxygenation was assessed using functional NearinfraRed Spectroscopy (fNIRS) on frontopolar cortices of each hemisphere. Postural sway was measured by the analysis of ground reaction forces. Results: Symptomatic athletes showed greater postural sway when compared to asymptomatic athletes during postural control, particularly during closed eyes and/or unstable surface conditions. Changes of oxygenated hemoglobin (Delta HbO(2)) within the left hemispheric frontopolar cortex were significantly reduced in symptomatic athletes when compared to asymptomatic athletes during the eyes closed condition. A stepwise linear regression analysis revealed that self-reported post-concussion symptoms such as headaches and sadness predict decreased brain oxygenation during postural control with closed eyes. Conclusion: Symptomatic athletes with increased postural sway are characterized by decreased frontopolar brain oxygenation during postural control tasks, particularly during conditions with closed eyes. Because the frontopolar cortex showed to be involved in redistributing executive functions to novel task situations, we conclude that athletes with post-concussion symptoms suffer from a deficit in coordinating postural adjustments to balance control tasks with reduced sensory input.	[Helmich, I.; Coenen, J.; Henckert, S.; Pardalis, E.; Schupp, S.; Lausberg, H.] German Sport Univ GSU Cologne, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Sportpk Mungersdorf 6, D-50933 Cologne, Germany; [Coenen, J.] Paderborn Univ, Inst Sport Med, Dept Sport & Hlth, Warburger Str 100, D-33098 Paderborn, Germany		Helmich, I (corresponding author), German Sport Univ GSU Cologne, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Sportpk Mungersdorf 6, D-50933 Cologne, Germany.	in.helmich@gmail.com			German Sports University, Cologne [920157]	The study was funded by the University research funding (920157) of the German Sports University, Cologne.	Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Beurskens R, 2014, INT J PSYCHOPHYSIOL, V92, P122, DOI 10.1016/j.ijpsycho.2014.03.005; Biondi DM, 2005, J AM OSTEOPATH ASSOC, V105, pS16; Boschin EA, 2015, P NATL ACAD SCI USA, V112, pE1020, DOI 10.1073/pnas.1419649112; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Cope M, 1988, Adv Exp Med Biol, V222, P183; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; El Shemy SA, 2018, ANN REHABIL MED-ARM, V42, P854, DOI 10.5535/arm.2018.42.6.854; Ferrari M, 2014, BRAIN TOPOGR, V27, P353, DOI 10.1007/s10548-013-0320-z; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Fujimoto H, 2014, NEUROIMAGE, V85, P547, DOI 10.1016/j.neuroimage.2013.05.014; Fujita H, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7053867; Gagnon L., 2014, NEUROIMAGE; Giacomini PG, 2004, EUR J PAIN, V8, P579, DOI 10.1016/j.ejpain.2004.02.004; Greenberg S., 2017, ANESTH ANALG; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Helmich I, 2016, MED SCI SPORT EXER, V48, P2362, DOI 10.1249/MSS.0000000000001028; Helmich I, 2015, J NEUROPSYCH CLIN N, V27, P287, DOI 10.1176/appi.neuropsych.14100276; Herold F, 2017, HUM MOVEMENT SCI, V51, P51, DOI 10.1016/j.humov.2016.11.002; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Huppert T, 2013, HUM BRAIN MAPP, V34, P2817, DOI 10.1002/hbm.22106; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; Karim H, 2013, NEUROIMAGE, V74, P318, DOI 10.1016/j.neuroimage.2013.02.010; Karim H, 2012, GAIT POSTURE, V35, P367, DOI 10.1016/j.gaitpost.2011.10.007; Kitaoka K, 2004, NEUROSCI LETT, V370, P65, DOI 10.1016/j.neulet.2004.07.088; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kostopoulos P, 2007, P NATL ACAD SCI USA, V104, P10223, DOI 10.1073/pnas.0700253104; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lin CC, 2017, EXP BRAIN RES, V235, P1247, DOI 10.1007/s00221-017-4893-8; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; LUNDIN TM, 1993, J APPL BIOMECH, V9, P191, DOI 10.1123/jab.9.3.191; Mahoney JR, 2016, BRAIN RES, V1633, P126, DOI 10.1016/j.brainres.2015.10.053; Mallinson AI, 1998, AM J OTOL, V19, P814; Mansouri FA, 2015, P NATL ACAD SCI USA, V112, pE3940, DOI 10.1073/pnas.1422629112; Marx E, 2003, NEUROIMAGE, V19, P924, DOI 10.1016/S1053-8119(03)00150-2; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Moro SB, 2014, NEUROIMAGE, V85, P451, DOI 10.1016/j.neuroimage.2013.05.031; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Purkayastha S, 2019, PM&R, V11, P1184, DOI 10.1002/pmrj.12129; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; RUBIN AM, 1995, AM J OTOL, V16, P216; Schecklmann M, 2011, PSYCHIAT RES-NEUROIM, V194, P378, DOI 10.1016/j.pscychresns.2011.01.016; Schmidt JD, 2018, J ATHL TRAINING, V53, P109, DOI 10.4085/1062-6050-326-16; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Tachtsidis Ilias, 2016, Neurophotonics, V3, P030401, DOI 10.1117/1.NPh.3.3.030401; Takakura H, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00620; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; VanderVelde TJ, 2005, NEUROREPORT, V16, P773, DOI 10.1097/00001756-200505120-00023; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Wang BT, 2016, BEHAV BRAIN RES, V312, P238, DOI 10.1016/j.bbr.2016.06.037	69	2	3	4	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2020	25								102164	10.1016/j.nicl.2020.102164			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KU2JR	WOS:000519535200075	31954336	gold, Green Published			2022-02-06	
J	Hitti, FL; Piazza, M; Sinha, S; Kvint, S; Hudgins, E; Baltuch, G; Diaz-Arrastia, R; Davis, KA; Litt, B; Lucas, T; Chen, HI				Hitti, Frederick L.; Piazza, Matthew; Sinha, Saurabh; Kvint, Svetlana; Hudgins, Eric; Baltuch, Gordon; Diaz-Arrastia, Ramon; Davis, Kathryn A.; Litt, Brian; Lucas, Timothy; Chen, H. Isaac			Surgical Outcomes in Post-Traumatic Epilepsy: A Single Institutional Experience	OPERATIVE NEUROSURGERY			English	Article						Neuromodulation; Post-traumatic epilepsy; Temporal lobectomy; Traumatic brain injury	VAGUS NERVE-STIMULATION; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE; INTRACTABLE EPILEPSY; ASSOCIATION; PREVENTION; PHENYTOIN; EFFICACY; SEIZURES; SURGERY	BACKGROUND: Post-traumatic epilepsy (PTE) is a debilitating sequela of traumatic brain injury (TBI), occurring in up to 20% of severe cases. This entity is generally thought to be more difficult to treat with surgical intervention. OBJECTIVE: To detail our experience with the surgical treatment of PTE. METHODS: Patients with a history of head injury undergoing surgical treatment for epilepsy were retrospectively enrolled. Engel classification at the last follow-up was used to assess outcome of patients that underwent surgical resection of an epileptic focus. Reduction in seizure frequency was assessed for patients who underwent vagal nerve stimulator (VNS) or responsive neurostimulator (RNS) implantation. RESULTS: A total of 23 patients met inclusion criteria. Nineteen (82.6%) had mesial temporal sclerosis, 3 had lesional neocortical epilepsy (13.0%), and 1 had nonlesional neocortical epilepsy (4.3%). Fourteen patients (60.9%) underwent temporal lobectomy (TL), 2 underwent resection of a cortical focus (8.7%), and 7 underwent VNS implantation (30.4%). Three patients underwent RNS implantation after VNS failed to reduce seizure frequency more than 50%. In the patients treated with resection, 11(68.8%) were Engel I, 3 (18.8%) were Engel II, and 2 (12.5%) were Engel Ill at follow-up. Average seizure frequency reduction in the VNS group was 30.6% +/- 25.6%. RNS patients had reduction of seizure severity but seizure frequency was only reduced 9.6% +/- 13.6%. CONCLUSION: Surgical outcomes of PTE patients treated with TL were similar to reported surgical outcomes of patients with nontraumatic epilepsy treated with TL. Patients who were not candidates for resection demonstrated variable response rates to VNS or RNS implantation.	[Hitti, Frederick L.; Piazza, Matthew; Sinha, Saurabh; Kvint, Svetlana; Hudgins, Eric; Baltuch, Gordon; Lucas, Timothy; Chen, H. Isaac] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Diaz-Arrastia, Ramon; Davis, Kathryn A.; Litt, Brian] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA		Hitti, FL (corresponding author), Univ Penn, Dept Neurosurg, 3rd Floor Silverstein,3400 Spruce St, Philadelphia, PA 19104 USA.	Frederick.Hitti@uphs.upenn.edu	Morden, Frances/AAY-4233-2020	Hitti, Frederick/0000-0002-5308-9817	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS099348, K23 NS092973] Funding Source: Medline		Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cohen-Gadol AA, 2006, J NEUROSURG, V104, P513, DOI 10.3171/jns.2006.104.4.513; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Englot DJ, 2012, J NEUROSURG, V117, P970, DOI 10.3171/2012.8.JNS122; Englot DJ, 2011, J NEUROSURG, V115, P1248, DOI 10.3171/2011.7.JNS11977; GEORGE R, 1994, EPILEPSIA, V35, P637, DOI 10.1111/j.1528-1157.1994.tb02484.x; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Hakimian S, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11329; Hartzfeld P, 2008, BRIT J NEUROSURG, V22, P224, DOI 10.1080/02688690701818901; Heck CN, 2014, EPILEPSIA, V55, P432, DOI 10.1111/epi.12534; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Irimia A, 2015, J CLIN NEUROSCI, V22, P627, DOI 10.1016/j.jocn.2014.09.019; Larkin M, 2016, CUREUS, V8, DOI 10.7759/cureus.744; MATHERN GW, 1994, EPILEPSY RES, V19, P129, DOI 10.1016/0920-1211(94)90023-X; McGirt MJ, 2011, J NEUROSURG-SPINE, V14, P771, DOI 10.3171/2011.1.SPINE10571; PECHADRE JC, 1991, PRESSE MED, V20, P841; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Salinsky MC, 1996, ARCH NEUROL-CHICAGO, V53, P1176, DOI 10.1001/archneur.1996.00550110128021; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Schuele SU, 2008, LANCET NEUROL, V7, P514, DOI 10.1016/S1474-4422(08)70108-X; Schuh LA, 1998, ARCH NEUROL-CHICAGO, V55, P1325, DOI 10.1001/archneur.55.10.1325; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Sperling MR, 1996, JAMA-J AM MED ASSOC, V276, P470, DOI 10.1001/jama.276.6.470; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	32	2	2	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	2332-4252	2332-4260		OPER NEUROSURG	Oper. Neurosurg.	JAN	2020	18	1					12	18		10.1093/ons/opz043			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KY8VM	WOS:000522854200021	30924499	Green Published			2022-02-06	
J	Huang, YM; Li, Q; Tian, H; Yao, XL; Bakina, O; Zhang, HQ; Lei, T; Hu, F				Huang, Yimin; Li, Qing; Tian, Hao; Yao, Xiaolong; Bakina, Olga; Zhang, Huaqiu; Lei, Ting; Hu, Feng			MEK inhibitor trametinib attenuates neuroinflammation and cognitive deficits following traumatic brain injury in mice	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Traumatic brain injury; microglia; neuroinflammation; MEK/ERK; trametinib	NF-KAPPA-B; GROWTH-FACTOR; SIGNALING PATHWAYS; MICROGLIAL CELLS; PROTEIN-KINASES; ERK; ACTIVATION; SURVIVAL; ROLES; BETA	Microglia-mediated neuroinflammation is one of the hallmark pathological features following traumatic brain injury (TBI) that contributes to aggravated brain damage and cognitive deficits. These pathologies require novel effective treatments to improve prognosis. Trametinib, a mitogen-activated protein kinase inhibitor approved by the Food and Drug Administration in treating various malignant tumors, has been shown to exert anti-inflammatory effects. The present study demonstrated that TBI mice treated with trametinib exhibited improved cognitive function. Trametinib treatment rescued oligodendrocytes and decreased infiltrating microglial density in the TBI area. Furthermore, this study revealed that ameliorated lipopolysaccharides (LPS) induced inflammatory reaction in microglial cells. Besides, trametinib attenuated inflammation factors expression during the early stages of TBI. In addition, trametinib inhibited LPS-induced microglial chemotactic activity. In conclusion, the results indicate that trametinib efficiently suppresses microglia-induced neuroinflammation and improves cognitive function of TBI mice, providing a potential therapy strategy for TBI patients.	[Huang, Yimin; Yao, Xiaolong; Zhang, Huaqiu; Lei, Ting; Hu, Feng] Huazhong Univ Sci & Technol, Dept Neurosurg, Tongji Hosp, Tongji Med Coll, Jiefang Ave 1095, Wuhan 430030, Hubei, Peoples R China; [Huang, Yimin; Bakina, Olga] Max Delbrueck Ctr Mol Med, Helmholtz Assoc, D-13125 Berlin, Germany; [Huang, Yimin] Charite Univ Med Berlin, Dept Cell Biol & Neurobiol, D-10117 Berlin, Germany; [Li, Qing] Charite Univ Med Berlin, Dept Nephrol & Med Intens Care, D-10117 Berlin, Germany; [Tian, Hao] Third Peoples Hosp Hubei Prov, Dept Neurol, Wuhan 430030, Hubei, Peoples R China		Hu, F (corresponding author), Huazhong Univ Sci & Technol, Dept Neurosurg, Tongji Hosp, Tongji Med Coll, Jiefang Ave 1095, Wuhan 430030, Hubei, Peoples R China.	hufeng@tjh.tjmu.edu.cn		zhang, huaqiu/0000-0003-3023-2040	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81602202]	This research was funded by the National Natural Science Foundation of China [grant no. 81602202(FH)]. We thank the microscope facility of the Tongji Hospital of Huazhong University of Science and Technology. Special thanks to Regina Piske and Maren Wendt from Max Delbrueck Center of Molecular Medicine (Berlin, Germany).	Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Du SL, 2015, BIOCHEM BIOPH RES CO, V458, P667, DOI 10.1016/j.bbrc.2015.01.160; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hu F, 2015, NEURO-ONCOLOGY, V17, P200, DOI 10.1093/neuonc/nou324; Hutchinson, 2018, SURGERY, V36, P613, DOI [10.1016/j.mpsur.2018.09.007, DOI 10.1016/J.MPSUR.2018.09.007]; Ifuku M, 2016, BRAIN BEHAV IMMUN, V58, P338, DOI 10.1016/j.bbi.2016.08.003; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jiang SC, 2008, PURINERG SIGNAL, V4, P61, DOI 10.1007/s11302-007-9093-8; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Ju SM, 2019, J ALZHEIMERS DIS, V68, P1687, DOI 10.3233/JAD-190063; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kreipke CW, 2007, NEUROL RES, V29, P388, DOI 10.1179/016164107X204710; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Lugowska I, 2015, ONCOTARGETS THER, V8, P2251, DOI 10.2147/OTT.S72951; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Mattson MP, 1997, BRAIN RES REV, V23, P47, DOI 10.1016/S0165-0173(96)00014-8; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Merrill MJ, 2005, J NEUROSURG, V103, P853, DOI 10.3171/jns.2005.103.5.0853; Minelli A, 2000, PFLUG ARCH EUR J PHY, V439, P370, DOI 10.1007/s004240050952; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Qu WS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-178; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Satyamoorthy K, 2003, CANCER RES, V63, P756; Scheller A, 2017, NEUROCHEM RES, V42, P2479, DOI 10.1007/s11064-017-2343-4; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Taetzsch T, 2012, FREE RADICAL BIO MED, V53, pS64, DOI 10.1016/j.freeradbiomed.2012.10.192; Takase H, 2018, BEHAV BRAIN RES, V340, P205, DOI 10.1016/j.bbr.2016.10.042; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	52	2	2	1	2	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2020	12	10					6351	6365					15	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	OJ3WD	WOS:000583894800027	33194035				2022-02-06	
J	Jones, KF; Pryor, J; Care-Unger, C; Descallar, J; Simpson, GK				Jones, Kate Fiona; Pryor, Julie; Care-Unger, Candice; Descallar, Joseph; Simpson, Grahame Kenneth			Effectiveness of spiritual care training for rehabilitation professionals: An exploratory controlled trial	NEUROREHABILITATION			English	Article						Spirituality; spiritual care; health professionals; spinal cord injury; traumatic brain injury; rehabilitation	FAMILY RESILIENCE; PALLIATIVE CARE; NURSES; PERCEPTIONS; ADJUSTMENT; VALIDITY; RELIGION	BACKGROUND: Spirituality may play an important role in neurorehabilitation, however research findings indicate that rehabilitation professionals do not feel well equipped to deliver spiritual care. OBJECTIVE: To evaluate a spiritual care training program for rehabilitation professionals. METHODS: An exploratory controlled trial was conducted. Participants enrolled in a two-module spiritual care training program. Spiritual care competency was measured with the Spiritual Care Competency Scale. Confidence and comfort levels were measured using the Spiritual Care Competency Scale domains. The Spirituality and Spiritual Care Rating Scale assessed participant attitudes and knowledge. Measures were administered three times: pre-program, post-program and six weeks follow-up. RESULTS: The training (n = 41) and control (n = 32) groups comprised rehabilitation professionals working in spinal cord or traumatic brain injury units. No between-group differences were observed on the study variables at the pre-program time point. Multilevel models found that levels of spiritual care competency, confidence, comfort, and ratings on existential spirituality increased significantly for the training group (versus control) post-program (p < 0.05) and these significant differences were maintained at follow-up. CONCLUSIONS: A brief spiritual care training program can be effective in increasing levels of self-reported competency, confidence and comfort in delivery of spiritual care for rehabilitation professionals.	[Jones, Kate Fiona; Pryor, Julie; Care-Unger, Candice] Royal Rehab, POB 6, Sydney, NSW, Australia; [Pryor, Julie] Univ Sydney, Susan Wakil Sch Nursing & Midwifery, Sydney, NSW, Australia; [Simpson, Grahame Kenneth] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Simpson, Grahame Kenneth] Griffith Univ, Sch Human Serv & Social Work, Brisbane, Qld, Australia; [Descallar, Joseph] Ingham Inst Appl Med Res, Biostat Unit, Liverpool, NSW, Australia; [Descallar, Joseph] Univ New South Wales, South Western Sydney Clin Sch, Liverpool, Australia; [Jones, Kate Fiona] Univ Notre Dame, Inst Eth & Soc, Sydney, NSW, Australia; [Simpson, Grahame Kenneth] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney Sch Med, Sydney, NSW, Australia		Jones, KF (corresponding author), Univ Notre Dame, Inst Eth & Soc, POB 944, Broadway, NSW 2007, Australia.	kate.jones1@nd.edu.au	Jones, Kate/AAV-7641-2021	Simpson, Grahame/0000-0001-8156-9060	Royal Rehab; Liverpool Brain Injury Rehabilitation Unit; Prince of Wales Spinal Injuries Unit; Community of Christ	The authors would like to thank all the health professionals who participated in this study, and Royal Rehab, Liverpool Brain Injury Rehabilitation Unit, Prince of Wales Spinal Injuries Unit and Community of Christ for their support. Wewould also like to thank Jackie Francis for her assistance on this project.	Austin PD, 2016, J STUDY SPIRITUAL, V6, P20, DOI 10.1080/20440243.2016.1158453; Best M, 2016, SUPPORT CARE CANCER, V24, P3295, DOI 10.1007/s00520-016-3135-0; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Canda E.R, 2009, SPIRITUAL DIVERSITY; Cerra A, 2008, J CHRIST NURS, V25, P204, DOI 10.1097/01.CNJ.0000337006.04272.d1; Cobb Mark, 2012, OXFORD TXB SPIRITUAL; Davis DE, 2015, J COUNS PSYCHOL, V62, P503, DOI 10.1037/cou0000082; Fricchione G., 2012, OXFORD TXB SPIRITUAL, P367; Gallison BS, 2013, J HOLIST NURS, V31, P95, DOI 10.1177/0898010112464121; GREGORYALLEN RB, 2012, OXFORD HDB PSYCHOL S, P437, DOI DOI 10.1016/B978-0-12-387724-6.00030-1; Hodge DR, 2013, SOC WORK, V58, P223, DOI 10.1093/sw/swt019; Johnstone B, 2007, DISABIL REHABIL, V29, P1153, DOI 10.1080/09638280600955693; Jones K, 2016, DISABIL REHABIL, V38, P921, DOI 10.3109/09638288.2015.1066884; Jones KF, 2020, NEUROREHABILITATION, V46, P17, DOI 10.3233/NRE-192857; Jones KF, 2018, BRAIN INJURY, V32, P1612, DOI 10.1080/02699052.2018.1511066; Jones KF, 2018, REHABIL PSYCHOL, V63, P521, DOI 10.1037/rep0000229; Jones Kate Fiona, 2018, Spinal Cord Ser Cases, V4, P54, DOI 10.1038/s41394-018-0078-3; Koenig Harold G, 2012, ISRN Psychiatry, V2012, P278730, DOI 10.5402/2012/278730; McSherry W, 2002, INT J NURS STUD, V39, P723, DOI 10.1016/S0020-7489(02)00014-7; McSherry W., 1997, DESCRIPTIVE SURVEY N; Meredith P, 2012, J RELIG HEALTH, V51, P879, DOI 10.1007/s10943-010-9399-7; Millar LA., 2010, J PHYS THERAPY ED, V24; NHS Education for Scotland, 2013, SPIRITUAL CARE; NHSEducation for Scotland, 2009, SPIR CAR MATT; Oxhandler HK, 2015, SOC WORK, V60, P228, DOI 10.1093/sw/swv018; Paal P, 2015, J PASTOR CARE COUNS, V69, P19, DOI 10.1177/1542305015572955; Pearce MJ, 2019, SPIRITUAL CLIN PRACT, V6, P73, DOI 10.1037/scp0000195; Puchalski C, 2000, J Palliat Med, V3, P129, DOI 10.1089/jpm.2000.3.129; Puchalski C, 2009, J PALLIAT MED, V12, P885, DOI 10.1089/jpm.2009.0142; Ross L, 2014, NURS EDUC TODAY, V34, P697, DOI 10.1016/j.nedt.2013.09.014; van Leeuwen R, 2009, J CLIN NURS, V18, P2857, DOI 10.1111/j.1365-2702.2008.02594.x; Walsh F, 2003, FAM PROCESS, V42, P1, DOI 10.1111/j.1545-5300.2003.00001.x; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9	33	2	2	1	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	47	4					393	403		10.3233/NRE-203221			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PK9UM	WOS:000602780400004	33164955	Green Published			2022-02-06	
J	Kabatas, S; Civelek, E; Sezen, GB; Kaplan, N; Savrunlu, EC; Cetin, E; Diren, F; KaraOz, E				Kabatas, Serdar; Civelek, Erdinc; Sezen, Gulseli Berivan; Kaplan, Necati; Savrunlu, Eyup Can; Cetin, Ercan; Diren, Furkan; KaraOz, Erdal			Functional Recovery After Wharton's Jelly-Derived Mesenchymal Stem Cell Administration in a Patient with Traumatic Brain Injury: A Pilot Study	TURKISH NEUROSURGERY			English	Article						Stem cell; Brain injury; Umbilical cord; Transplantation	TRANSPLANTATION; EPIDEMIOLOGY	AIM: To introduce a traumatic brain injury (TBI) patient who underwent stem cell transplantation (SCT) in order to minimize the remaining injury deficiencies. MATERIAL and METHODS: This study included a 29 years old male who had TBI resulting from a vehicle accident which took place one and a half years ago. The participant received six doses of intrathecal, intramuscular, and intravenous transplantation of Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) at a goal dose of 1 x10(6) / kg respectively for each route of administration for six months. RESULTS: No important negative effects were reported. The patients' speech, cognitive, memory and fine motor skills were improved. The efficacy of treatment with SCT was assessed with cranial magnetic resonance imaging (MRI), computed tomography (CT) screening, and electroencephalography (EEG). CONCLUSION: SCT can have a promising future as a medical approach in recurrent TBI.	[Kabatas, Serdar; Civelek, Erdinc; Sezen, Gulseli Berivan; Savrunlu, Eyup Can; Cetin, Ercan; Diren, Furkan] Univ Hlth Sci, Gaziosmanpasa Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Kabatas, Serdar; Civelek, Erdinc] Marmara Univ, Inst Hlth Sci, Dept Pediat Allergy Immunol, Istanbul, Turkey; [Kabatas, Serdar] Univ Hlth Sci, Ctr Stem Cell & Gene Therapy Res & Practice, Istanbul, Turkey; [Kaplan, Necati] Istanbul Rumeli Univ, Corlu Reyap Hosp, Dept Neurosurg, Istanbul, Turkey; [KaraOz, Erdal] Istinye Univ, Fac Med, Dept Histol & Embryol, Istanbul, Turkey; [KaraOz, Erdal] Liv Hosp, Ctr Regenerat Med & Stem Cell Res & Mfg LivMedCel, Istanbul, Turkey; [KaraOz, Erdal] Istinye Univ, Ctr Stem Cell & Tissue Engn Res & Practice, Istanbul, Turkey		Savrunlu, EC (corresponding author), Univ Hlth Sci, Gaziosmanpasa Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey.	esavrunlu@gmail.com	Karaoz, Erdal/AAO-1470-2020; Civelek, Erdinc/ABI-6105-2020	Civelek, Erdinc/0000-0002-3988-4064			Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Hlebokazov F, 2017, ADV MED SCI-POLAND, V62, P273, DOI 10.1016/j.advms.2016.12.004; Kabatas S, 2018, CELL TRANSPLANT, V27, P1425, DOI 10.1177/0963689718786692; Kamelska-Sadowska AM, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3290894; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li G, 2018, TURK NEUROSURG, V28, P696, DOI 10.5137/1019-5149.JTN.20829-17.1; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; McKintosh T, 2009, J NEUROTRAUM, V10, P215; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Okur SC, 2018, INT J STEM CELLS, V11, P141, DOI 10.15283/ijsc17077; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sharma A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0794-0; Sharma AK, 2015, AM J STEM CELLS, V4, P50; Strauer BE, 2003, CIRCULATION, V107, P929, DOI 10.1161/01.CIR.0000057525.13182.24; Thorpe ER, 2018, J NEUROL PHYS THER, V42, P2, DOI 10.1097/NPT.0000000000000211; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Weiner Leslie P., 2008, V438, P3, DOI 10.1007/978-1-59745-133-8_1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x	26	2	2	0	0	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2020	30	6					914	922		10.5137/1019-5149.JTN.31732-20.1			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OX0NH	WOS:000593272300017	33216342	Bronze			2022-02-06	
J	Kannus, P; Niemi, S; Parkkari, J; Mattila, V; Sievanen, H				Kannus, Pekka; Niemi, Seppo; Parkkari, Jan; Mattila, Ville; Sievanen, Harri			Fall-induced hospital-treated traumatic brain injuries among elderly Finns in 1970-2017	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Fall-induced traumatic brain injury; Elderly Finnish persons; Secular trends	OLDER-ADULTS; PREVENTING FALLS; UNITED-STATES; RISK; DEATHS	Background: Fall-induced traumatic brain injuries (TBI) of elderly adults are a major public health concern. Methods: We determined the current trends in the absolute number and incidence (per 100,000 persons) of severe fall-induced TBI among 80-year-old or older Finns by taking into account all persons who were admitted to Finnish hospitals for primary treatment of such injury between 1970 and 2017. Results: The total number of hospitalized older Finns with a fall-induced TBI increased considerably between the years 1970 and 2017, from 60 (women) and 25 (men) in 1970 to 1622 (women) and 991 (men) in 2017. The age-adjusted incidence of TBI (per 100,000 persons) also showed a clear increase from 1970 to 2017: from 167.9 to 800.4 in women (377% increase), and from 176.8 to 927.3 in men (424% increase). If this trend in the ageadjusted incidence of hospital-treated TBI continues, and the size of the 80-year-old or older Finnish population increases as predicted (from 0.29 million in 2017 to 0.49 million in 2030), the number of these severe injuries among 80-year-old or older Finns will be approximately 1.8 times higher in 2030 (4811 injuries) compared with 2613 injuries in 2017. Conclusions: The number and age-adjusted incidence of fall-induced hospital-treated TBI among elderly Finns increased considerably between 1970 and 2017. Wide-scale fall and injury prevention measures are urgently needed, because further aging of the population is likely to worsen the problem in the near future.	[Kannus, Pekka; Niemi, Seppo; Sievanen, Harri] UKK Inst Hlth Promot Res, Injury & Osteoporosis Res Ctr, Tampere, Finland; [Kannus, Pekka; Parkkari, Jan] UKK Inst Hlth Promot Res, Tampere Res Ctr Sports Med, Tampere, Finland; [Kannus, Pekka; Mattila, Ville] Tampere Univ, Med Sch, Tampere, Finland; [Kannus, Pekka; Mattila, Ville] Tampere Univ Hosp, Dept Orthoped & Traumatol, Tampere, Finland		Kannus, P (corresponding author), UKK Inst, POB 30, FIN-33501 Tampere, Finland.	Pekka.Kannus@ukkinstituutti.fi			Comparative Research Funding of the Pirkanmaa Hospital District, Tampere, Finland [9V015]	This study was funded by the Comparative Research Funding of the Pirkanmaa Hospital District, Tampere, Finland (grant no 9V015). The organization had no involvement in the (1) study design; (2) collection, analysis and interpretation of data; (3) writing of the manuscript; and (4) decision to submit the manuscript for publication.	Buchele G, 2016, J AM MED DIR ASSOC, V17, P609, DOI 10.1016/j.jamda.2016.02.032; Ferrucci L, 2016, J GERONTOL A-BIOL, V71, P1184, DOI 10.1093/gerona/glw043; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Harvey LA, 2017, AUSTRALAS J AGEING, V36, P144, DOI 10.1111/ajag.12422; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hopewell S., 2019, BRIT J SPORT MED, DOI [10.1136/bjsports-2019-100732epubl, DOI 10.1136/BJSPORTS-2019-100732EPUBL]; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kannus P, 2017, J GERONTOL A-BIOL, V72, P1390, DOI 10.1093/gerona/glx073; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Korhonen N, 2014, AGE AGEING, V43, P567, DOI 10.1093/ageing/afu060; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Mattila VM, 2008, INJURY, V39, P1373, DOI 10.1016/j.injury.2008.05.007; Official Statistics of Finland, 2017, POP PROJ MUN 2018 20; Official Statistics of Finland, 2018, POP STRUCT 1970 2017; Palvanen M, 2014, INJURY, V45, P265, DOI 10.1016/j.injury.2013.03.010; Sherrington C, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012424.pub2; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Sung KC, 2015, J NEUROTRAUM, V32, P1078, DOI 10.1089/neu.2014.3509; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Tricco AC, 2017, JAMA-J AM MED ASSOC, V318, P1687, DOI 10.1001/jama.2017.15006; Uusi-Rasi K, 2017, J GERONTOL A-BIOL, V72, P1239, DOI 10.1093/gerona/glx044; Welmer AK, 2017, J GERONTOL A-BIOL, V72, P669, DOI 10.1093/gerona/glw141; Yang Y, 2017, J HEAD TRAUMA REHAB, V32, P168, DOI 10.1097/HTR.0000000000000257	27	2	3	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943	1872-6976		ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	JAN-FEB	2020	86								103958	10.1016/j.archger.2019.103958			4	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	JN5RD	WOS:000496954500015	31581022	Green Accepted			2022-02-06	
J	Kim, M; Song, M; Oh, HJ; Hui, J; Bae, W; Shin, J; Ji, SD; Koh, YH; Suh, JW; Park, H; Maeng, S				Kim, Minsang; Song, Minah; Oh, Hee-Jin; Hui, Jin; Bae, Woori; Shin, Jihwan; Ji, Sang-Dock; Koh, Young Ho; Suh, Joo Won; Park, Hyunwoo; Maeng, Sungho			Evaluating the Memory Enhancing Effects of Angelica gigas in Mouse Models of Mild Cognitive Impairments	NUTRIENTS			English	Article						Angelica gigas; mild cognitive impairment; traumatic brain injury; chronic mild stress	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; CONDITIONED FEAR; STRESS MODEL; DEMENTIA; DEPRESSION; DEFICITS; CONSEQUENCES; PERFORMANCE; INCREASES	(1) Background: By 2050, it is estimated that 130 million people will be diagnosed with dementia, and currently approved medicines only slow the progression. So preventive intervention is important to treat dementia. Mild cognitive impairment is a condition characterized by some deterioration in cognitive function and increased risk of progressing to dementia. Therefore, the treatment of mild cognitive impairment (MCI) is a possible way to prevent dementia. Angelica gigas reduces neuroinflammation, improves circulation, and inhibits cholinesterase, which can be effective in the prevention of Alzheimer's disease and vascular dementia and the progression of mild cognitive impairment. (2) Methods: Angelica gigas (AG) extract 1 mg/kg was administered to mildly cognitive impaired mice, models based on mild traumatic brain injury and chronic mild stress. Then, spatial, working, and object recognition and fear memory were measured. (3) Result: Angelica gigas improved spatial learning, working memory, and suppressed fear memory in the mild traumatic brain injury model. It also improved spatial learning and suppressed cued fear memory in the chronic mild stress model animals. (4) Conclusions: Angelica gigas can improve cognitive symptoms in mild cognitive impairment model mice.	[Kim, Minsang] Myongji Univ, Collage Nat Sci, Grad Sch, Interdisciplinary Program Biomodulat, Yongin 17058, South Korea; [Song, Minah; Oh, Hee-Jin; Bae, Woori; Shin, Jihwan; Maeng, Sungho] Kyung Hee Univ, Grad Sch East West Med Sci, Yongin 17104, South Korea; [Hui, Jin; Suh, Joo Won] Myongji Univ, Ctr Nutraceut & Pharmaceut Mat, Yongin 17058, South Korea; [Ji, Sang-Dock] Natl Acad Agr Sci, Rural Dev Adm, Dept Agr Biol, Jeollabuk Do 55365, South Korea; [Koh, Young Ho] Hallym Univ, ILSONG Inst Life Sci, Anyang 14066, South Korea; [Koh, Young Ho] Hallym Univ, Grad Sch, Dept Biomed Gerontol, Chunchon 24252, South Korea; [Park, Hyunwoo] Hlth Pk Co Ltd, 2502,Gangnam Dae Ro 305, Seoul 06628, South Korea		Maeng, S (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Yongin 17104, South Korea.; Park, H (corresponding author), Hlth Pk Co Ltd, 2502,Gangnam Dae Ro 305, Seoul 06628, South Korea.	kms0177@naver.com; bungu20@naver.com; julia110892@naver.com; kimhwi83@gmail.com; wrbae0328@naver.com; junikk0@naver.com; sdji11@korea.kr; kohyh@hallym.ac.kr; jwsuh@mju.ac.kr; hwpark75@gmail.com; jethrot@khu.ac.kr		gim, minsang/0000-0003-1242-0929	Cooperative Research Program for Agriculture Science and Technology DevelopmentRural Development Administration (RDA) [PJ01331402]	This research was funded by the Cooperative Research Program for Agriculture Science and Technology Development, grant number PJ01331402.	Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Cha Y.-S., 1999, APPL BIOL CHEM, V42, P29; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Chertkow H, 2008, CAN MED ASSOC J, V178, P1273, DOI 10.1503/cmaj.070797; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Cuadrado-Tejedor M, 2011, BEHAV BRAIN RES, V220, P338, DOI 10.1016/j.bbr.2011.01.005; DYWAN J, 1993, BRAIN COGNITION, V21, P20, DOI 10.1006/brcg.1993.1002; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; EBLY EM, 1995, ARCH NEUROL-CHICAGO, V52, P612, DOI 10.1001/archneur.1995.00540300086018; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Geda YE, 2010, ARCH NEUROL-CHICAGO, V67, P80, DOI 10.1001/archneurol.2009.297; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Haridas S, 2013, PHYSIOL BEHAV, V119, P201, DOI 10.1016/j.physbeh.2013.06.015; Henningsen K, 2009, BEHAV BRAIN RES, V198, P136, DOI 10.1016/j.bbr.2008.10.039; Hernandez CM, 2003, J PSYCHIATR NEUROSCI, V28, P197; Kang SY, 2001, J NAT PROD, V64, P683, DOI 10.1021/np000441w; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Morrissey MD, 2011, NEUROBIOL LEARN MEM, V95, P46, DOI 10.1016/j.nlm.2010.10.007; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Pepeu Giancarlo, 2004, Dialogues Clin Neurosci, V6, P369; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Reischies FM, 2000, EUR ARCH PSY CLIN N, V250, P186, DOI 10.1007/s004060070023; Sarker SD, 2004, CURR MED CHEM, V11, P1479, DOI 10.2174/0929867043365189; Sattler C, 2012, PSYCHIAT RES, V196, P90, DOI 10.1016/j.psychres.2011.11.012; Song L, 2006, PHARMACOL BIOCHEM BE, V83, P186, DOI 10.1016/j.pbb.2006.01.004; Sowndhararajan K, 2017, SCI PHARM, V85, DOI 10.3390/scipharm85020021; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Terry AV, 2000, NEUROSCIENCE, V101, P357, DOI 10.1016/S0306-4522(00)00377-8; Tuokko H, 2003, ARCH NEUROL-CHICAGO, V60, P577, DOI 10.1001/archneur.60.4.577; Visser PJ, 2000, J AM GERIATR SOC, V48, P479, DOI 10.1111/j.1532-5415.2000.tb04992.x; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Wright RL, 2005, STRESS, V8, P151, DOI 10.1080/10253890500156663; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan JJ, 2004, PROG NEURO-PSYCHOPH, V28, P25, DOI 10.1016/S0278-5846(03)00168-4; Zhao RJ, 2005, BIOL PHARM BULL, V28, P2323, DOI 10.1248/bpb.28.2323	46	2	2	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2072-6643		NUTRIENTS	Nutrients	JAN	2020	12	1							97	10.3390/nu12010097			12	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nutrition & Dietetics	KQ3KN	WOS:000516825500097	31905851	Green Published, gold			2022-02-06	
J	Kronsbein, K; Karger, B; Budczies, J; Pfeiffer, H; Wittschieber, D				Kronsbein, Katharina; Karger, Bernd; Budczies, Jan; Pfeiffer, Heidi; Wittschieber, Daniel			Updating the risk profile of fatal head trauma: an autopsy study with focus on age- and sex-dependent differences	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Fatal head trauma; Traumatic brain injury; Autopsy; Retrospective analysis; Medico-legal assessment	BRAIN-INJURY; EPIDEMIOLOGY; OUTCOMES; SUICIDE; GERMANY; DEATHS; MARKER	Fatal head trauma (FHT) represents one of the most frequent causes of death diagnosed in forensic pathology. However, profound statistic autopsy data on FHT is still sparse. Therefore, the purpose of this study was to investigate the circumstances and injury patterns of FHT with particular focus on age and sex, and additionally, to describe a recent risk profile of FHT. To this end, the forensic autopsy records of each FHT case at a large German university hospital during a 10-year period (2006-2015) were analyzed retrospectively (n = 372). The male-female ratio was 2.6:1. Regarding median age, females were 12.5 years older than males. Traffic-associated FHTrepresents the major mechanismof death, followed by fall-associated FHT. While accident was the major manner of death and presented a similar distribution of age and sex, homicides were the only subgroup with a significantly lower ratio between males and females. Skull fractures occurred in 78.2% and intracranial hemorrhages in 80.6% of all cases. In summary and partly in contrast to clinical data on head trauma, FHT still occurs predominantly in male individuals under the age of 45 years, in the context of traffic accidents and affected by alcohol intake. Improvements in traffic security as well as continuing surveillance of the incidence of FHT by forensic autopsies are necessary to further reduce the incidence of FHT.	[Kronsbein, Katharina; Karger, Bernd; Pfeiffer, Heidi; Wittschieber, Daniel] Westfalian Wilhelms Univ, Univ Hosp Munster, Inst Legal Med, Munster, Germany; [Budczies, Jan] Ruprecht Karls Univ Heidelberg, Univ Hosp Heidelberg, Inst Pathol, Div Biostat, Heidelberg, Germany; [Wittschieber, Daniel] Friedrich Schiller Univ, Jena Univ Hosp, Inst Legal Med, Klinikum 1, D-07747 Jena, Germany		Wittschieber, D (corresponding author), Westfalian Wilhelms Univ, Univ Hosp Munster, Inst Legal Med, Munster, Germany.; Wittschieber, D (corresponding author), Friedrich Schiller Univ, Jena Univ Hosp, Inst Legal Med, Klinikum 1, D-07747 Jena, Germany.	daniel.wittschieber@med.uni-jena.de	Budczies, Jan/AAG-8122-2020				Aghakhani K, 2014, J FORENSIC LEG MED, V28, P36, DOI 10.1016/j.jflm.2014.09.009; Akang EEU, 2002, MED SCI LAW, V42, P160, DOI 10.1177/002580240204200207; Armstead WM, 2017, J NEUROTRAUM, V34, P1666, DOI 10.1089/neu.2016.4770; Bjarko VV, 2019, WORLD NEUROSURG, V122, pE684, DOI 10.1016/j.wneu.2018.10.122; Bratzke H, 2011, RECHTSMEDIZIN, V21, P258, DOI 10.1007/s00194-011-0760-2; Brewer JW, 2019, J PEDIATR SURG, V54, P783, DOI 10.1016/j.jpedsurg.2018.10.061; Choudhary AK, 2018, PEDIATR RADIOL, V48, P1048, DOI 10.1007/s00247-018-4149-1; El-Menyar A, 2019, BRAIN INJURY, V33, P419, DOI 10.1080/02699052.2018.1553065; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Ferguson SA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00416; Firsching R, 2015, AWMF S2E LEITLINIE S; Florou C, 2016, ROM J MORPHOL EMBRYO, V57, P391; Gesundheitsberichterstattung des Bundes, 2019, GESUNDHEITSBERICHTER; Hahnemann ML, 2015, EUR RADIOL, V25, P299, DOI 10.1007/s00330-014-3443-z; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Leo P, 2016, TRANSLATIONAL RES TR; LYLE DM, 1990, COMMUNITY HEALTH ST, V14, P118; Maegele M, 2019, DTSCH ARZTEBL INT, V116, P167, DOI 10.3238/arztebl.2019.0167; Mauritz W, 2014, BRAIN INJURY, V28, P1096, DOI 10.3109/02699052.2014.904522; Menon Anand, 2008, J Forensic Leg Med, V15, P75, DOI 10.1016/j.jflm.2007.06.001; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Naghavi M, 2018, JAMA-J AM MED ASSOC, V320, P792, DOI 10.1001/jama.2018.10060; Neri M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113544; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Oerter S, 2019, INT J LEGAL MED, V133, P1107, DOI 10.1007/s00414-018-1893-6; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Osuna E, 1997, FORENSIC SCI INT, V87, P73, DOI 10.1016/S0379-0738(97)00046-7; Panzer S, 2017, J FORENSIC LEG MED, V52, P62, DOI 10.1016/j.jflm.2017.08.007; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peschel O, 2013, FORENSIC SCI INT, V233, P45, DOI 10.1016/j.forsciint.2013.08.012; Pinchi E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20699-1; Probst C, 2009, J TRAUMA, V66, P1212, DOI 10.1097/TA.0b013e318197b97c; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Russell AL, 2018, NEUROSCIENCE, V392, P1, DOI 10.1016/j.neuroscience.2018.09.014; Schober K, 2015, INT J LEGAL MED, V129, P701, DOI 10.1007/s00414-014-1129-3; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Statistisches Bundesamt (Destatis), 2018, STAT JB 2018, V2018, P23; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tsirigotis K, 2011, MED SCI MONITOR, V17, pPH65, DOI 10.12659/MSM.881887; Wittschieber D, 2019, AM J NEURORADIOL, V40, P388, DOI 10.3174/ajnr.A5855; Wittschieber D, 2018, RECHTSMEDIZIN, V28, P486, DOI 10.1007/s00194-018-0274-2; Wittschieber D, 2016, FORENSIC SCI INT, V266, pE59, DOI 10.1016/j.forsciint.2016.05.025; Wittschieber D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037460	48	2	2	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JAN	2020	134	1					295	307		10.1007/s00414-019-02187-x			13	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	KG5BM	WOS:000509962400035	31735980				2022-02-06	
J	Kural, A; Neijmann, ST; Toker, A; Dogan, H; Sever, N; Sarikaya, S				Kural, Alev; Neijmann, Sebnem Tekin; Toker, Aysun; Dogan, Halil; Sever, Nurten; Sarikaya, Sezgin			Evaluation of rat major celluler prion protein for early diagnosis in experimental rat brain trauma model	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Major cellular protein prion (PrPC); S100B; traumatic brain injury	MINOR HEAD-INJURY; S100B CONCENTRATIONS; COMPUTED-TOMOGRAPHY; SERUM MEASUREMENTS; SERIAL S-100; BIOMARKERS; DAMAGE; PRPC; ACTIVATION; CHILDREN	BACKGROUND: Although traumatic brain injury (TBI) is an important problem, there has been no widespread utilization of neuro-biomarkers to aid the diagnosis of TBI. This study was conducted to evaluate serum S100B and prion protein (PrPC) levels in rats with TBI. METHODS: In this study, 15 albino rats were categorized into three groups as follows: sham-operated (1), control (6) and trauma (8) groups. The TBI model was based on the modified free falling model. S100B, PrPC levels were measured using ELISA. Brain specimens were obtained for the pathological examination. RESULTS: Serum S100B and PrPC levels were found to increase in T group at both 2h and 24h after trauma (p<0.002, p<0.002, respectively). We also found higher histopathological injury scores of brain tissues in the T group. Only a positive correlation was found between serum PrPC levels and the extent of brain injury (p=0.039, r=0.73 1). Using ROC analysis, among the two serum markers investigated, both of them revealed the same sensitivity and specificity for diagnosing TBI. CONCLUSION: The changes in serum S100B and PrPC levels showed good sensitivity in our experimental model. Therefore, PrPC could be helpful in the early prognostic prediction in patients with TBI. Further studies are needed to test our findings in humans following TBI (penetrating bodies, blunt trauma) to definitively acknowledge it as a reliable biomarker and its subsequent diagnostic utility.	[Kural, Alev; Neijmann, Sebnem Tekin] Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Biochem, Istanbul, Turkey; [Toker, Aysun] Karaman Private Hosp, Dept Biochem, Karaman, Turkey; [Dogan, Halil] Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Emergency Med, Istanbul, Turkey; [Sever, Nurten] Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Pathol, Istanbul, Turkey; [Sarikaya, Sezgin] Yeditepe Univ, Dept Emergency Med, Fac Med, Istanbul, Turkey		Kural, A (corresponding author), Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Biochem, Istanbul, Turkey.; Kural, A (corresponding author), Bakirkoy Dr Sadi Konuk Egitim & Arastirma Hastane, Biyokimya Klin, Istanbul, Turkey.	alevkural@hotmail.com					Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Carulla P, 2011, MOL BIOL CELL, V22, P3041, DOI 10.1091/mbc.E11-04-0321; Chen Da-qing, 2005, Chin J Traumatol, V8, P245; Hoshino S, 2003, ACT NEUR S, V86, P297; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 1997, ACTA NEUROL SCAND, V95, P51, DOI 10.1111/j.1600-0404.1997.tb00068.x; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Isaacs JD, 2006, CLIN EXP IMMUNOL, V146, P1, DOI 10.1111/j.1365-2249.2006.03194.x; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lima JE, 2006, BRAZ J MED BIOL RES, V39, P129, DOI 10.1590/S0100-879X2006000100015; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manzano S, 2016, EMERG MED J, V33, P42, DOI 10.1136/emermed-2014-204513; Marklund N., 1997, NEUROREPORT, V717, P109; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Pham N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117286; Papa L, 2012, POTEOMICS HUMAN DIS; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pham N, 2015, J NEUROTRAUM, V32, P58, DOI 10.1089/neu.2014.3471; PHILLIPS JP, 1980, BRIT MED J, V281, P777, DOI 10.1136/bmj.281.6243.777; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Rothoerl RD, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00054; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; Spudich A, 2005, NEUROBIOL DIS, V20, P442, DOI 10.1016/j.nbd.2005.04.002; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Xiong H, 2000, Sheng Li Ke Xue Jin Zhan, V31, P217; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Yusa S, 2012, VIRUSES-BASEL, V4, P3109, DOI 10.3390/v4113109	64	2	2	0	6	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JAN	2020	26	1					1	8		10.5505/tjtes.2018.46923			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KC9MN	WOS:000507495500001	31942738				2022-02-06	
J	Kwak, EH; Wi, S; Kim, M; Pyo, S; Shin, YK; Oh, KJ; Han, K; Kim, YW; Cho, SR				Kwak, Eun Hee; Wi, Soohyun; Kim, MinGi; Pyo, Soonil; Shin, Yoon-Kyum; Oh, Kyung Ja; Han, Kyunghun; Kim, Yong Wook; Cho, Sung-Rae			Factors affecting cognition and emotion in patients with traumatic brain injury	NEUROREHABILITATION			English	Article						Traumatic brain injury; executive function; memory; emotion	SORTING TEST-PERFORMANCE; BLUNT HEAD-INJURY; FOCAL LESIONS; REHABILITATION; PREDICTORS; AGITATION; MEMORY; NEUROPSYCHOLOGY; IMPAIRMENT; SYMPTOMS	BACKGROUND: Cognitive and emotional disturbances are common serious issues in patients with traumatic brain injury (TBI). However, predictors associated with neuropsychological functions were not consistent. OBJECTIVE: To investigate factors affecting cognition and emotion in patients with TBI, we evaluated executive function, memory, and emotion based on injury severity and lesion location. METHODS: Neuropsychological outcomes of 80 TBI patients were evaluated via Wisconsin Card Sorting Test (WCST), Color Trail Test (CTT), Controlled OralWord Association Test (COWAT), Everyday Memory Questionnaire (EMQ), Geriatric Depression Scale (GDS), State-Trait Anxiety Inventory (STAI), and Agitated Behavior Scale (ABS). WCST, CTT, and COWAT assessed executive function; EMQ assessed everyday memory; and GDS, STAI, and ABS assessed emotion. Patients were categorized according to lateralization of lesion and existence of frontal lobe injury. RESULTS: Patients with longer duration of loss of consciousness (LOC) showed more severe deficits in everyday memory and agitated behaviors. The frontal lesion group showed poorer performance in executive function and higher agitation than the non-frontal lesion group. Patients with bilateral frontal lesion showed greater deficits in executive function and were more depressed than unilateral frontal lesion groups. Especially in those unilateral frontal lesion groups, right side frontal lesion group was worse on executive function than left side frontal lesion group. CONCLUSIONS: Duration of LOC and lesion location are main parameters affecting executive function, everyday memory, and emotion in neuropsychological outcomes following TBI, suggesting that these parameters need to be considered for cognitive rehabilitation interventions.	[Kwak, Eun Hee; Wi, Soohyun; Kim, MinGi; Pyo, Soonil; Shin, Yoon-Kyum; Kim, Yong Wook; Cho, Sung-Rae] Yonsei Univ, Dept & Res Inst Rehabil Med, Med Ctr, Seoul, South Korea; [Kwak, Eun Hee; Oh, Kyung Ja] Yonsei Univ, Dept Psychol, Seoul, South Korea; [Wi, Soohyun; Kim, MinGi; Pyo, Soonil; Shin, Yoon-Kyum; Cho, Sung-Rae] Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Seoul, South Korea; [Han, Kyunghun] Pusan Natl Univ, Div Sport Sci, Busan, South Korea; [Cho, Sung-Rae] Yonsei Univ, Rehabil Inst Neuromuscular Dis, Coll Med, Seoul, South Korea; [Cho, Sung-Rae] Yonsei Univ, Coll Med, Grad Program Nano Sci & Technol, Seoul, South Korea		Kim, YW; Cho, SR (corresponding author), Yonsei Univ, Dept & Res Inst Rehabil Med, Coll Med, Rehabil Hosp, 5th Floor,50 Yonsei Ro, Seoul 03722, South Korea.	YWKIM1@yuhs.ac; srcho918@yuhs.ac		Cho, Sung-Rae/0000-0003-1429-2684; KIM, YONGWOOK/0000-0002-5234-2454			Alexander MP, 2003, BRAIN, V126, P1493, DOI 10.1093/brain/awg128; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Gazzaniga M., 2002, COGNITIVE NEUROSCIEN; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hahn D. W., 2000, KOREAN VERSION STATE; Halldorsson Jonas G, 2008, Neuropsychiatr Dis Treat, V4, P405; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Haut MW, 1996, PSYCHIAT RES, V65, P15, DOI 10.1016/0165-1781(96)02940-X; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; 김민경, 2003, Korean Journal of Clinical Psychology, V22, P463; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jung IK, 1997, KOREAN NEUROPSYCHIAT, V36, P103; Kang Y., 2000, NORMATIVE STUDY KORE; Kim J. S., 1991, J KOREAN NEUROPSYCHI, V30, P996; Lee J. Y., 1990, J KOREAN NEUROPSYCHI, V29, P1059; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Levy M, 2005, NEUROREHABILITATION, V20, P279; MILNER B, 1984, TRENDS NEUROSCI, V7, P403, DOI 10.1016/S0166-2236(84)80143-5; Norton LE, 2001, AM J GERIAT PSYCHIAT, V9, P41; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Robinson R G, 1999, Int Psychogeriatr, V11, P375, DOI 10.1017/S1041610299005992; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Sole-Padulles C, 2009, NEUROBIOL AGING, V30, P1114, DOI 10.1016/j.neurobiolaging.2007.10.008; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; White T., 1996, COLOR TRAILS TEST PR; WILSON J T L, 1990, Brain Injury, V4, P349; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zillmer E., 2001, PRINCIPLES NEUROPSYC, P321	53	2	3	6	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	3					369	379		10.3233/NRE-192893			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LZ2AH	WOS:000541030200010	32310194	Green Published			2022-02-06	
J	Abreu, MGL; Milani, AJ; Fernandes, TD; Gomes, CC; Antunes, LS; Antunes, LAA				Latini Abreu, Mariana Gouvea; Milani, Ana Julia; Fernandes, Thais de Oliveira; Gomes, Cinthya Cristina; Antunes, Leonardo Santos; Alves Antunes, Livia Azeredo			Dental trauma in primary dentition, its effect on permanent successors and on Oral Health-Related Quality of Life: a 4-year follow-up case report	INTERNATIONAL JOURNAL OF BURNS AND TRAUMA			English	Article						Tooth injuries; deciduous teeth; dental trauma; quality of life	INJURIES 3. INJURIES; INTERNATIONAL ASSOCIATION; PRIMARY INCISORS; ENAMEL DEFECTS; TEETH; GUIDELINES; MANAGEMENT; CHILDREN; POPULATION; PROGNOSIS	Traumatic dental injury (TDI) in deciduous teeth can affect itself and subsequent dentition due to its close anatomical relationship with the permanent germ. Besides, it can have psychologically undesirable effects on children and their parents and impact their Oral Health-Related Quality of Life (OHRQoL). In this case report, we aimed to describe a TDI in primary dentition that presented sequel on primary and on permanent dentition as well to describe the impact on OHRQoL after 4 years of follow-up. A 4-year-old boy was referred to the Dental Trauma Care Program (DTCP) six months after an accident at school that resulted in TDI. In deciduous dentition, the tooth 51 presented periapical lesion due to lateral luxation and tooth 61 presented pulp canal obliteration due to a concussion. The teeth received appropriate treatment. After 4 years of follow-up, in the permanent dentition, tooth 11 presented mild disturbance (demarcated opacity) as sequel of TDI in deciduous dentition. The patient's OHRQoL was evaluated throughout this process until the eruption of the permanent tooth. TDI and the sequelae on permanent tooth had a negative impact on the patient's OHRQoL. TDI treatment improved the patient's OHRQoL. This case report reinforces the importance of regular follow-up of traumatized teeth as it can affect both dentitions with a negative impact on OHRQoL.	[Latini Abreu, Mariana Gouvea; Gomes, Cinthya Cristina; Antunes, Leonardo Santos; Alves Antunes, Livia Azeredo] Fed Fluminense Univ, Fac Dent, Postgrad Program Dent, Niteroi, RJ, Brazil; [Milani, Ana Julia; Gomes, Cinthya Cristina; Antunes, Leonardo Santos; Alves Antunes, Livia Azeredo] Fluminense Fed Univ, Hlth Inst Nova Friburgo, Postgrad Program Dent, Nova Friburgo, Brazil; [Fernandes, Thais de Oliveira; Gomes, Cinthya Cristina; Antunes, Leonardo Santos; Alves Antunes, Livia Azeredo] Fluminense Fed Univ, Dept Specif Format, Hlth Inst Nova Friburgo, Sch Dent, Rua Doutor Silvio Henrique Braune,22 Ctr, BR-28625650 Nova Friburgo, RJ, Brazil		Antunes, LAA (corresponding author), Fluminense Fed Univ, Dept Specif Format, Hlth Inst Nova Friburgo, Sch Dent, Rua Doutor Silvio Henrique Braune,22 Ctr, BR-28625650 Nova Friburgo, RJ, Brazil.	liviaazeredo@gmail.com		Fernandes, Thais/0000-0002-1919-543X	Pro-Reitoria de Extensao Universidade Federal Fluminense (PROEX/UFF)	The authors would like to thank the participants of this report, his parents, and we would like to thank the Pro-Reitoria de Extensao Universidade Federal Fluminense (PROEX/UFF) for support of the Dental Trauma Care Program.	Abanto J, 2015, INT J PAEDIATR DENT, V25, P18, DOI 10.1111/ipd.12092; Aldrigui JM, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-78; Altun C, 2009, ORAL SURG ORAL MED O, V107, P493, DOI 10.1016/j.tripleo.2008.10.016; Antunes LAA, 2012, CIENC SAUDE COLETIVA, V17, P3417, DOI 10.1590/S1413-81232012001200026; Antunes LAA, 2020, INT J DENT HYG, V18, P142, DOI 10.1111/idh.12425; Arenas M, 2006, DENT TRAUMATOL, V22, P226, DOI 10.1111/j.1600-9657.2006.00352.x; Berger TD, 2009, DENT TRAUMATOL, V25, P462, DOI 10.1111/j.1600-9657.2009.00809.x; Borges TS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172235; Brin I, 1984, Pediatr Dent, V6, P78; Cagetti MG, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0734-7; Clark D, 2018, DENT TRAUMATOL; Da Fidalgo T.K., 2012, GEN DENT, V60, P158; Day PF, 2020, DENT TRAUMATOL, V36, P343, DOI 10.1111/edt.12576; Diab M, 2000, QUINTESSENCE INT, V31, P377; Feldens CA, 2016, DENT TRAUMATOL, V32, P429, DOI 10.1111/edt.12281; Flores MT, 2002, DENT TRAUMATOL, V18, P287, DOI 10.1034/j.1600-9657.2002.00153.x; Glick M, 2017, J PUBLIC HEALTH DENT, V77, P3, DOI 10.1111/jphd.12213; Gomes MC, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-55; JACOBSEN I, 1978, ACTA ODONTOL SCAND, V36, P199, DOI 10.3109/00016357809004668; Karatas MS, 2013, MED PRIN PRACT, V22, P590, DOI 10.1159/000350500; Korolenkova M V, 2019, Stomatologiia (Mosk), V98, P116, DOI 10.17116/stomat201998041116; Kratunova Evelina, 2018, General Dentistry, V66, P30; La Monaca G, 2019, MINERVA STOMATOL, V68, P332, DOI 10.23736/S0026-4970.19.04297-3; Li Y, 1996, CARIES RES, V30, P8, DOI 10.1159/000262130; Magno MB, 2019, INT J PAEDIATR DENT, V29, P86, DOI 10.1111/ipd.12437; Malmgren Barbro, 2017, Pediatr Dent, V39, P420, DOI 10.1111/j.1600-9657.2012.01146.x; Malmgren Barbro, 2016, Pediatr Dent, V38, P377; Mello-Moura A C V, 2009, J Indian Soc Pedod Prev Dent, V27, P125, DOI 10.4103/0970-4388.55341; Mendoza AM, 2010, AM J DENT, V23, P265; Nikoui M, 2003, DENT TRAUMATOL, V19, P280, DOI 10.1034/j.1600-9657.2003.00209.x; Oginni Adeleke O, 2007, BMC Oral Health, V7, P11, DOI 10.1186/1472-6831-7-11; Oliveira AFB, 2006, CARIES RES, V40, P296, DOI 10.1159/000093188; Page LAF, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-26; Peariasamy K, 2001, Int J Paediatr Dent, V11, P193, DOI 10.1046/j.1365-263X.2001.00267.x; Ranka M, 2013, DENT UPDATE, V40, P539; Ranka M, 2013, DENT UPDATE, V40, P542; Ranka Meena, 2013, Dent Update, V40, P534; Santos BZ, 2011, PEDIATR DENT, V33, P399; Scarpelli AC, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-19; Sennhenn-Kirchner S, 2006, DENT TRAUMATOL, V22, P237, DOI 10.1111/j.1600-9657.2006.00383.x; Skaare AB, 2013, DENT TRAUMATOL, V29, P79, DOI 10.1111/j.1600-9657.2012.01153.x; Flores MT, 2019, DENT TRAUMATOL, V35, P312, DOI 10.1111/edt.12496; Frujeri MDV, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-91	43	2	2	1	1	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	2160-2026			INT J BURNS TRAUMA	Int. J. Burns Trauma		2020	10	5					201	209					9	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	OP9IP	WOS:000588404100003	33224607				2022-02-06	
J	LaTorre, A; Kwong, MT; Garcia-Grajales, JA; Shi, RY; Jerusalem, A; Pena, JM				LaTorre, Antonio; Kwong, Man Ting; Garcia-Grajales, Julian A.; Shi, Riyi; Jerusalem, Antoine; Pena, Jose-Maria			Model calibration using a parallel differential evolution algorithm in computational neuroscience: Simulation of stretch induced nerve deficit	JOURNAL OF COMPUTATIONAL SCIENCE			English	Article						Parallel differential evolution; Mechanical damage model; Axonal deficit; NEURITE	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CONDUCTION DEFICITS; GENETIC ALGORITHM; OPTIMIZATION; DEGENERATION; TISSUE; AXONS; EXCITOTOXICITY; DEMYELINATION	Neuronal damage, in the form of both brain and spinal cord injuries, is one of the major causes of disability and death in young adults worldwide. One way to assess the direct damage occurring after a mechanical insult is the simulation of the neuronal cells functional deficits following the mechanical event. In this study, we use a coupled electrophysiological-mechanical model with several free parameters that are required to be calibrated against experimental results. The calibration is carried out by means of an evolutionary algorithm (differential evolution, DE) that needs to evaluate each configuration of parameters on six different damage cases, each of them taking several minutes to compute. To minimise the simulation time of the parameter tuning for the DE, the stretch of one unique fixed-diameter axon with a simplified triggering process is used to speed up the calculations. The model is then leveraged for the parameter optimization of the more realistic bundle of independent axons, an impractical configuration to run on a single processor computer. To this end, we have developed a parallel implementation based on OpenMP that runs on a multi-processor taking advantage of all the available computational power. The parallel DE algorithm obtains good results, outperforming the best effort achieved by published manual calibration, in a fraction of the time. While not being able to fully capture the experimental results, the resulting nerve model provides a complex averaging framework for nerve damage simulation able to simulate gradual axonal functional alteration in a bundle. (C) 2019 Elsevier B.V. All rights reserved.	[LaTorre, Antonio; Garcia-Grajales, Julian A.; Pena, Jose-Maria] Univ Politecn Madrid, ETSIINF, DATSI, Madrid, Spain; [LaTorre, Antonio; Pena, Jose-Maria] Univ Politecn Madrid, Ctr Computat Simulat, Madrid, Spain; [Kwong, Man Ting; Jerusalem, Antoine; Pena, Jose-Maria] Univ Oxford, Dept Engn Sci, Oxford, England; [Shi, Riyi] Purdue Univ, Dept Basic Med Sci, Coll Vet Med, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Pena, Jose-Maria] Lurtis Ltd, Oxford, England		LaTorre, A; Garcia-Grajales, JA; Pena, JM (corresponding author), Univ Politecn Madrid, ETSIINF, DATSI, Madrid, Spain.; LaTorre, A; Pena, JM (corresponding author), Univ Politecn Madrid, Ctr Computat Simulat, Madrid, Spain.; Jerusalem, A; Pena, JM (corresponding author), Univ Oxford, Dept Engn Sci, Oxford, England.; Pena, JM (corresponding author), Lurtis Ltd, Oxford, England.	a.latorre@upm.es; antoine.jerusalem@eng.ox.ac.uk; jm.penya@lurtis.com		Pena, Jose Maria/0000-0002-3303-0455	Spanish Ministry of ScienceSpanish Government [TIN2017-83132-C2-2-R]; Universidad Politecnica de Madrid [PINV-18-XEOGHQ-19-4QTEBP]; European Research Council under the European UnionEuropean Research Council (ERC) [306587]	J.-M.P. and A.L. acknowledge funding from the Spanish Ministry of Science (TIN2017-83132-C2-2-R) and Universidad Politecnica de Madrid (PINV-18-XEOGHQ-19-4QTEBP). M.T.K. and A.J. acknowledge funding from the European Research Council under the European Union's Seventh Framework Programme (FP7 2007-2013)/European Research Council Grant Agreement No. 306587.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abe Y, 1999, J NEUROTRAUM, V16, P945, DOI 10.1089/neu.1999.16.945; Amar A.P., 2007, SURG MANAGEMENT SPIN, P1; Arsenault R, 2014, J HYDROL ENG, V19, P1374, DOI 10.1061/(ASCE)HE.1943-5584.0000938; Babu BV, 2007, CHEM ENG SCI, V62, P3720, DOI 10.1016/j.ces.2007.03.039; BANIK NL, 1982, NEUROCHEM RES, V7, P1465, DOI 10.1007/BF00965089; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Bjorck M, 2007, J APPL CRYSTALLOGR, V40, P1174, DOI 10.1107/S0021889807045086; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Bower J.M., 1995, Q REV BIOL, V70, P534; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Calvez B., 2007, MULT MOD COMPL SYST, P16; Chan P.H., 1984, FED PROC, V43, P201; Chin VJ, 2016, ENERG CONVERS MANAGE, V124, P42, DOI 10.1016/j.enconman.2016.06.076; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Cinelli I, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2942; Delorme A, 1999, NEUROCOMPUTING, V26-7, P989, DOI 10.1016/S0925-2312(99)00095-8; Dronne MA, 2006, J THEOR BIOL, V240, P599, DOI 10.1016/j.jtbi.2005.10.023; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Ezquerro F, 2011, MED ENG PHYS, V33, P89, DOI 10.1016/j.medengphy.2010.09.010; Fletcher R., 1994, OVERVIEW UNCONSTRAIN, P109, DOI [10.1007/978-94-009-0369-25., 10.1007/978-94-009-0369-25]; Fletcher TL, 2016, ANN BIOMED ENG, V44, P3495, DOI 10.1007/s10439-016-1666-7; FRIEDE RL, 1985, J NEUROL NEUROSUR PS, V48, P749, DOI 10.1136/jnnp.48.8.749; FRIEDE RL, 1980, J NEUROL SCI, V48, P367, DOI 10.1016/0022-510X(80)90109-4; FRIEDE RL, 1986, EXP NEUROL, V92, P234, DOI 10.1016/0014-4886(86)90137-8; FRIEDE RL, 1985, J ANAT, V143, P103; Garcia-Gonzalez D, 2019, J MECH PHYS SOLIDS, V125, P22, DOI 10.1016/j.jmps.2018.12.009; Garcia-Martin JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137859; Gewaltig M.-O., 2007, SCHOLARPEDIA, V2, P1430, DOI [10.4249/scholarpedia.1430, DOI 10.4249/SCHOLARPEDIA.1430]; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Goicoechea HC, 2002, J CHEM INF COMP SCI, V42, P1146, DOI 10.1021/ci0255228; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Guo P, 2014, IEEE T PARALL DISTR, V25, P1112, DOI 10.1109/TPDS.2013.123; Hammarlund P, 1997, COMPUTATIONAL NEUROSCIENCE: TRENDS IN RESEARCH, 1997, P919; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hilderbrand C., 1985, J NEUROSCI, V38, P421; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Hu R, 2011, ANN SURG, V254, P353, DOI 10.1097/SLA.0b013e31822645b4; Jean A, 2014, P NATL ACAD SCI USA, V111, P15310, DOI 10.1073/pnas.1415743111; Jerusalem A, 2014, BIOMECH MODEL MECHAN, V13, P883, DOI 10.1007/s10237-013-0543-7; Jerusalem A, 2012, ACTA BIOMATER, V8, P3360, DOI 10.1016/j.actbio.2012.04.039; Karaboga D., 2004, Turkish Journal Electrical Engineering and Computer Sciences, Elektrik, V12, P53; Kim KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-202; Koch Christof, 1999, P1; Kuzhandaivel Anujaianthi, 2011, Front Cell Neurosci, V5, P9, DOI 10.3389/fncel.2011.00009; Kwong MT, 2019, COMPUT METHOD APPL M, V346, P1025, DOI 10.1016/j.cma.2018.09.006; LASCELLES RG, 1966, J NEUROL NEUROSUR PS, V29, P40, DOI 10.1136/jnnp.29.1.40; LaTorre A, 2010, GECCO-2010 COMPANION PUBLICATION: PROCEEDINGS OF THE 12TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1725; LaTorre A, 2010, GECCO-2010 COMPANION PUBLICATION: PROCEEDINGS OF THE 12TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1649; Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112; Li H, 2018, IEEE T PARALL DISTR, V29, P1530, DOI 10.1109/TPDS.2017.2718515; Li JM, 2007, J BIOMECH, V40, P569, DOI 10.1016/j.jbiomech.2006.02.009; Li KL, 2015, IEEE T PARALL DISTR, V26, P196, DOI 10.1109/TPDS.2014.2308221; Liberatore S, 2009, WATER RESOUR MANAG, V23, P1479, DOI 10.1007/s11269-008-9337-6; Lidbe AD, 2017, SIMUL-T SOC MOD SIM, V93, P21, DOI 10.1177/0037549716683028; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Mendizabal A, 2015, J MECH BEHAV BIOMED, V45, P1, DOI 10.1016/j.jmbbm.2015.01.016; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Montagna S, 2009, LECT NOTES ARTIF INT, V5883, P466, DOI 10.1007/978-3-642-10291-2_47; Montes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130924; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Paz A, 2015, TRANSPORT RES C-EMER, V55, P432, DOI 10.1016/j.trc.2015.03.001; Pena J. M., INT J NUMERICAL METH, DOI [10.1002/nme.6029, DOI 10.1002/NME.6029.]; Perge JA, 2012, J NEUROSCI, V32, P626, DOI 10.1523/JNEUROSCI.4254-11.2012; Plasencia M, 2014, COMPUT GEOSCI-UK, V65, P110, DOI 10.1016/j.cageo.2013.09.007; Qing A., 2009, DIFFERENTIAL EVOLUTI; Rim KO, 2001, 2001 IEEE INTELLIGENT TRANSPORTATION SYSTEMS - PROCEEDINGS, P698, DOI 10.1109/ITSC.2001.948745; Rochel O., 2003, 11 EUR S ART NEUR NE, P6; Ruiz AN, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/139; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Scheerlinck K, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR008051; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 2000, NEUROSCIENCE, V98, P157, DOI 10.1016/S0306-4522(00)00096-8; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Stiles JR, 2001, METH NE FRO NEUROSCI, P87; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Tahmasebi F., 2012, SIMULATE BUDOV TECHN; Tanabe R, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1658, DOI 10.1109/CEC.2014.6900380; Tator C.H., 1990, REV EXPT SPINAL CORD, V37, P291; Toborek M, 1999, J NEUROCHEM, V73, P684, DOI 10.1046/j.1471-4159.1999.0730684.x; Tsai JT, 2015, NEUROCOMPUTING, V148, P628, DOI 10.1016/j.neucom.2014.07.001; TUCKWELL HC, 1988, INTRO THEORETICAL NE, V1; Tully B, 2011, J FLUID MECH, V667, P188, DOI 10.1017/S0022112010004428; Vargas MJ, 2003, APPL RADIAT ISOTOPES, V58, P707, DOI 10.1016/S0969-8043(03)00091-5; Verweij B.H., 1997, CLIN NEUROL NEUROSUR, V99, P5102; VIZOSO AD, 1950, J ANAT, V84, P342; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xu GY, 1998, NEUROSCIENCE, V86, P1011, DOI 10.1016/S0306-4522(98)00063-3; Yan J., 1993, SAE T, P755; Yang WD, 2015, IEEE T COMPUT, V64, P2623, DOI 10.1109/TC.2014.2366731	104	2	2	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1877-7503	1877-7511		J COMPUT SCI-NETH	J. Comput. Sci.	JAN	2020	39								101053	10.1016/j.jocs.2019.101053			15	Computer Science, Interdisciplinary Applications; Computer Science, Theory & Methods	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	KM3LQ	WOS:000514022900005		Green Submitted			2022-02-06	
J	Lu, LH; Bowles, AO; Kennedy, JE; Eapen, BC; Cooper, DB				Lu, Lisa H.; Bowles, Amy O.; Kennedy, Jan E.; Eapen, Blessen C.; Cooper, Douglas B.			Single-Item Versus Multiple-Item Headache Ratings in Service Members Seeking Treatment for Brain Injury	MILITARY MEDICINE			English	Article							RESPONSE THEORY	Introduction Headaches are the most common complaint after traumatic brain injury (TBI) and a significant cause of morbidity and disability among military personnel. Currently, there are a several measures which can assess headache disability, but there is a significant burden to assess each individual symptom given this heterogeneous polymorbid population. The objective of this proposed study was to validate the single headache item from the Neurobehavioral Symptom Inventory (NSI) compared to the 6-item Headache Impact Test (HIT-6). Materials and Methods Participants included consecutive treatment-seeking outpatients at the Brain Injury Rehabilitation Service at the Brooke Army Medical Center from August 2007 to January 2010 who were administered a battery of assessment measures at initial intake, as part of usual care. Archival record review was conducted using procedures approved by the local Institutional Review Board. Inclusionary criteria included completion of both the HIT-6 and NSI. Participants with a cut-off score of >22 on the NSI Validity-10 were excluded in a post hoc analysis to validate findings among those who passed validity screen. Results The Pearson correlation between the single-item NSI headache measure and the HIT-6 revealed at least 64% shared variance in this military sample (r = 0.8, p < 0.001), indication a high association between the two measures. Conclusion The NSI single-item headache measure adequately captured headache severity in this military cohort. Use of the single-item NSI headache measure may minimize survey burden on participants whose primary complaint is not headaches, or who present with multiple symptoms. Future studies are needed to validate the single-item headache measure in other samples.	[Lu, Lisa H.; Kennedy, Jan E.] Brooke Army Med Ctr, Def & Vet Brain Injury Ctr, Neurol Serv, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA; [Lu, Lisa H.; Kennedy, Jan E.; Cooper, Douglas B.] Gen Dynam Informat Technol, San Antonio, TX 78234 USA; [Bowles, Amy O.] Brooke Army Med Ctr, Dept Rehabil Med, Brain Injury Rehabil Serv, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA; [Eapen, Blessen C.] VA Greater Los Angeles Hlth Care Syst, Dept Phys Med & Rehabil, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA; [Eapen, Blessen C.] UCLA, Dept Med, David Geffen Sch Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA; [Cooper, Douglas B.] Audie L Murphy Vet Affairs Med Ctr, Polytrauma Rehabil Ctr, Def & Vet Brain Injury Ctr, 7400 Merton Minter, San Antonio, TX 78229 USA		Lu, LH (corresponding author), Brooke Army Med Ctr, Def & Vet Brain Injury Ctr, Neurol Serv, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA.; Lu, LH (corresponding author), Gen Dynam Informat Technol, San Antonio, TX 78234 USA.			Bowles, Amy/0000-0002-3690-1906			[Anonymous], 2016, VA DOD CLIN PRACT GU; Bjorner JB, 2003, QUAL LIFE RES, V12, P981, DOI 10.1023/A:1026123400242; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Ware JE, 2000, MED CARE, V38, P73	9	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185	1-2					E43	E46		10.1093/milmed/usz173			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KM6BW	WOS:000514224500017	31334803	hybrid			2022-02-06	
J	Dominguez-Roldan, JM; Lubillo, S; Videtta, W; Llompart-Pou, JA; Badenes, R; Rivas, JM; Ibanez, J; Godoy, DA; Murillo-Cabezas, F; Gomez-Abascal, L; Paranhos, JL; Recalde, R; Montes, JM				Maria Dominguez-Roldan, Jose; Lubillo, Santiago; Videtta, Walter; Antonio Llompart-Pou, Juan; Badenes, Rafael; Marquez Rivas, Javier; Ibanez, Javier; Godoy, Daniel A.; Murillo-Cabezas, Francisco; Gomez-Abascal, Lagares; Paranhos, Jorge Luiz; Recalde, Rodolfo; Miguel Montes, Jose		Grp Expertos Monitorizacion Pacien	International consensus on the monitoring of cerebral oxygen tissue pressure in neurocritical patients	NEUROCIRUGIA			Spanish	Article						Brain tissue oxygenation; Cerebral tissue oxygen pressure; Traumatic Brain Injury; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; COMA DATA-BANK; INTRACRANIAL-PRESSURE; METABOLIC CRISIS; HEAD-INJURY; BLOOD-FLOW; TENSION; CARE; HYPERTENSION; AUTOREGULATION	Continuous monitoring of cerebral oxygenation and its application to the management of the severe neurological patient is a challenge for the management of patients with acute critical brain damage. Although several techniques have been described for monitoring brain, brain tissue oxygen monitoring provides relevant information about oxygen levels of brain tissue. However, the development of this technique has been associated with the need to answer not only some technical aspects of it as well as the meaning of the changes of the cerebral oxygenation in the neurocritical patient. The consensus document responds to various questions related to the monitoring of cerebral oxygenation by means of a cerebral oxygen tissue pressure sensor. For this purpose, a list of questions was prepared and a reviewed of the medical literature was made. The quality of the evidence and the degree of recommendation was evaluated using the GRADE methodology. (C) 2019 Sociedad Espanola de Neurocirugia. Published by Elsevier Espana, S.L.U. All rights reserved.	[Maria Dominguez-Roldan, Jose; Lubillo, Santiago; Videtta, Walter; Antonio Llompart-Pou, Juan; Badenes, Rafael; Godoy, Daniel A.; Murillo-Cabezas, Francisco] Hosp Univ Virgen del Rocio, Serv Cuidados Intensivos, Seville, Spain; [Maria Dominguez-Roldan, Jose; Marquez Rivas, Javier; Murillo-Cabezas, Francisco] Hosp Univ Virgen del Rocio, Serv Med Intens, Seville, Spain; [Maria Dominguez-Roldan, Jose; Murillo-Cabezas, Francisco] Univ Seville, Dept Med, Seville, Spain; [Lubillo, Santiago] Hosp Univ Nuestra Senora Candelaria, Serv Med Intens, Tenerife, Spain; [Videtta, Walter] Hosp Nacl Prof A Posadas, Unidad Cuidados Intensivos, Buenos Aires, DF, Argentina; [Antonio Llompart-Pou, Juan; Ibanez, Javier] Hosp Univ Son Espases, Servei Med Intens, Palma De Mallorca, Spain; [Badenes, Rafael] Hosp Clin Univ, Dept Anestesiol & Cuidados Intensivos, Valencia, Spain; [Marquez Rivas, Javier; Ibanez, Javier] Hosp Univ Virgen del Rocio, Serv Neurocirugia, Seville, Spain; [Godoy, Daniel A.] Hosp San Juan Bautista & Sanatorio Pasteur, Unidad Cuidados Neurocrit, Catamarca, Argentina; [Gomez-Abascal, Lagares] Hosp 12 Octubre Madrid, Madrid, Spain; [Paranhos, Jorge Luiz] Santa Casa Misericordia Sao Joao Rei, Mina Gerais, Brazil; [Recalde, Rodolfo] Hosp Nacl Prof Posadas, Buenos Aires, DF, Argentina; [Miguel Montes, Jose] Clin Alemana, Santiago, Chile		Dominguez-Roldan, JM (corresponding author), Hosp Univ Virgen del Rocio, Serv Cuidados Intensivos, Seville, Spain.; Dominguez-Roldan, JM (corresponding author), Hosp Univ Virgen del Rocio, Serv Med Intens, Seville, Spain.; Dominguez-Roldan, JM (corresponding author), Univ Seville, Dept Med, Seville, Spain.	jmdominguez@telefonica.net	Badenes, Rafael/K-6628-2019; Lagares, Alfonso/B-2969-2011; Murillo-Cabezas, Francisco/AAO-3348-2021	Badenes, Rafael/0000-0001-7017-0150; Lagares, Alfonso/0000-0003-3996-0554; Ibanez, Javier/0000-0003-3735-8332			Andrews FL, INTENSIVE CARE MED; Arikan F, 2014, J NEUROSURG ANESTH, V26, P328, DOI 10.1097/ANA.0000000000000033; Bailey R, 2019, WORLD NEUROSURG; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chen HI, 2008, NEUROSURGERY, V63, P880, DOI 10.1227/01.NEU.0000327882.10629.06; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; De Georgia MA, 2015, J INTENSIVE CARE MED, V30, P473, DOI 10.1177/0885066614529254; Dengler J, 2011, INTENS CARE MED, V37, P1809, DOI 10.1007/s00134-011-2316-z; Deshaies EM, 2012, AM J NEURORADIOL, V33, P1411, DOI 10.3174/ajnr.A2971; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; Flynn LM, 2015, THER HYPOTHERMIA TEM, V5, P143; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Hirst T.C., 2016, EVID BASED PRECLIN M, V3, pe00020, DOI DOI 10.1002/EBM2.20; Jaeger M, 2005, ACTA NEUROCHIR SUPPL, V95, P79; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kirkman MA, 2014, BRIT J ANAESTH, V112, P35, DOI 10.1093/bja/aet418; Kurtz P, 2014, NEUROCRIT CARE, V20, P247, DOI 10.1007/s12028-013-9910-6; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Le Roux PD, 2013, NEUROSURG CLIN N AM, V24, P427, DOI 10.1016/j.nec.2013.03.001; Lee HC, 2010, WORLD NEUROSURG, V74, P654, DOI 10.1016/j.wneu.2010.06.019; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Lin C-M, 2015, BIOMED RES INT, V2015; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Lubillo S, 2011, MED INTENSIVA, V35, P166, DOI 10.1016/j.medin.2010.09.011; Lubillo S, 2002, INTENS CARE MED, V28, pS191; Maloney-Wilensky E, 2010, CHILD NERV SYST, V26, P419, DOI 10.1007/s00381-009-1037-x; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; Marin-Caballos AJ, 2008, MED INTENSIVA, P3281; Marin-Caballos AJ, 2015, MED INTENSIVA, V39, P179; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Meixensberger J, 2003, NEUROL RES, V25, P445, DOI 10.1179/016164103101201823; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Park S, 2016, ACTA NEUROCHIR SUPPL, V122, P133, DOI 10.1007/978-3-319-22533-3_27; Pennings FA, 2008, J NEUROTRAUM, V25, P1173, DOI 10.1089/neu.2007.0402; Poca MA, 2005, NEUROCIRUGIA, V16, P385110; Raabe A, 2005, J NEUROSURG, V103, P974, DOI 10.3171/jns.2005.103.6.0974; Radolovich DK, 2010, ANESTH ANALG, V110, P165, DOI 10.1213/ANE.0b013e3181c0722f; Ramakrishna R, 2008, J NEUROSURG, V109, P1075, DOI 10.3171/JNS.2008.109.12.1075; Rhodes JK, 2016, ACTA NEUROCHIR SUPPL, V122, P9, DOI 10.1007/978-3-319-22533-3_2; Rosenthal G, 2009, CRIT CARE MED, V37, P379, DOI 10.1097/CCM.0b013e318193265f; Rostami E, 2013, RESP PHYSIOL NEUROBI, V189, P537, DOI 10.1016/j.resp.2013.08.010; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Sarrafzadeh AS, 1998, ACT NEUR S, V71, P186; Scheufler KM, 2002, ANESTH ANALG, V95, P1042, DOI 10.1097/00000539-200210000-00046; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Schunemann HT, 2008, EVIDENCE BASED MED, V13, P167; SIGGAARDANDERSEN O, 1995, CRIT CARE MED, V23, P1284, DOI 10.1097/00003246-199507000-00020; SIGGAARDANDERSEN O, 1995, ACTA ANAESTH SCAND, V39, P137; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2004, J NEUROSURG, V101, P594, DOI 10.3171/jns.2004.101.4.0594; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Stippler M, 2012, J NEUROSURG-PEDIATR, V10, P383, DOI 10.3171/2012.8.PEDS12165; Sun H, 2016, NEUROPSYCH DIS TREAT, V12, P2175; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073	80	2	2	0	3	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473	2340-6305		NEUROCIRUGIA	Neurocirugia	JAN-FEB	2020	31	1					24	36		10.1016/j.neucir.2019.08.003			13	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KH4LP	WOS:000510619100004	31708419				2022-02-06	
J	Mejia-Lancheros, C; Lachaud, J; Stergiopoulos, V; Matheson, FI; Nisenbaum, R; O'Campo, P; Hwang, SW				Mejia-Lancheros, Cilia; Lachaud, James; Stergiopoulos, Vicky; Matheson, Flora I.; Nisenbaum, Rosane; O'Campo, Patricia; Hwang, Stephen W.			Effect of Housing First on violence-related traumatic brain injury in adults with experiences of homelessness and mental illness: findings from the At Home/Chez Soi randomised trial, Toronto site	BMJ OPEN			English	Article						mental health; adult psychiatry; preventive medicine; public health; social medicine	HEALTH; VICTIMIZATION; BURDEN; COHORT	Objectives People experiencing homelessness have a high prevalence and incidence of traumatic brain injury (TBI) due to violence. Little is known about the effectiveness of interventions to reduce TBI in this population. This study assessed the effect of Housing First (HF) on violence-related TBI in adults with experiences of homelessness and mental illness. Design Pragmatic randomised trial. Participants 381 participants in the Toronto site of the At Home/Chez randomised trial. Intervention HF participants were provided with scattered-site housing using rent supplements and supports from assertive community treatment or intensive case management teams (n=218, 57.2%). Control participants had access to treatment as usual (TAU) in the community (n=163, 42.8%). Main outcome measures Primary outcomes were an incident physical violence-related TBI event and the number of physical violence-related TBI events during the follow-up period (January 2014 to March 2017). Interval-censored survival time regression and zero-inflated negative binomial regression were used to assess the effect of HF on primary outcomes. Results Among study participants, 9.2% (n=35) had an incident physical violence-related TBI event, and the mean physical violence-related TBI events was 0.16 (SD +/- 0.6). Compared with TAU participants, HF participants did not have a significantly lower risk of an incident violence-related TBI event (adjusted HR : 0.58 (95% CI, 0.29 to 1.14)), but they had a significantly lower number of physical violence-related TBI events (unadjusted incidence rate ratio (IRR): 0.22 (95% CI, 0.06 to 0.78); adjusted IRR: 0.15 (95% CI, 0.05 to 0.48)). Conclusion HF may be a useful intervention to reduce the burden of TBI due to physical violence among homeless individuals with mental illness.	[Mejia-Lancheros, Cilia; Lachaud, James; Matheson, Flora I.; Nisenbaum, Rosane; O'Campo, Patricia; Hwang, Stephen W.] Unity Hlth Toronto, Li Ka Shing Knowledge Inst, MAP Ctr Urban Hlth Solut, St Michaels Hosp, Toronto, ON, Canada; [Stergiopoulos, Vicky] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Stergiopoulos, Vicky] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Matheson, Flora I.] Univ Toronto, Ctr Criminol & Sociolegal Studies, Toronto, ON, Canada; [Nisenbaum, Rosane; O'Campo, Patricia] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hwang, Stephen W.] Univ Toronto, Div Gen Internal Med, Dept Med, Toronto, ON, Canada		Mejia-Lancheros, C (corresponding author), Unity Hlth Toronto, Li Ka Shing Knowledge Inst, MAP Ctr Urban Hlth Solut, St Michaels Hosp, Toronto, ON, Canada.	Cilia.Mejia-Lancheros@unityhealth.to	Mejia-Lancheros, Cilia/ABG-6716-2020	Lachaud, James/0000-0001-8498-8922; Mejia-Lancheros, Cilia/0000-0003-1131-8439	Mental Health Commission of Canada; Ontario Ministry of Health and Long-Term Care (HSRF) [259]; Canadian Institute of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP-130405]; St Michael's Hospital Research Training Centre	The Toronto site of the At Home/Chez Soi study was funded by the Mental Health Commission of Canada (Grant number: NA), Ontario Ministry of Health and Long-Term Care (HSRF #259) and the Canadian Institute of Health Research (CIHR MOP-130405). This study also received funding from St Michael's Hospital Research Training Centre Scholarship awarded (RTC-2019-scholarship) to Dr Cilia Mejia-Lancheros. The funding institutions had no role in the study design, collection, analysis and interpretation of the data, or in the preparation, revision or approval of the present manuscript. Thus, the views expressed in this publication are the views of the authors.	Andersen J, 2014, DISABIL REHABIL, V36, P2210, DOI 10.3109/09638288.2014.895870; [Anonymous], 2007, IMPR HLTH CAN MENT H; Apraxine P, 2012, URBAN VIOLENCE HUMAN; Bacciardi S, 2017, RIV PSICHIATR, V52, P40, DOI 10.1708/2631.27053; Badhiwala JH, 2019, LANCET NEUROL, V18, P24, DOI 10.1016/S1474-4422(18)30444-7; BARKER S, 1994, COMMUNITY MENT HLT J, V30, P459, DOI 10.1007/BF02189063; Barnes SM, 2015, J HEALTH CARE POOR U, V26, P92, DOI 10.1353/hpu.2015.0010; Busch-Geertsema V., 2013, HOUSING 1 EUROPE; Daugherty J, 2019, MMWR-MORBID MORTAL W, V68, P1050, DOI 10.15585/mmwr.mm6846a2; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dreer LE, 2018, CURR OPIN PSYCHOL, V22, P73, DOI 10.1016/j.copsyc.2017.08.030; Elder GA, 2019, NEUROSCI LETT, V707, DOI 10.1016/j.neulet.2019.134294; Ellsworth JT, 2019, VICTIMS OFFENDERS, V14, P96, DOI 10.1080/15564886.2018.1547997; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Hsieh E, 2017, SOC WORK PUBLIC HLTH, V32, P110, DOI 10.1080/19371918.2016.1230081; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-787; Ilie G, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-016-0385-3; Immonen R, 2019, NEUROBIOL DIS, V123, P75, DOI 10.1016/j.nbd.2018.10.008; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jasinski J.L., 2005, EXPERIENCE VIOLENCE; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Labrum T, 2018, J PSYCHOSOC REHABIL, V5, P209, DOI [10.1007/s40737-018-0123-3, DOI 10.1007/S40737-018-0123-3]; Latalova K, 2014, NEUROPSYCH DIS TREAT, V10, P1925, DOI 10.2147/NDT.S68321; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McMillan TM, 2015, J NEUROTRAUM, V32, P116, DOI 10.1089/neu.2014.3387; Mejia-Lancheros C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229385; Mollayeva T, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0800-z; Muggah R., 2012, RES URBAN DILEMMA UR; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nikoo M, 2017, J HEAD TRAUMA REHAB, V32, pE19, DOI 10.1097/HTR.0000000000000262; Osborne-Crowley K, 2018, J NEUROPSYCHOL, V12, P176, DOI 10.1111/jnp.12113; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Rueve Marie E, 2008, Psychiatry (Edgmont), V5, P34; Schmitt T, 2017, J NEUROTRAUM, V34, P3301, DOI 10.1089/neu.2017.5076; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Seeman N, 2016, J AFFECT DISORDERS, V190, P115, DOI 10.1016/j.jad.2015.10.011; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Sharma R, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2019-000358; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; StataCorp, 2019, STATA STAT SOFTWARE; StataCorp LLC, 2019, SURV AN REF MAN, P468; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Stergiopoulos V, 2019, LANCET PSYCHIAT, V6, P915, DOI 10.1016/S2215-0366(19)30371-2; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; Sun J., 2006, STAT ANAL INTERVAL C; Topolovec-Vranic J, 2017, J PSYCHIATR RES, V87, P53, DOI 10.1016/j.jpsychires.2016.12.004; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Tsemberis S., 2015, PATHWAYS MODEL END H; Waldmann CA, 2004, HLTH HOMELESS PERSON, P237; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Yang S, 2017, J MOD APPL STAT METH, V16, P518, DOI 10.22237/jmasm/1493598600; Zhang ZG, 2010, STAT METHODS MED RES, V19, P53, DOI 10.1177/0962280209105023; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.45	61	2	2	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	12							e038443	10.1136/bmjopen-2020-038443			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	PH1TC	WOS:000600203000036	33277277	Green Published, gold			2022-02-06	
J	Moore, C; Baharikhoob, P; Khodadadi, M; Tator, CH				Moore, Connor; Baharikhoob, Paria; Khodadadi, Mozhgan; Tator, Charles H.			Bicycling-related concussions leading to postconcussion syndrome in adults	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article						cycling; concussion; recovery	MINOR HEAD-INJURY; HELMET USE; EXERCISE; LEGISLATION; PREDICTORS; DIAGNOSIS; SYMPTOMS	BackgroundConcussions among adult bicyclists are common, but little is known about the long-term effects of the consequences of these concussions such as postconcussion syndrome (PCS) including its occurrence, clinical features and recovery potential. Indeed, our study is the first to examine PCS due to bicycling in any age group.ObjectivesWe examined patient demographics, concussion mechanisms and persistent symptoms as factors leading to PCS in adults and the potential for recovery.MethodsWe conducted a retrospective chart review of 28 patients age 18 or older who sustained a concussion while bicycling and were referred to the Canadian Concussion Centre for management of PCS.ResultsEighteen patients (64.3%) fell from their bicycles due to loss of control, attempts to avoid a crash or collision with an object. Eight patients (28.6%) were struck by a motor vehicle, and two patients (7.1%) were injured by collision with another bicycle. The mean duration of PCS was 23.7 months and at the time of the last follow-up, 23 (82.1%) patients had failed to recover completely. Patients with one or more previous concussions had a significantly longer duration of PCS (p=0.042). Bicycling concussions resulted in a greater mean duration of PCS (23.7 months) than a comparison group of patients with PCS due to collision sports (16.1 months) (p=0.07).ConclusionAdults who sustain bicycling-related concussions and develop PCS often have long-lasting symptoms; greater attention should be given to prevention strategies such as improved bicycling infrastructure and safer bicycling practices to reduce concussions in adult bicyclists.	[Moore, Connor; Baharikhoob, Paria; Khodadadi, Mozhgan; Tator, Charles H.] Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada; [Baharikhoob, Paria] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Tator, Charles H.] Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Toronto, ON, Canada		Tator, CH (corresponding author), Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada.; Tator, CH (corresponding author), Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada.; Tator, CH (corresponding author), Univ Toronto, Toronto, ON, Canada.	Charles.Tator@uhn.ca			Canadian Concussion Centre, Krembil Brain Institute, at the Toronto Western Hospital - Toronto General and Western Hospital Foundation	Funds for this study were provided by the Canadian Concussion Centre, Krembil Brain Institute, at the Toronto Western Hospital, which is funded by the Toronto General and Western Hospital Foundation.	[Anonymous], 2020, GUID RET PLAY CONC; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Ben Arzi N, 2000, BRAIN INJURY, V14, P725; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carpenter CS, 2018, DO ALL AGE BICYCLE H; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Cripton PA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006654; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Dennis J, 2010, INJURY PREV, V16, P219, DOI 10.1136/ip.2009.025353; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Emanuelson I, 2003, INT J REHABIL RES, V26, P257, DOI 10.1097/00004356-200312000-00002; Gu J, 2017, INJURY PREV, V23, P239, DOI 10.1136/injuryprev-2016-042057; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; LI GH, 1995, J TRAUMA, V38, P871, DOI 10.1097/00005373-199506000-00007; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Page JL, 2012, INJURY PREV, V18, P94, DOI 10.1136/injuryprev-2011-040029; Parachute, 2015, COST INJ CAN; Park Jun Chul, 2017, Korean J Neurotrauma, V13, P90, DOI 10.13004/kjnt.2017.13.2.90; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Ramage-Morin PL, 2017, CYCLING; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Saleh F, 2008, CATASTROPHIC INJURIE, P371; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Tator Charles H, 2014, Neurosurgery, V75 Suppl 4, pS106, DOI 10.1227/NEU.0000000000000484; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Teschke K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008052; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414	35	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.		2020	6	1							e000746	10.1136/bmjsem-2020-000746			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PF8II	WOS:000599290900001	32341802	gold, Green Published			2022-02-06	
J	Morrison, R; Petit, KM; Kuenze, C; Moran, RN; Covassin, T				Morrison, Ryan; Petit, Kyle M.; Kuenze, Chris; Moran, Ryan N.; Covassin, Tracey			Preseason to Postseason Changes on the BTrackS Force Plate in a Sample of College Athletes	JOURNAL OF SPORT REHABILITATION			English	Article						balance; concussion; postural sway; reliability	BALANCE PLATE; CONCUSSION; PLAYERS; ERROR	Context: Balance testing is a vital component in the evaluation and management of sport-related concussion. Few studies have examined the use of objective, low-cost, force-plate balance systems and changes in balance after a competitive season. Objective: To examine the extent of preseason versus postseason static balance changes using the Balance Tracking System (BTrackS) force plate in college athletes. Design: Pretest, posttest design. Setting: Athletic training facility. Participants: A total of 47 healthy, Division-I student-athletes (33 males and 14 females; age 18.4 [0.5] y, height 71.8 [10.8] cm, weight 85.6 [21.7] kg) participated in this study. Main Outcome Measures: Total center of pressure path length was measured preseason and postseason using the BTrackS force plate. A Wilcoxon signed-rank test was conducted to examine preseason and postseason changes. SEM and minimal detectable change were also calculated. Results: There was a significant difference in center of pressure path length differed between preseason (24.6 [6.8] cm) and postseason (22.7 [5.4] cm) intervals (P = .03), with an SEM of 3.8 cm and minimal detectable change of 10.5 cm. Conclusions: Significant improvements occurred for center of pressure path length after a competitive season, when assessed using the BTrackS in a sample of college athletes. Further research is warranted to determine the effectiveness of the BTrackS as a reliable, low-cost alternative to force-plate balance systems. In addition, clinicians may need to update baseline balance assessments more frequently to account for improvements.	[Morrison, Ryan] Univ Maryland, Athlet Dept, College Pk, MD 20742 USA; [Petit, Kyle M.; Kuenze, Chris; Covassin, Tracey] Michigan State Univ, Dept Kinesiol, Sports Injury Res Lab, E Lansing, MI 48824 USA; [Moran, Ryan N.] Univ Alabama, Dept Hlth Sci, Athlet Training Res Lab, Tuscaloosa, AL USA		Petit, KM (corresponding author), Michigan State Univ, Dept Kinesiol, Sports Injury Res Lab, E Lansing, MI 48824 USA.	petitkyl@msu.edu	Kuenze, Christopher/P-7804-2017	Kuenze, Christopher/0000-0001-9184-4636			Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Daneshjoo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051568; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Goble DJ, 2016, INT J SPORTS PHYS TH, V11, P149; Hearn MC, 2018, CLIN J SPORT MED, V28, P177, DOI 10.1097/JSM.0000000000000435; Heleno LR, 2016, PHYS THER SPORT, V22, P74, DOI 10.1016/j.ptsp.2016.05.004; Jacobson GP, 2011, EAR HEARING, V32, pE1, DOI 10.1097/AUD.0b013e31822802bb; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; McManus IC, 2012, MED TEACH, V34, P569, DOI 10.3109/0142159X.2012.670318; NCAA, 2014, CONC GUID DIAGN MAN; O'Connor SM, 2016, J BIOMECH, V49, P4142, DOI 10.1016/j.jbiomech.2016.10.020; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Thompson LA, 2017, SPORTS, V5, DOI 10.3390/sports5040086	15	2	2	0	2	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JAN	2020	29	1					134	136		10.1123/jsr.2018-0304			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	LX7LQ	WOS:000540009300020	31034328	Bronze			2022-02-06	
J	Niu, F; Qian, K; Qi, HY; Zhao, YM; Jiang, YY; Jia, W; Sun, M				Niu, Fei; Qian, Ke; Qi, Hongyan; Zhao, Yumei; Jiang, Yingying; Jia, Wang; Sun, Ming			CPCGI Reduces Gray and White Matter Injury by Upregulating Nrf2 Signaling and Suppressing Calpain Overactivation in a Rat Model of Controlled Cortical Impact	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						compound porcine cerebroside and ganglioside injection; traumatic brain injury; Nrf2 signaling; oxidative stress; calpain	TRAUMATIC BRAIN-INJURY; NEURONAL CYTOSKELETAL DEGRADATION; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; DAMAGE; INHIBITION; ISCHEMIA; SPECTRIN; RECOVERY; XANTHINE	Background: Compound porcine cerebroside and ganglioside injection (CPCGI), which involves injection of a neurotrophic drug, has been widely used to treat certain brain disorders in the clinic; however, the detailed mechanism is unknown. This study investigated whether CPCGI protects the brain from trauma by stimulating antioxidative nuclear factor elythroid-2-related factor 2 (Nrf2) signaling and suppressing calpain overactivation in a rat model of controlled cortical impact (CCI). Materials and Methods: The rat model of CCI was used. Neurological deficits, contusion, and white matter damage were evaluated 3 days after CCI. Calpain activation, Nrf2 signaling and oxidative stress were determined 24 h after CCI. Results: CPCGI dose-dependently reduced neurological deficits, attenuated axonal and myelin sheath injury, and decreased contusion volume 3 days post-CCI. Moreover, CPCGI reduced calpain activity, and enhanced the cytosolic levels of calpastatin, alpha II-spectrin, microtubule-associated protein 2 (MAP2), neurofilament heavy chain (NF-H) and myelin basic protein (MBP) in traumatic tissues 24 h post-CCI. Furthermore, CPCGI reduced the levels of nuclear Kelch-like ECH-associated protein 1 (Keap1) and thioredoxin interacting protein (TXNIP); increased the levels of cytosolic Nrf2 and thioredoxin 1 (Trx 1) and nuclear Nrf2; increased the cytosolic and nuclear Nrf2/Keapl and Trx 1/TXNIP ratios; enhanced the levels of heme oxygenase 1 (HO-1), glutathione (GSH), superoxide dismutase activity, and total antioxidative capacity; and reduced the levels of malondialdehyde in TBI tissues. Conclusion: These data confirm the neuroprotective effect of CPCGI against gray and white matter damage due to CCI and suggest that activating Nrf2 signaling and alleviating oxidative stress-mediated calpain activation could be one mechanism by which CPCGI protects against brain trauma.	[Niu, Fei] Capital Med Univ, Beijing Neurosurg Inst, Dept Neurotrauma, Beijing Key Lab Cent Nervous Syst Injury, Beijing 100070, Peoples R China; [Qian, Ke; Jia, Wang] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing 100070, Peoples R China; [Qi, Hongyan] Nanjing Univ Chinese Med, Dept Acupuncture, Lianyungang TCM Hosp, Lianyungang 222000, Jiangsu, Peoples R China; [Zhao, Yumei; Jiang, Yingying; Sun, Ming] Capital Med Univ, Beijing Neurosurg Inst, Dept Neuropharmacol, Beijing Key Lab Cent Nervous Syst Injury, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China		Sun, M (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Neuropharmacol, Beijing Key Lab Cent Nervous Syst Injury, 119 South Fourth Ring West Rd, Beijing 100070, Peoples R China.	sunming999@yahoo.com			Platform Construction of Basic Research and Clinical Translation of Nervous System Injury (Beijing Municipal Health Commission) [PXM2020_026280_000002]; Buchang Pharmaceutical Co. Ltd.	This study was supported by the Platform Construction of Basic Research and Clinical Translation of Nervous System Injury (PXM2020_026280_000002, Beijing Municipal Health Commission) and grants from Buchang Pharmaceutical Co. Ltd.	Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Benady A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31623-y; Bodakuntla S, 2019, TRENDS CELL BIOL, V29, P804, DOI 10.1016/j.tcb.2019.07.004; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Bornstein N, 2012, DRUG TODAY, V48, P43, DOI 10.1358/dot.2012.48(Suppl.A).1739723; Brainin M, 2018, EXPERT REV NEUROTHER, V18, P681, DOI 10.1080/14737175.2018.1500459; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Chen Xudong, 2019, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V35, P721; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Gu Y, 2015, NEUROSCIENCE, V291, P331, DOI 10.1016/j.neuroscience.2014.09.073; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Huang CYM, 2017, J NEUROSCI, V37, P11323, DOI 10.1523/JNEUROSCI.2113-17.2017; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kopacz A, 2020, FREE RADICAL BIO MED, V157, P63, DOI 10.1016/j.freeradbiomed.2020.03.023; Laser-Azogui A, 2015, CURR OPIN CELL BIOL, V32, P92, DOI 10.1016/j.ceb.2015.01.003; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Lu XY, 2015, CELL MOL NEUROBIOL, V35, P713, DOI 10.1007/s10571-015-0167-9; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Miao YF, 2019, MOL MED REP, V20, P2365, DOI 10.3892/mmr.2019.10472; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; MINK RB, 1990, AM J PHYSIOL, V259, pH1655; Mink R, 2007, BRAIN RES, V1147, P256, DOI 10.1016/j.brainres.2007.02.004; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Pei DS, 2006, BRAIN, V129, P465, DOI 10.1093/brain/awh700; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Schabitz WR, 2000, STROKE, V31, P1709, DOI 10.1161/01.STR.31.7.1709; Schmidlin CJ, 2019, FREE RADICAL BIO MED, V134, P702, DOI 10.1016/j.freeradbiomed.2019.01.016; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Wang MY, 2017, NEUROPSYCH DIS TREAT, V13, DOI 10.2147/NDT.S129522; Wang XP, 2020, MOL MED REP, V21, P115, DOI 10.3892/mmr.2019.10835; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z; Zhang M, 2017, NEUROCRIT CARE, V26, P292, DOI 10.1007/s12028-016-0342-y; Zweckberger K, 2011, NEUROL RES, V33, P875, DOI 10.1179/1743132811Y.0000000017	46	2	2	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2020	16						1929	1941		10.2147/NDT.S266136			13	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	OE6MR	WOS:000580643200001	32904488	Green Published, gold			2022-02-06	
J	Ozevren, H; Deveci, E; Tuncer, MC				Ozevren, Huseyin; Deveci, Engin; Tuncer, Mehmet Cudi			The effect of rosmarinic acid on deformities occurring in brain tissue by craniectomy method. Histopathological evaluation of IBA-1 and GFAP expressions	ACTA CIRURGICA BRASILEIRA			English	Article						Rosmarinic Acid; Glial Fibrillary Acidic Protein; Brain Injuries,Traumati; Rats	CELL COMMUNICATION; INJURY; INHIBITION; ACTIVATION; ISCHEMIA; EXTRACT; PROTEIN; BLOOD; MODEL	Purpose: To investigate the role of Rosmarinic acid (RA) in the prevention of traumatic brain injury and the immunohistochemical analysis of IBA-1 and GFAP expressions. Methods: Healthy male rats were randomly divided into 3 groups consisting of 10 rats. Groups were as follows; control group, traumatic brain injury (TBI) group, and TBI+RA group. After traumatic brain injury, blood samples were taken from the animals and analyzed with various biochemical markers. And then IBA-1 and GFAP expressions were evaluated immunohistochemically. Results: Significant results were obtained in all biochemical parameters between groups. Immunohistochemical sections showed IBA-1 not only in microglia and macrophage activity but also in degenerative neurons in blood vessel endothelial cells. However, GFAP reaction and post-traumatic rosmarinic acid administration showed positive expression in astrocytes with regular structure around the blood vessel. Conclusion: Rosmarinic acid in blood vessel endothelial cells showed that preserving the integrity of astrocytic structure in the blood brain barrier may be an important antioxidant.	[Ozevren, Huseyin] Dicle Univ, Fac Med, Dept Neurosurg, Diyarbakir, Turkey; [Deveci, Engin] Dicle Univ, Fac Med, Dept Histol & Embryol, Diyarbakir, Turkey; [Tuncer, Mehmet Cudi] Dicle Univ, Fac Med, Dept Anat, Diyarbakir, Turkey		Deveci, E (corresponding author), Dicle Univ, Fac Med, Dept Histol & Embryol, Diyarbakir, Turkey.	devecie32@hotmail.com	Ozevren, Huseyin/AAC-1236-2021	Ozevren, Huseyin/0000-0002-5437-4003; Tuncer, Mehmet Cudi/0000-0001-7317-5467			Areti A, 2018, MOL NEUROBIOL, V55, P7463, DOI 10.1007/s12035-018-0920-4; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Baloglu M, 2019, FOLIA MORPHOL, V78, P17, DOI 10.5603/FM.a2018.0050; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cetin A, 2019, FOLIA MORPHOL, V78, P684, DOI 10.5603/FM.a2019.0029; Chu X, 2012, MOLECULES, V17, P3586, DOI 10.3390/molecules17033586; Domitrovic R, 2013, FOOD CHEM TOXICOL, V51, P370, DOI 10.1016/j.fct.2012.10.021; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Han S, 2015, DRUG DES DEV THER, V9, P2695, DOI 10.2147/DDDT.S82342; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; Kim YS, 2009, ANESTH ANALG, V108, P1958, DOI 10.1213/ane.0b013e31819f1972; Lee HJ, 2008, TOXICOLOGY, V250, P109, DOI 10.1016/j.tox.2008.06.010; Lee S, 2015, INT J MOL SCI, V16, P19657, DOI 10.3390/ijms160819657; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Missler U, 1999, CLIN CHEM, V45, P138; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Oguz A, 2020, FOLIA MORPHOL, V79, P288, DOI 10.5603/FM.a2019.0087; Ohsawa K, 2000, J CELL SCI, V113, P3073; Ozevren H, 2017, ANAL QUANT CYTOPATHO, V39, P35; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Ramalho LNZ, 2014, FOOD CHEM TOXICOL, V74, P270, DOI 10.1016/j.fct.2014.10.004; Rocha J, 2015, BASIC CLIN PHARMACOL, V116, P398, DOI 10.1111/bcpt.12335; Rong H, 2018, FREE RADICAL BIO MED, V120, P114, DOI 10.1016/j.freeradbiomed.2018.03.028; Sahu A, 1999, BIOCHEM PHARMACOL, V57, P1439, DOI 10.1016/S0006-2952(99)00044-1; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schettler V, 1999, Ther Apher, V3, P219; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Taram Faten, 2018, Molecules, V23, DOI 10.3390/molecules23112956; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Wang W, 2008, ANAT REC, V291, P513, DOI 10.1002/ar.20673; Xu YC, 2010, PLANTA MED, V76, P956, DOI 10.1055/s-0029-1240893; Yu HM, 2004, NEUROPATHOLOGY, V24, P136, DOI 10.1111/j.1440-1789.2003.00539.x; Yuan W, 2017, NEURAL REGEN RES, V12, P235, DOI 10.4103/1673-5374.200807; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104	40	2	3	3	3	ACTA CIRURGICA BRASILEIRA	SAO PAULO	ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL	0102-8650	1678-2674		ACTA CIR BRAS	Acta Cir. Bras.		2020	35	4							e202000406	10.1590/s0102-865020200040000006			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	MD0TV	WOS:000543690200001	32578724	Green Published, gold			2022-02-06	
J	Pan, WY; Cao, ZG; Liu, DY; Jiao, YB				Pan, Wenyong; Cao, Zhigang; Liu, Dongyang; Jiao, Yingbin			Protective Effect of Diphenhydramine against Traumatic Brain Injury in Rats via Modulation of Oxidative Stress and Inflammation	PHARMACOLOGY			English	Article						Traumatic brain injury; Neuronal degeneration; Oxidative stress; Inflammation; Apoptosis	DNA FRAGMENTATION; CASPASE-3; PATHOPHYSIOLOGY; NEUROPROTECTION; EPIDEMIOLOGY; THERAPIES; BCL2	Background: Traumatic brain injury (TBI) is considered a major burden across the globe affecting both individuals and their families. Therefore, the present study was conducted to determine the protective effect of diphenhydramine (DPM) against TBI in experimental rats. Methods: The effect of DPM was evaluated on the cerebral edema (CE) and neuronal degeneration after the induction of experimental brain injury in rats. The effect of DPM was also investigated on the inflammatory cytokines, for example, tumor necrosis factor-alpha and interleukin 1 beta and oxidative stress markers, such as malondialdehyde, superoxide dismutase, and glutathione peroxidase. Western blot analysis was used to investigate the effect of DPM on B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax) and cleaved caspase-3. Results: Results of the study suggest that DPM causes reduction in CE and prevents neuronal degeneration. It also causes reduction in inflammation and oxidative stress in a dose-dependent manner. The level of Bax was found to be elevated, together with reduction in the Bcl-2 level in the DPM-treated group. Conclusion: DPM exerts a neuroprotective effect after TBI via the attenuation of oxidative stress, inflammation, and mitochondrial apoptosis pathways.	[Pan, Wenyong; Cao, Zhigang] Qingdao Chengyang Peoples Hosp, Dept Neurosurg, Qingdao, Peoples R China; [Liu, Dongyang] Qingdao Univ, Dept Emergency Internal Med, Affiliated Hosp, Qingdao, Peoples R China; [Jiao, Yingbin] Qingdao Univ, Dept Neurosurg, Affiliated Hosp, Qingdao 266100, Shandong, Peoples R China		Jiao, YB (corresponding author), Qingdao Univ, Dept Neurosurg, Affiliated Hosp, Qingdao 266100, Shandong, Peoples R China.	BradyMaynardald@yahoo.com					Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Cheng ZQ, 2016, JOURNAL PRACT, V10, P744, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dai H., 2016, CANCER TRANSL MED, V2, P7; Desai M, 2018, J NEUROSURG SCI, V62, P563, DOI 10.23736/S0390-5616.18.04476-4; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Hofmeister EH, 2005, JAVMA-J AM VET MED A, V226, P1092, DOI 10.2460/javma.2005.226.1092; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kesiova M, 2006, PHARMACOL REP, V58, P221; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Li XK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160026; Lin TF, 2005, BRIT J ANAESTH, V94, P835, DOI 10.1093/bja/aei137; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Miller SM, 2014, ENCY TOXICOLOGY, P195; Or CHR, 2016, ONCOL REP, V36, P3465, DOI 10.3892/or.2016.5201; Orzechowski RF, 2005, EUR J PHARMACOL, V506, P257, DOI 10.1016/j.ejphar.2004.11.006; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Pavlidakey Peter G, 2009, J Clin Aesthet Dermatol, V2, P37; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raslan A, 2008, NEUROSURG FOCUS, V22, P1; Romner B, 2013, NAT REV NEUROL, V9, P185, DOI 10.1038/nrneurol.2013.37; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zaninotto ALC, 2018, NEUROMETHODS, V138, P105, DOI 10.1007/978-1-4939-7880-9_4; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	47	2	2	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0031-7012	1423-0313		PHARMACOLOGY	Pharmacology	JAN	2020	105	1-2					47	53		10.1159/000502767			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	KE9ET	WOS:000508853800007	31553997	Bronze			2022-02-06	
J	Perumparaichallai, RK; Lewin, RK; Klonoff, PS				Perumparaichallai, Ramaswamy Kavitha; Lewin, Rivian K.; Klonoff, Pamela S.			Community reintegration following holistic milieu-oriented neurorehabilitation up to 30 years post-discharge	NEUROREHABILITATION			English	Article						Holistic neurorehabilitation; long-term outcome; traumatic brain injury; acquired brain injury; return to work; return to driving; community reintegration	TRAUMATIC BRAIN-INJURY; COMPREHENSIVE DAY TREATMENT; REHABILITATION; INTEGRATION; OUTCOMES; PROGRAM; EVALUATE; MODERATE; IMPACT; RETURN	BACKGROUND: The primary goal of neurorehabilitation for individuals with acquired brain injury (ABI) is successful community reintegration, which commonly focuses on home independence, productivity, and social engagement. Previous research has demonstrated that holistic treatment approaches have better long-term outcomes than other treatment approaches. Holistic approaches go beyond the fundamental components of neurorehabilitation and address metacognition and self-awareness, as well as interpersonal and functional skills. OBJECTIVES: The present study aimed to examine community reintegration of individuals with ABI who completed holistic milieu-oriented neurorehabilitation at the Center for Transitional Neuro-Rehabilitation (CTN), Barrow Neurological Institute (BNI) at up to 30-years post-discharge. We evaluated (a) functional independence, (b) productivity and driving status, and (c) psychosocial profiles of the brain injury survivors. METHOD: Participants included 107 individuals with ABI with heterogeneous etiologies who attended holistic milieu-oriented neurorehabilitation between 1986 and 2016. These participants completed the Mayo-Portland Adaptability Inventory4 (MPAI-4) and a long-term outcome questionnaire (LOQ) specifically developed for this study. RESULTS: The results demonstrate that 89% of participants were productive at up to 30 years post-discharge (73% engaged in competitive work and/or school) after excluding the retired participants. Almost all of the participants who were engaged in work and/or school reported using compensatory strategies on a long-term basis. Furthermore, only 14% out of 102 study participants were driving at the time of program admission; whereas 58% out of 96 were driving at the time of discharge; and impressively, 70% out of 107 participants were driving at the time of follow-up. Regression analyses revealed that older age at the time of injury, shorter duration between injury and treatment, and better functionality indicated by lower MPAI-4 Ability Index scores significantly predicted a return to driving status at the time of study participation. Psychosocial data from the LOQ revealed positive findings with respect to patients' marital status, living situation, income, and quality of social life. CONCLUSION: The findings from this study suggest that functional gains made during holistic neurorehabilitation have enduring effects and that patients can benefit highly from holistic milieu therapy beyond the early post-acute phases of their recovery. Additionally, they provide evidence that there is potential to return to driving, years after treatment completion. Our holistic milieu treatment approach addressing metacognition, self-awareness, social and coping skills training, and actively transitioning to community settings, is thought to have contributed to the exceptional and long-lasting outcomes in this study.	[Perumparaichallai, Ramaswamy Kavitha; Lewin, Rivian K.; Klonoff, Pamela S.] St Josephs Hosp, Barrow Neurol Inst, Ctr Transit Neurorehabil, Phoenix, AZ USA; [Lewin, Rivian K.] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA		Klonoff, PS (corresponding author), 222 W Thomas Rd,Suite 401, Phoenix, AZ 85013 USA.	Pamela.Klonoff@dignityhealth.org			GilesW; Elise G. Mead Foundation	The study was supported by a research grant from GilesW. and Elise G. Mead Foundation. The authors would like to gratefully acknowledge Edward Koberstein for assistance with manuscript preparation. The authors thank the staff of Neuroscience Publications at Barrow Neurological Institute for assistance with manuscript preparation.	Altman IM, 2013, ARCH PHYS MED REHAB, V94, P1837, DOI 10.1016/j.apmr.2013.02.014; Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Arwert HJ, 2017, J OCCUP REHABIL, V27, P239, DOI 10.1007/s10926-016-9651-4; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cohen J., 2013, STAT POWER ANAL BEHA; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Eicher V, 2012, ARCH PHYS MED REHAB, V93, P100, DOI 10.1016/j.apmr.2011.06.038; Forslund MV, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00219; Foy CML, 2014, J OCCUP REHABIL, V24, P533, DOI 10.1007/s10926-013-9488-z; Geurtsen GJ, 2008, BRAIN INJURY, V22, P545, DOI 10.1080/02699050802132479; Geurtsen GJ, 2011, ARCH PHYS MED REHAB, V92, P696, DOI 10.1016/j.apmr.2010.12.022; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Hayden ME, 2013, PM&R, V5, P319, DOI 10.1016/j.pmrj.2012.12.005; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hylin MJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7125057; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Klonoff P. S., 2010, PSYCHOTHERAPY BRAIN; Klonoff P. S., 2015, NEURODISABILITY PSYC, V3, P93; Klonoff PS, 2007, BRAIN INJURY, V21, P1097, DOI 10.1080/02699050701687342; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Klonoff PS, 2010, BRAIN INJURY, V24, P63, DOI 10.3109/02699050903512863; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; Klonoff PS, 2014, PSYCHOTHERAPY FAMILI; Leon-Carrion J, 2005, BRAIN INJURY, V19, P213, DOI 10.1080/02699050400017205; Leon-Carrion J, 2013, BRAIN INJURY, V27, P1119, DOI 10.3109/02699052.2013.804204; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malec JF, 2016, J NEUROTRAUM, V33, P1371, DOI 10.1089/neu.2015.4080; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Micklewright JL, 2011, ARCH PHYS MED REHAB, V92, P1974, DOI 10.1016/j.apmr.2011.07.199; Novack TA, 2010, BRAIN INJURY, V24, P464, DOI 10.3109/02699051003601713; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Perumparaichallai RK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00056; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Ruet A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00120; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167	45	2	2	1	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	2					243	253		10.3233/NRE-192968			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LE6CR	WOS:000526811100010	32083599	Bronze			2022-02-06	
J	Pundlik, J; Perna, R; Arenivas, A				Pundlik, Jyoti; Perna, Robert; Arenivas, Ana			Mild TBI in interdisciplinary neurorehabilitation: Treatment challenges and insights	NEUROREHABILITATION			English	Article						Mild TBI; neurorehabilitation; interdisciplinary rehabilitation	TRAUMATIC BRAIN-INJURY; SYMPTOMS; CONCUSSION; HEALTH; PREDICTION; RECOVERY; SEQUELAE; IMPACT; POLICY; TRIAL	BACKROUND: Traumatic brain injury (TBI) has an estimated prevalence rate of 1.7 million occurrences a year in the United States with over 75% of traumatic brain injuries classified as 'mild.' The majority of individuals with mild traumatic brain injuries resume their daily functioning fairly quickly, and many fully within the first year. However, a minority of persons with mild TBI (mTBI), with estimates ranging between 1% and 20%, develop persistent cognitive, emotional, behavioral, and physical symptoms. Clinicians vary considerably in their clinical opinions regarding these individuals and there is no consensus on the treatment protocol for this population. OBJECTIVE: This manuscript presents four case studies of mild TBI with persistent symptoms treated by a transdisciplinary team in an outpatient neurorehabilitation setting based on community reintegration. Clinical challenges and insights involved in conceptualizing and effectively treating these individuals are discussed to facilitate future direction. METHODS: Four different mild TBI cases, each with persistent symptoms, but different injury mechanisms, dynamics, and factors affecting symptom persistence, expression, course, and outcome were included in the analysis of their treatment course and outcome. The treatment protocol included: brain injury education combined with supportive counseling for cultivation of positive expectancy effects, symptom-based, graded treatment involving most disciplines, frequent treatment team consultations, collaborations, and planning, and consistent team messages about post-injury recovery and expected return to community activities. Treatment outcomes were assessed with self and family reports, as well as the Mayo Portland Adaptability Inventory (MPAI-4) at admission and at discharge. RESULTS AND CONCLUSIONS: Each of the individuals made functional progress during rehabilitation, as evidenced by self and family reports and the MPAI-4. The cases posed various challenges to the treatment team, though a transdisciplinary team under the guidance of a rehabilitation physician and rehabilitation neuropsychologist was able to help patients navigate the path to their functional recovery. In addition to the specific treatment protocol, transdisciplinary team collaboration guided by rehabilitation neuropsychology contributed to treatment success.	[Pundlik, Jyoti; Arenivas, Ana] Inst Rehabil Res TIRR, Houston, TX USA; [Pundlik, Jyoti; Arenivas, Ana] Baylor Coll Med, Houston, TX 77030 USA; [Perna, Robert] Pate Rehabil, Dallas, TX USA		Perna, R (corresponding author), 3605 Redwood Circle, Melissa, TX 75454 USA.	rperna@paterehab.com	Perna, Robert/AAQ-7719-2021				Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Arcinegas D. B., 2006, NEUROPSYCHIATRIC DIS, V1, P311; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Choi BCK, 2006, CLIN INVEST MED, V29, P351; Department of Veterans Affairs and Department of Defense, 2009, CLIN PRACT GUID MAN; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Giza CC, 2001, J ATHL TRAINING, V36, P228; Graham R, 2014, BOARD CHILDREN YOUTH; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrae M., 2008, MILD TRAUMATIC BRAIN; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Mounce LTA, 2013, J HEAD TRAUMA REHAB, V28, P397, DOI 10.1097/HTR.0b013e318252dd75; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Roth, 2014, MILD TRAUMATIC BRAIN, P321; Schilling EA, 2008, SOC SCI MED, V66, P1140, DOI 10.1016/j.socscimed.2007.11.023; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith DH, 2006, PSYCHOSOMATICS, V47, P271, DOI 10.1176/appi.psy.47.3.271; Son BC, 2000, ACT NEUR S, V76, P13; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Vanderploeg RD, 2014, PSYCHOL INJ LAW, V7, P245, DOI 10.1007/s12207-014-9201-3; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vikane E, 2017, BRAIN INJURY, V31, P475, DOI 10.1080/02699052.2017.1280852; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Zemek R, 2014, GUIDELINES DIAGNOSIN	46	2	4	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	2					227	241		10.3233/NRE-192971			15	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LE6CR	WOS:000526811100009	32083602				2022-02-06	
J	Raukola-Lindblom, M; Vuorinen, E; Vartiainen, R				Raukola-Lindblom, Marjaana; Vuorinen, Elina; Vartiainen, Riitta			Recovering social participation - experience with a relational group intervention for traumatic brain injury patients	NEUROREHABILITATION			English	Article						Communication; social participation; traumatic brain injury; group treatment; rehabilitation	OF-THE-LITERATURE; COGNITIVE REHABILITATION; COMPETENCE; SELF	BACKGROUND: Traumatic brain injuries often result in impaired social functioning that may cause uncertainty, isolation, and precipitation of significant stress in social situations. Involvement in directed group treatment helps participants to develop new capabilities for feeling relationally connected, improving verbal and nonverbal communication skills, as well as building the capacity for empathic intersubjectivity. We suggest that group intervention to improve communication and social skills may provide an efficient and effective way for a patient to return to successful social participation. OBJECTIVE: The purpose of this paper is to describe and discuss the principles of a clinical group intervention for increasing the social participation of persons with traumatic brain injury. METHODS: Since 2000, several intervention periods, each with 10-20 group meetings, including some individual sessions for guidance, have been carried out under our direction in Finland. The intervention periods include education, reflection, and practical experiential exercises and can be multidisciplinary with both speech-language pathologists and neuropsychologists providing oversight and direction. The main goal of the described group interventions is to support community participation and social reintegration. In this article, we describe guiding principles and provide examples of the clinical group interventions drawn from our experience. CONCLUSION: As determined by clinical observations and patient reports, the group intervention for social participation has proven to be beneficial. The participants report gaining more understanding of and insight into social situations, nonverbal and verbal communication, as well as affective interactive experience. Practicing social skills in a group situation is inherently self-motivating and encourages a constructive, positive impetus toward greater social participation. Based on our experience with this approach, it appears that this experiential form of group intervention is an effective bridge between structured cognitive-communication rehabilitation and successful real-life social participation.	[Raukola-Lindblom, Marjaana] Univ Turku, Fac Social Sci, Dept Psychol & Speech Language Pathol, Assistentinkatu 7, Turku 20114, Finland; [Raukola-Lindblom, Marjaana] RL Specialized Serv Ltd, Turku, Finland; [Vuorinen, Elina] Neutera Neuropsychol & Therapy Serv Vuorinen Ltd, Turku, Finland; [Vartiainen, Riitta] Specialized Speech & Language Serv Riitta Vartiai, Helsinki, Finland		Raukola-Lindblom, M (corresponding author), Univ Turku, Fac Social Sci, Dept Psychol & Speech Language Pathol, Assistentinkatu 7, Turku 20114, Finland.	marjaana.raukola-lindblom@utu.fi	Raukola-Lindblom, Marjaana/ABD-7445-2021	Raukola-Lindblom, Marjaana/0000-0002-7662-8959	Finnish public health care, social insurance, and the insurance companies	We want to acknowledge the participants in our group intervention programs and the healthcare professionals who have affirmed the importance of rehabilitation intervention for complications impacting social participation. We also want to acknowledge Finnish public health care, social insurance, and the insurance companies for funding these intervention programs for people with TBI.	Barwood CHS, 2013, BRAIN INJURY, V27, P671, DOI 10.3109/02699052.2013.775500; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Douglas J, 2015, INT J SPEECH-LANG PA, V17, P199, DOI 10.3109/17549507.2015.1016113; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Erbas Y, 2018, J PERS SOC PSYCHOL, V115, P179, DOI 10.1037/pspa0000126; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; McLean AM, 2012, BRAIN INJURY, V26, P83, DOI 10.3109/02699052.2011.635353; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Struchen M. A., 2005, REHABILITATION TRAUM, P88; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Vartiainen R., 2014, TROBE KOMMUNIKAATION; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164	18	2	2	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	47	1					55	64		10.3233/NRE-203083			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NE7EM	WOS:000562764300006	32675427				2022-02-06	
J	Ripley, DL; Gerber, D; Pretz, C; Weintraub, AH; Wierman, ME				Ripley, David L.; Gerber, Don; Pretz, Christopher; Weintraub, Alan H.; Wierman, Margaret E.			Testosterone replacement in hypogonadal men during inpatient rehabilitation following traumatic brain injury: Results from a double-blind, placebo-controlled clinical pilot study	NEUROREHABILITATION			English	Article						Traumatic brain injury; TBI; hypogonadism; testosterone; outcomes; function; Functional Independence Measure (FIM); strength; agitation; aggression; randomized drug trial	ANEURYSMAL SUBARACHNOID HEMORRHAGE; FUNCTIONAL ASSESSMENT SCALES; EXOGENOUS TESTOSTERONE; COGNITIVE FUNCTION; PERFORMANCE; HYPOPITUITARISM; AGGRESSION; DISABILITY; STRENGTH	BACKGROUND: Endocrinopathy, including hypogonadism, is common following traumatic brain injury (TBI). Prior evidence suggests hypogonadism is associated with poorer function. OBJECTIVE: Determine the feasibility, safety, and efficacy of testosterone (T) therapy in hypogonadal men following TBI in acute rehabilitation. DESIGN: Randomized, double blind, placebo-controlled pilot trial. SETTING: Inpatient rehabilitation brain injury unit. PARTICIPANTS: Men ages 18 - 65, post moderate to severe TBI receiving inpatient rehabilitation. INTERVENTIONS: Transdermal T gel or placebo. MAIN OUTCOME MEASURES: Revised FIMT score, strength, adverse events. RESULTS: Of 498 screened, 70 participants were enrolled, and 22 meeting all criteria were randomized into placebo (n = 10) or physiologic T therapy (n = 12). There was no significant difference between groups in rate of improvement on the FIMT (intercepts t = -0.31, p = 0.7593, or slopes t = 0.61, p = 0.5472). The Treatment group demonstrated the greatest absolute improvement in FIMT scores and grip strength compared to Placebo or Normal T groups. There was no difference in adverse events between groups. Percentage of time with agitation or aggression was highest in the Placebo group. CONCLUSIONS: Although there were no significant differences in rates of recovery, treatment group subjects showed greater absolute functional and strength improvement compared to the Placebo or Normal T groups.	[Ripley, David L.] Shirley Ryan Abil Lab, 355 East Erie St, Chicago, IL 60611 USA; [Ripley, David L.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Gerber, Don; Weintraub, Alan H.] Craig Hosp, Englewood, CO USA; [Pretz, Christopher] Johnson & Johnson, Irvine, CA USA; [Wierman, Margaret E.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO USA; [Wierman, Margaret E.] Rocky Mt Reg Vet Affairs Res Serv, Aurora, CO USA		Ripley, DL (corresponding author), Shirley Ryan Abil Lab, 355 East Erie St, Chicago, IL 60611 USA.	dripley@sralab.org			MINDSOURCE - Brain Injury Network, Colorado Traumatic Brain Injury Trust Fund Research Program	This project received funding from MINDSOURCE - Brain Injury Network, Colorado Traumatic Brain Injury Trust Fund Research Program.	Agha Amar, 2005, Am J Med, V118, P1416; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Beauchet O, 2006, EUR J ENDOCRINOL, V155, P773, DOI 10.1530/eje.1.02306; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Cherrier MM, 2003, J ANDROL, V24, P568; DITUNNO JF, 1992, J NEUROTRAUM, V9, pS301; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Fitzmaurice GM, 2011, APPL LONGITUDINAL AN, V2nd; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gibney J, 2005, AM J PHYSIOL-ENDOC M, V289, pE266, DOI 10.1152/ajpendo.00483.2004; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; JANOWSKY JS, 1994, BEHAV NEUROSCI, V108, P325, DOI 10.1037/0735-7044.108.2.325; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kenward, 2007, MISSING DATA CLIN ST; Kido Y, 2013, AM J MED GENET A, V161, P2167, DOI 10.1002/ajmg.a.36048; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Mehta NM, 2008, JPEN-PARENTER ENTER, V32, P281, DOI 10.1177/0148607108316196; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; O'Connor DB, 2002, PHYSIOL BEHAV, V75, P557, DOI 10.1016/S0031-9384(02)00647-9; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SOURIAL N, 1988, CAN J PSYCHIAT, V33, P846, DOI 10.1177/070674378803300912; Storer TW, 2003, J CLIN ENDOCR METAB, V88, P1478, DOI 10.1210/jc.2002-021231; Traumatic Brain Injury Model Systems National Data Center, 2007, TRAUM BRAIN INJ MOD; WOOLF PD, 1985, J CLIN ENDOCR METAB, V60, P444, DOI 10.1210/jcem-60-3-444; Yaffe K, 2002, J AM GERIATR SOC, V50, P707, DOI 10.1046/j.1532-5415.2002.50166.x; Zitzmann M, 2006, AGING MALE, V9, P195, DOI 10.1080/13685530601040679	40	2	2	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	3					355	368		10.3233/NRE-192992			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LZ2AH	WOS:000541030200009	32250330				2022-02-06	
J	Rona, RJ; Jones, M; Jones, N; Fear, NT; Wessely, S				Rona, Roberto J.; Jones, Margaret; Jones, Norman; Fear, Nicola T.; Wessely, Simon			Long-Term Correlates of Mild Traumatic Brain Injury on Postconcussion Symptoms After Deployment to Iraq and Afghanistan in the UK Military	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; deployment; military personnel; prospective studies	POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSIVE SYMPTOMS; NEUROPSYCHOLOGICAL OUTCOMES; PERSONNEL; HEALTH; SOLDIERS; VALIDITY; CONFLICTS; VETERANS; SEQUELAE	Objectives: We assessed whether mild traumatic brain injury (mTBI) reported by UK service personnel between 2007 and 2009 was associated with postconcussion symptoms (PCS) 7 to 8 years later. Setting: United Kingdom. Participants: A total of 4601 service personnel all of whom had deployed to Iraq and/or Afghanistan. Design: Longitudinal study. Main Outcome Measures: Nine PCS reported in a survey carried out between 2014 and 2016. The main independent variable was mTBI reported between 2007 and 2009. Results: A total of 2318 (50.4%) out of 4601 participants completed the follow-up questionnaire. Mild traumatic brain injury was associated with 2 of 9 PCS. Mild traumatic brain injury at baseline was associated with dizziness at follow-up in the fully adjusted model, in comparison with either "other injury" or "no injury" group. Mild traumatic brain injury was associated with loss of concentration in comparison with "no injury" but in comparison with the "other injury" group, it was not in the fully adjusted model. The prevalence of 7 of the 9 PCS increased over time regardless of mTBI status. Conclusions: Mild traumatic brain injury reported in 2007-2009 was associated with dizziness and possibly with loss of concentration 7 years later but not with most PCS. The prevalence of most PCS increased over time independently of mTBI.	[Rona, Roberto J.; Jones, Margaret; Wessely, Simon] Kings Coll London, Kings Ctr Mil Hlth Res, London, England; [Jones, Norman; Fear, Nicola T.] Kings Coll London, Dept Mil Mental Hlth, London, England		Rona, RJ (corresponding author), Kings Coll London, Kings Ctr Mil Hlth Res, Weston Educ Ctr, 10 Cutcombe Rd, London SE5 9RJ, England.	Roberto.rona@kcl.ac.uk			Ministry of Defence (MOD)Ministry of Defence (MoD), Government of India; Forces in Mind Trust (FiMT); US Department of DefenseUnited States Department of Defense; UK MOD	All authors are based on King's College London and the study receives funding from the Ministry of Defence (MOD). The salaries of Professors Rona and Fear and Ms Jones are paid totally or partially for this grant. Professor Rona is also partially paid by a grant of Forces in Mind Trust (FiMT). Dr Jones is a full-time member of the Armed Forces seconded to King's College London. Professor Fear reports grants from the US Department of Defense and the UK MOD, is a trustee (unpaid) of the Warrior Programme, and an independent advisor to the Independent Group Advising on the Release of Data (IGARD). Professor Wessely is a trustee (unpaid) of Combat Stress and Honorary Civilian Consultant Advisor in Psychiatry for the British Army (unpaid). He is affiliated to the National Institute for Health Research Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response at King's College London in Partnership with Public Health England in collaboration with the University of East Anglia and Newcastle University.	Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Babor TF, 2001, AUDIT ALCOHOL USE DI; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Fear NT, 2007, ADDICTION, V102, P1749, DOI 10.1111/j.1360-0443.2007.01978.x; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Garber BG, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010780; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Jones N, 2014, BRAIN INJURY, V28, P896, DOI 10.3109/02699052.2014.888479; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rona RJ, 2012, J PSYCHIATR RES, V46, P1191, DOI 10.1016/j.jpsychires.2012.05.009; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P75, DOI 10.1097/HTR.0b013e31823029f6; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stevelink SAM, 2018, BRIT J PSYCHIAT, V213, P690, DOI 10.1192/bjp.2018.175; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000095; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461	37	2	2	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2020	35	1			SI		46	56		10.1097/HTR.0000000000000497			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KL0UE	WOS:000513147300010	31033752				2022-02-06	
J	Rubin, E; Klonoff, P; Perumparaichallai, RK				Rubin, Evan; Klonoff, Pamela; Perumparaichallai, Ramaswamy Kavitha			Does self-awareness influence caregiver burden?	NEUROREHABILITATION			English	Article						Anosognosia; awareness; brain injuries; neurological rehabilitation; caregivers	TRAUMATIC BRAIN-INJURY; ZARIT BURDEN; IMPAIRED AWARENESS; INTERVIEW	BACKGROUND: Caregiver burden is experienced by a significant number of caregivers of survivors of acquired brain injury (ABI). It is known that self-awareness can impact functioning following ABI. However, the impact of self-awareness on caregiver burden has not been established. OBJECTIVE: To investigate the relationship between self-awareness and caregiver burden following ABI. METHODS: We studied 57 patient-caregiver pairs up to 28 years post-discharge from a post-acute comprehensive holistic milieu-oriented neurorehabilitation program. The Mayo-Portland Adaptability Inventory-4 (MPAI-4) was completed by survivors of ABI and their caregivers. Discrepancies in reports between survivors of ABI and their caregivers were used to determine self-awareness. Additionally, caregivers completed the Zarit Burden Interview (ZBI). RESULTS: Survivors of ABI with impaired self-awareness reported significantly higher levels of functioning than survivors of ABI with unimpaired self-awareness (p < 0.001). Unimpaired self-awareness (p < 0.001) and lower survivor self-reported MPAI-4 Total Score (p < 0.001) significantly predicted caregiver burden. CONCLUSIONS: Survivors of ABI's level of functioning and their level of self-awareness significantly impacted caregiver burden. Survivors of ABI with impaired self-awareness not only lack insight into their functional abilities but also tend to overestimate their capabilities; this likely contributes to the need for greater levels of supervision and worsened caregiver burden.	[Rubin, Evan; Klonoff, Pamela; Perumparaichallai, Ramaswamy Kavitha] St Josephs Hosp, Barrow Neurol Inst, Ctr Transit Neurorehabil, Phoenix, AZ USA; [Rubin, Evan] Main Line Hlth Care, Bryn Mawr Rehab Psychol Associates, Malvern, PA USA		Perumparaichallai, RK (corresponding author), 222 W Thomas Rd,Suite 401, Phoenix, AZ 85013 USA.	Kavitha.Perumparaichallai@DignityHealth.org			Giles W. and Elise G. Mead Foundation for the Center for Transitional Neuro-Rehabilitation	This work was supported by the Giles W. and Elise G. Mead Foundation for the Center for Transitional Neuro-Rehabilitation.	Al-Rawashdeh SY, 2016, J CARDIOVASC NURS, V31, pE21, DOI 10.1097/JCN.0000000000000348; Blumenfeld H, 2010, NEUROANATOMY THROUGH CLINICAL CASES, SECOND EDITION, P1; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Geytenbeek M, 2017, BRAIN INJURY, V31, P1791, DOI 10.1080/02699052.2017.1346297; HUMPHERYS I, 2013, CLINICOECONOMICS OUT, V2013, P281, DOI DOI 10.2147/CEOR.S44625; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Klonoff P. S., 2010, PSYCHOTHERAPY BRAIN; Klonoff PS, 2014, PSYCHOTHERAPY FAMILI; Malec J., 2005, MAYO PORTLAND ADAPTA; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano GP, 2012, ACTA NEUROPSYCHOL, V10, P371, DOI 10.5604/17307503.1023676; Qadeer A, 2017, CUREUS, V9, DOI 10.7759/cureus.1590; Seng BK, 2010, ANN ACAD MED SINGAP, V39, P758; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Siegert RJ, 2010, J REHABIL MED, V42, P302, DOI 10.2340/16501977-0511; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	25	2	2	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	4					511	518		10.3233/NRE-203093			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MM3DS	WOS:000550036100007	32538884				2022-02-06	
J	Rui, TY; Wang, ZF; Li, QQ; Wang, HC; Wang, T; Zhang, MY; Tao, LY; Luo, CL				Rui, Tongyu; Wang, Zufeng; Li, Qianqian; Wang, Haochen; Wang, Tao; Zhang, Mingyang; Tao, Luyang; Luo, Chengliang			A TrkB receptor agonist N-acetyl serotonin provides cerebral protection after traumatic brain injury by mitigating apoptotic activation and autophagic dysfunction	NEUROCHEMISTRY INTERNATIONAL			English	Article						Tropomyosin-related kinase B (TrkB); N-acetyl serotonin (NAS); Traumatic brain injury; Apoptosis; Autophagy	ISCHEMIA-REPERFUSION INJURY; INDUCED CELL-DEATH; ACETYLSEROTONIN; CONSEQUENCES; CONTRIBUTES; PATHWAY; MODEL	Tropomyosin-related kinase B (TrkB) has emerged as a key mediator in the pathophysiology of traumatic brain injury (TBI). However, it is not known whether TrkB's agonist N-acetyl serotonin (NAS) involves in neuronal damage and brain dysfunction caused by TBI that is known as one of the most important causes of disability and death worldwide. Here, we investigated the effects of NAS on brain edema, blood-brain barrier (BBB), apoptosis activation and autophagy dysfunction after experimental TBI. A mouse TBI model was applied, NAS and ANA-12 (an antagonist of TrkB) were administered. Here, we first found that NAS administration ameliorated TBI-induced brain edema, blood-brain barrier (BBB) disruption, increase of matrix metalloproteinase-9 (MMP-9) expression and decrease of claudin-5 expression. NAS treatment decreased TBI-induced cell death and apoptosis activation (detected by propidium iodide labeling, TUNEL staining, blots for Bcl-2, Bax and caspase-3). In addition, NAS treatment decreased the expression of Beclin-1 and LC3, along with ratio of Beclin-1/Bcl-2, but increased p62 expression following TBI. NAS also enhanced the activation of the TrkB/Akt pathway following TBI. Whereas, the above protective effect of NAS following TBI was blocked by ANA-12 addition. Thus, we conclude that NAS-initiating the TrkB/Akt signaling cascade provides neuroprotection after experimental TBI in mice, which at least in part through inhibiting apoptosis activation and autophagic dysfunction.	[Rui, Tongyu; Wang, Zufeng; Wang, Haochen; Wang, Tao; Zhang, Mingyang; Tao, Luyang; Luo, Chengliang] Soochow Univ, Dept Forens Med, Med Coll, 178 Ganjiang East Rd, Suzhou 215123, Jiangsu, Peoples R China; [Li, Qianqian] Wannan Med Coll, Sch Forens Med, Wuhu 241002, Anhui, Peoples R China		Luo, CL (corresponding author), Soochow Univ, Dept Forens Med, Med Coll, 178 Ganjiang East Rd, Suzhou 215123, Jiangsu, Peoples R China.	clluo@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971163, 81400999, 81971800]; Suzhou Science and Technology for People's Livelihood [SYS2019027]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (81971163, 81400999 and 81971800), Suzhou Science and Technology for People's Livelihood (SYS2019027), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Ben Shahar Y, 2016, EUR J PEDIATR SURG, V26, P47, DOI 10.1055/s-0035-1559886; Cazorla M, 2011, J CLIN INVEST, V121, P1846, DOI 10.1172/JCI43992; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Cui T, 2015, CELL BIOCHEM BIOPHYS, V71, P595, DOI 10.1007/s12013-014-0239-3; Gao Y, 2017, MOL NEUROBIOL, V54, P3879, DOI 10.1007/s12035-016-9947-6; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Jang SW, 2010, P NATL ACAD SCI USA, V107, P3876, DOI 10.1073/pnas.0912531107; Li QZ, 2019, J MOL NEUROSCI, V67, P574, DOI 10.1007/s12031-019-01263-6; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Nikoletopoulou V, 2017, CELL METAB, V26, P230, DOI 10.1016/j.cmet.2017.06.005; Oxenkrug G, 2012, AGING DIS, V3, P330; Qi XQ, 2019, CELL TRANSPLANT, V28, P1002, DOI 10.1177/0963689719857649; VOISIN P, 1984, J BIOL CHEM, V259, P913; Wang T, 2015, J MOL NEUROSCI, V55, P240, DOI 10.1007/s12031-014-0313-8; Wolfler A, 1999, FEBS LETT, V449, P206, DOI 10.1016/S0014-5793(99)00435-4; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Yang C, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu121; Yoo JM, 2017, REDOX BIOL, V11, P592, DOI 10.1016/j.redox.2016.12.034; Yu SN, 2013, INT J MOL SCI, V14, P17680, DOI 10.3390/ijms140917680; Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200	26	2	2	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JAN	2020	132								104606	10.1016/j.neuint.2019.104606			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	KE7QW	WOS:000508747200009	31760035				2022-02-06	
J	Sander, AM; Boileau, NR; Hanks, RA; Tulsky, DS; Carlozzi, NE				Sander, Angelle M.; Boileau, Nicholas R.; Hanks, Robin A.; Tulsky, David S.; Carlozzi, Noelle E.			Emotional Suppression and Hypervigilance in Military Caregivers: Relationship to Negative and Positive Affect	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						caregiver; health-related quality of life; service members; traumatic brain injury; veterans	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; ITEM BANKS; EXPRESSIVE SUPPRESSION; INDIVIDUAL-DIFFERENCES; HEALTH; VETERANS; OUTCOMES; ANXIETY; STRATEGIES	Objective: To investigate the relationship of 2 health-related quality-of-life (QOL) item banks (Emotional Suppression and Caregiver Vigilance), developed for caregivers of service members/veterans with traumatic brain injury (TBI), to caregivers' positive and negative affect. Setting: Community. Participants: One hundred sixty-five caregivers of service members/veterans with TBI. Design: Retrospective database analysis. Main Measures: TBI-CareQOL Emotional Suppression; TBI-CareQOL Caregiver Vigilance; measures of negative (Patient-Reported Outcomes Measurement Information System [PROMIS] Depression, PROMIS Anger, TBI-CareQOL Caregiver-Specific Anxiety, National Institutes of Health Toolbox [NIHTB] Perceived Stress, GAD-7) and positive affect (Neuro-QOL Positive Affect and Well-being, NIHTB Self-efficacy, NIHTB General Life Satisfaction, Family Resilience Scale for Veterans, TBI-QOL Resilience). Results: When considered separately, linear regression showed that higher levels of Emotional Suppression and greater Caregiver Vigilance were individually associated with more negative affect and less positive affect. When considered together, the pattern of findings was generally consistent for both Emotional Suppression and Caregiver Vigilance with regard to negative affect and for Emotional Suppression with regard to positive affect. However, when considered together, Caregiver Vigilance was no longer related to positive affect. Conclusions: Caregivers with high emotional suppression and/or vigilance are more likely to show emotional distress and less likely to have positive affect than caregivers with lower levels of emotional suppression and vigilance. A combination of education and individual counseling targeting coping with negative emotions and TBI-related problems may be beneficial.	[Sander, Angelle M.] Baylor Coll Med, Harris Hlth Syst, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Boileau, Nicholas R.; Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy & Psychol, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Brain Sci, Newark, DE USA		Sander, AM (corresponding author), TIRR Mem Hermann Res Ctr, 1333 Moursund St, Houston, TX 77030 USA.	asander@bcm.edu	Boileau, Nicholas/V-4832-2019	Tulsky, David/0000-0002-4335-4509; Boileau, Nicholas/0000-0002-4056-4404	National Institutes of Health (NIH)-National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0016]	The contents of this publication were developed under grants from the National Institutes of Health (NIH)-National Institute of Nursing Research (R01NR013658), and the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR; 90DPTB0016). NIDILRR is a center within the Administration for Community Living, Department of Health and Human Services. The contents of this publication do not necessarily represent the policy or official views of NIDILRR or NIH, and you should not assume endorsement by the federal government.	Abler B, 2010, PSYCHIAT RES, V183, P1050113; Brickell TA, 2019, REHABIL PSYCHOL, V64, P72, DOI 10.1037/rep0000249; Brickell TA, 2018, J HEAD TRAUMA REHAB, V33, P133, DOI 10.1097/HTR.0000000000000384; Butler EA, 2003, EMOTION, V3, P48, DOI 10.1037/1528-3542.3.1.48; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS22, DOI 10.1016/j.apmr.2018.05.027; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2014, QUAL LIFE RES, V23, P2651, DOI 10.1007/s11136-014-0732-6; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; Cohen J., 2013, STAT POWER ANAL BEHA; Cook KF, 2015, QUAL LIFE RES, V24, P575, DOI 10.1007/s11136-014-0790-9; Egloff B, 2006, EMOTION, V6, P356, DOI 10.1037/1528-3542.6.3.356; Evers C, 2010, PERS SOC PSYCHOL B, V36, P792, DOI 10.1177/0146167210371383; Finley Erin P, 2016, Mil Behav Health, V4, P205, DOI 10.1080/21635781.2016.1153530; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Griffin JM, 2010, J HEAD TRAUMA REHAB, V27, P3; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Hayes JP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00230; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; Kimble M, 2014, J ANXIETY DISORD, V28, P241, DOI 10.1016/j.janxdis.2013.12.006; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kwon H, 2019, INT J PSYCHOL, V54, P448, DOI 10.1002/ijop.12486; Larsen JK, 2012, J YOUTH ADOLESCENCE, V41, P1628, DOI 10.1007/s10964-012-9782-7; MAHONEY F I, 1965, Md State Med J, V14, P61; Mallery P, 2011, SPSS WINDOWS STEP ST; Moore Sally A, 2012, J Exp Psychopathol, V3, P368; Nagaraja V, 2018, QUAL LIFE RES, V27, P755, DOI 10.1007/s11136-017-1709-z; Paap MCS, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0500-0; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Ramchand R., 2014, HIDDEN HEROES AM MIL; Richards JM, 2000, J PERS SOC PSYCHOL, V79, P410, DOI 10.1037//0022-3514.79.3.410; Roberts NA, 2008, INT J PSYCHOPHYSIOL, V70, P82, DOI 10.1016/j.ijpsycho.2008.06.003; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Samejima F, 1996, HDB MODERN ITEM RESP, P85; Samuel L, 2018, ARCH GERONTOL GERIAT, V78, P127, DOI 10.1016/j.archger.2018.06.012; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Sheather SJ, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-09608-7_1; Sheldon KM, 1997, J PERS SOC PSYCHOL, V73, P1380, DOI 10.1037/0022-3514.73.6.1380; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Troy AS, 2019, EMOTION, V19, P751, DOI 10.1037/emo0000486; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Walsh F, 2006, STRENGTHENING FAMILY, V2; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001	52	2	2	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2020	35	1			SI		E10	E20		10.1097/HTR.0000000000000507			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KL0UE	WOS:000513147300003	31365438	Green Accepted			2022-02-06	
J	Sawadogo, D; Moore, L; Tardif, PA; Farhat, I; Lauzier, F; Turgeon, AF				Sawadogo, D.; Moore, L.; Tardif, P. A.; Farhat, I; Lauzier, F.; Turgeon, A. F.			Trends of clinical outcomes in patients with a Traumatic Brain Injury (TBI) in Canada between 2006 and 2012	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trends; Traumatic brain injury; Clinical outcomes; Mortality; Readmission; Hospital length of stay; Intensive care unit; Trauma systems; Province; Canada; Reduction	MORTALITY; ACCESS	Background: Traumatic brain injuries (TBI) are the leading cause of death for people aged <40 years. In Canada, the structure of trauma care has evolved independently across provinces during the last decade. However, little is known about the evolution of clinical outcomes. We aimed to compare trends in hospital mortality, unplanned readmission, hospital length of stay (LOS) and intensive care unit (ICU) LOS for TBI between 2006 and 2012 across Canadian provinces. Methods: We conducted a retrospective multicentre cohort study based on TBI admissions across Canadian level I and II trauma centres. Data were extracted from the National Trauma Registry linked to hospital discharge databases. All adults with an injury severity score >= 12 were included. Multilevel generalized linear models were used to evaluate trends in clinical outcomes. Results: Between 2006 and 2012, we observed a decrease in mortality in Canada (odd ratio [OR] = 0.95; 95% confidence intervals [CI] = 0.92-0.98) mostly driven by Ontario (OR = 0.95; 95% CI = 0.93-0.98). We observed a significant decrease in hospital length of stay in Canada (hazard ratio [HR]: hazard of being discharged alive from hospital =1.02; 95% CI =1.01-1.02) mostly driven by a decrease in Quebec (HR = 1.03; 95% CI = 1.01-1.04). We observed a decrease in ICU Length of stay only in Alberta (HR = 1.05; 95% CI = 1.01-1.09). No trend was observed for hospital readmissions. Conclusion: We observed significant decreases in mortality, hospital and ICU length of stay for TBI in Canada between 2006 and 2012 but only in certain provinces. This study may represent the first step towards a better understanding of the influence of trauma system configuration on the burden of injuries in Canada. (C) 2019 Elsevier Ltd. All rights reserved.	[Sawadogo, D.; Moore, L.; Tardif, P. A.; Farhat, I; Lauzier, F.; Turgeon, A. F.] Univ Laval, Fac Med, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Sawadogo, D.; Moore, L.; Tardif, P. A.; Farhat, I; Lauzier, F.; Turgeon, A. F.] Hop Enfants Jesus, Ctr Rech CHU Quebec, Quebec City, PQ, Canada; [Lauzier, F.] Univ Laval, Fac Med, Dept Anesthesiol, Quebec City, PQ, Canada		Sawadogo, D (corresponding author), 757 Rue Rougemt 402, Quebec City, PQ G1X 2M1, Canada.	sawjas@hotmail.fr	Lauzier, Francois/B-9237-2015	Lauzier, Francois/0000-0002-6530-5513	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec-Sante New Investigator Award; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [110996]	Parts of this material are based on data and information provided by the Canadian Institute for Health Information (CIHI). However, the analyses, conclusions, opinions and statements expressed herein are those of the authors and not those of CIHI. The authors also thank Amina Belcaid, Xavier Neuveu, Valerie Porgo, Khadidja Maloum Boukar, Coralie Assy and Marie-Pier Patton for their support in this project. This study was supported by a Canadian Institutes of Health Research New Investigator Award (Drs. Moore, Stelfox, and Turgeon), Fonds de Recherche du Quebec-Sante New Investigator Award (Dr. Lauzier), and research grant 110996 from the Canadian Institutes of Health Research (Dr Moore).	Beck B, 2016, MED J AUSTRALIA, V204, P407, DOI 10.5694/mja15.01369; Brain Trauma Foundation, 2016, GUID MAN SEV TRAUM B; Canadian Insitute for Health Information, 2014, NAT TRAUM REG COMPR; Centers for Disease Control and Prevention, 2018, TRAUM BRAIN INJ CONC; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Evans David C., 2007, J CAN CHIROPR, V50; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Hameed SM, 2010, J TRAUMA, V69, P1350, DOI 10.1097/TA.0b013e3181e751f7; Institut Canadien d'Information sur la Sante, 2017, MET BAS DONN CONG PA; Kuimi BLB, 2015, INJURY, V46, P1257, DOI 10.1016/j.injury.2015.02.024; Ministere de la Sante et des Services Sociaux, 2017, SOURC DONN MET MED E; Moore L, 2016, ANN SURG, P264; Moore L, 2017, JAMA SURG, V152, P168, DOI 10.1001/jamasurg.2016.4212; Moore L, 2015, WORLD J SURG, V39, P1397, DOI 10.1007/s00268-015-2977-9; Moore L, 2014, J TRAUMA ACUTE CARE, V76, P1310, DOI 10.1097/TA.0000000000000202; Moore L, 2010, ANN SURG, V251, P952, DOI 10.1097/SLA.0b013e3181d97589; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Victoria B, 2016, NATL ACAD MANAG STA, P47	22	2	2	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2020	51	1					76	83		10.1016/j.injury.2019.08.023			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	JY8UQ	WOS:000504683800014	31515061				2022-02-06	
J	Shim, VB; Holdsworth, S; Champagne, AA; Coverdale, NS; Cook, DJ; Lee, TR; Wang, AD; Li, SF; Fernandez, JW				Shim, Vickie B.; Holdsworth, Samantha; Champagne, Allen A.; Coverdale, Nicole S.; Cook, Douglas J.; Lee, Tae-Rin; Wang, Alan D.; Li, Shaofan; Fernandez, Justin W.			Rapid Prediction of Brain Injury Pattern in mTBI by Combining FE Analysis With a Machine-Learning Based Approach	IEEE ACCESS			English	Article						Brain modeling; Strain; Computational modeling; Head; Magnetic heads; Finite element analysis; Magnetic resonance imaging; Diffusion tensor imaging; finite element analysis; magnetic resonance imaging; mild traumatic brain injury; partial least squares regression	MAXIMUM PRINCIPAL STRAIN; TISSUE; MODEL; IMPLEMENTATION; VALIDATION; IMPACTS	Mild traumatic brain injury (mTBI) is a significant issue worldwide. Public awareness of the dangers of mTBI has increased sharply in recent years, yet there is no easy-to-use tool available for early detection and post injury management. Computational models of the head impact, usually in the form of finite element analysis, are a method of choice for characterizing how mechanical impacts lead to brain damage by causing high strains in certain regions of the brain. However, those models require a prohibitively large amount of computational power as well as pre and post processing expertise, making them unrealistic to be used in clinical settings. In this study, we propose a framework that combines finite element analysis with a machine learning based approach where a large number of pre-computed FE results are used to train a statistical model. We analyzed a number of different head impact scenarios in which a football player would sustain a minor brain injury and computed brain internal strain patterns. These pre-computed strain patterns were then used to train a partial least squares regression model to be able to predict the general strain pattern and the location and magnitude of peak strains. Our models were able to predict the overall distribution pattern, including the location of the peak strain, with an average error of 3%. The peak strain magnitudes were also predicted accurately with the average error of 9% at almost real time speed (less than 10 seconds). This model may play an important role in developing a diagnostic tool for mTBI that can predict the severity of head impacts.	[Shim, Vickie B.; Wang, Alan D.; Fernandez, Justin W.] Univ Auckland, Auckland Bioengn Inst, Auckland 1010, New Zealand; [Holdsworth, Samantha; Wang, Alan D.] Univ Auckland, Dept Anat & Med Imaging, Auckland 1010, New Zealand; [Holdsworth, Samantha; Wang, Alan D.] Univ Auckland, Fac Med & Hlth Sci, Ctr Brain Res, Auckland 1010, New Zealand; [Holdsworth, Samantha] Matai, Med Res Inst, Gisborne 4010, New Zealand; [Champagne, Allen A.; Coverdale, Nicole S.; Cook, Douglas J.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Cook, Douglas J.] Queens Univ, Dept Surg, Kingston, ON K7L 3N6, Canada; [Lee, Tae-Rin] Seoul Natl Univ, Adv Inst Convergence Technol, Seoul 08826, South Korea; [Li, Shaofan] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Fernandez, Justin W.] Univ Auckland, Dept Engn Sci, Auckland 1010, New Zealand		Shim, VB (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland 1010, New Zealand.	v.shim@Auckland.ac.nz	Li, Shaofan/G-8082-2011	Li, Shaofan/0000-0002-6950-1474; Holdsworth, Samantha/0000-0002-2929-1169; Shim, Vickie Bo Kyung/0000-0002-1680-4287	Ministry of Business, Innovation, and Employment of New Zealand Catalyst [PROP-55749-INTCS-UOA]; National Research Foundation of Korea through the Global Infrastructure Program - Ministry of Science and ICT [NRF-2017K1A3A1A17092641]; South-Eastern Ontario Academic Medical Organization (SEAMO), ON, Canada; Globalink Research Award from MITACS, Canada	This work was supported in part by the Ministry of Business, Innovation, and Employment of New Zealand Catalyst under Grant PROP-55749-INTCS-UOA, in part by the National Research Foundation of Korea through the Global Infrastructure Program funded by the Ministry of Science and ICT under Grant NRF-2017K1A3A1A17092641, and in part by the South-Eastern Ontario Academic Medical Organization (SEAMO), ON, Canada. The work of Allen A. Champagne was supported by the Globalink Research Award from MITACS, Canada.	Atsumi N, 2018, ANN BIOMED ENG, V46, P736, DOI 10.1007/s10439-018-1988-8; Brands DWA, 2004, J BIOMECH, V37, P127, DOI 10.1016/S0021-9290(03)00243-4; Champagne AA, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz021; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fernandez J, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0084; Fernandez J., 2017, MULTISCALE MECHANOBI, V578, P123; Fernandez J, 2020, BIOMECH MODEL MECHAN, V19, P1165, DOI 10.1007/s10237-020-01364-x; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giudice JS, 2019, ANN BIOMED ENG, V47, P1855, DOI 10.1007/s10439-018-02161-5; Hrapko M, 2009, INT J CRASHWORTHINES, V14, P245, DOI 10.1080/13588260802440290; Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kwon E., ENG REP; Lin YC, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005152; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mateos-Aparicio G, 2011, COMMUN STAT-THEOR M, V40, P2305, DOI 10.1080/03610921003778225; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Miller R. T., 1998, 983154 SAE, V107, P2798; Mithraratne K, 2010, IFMBE PROC, V31, P1024, DOI 10.1007/978-3-642-14515-5_261; Newman J., 2000, P INT RES COUNC BIOM, V28, P1; Newman J., 1999, INT RES COUNC BIOM I, P17; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pizzolato C, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00878; Saboori P, 2011, SCI IRAN, V18, P1492, DOI 10.1016/j.scient.2011.11.032; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Shim VB, 2014, CMES-COMP MODEL ENG, V98, P279; Shim VB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31587-z; Shim VB, 2016, BIOMECH MODEL MECHAN, V15, P195, DOI 10.1007/s10237-015-0668-y; Shim VB, 2015, COMPUT METHOD BIOMEC, V18, P1495, DOI 10.1080/10255842.2014.920831; Spitzer VM, 1998, ANAT RECORD, V253, P49, DOI 10.1002/(SICI)1097-0185(199804)253:2<49::AID-AR8>3.0.CO;2-9; Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3; Zhang J, 2016, J BIOMECH, V49, P3875, DOI 10.1016/j.jbiomech.2016.10.021; Zhang J, 2016, MED ENG PHYS, V38, P450, DOI 10.1016/j.medengphy.2016.02.003; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhao W, 2019, ANN BIOMED ENG, V47, P475, DOI 10.1007/s10439-018-02159-z; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634	45	2	2	0	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2169-3536			IEEE ACCESS	IEEE Access		2020	8						179457	179465		10.1109/ACCESS.2020.3026350			9	Computer Science, Information Systems; Engineering, Electrical & Electronic; Telecommunications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Telecommunications	OA5PD	WOS:000577836000001		gold			2022-02-06	
J	Sinha, R; Dijkshoorn, ABC; Li, C; Manly, T; Price, SJ				Sinha, Rohitashwa; Dijkshoorn, Aicha B. C.; Li, Chao; Manly, Tom; Price, Stephen J.			Glioblastoma surgery related emotion recognition deficits are associated with right cerebral hemisphere tract changes	BRAIN COMMUNICATIONS			English	Article						glioblastoma; surgery; cognition; function; registration	DIFFUSION; REGISTRATION; DISORDERS; DISEASE; DAMAGE; FACES	Patients with glioblastoma face abysmal overall survival, cognitive deficits, poor quality of life and limitations to social participation; partly attributable to surgery. Emotion recognition deficits mediated by pathophysiological mechanisms in the right inferior fronto-occipital fasciculus and right inferior longitudinal fasciculus have been demonstrated in traumatic brain injury and dementia, with negative associations for social participation. We hypothesize similar mechanisms occur in patients undergoing resection surgery for glioblastoma. Here, we apply tract-based spatial statistics using a combination of automated image registration methods alongside cognitive testing before and after surgery. In this prospective, longitudinal, observational study of 15 patients, surgery is associated with an increase in emotion recognition deficits (P = 0.009) and this is correlated with decreases in fractional anisotropy in the inferior longitudinal fasciculus, inferior fronto-occipital fasciculus, anterior thalamic radiation and uncinate fasciculus; all in the right hemisphere (P = 0.014). Methodologically, the combination of registration steps used demonstrate that tract-based spatial statistics can be applied in the context of large, scan distorting lesions such as glioblastoma. These results can inform clinical consultations with patients undergoing surgery, support consideration for social cognition rehabilitation and are consistent with theoretical mechanisms that implicate these tracts in emotion recognition deficits across different diseases.	[Sinha, Rohitashwa; Dijkshoorn, Aicha B. C.; Li, Chao; Price, Stephen J.] Univ Cambridge, Dept Clin Neurosci, Cambridge Brain Tumour Imaging Lab, Cambridge, England; [Manly, Tom] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge CB2 7EF, England		Sinha, R (corresponding author), Univ Cambridge, Acad Dept Neurosurg, Dept Clin Neurosci, Addenbrookes Hosp, Level 4,A Block,Hills Rd, Cambridge CB2 0QQ, England.	rs693@cam.ac.uk		Li, Chao/0000-0002-0734-0011	Cancer Research UKCancer Research UK [RRZB/040, CRUK/A19732]; Royal College of Surgeons of England [RRAG/093]; Fundatie van Renswoude [AV20180147]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [SUAG/049, G101-400]; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR) [CDF-2018-11-ST-2003]; NIHR Brain Injury MedTech Co-operative; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105559837] Funding Source: UKRI	Cancer Research UK (RRZB/040 to R.S.) and the Royal College of Surgeons of England (RRAG/093); Fundatie van Renswoude (AV20180147 to A.D.); Cancer Research UK (CRUK/A19732 to C.L.); Medical Research Council (SUAG/049 and G101-400 to T.M.); National Institute for Health Research (NIHR), Career Development Fellowship for this research project (CDF-2018-11-ST-2003 to S.P.); NIHR Brain Injury MedTech Co-operative. This publication presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Baggio HC, 2012, NEUROPSYCHOLOGIA, V50, P2121, DOI 10.1016/j.neuropsychologia.2012.05.020; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Campanella F, 2015, NEURO-ONCOLOGY, V17, P1121, DOI 10.1093/neuonc/nov065; Downey LE, 2015, NEUROIMAGE-CLIN, V8, P640, DOI 10.1016/j.nicl.2015.06.005; Ffytche DH, 2010, J NEUROL NEUROSUR PS, V81, P1280, DOI 10.1136/jnnp.2008.171348; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Giovagnoli AR, 2005, J NEUROL NEUROSUR PS, V76, P562, DOI 10.1136/jnnp.2004.036186; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kalafatakis K, 2018, P NATL ACAD SCI USA, V115, pE4091, DOI 10.1073/pnas.1714239115; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larner AJ, 2014, DEMENT GER COGN D EX, V4, P236, DOI 10.1159/000363735; Mike A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082422; Peters KB, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.10125; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Scherer HJ, 1940, BRAIN, V63, P1, DOI 10.1093/brain/63.1.1; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Snowden JS, 2008, NEUROPSYCHOLOGIA, V46, P2638, DOI 10.1016/j.neuropsychologia.2008.04.018; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stoecklein VM, 2020, NEURO-ONCOLOGY, V22, P1388, DOI 10.1093/neuonc/noaa044; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Tavor I, 2014, NEUROIMAGE, V86, P123, DOI 10.1016/j.neuroimage.2013.07.085; The Brain Tumour Charity, 2015, LOS MYS REAL LIF BRA; Unger A, 2016, J INT NEUROPSYCH SOC, V22, P180, DOI 10.1017/S1355617715001009; van der Hoorn A, 2016, NMR BIOMED, V29, P882, DOI 10.1002/nbm.3538; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wang Y, 2018, NEUROSCI BIOBEHAV R, V90, P350, DOI 10.1016/j.neubiorev.2018.04.015; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhao XX, 2017, PROG NEURO-PSYCHOPH, V77, P57, DOI 10.1016/j.pnpbp.2017.03.025	31	2	2	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2020	2	2							169	10.1093/braincomms/fcaa169			9	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RM1PH	WOS:000639431800107	33426526	Green Published, Green Submitted, gold			2022-02-06	
J	Sullivan, KW; Law, WA; Loyola, L; Knoll, MA; Shub, DE; French, LM				Sullivan, Katherine W.; Law, Wendy A.; Loyola, Laura; Knoll, Martin A.; Shub, Daniel E.; French, Louis M.			A Novel Intervention Platform for Service Members With Subjective Cognitive Complaints: Implementation, Patient Participation, and Satisfaction	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; INFORMATION-SYSTEM PROMIS; OF-THE-LITERATURE; SELF-EFFICACY; REPORTED OUTCOMES; TRAINING-PROGRAM; OLDER-ADULTS; REHABILITATION; DEPRESSION	Introduction: Program overview of a novel cognitive training platform at Walter Reed National Military Medical Center (WRNMMC) for service members with subjective cognitive complaints: analysis of patient participation, satisfaction with the program, and perceived areas of improvement. Materials and Method: Retrospective review of 1,030 participants from November 2008 through May 2017. Data were obtained within an approved protocol (WRNMMC-EDO-2017-0004/# 876230). Results: The program has shown growth in numbers of referrals, types of patient populations served, and patient visits. Patients report satisfaction with the program and endorse improvements in cognitive functions. Conclusions: This program model may benefit other military facilities looking to provide and assess novel therapeutic approaches.	[Sullivan, Katherine W.; Law, Wendy A.; Loyola, Laura; Knoll, Martin A.; Shub, Daniel E.; French, Louis M.] Walter Reed Natl Mil Med Ctr, 8901 Rockville Pike, Bethesda, MD 20889 USA; [Sullivan, Katherine W.; Law, Wendy A.; Loyola, Laura; Knoll, Martin A.; French, Louis M.] Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA; [Sullivan, Katherine W.; Loyola, Laura; French, Louis M.] Def & Vet Brain Injury Ctr, 1335 East West Highway, Silver Spring, MD 20910 USA; [Law, Wendy A.] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [French, Louis M.] Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Sullivan, KW (corresponding author), Walter Reed Natl Mil Med Ctr, 8901 Rockville Pike, Bethesda, MD 20889 USA.; Sullivan, KW (corresponding author), Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA.; Sullivan, KW (corresponding author), Def & Vet Brain Injury Ctr, 1335 East West Highway, Silver Spring, MD 20910 USA.			french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs [W91YTZ-13-C-0015]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [HU0001-09-2-0004]	Defense and Veterans Brain Injury Center (W91YTZ-13-C-0015) and the Center for Neuroscience and Regenerative Medicine (HU0001-09-2-0004).	Adamson BC, 2015, ARCH PHYS MED REHAB, V96, P1329, DOI 10.1016/j.apmr.2015.01.005; Alia C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00076; Basso Anna, 2013, Handb Clin Neurol, V110, P325, DOI 10.1016/B978-0-444-52901-5.00027-7; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96, pS222, DOI 10.1016/j.apmr.2014.10.028; Benedetti F, 2016, J PHYSIOL-LONDON, V594, P5647, DOI 10.1113/JP271322; Benyon K, 2010, MUSCULOSKELET CARE, V8, P224, DOI 10.1002/msc.187; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bonavita S, 2015, J NEUROL, V262, P91, DOI 10.1007/s00415-014-7528-z; Bowen A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub3; Bracy O.L., 1983, COGN REHABIL, V1, P7; Bracy OL, 1983, COGNITIVE REHABILITA, V1, P18; Choi J, 2013, NEUROPSYCHOL REV, V23, P48, DOI 10.1007/s11065-013-9227-4; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Cosentino S, 2018, J ALZHEIMERS DIS, V61, P1387, DOI 10.3233/JAD-170495; Cramer SC, 2018, J STROKE, V20, P57, DOI 10.5853/jos.2017.02796; Driban JB, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0715-y; Egan MY, 2013, DISABIL REHABIL, V35, P2245, DOI 10.3109/09638288.2013.774441; Elhai JD, 2011, J ANXIETY DISORD, V25, P849, DOI 10.1016/j.janxdis.2011.04.007; Fetta J, 2017, J NEUROSCI NURS, V49, P235, DOI 10.1097/JNN.0000000000000298; Foster Erin R, 2018, Disabil Rehabil, V40, P1127, DOI 10.1080/09638288.2017.1288275; Francis HM, 2016, NEUROPSYCHOL REHABIL, V26, P103, DOI 10.1080/09602011.2014.1003246; French LM, 2015, J INT NEUROPSYCH SOC, V21, P12; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Gevirtz, 2013, BIOFEEDBACK, V41, P110, DOI [10.5298/1081-5937-41.3.01, DOI 10.5298/1081-5937-41.3.01]; Giuli C, 2016, REJUV RES, V19, P485, DOI 10.1089/rej.2015.1791; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Innes KE, 2017, J ALZHEIMERS DIS, V56, P899, DOI 10.3233/JAD-160867; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jensen RE, 2017, CANCER-AM CANCER SOC, V123, P327, DOI 10.1002/cncr.30354; Johnson DC, 2011, MIL MED, V176, P161, DOI 10.7205/MILMED-D-10-00258; Kadden RM, 2011, ADDICT BEHAV, V36, P1120, DOI 10.1016/j.addbeh.2011.07.032; Kamegaya T, 2012, GERIATR GERONTOL INT, V12, P673, DOI 10.1111/j.1447-0594.2012.00840.x; Kean J, 2013, ARCH PHYS MED REHAB, V94, P2417, DOI 10.1016/j.apmr.2013.08.006; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Kinsinger SW, 2010, NEUROPSYCHOLOGY, V24, P573, DOI 10.1037/a0019222; Kongkaew C, 2014, EUR J PEDIATR, V173, P203, DOI 10.1007/s00431-013-2128-y; Korpershoek C, 2011, J ADV NURS, V67, P1876, DOI 10.1111/j.1365-2648.2011.05659.x; Krucoff MO, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00584; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Li S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00120; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Matcham F, 2014, CLIN PSYCHOL REV, V34, P141, DOI 10.1016/j.cpr.2014.01.005; Merritt VC, 2015, BRAIN INJURY, V29, P1; Merzenich MM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00385; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Neville BGR, 1999, BRAIN DEV-JPN, V21, P82, DOI 10.1016/S0387-7604(98)00097-7; OBOYLE M, 1990, PSYCHOL AGING, V5, P467, DOI 10.1037/0882-7974.5.3.467; Pocnet C, 2015, INT PSYCHOGERIATR, V27, P1379, DOI 10.1017/S104161021400283X; Politis AM, 2016, PERSPECT ASHA SPEC I, V1, P18; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Riley WT, 2011, J MENT HEALTH POLICY, V14, P201; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Sohlberg M. K. M., 2017, COGNITIVE REHABILITA; Straudi S, 2017, ADV EXP MED BIOL, V958, P171, DOI 10.1007/978-3-319-47861-6_11; Sullivan KW, 2012, STUD HEALTH TECHNOL, V181, P71, DOI 10.3233/978-1-61499-121-2-71; Underwood E, 2016, SCIENCE, V351, P212, DOI 10.1126/science.351.6270.212; Vassar M, 2008, SOC INDIC RES, V86, P47, DOI 10.1007/s11205-007-9113-7; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vincent AS, 2018, APPL NEUROPSYCH-ADUL, V25, P366, DOI 10.1080/23279095.2017.1314967; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Woods AJ, 2018, CONTEMP CLIN TRIALS, V65, P19, DOI 10.1016/j.cct.2017.11.017; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260; Yang M, 2011, CEPHALALGIA, V31, P357, DOI 10.1177/0333102410379890; Yost KJ, 2013, LEUKEMIA LYMPHOMA, V54, P290, DOI 10.3109/10428194.2012.711830; Zelinski EM, 2007, J AM GERIATR SOC, V57, P594	71	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			326	333		10.1093/milmed/usz218			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600046	32074374	Bronze			2022-02-06	
J	Syed, MA; Yang, Z; Rangaprakash, D; Hu, XP; Dretsch, MN; Katz, JS; Denney, TS; Deshpande, G				Syed, Mohammed A.; Yang, Zhi; Rangaprakash, D.; Hu, Xiaoping; Dretsch, Michael N.; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna			DisConICA: a Software Package for Assessing Reproducibility of Brain Networks and their Discriminability across Disorders	NEUROINFORMATICS			English	Article						Functional MRI; Independent component analysis; Reproducibility; Clustering; Posttraumatic stress disorder; Post-concussion syndrome	ABNORMAL FUNCTIONAL CONNECTIVITY; INDEPENDENT COMPONENT ANALYSIS; ANTERIOR CINGULATE CORTEX; VETERANS; PTSD; REGISTRATION; MAXIMIZATION; PRECUNEUS	There is a lack of objective biomarkers to accurately identify the underlying etiology and related pathophysiology of disparate brain-based disorders that are less distinguishable clinically. Brain networks derived from resting-state functional magnetic resonance imaging (rs-fMRI) has been a popular tool for discovering candidate biomarkers. Specifically, independent component analysis (ICA) of rs-fMRI data is a powerful multivariate technique for investigating brain networks. However, ICA-derived brain networks that are not highly reproducible within heterogeneous clinical populations may exhibit mean statistical separation between groups, yet not be sufficiently discriminative at the individual-subject level. We hypothesize that functional brain networks that are most reproducible in subjects within clinical and control groups separately, but not when the two groups are merged, may possess the ability to discriminate effectively between the groups even at the individual-subject level. In this study, we present DisConICA or "Discover Confirm Independent Component Analysis", a software package that implements the methodology in support of our hypothesis. It relies on a "discover-confirm" approach based upon the assessment of reproducibility of independent components (representing brain networks) obtained from rs-fMRI (discover phase) using the gRAICAR (generalized Ranking and Averaging Independent Component Analysis by Reproducibility) algorithm, followed by unsupervised clustering analysis of these components to evaluate their ability to discriminate between groups (confirm phase). The unique feature of our software package is its ability to seamlessly interface with other software packages such as SPM and FSL, so that all related analyses utilizing features of other software can be performed within our package, thus providing a one-stop software solution starting with raw DICOM images to the final results. We showcase our software using rs-fMRI data acquired from US Army soldiers returning from the wars in Iraq and Afghanistan who were clinically grouped into the following groups: PTSD (posttraumatic stress disorder), comorbid PCS (post-concussion syndrome) + PTSD, and matched healthy combat controls. This software package along with test data sets is available for download at .	[Syed, Mohammed A.; Rangaprakash, D.; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, AU MRI Res Ctr, Dept Elect & Comp Engn, 560 Devall Dr,Suite 266D, Auburn, AL 36849 USA; [Syed, Mohammed A.] Auburn Univ, Dept Comp Sci & Software Engn, Auburn, AL 36849 USA; [Syed, Mohammed A.] Boeing Co, Seattle, WA USA; [Yang, Zhi] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing, Peoples R China; [Rangaprakash, D.] Northwestern Univ, Dept Radiol, Chicago, IL USA; [Hu, Xiaoping] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Dretsch, Michael N.] US Army, Aeromed Res Lab, Ft Rucker, AL USA; [Dretsch, Michael N.] US Army, Joint Base Lewis McCord, Med Res Directorate West, Tacoma, WA USA; [Dretsch, Michael N.; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Ctr Neurosci, Birmingham, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Alabama Adv Imaging Consortium, Birmingham, AL 36207 USA; [Deshpande, Gopikrishna] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bangalore, Karnataka, India; [Deshpande, Gopikrishna] Auburn Univ, Ctr Hlth Ecol & Equ Res, Auburn, AL 36849 USA		Deshpande, G (corresponding author), Auburn Univ, AU MRI Res Ctr, Dept Elect & Comp Engn, 560 Devall Dr,Suite 266D, Auburn, AL 36849 USA.; Deshpande, G (corresponding author), Auburn Univ, Dept Psychol, Auburn, AL 36849 USA.; Deshpande, G (corresponding author), Auburn Univ, Ctr Neurosci, Birmingham, AL 36849 USA.; Deshpande, G (corresponding author), Alabama Adv Imaging Consortium, Birmingham, AL 36207 USA.; Deshpande, G (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bangalore, Karnataka, India.; Deshpande, G (corresponding author), Auburn Univ, Ctr Hlth Ecol & Equ Res, Auburn, AL 36849 USA.	gopi@auburn.edu	Yang, Zhi/W-6459-2019	Yang, Zhi/0000-0002-2222-2312; Hu, Xiaoping/0000-0001-7014-5983	National Science Foundation - NSFNational Science Foundation (NSF) [0966278]; U.S. Army Medical Research and Materials Command (MRMC) [00007218]; National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81270023]; Foundation of Beijing Key Laboratory of Mental Disorders [2014JSJB03]; Beijing Nova Program for Science and Technology [XXJH2015B079]; Outstanding Young Investigator Award of Institute of Psychology, Chinese Academy of Sciences [Y4CX062008]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA033393, R01EY025978]	The authors would like to thank National Science Foundation - NSF (Grant #0966278) for funding the author MA Syed during this study. The authors acknowledge financial support for data acquisition from the U.S. Army Medical Research and Materials Command (MRMC) (Grant #00007218, PI: M. Dretsch). Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the author, and are not to be construed as official, or as reflecting true views of the Department of the Army or the Department of Defense. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the personnel at the TBI clinic and behavioral health clinic, Fort Benning, GA, USA and the US Army Aeromedical Research Laboratory, Fort Rucker, AL, USA, and most of all, the soldiers who participated in the study. The authors thank Julie Rodiek andWayne Duggan for facilitating data acquisition and Adam Goodman and Thomas Daniel for assistance in data collection. The author MA Syed is not representing the Boeing Company through this article. Author Z Yang is funded by the National Science Foundation of China (81270023, PI: Z. Yang), Foundation of Beijing Key Laboratory of Mental Disorders (2014JSJB03, PI: Z. Yang), Beijing Nova Program for Science and Technology (XXJH2015B079, PI: Z. Yang), and The Outstanding Young Investigator Award of Institute of Psychology, Chinese Academy of Sciences (Y4CX062008, PI: Z. Yang). X Hu and G Deshpande are supported in part by NIH (DA033393) and NIH (R01EY025978), respectively.	A. P. Association, 1994, DIAGN STAT MAN MENT; Abdallah CG, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.12; Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Adams KM, 2014, SYSTEMS ENG, V17, P112, DOI 10.1002/sys.21255; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Calhoun V. D., 2017, GROUP ICA FMRI TOOLB; Camchong J, 2011, BIOL PSYCHIAT, V69, P1117, DOI 10.1016/j.biopsych.2011.01.008; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Choi EY, 2017, NEUROIMAGE, V146, P821, DOI 10.1016/j.neuroimage.2016.09.037; Cisler JM, 2013, PSYCHIAT RES-NEUROIM, V214, P238, DOI 10.1016/j.pscychresns.2013.06.003; Davey CG, 2012, PSYCHOL MED, V42, P2071, DOI 10.1017/S0033291712000323; DiGangi JA, 2016, NEUROSCI LETT, V615, P37, DOI 10.1016/j.neulet.2016.01.010; Dretsch MN, 2019, J EXP NEUROSCI, V13, DOI [10.1177/1179069519833966, 10.1177/1179069619833966]; Goebel R., 2019, BRAINVOYAGER BRAIN I; Gorgolewski KJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002506; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kaczkurkin AN, 2017, AM J PSYCHIAT, V174, P125, DOI 10.1176/appi.ajp.2016.15121549; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kennis M, 2015, HUM BRAIN MAPP, V36, P99, DOI 10.1002/hbm.22615; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Liu W., 2012, LECT NOTES COMPUTER; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Moher D, 2016, LANCET, V387, P1573, DOI 10.1016/S0140-6736(15)00307-4; N. I. o. M. Health, 2019, AN FUNCT NEUROIMAGES; Patriat R, 2016, J AM ACAD CHILD PSY, V55, P319, DOI 10.1016/j.jaac.2016.01.010; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Ross DA, 2017, JAMA PSYCHIAT, V74, P407, DOI 10.1001/jamapsychiatry.2016.3325; Schulz JB, 2016, J NEUROCHEM, V139, P253, DOI 10.1111/jnc.13844; Shang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096834; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sussman D, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0247-x; Syed M., 2017, FRONTIERS NEUROSCIEN, P11; Thome J, 2014, BORDER PERS DIS EMOT, V1, DOI 10.1186/2051-6673-1-17; U. Research Imaging Institute, 2011, MULT AN GUI; von dem Hagen EAH, 2013, SOC COGN AFFECT NEUR, V8, P694, DOI 10.1093/scan/nss053; von Rhein D, 2017, HUM BRAIN MAPP, V38, P2359, DOI 10.1002/hbm.23522; Waltzman D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170564; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wrocklage KM, 2017, EUR NEUROPSYCHOPHARM, V27, P515, DOI 10.1016/j.euroneuro.2017.02.010; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang L, 2016, PLOS ONE, V11; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Yang Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep05549; Yang Z, 2014, NEUROIMAGE, V89, P45, DOI 10.1016/j.neuroimage.2013.10.039; Yang Z, 2012, NEUROIMAGE, V63, P403, DOI 10.1016/j.neuroimage.2012.06.060; Young G, 2017, INT J LAW PSYCHIAT, V51, P1, DOI 10.1016/j.ijlp.2017.02.002; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zhang YX, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004083; Zhang YX, 2016, BRAIN TOPOGR, V29, P405, DOI 10.1007/s10548-016-0472-8	66	2	2	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1539-2791	1559-0089		NEUROINFORMATICS	Neuroinformatics	JAN	2020	18	1					87	107		10.1007/s12021-019-09422-1			21	Computer Science, Interdisciplinary Applications; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Neurosciences & Neurology	KM6XL	WOS:000514280700006	31187352	Green Accepted			2022-02-06	
J	Tan, XG; Matic, P				Tan, X. Gary; Matic, Peter			Simulation of Cumulative Exposure Statistics for Blast Pressure Transmission Into the Brain	MILITARY MEDICINE			English	Article; Proceedings Paper	10th Annual Military Health System Research Symposium (MHSRS)	AUG 20-23, 2018	Kissimmee, FL				INJURY	Introduction This study develops and demonstrates an analysis approach to understand the statistics of cumulative pressure exposure of the brain to repetitive blasts events. Materials and Methods A finite element model of blast loading on the head was used for brain model biomechanical responses. The cumulative pressure exposure fraction (CPEF), ranging from 0.0 to 1.0, was used to characterize the extent and repetition of high pressures. Monte Carlo simulations were performed to generate repetitive blast cumulative exposures. Results The blast orientation effect is as influential as the blast overpressure magnitudes. A 75 degrees (from the side) blast orientation can produce CPEF values exceeding traumatic brain injury pressure thresholds >0.95 while, for the same blast overpressure, a 0 degrees (front) blast orientation results in a CPEF <0.25. Monte Carlo results for different sequences reflecting notional operational and training environments show that both mean values and standard deviations of CPEF reach the statistically equilibrium state at a finite value of n exposures for each sequence. Conclusions Statistical convergence of the brain pressure response metrics versus number of blasts for different exposures characterizes the transitions from "low" to "high" number of blasts and quantitatively highlights the differences between operational and training exposures.	[Tan, X. Gary; Matic, Peter] US Naval Res Lab, Mat Sci & Technol Div Code 6300, 4555 Overlook Ave SW, Washington, DC 20375 USA		Tan, XG (corresponding author), US Naval Res Lab, Mat Sci & Technol Div Code 6300, 4555 Overlook Ave SW, Washington, DC 20375 USA.				Office of Naval Research (ONR) through the Naval Research Laboratory's Basic Research ProgramOffice of Naval Research; Department of Defense (DOD) High Performance Computing Modernization Program at the Army Research Laboratory, Air Force Research Laboratory; Army Engineer Research Laboratory DOD Supercomputing Resource Centers	This study was supported by the Office of Naval Research (ONR) through the Naval Research Laboratory's Basic Research Program and the Department of Defense (DOD) High Performance Computing Modernization Program at the Army Research Laboratory, Air Force Research Laboratory, and Army Engineer Research Laboratory DOD Supercomputing Resource Centers.	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Brewick PT, 2018, J MECH BEHAV BIOMED, V85, P237, DOI 10.1016/j.jmbbm.2018.05.037; Brix KA, 2017, J NEUROTRAUM, V34, pS18, DOI 10.1089/neu.2017.5222; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cernak I:, 2017, CONCUSSION, V2; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Haniff S, 2017, SHOCK WAVES, V27, P929, DOI 10.1007/s00193-017-0765-1; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hua Y, 2017, BIOMED ENG LETT, V7, P253, DOI 10.1007/s13534-017-0027-2; Institute of Medicine, 2014, GULF WAR HLTH, V9; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kingery CN, 1984, 02555 BRL US ARM BAL; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Saunders R, 2019, MIL MED, V184, P181, DOI 10.1093/milmed/usy360; Saunders RN, 2019, ANN BIOMED ENG, V47, P2005, DOI 10.1007/s10439-018-02157-1; Tan XG, 2017, SHOCK WAVES, V27, P889, DOI 10.1007/s00193-017-0740-x; Tan XG, 2018, P 25 INT S MIL ASP B; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	27	2	2	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2020	185			1			214	226		10.1093/milmed/usz308			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	KN8UM	WOS:000515120600032	32074364	hybrid			2022-02-06	
J	Treleaven, J; Joloud, V; Nevo, Y; Radcliffe, C; Ryder, M				Treleaven, Julia; Joloud, Vladimir; Nevo, Yoav; Radcliffe, Clare; Ryder, Mollie			Normative Responses to Clinical Tests for Cervicogenic Dizziness: Clinical Cervical Torsion Test and Head-Neck Differentiation Test	PHYSICAL THERAPY			English	Article							DISTURBANCES; CONCUSSION; DIAGNOSIS	Background. The clinical diagnosis of cervicogenic dizziness (CGD) is challenging because of a lack of sensitive and specific diagnostic tests. It is vital for clinicians to know normative responses to suggested clinical tests to help them develop the method and interpretation of these tests and maximize their diagnostic value for CGD. Objective. The purpose of the study was to determine normative responses to the clinical application of the cervical torsion test and the head-neck differentiation test, with consideration of different age groups and sex. Design. This was an observational study. Methods. One hundred forty-seven people who were healthy and asymptomatic served as controls and performed both tests, which involved 3 components: cervical torsion, cervical rotation, and en bloc rotation (head and trunk rotation together). Results. Thirty-five (23.81%) of the 147 participants reported some symptoms (mild dizziness, visual disturbances, unusual eye movements on opening eyes after the test, motion sickness, or nausea) on 1 or more of the 3 test components in either test. The specificity when using a positive response to torsion alone (ie, a negative response to the rotation or en bloc component) was high (for the cervical torsion test, 98.64%; for the head-neck differentiation test, 89.8%), as participants with likely global sensorimotor sensitivity were eliminated. The combined specificity was 100%, as no participants presented with exclusive positive torsion results in both tests. Age and sex did not influence the results. Limitations. There were several examiners who were not blinded. Conclusions. Confirmation of the high specificity of these clinical tests with the method used in this study to conduct and interpret the results will allow future research to determine the sensitivity of these clinical measures in a population with CGD and specificity in those with dizziness of other origins.	[Treleaven, Julia; Joloud, Vladimir; Nevo, Yoav; Radcliffe, Clare; Ryder, Mollie] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Neck Pain & Whiplash Res Unit, Brisbane, Qld 4072, Australia		Treleaven, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Neck Pain & Whiplash Res Unit, Brisbane, Qld 4072, Australia.	j.treleaven@uq.edu.au	Treleaven, Julia/N-1379-2019	Treleaven, Julia/0000-0002-6258-3972			Akiduki H, 2003, NEUROSCI LETT, V340, P197, DOI 10.1016/S0304-3940(03)00098-3; Baloh R. W., 1996, DISORDERS VESTIBULAR; Bronstein A, 2005, NEUROL CLIN, V23, P705, DOI 10.1016/j.ncl.2005.01.004; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Daly L, 2018, MUSCULOSKEL SCI PRAC, V33, P18, DOI 10.1016/j.msksp.2017.10.007; FITZRITSON D, 1991, J MANIP PHYSIOL THER, V14, P193; Garzorz IT, 2017, CURR BIOL, V27, P2856, DOI 10.1016/j.cub.2017.08.011; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Hain TC, 2015, CURR OPIN NEUROL, V28, P69, DOI 10.1097/WCO.0000000000000161; Halmagyi GM, 1999, ANN NY ACAD SCI, V871, P195, DOI 10.1111/j.1749-6632.1999.tb09185.x; Herdman SJ, 2014, VESTIBULAR REHABILIT; L'Heureux-Lebeau B, 2014, OTOL NEUROTOL, V35, P1858, DOI 10.1097/MAO.0000000000000506; NORRE M E, 1987, Acta Oto-Rhino-Laryngologica Belgica, V41, P436; Reiley Alexander S, 2017, Arch Physiother, V7, P12, DOI 10.1186/s40945-017-0040-x; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Wrisley DM, 2000, J ORTHOP SPORT PHYS, V30, P755, DOI 10.2519/jospt.2000.30.12.755	18	2	2	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JAN	2020	100	1					192	200		10.1093/ptj/pzz143			9	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	KS8CK	WOS:000518533000018	31584656				2022-02-06	
J	Tsai, SJ				Tsai, Shih-Jen			Preventive potential of low intensity pulsed ultrasound for chronic traumatic encephalopathy after repetitive head collisions in contact sports	MEDICAL HYPOTHESES			English	Article						Ultrasound; Chronic traumatic encephalopathy; Prevention; Neurotrophic factors; Inflammation	NEUROTROPHIC FACTOR; BRAIN-INJURY; FOOTBALL PLAYER; BIOMARKERS; TAU	Chronic traumatic encephalopathy (CTE), a disease process well-recognized in boxers, American football players and military personnel, is a progressive neurodegenerative disease caused by repetitive blows to the head. Subjects with CTE can have a wide range of emotional, cognitive and physical symptoms. The cognitive group patients had a significantly higher probability of developing dementia in later years. Currently, there are no disease modifying regimen for CTE. Timely intervention of head blow could diminish the development of CTE. Low-intensity pulsed ultrasound (LIPUS) is a common adjunct used to promote bone healing for fresh fracture. Recent reports suggest that LIPUS can noninvasively modulate the cortical function and have neuroprotective effect in various animal models of traumatic brain injury, stroke, Alzheimer's disease and major depressive disorder. The multifunctional mechanisms of LIPUS neuroprotective effect include several trophic factor stimulations, anti-inflammatory properties and reduction of brain edema. From the above evidence, LIPUS intervention could be a strategy for the prevention of the clinical CTE sequelae of repetitive head blows. We hypothesized that due to its neuroprotective effects, the non-invasive and easy-to-use method of LIPUS brain stimulation could have a preventive effect on players who have head blows during the match. The development of a time sensitive protocol, resembling the therapeutic algorithm for traumatic brain injury, would potentially prevent the development of subsequent CTE adverse outcome. Further long-term longitudinal studies of LIPUS stimulation are warranted to verify the prevention efficacy of this intervention for CTE.	[Tsai, Shih-Jen] Taipei Vet Gen Hosp, Dept Psychiat, 201 Shih Pai Rd,Sec 2, Taipei 11217, Taiwan; [Tsai, Shih-Jen] Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei, Taiwan; [Tsai, Shih-Jen] Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan		Tsai, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, 201 Shih Pai Rd,Sec 2, Taipei 11217, Taiwan.	tsai610913@gmail.com	Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X			Busse JW, 2002, CAN MED ASSOC J, V166, P437; Chen CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23929-8; Chen TT, 2019, CEREB CORTEX, V29, P1430, DOI 10.1093/cercor/bhy039; Fesharaki-Zadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00713; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; Hong CJ, 2011, BRAIN RES BULL, V86, P287, DOI 10.1016/j.brainresbull.2011.08.019; Levin B, 2014, NEUROCRIT CARE, V20, P334, DOI 10.1007/s12028-013-9931-1; Li HD, 2017, BRAIN STIMUL, V10, P695, DOI 10.1016/j.brs.2017.02.008; Lin WT, 2015, SCI REP-UK, V5, DOI 10.1038/srep09671; Lindsley CW, 2017, ACS CHEM NEUROSCI, V8, P1629, DOI 10.1021/acschemneuro.7b00291; Liu SH, 2017, CEREB CORTEX, V27, P3152, DOI 10.1093/cercor/bhw169; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Raji CA, 2016, AM J GERIAT PSYCHIAT, V24, P784, DOI 10.1016/j.jagp.2016.07.018; Rogatzki MJ, 2016, INT J IMMUNOPATH PH, V29, P450, DOI 10.1177/0394632016657091; SCHANDELMAIER S, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J656; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Su WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15916-2; Su WS, 2017, BRAIN STIMUL, V10, P1032, DOI 10.1016/j.brs.2017.09.003; Tharmaratnam T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00445; Tsai SJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00156; Tsai SJ, 2015, MED HYPOTHESES, V84, P381, DOI 10.1016/j.mehy.2015.01.030; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Wang Y, 2013, EXP THER MED, V6, P826, DOI 10.3892/etm.2013.1215; Yang Feng-Yi, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P6056, DOI 10.1109/EMBC.2018.8513558; Yang FY, 2015, BRAIN STIMUL, V8, P465, DOI 10.1016/j.brs.2014.11.017; Zhang DQ, 2019, IEEE T BIO-MED ENG, V66, P411, DOI 10.1109/TBME.2018.2845689; Zhang H, 2009, MICROSURG, V29, P479, DOI 10.1002/micr.20644; Zhou H, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7159592; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	38	2	2	3	12	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	JAN	2020	134								109422	10.1016/j.mehy.2019.109422			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	KH9MA	WOS:000510971500018	31654885				2022-02-06	
J	Tyner, CE; Boulton, AJ; Sherer, M; Kisala, PA; Glutting, JJ; Tulsky, DS				Tyner, Callie E.; Boulton, Aaron J.; Sherer, Mark; Kisala, Pam A.; Glutting, Joseph J.; Tulsky, David S.			Development of Composite Scores for the TBI-QOL	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Health-related quality of life; Patient reported outcome measures; Psychometrics; Rehabilitation; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; BASIC ISSUES; WISC-III; VALIDITY; RECOMMENDATIONS	Objective: To develop a set of composite scores that can be used for interpreting quality of life (QOL) after traumatic brain injury (TBI) using 9 of the patient-reported outcomes measures from the Traumatic Brain Injury Quality of Life (TBI-QOL) measurement system. Design: Participants completed 20 item banks from the TBI-QOL as part of a larger assessment. Composite index scores were created with normalized transformation with nonlinear area conversion using scores from 9 of the banks, and are expressed in index score units, with higher composite scores indicating better functioning. For descriptive purposes, associations among composites and individual banks were evaluated using regression, along with patterns of composite scores by injury severity groups using analysis of variance. Setting: Three medical centers in the United States. Participants: Community-dwelling adults (n=504) with a history of TBI. Interventions: Not applicable. Main Outcomes Measure: TBI-QOL. Results: Five composite indices were generated: global QOL, physical health, emotional health, cognitive health, and social health. Lookup tables are provided herein. Composite scores were highly intercorrelated (all r>.60, P<.0001), and individual TBI-QOL banks all correlate strongly with the global QOL composite in the expected direction (all r>.50, P<.0001). Conclusion: Researchers and clinicians can use the TBI-QOL global QOL, physical health, emotional health, cognitive health, and social health composite scores to aggregate results from multiple TBI-QOL banks, which is anticipated to ease interpretation and reliability. This work additionally highlights the importance of considering nonphysical symptoms as outcomes variables for TBI research, as cognitive, social, and emotional domains were some of the most strongly correlated banks with the global QOL composite. (C) 2018 by the American Congress of Rehabilitation Medicine	[Tyner, Callie E.; Boulton, Aaron J.; Kisala, Pam A.; Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, STAR Hlth Sci Complex,540 S Coll Ave, Newark, DE 19713 USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Glutting, Joseph J.] Univ Delaware, Sch Educ, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA		Tyner, CE (corresponding author), Univ Delaware, Ctr Hlth Assessment Res & Translat, STAR Hlth Sci Complex,540 S Coll Ave, Newark, DE 19713 USA.	ctyner@udel.edu	Tyner, Callie/K-8935-2019	Tyner, Callie/0000-0003-2945-392X; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, H133A70038]	Supported by grant numbers H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, and H133A70038 from the National Institute on Disability, Independent Living, and Rehabilitation Research.	Akshoomoff N, 2013, MONOGR SOC RES CHILD, V78, P119, DOI 10.1111/mono.12038; [Anonymous], 2009, EST REL COMP SCOR; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D F, 1995, Oncology (Williston Park), V9, P47; CELLA DF, 1993, CANCER INVEST, V11, P327, DOI 10.3109/07357909309024860; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; EPSTEIN S, 1983, J PERS, V51, P360, DOI 10.1111/j.1467-6494.1983.tb00338.x; EPSTEIN S, 1980, AM PSYCHOL, V35, P790, DOI 10.1037/0003-066X.35.9.790; Glutting JJ, 1997, PSYCHOL ASSESSMENT, V9, P295, DOI 10.1037/1040-3590.9.3.295; GLUTTING JJ, 1987, EDUC PSYCHOL MEAS, V47, P607, DOI 10.1177/001316448704700307; Hunsley J, 2003, PSYCHOL ASSESSMENT, V15, P446, DOI 10.1037/1040-3590.15.4.446; John OP, 2014, HANDBOOK OF RESEARCH METHODS IN SOCIAL AND PERSONALITY PSYCHOLOGY, SECOND EDITION, P473; Lange RT, 2016, J HEAD TRAUMA REHAB, V31, P62, DOI 10.1097/HTR.0000000000000149; Osburn HG, 2000, PSYCHOL METHODS, V5, P343, DOI 10.1037//1082-989X.5.3.343; RUSHTON JP, 1983, PSYCHOL BULL, V94, P18, DOI 10.1037/0033-2909.94.1.18; SATTLER JM, ASSESSMENT CHILDREN; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Sherer M, 2020, ARCH PHYS MED REHAB, V101, P62, DOI 10.1016/j.apmr.2017.04.016; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Thomdike RL, 1982, APPL PSYCHOMETRICS; Toyinbo PA, 2016, J HEAD TRAUMA REHAB, V31, P52, DOI 10.1097/HTR.0000000000000089; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; WATERS E, 1983, DEV REV, V3, P79, DOI 10.1016/0273-2297(83)90010-2; Watkins MW, 2007, APPL NEUROPSYCHOL, V14, P13, DOI 10.1080/09084280701280353; Watkins MW, 2000, SCHOOL PSYCHOL QUART, V15, P465, DOI 10.1037/h0088802; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 1946, WHO INT HLTH C NEW Y	29	2	2	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2020	101	1					43	53		10.1016/j.apmr.2018.05.03			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	KA2PR	WOS:000505640300005	31875840				2022-02-06	
J	Vestergaard, SV; Rasmussen, TB; Stallknecht, S; Olsen, J; Skipper, N; Sorensen, HT; Christiansen, CF				Vestergaard, Soren Viborg; Rasmussen, Thomas Bojer; Stallknecht, Sandra; Olsen, Jens; Skipper, Niels; Sorensen, Henrik Toft; Christiansen, Christian Fynbo			Occurrence, mortality and cost of brain disorders in Denmark: a population-based cohort study	BMJ OPEN			English	Article						epidemiology; health economics; neurology; psychiatry	HEALTH-CARE; CONSEQUENCES; EPIDEMIOLOGY; BURDEN; EUROPE	Objectives To examine the occurrence of brain disorders (ie, neurological and mental disorders) in Denmark and mortality and cost of illness among affected persons. Design Matched cohort study. Setting We obtained routinely collected registry data on all Danish residents during 1995-2015. Participants We identified all persons alive on 1 January 2015 with a diagnosis of 25 specific brain disorders (prevalent cohort) and all persons with an incident diagnosis during 2011-2015 (incident cohort). Each person was matched on age and sex with 10 persons from the general population without the brain disorder of interest. Primary and secondary outcome measures Prevalence and incidence of hospital-diagnosed brain disorders, 1-year absolute and relative mortality, and attributable direct and indirect costs of illness compared with the corresponding matched cohorts. Results We identified 1 075 081 persons with at least one prevalent brain disorder (any brain disorder) on 1 January 2015, corresponding to 18.9% of the Danish population. The incidence rate of any brain disorder during 2011-2015 was 1349 per 100 000 person-years (95% CI 1345 to 1353). One-year mortality after diagnosis was increased in persons with any brain disorder (HR 4.7, 95% CI 4.7 to 4.8) and in persons in every group of specific brain disorders compared with the matched cohort from the general population. The total attributable direct costs of brain disorders in 2015 were euro5.2 billion and total attributable indirect costs were euro11.2 billion. Traumatic brain injury, stress-related disorders, depression and stroke were the most common brain disorders. Attributable costs were highest for depression, dementia, stress-related disorders and stroke. Conclusions One in five Danish residents alive on 1 January 2015 had been diagnosed with at least one brain disorder, and mortality was five times higher in persons with any diagnosed brain disorder than in the general population. We found high attributable direct and indirect costs of brain disorders.	[Vestergaard, Soren Viborg; Rasmussen, Thomas Bojer; Sorensen, Henrik Toft; Christiansen, Christian Fynbo] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Stallknecht, Sandra; Olsen, Jens] Incentive, Holte, Denmark; [Skipper, Niels] Aarhus Univ, Dept Econ & Business Econ, Aarhus, Denmark		Vestergaard, SV (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.	sovi@clin.au.dk	Christiansen, Christian Fynbo/B-5870-2014; Christiansen, Christian/ABE-9423-2021	Christiansen, Christian Fynbo/0000-0002-0727-953X; Christiansen, Christian/0000-0002-0727-953X; Stallknecht, Sandra Elkjaer/0000-0002-1721-3665; Toft Sorensen, Henrik/0000-0003-4299-7040; Vestergaard, Soren Viborg/0000-0002-8445-7758; Bojer Rasmussen, Thomas/0000-0003-0120-1712	LundbeckfondenLundbeckfonden [R248-2017-521]	This work was supported by a grant from Lundbeckfonden (grant no. R248-2017-521).	Alonso J, 2004, ACTA PSYCHIAT SCAN S, V420, P21, DOI DOI 10.1111/J.1600-0047.2004.00327.X]; Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Ankjaer-Jensen Anni, 2006, Health Care Manag Sci, V9, P259, DOI 10.1007/s10729-006-9093-1; Arango C, 2018, LANCET PSYCHIAT, V5, P591, DOI 10.1016/S2215-0366(18)30057-9; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Cantarero-Prieto D, 2020, DEMENTIA-LONDON, V19, P2637, DOI 10.1177/1471301219837776; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Drummond JM, 2005, J HIGH ENERGY PHYS; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Frahm-Falkenberg S, 2016, EUR J NEUROL, V23, P1400, DOI 10.1111/ene.13043; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Heide-Jorgensen U, 2018, CLIN EPIDEMIOL, V10, P1325, DOI 10.2147/CLEP.S164456; Jane-Llopis E, 2011, GLOBAL EC BURDEN NON; Jennum P, 2017, SEIZURE-EUR J EPILEP, V49, P17, DOI 10.1016/j.seizure.2017.05.007; Jennum P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1100-0; Jennum P, 2011, J NEUROL, V258, P1497, DOI 10.1007/s00415-011-5969-1; Kerkhof GA, 2017, SLEEP MED, V30, P229, DOI 10.1016/j.sleep.2016.09.015; Lawrence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2539; McGuire A, 2001, EC EVALUATION HLTH C; OECD/EU, 2018, HLTH GLANC EUR 2018, DOI [10.1787/health_glance_eur-2018-en, DOI 10.1787/HEALTH_GLANCE_EUR-2018-EN]; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Plana-Ripoll O, 2019, LANCET, V394, P1827, DOI 10.1016/S0140-6736(19)32316-5; Plana-Ripoll O, 2019, JAMA PSYCHIAT, V76, P259, DOI 10.1001/jamapsychiatry.2018.3658; Pottegard A, 2017, INT J EPIDEMIOL, V46, P798, DOI 10.1093/ije/dyw213; Rudd AG, 1997, J NEUROL NEUROSUR PS, V63, pS39, DOI 10.1136/jnnp.63.2008.39S; Schaller S, 2015, INT J GERIATR PSYCH, V30, P111, DOI 10.1002/gps.4198; Schmidt M, 2019, CLIN EPIDEMIOL, V11, P563, DOI 10.2147/CLEP.S179083; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Sorensen HT, 2019, LANCET NEUROL, V18, P420, DOI 10.1016/S1474-4422(19)30027-4; Statistics Denmark, DOC STAT; Statistics Denmark, ANN NAT ACC; Stovner LJ, 2010, J HEADACHE PAIN, V11, P289, DOI 10.1007/s10194-010-0217-0; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Trautmann S, 2016, EMBO REP, V17, P1245, DOI 10.15252/embr.201642951; Vigo D, 2016, LANCET PSYCHIAT, V3, P171, DOI 10.1016/S2215-0366(15)00505-2; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]	38	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	11							e037564	10.1136/bmjopen-2020-037564			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA5XN	WOS:000595708300011	33208323	gold, Green Published			2022-02-06	
J	Vivash, L; Malpas, CB; Churilov, L; Walterfang, M; Brodtmann, A; Piguet, O; Ahmed, RM; Bush, AI; Hovens, CM; Kalincik, T; Darby, D; Velakoulis, D; O'Brien, TJ				Vivash, Lucy; Malpas, Charles B.; Churilov, Leonid; Walterfang, Mark; Brodtmann, Amy; Piguet, Olivier; Ahmed, Rebekah M.; Bush, Ashley, I; Hovens, Christopher M.; Kalincik, T.; Darby, David; Velakoulis, Dennis; O'Brien, Terence J.			A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia	BMJ OPEN			English	Article						dementia; clinical trials; psychiatry	PROTEIN PHOSPHATASE 2A; TRAUMATIC BRAIN-INJURY; HYPERPHOSPHORYLATED TAU; ALZHEIMERS-DISEASE; ACQUIRED EPILEPSY; PATHOLOGY; DEGENERATION; PREVALENCE; ACTIVATOR; ACCURATE	Introduction Behavioural variant frontotemporal dementia (bvFTD) is a neurodegenerative disorder often neuropathologically associated with the accumulation of abnormally hyperphosphorylated tau, for which there is currently no disease-modifying treatment. Previous work by our group has shown sodium selenate upregulates the activity of protein phosphatase 2 in the brain, increasing the rate of tau dephosphorylation. The objective of this study is to evaluate the efficacy and safety of sodium selenate as a disease-modifying treatment for bvFTD. Methods and analysis This will be a multisite, phase IIb, double-blind placebo-controlled trial of sodium selenate. One hundred and twenty participants will be enrolled across 4 Australian academic hospitals. Following screening eligible participants will be randomised (1:1) to sodium selenate (15 mg three times a day) or placebo for 52 weeks. Participants will have regular safety and efficacy visits throughout the study period. The primary study outcome will be percentage brain volume change (PBVC) as measured on MRI over 52 weeks of treatment. This will be analysed with a general linear model (analysis of covariance (ANCOVA)) with the PBVC as an output, the treatment as an input and the baseline brain volume as covariate for adjustment purposes. Secondary outcomes include safety and tolerability measures, and efficacy measures; change in cerebrospinal fluid total-tau, Addenbrooke's Cognitive Examination-III and Cambridge Behavioural Inventory-Revised scores over the 52 weeks of treatment. These will also be analysed with ANCOVA where the corresponding baseline measure will be incorporated in the model. Additional exploratory outcomes will include other imaging, cognitive and biospecimen analyses. Ethics and dissemination The study was approved by the Human Research and Ethics Committee of the lead site as part of the Australian Multisite Ethics approval system. The results of the study will be presented at national and international conferences and published in peer-reviewed journals.	[Vivash, Lucy; Malpas, Charles B.; Darby, David; O'Brien, Terence J.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [Vivash, Lucy; Malpas, Charles B.; Darby, David; O'Brien, Terence J.] Alfred Hosp, Dept Neurol, Melbourne, Vic, Australia; [Vivash, Lucy; Malpas, Charles B.; Brodtmann, Amy; Kalincik, T.; Darby, David; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia; [Vivash, Lucy; Churilov, Leonid; Darby, David; O'Brien, Terence J.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Vivash, Lucy; Churilov, Leonid; Darby, David; O'Brien, Terence J.] Univ Melbourne, Dept Radiol, Parkville, Vic, Australia; [Malpas, Charles B.; Kalincik, T.] Univ Melbourne, Dept Med, CORe, Parkville, Vic, Australia; [Walterfang, Mark; Velakoulis, Dennis] Royal Melbourne Hosp, Dept Neuropsychiat, Melbourne, Vic, Australia; [Walterfang, Mark; Velakoulis, Dennis] Univ Melbourne, Melbourne Neuropsychiat Ctr, Parkville, Vic, Australia; [Brodtmann, Amy; Bush, Ashley, I] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Brodtmann, Amy; Darby, David] Monash Univ, Eastern Cognit Disorders Clin, Box Hill, Vic, Australia; [Brodtmann, Amy; Bush, Ashley, I] Univ Melbourne, Melbourne Dementia Res Ctr, Parkville, Vic, Australia; [Piguet, Olivier] Univ Sydney, Sch Psychol, Sydney, NSW, Australia; [Piguet, Olivier; Ahmed, Rebekah M.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Ahmed, Rebekah M.] Royal Prince Alfred Hosp, Memory & Cognit Clin, Sydney, NSW, Australia; [Hovens, Christopher M.] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic, Australia		Vivash, L (corresponding author), Monash Univ, Dept Neurosci, Melbourne, Vic, Australia.; Vivash, L (corresponding author), Alfred Hosp, Dept Neurol, Melbourne, Vic, Australia.; Vivash, L (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia.; Vivash, L (corresponding author), Univ Melbourne, Dept Med, Parkville, Vic, Australia.; Vivash, L (corresponding author), Univ Melbourne, Dept Radiol, Parkville, Vic, Australia.	lucy.vivash@monash.edu	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	Vivash, Lucy/0000-0002-1182-0907; Malpas, Charles/0000-0003-0534-3718; O'Brien, Terence/0000-0002-7198-8621	Australian National Health and Medical Research Council (NHMRC) Medical Research Future FundNational Health and Medical Research Council of Australia [APP1170276]; NHMRC Senior Research FellowshipNational Health and Medical Research Council of Australia [GNT1103258]	This work is supported by the Australian National Health and Medical Research Council (NHMRC) Medical Research Future Fund grant number APP1170276. OP is supported by an NHMRC Senior Research Fellowship (GNT1103258).	Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Benton A., 1976, MULTILINGUAL APHASIA; Bertoux M, 2012, J NEUROL NEUROSUR PS, V83, P411, DOI 10.1136/jnnp-2011-301849; Brady RD, 2016, J MUSCULOSKEL NEURON, V16, P369; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cardoso BR, 2019, NEUROTHERAPEUTICS, V16, P192, DOI 10.1007/s13311-018-0662-z; Chan D, 2001, NEUROLOGY, V57, P1756, DOI 10.1212/WNL.57.10.1756; Chare L, 2014, J NEUROL NEUROSUR PS, V85, P866, DOI 10.1136/jnnp-2013-306948; Corcoran NM, 2010, BRIT J CANCER, V103, P462, DOI 10.1038/sj.bjc.6605798; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; Coyle-Gilchrist ITS, 2016, NEUROLOGY, V86, P1736, DOI 10.1212/WNL.0000000000002638; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hsieh S, 2013, DEMENT GERIATR COGN, V36, P242, DOI 10.1159/000351671; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jones NC, 2012, NEUROBIOL DIS, V45, P897, DOI 10.1016/j.nbd.2011.12.005; Kettle M, 2011, FRONTOTEMPORAL DEMEN, P1; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Malpas CB, 2016, J ALZHEIMERS DIS, P1; Moroney JT, 1997, NEUROLOGY, V49, P1096, DOI 10.1212/WNL.49.4.1096; Piguet O, 2017, MED J AUSTRALIA, V207, P303, DOI 10.5694/mja16.01458; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; Savage S, 2013, DEMENT GERIATR COGN, V35, P208, DOI 10.1159/000346389; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Wear Helen J., 2008, Dement. neuropsychol., V2, P102, DOI 10.1590/S1980-57642009DN20200005; Wechsler D, 2008, WECHSLER ADULT INTEL, V22; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zheng P, 2014, MOL NEUROBIOL, V49, P1532, DOI 10.1007/s12035-013-8601-9	39	2	2	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2020	10	11							e040100	10.1136/bmjopen-2020-040100			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PA2DA	WOS:000595442000013	33199422	gold, Green Published			2022-02-06	
J	Whitworth, A; Ng, N; Timms, L; Power, E				Whitworth, Anne; Ng, Naomi; Timms, Lydia; Power, Emma			Exploring the Viability of NARNIA with Cognitive-Communication Difficulties: A Pilot Study	SEMINARS IN SPEECH AND LANGUAGE			English	Article						discourse intervention; multilevel intervention; cognitive-communication; aphasia	TRAUMATIC BRAIN-INJURY; TREATMENT EFFICACY; DISCOURSE; APHASIA; PEOPLE; LANGUAGE; DEFICITS; RELIABILITY; THERAPY; ADULTS	Everyday discourse is a common context for the difficulties experienced by people with acquired neurogenic communication disorders. While evidence is present for effective manualized interventions that directly improve the discourse skills in aphasia, this remains limited for people with cognitive-communication disorders. This proof of concept study used an in-depth case series approach to trial the NARNIA discourse intervention used successfully in aphasia to explore transferability of the protocol and effectiveness in people with cognitive-communication impairments. Four female participants with mild to moderate cognitive-communication difficulties (mean age: 52.8 years)-two following traumatic brain injury and two following vascular episodes-were recruited. Modifications were made to the protocol to accommodate the participant group. Cognitive-linguistic abilities, self-perceptions of communicative behavior and psychosocial recovery, and repeated discourse measures were assessed pre-, immediately post, and at 4 weeks following intervention, to measure treatment effectiveness. Significant gains were observed in quantity of output, informativeness, and efficiency of information across both everyday and narrative discourse genres for all participants. However, in contrast to previous studies, minimal change was observed in discourse macrostructure elements. Significant improvements were also observed in memory or working memory for two participants. This study provides preliminary evidence for the effectiveness of using an adapted protocol with people with cognitive-communication disorders, highlighting how adaptations may address the cognitive needs of this diverse clinical group.	[Whitworth, Anne; Ng, Naomi; Timms, Lydia] Curtin Univ, Fac Hlth Sci, Sch Occupat Therapy Social Work & Speech Pathol, Perth, WA, Australia; [Power, Emma] Univ Technol Sydney, Grad Sch Hlth, Speech Pathol, Sydney, NSW, Australia		Whitworth, A (corresponding author), Curtin Univ, Sch Occupat Therapy Social Work & Speech Pathol, Fac Hlth Sci, Bentley, WA 6102, Australia.	anne.whitworth@curtin.edu.au	timms, lydia/AAR-6180-2020; Whitworth, Anne/AAX-4888-2020; Power, Emma/A-9263-2015	timms, lydia/0000-0001-8597-328X; Whitworth, Anne/0000-0002-4653-0782; Power, Emma/0000-0002-2638-0406			Beales A, 2018, INT J SPEECH-LANG PA, V20, P361, DOI 10.1080/17549507.2018.1442498; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Cahana-Amitay D., 2015, REDEFINING RECOVERY; Carragher M, 2015, APHASIOLOGY, V29, P1383, DOI 10.1080/02687038.2014.988110; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; DeDe G, 2014, APHASIOLOGY, V28, P692, DOI 10.1080/02687038.2014.895973; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Green G., 1982, AUSTR J HUMAN COMMUN, V10, P11; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Holland A., 1980, COMMUNICATIVE ABILIT; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lannin N, 2014, CLIN REHABIL, V28, P470, DOI 10.1177/0269215513512216; Levelt W.J.M., 1989, SPEAKING INTENTION A; Loban Walter, 1976, LANGUAGE DEV KINDERG; MacDonald S, 2019, SOCIAL COMMUNICATION; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Marshall J, 2013, APHASIA RELATED NEUR, P197; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Milman L, 2016, TOP LANG DISORD, V36, P80, DOI 10.1097/TLD.0000000000000076; Milman L, 2014, AM J SPEECH-LANG PAT, V23, P105, DOI 10.1044/2014_AJSLP-12-0054; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Nickels L, 2002, APHASIOLOGY, V16, P935, DOI 10.1080/02687030244000563; Robertson A, 1994, 1994 INTERNATIONAL CONFERENCE ON WORK TEAMS, PROCEEDINGS, P1; Sohlberg McKay Moore, 2005, Seminars in Speech and Language, V26, P268, DOI 10.1055/s-2005-922105; Tate R, 2019, SYDNEY PSYCHOSOCIAL; Thompson CK, 2003, J SPEECH LANG HEAR R, V46, P591, DOI 10.1044/1092-4388(2003/047); Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Wall KJ, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00149; Whitworth A, 2014, COGNITIVE NEUROPSYCHOLOGICAL APPROACH TO ASSESSMENT AND INTERVENTION IN APHASIA: A CLINICIAN'S GUIDE, 2ND EDITION, P1; Whitworth A, 2015, APHASIOLOGY, V29, P1345, DOI 10.1080/02687038.2015.1081143; Whitworth A, 2018, APHASIOLOGY, V32, P1284, DOI 10.1080/02687038.2017.1390543; Whitworth A, 2015, CLIN LINGUIST PHONET, V29, P455, DOI 10.3109/02699206.2015.1020450; Whitworth Anne, 2010, Seminars in Speech and Language, V31, P64, DOI 10.1055/s-0029-1244954; Worrall L, 2000, APHASIOLOGY, V14, P911, DOI 10.1080/02687030050127711	39	2	2	0	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	JAN	2020	41	1					83	98		10.1055/s-0039-3400512			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	JY2SA	WOS:000504269300008	31869851				2022-02-06	
J	Zelencich, LM; Wong, DN; Kazantzis, N; McKenzie, DP; Downing, M; Ponsford, JL				Zelencich, Leah M.; Wong, Dana; Kazantzis, Nikolaos; McKenzie, Dean P.; Downing, Marina; Ponsford, Jennie L.			Predictors of Anxiety and Depression Symptom Improvement in CBT Adapted for Traumatic Brain Injury: Pre/Post-Injury and Therapy Process Factors	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Psychotherapeutic processes; Treatment outcome; Working alliance; Homework; Therapist competence; Head injury; Mood disorders	COGNITIVE-BEHAVIORAL THERAPY; HOMEWORK COMPLIANCE; WORKING ALLIANCE; STRESS SCALES; CLIENT; REHABILITATION; VARIABLES; METAANALYSIS; ASSIGNMENTS; COMPETENCE	Objectives: The current study examined the association of demographic/preinjury, injury-related, and cognitive behavior therapy (CBT) process variables, with anxiety and depression symptom change in traumatic brain injury (TBI)-adapted CBT (CBT-ABI). Methods: The audio recordings of 177 CBT-ABI sessions representing 31 therapist-client dyads were assessed from the independent observer perspective on measures of working alliance, homework engagement, and therapist competency in using homework. Results: Linear regressions showed that older client age, longer post-TBI recovery period, better executive functioning, higher levels of client homework engagement, as well as higher levels of therapist competence in reviewing homework were associated with greater improvement in anxiety and/or depression symptoms. Conclusions: CBT-ABI is a promising treatment for post-TBI depression and anxiety. The current study highlights how therapists can enhance CBT-ABI effectiveness, specifically: comprehensive facilitation of client homework engagement with emphasis on homework review, and accommodation of executive deficits. The current study also suggests that the role of client age and the length of post-TBI recovery period require further investigation.	[Zelencich, Leah M.; Wong, Dana; Kazantzis, Nikolaos; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Wong, Dana] La Trobe Univ, Sch Psychol & Publ Hlth, Bundoora, Vic 3800, Australia; [Wong, Dana; McKenzie, Dean P.; Downing, Marina; Ponsford, Jennie L.] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic 3121, Australia; [McKenzie, Dean P.] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020; Kazantzis, Nikolaos/F-9520-2013; Ponsford, Jennie/H-8341-2014	Downing, Marina/0000-0002-3126-6632; Kazantzis, Nikolaos/0000-0001-9559-4160; Ponsford, Jennie/0000-0003-0430-125X; Wong, Dana/0000-0001-9619-1929; McKenzie, Dean/0000-0002-0006-9062	NHMRCNational Health and Medical Research Council of Australia [606432]	The parent RCT was supported by the NHMRC under Grant number 606432. The authors would like to thank Lilas Carstairs for assistance with data collection, and acknowledge Alex Petrik and Timothy Cronin for provision of CBT process scale training.	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Beck J.S., 2011, COGNITIVE BEHAV THER, V2nd ed; Burgess P.W., 1997, HAYLING BRIXTON TEST; Cervera-Crespo T, 2017, ARCH CLIN NEUROPSYCH, V32, P198, DOI 10.1093/arclin/acw088; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cleveland WS, 1993, VISUALIZING DATA; Coughlan A. K., 2007, BIRT MEMORY INFORM P; Cummins A, 2013, THERAPIST COMPETENCE; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Detweiler-Bedell JB, 2005, PROF PSYCHOL-RES PR, V36, P219, DOI 10.1037/0735-7028.36.2.219; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; FINN RH, 1970, EDUC PSYCHOL MEAS, V30, P71, DOI 10.1177/001316447003000106; First M, 2007, STRUCTURED CLIN INTE; FLAMPUUMLCKIGER C, 2012, J COUNS PSYCHOL, V59, P10, DOI DOI 10.1037/A0025749; Fleiss J. L., 2013, STAT METHODS RATES P; Fluckiger C, 2018, PSYCHOTHERAPY, V55, P316, DOI 10.1037/pst0000172; Hara KM, 2015, COGN BEHAV THERAPY, V44, P162, DOI 10.1080/16506073.2014.998705; Harrell FE, 2015, SPRINGER SER STAT, P311, DOI 10.1007/978-3-319-19425-7_13; Holdsworth E, 2014, CLIN PSYCHOL REV, V34, P428, DOI 10.1016/j.cpr.2014.06.004; Horvath AO, 2011, PSYCHOTHERAPY, V48, P9, DOI 10.1037/a0022186; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Hsieh MY, 2012, DISABIL REHABIL, V34, P408, DOI 10.3109/09638288.2011.607219; Huber P., 1967, P 5 BERK S MATH STAT; Huppert JD, 2006, COGN BEHAV PRACT, V13, P198, DOI 10.1016/j.cbpra.2005.10.001; Kazantzis N, 2004, J CLIN PSYCHOL, V60, P627, DOI 10.1002/jclp.10239; Kazantzis N, 2000, CLIN PSYCHOL-SCI PR, V7, P189, DOI 10.1093/clipsy/7.2.189; Kazantzis N., 2018, WORKING ALLIAN UNPUB; Kazantzis N., 2006, ANN CONV ASS COGN BE; Kazantzis N., 2005, USING HOMEWORK ASSIG; Kazantzis N., 2018, DIMENSIONS BEL UNPUB; Kazantzis N, 2018, COGNITIVE THER RES, V42, P349, DOI 10.1007/s10608-018-9920-y; Kazantzis N, 2016, BEHAV THER, V47, P755, DOI 10.1016/j.beth.2016.05.002; Kazantzis N, 2010, CLIN PSYCHOL-SCI PR, V17, P144, DOI 10.1111/j.1468-2850.2010.01204.x; Kelly AC, 2015, PSYCHOL PSYCHOTHER-T, V88, P285, DOI 10.1111/papt.12044; Kuyken W, 2009, PSYCHOTHER PSYCHOSOM, V78, P42, DOI 10.1159/000172619; Laakso HM, 2019, EUR J NEUROL, V26, P546, DOI 10.1111/ene.13854; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; Mausbach BT, 2010, COGNITIVE THER RES, V34, P429, DOI 10.1007/s10608-010-9297-z; Mohlman J, 2005, BEHAV RES THER, V43, P447, DOI 10.1016/j.brat.2004.03.007; Mohlman J, 2013, J ANXIETY DISORD, V27, P131, DOI 10.1016/j.janxdis.2012.12.001; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Sachsenweger MA, 2015, J CLIN PSYCHOL, V71, P1153, DOI 10.1002/jclp.22227; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; StataCorp LP, 2017, STAT STAT SOFTW VERS; Streiner D.L., 2015, HLTH MEASUREMENT SCA, V5th ed.; Strunk DR, 2010, J CONSULT CLIN PSYCH, V78, P429, DOI 10.1037/a0019631; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Tabachnick B.G., 2013, USING MULTIVARIATE S; Thomas N, 2011, BEHAV COGN PSYCHOTH, V39, P129, DOI 10.1017/S1352465810000548; Tinsley H.E., 2000, HDB APPL MULTIVARIAT, P95, DOI DOI 10.1016/B978-012691360-6/50005-7; Webb CA, 2010, J CONSULT CLIN PSYCH, V78, P200, DOI 10.1037/a0018912; Weck F, 2013, BEHAV THER, V44, P162, DOI 10.1016/j.beth.2012.09.004; White H., 1984, ASYMPTOTIC THEORY EC; WHITEHURST GJ, 1984, AM PSYCHOL, V39, P22, DOI 10.1037/0003-066X.39.1.22; Willner-Reid J, 2016, PSYCHOL PSYCHOTHER-T, V89, P276, DOI 10.1111/papt.12080; Wong D., 2019, COGNITIVE BEHAV THER; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	68	2	2	3	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2020	26	1			SI		97	107	PII S1355617719000791	10.1017/S1355617719000791			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	KH1RZ	WOS:000510425100010	31983372				2022-02-06	
J	Zhang, QH; Hao, JW; Li, GL; Ji, XJ; Zhou, M; Yao, YM				Zhang, Qing-Hong; Hao, Ji-Wei; Li, Guang-Lei; Ji, Xiao-Jing; Zhou, Min; Yao, Yong-Ming			Long-lasting neurobehavioral alterations in burn-injured mice resembling post-traumatic stress disorder in humans	EXPERIMENTAL NEUROLOGY			English	Article						Burn injury; Neurobehavior; Posttraumatic stress disorder; CD4T(+) T cell; Brain-derived neurotrophic factor	COGNITIVE DEFICITS; NMDA RECEPTORS; MESSENGER-RNA; T-CELLS; BRAIN; PATHWAY; BDNF; FEAR; INVOLVEMENT; RESPONSES	Objective: To establish an animal model for posttraumatic stress disorder in burn-injured patients. Methods: Thermal-injured mice with 15% total body surface area were subjected to a series of neurobehavioral tests at 1 and 3 months postburn. Brains were collected for analysis of key molecules expression, spleens for T cell function analysis, and blood for biochemistry and hormones detection. Results: Comparison with sham mice, burn mice showed extremely high locomotion in homecage, open field, and forced swimming tests, indicating a hyper-arousal state. Burn mice exhibited improved spatial memory in Morris Water Maze test and heightened context fear memory in context fear conditioning, suggesting re-experiencing behavior. Although burn mice showed pronounced passive avoidance in the step-through test, their active avoidance capability in response to the conditional stimulus in the shuttle box test was relatively deteriorated. Likewise, the retention of cue-feared memory was impaired in fear conditioning test. The above negative alterations in mood were recapitulated in open-field test, in which the burn mice displayed an anxiety-like behavior with less time spent in the center. However, no sign of depression was found in the forced swimming and sucrose preference tests. The negative mood of burn mice was reinforced by a deficit in sociality and preference for social novelty in social interaction test. These neurobehavioral alterations were associated with an increased expression of brain-derived neurotrophic factor along with a remarkable microgliosis and a moderate astrocytosis in the brain of burn vs. sham mice. Moreover, a prominent Th2 switch and consequent increased nuclear NF-kappa B translocation were seen in the splenic T cells from burn relative to sham mice. Conclusions: We conclude that even mild burn injury could lead to long-lasting cognitive and effective alterations in mice. These findings shed light on the interactions among neuropsychology, neurobiology, and immunology throughout the recovery period of burn injury.	[Zhang, Qing-Hong; Hao, Ji-Wei; Li, Guang-Lei; Ji, Xiao-Jing; Yao, Yong-Ming] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 4, Trauma Res Ctr, 51 Fucheng Rd, Beijing 100048, Peoples R China; [Ji, Xiao-Jing] Wenzhou Med Coll, Hosp Affiliated 1, Dept Emergency, Wenzhou 325000, Zhejiang, Peoples R China; [Zhou, Min] Univ Sci & Technol China, Affiliated Hosp 1, Neurocrit Care Unit, Div Life Sci & Med, Hefei 230001, Anhui, Peoples R China		Zhang, QH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Ctr 4, Trauma Res Ctr, 51 Fucheng Rd, Beijing 100048, Peoples R China.	z_qinghong@aliyun.com			Chinese National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81272089, 81730057]; Chinese Twelve-Five Plan for Military Scientific Foundation [BWS12J050]	This study was supported by Chinese National Natural Science Foundation (81272089, 81730057) and Chinese Twelve-Five Plan for Military Scientific Foundation (BWS12J050).	Acharjee S, 2013, BRAIN BEHAV IMMUN, V33, P164, DOI 10.1016/j.bbi.2013.07.003; Anderson ST, 2015, BRAIN BEHAV IMMUN, V43, P98, DOI 10.1016/j.bbi.2014.07.007; Baillie SE, 2014, BURNS, V40, P1089, DOI 10.1016/j.burns.2014.04.007; Bam M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31209; Bam M, 2016, J NEUROIMMUNE PHARM, V11, P168, DOI 10.1007/s11481-015-9643-8; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Bosmans MWG, 2015, J BEHAV MED, V38, P642, DOI 10.1007/s10865-015-9638-1; Brocardo PD, 2008, EUR J PHARMACOL, V598, P37, DOI 10.1016/j.ejphar.2008.08.033; Cakir U, 2015, INT J PSYCHIAT CLIN, V19, P56, DOI 10.3109/13651501.2014.981545; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; Cigarroa I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153687; Dadalko OI, 2015, J NEUROSCI, V35, P8843, DOI 10.1523/JNEUROSCI.0887-15.2015; Dahl O, 2016, BURNS, V42, P1678, DOI 10.1016/j.burns.2016.09.012; de la Hoz RE, 2016, AM J RESP CRIT CARE, V194, P1383, DOI 10.1164/rccm.201605-1067OC; Dehne MG, 2002, BURNS, V28, P535, DOI 10.1016/S0305-4179(02)00050-5; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Deslauriers J, 2018, BIOL PSYCHIAT, V83, P895, DOI 10.1016/j.biopsych.2017.11.019; Enman NM, 2015, BIOL PSYCHIAT, V78, P871, DOI 10.1016/j.biopsych.2015.04.024; Felmingham KL, 2013, BIOL PSYCHIAT, V73, P1059, DOI 10.1016/j.biopsych.2012.10.033; Flandreau EI, 2018, CURR TOP BEHAV NEURO, V38, P47, DOI 10.1007/7854_2016_65; Furtado M, 2015, PSYCHIAT RES, V229, P37, DOI 10.1016/j.psychres.2015.05.036; Gallo EF, 2015, NEUROPSYCHOPHARMACOL, V40, P1609, DOI 10.1038/npp.2015.11; Ganon-Elazar E, 2012, NEUROPSYCHOPHARMACOL, V37, P456, DOI 10.1038/npp.2011.204; Gu LJ, 2012, STROKE, V43, P1941, DOI 10.1161/STROKEAHA.112.656611; Guo M, 2013, INT J NEUROPSYCHOPH, V16, P857, DOI 10.1017/S1461145712000703; Guo ZG, 2017, J BURN CARE RES, V38, pE370, DOI 10.1097/BCR.0000000000000397; Guo ZJ, 2003, J IMMUNOL, V171, P3983, DOI 10.4049/jimmunol.171.8.3983; Halm MP, 2006, BURNS, V32, P570, DOI 10.1016/j.burns.2005.12.005; Harmatz ES, 2017, BIOL PSYCHIAT, V81, P1003, DOI 10.1016/j.biopsych.2016.11.009; Harre EM, 2008, EUR J NEUROSCI, V27, P644, DOI 10.1111/j.1460-9568.2008.06031.x; Hill JL, 2016, CURR OPIN NEUROBIOL, V36, P59, DOI 10.1016/j.conb.2015.10.001; Hisaoka-Nakashima K, 2016, BRAIN RES, V1634, P57, DOI 10.1016/j.brainres.2015.12.057; Jiang MQ, 2017, BRAIN PATHOL, V27, P480, DOI 10.1111/bpa.12425; Kahn MS, 2012, BEHAV BRAIN RES, V229, P176, DOI 10.1016/j.bbr.2012.01.010; Kaster MP, 2005, INT J NEUROPSYCHOPH, V8, P601, DOI 10.1017/S1461145705005316; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Knox D, 2012, LEARN MEMORY, V19, P43, DOI 10.1101/lm.024356.111; Lalanza JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep16166; Lichtenberg NT, 2014, NEUROSCIENCE, V258, P340, DOI 10.1016/j.neuroscience.2013.11.028; Lin CW, 2014, BRAIN BEHAV IMMUN, V37, P142, DOI 10.1016/j.bbi.2013.12.002; Logsetty S, 2016, BURNS, V42, P738, DOI 10.1016/j.burns.2016.03.006; Long HB, 2016, AM J EMERG MED, V34, P772, DOI 10.1016/j.ajem.2015.12.075; Lopez-Aumatell R, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-48; Lotfipour S, 2013, J NEUROSCI, V33, P7728, DOI 10.1523/JNEUROSCI.4731-12.2013; Madathil SK, 2017, J TRAUMA ACUTE CARE, V83, pS16, DOI 10.1097/TA.0000000000001471; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Martinotti G, 2015, PSYCHIAT RES, V229, P814, DOI 10.1016/j.psychres.2015.07.085; Newton TL, 2014, BIOL PSYCHOL, V99, P150, DOI 10.1016/j.biopsycho.2014.03.009; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pugh CR, 1999, BEHAV BRAIN RES, V106, P109, DOI 10.1016/S0166-4328(99)00098-4; Purohit M, 2014, ARCH PHYS MED REHAB, V95, P1342, DOI 10.1016/j.apmr.2014.01.029; Radjavi A, 2014, BRAIN BEHAV IMMUN, V35, P58, DOI 10.1016/j.bbi.2013.08.013; Reyes R, 2006, NEUROSCI LETT, V407, P11, DOI 10.1016/j.neulet.2006.07.071; Rilett KC, 2015, BRAIN BEHAV IMMUN, V46, P249, DOI 10.1016/j.bbi.2015.02.016; Rimmer RB, 2014, J BURN CARE RES, V35, P154, DOI 10.1097/BCR.0b013e31828c73ac; Rosa AO, 2003, BEHAV BRAIN RES, V144, P87, DOI 10.1016/S0166-4328(03)00069-X; Ross DA, 2017, JAMA PSYCHIAT, V74, P407, DOI 10.1001/jamapsychiatry.2016.3325; Scharfman HE, 2014, NEUROPHARMACOLOGY, V76, P696, DOI 10.1016/j.neuropharm.2013.04.029; Sheridan RL, 2014, J TRAUMA ACUTE CARE, V76, P828, DOI 10.1097/TA.0b013e3182ab111c; Song SJ, 2016, RESTOR NEUROL NEUROS, V34, P415, DOI 10.3233/RNN-150607; Su ZJ, 2009, J NEUROTRAUM, V26, P1695, DOI 10.1089/neu.2008.0519; Torres L, 2016, BRAIN BEHAV IMMUN, V55, P6, DOI 10.1016/j.bbi.2015.09.001; Wang HH, 2017, METAB BRAIN DIS, V32, P247, DOI 10.1007/s11011-016-9905-z; Wang YJ, 2011, NEUROBIOL LEARN MEM, V96, P156, DOI 10.1016/j.nlm.2011.03.010; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Wei CG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16890-5; Wiechman SA, 2004, BRIT MED J, V329, P391, DOI 10.1136/bmj.329.7462.391; Wisely JA, 2007, BURNS, V33, P736, DOI 10.1016/j.burns.2006.10.379; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218; Wuri G, 2011, ACTA ANAESTH SCAND, V55, P474, DOI 10.1111/j.1399-6576.2011.02402.x; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yuan Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep21087; Zang Y, 2004, J IMMUNOL, V172, P4883, DOI 10.4049/jimmunol.172.8.4883; Zhang L, 2014, MOL PSYCHIATR, V19, P8, DOI 10.1038/mp.2012.180; Zhang MD, 2016, P NATL ACAD SCI USA, V113, pE6686, DOI 10.1073/pnas.1614017113; Zhang QH, 2013, NEUROSCIENCE, V228, P60, DOI 10.1016/j.neuroscience.2012.10.013; Zhang QH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-118; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	78	2	2	3	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2020	323								113084	10.1016/j.expneurol.2019.113084			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JZ0OC	WOS:000504802800020	31697945				2022-02-06	
J	Hoffman, NL; O'Connor, PJ; Schmidt, MD; Lynall, RC; Schmidt, JD				Hoffman, Nicole L.; O'Connor, Patrick J.; Schmidt, Michael D.; Lynall, Robert C.; Schmidt, Julianne D.			Relationships between Post-Concussion Sleep and Symptom Recovery: A Preliminary Study	JOURNAL OF NEUROTRAUMA			English	Article						actigraphy; concussion; Pittsburgh Sleep Quality Index; sleep; symptom recovery	TRAUMATIC BRAIN-INJURY; QUALITY INDEX; DISTURBANCES; INSOMNIA; DISORDERS; PREVALENCE; PREDICTORS; TOOL	Post-concussion sleep disturbances can be debilitating and may influence days to symptom recovery; however, evidence is minimal. The purpose of this study was to explore relationships between days to symptom recovery and aspects of sleep, as measured by actigraphy and subjective sleep questionnaires in a concussed sample. Thirty-one college students were physician-diagnosed with a concussion and asked to complete a daily sleep symptom checklist. Participants (n = 14) were excluded based on lack of compliance/early termination (22.6%), recorded <5 nights of data (12.9%), and protracted recoveries (3.2%). Final concussed sample included 17 college-aged students (varsity student-athletes, n = 5; university students, n = 12). A wrist-worn ActiGraph GT9X Link was provided during initial evaluation (within 72 h post-injury) and worn continuously until symptom recovery (follow-up evaluation; 14.3 +/- 5.9 days post-injury). The Pittsburgh Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS) also were completed at follow-up. Pearson's correlations were conducted to determine relationships between days to symptom recovery and actigraphy sleep outcomes (sleep onset latency, wake after sleep onset (WASO(norm)), total sleep time, sleep efficiency (SE), and number of awakenings) across recovery stages (2-3 days post-injury, mid-point, and end). Spearman's rho correlations were used to determine relationships between subjective sleep (PSQI global), sleepiness (ESS total), and sleep cluster symptom severity and days to symptom recovery. At recovery mid-point, individuals who were awake longer throughout the night (24.1 +/- 9.0%) and/or were less efficient at sleeping (73.7 +/- 9.7%) took longer to recover (WASO(norm): r = 0.58, p = 0.015; SE: r = -0.51, p = 0.035). Poorer post-concussion sleep quality (based on PSQI) was correlated with longer recovery (r(s) = 0.70, p = 0.001). Post-concussion sleep-wake disturbances at recovery mid-point and overall poorer sleep quality may be associated with longer symptom recovery. Our findings provide preliminary guidance on identifying those who may be at risk for longer recoveries based on poorer sleep post-injury.	[Hoffman, Nicole L.] Illinois State Univ, Sch Kinesiol & Recreat, Campus Box 5120,250 McCormick Hall, Normal, IL 61790 USA; [O'Connor, Patrick J.; Schmidt, Michael D.; Lynall, Robert C.; Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Hoffman, NL (corresponding author), Illinois State Univ, Sch Kinesiol & Recreat, Campus Box 5120,250 McCormick Hall, Normal, IL 61790 USA.	nlhoff1@ilstu.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640; Schmidt, Michael/0000-0002-8062-4491			Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Dietch JR, 2016, J CLIN SLEEP MED, V12, P1121, DOI 10.5664/jcsm.6050; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Edwards MK, 2017, MENT HEALTH PHYS ACT, V12, P132, DOI 10.1016/j.mhpa.2017.04.002; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hall EE, 2015, CLIN J SPORT MED, V25, P291, DOI 10.1097/JSM.0000000000000133; Hoffman N.L., 2019, SLEEP, P42; Hoffman N.L., 2017, CLIN J SPORT MED; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kostyun Regina, 2015, Conn Med, V79, P161; Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Mezick EJ, 2009, PSYCHONEUROENDOCRINO, V34, P1346, DOI 10.1016/j.psyneuen.2009.04.005; Mollayeva T, 2016, SLEEP MED, V19, P153, DOI 10.1016/j.sleep.2015.05.014; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Mondal P, 2013, NAT SCI SLEEP, V5, P15, DOI 10.2147/NSS.S40608; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Raikes AC, 2019, SLEEP MED, V54, P62, DOI 10.1016/j.sleep.2018.09.018; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Riedel BW, 2000, SLEEP MED REV, V4, P277, DOI 10.1053/smrv.1999.0074; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Schmidt AT, 2015, COGN BEHAV NEUROL, V28, P53, DOI 10.1097/WNN.0000000000000056; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Sufrinko AM, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000387; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003	46	2	2	2	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2020	37	8					1029	1036		10.1089/neu.2019.6761		DEC 2019	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LC5EK	WOS:000504686800001	31774024				2022-02-06	
J	Eapen, N; Borland, ML; Phillips, N; Kochar, A; Dalton, S; Cheek, JA; Gilhotra, Y; Neutze, J; Lyttle, MD; Donath, S; Crowe, L; Dalziel, SR; Oakley, E; Williams, A; Hearps, S; Bressan, S; Babl, FE				Eapen, Nitaa; Borland, Meredith L.; Phillips, Natalie; Kochar, Amit; Dalton, Sarah; Cheek, John A.; Gilhotra, Yuri; Neutze, Jocelyn; Lyttle, Mark D.; Donath, Susan; Crowe, Louise; Dalziel, Stuart R.; Oakley, Ed; Williams, Amanda; Hearps, Stephen; Bressan, Silvia; Babl, Franz E.			Neonatal head injuries: A prospective Paediatric Research in Emergency Departments International Collaborative cohort study	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						emergency department; head injury; neonates	TRAUMATIC BRAIN-INJURY; SUSPECTED CHILD-ABUSE; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; DECISION RULES; MAJOR TRAUMA; INFANTS; RISK; MECHANISMS; MANAGEMENT	Aim To characterise the causes, clinical characteristics and short-term outcomes of neonates who presented to paediatric emergency departments with a head injury. Methods Secondary analysis of a prospective data set of paediatric head injuries at 10 emergency departments in Australia and New Zealand. Patients without neuroimaging were followed up by telephone call. We extracted epidemiological information, clinical findings and outcomes in neonates (<= 28 days). Results Of 20 137 children with head injuries, 93 (0.5%) occurred in neonates. These were mostly fall-related (75.2%), commonly from a care giver's arms, or due to being accidentally struck by a person/object (20.4%). There were three cases of non-accidental head injuries (3.2%). Most neonates were asymptomatic (67.7%) and many had no findings on examination (47.3%). Most neonates had a Glasgow Coma Scale 15 (89.2%) or 14 (7.5%). A total of 15.1% presented with vomiting and 5.4% were abnormally drowsy. None had experienced a loss of consciousness. The most common findings on examination were scalp haematoma (28.0%) and possible palpable skull fracture (6.5%); 8.6% underwent computed tomography brain scan and 4.3% received an ultrasound. Five of eight computed tomography scan (5.4% of neonates overall) showed traumatic brain injury and two of four (2.2% overall) had traumatic brain injury on ultrasound. Thirty-seven percent were admitted, one patient was intubated and none had neurosurgery or died. Conclusions Neonatal head injuries are rare with a mostly benign short-term outcome and are appropriate for observation. However, non-accidental injuries need to be considered.	[Eapen, Nitaa; Cheek, John A.; Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Eapen, Nitaa; Cheek, John A.; Lyttle, Mark D.; Donath, Susan; Crowe, Louise; Oakley, Ed; Williams, Amanda; Hearps, Stephen; Bressan, Silvia; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Cheek, John A.] Monash Med Ctr, Emergency Dept, Melbourne, Vic, Australia; [Donath, Susan; Oakley, Ed; Babl, Franz E.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Melbourne, Vic, Australia; [Borland, Meredith L.] Perth Childrens Hosp, Emergency Dept, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Emergency Med, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia; [Phillips, Natalie; Gilhotra, Yuri] Queensland Childrens Hosp, Emergency Dept, Brisbane, Qld, Australia; [Phillips, Natalie] Univ Queensland, Med Res Inst, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Phillips, Natalie] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Sydney, NSW, Australia; [Neutze, Jocelyn] Kidzfirst Middlemore Hosp, Emergency Dept, Auckland, New Zealand; [Dalziel, Stuart R.] Starship Childrens Hlth, Emergency Dept, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Lyttle, Mark D.] Bristol Royal Hosp Children, Emergency Dept, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Fac Hlth & Life Sci, Bristol, Avon, England; [Bressan, Silvia] Univ Padua, Dept Womens & Child Heath, Padua, Italy		Babl, FE (corresponding author), Murdoch Childrens Res Inst, Emergency Res, Flemington Rd, Parkville, Vic 3052, Australia.	franz.babl@rch.org.au		Hearps, Stephen/0000-0003-2984-1172; Lyttle, Mark/0000-0002-8634-7210; Crowe, Louise/0000-0003-4619-9708; Donath, Susan/0000-0003-2489-3977	National Health and Medical Research Council (Centre of Research Excellence for Paediatric Emergency Medicine), Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727, GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation, Auckland, New Zealand [3112011]; A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; Townsville Hospital, Townsville, Australia; Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Royal Children's Hospital Foundation, Melbourne, Australia; Melbourne Children's Clinician Scientist Fellowship, Melbourne, Australia; NHMRC Practitioner Fellowship, Canberra, Australia; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]	We thank the participating families, ED staff and research staff at participating sites. The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; and the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia, and was supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. Franz Babl's time was partly funded by a grant from the Royal Children's Hospital Foundation, Melbourne, Australia; a Melbourne Children's Clinician Scientist Fellowship, Melbourne, Australia; and a NHMRC Practitioner Fellowship, Canberra, Australia. Stuart Dalziel's time was partly funded by the Health Research Council of New Zealand (HRC13/556).	Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Case Mary E., 2007, Legal Medicine, V9, P83, DOI 10.1016/j.legalmed.2006.11.017; Choi JY, 2020, PEDIATR EMERG CARE, V36, pE268, DOI 10.1097/PEC.0000000000001485; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Davies FC, 2017, EMERG MED J, V34, P562, DOI 10.1136/emermed-2016-206296; Davies FC, 2015, EMERG MED J, V32, P921, DOI 10.1136/emermed-2015-205285; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Eisele JA, 2006, J HEAD TRAUMA REHAB, V21, P537, DOI 10.1097/00001199-200611000-00008; Figaji AA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00685; Graham CA, 2000, J ACCID EMERG MED, V17, P334; Greeley CS, 2015, AM J ROENTGENOL, V204, P967, DOI 10.2214/AJR.14.14191; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Khan Z, 2017, PEDIATR DEVEL PATHOL, V20, P176, DOI 10.1177/1093526616686259; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mulligan CS, 2017, J PAEDIATR CHILD H, V53, P754, DOI 10.1111/jpc.13568; Nadarasa J, 2014, PEDIATR RADIOL, V44, P565, DOI 10.1007/s00247-014-3168-9; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pickering A, 2011, ARCH DIS CHILD, V96, P414, DOI 10.1136/adc.2010.202820; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Pointer S, 2014, HOSP INJURY CHILDREN; Rabiner JE, 2013, PEDIATRICS, V131, pE1757, DOI 10.1542/peds.2012-3921; Reilly P, 1998, CHILD NERV SYST, V4, P30; Ryan ME, 2014, J AM COLL RADIOL, V11, P939, DOI 10.1016/j.jacr.2014.07.017; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Shin SS, 2018, J ULTRAS MED, V37, P1857, DOI 10.1002/jum.14547; Standring S, 2008, GRAYS ANATOMY, P416; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; van Wezel-Meijler G, 2010, SEMIN PERINATOL, V34, P28, DOI 10.1053/j.semperi.2009.10.002; Warrington SA, 2001, ARCH DIS CHILD, V85, P104, DOI 10.1136/adc.85.2.104; Willis AP, 2008, CLIN RADIOL, V63, P165, DOI 10.1016/j.crad.2007.05.027	46	2	2	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1034-4810	1440-1754		J PAEDIATR CHILD H	J. Paediatr. Child Health	MAY	2020	56	5					764	769		10.1111/jpc.14736		DEC 2019	6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	LN6FD	WOS:000503876800001	31868278	Green Published			2022-02-06	
J	Malone, C; Erler, KS; Giacino, JT; Hammond, FM; Juengst, SB; Locascio, JJ; Nakase-Richardson, R; Verduzco-Gutierrez, M; Whyte, J; Zasler, N; Bodien, YG				Malone, Christopher; Erler, Kimberly S.; Giacino, Joseph T.; Hammond, Flora M.; Juengst, Shannon B.; Locascio, Joseph J.; Nakase-Richardson, Risa; Verduzco-Gutierrez, Monica; Whyte, John; Zasler, Nathan; Bodien, Yelena G.			Participation Following Inpatient Rehabilitation for Traumatic Disorders of Consciousness: A TBI Model Systems Study	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; minimally conscious state; participation; rehabilitation; outcome	BRAIN-INJURY; FUNCTIONAL OUTCOMES; DISABILITY; COMMUNITY; COMA	Severe traumatic brain injury (TBI) may result in a disorder of consciousness (DoC) and lead to substantial long-term disability. While level of independence with activities of daily living, especially for persons who recover consciousness during inpatient rehabilitation, generally improves over time, the degree of change in participation remains unknown. We determined level of participation among persons with TBI between 2005 and 2017 who were admitted to inpatient rehabilitation unable to follow commands and subsequently enrolled in the TBI Model Systems National Database. Participation on the Participation Assessment with Recombined Tools-Objective (PART-O) Productivity, Social Relations, and Out and About subscales was evaluated at 1-5 years post-injury. We used a mixed-effects model to longitudinally compare participation between persons who did and did not regain command-following during inpatient rehabilitation. We further explored the level of participation associated with increasing levels of functional independence (FIM). The analysis included 333 persons (229 recovered command-following during rehabilitation, mean age = 35.46 years, 74.9% male). Participation across groups, at all follow-up time points, on all PART-O subscales, was remarkably low (mean range = 0.021-1.91, maximum possible score = 5). Performance was highest on the Social Relations subscale and lowest on the Productivity subscale. Longitudinal analyses revealed no difference in level of participation or change in participation across time for persons who regained command-following during rehabilitation compared to those who did not. While productivity increased over time, social participation did not and participation outside the home increased more for younger than for older persons. Across all three PART-O subscales, FIM Motor scores positively predicted participation. FIM Cognitive scores positively predicted level of participation on the Productivity and Social Relations subscales. Exploratory analyses revealed that even persons who achieved independence on the FIM Motor and Cognitive subscales had low levels of participation across domains and follow-up years. In summary, persons with severe TBI who were admitted to inpatient rehabilitation unable to follow commands were found to be unlikely to participate in productive tasks, social endeavors, or activities outside of the home up to 5 years post-injury, even if functional independence was recovered.	[Malone, Christopher; Giacino, Joseph T.; Bodien, Yelena G.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Malone, Christopher; Giacino, Joseph T.; Bodien, Yelena G.] Spaulding Rehabil Hosp, Neurorehabilitat Lab, Boston, MA 02129 USA; [Erler, Kimberly S.] MGH Inst Hlth Profess, Dept Occupat Therapy, Boston, MA USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Locascio, Joseph J.; Bodien, Yelena G.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Div Pulm & Sleep Med, Tampa, FL 33620 USA; [Verduzco-Gutierrez, Monica] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Verduzco-Gutierrez, Monica] TIRR Mem Hermann, Houston, TX 77030 USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Zasler, Nathan] Virginia Commonwealth Univ, Concuss Care Ctr Virginia Ltd, Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan] Virginia Commonwealth Univ, Tree Life Serv, Richmond, VA USA		Bodien, YG (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Bodien, YG (corresponding author), Spaulding Rehabil Hosp, Neurorehabilitat Lab, Boston, MA 02129 USA.; Bodien, YG (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	ybodien@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Verduzco-Gutierrez, Monica/0000-0003-0964-5908	NIDILRRUnited States Department of Health & Human Services [90DP0039]; VA TBIMS/DVBIC [W91YTZ-13-C-0015]; NTX-TBIMS [90DPTB0013-01-00]; Indiana TBIMS [90DRTB0002]; Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL 1TR002541]; Harvard University	NIDILRR (90DP0039) VA TBIMS/DVBIC (W91YTZ-13-C-0015) NTX-TBIMS (90DPTB0013-01-00) Indiana TBIMS (90DRTB0002). This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL 1TR002541) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	Analytis P, 2018, BRAIN INJURY, V32, P209, DOI 10.1080/02699052.2017.1395479; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Chung P, 2014, J REHABIL MED, V46, P108, DOI 10.2340/16501977-1257; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Clark RA, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-37; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Erler KS, 2018, OTJR-OCCUP PART HEAL, V38, P143, DOI 10.1177/1539449218757739; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, pE77, DOI 10.1097/HTR.0000000000000386; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Lequerica A, 2015, BRAIN INJURY, V29, P1445, DOI 10.3109/02699052.2015.1075144; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Piskur B, 2014, CLIN REHABIL, V28, P211, DOI 10.1177/0269215513499029; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roe C, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00557; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; TEASDALE G, 1974, LANCET, V2, P81; VANDEKELFT E, 1994, CRIT CARE MED, V22, P1108; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Wen PS, 2018, ARCH PHYS MED REHAB, V99, pS86, DOI 10.1016/j.apmr.2017.04.026; Westerhof-Evers HJ, 2019, BRAIN INJURY, V33, P78, DOI 10.1080/02699052.2018.1531303; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	42	2	2	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 18	2019	10								1314	10.3389/fneur.2019.01314			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JZ5ZB	WOS:000505180100001	31920935	gold, Green Published			2022-02-06	
J	Heathcote, K; Sun, J; Horn, Z; Gardiner, P; Haigh, R; Wake, E; Wullschleger, M				Heathcote, Katharine; Sun, Jing; Horn, Zachary; Gardiner, Philippa; Haigh, Rebecca; Wake, Elizabeth; Wullschleger, Martin			Caregiver resilience and patients with severe musculoskeletal traumatic injuries	DISABILITY AND REHABILITATION			English	Article						Trauma; caregiver; health related quality of life; prospective studies; social support; rehabilitation	QUALITY-OF-LIFE; CONNOR-DAVIDSON RESILIENCE; BRAIN-INJURY; SOCIAL SUPPORT; SELF-EFFICACY; HEALTH-PROMOTION; MAJOR TRAUMA; FOLLOW-UP; OUTCOMES; BURDEN	Aims: This study investigated the association of resilience on caregiver burden and quality of life in informal caregivers of patients with severe traumatic musculoskeletal injuries. Methods: A prospective cohort study of eligible caregivers and acutely injured trauma patients was conducted during 2018 in South East Queensland, with follow-up 3 months after patient discharge. Resilience was examined using the 10-item Connor Davidson Resilience Scale. The primary outcomes, caregiver burden and quality of life were measured respectively, using the Caregiver Strain Index and the Short Form Version 12 Health Survey. Results: Baseline measures were completed with fifty-three (77%) patient/carer dyads. Thirty-eight (28%) were available for follow up at 3 months. Significant reductions from baseline were found at follow up, for levels of resilience, mental health, physical exercise and community support. In multiple regression models, caregiver resilience at follow-up independently predicted lower caregiver burden (beta = -0.74, p = 0.008) and higher levels of patient physical health and function (beta = -0.69, p = 0.003). Conclusions: Upon commencing informal care, caregivers' resilience, mental health and support systems are adversely affected. Higher levels of caregiver resilience appear to be protective against caregiver burden and declines in patient physical function. Early evaluation of caregivers' resilience, their physical and mental health and socio-ecological networks could improve carer and patient health outcomes.	[Heathcote, Katharine; Sun, Jing; Horn, Zachary; Gardiner, Philippa; Wake, Elizabeth; Wullschleger, Martin] Griffith Univ, Sch Med, Gold Coast Campus,Parkland St, Southport, Qld 4222, Australia; [Haigh, Rebecca; Wake, Elizabeth; Wullschleger, Martin] Gold Coast Univ Hosp, Div Specialty & Procedural Serv, Southport, Qld, Australia		Sun, J (corresponding author), Griffith Univ, Sch Med, Gold Coast Campus,Parkland St, Southport, Qld 4222, Australia.	j.sun@griffith.edu.au	Wake, Elizabeth/AAA-5404-2022; Sun, J/AAS-1582-2020	Sun, J/0000-0002-0097-2438; Horn, Zachary/0000-0001-5249-2367; Heathcote, Kathy/0000-0001-7776-8534	Australian Commonwealth Government's Research Training PhD Scholarship Program	Dr. Heathcote was supported by the Australian Commonwealth Government's Research Training PhD Scholarship Program. The other authors report no declarations of interest.	Adelman RD, 2014, JAMA-J AM MED ASSOC, V311, P1052, DOI 10.1001/jama.2014.304; Alsheikhly AS, 2018, ESSENTIALS ACCIDENT; Anderson MI, 2015, ANNU REV NURS RES-SE, V33, P219, DOI 10.1891/0739-6686.33.219; [Anonymous], 2015, EC VAL INF CAR AUSTR; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; Ballabeni P, 2011, J OCCUP REHABIL, V21, P43, DOI 10.1007/s10926-010-9255-3; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BANDURA A, 1986, J SOC CLIN PSYCHOL, V4, P359, DOI 10.1521/jscp.1986.4.3.359; Bhandari M, 2008, CAN J SURG, V51, P15; Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Braithwaite IJ, 1998, INJURY, V29, P55; Brewer-Smyth K, 2014, ISSUES MENT HEALTH N, V35, P251, DOI 10.3109/01612840.2013.873101; Burton LC, 1997, PREV MED, V26, P162, DOI 10.1006/pmed.1996.0129; Busija L, 2011, ARTHRIT CARE RES, V63, pS383, DOI 10.1002/acr.20541; Cameron CM, 2006, J EPIDEMIOL COMMUN H, V60, P341, DOI 10.1136/jech.2005.041046; Cameron JI, 2015, NEUROLOGY, V84, P1292, DOI 10.1212/WNL.0000000000001430; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Capistrant BD, 2012, J EPIDEMIOL COMMUN H, V66, P951, DOI 10.1136/jech-2011-200040; Caputo J, 2016, J MARRIAGE FAM, V78, P1382, DOI 10.1111/jomf.12332; Card NA, 2015, FAM RELAT, V64, P120, DOI 10.1111/fare.12102; Chang HY, 2010, ARCH GERONTOL GERIAT, V50, P267, DOI 10.1016/j.archger.2009.04.006; Clay FJ, 2012, J OCCUP REHABIL, V22, P363, DOI 10.1007/s10926-012-9354-4; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; Connelly LB, 2006, ACCIDENT ANAL PREV, V38, P1087, DOI 10.1016/j.aap.2006.04.015; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cosco TD, 2017, J EPIDEMIOL COMMUN H, V71, P98, DOI 10.1136/jech-2015-206980; Davidson J.R., 2015, CONNOR DAVIDSO UNPUB; Dias Rachel, 2015, Trends Psychiatry Psychother., V37, P12, DOI 10.1590/2237-6089-2014-0032; Doyle DJ, STATPEARLS; Elliott TR, 2014, J CONSULT CLIN PSYCH, V82, P1072, DOI 10.1037/a0037593; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Etters L, 2008, J AM ACAD NURSE PRAC, V20, P423, DOI 10.1111/j.1745-7599.2008.00342.x; Fernandez-Lansac Violeta, 2012, Rev Esp Geriatr Gerontol, V47, P102, DOI 10.1016/j.regg.2011.11.004; Gabbe BJ, 2016, ANN SURG, V263, P623, DOI 10.1097/SLA.0000000000001564; Gabbe BJ, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0047-z; Gabbe BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113467; Gabbe BJ, 2005, ACAD EMERG MED, V12, P751, DOI 10.1197/j.aem.2005.03.527; Gennarelli TA., 2008, ABBREVIATED INJURY S; Glanz K., 2008, HLTH BEHAV HLTH ED T; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Haley WE, 2015, NEUROLOGY, V84, P1323, DOI 10.1212/WNL.0000000000001418; Harmell AL, 2011, CURR PSYCHIAT REP, V13, P219, DOI 10.1007/s11920-011-0187-1; Herrman H, 2010, AUST J PUBLIC HEALTH, V17, P261; Herrman H, 2011, CAN J PSYCHIAT, V56, P258, DOI 10.1177/070674371105600504; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Jerusalem M, 1979, GEN SELF EFFICACY SC; Kendall E, 2009, SOC SCI MED, V69, P947, DOI 10.1016/j.socscimed.2009.06.021; Lee JH, 2013, J COUNS DEV, V91, P269, DOI 10.1002/j.1556-6676.2013.00095.x; LIN N, 1979, J HEALTH SOC BEHAV, V20, P108, DOI 10.2307/2136433; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; MacKenzie EJ, 2005, J BONE JOINT SURG AM, V87A, P1801, DOI 10.2106/JBJS.E.00032; Mancini AD, 2006, J CLIN PSYCHOL, V62, P971, DOI 10.1002/jclp.20283; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Marmot, 1999, HEALTH PROMOT J AUST, V9, P133; McCubbin H. I., 1997, J FAMILY CONSUMER SC, V89, P2; McCubbin HI., 1982, FAMILY ASSESSMENT RE, P357; McCubbin M, 1986, FAMILY ASSESSMENT RE, P239; Murgatroyd DF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117597; Niitsu K, 2019, BIOL RES NURS, V21, P61, DOI 10.1177/1099800418800396; Ozbay Fatih, 2007, Psychiatry (Edgmont), V4, P35; Ozbay Fatih, 2008, Curr Psychiatry Rep, V10, P304, DOI 10.1007/s11920-008-0049-7; Pape HC, 2016, POLY TRAUMATIZED PAT; Richard L, 1996, AM J HEALTH PROMOT, V10, P318, DOI 10.4278/0890-1171-10.4.318; Richard L, 2011, ANNU REV PUBL HEALTH, V32, P307, DOI 10.1146/annurev-publhealth-031210-101141; Rosenbloom BN, 2013, J PAIN RES, V6, P39, DOI 10.2147/JPR.S38878; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; Rumsfeld JS, 1999, JAMA-J AM MED ASSOC, V281, P1298, DOI 10.1001/jama.281.14.1298; Rutter M, 2003, RESILIENCE VULNERABI, P489; Rutter M, 2013, J CHILD PSYCHOL PSYC, V54, P474, DOI 10.1111/j.1469-7610.2012.02615.x; Rutter M, 2012, DEV PSYCHOPATHOL, V24, P335, DOI 10.1017/S0954579412000028; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Savage Sally, 2004, Aust Health Rev, V27, P111; Schofield D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-561; Scholz U, 2002, EUR J PSYCHOL ASSESS, V18, P242, DOI 10.1027//1015-5759.18.3.242; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Schwarzer R., 2010, ANXIETY STRESS COPIN, V12, P329; Siegel K, 2001, PSYCHOL HEALTH, V16, P631, DOI 10.1080/08870440108405864; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; Stewart DE, 2011, PSYCHOSOMATICS, V52, P199, DOI 10.1016/j.psym.2011.01.036; Sun J, 2007, INT J MENT HEALTH PR, V9, P16, DOI DOI 10.1080/14623730.2007.9721845; Talley RC, 2007, AM J PUBLIC HEALTH, V97, P224, DOI 10.2105/AJPH.2004.059337; Thornton M, 2003, J GERONTOL B-PSYCHOL, V58, pS127, DOI 10.1093/geronb/58.2.S127; Ungar M, 2011, AM J ORTHOPSYCHIAT, V81, P1, DOI 10.1111/j.1939-0025.2010.01067.x; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Ware J., 1998, SF 12 SCORE SF 12 PH, V2nd Ed; Ware JE, 2007, USERS MANUAL SF 12V2; WHO, 2010, INJ VOIL FACT; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420; Zhang HL, 2017, MED SCI MONITOR, V23, P5969, DOI 10.12659/MSM.907730; Zwingmann J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003515	97	2	2	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUL 31	2021	43	16					2320	2331		10.1080/09638288.2019.1698662		DEC 2019	12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	TQ5YQ	WOS:000502497700001	31841056				2022-02-06	
J	Kelley, CM; Perez, SE; Mufson, EJ				Kelley, Christy M.; Perez, Sylvia E.; Mufson, Elliott J.			Tau pathology in the medial temporal lobe of athletes with chronic traumatic encephalopathy: a chronic effects of neurotrauma consortium study	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Chronic traumatic encephalopathy; Tau; Athletes; Medial temporal lobe; Hippocampus; Repetitive traumatic brain injury	CHOLINERGIC BASAL FOREBRAIN; MILD COGNITIVE IMPAIRMENT; SMALLER THALAMIC VOLUMES; REPETITIVE HEAD IMPACTS; LONG-TERM CONSEQUENCES; CA3 PYRAMIDAL NEURONS; BRAIN-INJURY; ALZHEIMERS-DISEASE; A-BETA; NEUROFIBRILLARY TANGLES	Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative condition associated with repetitive traumatic brain injury (rTBI) seen in contact-sport athletes and military personnel. The medial temporal lobe (MTL; i.e., hippocampus, subiculum, and entorhinal and perirhinal cortices) memory circuit displays tau lesions during the pathological progression of CTE. We examined MTL tissue obtained from 40 male Caucasian and African American athletes who received a postmortem CTE neuropathological diagnosis defined as stage II, III, or IV. Sections were immunolabeled using an early (AT8) or a late (TauC3) marker for pathological tau and for amyloid beta (A beta) species (6E10, A beta(1-42) and thioflavin S). Stereological analysis revealed that stage III had significantly less AT8-positive neurons and dystrophic neurites than stage IV in all MTL regions except hippocampal subfield CA3, whereas significantly more AT8-positive neurons, dystrophic neurites, and neurite clusters were found in the perirhinal cortex, entorhinal cortex, hippocampal CA1, and subiculum of CTE stage III compared with stage II. TauC3-positive pathology was significantly higher in the perirhinal and subicular cortex of stage IV compared to stage III and the perirhinal cortex of stage III compared to stage II. AT8-positive neurite clusters were observed in stages III and IV, but virtually absent in stage II. When observed, A beta pathology appeared as amyloid precursor protein (APP)/A beta (6E10)-positive diffuse plaques independent of region. Thioflavine S labeling, did not reveal evidence for fibril or neuritic pathology associated with plaques, confirming a diffuse, non-cored plaque phenotype in CTE. Total number of AT8-positive profiles correlated with age at death, age at symptom onset, and time from retirement to death. There was no association between AT8-positive tau pathology and age sport began, years played, or retirement age, and no difference between CTE stage and the highest level of sport played. In summary, our findings demonstrate different tau profiles in the MTL across CTE stages, proffering CA3 tau pathology and MTL dystrophic neurite clusters as possible markers for the transition between early (II) and late (III/IV) stages, while highlighting CTE as a progressive noncommunicative tauopathy.	[Kelley, Christy M.; Perez, Sylvia E.; Mufson, Elliott J.] Barrow Neurol Inst, Dept Neurobiol & Neurol, 350 West Thomas Rd, Phoenix, AZ 85013 USA		Mufson, EJ (corresponding author), Barrow Neurol Inst, Dept Neurobiol & Neurol, 350 West Thomas Rd, Phoenix, AZ 85013 USA.	Elliott.Mufson@DignityHealth.org	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146	DODUnited States Department of Defense [W81XWH-13-2-0095]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U01NS086659-01]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Affairs Biorepository [CSP 501]; National Operating Committee on Standards for Athletic Equipment; Concussion Legacy Foundation; Andlinger Foundation; World Wrestling Entertainment; National Football League; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	Supported by DOD Award W81XWH-13-2-0095, National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering (U01NS086659-01); National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5). The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA, USA). This work was also supported by the Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501, the National Operating Committee on Standards for Athletic Equipment, the Concussion Legacy Foundation, the Andlinger Foundation, the World Wrestling Entertainment and the National Football League.	Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; Albayram O, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0124-4; Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Armstrong RA, 2019, NEUROL SCI, V40, P529, DOI 10.1007/s10072-018-3686-6; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Banks SJ, 2017, J NEUROTRAUM, V34, P380, DOI 10.1089/neu.2016.4453; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Blazquez-Llorca L, 2011, J ALZHEIMERS DIS, V26, P683, DOI 10.3233/JAD-2011-110659; Bozdogan H, 2000, J MATH PSYCHOL, V44, P62, DOI 10.1006/jmps.1999.1277; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714, DOI 10.1192/bjp.105.440.714; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Elbin RJ, 2013, TRANSL STROKE RES, V4, P425, DOI 10.1007/s12975-012-0237-y; FITCH JM, 1989, BRAIN RES, V479, P105, DOI 10.1016/0006-8993(89)91340-1; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gonzales RB, 2001, J COMP NEUROL, V430, P357, DOI 10.1002/1096-9861(20010212)430:3<357::AID-CNE1036>3.0.CO;2-K; Grodin EN, 2016, ALCOHOL ALCOHOLISM, V51, P638, DOI 10.1093/alcalc/agw003; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; GUNDERSEN HJG, 1988, J MICROSC-OXFORD, V151, P3, DOI 10.1111/j.1365-2818.1988.tb04609.x; Heim C, 2009, CNS SPECTRUMS, V14, P13; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kelley CM, 2014, BRAIN PATHOL, V24, P33, DOI 10.1111/bpa.12073; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Kondo H, 2008, J COMP NEUROL, V511, P497, DOI 10.1002/cne.21825; Kondo H, 2009, J COMP NEUROL, V515, P349, DOI 10.1002/cne.22056; Kraus A, 2019, ACTA NEUROPATHOL, V137, P585, DOI 10.1007/s00401-018-1947-3; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lauer M, 2006, J NEURAL TRANSM, V113, P1469, DOI 10.1007/s00702-005-0428-8; Lepage C, 2019, BRAIN IMAGING BEHAV, V13, P725, DOI 10.1007/s11682-018-9895-z; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lu KP, 2016, JAMA NEUROL, V73, P1356, DOI 10.1001/jamaneurol.2016.2027; LUCKEWOLD B, 2017, J NEUROL NEUROSUR PS, V4, P2; Mai J. K., 2017, HUMAN BRAIN STANDARD; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mohammed E. A., 2015, EMERGING TRENDS COMP, P577; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morley WA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00166; Mufson EJ, 1999, EXP NEUROL, V158, P469, DOI 10.1006/exnr.1999.7086; Mufson EJ, 2016, BRAIN INJURY, V30, P1399, DOI 10.1080/02699052.2016.1219058; Mufson EJ, 2014, NEURODEGENER DIS, V13, P151, DOI 10.1159/000353687; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; Nicholls SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177914; Nogueira ML, 2018, ALZHEIMERS DEMENT, V14, P444, DOI 10.1016/j.jalz.2017.11.003; Oliver JM, 2019, J NEUROSURG, V130, P1655, DOI 10.3171/2017.12.JNS172035; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pedersen JT, 2015, TRENDS MOL MED, V21, P394, DOI 10.1016/j.molmed.2015.03.003; Reyes JF, 2012, ACTA NEUROPATHOL, V123, P119, DOI 10.1007/s00401-011-0898-8; Riederer P, 2017, J NEURAL TRANSM, V124, P1431, DOI 10.1007/s00702-017-1763-2; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Rosenmann H, 2013, CURR ALZHEIMER RES, V10, P217, DOI 10.2174/1567205011310030001; RUDELLI R, 1982, ARCH NEUROL-CHICAGO, V39, P570, DOI 10.1001/archneur.1982.00510210040009; SAMUEL W, 1994, NEUROLOGY, V44, P2081, DOI 10.1212/WNL.44.11.2081; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schmidt JD, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4231; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Thal Dietmar Rudolf, 2004, Sci Aging Knowledge Environ, V2004, ppe26; Vana L, 2011, AM J PATHOL, V179, P2533, DOI 10.1016/j.ajpath.2011.07.044; Vythilingam M, 2005, PSYCHIAT RES-NEUROIM, V139, P89, DOI 10.1016/j.pscychresns.2005.04.003; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Webb NE, 2014, NEUROREHABILITATION, V34, P625, DOI 10.3233/NRE-141074; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274; Wortzel HS, 2010, J AM ACAD PSYCHIATRY, V38, P407; Young NH, 2008, PLOS MED, V5, P1186, DOI 10.1371/journal.pmed.0050168; Ziontz J, 2019, ALZH DEMENT-DADM, V11, P637, DOI 10.1016/j.dadm.2019.07.007; Zwan MD, 2014, Q J NUCL MED MOL IM, V58, P398	110	2	2	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	DEC 12	2019	7	1							207	10.1186/s40478-019-0861-9			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JW0SH	WOS:000502769200001	31831066	gold, Green Published			2022-02-06	
J	Chung, AW; Mannix, R; Feldman, HA; Grant, PE; Im, K				Chung, Ai Wern; Mannix, Rebekah; Feldman, Henry A.; Grant, P. Ellen; Im, Kiho			Longitudinal structural connectomic and rich-club analysis in adolescent mTBI reveals persistent, distributed brain alterations acutely through to one year post-injury	SCIENTIFIC REPORTS			English	Article							DIFFUSION MRI; INJURY; ORGANIZATION; CHILDREN; CONNECTIVITY; REPRODUCIBILITY; NETWORKS; DYNAMICS; MODELS; STRAIN	The diffuse nature of mild traumatic brain injury (mTBI) impacts brain white-matter pathways with potentially long-term consequences, even after initial symptoms have resolved. To understand post-mTBI recovery in adolescents, longitudinal studies are needed to determine the interplay between highly individualised recovery trajectories and ongoing development. To capture the distributed nature of mTBI and recovery, we employ connectomes to probe the brain's structural organisation. We present a diffusion MRI study on adolescent mTBI subjects scanned one day, two weeks and one year after injury with controls. Longitudinal global network changes over time suggests an altered and more 'diffuse' network topology post-injury (specifically lower transitivity and global efficiency). Stratifying the connectome by its back-bone, known as the 'rich-club', these network changes were driven by the 'peripheral' local subnetwork by way of increased network density, fractional anisotropy and decreased diffusivities. This increased structural integrity of the local subnetwork may be to compensate for an injured network, or it may be robust to mTBI and is exhibiting a normal developmental trend. The rich-club also revealed lower diffusivities over time with controls, potentially indicative of longer-term structural ramifications. Our results show evolving, diffuse alterations in adolescent mTBI connectomes beginning acutely and continuing to one year.	[Chung, Ai Wern; Grant, P. Ellen; Im, Kiho] Harvard Med Sch, Boston Childrens Hosp, Div Newborn Med, Fetal Neonatal Neuroimaging & Dev Sci Ctr, Boston, MA 02115 USA; [Mannix, Rebekah] Harvard Med Sch, Boston Childrens Hosp, Brain Injury Ctr, Div Emergency Med, Boston, MA 02115 USA; [Feldman, Henry A.] Harvard Med Sch, Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA 02115 USA; [Feldman, Henry A.] Harvard Med Sch, Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Grant, P. Ellen] Harvard Med Sch, Boston Childrens Hosp, Dept Radiol, Neuroradiol Div, Boston, MA 02115 USA		Chung, AW; Im, K (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Newborn Med, Fetal Neonatal Neuroimaging & Dev Sci Ctr, Boston, MA 02115 USA.	aiwern.chung@childrens.harvard.edu; kiho.im@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020	Chung, Ai Wern/0000-0002-0905-6698	Harvard Catalyst; American Heart AssociationAmerican Heart Association; Children's Heart Foundation [19POST34880005]	The authors wish to thank the families that participated and our colleagues at Boston Children's Hospital for their help. This study was partially funded by the Harvard Catalyst, and the American Heart Association and Children's Heart Foundation 19POST34880005.	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Antonakakis M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00416; Ball G, 2014, P NATL ACAD SCI USA, V111, P7456, DOI 10.1073/pnas.1324118111; Baumann PS, 2012, PSYCHIAT RES-NEUROIM, V201, P144, DOI 10.1016/j.pscychresns.2011.08.003; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chung Ai Wern, 2019, Connectomics in NeuroImaging. Third International Workshop, CNI 2019. Held in Conjunction with MICCAI 2019. Proceedings. Lecture Notes in Computer Science (LNCS 11848), P126, DOI 10.1007/978-3-030-32391-2_13; Chung AW, 2016, NEUROIMAGE, V141, P490, DOI 10.1016/j.neuroimage.2016.07.006; Chung AW, 2016, HUM BRAIN MAPP, V37, P4550, DOI 10.1002/hbm.23328; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Collin G, 2016, SCHIZOPHR RES, V173, P166, DOI 10.1016/j.schres.2015.03.012; Collin G., 2013, Society for Neuroscience Abstract Viewer and Itinerary Planner, V43, DOI 10.1093/schbul/sbt162; Collin G, 2014, CEREB CORTEX, V24, P2258, DOI 10.1093/cercor/bht064; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Csermely P, 2013, J COMPLEX NETW, V1, P93, DOI 10.1093/comnet/cnt016; Daianu M, 2015, HUM BRAIN MAPP, V36, P3087, DOI 10.1002/hbm.22830; de Reus MA, 2013, J NEUROSCI, V33, P12929, DOI 10.1523/JNEUROSCI.1448-13.2013; Dennis EL, 2017, CHILD NERV SYST, V33, P1683, DOI 10.1007/s00381-017-3522-y; Dudink J, 2008, AM J NEURORADIOL, V29, P1966, DOI 10.3174/ajnr.A1241; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Grayson DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088297; Griffa A, 2018, DIALOGUES CLIN NEURO, V20, P121; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Maier-Hein KH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01285-x; Markett S, 2017, CEREB CORTEX, V27, P2166, DOI 10.1093/cercor/bhw059; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Meyer EJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00556; Muscoloni A., 2017, ARXIV170403526; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Richmond S, 2016, NEUROSCI BIOBEHAV R, V71, P215, DOI 10.1016/j.neubiorev.2016.08.024; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schirmer Markus D., 2019, Connectomics in NeuroImaging. Third International Workshop, CNI 2019. Held in Conjunction with MICCAI 2019. Proceedings. Lecture Notes in Computer Science (LNCS 11848), P54, DOI 10.1007/978-3-030-32391-2_6; Schirmer MD, 2019, NETW NEUROSCI, V3, P792, DOI 10.1162/netn_a_00081; Schirmer MD, 2018, LECT NOTES COMPUT SC, V11083, P136, DOI 10.1007/978-3-030-00755-3_15; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Tamnes CK, 2018, DEV COGN NEUROS-NETH, V33, P161, DOI 10.1016/j.dcn.2017.12.002; Tisdall MD, 2012, MAGN RESON MED, V68, P389, DOI 10.1002/mrm.23228; Van Beek L, 2015, BRAIN INJURY, V29, P1701, DOI 10.3109/02699052.2015.1075172; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Verhelst H, 2018, HUM BRAIN MAPP, V39, P2800, DOI 10.1002/hbm.24041; Wang R, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS I-V, CONFERENCE PROCEEDINGS, P372, DOI 10.1109/ICMA.2007.4303571; Welton T, 2015, BRAIN CONNECT, V5, P193, DOI 10.1089/brain.2014.0313; Wierenga LM, 2018, HUM BRAIN MAPP, V39, P157, DOI 10.1002/hbm.23833; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zalesky A, 2016, NEUROIMAGE, V142, P397, DOI 10.1016/j.neuroimage.2016.06.035; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	71	2	2	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	DEC 11	2019	9								18833	10.1038/s41598-019-54950-0			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JV8KZ	WOS:000502610200001	31827105	Green Published, gold, Green Submitted			2022-02-06	
J	Sekely, A; Xie, YM; Makani, A; Brown, T; Zakzanis, KK				Sekely, Angela; Xie, Yimin; Makani, Aalim; Brown, Tyler; Zakzanis, Konstantine K.			Spiritual Well-Being as a Predictor of Emotional Impairment Following Mild Traumatic Brain Injury	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						Mild traumatic brain injury; Spiritual well-being; Existential well-being; Depression; Anxiety	MENTAL-HEALTH; MAJOR DEPRESSION; RELIGION; ANXIETY; SEQUELAE; CONCEPTUALIZATION; INDIVIDUALS; DISABILITY; ATTENDANCE; COMPLAINTS	Traumatic brain injury (TBI) is a leading cause of death and disability, with injuries classified as mild in severity being the most frequently sustained. While the majority of patients recover within 3 months post-injury, many individuals continue to experience debilitating emotional sequelae several months after the injury. While spiritual well-being has been shown to carry protective benefits against both depression and anxiety in the general population, it has not been investigated as a protective factor in this population. The aim of this study was to investigate whether spiritual well-being leads to a reduction in anxious and depressive symptomatology following mild TBI (mTBI). The Beck Anxiety Inventory, Beck Depression Inventory-II, and Spiritual Well-Being Scale were administered to a sample of 83 litigating examinees who had undergone neuropsychological testing to assess their present functioning secondary to mTBI. The existential well-being (EWB) subscale significantly predicted depressive symptomatology. These findings support the role of EWB as contributory factor related to depressive symptomatology following mTBI. Rehabilitation practitioners should consider treatment paradigms that address EWB as a primary contributor to reduce depressive symptomatology, which may ultimately lead to improved functional ability.	[Sekely, Angela; Zakzanis, Konstantine K.] Univ Toronto, Grad Dept Psychol Clin Sci, Toronto, ON, Canada; [Xie, Yimin; Makani, Aalim; Brown, Tyler; Zakzanis, Konstantine K.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Sekely, Angela] Univ Toronto Scarborough, 1265 Mil Trail SY171, Toronto, ON M1C 1A4, Canada		Sekely, A (corresponding author), Univ Toronto, Grad Dept Psychol Clin Sci, Toronto, ON, Canada.; Sekely, A (corresponding author), Univ Toronto Scarborough, 1265 Mil Trail SY171, Toronto, ON M1C 1A4, Canada.	angie.sekely@mail.utoronto.ca		Sekely, Angela/0000-0002-5823-4294			Agorastos A, 2014, PSYCHOL RES BEHAV MA, V7, P93, DOI 10.2147/PRBM.S43666; Army Individual Test Battery, 1944, MAN DIR SCOR; Balbuena L, 2013, CAN J PSYCHIAT, V58, P225, DOI 10.1177/070674371305800408; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1993, BECK ANXIETY INVENTO; Bekelman DB, 2007, J GEN INTERN MED, V22, P470, DOI 10.1007/s11606-006-0044-9; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cohen D, 2009, INT J PSYCHOL RELIG, V19, P121, DOI 10.1080/10508610802711335; Corp IBM, 2016, IBM SPSS STAT WIND V; ELLISON CW, 1983, J PSYCHOL THEOL, V11, P330, DOI 10.1177/009164718301100406; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEHRING RJ, 1987, RES NURS HEALTH, V10, P391, DOI 10.1002/nur.4770100607; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Frankl V, 1992, TEORIA TERAPIA NEURO; Genia V., 2001, INT J PSYCHOL RELIG, V11, P25, DOI DOI 10.1207/S15327582IJPR1101_03; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hill P. C., 2013, APA HDB PSYCHOL RELI, V1, P51, DOI [10.1037/14045-003, DOI 10.1037/14045-003]; Hill PC, 2003, AM PSYCHOL, V58, P64, DOI 10.1037/0003-066X.58.1.64; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnstone B, 2007, DISABIL REHABIL, V29, P1153, DOI 10.1080/09638280600955693; Koenig HG, 2009, CAN J PSYCHIAT, V54, P283, DOI 10.1177/070674370905400502; Koenig HaroldG., 2001, HDB RELIG HLTH; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kuhner C, 2007, NERVENARZT, V78, P651, DOI 10.1007/s00115-006-2098-7; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Maselko J, 2009, PSYCHOL MED, V39, P1009, DOI 10.1017/S0033291708004418; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McClain CS, 2003, LANCET, V361, P1603, DOI 10.1016/S0140-6736(03)13310-7; Mela MA, 2008, MENT HEALTH RELIG CU, V11, P517, DOI 10.1080/13674670701584847; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Perlman, 1982, LONELINESS SOURCEBOO; Portnoff L, 2017, SPIRITUAL CLIN PRACT, V4, P22, DOI 10.1037/scp0000127; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; REITAN R M, 1955, AMA Arch Neurol Psychiatry, V73, P28; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shiah YJ, 2015, J RELIG HEALTH, V54, P35, DOI 10.1007/s10943-013-9781-3; Shreve-Neiger AK, 2004, CLIN PSYCHOL REV, V24, P379, DOI 10.1016/j.cpr.2004.02.003; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Tombaugh T.N., 1996, TEST MEMORY MALINGER; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Waldron-Perrine B, 2011, REHABIL PSYCHOL, V56, P107, DOI 10.1037/a0023552; Wolfson, 1993, HALSTEAD REITAN NEUR	54	2	2	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9583	1573-3572		J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	DEC	2020	27	4					859	866		10.1007/s10880-019-09687-3		DEC 2019	8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	OP2HA	WOS:000574651400001	31813099				2022-02-06	
J	Li, KC; Tam, CWY; Shum, HP; Yan, WW				Li, Kin Chio; Tam, Catherine Wing Yan; Shum, Hoi-Ping; Yan, Wing Wa			Impact of Hyperoxia and Hypocapnia on Neurological Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage: A Retrospective Study	CRITICAL CARE RESEARCH AND PRACTICE			English	Article							DELAYED CEREBRAL-ISCHEMIA; SPONTANEOUS HYPERVENTILATION; HEAD-INJURY; ASSOCIATION; MANAGEMENT	In recent decades, there is increasing evidence suggesting that hyperoxia and hypocapnia are associated with poor outcomes in critically ill patients with cardiac arrest or traumatic brain injury. Yet, the impact of hyperoxia and hypocapnia on neurological outcome in patients with subarachnoid hemorrhage (SAH) has not been well studied. In the present study, we evaluated the impact of hyperoxia and hypocapnia on neurological outcomes in patients with aneurysmal SAH (aSAH). Patients with aSAH who were admitted to the intensive care unit (ICU) of a tertiary hospital in Hong Kong between January 2011 and December 2016 were retrospectively recruited. Patients' demographics, comorbidities, radiological findings, clinical grades of SAH, PO2, and PCO2 within 24 hours of ICU admission, and Glasgow Outcome Scale (GOS) at 3 months after admission were recorded. Patients with a GOS score of 3 or less were considered having poor neurological outcomes. Among the 244 patients with aSAH, 122 of them (50%) had poor neurological outcomes at 3 months. Early hyperoxia (PO2 > 200 mmHg) and hypercapnia (PCO2 > 45 mmHg) were more common among patients with poor neurological outcomes. Logistic regression analysis indicated that hyperoxia independently predicted poor neurological outcomes (OR 3.788, 95% CI 1.131-12.690, P=0.031). Classification tree analysis revealed that hypocapnia was associated with poor neurological outcomes in patients who were less critically ill (APACHE < 50) and without concomitant intracranial hemorrhage (ICH) or intraventricular hemorrhage (IVH) (adjusted P=0.006, chi(2) = 7.452). These findings suggested that hyperoxia and hypocapnia may be associated with poor neurological outcomes in patients with aSAH.	[Li, Kin Chio; Shum, Hoi-Ping; Yan, Wing Wa] Pamela Youde Nethersole Eastern Hosp, Dept Intens Care, Chai Wan, 3 Lok Man Rd, Hong Kong, Peoples R China; [Tam, Catherine Wing Yan] North Dist Hosp, Dept Radiol, Sheung Shui, 9 Po Kin Rd, Hong Kong, Peoples R China		Li, KC (corresponding author), Pamela Youde Nethersole Eastern Hosp, Dept Intens Care, Chai Wan, 3 Lok Man Rd, Hong Kong, Peoples R China.	jli.jacky@gmail.com		Shum, Hoi Ping/0000-0001-7002-3548; YAN, WING WA/0000-0003-1257-715X; Li, Kin Chio/0000-0002-9528-2906			Abla AA, 2014, J NEUROSURG, V120, P391, DOI 10.3171/2013.10.JNS13419; Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Attaye I, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0135-4; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Buonocore G, 2010, SEMIN FETAL NEONAT M, V15, P186, DOI 10.1016/j.siny.2010.04.003; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carrera E, 2010, J NEUROL NEUROSUR PS, V81, P793, DOI 10.1136/jnnp.2009.174425; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Detsky AS, 1997, MED DECIS MAKING, V17, P123, DOI 10.1177/0272989X9701700201; Esposito E, 2013, EXP NEUROL, V249, P33, DOI 10.1016/j.expneurol.2013.08.005; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Jeon SB, 2014, J NEUROL NEUROSUR PS, V85, P1301, DOI 10.1136/jnnp-2013-307314; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Lang M, 2016, NEUROSURGERY, V78, P540, DOI 10.1227/NEU.0000000000001111; Lindgren A, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003085.pub3; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Samra SK, 2007, STROKE, V38, P1864, DOI 10.1161/STROKEAHA.106.477448; Shin HK, 2014, J NEUROSCI, V34, P15200, DOI 10.1523/JNEUROSCI.1110-14.2014; Westermaier T, 2014, J NEUROSURG, V121, P1056, DOI 10.3171/2014.7.JNS132611; Williamson CA, 2015, NEUROCRIT CARE, V23, P330, DOI 10.1007/s12028-015-0138-5; Wong GKC, 2014, WORLD NEUROSURG, V81, P552, DOI 10.1016/j.wneu.2013.07.128; Yokoyama S, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0353-1; Yokoyama S, 2019, SHOCK, V51, P593, DOI 10.1097/SHK.0000000000001221	26	2	2	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-1305	2090-1313		CRIT CARE RES PRACT	Crit. Care Res. Pract.	DEC 6	2019	2019								7584573	10.1155/2019/7584573			8	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JX1BH	WOS:000503477400001	31885915	Green Published, gold			2022-02-06	
J	Zahabi, M; Park, J; Razak, AMA; McDonald, AD				Zahabi, Maryam; Park, Junho; Razak, Ashiq Mohammed Abdul; McDonald, Anthony D.			Adaptive driving simulation-based training: framework, status, and needs	THEORETICAL ISSUES IN ERGONOMICS SCIENCE			English	Article						Adaptive training; driving simulator; performance; learning; safety	INTELLIGENT TUTORING SYSTEMS; TRAUMATIC BRAIN-INJURY; LEARNING-SYSTEM; COGNITIVE LOAD; PERFORMANCE; DRIVERS; IMPACT; FEEDBACK; AUTOMATION; EVALUATE	Motor vehicle crashes are the major cause of deaths in the United States. Conventional driving training approaches including classroom education, vehicle owner manuals, training videos, on-the-road skill training, and non-adaptive driving simulation-based training have limited effect on crash and traffic violation reduction. The objectives of this research were to: (1) develop a framework for adaptive driving simulation-based training (ADST); (2) review the recent advances in ADST; (3) provide recommendations to improve adaptive training in this area; and (4) identify the domains that can benefit from ADST. A systematic literature search was conducted using Compendex, Web of Science, and Google Scholar databases to find relevant research published since 2000. Results indicated that the ADST framework consists of three components including performance measures, adaptive logic, and adaptive variables. Adaptations can occur on the training content and/or feedback and prior (i.e., parametering) or during the training session (i.e., dynamic adaptation). Based on the developed framework and literature review, a set of guidelines was provided to improve ADST along with some specific domains that can benefit from this approach. Finally, recommendations were provided to evaluate ADST effectiveness and transfer of knowledge in future.	[Zahabi, Maryam; Park, Junho; Razak, Ashiq Mohammed Abdul; McDonald, Anthony D.] Texas A&M Univ, Ind & Syst Engn, College Stn, TX 77843 USA		Zahabi, M (corresponding author), Texas A&M Univ, Ind & Syst Engn Dept, Emerging Technol Bldg, College Stn, TX 77843 USA.	mzahabi@tamu.edu		McDonald, Anthony/0000-0001-7827-8828; Park, Junho/0000-0001-6348-3765			Akinwuntan AE, 2005, NEUROLOGY, V65, P843, DOI 10.1212/01.wnl.0000171749.71919.fa; Anderson GS, 2005, POLICE PRACT RES, V6, P39, DOI 10.1080/15614260500047119; BALDWIN TT, 1988, PERS PSYCHOL, V41, P63, DOI 10.1111/j.1744-6570.1988.tb00632.x; Beck JG, 2007, BEHAV THER, V38, P39, DOI 10.1016/j.beth.2006.04.001; Bergeron B, 2019, MIL MED, V184, P579, DOI 10.1093/milmed/usy372; Best A. M., 2014, SYSTEM METHOD APPARA; Bian D, 2016, INT C UN ACC HUM COM; Blanco M., 2011, COMMERCIAL DRIVER; Branson R., 1975, INTERSERVICE PROCEDU; Brawner Keith, 2017, International Journal of Simulation and Process Modelling, V12, P300; Burkhardt JM, 2016, IFAC PAPERSONLINE, V49, P66, DOI 10.1016/j.ifacol.2016.12.191; Cabestrero R, 2018, BEHAV INFORM TECHNOL, V37, P1252, DOI 10.1080/0144929X.2018.1499803; CANNONBOWERS JA, 1995, MIL PSYCHOL, V7, P141, DOI 10.1207/s15327876mp0703_1; Chou CY, 2015, COMPUT EDUC, V88, P215, DOI 10.1016/j.compedu.2015.05.007; Christie R., 2001, ROAD SAF RES POL ED; Cox DJ, 2017, J AUTISM DEV DISORD, V47, P2544, DOI 10.1007/s10803-017-3164-7; Cox DJ, 2010, MIL MED, V175, P411, DOI 10.7205/MILMED-D-09-00081; Cuenen A, 2016, TRANSPORT RES F-TRAF, V42, P15, DOI 10.1016/j.trf.2016.06.012; Custalow Catherine B, 2004, Prehosp Emerg Care, V8, P175, DOI 10.1016/S1090-3127(03)00279-X; Feidakis M., 2016, REV EMOTION AWARE SY, P217; Forster Y, 2019, MULTIMODAL TECHNOLOG, V3, DOI 10.3390/mti3020029; Gerbaud S, 2009, LECT NOTES COMPUT SC, V5670, P316, DOI 10.1007/978-3-642-03364-3_40; Gold C, 2018, ACCIDENT ANAL PREV, V116, P3, DOI 10.1016/j.aap.2017.11.009; Goldberg B, 2018, INT J ARTIF INTELL E, V28, P194, DOI 10.1007/s40593-017-0155-y; Gwak J, 2018, IEEE INT C INTELL TR, P1794, DOI 10.1109/ITSC.2018.8569493; Hembroff CC, 2018, TRANSPORT RES F-TRAF, V59, P222, DOI 10.1016/j.trf.2018.08.019; Hergeth S, 2017, HUM FACTORS, V59, P457, DOI 10.1177/0018720816678714; Holding D. H., 2013, PRINCIPLES TRAINING; Houa M, 2017, THEOR ISS ERGON SCI, V18, P167, DOI 10.1080/1463922X.2016.1166405; Hu SY, 2009, EXPERT SYST APPL, V36, P7651, DOI 10.1016/j.eswa.2008.09.030; James SM, 2015, POLICING, V38, P517, DOI 10.1108/PIJPSM-03-2015-0033; Jones N, 2016, BIOL SPORT, V33, P117, DOI 10.5604/20831862.1198210; Kahn C A, 2001, Prehosp Emerg Care, V5, P261, DOI 10.1080/10903120190939751; Kalyuga S., 2009, EXPERTISE REVERSAL E, P58; Kandadai V., 2015, LIVEMETRICS PROVIDIN; KELLEY CR, 1969, HUM FACTORS, V11, P547, DOI 10.1177/001872086901100602; Kirkpatrick D. L., 1976, EVALUATION TRAINING, P1; Knowles M., 1990, ADULT LEARNER NEGLEC; Koustanai A, 2012, HUM FACTORS, V54, P709, DOI 10.1177/0018720812441796; Landsberg CR, 2012, MIL PSYCHOL, V24, P96, DOI 10.1080/08995605.2012.672903; Lang YN, 2018, 25TH 2018 IEEE CONFERENCE ON VIRTUAL REALITY AND 3D USER INTERFACES (VR), P297, DOI 10.1109/VR.2018.8448290; Lau M. Y., 2016, DRIVING PERFORMANCE; Lee JD, 2004, HUM FACTORS, V46, P50, DOI 10.1518/hfes.46.1.50.30392; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; LINTERN G, 1978, INT J MAN MACH STUD, V10, P521, DOI 10.1016/S0020-7373(78)80018-2; Liu TC, 2016, IEEE T INTELL TRANSP, V17, P1108, DOI 10.1109/TITS.2015.2496157; Lopez-Garate M., 2008, P 7 INT JOINT C AUT, V3; Louw T, 2017, ACCIDENT ANAL PREV, V108, P9, DOI 10.1016/j.aap.2017.08.011; Malik H, 2015, IEEE T INTELL TRANSP, V16, P1728, DOI 10.1109/TITS.2014.2371061; Mariani Andrea, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P2162, DOI 10.1109/EMBC.2018.8512728; McDonald AD, 2020, HUM FACTORS, V62, P1019, DOI 10.1177/0018720819856454; McDonald AD, 2019, HUM FACTORS, V61, P642, DOI 10.1177/0018720819829572; McGinley j, 2013, INVESTIGATING IMPACT; Michon J. A., 1985, HUMAN BEHAV TRAFFIC, P485, DOI [DOI 10.1007/978-1-4613-2173-6_19, 10.1007/978-1-4613-2173-6_19]; Miletto E., 2005, ORGAN SOUND, V10, P243, DOI [10.1017/S1355771805000981, DOI 10.1017/S1355771805000981]; Mnih V., 2013, ARXIV PREPRINT ARXIV, DOI DOI 10.1038/NATURE14236; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Mugford R, 2013, POLICING, V36, P312, DOI 10.1108/13639511311329723; NLEMF, 2018, CAUS LAW ENF DEATHS; NLEOMF, 2018, PREL LAW ENF OFF FAT; NSC, 2019, PREL EST; NWANA HS, 1990, ARTIF INTELL REV, V4, P251; Oskarsson P.-A., 2010, P HUM FACT ERG SOC A; Payre W, 2017, TRANSPORT RES F-TRAF, V46, P216, DOI 10.1016/j.trf.2017.02.001; Payre W, 2016, HUM FACTORS, V58, P229, DOI 10.1177/0018720815612319; Peck RC, 2011, IATSS RES, V34, P63, DOI 10.1016/j.iatssr.2011.01.001; Peretz C, 2011, NEUROEPIDEMIOLOGY, V36, P91, DOI 10.1159/000323950; Petzoldt T, 2013, ACCIDENT ANAL PREV, V50, P1185, DOI 10.1016/j.aap.2012.09.016; Popovic S, 2009, STRESS INOCULATION T; Pozueco L, 2017, IET INTELL TRANSP SY, V11, P196, DOI 10.1049/iet-its.2016.0079; Pozueco L, 2015, INT CONF COMP INFO; Pradhan AK, 2006, TRANSPORT RES REC, P58, DOI 10.3141/1969-10; Rionda Abel, 2012, IEEE-RITA Latin American Learning Technologies Journal, V7, P133; Rionda A, 2014, COMPUT EDUC, V78, P124, DOI 10.1016/j.compedu.2014.05.008; Ritter F. E., 2013, LEARNING RETENTION O, P125; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Ropelato S., 2017, P AIVRAR BANGK; ROSSOL N, 2011, P 10 INT C VIRT REAL, P343; Salas E., 2006, HDB HUMAN FACTORS ER, P472, DOI DOI 10.1002/0470048204; Sarasin LC, 1999, LEARNING STYLE PERSP; Savolainen P.T., 2009, INVESTIGATION EMERGE; Serge SR, 2013, COMPUT HUM BEHAV, V29, P1150, DOI 10.1016/j.chb.2012.10.007; Singh H., 2011, HDB DRIVING SIMULATI, P1; Skinner A, 2018, INT J STEM EDUC, V5, DOI 10.1186/s40594-018-0108-5; Sottilare R. A., 2018, C INT ERG ASS; Spain RD, 2012, MIL PSYCHOL, V24, P87, DOI 10.1080/08995605.2012.676984; Staff, 2018, 2017 TRAIN IND REP; SWELLER J, 1988, COGNITIVE SCI, V12, P257, DOI 10.1207/s15516709cog1202_4; Thayer P.W., 1995, CLIMATE TRANSFER MOD; Toh, 2015, P ELM 2014, V4, P389, DOI [10.1007/978-3-319-14066-7_37, DOI 10.1007/978-3-319-14066-7_37]; Tomasevic N., 2000, J CONSULT CLIN PSYCH, V1, P1020; van Amelsvoort M, 2013, COMPUT HUM BEHAV, V29, P654, DOI 10.1016/j.chb.2012.10.016; van Gent P, 2018, TRANSPORT RES REC, V2672, P141, DOI 10.1177/0361198118790372; VanLehn K, 2011, EDUC PSYCHOL-US, V46, P197, DOI 10.1080/00461520.2011.611369; Victor TW, 2018, HUM FACTORS, V60, P1095, DOI 10.1177/0018720818788164; Wade J, 2017, J AUTISM DEV DISORD, V47, P3405, DOI 10.1007/s10803-017-3261-7; Weevers I., 2003, STUDENT ADAPTIVE SYS; Westerfield G, 2015, INT J ARTIF INTELL E, V25, P157, DOI 10.1007/s40593-014-0032-x; White MM, 2017, IEEE T HUM-MACH SYST, V47, P1146, DOI 10.1109/THMS.2017.2759762; Wickens C. D., 2017, DESIGNING PEOPLE INT; Yaghmaie M, 2011, EXPERT SYST APPL, V38, P3280, DOI 10.1016/j.eswa.2010.08.113; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Zahabi M, 2018, APPL ERGON, V67, P26, DOI 10.1016/j.apergo.2017.09.006; Zahabi M, 2018, APPL ERGON, V66, P161, DOI 10.1016/j.apergo.2017.08.013	104	2	2	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1463-922X	1464-536X		THEOR ISS ERGON SCI	Theor. Iss. Ergon. Sci.	SEP 2	2020	21	5					537	561		10.1080/1463922X.2019.1698673		DEC 2019	25	Ergonomics	Emerging Sources Citation Index (ESCI)	Engineering	MZ5UP	WOS:000501539600001					2022-02-06	
J	Bouras, M; Roquilly, A; Mahe, PJ; Cinotti, R; Vourc'h, M; Perrot, B; Bach-Ngohou, K; Masson, D; Asehnoune, K				Bouras, Marwan; Roquilly, Antoine; Mahe, Pierre-Joachim; Cinotti, Raphael; Vourc'h, Mickael; Perrot, Bastien; Bach-Ngohou, Kalyane; Masson, Damien; Asehnoune, Karim			Cortisol total/CRP ratio for the prediction of hospital-acquired pneumonia and initiation of corticosteroid therapy in traumatic brain-injured patients	CRITICAL CARE			English	Article						Traumatic; Brain; Injury; Pneumonia; Cortisol; CRP; Corticosteroid; Biomarkers	C-REACTIVE PROTEIN; INFLAMMATORY RESPONSE; SEPTIC SHOCK; DOUBLE-BLIND; HEAD-INJURY; MANAGEMENT; HYDROCORTISONE; GUIDELINES; IMMUNOSUPPRESSION; INTERLEUKIN-6	Background: To propose a combination of blood biomarkers for the prediction of hospital-acquired pneumonia (HAP) and for the selection of traumatic brain-injured (TBI) patients eligible for corticosteroid therapy for the prevention of HAP. Methods: This was a sub-study of the CORTI-TC trial, a multicenter, randomized, double-blind, controlled trial evaluating the risk of HAP at day 28 in 336 TBI patients treated or not with corticosteroid therapy. Patients were between 15 and 65 years with severe traumatic brain injury (Glasgow coma scale score <= 8 and trauma-associated lesion on brain CT scan) and were enrolled within 24 h of trauma. The blood levels of CRP and cortisol(total&free), as a surrogate marker of the pro/anti-inflammatory response balance, were measured in samples collected before the treatment initiation. Endpoint was HAP on day 28. Results: Of the 179 patients with available samples, 89 (49.7%) developed an HAP. Cortisol(total&free) and CRP blood levels upon ICU admission were not significantly different between patients with or without HAP. The cortisol(total/CRP) ratio upon admission was 2.30 [1.25-3.91] in patients without HAP and 3.36 [1.74-5.09] in patients with HAP (p = 0.021). In multivariate analysis, a cortisol(total/CRP) ratio > 3, selected upon the best Youden index on the ROC curve, was independently associated with HAP (OR 2.50, CI95% [1.34-4.64] p = 0.004). The HR for HAP with corticosteroid treatment was 0.59 (CI95% [0.34-1.00], p = 0.005) in patients with a cortisol(total/CRP) ratio > 3, and 0.89 (CI95% [0.49-1.64], p = 0.85) in patients with a ratio < 3. Conclusion: A cortisol(total/CRP) ratio > 3 upon admission may predict the development of HAP in severe TBI. Among these patients, corticosteroids reduce the occurrence HAP. We suggest that this ratio may select the patients who may benefit from corticosteroid therapy for the prevention of HAP.	[Bouras, Marwan; Roquilly, Antoine; Mahe, Pierre-Joachim; Cinotti, Raphael; Vourc'h, Mickael; Asehnoune, Karim] Univ Hosp Nantes, Hotel Dieu, Surg Intens Care Unit, F-44093 Nantes, France; [Bouras, Marwan; Roquilly, Antoine; Vourc'h, Mickael; Asehnoune, Karim] Med Univ Nantes, Inst Rech Sante 2 Nantes Biotech, EA3826 Therapeut Antiinfect, F-44000 Nantes, France; [Perrot, Bastien] Nantes Univ, UMR S 1246 Methods Patient Ctr Outcomes & Hlth Re, F-44000 Nantes, France; [Bach-Ngohou, Kalyane; Masson, Damien] Univ Hosp Nantes, UMR INSERM 1235, Biochem Lab, F-44093 Nantes, France; [Asehnoune, Karim] Univ Hosp Nantes, Hotel Dieu, Dept Anesthesia & Crit Care, 1 Pl Alexis Ricordeau, F-44093 Nantes 9, France		Asehnoune, K (corresponding author), Univ Hosp Nantes, Hotel Dieu, Surg Intens Care Unit, F-44093 Nantes, France.; Asehnoune, K (corresponding author), Med Univ Nantes, Inst Rech Sante 2 Nantes Biotech, EA3826 Therapeut Antiinfect, F-44000 Nantes, France.	karim.asehnoune@chu-nantes.fr		VOURC'H, Mickael/0000-0002-1576-7728; Perrot, Bastien/0000-0002-3701-6693	French Society of Anesthesiology and Intensive care (SFAR)	The French Society of Anesthesiology and Intensive care (SFAR) and institutional funds.	Aisiku IP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1470-7; Alcon A, 2005, CLIN CHEST MED, V26, P39, DOI 10.1016/j.ccm.2004.10.013; Annane D, 2017, INTENS CARE MED, V43, P1751, DOI 10.1007/s00134-017-4919-5; Asehnoune K, 2017, INTENS CARE MED, V43, P957, DOI 10.1007/s00134-017-4764-6; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Asehnoune K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-228; Boonen E, 2013, NEW ENGL J MED, V368, P1477, DOI 10.1056/NEJMoa1214969; Bouras M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02590; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Caulfield JJ, 1999, IMMUNOLOGY, V98, P104; Cinotti R, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.08.16; Engel O, 2015, STROKE, V46, P3232, DOI 10.1161/STROKEAHA.115.008989; Fabregas N, 1996, ANESTHESIOLOGY, V84, P760, DOI 10.1097/00000542-199604000-00002; Fernandez-Serrano S, 2011, CRIT CARE, V15, DOI 10.1186/cc10103; Fujio N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167854; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; Hoover L, 2006, J TRAUMA, V61, P310, DOI 10.1097/01.ta.0000229052.75460.c2; Huang J, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014636; Jamieson AM, 2010, CELL HOST MICROBE, V7, P103, DOI 10.1016/j.chom.2010.01.010; Kahn JM, 2006, CRIT CARE MED, V34, P196, DOI 10.1097/01.CCM.0000194540.44020.8E; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; MASTORAKOS G, 1993, J CLIN ENDOCR METAB, V77, P1690, DOI 10.1210/jc.77.6.1690; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2011, NEW ENGL J MED, V365, P2134, DOI 10.1056/NEJMcibr1112454; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Mimoz O, 1998, INTENS CARE MED, V24, P185, DOI 10.1007/s001340050543; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Roquilly A, 2017, IMMUNITY, V47, P135, DOI 10.1016/j.immuni.2017.06.021; Roquilly A, 2014, CRIT CARE MED, V42, pE752, DOI 10.1097/CCM.0000000000000658; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Spruijt NE, 2010, CRIT CARE, V14, DOI 10.1186/cc9218; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; van Vught LA, 2016, AM J RESP CRIT CARE, V194, P1366, DOI 10.1164/rccm.201602-0368OC; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021	43	2	3	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	DEC 5	2019	23	1							394	10.1186/s13054-019-2680-6			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JW8GN	WOS:000503285700002	31805967	Green Published, gold			2022-02-06	
J	Cong, PF; Tong, CC; Liu, Y; Shi, L; Shi, XY; Zhao, Y; Xiao, KS; Jin, HX; Liu, YN; Hou, MX				Cong, Peifang; Tong, Changci; Liu, Ying; Shi, Lin; Shi, Xiuyun; Zhao, Yan; Xiao, Keshen; Jin, Hongxu; Liu, Yunen; Hou, Mingxiao			CD28 Deficiency Ameliorates Thoracic Blast Exposure-Induced Oxidative Stress and Apoptosis in the Brain through the PI3K/Nrf2/Keap1 Signaling Pathway	OXIDATIVE MEDICINE AND CELLULAR LONGEVITY			English	Article							T-CELLS; INJURY; NRF2; ACTIVATION; COMPLEX; PROTEIN; MECHANISMS; PREVENTION; MIGRATION; FACTOR-2	Blast exposure is a worldwide public health concern, but most related research has been focused on direct injury. Thoracic blast exposure-induced neurotrauma is a type of indirect injuries where research is lacking. As CD28 stimulates T cell activation and survival and contributes to inflammation initiation, it may play a role in thoracic blast exposure-induced neurotrauma. However, it has not been investigated. To explore the effects of CD28 on thoracic blast exposure-induced brain injury and its potential molecular mechanisms, a mouse model of thoracic blast exposure-induced brain injury was established. Fifty C57BL/6 wild-type (WT) and fifty CD28 knockout (CD28(-/-)) mice were randomly divided into five groups (one control group and four model groups), with ten mice (from each of the two models) for each group. Lung and brain tissue and serum samples were collected at 12 h, 24 h, 48 h, and 1 week after thoracic blast exposure. Histopathological changes were detected by hematoxylin-eosin staining. The expressions of inflammatory-related factors were detected by ELISA. Oxidative stress in the brain tissue was evaluated by determining the generation of reactive oxygen species (ROS) and the expressions of thioredoxin (TRX), malondialdehyde (MDA), SOD-1, and SOD-2. Apoptosis in the brain tissue was evaluated by TUNEL staining and the levels of Bax, Bcl-xL, Bad, Cytochrome C, and caspase-3. In addition, proteins of related pathways were also studied by western blotting and immunofluorescence. We found that CD28 deficiency significantly reduced thoracic blast exposure-induced histopathological changes and decreased the levels of inflammatory-related factors, including IL-1 beta, TNF-alpha, and S100 beta. In the brain tissue, CD28 deficiency also significantly attenuated thoracic blast exposure-induced generation of ROS and expressions of MDA, TRX, SOD-1, and SOD-2; lowered the number of apoptotic cells and the expression of Bax, cleaved caspase-3, Cytochrome C, and Bad; and maintained Bcl-xL expression. Additionally, CD28 deficiency significantly ameliorated thoracic blast exposure-induced increases of p-PI3K and Keap1 and the decrease of Nrf2 expression in the brain. Our results indicate that CD28 deficiency has a protective effect on thoracic blast exposure-induced brain injury that might be associated with the PI3K/Nrf2/Keap1 signaling pathway.	[Cong, Peifang; Hou, Mingxiao] Northeastern Univ, Coll Med & Biol Informat Engn, 195 Chuangxin Rd, Shenyang 110016, Liaoning, Peoples R China; [Cong, Peifang; Tong, Changci; Liu, Ying; Shi, Lin; Shi, Xiuyun; Jin, Hongxu; Liu, Yunen] Gen Hosp Northern Theater Command, Emergency Med Deptauma, Lab Rescue Ctr Severe Wound & Trauma PLA, 83 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China; [Zhao, Yan; Xiao, Keshen] Chinese Acad Sci, Inst Met Res, 72 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China		Hou, MX (corresponding author), Northeastern Univ, Coll Med & Biol Informat Engn, 195 Chuangxin Rd, Shenyang 110016, Liaoning, Peoples R China.; Liu, YN (corresponding author), Gen Hosp Northern Theater Command, Emergency Med Deptauma, Lab Rescue Ctr Severe Wound & Trauma PLA, 83 Wenhua Rd, Shenyang 110016, Liaoning, Peoples R China.	lye9901@163.com; houmingxiao188@163.com	Yunen, Liu/X-4121-2019	Tong, Changci/0000-0003-2999-7011; Cong, Peifang/0000-0003-1991-0330; Liu, Yun-en/0000-0001-8761-2402	Liaoning Province Key Scientific and Technological Project [201602774, 20170540947, 20180540045]; PLA foundation of China [CSY12J002, AWS14L008, CSY13J003]; Edanz Group China	We would like to acknowledge the funding support by the grants from the Liaoning Province Key Scientific and Technological Project (No. 201602774, No. 20170540947, and No. 20180540045) and the PLA foundation of China (No. CSY12J002, No. AWS14L008, and No. CSY13J003). We thank Jeremy Allen, PhD, from Liwen Bianji, Edanz Group China (https://www.liwenbianji.cn/ac), for editing the English text of the draft of this manuscript.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Barancik M, 2016, PHYSIOL RES, V65, pS1, DOI 10.33549/physiolres.933403; Bell Monte K, 2008, Mil Med, V173, pv; Bellezza I, 2018, BBA-MOL CELL RES, V1865, P721, DOI 10.1016/j.bbamcr.2018.02.010; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Boutten A, 2011, TRENDS MOL MED, V17, P363, DOI 10.1016/j.molmed.2011.02.006; Busl KM, 2015, CRIT CARE MED, V43, P1710, DOI 10.1097/CCM.0000000000001101; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 1991, Vojnosanit Pregl, V48, P515; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cevik S, 2019, CLIN NEUROL NEUROSUR, V183, DOI 10.1016/j.clineuro.2019.105380; Chai JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163634; Chuang CH, 2018, EUR REV MED PHARMACO, V22, P5394, DOI 10.26355/eurrev_201808_15742; Cong PF, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0748-x; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; del Pulgar TG, 2002, J BIOL CHEM, V277, P36527, DOI 10.1074/jbc.M205797200; Deng C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058371; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Golden Nyoman, 2018, Open Access Maced J Med Sci, V6, P2239, DOI 10.3889/oamjms.2018.432; Guy R J, 1998, J R Nav Med Serv, V84, P79; Guy R J, 2000, J R Nav Med Serv, V86, P27; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; Hernandez A, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0408-1; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Ke BB, 2013, J HEPATOL, V59, P1200, DOI 10.1016/j.jhep.2013.07.016; Kim KC, 2010, INT J BIOCHEM CELL B, V42, P297, DOI 10.1016/j.biocel.2009.11.009; Korenori Y, 2013, MOL NUTR FOOD RES, V57, P854, DOI 10.1002/mnfr.201200689; KUO CL, 1987, P NATL ACAD SCI USA, V84, P7614, DOI 10.1073/pnas.84.21.7614; Laurent L, 2017, EUR J IMMUNOL, V47, P1368, DOI 10.1002/eji.201746923; Li H, 2016, SCI REP-UK, V6, DOI 10.1038/srep23693; Liu SK, 1998, ONCOGENE, V17, P3073, DOI 10.1038/sj.onc.1202337; Liu Y, 2020, BMJ MILITARY HEALTH, V166, pE66, DOI 10.1136/jramc-2019-001181; Liu YE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192135; Loo DT, 2011, METHODS MOL BIOL, V682, P3, DOI 10.1007/978-1-60327-409-8_1; Macal M, 2016, J IMMUNOL, V196, P1900, DOI 10.4049/jimmunol.1501658; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Masuda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131012; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Mirzoeva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101161; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Porritt MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041090; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Retamal J, 2018, CRIT CARE MED, V46, pE591, DOI 10.1097/CCM.0000000000003072; Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536; Ryu MJ, 2014, IN VITRO CELL DEV-AN, V50, P549, DOI 10.1007/s11626-014-9735-4; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schmidt J, 2003, J NEUROIMMUNOL, V140, P143, DOI 10.1016/S0165-5728(03)00182-6; SCHNEIDER H, 1995, EUR J IMMUNOL, V25, P1044, DOI 10.1002/eji.1830250428; Sedy J, 2015, J NEUROTRAUM, V32, P1135, DOI 10.1089/neu.2014.3609; Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016; Shelton LM, 2013, KIDNEY INT, V84, P1090, DOI 10.1038/ki.2013.248; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Singh TP, 2014, J INVEST DERMATOL, V134, P861, DOI 10.1038/jid.2013.397; Sun B, 2018, MED SCI MONITOR, V24, P6422, DOI 10.12659/MSM.909221; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Tada Y, 1999, J IMMUNOL, V162, P203; Tsokos M, 2003, AM J RESP CRIT CARE, V168, P549, DOI 10.1164/rccm.200304-528OC; Wang Y, 2018, MED SCI MONITOR, V24, P3604, DOI 10.12659/MSM.910245; Wen ZM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8678267; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Wu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059843; Xu JJ, 2014, J NEUROTRAUM, V31, P1343, DOI 10.1089/neu.2013.3222; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Zhao X, 2012, AM J TRANSPLANT, V12, P90, DOI 10.1111/j.1600-6143.2011.03770.x; Zhou QM, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0453-3; Zhuang RJ, 2017, J MOL NEUROSCI, V63, P142, DOI 10.1007/s12031-017-0964-3; Zinter MS, 2017, CRIT CARE MED, V45, P858, DOI 10.1097/CCM.0000000000002370	73	2	2	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1942-0900	1942-0994		OXID MED CELL LONGEV	Oxidative Med. Cell. Longev.	DEC 4	2019	2019								8460290	10.1155/2019/8460290			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	JX5MQ	WOS:000503779300005	31885821	Green Published, gold			2022-02-06	
J	He, Y; Wang, L; Ou, YB; Wang, HP; Wang, S; Zhang, P; He, XB; Gou, DS				He, Yue; Wang, Ling; Ou, Yibo; Wang, Heping; Wang, Sheng; Zhang, Po; He, Xiaobing; Gou, Dongsheng			Surgical treatment of traumatic distal anterior cerebral artery aneurysm: a report of nine cases from a single centre	ACTA NEUROCHIRURGICA			English	Article						Traumatic; Anterior cerebral artery; Distal; Microsurgery; Treatment	PERICALLOSAL ARTERY; INTRACRANIAL ANEURYSMS; HEAD TRAUMA; ENDOVASCULAR TREATMENT; MANAGEMENT; PSEUDOANEURYSM; RUPTURE; PATIENT; INJURY; COIL	Background Traumatic distal anterior cerebral artery (dACA) aneurysm is rare and can be easily neglected and misdiagnosed in patients with trauma. The aim of this study was to explore the radiologic characteristics of and therapeutic strategies for traumatic dACA aneurysm and to improve our understanding of unusual complications after trauma. Methods The clinical data of nine cases of traumatic dACA aneurysm from our neurosurgical department from July 1, 2010, to July 1, 2018, were retrospectively analysed. Results All 9 patients had a history of brain trauma. The initial computed tomography scan immediately after trauma showed subarachnoid haemorrhage in 8 cases. Among these cases, delayed intracranial haemorrhage occurred in 7 cases. The average interval between injury and diagnosis was 13.67 +/- 9.43 days. All 9 cases were confirmed as traumatic dACA aneurysm by computed tomography angiography (CTA) and/or digital subtraction angiography. According to Lehecka's classification system, traumatic dACA aneurysm located in the A3 and A4 segment was found in 3 and 6 cases, respectively. Surgical treatment was performed in 8 cases, including neck clipping, with or without wrapping in 3 cases, trapping in 4 cases, aneurysm excision and suturing in 1 case and conservative treatment in 1 case. Three patients required a ventriculoperitoneal shunt due to severe hydrocephalus. According to the Glasgow Outcome Scale scoring system, good recovery was achieved in 4 cases, moderate disability in 2 cases, severe disability in 1 case, and death in 2 cases. Conclusion Traumatic dACA aneurysm is a rare complication of brain trauma. Delayed intracranial haemorrhage and the sudden deterioration of neurologic function were the typical characteristics in patients with traumatic dACA aneurysm. CTA is the first-line screening modality for patients who present with intracerebral haemorrhage in the corpus callosum after trauma, particularly for patients who are older, in a poorer or critical condition. When the aneurysm is located in the A4 segment or involves a small branch, surgical trapping is the preferred definitive therapy to prevent further growth and disastrous bleeding. Early diagnosis and prompt treatment could help to improve clinical outcomes.	[He, Yue; Ou, Yibo; Wang, Heping; Wang, Sheng; Zhang, Po; Gou, Dongsheng] Huazhong Univ Sci & Technol, Dept Neurosurg, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Wang, Ling] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Operating Room, Wuhan 430030, Hubei, Peoples R China; [He, Xiaobing] Jianghan Oilfield Cent Hosp, Dept Neurosurg, Qianjiang 433100, Hubei, Peoples R China		Gou, DS (corresponding author), Huazhong Univ Sci & Technol, Dept Neurosurg, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China.	Tjguodongsheng@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671154]	This study was supported by a grant from the National Natural Science Foundation of China No.81671154 to Dr. He.	Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; Barua NU, 2007, BRIT J NEUROSURG, V21, P237, DOI 10.1080/02688690701222849; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; Cohen JE, 2005, J NEUROSURG, V102, P555, DOI 10.3171/jns.2005.102.3.0555; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; Cummings TJ, 2000, NEUROL RES, V22, P165, DOI 10.1080/01616412.2000.11741055; Dunn GP, 2011, NEUROSURGERY, V68, pE587, DOI 10.1227/NEU.0b013e3182036012; Dunn IF, 2007, J NEUROSURG, V106, P153, DOI 10.3171/ped.2007.106.2.153; Gillis CC, 2013, CLIN NEUROL NEUROSUR, V115, P498, DOI 10.1016/j.clineuro.2012.06.008; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Hsieh CT, 2007, J CLIN NEUROSCI, V14, P1120, DOI 10.1016/j.jocn.2006.03.014; Jung SH, 2017, WORLD NEUROSURG, V98, P243, DOI 10.1016/j.wneu.2016.11.005; Kim MS, 2014, J KOREAN NEUROSURG S, V55, P222, DOI 10.3340/jkns.2014.55.4.222; Kumar A, 2016, J CLIN NEUROSCI, V25, P90, DOI 10.1016/j.jocn.2015.05.063; Lam CH, 1996, NEUROSURGERY, V39, P1252, DOI 10.1097/00006123-199612000-00041; Lath R, 2002, J CLIN NEUROSCI, V9, P466, DOI 10.1054/jocn.2001.1050; Lehecka M, 2008, NEUROSURGERY, V63, P219, DOI 10.1227/01.NEU.0000310695.44670.32; Levine NB, 2004, PEDIATR NEUROSURG, V40, P128, DOI 10.1159/000079855; Mao ZQ, 2012, ACTA NEUROCHIR, V154, P2187, DOI 10.1007/s00701-012-1487-x; Nakstad PH, 2008, INTERV NEURORADIOL, V14, P33, DOI 10.1177/159101990801400104; OBrien D, 1997, ARCH PHYS MED REHAB, V78, P883, DOI 10.1016/S0003-9993(97)90205-7; Pradilla G, 2013, WORLD NEUROSURG, V80, P845, DOI 10.1016/j.wneu.2012.12.001; Scholtes F, 2015, J NEUROL SURG PART A, V76, P72, DOI 10.1055/s-0033-1354748; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; Shih TY, 2002, PEDIATR NEUROSURG, V37, P35, DOI 10.1159/000065100; Sim SY, 2008, SURG NEUROL, V69, P418, DOI 10.1016/j.surneu.2007.02.042; Sui MX, 2015, INT J CLIN EXP MED, V8, P1598; Tubbs RS, 2006, J NEUROSURG, V105, P140, DOI 10.3171/ped.2006.105.2.140; Ture U, 1996, NEUROSURGERY, V39, P1075; Van Rooij WJ, 2013, INTERV NEURORADIOL, V19, P56, DOI 10.1177/159101991301900108; Yamanaka K, 2011, NEUROL MED-CHIR, V51, P572, DOI 10.2176/nmc.51.572; Yang TC, 2007, EUR NEUROL, V58, P239, DOI 10.1159/000107970; Yuen CM, 2007, J CLIN NEUROSCI, V14, P1215, DOI 10.1016/j.jocn.2006.04.013	33	2	3	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAR	2020	162	3					523	529		10.1007/s00701-019-04121-x		DEC 2019	7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KQ5WX	WOS:000500619400001	31802275				2022-02-06	
J	Daniels, KAJ; Henderson, G; Strike, S; Cosgrave, C; Fuller, C; Falvey, E				Daniels, Katherine A. J.; Henderson, George; Strike, Siobhan; Cosgrave, Ciaran; Fuller, Colm; Falvey, Eanna			The use of continuous spectral analysis for the assessment of postural stability changes after sports-related concussion	JOURNAL OF BIOMECHANICS			English	Article						Centre of pressure; Balance; Postural stability control; Concussion; Frequency domain analysis; Fourier transform	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; FREQUENCY-ANALYSIS; HEALTHY-YOUNG; BALANCE; RELIABILITY; DEFICITS; STANCE; SWAY; STABILIZATION	Impaired postural stability is associated with a variety of pathologies including sports-related concussion (SRC). Quantification of centre of pressure (COP) movement is the most common focus of instrumented assessment. Frequency-domain COP analyses have focused primarily on summary measures or pre-defined frequency bands but continuous analysis may provide novel and complementary insight into pathological control mechanisms. Our aims were (i) to compare post-SRC COP trajectory changes identified using clinician scores (Modified Balance Error Scoring System (M-BESS)), time-domain COP variables and continuous frequency spectral comparison; and (ii) to characterise frequency spectra changes. Male rugby players aged 15-19 years (n = 135) completed a pre-season baseline assessment comprising vision-obscured double-leg, single-leg and tandem stances on a force platform. Participants diagnosed with SRC during the season (n = 15) underwent repeat testing (median 4 days post-SRC; IQR 2.5-6.5). Baseline and post-SRC COP trajectories were compared using common time-domain COP variables. M-BESS scores and continuous frequency spectra. Post-SRC changes were identified using all three approaches. Spectral analysis revealed the largest effect size (Cliff's delta 0.39) and was the only method to identify differences in all three stances and in double-leg stance. All post-SRC increases in spectral content were in the anteroposterior direction; all decreases were in the mediolateral direction. Changes were localised to higher frequencies (1.7-8 Hz) except for double-leg stance anteroposterior direction, for which increases were observed throughout the analysed range. Our findings suggest that this method of spectral comparison may provide a more responsive and meaningful measure of postural stability changes after SRC than other commonly-used variables. (C) 2019 Elsevier Ltd. All rights reserved.	[Daniels, Katherine A. J.; Henderson, George; Cosgrave, Ciaran; Fuller, Colm; Falvey, Eanna] Sports Surg Clin, Sports Med Dept, Northwood Ave, Dublin 9, Ireland; [Daniels, Katherine A. J.] Univ Bristol, Queens Sch Engn, Univ Walk, Bristol BS8 1TR, Avon, England; [Henderson, George] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Clyde Williams Bldg,Epinal Way, Loughborough LE11 3TU, Leics, England; [Strike, Siobhan] Univ Roehampton, Dept Life Sci, Holybourne Ave, London SW15 4JD, England; [Fuller, Colm; Falvey, Eanna] Univ Coll Cork, Dept Med, Coll Rd, Cork, Ireland		Daniels, KAJ (corresponding author), Sports Surg Clin, Sports Med Dept, Northwood Ave, Dublin 9, Ireland.	k.a.j.daniels@outlook.com		Henderson, George/0000-0002-8923-8319; Falvey, Eanna/0000-0003-3961-1805; Strike, Siobhan/0000-0001-8195-6888	Sports Surgery Clinic, Dublin, Ireland	This work was funded by Sports Surgery Clinic, Dublin, Ireland. We would like to thank our colleagues at Sports Surgery Clinic for assistance with data collection, Dr. Omar Mian for comments on an earlier version of the manuscript and Dr. J.F. Burn for helpful discussions on time series analysis.	Albe-Fessard D., 1973, SOMATOSENSORY SYSTEM, P29, DOI DOI 10.1007/978-3-642-65438-1_3; Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; Amjad AM, 1997, J NEUROSCI METH, V73, P69, DOI 10.1016/S0165-0270(96)02214-5; [Anonymous], 1995, GAIT POSTURE; Azad AM., 2016, BMJ OPEN SPORT EXERC, V2, pe000117, DOI [10.1136/bmjsem-2016-000117, DOI 10.1136/BMJSEM-2016-000117]; Baracks J, 2018, J ATHL TRAINING, V53, P597, DOI 10.4085/1062-6050-174-17; Barela JA, 2014, NEUROSCI LETT, V566, P6, DOI 10.1016/j.neulet.2014.02.029; Barozzi S, 2014, EUR ARCH OTO-RHINO-L, V271, P2069, DOI 10.1007/s00405-014-2930-9; Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; CARROLL JP, 1993, J BIOMECH, V26, P409, DOI 10.1016/0021-9290(93)90004-X; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Christy JB, 2019, J NEUROL PHYS THER, V43, P153, DOI 10.1097/NPT.0000000000000280; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; Cohen J, 1977, STAT POWER ANAL BEHA; Cosgrave C., 2018, BMJ OPEN SPORT EXERC, V4; Creath R, 2008, J VESTIBUL RES-EQUIL, V18, P39; Cretual A, 2015, NEUROPHYSIOL CLIN, V45, P285, DOI 10.1016/j.neucli.2015.07.004; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Degani AM, 2017, BRAIN INJURY, V31, P49, DOI 10.1080/02699052.2016.1225982; Delaney HD, 2002, PSYCHOL METHODS, V7, P485, DOI 10.1037//1082-989X.7.4.485; DIENER HC, 1984, EXP BRAIN RES, V56, P126; DIETZ V, 1980, EXP BRAIN RES, V40, P89; Diggle P., 1990, TIME SERIES BIOSTATI; Doherty C, 2017, CLIN BIOMECH, V42, P79, DOI 10.1016/j.clinbiomech.2017.01.007; ESTEKY H, 1994, J NEUROPHYSIOL, V72, P2269, DOI 10.1152/jn.1994.72.5.2269; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; FITZPATRICK RC, 1992, J PHYSIOL-LONDON, V458, P69, DOI 10.1113/jphysiol.1992.sp019406; Gilfriche P, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01566; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; GOLOMER E, 1994, ARCH INT PHYSIOL BIO, V102, P225, DOI 10.3109/13813459409007543; Gouleme N, 2014, INT J DEV NEUROSCI, V38, P169, DOI 10.1016/j.ijdevneu.2014.08.011; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Haid T, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20010030; Halliday D. M., 1999, MODERN TECHNIQUES NE; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Horak F., 1996, HDB PHYSL EXERCISE R, DOI 10.1002/cphy.cp120107; Horak FB, 1997, GAIT POSTURE, V6, P76, DOI 10.1016/S0966-6362(97)00018-0; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Hugentobler JA, 2016, CLIN J SPORT MED, V26, P510, DOI 10.1097/JSM.0000000000000286; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Hwang S, 2016, EXP BRAIN RES, V234, P2369, DOI 10.1007/s00221-016-4642-4; Jeka J, 2004, J NEUROPHYSIOL, V92, P2368, DOI 10.1152/jn.00983.2003; Jeka J, 2000, EXP BRAIN RES, V134, P107, DOI 10.1007/s002210000412; Kanekar N, 2014, J NEUROSCI METH, V222, P91, DOI 10.1016/j.jneumeth.2013.10.020; Kiemel T, 2002, BIOL CYBERN, V87, P262, DOI 10.1007/s00422-002-0333-2; Kiemel T, 2011, J NEUROSCI, V31, P15144, DOI 10.1523/JNEUROSCI.1013-11.2011; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Mallinson A., 1998, AM J OTOLARYNGOL, V19; MAURITZ KH, 1980, EXP BRAIN RES, V38, P117; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Murnaghan CD, 2011, NEUROSCIENCE, V195, P54, DOI 10.1016/j.neuroscience.2011.08.020; Murnaghan CD, 2013, GAIT POSTURE, V38, P734, DOI 10.1016/j.gaitpost.2013.03.012; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Nowak MK, 2018, J NEUROPHYSIOL, V120, P391, DOI 10.1152/jn.00895.2017; Paillard T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/891390; Palmieri RM, 2002, J SPORT REHABIL, V11, P51, DOI 10.1123/jsr.11.1.51; Parrington L, 2019, J ATHL TRAINING, V54, P429, DOI 10.4085/1062-6050-46-18; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Polastri PF, 2012, EXP BRAIN RES, V223, P99, DOI 10.1007/s00221-012-3244-z; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Quatman-Yates C, 2018, HUM MOVEMENT SCI, V58, P148, DOI 10.1016/j.humov.2018.02.002; Riemann B.L., 1999, J SPORT REHABILIT, V8; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rougier PR, 2008, NEUROPHYSIOL CLIN, V38, P363, DOI 10.1016/j.neucli.2008.09.006; Ruhe A, 2014, SPORTS HEALTH, V6, P427, DOI 10.1177/1941738114541238; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Singh NB, 2012, J ELECTROMYOGR KINES, V22, P131, DOI 10.1016/j.jelekin.2011.10.007; SOAMES RW, 1982, EUR J APPL PHYSIOL O, V49, P169, DOI 10.1007/BF02334065; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Sport Concussion Assessment Tool, 2013, BRIT J SPORT MED, P259; Vargha A, 2000, J EDUC BEHAV STAT, V25, P101, DOI 10.3102/10769986025002101; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Williams HG, 1997, ARCH PHYS MED REHAB, V78, P737, DOI 10.1016/S0003-9993(97)90082-4; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607	83	2	2	1	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	DEC 3	2019	97								109400	10.1016/j.jbiomech.2019.109400			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering	JW2LU	WOS:000502890000017	31668719	Green Accepted, Green Submitted			2022-02-06	
J	Lorente, L; Martin, MM; Abreu-Gonzalez, P; Ramos, L; Caceres, JJ; Argueso, M; Sole-Violan, J; Jimenez, A; Garcia-Marin, V				Lorente, Leonardo; Martin, Maria M.; Abreu-Gonzalez, Pedro; Ramos, Luis; Caceres, Juan J.; Argueso, Monica; Sole-Violan, Jordi; Jimenez, Alejandro; Garcia-Marin, Victor			Maintained high sustained serum malondialdehyde levels after severe brain trauma injury in non-survivor patients	BMC RESEARCH NOTES			English	Article						Malondialdehyde; Brain trauma; Patients; Mortality; Injury	LIPID-PEROXIDATION; HEAD-INJURY; OXIDATIVE STRESS; ANTIOXIDANTS; MELATONIN; DAMAGE	Objective Higher blood malondialdehyde (biomarker of lipid peroxidation) levels in the first hours of traumatic brain injury (TBI) have been found in patients with a worst prognosis. The objective of this study was to determine whether serum malondialdehyde levels during the first week of severe TBI could be used as mortality biomarkers. This was a multicenter, prospective and observational study performed in six Spanish Intensive Care Units. We included patients with severe TBI (defined as Glasgow Coma Scale < 9), and with Injury Severity Score in non-cranial aspects < 9. We determined serum malondialdehyde concentrations at days 1, 4 and 8 of TBI. We stablished 30-day mortality as the end-point study. Results We found that serum malondialdehyde concentrations at days 1 (p < 0.001), 4 (p < 0.001), and 8 (p < 0.001) of TBI were higher in non-survivor (n = 34) than in survivor (n = 90) patients. We found an area under curve of serum malondialdehyde concentrations at days 1, 4, and 8 of TBI to predict 30-day mortality of 77% (p < 0.001), 87% (p < 0.001) and 84% (p < 0.001) respectively. Thus, the new and most relevant findings of our study were serum malondialdehyde levels during the first week of TBI could be used as mortality biomarkers.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Crta Rosario S-N, Santa Cruz De Tenerife 38010, Spain; [Abreu-Gonzalez, Pedro] Univ La Laguna, Fac Med, Dept Physiol, Santa Cruz De Tenerife, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Buenavista de Arriba S-N, Brena Alta 38713, La Palma, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Plaza Dr Pasteur S-N, Las Palmas Gran Canaria 35016, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Avda Blasco Ibanez 17-19, Valencia 46004, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, CIBERES, Barranco Ballena S-N, Las Palmas Gran Canaria 35010, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Garcia-Marin, Victor] Hosp Univ Canarias, Dept Neurosurg, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain.	lorentemartin@msn.com		Jimenez-Sosa, Alejandro/0000-0001-8732-2616	Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife. Spain) [OA18/011]	This study was supported by a Grant (OA18/011) from Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife. Spain). Funding did not influence in the study design, the collection, analysis, and interpretation of data, the manuscript writing, and the decision to submit it for publication.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Horakova L, 2000, GEN PHYSIOL BIOPHYS, V19, P195; Hu Shouxing, 1999, Hunan Yike Daxue Xuebao, V24, P56; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kerman M, 2005, EXP BRAIN RES, V163, P406, DOI 10.1007/s00221-005-2338-2; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lin WM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/340936; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Saniova B, 2006, CELL MOL NEUROBIOL, V26, P1475, DOI 10.1007/s10571-006-9033-0; TEASDALE G, 1974, LANCET, V2, P81; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022	28	2	2	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		1756-0500		BMC RES NOTES	BMC Res. Notes	DEC 3	2019	12	1							789	10.1186/s13104-019-4828-5			5	Biology; Multidisciplinary Sciences	Emerging Sources Citation Index (ESCI)	Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics	NO5ZI	WOS:000569568900002	31796118	Green Published, gold			2022-02-06	
J	Wang, YJ; Wong, HSC; Wu, CC; Chiang, YH; Chiu, WT; Chen, KY; Chang, WC				Wang, Yu-Jia; Wong, Henry Sung-Ching; Wu, Chung-Che; Chiang, Yung-Hsiao; Chiu, Wen-Ta; Chen, Kai-Yun; Chang, Wei-Chiao			The functional roles of IGF-1 variants in the susceptibility and clinical outcomes of mild traumatic brain injury	JOURNAL OF BIOMEDICAL SCIENCE			English	Article						Mild traumatic brain injury; Genetic variants; Insulin-like growth factor 1; Anxiety; Depression; Dizziness; Sleep disorders	GROWTH-FACTOR-I; ALZHEIMERS-DISEASE; GENETIC-VARIATION; EARLY PREDICTORS; POLYMORPHISMS; CONCUSSION; INVENTORY; RECOVERY; ANXIETY	Background Insulin-like growth factor 1 (IGF-1) is an important pleiotropic hormone that exerts neuroprotective and neuroreparative effects after a brain injury. However, the roles of IGF-1 variants in mild traumatic brain injury (mTBI) are not yet fully understood. This study attempted to elucidate the effects of IGF-1 variants on the risk and neuropsychiatric outcomes of mTBI. Methods Based on 176 recruited mTBI patients and 1517 control subjects from the Taiwan Biobank project, we first compared the genotypic distributions of IGF-1 variants between the two groups. Then, we analyzed associations of IGF-1 variants with neuropsychiatric symptoms after mTBI, including anxiety, depression, dizziness, and sleep disturbances. Functional annotation of IGF-1 variants was also performed through bioinformatics databases. Results The minor allele of rs7136446 was over-represented in mTBI patients compared to community-based control subjects. Patients carrying minor alleles of rs7136446 and rs972936 showed more dizziness and multiple neuropsychiatric symptoms after brain injury. Conclusions IGF-1 variants were associated with the risk and neuropsychiatric symptoms of mTBI. The findings highlight the important role of IGF-1 in the susceptibility and clinical outcomes of mTBI.	[Wang, Yu-Jia; Chen, Kai-Yun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Wang, Yu-Jia; Chen, Kai-Yun] Natl Hlth Res Inst, Taipei, Taiwan; [Wong, Henry Sung-Ching; Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Coll Publ Hlth & Nutr, Inst Injury Prevent & Control, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wan Fang Hosp, Dept Pharm, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Shuang Ho Hosp, Dept Med Res, New Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wan Fang Hosp, Pain Res Ctr, Taipei, Taiwan		Chen, KY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan.; Chen, KY (corresponding author), Natl Hlth Res Inst, Taipei, Taiwan.; Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	kychen08@tmu.edu.tw; wcc@tmu.edu.tw			Ministry of Science and Technology [MOST104-2923-B-038-004-MY2, MOST105-2628-B-038-001-MY4]; Ministry of Health and WelfareMinistry of Health, Labour and Welfare, Japan [MOHW105-TDU-B-212-133018]; National Health Research InstitutesNational Health Research Institutes, Japan [08A1-MGGP08-037]; Taipei Medical University [DP2-108-21121-01-N-05-01, 106-5807-001-400]	This work was supported by grants from Ministry of Science and Technology (MOST104-2923-B-038-004-MY2, MOST105-2628-B-038-001-MY4), Ministry of Health and Welfare (MOHW105-TDU-B-212-133018), National Health Research Institutes (08A1-MGGP08-037), and Taipei Medical University (DP2-108-21121-01-N-05-01, 106-5807-001-400).	Aberg ND, 2013, EUR J ENDOCRINOL, V169, P759, DOI 10.1530/EJE-13-0486; Abrahams S, 2019, J SCI MED SPORT, V22, P22, DOI 10.1016/j.jsams.2018.06.012; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Baykara B, 2013, BIOTECH HISTOCHEM, V88, P250, DOI 10.3109/10520295.2013.769630; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bennett E.R., 2016, TRANSLATIONAL RES TR; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Chen CH, 2016, HUM MOL GENET, V25, P5321, DOI 10.1093/hmg/ddw346; Cheng CM, 2005, ENDOCRINOLOGY, V146, P5086, DOI 10.1210/en.2005-0063; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Eme R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7050046; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Garcia-Segura LM, 2010, PROG BRAIN RES, V181, P251, DOI 10.1016/S0079-6123(08)81014-X; Giuffrida ML, 2012, MOL NEUROBIOL, V46, P605, DOI 10.1007/s12035-012-8313-6; Huffman J, 2017, WORLD J DIABETES, V8, P45, DOI 10.4239/wjd.v8.i2.45; Huuskonen A, 2011, MED SCI SPORT EXER, V43, P2368, DOI 10.1249/MSS.0b013e3182220179; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; Kamei H, 2011, DEVELOPMENT, V138, P777, DOI 10.1242/dev.056853; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Mangiola A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/736104; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Miller JA, 2017, ELIFE, V6, DOI 10.7554/eLife.31126; Ong J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090916; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Rao V, 2014, BRAIN INJURY, V28, P20, DOI 10.3109/02699052.2013.847210; Ratcliffe LE, 2018, NEUROSCIENCE, V390, P46, DOI 10.1016/j.neuroscience.2018.07.029; Sanus GZ, 2007, ULUS TRAVMA ACIL CER, V13, P281; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi J, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00136; Sohrabji F, 2015, FRONT NEUROENDOCRIN, V36, P1, DOI 10.1016/j.yfrne.2014.05.003; Sung CW, 2016, CLIN NEUROPHYSIOL, V127, P1629, DOI 10.1016/j.clinph.2015.08.006; TEASDALE G, 1974, LANCET, V2, P81; Terrell TR, 2018, BRIT J SPORT MED, V52, P192, DOI 10.1136/bjsports-2016-097419; Trejo JL, 2004, J MOL MED, V82, P156, DOI 10.1007/s00109-003-0499-7; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Walter HJ, 1997, ENDOCRINOLOGY, V138, P3024, DOI 10.1210/en.138.7.3024; Wang W, 2012, NEUROSCI LETT, V531, P20, DOI 10.1016/j.neulet.2012.10.015; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Xiao YS, 2017, J GENE MED, V19, DOI 10.1002/jgm.2949	60	2	3	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1021-7770	1423-0127		J BIOMED SCI	J. Biomed. Sci.	DEC 2	2019	26	1							94	10.1186/s12929-019-0587-9			12	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	JT5CG	WOS:000501007000001	31787098	Green Published, gold			2022-02-06	
J	Arnaud, F; Pappas, G; Maudlin-Jeronimo, E; Goforth, C				Arnaud, Francoise; Pappas, Georgina; Maudlin-Jeronimo, Eric; Goforth, Carl			Simulated Aeromedical Evacuation in a Polytrauma Rat Model	AEROSPACE MEDICINE AND HUMAN PERFORMANCE			English	Article						altitude; aero-evacuation; blast; hemorrhage; hypobaria; trauma; resuscitation	BRAIN-INJURY; STRESS; CARE; EXPOSURE; RECOVERY; TRAUMA; SHOCK	BACKGROUND: Hemorrhage and traumatic brain injury can be lethal if left unattended. The transportation of severely wounded combat casualties from the battlefield to higher level of care via aeromedical evacuation (AE) may result in unintended complications. This could become a serious concern at the time of evacuation of mass casualties or for prolonged field care scenarios with limited resources. METHODS: Following instrumentation (t1), anesthetized Sprague-Dawley rats were injured or not [75-kPa blast and 30% estimated blood-volume controlled hemorrhage] (t2). After 15 min, all rats were resuscitated with saline. During the simulated 3-h evacuation, 8000 ft (2440 m) vs. sea-level heart rate, temperature, and oxygenation (S(p)o(2)) were continuously recorded. One group of rats was euthanized immediately after evacuation (t3) and another after a 72-h recovery period (t4). Hematology and metabolic levels were measured at t1, t2, t3, and t4. RESULTS: Survival was 100% in control-uninjured animals, 83% in injured animals under normobaria, and significantly reduced to 50% under hypobaria. This AE setting resulted in significantly lower hemodynamics, thermoregulation, and oxygenation parameters in the animals under hypobaria than those under normobaria. The initial lower mean arterial pressure (MAP) with the reduced oxygen level before AE were critical factors for the survival of injured animals. We observed a general increase of white blood cells and platelet ability to aggregate at t4 in all experimental groups. CONCLUSION: Physiological parameters were affected during aeromedical evacuation in all groups. This was worsened for injured animals with MAP less than 60 mmHg associated with low Spo2 in a simulated aeromedical evacuation. This represented a high risk of mortality for secerely polytraumatized animals.	[Arnaud, Francoise; Pappas, Georgina; Maudlin-Jeronimo, Eric; Goforth, Carl] Naval Med Res Ctr, NeuroTrauma Dept, Silver Spring, MD USA; [Arnaud, Francoise] Adv Mil Med Inc, Henry M Jackson Fdn, Bethesda, MD USA; [Arnaud, Francoise; Goforth, Carl] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Arnaud, F (corresponding author), NMRC, Operat & Undersea Med, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Francoise.arnaud.ctr@mail.mil			 [DHP 603115HP.2380.001];  [A1304]	This work was supported by the DHP 603115HP.2380.001.A1304. None of the authors have any commercial associations that might create a conflict of interest nor do any of the authors have any financial interests or personal relationships with other people or organizations that would represent a conflict of interest.	Acar D, 2015, TURK J ANAESTHESIOL, V43, P91, DOI 10.5152/TJAR.2014.49092; Albreiki M, 2018, EUR J TRAUMA EMERG S, V44, P191, DOI 10.1007/s00068-017-0862-y; Arnaud F, 2018, NEUROSCI LETT, V684, P91, DOI 10.1016/j.neulet.2018.07.006; Bradley M, 2017, CURR PROB SURG, V54, P315, DOI 10.1067/j.cpsurg.2017.02.004; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Christian MD, 2014, CHEST, V146, pE61S, DOI 10.1378/chest.14-0736; Cognasse F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01478; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Davis R Scott, 2011, US Army Med Dep J, P45; Dayani Y, 2019, J TRAUMA ACUTE CARE, V87, P205, DOI 10.1097/TA.0000000000002337; De Jong Marla J, 2010, J Trauma Nurs, V17, P45, DOI 10.1097/JTN.0b013e3181d914ed; Dispersyn G, 2009, CHRONOBIOL INT, V26, P697, DOI 10.1080/07420520902926033; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fiskum GPJ, 2019, AEROSP MED HUM PERF, V90, P196; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Gurney JM, 2018, CURR OPIN ANESTHESIO, V31, P207, DOI 10.1097/ACO.0000000000000574; Ingalls N, 2014, JAMA SURG, V149, P807, DOI 10.1001/jamasurg.2014.621; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; Johannigman Jay, 2015, J Trauma Acute Care Surg, V79, pS216, DOI 10.1097/TA.0000000000000736; JOHNSON A, 1977, AVIAT SPACE ENVIR MD, V48, P550; Johnson EM, 2014, PREHOSP DISASTER MED, V29, P455, DOI 10.1017/S1049023X14000909; Joshi M C, 2010, Med J Armed Forces India, V66, P63, DOI 10.1016/S0377-1237(10)80097-8; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Ohnishi M, 2001, EXP PHYSIOL, V86, P357, DOI 10.1113/eph8602145; Patel JA, 2018, J VASC SURG, V68, P1872, DOI 10.1016/j.jvs.2018.04.038; Rincon F, 2015, J INTENSIVE CARE MED, V30, P107, DOI 10.1177/0885066613508266; Sanchez-Alavez M, 2019, ALCOHOL, V76, P37, DOI 10.1016/j.alcohol.2018.07.005; Shukla D, 2007, CLIN NEUROPATHOL, V26, P197; Skovira JW, 2016, J NEUROTRAUM, V33, P1292, DOI 10.1089/neu.2015.4189; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Tobin Joshua M, 2015, J Spec Oper Med, V15, P72; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Vugrin ED, 2015, J HEALTHC ENG, V6, P85, DOI 10.1260/2040-2295.6.1.85; Wigginton JG, 2011, MINERVA ANESTESIOL, V77, P993	36	2	2	0	2	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	2375-6314	2375-6322		AEROSP MED HUM PERF	Aerosp. Med.Hum. Perform.	DEC	2019	90	12					1016	1025		10.3357/AMHP.5477.2019			10	Biophysics; Public, Environmental & Occupational Health; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Public, Environmental & Occupational Health; Research & Experimental Medicine	JP1LL	WOS:000498033600004	31747998	hybrid			2022-02-06	
J	Batchelor, G; McNaughten, B; Bourke, T; Dick, J; Leonard, C; Thompson, A				Batchelor, Gemma; McNaughten, Ben; Bourke, Thomas; Dick, Julie; Leonard, Claire; Thompson, Andrew			How to use the videofluoroscopy swallow study in paediatric practice	ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION			English	Article						imaging; general paediatrics; aspiration; dysphagia; videofluroscopy	CHILDREN	In paediatric practice feeding, eating, drinking and swallowing difficulties are present in up to 1% of children. Dysphagia is any disruption to the swallow sequence that results in compromise to the safety, efficiency or adequacy of nutritional intake. Swallowing difficulties may lead to pharyngeal aspiration, respiratory compromise or poor nutritional intake. It causes sensory and motor dysfunction impacting on a child's ability to experience normal feeding. Incoordination can result in oral pharyngeal aspiration where fluid or food is misdirected and enters the airway, or choking where food physically blocks the airway The incidence is much higher in some clinical populations, including children with neuromuscular disease, traumatic brain injury and airway malformations. The prevalence of dysphagia and aspiration-related disease is increasing secondary to the better survival of children with highly complex medical and surgical needs. This article aims to outline the indications for performing videofluoroscopy swallow (VFS). This includes the technical aspects of the study, how to interrupt a VFS report and some of the limitations to the study.	[Batchelor, Gemma; McNaughten, Ben; Bourke, Thomas; Dick, Julie; Leonard, Claire; Thompson, Andrew] Royal Belfast Hosp Sick Children, Belfast BT12 6BA, Antrim, North Ireland; [Bourke, Thomas] Queens Univ Belfast, Ctr Med Educ, Belfast, Antrim, North Ireland		Batchelor, G (corresponding author), Royal Belfast Hosp Sick Children, Belfast BT12 6BA, Antrim, North Ireland.	g.batchelor@doctors.org.uk		McNaughten, Ben/0000-0003-1805-0893; Bourke, Thomas/0000-0003-4786-962X			Altman KW, 2009, 2010 SANDWELL COMMUN; [Anonymous], 2017, CEREBRAL PALSY 25S A; [Anonymous], 2013, VIDEOFLUOROSCOPIC EV; [Anonymous], 2011, DYSPHAGIA DIET FOOD; Belafsky PC., 2014, CLIN GUIDE SWALLOWIN; Bhattacharyya N, 2015, LARYNGOSCOPE, V125, P746, DOI 10.1002/lary.24931; Carter J, 2016, INT J PEDIATR OTORHI, V86, P256, DOI 10.1016/j.ijporl.2016.04.007; Clarke P, 2004, ARCH DIS CHILD-FETAL, V89, pF280, DOI 10.1136/adc.2003.036392; Department of Health, 2011, ION RAD MED EXP AM R; Dodrill P, 2014, J GASTROENTEROLHEPAT; DOH NHS England, 2015, NEW CONG HEART DIS R; Hull J, 2012, THORAX, V67, P654, DOI 10.1136/thoraxjnl-2012-202043; Kwok TC, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003211.pub2; Lefton-Greif MA, 2018, DYSPHAGIA, V33, P76, DOI 10.1007/s00455-017-9834-y; Royal College of Speech and Language Therapists, 2013, VID EV OR SWALL FUNC; Steele C, 2014, DYSPHAGIA; Uhm KE, 2013, ANN REHABIL MED, V37, P175; Weir KA, 2007, PEDIATR RADIOL, V37, P283, DOI 10.1007/s00247-006-0397-6	18	2	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1743-0585	1743-0593		ARCH DIS CHILDHOOD-E	Arch. Dis. Childhood-Educ. Pract. Ed.	DEC	2019	104	6					313	320		10.1136/archdischild-2017-313787			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	JW0AW	WOS:000502722800008	30322859				2022-02-06	
J	Bolduc-Teasdale, J; Jolicoeur, P; McKerral, M				Bolduc-Teasdale, Julie; Jolicoeur, Pierre; McKerral, Michelle			Electrophysiological Markers of Visuospatial Attention Recovery after Mild Traumatic Brain Injury	BRAIN SCIENCES			English	Article						mTBI; event-related potentials; visual-attentional processing; brain connectivity; neuropsychological measures; postconcussion symptoms	DEFICITS; CONCUSSION; HISTORY; MEMORY; NEUROPHYSIOLOGY; ABNORMALITIES; RELIABILITY; MODERATE; INDEX; P3A	Objective: Attentional problems are amongst the most commonly reported complaints following mild traumatic brain injury (mTBI), including difficulties orienting and disengaging attention, sustaining it over time, and dividing attentional resources across multiple simultaneous demands. The objective of this study was to track, using a single novel electrophysiological task, various components associated with the deployment of visuospatial selective attention. Methods: A paradigm was designed to evoke earlier visual evoked potentials (VEPs), as well as attention-related and visuocognitive ERPs. Data from 36 individuals with mTBI (19 subacute, 17 chronic) and 22 uninjured controls are presented. Postconcussion symptoms (PCS), anxiety (BAI), depression (BDI-II) and visual attention (TEA Map Search, DKEFS Trail Making Test) were also assessed. Results: Earlier VEPs (P1, N1), as well as processes related to visuospatial orientation (N2pc) and encoding in visual short-term memory (SPCN), appear comparable in mTBI and control participants. However, there appears to be a disruption in the spatiotemporal dynamics of attention (N2pc-Ptc, P2) in subacute mTBI, which recovers within six months. This is also reflected in altered neuropsychological performance (information processing speed, attentional shifting). Furthermore, orientation of attention (P3a) and working memory processes (P3b) are also affected and remain as such in the chronic post-mTBI period, in co-occurrence with persisting postconcussion symptomatology. Conclusions: This study adds original findings indicating that such a sensitive and rigorous ERP task implemented at diagnostic and follow-up levels could allow for the identification of subtle but complex brain activation and connectivity deficits that can occur following mTBI.	[Bolduc-Teasdale, Julie; McKerral, Michelle] CIUSSS Ctr Sud de Ile de Lile Montreal, IURDPM, Ctr Interdisciplinary Res Rehabil CRIR, Montreal, PQ H3S 1M9, Canada; [Bolduc-Teasdale, Julie; Jolicoeur, Pierre; McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada		McKerral, M (corresponding author), CIUSSS Ctr Sud de Ile de Lile Montreal, IURDPM, Ctr Interdisciplinary Res Rehabil CRIR, Montreal, PQ H3S 1M9, Canada.; McKerral, M (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada.	juliebolduct@me.com; pierre.jolicoeur@umontreal.ca; michelle.mckerral@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (N.S.E.R.C.) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Quebec Rehabilitation Research Network; N.S.E.R.C.Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Canada Research Chairs programCanada Research Chairs	This work was supported by the Canadian Institutes of Health Research (scholarship to J.B.-T.), by research funds (awarded to M.M.) from the Natural Sciences and Engineering Research Council (N.S.E.R.C.) of Canada and the Quebec Rehabilitation Research Network, and funding from the N.S.E.R.C., the Canada Foundation for Innovation and the Canada Research Chairs program awarded to P.J., and finally by infrastructure support to the Centre for Research in Neuropsychology and Cognition, and the Centre for Interdisciplinary Research in Rehabilitation from the Fonds de Recherche du Quebec-Sante (F.R.Q.S.).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arlinghaus K.A., 2007, TXB TRAUMATIC BRAIN, P59; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bolduc-Teasdale J, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/618654; Brisson B, 2007, NEUROPSYCHOLOGIA, V45, P3038, DOI 10.1016/j.neuropsychologia.2007.05.022; Brisson B, 2007, PSYCHOPHYSIOLOGY, V44, P323, DOI 10.1111/j.1469-8986.2007.00503.x; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Hagen GF, 2006, INT J PSYCHOPHYSIOL, V59, P8, DOI 10.1016/j.ijpsycho.2005.08.003; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hilimire MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012677; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Luck S.J., 2005, INTRO EVENT RELATED, V1st ed.; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Pare N, 2009, NEUROPSYCHOL REHABIL, V19, P110, DOI 10.1080/09602010802106486; POLICH J, 2004, BRAINWAVES MIND RECE; Qian C, 2012, COGN NEUROSCI-UK, V3, P98, DOI 10.1080/17588928.2012.658363; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; RIZZO M, 1996, HEAD INJURY POSTCONC; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Sessa P, 2007, BRAIN RES, V1137, P131, DOI 10.1016/j.brainres.2006.12.066; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1017/S0048577200981265; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578	53	2	3	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	DEC	2019	9	12							343	10.3390/brainsci9120343			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KC0JM	WOS:000506873500037	31783501	Green Published, gold			2022-02-06	
J	Dimitriadis, SI; Simos, PG; Fletcher, JM; Papanicolaou, AC				Dimitriadis, Stavros, I; Simos, Panagiotis G.; Fletcher, Jack M.; Papanicolaou, Andrew C.			Typical and Aberrant Functional Brain Flexibility: Lifespan Development and Aberrant Organization in Traumatic Brain Injury and Dyslexia	BRAIN SCIENCES			English	Article						resting-state activity; magnetoencephalography; brain maturation; cross-frequency coupling; reading disability; traumatic brain injury	CONNECTIVITY CHANGES; COUPLING MODES; TIME-SERIES; OSCILLATIONS; NETWORKS; MEG; RECONFIGURATION; SYNCHRONY; COHERENCE; NONLINEARITY	Intrinsic functional connectivity networks derived from different neuroimaging methods and connectivity estimators have revealed robust developmental trends linked to behavioural and cognitive maturation. The present study employed a dynamic functional connectivity approach to determine dominant intrinsic coupling modes in resting-state neuromagnetic data from 178 healthy participants aged 8-60 years. Results revealed significant developmental trends in three types of dominant intra- and inter-hemispheric neuronal population interactions (amplitude envelope, phase coupling, and phase-amplitude synchronization) involving frontal, temporal, and parieto-occipital regions. Multi-class support vector machines achieved 89% correct classification of participants according to their chronological age using dynamic functional connectivity indices. Moreover, systematic temporal variability in functional connectivity profiles, which was used to empirically derive a composite flexibility index, displayed an inverse U-shaped curve among healthy participants. Lower flexibility values were found among age-matched children with reading disability and adults who had suffered mild traumatic brain injury. The importance of these results for normal and abnormal brain development are discussed in light of the recently proposed role of cross-frequency interactions in the fine-grained coordination of neuronal population activity.	[Dimitriadis, Stavros, I] Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff CF14 4XN, Wales; [Dimitriadis, Stavros, I] Cardiff Univ, Brain Res Imaging Ctr, Sch Psychol, Cardiff CF24 4HQ, Wales; [Dimitriadis, Stavros, I] Cardiff Univ, Sch Psychol, Cardiff CF10 3AT, Wales; [Dimitriadis, Stavros, I] Cardiff Univ, Brain Res Imaging Ctr, Sch Psychol, Neuroinformat Grp, Cardiff CF24 4HQ, Wales; [Dimitriadis, Stavros, I] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF24 4HQ, Wales; [Dimitriadis, Stavros, I] Cardiff Univ, MRC, Sch Med, Ctr Neuropsychiat Genet & Genom, Cardiff CF24 4HQ, Wales; [Simos, Panagiotis G.] Univ Crete, Sch Med, Iraklion 70013, Greece; [Simos, Panagiotis G.] Fdn Res & Technol, Inst Comp Sci, Iraklion 70013, Greece; [Fletcher, Jack M.] Univ Houston, Dept Psychol, Houston, TX 77204 USA; [Papanicolaou, Andrew C.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Div Clin Neurosci, Memphis, TN 38103 USA; [Papanicolaou, Andrew C.] Le Bonheur Childrens Hosp, Le Bonheur Neurosci Inst, Memphis, TN 38103 USA		Dimitriadis, SI (corresponding author), Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff CF14 4XN, Wales.; Dimitriadis, SI (corresponding author), Cardiff Univ, Brain Res Imaging Ctr, Sch Psychol, Cardiff CF24 4HQ, Wales.; Dimitriadis, SI (corresponding author), Cardiff Univ, Sch Psychol, Cardiff CF10 3AT, Wales.; Dimitriadis, SI (corresponding author), Cardiff Univ, Brain Res Imaging Ctr, Sch Psychol, Neuroinformat Grp, Cardiff CF24 4HQ, Wales.; Dimitriadis, SI (corresponding author), Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF24 4HQ, Wales.; Dimitriadis, SI (corresponding author), Cardiff Univ, MRC, Sch Med, Ctr Neuropsychiat Genet & Genom, Cardiff CF24 4HQ, Wales.	stidimitriadis@gmail.com; akis.simos@gmail.com; Jack.Fletcher@times.uh.edu; apapanic@uthsc.edu	Fletcher, Jack/AAX-2931-2020; DIMITRIADIS, STAVROS I/AAN-8992-2020	DIMITRIADIS, STAVROS I/0000-0002-0000-5392; Simos, Panagiotis/0000-0002-0116-8564	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P50 HD052117]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/K004360/1]; MARIE-CURIE COFUND EU-UK RESEARCH FELLOWSHIP; Cardiff RCUK/Wellcome Trust Foundation scheme	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; grant number P50 HD052117), MRC (grant number MR/K004360/1), a MARIE-CURIE COFUND EU-UK RESEARCH FELLOWSHIP to S.I.D., and a Cardiff RCUK/Wellcome Trust Foundation funding scheme (publication fee). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NICHD or the National Institutes of Health.	Antonakakis M., 2016, P 2016 IEEE INT C IM; Antonakakis M, 2019, ALTERATIONS DYNAMIC, DOI [10.1101/596155, DOI 10.1101/596155]; Antonakakis M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00416; Antonakakis M, 2017, NEUROSCIENCE, V356, P275, DOI 10.1016/j.neuroscience.2017.05.032; Antonakakis M, 2016, INT J PSYCHOPHYSIOL, V102, P1, DOI 10.1016/j.ijpsycho.2016.02.002; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067; Blankenship TL, 2015, DEV NEUROPSYCHOL, V40, P430, DOI 10.1080/87565641.2016.1153099; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cabral J, 2014, NEUROIMAGE, V90, P423, DOI 10.1016/j.neuroimage.2013.11.047; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cohen MX, 2008, J NEUROSCI METH, V168, P494, DOI 10.1016/j.jneumeth.2007.10.012; Contreras D, 1996, SCIENCE, V274, P771, DOI 10.1126/science.274.5288.771; Destexhe A, 1999, NEUROSCIENCE, V92, P427, DOI 10.1016/S0306-4522(99)00024-X; Dimitriadis SI, 2013, NEUROIMAGE, V83, P307, DOI 10.1016/j.neuroimage.2013.06.036; Dimitriadis SI, 2018, J NEUROSCI RES, V96, P1741, DOI 10.1002/jnr.24316; Dimitriadis SI, 2018, INT J PSYCHOPHYSIOL, V126, P20, DOI 10.1016/j.ijpsycho.2018.02.008; Dimitriadis SI, 2017, BRAIN CONNECT, V7, P661, DOI 10.1089/brain.2017.0512; Dimitriadis Stavros I, 2016, Alzheimers Dement (N Y), V2, P241, DOI 10.1016/j.trci.2016.08.004; Dimitriadis SI, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00423; Dimitriadis SI, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00028; Dimitriadis SI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00454; Dimitriadis SI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00163; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dimitriadis SI, 2012, BRAIN COGNITION, V80, P45, DOI 10.1016/j.bandc.2012.04.001; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gautama T, 2004, PHYSICA D, V190, P167, DOI 10.1016/j.physd.2003.11.001; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hwang K, 2010, J NEUROSCI, V30, P15535, DOI 10.1523/JNEUROSCI.2825-10.2010; Kang HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162034; Kessler D, 2016, JAMA PSYCHIAT, V73, P481, DOI 10.1001/jamapsychiatry.2016.0088; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; MARTINETZ TM, 1993, IEEE T NEURAL NETWOR, V4, P558, DOI 10.1109/72.238311; Niso G, 2016, NEUROIMAGE, V124, P1182, DOI 10.1016/j.neuroimage.2015.04.028; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Qin J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00418; Schafer CB, 2014, HUM BRAIN MAPP, V35, P5249, DOI 10.1002/hbm.22547; Stam CJ, 2012, NEUROIMAGE, V62, P1415, DOI 10.1016/j.neuroimage.2012.05.050; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Uhlhaas PJ, 2015, BIOL PSYCHIAT, V77, P1001, DOI 10.1016/j.biopsych.2014.11.019; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; Verdes PF, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026222; Vergun S, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00038; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Zhang J, 2016, BRAIN, V139, P2307, DOI 10.1093/brain/aww143	66	2	2	3	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	DEC	2019	9	12							380	10.3390/brainsci9120380			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KC0JM	WOS:000506873500043	31888230	Green Published, Green Accepted, gold			2022-02-06	
J	Fanton, M; Sganga, J; Camarillo, DB				Fanton, Michael; Sganga, Jake; Camarillo, David B.			Vulnerable Locations on the Head to Brain Injury and Implications for Helmet Design	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							DIFFUSE AXONAL INJURY; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; CONCUSSION; IMPACTS; MODEL; SPORTS; ACCELERATION; BIOMECHANICS; CRITERION	In studying traumatic brain injury (TBI), it has been long hypothesized that the head is more vulnerable to injury from impacts in certain directions or locations, as the relationship between impact force and the resulting neurological outcome is complex and can vary significantly between individual cases. Many studies have identified head angular acceleration to be the putative cause of brain trauma, but it is not well understood how impact location can affect the resulting head kinematics and tissue strain. Here, we identify the susceptibility of the head to accelerations and brain strain from normal forces at contact points across the surface of the skull and jaw using a three-dimensional, 20-degree-of-freedom rigid-body head and cervical spine model. We find that head angular acceleration and brain tissue strain resulting from an input force can vary by orders of magnitude based on impact location on the skull, with the mandible as the most vulnerable region. Conversely, head linear acceleration is not sensitive to contact location. Using these analyses, we present an optimization scheme to distribute helmet padding thickness to minimize angular acceleration, resulting in a reduction of angular acceleration by an estimated 25% at the most vulnerable contact point compared to uniform thickness padding. This work gives intuition behind the relationship between input force and resulting brain injury risk, and presents a framework for developing and evaluating novel head protection gear.	[Fanton, Michael] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Sganga, Jake; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA		Fanton, M (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	mfanton@stanford.edu; sganga@stanford.edu; dcamarillo@stanford.edu			Office of Naval Research (ONR)Office of Naval Research [N00014-16-1-2949]; Stanford Child Health Research Institute (CHRI); National Science FoundationNational Science Foundation (NSF); Siebel Scholar Foundation; Stanford Bio-X Graduate Student Fellowship Program	Office of Naval Research (ONR) Young Investigator Program (N00014-16-1-2949).; The Stanford Child Health Research Institute (CHRI).; The National Science Foundation Graduate Student Fellowship Program (Funder ID: 10.13039/501100008982).; The Siebel Scholar Foundation (Funder ID: 10.13039/100011225).; Stanford Bio-X Graduate Student Fellowship Program (Funder ID: 10.13039/100011098).	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bliven E, 2019, ACCIDENT ANAL PREV, V124, P58, DOI 10.1016/j.aap.2018.12.017; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Cournoyer J, 2019, CLIN BIOMECH, V67, P96, DOI 10.1016/j.clinbiomech.2019.05.003; Department of Transportation NHTSA, 1971, OCC CRASH PROT HEAD; Dixit P, 2017, ARCH COMPUT METHOD E, V24, P979, DOI 10.1007/s11831-016-9196-x; Eckersley CP, 2019, J SCI MED SPORT, V22, P667, DOI 10.1016/j.jsams.2019.01.009; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Ewing C., 1978, 780888 SAE; Fanton M, 2019, IEEE T BIO-MED ENG, V66, P988, DOI 10.1109/TBME.2018.2866147; Gennarelli T. A., 2010, 872197 SAE; Gennarelli T. A., 2010, 720970 SAE; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giordano C., 2014, STAPP CAR CRASH J, V58, p14S; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Heck JF, 2004, J ATHL TRAINING, V39, P101; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hodgson V. R., 1983, SAE T, V92, P512; Holbourn AHS, 1943, LANCET, V2, P438; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; KHATIB O, 1995, INT J ROBOT RES, V14, P19, DOI 10.1177/027836499501400103; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kochenderfer MJ, 2019, ALGORITHMS FOR OPTIMIZATION; Kuo C, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0086; Kuo C, 2018, J BIOMECH, V76, P220, DOI 10.1016/j.jbiomech.2018.05.024; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Kurt M, 2017, ANN BIOMED ENG, V45, P1148, DOI 10.1007/s10439-016-1732-1; Laksari K., 2018, J NEUROTRAUMA; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Mortensen JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199912; Moss WC, 2011, IMPACT RESPONSE US A; NOCSAE, 2015, ND00213M15 NOCSAE; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2018, COMPUT METHOD BIOMEC, V21, P264, DOI 10.1080/10255842.2018.1445229; Rowson, 2018, VARSITY FOOTBALL HEL; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Taylor K., 2018, THESIS; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Versace J., 1971, 710881 SAE; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; WILLIAMS JL, 1983, J BIOMECH ENG-T ASME, V105, P321, DOI 10.1115/1.3138428; Withnall, 2017, NFL LINEAR IMPACTOR; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029	59	2	3	1	9	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	DEC	2019	141	12							121002	10.1115/1.4044876			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	KC0LE	WOS:000506878100003	31523753				2022-02-06	
J	Gibbons, PW; Goldberg, RJ; Muehlschlegel, S				Gibbons, Patric W.; Goldberg, Robert J.; Muehlschlegel, Susanne			A pilot study evaluating a simple cardiac dysfunction score to predict complications and survival among critically-ill patients with traumatic brain injury	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Cardiac dysfunction; ECG; Echo; Outcomes; Critical care	GLASGOW COMA SCALE; HEART; IMPACT	Purpose: To describe the frequency of cardiovascular complications and cardiac dysfunction in critically-ill patients with moderate-severe traumatic brain injury (msTBI) and cardiac factors associated with in-hospital survival. Methods: Retrospective analysis of a prospective cohort study at a single Level-1 trauma center with a dedicated neuro-trauma intensive care unit (ICU). Adult patients admitted to the ICU with msTBI were consecutively enrolled in the prospective OPTIMISM study between November 2009 and January 2017. Cardiac dysfunction was measured using a combination of EKG parameters, echocardiography abnormalities, and peak serum troponin-I levels during the index hospitalization. These items were combined into a cardiac dysfunction index (CDI), ranging from 0 to 3 points and modeled in a Cox regression analysis. Results: A total of 326 patients with msTBI were included. For every one-point increase in the CDI, the multivariable adjusted risk of dying during the patient's acute hospitalization more than doubled (adjusted HR 2.41; 95% CI 1.29-4.53). Conclusion: Cardiac dysfunction was common in patients with msTBI and independently associated with more severe brain injury and a reduction in hospital survival in this population. Further research is needed to validate the CDI and create more precise scoring tools. (C) 2019 Elsevier Inc. All rights reserved.	[Gibbons, Patric W.; Goldberg, Robert J.; Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, 55 Lake Ave, Worcester, MA 01655 USA; [Goldberg, Robert J.] Dept Quantitat Hlth Sci, Div Epidemiol Chron Dis & Vulnerable Populat, Worcester, MA USA; [Muehlschlegel, Susanne] Dept Neurol Neurocrit Care, Anesthesia Crit Care & Surg, Worcester, MA USA		Gibbons, PW (corresponding author), Univ Massachusetts, Med Sch, 55 Lake Ave, Worcester, MA 01655 USA.	Patric.gibbons@icloud.com			NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K23HD080971]; University of Massachusetts Medical School Center for Clinical and Translational Science [UL1TR000161]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971] Funding Source: NIH RePORTER	This work was supported by the NIH/NICHD (5K23HD080971 [PI Muehlschlegel]); The University of Massachusetts Medical School Center for Clinical and Translational Science (UL1TR000161).	Adeoye AM, 2017, GLOB HEART, V12, P99, DOI 10.1016/j.gheart.2017.01.002; Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bulsara KR, 2003, J NEUROSURG, V98, P524, DOI 10.3171/jns.2003.98.3.0524; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; Cheng K, 2017, J NEUROTRAUM, V34, P1603, DOI 10.1089/neu.2016.4657; Cheung Raymond T.F., 2004, Curr Treat Options Cardiovasc Med, V6, P199, DOI 10.1007/s11936-996-0014-x; Gao L, 2017, J NEUROTRAUM, V34, P2743, DOI 10.1089/neu.2016.4787; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; Krishnamoorthy V, 2018, CRIT CARE MED, V46, P965, DOI 10.1097/CCM.0000000000003052; Krishnamoorthy V, 2017, CRIT CARE MED, V45, P1028, DOI 10.1097/CCM.0000000000002404; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Manea M M, 2015, J Med Life, V8, P266; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Porto I, 2013, INT J CARDIOL, V167, P2441, DOI 10.1016/j.ijcard.2013.01.031; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Ranieri M, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0833-7; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van der Wall EE, 2013, NETH HEART J, V21, P51, DOI 10.1007/s12471-012-0369-4; Veillet-Chowdhury Mahdi, 2014, Acute Card Care, V16, P15, DOI 10.3109/17482941.2013.869346; Zangbar B, 2016, J SURG RES, V200, P586, DOI 10.1016/j.jss.2015.08.020	25	2	2	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2019	54						130	135		10.1016/j.jcrc.2019.08.017			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT4BE	WOS:000500935700025	31446230	Green Accepted			2022-02-06	
J	Hanson, E; Salzmann, A; Dorum, G; Fliss, B; Hess, S; Haas, C; Ballantyne, J				Hanson, Erin; Salzmann, Andrea; Dorum, Guro; Fliss, Barbara; Hess, Sabine; Haas, Cordula; Ballantyne, Jack			mRNA MPS tissue identification assay to aid in the investigation of traumatic injuries	FORENSIC SCIENCE INTERNATIONAL GENETICS SUPPLEMENT SERIES			English	Article						Massively parallel sequencing (MPS); Tissue identification; mRNA profiling; Forensic science		Molecular analysis of the RNA transcriptome from a putative tissue fragment should permit assignment to a specific organ since each tissue will exhibit a unique pattern of gene expression. Determination of the organ source of tissues from crime scenes may aid in shooting and stabbing investigations. We have developed a new prototype massively parallel sequencing (MPS) mRNA profiling assay for organ tissue identification, designed to definitively identify 13 organ/tissue types using a targeted panel of 48 mRNA biomarkers. The identifiable organs and tissues include brain, spinal cord, lung, trachea, liver, skeletal muscle, heart, kidney, adipose, intestine, stomach, skin and spleen. The biomarkers were chosen after iterative specificity testing of numerous candidate genes in various tissue types. The assay is very specific with little cross reactivity with non-targeted tissue, and can detect RNA mixtures from different tissues, including two- to five-tissue admixtures. The sensitivity of the assay was evaluated as well as assay reproducibility between library preparations and sequencing runs. We also demonstrate the ability of the assay to successfully identify the tissue source of origin in cadaver samples, tissue samples with varying post mortem intervals (PMI) and mock and bona fide casework samples. We are using the data to train a multivariate statistical model that predicts the tissue type based on the mRNA profile. By considering co-expression of markers the model can recognize distinct expression patterns in each tissue.	[Hanson, Erin; Ballantyne, Jack] Univ Cent Florida, Natl Ctr Forens Sci, Orlando, FL 32816 USA; [Salzmann, Andrea; Dorum, Guro; Fliss, Barbara; Haas, Cordula] Univ Zurich, Zurich Inst Forens Med, Zurich, Switzerland; [Hess, Sabine] Forens Sci Inst Zurich, Zurich, Switzerland; [Ballantyne, Jack] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA		Ballantyne, J (corresponding author), Univ Cent Florida, POB 162367, Orlando, FL 32816 USA.	Jack.Ballantyne@ucf.edu		Dorum, Guro/0000-0002-8566-3131	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice [2014-DN-BX-K019and2016-DN-BX-0165]	Portions of this work were funded by Award No. 2014-DN-BX-K019and2016-DN-BX-0165, awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The funders have no role in the study design, collection analysis or interpretation of data, in writing of the report or the decision to submit the paper for publication.	DiMaio V.J.M., 2015, P 9 EUR C ANT PROP E, P1; Hanson E, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110319	2	2	2	0	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1875-1768	1875-175X		FORENS SCI INT-GEN S	Forensic Sci. Int. Genet. Suppl. Ser.	DEC	2019	7	1					25	26		10.1016/j.fsigss.2019.09.012			2	Genetics & Heredity	Emerging Sources Citation Index (ESCI)	Genetics & Heredity	KD9YH	WOS:000508217000012		Bronze			2022-02-06	
J	Hersh, D; Armstrong, E; McAllister, M; Ciccone, N; Katzenellenbogen, J; Coffin, J; Thompson, S; Hayward, C; Flicker, L; Woods, D				Hersh, Deborah; Armstrong, Elizabeth; McAllister, Meaghan; Ciccone, Natalie; Katzenellenbogen, Judith; Coffin, Juli; Thompson, Sandra; Hayward, Colleen; Flicker, Leon; Woods, Deborah			General practitioners' perceptions of their communication with Australian Aboriginal patients with acquired neurogenic communication disorders	PATIENT EDUCATION AND COUNSELING			English	Article; Proceedings Paper	International Conference on Communication in Healthcare (ICCH)	SEP 01-04, 2018	Porto, PORTUGAL			General Practitioners; Australian Aboriginal patients; Acquired communication disorders; Stroke; Traumatic brain injury; Qualitative research	QUALITY-OF-LIFE; CULTURAL RESPECT; PRIMARY-CARE; HEALTH; STROKE; PEOPLE; APHASIA; REHABILITATION; PARTICIPATION; STRATEGIES	Objective: Aboriginal people have high rates of stroke and traumatic brain injury (TBI), often with residual, chronic communication deficits and multiple co-morbidities. This study examined general practitioners' (GPs') perceptions of their communication with Aboriginal patients with acquired communication disorders (ACD) after brain injury. Effective communication underpins good care but no previous research has explored this specific context. Methods: A qualitative descriptive approach was employed using interviews and focus groups with 23 GPs from metropolitan Perth and five regional sites in Western Australia. Data were analysed thematically. Results: GPs reported low visibility of Aboriginal patients with ACD in their practices, minimal training on neurogenic ACD, and difficulty distinguishing ACD from cultural-linguistic factors. They had few communication resources, and depended on families and Aboriginal Health Workers to assist in interactions. They rarely used formal interpreting services or referred to speech pathology. They reported communication (dis)ability having low priority in consultations. Conclusion: GPs report difficulty recognising ACD and their lack of prioritising assessment and treatment of communication ability after brain injury potentially compounds the disadvantage and disempowerment experienced by many Aboriginal people. Practice implications: GPs require further communication and cultural training. Improved access to speech pathology and formal interpreting services would be beneficial. (c) 2019 Elsevier B.V. All rights reserved.	[Hersh, Deborah; Armstrong, Elizabeth; McAllister, Meaghan; Ciccone, Natalie; Hayward, Colleen] Edith Cowan Univ, Speech Pathol, Perth, WA, Australia; [Katzenellenbogen, Judith; Coffin, Juli] Telethon Kids Inst, Broome, Australia; [Katzenellenbogen, Judith; Coffin, Juli] Telethon Kids Inst, Perth, WA, Australia; [Katzenellenbogen, Judith; Thompson, Sandra; Flicker, Leon] Univ Western Australia, CWA Ctr Rural Hlth, Perth, WA, Australia; [Flicker, Leon] Univ Western Australia, Royal Perth Hosp, Perth, WA, Australia; [Woods, Deborah] Geraldton Reg Aboriginal Med Serv, Geraldton, Australia		Hersh, D (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, 270 Joondalup Dr, Joondalup, WA 6027, Australia.	d.hersh@ecu.edu.au	; Thompson, Sandra/H-5955-2014	Hersh, Deborah/0000-0003-2466-0225; Thompson, Sandra/0000-0003-0327-7155; Ciccone, Natalie/0000-0002-1822-7217; Flicker, Leon/0000-0002-3650-0475; Katzenellenbogen, Judith/0000-0001-5287-5819; Armstrong, Elizabeth/0000-0003-4469-1117	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [1046228]	This work was supported by the National Health and Medical Research Council (NHMRC) Project Grant #1046228, 2013-2016.	Abbott P, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-167; Andrews Bruce, 2002, Aust J Rural Health, V10, P196, DOI 10.1046/j.1440-1584.2002.00440.x; Armstrong E., 2017, J CLIN PRACT SPEECH, V19, P4; Armstrong E, 2015, BRAIN IMPAIR, V16, P145, DOI 10.1017/BrImp.2015.15; Brady MC, 2011, DISABIL REHABIL, V33, P178, DOI 10.3109/09638288.2010.517897; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cass A, 2002, MED J AUSTRALIA, V176, P466, DOI 10.5694/j.1326-5377.2002.tb04517.x; Cruice M, 2006, TOP STROKE REHABIL, V13, P14, DOI 10.1310/4JW5-7VG8-G6X3-1QVJ; Eades D., 1992, HDB LEGAL PRACTITION; Eades Diane, 1993, LANGUAGE CULTURE ABO, P181; Engelter ST, 2006, STROKE, V37, P1379, DOI 10.1161/01.STR.0000221815.64093.8c; Fatahi N, 2005, SCAND J PRIM HEALTH, V23, P159, DOI 10.1080/02813430510018509; Freeman T, 2014, AUST NZ J PUBL HEAL, V38, P355, DOI 10.1111/1753-6405.12231; Gauld S, 2011, DISABIL REHABIL, V33, P1901, DOI 10.3109/09638288.2010.550382; Graessel E, 2014, INT J REHABIL RES, V37, P212, DOI 10.1097/MRR.0000000000000060; Hemsley B, 2013, APHASIOLOGY, V27, P706, DOI 10.1080/02687038.2012.748181; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Jennings W, 2014, AUST J PRIM HEALTH, V20, P151, DOI 10.1071/PY12138; Katzenellenbogen JM, 2016, INT J STROKE, V11, P103, DOI 10.1177/1747493015607521; Katzenellenbogen JM, 2018, J HEAD TRAUMA REHAB, V33, P412, DOI 10.1097/HTR.0000000000000371; Katzenellenbogen JM, 2011, STROKE, V42, P1515, DOI 10.1161/STROKEAHA.110.601799; Kendall E, 2004, REHABIL PSYCHOL, V49, P5, DOI 10.1037/0090-5550.49.1.5; Kendall E, 2015, ETHNIC HEALTH, V20, P437, DOI 10.1080/13557858.2014.921897; Kenny DA, 2010, SOC SCI MED, V70, P763, DOI 10.1016/j.socscimed.2009.10.065; Kilkenny MF, 2013, INT J STROKE, V8, P164, DOI 10.1111/j.1747-4949.2011.00717.x; Law J, 2005, DISABIL SOC, V20, P169, DOI 10.1080/09687590500059267; Liaw ST, 2015, AUST FAM PHYSICIAN, V44, P387; Lin I, 2014, AUST FAM PHYSICIAN, V43, P320; Lowell A, 2012, INT J SPEECH-LANG PA, V14, P200, DOI 10.3109/17549507.2012.663791; Minichiello V., 2008, IN DEPTH INTERVIEWIN; Morris MA, 2015, DISABIL HEALTH J, V8, P208, DOI 10.1016/j.dhjo.2014.09.007; Murphy J, 2006, HEALTH EXPECT, V9, P49, DOI 10.1111/j.1369-7625.2006.00366.x; Mushin I, 2009, J PRAGMATICS, V41, P2033, DOI 10.1016/j.pragma.2008.11.004; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pilnick A, 2011, SOC SCI MED, V72, P1374, DOI 10.1016/j.socscimed.2011.02.033; QSR International Pty Ltd, 2006, NVIVO QUALITATIVE DA; Ralph AP, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2689-y; Roberts C, 2005, MED EDUC, V39, P632, DOI 10.1111/j.1365-2929.2005.02171.x; Roberts C, 2005, MED EDUC, V39, P465, DOI 10.1111/j.1365-2929.2005.02121.x; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Shahid S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-460; Shahid S, 2011, AUST HEALTH REV, V35, P235, DOI 10.1071/AH09835; Shahid S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-60; Thomson A, 2016, AUST NZ J PUBL HEAL, V40, pS75, DOI 10.1111/1753-6405.12412; van Mierlo ML, 2014, INT J STROKE, V9, P341, DOI 10.1111/ijs.12149; Worrall L, 2011, APHASIOLOGY, V25, P309, DOI 10.1080/02687038.2010.508530	46	2	2	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0738-3991			PATIENT EDUC COUNS	Patient Educ. Couns.	DEC	2019	102	12					2310	2317		10.1016/j.pec.2019.07.029			8	Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Public, Environmental & Occupational Health; Social Sciences - Other Topics	JM3PJ	WOS:000496130200022	31427169	Green Published			2022-02-06	
J	Ivins, BJ; Arrieux, JP; Schwab, KA; Haran, FJ; Cole, WR				Ivins, Brian J.; Arrieux, Jacques P.; Schwab, Karen A.; Haran, F. J.; Cole, Wesley R.			Using Rates of Low Scores to Assess Agreement between Brief Computerized Neuropsychological Assessment Batteries: A Clinically-based Approach for Psychometric Comparisons	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Psychometrics; Agreement; Base rates; Low scores; Effect size; Mild traumatic brain injury	NEUROCOGNITIVE ASSESSMENT TOOLS; TRAUMATIC BRAIN-INJURY; HEAD-TO-HEAD; RELIABILITY; VALIDATION; IMPACT	Objective: To assess agreement between four brief computerized neurocognitive assessment tools (CNTs), ANAM, CogState, CNS Vital Signs, and ImPACT, by comparing rates of low scores. Methods: Four hundred and six US Army service members (SMs) with and without acute mild traumatic brain injury completed two randomly assigned CNTs with order of administration also randomly assigned. We performed a base rate analysis for each CNT to determine the proportions of SMs in the control and mTBI groups who had various numbers of scores that were 1.0+, 1.5+, and 2.0+ standard deviations below the normative mean. We used these results to identify a hierarchy of low score levels ranging from poorest to least poor performance. We then compared the agreement between every low score level from each CNT pair administered to the SMs. Results: More SMs in the mTBI group had low scores on all CNTs than SMs in the control group. As performance worsened, the association with mTBI became stronger for all CNTs. Most if not all SMs who performed at the worst level on any given CNT also had low scores on the other CNTs they completed but not necessarily at an equally low level. Conclusion: These results suggest that all of the CNTs we examined are broadly similar but still retain some psychometric differences that need to be better understood. Furthermore, the base rates of low scores we present could themselves be useful to clinicians and researchers as a guide for interpreting results from the CNTs.	[Ivins, Brian J.; Schwab, Karen A.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Ivins, Brian J.; Arrieux, Jacques P.] Gen Dynam Hlth Solut, Fairfax, VA USA; [Arrieux, Jacques P.] Def & Vet Brain Injury Ctr, Ft Bragg, NC USA; [Arrieux, Jacques P.; Cole, Wesley R.] Womack Army Med Ctr, Intrepid Spirit, Ft Bragg, NC USA; [Schwab, Karen A.] Salient CRGT, Fairfax, VA USA; [Schwab, Karen A.; Haran, F. J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Ivins, BJ (corresponding author), Def & Vet Brain Injury Ctr, Div Res, 1335 East West Hwy, Silver Spring, MD 20910 USA.	Brian.Ivins@gdit.com			Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs [W91-YTZ-13-C-0015]; General Dynamics Health Solutions	The study was internally funded by the Defense and Veterans Brain Injury Center through contract W91-YTZ-13-C-0015 with General Dynamics Health Solutions.	Allen L. M, 2006, COMPUTERIZED ASSESSM; [Anonymous], 2018, WHAT IS BAS POST TES; Arrieux Jacques P, 2017, Concussion, V2, pCNC31, DOI 10.2217/cnc-2016-0021; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Broglio SP, 2007, J ATHL TRAINING, V42, P509; CNS Vital Signs LLC, 2014, CNS VIT SIGNS INT GU; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cole WR, 2018, ARCH CLIN NEUROPSYCH, V33, P102, DOI 10.1093/arclin/acx036; Cole WR, 2017, J CLIN EXP NEUROPSYC, V39, P35, DOI 10.1080/13803395.2016.1198470; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Crawford JR, 2007, NEUROPSYCHOLOGY, V21, P419, DOI 10.1037/0894-4105.21.4.419; Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury, 2015, INF MEM 1 QUART CAL; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Friedman LM, 2010, FUNDAMENTALS OF CLINICAL TRIALS, FOURTH EDITION, P1, DOI 10.1007/978-1-4419-1586-3_1; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; IBM Corp, 2016, IBM SPSS STAT WINDOW; ImPACT Applications Inc, 2011, IMM POSTC ASS TEST I; Ingraham LJ, 1996, NEUROPSYCHOLOGY, V10, P120, DOI 10.1037/0894-4105.10.1.120; Ivins BJ, 2015, ARCH CLIN NEUROPSYCH, V30, P26, DOI 10.1093/arclin/acu072; Kianifard F, 1995, J Biopharm Stat, V5, P115, DOI 10.1080/10543409508835101; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Nelson LD, 2017, J INT NEUROPSYCH SOC, V23, P293, DOI 10.1017/S1355617717000157; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289	28	2	2	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2019	34	8					1392	1408		10.1093/arclin/acz004			17	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	KF8XX	WOS:000509521200010	30796808				2022-02-06	
J	Jang, SH; Lee, HD				Jang, Sung Ho; Lee, Han Do			Diagnostic Approach to Traumatic Axonal Injury of the Spinothalamic Tract in Individual Patients with Mild Traumatic Brain Injury	DIAGNOSTICS			English	Article						Spinothalamic tract; Mild traumatic brain injury; Traumatic axonal injury; Diffusion tensor tractography	NEUROPATHIC PAIN; PATHOPHYSIOLOGY; TRACTOGRAPHY; MECHANISMS	Objectives: We investigated an approach for the diagnosis of traumatic axonal injury (TAI) of the spinothalamic tract (STT) that was based on diffusion tensor tractography (DTT) results and a statistical comparison of individual patients who showed central pain following mild traumatic brain injury (mTBI) with the control group. Methods: Five right-handed female patients in their forties and with central pain following mTBI and 12 age-, sex-, and handedness-matched healthy control subjects were recruited. After DTT reconstruction of the STT, we analyzed the STT in terms of three DTT parameters (fractional anisotropy (FA), mean diffusivity (MD), and fiber number (FN)) and its configuration (narrowing and tearing). To assess narrowing, we determined the area of the STT on an axial slice of the subcortical white matter. Results: the FN values were significantly lower in at least one hemisphere of each patient when compared to those of the control subjects (p < 0.05). Significant decrements from the STT area in the control group were observed in at least one hemisphere of each patient (p < 0.05). Regarding configurational analysis, the STT showed narrowing and/or partial tearing in at least one hemisphere of each of the five patients. Conclusions: Herein, we demonstrate a DTT-based approach for the diagnosis of TAI of the STT. The approach involves a statistical comparison between DTT parameters of individual patients who show central pain following mTBI and those of an age-, gender-, and handedness-matched control group. We think that the method described in this study can be useful in the diagnosis of TAI of the STT in individual mTBI patients.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, HyunChungro 170, Daegu 705717, South Korea; [Lee, Han Do] Ulsan Coll Univ, Coll Nat Sci, Dept Phys Therapy, Bongsuro 101 Dongku, Ulsan 44022, South Korea		Lee, HD (corresponding author), Ulsan Coll Univ, Coll Nat Sci, Dept Phys Therapy, Bongsuro 101 Dongku, Ulsan 44022, South Korea.	rehab6467@hanmail.net; lhd890221@hanmail.net			Medical Research Center Program [2015R1A5A2009124]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Barad M., 2009, CONTINUUM MINNEAP MI, V15, P30, DOI 10.1212/01.con.0000348853.20265.b7; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967; Devulder J, 2002, ACTA NEUROL BELG, V102, P97; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Hong JH, 2010, NEUROSCI LETT, V468, P102, DOI 10.1016/j.neulet.2009.10.075; Jang S.H., 2018, BRAIN NEUROREHABIL, V11, pe7, DOI [10.12786/bn.2018.11.e7, DOI 10.12786/BN.2018.11.E7]; Jang SH, 2018, TRAUMATIC BRAIN INJU, P137, DOI DOI 10.5772/INTECHOPEN.70988; Jang SH, 2018, AM J PHYS MED REHABI, V98, pe92, DOI DOI 10.1097/PHM.0000000000001078; Jang SH, 2017, AM J PHYS MED REHAB, V96, pE130, DOI 10.1097/PHM.0000000000000630; Jang SH, 2009, NEUROREHABILITATION, V24, P279, DOI 10.3233/NRE-2009-0479; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Seo Jeong Pyo, 2019, Investigative Magnetic Resonance Imaging, V23, P26; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shenton ME, 2018, INT J LAW PSYCHIAT, V61, P50, DOI 10.1016/j.ijlp.2018.09.002; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yamada K, 2009, P NATL ACAD SCI USA, V106, pE14, DOI 10.1073/pnas.0812352106	30	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	DEC	2019	9	4							199	10.3390/diagnostics9040199			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KB6YH	WOS:000506637600072	31766511	Green Published, gold			2022-02-06	
J	Joubert, C; Sellier, A; Morvan, JB; Beucler, N; Bordes, J; Dagain, A				Joubert, Christophe; Sellier, A.; Morvan, J-B; Beucler, N.; Bordes, J.; Dagain, A.			Vacuum-assisted closure (VAC) for craniocerebral wounds in severely injured patients: technical note of a damage control procedure	JOURNAL OF THE ROYAL ARMY MEDICAL CORPS			English	Article						vacuum-assisted closure; penetrating craniocerebral trauma; severe traumatic brain injury; damage control; trauma management	GUNSHOT WOUNDS; BRAIN; HEAD; MANAGEMENT; SCALP	The management of a craniocerebral wound (CCW) remains challenging, particularly in a severely injured patient. Considering the complexity of the multilayer insult and damage control care in an unstable patient, every procedure performed should promptly benefit the patient. We report an illustrative case of a patient with a gunshot wound to the head that resulted in a CCW for which we applied vacuum-assisted closure (VAC) therapy according to damage control principles. We describe the technical approach and discuss the indications, results and technique by considering the literature available. VAC can be used for CCWs, particularly for large defects in selected patients according to clinical and CT evaluations following immediate resuscitation. In severely injured and unstable patients, VAC aims to delay definitive reconstructive and time-consuming treatment. Interestingly, it appears to be a safe treatment based on the previously described-but not exclusively trauma-cases with no secondary cerebrospinal fluid leakage encountered.	[Joubert, Christophe; Sellier, A.; Beucler, N.; Dagain, A.] Mil Teaching Hosp St Anne, Neurosurg, Toulon Armees, France; [Morvan, J-B] Mil Teaching Hosp St Anne, Ear Nose Throat & Cervicofacial Surg, Toulon Armee, France; [Bordes, J.] HIA St Anne, Anesthesiol & Intens Care Unit, Toulon Armees, France		Joubert, C (corresponding author), Neurosurg, F-83000 Toulon, France.	christophe.joubert@neurochirurgie.fr	Joubert, Christophe/AAU-4807-2020				Aarabi B, 2001, J TRAUMA, V51, pS3; Afifi AM, 2010, J CRANIOFAC SURG, V21, P1205, DOI 10.1097/SCS.0b013e3181e17c1e; Ambrosi PB, 2012, NEUROSURG REV, V35, P429, DOI 10.1007/s10143-012-0377-2; Andrews BT, 2006, HEAD NECK-J SCI SPEC, V28, P974, DOI 10.1002/hed.20496; Bordes J, 2017, INJURY, V48, P1047, DOI 10.1016/j.injury.2016.11.023; Carey ME, 2003, SURG NEUROL, V60, P112, DOI 10.1016/S0090-3019(03)00352-5; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; Dagain A, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.9.FOCUS18368; Dagain A, 2017, WORLD NEUROSURG, V102, P6, DOI 10.1016/j.wneu.2017.02.097; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Kim EK, 2008, J CRANIOFAC SURG, V19, P1577, DOI 10.1097/SCS.0b013e3181897376; Morykwas MJ, 2006, PLAST RECONSTR SURG, V117, p121S, DOI 10.1097/01.prs.0000225450.12593.12; Morykwas MJ, 1997, ANN PLAS SURG, V38, P553, DOI 10.1097/00000637-199706000-00001; Powers AK, 2013, J NEUROSURG, V118, P302, DOI 10.3171/2012.10.JNS112241; Prince N, 2015, ANN PLAS SURG, V74, pS218, DOI 10.1097/SAP.0000000000000374; Satteson Ellen S, 2015, J Craniofac Surg, V26, pe599, DOI 10.1097/SCS.0000000000002047	16	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0035-8665	2052-0468		J ROY ARMY MED CORPS	J. R. Army Med. Corps	DEC	2019	165	6								10.1136/jramc-2019-001201			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT1MJ	WOS:000500761800001	30992341				2022-02-06	
J	Lewis, CT; Savarraj, JPJ; McGuire, MF; Hergenroeder, GW; Choi, HA; Kitagawa, RS				Lewis, Cole T.; Savarraj, Jude P. J.; McGuire, Mary F.; Hergenroeder, Georgene W.; Choi, H. Alex; Kitagawa, Ryan S.			Elevated inflammation and decreased platelet activity is associated with poor outcomes after traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Traumatic brain injury; Functional outcome; Inflammation; Cytokine levels; Early brain injury; Neuroinflammation; Cytokine analysis	GROWTH-FACTOR; ACTIVATION; INVOLVEMENT; DYSFUNCTION	The inflammatory processes following traumatic brain injury (TBI) have not been fully characterized. We hypothesize that differences in systemic cytokine/chemokine (CC) levels are associated with TBI clinical outcomes. To test this hypothesis, we examined systemic levels of CCs and their relationship with patient outcomes. Plasma from acute TBI subjects was collected at 24-48 h, and the CC levels were measured using a multiplex 41-plex-kit. Clinical outcomes were assessed using the modified Rankin scale (mRS) with good outcomes defined as mRS <= 3 and poor outcome as mRS >= 4. The differences in CC concentrations between groups were then compared using the Mann-Whitney U test. Seventy-six acute TBI subjects were included in this study. In the mRS >= 4 group, interleukin-6 (IL-6) and interleukin-10 (IL-10) were elevated, indicating early activation of immune reaction and modulation. Simultaneously, PDGFAA and RANTES were lower in the mRS >= 4 group. Poor outcomes after TBI were associated with elevated levels of IL-6 and IL-10 and lower levels of PDGFAA and RANTES within 24-48 h after injury.	[Lewis, Cole T.; Savarraj, Jude P. J.; McGuire, Mary F.; Hergenroeder, Georgene W.; Choi, H. Alex; Kitagawa, Ryan S.] Univ Texas Houston, McGovern Med Sch, Dept Neurosurg, 6400 Fannin St, Houston, TX 77030 USA		Kitagawa, RS (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Neurosurg, 6400 Fannin St, Houston, TX 77030 USA.	Ryan.S.Kitagawa@uth.tmc.edu	Savarraj, Jude/AAJ-4969-2021	Savarraj, Jude/0000-0003-0194-0734	CCTS KL2 Scholars programUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; UTHealth McGovern Medical School	Support from CCTS KL2 Scholars program, UTHealth McGovern Medical School.	Abboud A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00342; Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241; Bartels A, 2015, SURGERY, V158, P1012, DOI 10.1016/j.surg.2015.07.011; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Frontera JA, 2012, J THROMB HAEMOST, V10, P711, DOI 10.1111/j.1538-7836.2012.04651.x; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Jastrow KM, 2009, J AM COLL SURGEONS, V209, P320, DOI 10.1016/j.jamcollsurg.2009.05.002; John GR, 2005, GLIA, V49, P161, DOI 10.1002/glia.20109; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Linke B, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/1463216; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Parry PV, 2017, NEUROSURGERY, V80, P92, DOI 10.1227/NEU.0000000000001406; RANKIN J, 1957, Scott Med J, V2, P200; Ringheim GE, 1995, J NEUROIMMUNOL, V63, P113, DOI 10.1016/0165-5728(95)00134-4; Rowland B, 2020, SHOCK, V53, P24, DOI 10.1097/SHK.0000000000001349; Savarraj J, 2018, NEUROCRIT CARE, V28, P203, DOI 10.1007/s12028-017-0471-y; Savarraj JPJ, 2018, CYTOKINE, V111, P334, DOI 10.1016/j.cyto.2018.09.003; Savarraj JPJ, 2017, NEUROLOGY, V88, P1535, DOI 10.1212/WNL.0000000000003842; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; SOMA Y, 1992, FASEB J, V6, P2996, DOI 10.1096/fasebj.6.11.1644262; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	30	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2019	70						37	41		10.1016/j.jocn.2019.09.004			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JS5QM	WOS:000500360600007	31558362				2022-02-06	
J	Mazzeo, AT; Guaraldi, F; Filippini, C; Tesio, R; Settanni, F; Lucchiari, M; Mengozzi, G; Grottoli, S; Ghigo, E; Mascia, L				Mazzeo, Anna Teresa; Guaraldi, Federica; Filippini, Claudia; Tesio, Rachele; Settanni, Fabio; Lucchiari, Manuela; Mengozzi, Giulio; Grottoli, Silvia; Ghigo, Ezio; Mascia, Luciana			Activation of pituitary axis according to underlying critical illness and its effect on outcome	JOURNAL OF CRITICAL CARE			English	Article						Neuroendocrine dysfunction; Intensive care; Traumatic brain injury; Acute respiratory distress syndrome; Subarachnoid hemorrhage; Brain death	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; DYSFUNCTION; HYPOPITUITARISM; COPEPTIN; ADULTS; MANAGEMENT; SURVIVORS; SOCIETY; SCORE	Purpose: Critical illness is a life threatening condition inducing a severe acute physical stress. The aim of the study was to investigate the activation of pituitary axis early after ICU admission in patients with critical illnesses of different etiology and its association with outcome. Materials and methods: Patients admitted for acute respiratory distress syndrome (ARDS), severe traumatic brain injury (TBI), subarachnoid hemorrhage (SAH) and neurocritically ill patients at the moment of brain death (BD) diagnosis were included in the present post-hoc analysis. On day 1, 2-3 and 4-5 after admission the following pituitary axes were assessed: hypothalamic-pituitary-adrenal, hypothalamic-pituitary-thyroid, somatotroph, prolactin and copeptin. ICU mortality was used as outcome measure. Results: One hundred-thirteen critical ill patients were studied. Thyroid axis suppression and activation of copeptin axis were the most frequent pituitary hormone alterations, present in almost 60% of patients. Activation of the hypothalamic pituitary adrenal axis was a predictor of ICU mortality independently from the underlying critical illness [OR 3.952 (C.I.95% 1.129-13.838)]. Conclusions: Pituitary axis function is frequently altered early after ICU admission, the magnitude of hormonal response being different according to the underlying critical illness. The activation of the hypothalamic pituitary adrenal axis was a strong predictor of ICU mortality. (C) 2019 Elsevier Inc. All rights reserved.	[Mazzeo, Anna Teresa; Filippini, Claudia; Tesio, Rachele] Univ Torino, Azienda Osped Univ Citta Salute & Sci Torino, Dipartimento Sci Chirurg, Anestesiol & Rianimaz, Turin, Italy; [Guaraldi, Federica] Univ Bologna, Ctr Diag & Treatment Hypothalam Pituitary Disorde, Dept Biomed & Neuromotor Sci DIBINEM, IRCCS Inst Neurol Sci Bologna,Pituitary Unit, Bologna, Italy; [Settanni, Fabio; Lucchiari, Manuela; Mengozzi, Giulio] Azienda Osped Univ Citta Salute & Sci Torino, Div Lab, Turin, Italy; [Grottoli, Silvia; Ghigo, Ezio] Univ Torino, Azienda Osped Citta Salute & Sci Torino, Div Endocrinol Diabet & Metab, Turin, Italy; [Mascia, Luciana] Univ Roma La Sapienza, Dipartimento Sci & Biotecnol Med Chirurg, Anestesiol & Rianimaz, Corso Repubbl 79, I-04100 Rome, Italy		Mascia, L (corresponding author), Univ Roma La Sapienza, Dipartimento Sci & Biotecnol Med Chirurg, Anestesiol & Rianimaz, Corso Repubbl 79, I-04100 Rome, Italy.	anna.mazzeo@unito.it; claudia.filippini@unito.it; fsettann@unito.it; gmengozzi@cittadellasalute.to.it; silvia.grottoli@unito.it; ezio.ghigo@unito.it; luciana.mascia@uniroma1.it	Mengozzi, Giulio/AAY-5322-2020	Mengozzi, Giulio/0000-0003-0431-8369; Guaraldi, Federica/0000-0001-8416-1669; Mazzeo, Anna Teresa/0000-0002-8454-7243	University of Torino (grant CRT-B)	This work was supported by the University of Torino (grant CRT-B).	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 1998, J ENDOCRINOL INVEST, V21, P506, DOI 10.1007/BF03347336; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2003, CLIN ENDOCRINOL, V59, P56, DOI 10.1046/j.1365-2265.2003.01794.x; Annane D, 2017, INTENS CARE MED, V43, P1751, DOI 10.1007/s00134-017-4919-5; Assenzio B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116456; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boonen E, 2014, J CLIN ENDOCR METAB, V99, P4214, DOI 10.1210/jc.2014-2429; Boonen E, 2013, NEW ENGL J MED, V368, P1477, DOI 10.1056/NEJMoa1214969; Christ-Crain M, 2016, BEST PRACT RES CL EN, V30, P235, DOI 10.1016/j.beem.2016.02.003; Corneli Ginevra, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P301, DOI 10.1097/MED.0b013e3281e7e6e6; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; DRAKE CG, 1988, J NEUROSURG, V68, P985; Elijah IE, 2011, BEST PRACT RES CL EN, V25, P759, DOI 10.1016/j.beem.2011.06.002; Fleseriu M, 2016, J CLIN ENDOCR METAB, V101, P3888, DOI 10.1210/jc.2016-2118; Grottoli S, 2003, J Endocrinol Invest, V26, P27; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Jochberger S, 2009, CRIT CARE MED, V37, P476, DOI 10.1097/CCM.0b013e3181957532; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Klose M, 2018, NAT REV ENDOCRINOL, V14, P57, DOI 10.1038/nrendo.2017.103; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Kotloff RM, 2015, CRIT CARE MED, V43, P1291, DOI 10.1097/CCM.0000000000000958; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Mascia L, 2010, JAMA-J AM MED ASSOC, V304, P2620, DOI 10.1001/jama.2010.1796; Mazzeo AT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0624-5; Mebis L, 2011, BEST PRACT RES CL EN, V25, P745, DOI 10.1016/j.beem.2011.03.002; Papi G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00102; Peeters B, 2018, INTENS CARE MED, V44, P2048, DOI 10.1007/s00134-018-5427-y; Peeters B, 2018, INTENS CARE MED, V44, P1720, DOI 10.1007/s00134-018-5366-7; Peeters B, 2018, COMPR PHYSIOL, V8, P283, DOI 10.1002/cphy.c170022; Preiser JC, 2014, BRIT J ANAESTH, V113, P945, DOI 10.1093/bja/aeu187; Ranasinghe AM, 2009, BEST PRACT RES CLIN, V25, P799; Robba C, 2016, PITUITARY, V19, P522, DOI 10.1007/s11102-016-0733-2; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sharshar T, 2011, CRIT CARE, V15, DOI 10.1186/cc10010; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tan CL, 2017, J NEUROL NEUROSUR PS, V88, P971, DOI 10.1136/jnnp-2016-315500; TEASDALE G, 1974, LANCET, V2, P81; Terragni PP, 2013, ANESTHESIOLOGY, V119, P880, DOI 10.1097/ALN.0b013e3182a05bb8; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; Van den Berghe G, 2016, AM J RESP CRIT CARE, V194, P1337, DOI 10.1164/rccm.201607-1516CI; Van den Berghe G, 2014, THYROID, V24, P1456, DOI 10.1089/thy.2014.0201; Vassiliadi DA, 2014, J CLIN ENDOCR METAB, V99, P4471, DOI 10.1210/jc.2014-2619; Veldhuis JD, 2003, J ENDOCRINOL INVEST, V26, P799, DOI 10.1007/BF03345229; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Winzeler B, 2015, J CLIN ENDOCR METAB, V100, P2275, DOI 10.1210/jc.2014-4527; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575	52	2	2	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2019	54						22	29		10.1016/j.jcrc.2019.07.006			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT4BE	WOS:000500935700005	31326617				2022-02-06	
J	Montanino, A; Saeedimasine, M; Villa, A; Kleiven, S				Montanino, Annaclaudia; Saeedimasine, Marzieh; Villa, Alessandra; Kleiven, Svein			Axons Embedded in a Tissue May Withstand Larger Deformations Than Isolated Axons Before Mechanoporation Occurs	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						DAI; injury thresholds; mechanoporation; multiscale	TRAUMATIC BRAIN-INJURY; SPINAL-CORD AXONS; WHITE-MATTER; STRETCH-INJURY; MECHANICAL STRETCH; COMPOSITE MODEL; TAU PROTEINS; STRAIN-RATE; MICROTUBULES; TENSION	Diffuse axonal injury (DAI) is the pathological consequence of traumatic brain injury (TBI) that most of all requires a multiscale approach in order to be, first, understood and then possibly prevented. While in fact the mechanical insult usually happens at the head (or macro) level, the consequences affect structures at the cellular (or microlevel). The quest for axonal injury tolerances has so far been addressed both with experimental and computational approaches. On one hand, the experimental approach presents challenges connected to both temporal and spatial resolution in the identification of a clear axonal injury trigger after the application of a mechanical load. On the other hand, computational approaches usually consider axons as homogeneous entities and therefore are unable to make inferences about their viability, which is thought to depend on subcellular damages. Here, we propose a computational multiscale approach to investigate the onset of axonal injury in two typical experimental scenarios. We simulated single-cell and tissue stretch injury using a composite finite element axonal model in isolation and embedded in a matrix, respectively. Inferences on axonal damage are based on the comparison between axolemma strains and previously established mechanoporation thresholds. Our results show that, axons embedded in a tissue could withstand higher deformations than isolated axons before mechanoporation occurred and this is exacerbated by the increase in strain rate from 1/s to 10/s.	[Montanino, Annaclaudia; Kleiven, Svein] Royal Inst Technol KTH, Div Neuron Engn, SE-14152 Huddinge, Sweden; [Saeedimasine, Marzieh; Villa, Alessandra] Karolinska Inst, Dept Biosci & Nutr, SE-14152 Huddinge, Sweden		Montanino, A (corresponding author), Royal Inst Technol KTH, Div Neuron Engn, SE-14152 Huddinge, Sweden.		Villa, Alessandra/A-1554-2010	Villa, Alessandra/0000-0002-9573-0326; test, atypon/0000-0003-0572-6719	European UnionEuropean Commission [642662]; Swedish National Infrastructure for Computing [SNIC2017-1-491]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [VR-2016-05314]	European Union Horizon 2020 Research and Innovation Framework Programme, Marie Sklodowska-Curie (No. 642662; Funder ID: 10.13039/100010661).; Swedish National Infrastructure for Computing (SNIC2017-1-491).; Swedish Research Council (VR-2016-05314).	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Abolfathi N, 2009, COMPUT METHOD BIOMEC, V12, P249, DOI [10.1080/10255840802430587, 10.1080/10255840903097871]; Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bain A. C., 1999, 99SC19 SAE; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; BAUMGAERTEL M, 1989, RHEOL ACTA, V28, P511, DOI 10.1007/BF01332922; Bianchi F, 2018, J NEUROSCI METH, V309, P1, DOI 10.1016/j.jneumeth.2018.08.003; BRAY D, 1981, J NEUROCYTOL, V10, P589, DOI 10.1007/BF01262592; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chetta J, 2010, CYTOSKELETON, V67, P650, DOI 10.1002/cm.20478; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2012, J MECH BEHAV BIOMED, V5, P41, DOI 10.1016/j.jmbbm.2011.09.012; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; DENNERLL TJ, 1988, J CELL BIOL, V107, P665, DOI 10.1083/jcb.107.2.665; Duke T, 1996, BIOPHYS J, V71, P1235, DOI 10.1016/S0006-3495(96)79323-2; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; EVANS EA, 1977, J MEMBRANE BIOL, V30, P351; Faul M, 2010, TRAUMATIC BRAIN INJU; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Goldberg N., 2014, ARXIV14084655; Hao H, 2007, J BIOMECH ENG-T ASME, V129, P511, DOI 10.1115/1.2746372; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Holbourn AHS, 1943, LANCET, V2, P438; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; Javid S, 2014, J MECH BEHAV BIOMED, V30, P290, DOI 10.1016/j.jmbbm.2013.11.010; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Johnson V. E., 2018, ACTA NEUROPATHOL, P1; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Kazempour M, 2019, BIOMECH MODEL MECHAN, V18, P969, DOI 10.1007/s10237-019-01124-6; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Labus KM, 2016, J MECH BEHAV BIOMED, V62, P195, DOI 10.1016/j.jmbbm.2016.05.003; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; MALBOUISSON AMB, 1985, ANAT EMBRYOL, V171, P339, DOI 10.1007/BF00347022; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Mikula S, 2012, NAT METHODS, V9, P1198, DOI [10.1038/nmeth.2213, 10.1038/NMETH.2213]; Mohammadipour A, 2017, J BIOMECH, V65, P61, DOI 10.1016/j.jbiomech.2017.09.029; Montanino A., 2019, J NEUROTRAUMA; Montanino A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45446-y; Montanino A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00643; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison B., 2003, 2003220006 SAE; Nilsson M, 2012, NMR BIOMED, V25, P795, DOI 10.1002/nbm.1795; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Pan Y, 2013, FRONT BIOENG BIOTECH, V1, P1, DOI DOI 10.3389/FBIOE.2013.00019; Pan Y, 2011, IEEE T BIO-MED ENG, V58, P3443, DOI 10.1109/TBME.2011.2163189; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; Pullarkat PA, 2007, PHYS REP, V449, P29, DOI 10.1016/j.physrep.2007.03.002; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Rajagopalan J, 2010, BIOPHYS J, V99, P3208, DOI 10.1016/j.bpj.2010.09.029; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shreiber DI, 2009, BIOMECH MODEL MECHAN, V8, P311, DOI 10.1007/s10237-008-0137-y; Singh S, 2017, J BIOMECH, V51, P32, DOI 10.1016/j.jbiomech.2016.11.055; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; The MathWorks Inc., 2017, MATLAB VERS 9 3 R201; Thibault L.E., 1990, P INT C BIOM IMP LYO, P191; Tschoegl N. W, 2012, PHENOMENOLOGICAL THE; Yousefsani SA, 2018, J MECH BEHAV BIOMED, V88, P288, DOI 10.1016/j.jmbbm.2018.08.042; YU WQ, 1994, J NEUROSCI, V14, P2818; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang MG, 2014, BIOMECH MODEL MECHAN, V13, P1, DOI 10.1007/s10237-013-0481-4; Zhang Y., 2017, PLOS GENET, V13, P1	88	2	2	2	3	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	DEC	2019	141	12							124502	10.1115/1.4044953			9	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	KC0LE	WOS:000506878100014	31556941				2022-02-06	
J	Niemeier, JP				Niemeier, Janet P.			Biological Sex/Gender and Biopsychosocial Determinants of Traumatic Brain Injury Recovery Trajectories	CURRENT PHYSICAL MEDICINE AND REHABILITATION REPORTS			English	Article						Traumatic brain injury; Sex; gender; Rehabilitation; Outcomes; Biopsychosocial		Purpose of ReviewThe goals of the report are to integrate recent and key foundational gender- and sex-related, post-traumatic brain injury (TBI) literature across several research domains, to highlight need for increased cross-field communication using an integrative biopsychosocial research model, and to provide recommendations for further research approaches and foci.Recent FindingsRecent findings of TBI studies addressing gender and/or biological sex provide evidence of women's unique risks for injury, significant differences in severity, type, and number of post-TBI symptoms reported by women vs. men, and complex, interactive molecular, genetic, psychosocial, and physiological factors that contribute differently to TBI outcomes for the sexes.SummaryBrain injury researchers, following years of failed clinical trials and mixed findings, are adopting new methods for more precisely characterizing differing effects of sex on both responses to TBI and recovery trajectories as well as underlying causes of these differences. New approaches include analysis of large data sets, use of sophisticated statistical models, more consistent exploration of sex-specific effects of TBI in more TBI study domains, and use of more precise measures. Increased cross-field communication and collaboration, stratification by sex, and increased adoption of these approaches are recommended to help advance understanding of TBI and move us closer to treatment development.	[Niemeier, Janet P.] Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, 1717 6th Ave South, Birmingham, AL 35233 USA		Niemeier, JP (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, 1717 6th Ave South, Birmingham, AL 35233 USA.	jniemeier@uabmc.edu					Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Clayton JA, 2016, JAMA-J AM MED ASSOC, V316, P1863, DOI 10.1001/jama.2016.16405; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Davanzo JR, 2017, SURG CLIN N AM, V97, P1237, DOI 10.1016/j.suc.2017.08.001; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; de Abreu PMJE, 2014, MEMORY, V22, P323, DOI 10.1080/09658211.2013.781186; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Drapeau A, 2009, J BEHAV HEALTH SER R, V36, P372, DOI 10.1007/s11414-009-9168-0; Farace E, 2000, Neurosurg Focus, V8, pe6; Flanagan SR, 2015, ARCH PHYS MED REHAB, V96, P1753, DOI 10.1016/j.apmr.2015.07.001; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Gauvin-Lepage J, 2018, J HEAD TRAUMA REHAB, DOI [10.10897/HTR.0000000000000402, DOI 10.10897/HTR.0000000000000402]; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Herrera-Melero MC, 2015, BRAIN INJURY, V29, P1439, DOI 10.3109/02699052.2015.1071428; Howrey BT, 2017, ARCH PHYS MED REHAB, V98, P1606, DOI 10.1016/j.apmr.2017.03.009; Iverson KM., 2017, J INTERPERS VIOLENCE, V1, DOI [10.1177/088626051770491, DOI 10.1177/088626051770491]; Juengst SB, 2015, ARCH PHYS MED REHAB, V96, pe98, DOI [10.1016/j.apmr.2015.08.330, DOI 10.1016/J.APMR.2015.08.330]; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Lin CY, 2018, PM&R, V10, P1073, DOI 10.1016/j.pmrj.2018.03.008; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Lippa SM, 2018, J HEAD TRAUMA REHAB, V33, P101, DOI 10.1097/HTR.0000000000000353; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; Munro CA, 2012, AGING NEUROPSYCHOL C, V19, P759, DOI 10.1080/13825585.2012.690366; Murre JMJ, 2013, ACTA PSYCHOL, V142, P96, DOI 10.1016/j.actpsy.2012.10.005; National Institutes of Health, THIS IS ANN NIH GUID; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Niemeier JP, 2013, NEUROPSYCHOL REHABIL, V23, P363, DOI 10.1080/09602011.2012.761944; Olga NK, 2006, BEHAV BRAIN RES, V170, P233, DOI 10.1016/j.bbr.2006.02.026; Oyegbile TO, 2017, SLEEP MED, V40, P110, DOI 10.1016/j.sleep.2017.09.026; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Ranganathan P, 2016, BRAIN INJURY, V30, P452, DOI 10.3109/02699052.2016.1144081; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Richardson C, 2014, BRAIN INJURY, V28, P1711, DOI 10.3109/02699052.2014.954270; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Russell KC, 2012, BRAIN INJURY, V26, P984, DOI 10.3109/02699052.2012.660513; Saban KL, 2015, REHABIL NURS, V40, P277, DOI 10.1002/rnj.182; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG., 2017, FEAT SESS AM C REH A; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stergiou-Kita M, 2016, ARCH PHYS MED REHAB, V97, pS40, DOI 10.1016/j.apmr.2015.04.008; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Thompson HJ, 2015, ANNU REV NURS RES-SE, V33, P1, DOI 10.1891/0739-6686.33.1; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Wade DT, 2017, CLIN REHABIL, V31, P995, DOI 10.1177/0269215517709890; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0791-5; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weiss PS, 2013, ACS NANO, V7, P2873, DOI 10.1021/nn401796f; Wirth P, 2017, J NEUROSCI METH, V290, P133, DOI 10.1016/j.jneumeth.2017.07.030; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xiong C, 2016, DISABIL HEALTH J, V9, P439, DOI 10.1016/j.dhjo.2015.12.002; Yeung JHH, 2011, ARCH SURG-CHICAGO, V146, P436, DOI 10.1001/archsurg.2011.46; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429; Zuckerman SL, 2016, AM J SPORT MED, V44, pNP5, DOI 10.1177/0363546515623241; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	89	2	2	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2167-4833		CURR PHYS MED REHAB	Curr. Phys. Med. Rehabil. Rep.	DEC	2019	7	4					297	304		10.1007/s40141-019-00238-3			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VK2QF	WOS:000670357000001					2022-02-06	
J	Pan, PF; Bai, LL; Hua, XL; Wang, YQ; Jiang, XF; Cheng, X; Song, YL; Yu, XY				Pan, Pengfei; Bai, Linlin; Hua, Xiaoli; Wang, Yuqiang; Jiang, Xiaofang; Cheng, Xi; Song, Yunlin; Yu, Xiangyou			miR-155 Regulates claudin1 Expression in Humans With Intestinal Mucosa Dysfunction After Brain Injury	TRANSPLANTATION PROCEEDINGS			English	Article							BARRIER FUNCTION; CANCER CELLS; DIFFERENTIATION; PROMOTES; INVASION; DISEASE; GROWTH; ALPHA	Patients with craniocerebral trauma often have intestinal mucosal dysfunction, and the claudin1 protein plays an important role in intestinal mucosal function. Our previous work has shown that the expression of microRNA-155 (miR-155) in the peripheral blood of patients with craniocerebral trauma is decreased. Animal experiments also suggest that the expression of miR-155 is increased in the intestinal mucosa of mice with brain injury and the expression of claudin1 is decreased. We recruited 56 samples (35 patients with traumatic brain injury [TBI] and 21 patients without history of head trauma) to detect the expression of miR-155 on claudin1 regulation by quantitative polymerase chain reaction, reverse transcriptase polymerase chain reaction, and so on. We also used the receiver operating characteristic curve (ROC) to further evaluate the diagnostic value of the 2 biomarkers. From the results, we found that the expression level of miR-155 and claudin1 in the case group was lower than that in the control group. Human miR-155 (Hsa-miR-155) may positively regulate intestinal mucosal function by inhibiting the expression of claudin1, leading to intestinal mucosal barrier dysfunction. Combining the ROC curve data, the results further prove that miR-155 and claudin1 might be the new clinical diagnostic markers and treatment targets for the intestinal mucosal barrier dysfunction after TBI.	[Pan, Pengfei; Bai, Linlin; Hua, Xiaoli; Wang, Yuqiang; Jiang, Xiaofang; Cheng, Xi; Song, Yunlin; Yu, Xiangyou] Xinjiang Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Urumqi, Xinjiang, Peoples R China		Song, YL (corresponding author), 138 Liyushan South Rd, Urumqi, Xinjiang, Peoples R China.	17929294@qq.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81560310]	The work was supported by the National Natural Science Foundation of China (81560310). We thank the patients and healthy volunteers for their participation in our study.	Abdul-Maksoud RS, 2017, BRIT J BIOMED SCI, V74, P209, DOI 10.1080/09674845.2017.1343545; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Dinami R, 2014, CANCER RES, V74, P4145, DOI 10.1158/0008-5472.CAN-13-2038; Gan L, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007515, 10.1097/md.0000000000007515]; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Hernandez G, 2007, NEUROCRIT CARE, V7, P40, DOI 10.1007/s12028-007-0026-8; Hirshson CI, 2013, NEUROREHABILITATION, V32, P225, DOI 10.3233/NRE-130840; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Kwak YK, 2012, INFECT IMMUN, V80, P1670, DOI 10.1128/IAI.00001-12; Li XC, 2013, INT J MOL SCI, V14, P23910, DOI 10.3390/ijms141223910; Lin YH, 2018, GENE, V658, P63, DOI 10.1016/j.gene.2018.03.020; Ling HP, 2013, J SURG RES, V179, pE227, DOI 10.1016/j.jss.2012.03.030; Liu Y, 2012, TUMOR BIOL, V33, P2307, DOI 10.1007/s13277-012-0493-1; Mahdavi R, 2018, CLIN LAB, V64, P77, DOI 10.7754/Clin.Lab.2017.170618; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Pan PF, 2019, NEUROL SCI, V40, P1105, DOI 10.1007/s10072-019-03739-0; Quinn SR, 2014, J BIOL CHEM, V289, P4316, DOI 10.1074/jbc.M113.522730; Ragupathy S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.29166; de Medina FS, 2014, INFLAMM BOWEL DIS, V20, P2394, DOI 10.1097/MIB.0000000000000204; Stroynowska-Czerwinska A, 2014, CELL MOL LIFE SCI, V71, P2253, DOI 10.1007/s00018-013-1551-6; Swisshelm K, 1999, GENE, V226, P285, DOI 10.1016/S0378-1119(98)00553-8; Thai TH, 2013, P NATL ACAD SCI USA, V110, P20194, DOI 10.1073/pnas.1317632110; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ubelmann F, 2013, P NATL ACAD SCI USA, V110, pE1380, DOI 10.1073/pnas.1218446110; Wang WW, 2018, CELL MOL LIFE SCI, V75, P2627, DOI 10.1007/s00018-018-2753-8; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xiao DF, 2013, INT IMMUNOPHARMACOL, V17, P670, DOI 10.1016/j.intimp.2013.07.023; Yan LH, 2016, TUMOR BIOL, V37, P15925, DOI 10.1007/s13277-016-5446-7; Zhang GJ, 2013, INT J MOL MED, V31, P1375, DOI 10.3892/ijmm.2013.1348; Zhou JJ, 2017, ONCOL REP, V37, P1227, DOI 10.3892/or.2016.5290	31	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	DEC	2019	51	10					3474	3480		10.1016/j.transproceed.2019.08.042			7	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	JZ2RI	WOS:000504951000047	31810510	hybrid			2022-02-06	
J	Qiu, LM; Han, JX; See, AAQ; King, NKK				Qiu, Liming; Han, Julian Xinguang; See, Angela An Qi; King, Nicolas Kon Kam			Effects of anticoagulant and antiplatelet agents in severe traumatic brain injury in an asian population - A matched case-control study	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Severe traumatic brain injury; Antithrombotic agent; Anticoagulation; Antiplatelet; Mortality; Glasgow Outcome Scale	PREINJURY WARFARIN; INTRACRANIAL HEMORRHAGE; ELDERLY-PATIENTS; HEAD-INJURY; PLATELET TRANSFUSION; EXTERNAL VALIDATION; MRC CRASH; OUTCOMES; IMPACT; MORTALITY	The use of anticoagulation and antiplatelet agents (ACAP) has steadily increased over recent years. However, the effects of ACAP on traumatic brain injuries (TBI) are not well investigated. The aim of this study was to investigate the effects of pre-injury ACAP use on clinical outcome and mortality in severe TBI. A retrospective case-control study was performed for all patients who presented with severe TBI (GCS < 8) to the National Neuroscience Institute, Singapore, between 2006 and 2009. Patients with pre-injury ACAP use were compared to matched controls. Outcome measures were mortality at 14 days and 6 months, and Glasgow Outcome Score (GOS) at 6 months using a sliding dichotomy approach. Univariate analysis was performed using Chi-square and student's t-test and logistic regression was used to model the effect of ACAP on mortality rate. Forty-five patients with pre-injury use of ACAP were compared with matched controls. The mortality at 14 days (OR = 0.5, 95% CI 0.2-1.4) and 6 months (OR = 0.7, 95% CI 0.2-1.9) were not significantly different between the 2 groups. Using the sliding dichotomy approach, there was no difference in the odds for unfavorable functional outcomes at 6 months (OR = 1.2, 95% CI 0.4-3.7). In this case-control study, the use of ACAP did not have a significant effect on mortality and adverse outcomes in patients with severe TBI. This would suggest that in severe TBI, ACAP use may not contribute significantly to the overall prognosis. (C) 2019 Elsevier Ltd. All rights reserved.	[Qiu, Liming; Han, Julian Xinguang; See, Angela An Qi; King, Nicolas Kon Kam] Natl Neurosci Inst, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore; [Qiu, Liming; Han, Julian Xinguang; See, Angela An Qi; King, Nicolas Kon Kam] Singapore Gen Hosp, Outram Rd, Singapore 169608, Singapore; [King, Nicolas Kon Kam] Duke NUS Med Sch, 8 Coll Rd, Singapore 169857, Singapore		King, NKK (corresponding author), Natl Neurosci Inst, Dept Neurosurg, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	nicolas.kon.k.k@singhealth.com.sg		Kon Kam King, Nicolas/0000-0002-6009-4411			Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; Akinosoglou K, 2014, THROMB RES, V133, P131, DOI 10.1016/j.thromres.2013.07.002; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Batchelor JS, 2013, BRIT J NEUROSURG, V27, P12, DOI 10.3109/02688697.2012.705361; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; Cull JD, 2015, AM SURGEON, V81, P128; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Edwards P, 2005, LANCET, V365, P1957; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Guillotte AR, 2018, BRAIN INJURY, V32, P1849, DOI 10.1080/02699052.2018.1536805; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Howard JL, 2009, J TRAUMA, V66, P1518, DOI 10.1097/TA.0b013e3181a59728; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Julien J, 2017, J CLIN NEUROSCI, V38, P122, DOI 10.1016/j.jocn.2016.12.032; Karni A, 2001, AM SURGEON, V67, P1098; Lindblad C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00015; Macdonald RL, 2018, NEUROSURG CLIN N AM, V29, P605, DOI 10.1016/j.nec.2018.06.013; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Pang CH, 2015, J KOREAN NEUROSURG S, V58, P262, DOI 10.3340/jkns.2015.58.3.262; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pelaez CA, 2019, INJURY, V50, P73, DOI 10.1016/j.injury.2018.08.020; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Reuvers R., 2014, INT J EMERG MED, V9, P1; Sadaka F, 2014, J BLOOD DISORDERS TR, V5, P9864, DOI [10.4172/2155-9864.1000e113, DOI 10.4172/2155-9864.1000E113]; Saraf S, 2009, CLIN MED INSIGHTS-CA, V3, P77; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Siracuse JJ, 2010, SURGERY, V148, P724, DOI 10.1016/j.surg.2010.07.014; Sumiyoshi K, 2017, BRAIN INJURY, V31, P1445, DOI 10.1080/02699052.2017.1377349; Tykocki T, 2016, WORLD NEUROSURG, V89, P497, DOI 10.1016/j.wneu.2016.01.063; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Wang YH, 2018, THROMB RES, V166, P28, DOI 10.1016/j.thromres.2018.04.007; Wee XT, 2017, CLIN CARDIOL, V40, P1218, DOI 10.1002/clc.22811; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	43	2	2	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2019	70						61	66		10.1016/j.jocn.2019.08.087			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JS5QM	WOS:000500360600011	31606287				2022-02-06	
J	Taguchi, S; Choudhury, ME; Miyanishi, K; Nakanishi, Y; Kameda, K; Abe, N; Yano, H; Yorozuya, T; Tanaka, J				Taguchi, Satoru; Choudhury, Mohammed E.; Miyanishi, Kazuya; Nakanishi, Yuiko; Kameda, Kenji; Abe, Naoki; Yano, Hajime; Yorozuya, Toshihiro; Tanaka, Junya			Aggravating effects of treadmill exercises during the early-onset period in a rat traumatic brain injury model: When should rehabilitation exercises be initiated?	IBRO REPORTS			English	Article						Cylinder test; Beam test; IL-1 beta; CCL2; TGF beta; IL-6		Physical exercise is one of the best interventions for improving traumatic brain injury (TBI) outcomes. However, an argument has been raised regarding the timing at which physical exercise should be initiated. In this study, male Wistar rats were subjected to stab wounding of the right hemisphere to develop a TBI model and were forced to walk once on a treadmill at a 5-m/min pace at 24 h or 48 h after TBI for 10 min. Injured brain tissue was dissected after TBI to evaluate the effects of exercise. Behavioral abnormalities and motor impairment were assessed by various behavioral tests between 2 and 3 weeks after TBI. Exercise did not affect the circulating corticosterone levels and the weight of the adrenal glands. Exercise particularly that at 24 h, worsened the motor impairment of the left forelimbs. Quantitative reverse-transcription polymerase chain reaction showed that exercise at 24 h increased proinflammatory cytokines and chemokines on the third day while suppressing the proinflammatory reactions on the fourth day. Exercise at both time points decreased expression of transforming growth factor (TGF) beta 1 and its receptor TGF beta R1. Exercise at 24 h increased phosphorylation of I.B kinase on the fourth day, which may be correlated with the decreased effects of TGF beta 1. Even a low-intensity exercise activity could cause deleterious effects when it is initiated within 48 h after the onset of severe TBI, probably because of the resulting proinflammatory effects. Therefore, rehabilitation exercise programs should be initiated after 48 h of TBI onset.	[Taguchi, Satoru; Choudhury, Mohammed E.; Miyanishi, Kazuya; Nakanishi, Yuiko; Yano, Hajime; Tanaka, Junya] Ehime Univ, Grad Sch Med, Dept Mol & Cellular Physiol, Toon, Ehime, Japan; [Kameda, Kenji] Ehime Univ, Adv Res Support Ctr, Div Analyt Biomed, Toon, Ehime, Japan; [Abe, Naoki; Yorozuya, Toshihiro] Ehime Univ, Grad Sch Med, Dept Anesthesia & Perioperat Med, Toon, Ehime, Japan		Tanaka, J (corresponding author), Ehime Univ, Dept Mol & Cellular Physiol, Sch Med, Toon City, Ehime 7910295, Japan.	jtanaka@m.ehime-u.ac.jp	Choudhury, Mohammed/AAB-5611-2022; Miyanishi, Kazuya/AAM-4952-2021	Miyanishi, Kazuya/0000-0002-0010-4112; Tanaka, Junya/0000-0003-1056-5948	Ehime University [0503003000]; Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [17K16650]	We are grateful to the staff of the Animal Center, Ehime University, for their careful and gentle handling of the animals. The authors would like to thank Enago (WWW.enago.jp) for the English language review. This study was partly supported by grants from Ehime University (#0503003000) and Japan Society for the Promotion of Science (17K16650 to MEC).	Abe N, 2018, GLIA, V66, P2158, DOI 10.1002/glia.23469; Aono H, 2017, GLIA, V65, P1833, DOI 10.1002/glia.23199; Bernhardt J, 2008, STROKE, V39, P390, DOI 10.1161/STROKEAHA.107.492363; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Forrest Alexandra D, 2014, Curr Behav Neurosci Rep, V1, P100; Giraud SN, 2010, P NATL ACAD SCI USA, V107, P8416, DOI 10.1073/pnas.0910627107; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hayes K, 2008, ACTA NEUROPATHOL, V115, P289, DOI 10.1007/s00401-008-0340-z; Ishii Y, 2015, NEUROCHEM INT, V90, P56, DOI 10.1016/j.neuint.2015.07.010; Islam A, 2018, BBA-MOL BASIS DIS, V1864, P721, DOI 10.1016/j.bbadis.2017.12.022; Kazanis I, 2004, EXP NEUROL, V186, P221, DOI 10.1016/j.expneurol.2003.12.004; Li FW, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00311; Li FW, 2017, NEUROL RES, V39, P530, DOI 10.1080/01616412.2017.1315882; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mangiola A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/736104; Maulden SA, 2005, ARCH PHYS MED REHAB, V86, pS34, DOI 10.1016/j.apmr.2005.08.119; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Miyanishi K, 2019, NEUROCHEM INT, V122, P38, DOI 10.1016/j.neuint.2018.11.005; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; Nishioka R, 2016, EXP NEUROL, V277, P150, DOI 10.1016/j.expneurol.2015.12.016; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pietrelli A, 2012, NEUROSCIENCE, V202, P252, DOI 10.1016/j.neuroscience.2011.11.054; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Rimmer JH, 2010, AM J PHYS MED REHAB, V89, P249, DOI 10.1097/PHM.0b013e3181c9fa9d; Risedal A, 1999, J CEREBR BLOOD F MET, V19, P997, DOI 10.1097/00004647-199909000-00007; Shen JM, 2016, BRAIN RES, V1648, P266, DOI 10.1016/j.brainres.2016.08.001; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Sugimoto K, 2014, GLIA, V62, P185, DOI 10.1002/glia.22598; Svensson M, 2016, NEUROBIOL STRESS, V5, P8, DOI 10.1016/j.ynstr.2016.09.002; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tei N, 2013, J NEUROSCI RES, V91, P681, DOI 10.1002/jnr.23202; Tian S, 2013, BRAIN RES, V1533, P114, DOI 10.1016/j.brainres.2013.07.049; Tong YN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00113; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098; Yokoyama A, 2006, GLIA, V53, P754, DOI 10.1002/glia.20332; Yoon KJ, 2018, ANN REHABIL MED-ARM, V42, P643, DOI 10.5535/arm.2018.42.5.643; Zhang Pengyue, 2012, Front Biosci (Elite Ed), V4, P2476; Zhang Y, 2016, NEUROPSYCH DIS TREAT, V12, P3161, DOI 10.2147/NDT.S121779	40	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2451-8301			IBRO REP	IBRO Rep.	DEC	2019	7						82	89		10.1016/j.ibror.2019.10.002			8	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VJ5SJ	WOS:000608622100011	31720487	gold, Green Published			2022-02-06	
J	Var, SR; Byrd-Jacobs, CA				Var, Susanna R.; Byrd-Jacobs, Christine A.			ISMicroglial response patterns following damage to the zebrafish olfactory bulb	IBRO REPORTS			English	Article						Microglia; Immune response; Deafferentation; Direct lesion; Olfactory bulb; Zebrafish	PERIPHERAL SENSORY DEAFFERENTATION; TRAUMATIC BRAIN-INJURY; STAB INJURY; REVERSIBLE DEAFFERENTATION; REGENERATIVE RESPONSE; RESIDENT MICROGLIA; EARLY MACROPHAGES; APOPTOTIC CELLS; SPINAL-CORD; ADULT	The inherent plasticity of the zebrafish olfactory system serves as a useful model for examining immune cell responses after injury. Microglia are the resident immune cells of the CNS that respond to damage by migrating to the site of injury and phagocytizing neuronal debris. While the olfactory system is renowned for its ability to recover from damage, the specific mechanisms of microglial involvement in olfactory system plasticity are unknown. To approach the potentially time-dependent effects of microglial activation after injury, we performed a time course analysis of microglial response profiles and patterns following different forms of damage: deafferentation by cautery ablation of the olfactory organ, deafferentation by chemical ablation of the olfactory epithelium, and direct lesioning of the olfactory bulb. Our aim was to demonstrate that immunocytochemistry and microscopy methods in zebrafish can be used to determine the timing of distinct microglial response patterns following various forms of injury. We found that permanent and temporary forms of damage to the olfactory bulb resulted in different microglial response profiles from 1 to 72 h after injury, suggesting that there may be critical timepoints in which microglia are activated that contribute to tissue and neuronal repair with a regenerative outcome versus a degenerative outcome. These distinctions between the different forms of damage suggest temporal changes relative to the potential for regeneration, since cautery deafferentation is permanent and unrecoverable while chemical ablation deafferentation and direct lesioning is reversible and can be used to observe the microglial relationship in neural regeneration and functional recovery in future studies.	[Var, Susanna R.; Byrd-Jacobs, Christine A.] Western Michigan Univ, Kalamazoo, MI 49008 USA		Byrd-Jacobs, CA (corresponding author), Western Michigan Univ, Kalamazoo, MI 49008 USA.				WMU funds; WMU graduate student research grant	We are very grateful to A. McKenna and Dr. D. Trimpe for their contributions to initial studies of this project. This work was supported financially by WMU funds (CBJ) and WMU graduate student research grant (SRV).	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Anand SK, 2018, NEUROSCI LETT, V672, P28, DOI 10.1016/j.neulet.2018.02.040; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Becker T, 2001, J COMP NEUROL, V433, P131, DOI 10.1002/cne.1131; Brann JH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00182; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Bruttger J, 2015, IMMUNITY, V43, P92, DOI 10.1016/j.immuni.2015.06.012; Byrd CA, 2001, NEUROSCIENCE, V105, P793, DOI 10.1016/S0306-4522(01)00215-9; Byrd CA, 2000, BRAIN RES, V866, P92, DOI 10.1016/S0006-8993(00)02252-6; Cacialli P, 2018, NEURAL REGEN RES, V13, P941, DOI 10.4103/1673-5374.233430; Calvo CF, 1996, EUR J NEUROSCI, V8, P1725, DOI 10.1111/j.1460-9568.1996.tb01316.x; Carrillo SA, 2016, J CELL BIOCHEM, V117, P1880, DOI 10.1002/jcb.25487; Charles ASD, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160102; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gomez-Nicola D, 2015, NEUROSCIENTIST, V21, P169, DOI 10.1177/1073858414530512; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Harry GJ, 2012, NEUROTOXICOLOGY, V33, P191, DOI 10.1016/j.neuro.2012.01.012; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Inman KE, 2007, GENESIS, V45, P237, DOI 10.1002/dvg.20281; Iqbal T, 2010, CHEM SENSES, V35, P351, DOI 10.1093/chemse/bjq019; Jonas RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030763; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; MCCARTHY GF, 1988, J COMP NEUROL, V271, P589, DOI 10.1002/cne.902710409; Missinato MA, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.157206; Mittelbronn M, 2001, ACTA NEUROPATHOL, V101, P249; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Paskin TR, 2011, NEUROSCIENCE, V196, P276, DOI 10.1016/j.neuroscience.2011.09.005; Paskin TR, 2012, BEHAV BRAIN RES, V235, P293, DOI 10.1016/j.bbr.2012.08.018; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Pozzuto JM, 2019, J BIOENERG BIOMEMBR, V51, P29, DOI 10.1007/s10863-018-9772-x; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00566; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scheib JJ, 2019, J NEUROSCI METH, V311, P47, DOI 10.1016/j.jneumeth.2018.10.014; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shimizu Y, 2018, GLIA, V66, P1382, DOI 10.1002/glia.23311; Silverman SM, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0089-0; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Tsarouchas TM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07036-w; van Ham TJ, 2014, DIS MODEL MECH, V7, P857, DOI 10.1242/dmm.014886; Vankirk AM, 2003, J COMP NEUROL, V455, P488, DOI 10.1002/cne.10502; Varvel NH, 2012, P NATL ACAD SCI USA, V109, P18150, DOI 10.1073/pnas.1210150109; Villanueva R, 2009, BRAIN RES, V1269, P31, DOI 10.1016/j.brainres.2009.03.005; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; White EJ, 2015, NEUROSCIENCE, V284, P622, DOI 10.1016/j.neuroscience.2014.10.036; Woodcock TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188305	61	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2451-8301			IBRO REP	IBRO Rep.	DEC	2019	7						70	79		10.1016/j.ibror.2019.08.002			10	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VJ5SJ	WOS:000608622100008	31650065	Green Published, gold			2022-02-06	
J	Wang, W; Mu, SW; Xue, L; Liang, SX; Li, ZF; Wang, SS				Wang, Wei; Mu, Shuwen; Xue, Liang; Liang, Shengxiang; Li, Zuanfang; Wang, Shousen			Wide-area measurement-based supervision of the cerebral venous hemodynamic in a novel rat model	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Animal model; Cerebral venous blood flow; Acute epidural hematoma; Secondary brain injury; Laser speckle contrast imaging	TRAUMATIC BRAIN-INJURY; PRESSURE	Background: Traumatic brain injury (TBI) includes primary and secondary injuries, while monitoring intracranial pressure (ICP) and cerebral blood flow (CBF) is conducive to improve the prognosis of patients. However, the function of cerebral venous in this process is still unclear. New method: An acute epidural hematoma (AEDH) model was developed by placing a controllable micro balloon in the right epidural space of a rat. The laser speckle contrast imaging (LSCI) system was used to observe CBF in real time, while ICP was monitored simultaneously. And the stability of this model was examined by magnetic resonance imaging (MRI). Results: The blood perfusion rate (BPR) of venous was significantly negatively correlated with ICP. In the 100 mu L group, the ipsilateral cerebral venous and microcirculation blood flow significantly decreased. According to the gross observations and pathological results, ischemic brain injury was the most serious on this condition. Comparison with existing method(s): Modeling method is relatively simple, which effectively reduces the cost. The volume of the micro balloon is adjusted to simulate the volume of different size of hematomas. In addition, LSCI, as an advanced blood flow monitoring technology, has high sensitivity to detect subtle changes in CBF. Conclusion: This study successfully developed a stable and reproducible AEDH rat model. Based on this model, it is preliminarily demonstrated that local intracranial hypertension can cause cerebral venous return restriction, which is an indispensable factor leading to the aggravation of secondary brain injury.	[Wang, Wei; Wang, Shousen] Fujian Med Univ, Fuzong Clin Med Coll, Xierhuanbei Rd 156, Fuzhou 350025, Fujian, Peoples R China; [Mu, Shuwen] Xiamen Univ, Hosp 900, Dongfang Affiliated Hosp, Dept Neurosurg, Fuzhou 350025, Fujian, Peoples R China; [Xue, Liang; Wang, Shousen] 900 Hosp, Joint Logist Team, Dept Neurosurg, Fuzhou 350025, Fujian, Peoples R China; [Liang, Shengxiang] Fujian Univ Tradit Chinese Med, Natl Local Joint Engn Res Ctr Rehabil Med Technol, Fuzhou 350122, Fujian, Peoples R China; [Li, Zuanfang] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Fuzhou 350122, Fujian, Peoples R China		Wang, SS (corresponding author), Fujian Med Univ, Fuzong Clin Med Coll, Xierhuanbei Rd 156, Fuzhou 350025, Fujian, Peoples R China.	wshsen@126.com		Wang, Wei/0000-0002-9171-9269	Startup Fund for scientific research, Fujian Medical University [2017XQ2049]; Major Science and Technology Projects of General Logistics Department of Chinese People's Liberation Army [AHJ14J001]; Key Project of Science and Technology Plan of Fujian Province, China [2014Y0036]	This work was financially supported by Startup Fund for scientific research, Fujian Medical University (no. 2017XQ2049); Major Science and Technology Projects of General Logistics Department of Chinese People's Liberation Army (no. AHJ14J001); Key Project of Science and Technology Plan of Fujian Province, China (no. 2014Y0036).	Akbik OS, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0672-3; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cheng HW, 2017, ONCOTARGET, V8, P93373, DOI 10.18632/oncotarget.21795; Dunn AK, 2012, ANN BIOMED ENG, V40, P367, DOI 10.1007/s10439-011-0469-0; Friesenecker BE, 2006, CRIT CARE, V10, DOI 10.1186/cc4922; HE J, 2017, J CEREB BLOOD FLOW M, V27, DOI DOI 10.1002/NEM.1992; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Kasapas K, 2014, SCI WORLD J, DOI 10.1155/2014/504248; Lang EW, 2016, ACTA NEUROCHIR SUPPL, V122, P221, DOI 10.1007/978-3-319-22533-3_44; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Myers RB, 2016, CRIT CARE MED, V44, P1754, DOI 10.1097/CCM.0000000000001838; NATH FP, 1986, J NEUROSURG, V65, P697, DOI 10.3171/jns.1986.65.5.0697; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Radford K, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22330; Sacchetti DC, 2017, J CLIN NEUROSCI, V39, P4, DOI 10.1016/j.jocn.2017.02.054; Sagoo RS, 2017, J CEREBR BLOOD F MET, V37, P319, DOI 10.1177/0271678X15625350; Schuchardt F, 2017, STROKE, V48, P671, DOI 10.1161/STROKEAHA.116.015102; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Sundaram P.K, 2018, BRIT J NEUROSURG, P1; Unnerback M, 2018, ACTA NEUROCHIR, V160, P219, DOI 10.1007/s00701-017-3435-2; Wang W, 2018, WORLD NEUROSURG, V120, pE161, DOI 10.1016/j.wneu.2018.07.264	22	2	3	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	DEC 1	2019	328								108448	10.1016/j.jneumeth.2019.108448			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	JN0PL	WOS:000496606400029	31580850				2022-02-06	
J	Yang, JG; Sun, T; Yuan, YK; Li, XP; Yu, H; Guan, JW				Yang, Jingguo; Sun, Tong; Yuan, Yikai; Li, Xuepei; Yu, Hang; Guan, Junwen			Evaluation of titanium mesh cranioplasty and polyetheretherketone cranioplasty: protocol for a multicentre, assessor-blinded, randomised controlled trial	BMJ OPEN			English	Article							DECOMPRESSIVE CRANIECTOMY	Introduction Cranioplasty is a common surgery in neurosurgery department. However, restoring the integrity of skull brings many challenges to surgeons, and the selection of ideal implant materials is throughout the history of cranioplasty. Although titanium mesh was still preferred by many neurosurgeons in cranial reconstruction, the new polyetheretherketone (PEEK) material, for example, is gaining popularity for craniofacial reconstruction today. There remain limited data that compare the outcome of PEEK cranioplasty and titanium mesh cranioplasty. It is necessary to conduct a study to compare outcome of different materials for cranioplasty. Methods/design In this multicentre, assessor-blinded, randomised controlled study, we will randomise 140 patients in a 1:1 ratio to PEEK cranioplasty versus titanium cranioplasty. Eligible patients are adults who were diagnosed with cranial defect (due to severe traumatic brain injury, ischaemic stroke, haemorrhagic stroke, infiltrative tumour and so on), the defect size is over 25 cm(2), and they need to agree to participate in this trial. Instead of standard examinations, the enrolled patients receive neurological, motor, cognitive function and cerebral hemodynamics examinations as well as cosmetic evaluation. The procedures are repeated 3, 6 months after cranioplasty. The primary outcome, defined as infection or implant exposure after surgery, is the implant failure rate within 6 months. Secondary outcomes include postoperative complication rates, neurological outcomes, motor function, cerebral hemodynamics, cosmetic outcome and the total cost over a 6-month period. Ethics and dissemination This trial protocol has been approved by Biomedical Research Ethics Committee of West China Hospital of Sichuan University. All patients will be fully informed the implant materials, potential complications after surgery, responsibilities during the trial, and they will sign the informed consent before joining in this trial. If the patient's cognitive function is impaired, the patients next of kin would be carefully informed. The results will be disseminated through academic conferences, student theses and will be published in a peer-reviewed journal.	[Yang, Jingguo; Sun, Tong; Yuan, Yikai; Guan, Junwen] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China; [Li, Xuepei] Sichuan Univ, Coll Basic Med & Forens Med, Hlth Minist, Key Lab Chronobiol, Chengdu, Sichuan, Peoples R China; [Yu, Hang] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Inst Neurol, Chengdu, Sichuan, Peoples R China		Guan, JW (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.	guanjunwen_scu@163.com			Sichuan Science and Technology support program [2015SZ0193]; Johnson (Shanghai) Medical Equipment Co., LTD; Kontour(Xi'an)Medical Technology Co., LTD; Medprin Regenerative Medical Technologies Co., LTD.	This study is supported by Sichuan Science and Technology support program (2015SZ0193), along with unrestricted research grants from Johnson (Shanghai) Medical Equipment Co., LTD, Kontour(Xi'an)Medical Technology Co., LTD and Medprin Regenerative Medical Technologies Co., LTD.	Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Di Stefano C, 2016, BRAIN INJURY, V30, P164, DOI 10.3109/02699052.2015.1090013; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Hanasono MM, 2009, ANN PLAS SURG, V62, P653, DOI 10.1097/SAP.0b013e318184abc7; Harris DA, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13560; HENRY HM, 1976, J NEUROSURG, V45, P227, DOI 10.3171/jns.1976.45.2.0227; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Lethaus B, 2012, J NEUROTRAUM, V29, P1077, DOI 10.1089/neu.2011.1794; Punchak M, 2017, J CLIN NEUROSCI, V41, P30, DOI 10.1016/j.jocn.2017.03.028; Qiu SZ, 2019, J CRANIOFAC SURG, V30, pE241, DOI 10.1097/SCS.0000000000005192; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; Shahid AH, 2018, J NEUROSURG, V128, P229, DOI 10.3171/2016.10.JNS16678; SPENCE WT, 1954, J NEUROSURG, V11, P219, DOI 10.3171/jns.1954.11.3.0219; Sun Y, 2020, J BUS RES, V117, P615, DOI 10.1016/j.jbusres.2018.09.007; Thien A, 2015, WORLD NEUROSURG, V83, P176, DOI 10.1016/j.wneu.2014.06.003; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Yoshioka N, 2018, WORLD NEUROSURG, V119, pE734, DOI 10.1016/j.wneu.2018.07.255; Zanotti B, 2016, J CRANIOFAC SURG, V27, P2061, DOI 10.1097/SCS.0000000000003025; Zhang QM, 2018, WORLD NEUROSURG, V112, pE645, DOI 10.1016/j.wneu.2018.01.114	24	2	2	3	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	DEC	2019	9	12							e033997	10.1136/bmjopen-2019-033997			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KK5HS	WOS:000512773400286	31796495	Green Published, gold			2022-02-06	
J	Gannon, JM; Kelly, DL; Besch, A; Thakur, T; Khurana, N; Shurin, MR; Shurin, GV; Brar, JS; Cihakova, D; Talor, MV; Chengappa, KNR				Gannon, Jessica M.; Kelly, Deanna L.; Besch, Abigail; Thakur, Tanu; Khurana, Neil; Shurin, Michael R.; Shurin, Galina, V; Brar, Jaspreet S.; Cihakova, Daniela; Talor, Monica, V; Chengappa, K. N. Roy			Racial Differences in S100b Levels in Persons with Schizophrenia	PSYCHIATRIC QUARTERLY			English	Article						Schizophrenia; S100b; African-American; Caucasian; Inflammation; Race	NEURON-SPECIFIC ENOLASE; MYELIN BASIC-PROTEIN; CEREBROSPINAL-FLUID; S-100 PROTEIN; SERUM	The calcium-binding protein S100b is secreted by glial cells in the brain and is also expressed by melanocytes. In nanomolar concentrations, S100b is considered to be a neurotrophic factor, but in micromolar concentrations, it is thought to reflect CNS injury and inflammation. Seen as a potential biomarker in traumatic brain injury, meta-analytic data from several studies report that S100b levels are significantly higher in persons with long standing schizophrenia, but also among first-episode patients compared to healthy control subjects. However, ethnic or racial differences are typically not mentioned when reporting levels of S100b. We assessed serum S100b levels in persons with schizophrenia (n = 136) who were participants in two independent research studies using the same enzyme-linked immunoassay (ELISA). African-American subjects had significantly higher levels of S100b (41.9 pg/ml +/- 62.2) than Caucasian subjects (24.9 pg/ml +/- 45.4) in the combined dataset (Mann-Whitney U = 1307, p < 0.001), as well as in each independent study. There were no significant differences in S100b levels between men and women. No significant correlations were observed between S100b levels and demographic or clinical variables. These data suggest that ethnicity or race should be given serious consideration when studying and interpreting S100b levels in persons with schizophrenia.	[Gannon, Jessica M.; Besch, Abigail; Brar, Jaspreet S.; Chengappa, K. N. Roy] Univ Pittsburgh, Western Psychiat Hosp, Med Ctr, 3811 OHara St, Pittsburgh, PA 15213 USA; [Gannon, Jessica M.; Besch, Abigail; Chengappa, K. N. Roy] Univ Pittsburgh, Sch Med, 3811 OHara St, Pittsburgh, PA 15213 USA; [Kelly, Deanna L.] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA; [Thakur, Tanu] Inst Human Behav & Allied Sci, New Delhi, India; [Khurana, Neil] Univ Pittsburgh, Med Ctr, 200 Lothrop St, Pittsburgh, PA 15213 USA; [Shurin, Michael R.; Shurin, Galina, V] Univ Pittsburgh, Dept Pathol, Med Ctr, 200 Lothrop St, Pittsburgh, PA 15213 USA; [Cihakova, Daniela; Talor, Monica, V] Johns Hopkins Univ, Sch Med, Dept Pathol, Ross 659,720 Rutland Ave, Baltimore, MD 21210 USA		Gannon, JM (corresponding author), Univ Pittsburgh, Western Psychiat Hosp, Med Ctr, 3811 OHara St, Pittsburgh, PA 15213 USA.; Gannon, JM (corresponding author), Univ Pittsburgh, Sch Med, 3811 OHara St, Pittsburgh, PA 15213 USA.	gannonjm@upmc.edu	Gannon, Jessica/AAU-5198-2020		Stanley Medical Research Institute; Maryland Psychiatric Research Center	Study 1 was funded by an award to K. N. Roy Chengappa (PI) by the Stanley Medical Research Institute, and Study 2 was funded by pilot funding from the Maryland Psychiatric Research Center to Deanna Kelly (PI).	Asken BM, 2018, NEUROLOGY, V91, pE2109, DOI 10.1212/WNL.0000000000006613; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Chengappa KNR, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11826; Deng HQ, 2018, PSYCHIAT QUART, V89, P53, DOI 10.1007/s11126-017-9514-y; Jackson J, 2012, SCHIZOPHR RES, V140, P262, DOI 10.1016/j.schres.2012.06.011; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Leucht S, 2016, SCHIZOPHRENIA BULL, V42, pS90, DOI 10.1093/schbul/sbv167; Milleit B, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00033; Morera-Fumero AL, 2017, PROG NEURO-PSYCHOPH, V75, P207, DOI 10.1016/j.pnpbp.2017.02.007; Nygaard O, 1997, CLIN CHEM, V43, P541; O'Connell K, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-146; Rothermundt M, 2007, PROG NEURO-PSYCHOPH, V31, P361, DOI 10.1016/j.pnpbp.2006.09.013; Rothermundt M, 2009, GEN PHYSIOL BIOPHYS, V28, pF76; Schumberg K, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00046; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Steiner J, 2006, J NEUROL NEUROSUR PS, V77, P1284, DOI 10.1136/jnnp.2006.093427; Steiner J, 2010, CARDIOVASC PSYCHIAT, V2010, DOI DOI 10.1155/2010/480707; Tarhini AA, 2009, J CLIN ONCOL, V27, P38, DOI 10.1200/JCO.2008.17.1777; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813	20	2	2	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0033-2720	1573-6709		PSYCHIAT QUART	Psychiatr. Q.	MAR	2020	91	1					137	145		10.1007/s11126-019-09687-4		NOV 2019	9	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	KN6YC	WOS:000500826400001	31786729				2022-02-06	
J	Chen, T; Zhu, J; Hang, CH; Wang, YH				Chen, Tao; Zhu, Jie; Hang, Chun-Hua; Wang, Yu-Hai			The Potassium SK Channel Activator NS309 Protects Against Experimental Traumatic Brain Injury Through Anti-Inflammatory and Immunomodulatory Mechanisms	FRONTIERS IN PHARMACOLOGY			English	Article						traumatic brain injury; neuroinflammation; SK channels; NS309; TSG-6	TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; FACTOR-STIMULATED GENE-6; CELL-DEATH MECHANISMS; SMALL-CONDUCTANCE; TNF-ALPHA; INTERMEDIATE-CONDUCTANCE; CYTOKINE PRODUCTION; UP-REGULATION; TSG-6	Neuroinflammation plays important roles in neuronal cell death and functional deficits after TBI. Small conductance Ca2+-activated K+ channels (SK) have been shown to be potential therapeutic targets for treatment of neurological disorders, such as stroke and Parkinson's disease (PD). The aim of the present study was to investigate the role of SK channels in an animal model of TBI induced by controlled cortical impact (CCI). The SK channels activator NS309 at a concentration of 2 mg/kg was administered by intraperitoneal injection, and no obviously organ-related toxicity of NS309 was found in Sprague-Dawley (SD) rats. Treatment with NS309 significantly reduced brain edema after TBI, but had no effect on contusion volume. This protection can be observed even when the administration was delayed by 4 h after injury. NS309 attenuated the TBI-induced deficits in neurological function, which was accompanied by the reduced neuronal apoptosis. The results of immunohistochemistry showed that NS309 decreased the number of neutrophils, lymphocytes, and microglia cells, with no effect on astrocytes. In addition, NS309 markedly decreased the levels of pro-inflammatory cytokines (IL-1 beta, IL-6 and TNF-alpha) and chemokines (MCP-1, MIP-2, and RANTES), but increased the levels of anti-inflammatory cytokines (IL-4, IL-10, and TGF-beta 1) after TBI. The results of RT-PCR and western blot showed that NS309 increased TSG-6 expression and inhibited NF-kappa B activation. Furthermore, knockdown of TSG-6 using in vivo transfection with TSG-6 specific shRNA partially reversed the protective and anti-inflammatory effects of NS309 against TBI. In summary, our results indicate that the SK channel activator NS309 could modulate inflammation-associated immune cells and cytokines via regulating the TSG-6/NF-kappa B pathway after TBI. The present study offers a new sight into the mechanisms responsible for SK channels activation with implications for the treatment of TBI.	[Chen, Tao; Zhu, Jie; Wang, Yu-Hai] Anhui Med Univ, Dept Neurosurg, Sch Med, Hosp PLA 904, Wuxi, Jiangsu, Peoples R China; [Chen, Tao; Hang, Chun-Hua] Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Chen, T; Wang, YH (corresponding author), Anhui Med Univ, Dept Neurosurg, Sch Med, Hosp PLA 904, Wuxi, Jiangsu, Peoples R China.; Chen, T (corresponding author), Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	fmmuchentao@163.com; prof_wyh101@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701932, 81871589, 81601719]; Clinical Medical Science and Technology Development Foundation of Jiangsu University [JLY20180028]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2019M651803]	This work was supported by the National Natural Science Foundation of China (No. 81701932, No. 81871589, and No. 81601719), the Clinical Medical Science and Technology Development Foundation of Jiangsu University (No. JLY20180028), and the China Postdoctoral Science Foundation funded project (No. 2019M651803).	Adelman JP, 2016, CHANNELS, V10, P1, DOI 10.1080/19336950.2015.1029688; Aisiku IP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1470-7; Albensi BC, 2001, J NEUROSCI RES, V66, P151, DOI 10.1002/jnr.1206; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Aloor R, 2015, J NEUROSCI RES, V93, P1471, DOI 10.1002/jnr.23547; Anderson NJ, 2006, EUR J PHARMACOL, V546, P48, DOI 10.1016/j.ejphar.2006.07.007; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bond CT, 2005, CURR OPIN NEUROBIOL, V15, P305, DOI 10.1016/j.conb.2005.05.001; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Coulson-Thomas VJ, 2016, J BIOL CHEM, V291, P19939, DOI 10.1074/jbc.M115.710673; Day AJ, 2019, MATRIX BIOL, V78-79, P60, DOI 10.1016/j.matbio.2018.01.011; Dolga AM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.30; Dolga AM, 2013, J BIOL CHEM, V288, P10792, DOI 10.1074/jbc.M113.453522; Dolga AM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00196; Dolga AM, 2012, GLIA, V60, P2050, DOI 10.1002/glia.22419; Drews G, 2009, ISLETS, V1, P148, DOI 10.4161/isl.1.2.9056; Faber ESL, 2007, CLIN EXP PHARMACOL P, V34, P1077, DOI 10.1111/j.1440-1681.2007.04725.x; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Fee DB, 2004, BRAIN RES, V1012, P52, DOI 10.1016/j.brainres.2004.03.028; Hang CH, 2005, NEUROL INDIA, V53, P312, DOI 10.4103/0028-3886.16930; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li W, 2014, MOL NEUROBIOL, V49, P187, DOI 10.1007/s12035-013-8509-4; Liu LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30121; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Lujan R, 2009, NAT REV NEUROSCI, V10, P475, DOI 10.1038/nrn2668; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Marrelli SP, 2003, AM J PHYSIOL-HEART C, V285, pH1590, DOI 10.1152/ajpheart.00376.2003; McNeish AJ, 2005, STROKE, V36, P1526, DOI 10.1161/01.STR.0000169929.66497.73; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Mittal M, 2016, P NATL ACAD SCI USA, V113, pE8151, DOI 10.1073/pnas.1614935113; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Spitzbarth I, 2012, VET IMMUNOL IMMUNOP, V147, P6, DOI 10.1016/j.vetimm.2012.04.005; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Strobaek D, 2004, BBA-BIOMEMBRANES, V1665, P1, DOI 10.1016/j.bbamem.2004.07.006; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041; Zhu J, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00325; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	58	2	2	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	NOV 29	2019	10								1432	10.3389/fphar.2019.01432			13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	JW0KA	WOS:000502747100001	31849677	Green Published, gold			2022-02-06	
J	McDonald, S; Trimmer, E; Newby, J; Grant, S; Gertler, P; Simpson, GK				McDonald, Skye; Trimmer, Emily; Newby, Jill; Grant, Samantha; Gertler, Paul; Simpson, Grahame K.			Providing on-line support to families of people with brain injury and challenging behaviour: A feasibility study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Family; Caregiver; Telehealth; Traumatic brain injury; Challenging behaviour	ANXIETY STRESS SCALES; COMMUNITY-DWELLING ADULTS; PSYCHOMETRIC PROPERTIES; RANDOMIZED-TRIAL; CLINICAL-TRIAL; DEPRESSION; OUTCOMES; CAREGIVERS; THERAPY; REHABILITATION	Challenging behaviour following traumatic brain injury (TBI) is a major source of stress for families. Providing support can be limited by availability of clinicians and geographic location. A solution is to provide support on-line. This study aimed to evaluate the feasibility of an on-line treatment programme "Carer's Way Ahead" that provides families and carers with psychoeducation about TBI and challenging behaviours, specific approaches to managing apathy, irritability/aggression, acting without thinking and social difficulties and also self-care for the family member. Each module was supplemented with detailed notes and summaries of the sessions. Six family carers, five caring for a person with TBI and one caring for a person with stroke, worked through the programme, providing feedback on wording, content, structure and useability. They also completed measures of family functioning, social problem solving, carer strain, mood and the nature and severity of challenging behaviours. In general, the families were positive about the programme with most finding it useful, practical and logically structured although not all believed it was helpful. There was little change in self-reported challenging behaviour, mood, carer strain and family function over the few months of the programme. Longer-term effects were not examined but this requires further research.	[McDonald, Skye; Trimmer, Emily; Newby, Jill] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Grant, Samantha] Inspire Psychol, Sydney, NSW, Australia; [Gertler, Paul] Gertler Psychol Serv, Sydney, NSW, Australia; [Simpson, Grahame K.] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia		McDonald, S (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	; McDonald, Skye/G-4118-2014	Simpson, Grahame/0000-0001-8156-9060; McDonald, Skye/0000-0003-0723-6094; Newby, Jill/0000-0002-6473-9811	Insurance and Care NSW	This work was supported by Insurance and Care NSW (icare).	Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Anderson MI, 2009, BRAIN INJURY, V23, P931, DOI 10.3109/02699050903302336; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Bauer S, 2004, J PERS ASSESS, V82, P60, DOI 10.1207/s15327752jpa8201_11; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Boyle GJ, 2002, PSYCHOL REP, V90, P415, DOI 10.2466/PR0.90.2.415-425; Coleman JJ, 2015, AM J SPEECH-LANG PAT, V24, P295, DOI 10.1044/2015_AJSLP-14-0028; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dreer LE, 2009, J CLIN PSYCHOL, V65, P653, DOI 10.1002/jclp.20573; Easom LR, 2018, J CLIN PSYCHOL, V74, P536, DOI 10.1002/jclp.22536; Heinicke MR, 2014, BEHAV INTERVENT, V29, P77, DOI 10.1002/bin.1380; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Jones KF, 2019, CLIN REHABIL, V33, P1503, DOI 10.1177/0269215519845034; Kairy D, 2009, DISABIL REHABIL, V31, P427, DOI 10.1080/09638280802062553; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; Kelly G, 2008, BRAIN IMPAIR, V9, P293, DOI 10.1375/brim.9.3.293; Kladnitski N, 2018, INTERNET INTERV, V13, P41, DOI 10.1016/j.invent.2018.06.003; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Livingston LA, 2010, NEUROREHABILITATION, V27, P73, DOI 10.3233/NRE-2010-0582; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McClure J, 2009, BRAIN IMPAIR, V10, P180, DOI 10.1375/brim.10.2.180; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; MCMORDIE W R, 1991, Brain Injury, V5, P43, DOI 10.3109/02699059108998510; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Moos R., 1994, FAMILY ENV SCALE MAN; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; Newby JM, 2013, PSYCHOL MED, V43, P2635, DOI 10.1017/S0033291713000111; Newby JM, 2018, J CONSULT CLIN PSYCH, V86, DOI 10.1037/ccp0000248; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2018, J HEAD TRAUMA REHAB, V33, pE33, DOI 10.1097/HTR.0000000000000350; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Simpson GK, 2020, NEUROPSYCHOL REHABIL, V30, P995, DOI 10.1080/09602011.2018.1531769; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; Sloane S., 2017, UNDERSTANDING ACQUIR; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Watanabe Y, 2001, DISABIL REHABIL, V23, P370; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Winter L, 2018, BRAIN INJURY, V32, P593, DOI 10.1080/02699052.2018.1432895; Woods D., 2014, SOC CARE NEURODIS, V5, P145, DOI DOI 10.1108/SCN-03-2013-0006; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	62	2	2	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 16	2021	31	3					392	413		10.1080/09602011.2019.1696846		NOV 2019	22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	QP1RY	WOS:000499072800001	31778091				2022-02-06	
J	Gertler, P; Tate, RL				Gertler, Paul; Tate, Robyn L.			Behavioural activation therapy to improve participation in adults with depression following brain injury: A single-case experimental design study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Acquired brain injury; Behavioural activation; Major depressive disorder; Single-item mood scale; Single case experimental design	RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; ANXIETY; INTERVENTION; IMPACT; SCALE; SATISFACTION; PREVALENCE; ADJUSTMENT; SYMPTOMS	Following brain injury, the risk of depression increases. There are few studies of non-pharmacological interventions for this problem. Behavioural Activation (BA) could help because it has been demonstrated to be as effective as cognitive-behaviour therapy but is less cognitively demanding and more suitable for people with brain impairment. The current study evaluated BA using a multiple-baseline design across behaviours with replication. Three male participants with clinically significant depressive symptoms (two with traumatic brain injury aged 26 and 46, one who experienced strokes in infancy, aged 26) engaged in a 10-14-week trial of BA focusing on three activity domains: physical, social and functional activities. Participants completed an online form three times a day which recorded activity participation and responses to a single-item mood scale. There was little evidence in support of BA for increasing participation. There was also a lack of change in average mood, but some positive effects were found on measures of depression symptoms and quality of life in these participants. Various factors affected participation which might have been mitigated by extended treatment contact, greater use of prompts or electronic aids or the addition of other therapy modes.	[Gertler, Paul; Tate, Robyn L.] Univ Sydney, John Walsh Ctr Rehabil Res, Kolling Inst Med Res, Fac Med & Hlth, Sydney, NSW, Australia		Gertler, P (corresponding author), Univ Sydney, John Walsh Ctr Rehabil Res, Kolling Inst Med Res, Fac Med & Hlth, Sydney, NSW, Australia.	pger8510@uni.sydney.edu.au			Moving Ahead Centre for Research Excellence	The authors acknowledge the provision of a grant from the Moving Ahead Centre for Research Excellence, which funded the rating of outcome data and treatment adherence.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Balan IC, 2016, COGN BEHAV PRACT, V23, P205, DOI 10.1016/j.cbpra.2015.07.001; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Choi KW, 2019, JAMA PSYCHIAT, V76, P399, DOI 10.1001/jamapsychiatry.2018.4175; Corrigan JD, 2013, J HEAD TRAUMA REHAB, V28, P489, DOI 10.1097/HTR.0000000000000004; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Gast D. L., 2014, SINGLE CASE RES METH, P176, DOI DOI 10.4324/9780203521892-9; Gertler P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009871.pub2; Hart T, 2017, BRAIN INJURY, V31, P297, DOI 10.1080/02699052.2016.1251612; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; HUITEMA BE, 1991, PSYCHOL BULL, V110, P291, DOI 10.1037/0033-2909.110.2.291; Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jamieson M, 2019, NEUROPSYCHOL REHABIL, V29, P513, DOI 10.1080/09602011.2017.1310658; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Kelly A, 2013, NEUROPSYCHOL REHABIL, V23, P563, DOI 10.1080/09602011.2013.795903; Kratochwill TR, 2013, REM SPEC EDUC, V34, P26, DOI 10.1177/0741932512452794; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Lejuez CW, 2011, BEHAV MODIF, V35, P111, DOI 10.1177/0145445510390929; Lejuez CW, 2001, BEHAV MODIF, V25, P255, DOI 10.1177/0145445501252005; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Manolov R, 2018, BRAIN IMPAIR, V19, P18, DOI 10.1017/BrImp.2017.17; Manolov R, 2017, BEHAV THER, V48, P97, DOI 10.1016/j.beth.2016.04.008; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Parker RI, 2011, BEHAV THER, V42, P284, DOI 10.1016/j.beth.2010.08.006; Perdices M, 2019, BEHAV MODIF, DOI 10.1177/0145445519863035; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Rosenberg M., 1965, SOC ADOLESCENT SELF; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Sinclair SJ, 2010, EVAL HEALTH PROF, V33, P56, DOI 10.1177/0163278709356187; Solanas A., 2010, PSICOLOGICA INT J ME; Tate RL, 2020, NEUROPSYCHOL REHABIL, V30, P641, DOI 10.1080/09602011.2018.1488746; Tate RL, 2016, PHYS THER, V96, P932, DOI 10.1037/arc0000026.supp; Tate RL, 2013, NEUROPSYCHOL REHABIL, V23, P619, DOI 10.1080/09602011.2013.824383; Tate RL, 2013, J HEAD TRAUMA REHAB, V28, P77, DOI 10.1097/HTR.0b013e31824e103e; Thomas SA, 2013, CLIN REHABIL, V27, P398, DOI 10.1177/0269215512462227; Vannest KJ, 2018, RES DEV DISABIL, V79, P10, DOI 10.1016/j.ridd.2018.04.029; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434; World Health Organization, 2001, ICF INT CLASFUNCT	50	2	2	2	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 16	2021	31	3					369	391		10.1080/09602011.2019.1696212		NOV 2019	23	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	QP1RY	WOS:000500142600001	31793383				2022-02-06	
J	Hannah, T; Dreher, N; Shankar, DS; Li, AY; Dai, J; Lovell, MR; Choudhri, TF				Hannah, Theodore; Dreher, Nickolas; Shankar, Dhruv S.; Li, Adam Y.; Dai, Jennifer; Lovell, Mark R.; Choudhri, Tanvir F.			The Effect of Game Importance on Concussion Incidence in the National Football League: An Observational Study	CUREUS			English	Article						football; concussion; national football league (nfl); head injuries; traumatic brain injury (tbi); sports medicine; american football	PROFESSIONAL FOOTBALL; HIGH-SCHOOL; INJURY; PERFORMANCE; COLLEGIATE	Introduction Concussion incidence in the National Football League (NFL) has been shown to generally increase as the season progresses. Yet, there is evidence that suggests that the incidence stagnates or decreases in the final quarter of the season in comparison to the third quarter. This anomaly cannot be explained by any of the known modulators of concussion incidence. However, the fact that the teams start getting eliminated from playoff contention in the fourth quarter of the season may explain this pattern in concussion incidence. This study tests whether there is a difference in concussion incidence in games between teams who are still in the playoff hunt [in the hunt (IH) games] versus games where both teams have had their playoff fate already determined (non-IH games). Methods We obtained details of 166 documented concussions from weeks 13-16 of each of the four NFL seasons from 2012 to 2015 from Public Broadcasting Service's (PBS) Frontline Concussion Watch and matched them to the games in which they occurred. Each game was categorized based on the playoff status [clinched (CL), eliminated (EL), or IH] of the teams playing in the game. Concussion incidence of the game types was compared to each other using a one-way analysis of variance (ANOVA) test and student t-tests. Additionally, concussion incidences at six different player positions in important games were compared to the corresponding incidences in unimportant games. An ordinary least squares regression was used to examine the effects of game importance and plays per game on concussion incidence. Results Concussion incidence in important games (mean = 0.651 +/- 0.055) did not differ significantly (p: 0.890) from the incidence in unimportant games (mean = 0.623 +/- 0.143). Instead, plays per game was found to be the primary driver of concussion in the regression analysis (beta = 0.01605; p: 0.025). At the position-specific level, running backs (RB) were the only position to demonstrate a significant increase in concussion incidence (p: 0.004) in important games (mean = 0.049 +/- 0.017) compared to unimportant games (mean = 0.00 +/- 0.00). Conclusions The results suggest that, in general, players are not more likely to suffer concussions in IH games than in non-IH games. However, RBs may have an increased risk of concussion in games with playoff implications than in games without.	[Hannah, Theodore; Dreher, Nickolas; Shankar, Dhruv S.; Li, Adam Y.; Dai, Jennifer; Choudhri, Tanvir F.] Icahn Sch Med Mt Sinai, Neurol Surg, New York, NY 10029 USA; [Lovell, Mark R.] Univ Pittsburgh, Neurol, Med Ctr, Pittsburgh, PA USA		Hannah, T (corresponding author), Icahn Sch Med Mt Sinai, Neurol Surg, New York, NY 10029 USA.	theodore.hannah@icahn.mssm.edu	Li, Adam Y./AAS-6860-2020	Li, Adam Y./0000-0001-7654-1469; Shankar, Dhruv/0000-0002-4153-9382; Hannah, Theodore/0000-0001-6527-9725			[Anonymous], 2018, CONCUSSION WATCH; [Anonymous], 2019, NFL TEAM PLAYS PER G; [Anonymous], 2019, NFL WEATHER HIST ANA; [Anonymous], 2019, NFL STADIUMS ELEVATI; Becker S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08454-4; Connolly JG, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118794928; Dai JB, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118815448; Gabbett TJ, 2004, SPORTS MED, V34, P849, DOI 10.2165/00007256-200434120-00004; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Haider S, 2018, CUREUS, V10, DOI 10.7759/cureus.3627; Kacelnik A, 2007, CIBA F SYMP, P51; Kerr ZY, 2017, J ATHL TRAINING, V52, P955, DOI 10.4085/1062-6050-52.7.06; Lawrence DW, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116639222; Nguyen D, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00108; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Rahnama N, 2002, BRIT J SPORT MED, V36, P354, DOI 10.1136/bjsm.36.5.354; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Talmi D, 2009, J NEUROSCI, V29, P14617, DOI 10.1523/JNEUROSCI.2026-09.2009; Teramoto M, 2015, ORTHOP J SPORTS MED, P3; Teramoto M, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740862; Zeeb FD, 2011, J NEUROSCI, V31, P2197, DOI 10.1523/JNEUROSCI.5597-10.2011; Zimmerman DW, 2004, BRIT J MATH STAT PSY, V57, P173, DOI 10.1348/000711004849222	24	2	2	0	1	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	NOV 28	2019	11	11							e6252	10.7759/cureus.6252			10	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JY9YN	WOS:000504761500001	31893178	gold, Green Published			2022-02-06	
J	Lo, W; Li, XR; Hoskinson, K; McNally, K; Chung, M; Lee, J; Wang, J; Lu, ZL; Yeates, K				Lo, Warren; Li, Xiangrui; Hoskinson, Kristen; McNally, Kelly; Chung, Melissa; Lee, JoEllen; Wang, Ji; Lu, Zhong-Lin; Yeates, Keith			Pediatric Stroke Impairs Theory of Mind Performance	JOURNAL OF CHILD NEUROLOGY			English	Article						cognition; fMRI; outcome; pediatric; stroke	ARTERIAL ISCHEMIC-STROKE; TRAUMATIC BRAIN-INJURY; CONATIVE THEORY; CHILDREN; CONNECTIVITY; EXPRESSION; DISORDER; OUTCOMES	Aim: This pilot study explored whether childhood stroke impairs performance on theory of mind (ToM) tasks and whether ToM task performance correlates with resting state connectivity in brain regions linked with social cognition. Method: We performed a case-control study of 10 children with stroke and 10 age- and gender-matched controls. They completed 2 ToM tasks, and resting state connectivity was measured with functional magnetic resonance imaging (MRI). Results: Children with stroke performed worse than controls on conative ToM tasks. Resting state connectivity in the central executive network was significantly higher and connectivity between right and left inferior parietal lobules was significantly decreased in children with stroke. Resting state activity and ToM performance were not significantly correlated. Interpretation: Childhood stroke results in poorer performance on specific ToM tasks. Stroke is associated with changes in resting state connectivity in networks linked with social cognition including ToM. Although the basis for these changes in connectivity is not well understood, these results may provide preliminary insights into potential mechanisms affecting social cognition after stroke. The findings suggest that further study of the effect of childhood stroke on network connectivity may yield insights as to how stroke affects cognitive functions in children.	[Lo, Warren; Hoskinson, Kristen; McNally, Kelly; Chung, Melissa] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Lo, Warren] Ohio State Univ, Dept Neurol, Columbus, OH 43205 USA; [Lo, Warren; McNally, Kelly; Chung, Melissa] Nationwide Childrens Hosp, FOB 4174,700 Childrens Dr, Columbus, OH 43205 USA; [Li, Xiangrui] Ohio State Univ, Ctr Cognit & Behav Brain Imaging, Dept Psychol, Columbus, OH 43205 USA; [Hoskinson, Kristen] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Dept Pediat, Columbus, OH 43205 USA; [Lee, JoEllen] Ohio State Univ, Nationwide Childrens Hosp, Coll Nursing, Dept Pediat, Columbus, OH 43205 USA; [Wang, Ji] Fudan Univ, Dept Neurol, Childrens Hosp, Shanghai, Peoples R China; [Lu, Zhong-Lin] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Lu, Zhong-Lin] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Yeates, Keith] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Yeates, Keith] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada		Lo, W (corresponding author), Nationwide Childrens Hosp, FOB 4174,700 Childrens Dr, Columbus, OH 43205 USA.	Warren.Lo@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020; Hoskinson, Kristen/AAL-9162-2020	Hoskinson, Kristen/0000-0003-4044-9753; McNally, Kelly/0000-0001-9278-9413; Lo, Warren/0000-0002-8079-8977	Research Institute of Nationwide Children's Hospital [20059215]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Research Institute of Nationwide Children's Hospital 20059215.	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Anderson V, 2014, SOC NEUROSCI-UK, V9, P471, DOI 10.1080/17470919.2014.932308; Androulakis XM, 2017, NEUROLOGY, V89, P163, DOI 10.1212/WNL.0000000000004089; Bedell G, 2009, DEV NEUROREHABIL, V12, P342, DOI 10.3109/17518420903087277; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Burgess GC, 2016, BRAIN CONNECT, V6, P669, DOI 10.1089/brain.2016.0435; Cheng W, 2015, BRAIN, V138, P1382, DOI 10.1093/brain/awv051; Cox NJ, 2008, STATA J, V8, P413, DOI 10.1177/1536867X0800800307; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P338, DOI 10.1017/S1355617712001440; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; deVeber GA, 2000, J CHILD NEUROL, V15, P316, DOI 10.1177/088307380001500508; deVeber GA, 2017, PEDIATR NEUROL, V69, P58, DOI 10.1016/j.pediatrneurol.2017.01.016; Dickerson Bradford C, 2015, Continuum (Minneap Minn), V21, P660, DOI 10.1212/01.CON.0000466659.05156.1d; Happe F, 2016, CURR OPIN PEDIATR, V28, P736, DOI 10.1097/MOP.0000000000000417; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Ilves N, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2306406; Jacomb I, 2018, CHILD NEUROPSYCHOL, V24, P287, DOI 10.1080/09297049.2016.1265102; Kornfeld S, 2018, NEUROIMAGE-CLIN, V17, P359, DOI 10.1016/j.nicl.2017.10.016; Mary A, 2016, CHILD NEUROPSYCHOL, V22, P345, DOI 10.1080/09297049.2015.1012491; O'Keeffe F, 2014, CHILD NEUROPSYCHOL, V20, P557, DOI 10.1080/09297049.2013.832740; Pluta A, 2017, NEUROPSYCHOLOGY, V31, P666, DOI 10.1037/neu0000379; Ryan NP, 2017, SOC COGN AFFECT NEUR, V12, P1414, DOI 10.1093/scan/nsx066; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Studer M, 2014, NEUROLOGY, V82, P784, DOI 10.1212/WNL.0000000000000162; Wechsler D., 2011, WECHSLER ABBREVIATED; Westmacott R, 2010, DEV MED CHILD NEUROL, V52, P386, DOI 10.1111/j.1469-8749.2009.03403.x; Wiig E. H., 1989, TEST LANGUAGE COMPET; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	30	2	2	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	MAR	2020	35	3					228	234	0883073819887590	10.1177/0883073819887590		NOV 2019	7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	KF9TL	WOS:000499777400001	31775563				2022-02-06	
J	Echemendia, RJ; Thelen, J; Meeuwisse, W; Comper, P; Hutchison, MG; Bruce, JM				Echemendia, Ruben J.; Thelen, Joanie; Meeuwisse, Willem; Comper, Paul; Hutchison, Michael G.; Bruce, Jared M.			Testing the hybrid battery approach to evaluating sports-related concussion in the National Hockey League: A factor analytic study	CLINICAL NEUROPSYCHOLOGIST			English	Article						Sports concussion; Assessment; Hybrid Battery	COMPUTERIZED NEUROPSYCHOLOGICAL ASSESSMENT; TEST-RETEST RELIABILITY; NEUROCOGNITIVE PERFORMANCE; COGNITIVE IMPAIRMENT; CONSTRUCT-VALIDITY; IMPACT; MANAGEMENT; SYMBOL; SENSITIVITY; VALIDATION	Objective: There has been an increased interest in the use of "Hybrid" neuropsychological test batteries to evaluate neurocognitive functioning prior to and following sports-related concussion. Typically, these test batteries include a combination of traditional "paper and pencil" (P&P) and computerized measures. The National Hockey League (NHL) employs a Hybrid approach consisting of ImPACT and a brief battery of P&P measures. The purpose of this paper was to examine the NHL's Hybrid model by means of factor analytic techniques in order to determine the extent to which the measures included in the battery are independent of each other or share common variance. Method: Principal components analyses with promax rotations were conducted on the P&P measures alone and when combined with ImPACT. A total of 360 recently concussed NHL players underwent testing using the combined hybrid battery. Results: A principal components analysis with promax rotation of the combined hybrid battery yielded 5 factors (Verbal Learning/Memory, Visual Learning/Memory, Processing Speed/Executive Functioning, Cued/Recognition Memory and Reaction Time/Speed). The factors appear to be relatively independent of each other with the P&P measures comprising the Verbal Learning/Memory, Visual Learning/Memory, and Processing Speed/Executive Functioning and ImPACT loading on the Cued/Recognition Memory and Reaction Time/Speed factors. Conclusions: These data provide support for the Hybrid model with evidence that the P&P measures and ImPACT do not measure the same domains of cognitive functioning. The clinical implications of the findings are discussed in detail.	[Echemendia, Ruben J.] Univ Missouri Kansas City, Psychol & Neurobehav Associates Inc, Kansas City, MO USA; [Thelen, Joanie] Univ Missouri Kansas City, Dept Psychol, Kansas City, MO USA; [Meeuwisse, Willem] Natl Hockey League, Calgary, AB, Canada; [Comper, Paul] Toronto Rehabil Inst, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Kinesiol & Phys Educ, Toronto, ON, Canada; [Bruce, Jared M.] Univ Missouri Kansas City, Sch Med, Dept Biomed & Hlth Informat, Kansas City, MO USA		Echemendia, RJ (corresponding author), Concuss Care Clin, Univ Orthoped Ctr, 101 Regent Ct, State Coll, PA 16801 USA.	rechemendia@comcast.net		Thelen, Joan/0000-0003-1802-9111			Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R. H. B., 1997, BRIEF VISUOSPATIAL M, DOI [10.1037/1040-3590.8.2.145, DOI 10.1037/1040-3590.8.2.145]; Benton AL, 1994, MULTILINGUAL APHASIA; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Bruce J., 2019, DECISION MAKIN UNPUB; Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Conder RL, 2015, APPL NEUROPSYCH-CHIL, V4, P141, DOI 10.1080/21622965.2013.816849; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Darby D, 2002, NEUROLOGY, V59, P1042, DOI 10.1212/WNL.59.7.1042; Dugbartey AT, 2000, ARCH CLIN NEUROPSYCH, V15, P425, DOI 10.1016/S0887-6177(99)00034-7; Echemendia R., 2019, HDB PSYCHOL ASSESSME, P275; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2004, APPL NEUROPSYCHOL, V11, P1, DOI 10.1207/s15324826an1101_1; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2018, HAND CLINIC, V158, P179, DOI 10.1016/B978-0-444-63954-7.00018-5; Echemendia RJ, 2016, CLIN NEUROPSYCHOL, V30, P311, DOI 10.1080/13854046.2016.1158320; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Forn C, 2009, NEUROSCI LETT, V456, P11, DOI 10.1016/j.neulet.2009.03.081; Graham R., 2014, SPORTS RELATED CONCU, P99; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; ImPACT Applications, 2006, IMM POSTC ASS COGN T; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell M. R., 2004, TRAUMATIC BRAIN INJU; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Masterson CJ, 2019, J CLIN EXP NEUROPSYC, V41, P925, DOI 10.1080/13803395.2019.1641184; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Osborne J.W., 2014, BEST PRACTICES EXPLO; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Smith A., 1982, SYMBOL DIGIT MODALIT; Sports Neuropsychology Society, 2019, SUP ADM NEUR TESTS S; White T., 1996, COLOR TRAILS TEST PR	73	2	2	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 3	2020	34	5					899	918		10.1080/13854046.2019.1690051		NOV 2019	20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	ME2MY	WOS:000499086400001	31777320				2022-02-06	
J	Phillips, N; Dalziel, SR; Borland, ML; Dalton, S; Lyttle, MD; Bressan, S; Oakley, E; Hearps, SJC; Kochar, A; Furyk, J; Cheek, JA; Gilhotra, Y; Neutze, J; Babl, FE; Phillips, N; Dalziel, SR; Borland, ML; Dalton, S; Lyttle, MD; Bressan, S; Oakley, E; Hearps, SJC; Kochar, A; Furyk, J; Cheek, JA; Gilhotra, Y; Neutze, J; Babl, FE				Phillips, Natalie; Dalziel, Stuart R.; Borland, Meredith L.; Dalton, Sarah; Lyttle, Mark D.; Bressan, Silvia; Oakley, Ed; Hearps, Stephen J. C.; Kochar, Amit; Furyk, Jeremy; Cheek, John A.; Gilhotra, Yuri; Neutze, Jocelyn; Babl, Franz E.; Phillips, Natalie; Dalziel, Stuart R.; Borland, Meredith L.; Dalton, Sarah; Lyttle, Mark D.; Bressan, Silvia; Oakley, Ed; Hearps, Stephen J. C.; Kochar, Amit; Furyk, Jeremy; Cheek, John A.; Gilhotra, Yuri; Neutze, Jocelyn; Babl, Franz E.		Paediat Res Emergency Dept Int C	Imaging and admission practices in paediatric head injury across emergency departments in Australia and New Zealand: A PREDICT study	EMERGENCY MEDICINE AUSTRALASIA			English	Article						child; craniocerebral trauma; emergency service; hospital; tomography; X-ray computed	COMPUTED-TOMOGRAPHY USE; DECISION RULE; RADIATION-EXPOSURE; CHILDREN; PECARN; TRAUMA	Objectives Variation in the management of paediatric head injury has been identified worldwide. This prospective study describes imaging and admission practices of children presenting with head injury across 10 hospital EDs in Australia and New Zealand. Methods Prospective observational multicentre study of 20 137 children (under 18 years) as a planned secondary analysis of the Australasian Paediatric Head Injury Rules Study. All presentations with head injury without prior imaging were eligible for inclusion. Variations in rates of computed tomography of the brain (CTB) and admission practices between sites, ED type and country were investigated, as were clinically important traumatic brain injuries (ciTBIs) and abnormal CTBs within CTBs. Results Among the 20 137 enrolled patients, the site adjusted CTB rate was 11.2% (95% confidence interval [CI] 7.8-14.6); individual sites ranged from 2.6 to 18.6%. ciTBI was found in 0.4-2.2%, with abnormal scans documented in 0.7-6.5%. As a percentage of CTBs undertaken, ciTBIs were found in 12.8% (95% CI 10.8-14.7) with individual site variation of 8.8-16.9%, and no statistically significant difference noted, and traumatic abnormalities in 29.3% (95% CI 26.2-32.3) with individual site variation between 19.4 and 35.6%. Among those under 2 years,traumatic abnormalities were found in greater than 50% of CTBs at 90% of sites. Admission rate overall was 24.0% (site adjusted) with wide variation between sites (5.0-48.9%). Conclusion Across the 10 largely tertiary EDs included in this study, the overall CTB rate was low with no significant variation between sites when adjusted for ciTBIs.	[Phillips, Natalie; Gilhotra, Yuri] Queensland Childrens Hosp, Emergency Dept, Brisbane, Qld, Australia; [Phillips, Natalie; Gilhotra, Yuri] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia; [Dalziel, Stuart R.] Starship Childrens Hlth, Emergency Dept, Auckland, New Zealand; [Dalziel, Stuart R.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Borland, Meredith L.] Perth Childrens Hosp, Emergency Dept, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Paediat, Perth, WA, Australia; [Borland, Meredith L.] Univ Western Australia, Sch Med, Div Emergency Med, Perth, WA, Australia; [Dalton, Sarah] Childrens Hosp Westmead, Emergency Dept, Sydney, NSW, Australia; [Lyttle, Mark D.; Bressan, Silvia; Oakley, Ed; Hearps, Stephen J. C.; Cheek, John A.; Babl, Franz E.] Murdoch Childrens Res Inst, Emergency Res Unit, Melbourne, Vic, Australia; [Lyttle, Mark D.] Bristol Royal Hosp Children, Emergency Dept, Bristol, Avon, England; [Lyttle, Mark D.] Univ West England, Acad Dept Emergency Care, Bristol, Avon, England; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Oakley, Ed; Cheek, John A.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Oakley, Ed; Babl, Franz E.] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Paediat, Melbourne, Vic, Australia; [Kochar, Amit] Womens & Childrens Hosp, Emergency Dept, Adelaide, SA, Australia; [Furyk, Jeremy] Townsville Hosp, Emergency Dept, Townsville, Qld, Australia; Kidz First Childrens Hosp, Emergency Dept, Auckland, New Zealand		Phillips, N (corresponding author), Queensland Childrens Hosp, Emergency Dept, Stanley St, South Brisbane, Qld 4101, Australia.	natalie.phillips@health.qld.gov.au		Hearps, Stephen/0000-0003-2984-1172; Furyk, Jeremy/0000-0002-9503-0928; Lyttle, Mark/0000-0002-8634-7210	National Health and Medical Research Council (Centre of Research Excellence for Paediatric Emergency Medicine), Canberra, AustraliaNational Health and Medical Research Council of Australia [GNT1046727, GNT1058560]; Murdoch Children's Research Institute, Melbourne, Australia; Emergency Medicine Foundation, Brisbane, Australia [EMPJ-11162]; Perpetual Philanthropic Services, Australia [2012/1140]; Auckland Medical Research Foundation, Auckland, New Zealand [3112011]; A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; Royal Children's Hospital Foundation; Melbourne Campus Clinician Scientist Fellowship, Melbourne, Australia; NHMRC Practitioner Fellowship, Canberra, Australia; Health Research Council of New ZealandHealth Research Council of New Zealand [HRC13/556]; Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; Townsville Hospital, Townsville, Australia	We thank the participating families and ED staff at participating sites. We thank research staff from the following sites: Kaya Gardiner, Nicola Williams, Elle Goss, Triona Stephens, Marta Arpone, and Joseph Mabuti (The Royal Children's Hospital, Melbourne, VIC, Australia); Sharon O'Brien, Timothy Loy, Jeremy Rogers, Samantha Oosterhof, and Verity Watt (Princess Margaret Hospital, Perth, WA, Australia); Susan Montgomery (The Townsville Hospital, Townsville, QLD, Australia); Rebecca Saul, Meegan Price, Petrina Hetherington, Emily Casey, Mary Lang, Jane O'Shea, Anne Cook, Kerrie-Ann Abel, and Bronwyn Griffin (The Royal Children's Hospital, Brisbane, QLD, Australia); Tamara Brunton (Monash Medical Centre, Melbourne, VIC, Australia); Shirley Lawrence (Kidz First Children's Hospital, Auckland, New Zealand); Megan Bonisch (Starship Children's Hospital, Auckland, New Zealand); Carey Alymer and Simone Green (Women's and Children's Hospital, Adelaide, SA, Australia); Laura Phillips and Elizabeth Moss (Children's Hospital Westmead, Sydney, NSW, Australia); and Meg Jepperson (Mater Children's Hospital, Brisbane, QLD, Australia). The study was funded by grants from the National Health and Medical Research Council (project grant GNT1046727, Centre of Research Excellence for Paediatric Emergency Medicine GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; the Emergency Medicine Foundation (EMPJ-11162), Brisbane, Australia; Perpetual Philanthropic Services (2012/1140), Australia; Auckland Medical Research Foundation (No. 3112011) and the A+ Trust (Auckland District Health Board), Auckland, New Zealand; WA Health Targeted Research Funds 2013, Perth, Australia; the Townsville Hospital and Health Service Private Practice Research and Education Trust Fund, Townsville, Australia; and supported by the Victorian Government's Infrastructure Support Program, Melbourne, Australia. FEB's time was part funded by a grant from the Royal Children's Hospital Foundation and the Melbourne Campus Clinician Scientist Fellowship, Melbourne, Australia and an NHMRC Practitioner Fellowship, Canberra, Australia. SRD's time was part funded by the Health Research Council of New Zealand (HRC13/556).	Babl Franz, 2006, Emerg Med Australas, V18, P143, DOI 10.1111/j.1742-6723.2006.00823.x; Babl FE, 2018, ANN EMERG MED, V71, P703, DOI 10.1016/j.annemergmed.2018.01.015; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Dalziel K, 2019, ANN EMERG MED, V73, P429, DOI 10.1016/j.annemergmed.2018.09.030; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Elliot RR, 2011, INJURY, V42, P896, DOI 10.1016/j.injury.2010.06.007; Ghosh R, 2012, EMERG MED J, V29, P197, DOI 10.1136/emj.2009.085639; Goldwasser T, 2015, EUR J EMERG MED, V22, P413, DOI 10.1097/MEJ.0000000000000201; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kemp A, 2016, ARCH DIS CHILD, V101, P929, DOI 10.1136/archdischild-2015-309078; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lockie FD, 2013, EMERG MED AUSTRALAS, V25, P75, DOI 10.1111/1742-6723.12019; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Miescier MJ, 2017, PEDIATR EMERG CARE, V33, P156, DOI 10.1097/PEC.0000000000000500; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; National Clinical Guideline Centre, 2014, NAT I HLTH CLIN EXC; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Oakley E, 2017, EMERG MED AUSTRALAS, V29, P192, DOI 10.1111/1742-6723.12732; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008	26	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-6731	1742-6723		EMERG MED AUSTRALAS	Emerg. Med. Australas.	APR	2020	32	2					240	249		10.1111/1742-6723.13396		NOV 2019	10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KU6SF	WOS:000498587400001	31773866	Green Published			2022-02-06	
J	Narasaki-Jara, M; Wagatsuma, M; Holt, JL; Acuna, SM; Vrongistinos, K; Jung, T				Narasaki-Jara, Mai; Wagatsuma, Mayumi; Holt, Jacob Lee; Acuna, Stephan Manuel; Vrongistinos, Konstantinos; Jung, Taeyou			Aquatic treadmill walking at three depths of water in people with traumatic brain injury	PHYSIOTHERAPY RESEARCH INTERNATIONAL			English	Article						Aquatic treadmill; gait kinematics; partial weight bearing; traumatic brain injury	BODY; INDIVIDUALS; ADULTS	Objective The purpose of this study was to analyse kinematic and spatiotemporal gait characteristics of aquatic treadmill walking among three different depths of water in individuals with traumatic brain injury. Methods A total of 13 individuals with traumatic brain injury participated in the study and completed walking trials at three different depths as follows: waist, chest, and neck level, which was adjusted by a movable floor pool. A self-selected comfortable walking speed at the waist level was used as a matched speed for all walking trials. Participants completed three aquatic treadmill walking trials under each of the three water depths. Each participant's gait was captured by a customized underwater motion analysis system and processed by a two-dimensional motion analysis software. Results The repeated measures analysis of variance showed significant differences in spatiotemporal and joint kinematic variables across three conditions: stance swing ratio (p = .023), peak hip flexion (p = .001), hip range of motion (p = .047), and peak ankle dorsiflexion (p = .000). Various water properties in conjunction with motor impairments might have contributed to alterations in gait kinematics. Conclusion Our findings suggest that walking in neck-depth water may not be ideal for gait training as it appears to limit hip flexion and ankle dorsiflexion. It is recommended that waist to chest-depth water be used to provide an accommodating environment for aquatic gait rehabilitation.	[Narasaki-Jara, Mai; Wagatsuma, Mayumi; Holt, Jacob Lee; Acuna, Stephan Manuel; Vrongistinos, Konstantinos; Jung, Taeyou] Calif State Univ Northridge, Ctr Achievement, Northridge, CA 91325 USA		Narasaki-Jara, M (corresponding author), Calif State Univ Northridge, 18111 Nordhoff St, Northridge, CA 91325 USA.	mai.narasaki@csun.edu		Narasaki-Jara, Mai/0000-0003-3162-9955			Acuna SA, 2018, GAIT POSTURE, V62, P510, DOI 10.1016/j.gaitpost.2018.04.012; Ambrus M, 2019, GAIT POSTURE, V68, P136, DOI 10.1016/j.gaitpost.2018.11.025; Barela AMF, 2006, J ELECTROMYOGR KINES, V16, P250, DOI 10.1016/j.jelekin.2005.06.013; Bates A., 1996, AQUATIC EXERCISE THE; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Cheng C, 2018, INT J OLDER PEOPLE N, V13, DOI 10.1111/opn.12208; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Ferrarin M, 2018, P I MECH ENG H, V232, P619, DOI 10.1177/0954411918776682; Foley A, 2003, ANN RHEUM DIS, V62, P1162, DOI 10.1136/ard.2002.005272; Jung T, 2014, PHYSIOTHER RES INT, V19, P55, DOI 10.1002/pri.1564; Lorenz LS, 2018, DISABIL HEALTH J, V11, P70, DOI 10.1016/j.dhjo.2017.08.005; Mao YR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/175719; Miyoshi T, 2005, CLIN BIOMECH, V20, P194, DOI 10.1016/j.clinbiomech.2004.10.006; Perez OH, 2018, PHYS THER, V98, P786, DOI 10.1093/ptj/pzy065; Ptyushkin P, 2015, INT J REHABIL RES, V38, P253, DOI 10.1097/MRR.0000000000000124; Salem Y, 2011, DISABIL REHABIL, V33, P720, DOI 10.3109/09638288.2010.507855; Seif-Naraghi AH, 1999, J HEAD TRAUMA REHAB, V14, P146, DOI 10.1097/00001199-199904000-00005; Shon A, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18010001; Stephenson JL, 2010, GAIT POSTURE, V31, P109, DOI 10.1016/j.gaitpost.2009.09.008; Vivas J, 2011, ARCH PHYS MED REHAB, V92, P1202, DOI 10.1016/j.apmr.2011.03.017; Williams GP, 2013, J HEAD TRAUMA REHAB, V28, P371, DOI 10.1097/HTR.0b013e31824a1d40	21	2	2	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1358-2267	1471-2865		PHYSIOTHER RES INT	Physiother. Res. Int.	APR	2020	25	2							e1817	10.1002/pri.1817		NOV 2019	6	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	KZ0LW	WOS:000498070100001	31758753				2022-02-06	
J	Iyer, KK; Zalesky, A; Barlow, KM; Cocchi, L				Iyer, Kartik K.; Zalesky, Andrew; Barlow, Karen M.; Cocchi, Luca			Default mode network anatomy and function is linked to pediatric concussion recovery	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article; Early Access							VOXEL-BASED MORPHOMETRY; TRAUMATIC BRAIN-INJURY; STRUCTURAL CONNECTIVITY; POSTCONCUSSION SYNDROME; RESTING BRAIN; RELIABILITY; IMPAIRMENT; QUALITY; MATTER	Objective To determine whether anatomical and functional brain features relate to key persistent post-concussion symptoms (PPCS) in children recovering from mild traumatic brain injuries (mTBI), and whether such brain indices can predict individual recovery from PPCS. Methods One hundred and ten children with mixed recovery following mTBI were seen at the concussion clinic at Neurology department Alberta Children's Hospital. The primary outcome was the Post-Concussion Symptom Inventory (PCSI, parent proxy). Sleep disturbance scores (PCSI subdomain) and the Neurocognition Index (CNS Vital Signs) were also measured longitudinally. PPCS was assessed at 4 weeks postinjury and 8-10 weeks postinjury. Gray matter volumes were assessed using magnetic resonance imaging (MRI) and voxel-based morphometry at 4 weeks postinjury. Functional connectivity was estimated at the same timepoint using resting-state MRI. Two complementary machine learning methods were used to assess if the combination of gray matter and functional connectivity indices carried meaningful prognostic information. Results Higher scores on a composite index of sleep disturbance, including fatigue, were associated with converging decreases in gray matter volume and local functional connectivity in two key nodes of the default mode network: the posterior cingulate cortex and the medial prefrontal cortex. Sleep-related disturbances also significantly correlated with reductions in functional connectivity between these brain regions. The combination of structural and functional brain indices associated to individual variations in the default mode network accurately predicted clinical outcomes at follow-up (area under the curve = 0.86). Interpretation These results highlight that the function-structure profile of core default mode regions underpins sleep-related problems following mTBI and carries meaningful prognostic information for pediatric concussion recovery.	[Iyer, Kartik K.; Barlow, Karen M.] Univ Queensland, Fac Med, Child Hlth Res Ctr, 62 Graham St, Brisbane, Qld 4101, Australia; [Zalesky, Andrew] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Zalesky, Andrew] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia; [Barlow, Karen M.] Queensland Childrens Hosp, Dept Neurol, Brisbane, Qld, Australia; [Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Barlow, Karen M.] Univ Calgary, Calgary, AB, Canada; [Cocchi, Luca] QIMR Berghofer Med Res Inst, Clin Brain Networks Grp, Herston, Qld, Australia		Iyer, KK (corresponding author), Univ Queensland, Fac Med, Child Hlth Res Ctr, 62 Graham St, Brisbane, Qld 4101, Australia.	k.iyer@uq.edu.au	Barlow, Karen/I-6492-2019	Barlow, Karen/0000-0003-2612-8507; ZALESKY, ANDREW/0000-0003-2298-9908	Brain Foundation; Motor Accident Insurance Commission (MAIC, Queensland, Australia); Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [293375]; Australian National Health Medical Research CouncilNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [1099082, 1138711]	K.K.I acknowledges funding support from the Brain Foundation. K.M.B. acknowledges funding support from the Motor Accident Insurance Commission (MAIC, Queensland, Australia) and the Canadian Institutes of Health Research (grant number: 293375). L.C. is supported by the Australian National Health Medical Research Council (L.C. 1099082 and 1138711).	Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Dacosta-Aguayo R, 2015, HUM BRAIN MAPP, V36, P577, DOI 10.1002/hbm.22648; Davey CG, 2018, WORLD PSYCHIATRY, V17, P278, DOI 10.1002/wps.20553; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; Fonov V., 2009, NEUROIMAGE, V47, pS102; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Grossner EC, 2019, NEUROPSYCHOLOGY, V33, P922, DOI 10.1037/neu0000559; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gujar N, 2010, J COGNITIVE NEUROSCI, V22, P1637, DOI 10.1162/jocn.2009.21331; Hamilton JP, 2015, BIOL PSYCHIAT, V78, P224, DOI 10.1016/j.biopsych.2015.02.020; Hearne LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32328; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Iyer KK, 2019, ANN CLIN TRANSL NEUR, V6, P954, DOI 10.1002/acn3.764; Janusz JA, 2012, MILD TRAUMATIC BRAIN, DOI [10.1249/JSR.0b013-31819c7-87, DOI 10.1249/JSR.0B013-31819C7-87]; Jiang LL, 2016, NEUROSCIENTIST, V22, P486, DOI 10.1177/1073858415595004; Khetani A, 2019, J NEUROTRAUM, V36, P1; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Ledoux AA, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2018.3820; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lv H, 2018, AM J NEURORADIOL, V39, P1390, DOI 10.3174/ajnr.A5527; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schaefer A, 2018, CEREB CORTEX, V28, P3095, DOI 10.1093/cercor/bhx179; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shen S, 2013, J MAGN RESON IMAGING, V37, P1468, DOI 10.1002/jmri.23927; Shine JM, 2018, TRENDS NEUROSCI, V41, P244, DOI 10.1016/j.tins.2018.03.004; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Suthaharan S., 2016, INTEGR SER INF SYST; Tashjian SM, 2018, SOC COGN AFFECT NEUR, V13, P290, DOI 10.1093/scan/nsy009; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Yeates KO, 2019, J NEUROTRAUM, V36, P1758, DOI 10.1089/neu.2018.6009; Zhong S, 2017, CEREB CORTEX, V27, P2560, DOI 10.1093/cercor/bhw109; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	56	2	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.												10.1002/acn3.50951		NOV 2019	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JO8UO	WOS:000497851200001	31755665	Green Published, Green Submitted, gold			2022-02-06	
J	Nott, MT; Barden, HLH; Chapparo, C; Ranka, JL				Nott, Melissa T.; Barden, Hannah L. H.; Chapparo, Chris; Ranka, Judy L.			Evidence based practice and knowledge translation: A survey of Australian occupational therapy practice with clients experiencing neurocognitive impairments	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						acquired brain injury; evidence based practice; knowledge translation; metacognitive strategy training; occupational therapy	TRAUMATIC BRAIN-INJURY; COGNITIVE STRATEGY USE; INCOG RECOMMENDATIONS; MANAGEMENT; STROKE; REHABILITATION; PERFORMANCE; ADULTS; INTERVENTION; ORIENTATION	Introduction The clinical practice patterns and use of research evidence by Australian occupational therapists working with clients experiencing neurocognitive impairments has not been surveyed for nearly 10 years. This survey aimed to evaluate the current status of occupational therapy practice and evidence use and provide recommendations for ongoing evidence translation. Methods An online survey of occupational therapists working in Australia was conducted over four months targeting registered clinicians working with adults experiencing neurocognitive impairments. Results 191 occupational therapists from a wide range of clinical practice areas, with a significant level of experience completed the survey. Functional retraining (n = 180, 94%), compensatory training (n = 173, 91%) and task/environmental modifications (n = 161, 84%) were the most commonly reported intervention techniques, while more targeted interventions such as context-sensitive training (n = 54, 28%), positive behaviour supports (n = 42, 22%) and metacognitive strategy training (n = 37, 19%) were used less frequently. Half the respondents were aware of current research evidence and suggested a wide range of strategies supporting evidence translation. Traditional barriers of limited time, access and skills to interpret research were also reported. Conclusion Consistent with earlier surveys most occupational therapists continue to use a functional/compensatory approach to cognitive rehabilitation, with an increasing number of therapists using specialist cognitive interventions. The current challenge for occupational therapists is embedding specialist techniques into occupation-based intervention. Knowledge translation and implementation strategies will be a critical component to achieving this.	[Nott, Melissa T.] Charles Sturt Univ, Sch Community Hlth, Albury, NSW 2640, Australia; [Barden, Hannah L. H.] Westmead Hosp, Brain Injury Rehabil Serv, Sydney, NSW, Australia; [Chapparo, Chris] Univ Sydney, Discipline Occupat Therapy, Sydney, NSW, Australia; [Ranka, Judy L.] Occupat Performance Network, Sydney, NSW, Australia		Nott, MT (corresponding author), Charles Sturt Univ, Sch Community Hlth, Albury, NSW 2640, Australia.	mnott@csu.edu.au		Nott, Melissa/0000-0001-7088-5826; Chapparo, Christine/0000-0003-0821-5076			Ahn SN, 2017, NEUROREHABILITATION, V40, P285, DOI 10.3233/NRE-161416; Aubin G, 2009, SCHIZOPHR RES, V107, P313, DOI 10.1016/j.schres.2008.08.002; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bennett S, 2018, AUST OCCUP THER J, V65, P156, DOI 10.1111/1440-1630.12473; Chapparo C, 2017, OCCUPATIONAL THERAPY, P236; Chung CSY, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008391.pub2; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Dawson DR, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-306; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Henshaw E, 2011, AM J OCCUP THER, V65, P55, DOI 10.5014/ajot.2011.09010; Holmqvist K, 2014, BRAIN INJURY, V28, P1365, DOI 10.3109/02699052.2014.919529; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Koh CL, 2009, AUST OCCUP THER J, V56, P324, DOI 10.1111/j.1440-1630.2008.00764.x; Korner-Bitensky N, 2011, AUST OCCUP THER J, V58, P241, DOI 10.1111/j.1440-1630.2011.00943.x; McEwen S, 2015, NEUROREHAB NEURAL RE, V29, P526, DOI 10.1177/1545968314558602; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Nott MT, 2012, BRIT J OCCUP THER, V75, P256, DOI 10.4276/030802212X13383757345067; Polatajko HJ, 2012, AM J OCCUP THER, V66, P104, DOI 10.5014/ajot.2012.001784; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; SurveyMonkey Inc, SURVEY MONKEY; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Ziviani J, 2003, AUST OCCUP THER J, V50, P13, DOI DOI 10.1046/J.1440-1630.2003.00341.X	26	2	2	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	FEB	2020	67	1					74	82		10.1111/1440-1630.12625		NOV 2019	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	KH4AY	WOS:000497991900001	31758581				2022-02-06	
J	Kinney, AR; Schmid, AA; Henry, KL; Coatsworth, JD; Eakman, AM				Kinney, Adam R.; Schmid, Arlene A.; Henry, Kimberly L.; Coatsworth, J. Douglas; Eakman, Aaron M.			Combat exposure undermines student veterans' achievement of a meaningful life through its association with health-related symptoms: A longitudinal study	JOURNAL OF AMERICAN COLLEGE HEALTH			English	Article						Combat exposure; meaning in life; psychological wellbeing; service-related health conditions; student Veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; ACADEMIC SELF-EFFICACY; SERVICE MEMBERS/VETERANS; COMMUNITY REINTEGRATION; AUTONOMY SUPPORT; INTERNATIONAL-CLASSIFICATION; PTSD SYMPTOMS; EXPERIENCES; EDUCATION	Objective: To understand whether symptoms of health conditions explain the negative association between combat exposure and student Veterans' achievement of a meaningful life. Participants: 153 combat Veterans enrolled in college between November 2013 and April 2018. Methods: Through an online survey, participants reported combat exposure, health status (symptoms of conditions such as depression), and aspects of a meaningful life (belonging, self-understanding, and doing) at two time points. Path analysis was used to explore whether baseline health status mediated the relationship between combat exposure and belonging, self-understanding, and doing at follow-up. Results: Indirect effects indicated that the negative influence of combat on student Veterans' sense of belonging, self-understanding, and doing at follow-up was mediated by poor health at baseline. Conclusions: Combat exposure may contribute to the development of health conditions, which in turn limit student Veterans' experience of three aspects of a meaningful life: a sense of belonging, self-understanding, and doing.	[Kinney, Adam R.] Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, Dept Vet Affairs, Aurora, CO USA; [Kinney, Adam R.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA; [Schmid, Arlene A.; Eakman, Aaron M.] Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; [Henry, Kimberly L.] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Coatsworth, J. Douglas] Colorado State Univ, Dept Human Dev & Family Studies, Ft Collins, CO 80523 USA		Kinney, AR (corresponding author), Rocky Mt Mental Illness Res Educ & Clin Ctr, Dept Vet Affairs, Aurora, CO 80045 USA.	akinney9797@gmail.com		Coatsworth, J Douglas/0000-0003-0306-2760; Schmid, Arlene/0000-0002-7755-199X; Henry, Kimberly/0000-0002-2303-3759	Center for Meaning and Purpose at Colorado State University	Funding for this study was provided through Philanthropic Support of the NSSV Program by a private donor, and through the Center for Meaning and Purpose at Colorado State University.	Albright DL, 2020, J AM COLL HEALTH, V68, P387, DOI 10.1080/07448481.2018.1559170; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armstrong Erica L, 2014, J Spec Oper Med, V14, P26; Barry AE, 2014, J STUD AFF RES PRACT, V51, P30, DOI 10.1515/jsarp-2014-0003; Barry AE, 2012, J AM COLL HEALTH, V60, P562, DOI 10.1080/07448481.2012.721427; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Black AE, 2000, SCI EDUC, V84, P740, DOI 10.1002/1098-237X(200011)84:6<740::AID-SCE4>3.0.CO;2-3; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonar EE, 2015, J AM COLL HEALTH, V63, P437, DOI 10.1080/07448481.2014.975718; Borsari B, 2017, AM J ORTHOPSYCHIAT, V87, P166, DOI 10.1037/ort0000199; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Chang FH, 2013, ARCH PHYS MED REHAB, V94, P771, DOI 10.1016/j.apmr.2012.10.031; Chemers MM, 2001, J EDUC PSYCHOL, V93, P55, DOI 10.1037//0022-0663.93.1.55; Church TE, 2009, J POSTSECOND EDUC DI, V22, P43; Currier JM, 2018, J AM COLL HEALTH, V66, P821, DOI 10.1080/07448481.2018.1440569; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Eakman AM, 2019, EDUC PSYCHOL-UK, V39, P1005, DOI 10.1080/01443410.2019.1605048; Eakman AM, 2019, OTJR-OCCUP PART HEAL, V39, P222, DOI 10.1177/1539449219833351; Eakman AM, 2018, J OCCUP SCI, V25, P346, DOI 10.1080/14427591.2018.1492958; Eakman AM, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.016519; Eakman Aaron M, 2012, Am J Occup Ther, V66, pe20, DOI 10.5014/ajot.2012.001867; Eakman AM, 2015, OCCUPATIONAL THERAPY, P313; Ellison ML, 2012, PSYCHIATR REHABIL J, V35, P209, DOI 10.2975/35.3.2012.209.217; Goldberg B., 2002, OCCUP THER MENT HEAL, V18, P17, DOI [10.1300/J004v18n02_03, DOI 10.1300/J004V18N02_03, DOI 10.1300/J004V18N02_]; Hammell Karen Whalley, 2004, Can J Occup Ther, V71, P296; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hawkins BL, 2015, J REHABIL RES DEV, V52, P527, DOI 10.1682/JRRD.2014.08.0196; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Jim HS, 2006, HEALTH PSYCHOL, V25, P753, DOI 10.1037/0278-6133.25.6.753; King GA, 2004, AM J ORTHOPSYCHIAT, V74, P72, DOI 10.1037/0002-9432.74.1.72; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kinney AR, 2017, J POSTSECOND EDUC DI, V30, P345; Kinney AR, AM J OCCUP THER; Kraemer HC, 1997, ARCH GEN PSYCHIAT, V54, P337; Kraus A., 2013, CALLED SERVE HDB STU, P116; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lambert NM, 2013, PERS SOC PSYCHOL B, V39, P1418, DOI 10.1177/0146167213499186; Levasseur M, 2010, SOC SCI MED, V71, P2141, DOI 10.1016/j.socscimed.2010.09.041; Martela F, 2018, J HAPPINESS STUD, V19, P1261, DOI 10.1007/s10902-017-9869-7; Menard S., 2002, LONGITUDINAL RES; Miocevic M, 2018, BEHAV RES METHODS, V50, P285, DOI 10.3758/s13428-017-0870-1; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Ness BM, 2014, NEUROREHABILITATION, V35, P147, DOI 10.3233/NRE-141098; Ness BM, 2014, J HEAD TRAUMA REHAB, V29, P33, DOI 10.1097/HTR.0b013e3182a1cd4e; Park CL, 2008, QUAL LIFE RES, V17, P21, DOI 10.1007/s11136-007-9279-0; Pietrzak RH, 2015, J AFFECT DISORDERS, V174, P522, DOI 10.1016/j.jad.2014.12.007; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Reker GT, 1988, EMERGENT THEORIES AG; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; SCHUNK DH, 1991, EDUC PSYCHOL, V26, P207, DOI 10.1207/s15326985ep2603&4_2; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Shallcross SL, 2016, J TRAUMA STRESS, V29, P167, DOI 10.1002/jts.22086; Shen B, 2009, RES Q EXERCISE SPORT, V80, P44, DOI 10.5641/027013609X13087704027553; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Steger MF, 2006, J COUNS PSYCHOL, V53, P80, DOI 10.1037/0022-0167.53.1.80; Umucu E, 2020, J AM COLL HEALTH, V68, P271, DOI 10.1080/07448481.2018.1546182; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Williston SK, 2017, J AM COLL HEALTH, V65, P404, DOI 10.1080/07448481.2017.1341891; Willoughby C, 2003, RESILIENCE LEARNING, P31; World Health Organization, 2004, PROMOTING MENTAL HLT	65	2	2	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0744-8481	1940-3208		J AM COLL HEALTH	J. Am. Coll. Health	FEB 17	2021	69	2					142	150		10.1080/07448481.2019.1656637		NOV 2019	9	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	RA3AA	WOS:000498446000001	31765275				2022-02-06	
J	Sandelius, A; Sandgren, S; Axelsson, M; Malmestrom, C; Novakova, L; Kostanjevecki, V; Vandijck, M; Blennow, K; Zetterberg, H; Lycke, J				Sandelius, Asa; Sandgren, Sofia; Axelsson, Markus; Malmestrom, Clas; Novakova, Lenka; Kostanjevecki, Vesna; Vandijck, Manu; Blennow, Kaj; Zetterberg, Henrik; Lycke, Jan			Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; INCREASED EXPRESSION; GAP-43; BIOMARKERS; INFLAMMATION; GUIDELINES; ISCHEMIA; EFFICACY	Neurodegeneration in multiple sclerosis (MS) correlates with disease progression and reparative processes may be triggered. Growth-associated protein 43 (GAP-43) exhibits induced expression during axonal growth and reduced expression during MS progression. We aimed to evaluate if GAP-43 can serve as a biomarker of regeneration in relapsing-remitting MS (RRMS) and whether disease-modifying therapies (DMTs) influence GAP-43 concentration in cerebrospinal fluid (CSF). GAP-43 was measured using an enzyme-linked immunosorbent assay in 105 MS patients (73 RRMS, 12 primary progressive MS, 20 secondary progressive MS) and 23 healthy controls (HCs). In 35 of the patients, lumbar puncture, clinical assessment, and magnetic resonance imaging was performed before initiation of therapeutic intervention, and at follow-up. CSF GAP-43 concentration was significantly lower in progressive MS compared with HCs (p = 0.004) and RRMS (p = < 0.001) and correlated negatively with disability (p = 0.026). However, DMTs did not alter CSF GAP-43. Interestingly, in RRMS CSF GAP-43 levels were higher in patients with signs of active inflammatory disease than in patients in remission (p = 0.042). According to CSF GAP-43 concentrations, regeneration seems reduced in progressive MS, increased during disease activity in RRMS but is unaffected by treatment of highly active DMTs.	[Sandelius, Asa; Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Sandgren, Sofia; Axelsson, Markus; Malmestrom, Clas; Novakova, Lenka; Lycke, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Molndal, Sweden; [Kostanjevecki, Vesna; Vandijck, Manu] Fujirebio Europe NV, Ghent, Belgium; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England		Sandgren, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Molndal, Sweden.	sofia.sandgren@vgregion.se	Malmestrom, Clas/A-8749-2012; Novakova, Lenka/ABF-5492-2020	Malmestrom, Clas/0000-0003-2477-0088; Novakova, Lenka/0000-0001-7899-6395; Sandgren, Sofia/0000-0001-6206-3339	Swedish Federal Government (LUA/ALF) [ALFGBG-722081]; Swedish Association of Persons with Neurological Disabilities; Research Foundation of the Multiple Sclerosis Society of Gothenburg; Edit Jacobson Foundation; AFA Insurance Foundation; Swedish Society for Medical Research; Swedish Brain Foundation; NEURO Sweden; Torsten Soderberg Foundation; Novartis FoundationNovartis; BiogenBiogen	The authors would like to thank and acknowledge all of the participants who have helped support and contribute to this study. This study was funded by grants from the Swedish Federal Government (LUA/ALF agreement, ALFGBG-722081), the Swedish Association of Persons with Neurological Disabilities, the Research Foundation of the Multiple Sclerosis Society of Gothenburg, the Edit Jacobson Foundation, the AFA Insurance Foundation, the Swedish Society for Medical Research, the Swedish Brain Foundation, NEURO Sweden, the Torsten Soderberg Foundation, as well as Novartis Foundation and Biogen (unconditional grants).	Axelsson M, 2011, J NEUROL, V258, P882, DOI 10.1007/s00415-010-5863-2; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; CHONG MS, 1994, J NEUROSCI, V14, P4375; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; GOSLIN K, 1988, NATURE, V336, P672, DOI 10.1038/336672a0; GOTO S, 1994, BRAIN RES, V647, P333, DOI 10.1016/0006-8993(94)91332-3; Haggmark A, 2013, PROTEOMICS, V13, P2256, DOI 10.1002/pmic.201200580; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li Y, 1998, STROKE, V29, P1972, DOI 10.1161/01.STR.29.9.1972; Lycke JN, 1998, J NEUROL NEUROSUR PS, V64, P402, DOI 10.1136/jnnp.64.3.402; Malmestrom C, 2003, NEUROLOGY, V61, P1720, DOI 10.1212/01.WNL.0000098880.19793.B6; Mascaro ALA, 2013, P NATL ACAD SCI USA, V110, P10824, DOI 10.1073/pnas.1219256110; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Novakova L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194828; Novakova L, 2017, J NEUROCHEM, V141, P296, DOI 10.1111/jnc.13881; Novakova L, 2017, MULT SCLER J, V23, P62, DOI 10.1177/1352458516639384; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu Bogdan F Gh, 2013, Continuum (Minneap Minn), V19, P901, DOI 10.1212/01.CON.0000433291.23091.65; Rot U, 2018, Mult Scler J Exp Transl Clin, V4, p2055217318792931, DOI 10.1177/2055217318792931; Sandelius A, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1210-5; Sandelius A, 2019, ALZHEIMERS DEMENT, V15, P55, DOI 10.1016/j.jalz.2018.08.006; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Sjogren M, 2000, J NEURAL TRANSM, V107, P563, DOI 10.1007/s007020070079; SKENE JHP, 1986, SCIENCE, V233, P783, DOI 10.1126/science.3738509; STROEMER RP, 1993, NEUROSCI LETT, V162, P51, DOI 10.1016/0304-3940(93)90557-2; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Teunissen CE, 2006, NEUROPATH APPL NEURO, V32, P318, DOI 10.1111/j.1365-2990.2006.00730.x; Teunissen CE, 2012, MULT SCLER J, V18, P552, DOI 10.1177/1352458512443092; TIBBLING G, 1977, SCAND J CLIN LAB INV, V37, P385, DOI 10.3109/00365517709091496; Vagberg M, 2017, ACTA NEUROL SCAND, V135, P17, DOI 10.1111/ane.12667; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; ZWIERS H, 1980, J NEUROCHEM, V34, P1689, DOI 10.1111/j.1471-4159.1980.tb11262.x	34	2	2	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	NOV 21	2019	9								17309	10.1038/s41598-019-54032-1			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP1RE	WOS:000498048500044	31754174	Green Published, gold			2022-02-06	
J	O'Sullivan, M; Fitzsimons, S; Ramos, SD; Oddy, M; Glorney, E; Sterr, A				O'Sullivan, Michelle; Fitzsimons, Steven; Ramos, Sara da Silva; Oddy, Michael; Glorney, Emily; Sterr, Annette			Utility of the Brain Injury Screening Index in Identifying Female Prisoners With a Traumatic Brain Injury and Associated Cognitive Impairment	JOURNAL OF CORRECTIONAL HEALTH CARE			English	Article						head injury; prisoners; reliability; validity; screen; assessment	NEUROPSYCHOLOGICAL PERFORMANCE; GENDER-DIFFERENCES; HEAD-INJURY; RELIABILITY; PREVALENCE; TBI; DEPRESSION; VALIDITY; AGREEMENT; BEHAVIOR	There is a high prevalence of traumatic brain injury (TBI) in prisoners, but screening tools for identifying TBI in female prisoners are not readily available. Using a cross-sectional design, the psychometric properties of the Brain Injury Screening Index (BISI) were investigated in a closed United Kingdom female prison. Purposive sampling comprised 56 females. Assessment included clinical interview, the BISI, self-report measures of mood, and a battery of measures of cognitive functioning. Seven of the 10 clinical indicators on the BISI met test-retest reliability criteria. Two of the three BISI summary variables demonstrated correlations with questionnaires in the hypothesized directions; however, only two BISI variables were associated with cognitive functioning. Findings support further investigation into the validity and reliability of the BISI with a larger sample.	[O'Sullivan, Michelle; Fitzsimons, Steven; Sterr, Annette] Univ Surrey, Sch Psychol, Guildford GU2 7XH, Surrey, England; [O'Sullivan, Michelle] Rail Safety & Stand Board, London, England; [Ramos, Sara da Silva; Oddy, Michael] Disabil Trust Fdn, Brain Injury Rehabil Trust, Horsham, W Sussex, England; [Glorney, Emily] Royal Holloway Univ London, Sch Law, Egham, Surrey, England		O'Sullivan, M (corresponding author), Univ Surrey, Sch Psychol, Guildford GU2 7XH, Surrey, England.	michelle.osullivan@rssb.co.uk	O'Sullivan, Michelle/AAU-4074-2021	O'Sullivan, Michelle/0000-0002-8259-6164; Fitzsimons, Steve/0000-0001-8756-3866; Glorney, Emily/0000-0001-7523-2381	Disabilities Trust	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Assessment materials were funded by the Disabilities Trust.	Albicini M., 2014, TRAUMATIC BRAIN INJU, DOI [10.5772/57208, DOI 10.5772/57208]; Allely CS, 2016, BRAIN INJURY, V30, P1161, DOI 10.1080/02699052.2016.1191674; Beck A., 1996, BECK DEPRESSION INVE; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Brewer-Smyth K, 2004, BIOL PSYCHIAT, V55, P21, DOI 10.1016/S0006-3223(03)00705-4; Burgess P, 1996, BEHAV ASSESSMENT DYS; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Durand E, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.535; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Hawley CA, 2003, BRAIN INJURY, V17, P743, DOI 10.1080/0269905031000089341; HORWITZ RI, 1984, J CHRON DIS, V37, P825, DOI 10.1016/0021-9681(84)90015-8; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; Jackson M., 2011, CORRECTIONS RES PAPE; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; McKinlay A, 2014, AUST PSYCHOL, V49, P323, DOI 10.1111/ap.12084; McMillan TM, 2015, J NEUROTRAUM, V32, P116, DOI 10.1089/neu.2014.3387; Merbitz C., 1995, J OFFENDER REHABILIT, V22, P11, DOI DOI 10.1300/J076V22N03_02; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Morrell R.F., 1998, J OFFENDER REHABIL, V27, P1, DOI [DOI 10.1300/J076V27N03_01, https://doi.org/10.1300/J076v27n03_01]; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; O'Sullivan M, 2015, AGGRESS VIOLENT BEH, V25, P54, DOI 10.1016/j.avb.2015.07.006; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Ramos SD, 2020, NEUROPSYCHOL REHABIL, V30, P948, DOI 10.1080/09602011.2018.1526692; Randolph C., 1998, REPEATABLE BATTERY A; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Rasinski, 2000, PSYCHOL SURVEY RESPO; Ray B, 2017, CRIM JUSTICE BEHAV, V44, P472, DOI 10.1177/0093854816686631; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Sigmon ST, 2005, SEX ROLES, V53, P401, DOI 10.1007/s11199-005-6762-3; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Silverstein B, 2002, AM J PSYCHIAT, V159, P1051, DOI 10.1176/appi.ajp.159.6.1051; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Disabilities Trust, 2019, BRAIN INJ SCREEN IND; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D., 2009, TEST PREMORBID FUNCT; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Weiss Daniel S., 1997, P399; Williams H., 2012, REPAIRING SHATTERED; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Woolhouse R, 2018, INT J OFFENDER THER, V62, P3135, DOI 10.1177/0306624X17726519	65	2	2	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1078-3458	1940-5200		J CORRECT HEALTH CAR	J. Correct. Health Care	OCT	2019	25	4					313	327	1078345819879898	10.1177/1078345819879898		NOV 2019	15	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	JU8CK	WOS:000498332100001	31742464	Bronze			2022-02-06	
J	Vidal, PM; Ulndreaj, A; Tetreault, L; Hong, J; Fehlings, MG				Vidal, Pia M.; Ulndreaj, Antigona; Tetreault, Lindsay; Hong, James; Fehlings, Michael G.			The changes in systemic monocytes in humans undergoing surgical decompression for degenerative cervical myelopathy may influence clinical neurological recovery	JOURNAL OF NEUROIMMUNOLOGY			English	Article						Degenerative cervical myelopathy (DCM); Decompression; Monocytes; Systemic inflammation; Non-classical monocytes	SPONDYLOTIC MYELOPATHY; FUNCTIONAL RECOVERY; MODEL; MICROGLIA; OUTCOMES; RECRUITMENT; IMPAIRMENT; DISABILITY; RESERVOIR; STROKE	Background: Degenerative cervical myelopathy (DCM) is the most common cause of non-traumatic spinal cord injury worldwide. Surgical decompression is recommended as the preferred treatment strategy for DCM as it halts disease progression and improves neurologic symptoms. We previously demonstrated that neuroinflammation, including monocytes, plays a critical role in the pathobiology of DCM and in ischemic-reperfusion injury (IRI) following surgical decompression. Monocytes are able to enter the spinal cord and brain tissues due to damage to the blood spinal cord and blood brain barrier following injury. Studies have demonstrated that stroke patients and individuals undergoing hip replacement surgery have increased systemic levels of monocytes. Additionally, changes in the signalling responses of monocytes are associated with post-surgical recovery or with ischemic neural tissue damage. Herein, we investigated the role of systemic monocytes as a predictive biomarker for clinical recovery following decompressive surgery for DCM. Findings: There was a 2-fold increase in the number of monocytes in DCM patients at 24 h following decompression as compared to baseline levels, which was associated with a significant improvement in the modified Japanese Orthopedic Association scale (mJOA) at 6-months after surgery (p <.0001). In a mouse model of DCM, depleting acute monocytes reduced the non-classical (Ly6C(low)) subset from circulation (p <.05) and resulted in a 1.8-fold increase in CD11b expression in the spinal cord at 5 weeks following decompression. Acute monocyte depletion was accompanied by a modest decline in long-term overground locomotion, as evidenced by significantly reduced hindlimb swing speed. Conclusions: This work demonstrated that decompressive surgery leads to an acute increase in peripheral monocytes in human DCM patients, which is modestly associated with clinical recovery. We anticipate that this work could contribute to the implementation of routine measurements of blood monocyte subsets, their activation state, and production of cytokines following decompressive surgery. This information could help to select perioperative anti-inflammatory treatments that can enhance the beneficial effects of decompressive surgery and reduce the incidence of post-operative complications, while avoiding a reduction in systemic monocytes.	[Vidal, Pia M.; Ulndreaj, Antigona; Hong, James; Fehlings, Michael G.] Univ Hlth Network, Krembil Neurosci Ctr, Div Genet & Dev, Toronto, ON, Canada; [Vidal, Pia M.; Ulndreaj, Antigona; Hong, James; Fehlings, Michael G.] Univ Hlth Network, Spine Program, Toronto, ON, Canada; [Ulndreaj, Antigona; Hong, James; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Tetreault, Lindsay] Univ Coll Cork, Grad Entry Med, Cork, Ireland; [Tetreault, Lindsay; Fehlings, Michael G.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Tetreault, Lindsay; Fehlings, Michael G.] Univ Toronto, Spine Program, Toronto, ON, Canada; [Vidal, Pia M.] Univ Catolica Santisima Concepcion, Fac Med, Dept Basic Sci, Biomed Sci Res Lab, Concepcion, Chile		Fehlings, MG (corresponding author), Toronto Western Hosp, 399 Bathurst St,Suite 4W-449, Toronto, ON M5T 2S8, Canada.	Michael.Fehlings@uhn.ca			Krembil Research Institute; Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration; DeZwirek Family Foundation	This work was supported by funds from the Krembil Research Institute post-doctoral fellowship awarded to PMV. MGF is supported by the Gerry and Tootsie Halbert Chair in Neural Repair and Regeneration and the DeZwirek Family Foundation.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Dhillon RS, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0359-7; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Edin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074982; Fehlings M. G., 2017, SPINE J, V18, P593; Fehlings MG, 2017, GLOB SPINE J, V7, p53S, DOI 10.1177/2192568217710137; Fehlings MG, 2015, SPINE, V40, P1322, DOI 10.1097/BRS.0000000000000988; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Ferguson AR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00399; Fouad K, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00085; Garcia-Bonilla L, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0750-0; Gaudilliere B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009701; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Green A, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/389531; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Hansen CN, 2016, EXP NEUROL, V282, P86, DOI 10.1016/j.expneurol.2016.05.019; Herz J, 2017, IMMUNITY, V46, P943, DOI 10.1016/j.immuni.2017.06.007; Hirai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064528; Huie JR, 2017, J NEUROTRAUM, V34, P1831, DOI 10.1089/neu.2016.4562; Kaito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069409; Karadimas SK, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac6524; Karadimas SK, 2013, NEUROBIOL DIS, V54, P43, DOI 10.1016/j.nbd.2013.02.013; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Liberale L, 2017, EUR J CLIN INVEST, V47, P702, DOI 10.1111/eci.12795; Machado AS, 2015, ELIFE, V4, DOI 10.7554/eLife.07892; Makinde HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202722; McCreedy DA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0101-18.2018; Meyer U, 2013, PROG NEURO-PSYCHOPH, V42, P20, DOI 10.1016/j.pnpbp.2011.11.003; Morara S, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/135342; Nouri A., 2019, NEUROSURGERY; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; Olingy CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00477-1; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sellgren CM, 2019, NAT NEUROSCI, V22, P374, DOI 10.1038/s41593-018-0334-7; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tarique AA, 2015, AM J RESP CELL MOL, V53, P676, DOI 10.1165/rcmb.2015-0012OC; Tetreault L, 2017, EUR SPINE J, V26, P78, DOI 10.1007/s00586-016-4660-8; Tetreault L, 2015, NEUROSURGERY, V77, pS51, DOI 10.1227/NEU.0000000000000951; Tetreault LA, 2013, J BONE JOINT SURG AM, V95A, P1659, DOI 10.2106/JBJS.L.01323; Ulndreaj A, 2017, J NEUROTRAUM, V34, P1209, DOI 10.1089/neu.2016.4498; Vidal PM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1257-7; Vidal PM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92512; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yu WR, 2011, BRAIN, V134, P1277, DOI 10.1093/brain/awr054; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Ziegler-Heitbrock L, 2014, CELL IMMUNOL, V291, P11, DOI 10.1016/j.cellimm.2014.06.008	53	2	2	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	NOV 15	2019	336								577024	10.1016/j.jneuroim.2019.577024			10	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	JB1KE	WOS:000488318600001	31450156				2022-02-06	
J	Wang, JN; Wang, J; Hu, XH; Xu, LQ; Tian, JN; Li, JY; Fang, DR; Huang, WS; Sun, YX; He, MH; Laureys, S; Di, HB				Wang, Jianan; Wang, Jing; Hu, Xiaohua; Xu, Lingqi; Tian, Jinna; Li, Jiayin; Fang, Danruo; Huang, Wangshan; Sun, Yuxiao; He, Minhui; Laureys, Steven; Di, Haibo			The Initiation of Swallowing Can Indicate the Prognosis of Disorders of Consciousness: A Self-Controlled Study	FRONTIERS IN NEUROLOGY			English	Article						disorders of consciousness; swallowing; consciousness; minimally conscious state; prognosis	COMA RECOVERY SCALE; TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; DYSPHAGIA; APHASIA	Objective: To detect the initiation of swallowing in patients with disorders of consciousness (DOC) as well as the relationship between the initiation of swallowing and the prognosis of DOC patients. Methods: Nineteen DOC patients were included in this study, and a self-controlled trial compared five different stimuli. The five different stimuli were as follows: (1) one command, as recommended by the Coma Recovery Scale-Revised (CRS-R), which was "open your mouth"; (2) placing a spoon in front of the patient's mouth without a command; (3) placing a spoon filled with water in front of the patient's mouth without a command; (4) one command-"there is a spoon; open your mouth"-with a spoon in front of the patient's mouth; (5) one command, "there is a spoon with water; open your mouth," with a spoon filled with water in front of the patient's mouth. All 19 patients were given these five stimuli randomly, and any one of the commands was presented four times to a patient, one at a time, at 15-s intervals. The sensitivity and specificity of the initiation of swallowing in detecting conscious awareness were determined. Results: None of the patients responded to the first four stimuli. However, six patients showed initiated swallowing toward the fifth stimulus. Among those six, five patients showed improvement in their consciousness state 6 months later. The sensitivity and specificity of the initiation of swallowing for DOC patients was 83.33% [95% CIs (36%, 100%)] and 92.31% [95% CIs (64%, 100%)], respectively. Conclusions: The initiation of swallowing can be an early indication of conscious behavior and can likely provide evidence of conscious awareness.	[Wang, Jianan; Wang, Jing; Xu, Lingqi; Tian, Jinna; Li, Jiayin; Fang, Danruo; Huang, Wangshan; Sun, Yuxiao; He, Minhui; Di, Haibo] Hangzhou Normal Univ, Int Unrespons Wakefulness Syndrome & Consciousnes, Hangzhou, Zhejiang, Peoples R China; [Hu, Xiaohua] Wujing Hosp Hangzhou City, Rehabil Ctr Brain Damage, Hangzhou, Zhejiang, Peoples R China; [Laureys, Steven] Univ Liege, Univ Hosp Liege, Neurobgy Dept, GIGA,GIGA Consciousness,Coma Sci Grp, Liege, Belgium		Di, HB (corresponding author), Hangzhou Normal Univ, Int Unrespons Wakefulness Syndrome & Consciousnes, Hangzhou, Zhejiang, Peoples R China.	dihaibo19@aliyun.com	Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Laureys, Steven/0000-0002-3096-3807; Wang, Jing/0000-0003-2445-4966	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81920108023]; National High Technology Research and Development Program of ChinaNational High Technology Research and Development Program of China [2015AA020514]; Hangzhou Normal University [2018PYXML007]	This work was supported by the National Natural Science Foundation of China (Grant nos. 81471100, 811247008), the National High Technology Research and Development Program of China (Grant no. 2015AA020514), the National Natural Science Foundation of China (Grant no. 81920108023), and Hangzhou Normal University (Grant no. 2018PYXML007).	Alhashemi HH, 2010, NEUROSCIENCES, V15, P231; Andrews K, 2004, NEUROREHABILITATION, V19, P299; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bekinschtein T, 2004, J NEUROL NEUROSUR PS, V75, P1086, DOI 10.1136/jnnp.2003.034876corr1; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Bremare A, 2016, DYSPHAGIA, V31, P511, DOI 10.1007/s00455-016-9707-9; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Buchholz D. W., 1994, Acta Oto-Rhino-Laryngologica Belgica, V48, P143; Calabro RS, 2016, NEUROREHABILITATION, V38, P53, DOI 10.3233/NRE-151295; Cheng LJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-27; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Di HB, 2017, BRAIN INJURY, V31, P363, DOI 10.1080/02699052.2016.1255780; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 2006, BRAIN INJURY, V20, P1321, DOI 10.1080/02699050601081802; Gosseries O, 2014, ANNU REV NEUROSCI, V37, P457, DOI 10.1146/annurev-neuro-062012-170339; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P1556, DOI 10.1016/j.apmr.2007.11.063; Humbert IA, 2007, DYSPHAGIA, V22, P266, DOI 10.1007/s00455-007-9080-9; Inatomi Y, 2008, CEREBROVASC DIS, V25, P316, DOI 10.1159/000118376; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Laska AC, 2001, J INTERN MED, V249, P413, DOI 10.1046/j.1365-2796.2001.00812.x; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; Lowell SY, 2012, EXP BRAIN RES, V219, P85, DOI 10.1007/s00221-012-3069-9; Ludlow CL, 2015, J CLIN NEUROPHYSIOL, V32, P294, DOI 10.1097/WNP.0000000000000186; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Majerus S, 2009, PROG BRAIN RES, V177, P49, DOI 10.1016/S0079-6123(09)17705-1; Owen AM, 2008, ANN NY ACAD SCI, V1129, P130, DOI 10.1196/annals.1417.018; Pascarella A, 2018, FUNCT NEUROL, V33, P19, DOI 10.11138/FNeur/2018.33.1.019; RIGHARD L, 1990, LANCET, V336, P1105, DOI 10.1016/0140-6736(90)92579-7; Schnakers C, 2012, ARCH ITAL BIOL, V150, P36, DOI 10.4449/aib.v150i2.1371; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sharon H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074711; Sun YX, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1040-5; Terre R, 2009, NEUROGASTROENT MOTIL, V21, P361, DOI 10.1111/j.1365-2982.2008.01208.x; Wang FY, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0330-7; Wieseke A, 2008, GERIATR NURS, V29, P376, DOI 10.1016/j.gerinurse.2007.12.001; Xiao J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32917	41	2	2	3	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 14	2019	10								1184	10.3389/fneur.2019.01184			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JR2BU	WOS:000499437900001	31798516	Green Published, gold			2022-02-06	
J	Jonesco, DS; Hassager, C; Frydland, M; Kjaergaard, J; Karsdal, M; Henriksen, K				Jonesco, Ditte S.; Hassager, Christian; Frydland, Martin; Kjaergaard, Jesper; Karsdal, Morten; Henriksen, Kim			A caspase-6-cleaved fragment of Glial Fibrillary Acidic Protein as a potential serological biomarker of CNS injury after cardiac arrest	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; TARGETED TEMPERATURE MANAGEMENT; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; CELL-DEATH; TAU FRAGMENTS; SERUM-LEVELS; ACTIVATION; ASTROCYTES; INTERFERENCE	Blood levels of Glial Fibrillary Acidic protein (GFAP) reflect processes associated with different types of CNS injury. Evidence suggests that GFAP is cleaved by caspases during CNS injury, hence positioning GFAP fragments as potential biomarkers of injury-associated processes. We set out to develop an assay detecting the neo-epitope generated by caspase-6 cleavage of GFAP (GFAP-C6), and to assess the ability of GFAP-C6 to reflect pathological processes in patients suffering a cardiac arrest and subsequent global cerebral ischemia. Anti-GFAP-C6 antibodies recognized their specific target sequence, and dilution and spike recoveries in serum were within limits of 20% reflecting high precision and accuracy of measurements. Intra-and inter-assay CVs were below limits of 10% and 15%, respectively. Serological levels of GFAP-C6 were significantly elevated 72 hours after CA (Mean +/- SD) (20.39 +/- 10.59 ng/mL) compared to time of admission (17.79 +/- 10.77 ng/mL, p<0.0001), 24 hours (17.40 +/- 7.99 ng/mL, p<0.0001) and 48 hours (17.87 +/- 8.56 ng/mL, p<0.0001) after CA, but were not related to neurological outcome at day 180. GFAP-C6 levels at admission, 24, 48, and 72 hours after cardiac arrest correlated with two proteolytic fragments of tau, tau-A (r = 0.30, r = 0.40, r = 0.50, r = 0.53, p < 0.0001) and tau-C (r = 54, r = 0.48, r = 0.55, r = 0.54, p < 0.0001), respectively. GFAP-C6 levels did not correlate with other markers of CNS damage; total tau, NSE and S100B. In conclusion, we developed the first assay detecting a caspase-6 cleaved fragment of GFAP in blood. Increased levels at 72 hours after cardiac arrest as well as moderate correlations between GFAP-C6 and two other blood biomarkers of neurodegeneration suggest the ability of GFAP-C6 to reflect pathological processes of the injured brain. Investigations into the potential of GFAP-C6 in other types of CNS injury are warranted.	[Jonesco, Ditte S.; Karsdal, Morten; Henriksen, Kim] Nordic Biosci, Biomarkers & Res, Herlev, Denmark; [Hassager, Christian; Frydland, Martin; Kjaergaard, Jesper] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol B, Copenhagen, Denmark		Jonesco, DS (corresponding author), Nordic Biosci, Biomarkers & Res, Herlev, Denmark.	djo@nordicbio.com		Hassager, Christian/0000-0002-1199-0981; Karsdal, Morten/0000-0001-5026-8740; Jonesco, Ditte/0000-0002-3211-9335; Kjaergaard, Jesper/0000-0001-5244-0399	Danish research fund "Den Danske Forskningsfond"; TrygFonden (Denmark) [7-12-0454]; Swedish Heart-Lung FoundationSwedish Heart-Lung Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission	The Danish research fund "Den Danske Forskningsfond" supported this study by funding DSJ PhD project. The TTM-trial was supported by independent research grant from TrygFonden (Denmark) (grant no: 7-12-0454). The work was funded by the Swedish Heart-Lung Foundation and the Swedish Research Council. DSJ, KH and MK are employed by Nordic Bioscience and thus received support in the form of a salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Aldhoon B, 2012, COR VASA, V54, pE68, DOI 10.1016/j.crvasa.2012.01.005; Aras R, 2012, BRAIN RES, V1450, P102, DOI 10.1016/j.brainres.2012.02.056; Broe M, 2004, BRAIN, V127, P2214, DOI 10.1093/brain/awh250; Brouns R, 2010, CLIN CHEM, V56, P451, DOI 10.1373/clinchem.2009.134122; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chen J, 1997, J NEUROCHEM, V69, P232; Chen MH, 2013, ASN NEURO, V5, DOI 10.1042/AN20130032; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Danda R, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201700101; Dell'Anna AM, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0321-2; Devaux Y, 2016, JAMA CARDIOL, V1, P305, DOI 10.1001/jamacardio.2016.0480; Elston MS, 2016, J CLIN ENDOCR METAB, V101, P3251, DOI 10.1210/jc.2016-1971; Fukuyama R, 2001, EUR NEUROL, V46, P35, DOI 10.1159/000050753; Gao YT, 2018, MED SCI MONITOR, V24, P4481, DOI 10.12659/MSM.908567; Grand J, 2019, BIOMARKERS, V24, P584, DOI 10.1080/1354750X.2019.1609580; Gul SS, 2017, MED HYPOTHESES, V105, P34, DOI 10.1016/j.mehy.2017.06.016; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hayashida H, 2010, NEUROCRIT CARE, V12, P252, DOI 10.1007/s12028-009-9318-5; Henriksen K, 2015, J ALZHEIMERS DIS, V43, P1331, DOI 10.3233/JAD-140984; Henriksen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064990; Iesu E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206655; Inekci D, 2015, CURR ALZHEIMER RES, V12, P829, DOI 10.2174/1567205012666150710111211; Ishiki A, 2016, J NEUROCHEM, V136, P258, DOI 10.1111/jnc.13399; Jesse S, 2009, J ALZHEIMERS DIS, V17, P541, DOI 10.3233/JAD-2009-1075; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Koizumi S, 2018, NEUROCHEM INT, V119, P107, DOI 10.1016/j.neuint.2018.01.007; Komatsu T, 2014, EMERG MED J, V31, P549, DOI 10.1136/emermed-2013-202457; Krajewska M, 2004, EXP NEUROL, V189, P261, DOI 10.1016/j.expneurol.2004.05.020; Krupinski J, 2000, NEUROBIOL DIS, V7, P332, DOI 10.1006/nbdi.2000.0310; Larsson IM, 2014, RESUSCITATION, V85, P1654, DOI 10.1016/j.resuscitation.2014.09.007; LeBlanc AC, 2013, EUR J NEUROSCI, V37, P2005, DOI 10.1111/ejn.12250; Lee Jae-Eun, 2015, Osong Public Health Res Perspect, V6, P357, DOI 10.1016/j.phrp.2015.11.005; Lin NH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180694; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mitchell BL, 2005, CANCER INFORM, V1, P98; Molinuevo JL, 2018, ACTA NEUROPATHOL, V136, P821, DOI 10.1007/s00401-018-1932-x; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nielsen N, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-300; Nielsen N, 2012, AM HEART J, V163, P541, DOI 10.1016/j.ahj.2012.01.013; Nikolac N, 2014, BIOCHEM MEDICA, V24, P57, DOI 10.11613/BM.2014.008; Nolan JP, 2015, RESUSCITATION, V95, P202, DOI 10.1016/j.resuscitation.2015.07.018; Noorbakhsh F, 2010, FASEB J, V24, P1799, DOI 10.1096/fj.09-147819; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Oeckl P, 2019, J ALZHEIMERS DIS, V67, P481, DOI 10.3233/JAD-180325; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2013, ANN EMERG MED, V59, P3; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Ren C, 2016, SCI REP, V14, P1; Rohn TT, 2013, INT J CLIN EXP PATHO, V6, P41; Rohn TT, 2004, EXP CELL RES, V295, P215, DOI 10.1016/j.yexcr.2003.12.029; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; SIMONI J, 1995, ANAL CHIM ACTA, V313, P1, DOI 10.1016/0003-2670(95)00169-Z; Stammet P, 2015, J AM COLL CARDIOL, V65, P2104, DOI 10.1016/j.jacc.2015.03.538; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; van Eijk JJJ, 2010, J ALZHEIMERS DIS, V21, P569, DOI 10.3233/JAD-2010-090649; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC	65	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2019	14	11							e0224633	10.1371/journal.pone.0224633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LN1FJ	WOS:000532690100031	31693684	gold, Green Published			2022-02-06	
J	Wang, YJ; Chang, WC; Wu, CC; Chiang, YH; Chiu, WT; Chen, KY; Chang, WP				Wang, Yu-Jia; Chang, Wei-Chiao; Wu, Chung-Che; Chiang, Yung-Hsiao; Chiu, Wen-Ta; Chen, Kai-Yun; Chang, Wei-Pin			Increased short- and long-term risk of sleep disorders in people with traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Sleep quality; Sleep disorders; Nationwide population-based cohort study	DAYTIME SLEEPINESS; WAKE DISTURBANCES; QUALITY INDEX; INSOMNIA; PREVALENCE; ADULTS; APNEA; TBI; ASSOCIATION; PATHOPHYSIOLOGY	This study aims to evaluate the relationship between traumatic brain injury (TBI) and sleep disorders (SDs). We first initiated a questionnaire-based clinical survey to assess sleep problems in the early stage after a TBI, followed by a population-based cohort study to evaluate the long-term risk of SDs in TBI patients. For short-term clinical survey, mild (m)TBI patients and healthy controls were recruited to evaluate the sleep quality and daytime sleepiness using the Pittsburg Sleep Quality Index (PSQI) and Epworth Sleepiness Scale (ESS) within two weeks after a TBI. For long-term observation, a 5-year nationwide population-based cohort study that utilized a large administrative database was conducted. In the short-term survey, 236 mTBI patients and 223 controls were analyzed. Total scores of the PSQI and ESS were significantly higher in mTBI patients than in the controls. In the long-term cohort study, 6932 TBI cases and 34,660 matched controls were included. TBI cases had a 1.36-fold greater risk of SDs compared to the non-TBI controls during the 5-year follow-up period. Results showed that patients with TBI had a significantly higher risk of SDs than did controls both in the early stage and during a 5-year follow-up period.	[Wang, Yu-Jia; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei, Taiwan; [Wang, Yu-Jia; Chiang, Yung-Hsiao; Chen, Kai-Yun] Natl Hlth Res Inst, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wan Fang Hosp, Dept Pharm, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wan Fang Hosp, Pain Res Ctr, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Shuang Ho Hosp, Dept Med Res, New Taipei, Taiwan; [Wu, Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Coll Publ Hlth, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Chang, Wei-Pin] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan		Chen, KY; Chang, WP (corresponding author), 250 Wu Hsing St, Taipei 110, Taiwan.	kychen08@tmu.edu.tw; wpchang@tmu.edu.tw			Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [NSC 98-2321-B-038-003-MY3, MOST 108-2314-B-038-062]; Department of Taiwan Food and Drug Administration [MOHW108-FDA-113-000005]; Bureau of Taipei City Health [10832]; Higher Education Sprout Project of the Ministry of Education in Taiwan [DP2-107-21121-A-05]; Taipei Medical University [DP2-108-21121-01-N-05-01]	This work was supported by the Ministry of Science and Technology, Taiwan [grant number NSC 98-2321-B-038-003-MY3, MOST 108-2314-B-038-062]; Department of Taiwan Food and Drug Administration [grant number MOHW108-FDA-113-000005]; Bureau of Taipei City Health [grant number 10832]; Higher Education Sprout Project of the Ministry of Education in Taiwan [grant number DP2-107-21121-A-05]; and Taipei Medical University [grant number DP2-108-21121-01-N-05-01].	Ali T, 2014, INFLAMM BOWEL DIS, V20, P1986, DOI 10.1097/MIB.0000000000000108; Appleton SL, 2018, SLEEP HEALTH, V4, P13, DOI 10.1016/j.sleh.2017.10.006; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Chang WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078655; Chiu HY, 2015, EUR NEUROPSYCHOPHARM, V25, P2271, DOI 10.1016/j.euroneuro.2015.09.011; Chung WS, 2013, SLEEP, V36, P1963, DOI 10.5665/sleep.3240; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; De Guzman E, 2017, CRIT CARE CLIN, V33, P423, DOI 10.1016/j.ccc.2017.03.011; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Fang HF, 2015, J CANCER, V6, P1140, DOI 10.7150/jca.12490; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fichtenberg NL, 2000, BRAIN INJURY, V14, P659; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Ioja S, 2012, POSTGRAD MED, V124, P119, DOI 10.3810/pgm.2012.07.2573; Javaheri S, 2017, CHEST, V152, P435, DOI 10.1016/j.chest.2017.01.026; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kalmbach DA, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy147; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Lee M, 2009, J NUTR HEALTH AGING, V13, P576, DOI 10.1007/s12603-009-0110-1; Lequerica A, 2014, NEUROREHABILITATION, V35, P485, DOI 10.3233/NRE-141141; Lin CL, 2017, J HUM HYPERTENS, V31, P220, DOI 10.1038/jhh.2016.55; Lin TY, 2017, SLEEP MED, V36, P165, DOI 10.1016/j.sleep.2016.12.029; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Murphy TE, 2013, J AM GERIATR SOC, V61, P1763, DOI 10.1111/jgs.12462; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Rapp PE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00091; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Shen TC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013151; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Swanson LM, 2011, J SLEEP RES, V20, P487, DOI 10.1111/j.1365-2869.2010.00890.x; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Viola-Saltzman M, 2016, NEUROPSYCH DIS TREAT, V12, P339, DOI 10.2147/NDT.S69105; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Wang HC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/720870; Wang LU, 2017, SLEEP MED, V36, P44, DOI 10.1016/j.sleep.2017.04.016; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Werner JK, 2017, SEMIN NEUROL, V37, P419, DOI 10.1055/s-0037-1604487; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85	64	2	2	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2021	31	2					211	230		10.1080/09602011.2019.1682622		NOV 2019	20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	QA9MZ	WOS:000494917300001	31696782				2022-02-06	
J	Agtarap, S; Campbell-Sills, L; Thomas, ML; Kessler, RC; Ursano, RJ; Stein, MB				Agtarap, Stephanie; Campbell-Sills, Laura; Thomas, Michael L.; Kessler, Ronald C.; Ursano, Robert J.; Stein, Murray B.			Postconcussive, Posttraumatic Stress and Depressive Symptoms in Recently Deployed US Army Soldiers With Traumatic Brain Injury	PSYCHOLOGICAL ASSESSMENT			English	Article						bifactor modeling; construct validity; postconcussive syndrome; posttraumatic stress disorder; TBI symptoms	POST-CONCUSSION SYMPTOMS; ASSESS RISK; MENTAL-DISORDERS; MILD; RESILIENCE; COMBAT; MILITARY; PREVALENCE; ANXIETY; MODEL	Prior studies raise questions about whether persistent postconcussive symptoms (PCS) are differentiable from mental health sequelae of traumatic brain injury (TBI). To investigate whether PCS represented a distinct symptom domain, we evaluated the structure of post-concussive and psychological symptoms using data from The Army STARRS Pre/Post Deployment Study, a panel survey of three U.S. Army Brigade Combat Teams that deployed to Afghanistan. Data from 1229 participants who sustained probable TBI during deployment completed ratings of past-30-day post-concussive, posttraumatic stress, and depressive symptoms three months after their return. Exploratory factor analysis (EFA; n = 300) and confirmatory factor analysis (CFA; n = 929) of symptom ratings were performed in independent subsamples. EFA suggested a model with 3 correlated factors resembling PCS, posttraumatic stress, and depression. CFA confirmed adequate fit of the 3-factor model (CFI = .964, RMSEA = .073 [.070, .075]), contingent upon allowing theoretically defensible cross-loadings. Bifactor CFA indicated that variance in all symptoms was explained by a general factor (lambda = .36-.93), but also provided evidence of domain factors defined by (a) reexperiencing/hyperarousal, (b) cognitive/somatic symptoms, and (c) depressed mood/anhedonia. Soldiers with more severe TBI had higher cognitive/somatic scores, whereas soldiers with more deployment stress had higher general and reexperiencing/hyperarousal scores. Thus, variance in PCS is attributable to both a specific cognitive/somatic symptom factor and a general factor that also explains variance in posttraumatic stress and depression. Measurement of specific domains representing cognitive/somatic symptoms, reexperiencing/hyperarousal, and depressed mood/anhedonia may help clarify the relative severity of PCS, posttraumatic stress, and depression among individuals with recent TBI.	[Agtarap, Stephanie; Campbell-Sills, Laura; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr,Mailcode 0855, La Jolla, CA 92093 USA; [Thomas, Michael L.] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Kessler, Ronald C.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Ursano, Robert J.] Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Dept Psychiat, Bethesda, MD 20814 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA		Agtarap, S (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr,Mailcode 0855, La Jolla, CA 92093 USA.	sagtarap@ucsd.edu	Ursano, Robert/ABE-6533-2020	Agtarap, Stephanie/0000-0002-1188-0897	Department of the Army; U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH) [U01MH087981]; Department of Defense (USUHS Grant)United States Department of Defense [HU0001-15-2-0004]; Sanofi AventisSanofi-Aventis	Army STARRS was sponsored by the Department of the Army and funded under cooperative agreement U01MH087981 (2009-2015) with the U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH). Subsequently, STARRS-LS was sponsored and funded by the Department of Defense (USUHS Grant HU0001-15-2-0004). The contents are solely the responsibility of the authors and do not necessarily represent the views of the Department of Health and Human Services, NIMH, the Department of the Army, the Department of Veterans Affairs, or the Department of Defense. Murray B. Stein has in the past three years been a consultant for Actelion, Aptinyx, Bionomics, Dart Neuroscience, Healthcare Management Technologies, Janssen, Oxeia Biopharmaceuticals, Pfizer, and Resilience Therapeutics. In the past 3 years, Ronald C. Kessler received support for his epidemiological studies from Sanofi Aventis; was a consultant for Johnson & Johnson Wellness and Prevention, Sage Pharmaceuticals, Shire, Takeda; and served on an advisory board for the Johnson & Johnson Services, Inc., Lake Nona Life Project. Ronald C. Kessler is a co-owner of DataStat, Inc., a market research firm that carries out healthcare research. The remaining authors have no disclosures.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson L, 2019, DEPRESS ANXIETY, V36, P511, DOI 10.1002/da.22884; Au TM, 2013, J AFFECT DISORDERS, V149, P209, DOI 10.1016/j.jad.2013.01.026; Barlow DH, 2002, ANXIETY ITS DISORDER, V2nd; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Brown TA, 1998, J ABNORM PSYCHOL, V107, P179, DOI 10.1037/0021-843X.107.2.179; Brown TA, 2009, BEHAV RES THER, V47, P487, DOI 10.1016/j.brat.2009.02.016; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Campbell-Sills L, 2018, PSYCHOL MED, V48, P1624, DOI 10.1017/S0033291717003105; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Costello A., 2005, PAN PACIFIC MANAGEME, V10, P1, DOI DOI 10.7275/JYJ1-4868; Dekel S, 2014, J PSYCHIATR RES, V54, P64, DOI 10.1016/j.jpsychires.2014.03.003; Elhai JD, 2011, J ANXIETY DISORD, V25, P404, DOI 10.1016/j.janxdis.2010.11.003; Goldberg DP, 2009, PSYCHOL MED, V39, P2043, DOI 10.1017/S0033291709990298; Gorsuch R.L., 1983, FACTOR ANAL; Gros DF, 2010, J NERV MENT DIS, V198, P885, DOI 10.1097/NMD.0b013e3181fe7410; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holowka DW, 2012, PSYCHOL TRAUMA-US, V4, P285, DOI 10.1037/a0023267; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Joint Mental Health Advisory Team 7, 2011, OPERATION ENDURING F; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2013, INT J METH PSYCH RES, V22, P267, DOI 10.1002/mpr.1401; Kessler RC, 2013, INT J METH PSYCH RES, V22, P303, DOI 10.1002/mpr.1398; Kessler RC, 2013, INT J METH PSYCH RES, V22, P288, DOI 10.1002/mpr.1399; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kirkham B, 2016, BRAIN INJURY, V30, P681; Kleffelgaard I, 2017, BRAIN INJURY, V31, P1436, DOI 10.1080/02699052.2017.1377348; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; McCrea M., 2008, MILD TRAUMATIC BRAIN; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Post LM, 2016, PSYCHOL PSYCHOTHER-T, V89, P418, DOI 10.1111/papt.12087; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rodriguez A, 2016, PSYCHOL METHODS, V21, P137, DOI 10.1037/met0000045; Rosellini AJ, 2015, DEPRESS ANXIETY, V32, P13, DOI 10.1002/da.22316; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Segev S, 2016, NEUROPSYCHOLOGY, V30, P800, DOI 10.1037/neu0000299; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strauss ME, 2009, ANNU REV CLIN PSYCHO, V5, P1, DOI 10.1146/annurev.clinpsy.032408.153639; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas ML, 2012, PSYCHOL ASSESSMENT, V24, P101, DOI 10.1037/a0024712; Tull MT, 2004, J NERV MENT DIS, V192, P754, DOI 10.1097/01.nmd.0000144694.30121.89; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Watson D, 2005, J ABNORM PSYCHOL, V114, P522, DOI 10.1037/0021-843X.114.4.522; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Weathers F. W., 1993, PAPER PRESENTED AT T; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yurgil KA, 2016, J HEAD TRAUMA REHAB, V31, P30, DOI 10.1097/HTR.0000000000000117	68	2	2	0	6	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	NOV	2019	31	11					1340	1356		10.1037/pas0000756			17	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	JH5BE	WOS:000492783300006	31380697	Bronze			2022-02-06	
J	Candy, N; Tsimiklis, C; Poonnoose, S; Trivedi, R				Candy, Nicholas; Tsimiklis, Chrisovalantis; Poonnoose, Santosh; Trivedi, Riki			The use of antiepileptic medication in early post traumatic seizure prophylaxis at a single institution	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Antiepileptic drugs; Early post traumatic seizure prophylaxis; Traumatic brain injury; Early post traumatic seizures; Antiepileptic medication	BRAIN-INJURY; PHENYTOIN; LEVETIRACETAM	Background: Current international guidelines for traumatic brain injury (TBI) recommend the use of phenytoin for the prevention of early post traumatic seizures (PTS) when the benefits are thought to outweigh the risks. In practice however, alternative antiepileptic drugs (AEDs) such as levetiracetam and valproate are being used as they are believed to have a more favourable risk profile. This is despite there being insufficient evidence to support their efficacy. The purpose of this study was to identify which AED was prescribed to patients presenting with a TBI at a single institution, and to determine the rate of early PTSs. Methods: This was a retrospective case-note review study done at the Flinders Medical Centre including patients admitted from May 2013 to June 2017. All patients with traumatic intracranial haematomas were included. Patients were excluded if they had seizures prior to presentation to hospital or died within 24 h of injury. The primary outcomes were rate of early PTSs and the type of prophylactic AED prescribed. Results: During this study period, 610 patients presented with a mild, moderate or severe traumatic brain injury. Overall, 16% of patients were prescribed an AED, with more than 90% of these patients being prescribed levetiracetam. Overall, the rate of early PTSs for patients prescribed AEDs was 2.9% compared with 3.5% for patients not prescribed AEDs (OR 0.83 CI 0.24-2.85 p = 1). Conclusions: This study showed that levetiracetam was the most commonly prescribed AED. It also demonstrated no statistically significant difference in the rate of early PTSs in patients with TBI, with or without prophylactic AEDs. This is in keeping with other contemporary studies, and therefore the routine administration of prophylactic AEDs may need to be re-examined. (C) 2019 Elsevier Ltd. All rights reserved.	[Candy, Nicholas; Tsimiklis, Chrisovalantis; Poonnoose, Santosh] Flinders Med Ctr, Dept Neurosurg, Adelaide, SA 5042, Australia; [Trivedi, Riki] Addenbrookes Hosp, Div Neurosurg, Hills Rd, Cambridge CB2 0QQ, England		Candy, N (corresponding author), Flinders Med Ctr, Dept Neurosurg, Adelaide, SA 5042, Australia.	nicholas.candy@sa.gov.au					Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Debenham S, 2011, CAN J NEUROL SCI, V38, P896, DOI 10.1017/S031716710001249X; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Gabriel WM, 2014, ANN PHARMACOTHER, V48, P1440, DOI 10.1177/1060028014549013; Helps Y., 2008, HOSP SEPARATIONS DUE; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Javed G, 2016, TURK NEUROSURG, V26, P732, DOI 10.5137/1019-5149.JTN.8245-13.1; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Keret A, 2018, SEIZURE-EUR J EPILEP, V58, P29, DOI 10.1016/j.seizure.2018.03.018; Khor D, 2018, WORLD J SURG, V42, P1727, DOI 10.1007/s00268-017-4373-0; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Lee ST, 1997, CAN J NEUROL SCI, V24, P40, DOI 10.1017/S0317167100021077; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; RISH BL, 1973, J NEUROSURG, V38, P155, DOI 10.3171/jns.1973.38.2.0155; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Wang H, 2013, AASRI PROC, V5, P228, DOI 10.1016/j.aasri.2013.10.083; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231	19	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2019	69						198	205		10.1016/j.jocn.2019.07.066			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JP5SV	WOS:000498325100035	31451375				2022-02-06	
J	Davitz, MS; Gonen, O; Tal, A; Babb, JS; Lui, YW; Kirov, II				Davitz, Matthew S.; Gonen, Oded; Tal, Assaf; Babb, James S.; Lui, Yvonne W.; Kirov, Ivan I.			Quantitative multivoxel proton MR spectroscopy for the identification of white matter abnormalities in mild traumatic brain injury: Comparison between regional and global analysis	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						MR spectroscopy; multivoxel MRS; traumatic brain injury; white matter; human studies	DIFFUSE AXONAL INJURY; RELAXATION-TIMES; SHORT-ECHO; DISTRIBUTIONS; MODEL; GRAY	Background 3D brain proton MR spectroscopic imaging (H-1 MRSI) facilitates simultaneous metabolic profiling of multiple loci, at higher, sub-1 cm(3), spatial resolution than single-voxel H-1 MRS with the ability to separate tissue-type partial volume contribution(s). Purpose To determine if: 1) white matter (WM) damage in mild traumatic brain injury (mTBI) is homogeneously diffuse, or if specific regions are more affected; 2) partial-volume-corrected, structure-specific H-1 MRSI voxel averaging is sensitive to regional WM metabolic abnormalities. Study Type Retrospective cross-sectional cohort study. Population Twenty-seven subjects: 15 symptomatic mTBI patients, 12 matched controls. Field Strength/Sequence 3T using 3D H-1 MRSI over a 360-cm(3) volume of interest (VOI) centered over the corpus callosum, partitioned into 480 voxels, each 0.75 cm(3). Assessment N-acetyl-aspartate (NAA), creatine, choline, and myo-inositol concentrations estimated in predominantly WM regions: body, genu, and splenium of the corpus callosum, corona radiata, frontal, and occipital WM. Statistical Tests Analysis of covariance (ANCOVA) to compare patients with controls in terms of regional concentrations. The effect sizes (Cohen's d) of the mean differences were compared across regions and with previously published global data obtained with linear regression of the WM over the entire VOI in the same dataset. Results Despite patients' global VOI WM NAA being significantly lower than the controls', no regional differences were observed for any metabolite. Regional NAA comparisons, however, were all unidirectional (patients' NAA concentrations < controls') within a narrow range: 0.3 <= Cohen's d <= 0.6. Data Conclusion Since the patient group was symptomatic and exhibiting global WM NAA deficits, these findings suggest: 1) diffuse axonal mTBI damage; that is 2) below the H-1 MRSI detection threshold in small regions. Therefore, larger, ie, more sensitive, single-voxel H-1 MRS, placed anywhere in WM regions, may be well suited for mTBI H-1 MRS studies, given that these results are confirmed in other cohorts. Technical Efficacy: Stage 3 J. Magn. Reson. Imaging 2019;50:1424-1432.	[Davitz, Matthew S.; Gonen, Oded; Babb, James S.; Lui, Yvonne W.; Kirov, Ivan I.] NYU, Ctr Adv Imaging Innovat & Res, Bernard & Irene Schwartz Ctr Biomed Imaging, Dept Radiol,Sch Med, 660 1st Ave, New York, NY 10016 USA; [Tal, Assaf] Weizmann Inst Sci, Dept Chem Phys, Rehovot, Israel		Kirov, II (corresponding author), NYU, Ctr Adv Imaging Innovat & Res, Bernard & Irene Schwartz Ctr Biomed Imaging, Dept Radiol,Sch Med, 660 1st Ave, New York, NY 10016 USA.	Ivan.Kirov@nyulangone.org		Kirov, Ivan/0000-0001-5641-8578; Babb, James/0000-0003-1798-1186; Gonen, Oded/0000-0002-3148-2028	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U24 EB028980, P41 EB017183] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH110418, R01 MH108962] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS090417, R01 NS039135, R01 NS097494] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB017183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH110418, R01MH108962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039135, R01NS097494, R01NS090417] Funding Source: NIH RePORTER		Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Cecil KM, 1998, J NEUROCHEM, V70, P2038; Dhandapani S, 2014, J CLIN NEUROSCI, V21, P745, DOI 10.1016/j.jocn.2013.07.038; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gasparovic C, 2011, MAGN RESON MED, V66, P324, DOI 10.1002/mrm.22858; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Goelman G, 2006, MAGN RESON MED, V56, P34, DOI 10.1002/mrm.20942; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; HU J, 1995, J MAGN RESON SER B, V108, P213, DOI 10.1006/jmrb.1995.1126; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kirov II, 2008, MAGN RESON MED, V60, P790, DOI 10.1002/mrm.21715; Kirov II, 2017, HUM BRAIN MAPP, V38, P4047, DOI 10.1002/hbm.23647; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; McLean MA, 2000, MAGNET RESON MED, V44, P401, DOI 10.1002/1522-2594(200009)44:3<401::AID-MRM10>3.0.CO;2-W; Mikheev, 2013, INT J CARS S1, V8, P289; Mori S., 2011, MRI ATLAS HUMAN WHIT; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Oz G, 2014, RADIOLOGY, V270, P658, DOI 10.1148/radiol.13130531; Posse S, 2007, MAGN RESON MED, V58, P236, DOI 10.1002/mrm.21287; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Soher BJ, 1998, MAGNET RESON MED, V40, P822, DOI 10.1002/mrm.1910400607; Tal A, 2012, NMR BIOMED, V25, P1392, DOI 10.1002/nbm.2812; Terpstra M, 2016, MAGN RESON MED, V76, P1083, DOI 10.1002/mrm.26022; THURMAN D, 2001, EPIDEMIOLOGY EC HEAD; Traber F, 2004, J MAGN RESON IMAGING, V19, P537, DOI 10.1002/jmri.20053; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wijtenburg SA, 2014, MAGN RESON MED, V72, P603, DOI 10.1002/mrm.24959; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578	40	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	NOV	2019	50	5					1424	1432		10.1002/jmri.26718			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	JD8UF	WOS:000490258000007	30868703	Green Accepted			2022-02-06	
J	Dharia, A; Lacci, JV; Gupte, N; Seifi, A				Dharia, Anand; Lacci, John Vincent; Gupte, Nikhil; Seifi, Ali			Multiple significant trauma with craniotomy: What impacts mortality?	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Nationwide inpatient sample; Mortality; Craniotomy; Multiple significant trauma; Socioeconomic factors; Teaching hospitals	BRAIN-INJURY; INSURANCE STATUS; UNITED-STATES; HEAD INJURY; OUTCOMES; CARE; DISPARITIES; TUMOR; HEMATOMA; PATIENT	Objective: The management of patients suffering traumatic brain injury (TBI) in the context of multiple significant trauma represents one of the most challenging scenarios in trauma critical care. The identification of risk factors, utilizing large national databases, may help in developing medical strategies and health care policies aimed at improving outcomes in these patients. In this study, our aim was to assess in-hospital mortality following craniotomy for multiple significant trauma in the United States. Patient and methods: A retrospective cohort study was conducted using the Nationwide Inpatient Sample (NIS) on subjects having "Craniotomy with Multiple Significant Trauma" between 2008-2016. Multivariate logistic regression was used to find the impact of selected variables on the odds of mortality. Results: There were 26,650 discharges within the study period that were predominantly male (73.2%), white (65.1%), with a mean age of 39.7 +/- 22.3, and in-hospital mortality of 35.4%. During the study period, the mortality of this population increased from 34.8% to 38.3% (p = 0.18). In a multivariate logistic regression analysis, the following conditions were associated with higher mortality: being on pressors (OR: 8.41; CI 95% 5.55-12.75, p = 0), having Status Epilepticus (OR: 3.33; CI 95% 1.26-8.81, p = 0.015), self-pay (OR: 4.81; CI 95% 1.49-2.59, p = 0), privately insured (OR: 1.97; CI 95% 1.49-2.59, p = 0) and discharge from urban teaching hospitals (OR = 1.4; CI 95% 1.16-1.68, p = 0). Conclusion: Patients who underwent craniotomy with multiple significant trauma had high mortality, at a rate of about one in three; mortality has been increasing during recent years. Those who required vasopressors and those who developed Status Epilepticus had a significant association with higher death. These associations may be due to the complexity of injuries in this population. Patients with these conditions should seek further attention by the clinicians. Further studies are warranted to characterize these differences.	[Dharia, Anand; Lacci, John Vincent; Gupte, Nikhil] Univ Texas Hlth San Antonio, Long Sch Med, San Antonio, TX USA; [Seifi, Ali] Univ Texas Hlth San Antonio, Dept Neurosurg, San Antonio, TX USA		Seifi, A (corresponding author), Univ Texas Hlth San Antonio, Mail Code 7843,7703 Floyd Curl Dr, San Antonio, TX 78299 USA.	Dharia@livemail.uthscsa.edu; Lacci@livemail.uthscsa.edu; Gupte@livemail.uthscsa.edu; Seifi@uthscsa.edu	Seifi, Ali/AAR-6163-2020	Gupte, Nikhil/0000-0002-7154-2355; Seifi, Ali/0000-0002-5010-5041			Al-Dorzi HM, 2017, NEUROSCIENCES, V22, P107, DOI 10.17712/nsj.2017.2.20160570; [Anonymous], 2017, MMWR Morb Mortal Wkly Rep, V66, P413, DOI 10.15585/mmwr.mm6615a8; Bekelis K, 2018, WORLD NEUROSURG, V110, pE689, DOI 10.1016/j.wneu.2017.11.071; Bell TM, 2013, J TRAUMA ACUTE CARE, V75, P728, DOI 10.1097/TA.0b013e3182a53aaa; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Curry WT, 2010, NEUROSURGERY, V66, P427, DOI 10.1227/01.NEU.0000365265.10141.8E; Dasenbrock HH, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.10.FOCUS15386; De la Garza-Ramos R, 2016, J CLIN NEUROSCI, V31, P137, DOI 10.1016/j.jocn.2016.02.017; De la Garza-Ramos R, 2016, J NEUROSURG-SPINE, V25, P15, DOI 10.3171/2015.11.SPINE151021; Dimick JB, 2004, ARCH SURG-CHICAGO, V139, P137, DOI 10.1001/archsurg.139.2.137; El-Sayed AM, 2011, WORLD NEUROSURG, V76, P459, DOI 10.1016/j.wneu.2011.03.051; Englum B., 2010, J SURG RES, V158, P283; Fukai J, 2009, NEUROL MED-CHIR, V49, P22, DOI 10.2176/nmc.49.22; Gross T, 2012, ACTA ANAESTH SCAND, V56, P1163, DOI 10.1111/j.1399-6576.2012.02724.x; Gupta Babita, 2017, J Anaesthesiol Clin Pharmacol, V33, P3, DOI 10.4103/0970-9185.202185; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Jentzsch T, 2016, J SURG RES, V200, P236, DOI 10.1016/j.jss.2015.06.055; Lau D, 2012, J NEUROSURG, V116, P234, DOI 10.3171/2011.7.JNS11396; Lieber BA, 2016, J NEUROSURG, V125, P213, DOI 10.3171/2015.4.JNS142149; Lin JA, 2016, JAMA SURG, V151, P678, DOI 10.1001/jamasurg.2016.0040; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; McCutcheon BA, 2015, J NEUROSURG, V123, P406, DOI 10.3171/2015.3.JNS131356; McDermott FT, 2004, J TRAUMA, V56, P137, DOI 10.1097/01.TA.0000056163.58047.74; Mikhail JN, 2016, J TRAUMA NURS, V23, P347, DOI 10.1097/JTN.0000000000000246; Monchal T, 2016, J VISC SURG, V153, P3, DOI 10.1016/j.jviscsurg.2016.04.014; Monsivais DR, 2017, NEUROSURGERY, V64, P251, DOI 10.1093/neuros/nyx417.192; Muhlestein WE, 2017, WORLD NEUROSURG, V104, P24, DOI 10.1016/j.wneu.2017.04.061; Mukherjee D, 2013, J CLIN NEUROSCI, V20, P57, DOI 10.1016/j.jocn.2012.05.014; Ramakrishnan Vivek, 2015, Surg Neurol Int, V6, P8, DOI 10.4103/2152-7806.149613; Rosenfeld JV, 2004, INJURY, V35, P655, DOI 10.1016/j.injury.2004.03.006; Schuster JM, 2010, DAMAGE CONTROL MANAGEMENT IN THE POLYTRAUMA PATIENT, P279, DOI 10.1007/978-0-387-89508-6_15; Seifi A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-332; Velopulos CG, 2013, J SURG RES, V184, P444, DOI 10.1016/j.jss.2013.05.068; Wong George K C, 2011, J Emerg Trauma Shock, V4, P346, DOI 10.4103/0974-2700.83861; Yoon S, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.1.FOCUS17782; Young JS, 1998, AM SURGEON, V64, P88	37	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2019	186								105448	10.1016/j.clineuro.2019.105448			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JN0OS	WOS:000496604500015	31561130				2022-02-06	
J	Di Lu, L; Heinze, KL				Di Lu, Landy; Heinze, Kathryn L.			Sport Policy Institutionalization: Examining the Adoption of Concussion Legislation Across States	JOURNAL OF SPORT MANAGEMENT			English	Article						institutional theory; quantitative research; youth sport	HIGH-SCHOOL FOOTBALL; COMPETING LOGICS; HIGHER-EDUCATION; DECISION-MAKING; ORGANIZATIONS; ADVOCACY; CULTURE; RESPONSES; ENTREPRENEURSHIP; RESPONSIBILITY	Multilevel examinations of sport policy institutionalization are scarce in sport management scholarship. As sport policies diffuse across geographic boundaries, there is often variation in the timing of adoption. In this study, the authors used event history analysis to examine the effect of institutional factors, within and between states, on the speed of youth sport concussion legislation adoption. Our quantitative analyses show that a series of intrastate factors-state norms, disruptive events, and local advocacy-had a significant influence on the timing of state policy adoption, but interstate social networks did not. Supporting qualitative data provide additional insight about the relationship between disruptive events and local advocacy in the adoption of concussion legislation. This study contributes to a better understanding of institutional factors in the diffusion of sport policy across geographic boundaries and offers an approach for future research examining variation in sport policy or practice adoption.	[Di Lu, Landy; Heinze, Kathryn L.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA		Di Lu, L (corresponding author), Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA.	landylu@umich.edu					Aarts H, 1998, J APPL SOC PSYCHOL, V28, P1355, DOI 10.1111/j.1559-1816.1998.tb01681.x; Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Babiak K, 2011, CORP SOC RESP ENV MA, V18, P11, DOI 10.1002/csr.229; Battilana J, 2010, ACAD MANAGE J, V53, P1419, DOI 10.5465/AMJ.2010.57318391; Battilana J, 2009, ACAD MANAG ANN, V3, P65, DOI 10.1080/19416520903053598; Beland D, 2007, SOC SCI QUART, V88, P20, DOI 10.1111/j.1540-6237.2007.00444.x; BERRY FS, 1990, AM POLIT SCI REV, V84, P395, DOI 10.2307/1963526; Birchard M., 2014, MISSOURI J HLTH PHYS, V24, P74; Boehmke FJ, 2012, STATE POLIT POLICY Q, V12, P303, DOI 10.1177/1532440012438890; Borucka J., 2014, STUDIA OECONOMICA PO, V2, P91; Box-Steffensmeier JM., 2004, EVENT HIST MODELING; Briscoe F, 2008, ADMIN SCI QUART, V53, P460, DOI 10.2189/asqu.53.3.460; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; BURT RS, 1987, AM J SOCIOL, V92, P1287, DOI 10.1086/228667; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Carson R., 1962, SILENT SPRING; Comeau GS, 2010, J SPORT SOC ISSUES, V34, P457, DOI 10.1177/0193723510387053; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Cunningham GB, 2008, SEX ROLES, V58, P3, DOI 10.1007/s11199-007-9360-8; Dacin MT, 2002, ACAD MANAGE J, V45, P45, DOI 10.5465/AMJ.2002.6283388; Danylchuk KE, 1999, J SPORT MANAGE, V13, P148, DOI 10.1123/jsm.13.2.148; Davis GF, 1997, AM J SOCIOL, V103, P1, DOI 10.1086/231170; Den Hond F, 2007, ACAD MANAGE REV, V32, P901, DOI 10.5465/AMR.2007.25275682; DiMaggio P.J., 1991, NEW I ORG ANAL, V17; Doyle WR, 2006, EDUC EVAL POLICY AN, V28, P259, DOI 10.3102/01623737028003259; Ellenbogen Richard G, 2014, Neurosurgery, V75 Suppl 4, pS122, DOI 10.1227/NEU.0000000000000495; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Garud R, 2002, ACAD MANAGE J, V45, P196, DOI 10.2307/3069292; Greenwood R, 2002, ACAD MANAGE J, V45, P58, DOI 10.2307/3069285; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hannigan J.A., 1995, ENV SOCIOLOGY SOCIAL; Hays JC, 2015, POLIT ANAL, V23, P400, DOI 10.1093/pan/mpv012; Heinze K.L., 2017, HDB SPORT SUSTAINABI, P267, DOI [10.4324/9781315619514.ch20, DOI 10.4324/9781315619514.CH20]; Heinze KL, 2017, J SPORT MANAGE, V31, P497, DOI 10.1123/jsm.2016-0309; Hinings C.R., 2002, J APPL BEHAV SCI, V38, P436, DOI [10.1177/002188602237791, DOI 10.1177/002188602237791]; Hoffman AJ, 1999, ACAD MANAGE J, V42, P351, DOI 10.2307/257008; Hofstede G, 1998, ORGAN STUD, V19, P477, DOI 10.1177/017084069801900305; Husted BW, 2016, STRATEGIC MANAGE J, V37, P2050, DOI 10.1002/smj.2437; Kantor ShawnEverett., 2007, PRELUDE WELFARE STAT; Kezar A, 2002, J HIGH EDUC, V73, P435, DOI 10.1353/jhe.2002.0038; Kikulis LM, 2000, J SPORT MANAGE, V14, P293, DOI 10.1123/jsm.14.4.293; Laker S.R., 2014, THE OXFORD HANDBOOK, P1, DOI [10.1093/oxfordhb/9780199896585.001.0001/oxfordhb-9780199896585-e-9, DOI 10.1093/OXFORDHB/9780199896585.001.0001]; Lawrence TB., 2006, SAGE HDB ORG STUDIES, V2; Lee K, 2002, ACAD MANAGE J, V45, P144, DOI 10.2307/3069289; Lounsbury M, 2007, ACAD MANAGE J, V50, P289; Maguire S, 2004, ACAD MANAGE J, V47, P657, DOI 10.2307/20159610; Marano V, 2016, J MANAGE STUD, V53, P28, DOI 10.1111/joms.12124; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maroon JC, 2014, PROG NEUROL SURG, V28, P1, DOI 10.1159/000358746; Marquis C, 2007, ACAD MANAGE REV, V32, P925, DOI 10.5465/AMR.2007.25275683; Marquis C, 2007, ACAD MANAGE J, V50, P799, DOI 10.5465/amj.2007.26279172; Marquis C, 2009, RES ORGAN BEHAV, V29, P283, DOI 10.1016/j.riob.2009.06.001; Mason DS, 2006, J SPORT MANAGE, V20, P52, DOI 10.1123/jsm.20.1.52; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McLendon MK, 2005, J HIGH EDUC, V76, P363, DOI 10.1353/jhe.2005.0029; McNutt JG, 1999, NONPROF VOLUNT SEC Q, V28, P432, DOI 10.1177/0899764099284004; MEYER AD, 1982, ADMIN SCI QUART, V27, P515, DOI 10.2307/2392528; Mills M, 2011, INTRO SURVIVAL EVENT; Mintrom M, 1996, POLICY STUD J, V24, P420, DOI 10.1111/j.1541-0072.1996.tb01638.x; Mintz B, 2000, SOC PROBL, V47, P327, DOI 10.1525/sp.2000.47.3.03x0295i; Mokher CG, 2009, AM J EDUC, V115, P249, DOI 10.1086/595668; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Munir KA, 2005, ORGAN STUD, V26, P93, DOI 10.1177/0170840605049463; Nigam A, 2010, ORGAN SCI, V21, P823, DOI 10.1287/orsc.1090.0490; OLIVER C, 1991, ACAD MANAGE REV, V16, P145, DOI 10.2307/258610; Pache AC, 2010, ACAD MANAGE REV, V35, P455, DOI 10.5465/AMR.2010.51142368; Pe'er A, 2011, STRATEGIC MANAGE J, V32, P1356, DOI 10.1002/smj.934; Perkmann M, 2008, HUM RELAT, V61, P811, DOI 10.1177/0018726708092406; Quatman C, 2008, J SPORT MANAGE, V22, P338, DOI 10.1123/jsm.22.3.338; Rao H, 2006, RES ORGAN BEHAV, V27, P269, DOI 10.1016/S0191-3085(06)27007-2; Reid E., 2006, NONPROFITS GOVT COLL, V2nd, P343; Rosenson BA, 2006, POLIT RES QUART, V59, P619, DOI 10.1177/106591290605900411; Sage GH, 1999, SOCIOL SPORT J, V16, P206, DOI 10.1123/ssj.16.3.206; Saka-Helmhout A, 2011, MANAGE INT REV, V51, P567, DOI 10.1007/s11575-011-0091-2; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; SCHNEIBERG M, 2005, SOCIAL MOVEMENTS ORG, P122, DOI DOI 10.1017/CBO9780511791000.008; Scott W.R., 2001, I ORG; Shipan CR, 2008, AM J POLIT SCI, V52, P840, DOI 10.1111/j.1540-5907.2008.00346.x; Silk M., 2000, CULTURE SPORT SOC, V3, P1, DOI [10.1080/14610980008721859, DOI 10.1080/14610980008721859]; Sine WD, 2009, ADMIN SCI QUART, V54, P123, DOI 10.2189/asqu.2009.54.1.123; SLACK T, 1994, ORGAN STUD, V15, P803, DOI 10.1177/017084069401500602; Slack T., 1992, Journal of Sport Management, V6, P114; Soule SA, 1997, AM J SOCIOL, V103, P733, DOI 10.1086/231254; Stevens J. A., 1998, International Review for the Sociology of Sport, V33, P143, DOI 10.1177/101269098033002002; Suddaby R, 2010, ACAD MANAGE J, V53, P1234, DOI 10.5465/AMJ.2010.57317486; THOMPSON VA, 1965, ADMIN SCI QUART, V10, P1, DOI 10.2307/2391646; Thornton P.H., 2008, SAGE HDB ORG I, P99; Trendafilova S, 2013, SPORT MANAG REV, V16, P298, DOI 10.1016/j.smr.2012.12.006; Vogus T.J., 2005, SOCIAL MOVEMENTS ORG, P96; Volden C, 2006, AM J POLIT SCI, V50, P294, DOI 10.1111/j.1540-5907.2006.00185.x; WALKER JL, 1969, AM POLIT SCI REV, V63, P880, DOI 10.2307/1954434; Washington M, 2004, ORGAN SCI, V15, P82, DOI 10.1287/orsc.1030.0057; Washington M, 2011, SPORT MANAG REV, V14, P1, DOI 10.1016/j.smr.2010.06.003; Zietsma C, 2010, ADMIN SCI QUART, V55, P189, DOI 10.2189/asqu.2010.55.2.189	96	2	2	3	36	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0888-4773	1543-270X		J SPORT MANAGE	J.Sport Manage.	NOV	2019	33	6					493	505		10.1123/jsm.2018-0330			13	Hospitality, Leisure, Sport & Tourism; Management; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Business & Economics; Sport Sciences	JK3MG	WOS:000494748700001					2022-02-06	
J	Gagnon, I				Gagnon, Isabelle			Determining Outcome in Children and Adolescents After Concussion: Viewing Things More Holistically	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						mild traumatic brain injury; outcome measures; youths	TRAUMATIC BRAIN-INJURY; COMMON DATA ELEMENTS; SPORT-RELATED CONCUSSION; EMERGENCY-DEPARTMENT; SYMPTOMS; RECOVERY; HEALTH; RECOMMENDATIONS; INTERVENTIONS; DEMOGRAPHICS	SYNOPSIS: Pediatric and adolescent concussion is an increasingly high-profile public health issue, but it is also a highly heterogeneous phenomenon. Many factors interact dynamically to influence the recovery trajectory of adolescents and children. Diagnostic assessment must include domains other than self-reported symptoms, yet many prognostic models of outcome focus solely on the presence or absence of postconcussion symptoms to determine recovery. Function after concussion (recovery or persistence of problems) is the result of an interaction between biological, psychological, and social factors. Despite biopsychosocial models of assessment being advocated in rehabilitation for the last 20 years, they are still not routinely implemented in the evaluation of concussions, along the recovery trajectory, in children and adolescents. The International Classification of Functioning, Disability and Health is a framework anchored in a biopsychosocial perspective that can guide clinicians and researchers to include multiple perspectives in their assessments or research designs. By focusing on the patient as a person, researchers and clinicians can provide a more holistic approach that has the potential to contribute to a more successful and sustainable pediatric and adolescent concussion care model.	[Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Gagnon, Isabelle] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Concuss Res Lab,Trauma Ctr, 5252 Blvd Maisonneuve Ouest,Off 3F-45, Montreal, PQ H4A 3S5, Canada; [Gagnon, Isabelle] CanPedCDE Res Grp, Montreal, PQ, Canada		Gagnon, I (corresponding author), McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Concuss Res Lab,Trauma Ctr, 5252 Blvd Maisonneuve Ouest,Off 3F-45, Montreal, PQ H4A 3S5, Canada.	Isabelle.gagnon8@mcgill.ca		Gagnon, Isabelle/0000-0003-2043-1644	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec - SanteFonds de la Recherche en Sante du Quebec	The CanPedCDE research team and portions of this work were funded by the Canadian Institutes of Health Research and the Fonds de Recherche du Quebec - Sante. Dr Gagnon is supported by a clinical investigator award from the Fonds de Recherche du Quebec - Sante.	Adair B, 2015, DEV MED CHILD NEUROL, V57, P1093, DOI 10.1111/dmcn.12809; Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Beauchamp MH, 2018, NEUROPSYCHOLOGY, V32, P495, DOI 10.1037/neu0000419; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Gagnon I, 2018, SPORTS CONCUSSIONS A; Gagnon I, 2018, J NEUROTRAUM, V35, P1849, DOI 10.1089/neu.2018.5887; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstein JN, 2006, CEPHALALGIA, V26, P684, DOI 10.1111/j.1468-2982.2006.01093.x; Guty E, 2018, J INT NEUROPSYCH SOC, V24, P684, DOI 10.1017/S135561771800036X; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Keays G, 2018, CAN J PUBLIC HEALTH, V109, P52, DOI 10.17269/s41997-018-0037-6; Kenzie ES, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00203; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; King G, 2018, DISABIL REHABIL, V40, P1829, DOI 10.1080/09638288.2017.1309583; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; McCrory P, 2017, BRIT J SPORT MED, V51, P837, DOI 10.1136/bjsports-2017-097878; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Minen M, 2017, AM J EMERG MED, V35, P365, DOI 10.1016/j.ajem.2016.10.076; Mucha A, 2018, HAND CLINIC, V158, P135, DOI 10.1016/B978-0-444-63954-7.00014-8; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246; Parachute Concussion Expert Advisory Committee, 2017, CANADIAN GUIDELINE O; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Rausa VC, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0881-z; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Silverberg ND, 2016, JAMA PEDIATR, V170, P401, DOI 10.1001/jamapediatrics.2015.4649; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Underwood J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194760; Vogt H, 2016, MED HEALTH CARE PHIL, V19, P307, DOI 10.1007/s11019-016-9683-8; Wade DT, 2017, CLIN REHABIL, V31, P995, DOI 10.1177/0269215517709890; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; World Health Organisation, 2001, INTERNATIONAL CLASSI; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	54	2	2	0	6	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	NOV	2019	49	11					855	863		10.2519/jospt.2019.8918			9	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation; Sport Sciences	JJ1VP	WOS:000493950100010	31597547				2022-02-06	
J	Komiyama, K; Tosaka, M; Shimauchi-Ohtaki, H; Aihara, M; Shimizu, T; Yoshimoto, Y				Komiyama, Kazuki; Tosaka, Masahiko; Shimauchi-Ohtaki, Hiroya; Aihara, Masanori; Shimizu, Tatsuya; Yoshimoto, Yuhei			Computed tomography findings after head injury preceding chronic subdural hematoma	NEUROSURGICAL FOCUS			English	Article						chronic subdural hematoma; subdural effusion; head injury; dura-arachnoid interface layer	HYGROMA; PATHOGENESIS; COLLECTIONS; EVOLUTION; SPACE; SCANS; FATE	OBJECTIVE Head CT is sometimes performed immediately after minor head injury; however, which cases develop into chronic subdural hematoma (CSDH) remains unclear. Here, the authors retrospectively reviewed the rare cases of CSDH treated surgically in which early head CT had been performed after the initial head trauma. METHODS A total of 172 patients (133 male and 39 female, median age 76 years) underwent surgery for CSDH at Gunma University Hospital between April 2010 and December 2017. Among these patients were 23 who had visited Gunma University Hospital or a nearby hospital and had undergone head CT within 7 days after the initial head trauma. Characteristics of the initial head CT were examined to identify indicators of subsequent CSDH. RESULTS Among the 23 CSDH cases (17 male and 6 female, median age 80 years), CT scans were obtained on the day of the initial injury (day 0) in 19 cases (25 sides) and 1-7 days after injury in 12 cases (19 sides); scans were obtained during both periods in 8 cases (12 sides), so that a total of 44 sides were examined. These CT scans were divided into two groups according to when they were obtained; cases in which scans were taken during both periods were included in both groups. Head CT performed on the day of injury showed normal findings in 5 (20%) of 25 sides, thin subdural effusion (SDE) 6 mm in 16 (64%) of 25 sides, thick SDE > 6 mm in 3 (12%) of 25 sides, and acute subdural hematoma (ASDH) in 1 (4%) of 25 sides. CT from 1-7 days after trauma showed thick SDE in 9 (47%) of 19 sides, thin SDE in 8 (42%) of 19 sides, and ASDH in 2 (11%) of 19 sides. A high-density line in the lateral direction (onion skin-like) was found between the skull and the brain in 9 (35%) of 26 sides with SDE on initial CT 0-7 days after the injury. CONCLUSIONS ASDH was not a common cause of CSDH. Head CT at the time of trauma that precedes CSDH often showed SDE. Such SDE that precedes CSDH was often close to the detection limit of CT immediately after the injury but became more apparent from the day after the injury.	[Komiyama, Kazuki; Tosaka, Masahiko; Shimauchi-Ohtaki, Hiroya; Aihara, Masanori; Shimizu, Tatsuya; Yoshimoto, Yuhei] Gunma Univ, Dept Neurosurg, Grad Sch Med, Gunma, Japan		Tosaka, M (corresponding author), Gunma Univ, Grad Sch Med, Gunma, Japan.	nstosaka@gunma-u.ac.jp					Atkinson JLD, 2003, J MAGN RESON IMAGING, V17, P484, DOI 10.1002/jmri.10275; ECHLIN F, 1949, J NEUROSURG, V6, P294, DOI 10.3171/jns.1949.6.4.0294; Feng JF, 2008, MED HYPOTHESES, V70, P1147, DOI 10.1016/j.mehy.2007.11.014; FRENCH BN, 1978, SURG NEUROL, V9, P145; KOIZUMI H, 1987, SURG NEUROL, V27, P147, DOI 10.1016/0090-3019(87)90286-2; Kristof RA, 2008, J NEUROSURG, V108, P275, DOI 10.3171/JNS/2008/108/2/0275; Lee KS, 2000, J KOREAN MED SCI, V15, P560, DOI 10.3346/jkms.2000.15.5.560; Lee KS, 1998, BRAIN INJURY, V12, P901; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Liu YG, 2009, INJURY, V40, P968, DOI 10.1016/j.injury.2009.01.006; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; MCCLUNEY KW, 1992, AM J NEURORADIOL, V13, P1335; Murata Keiji, 1993, Neurologia Medico-Chirurgica, V33, P691, DOI 10.2176/nmc.33.691; NOMURA S, 1994, J NEUROSURG, V81, P910, DOI 10.3171/jns.1994.81.6.0910; OHNO K, 1987, J NEUROL NEUROSUR PS, V50, P1694, DOI 10.1136/jnnp.50.12.1694; Olivero WC, 2017, J CLIN NEUROSCI, V42, P129, DOI 10.1016/j.jocn.2017.03.005; PARK CK, 1994, ACTA NEUROCHIR, V127, P41, DOI 10.1007/BF01808545; Park SH, 2008, J CLIN NEUROSCI, V15, P868, DOI 10.1016/j.jocn.2007.08.003; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Tosaka M, 2008, AM J NEURORADIOL, V29, P1164, DOI 10.3174/ajnr.A1041; Tosaka M, 2015, ACTA NEUROCHIR, V157, P1205, DOI 10.1007/s00701-015-2435-3; Tosaka M, 2013, NEUROL MED-CHIR, V53, P273, DOI 10.2176/nmc.53.273; Wang YD, 2015, BRAIN INJURY, V29, P462, DOI 10.3109/02699052.2014.990513; YAMADA H, 1980, SURG NEUROL, V13, P441	24	2	2	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E12	10.3171/2019.8.FOCUS19535			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900012	31675707	gold			2022-02-06	
J	Lee, B; Bennett, LL; Bernick, C; Shan, GG; Banks, SJ				Lee, Bern; Bennett, Lauren L.; Bernick, Charles; Shan, Guogen; Banks, Sarah J.			The Relations Among Depression, Cognition, and Brain Volume in Professional Boxers: A Preliminary Examination Using Brief Clinical Measures	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						boxing; head injuries; concussion; imaging; magnetic resonance	CHRONIC TRAUMATIC ENCEPHALOPATHY; SMALLER THALAMIC VOLUMES; CONNECTIVITY; CONCUSSION; VALIDITY; HEALTH; RISK	Objective: Depression, neuropathology, and cognitive decline are commonly observed with repetitive head injuries (RHIs). We examined whether in boxers (a) clinically significant depression is associated with structural brain changes and cognition; (b) minimal symptoms of depression moderate the relations among RHI and brain volumes and cognition; and (c) baseline depression is associated with longitudinal cognitive changes. Setting: Clinical Research Center. Participants: A total of 205 male professional boxers. Design: Cross-sectional and longitudinal (subsample: n = 45; first visit to follow-up range = 1-6 years; mean = 2.61 years). Main Measures: Patient Health Questionnaire-9 depression; CNS Vital Signs cognitive battery; brain imaging. Results: Clinically significant depression was associated with smaller regional volumes in insula, cingulate, orbitofrontal cortex, thalami, and middle corpus-callosum subregions; and with poorer verbal memory and psychomotor speed performance. Depression symptoms moderated the relations between RHI and bilateral thalami, left hippocampus, left medial orbitofrontal cortex, and bilateral insula volumes; but not cognition. Baseline depression was associated with poorer psychomotor speed and reaction time longitudinally and improved verbal memory performance longitudinally. Conclusion: Clinical depression is associated with volumetric and cognitive changes occasioning RHI exposure, and even minimal depressive symptoms may moderate the relations between exposure and brain volumes in key regions. Longitudinally, there is preliminary evidence that depression precedes cognitive changes.	[Lee, Bern] Univ Nevada, Las Vegas, NV 89154 USA; [Lee, Bern; Bennett, Lauren L.; Bernick, Charles] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA; [Shan, Guogen] Univ Nevada, Sch Community Hlth Sci, Dept Environm & Occupat Hlth, Las Vegas, NV 89154 USA; [Banks, Sarah J.] Univ Calif San Diego, Dept Neurosci, Multidisciplinary Memory Clin, 9500 Gilman Dr, La Jolla, CA 92093 USA		Banks, SJ (corresponding author), Univ Calif San Diego, Dept Neurosci, Multidisciplinary Memory Clin, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sbanks@ucsd.edu		Lee, Bern/0000-0001-5876-1433	Belator; UFC; August Rapone Family Foundation; Top Rank; Haymon Boxing; Institutional Development Award from the National Institute of General Medical Sciences of theNational Institutes of Health [P20GM109025]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109025] Funding Source: NIH RePORTER	Funding for this study came from Belator, UFC, the August Rapone Family Foundation, Top Rank, Haymon Boxing, and an Institutional Development Award from the National Institute of General Medical Sciences of theNational Institutes of Health under grant number P20GM109025.	Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Bernick C, 2012, THRESHOLD EFFECT REP; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Cardoso EF, 2009, NEUROIMAGE, V47, P467, DOI 10.1016/j.neuroimage.2009.04.059; Chen GX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21825; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hayes A.F., 2017, INTRO MEDIATION MODE; IBM Corp, 2016, IBM SPSS STAT WINDOW; John A, 2019, PSYCHOL MED, V49, P353, DOI 10.1017/S0033291718001137; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee BG, 2018, J NEUROTRAUM, V35, P2015, DOI 10.1089/neu.2017.5558; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Pandya M, 2012, CURR PSYCHIAT REP, V14, P634, DOI 10.1007/s11920-012-0322-7; Prien A, 2019, ARCH CLIN NEUROPSYCH, V34, P575, DOI 10.1093/arclin/acy056; Riolo SA, 2005, AM J PUBLIC HEALTH, V95, P998, DOI 10.2105/AJPH.2004.047225; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Schmaal L, 2016, MOL PSYCHIATR, V21, P806, DOI 10.1038/mp.2015.69; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; US Department of Health and Human Services National Institutes of Health National Institute of Mental Health, 2016, MAJ DEPR	32	2	2	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					E29	E39		10.1097/HTR.0000000000000495			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200004	31033751				2022-02-06	
J	Matzopoulos, R; Prinsloo, M; Bradshaw, D; Abrahams, N				Matzopoulos, R.; Prinsloo, M.; Bradshaw, D.; Abrahams, N.			Reducing homicide through policy interventions: The case of gun control	SAMJ SOUTH AFRICAN MEDICAL JOURNAL			English	Article							INTERPERSONAL VIOLENCE PREVENTION; FIREARM-RELATED INJURIES; TRAUMATIC BRAIN INJURY; CAPE-TOWN; SOUTH-AFRICA; NONFATAL INJURIES; EXTERNAL CAUSES; MORTALITY; JOHANNESBURG; DEATHS	Injuries impose a fourth major disease burden on the South African population, which is driven in particular by the high incidence of interpersonal violence. There was a significant decline in mortality from interpersonal violence between 1997 and 2012, and research conducted by South African Medical Research Council (SAMRC) researchers has ascribed much of this decline to a decrease in firearm homicide. In the present brief review, we summarise South African research on fatal and non-fatal firearm injuries, with a particular focus on research conducted by SAMRC intra- and extramural units between 1969 and 2019. More recent data suggest a lapse in firearm control that has led to an increase in homicide and that the fluctuating homicide rate is being influenced by adherence to firearm control policies.	[Matzopoulos, R.; Prinsloo, M.; Bradshaw, D.] South African Med Res Council, Burden Dis Res Unit, Cape Town, South Africa; [Matzopoulos, R.; Bradshaw, D.] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Abrahams, N.] South African Med Res Council, Gender & Hlth Res Unit, Cape Town, South Africa		Matzopoulos, R (corresponding author), South African Med Res Council, Burden Dis Res Unit, Cape Town, South Africa.; Matzopoulos, R (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa.	richard.matzopoulos@uct.ac.za	Matzopoulos, Richard/AAL-9965-2021; Abrahams, Naeemah/AAF-1144-2020	Matzopoulos, Richard/0000-0001-9063-6210; Abrahams, Naeemah/0000-0002-6138-6256; Prinsloo, Megan/0000-0003-0415-0973	SAMRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	RM, MP, DB and NA are funded by the SAMRC.	Abrahams N, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001412; Abrahams N, 2010, SAMJ S AFR MED J, V100, P586, DOI 10.7196/SAMJ.3904; Allard D, 2005, SAMJ S AFR MED J, V95, P591; Alpers P, 2017, GUNS S AFRICA NUMBER; Baadjies M., 2015, DAILY VOICE 0715; Beautrais AL, 2006, AUST NZ J PSYCHIAT, V40, P253, DOI 10.1111/j.1440-1614.2006.01782.x; Bhalla K, 2012, SMALL ARMS SURVEY IS, P1; BROWN DSO, 1991, SOC SCI MED, V33, P283, DOI 10.1016/0277-9536(91)90362-G; BUTCHART A, 1991, S AFR MED J, V79, P466; BUTCHART A, 1991, FORENSIC SCI INT, V52, P35, DOI 10.1016/0379-0738(91)90095-Z; BUTCHART A, 1991, S AFR MED J, V79, P472; Butchart A, 2001, S AFR MED J, V91, P408; Campbell NM, 2013, S AFR J SURG, V51, P92, DOI [10.7196/SAJS.1220, 10.7196/sajs.1220]; Cassidy T, 2014, HEALTH PLACE, V26, P78, DOI 10.1016/j.healthplace.2013.12.009; Chapman S, 2006, INJURY PREV, V12, P365, DOI 10.1136/ip.2006.013714; Chetty R, 2000, FIREARM USE DISTRIBU; COHEN MA, 1985, S AFR MED J, V68, P849; Dolley C, 2014, WEEKEND ARGUS   0928; DUFLOU JALC, 1986, S AFR MED J, V70, P88; Evans J, 2018, W CAPE INJURY MORTAL; Gilmour S, 2018, AM J PUBLIC HEALTH, V108, P1511, DOI 10.2105/AJPH.2018.304640; Hepburn L, 2006, J TRAUMA, V61, P423, DOI 10.1097/01.ta.0000226396.51850.fc; Jewkes R., 2009, PREVENTING RAPE VIOL; Jewkes Rachel K., 2009, UNDERSTANDING MENS H; Kapusta ND, 2007, BRIT J PSYCHIAT, V191, P253, DOI 10.1192/bjp.bp.106.032862; KNOBEL GJ, 1986, S AFR MED J, V70, P83; Lerer LB, 1997, S AFR MED J, V87, P298; MACDONALD IL, 1994, INT J EPIDEMIOL, V23, P66, DOI 10.1093/ije/23.1.66; de Souza MDM, 2007, HEALTH AFFAIR, V26, P575, DOI 10.1377/hlthaff.26.2.575; Matzopoulos R, 2018, SAMJ S AFR MED J, V108, P197, DOI [10.7196/SAMJ.2018.v108i3.12756, 10.7196/samj.2018.v108i3.12756]; Matzopoulos R, 2016, SAMJ S AFR MED J, V106, P19, DOI [10.7196/SAMJ.2016.v106i6.11034, 10.7196/samj.2016.v106i6.11034]; Matzopoulos R, 2019, ROU STUD CIT DEVELOP, P69; Matzopoulos R, 2016, SAMJ, S. Afr. med. j., V106, P589, DOI [10.7196/samj.2016.v106i6.10379, 10.7196/SAMJ.2016.v106i6.10379]; Matzopoulos R, 2016, J PUBLIC HEALTH POL, V37, P260, DOI 10.1057/jphp.2016.13; Matzopoulos R, 2015, B WORLD HEALTH ORGAN, V93, P303, DOI 10.2471/BLT.14.145771; Matzopoulos R, 2014, AGGRESS VIOLENT BEH, V19, P649, DOI 10.1016/j.avb.2014.09.009; Matzopoulos R, 2010, HEALTH POLICY, V97, P62, DOI 10.1016/j.healthpol.2010.03.003; Matzopoulos RG, 2014, AM J PUBLIC HEALTH, V104, P455, DOI 10.2105/AJPH.2013.310650; Meel B, 2018, MED SCI LAW, V58, P102, DOI 10.1177/0025802418758802; Meel BL, 2005, SAMJ S AFR MED J, V95, P963; Mikton CR, 2017, B WORLD HEALTH ORGAN, V95, P36, DOI 10.2471/BLT.16.172965; Naidoo Sudeshni, 2011, Afr J Paediatr Surg, V8, P101, DOI 10.4103/0189-6725.79070; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Ozanne-Smith J, 2004, INJURY PREV, V10, P280, DOI 10.1136/ip.2003.004150; Peden M., 1998, TRAUMA REV, V6, P4; PERROT C A V, 1989, Journal of Emergency Medicine, V7, P485, DOI 10.1016/0736-4679(89)90151-0; Petersen T, 2016, NEWS24, P23; Pillay-van Wyk V, 2016, LANCET GLOB HEALTH, V4, pE642, DOI 10.1016/S2214-109X(16)30113-9; Prinsloo M, 2017, SAMJ S AFR MED J, V107, P470, DOI [10.7196/samj.2017.v107i6.12464, 10.7196/SAMJ.2017.v107i6.12464]; Prinsloo M, 2016, SAMJ S AFR MED J, V106, P193, DOI [10.7196/SAMJ.2016.v106i2.10211, 10.7196/SAMJ.2016.V106I2.10211]; Prinsloo M, 2019, ESTIMATING INJURY MO; Santaella-Tenorio J, 2016, EPIDEMIOL REV, V38, P140, DOI 10.1093/epirev/mxv012; Serrao A., 2015, STAR; South African Police Service, 2012, ANN REP 2011 2012; South African Police Service, 2018, JOURN SAF S AFR CRIM, P1; South African Police Service, 2011, CRIM REP 2010 2011 S; Thamm, 2016, DAILY MAVERICK; van Vuuren Hennie, 2018, APARTHEID GUNS MONEY; Villaveces A, 2000, JAMA-J AM MED ASSOC, V283, P1205, DOI 10.1001/jama.283.9.1205; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Webster DW, 2004, JAMA-J AM MED ASSOC, V292, P594, DOI 10.1001/jama.292.5.594; Wigton A, 1999, S AFR MED J, V89, P407; 2017, REPORT HIGH LEVEL PA	63	2	2	0	2	SA MEDICAL ASSOC	PRETORIA	BLOCK F CASTLE WALK CORPORATE PARK, NOSSOB STREET, ERASMUSKLOOF EXT3, PRETORIA, 0002, SOUTH AFRICA	0256-9574	2078-5135		SAMJ S AFR MED J	SAMJ S. Afr. Med. J.	NOV	2019	109	11	2				63	68		10.7196/SAMJ.2019.v109i11b.14256			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JW6OL	WOS:000503168800013	32252871	gold			2022-02-06	
J	Merritt, VC; Greenberg, LS; Guty, E; Bradson, ML; Rabinowitz, AR; Arnett, PA				Merritt, Victoria C.; Greenberg, Liora S.; Guty, Erin; Bradson, Megan L.; Rabinowitz, Amanda R.; Arnett, Peter A.			Beyond Measures of Central Tendency: Novel Methods to Examine Sex Differences in Neuropsychological Performance Following Sports-Related Concussion in Collegiate Athletes	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Cognition; Cognitive impairment; Intraindividual variability; Cognitive dispersion; Sports concussion; Gender differences	TRAUMATIC BRAIN-INJURY; INTRAINDIVIDUAL VARIABILITY; NEUROCOGNITIVE PERFORMANCE; AGE	Objective: The purpose of this study was to examine sex differences in neuropsychological functioning after sports-related concussion using several approaches to assess cognition: mean performance, number of impaired scores, and intraindividual variability (IIV). Method: In the study, 152 concussed college athletes were administered a battery of neuropsychological tests, on average, 10 days post-concussion (SD = 12.75; Mdn = 4 days; Range = 0-72 days). Mean performance was evaluated across 18 individual neuropsychological variables, and the total number of impaired test scores (>1.5 SD below the mean) was calculated for each athlete. Two measures of IIV were also computed: an intraindividual standard deviation (ISD) score and a maximum discrepancy (MD) score. Results: Analyses of covariance revealed that, compared with males, females had significantly more impaired scores and showed greater variability on both IIV indices (ISD and MD scores) after adjusting for time since injury and post-concussive symptoms. In contrast, no significant effects of sex were found when examining mean neuropsychological performance. Conclusion: Although females and males demonstrated similar mean performance following concussion, females exhibited a greater level of cognitive impairment and larger inconsistencies in cognitive performance than males. These results suggest that evaluating cognitive indices beyond mean neuropsychological scores may provide valuable information when determining the extent of post-concussion cognitive dysfunction.	[Merritt, Victoria C.] VA San Diego Healthcare Syst, 151B,3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Greenberg, Liora S.; Guty, Erin; Bradson, Megan L.; Arnett, Peter A.] Penn State Univ, State Coll, PA 16801 USA; [Rabinowitz, Amanda R.] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA		Merritt, VC (corresponding author), VA San Diego Healthcare Syst, 151B,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	victoria.merritt@va.gov		Merritt, Victoria/0000-0001-5683-4168			Arnett P., 2014, CONCUSSION ATHLETICS; Arnett P, 2016, SPORTS MED ARTHROSC, V24, P116, DOI 10.1097/JSA.0000000000000123; Bunce D, 2013, J INT NEUROPSYCH SOC, V19, P971, DOI 10.1017/S1355617713000830; Cole VT, 2011, SCHIZOPHR RES, V129, P91, DOI 10.1016/j.schres.2011.03.007; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Dykiert D, 2012, DEV PSYCHOL, V48, P1262, DOI 10.1037/a0027550; Ghisletta P, 2018, INT J BEHAV DEV, V42, P294, DOI 10.1177/0165025417739179; Haynes BI, 2017, J INT NEUROPSYCH SOC, V23, P431, DOI 10.1017/S1355617717000236; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lovell M.R., 2016, IMPACT ADM TECHNICAL; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MCCRORY P, 2013, J ATHL TRAINING, V5, P255, DOI DOI 10.1016/J.PMRJ.2013.02.012; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006	25	2	2	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2019	25	10					1094	1100		10.1017/S1355617719000882			7	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	KI4XA	WOS:000511352800011	31477193				2022-02-06	
J	Mirshekar, MA; Shahraki, M; Najafi, R; Shabani, S				Mirshekar, Mohammad Ali; Shahraki, Mohammadreza; Najafi, Reza; Shabani, Sahreh			The ameliorative effects of myricetin on neurobehavioral activity, electrophysiology, and biochemical changes in an animal model of traumatic brain injury	LEARNING AND MOTIVATION			English	Article						Traumatic brain injury; Myricetin; Long-term potentiation; Cognition; Rats	CHRONIC CEREBRAL HYPOPERFUSION; RAT MODEL; GALLIC ACID; TNF-ALPHA; FLAVONOIDS; MEMORY; DYSFUNCTION; MOUSE; POTENTIATION; INFLAMMATION	Traumatic brain injury (TBI) can produce cognitive disabilities and death. The most frequent clinical symptoms of TBI are memory loss and unusual behavior or mental health disorders. The present study was aimed to evaluate the effects of chronic oral administration of myricetin (MYR) on behavioral activities (spatial and passive avoidance memory, and motor coordination) and long-term potentiation (LTP) from cornu ammonis area as well as malondialdehyde (MDA) levels in the rat hippocampus following TBI. Brain injury was induced following Marmarou's method. Motor balance, spatial memory test, and passive avoidance task (PAT) were assessed in the Rotarod, Morris water maze, and shuttle-box apparatus, respectively. The level of MDA was measured by ELISA kits and LTP indices were recorded by Electromadule. The results indicated that step-through latency (p < 0.001), LTP indices (p < 0.001) at different times, the percentage of the total time spent by animals in the target quarter (p < 0.001), and the latency times (p < 0.001) were reduced significantly in the TBI rats compared with those of the control group but enhanced significantly in the group treated with MYR compared with those of the TBI group. Motor coordination decreased in the group with TBI (p < 0.001 vs. control). Also, the cerebral MDA concentrations increased following TBI (p < 0.001) and significantly decreased in the group treated with MYR (p < 0.01). MYR improved neurological scores (p < 0.001), memory (p < 0.05, p < 0.01, p < 0.001 at different time points) and LIP indices (p < 0.001) compared with those of the TBI group significantly. The results suggested that MYR could be used as a neuroprotective agent against TBI-induced electrophysiological and behavioral deficits. Several lines of studies are needed to elucidate the possible molecular mechanism of MYR involved in improving cognitive impairments.	[Mirshekar, Mohammad Ali; Shahraki, Mohammadreza; Najafi, Reza] Zahedan Univ Med Sci, Sch Med, Dept Physiol, Zahedan, Iran; [Mirshekar, Mohammad Ali] Zahedan Univ Med Sci, Clin Immunol Res Ctr, Zahedan, Iran; [Shabani, Sahreh] Shahrekord Univ Med Sci, Basic Hlth Sci Inst, Med Plants Res Ctr, Shahrekord, Iran; [Shabani, Sahreh] Ahvaz Jundishapur Univ Med Sci, Physiol Res Ctr, Fac Med, Dept Physiol, Ahvaz, Iran		Shabani, S (corresponding author), Shahrekord Univ Med Sci, Basic Hlth Sci Inst, Med Plants Res Ctr, Shahrekord, Iran.	sahre.shabani1@gmail.com	Mirshekar, Mohammad Ali/S-4167-2017; Shabani, Sahreh/AAG-4488-2021	Mirshekar, Mohammad Ali/0000-0002-0449-6440; 	research affairs of Zahedan University of Medical Sciences [9147]	The study was financially supported by research affairs of Zahedan University of Medical Sciences, Deputy of research and technology (Grant no. 9147). All stages of work were done in animal care and breeding center, Zahedan University of Medical Sciences (ZAUMS).	Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Arabmoazzen S, 2015, IRAN J BASIC MED SCI, V18, P745; Atalay T, 2017, TURK NEUROSURG, V27, P924, DOI 10.5137/1019-5149.JTN.17249-16.2; Baptista FI, 2014, ACS CHEM NEUROSCI, V5, P83, DOI 10.1021/cn400213r; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Das Sanchari, 2008, Curr Aging Sci, V1, P169; de la Torre JC, 2010, J ALZHEIMERS DIS, V20, P861, DOI 10.3233/JAD-2010-091579; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fu XB, 2014, PHARMACOL BIOCHEM BE, V126, P122, DOI 10.1016/j.pbb.2014.09.005; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Heldmann U, 2005, EXP NEUROL, V196, P204, DOI 10.1016/j.expneurol.2005.07.024; Kalish B. T, 2016, WEIGHT DROP MODELS T, P193; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Kim HD, 2016, J MED FOOD, V19, P374, DOI 10.1089/jmf.2015.3581; Krishnaveni M., 2012, Journal of Pharmacy Research, V5, P3870; Lorente L, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7110142; Lorente L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125893; Macready AL, 2009, GENES NUTR, V4, P227, DOI 10.1007/s12263-009-0135-4; Mansuri ML, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0400-z; Miller LS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00506; Mirshekar M. A., 2015, ZAHEDAN J RES MED SC, V17; Mirshekar MA, 2018, IRAN J BASIC MED SCI, V21, P1056, DOI 10.22038/IJBMS.2018.29639.7165; Mirshekar MA, 2017, BIOMED PHARMACOTHER, V93, P1220, DOI 10.1016/j.biopha.2017.07.014; Mirshekar M, 2011, IRAN J PHARM RES, V10, P569; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Oberbauer E, 2013, J NUTR BIOCHEM, V24, P1953, DOI 10.1016/j.jnutbio.2013.06.005; Ong KC, 2000, LIFE SCI, V67, P1695, DOI 10.1016/S0024-3205(00)00758-X; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ramezani M, 2016, NEURAL REGEN RES, V11, P1976, DOI 10.4103/1673-5374.197141; Rendeiro C, 2015, NEUROCHEM INT, V89, P126, DOI 10.1016/j.neuint.2015.08.002; Rendeiro C, 2012, P NUTR SOC, V71, P246, DOI 10.1017/S0029665112000146; Sarkaki A, 2015, CAN J PHYSIOL PHARM, V93, P687, DOI 10.1139/cjpp-2014-0546; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shabani S, 2018, BIOMED PHARMACOTHER, V108, P1376, DOI 10.1016/j.biopha.2018.09.127; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Shishido H, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/3248519; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Stokum JA, 2017, BEHAV BRAIN RES, V333, P43, DOI 10.1016/j.bbr.2017.06.038; Umesalma S, 2010, BASIC CLIN PHARMACOL, V107, P650, DOI 10.1111/j.1742-7843.2010.00565.x; Wang HM, 2016, MOL MED REP, V13, P4215, DOI 10.3892/mmr.2016.5052; Ward RJ, 2009, J NEUROCHEM, V111, P1119, DOI 10.1111/j.1471-4159.2009.06389.x; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Youdim KA, 2004, FREE RADICAL BIO MED, V37, P1683, DOI 10.1016/j.freeradbiomed.2004.08.002	50	2	2	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0023-9690	1095-9122		LEARN MOTIV	Learn. Motiv.	NOV	2019	68								101597	10.1016/j.lmot.2019.101597			11	Psychology, Biological; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	JV5QE	WOS:000502419200006					2022-02-06	
J	Morrison, L; Taylor, R; Mercuri, M; Thompson, J				Morrison, Laura; Taylor, Rachel; Mercuri, Mathew; Thompson, Jennifer			Examining Canada's return visits to the emergency department after a concussion	CANADIAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Concussion; emergency department; head injury; return visit	TRAUMATIC BRAIN-INJURY; EARLY INTERVENTION	Objectives: The purpose of this study was to identify 1) the proportion of patients discharged from the emergency department (ED) with a diagnosis of concussion and return within 14 days, and 2) the characteristics that prompt a return. Methods: A health records review was conducted on adult patients with a discharge diagnosis of a concussion who accessed care through Hamilton Health Sciences EDs and Urgent Care Centre in 2016. Subsequent data were collected from those who returned to the ED within 14 days. Clinical characteristics of returners were compared to those of non-returners. Results: Of the 389 patients included in the study, 38 (10%) returned within 14 days. Patients who sustained a concussion in a sport-related context or were referred to a specialized clinic were less likely to return (p = 0.03). Those who suffered an assault-related concussion were more likely to return (p= 0.01). Of those who did return, 42% received a CT scan with normal results, and 42% were given new discharge instructions. Conclusions: Approximately 10% of patients diagnosed with a concussion in a Canadian hospital setting returned to the ED within 14 days of their index visit. Our study suggests the opportunity to reduce this burden to both the healthcare system and the patient through careful discharge instructions outlining anticipated symptoms following a concussion (specifically, headache) or referral to a concussion clinic.	[Morrison, Laura] Univ Calgary, Dept Surg, Div Orthopaed Surg, Calgary, AB, Canada; [Taylor, Rachel] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Mercuri, Mathew; Thompson, Jennifer] McMaster Univ, Dept Med, Div Emergency Med, Hamilton, ON, Canada		Morrison, L (corresponding author), 216-2204 1 ST SW, Calgary, AB T2S 1P4, Canada.	laura.morrison1@medportal.ca					Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Bergman K, 2016, J TRAUMA NURS, V23, P327, DOI 10.1097/JTN.0000000000000242; Brown JA, 2006, OCCUP ENVIRON MED, V63, P396, DOI 10.1136/oem.2005.022707; Canadian Institute for Health Information, 2016, INJ TRAUM EM DEP HOS; Ganti L, 2015, WEST J EMERG MED, V16, P481, DOI 10.5811/westjem.2015.2.23546; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Matuseviciene G, 2013, BRAIN INJURY, V27, P318, DOI 10.3109/02699052.2012.750740; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Rowe BH, 2018, J EMERG MED, V54, P774, DOI 10.1016/j.jemermed.2018.02.013; Seeley H, 2014, EMERG MED J, V31, P724, DOI 10.1136/emermed-2013-202377; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Statistics Canada, 2015, ACC REG MED DOCT 201; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	14	2	2	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1481-8035	1481-8043		CAN J EMERG MED	Can. J. Emerg. Med.	NOV	2019	21	6					784	788		10.1017/cem.2019.22			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KJ8WB	WOS:000512335700023	30947758				2022-02-06	
J	Mosti, CB; Klingaman, EA; Brownlow, JA; Gehrman, PR				Mosti, Caterina B.; Klingaman, Elizabeth A.; Brownlow, Janeese A.; Gehrman, Philip R.			Insomnia Prevalence Among US Army Soldiers With History of TBI	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury (TBI); insomnia; sleep; head injury; military	TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCE; ASSESS RISK; RESILIENCE; EPIDEMIOLOGY; DEPLOYMENT; DISORDERS; VETERANS; PATTERNS; NEED	Purpose/Objective: To determine the rate of insomnia among active-duty soldiers with and without a history of traumatic brain injury (TBI). Research Method and Design: Data were extracted from the All Army Study (AAS), a cross-sectional, self-report survey completed by a representative sample of 21,499 U.S. Army soldiers from 2011 to 2013 as part of the Army Study to Assess Risk and Resilience in Servicemembers. History and severity of TBI were determined by participants' responses to questions regarding postinjury symptomology (i.e., loss of consciousness [LOC], amnesia, etc.). Insomnia symptoms were defined using DSM-5 criteria as measured by the Brief Insomnia Questionnaire. Results: Approximately 63% of respondents reported lifetime history of mild TBI (mTBI), with similar to 7% endorsing a history of moderate to severe TBI. Insomnia symptom prevalence rate increased with brain injury severity and number of TBIs with LOC, with similar to 51% of those with mTBI and similar to 55% of those with moderate to severe TBI demonstrating clinically elevated insomnia symptoms, compared to similar to 37% insomnia prevalence rate among servicemembers without TBI. Conclusion/Implications: Results suggest high (similar to 50%) prevalence rates of insomnia symptoms among servicemembers with a lifetime history of brain injury, underscoring the need for behavioral sleep medicine interventions among active-duty personnel. Impact and Implications Increased prevalence of sleep disturbance among individuals with history of traumatic brain injury (TBI) has been well documented. The current study extends this line of research by investigating the rate and severity of insomnia symptoms in individuals with and without history of TBI among a large, representative sample of active-duty U.S. soldiers as part of the Army Study to Assess Risk and Resilience in Servicemembers (STARRS). Rates of clinically elevated insomnia and lifetime-acquired TBI among active-duty servicemembers are considerably higher than the general population, and individuals with a positive history of brain injury endorsed higher rates of clinically elevated insomnia symptoms compared to peers with no history of TBI. While behavioral sleep interventions (i.e., cognitive- behavioral therapy for insomnia) are frequently employed throughout the Veterans Affairs system, application among active-duty personnel remains somewhat limited, although initial outcomes are promising. Current findings underscore the need for widespread implementation of behavioral sleep interventions among active-duty servicemembers, particularly given the known cognitive, physical, emotional, functional, and financial repercussions of untreated insomnia symptoms.	[Mosti, Caterina B.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat, 446 East Ontario St, Evanston, IL 60611 USA; [Klingaman, Elizabeth A.] US Dept Vet Affairs Capitol Healthcare Network VI, MIRECC, Baltimore, MD USA; [Klingaman, Elizabeth A.] Univ Maryland, Dept Psychiat, Sch Med, College Pk, MD USA; [Brownlow, Janeese A.; Gehrman, Philip R.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA		Mosti, CB (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat, 446 East Ontario St, Evanston, IL 60611 USA.	caterina.mosti@nm.org			NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM103653] Funding Source: Medline; RRD VA [IK2 RX001836] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103653] Funding Source: NIH RePORTER		Alexander M, 2016, SLEEP, V39, P1399, DOI 10.5665/sleep.5972; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW TBI NUMB; Heeringa SG, 2013, INT J METH PSYCH RES, V22, P276, DOI 10.1002/mpr.1400; Hermes E, 2014, SLEEP MED, V15, P508, DOI 10.1016/j.sleep.2013.12.010; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V361, P537; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Kessler RC, 2013, INT J METH PSYCH RES, V22, P267, DOI 10.1002/mpr.1401; Kessler RC, 2010, SLEEP, V33, P1539, DOI 10.1093/sleep/33.11.1539; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Mai E, 2008, SLEEP MED CLIN, V3, P167, DOI 10.1016/j.jsmc.2008.02.001; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Taylor DJ, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx075; Taylor DJ, 2016, SLEEP, V39, P1795, DOI 10.5665/sleep.6156; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; VetAdvisor, 2013, NAT VET SLEEP SURV R	30	2	2	0	8	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2019	64	4					475	481		10.1037/rep0000283			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	JF3KC	WOS:000491284200010	31204819	Green Accepted			2022-02-06	
J	Norman, RS; Shah, MN; Turkstra, LS				Norman, Rocio S.; Shah, Manish N.; Turkstra, Lyn S.			Language Comprehension After Mild Traumatic Brain Injury: The Role of Speed	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							WORKING-MEMORY; POSTCONCUSSIVE SYMPTOMS; PHONOTACTIC PROBABILITY; COMPLICATED MILD; CONCUSSION; MODERATE; DEFICITS; ABNORMALITIES; DYSFUNCTION; ATTENTION	Purpose: The aim of this study was to characterize language comprehension in mild traumatic brain injury (mTBI) by testing a speed-based hypothesis. We hypothesized that adults with mTBI would perform worse than a group of adults with orthopedic injuries (OIs) on an experimental language comprehension task. Method: The study employed a prospective experimental design. Participants were 19 adults with mTBI and 19 adults with OI ages 18-55 years. Participants completed the Whatdunit task, a sentence agent selection task in speeded and unspeeded conditions. Results: In the unspeeded condition, the mTBI group performed with a marginally significant higher accuracy than the OI group. In the speeded condition, the mTBI group performed with lower accuracy than the OI group; however, this difference did not reach statistical significance. There was a marginally significant interaction of Sentence Type x Group for reaction time in the speeded condition. Conclusions: While our task might have been sensitive to cognitive processing abilities in both groups (as evidenced by the main effects of condition and sentence type), the task was not specific enough to capture mTBI-related deficits. The similarities in performance between both groups have clinical implications for the treatment of not just brain-related trauma but also trauma in general.	[Norman, Rocio S.; Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA; [Shah, Manish N.] Univ Wisconsin, Sch Med & Publ Hlth, Berbee Walsh Dept Emergency Med, Madison, WI USA; [Turkstra, Lyn S.] Univ Wisconsin, Neurosci Training Program, Madison, WI USA; [Turkstra, Lyn S.] Univ Wisconsin, Dept Surg, Madison, WI USA		Norman, RS (corresponding author), Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA.	normanr@uthscsa.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921; Shah, Manish/0000-0001-6331-1074	National Institute of Child Health and Human Development/National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD071089]; National Institute of General Medical Sciences Awar [R25GMO83252]; American Speech-Hearing Association Foundation New Century Scholar Doctoral Scholarship; University of Wisconsin-Madison; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	This work was supported by National Institute of Child Health and Human Development/National Center for Medical Rehabilitation Research Award R01 HD071089, National Institute of General Medical Sciences Award R25GMO83252, an American Speech-Hearing Association Foundation New Century Scholar Doctoral Scholarship, and a University of Wisconsin-Madison Emma Allen Speech Pathology Fellowship. The authors thank Barbara Bendlin, Cynthia Fowler, Margarita Kaushanskaya, and Audra Sterling for their invaluable input on this study. They are also grateful to James Montgomery, Julia Evans, and Ronald Gillam for their generosity in facilitating the use of the Whatdunit experiment for this study. They also thank Aimee Balistreri and Kaytlin Hanson for their help with data collection, reliability, and scoring; Aimee Teo Broman for statistical guidance; and the faculty and staff at the University of Wisconsin-Madison Berbee Walsh Department of Emergency Medicine. Many thanks to Mackenzie Cross for assistance with final article preparation.	Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Chabok SY, 2012, NEUROPSYCHOLOGIA, V50, P1444, DOI 10.1016/j.neuropsychologia.2012.02.029; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul M, 2010, TRAUMATIC BRAIN INJU; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Gron G, 1996, J CLIN EXP NEUROPSYC, V18, P406, DOI 10.1080/01688639608408997; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Krug H., 2015, SIG 2 PERSPECTIVES N, V25, P17, DOI [10.1044/nnsld25.1.17., DOI 10.1044/NNSLD25.1.17, 10.1044/nnsld25.1.17]; Kuperman V, 2012, BEHAV RES METHODS, V44, P978, DOI 10.3758/s13428-012-0210-4; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; MacWhinney B, 2011, APHASIOLOGY, V25, P1286, DOI 10.1080/02687038.2011.589893; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Montgomery JW, 2016, APPL PSYCHOLINGUIST, V37, P1281, DOI 10.1017/S0142716415000570; Montgomery JW, 2009, J SPEECH LANG HEAR R, V52, P269, DOI 10.1044/1092-4388(2008/07-0116); Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Psychology Software Tools, 2012, E PRIME 2 0; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Riedeman S., 2016, AVAILABILITY QUALITY; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Storkel HL, 2010, BEHAV RES METHODS, V42, P497, DOI 10.3758/BRM.42.2.497; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Troyanskaya M, 2016, J CLIN EXP NEUROPSYC, V38, P811, DOI 10.1080/13803395.2016.1167172; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Vitevitch MS, 2004, BEHAV RES METH INS C, V36, P481, DOI 10.3758/BF03195594; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Wechsler D., 2008, WECHSLER ADULT INTEL; Wells JB, 2009, COGNITIVE PSYCHOL, V58, P250, DOI 10.1016/j.cogpsych.2008.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; World Health Organization, 2007, INT CLASS DIS REL HL; World Health Organization, 1977, INT CLASS DIS REL HL; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383; Zwaagstra R, 1996, J CLIN EXP NEUROPSYC, V18, P383, DOI 10.1080/01688639608408995	67	2	2	0	5	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2019	28	4					1479	1490		10.1044/2019_AJSLP-18-0203			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	JP0ML	WOS:000497966200007	31454258	Green Published			2022-02-06	
J	Pelatti, CY; Bush, EJ; Farquharson, K; Schneider-Cline, W; Harvey, J; Carter, MW				Pelatti, Christina Yeager; Bush, Erin J.; Farquharson, Kelly; Schneider-Cline, Whitney; Harvey, Judy; Carter, Mary W.			Speech-Language Pathologists' Comfort Providing Intervention to Children With Traumatic Brain Injury: Results From a National Survey	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							LATENT CLASS ANALYSIS; EDUCATIONAL-SERVICES; STUDENTS; CONFIDENCE; TBI; PERCEPTIONS; RESIDENTS; KNOWLEDGE; WORKING	Purpose: This exploratory study examined speech-language pathologists' (SLPs) clinical experience and work environment characteristics impacting comfort with providing intervention to children with traumatic brain injury (TBI). Method: This study included 162 SLPs who responded to a national survey about their comfort providing intervention to children with TBI, clinical experience (i.e., years of experience treating children with TBI, TBI preprofessional training and professional development, and licensure/credentialing), and work environment (i.e., work setting, caseload size, geographic location). Results: Findings from latent class analysis revealed 3 distinct groups of SLPs based on their comfort with providing services to children with TBI: those with low comfort, moderate comfort, and high comfort. Further analyses revealed statistically significant differences across the 3 groups in the areas of years of experience treating children with TBI, professional development, work setting, TBI caseload size, and geographic location. Conclusions: Our findings reveal that most SLPs feel comfortable providing intervention to children with TBI; however, differences in characteristics across groups suggest that specific steps can be taken to ensure increased comfort for all SLPs working with this population. Practicing SLPs may increase their level of comfort through professional development and hands-on, mentored experience with TBI. Efforts such as these may influence the quality of service provision and expand the population of SLPs who feel comfortable treating children with TBI. Future research is needed to further examine how comfort and SLP characteristics directly impact the quality of speech and language intervention and long-term outcomes of children with TBI.	[Pelatti, Christina Yeager] Towson Univ, Dept Audiol Speech Language Pathol & Deaf Studies, Towson, MD 21252 USA; [Bush, Erin J.] Univ Wyoming, Div Commun Disorders, Laramie, WY 82071 USA; [Farquharson, Kelly] Florida State Univ, Sch Commun Sci & Disorders, Tallahassee, FL 32306 USA; [Schneider-Cline, Whitney] Univ Nebraska, Dept Commun Disorders, Kearney, NE USA; [Harvey, Judy] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE USA; [Carter, Mary W.] Towson Univ, Dept Interprofess Hlth Studies, Towson, MD USA		Pelatti, CY (corresponding author), Towson Univ, Dept Audiol Speech Language Pathol & Deaf Studies, Towson, MD 21252 USA.	cpelatti@towson.edu	Carter, Mary/ABE-7432-2020; Bush, Erin J/I-9606-2016	Carter, Mary/0000-0001-7939-4337; Bush, Erin J/0000-0003-1710-8619	Towson University College of Health Professions	This research was supported by a small grant from Towson University College of Health Professions awarded to Christina Yeager Pelatti. The authors wish to express appreciation to those who participated in this research, without whom this study would not have been possible.	American Speech-Language-Hearing Association, 2018, CAA PROGR LIST; American Speech-Language-Hearing Association, 2018, HIGHL TRENDS MEMB AF; American Speech-Language-Hearing Association, 2017, ASHA 2017 SLP HLTH C; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; [Anonymous], PED TRAUM BRAIN INJ; Ball D.L., 1996, EDUC RESEARCHER, V25, DOI DOI 10.3102/0013189X025009006; Biancone TL, 2014, J COMMUN DISORD, V49, P13, DOI 10.1016/j.jcomdis.2014.03.001; Blood GW, 2002, LANG SPEECH HEAR SER, V33, P282, DOI 10.1044/0161-1461(2002/023); Centers for Disease Control and Prevention, 2018, REP C MAN TRAUM BRAI; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; Cook GA, 2012, EARLY CHILD RES Q, V27, P582, DOI 10.1016/j.ecresq.2012.06.001; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Daniels K, 2000, HUM RELAT, V53, P275, DOI 10.1177/a010564; Dean N, 2010, ANN I STAT MATH, V62, P11, DOI 10.1007/s10463-009-0258-9; DePompei R, 1987, LANG SPEECH HEAR SER, V18, P292, DOI 10.1044/0161-1461.1804.292; DePompei R, 2019, PEDIAT TRAUMATIC BRA, P5; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Ghoneim N, 2019, TEACH LEARN MED, V31, P207, DOI 10.1080/10401334.2018.1490649; Gibbs DM, 2017, OPEN JOURNAL OF OCCU, V5, P1, DOI DOI 10.HTTPS://D0I.0RG/10.15453/2168-6408.1225; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greene D, 2018, NEUROREHABILITATION, V42, P277, DOI 10.3233/NRE-172382; Haarbauer-Krupa J., 2012, ASHA LEADER, V17, P10; Hammer CS, 2004, J COMMUN DISORD, V37, P91, DOI 10.1016/j.jcomdis.2003.07.002; Harrison M, 2016, LANG SPEECH HEAR SER, V47, P16, DOI 10.1044/2015_LSHSS-14-0078; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Jantz PB, 2007, SUPPORT LEARN, V22, P84, DOI 10.1111/j.1467-9604.2007.00452.x; Kahn LG, 2018, NEUROREHABILITATION, V42, P299, DOI 10.3233/NRE-172380; Kimble C, 2013, COMMUN DISORD Q, V35, P21, DOI 10.1177/1525740113487404; KOLCABA KY, 1992, ADV NURS SCI, V15, P1; Laursen B, 2006, MERRILL PALMER QUART, V52, P377, DOI 10.1353/mpq.2006.0029; Morgan AT, 2011, J EVAL CLIN PRACT, V17, P275, DOI 10.1111/j.1365-2753.2010.01436.x; Muncy MP, 2019, LANG SPEECH HEAR SER, V50, P224, DOI 10.1044/2018_LSHSS-18-0091; Nagele DA, 2018, NEUROREHABILITATION, V42, P289, DOI 10.3233/NRE-172386; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Orgel E, 2010, J PALLIAT MED, V13, P677, DOI 10.1089/jpm.2009.0338; Page TA, 2018, LANG SPEECH HEAR SER, V49, P965, DOI 10.1044/2018_LSHSS-17-0145; Riedeman S, 2018, AM J SPEECH-LANG PAT, V27, P181, DOI 10.1044/2017_AJSLP-17-0011; Sales I, 2014, CURR PHARM TEACH LEA, V6, P455, DOI 10.1016/j.cptl.2014.02.014; Schreiber JB, 2017, RES SOC ADMIN PHARM, V13, P1196, DOI 10.1016/j.sapharm.2016.11.011; Silverman HJ, 2013, J MED ETHICS, V39, P55, DOI 10.1136/medethics-2011-100300; SIMMONS RG, 2001, EXTENDING SELF ESTEE, P198; StataCorp, 2011, STAT SE VERS 12 1; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Todis B, 2004, NAT C COUNC EXC CHIL; Todis B, 2018, NEUROREHABILITATION, V42, P269, DOI 10.3233/NRE-172383; Tomlin P, 2002, DEV MED CHILD NEUROL, V44, P828; Tutton E, 2003, J CLIN NURS, V12, P689, DOI 10.1046/j.1365-2702.2003.00775.x; U.S. Department of Education National Center for Education Statistics, 2018, 2017094 NCES US DEP; Vermunt J.K., 2002, APPL LATENT CLASS AN, P89, DOI [10.1017/CBO97805114995.31.004., DOI 10.1017/CBO9780511499531.004]; Warner H, 2018, PERSPECTIVES ASHA SP, V3, P21, DOI [10.1044/persp3.SIG11.21, DOI 10.1044/PERSP3.SIG11.21]; Weber-Mayrer MM, 2015, J EARLY CHILD TEACH, V36, P44, DOI 10.1080/10901027.2014.996927; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	57	2	2	0	0	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2019	28	4					1611	1624		10.1044/2019_AJSLP-19-0029			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	JP0ML	WOS:000497966200016	31618048				2022-02-06	
J	Pietri, M; Djillani, A; Mazella, J; Borsotto, M; Heurteaux, C				Pietri, Mariel; Djillani, Alaeddine; Mazella, Jean; Borsotto, Marc; Heurteaux, Catherine			First evidence of protective effects on stroke recovery and post-stroke depression induced by sortilin-derived peptides	NEUROPHARMACOLOGY			English	Article						Post-stroke depression; Mini-spadin; Stroke; TREK-1 channel; Antidepressant	PHARMACOLOGICALLY INDUCED HYPOTHERMIA; POLYUNSATURATED FATTY-ACIDS; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; ALPHA-LINOLENIC ACID; IN-VIVO; CHINESE MEDICINE; SUBVENTRICULAR ZONE; COGNITIVE DEFICITS; RECEPTOR AGONIST	Post-stroke depression (PSD) is the most common mood disorder following stroke with high relevance for outcome and survival of patients. The TREK-1 channel represents a crucial target in the pathogenesis of stroke and depression. Spadin and its short analog mini-spadin were reported to display potent antidepressant properties. We investigated the therapeutic effects of mini-spadin in a mouse model of focal ischemia and PSD. To activate TREK-1 and induce neuroprotection a single low dose of mini-spadin (0.03 mu g/kg) was intraperitoneally injected 30 min after the onset of ischemia, once a day during 7 days post-ischemia. Then, to inhibit TREK-1 and induce antidepressant effect, the peptide was injected at higher concentration (3 mu g/kg) once a day for 4 days/ week until the sacrifice of animals. Electrophysiological studies showed that mini-spadin had a biphasic action on TREK-1. At low doses, the channel activity was increased whereas at higher doses it was inhibited. Minispadin prevented the loss of body weight and the delayed dopaminergic degeneration in substantia nigra and improved the motor and cognitive ischemia-induced deficits. Moreover, mini-spadin prevented PSD analyzed in the Forced Swim (FST) and Novelty Suppressed Feeding (NSF) tests. Finally, enhanced neurogenesis and synaptogenesis contributed to the beneficial effects of mini-spadin against stroke and PSD. This work reveals the first evidence that the modulation of TREK-1 channels in the early and chronic phases of stroke as well as the stimulation of brain plasticity by mini-spadin could play a key role in its brain protective effects against stroke and its deleterious consequences such as PSD.	[Pietri, Mariel; Djillani, Alaeddine; Mazella, Jean; Borsotto, Marc; Heurteaux, Catherine] Univ Cote DAzur, IPMC, CNRS, UMR7275, 660 Route Lucioles, F-06560 Valbonne, France		Heurteaux, C (corresponding author), Univ Cote DAzur, IPMC, CNRS, UMR7275, 660 Route Lucioles, F-06560 Valbonne, France.	heurteau@ipmc.cnrs.fr	Mazella, Jean/A-6767-2012		French Government [ANR-11 LABX 0015]; Centre National de la Recherche ScientifiqueCentre National de la Recherche Scientifique (CNRS); Agence Nationale de la RechercheFrench National Research Agency (ANR)European Commission [ANR-13-SAMA-0001, ANR-13-SAMA-0002, ANR-13-RPIB-0001, ANR-13-RPIB-0002]	We thank the French Government for the "Investments for the Future" LABEX ICST # ANR-11 LABX 0015. This work was supported by the Centre National de la Recherche Scientifique and the Agence Nationale de la Recherche (ANR-13-SAMA-0001 and -0002 and ANR-13-RPIB-0001 and -0002).	Angelelli P, 2004, ACTA PSYCHIAT SCAND, V110, P55, DOI 10.1111/j.1600-0447.2004.00297.x; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Belzung C, 2013, CURR TOP BEHAV NEURO, V15, P243, DOI DOI 10.1007/7854_2012_234; Blondeau N, 2002, NEUROSCIENCE, V109, P231, DOI 10.1016/S0306-4522(01)00473-0; Blondeau N, 2002, J CEREBR BLOOD F MET, V22, P821, DOI 10.1097/00004647-200207000-00007; Borsotto M, 2015, BRIT J PHARMACOL, V172, P771, DOI 10.1111/bph.12953; Bourourou M, 2016, NEUROPHARMACOLOGY, V108, P60, DOI 10.1016/j.neuropharm.2016.04.040; Burke WJ, 2002, EXPERT OPIN INV DRUG, V11, P1477, DOI 10.1517/13543784.11.10.1477; Carmichael ST, 2003, NEUROSCIENTIST, V9, P64, DOI 10.1177/1073858402239592; Carota Antonio, 2003, Adv Neurol, V92, P435; Chen Y, 2006, ANN PHARMACOTHER, V40, P2115, DOI 10.1345/aph.1H389; Chen Y, 2007, INT CLIN PSYCHOPHARM, V22, P159, DOI 10.1097/YIC.0b013e32807fb028; Choi KE, 2012, FASEB J, V26, P2799, DOI 10.1096/fj.11-201822; Chollet F, 2014, J NEUROL, V261, P1461, DOI 10.1007/s00415-013-7172-z; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Cole MG, 2001, J GERIATR PSYCH NEUR, V14, P37, DOI 10.1177/089198870101400109; Cumming TB, 2013, INT J STROKE, V8, P38, DOI 10.1111/j.1747-4949.2012.00972.x; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; de Bartolomeis A, 2004, INT REV NEUROBIOL, V59, P221; Devader C, 2015, BRIT J PHARMACOL, V172, P2604, DOI 10.1111/bph.13083; Devader C, 2017, J AFFECT DISORDERS, V208, P443, DOI 10.1016/j.jad.2016.10.049; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Djillani A, 2019, PHARMACOL THERAPEUT, V194, P185, DOI 10.1016/j.pharmthera.2018.10.003; Djillani A, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00643; Llorca GE, 2015, NEUROLOGIA, V30, P23, DOI 10.1016/j.nrl.2012.06.008; Fantegrossi WE, 2005, PHARMACOL BIOCHEM BE, V80, P341, DOI 10.1016/j.pbb.2004.12.005; Fish EW, 2004, J PHARMACOL EXP THER, V308, P474, DOI 10.1124/jpet.103.058206; Francisco G S, 1993, N J Med, V90, P686; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Hackett ML, 2005, STROKE, V36, P1092, DOI 10.1161/01.STR.0000162391.27991.9d; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Heurteaux C, 2010, NEUROPHARMACOLOGY, V58, P987, DOI 10.1016/j.neuropharm.2010.01.001; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Johansen FF, 2014, J STROKE CEREBROVASC, V23, P2879, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.019; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Kronenberg G, 2014, BRIT J PHARMACOL, V171, P4673, DOI 10.1111/bph.12775; Kronenberg G, 2012, BIOL PSYCHIAT, V72, P273, DOI 10.1016/j.biopsych.2012.02.026; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Lee JH, 2016, STROKE, V47, P1907, DOI 10.1161/STROKEAHA.116.013061; Lee JH, 2014, J NEUROTRAUM, V31, P1417, DOI 10.1089/neu.2013.3251; Lorivel T, 2015, J NEUROSCI RES, V93, P1648, DOI 10.1002/jnr.23591; Maati HMO, 2012, NEUROPHARMACOLOGY, V62, P278, DOI 10.1016/j.neuropharm.2011.07.019; Maati HMO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025602; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Mazella J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000355; Mead GE, 2013, STROKE, V44, P844, DOI 10.1161/STROKEAHA.112.673947; Mirza FJ, 2018, NEUROSCI BULL, V34, P349, DOI 10.1007/s12264-017-0201-7; Montgomery SA, 2001, PHARMACOL TOXICOL, V88, P282, DOI 10.1034/j.1600-0773.2001.d01-118.x; Morris PLP, 1996, J NEUROPSYCH CLIN N, V8, P399; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Orwig KS, 2009, J MED CHEM, V52, P1803, DOI 10.1021/jm801072v; PERUCHE B, 1994, J NEURAL TRANSM-PARK, V8, P73, DOI 10.1007/BF02250918; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Pohjasvaara T, 2001, EUR J NEUROL, V8, P315, DOI 10.1046/j.1468-1331.2001.00182.x; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; QUAST U, 1992, FUND CLIN PHARMACOL, V6, P279, DOI 10.1111/j.1472-8206.1992.tb00122.x; Quintard H, 2014, NEUROSCIENCE, V277, P72, DOI 10.1016/j.neuroscience.2014.06.047; Ramos AJ, 2004, BRAIN RES, V1030, P201, DOI 10.1016/j.brainres.2004.10.019; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sun CR, 2013, J NEUROSCI, V33, P17314, DOI 10.1523/JNEUROSCI.2129-13.2013; Takatsuru Y, 2009, J NEUROSCI, V29, P10081, DOI 10.1523/JNEUROSCI.1638-09.2009; Vataja R, 2004, J NEUROPSYCH CLIN N, V16, P156, DOI 10.1176/appi.neuropsych.16.2.156; Veyssiere J, 2015, PSYCHOPHARMACOLOGY, V232, P561, DOI 10.1007/s00213-014-3683-2; Wang MH, 2012, J MOL NEUROSCI, V46, P384, DOI 10.1007/s12031-011-9598-z; Wei S, 2013, NEUROSCIENCE, V252, P489, DOI 10.1016/j.neuroscience.2013.07.052; Wei Z., 2017, BIOMED RES INT, V2017; Winter B, 2004, STROKE, V35, P191, DOI 10.1161/01.STR.0000107188.29688.2C; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009; ZOLI M, 1993, NEUROCHEM INT, V23, P139, DOI 10.1016/0197-0186(93)90091-I; Zomkowski ADE, 2010, EUR NEUROPSYCHOPHARM, V20, P793, DOI 10.1016/j.euroneuro.2010.07.011	78	2	3	1	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	NOV 1	2019	158								107715	10.1016/j.neuropharm.2019.107715			11	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	JC0VS	WOS:000488998500017	31325429	Green Published, Bronze			2022-02-06	
J	Sardinha, DS; Vieira, RDA; Paiva, WS; de Oliveira, DV; de Sousa, RMC				Sardinha, Debora Souza; Almeida Vieira, Rita de Cassia; Paiva, Wellingson Silva; de Oliveira, Daniel Vieira; Cardoso de Sousa, Regina Marcia			Behavioral Changes and Associated Factors After Diffuse Axonal Injury	JOURNAL OF TRAUMA NURSING			English	Article						Behavior; Brain injuries; Diffuse axonal injury; Outcome and process assessment; Social behavioral disorders	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; ADAPTATION; EXPERIENCE; RELATIVES; NEEDS; TBI	Diffuse axonal injury (DAI) is a frequent injury after traumatic brain injury (TBI), which causes cognitive and behavioral symptoms. Behavioral changes after DAI affect the patients' quality of life, in addition to causing great damage to their family and society. This study aimed to analyze the behavioral changes of patients with DAI according to family members and to identify the associated factors. This study included patients with DAI, aged between 18 and 60 years, who presented to a referral hospital for traumatic injuries. A prospective cohort study was conducted with 2 evaluations of family members at 3, 6, and 12 months posttrauma. Behavioral changes were evaluated using a questionnaire designed to identify changes according to the perception of family members. The mixed-effects model was applied to identify significant behavioral changes, the effect of time on these changes, and the association between sociodemographic variables, DAI severity, and behavioral changes. Anxiety, dependency, depression, irritability, memory, and mood swings were significantly different (p <= .05) before and after trauma. An analysis of the evolution of these behaviors showed that the changes persisted with the same intensity up to 12 months posttrauma. There was an association between depression and income, age and irritability, and DAI severity and dependency. Unfavorable behavioral changes were frequent consequences of DAI, and no improvement in these changes was noted up to 12 months after the injury. Income, age, and DAI severity were related to behavioral changes.	[Sardinha, Debora Souza; Almeida Vieira, Rita de Cassia; Cardoso de Sousa, Regina Marcia] Univ Sao Paolo, Nursing Sch, Sao Paulo, Brazil; [Paiva, Wellingson Silva; de Oliveira, Daniel Vieira] Univ Sao Paolo, Div Neurosurg, Sao Paulo, Brazil		Sardinha, DS (corresponding author), Rua Igarape 158,Apartamento 1, BR-09190680 Santo Andre, SP, Brazil.	debora.sardinha@usp.br	Paiva, Wellingson S/G-5517-2013; Sousa, Regina M/H-1108-2012	Paiva, Wellingson S/0000-0002-5165-7040; Sousa, Regina M/0000-0002-2575-7937	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; State of Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/21804-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Universal MCTI-CNPq [444855/214-9]	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil (CAPES), Finance Code 001, State of Sao Paulo Research Foundation (FAPESP) (Process No. 2013/21804-0), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Universal MCTI-CNPq (Process No. 444855/214-9).	Vieira RDA, 2018, WORLD NEUROSURG, V109, P140, DOI 10.1016/j.wneu.2017.09.101; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; American Psychiatric Association, 2015, DIAGNOSTIC STAT MANU; Antunes PC, 2013, REV KAIROS, V16, P123; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Association for the Advancement of Automotive Medicine (AAAM), 2008, ABBR INJ SCAL AIS 20; Bennet L, 2013, CLIN EXP PHARMACOL P, V40, P774, DOI 10.1111/1440-1681.12135; Boing AF, 2012, REV SAUDE PUBL, V46, P617, DOI 10.1590/S0034-89102012005000044; Braine ME, 2011, J NEUROSCI NURS, V43, P156, DOI 10.1097/JNN.0b013e3182135bb2; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; Esbjornsson E, 2013, BRAIN INJURY, V27, P521, DOI 10.3109/02699052.2012.743179; Fausto MA, 2008, CAD SAUDE PUBLICA, V24, P513, DOI 10.1590/S0102-311X2008000300005; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Frosch S, 1997, BRAIN INJURY, V11, P891; Gennarelli T. A., 1987, HEAD INJURY, P108; Gouveia P. A. R., 2009, CONTEXTOS CLIN, V2, P18; Hassan STS, 2013, TRAUMA MON, V18, P56, DOI 10.5812/traumamon.11522; Hora Edilene Curvelo, 2005, Rev. Latino-Am. Enfermagem, V13, P93; Hora EC, 2009, REV LAT-AM ENFERM, V17, P541, DOI 10.1590/S0104-11692009000400017; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Liew B S, 2009, Med J Malaysia, V64, P280; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; O'Neill B, 2014, BRAIN INJURY, V28, P378, DOI 10.3109/02699052.2013.865264; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Saxton ME, 2013, NEUROREHABILITATION, V33, P263, DOI 10.3233/NRE-130954; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schroeter ML, 2007, NEUROPSYCHOLOGIA, V45, P3149, DOI 10.1016/j.neuropsychologia.2007.07.004; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Solmaz B, 2017, HUM BRAIN MAPP, V38, P2913, DOI 10.1002/hbm.23561; Su E, 2016, TRANSLATIONAL RES TR; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134	35	2	2	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	NOV-DEC	2019	26	6					328	339		10.1097/JTN.0000000000000471			12	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	JU7KJ	WOS:000501851000008	31714494				2022-02-06	
J	Siddiqui, MI; Hawksworth, SA; Sun, DY				Siddiqui, Mehdi, I; Hawksworth, Shane A.; Sun, Derrick Y.			Removal of Migrating Lumbar Spine Bullet: Case Report and Surgical Video	WORLD NEUROSURGERY			English	Article						Gunshot wound; Migrating bullet; Spinal cord and nerve root injury; Trauma	GUNSHOT INJURIES	BACKGROUND: Gunshot wounds to the spine are devastating injuries. Rarely, the bullet has been reported to migrate. Migration is associated with progressive neurologic deficits that often improve with bullet removal. The authors report a case of removal of a migrating lumbar spine bullet. This is supplemented by an operative video and a review of the literature. CASE DESCRIPTION: A 31-year-old man presented to the emergency department with multiple gunshot wounds and lower-extremity paresthesia. A ballistic injury occurred with an entry wound in the right posterior soft tissues, traversing the right paraspinal muscle and fracturing the left lumbar 5 pedicle and left lumbar 4 transverse process. The bullet was positioned within the spinal canal at the lumbar 3/4 interspace. His spinal injury was managed non-operatively due to his traumatic injuries and findings of minimal neurologic deficit without cerebrospinal fluid leak. The patient returned to the neurosurgery clinic a year later and was found to have worsening low back pain, decreased sensation throughout the left leg, and radiating pain throughout the right leg. Imaging demonstrated the bullet had migrated caudally to the midlumbar 5 vertebral body. Given the patient's progressive symptoms and migration of the bullet fragment, informed consent was obtained for a laminectomy and removal of the intradural bullet fragment. CONCLUSIONS: Neurosurgical treatment for gunshot wounds remains controversial. Cauda equina or lumbosacral level wounds are often incomplete and may improve with surgical decompression and bullet removal. Migrating bullet fragments throughout the spine and brain lead to worsened neurologic function, which can be reversed by removal. Movement of the bullet during surgery should be expected, and intraoperative fluoroscopy and patient positioning can help to properly localize the bullet and aid in its removal.	[Siddiqui, Mehdi, I] Univ Texas Hlth Sci Ctr San Antonio, Long Sch Med, San Antonio, TX 78229 USA; [Sun, Derrick Y.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [Hawksworth, Shane A.] William Beaumont Army Med Ctr, Dept Neurosurg, El Paso, TX 79920 USA		Hawksworth, SA (corresponding author), William Beaumont Army Med Ctr, Dept Neurosurg, El Paso, TX 79920 USA.	hawksa3@gmail.com		Siddiqui, Mehdi/0000-0002-9432-5951			Baldawa S, 2017, EUR SPINE J, V26, pS128, DOI 10.1007/s00586-016-4913-6; Bordon G, 2014, CASE REP ORTHOP, V2014; Cheng JS, 2012, J NEUROSURG, V116, P921, DOI 10.3171/2011.12.JNS111047; Choi BD, 2021, BRIT J NEUROSURG, V35, P119, DOI 10.1080/02688697.2018.1485872; de Barros TEP, 2014, SPINAL CORD, V52, P504, DOI 10.1038/sc.2014.56; DESCHAMPS GT, 1991, J TRAUMA, V31, P293; Farrugia A, 2010, J FORENSIC SCI, V55, P1371, DOI 10.1111/j.1556-4029.2010.01439.x; Ghori SA, 2014, JCPSP-J COLL PHYSICI, V24, pS219, DOI 11.2014/JCPSP.S219S220; Kafadar AM, 2006, SPINAL CORD, V44, P326, DOI 10.1038/sj.sc.3101808; Kitchel SH, 2003, CLIN ORTHOP RELAT R, P115, DOI 10.1097/01.blo.0000053166.71678.86; Moisi MD, 2015, GLOB SPINE J, V5, P523, DOI 10.1055/s-0035-1566231; Rammo RA, 2012, WORLD NEUROSURG, V77, DOI 10.1016/j.wneu.2011.06.015; Sidhu GS, 2013, CLIN ORTHOP RELAT R, V471, P3945, DOI 10.1007/s11999-013-2901-2; Singh Roop, 2010, Am J Orthop (Belle Mead NJ), V39, P116; Vakil MT, 2017, EMERG RADIOL, V24, P301, DOI 10.1007/s10140-016-1477-z; Yadav YR, 2006, NEUROL INDIA, V54, P453, DOI 10.4103/0028-3886.28138	16	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2019	131						62	64		10.1016/j.wneu.2019.07.151			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JG3GV	WOS:000491963300091	31356981				2022-02-06	
J	Tunthanathip, T; Phuenpathom, N; Sae-Heng, S; Oearsakul, T; Sakarunchai, I; Kaewborisutsakul, A				Tunthanathip, Thara; Phuenpathom, Nakornchai; Sae-Heng, Sakchai; Oearsakul, Thakul; Sakarunchai, Ittichai; Kaewborisutsakul, Anukoon			Traumatic cerebrovascular injury: clinical characteristics and illustrative cases	NEUROSURGICAL FOCUS			English	Article						traumatic cerebrovascular injury; vascular injury; traumatic brain injury; penetrating brain injury	HELICAL CT ANGIOGRAPHY; PENETRATING BRAIN-INJURY; ARTERIAL INJURIES; SURGICAL-TREATMENT; CAVERNOUS FISTULA; NECK; ANEURYSMS; MANAGEMENT; DIAGNOSIS	OBJECTIVE Traumatic cerebrovascular injury (TCVI) is a rare and serious complication of traumatic brain injury (TBI). Various forms of TCVIs have been reported, including occlusions, arteriovenous fistulas, pseudoaneurysms, and transections. They can present at a variety of intervals after TBI and may manifest as sudden episodes, progressive symptoms, and even delayed fatal events. The purpose of this study was to analyze cases of TCVI identified at a single institution and further explore types and characteristics of these complications of TBI in order to improve recognition and treatment of these injuries. METHODS The authors performed a retrospective review of cases of TCVI identified at their institution between 2013 and 2016. A total of 5178 patients presented with TBI during this time period, and 42 of these patients qualified for a diagnosis of TCVI and had adequate medical and imaging records for analysis. Data from their cases were analyzed, and 3 illustrative cases are presented in detail. RESULTS The most common type of TCVI was arteriovenous fistula (86.4%), followed by pseudoaneurysm (11.9%), occlusion (2.4%), and transection (2.4%). The mortality rate of patients with TCVI was 7.1%. CONCLUSIONS The authors describe the clinical characteristics of patients with TCVI and provide data from a series of 42 cases. It is important to recognize TCVI in order to facilitate early diagnosis and treatment.	[Tunthanathip, Thara; Phuenpathom, Nakornchai; Sae-Heng, Sakchai; Oearsakul, Thakul; Sakarunchai, Ittichai; Kaewborisutsakul, Anukoon] Prince Songkla Univ, Fac Med, Dept Surg, Neurosurg Unit, Hat Yai, Songkhla, Thailand		Tunthanathip, T (corresponding author), Prince Songkla Univ, Hat Yai, Songkhla, Thailand.	tsus4@hotmail.com		Tunthanathip, Thara/0000-0002-6303-836X	Faculty of Medicine, Prince of Songkla University	We would like to offer our special thanks to Dr. Kittipong Riabroi and Dr. Rujimas Khumtong for their advice about cerebral angiogram information. Furthermore, we thank Dr. Osaree Akaraborworn for the funding from the Targeted Research Grants, Faculty of Medicine, Prince of Songkla University.	Atar E, 2005, EMERG RADIOL, V11, P291, DOI 10.1007/s10140-004-0380-1; Baerlocher MO, 2009, EUR J TRAUMA EMERG S, V35, P67, DOI 10.1007/s00068-008-7184-z; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Bodanapally UK, 2015, J NEUROSURG, V122, P219, DOI 10.3171/2014.9.JNS14679; Bodanapally UK, 2014, J NEUROSURG, V121, P1275, DOI 10.3171/2014.7.JNS132688; Cohen JE, 2005, SURG NEUROL, V64, P331, DOI 10.1016/j.surneu.2004.11.029; de Castro SMM, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-206; Fattahi TT, 2003, J CRANIOFAC SURG, V14, P240, DOI 10.1097/00001665-200303000-00020; Gemmete JJ, 2010, CURR TREAT OPTION N, V12, P43, DOI 10.1007/s11940-009-0051-3; Inaba K, 2006, J TRAUMA, V61, P144, DOI 10.1097/01.ta.0000222711.01410.bc; Ishibashi Akira, 1995, Neurologia Medico-Chirurgica, V35, P882, DOI 10.2176/nmc.35.882; JENNETT B, 1975, LANCET, V1, P480; Jung SH, 2017, WORLD NEUROSURG, V98, P243, DOI 10.1016/j.wneu.2016.11.005; Kobata H, 2017, NEUROL MED-CHIR, V57, P410, DOI 10.2176/nmc.oa.2017-0056; Larson P S, 2000, Neurosurg Focus, V8, pe4; Martin S, 2013, INT J SURG CASE REP, V4, P858, DOI 10.1016/j.ijscr.2013.07.002; Miley Jefferson T, 2008, J Vasc Interv Neurol, V1, P79; Miyata Masaru, 1994, Neurological Surgery, V22, P253; Munera F, 2002, RADIOLOGY, V224, P366, DOI 10.1148/radiol.2242010973; Munera F, 2000, RADIOLOGY, V216, P356, DOI 10.1148/radiology.216.2.r00jl25356; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; Onda H, 2013, NEUROL MED-CHIR, V53, P573; Quintana F, 1996, AM J NEURORADIOL, V17, P283; Steenburg SD, 2010, RADIOGRAPHICS, V30, P869, DOI 10.1148/rg.304105022; Sui MX, 2015, INT J CLIN EXP MED, V8, P1598; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; Tunthanathip T, 2019, AM J EMERG MED; Tunthanathip T, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.8.FOCUS18311; Van Rooij WJ, 2013, INTERV NEURORADIOL, V19, P56, DOI 10.1177/159101991301900108; Wu Z, 2000, INTERV NEURORADIOL, V6, P277, DOI 10.1177/159101990000600402; Yamada K, 1998, NEUROSURGERY, V43, P153, DOI 10.1097/00006123-199807000-00101; Zhang C, 2011, NEUROPEDIATRICS, V42, P204, DOI 10.1055/s-0031-1291221	32	2	3	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E4	10.3171/2019.8.FOCUS19382			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900004	31675714	gold			2022-02-06	
J	Asmamaw, Y; Yitayal, M; Debie, A; Handebo, S				Asmamaw, Yilak; Yitayal, Mezgebu; Debie, Ayal; Handebo, Simegnew			The costs of traumatic head injury and associated factors at University of Gondar Specialized Referral Hospital, Northwest Ethiopia	BMC PUBLIC HEALTH			English	Article						Cost; Traumatic head injury; Gondar; Ethiopia	BRAIN-INJURY; RISK-FACTORS; EPIDEMIOLOGY; BURDEN	Background: Head injuries account for 650,000 annual deaths worldwide. The cost for treating head injury was estimated at US $200 million annually. This contributes to economic impoverishment in low income countries like Ethiopia. Hence, this study was aimed to assess the cost of Traumatic Head Injury (THI) and associated factors in the University of Gondar Specialized Referral Hospital. Method: An institution-based cross-sectional study was conducted from March 01 to May 30, 2017. A total of 387 THI patients were included in the study. An interviewer-administered questionnaire was used for data collection. Direct costs and indirect costs were measured by using the bottom-up approach. Data were entered into Epi-Info version 7 and imported to SPSS version 20 for analysis. Simple and multiple linear regression analysis were done to identify factors associated with cost of THI. Results: The mean cost of THI per patient was 4673.43 Ethiopian Birr (ETB), 95% CI (4523.6-4823.3), and length of hospital stay averaged 1.73, 95% CI (1.63-1.82). Direct non-medical cost, like transportation fee 1896.19 ETB (+/- 762.56 SD) and medical costs 1101.66 ETB (+/- 534.13 SD) were account for 40.57 and 23.58% of total costs respectively. The indirect cost, loss of income by patient and their attendant due to injury, was 1675.58 ETB (+/- 459.26 SD). Patients with moderate and severe levels of injury have 635.167 ETB (Standardized coefficient = 0.173, p < 0.001) and 773.621 ETB (Standardized coefficient = 0.132, p < 0.001) increased costs, respectively, compared to mild level THI patients. Costs for patients ages 31-45 years were 252.504 ETB (Standardized coefficient = -0.066, p = 0.046) lower than costs for those 5-14 years old. The cost of THI patients increased by 1022.853 ETB for each additional day of hospital length of stay (Standardized coefficient = 0.648, p < 0.001). Conclusion: Most expenses of the THI were from direct non-medical cost. Prior health service use, length of stay, level of injury, and age were significant predictors of cost of THI.	[Asmamaw, Yilak] Univ Gondar, Specialized Referral Hosp, Med Ward, Gondar, Ethiopia; [Yitayal, Mezgebu; Debie, Ayal] Univ Gondar, Inst Publ Hlth, Dept Hlth Syst & Policy, Gondar, Ethiopia; [Handebo, Simegnew] Univ Gondar, Inst Publ Hlth, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia		Handebo, S (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia.	hsimegnew@yahoo.com		Yitayal, Mezgebu/0000-0002-9206-9528			[Anonymous], 2009, CONS REP; Campbell HE, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0987-5; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Federal Democratic Republic of Ethiopia Ministry of Health (MoH), 2014, ETH 5 NAT HLTH ACC 2; FMOH-USAID, 2011, NAT HLTH ACC 5 2010; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Gururaj G., 1995, NEUROL INDIA, V43, P95; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Heinrich S, 2010, OSTEOPOROSIS INT, V21, P891, DOI 10.1007/s00198-009-1100-1; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hunt C, 2016, CANADA CONCUSSION, V1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MATHIESON I, 2014, J CLIN RES BEST PRAC, V0010; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; Penberthy LT, 2005, SEIZURE-EUR J EPILEP, V14, P46, DOI 10.1016/j.seizure.2004.06.001; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Runge J W, 1993, Emerg Med Clin North Am, V11, P241; Scholten A., 2016, THESIS; Sharma BR, 2008, PUBLIC HEALTH, V122, P1399, DOI 10.1016/j.puhe.2008.06.009; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; World Health Organization, 2008, VIOL INJ DIS BIENN 2; World Health Organization, 2006, WORK TOG HLTH; World Health Organization, 2010, GLOB PLAN DEC ACT RO	26	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2458		BMC PUBLIC HEALTH	BMC Public Health	OCT 28	2019	19	1							1399	10.1186/s12889-019-7800-3			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	JR5OI	WOS:000499673800011	31660928	Green Published, gold			2022-02-06	
J	Kreber, LA; Ashley, MJ; Masel, BE; Singh, CK; Randle, KD; Johnson, C; Helvie, R; Ashley, MJ; Griesbach, GS				Kreber, Lisa A.; Ashley, Mark J.; Masel, Brent E.; Singh, Charan K.; Randle, Kevin D.; Johnson, Christine; Helvie, Richard; Ashley, Matthew J.; Griesbach, Grace S.			Prevalence of growth hormone deficiency in middle-age adults recovering from stroke	BRAIN INJURY			English	Article						Growth hormone; hemorrhagic stroke; hypopituitarism; ischemic stroke	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; QUALITY-OF-LIFE; ENDOCRINE-SOCIETY; GH DEFICIENCY; COMORBIDITY; DYSFUNCTION; DIAGNOSIS; IMPACT	Objective: The prevalence of chronic growth hormone deficiency (GHD) and its association with other hormonal deficiencies was determined in middle-aged patients post-stroke with and without consideration of body mass index (BMI). Methods: Clinical records were reviewed to determine pituitary function at least 3 months post-stroke. Patients with a history of endocrine anomalies were excluded. GHD was determined by utilizing standard peak GH cutoffs following the glucagon stimulation test. A secondary analysis was conducted with stricter BMI-adjusted cutoffs. The accuracy of IGF-1 in predicting GHD was also examined. Results: GHD was diagnosed in 54% of patients (>= 5.0 mu g/L), with 32% falling into the severe (<= 3 mu g/L) category. Patients with GHD had lower levels of FSH, T3, LH, and SHBG. Analyzes of BMI-adjusted GH levels, revealed that 14% of patients were GHD. These patients had higher prolactin. IGF-1 values were not predictive of GHD. Latency to be admitted to post-acute rehabilitation was greater in patients with GHD. Conclusions: Evidence suggests patients with stroke may be at risk for developing GHD. GHD was associated with decreased levels of other hormones. Co-morbidities for stroke and neuroendocrine dysfunction overlap and may have implications for recovery following stroke.	[Kreber, Lisa A.; Ashley, Mark J.; Masel, Brent E.; Singh, Charan K.; Randle, Kevin D.; Johnson, Christine; Helvie, Richard; Ashley, Matthew J.; Griesbach, Grace S.] Ctr Neuro Skills, 16542 Ventura Blvd, Bakersfield, CA 91436 USA; [Kreber, Lisa A.] Southern Illinois Univ, Sch Hlth Sci, Carbondale, IL USA; [Masel, Brent E.] Univ Texas, Dept Neurol, Med Branch, Galveston, TX USA; [Griesbach, Grace S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Ashley, Matthew J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA		Griesbach, GS (corresponding author), Ctr Neuro Skills, 16542 Ventura Blvd, Bakersfield, CA 91436 USA.	ggriesbach@neuroskills.com					Ashley JG, 2018, BRAIN INJURY, V32, P600, DOI 10.1080/02699052.2018.1432896; Boehncke S, 2011, CEREBROVASC DIS, V31, P163, DOI 10.1159/000321738; Bunevicius A, 2015, EXPERT REV NEUROTHER, V15, P315, DOI 10.1586/14737175.2015.1013465; Carmichael ST, 2016, ANN NEUROL, V79, P895, DOI 10.1002/ana.24653; Crespo I, 2015, CURR OPIN ENDOCRINOL, V22, P306, DOI 10.1097/MED.0000000000000169; Fischer U, 2006, ACTA NEUROL SCAND, V113, P108, DOI 10.1111/j.1600-0404.2005.00551.x; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Karatepe AG, 2008, J REHABIL MED, V40, P831, DOI 10.2340/16501977-0269; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Kreber LA, 2016, J NEUROTRAUM, V33, P1607, DOI 10.1089/neu.2015.4127; MEROLA B, 1993, J CLIN ENDOCR METAB, V77, P1658, DOI 10.1210/jcem.77.6.8263155; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Neidert S, 2011, J INTERN MED, V269, P420, DOI 10.1111/j.1365-2796.2010.02327.x; O'Keefe LM, 2015, THYROID RES, V8, DOI 10.1186/s13044-015-0021-7; Sattler FR, 2013, BEST PRACT RES CL EN, V27, P541, DOI 10.1016/j.beem.2013.05.003; Scacchi M, 2010, EUR J ENDOCRINOL, V163, P201, DOI 10.1530/EJE-10-0160; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sesmilo Gemma, 2007, Hormones (Athens), V6, P132; Xu XY, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/3470490	21	2	2	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2020	34	2					276	280		10.1080/02699052.2019.1682195		OCT 2019	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KF5YW	WOS:000493174400001	31661639				2022-02-06	
J	Kelber, MS; Smolenski, DJ; Workman, DE; Morgan, MA; Wilson, ALG; Campbell, MS; Evatt, DP; Belsher, BE				Kelber, Marija Spanovic; Smolenski, Derek J.; Workman, Don E.; Morgan, Maria A.; Garvey Wilson, Abigail L.; Campbell, Marjorie S.; Evatt, Daniel P.; Belsher, Bradley E.			Typologies of Combat Exposure and Their Effects on Posttraumatic Stress Disorder and Depression Symptoms	JOURNAL OF TRAUMATIC STRESS			English	Article							MENTAL-HEALTH PROBLEMS; MILITARY SERVICE MEMBERS; PRIMARY-CARE; PSYCHOMETRIC PROPERTIES; PTSD SYMPTOMS; IRAQ; DEPLOYMENT; AFGHANISTAN; VALIDITY; SAMPLE	The present study identified distinct classes of U.S. military service members based on their combat experiences and examined mental health outcomes and longitudinal growth curves of posttraumatic stress disorder (PTSD) and depression symptoms associated with each class. Participants were 551 active duty service members who screened positive for PTSD and/or depression based on DSM-IV-TR criteria. All participants completed the Combat Experiences Scale at baseline as well as PTSD and depression measures at baseline and at 3-, 6-, and 12-month follow-ups. A latent class analysis identified four classes of service members based on their combat experiences: limited exposure, medical exposure, unit exposure, and personal exposure. Service members in the personal exposure class were characterized by a distinct mental health profile: They reported a higher level of PTSD symptoms at baseline and a higher prevalence of traumatic brain injury and PTSD diagnoses during the course of the study. The limited exposure class was more likely to receive diagnoses of depression and adjustment disorders. All classes except the medical exposure class demonstrated a slight decrease in PTSD and depression symptoms over time. However, participants in the limited exposure class had a larger decrease in PTSD and depression symptoms earlier in care but did not demonstrate superior long-term symptom improvements at 12 months compared to the other groups. These results inform PTSD development models and have implications for the screening and clinical management of combat-exposed service members.	[Kelber, Marija Spanovic; Smolenski, Derek J.; Workman, Don E.; Morgan, Maria A.; Garvey Wilson, Abigail L.; Campbell, Marjorie S.; Evatt, Daniel P.; Belsher, Bradley E.] Def Hlth Agcy, Psychol Hlth Ctr Excellence, Falls Church, VA USA; [Workman, Don E.; Campbell, Marjorie S.; Evatt, Daniel P.; Belsher, Bradley E.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Garvey Wilson, Abigail L.] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC USA		Kelber, MS (corresponding author), Psychol Hlth Ctr Excellence, 7700 Arlington Blvd,Suite 5101 Box 22, Falls Church, VA 22041 USA.	marija.s.kelber.ctr@mail.mil			U.S. Department of Defense Deployment-Related Medical Research Program award [DR080409];  [W81XWH-09-2-0077];  [W81XWH-09-2-0078];  [W81XWH-09-2-0079]	This study was supported by a U.S. Department of Defense Deployment-Related Medical Research Program award (DR080409). The award was a joint award to the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (W81XWH-09-2-0077), Research Triangle Institute (W81XWH-09-2-0078), and RAND Corporation (W81XWH-09-2-0079). We wish to thank the initial principal investigators, Charles C. Engel, MD; Lisa H. Jaycox, PhD; Robert M. Bray, PhD; and Michael C. Freed, PhD; and the rest of the STEPS-UP team who supported the original study.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Armenta RF, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1590-5; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bray RM, 2016, J TRAUMA STRESS, V29, P340, DOI 10.1002/jts.22119; Collins LM., 2010, LATENT CLASS LATENT; Enders C. K., 2010, APPL MISSING DATA AN; Engel CC, 2016, JAMA INTERN MED, V176, P948, DOI 10.1001/jamainternmed.2016.2402; Engel CC, 2014, CONTEMP CLIN TRIALS, V39, P310, DOI 10.1016/j.cct.2014.10.002; Feingold A, 2009, PSYCHOL METHODS, V14, P43, DOI 10.1037/a0014699; First MG, 1995, STRUCTURED CLIN INTE, DOI [10.1037/t07827-000., DOI 10.1037/T07827-000, 10.1037/t07827-000]; Foa E., 1995, POSTTRAUMATIC DIAGNO; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; FONTANA A, 1992, J NERV MENT DIS, V180, P748, DOI 10.1097/00005053-199212000-00002; GRADY DA, 1989, J NERV MENT DIS, V177, P347, DOI 10.1097/00005053-198906000-00005; Griffin MG, 2004, J TRAUMA STRESS, V17, P497, DOI 10.1007/s10960-004-5798-4; Hayes CJ, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5020022; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hourani L, 2015, J ANXIETY DISORD, V29, P101, DOI 10.1016/j.janxdis.2014.11.007; Johns SA, 2013, J PAIN SYMPTOM MANAG, V45, P71, DOI 10.1016/j.jpainsymman.2011.12.284; Kamata A, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00130; King D. W., 2003, MANUAL DEPLOYMENT RI; KING DW, 1995, J ABNORM PSYCHOL, V104, P184, DOI 10.1037/0021-843X.104.1.184; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LAUFER RS, 1985, J NERV MENT DIS, V173, P538, DOI 10.1097/00005053-198509000-00004; Litz BT, 2018, J TRAUMA STRESS, V31, P286, DOI 10.1002/jts.22276; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; MacGregor AJ, 2015, MIL MED, V180, P882, DOI 10.7205/MILMED-D-14-00323; Maguen S, 2011, J ANXIETY DISORD, V25, P563, DOI 10.1016/j.janxdis.2011.01.003; Maguen S, 2010, J TRAUMA STRESS, V23, P86, DOI 10.1002/jts.20434; MCCARROLL JE, 1993, AM J PSYCHIAT, V150, P1875; McCarroll JE, 2001, J NERV MENT DIS, V189, P44, DOI 10.1097/00005053-200101000-00008; MCCARROLL JE, 1995, AM J PSYCHIAT, V152, P939; McCarthy S, 2008, OCCUP MED-OXFORD, V58, P379, DOI 10.1093/occmed/kqn062; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Morgan MA, 2019, GEN HOSP PSYCHIAT, V58, P33, DOI 10.1016/j.genhosppsych.2019.02.006; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; O'Donnell ML, 2017, CLIN PSYCHOL REV, V57, P208, DOI 10.1016/j.cpr.2017.08.009; Orcutt HK, 2004, J TRAUMA STRESS, V17, P195, DOI 10.1023/B:JOTS.0000029262.42865.c2; Pietrzak RH, 2011, J PSYCHIATR RES, V45, P1579, DOI 10.1016/j.jpsychires.2011.07.010; Porter B, 2018, J TRAUMA STRESS, V31, P296, DOI 10.1002/jts.22273; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Ryan ET, 2015, PSYCHOL SERV, V12, P412, DOI 10.1037/ser0000057; Schwab KA, 2006, NEUROLOGY, V66, pA235; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shea MT, 2017, PSYCHOL TRAUMA-US, V9, P19, DOI 10.1037/tra0000240; Sheeran T, 2002, J CONSULT CLIN PSYCH, V70, P961, DOI 10.1037//0022-006X.70.4.000; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Steffens DC, 2006, AM J GERIAT PSYCHIAT, V14, P401, DOI 10.1097/01.JGP.0000194646.65031.3f; Von Korff M., 2011, HDB PAIN ASSESSMENT, P455; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers F.W., 1993, 9 ANN C ISTSS; Wells TS, 2010, AM J PUBLIC HEALTH, V100, P90, DOI 10.2105/AJPH.2008.155432; Williams JW, 2004, INT J PSYCHIAT MED, V34, P37, DOI 10.2190/U1B0-NKWC-568V-4MAK; Williams RT, 2016, ARCH PHYS MED REHAB, V97, P929, DOI 10.1016/j.apmr.2016.01.017; Wilson ALG, 2010, ANN EPIDEMIOL, V20, P939, DOI 10.1016/j.annepidem.2010.08.007	60	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	DEC	2019	32	6					946	956		10.1002/jts.22459		OCT 2019	11	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	KA0QV	WOS:000492486200001	31652023	Bronze			2022-02-06	
J	Zafonte, RD; Fregni, F; Bergin, MJG; Goldstein, R; Boudreau, N; Monge, I; Luz, M; Frazier, J; Giacino, JT				Zafonte, Ross D.; Fregni, Felipe; Bergin, Michael J. G.; Goldstein, Richard; Boudreau, Nancy; Monge, Iris; Luz, Matthew; Frazier, Judith; Giacino, Joseph T.			Huperzine A for the treatment of cognitive, mood, and functional deficits after moderate and severe TBI (HUP-TBI): results of a Phase II randomized controlled pilot study: implications for understanding the placebo effect	BRAIN INJURY			English	Article						Traumatic brain injury; Huperzine A; cognitive dysfunction; placebo effect	TRAUMATIC BRAIN-INJURY; INHIBITORS; BINDING; TRIAL	Objective: To investigate the effect of Huperzine A on memory and learning in individuals with moderate-severe traumatic brain injury (TBI). Design: Randomized, double-blind, placebo-controlled Phase II clinical trial. Methods: Subjects were randomly assigned to receive Huperzine A or placebo for 12?weeks and were assessed during in-person visits at screening/baseline, and 6, 12, 24, and 52?weeks post-injury. Changes in memory and learning scores on the California Verbal Learning Test ? 2nd Edition (CVLT-II) from baseline to week 12 were assessed using permutation tests and regression analyses. Results: There was no difference between the Huperzine A and placebo groups in memory performance after 12?weeks of treatment. In the placebo group, significant improvements were noted in learning and memory scores. Both groups showed clinically important improvements in depression on the Beck Depression Index. Conclusions: The clinically important improvements in cognitive and emotional outcomes observed in both the placebo and active treatment arms of this clinical trial of Huperzine A are best understood in the context of a placebo effect. Future trials involving patients with moderate-severe TBI in the subacute to chronic phases of recovery should be designed to account for placebo effects as failure to do so may lead to spurious conclusions.	[Zafonte, Ross D.; Fregni, Felipe; Bergin, Michael J. G.; Goldstein, Richard; Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med Rehabil, Boston, MA 02115 USA; [Zafonte, Ross D.; Fregni, Felipe; Bergin, Michael J. G.; Boudreau, Nancy; Monge, Iris; Luz, Matthew; Frazier, Judith; Giacino, Joseph T.] Spaulding Rehabil Hosp, Spaulding Rehabil Inst, Boston, MA USA; [Zafonte, Ross D.; Fregni, Felipe; Giacino, Joseph T.] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Zafonte, Ross D.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA		Zafonte, RD (corresponding author), Spaulding Rehabil Hosp, Spaulding Rehabil Inst, 300 First Ave, Charlestown, MA 02129 USA.	RZAFONTE@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Fregni, Felipe/0000-0001-9359-8643	U.S. Department of Defense Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)United States Department of Defense [W81XWH-11-2-0210]	The research reported in this article was supported by U.S. Department of Defense Army Medical Research and Materiel Command grant W81XWH-11-2-0210. The study sponsor had no role in the design and conduct of this study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Ballou S, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1964-x; Button KS, 2015, PSYCHOL MED, V45, P3269, DOI 10.1017/S0033291715001270; Carvalho C, 2017, PAIN, V158, P365, DOI DOI 10.1097/j.pain.0000000000000700; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chu DF, 2006, PLANTA MED, V72, P552, DOI 10.1055/s-2006-931566; Damar U, 2018, J NEUROTRAUM, V35, P393, DOI 10.1089/neu.2017.5258; Edgington E., 2007, RANDOMIZATION TESTS; Evers AWM, 2018, PSYCHOTHER PSYCHOSOM, V87, P204, DOI 10.1159/000490354; Fava M, 2003, PSYCHOTHER PSYCHOSOM, V72, P115, DOI 10.1159/000069738; Garcia GE, 2004, J ANAL TOXICOL, V28, P379, DOI 10.1093/jat/28.5.379; Gordon RK, 2001, J APPL TOXICOL, V21, pS47, DOI 10.1002/jat.805; Hall KT, 2015, TRENDS MOL MED, V21, P285, DOI 10.1016/j.molmed.2015.02.009; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Kaiser J, 2009, STATA J, V9, P70, DOI 10.1177/1536867X0900900105; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Kaptchuk TJ, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k3889; Kelley JM, 2012, PSYCHOTHER PSYCHOSOM, V81, P312, DOI 10.1159/000337053; Lamm AG, 2019, J NEUROTRAUM, V36, P2513, DOI 10.1089/neu.2018.6014; Meeusen R, 2018, INT J SPORT NUTR EXE, V28, P200, DOI 10.1123/ijsnem.2017-0314; Mei ZR, 2017, METAB BRAIN DIS, V32, P1861, DOI 10.1007/s11011-017-0075-4; Ongaro G, 2019, PAIN, V160, P1, DOI 10.1097/j.pain.0000000000001367; Peng Y, 2006, J NEUROSCI RES, V84, P903, DOI 10.1002/jnr.20987; Polich G, 2018, J NEUROTRAUM, V35, P1205, DOI 10.1089/neu.2017.5506; Qian ZM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00216; Rafii MS, 2011, NEUROLOGY, V76, P1389, DOI 10.1212/WNL.0b013e318216eb7b; Rybin D, 2015, STAT MED, V34, P2281, DOI 10.1002/sim.6494; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tian GX, 2013, INT J IMMUNOPATH PH, V26, P757, DOI 10.1177/039463201302600320; Todman J. B., 2001, SINGLE CASE SMALL N; Wang R, 2006, ACTA PHARMACOL SIN, V27, P1, DOI 10.1111/j.1745-7254.2006.00255.x; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; XU SS, 1995, ACTA PHARM SINIC, V16, P391; Xu ZQ, 2012, CELL BIOCHEM BIOPHYS, V62, P55, DOI 10.1007/s12013-011-9258-5; Yang GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074916; Zangara A, 2003, PHARMACOL BIOCHEM BE, V75, P675, DOI 10.1016/S0091-3057(03)00111-4; Zhang YH, 2002, NEUROSCI LETT, V319, P107, DOI 10.1016/S0304-3940(01)02565-4; ZHU XD, 1995, J NEUROSCI RES, V41, P828, DOI 10.1002/jnr.490410613	39	2	2	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2020	34	1					34	41		10.1080/02699052.2019.1677941		OCT 2019	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC5XA	WOS:000494158400001	31638455				2022-02-06	
J	Sekely, A; Zakzanis, KK				Sekely, Angela; Zakzanis, Konstantine K.			The relationship between post-traumatic growth and return to work following mild traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; occupational functioning; return to work; post-traumatic growth; rehabilitation	HEAD-INJURY; SURVIVORS; PREDICTORS; OUTCOMES; HEALTH; TBI; INVENTORY; VETERANS; CANCER; SAMPLE	Purpose: To investigate the prevalence of post-traumatic growth (PTG) following mild traumatic brain injury (mTBI) and to examine whether PTG is associated with vocational status. Materials and methods: Archival data from a random sample of 74 individuals who sustained mTBI (mean age: 43.23; male, 55%) were obtained from a larger sample of litigating patients who were referred for a neuropsychological examination. Factors associated with return to work were ascertained using a multiple regression analysis. The demographic variables age, sex, and education were added to the first block, whilst relating to others, new possibilities, personal strength, spiritual change, and appreciation of life, as measured by the Posttraumatic Growth Inventory (PTGI), were added in the second block. Results: Approximately 31% of the sample exhibited moderate levels of PTG, as defined by endorsing a 3 or more on each item of the PTGI, with the most common aspects of PTG being appreciation of life, relating to others, and personal strength. The multiple regression analysis revealed that new possibilities and personal strength were independently associated with return to work. Conclusions: Results of this study suggest that there is evidence for the development of PTG among individuals with mTBI. These findings have important implications for rehabilitation planning, individual and family adjustment, and the prediction of long-term outcome as it pertains to return to work in particular.	[Sekely, Angela; Zakzanis, Konstantine K.] Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada		Sekely, A (corresponding author), Univ Toronto Scarborough, Dept Psychol, 1265 Mil Trail, Toronto, ON M1C 1A4, Canada.	Angie.sekely@mail.utoronto.ca					*ADJ GEN OFF WAR D, 1944, MAN DIR SCOR; Andrykowski MA, 2014, PSYCHO-ONCOLOGY, V23, P428, DOI 10.1002/pon.3440; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cohen J., 2013, STAT POWER ANAL BEHA; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Grace JJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01162; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Harms L, 2007, HEALTH SOC WORK, V32, P129, DOI 10.1093/hsw/32.2.129; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Hijazi AM, 2015, PEACE CONFL, V21, P395, DOI 10.1037/pac0000077; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jayawickreme E, 2014, EUR J PERSONALITY, V28, P312, DOI 10.1002/per.1963; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Lee JA, 2010, J CLIN PSYCHOL, V66, P813, DOI 10.1002/jclp.20692; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Manne S, 2004, PSYCHOSOM MED, V66, P442, DOI 10.1097/01.psy.0000127689.38525.7d; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; McGrath JC, 2011, BRAIN IMPAIR, V12, P82, DOI 10.1375/brim.12.2.82; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Powell T, 2012, DISABIL REHABIL, V34, P1461, DOI 10.3109/09638288.2011.644384; REITAN R M, 1955, AMA Arch Neurol Psychiatry, V73, P28; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reynolds S, 2003, J HEAD TRAUMA REHAB, V18, P139, DOI 10.1097/00001199-200303000-00005; Riva R, 2014, PSYCHO-ONCOLOGY, V23, P1307, DOI 10.1002/pon.3567; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Salter E, 2004, J TRAUMA STRESS, V17, P335, DOI 10.1023/B:JOTS.0000038482.53911.01; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Steffens RF, 2016, COMPREHENSIVE GUIDE; Tator CH., 2010, CAN J NEUROL SCI CAN, P58; Tedeschi RG, 1999, AGGRESS VIOLENT BEH, V4, P319, DOI 10.1016/S1359-1789(98)00005-6; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tsai J, 2017, ACTA PSYCHIAT SCAND, V136, P483, DOI 10.1111/acps.12800; Tsai J, 2015, PSYCHOL MED, V45, P165, DOI 10.1017/S0033291714001202; Tsai J, 2016, J AFFECT DISORDERS, V189, P269, DOI 10.1016/j.jad.2015.08.076; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Wolfson, 1993, HALSTEAD REITAN NEUR; World Health Organization, 2007, INT CLASS FUNCT DIS; Zakzanis KK, 1998, J CLIN EXP NEUROPSYC, V20, P419, DOI 10.1076/jcen.20.3.419.821; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7; Zakzanis KK, 2017, APPL NEUROPSYCH-ADUL, V24, P559, DOI 10.1080/23279095.2016.1225216; Zoellner T, 2008, J CLIN PSYCHOL, V64, P245, DOI 10.1002/jclp.20441	63	2	2	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	OCT 23	2019	41	22					2669	2675		10.1080/09638288.2018.1476598			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	JC2RM	WOS:000489124200008	29852778				2022-02-06	
J	Zhang, S; Wu, YH; Zhang, Y; Zhang, Y; Cheng, Y				Zhang, Shuang; Wu, Ye-Huan; Zhang, Yi; Zhang, Yu; Cheng, Yun			Preliminary study of the validity and reliability of the Chinese version of the Saint Louis University Mental Status Examination (SLUMS) in detecting cognitive impairment in patients with traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Chinese version of the Saint Louis University Mental Status Examination (SLUMS); cognitive assessment; reliability; traumatic brain injury; validity	SCREENING TOOL; OLDER-ADULTS; EPIDEMIOLOGY; DEFINITION; GUIDELINES; OUTCOMES; UTILITY	The Saint Louis University Mental Status Examination (SLUMS) has been shown to be useful in the cognitive assessment in older adults and patients with dementia. The aim of this study was to preliminarily explore the effectiveness of the Chinese version of the SLUMS in the detection of cognitive impairment in patients with traumatic brain injury (TBI) and to provide an objective basis for its clinical application in China. In this cross-sectional study, 42 patients with TBI and 30 matched normal controls were administered. Participants were assessed by the Chinese version of the Mini-Mental State Assessment scale (MMSE), Montreal Cognitive Assessment scale (MoCA) and SLUMS. Results showed that the Chinese version of the SLUMS had satisfactory internal consistency (Cronbach's alpha coefficient: 0.723), excellent interrater reliability (ICC: 0.990-0.998) and intrarater reliability (ICC: 0.968), as well as good validity. In the TBI group, the total SLUMS score was moderately positively correlated with the MMSE score (r = 0.702, p = .000) and highly positively correlated with the MoCA score (r = 0.831, p = .000). Receiver Operating Characteristic (ROC) curve analyses showed that the area under the curve (AUC) of the SLUMS, MMSE and MoCA were 0.872, 0.756 and 0.916, respectively. The optimal cutoff score of 22.5 or fewer points are suggested for the SLUMS to discriminate cognitive impairment, with a sensitivity of 0.844 and a specificity of 0.825. The Chinese version of the SLUMS has excellent reliability and validity, and can be used as a screening tool for cognitive impairment of patients with TBI in China.	[Zhang, Shuang; Wu, Ye-Huan; Zhang, Yi; Zhang, Yu; Cheng, Yun] First Peoples Hosp Changzhou, Dept Rehabil Med, 185 Jugian St, Changzhou 213003, Peoples R China; [Zhang, Shuang; Cheng, Yun] Soochow Univ, Sch Clin Med, Dept Rehabil Med, Suzhou, Peoples R China		Zhang, Y (corresponding author), First Peoples Hosp Changzhou, Dept Rehabil Med, 185 Jugian St, Changzhou 213003, Peoples R China.	zhangyizhe1975@aliyun.com					ABDELRAHMAN HMM, 2014, MIDDLE E J AGE AGEIN, V7, P11, DOI DOI 10.5742/MEAA.2014.92575; al-Dahhak R, 2018, CLIN GERIATR MED, V34, P617, DOI 10.1016/j.cger.2018.06.008; Arulsamy A, 2019, BEHAV BRAIN RES, V365, P66, DOI 10.1016/j.bbr.2019.02.045; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Cao L, 2012, J AM MED DIR ASSOC, V13, P626, DOI 10.1016/j.jamda.2012.05.003; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Chinese Guidelines Writing Group on Diagnosis and Treatment of Cognitive Impairment and Dementia, 2018, NATL MED J CHINA, V98, P1125; Cruz-Oliver DM, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2014.05.004; Cummings-Vaughn LA, 2014, J AM GERIATR SOC, V62, P1341, DOI 10.1111/jgs.12874; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; de Guise E, 2013, BRAIN INJURY, V27, P1428, DOI 10.3109/02699052.2013.835867; de Guise E, 2011, APPL NEUROPSYCHOL, V18, P179, DOI 10.1080/09084282.2011.595444; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Falk N, 2018, AM FAM PHYSICIAN, V97, P398; Feliciano L, 2013, AM J GERIAT PSYCHIAT, V21, P623, DOI 10.1016/j.jagp.2013.01.024; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frenette LC, 2019, BRAIN INJURY, V33, P189, DOI 10.1080/02699052.2018.1542506; Ganti L, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0091-4; Howland M, 2016, CNS NEUROSCI THER, V22, P413, DOI 10.1111/cns.12515; Kaya D, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.12.093; Kumar S, 2015, NEUROLOGY S, V84, P7; Lee Chung Nam, 2015, Korean J Neurotrauma, V11, P6, DOI 10.13004/kjnt.2015.11.1.6; Li YM, 2017, J CLIN NEUROSCI, V44, P107, DOI 10.1016/j.jocn.2017.05.026; Lu J, 2011, J GERIATR PSYCH NEUR, V24, P184, DOI 10.1177/0891988711422528; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Marsh NV, 2018, NEUROREHABILITATION, V43, P377, DOI 10.3233/NRE-182457; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ontario Neurotrauma Foundation Guidelines Development Team, 2018, GUID CONC MILD TRAUM; Panwar N, 2019, ASIAN J PSYCHIATR, V41, P60, DOI 10.1016/j.ajp.2018.08.007; Pervez M, 2018, NEUROIMAG CLIN N AM, V28, P1, DOI 10.1016/j.nic.2017.09.010; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Shwartz SK, 2019, APPL NEUROPSYCH-ADUL, V26, P101, DOI 10.1080/23279095.2017.1362407; Srivastava A, 2006, BRAIN INJURY, V20, P1377, DOI 10.1080/02699050601111385; Szczesniak D, 2016, PSYCHIATR POL, V50, P457, DOI 10.12740/PP/OnlineFirst/43141; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; Tay MRJ, 2019, AM J PHYS MED REHAB, V98, P971, DOI 10.1097/PHM.0000000000001227; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tumosa, 2002, AGING SUCCESS, V12, P4; Vissoci JRN, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1283-9; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yi Z., 2014, CHINESE J GERIATRICS, V31, P604; Zhang H, 2016, CHIN J TRAUMATOL, V19, P271, DOI 10.1016/j.cjtee.2015.03.007	50	2	2	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 2	2021	28	6					633	640		10.1080/23279095.2019.1680986		OCT 2019	8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	WC3NK	WOS:000492111600001	31646902				2022-02-06	
J	Wrede, AH; Al-Masri, F; Montazami, R; Hashemi, NN				Wrede, Alex H.; Al-Masri, Faisal; Montazami, Reza; Hashemi, Nicole N.			Investigation of cavitation-induced damage on PDMS films	ANALYTICAL METHODS			English	Article							BRAIN-INJURY; TISSUE	Traumatic brain injuries (TBIs) are complex phenomena that create epidemic healthcare and financial concerns. Recent studies have theorized that cavitation exists during a TBI and has potential to induce significant damage to the surrounding anatomy. This study seeks to implement polydimethylsiloxane (PDMS) films as a placeholder of the brain to elucidate the damage that the surrounding brain tissue would experience from nearby cavitation. The apparatus includes an existing methodology that implements controlled cavitation. 3D confocal microscopy and interferometry techniques are used to characterize the surface damage to the PDMS films. Visual representation and roughness parameters on the nanoscale help elucidate a distinct difference between control and experimental samples. These results help legitimize the concern of cavitation in the skull and also help motivate future studies to analyze the cellular response to surrounding cavitation.	[Wrede, Alex H.; Al-Masri, Faisal; Montazami, Reza; Hashemi, Nicole N.] Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA; [Hashemi, Nicole N.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA		Hashemi, NN (corresponding author), Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA.; Hashemi, NN (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA.	nastaran@iastate.edu	Montazami, Reza/A-6115-2012; Hashemi, Nicole/AAW-1384-2021	Montazami, Reza/0000-0002-8827-0026; Hashemi, Nicole/0000-0001-8921-7588; Wrede, Alex/0000-0001-9509-924X	Office of Naval Research (ONR)Office of Naval Research [N000141612246]; ONROffice of Naval Research [N000141712620]	The authors thank Timothy Bigelow for his help with ultrasound logistics and lending us a power amplification system. We also thank Curtis Mosher for his assistance and training with 3D confocal microscopy and interferometry. This work was supported by the Office of Naval Research (ONR) Grant N000141612246 and ONR Grant N000141712620.	Acar H, 2014, ADV FUNCT MATER, V24, P4135, DOI 10.1002/adfm.201304186; Bartyczak S, 2014, J PHYS CONF SER, V500, DOI 10.1088/1742-6596/500/18/182003; Cabello M, 2019, SENSOR ACTUAT B-CHEM, V288, P337, DOI 10.1016/j.snb.2019.02.118; Chanda A, 2018, MECH ADV MATER STRUC, V25, P1335, DOI 10.1080/15376494.2016.1143749; Chernin L, 2017, RENEW ENERG, V113, P688, DOI 10.1016/j.renene.2017.06.037; Clatz O, 2005, IEEE T MED IMAGING, V24, P1417, DOI 10.1109/TMI.2005.856734; Con Celal, 2013, Nanoscale Res Lett, V8, P394, DOI 10.1186/1556-276X-8-394; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Haniff S, 2017, SHOCK WAVES, V27, P929, DOI 10.1007/s00193-017-0765-1; HERBERT E, 2006, NONLINEAR SOFT MAT P, V74; Ji B, 2014, J MECH SCI TECHNOL, V28, P1339, DOI 10.1007/s12206-013-1166-8; Kang W, 2018, ACTA BIOMATER, V67, P295, DOI 10.1016/j.actbio.2017.11.030; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Petkovsek M, 2013, WEAR, V300, P55, DOI 10.1016/j.wear.2013.01.106; Soza G, 2005, INT J MED ROBOT COMP, V1, P87, DOI 10.1002/rcs.32; Sreedhar BK, 2017, WEAR, V372, P177, DOI 10.1016/j.wear.2016.12.009; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Wang ZX, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.41050; Ward C., 1980, 24 STAPP CAR CRASH C, P24; Wrede AH, 2018, ULTRASON SONOCHEM, V43, P114, DOI 10.1016/j.ultsonch.2018.01.006; Wu YT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05790-3; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhou Y, 2012, J CONTROL RELEASE, V157, P103, DOI 10.1016/j.jconrel.2011.09.068	26	2	2	0	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1759-9660	1759-9679		ANAL METHODS-UK	Anal. Methods	OCT 21	2019	11	39					5038	5043		10.1039/c9ay01576k			6	Chemistry, Analytical; Food Science & Technology; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Food Science & Technology; Spectroscopy	JC9RX	WOS:000489615200009		Green Published, hybrid			2022-02-06	
J	Pelissier, C; Fort, E; Fontana, L; Hours, M				Pelissier, C.; Fort, E.; Fontana, L.; Hours, M.			Medical and socio-occupational predictive factors of psychological distress 5 years after a road accident: a prospective study	SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY			English	Article						Psychosocial distress; Road accident; ESPARR cohort; Predictive factors; Long-term follow-up	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; GENERAL HEALTH; FOLLOW-UP; MENTAL-HEALTH; DISABILITY; CRASH; ANXIETY; CONSEQUENCES	Purpose Psychosocial consequences of road accidents are a major clinical problem that incurs significant social, occupational, and economic costs. The purpose of our study was to assess medical and socio-occupational factors of psychological distress in the severely injured 5 years after a road accident. Methods A total of 691 of the 1168 subjects enrolled in a prospective cohort of road accident casualties (ESPARR cohort) responded to both standardized follow-up questionnaires at 1 and 5 years, assessing socio-occupational characteristics, physical and psychological sequelae, pain and perceived quality of life. Results One quarter of participants exhibited psychological distress 5 years after the road accident; most of whom are women, with low educational level, and suffering from spinal lesions. After adjusting for several factors, psychological distress at 5 years was predicted by female gender and low educational level, and by several other factors observed 1 year after the road accident: poor self-reported quality of life, attention deficit and symptoms of anxiety. Conclusions Early-stage improvement in the screening and care of mental disorders in road accident casualties should help to reduce long-term psychological distress.	[Pelissier, C.; Fontana, L.] Univ Claude Bernard Lyon1, Univ Lyon, Ifsttar, Univ Jean Monnet,UMRESTTE,UMR T 9405, F-42100 St Etienne, France; [Pelissier, C.] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Med & Sante Travail, Pole Sante Publ, F-69495 Pierre Benite, France; [Fort, E.] Univ Claude Bernard Lyon1, UMRESTTE, Ifsttar, Univ Lyon,UMR T 9405, F-69373 Lyon, France; [Fontana, L.] CHU St Etienne, Serv Sante Travail, St Priest En Jarez, France; [Hours, M.] Univ Claude Bernard Lyon1, UMRESTTE, Ifsttar, Univ Lyon,UMR T 9405, F-69500 Bron, France		Pelissier, C (corresponding author), Univ Claude Bernard Lyon1, Univ Lyon, Ifsttar, Univ Jean Monnet,UMRESTTE,UMR T 9405, F-42100 St Etienne, France.; Pelissier, C (corresponding author), Ctr Hosp Lyon Sud, Hosp Civils Lyon, Serv Med & Sante Travail, Pole Sante Publ, F-69495 Pierre Benite, France.	pelissier.carole.chu@gmail.com	FONTANA, LUC/AAK-2701-2020	FONTANA, LUC/0000-0003-1870-3671	French Ministry of Equipment, Transport Housing, Tourism and SEA (Predit 3 Program "New Knowledge in the Field of Road Safety") [SU0400066]; National Agency for Research (Program Predit "Safe, reliable and adapted transport") [ANR-07-TSFA-007-01]; French Ministry of Health [PCRD 2003: PHRC-N03, PCRD 2005: N051]	This work was supported by the French Ministry of Equipment, Transport Housing, Tourism and SEA (Predit 3 Program "New Knowledge in the Field of Road Safety": no. SU0400066), by the National Agency for Research (Program Predit "Safe, reliable and adapted transport" no. ANR-07-TSFA-007-01) and by the French Ministry of Health (Program PCRD 2003: PHRC-N03 and PCRD 2005: N051). The role of the funding sources was in the collection and the analysis of data.	[Anonymous], 1990, ABBR INJ SCAL; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Berglund A, 2006, PAIN, V125, P244, DOI 10.1016/j.pain.2006.05.026; Bhutani S, 2016, J CLIN DIAGN RES, V10, pRC9, DOI 10.7860/JCDR/2016/20316.8417; Bryant R, 2010, PSYCHIAT SEQUELAE TR; Carroll LJ, 2006, PAIN, V124, P18, DOI 10.1016/j.pain.2006.03.012; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; Gao Fei, 2004, Health Qual Life Outcomes, V2, P63, DOI 10.1186/1477-7525-2-63; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Guest R, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1455-5; Nhac-Vu HT, 2014, TRAFFIC INJ PREV, V15, P138, DOI 10.1080/15389588.2013.804180; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Hours M, 2008, ACCIDENT ANAL PREV, V40, P1789, DOI 10.1016/j.aap.2008.06.017; Hours M, 2010, ACCIDENT ANAL PREV, V42, P412, DOI 10.1016/j.aap.2009.09.002; Kenardy J, 2018, J AFFECT DISORDERS, V236, P172, DOI 10.1016/j.jad.2018.04.090; Kenardy J, 2015, INJURY, V46, P883, DOI 10.1016/j.injury.2014.11.006; Kenardy J, 2015, ARCH PHYS MED REHAB, V96, P410, DOI 10.1016/j.apmr.2014.10.007; Kendrick D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-584; Khati I, 2013, J TRAUMA ACUTE CARE, V74, P301, DOI 10.1097/TA.0b013e318270d967; Laumon B, 1997, FRENCH ROAD ACCIDENT; Leon C, 2018, B EPIDEMIOL HEBD, P637; Limosin F, 2006, J PSYCHIAT RES, V40, P755, DOI 10.1016/j.jpsychires.2005.04.007; Matthews LR, 2005, BEHAV RES THER, V43, P475, DOI 10.1016/j.brat.2004.03.008; Mayou R, 2003, INJURY, V34, P197, DOI 10.1016/S0020-1383(02)00285-1; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702005470; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; Mayou R, 2001, AM J PSYCHIAT, V158, P1231, DOI 10.1176/appi.ajp.158.8.1231; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; O'Donnell ML, 2013, J CLIN PSYCHIAT, V74, pE137, DOI 10.4088/JCP.12m08011; Papadakaki M, 2017, INJURY, V48, P297, DOI 10.1016/j.injury.2016.11.011; Phillips LA, 2010, EUR SPINE J, V19, P945, DOI 10.1007/s00586-010-1276-2; POLITI PL, 1994, ACTA PSYCHIAT SCAND, V90, P432, DOI 10.1111/j.1600-0447.1994.tb01620.x; Pupo MC, 2015, PSYCHIAT RES, V228, P741, DOI 10.1016/j.psychres.2015.05.030; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Salama-Younes M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-22; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Scott W, 2012, PAIN RES MANAG; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Strebel HM, 2004, FORUM MED, V17, P1119; Ventureyra VAG, 2002, PSYCHOTHER PSYCHOSOM, V71, P47, DOI 10.1159/000049343; Wang CH, 2005, J ADV NURS, V52, P22, DOI 10.1111/j.1365-2648.2005.03560.x; Wesson HKH, 2014, HEALTH POLICY PLANN, V29, P795, DOI 10.1093/heapol/czt064	44	2	2	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0933-7954	1433-9285		SOC PSYCH PSYCH EPID	Soc. Psychiatry Psychiatr. Epidemiol.	MAR	2020	55	3					371	383		10.1007/s00127-019-01780-0		OCT 2019	13	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	KL5FN	WOS:000491406300001	31628512				2022-02-06	
J	Tripathi, BB; Espindola, D; Pinton, GF				Tripathi, Bharat B.; Espindola, David; Pinton, Gianmarco F.			Modeling and simulations of two dimensional propagation of shear shock waves in relaxing soft solids	JOURNAL OF COMPUTATIONAL PHYSICS			English	Article						Piecewise parabolic method; Shear shock waves; Relaxation mechanisms; Traumatic brain injury	PIECEWISE PARABOLIC METHOD; FLUID-FLOW; ATTENUATION; TISSUE; IMPLEMENTATION; NONLINEARITY; EPIDEMIOLOGY; DEFORMATION; REFLECTION; INJURY	Soft solids, such as gelatin or soft tissue, have a shear wave speed that is smaller than the compressional wave speed. Recent observations of shear shock wave generation in the brain, which can easily reach a large Mach number regime, suggest that the cubic nonlinear behavior of soft solids could be responsible for traumatic brain injury. However, currently there are no two-dimensional (2D) models describing the propagation of linearly-polarized shear shock waves in relaxing soft solids. These models are required to model the fundamental wave propagation physics like diffraction, focusing etc., and are related to traumatic brain injuries as it can be used to model the skull/brain morphology. In this work, we present a two-dimensional system of first-order equations modeling the propagation of shear shock waves in a relaxing soft solid, and then this system is solved numerically using the piecewise parabolic method, a high-order finite volume method. The numerical solutions are validated in two parts. First, the nonlinear component, which is designed for large Mach numbers, is validated with a step-shock Riemann problem. Then relaxation mechanisms based on a generalized Maxwell body, which model the non-classical attenuation that occurs in soft tissue, are compared to analytical solutions with an error of 5%-10%. The validation of attenuation also includes dispersion due to causality which is determined by the Kramers-Kronig relations. Finally, the full numerical method, which includes nonlinearity, attenuation, and dispersion, is compared to ultrasonic measurements of shear shock wave propagation in tissue-mimicking phantoms. Two experiments were performed based on high frame-rate ultrasound imaging and tracking in a gelatin phantom 1) planar shear shock waves, and 2) focused shear shock wave propagation. The experimental and numerical waveforms closely match, e.g. the RMS amplitude error is between 12.05% and 12.27%. Moreover, the frequency-content of the temporal signal was compared for third and fifth multiples of fundamental harmonic validating the generation of odd-harmonics due to cubic nonlinearity. Furthermore, the numerical tool was able to estimate the nonlinear parameter in the phantom (beta = 4.4) using a grid-parameter-search. In context of traumatic brain injury, the current method can be used to study the shear shock formation in 2D-sections of human skull, and can also be used for nonlinear parameter estimation in brain. (C) 2019 Elsevier Inc. All rights reserved.	[Tripathi, Bharat B.; Espindola, David; Pinton, Gianmarco F.] Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, 116 Manning Dr,9212A Mary Ellen Jones, Chapel Hill, NC 27599 USA; [Tripathi, Bharat B.; Espindola, David; Pinton, Gianmarco F.] North Carolina State Univ, 116 Manning Dr,9212A Mary Ellen Jones, Chapel Hill, NC 27599 USA; [Espindola, David] Univ OHiggins, Inst Ciencias Ingn, Ave Libertador Bernardo OHiggins 611, Rancagua, Chile		Pinton, GF (corresponding author), Univ North Carolina Chapel Hill, Joint Dept Biomed Engn, 116 Manning Dr,9212A Mary Ellen Jones, Chapel Hill, NC 27599 USA.; Pinton, GF (corresponding author), North Carolina State Univ, 116 Manning Dr,9212A Mary Ellen Jones, Chapel Hill, NC 27599 USA.	gia@email.unc.edu		Espindola, David/0000-0001-6675-9560; Tripathi, Bharat/0000-0001-6757-0735	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS091195]	We would like to acknowledge funding from the NIH (R01 NS091195).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Almgren AS, 2010, ASTROPHYS J, V715, P1221, DOI 10.1088/0004-637X/715/2/1221; Beckert J, 2018, ANN BIOMED ENG, P1, DOI [10.1093/oso/9780198820802.003.0001, DOI 10.1093/OSO/9780198820802.003.0001]; Blanc E, 2016, GEOPHYS J INT, V205, P427, DOI 10.1093/gji/ggw024; Brands DWA, 2004, J BIOMECH, V37, P127, DOI 10.1016/S0021-9290(03)00243-4; Carcione JM, 2007, HDB GEOPHYS EXPLOR I, V38, P385; Catheline S, 2003, J ACOUST SOC AM, V114, P3087, DOI 10.1121/1.1610457; Chen W, 2004, J ACOUST SOC AM, V115, P1424, DOI 10.1121/1.1646399; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; COLELLA P, 1990, J COMPUT PHYS, V87, P171, DOI 10.1016/0021-9991(90)90233-Q; COLELLA P, 1984, J COMPUT PHYS, V54, P174, DOI 10.1016/0021-9991(84)90143-8; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DAI WL, 1994, J COMPUT PHYS, V115, P485, DOI 10.1006/jcph.1994.1212; Deffieux T, 2009, IEEE T MED IMAGING, V28, P313, DOI 10.1109/TMI.2008.925077; Destrade M, 2010, J ACOUST SOC AM, V127, P2759, DOI 10.1121/1.3372624; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; EMMERICH H, 1987, GEOPHYSICS, V52, P1252, DOI 10.1190/1.1442386; Espindola D, 2017, J ACOUST SOC AM, V141, P3549, DOI DOI 10.1121/1.4987514; Espindola D, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.044024; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Giammarinaro B, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032643; Giammarinaro B, 2018, PHYS REV APPL, V9, DOI 10.1103/PhysRevApplied.9.014011; Godunov, 1959, MAT SBORNIK, V47, P271; Gutierrez-Lemini D., 2014, ENG VISCOELASTICITY; Hamilton MF, 2004, J ACOUST SOC AM, V116, P41, DOI 10.1121/1.1736652; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Kaser M, 2007, GEOPHYS J INT, V168, P224, DOI 10.1111/j.1365-246X.2006.03193.x; LAX PD, 1957, COMMUN PUR APPL MATH, V10, P537, DOI 10.1002/cpa.3160100406; LeVeque R.J., 2002, FINITE VOLUME METHOD, V31; Lifshitz E, 1986, COURSE THEORETICAL P, V7, P3; LIU HP, 1976, GEOPHYS J ROY ASTR S, V47, P41, DOI 10.1111/j.1365-246X.1976.tb01261.x; Lombard B, 2011, J COMPUT PHYS, V230, P6099, DOI 10.1016/j.jcp.2011.04.015; Mangan R, 2016, EXTREME MECH LETT, V9, P204, DOI 10.1016/j.eml.2016.07.004; MENIKOFF R, 1989, REV MOD PHYS, V61, P75, DOI 10.1103/RevModPhys.61.75; Mignone A, 2005, ASTROPHYS J SUPPL S, V160, P199, DOI 10.1086/430905; Miller GH, 2002, J COMPUT PHYS, V183, P26, DOI 10.1006/jcph.2002.7158; Miller GH, 2001, J COMPUT PHYS, V167, P131, DOI 10.1006/jcph.2000.6665; Moczo P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021598; Moczo P, 1997, B SEISMOL SOC AM, V87, P1305; Moczo P, 2014, FINITE-DIFFERENCE MODELLING OF EARTHQUAKE MOTIONS: WAVES AND RUPTURES, P1, DOI 10.1017/CBO9781139236911; Montgomery D. C., 2012, INTRO LINEAR REGRESS, V821; OCONNELL RJ, 1978, GEOPHYS RES LETT, V5, P5, DOI 10.1029/GL005i001p00005; Ogden R.W., 1997, NONLINEAR ELASTIC DE; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; OGDEN RW, 1974, P CAMB PHILOS SOC, V75, P427; Pinton G, 2014, IEEE T ULTRASON FERR, V61, P1489, DOI 10.1109/TUFFC.2014.3063; Pinton G, 2010, J ACOUST SOC AM, V127, P683, DOI 10.1121/1.3277202; Renier M, 2008, AIP CONF PROC, V1022, P303, DOI 10.1063/1.2956214; SALTZMAN J, 1994, J COMPUT PHYS, V115, P153, DOI 10.1006/jcph.1994.1184; Smoller J., 2012, SHOCK WAVES REACTION, V258; Sytine IV, 2000, J COMPUT PHYS, V158, P225, DOI 10.1006/jcph.1999.6416; Szabo TL, 2000, J ACOUST SOC AM, V107, P2437, DOI 10.1121/1.428630; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thurman DJ, 2001, HEAD TRAUMA, P327; TRANGENSTEIN JA, 2009, NUMERICAL SOLUTION H; Tripathi BB, 2017, SHOCK WAVES, V27, P879, DOI 10.1007/s00193-017-0734-8; Tripathi BB, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3187; Urban MW, 2009, PHYS MED BIOL, V54, P5919, DOI 10.1088/0031-9155/54/19/017; VAN LEER B, 1979, J COMPUT PHYS, V32, P101, DOI 10.1016/0021-9991(79)90145-1; Waters KR, 2000, J ACOUST SOC AM, V108, P556, DOI 10.1121/1.429586; Weiss JA, 1996, COMPUT METHOD APPL M, V135, P107, DOI 10.1016/0045-7825(96)01035-3; Westervelt P. J., 1963, J ACOUST SOC AM; Wochner MS, 2008, J ACOUST SOC AM, V123, P2488, DOI 10.1121/1.2890739; WOODWARD P, 1984, J COMPUT PHYS, V54, P115, DOI 10.1016/0021-9991(84)90142-6; Ye W, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2901; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Zabolotskaya EA, 2004, J ACOUST SOC AM, V116, P2807, DOI 10.1121/1.1802533	67	2	2	0	19	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9991	1090-2716		J COMPUT PHYS	J. Comput. Phys.	OCT 15	2019	395						205	222		10.1016/j.jcp.2019.06.014			18	Computer Science, Interdisciplinary Applications; Physics, Mathematical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Physics	IO3YR	WOS:000479317200011					2022-02-06	
J	Smith, EE; Smith, JAD; Juengst, SB				Smith, Emily E.; Smith, Jason A. D.; Juengst, Shannon B.			Cognitive process scores associated with self-reported behavioral dysfunction on the Frontal Systems Behavior Scale (FrSBe) in chronic traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; executive functioning; cognition; measurement; behavior	VERBAL-LEARNING TEST; QUALITY-OF-LIFE; NEUROPSYCHOLOGICAL TESTS; EXECUTIVE DYSFUNCTION; COMMUNITY INTEGRATION; HEAD-INJURY; PERFORMANCE; PREDICT; ABILITIES; SYMPTOMS	Introduction: Individuals with traumatic brain injury (TBI) often experience long-term cognitive impairment that affects daily functioning, but neuropsychological tests are often not associated with functional outcomes in chronic TBI. To identify better neuropsychological test predictors of functional outcomes, we identified process-oriented neuropsychological test scores associated with behavioral dysfunction in chronic TBI. Method: Adults (N =?65, age?=?49.9?years, education?=?14.6?years, 80% male, 97% white) with a >?6-month (median?=?55?months) history of TBI (31% complicated mild, 20% moderate, 49% severe) completed the self-reported Frontal Systems Behavior Scale (FrSBe) and a battery of neuropsychological tests. Cognitive scores significantly associated with FrSBe domain scores (Apathy, Disinhibition, Executive Dysfunction) were included in hierarchical linear regression analyses. Results: Pearson correlations were significant (|r|?=?.25 ? .41, p <?.05) between FrSBe Disinhibition and Executive Dysfunction domains and numerous cognitive scores, particularly cognitive process scores, including California Verbal Learning Test II (CVLT-II) and Letter (FAS) Fluency Intrusions and Repetitions. In the regression analyses, gender, injury severity, premorbid intelligence, time since injury, self-awareness, and depression status accounted for less than 1% (Disinhibition) and 6.1% (Executive Dysfunction) of the total adjusted variance in respective FrSBe domains. Cognitive process scores were the strongest factors associated with behavioral dysfunction, explaining an additional 22.9% of the total adjusted variance in Disinhibition [F(3, 50)?=?6.28, p =?.001]. For Executive Dysfunction, traditional scores explained 2.6% added variance on top of the base model, with cognitive process scores explaining an additional 17.2% [F(4, 48)?=?6.79, p =?.003] of the total adjusted variance. Conclusions: Less frequently utilized cognitive process scores from well-known neuropsychological tests may be better predictors of behavioral dysfunction in chronic TBI, as measured by the FrSBe. Future prospective study is required to validate these findings and test the sensitivity and specificity of these cognitive process scores for identifying risk for behavioral dysfunction.	[Smith, Emily E.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Smith, Jason A. D.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, Dept Phys Med & Rehabil, Dallas, TX 75390 USA		Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, Dept Phys Med & Rehabil, UT Southwestern, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Shannon.Juengst@utsouthwestern.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X	School of Health and Rehabilitation Science Research Development Fund, School of Health of Rehabilitation Science, University of Pittsburgh	This work was supported in part through funding received from the School of Health and Rehabilitation Science Research Development Fund, School of Health of Rehabilitation Science, University of Pittsburgh (SJ).	Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Barrett RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076916; Beebe DW, 2000, J CLIN EXP NEUROPSYC, V22, P779, DOI 10.1076/jcen.22.6.779.950; Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214; Braunstein J. W., 2007, IDENTIFYING MULTICOL; BROOKS D N, 1975, Cortex, V11, P329; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Carvalho JO, 2016, APPL NEUROPSYCH-ADUL, V23, P125, DOI 10.1080/23279095.2015.1012759; Carvalho JO, 2013, ASSESSMENT, V20, P632, DOI 10.1177/1073191113492845; Center for Disease Control, 2017, TBI GET THE FACTS; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; Davis A E, 2000, Crit Care Nurs Clin North Am, V12, P447; Delis D.C., 1991, PSYCHOL ASSESS, V3, P19, DOI [10.1037/1040-3590.3.1.19, DOI 10.1037/1040-3590.3.1.19]; Diaz AP, 2014, REV BRAS PSIQUIATR, V36, P213, DOI 10.1590/1516-4446-2013-1303; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Donders J, 2007, J INT NEUROPSYCH SOC, V13, P354, DOI 10.1017/S1355617707070439; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Fleming JM, 1996, BRAIN INJURY, V10, P1; Franzen M.D., 1996, ECOLOGICAL VALIDITY, P91; Goldstein, 1996, ECOLOGICAL VALIDITY, P75; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Grace J, 2001, FRSBE FRONTAL SYSTEM; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hart K, 2017, POETRY AND REVELATION: FOR A PHENOMENOLOGY OF RELIGIOUS POETRY, P1; Hill BD, 2012, APPL NEUROPSYCH-ADUL, V19, P198, DOI 10.1080/09084282.2011.643960; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoofien D, 2001, BRAIN INJURY, V15, P189; Johansson AEM, 2016, DISABIL REHABIL, V38, P423, DOI 10.3109/09638288.2015.1044034; KAPLAN E, 1988, APHASIOLOGY, V2, P309, DOI 10.1080/02687038808248930; Karzmark P, 2012, APPL NEUROPSYCH-ADUL, V19, P81, DOI 10.1080/09084282.2011.643942; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lengenfelder J, 2015, APPL NEUROPSYCH-ADUL, V22, P7, DOI 10.1080/23279095.2013.816703; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Long C.J., 1995, ADV MED PSYCHOTHERAP, V8, P59; Marcotte T.D., 2009, NEUROPSYCHOLOGY EVER; Marsh NV, 2016, NEUROREHABILITATION, V38, P71, DOI 10.3233/NRE-151297; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Milberg WP., 2009, NEUROPSYCHOLOGICAL A, V3, P49; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Ownsworth T, 2019, J REHABIL MED, V51, P376, DOI 10.2340/16501977-2537; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Raymond MJ, 1996, NEUROREHABILITATION, V6, P229, DOI 10.3233/NRE-1996-6309; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; RICHARDSON JTE, 1984, CORTEX, V20, P413, DOI 10.1016/S0010-9452(84)80009-X; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ryan JJ, 2013, APPL NEUROPSYCH-CHIL, V2, P43, DOI 10.1080/21622965.2012.670554; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Sbordone RJ, 2014, APPL NEUROPSYCH-ADUL, V21, P98, DOI 10.1080/09084282.2012.762630; Sbordone RJ, 2010, PSYCHOL INJ LAW, V3, P25, DOI 10.1007/s12207-010-9068-x; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Shapiro M., 2013, ARCH PHYS MED REHAB, V94, pe41; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Thomas KR, 2018, J ALZHEIMERS DIS, V64, P195, DOI 10.3233/JAD-180229; Thomas KR, 2018, NEUROPSYCHOLOGY, V32, P235, DOI 10.1037/neu0000413; Weber E, 2018, REHABIL PSYCHOL, V63, P383, DOI 10.1037/rep0000208; Wehman PH, 2017, PHYS MED REH CLIN N, V28, P351, DOI 10.1016/j.pmr.2016.12.010; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Worthington A, 2018, NEUROPSYCHOLOGIA, V118, P40, DOI 10.1016/j.neuropsychologia.2018.04.012; Zawacki TM, 2002, J NEUROPSYCH CLIN N, V14, P296, DOI 10.1176/appi.neuropsych.14.3.296; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	75	2	2	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN 2	2020	42	1					90	100		10.1080/13803395.2019.1676882		OCT 2019	11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KA8MP	WOS:000490266200001	31599186				2022-02-06	
J	Babakhanyan, I; Carlozzi, NE; McKenna, BS; Casaletto, KB; Heinemann, AW; Heaton, RK				Babakhanyan, Ida; Carlozzi, Noelle E.; McKenna, Benjamin S.; Casaletto, Kaitlin B.; Heinemann, Allen W.; Heaton, Robert K.			National Institutes of Health Toolbox Emotion Battery: Application of Summary Scores to Adults With Spinal Cord Injury, Traumatic Brain Injury, and Stroke	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							NIH TOOLBOX; ENVIRONMENTAL-FACTORS; SOCIAL SUPPORT; LIFE SATISFACTION; COGNITION BATTERY; NEGATIVE AFFECT; DEPRESSION; INDIVIDUALS; ANXIETY; PARTICIPATION	Objective: To examine the validity of factor analytically based summary scores that were developed using the National Institutes of Health Toolbox Emotion Battery (NIHTB-EB); (ie, psychological well-being, social satisfaction, negative affect) normative sample in individuals with neurologic conditions. Design: Cross-sectional, observational cohort. Setting: Community. Participants: A total of 1036 English-speaking adults from the National Institutes of Health Toolbox (NIHTB) normative project and 604 community-dwelling adults with neurologic conditions including spinal cord injury (SCI n=209), traumatic brain injury (TBI n=184), and stroke (cerebrovascular accident [CVA] n=211) (N=1640). Intervention: Not applicable. Main Outcome Measures: The NIHTB-EB. Results: A series of univariate analyses comparing summary scores across the 4 groups (SCI, TBI, CVA, normative group) were conducted to identify group differences. Base rates (defined as >1 SD toward the problematic direction) were also identified. The normative group demonstrated better emotional functioning characterized by greater social satisfaction and psychological well-being (normative group > SCI, TBI, CVA; P's <.0001), and less negative affect (normative group < SCI, P =.016; normative group < TBI, P<.001; normative group < CVA; P=.034) compared with each neurologic group. Using base rates to identify problematic emotions for the 3 summary scores, there were higher rates of problematic emotions on all 3 summary scores for the neurologic groups compared with the normative group. Conclusions: The NIHTB-EB summary scores demonstrate an increased prevalence of problematic emotions among individuals with 3 neurologic conditions, and might be useful for identifying individuals with similar conditions and potentially in need of psychological support. (C) 2019 by the American Congress of Rehabilitation Medicine	[Babakhanyan, Ida; McKenna, Benjamin S.; Heaton, Robert K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Casaletto, Kaitlin B.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Heinemann, Allen W.] Northwestern Univ, Shirley Ryan AbilityLab, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Babakhanyan, Ida; McKenna, Benjamin S.; Heaton, Robert K.] Def & Vet Brain Injury Ctr, Camp Pendleton, CA USA		Babakhanyan, I (corresponding author), Def & Vet Brain Injury Ctr, Intrepid Spirit Ctr, 2016 San Jacinto Rd, Pendleton, CA 92055 USA.	ibabakhanyan@gmail.com	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; mcKenna, Benjamin/0000-0002-5607-6376; Babakhanyan, Ida/0000-0001-5702-8141	National Institute on Disability, Independent Living, and Rehabilitation Research, Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes [H133B090024]; Blueprint for Neuroscience Research, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HHS-N-260-2006-00007-C]; NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [F31-DA035708]; Foundation for Rehabilitation Psychology Dissertation Award	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research, Rehabilitation Research and Training Center on Improving Measurement of Medical Rehabilitation Outcomes (award no. H133B090024, PI: Heinemann). This project was also supported in part with federal funds from the Blueprint for Neuroscience Research, National Institutes of Health (contract no. HHS-N-260-2006-00007-C, PI: Gershon). Kaitlin Casaletto was supported in part by NIDA F31-DA035708 and the Foundation for Rehabilitation Psychology Dissertation Award.	Aboulafia-Brakha T, 2016, J HEAD TRAUMA REHAB, V31, pE21, DOI 10.1097/HTR.0000000000000171; Babakhanyan I, 2018, PATIENT-RELAT OUTCOM, V9, P115, DOI 10.2147/PROM.S151658; Bailie JM, 2015, J HEAD TRAUMA REHAB, V30, P12, DOI 10.1097/HTR.0000000000000024; Balakrishnan Preethi, 2008, Curr Treat Options Cardiovasc Med, V10, P216, DOI 10.1007/s11936-008-0023-z; Berg A, 2009, STROKE, V40, P523, DOI 10.1161/STROKEAHA.108.527705; BOTHIG S, 1989, INT J EPIDEMIOL, V18, pS29; Broomfield NM, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0198-8; Carlozzi NE, 2017, ARCH CLIN NEUROPSYCH, V32, P555, DOI 10.1093/arclin/acx020; Carlozzi NE, 2017, REHABIL PSYCHOL, V62, P443, DOI 10.1037/rep0000195; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; CHARLIFUE SW, 1991, ARCH PHYS MED REHAB, V72, P488; Cohen ML, 2017, REHABIL PSYCHOL, V62, P425, DOI 10.1037/rep0000140; Cole W. R., 2016, TRANSLATIONAL RES TR; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cyranowski JM, 2013, HEALTH PSYCHOL, V32, P293, DOI 10.1037/a0028586; Enderby P, 1987, Int Rehabil Med, V8, P162; Farinelli M, 2015, J CLIN EXP NEUROPSYC, V37, P595, DOI 10.1080/13803395.2014.991279; Fisher AC, 2015, CLIN NEUROPHYSIOL, V126, P314, DOI 10.1016/j.clinph.2014.05.033; Gillespie DC, 2015, J NEUROL NEUROSUR PS, V86, P477, DOI 10.1136/jnnp-2014-309396; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Hackett ML, 2014, LANCET NEUROL, V13, P525, DOI [10.1016/S1474-4422(14)70016-X, 10.1016/s1474-4422(14)70016-X]; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; HANCOCK KM, 1993, PARAPLEGIA, V31, P349, DOI 10.1038/sc.1993.59; Heinemann AW, 2016, ARCH PHYS MED REHAB, V97, P2113, DOI 10.1016/j.apmr.2016.05.021; Heinemann AW, 2016, QUAL LIFE RES, V25, P2775, DOI 10.1007/s11136-016-1314-6; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Hollocks MJ, 2015, BRAIN, V138, P3803, DOI 10.1093/brain/awv304; Jeste DV, 2005, PSYCHIAT NEUROLOGIST; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Juengst SB, 2014, REHABIL PSYCHOL, V59, P242, DOI 10.1037/a0036294; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Klyce DW, 2015, ARCH PHYS MED REHAB, V96, P1419, DOI 10.1016/j.apmr.2015.02.018; Kupst MJ, 2015, ANXIETY STRESS COPIN, V28, P531, DOI 10.1080/10615806.2014.994204; Le J, 2016, SPINAL CORD, V54, P570, DOI 10.1038/sc.2016.15; Lyketsos Constantin G, 2007, Dialogues Clin Neurosci, V9, P111; Lyketsos CG, 2006, J NEUROPSYCH CLIN N, V18, P445, DOI 10.1176/appi.neuropsych.18.4.445; Magasi S, 2015, ARCH PHYS MED REHAB, V96, P569, DOI 10.1016/j.apmr.2014.12.002; Maryland Population Research Center, PEOPL DIS LESS GET M; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Migliorini C, 2013, J SPINAL CORD MED, V36, P660, DOI 10.1179/2045772313Y.0000000100; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Pilkonis PA, 2013, PSYCHIAT RES, V206, P88, DOI 10.1016/j.psychres.2012.09.034; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Post MWM, 1999, PSYCHOL HEALTH, V14, P679, DOI 10.1080/08870449908410757; Salsman JM, 2014, QUAL LIFE RES, V23, P205, DOI 10.1007/s11136-013-0452-3; Salsman JM, 2013, NEUROLOGY, V80, pS76, DOI 10.1212/WNL.0b013e3182872e11; Salter JE, 2013, SPINAL CORD, V51, P252, DOI 10.1038/sc.2012.105; Seale GS, 2010, REHABIL PSYCHOL, V55, P33, DOI 10.1037/a0018744; Shields C, 2016, NEUROPSYCHOL REHABIL, V26, P410, DOI 10.1080/09602011.2015.1037772; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Starkstein SE, 2014, PSYCHIAT CLIN N AM, V37, P103, DOI 10.1016/j.psc.2013.10.002; Taheri A, 2014, PROCD SOC BEHV, V159, P406, DOI 10.1016/j.sbspro.2014.12.397; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tran J, 2016, SPINAL CORD, V54, P640, DOI 10.1038/sc.2016.66; Tulsky DS, 2017, REHABIL PSYCHOL, V62, P413, DOI 10.1037/rep0000174; Valk-Kleibeuker L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087414; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wang YP, 2013, CLINICS, V68, P1274, DOI 10.6061/clinics/2013(09)15; Wong AWK, 2017, QUAL LIFE RES, V26, P2633, DOI 10.1007/s11136-017-1586-5	62	2	2	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2019	100	10					1863	1871		10.1016/j.apmr.2019.05.024			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	JF3QL	WOS:000491302000008	31153854				2022-02-06	
J	Bailes, JE; Origenes, AK; Alleva, JT				Bailes, Julian E.; Origenes, Andrea Kristin; Alleva, Joseph T.			Chronic traumatic encephalopathy	DM DISEASE-A-MONTH			English	Article							LONG-TERM CONSEQUENCES; BRAIN-INJURY; CLINICAL PRESENTATION; SPECTRUM		[Bailes, Julian E.] NorthShore Univ HealthSyst, Dept Neurosurg, 2650 Ridge Ave, Evanston, IL 60201 USA; [Bailes, Julian E.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Origenes, Andrea Kristin] Midwestern Univ, Chicago Coll Osteopath Med, Downers Grove, IL 60515 USA; [Alleva, Joseph T.] NorthShore Univ HealthSyst, Dept Phys Med & Rehabil, 2180 Pfingsten Rd, Glenview, IL 60026 USA		Bailes, JE (corresponding author), NorthShore Univ HealthSyst, Dept Neurosurg, 2650 Ridge Ave, Evanston, IL 60201 USA.; Bailes, JE (corresponding author), Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA.	jbailes@northshore.org	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146			Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Goldstein LE, 2017, JAMA NEUROL, V74, P1045, DOI 10.1001/jamaneurol.2017.0800; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tharmaratnam T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00445; Uematsu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046970	17	2	2	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0011-5029	1557-8194		DM-DIS MON	DM-Dis.-a-Mon.	OCT	2019	65	10							100855	10.1016/j.disamonth.2019.02.008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JH5HO	WOS:000492799900003	30878141				2022-02-06	
J	Bouferguene, S; Lapierre, A; Houze, B; Rainville, P; Arbour, C				Bouferguene, Sabrina; Lapierre, Alexandra; Houze, Berengere; Rainville, Pierre; Arbour, Caroline			Chronic Central Pain Among Community-Dwelling Survivors of Moderate-to-Severe Traumatic Brain Injury: A Quantitative Sensory Testing Study	BIOLOGICAL RESEARCH FOR NURSING			English	Article						traumatic brain injury; chronic pain; central pain; quantitative sensory testing	POST-STROKE PAIN; NEUROPATHIC PAIN; MULTIPLE-SCLEROSIS; FATIGUE; PREVALENCE; INVENTORY; PERCEPTION; MECHANISMS; DEPRESSION; HEADACHE	Background: Central pain associated with changes in sensory thresholds is one of the most enduring consequences of major trauma. Yet it remains sparsely studied among community-dwelling survivors of moderate-to-severe traumatic brain injury (TBI). Purpose: To describe and compare thermal and mechanical sensory thresholds in home-based patients with and without central pain after moderate-to-severe TBI with a cohort of healthy controls. Design: Cross-sectional. Method: Thresholds for cold/heat detection, thermal pain, touch, and distorted sensation were gathered using quantitative sensory testing (QST). QST was performed on the painful and contralateral pain-free body regions in TBI participants with pain (TBI-P) and on both forearms in TBI participants without pain (TBI-NP) and healthy controls (HC). Central pain was characterized using the Brief Pain Inventory-Short Form. Results: We tested 16 TBI-P patients, 17 TBI-NP patients, and 16 HC. Mean time since injury for TBI patients was 24 +/- 15 months. TBI-P and TBI-NP patients showed significant loss in innocuous mechanical sensitivity compared to HC (F = 18.929; Bonferroni-adjusted p <= .001). Right-left differences in cold pain sensations were significantly larger in TBI-P than in TBI-NP and HC participants (F = 14.352; Bonferroni-adjusted p <= .001). Elevated heat sensitivity thresholds were also observed in TBI-P participants but remained within normal range. Conclusion: Damage to cutaneous mechanoreceptors is a necessary, but not sufficient, condition for the development of chronic central pain following TBI. Damage or incomplete recovery of cutaneous thermoreceptors may be a contributing factor to chronic pain after TBI.	[Bouferguene, Sabrina; Lapierre, Alexandra; Arbour, Caroline] Hop Sacre Coeur Montreal, Res Ctr, Room E 1380, Montreal, PQ H4J 1C5, Canada; [Bouferguene, Sabrina; Lapierre, Alexandra; Arbour, Caroline] Hop Sacre Coeur Montreal, Trauma Div, Room E 1380, Montreal, PQ H4J 1C5, Canada; [Houze, Berengere; Rainville, Pierre] Inst Univ Geriatrie Montreal, Montreal, PQ, Canada		Arbour, C (corresponding author), Hop Sacre Coeur Montreal, Res Ctr, Room E 1380, Montreal, PQ H4J 1C5, Canada.; Arbour, C (corresponding author), Hop Sacre Coeur Montreal, Trauma Div, Room E 1380, Montreal, PQ H4J 1C5, Canada.	caroline.arbour@umontreal.ca		Lapierre, Alexandra/0000-0002-8704-4940			Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; [Anonymous], 2018, GLASG COM SCAL; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Baker S., 1974, INJURY SEVERITY SCOR, V14; Baron R, 2017, PAIN, V158, P261, DOI 10.1097/j.pain.0000000000000753; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bertisch HC, 2013, REHABIL PSYCHOL, V58, P429, DOI 10.1037/a0034554; Chen YW, 2018, EUR J PAIN, V22, P1718, DOI 10.1002/ejp.1258; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Diamond B., 2002, LEGAL ASPECTS PAIN M; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Geber C, 2008, PAIN, V139, P73, DOI 10.1016/j.pain.2008.03.006; Grinsell D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698256; Harrison RA, 2015, CEREBROVASC DIS, V39, P190, DOI 10.1159/000375397; Hendiani JA, 2003, J PAIN, V4, P203, DOI 10.1016/S1526-5900(03)00557-1; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Khoury S, 2018, PROG NEURO-PSYCHOPH, V87, P224, DOI 10.1016/j.pnpbp.2017.06.007; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lautenbacher S, 2017, NEUROSCI BIOBEHAV R, V75, P104, DOI 10.1016/j.neubiorev.2017.01.039; LEIJON G, 1989, PAIN, V36, P13, DOI 10.1016/0304-3959(89)90107-3; Liang DY, 2017, MOL PAIN, V13, DOI 10.1177/1744806917730212; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Louter MA, 2014, CEPHALALGIA, V34, P1187, DOI 10.1177/0333102414532554; Mendoza T, 2006, EUR J PAIN, V10, P353, DOI 10.1016/j.ejpain.2005.06.002; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merskey H., 1994, DESCRIPTIONS CHRONIC; Moreno CB, 2012, NEUROLOGIA, V27, P500, DOI 10.1016/j.nrl.2011.08.001; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nurmikko T, 2009, EUR J NEUROL, V16, pE104, DOI 10.1111/j.1468-1331.2009.02583.x; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Osterberg A, 2005, EUR J PAIN, V9, P531, DOI 10.1016/j.ejpain.2004.11.005; Petschow C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164607; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Shakoor N, 2008, ARTHRIT RHEUM-ARTHR, V59, P117, DOI 10.1002/art.23241; Singer J, 2017, INT J STROKE, V12, P343, DOI 10.1177/1747493017701149; Taylor RR, 2000, PSYCHOL MED, V30, P849, DOI 10.1017/S0033291799002500; TEASDALE G, 1974, LANCET, V2, P81; Tschugg A, 2017, NEUROSURG REV, V40, P411, DOI 10.1007/s10143-016-0798-4; Wasserman RA, 2015, REGION ANESTH PAIN M, V40, P687, DOI 10.1097/AAP.0000000000000315; Wu E, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000152; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	51	2	2	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	OCT	2019	21	5					519	531		10.1177/1099800419859078			13	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	IV8JM	WOS:000484511700009	31256632				2022-02-06	
J	Brooks, JS; Smith, WJ; Webb, BM; Heath, MD; Dickey, JP				Brooks, Jeffrey S.; Smith, William J.; Webb, Brandon M.; Heath, Matthew D.; Dickey, James P.			Development and validation of a high-speed video system for measuring saccadic eye movement	BEHAVIOR RESEARCH METHODS			English	Article						Antisaccades; Prosaccades; Subconcussive impacts; Oculomotor; Brain; Eye tracker; Reaction time		Laboratory-based retroreflective and magnetic scleral search-coil technologies are the current standards for collecting saccadometric data, but such equipment is costly and cumbersome. We have validated a novel, portable, high-speed video camera-based system (Exilim EX-FH20, Casio, Tokyo, Japan) for measuring saccade reaction time (RT) and error rate in a well-lit environment. This system would enable measurements of pro- and antisaccades in athletes, which is important because antisaccade metrics provide a valid tool for concussion diagnosis and determining an athlete's safe return to play. A total of 529 trials collected from 15 participants were used to compare saccade RT and error rate measurements of the high-speed camera system to a retroreflective video-based eye tracker (Eye-Trac 6: Applied Sciences Laboratories, Bedford, MA). Bland-Altman analysis revealed that the RT measurements made by the high-speed video system were 11 ms slower than those made by the retroreflective system. Error rate measurements were identical between the two systems. An excellent degree of reliability was found between the system measurements and in the ratings of independent researchers examining the video data. A strong association (r = .97) between the RTs determined via the retroreflective and high-speed camera systems was observed across all trials. Our high-speed camera system is portable and easily set up, does not require extensive equipment calibration, and can be used in a well-lit environment. Accordingly, the camera-based capture of saccadometric data may provide a valuable tool for neurological assessment following a concussive event and for the continued monitoring of recovery.	[Brooks, Jeffrey S.; Smith, William J.; Webb, Brandon M.; Heath, Matthew D.; Dickey, James P.] Western Univ, Fac Hlth Sci, Sch Kinesiol, London, ON, Canada		Dickey, JP (corresponding author), Western Univ, Fac Hlth Sci, Sch Kinesiol, London, ON, Canada.	jdickey@uwo.ca	Dickey, James P/K-6776-2013	Dickey, James P/0000-0002-4101-835X; Brooks, Jeffrey/0000-0002-1842-4763				0	2	2	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1554-351X	1554-3528		BEHAV RES METHODS	Behav. Res. Methods	OCT	2019	51	5					2302	2309		10.3758/s13428-019-01197-2			8	Psychology, Mathematical; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	JE8RP	WOS:000490957800024	30706347	Bronze			2022-02-06	
J	Citirik, M; Tekin, K; Teke, MY				Citirik, Mehmet; Tekin, Kemal; Teke, Mehmet Yasin			Terson syndrome with persistent vitreous hemorrhage following traumatic brain injury	SAUDI JOURNAL OF OPHTHALMOLOGY			English	Article						Intracerebral hemorrhage; Intraocular hemorrhage; Subarachnoid hemorrhage; Traumatic brain injury; Terson syndrome	VITRECTOMY	The objective of this study was to report clinical findings and surgical outcomes of 3 patients with persistent vitreous hemorrhage diagnosed as Terson syndrome (TS). Posterior segment changes, optical coherence tomography scans, fundus autofluorescence images, and fundus fluorescein angiography findings of patients were evaluated and pars plana vitrectomy (PPV) was performed on 3 eyes of three patients. All eyes operated after 6 months from the date of injury and final visual acuities were 20/200, 20/60 and 20/30. PPV is found as a safe and effective procedure for vitreous hemorrhage in TS. Delayed surgery in a young patient predicts a worse outcome.	[Citirik, Mehmet; Tekin, Kemal; Teke, Mehmet Yasin] Univ Hlth Sci, Ankara Ulucanlar Eye Educ & Res Hosp, Ulucanlar Cad 59, TR-06230 Ankara, Turkey		Citirik, M (corresponding author), Univ Hlth Sci, Ankara Ulucanlar Eye Educ & Res Hosp, Ulucanlar Cad 59, TR-06230 Ankara, Turkey.	mcitirik@hotmail.com	Tekin, Kemal/H-9507-2017; CITIRIK, Mehmet/A-1694-2018	Tekin, Kemal/0000-0002-7461-6129; CITIRIK, Mehmet/0000-0002-0558-5576			Augsten R, 2000, EUR J OPHTHALMOL, V10, P293, DOI 10.1177/112067210001000404; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; CASTREN JA, 1963, ACTA OPHTHALMOL, V41, P430; Fountas KN, 2008, J NEUROSURG, V109, P439, DOI 10.3171/JNS/2008/109/9/0439; Garweg JG, 2009, ACTA OPHTHALMOL, V87, P222, DOI 10.1111/j.1755-3768.2008.01200.x; Gnanaraj L, 2000, RETINA-J RET VIT DIS, V20, P374, DOI 10.1097/00006982-200007000-00009; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kuhn F, 1998, OPHTHALMOLOGY, V105, P472, DOI 10.1016/S0161-6420(98)93030-5; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Michalewska Zofia, 2010, Ophthalmic Surg Lasers Imaging, V41 Suppl, pS42, DOI 10.3928/15428877-20101031-15; Naseri A, 2001, NEUROLOGY, V57, P364, DOI 10.1212/WNL.57.2.364; Ogawa T, 2001, OPHTHALMOLOGY, V108, P1654, DOI 10.1016/S0161-6420(01)00673-X; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; SHAW HE, 1975, AM J OPHTHALMOL, V80, P207, DOI 10.1016/0002-9394(75)90134-8; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	15	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1319-4534			SAUDI J OPHTHALMOL	Saudi J. Ophthalmol.	OCT-DEC	2019	33	4					392	397		10.1016/j.sjopt.2018.11.003			6	Ophthalmology	Emerging Sources Citation Index (ESCI)	Ophthalmology	KB0XR	WOS:000506226500013	31920451	hybrid, Green Published			2022-02-06	
J	Doperak, J; Anderson, K; Collins, M; Emami, K				Doperak, Jeanne; Anderson, Kelley; Collins, Michael; Emami, Kouros			Sport-Related Concussion Evaluation and Management	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; VOMS testing; Neuropsychological testing	NEUROCOGNITIVE PERFORMANCE; POSTCONCUSSIVE SYMPTOMS; POSTTRAUMATIC MIGRAINE; RISK-FACTORS; HIGH-SCHOOL; DIZZINESS; RECOVERY; IMPACT; INJURY; ADHD	Concussion is a challenging and controversial medical diagnosis that can test even the most seasoned practitioner. Knowledge on this topic is ever evolving. It was not so long ago that grading guidelines were based on loss of consciousness and amnesia. Medicine has seen a renaissance of discovery over the past 20 years in concussion evaluation and management. A PubMed search for "concussion" between 1990 and 2000 produced just over 1000 articles and that same search including the last 18 years expands to over 10,000 publications. The most recent knowledge and recommendations are discussed based on the published evidence.	[Doperak, Jeanne; Anderson, Kelley] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA USA; [Collins, Michael] Univ Pittsburgh, Med Ctr, Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA USA; [Emami, Kouros] Univ Pittsburgh, Med Ctr, Sports Med Concuss Program, Pittsburgh, PA USA; [Anderson, Kelley] 1707 Waterless Dr, Sewickley, PA 15143 USA; [Collins, Michael] 179 Mohawk Dr, Pittsburgh, PA 15228 USA; [Emami, Kouros] 3345 Penn Ave,Unit E, Pittsburgh, PA 15201 USA		Doperak, J (corresponding author), 1052 Boomtown Lane, Latrobe, PA 15650 USA.	Doperakjm@upmc.edu					Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bogduk N, 2009, LANCET NEUROL, V8, P959, DOI 10.1016/S1474-4422(09)70209-1; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Furman JM, 2005, J NEUROL NEUROSUR PS, V76, P1, DOI 10.1136/jnnp.2004.048926; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Kontos A. P., 2018, CONCUSSION CLIN PROF; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lahmann C, 2015, J NEUROL NEUROSUR PS, V86, P302, DOI 10.1136/jnnp-2014-307601; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Turner S, 2017, SPORT EXERC PERFORM, V6, P277, DOI 10.1037/spy0000099; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	51	2	2	1	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	OCT	2019	38	4					497	+		10.1016/j.csm.2019.06.003			16	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	JB6MN	WOS:000488678300004	31472762				2022-02-06	
J	Esteves, LA; Ribeiro, AT; da Silva, EG; Amato, MCM; Rodrigues, LBH; Tedeschi, H; dos Santos, MJ; Lebrao, G; Joaquim, AF				Esteves, Luiz Adriano; Ribeiro, Andre Tosta; da Silva, Elton Gomes; Moraes Amato, Marcelo Campos; Rodrigues, Leandro Boa-Hora; Tedeschi, Helder; dos Santos, Marcos Juliano; Lebrao, Gustav; Joaquim, Andrei Fernandes			Evaluation of safety, effectiveness and reproducibility of telemedicine for neurosurgical screening	EINSTEIN-SAO PAULO			English	Article						Neurosurgery; Smartphones/trends; Telemedicine; Neurosurgery/methods; Sciences Health	INJURY; LEVEL	Objective: To ascertain the safety, effectiveness and reproducibility of screening potential neurosurgical patients by means of smartphones. Methods: This is a retrospective and multicentric study. Data were collected from the medical records of patients subjected to real emergency neurosurgical evaluations and compared with assessments by neurosurgeons using smartphones to determine the feasibility of identifying changes in cranial computed tomography scans, potentially serious conditions of patients, and the need for transfer to reference centers. Results: We analyzed 232 cases. The main diagnosis was traumatic brain injury, with 119 cases (51.3%). Of this, 105 (45.3%) patients were discharged immediately after the assessment. The telemedicine evaluators presented 95.69% accuracy in the identification of changes in computed tomography scans, with 0.858 concordance. Accuracy in the identification of severity was 95.26%, with 0.858 concordance. As for procedure, the concordance among evaluators was 0.672, increasing to 100% in cases that required surgical treatment. Conclusion: Our study indicated that the use of telemedicine for screening patients with acute neurological disorders was safe, effective and reproducible. Implementation of the method shows a promising potential to improve the patient's outcome by reducing unnecessary transfers and decreasing the time elapsed until a specialist can be consulted.	[Esteves, Luiz Adriano; da Silva, Elton Gomes; Tedeschi, Helder; dos Santos, Marcos Juliano; Joaquim, Andrei Fernandes] Univ Estadual Campinas, Campinas, SP, Brazil; [Ribeiro, Andre Tosta; Moraes Amato, Marcelo Campos; Rodrigues, Leandro Boa-Hora] Hosp Forca Aerea Sao Paulo, Sao Paulo, SP, Brazil; [Lebrao, Gustav] Hosp Estadual Franco da Rocha, Franco Da Rocha, SP, Brazil		Esteves, LA (corresponding author), Ave Olavo Fontoura 1,400 Santana, BR-02012021 Sao Paulo, SP, Brazil.	luizadriano@einstein.br		Esteves, Luiz Adriano/0000-0002-0103-9463			American College of Surgeons Committee on Trauma, 2012, ADV TRAUM LIF SUPP A; Bullard TB, 2013, J TELEMED TELECARE, V19, P80, DOI 10.1177/1357633X13476228; Chodroff PH, 1999, J TELEMED TELECARE, V5, P28, DOI 10.1258/1357633991932441; ESTEVES L.L., 2018, THESIS; Guler Nihal Fatma, 2002, J Med Syst, V26, P199, DOI 10.1023/A:1015010316958; Hersh WR, 2001, J AM MED INFORM ASSN, V8, P570, DOI 10.1136/jamia.2001.0080570; JENNETT B, 1975, LANCET, V1, P480; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Moore M, 1999, FUTURE GENER COMP SY, V15, P245, DOI 10.1016/S0167-739X(98)00067-3; Perumall Vinodh Vayara, 2015, Asian J Neurosurg, V10, P1, DOI 10.4103/1793-5482.151500; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Ryu S, 2010, HEALTHC INFORM RES, V16, P65, DOI 10.4258/hir.2010.16.1.65; Sinha Virendra Deo, 2012, Asian J Neurosurg, V7, P75, DOI 10.4103/1793-5482.98648; TEASDALE G, 1974, LANCET, V2, P81; Thapa A, 2013, NEUROL INDIA, V61, P610, DOI 10.4103/0028-3886.125260; Upadhyayula PS, 2018, J NEUROSCI RURAL PRA, V9, P123, DOI 10.4103/jnrp.jnrp_273_17; Vuckovic Ilvana, 2003, Bosn J Basic Med Sci, V3, P54; W.H. Organization, 2006, NEUR DIS PUBL HLTH C	19	2	2	0	0	INST ISRAELITA ENSINO & PESQUISA ALBERT EINSTEIN	SAO PAULO SP	AVENIDA ALBERT EINSTEIN, 627 701, SAO PAULO SP, 05651-901, BRAZIL	1679-4508	2317-6385		EINSTEIN-SAO PAULO	Einstein	OCT-DEC	2019	17	4							UNSP eAO4609	10.31744/einstein_journal/2019AO4609			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	IY4CY	WOS:000486340300004	31460616	Green Published, gold			2022-02-06	
J	Hempel, S; Gore, K; Belsher, B				Hempel, Susanne; Gore, Kristie; Belsher, Bradley			Identifying Research Gaps and Prioritizing Psychological Health Evidence Synthesis Needs	MEDICAL CARE			English	Article						evidence review; evidence synthesis; gap analysis; research prioritization; translational science	SYSTEMATIC REVIEWS; QUALITY	Background: Evidence synthesis is key in promoting evidence-based health care, but it is resource-intense. Methods are needed to identify and prioritize evidence synthesis needs within health care systems. We describe a collaboration between an agency charged with facilitating the implementation of evidence-based research and practices across the Military Health System and a research center specializing in evidence synthesis. Methods: Scoping searches targeted 15 sources, including the Veterans Affairs/Department of Defense Guidelines and National Defense Authorization Acts. We screened for evidence gaps in psychological health management approaches relevant to the target population. We translated gaps into potential topics for evidence maps and/or systematic reviews. Gaps amenable to evidence synthesis format provided the basis for stakeholder input. Stakeholders rated topics for their potential to inform psychological health care in the military health system. Feasibility scans determined whether topics were ready to be pursued, that is, sufficient literature exists, and duplicative efforts are avoided. Results: We identified 58 intervention, 9 diagnostics, 12 outcome, 19 population, and 24 health services evidence synthesis gaps. Areas included: posttraumatic stress disorder (PTSD) (19), suicide prevention (14), depression (9), bipolar disorder (9), substance use (24), traumatic brain injury (20), anxiety (1), and cross-cutting (14) synthesis topics. Stakeholder input helped prioritize 19 potential PTSD topics and 22 other psychological health topics. To date, 46 topics have undergone feasibility scans. We document lessons learned across clinical topics and research methods. Conclusion: We describe a transparent and structured approach to evidence synthesis topic selection for a health care system using scoping searches, translation into evidence synthesis format, stakeholder input, and feasibility scans.	[Hempel, Susanne] RAND Corp, Evidence Based Practice Ctr EPC, 1776 Main St, Santa Monica, CA 90407 USA; [Hempel, Susanne] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Gore, Kristie] RAND, Natl Secur Res Div, Arlington, TX USA; [Belsher, Bradley] Def Hlth Agcy, Psychol Hlth Ctr Excellence PHCoE, Falls Church, VA USA		Hempel, S (corresponding author), RAND Corp, Evidence Based Practice Ctr EPC, 1776 Main St, Santa Monica, CA 90407 USA.	susanne_hempel@rand.org			Office of the Secretary of Defense, Psychological Health Center of Excellence	Supported by the Office of the Secretary of Defense, Psychological Health Center of Excellence. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the Psychological Health Center of Excellence, the Office of the Secretary of Defense, or the United States government.	Alegria M, 2006, DRUG ALCOHOL DEPEN, V84, pS76, DOI 10.1016/j.drugalcdep.2006.05.009; [Anonymous], 2017, NATL DEFENSE AUTHORI; [Anonymous], 2016, NATL DEFENSE AUTHORI; Barlas F. M., 2013, 2011 DEP DEFENSE HLT; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Carey TY A, 2012, PRIORITIZING FUTURE; Danz MS, 2013, BMJ QUAL SAF, V22, P931, DOI 10.1136/bmjqs-2012-001722; EDDY DM, 1982, NEW ENGL J MED, V307, P343, DOI 10.1056/NEJM198208053070604; Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56; Herman PM, 2016, COMPLEMENTARY ALTERN; Ioannidis JPA, 2016, MILBANK Q, V94, P485, DOI 10.1111/1468-0009.12210; Management of Bipolar Disorders Working Group, 2010, VA DOD CLIN PRACT GU; McCaul Mary E, 2003, Recent Dev Alcohol, V16, P405; Miake-Lye IM, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0204-x; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Otto JL, 2018, MIL PSYCHOL, V30, P557, DOI 10.1080/08995605.2018.1521683; Robinson J, 2008, CRISIS, V29, P180, DOI 10.1027/0227-5910.29.4.180; Robinson K. A., 2013, FRAMEWORK DETERMININ; Saldanha IJ, 2013, J CLIN EPIDEMIOL, V66, P538, DOI 10.1016/j.jclinepi.2012.07.009; Shea CW, 2008, SOUTH MED J, V101, P179, DOI 10.1097/SMJ.0b013e3181617307; Snilstveit B, 2016, J CLIN EPIDEMIOL, V79, P120, DOI 10.1016/j.jclinepi.2016.05.015; The Assessment and Management of Risk for Suicide Working Group, 2013, VA DOD CLIN PRACT GU; The Management of Major Depressive Disorder Working Group, 2016, VA DOD CLIN PRACT GU; The Management of Posttraumatic Stress Disorder Work Group, 2017, VA DOD CLIN PRACT GU; The Management of Substance Use Disorders Work Group, 2015, VA DOD CLIN PRACT GU; The White House Office of the Press Secretary, 2013, NAT RES ACT PLAN RES; Valderas JM, 2007, BRIT MED J, V334, P1128, DOI 10.1136/bmj.39226.427095.3A; Weimer MB, 2014, J PAIN, V15, P366, DOI 10.1016/j.jpain.2014.01.496; Whitlock EP, 2010, J CLIN EPIDEMIOL, V63, P491, DOI 10.1016/j.jclinepi.2009.03.008; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	30	2	2	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7079	1537-1948		MED CARE	Med. Care	OCT	2019	57	10		3			S259	S264		10.1097/MLR.0000000000001175			6	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	JA2JR	WOS:000487643500010	31517797	Green Published, hybrid			2022-02-06	
J	Ikumi, A; Sakuyama, N; Takatori, N; Kamitani, T; Miyazaki, S; Nimura, Y; Maffulli, N; Malliaropoulos, NG; Nagahiro, S				Ikumi, A.; Sakuyama, N.; Takatori, N.; Kamitani, T.; Miyazaki, S.; Nimura, Y.; Maffulli, N.; Malliaropoulos, N. G.; Nagahiro, S.			Matside Medical Aid during Judo Competition in Japan	MLTJ-MUSCLES LIGAMENTS AND TENDONS JOURNAL			English	Article						athletic injuries; epidemiology; judo; martial arts	SPORTS INJURIES; NECK INJURIES; HEAD	Background. This study aimed to investigate the trend of injuries occurring during judo competition reported by matside healthcare professionals. Seventeen judo competitions were investigated. Methods. Injury data (severity, location, type and emergency transportation to medical institution) were recorded on-site using a simple injury reporting form with sex, age and weight category. A total of 420 injuries were recorded. Results. The overall injury incidence rate per 1,000 athlete-exposures (IIRAE) was 22.7. The occurrence of minor injuries was four times than that of major injuries, and most minor injuries were to the soft tissue (bleeding). Sprain was the most frequent major injury followed by concussion. The IIRAE of minor injury in males was almost twice as high as in females; the highest IIRAR of minor injuries were recorded in college and over-age category. In major injury, the IIRAE of middleweight was higher than other weight categories. The most common injury requiring emergency transportation was concussion. The frequencies and characteristics between minor and major injuries were different. The most common minor injury was bleeding, and major injury was sprain. Conclusions. To properly respond to injured athletes during a bout, matside healthcare professionals need to undergo training and learn the knowledge of judo-related injuries.	[Ikumi, A.] Univ Tsukuba, Fac Med, Dept Orthopaed Surg, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan; [Ikumi, A.; Sakuyama, N.; Takatori, N.; Kamitani, T.; Miyazaki, S.; Nimura, Y.; Nagahiro, S.] All Japan Judo Federat Med Comm, Tokyo, Japan; [Sakuyama, N.] Tokyo Metropolitan Hlth & Med Treatment Corp, Div Colorectal Surg, Tobu Chiiki Hosp, Tokyo, Japan; [Takatori, N.] Tokai Univ, Dept Orthopaed Surg, Sch Med, Hiratsuka, Kanagawa, Japan; [Kamitani, T.] Japan Community Healthcare Org, Dept Orthopaed, Tokyo Shinjuku Med Ctr, Tokyo, Japan; [Miyazaki, S.] Tokai Univ, Sch Phys Educ, Hiratsuka, Kanagawa, Japan; [Nimura, Y.] Int Judo Federat Med Commiss, Tokyo, Japan; [Maffulli, N.] Univ Salerno, Dept Musculoskeletal Disorders, Fac Med Surg & Dent, Salerno, Italy; [Maffulli, N.; Malliaropoulos, N. G.] Queen Mary Univ London, Ctr Sports & Exercise Med, London, England; [Malliaropoulos, N. G.] Keele Univ, Inst Sci & Technol Med, Sch Med, Stoke On Trent, Staffs, England; [Nagahiro, S.] Tokushima Univ, Dept Neurosurg, Tokushima, Japan		Ikumi, A (corresponding author), Univ Tsukuba, Fac Med, Dept Orthopaed Surg, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	ikumi@tsukuba-seikei.jp	Malliaropoulos, Nikos/AAV-9471-2020; Maffulli, Nicola/A-1839-2014	Maffulli, Nicola/0000-0002-5327-3702			Akoto R, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096849; Cierna D, 2017, CLIN J SPORT MED; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; Green CM, 2007, SCAND J MED SCI SPOR, V17, P205, DOI 10.1111/j.1600-0838.2006.00552.x; Intel, 2018, INT CLEAR CONT NOW P; International Judo Federation, HIST TIMELINE; James G, 2003, BIOL SPORT, V20, P25; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Kamitani T, 2017, BRIT J SPORT MED, V51, P1581, DOI 10.1136/bjsports-2017-097681; Kamitani T, 2013, AM J SPORT MED, V41, P1915, DOI 10.1177/0363546513490662; Kim KS, 2015, BRIT J SPORT MED, V49, P1144, DOI 10.1136/bjsports-2014-094365; KUJALA UM, 1995, BRIT MED J, V311, P1465, DOI 10.1136/bmj.311.7018.1465; Malliaropoulos Nikos G, 2014, Muscles Ligaments Tendons J, V4, P262; Miarka B, 2018, INT J PERF ANAL SPOR, V18, P229, DOI 10.1080/24748668.2018.1463777; Nagahiro S, 2014, NEUROL MED-CHIR, V54, P878, DOI 10.2176/nmc.ra.2014-0224; Padulo J, 2016, MLTJ-MUSCLE LIGAMENT, V6, P1, DOI 10.11138/mltj/2016.6.1.001; Pierantozzi E, 2009, MEDIT J MUSC SURV, V17, P26; Pieter W, 1997, P 2 ANN C EUR COLL S; Pocecco E, 2013, BRIT J SPORT MED, V47, P1139, DOI 10.1136/bjsports-2013-092886; Souza M, 2006, SCI SPORT, V21, P280, DOI 10.1016/j.scispo.2006.06.002; Sterkowicz S, 1996, MEDYCYNA SPORTOWA, P12; Yard EE, 2007, J SCI MED SPORT, V10, P219, DOI 10.1016/j.jsams.2006.06.016	24	2	2	2	4	EDRA SPA	MILANO	VIA G SPADOLINI, 7, MILANO, 20141, ITALY	2240-4554			MLTJ-MUSCLE LIGAMENT	MLTJ-Muscles Ligaments Tendons J.	OCT-DEC	2019	9	4					627	634		10.32098/mltj.04.2019.19			8	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	JP0JS	WOS:000497958700019		Bronze			2022-02-06	
J	Jackson, ML; Ruppert, KA; Kota, DJ; Prabhakara, KS; Hetz, RA; Aertker, BM; Bedi, S; Mays, RW; Olson, SD; Cox, CS				Jackson, Margaret L.; Ruppert, Katherine A.; Kota, Daniel J.; Prabhakara, Karthik S.; Hetz, Robert A.; Aertker, Benjamin M.; Bedi, Supinder; Mays, Robert W.; Olson, Scott D.; Cox, Charles S., Jr.			Clinical parameters affecting multipotent adult progenitor cells in vitro	HELIYON			English	Article						Stem cell research; Cell biology; Immunology; Medicine; Stem cells research; Inflammation; Regenerative medicine; Cell therapy; Traumatic brain injury; Translational medicine	TRAUMATIC BRAIN-INJURY; BLOOD-STREAM INFECTION; DOUBLE-BLIND; PHENYTOIN; DIFFERENTIATION; PREVENTION; THERAPY	Background: Human multipotent adult progenitor cells (MAPC (R)) are an emerging therapy for traumatic brain injury (TBI); however, clinically translating a therapy involves overcoming many factors in vivo which are not present in pre-clinical testing. In this study we examined clinical parameters in vitro that may impact cell therapy efficacy. Methods: MAPC were infused through varying gauged needles and catheters with and without chlorhexidine, and their viability tested with trypan blue exclusion. MAPC were co-cultured with phenytoin and celecoxib at relevant clinical concentrations for 1 h and 24 h. Anti-inflammatory potency was tested using a stimulated rat splenocyte co-culture and ELISA for TNF-alpha production. MAPC were cultured under different osmolar concentrations and stained with propidium iodide for viability. Anti-inflammatory potency was tested by co-culture of MAPC with naive lymphocytes activated by CD3/CD28 beads, and Click-iT (R) Plus EdU was used to quantify proliferation by flow cytometry. Results: The mean viability of the MAPC infused via needles was 95 +/- 1%; no difference was seen with varying flow rate, but viability was notably reduced by chlorhexidine. MAPC function was not impaired by co-culture with phenytoin, celecoxib, or combination with both. Co-culture with phenytoin showed a decrease in TNF-alpha production as compared to the MAPC control. MAPC cultured at varying osmolar concentrations all had viabilities greater than 90% with no statistical difference between them. Co-culture of MAPC with CD3/CD28 activated PBMCs showed a significant reduction in proliferation as measured by EdU uptake. Discussion: Needle diameter, phenytoin, celecoxib, and a relevant range of osmolarities do not impair MAPC viability or anti-inflammatory potency in vitro.	[Jackson, Margaret L.; Ruppert, Katherine A.; Prabhakara, Karthik S.; Hetz, Robert A.; Aertker, Benjamin M.; Bedi, Supinder; Olson, Scott D.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA; [Kota, Daniel J.] Emory Univ, Emory Personalized Immunotherapy Core, Atlanta, GA 30322 USA; [Hetz, Robert A.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Surg, Houston, TX 77030 USA; [Mays, Robert W.] Athersys Inc, Cleveland, OH USA		Olson, SD; Cox, CS (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA.; Cox, CS (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Surg, Houston, TX 77030 USA.	Scott.D.Olson@uth.tmc.edu; Charles.Cox@uth.tmc.edu		Olson, Scott/0000-0001-8032-3755	SBIR grant from the NIH, NINDS [U44-NS077511-01]; NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM 0879201-11]	This work was supported by an SBIR grant from the NIH, NINDS (#U44-NS077511-01) awarded to Dr. Cox and Athersys, Inc as well as support from NIGMS T32 GM 0879201-11.	Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Boozer Sherry, 2009, J Stem Cells, V4, P17, DOI jsc.2009.4.1.17; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Centers for Disease Control and Prevention, 2014, SURV REP TRAUM BRAIN; Cotton BA, 2011, J TRAUMA, V71, P375, DOI 10.1097/TA.0b013e318224d307; Cox CS, 2019, TRANSFUSION, V59, P858, DOI 10.1111/trf.14834; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; dos Santos AM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/497280; Hess DC, 2017, LANCET NEUROL, V16, P360, DOI 10.1016/S1474-4422(17)30046-7; Kane SP, 2013, ANN PHARMACOTHER, V47, P628, DOI 10.1345/aph.1R651; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lai N, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12970; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Liu YS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16522; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maki DG, 1997, ANN INTERN MED, V127, P257, DOI 10.7326/0003-4819-127-4-199708150-00001; Pelacho Beatriz, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS15, DOI 10.1038/ncpcardio0735; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Prevention C. F. D. C. a., 2019, TRAUM BRAIN INJ CONC; Roobrouck VD, 2011, STEM CELLS, V29, P871, DOI 10.1002/stem.633; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005	23	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND		2405-8440		HELIYON	Heliyon	OCT	2019	5	10							e02532	10.1016/j.heliyon.2019.e02532			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JK1XQ	WOS:000494641300051	31667385	gold, Green Published			2022-02-06	
J	Jain, RK; Chakraborty, P; Joshi, P; Pradhan, S; Kumari, R				Jain, Rajiv Kumar; Chakraborty, Priyanko; Joshi, Purnima; Pradhan, Sidharth; Kumari, Rakhi			Penetrating Neck Injuries: from ER to OR	INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY			English	Article						Penetrating neck injury; Resuscitation; Cut throat; Foreign body neck	COMPUTED-TOMOGRAPHY; TRAUMA	Neck contains several vital structures, in a small close space, in complex relationship to each other, and unprotected by any bony framework. Any injury to this crucial region, hence mostly becomes an acute emergency. Appropriately managing the same has always been a point of constant discussion amongst head and neck surgeons. The basic aim of the study was to discuss the management, comorbidities, prognosis and associated complications encountered in a series of patients with penetrating neck trauma (piercing platysma), presenting to the emergency over a period of 1 year. Combat injuries and patients declared as brought dead at the time of first examination were excluded. This was a retrospective study of patients with cut throat injury, managed at a tertiary center of northern India from June 2014 to September 2015. Following management in the ER as per ATLS guidelines, all patients were then operated for specific injuries. Graph pad software was used for statistical analysis. Of the 15 patients studied in total, 11 (73.3%) were males. The mean patient age was 33.67 years. Mean duration of presentation was 20.85 h. 60% patients had homicidal injuries. Tracheostomy and Ryle's tube insertion was done in 8 (53.3%) patients. Exploration and surgical repair was done in all patients without any mortality. 4 patients developed post-operative complications. Mean duration of hospital stay was 9.2 days. Immediate resuscitation followed by exploration and primary repair is a must in all patients of penetrating neck injury.	[Jain, Rajiv Kumar] IMS BHU, Dept ENT, Flat 114,Ambrosia Apartments, Varanasi 221005, Uttar Pradesh, India; [Chakraborty, Priyanko] IMS BHU, Dept ENT, Room 215,Susruta Hostel,Trauma Ctr Campus, Varanasi 221005, Uttar Pradesh, India; [Joshi, Purnima] IMS BHU, Dept ENT, Room 5,Ladies Doctors Hostel, Varanasi 221005, Uttar Pradesh, India; [Pradhan, Sidharth] IMS BHU, Dept ENT, Room 130,Susruta Hostel,Trauma Ctr Campus, Varanasi 221005, Uttar Pradesh, India; [Kumari, Rakhi] IMS BHU, Dept ENT, Patna 800006, Bihar, India		Joshi, P (corresponding author), IMS BHU, Dept ENT, Room 5,Ladies Doctors Hostel, Varanasi 221005, Uttar Pradesh, India.	jainrajivk@hotmail.com; cpriyanko@gmail.com; purnimajoshi4@gmail.com; pradhansidharth.1987@gmail.com; dr.rakhi.kumari@gmail.com	chakraborty, Priyanko/AAS-4019-2021	chakraborty, Priyanko/0000-0002-3581-670X; PRADHAN, SIDHARTH/0000-0002-3485-9687			Aich M, 2011, BANGLADESH J OTORHIN, V17, P5; Al-Thani Hassan, 2015, J Emerg Trauma Shock, V8, P154, DOI 10.4103/0974-2700.160723; American College of Surgeons Committee on Trauma, 2013, ADV TRAUM LIF SUPP P; Chen JD, 2001, AM J ROENTGENOL, V176, P1273, DOI 10.2214/ajr.176.5.1761273; Cicala R S, 1991, J Clin Anesth, V3, P91, DOI 10.1016/0952-8180(91)90003-6; Eggen J. Todd, 1993, Journal of Emergency Medicine, V11, P381; Fagan JJ, 2008, NECK TRAUMA SCOTT BR, P1768; Gordon O, 1988, FORENSIC MED GUIDE P, P300; Gracias VH, 2001, ARCH SURG-CHICAGO, V136, P1231, DOI 10.1001/archsurg.136.11.1231; Karaaslan T, 1995, J TRAUMA, V39, P1081, DOI 10.1097/00005373-199512000-00012; LEMAY SR, 1971, ARCHIV OTOLARYNGOL, V94, P558; Onotai L O, 2010, Niger J Med, V19, P264; Rao B, 2004, IND J CRITIC CARE ME, V8, P98; ROON AJ, 1979, J TRAUMA, V19, P391, DOI 10.1097/00005373-197906000-00001; Shiroff AM, 2013, AM SURGEON, V79, P23; Shreyas SJ, 2013, INT J OTOLARYNGOL HE, V2, P11, DOI [10.4236/ijohns.2013.21004, DOI 10.4236/IJOHNS.2013.21004]	16	2	2	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	2231-3796	0973-7707		INDIAN J OTOLARYNGOL	Indian J. Otolaryngol. Head Neck Surg.	OCT	2019	71			1			352	357		10.1007/s12070-018-1307-6			6	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	KV1JE	WOS:000520180100070	31741985	Green Published			2022-02-06	
J	Klyce, DW; Stromberg, KA; Walker, WC; Sima, AP; Hoffman, JM; Graham, KM; Agyemang, AA; Marwitz, JH				Klyce, Daniel W.; Stromberg, Katharine A.; Walker, William C.; Sima, Adam P.; Hoffman, Jeanne M.; Graham, Kristin M.; Agyemang, Amma A.; Marwitz, Jennifer H.			Depression as a Predictor of Long-term Employment Outcomes Among Individuals With Moderate-to-Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							WORKING-AGE INDIVIDUALS; COGNITIVE RECOVERY; IMPAIRMENT; VALIDITY; THERAPY	Objective: To examine the predictive ability of depression when considering long-term employment outcomes for individuals with moderate-to-severe traumatic brain injury (TBI) after controlling for key preinjury and injury-related variables. Design: Secondary data analysis. Setting: Community follow-up after discharge from an inpatient rehabilitation center. Participants: Individuals between 18 and 60 years old with moderate-to-severe TBI enrolled in the Traumatic Brain Injury Model Systems database. Interventions: Not applicable. Main Outcome Measures: Employment status. Results: The prevalence of employment at 2 and 5 years post injury was 40.3% and 44.5%, respectively. Individuals identified as depressed at 1 year were more likely to be unemployed at 2 years post injury (odds ratio [OR], 1.77; 95% CI, 1.38-2.27; P<.0001). Similar relations between current depression and future employment were observed from 1- and 2-year depression status predicting 5-year employment (1-year: OR, 1.88; 95% CI, 1.48-2.40; P<.0001: 2-year: OR, 1.72; 95% CI, 1.36-2.17; P<.0001). Conclusions: After controlling for baseline predictors variables, the experience of postinjury depression a modifiable condition contributes predictive ability to future employment outcomes. Incorporating assessments and/or interventions for depression into postacute rehabilitation programs could promote favorable employment outcomes after TBI. (C) 2019 by the American Congress of Rehabilitation Medicine	[Klyce, Daniel W.; Walker, William C.; Graham, Kristin M.; Agyemang, Amma A.; Marwitz, Jennifer H.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Stromberg, Katharine A.; Sima, Adam P.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Hoffman, Jeanne M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Klyce, DW (corresponding author), VCU Sch Med, 1300 E Marshall St,Box 980661, Richmond, VA 23298 USA.	daniel.klyce@vcuhealth.org		Walker, William/0000-0001-5813-3939; Sima, Adam/0000-0001-8426-9987	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RHD089097A]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90AR5025]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD089097] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002649] Funding Source: NIH RePORTER	Supported by the National Institute of Health (grant no. RHD089097A) and National Institute on Disability, Independent Living, and Rehabilitation Research (grant no. 90AR5025).	Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown AW, 2007, BRAIN INJURY, V21, P673, DOI 10.1080/02699050701468925; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Cuijpers P, 2007, EUR PSYCHIAT, V22, P9, DOI 10.1016/j.eurpsy.2006.11.001; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demler OV, 2012, STAT MED, V31, P2577, DOI 10.1002/sim.5328; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DiSanto D, 2019, ARCH PHYS MED REHAB, V100, P412, DOI 10.1016/j.apmr.2018.06.022; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hosmer Jr D.W., 2013, WILEY SERIES PROBABI, P398; Kortte K, 2016, PSYCHOL DESK REFEREN; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Powers MB, 2009, PSYCHOTHER PSYCHOSOM, V78, P73, DOI 10.1159/000190790; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Sander AM, 2018, J HEAD TRAUMA REHAB, V33, P219, DOI 10.1097/HTR.0000000000000395; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stromberg KA, 2019, J HEAD TRAUMA REHAB, V34, pE64, DOI 10.1097/HTR.0000000000000438; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wehman PH, 2017, PHYS MED REH CLIN N, V28, P351, DOI 10.1016/j.pmr.2016.12.010; West M, 2018, REHABIL RES POL EDUC, V32, P78, DOI 10.1891/2168-6653.32.2.78; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	38	2	2	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2019	100	10					1837	1843		10.1016/j.apmr.2019.06.009			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	JF3QL	WOS:000491302000005	31344363	Green Accepted			2022-02-06	
J	Liu, S; Jin, R; Xiao, AY; Chen, R; Li, J; Zhong, W; Feng, XZ; Li, GH				Liu, Shan; Jin, Rong; Xiao, Adam Y.; Chen, Rui; Li, Jarvis; Zhong, Wei; Feng, Xiaozhou; Li, Guohong			Induction of Neuronal PI3K gamma Contributes to Endoplasmic Reticulum Stress and Long-Term Functional Impairment in a Murine Model of Traumatic Brain Injury	NEUROTHERAPEUTICS			English	Article						PI3K gamma; endoplasmic reticulum stress; neurons; white matter; trauma	COGNITIVE DEFICITS; HIPPOCAMPAL-NEURONS; ER STRESS; INHIBITION; ACTIVATION; APOPTOSIS; MATTER; DEATH; PI3K; RAT	Phosphoinositide 3-kinase gamma (PI3K gamma) expressed in immune cells is linked to neuroinflammation in several neurological diseases. However, the expression and role of PI3K gamma in preclinical traumatic brain injury (TBI) have not been investigated. In WT mice, we found that TBI induced rapid and extensive expression of PI3K gamma in neurons within the perilesional cortex and the ipsilateral hippocampal subfields (CA1, CA3), which peaked between 1 and 3 days and declined significantly 7 days after TBI. Intriguingly, the induction of neuronal PI3K gamma in these subregions of the brain spatiotemporally coincided with both the TBI-induced activation of the neuronal ER stress pathway (p-eIF2 alpha, ATF4, and CHOP) and neuronal cell death (marked by TUNEL-positive neurons) 3 days after TBI. Further, we show that the absence of PI3K gamma in knockout mice profoundly reduced the TBI-induced activation of the ER stress pathway and neuronal cell death. White matter disruption is a better predictor of long-term clinical outcomes than focal lesion size. We show that PI3K gamma deficiency not only reduced brain tissue loss but also alleviated white matter injury (determined by axonal injury and demyelination) up to 28 days after TBI. Importantly, PI3K gamma-knockout mice exhibited greater functional recovery including forepaw use, sensorimotor balance and coordination, and spatial learning and memory up to 28 days after TBI. These results unveil a previously unappreciated role for neuronal PI3K gamma in the regulation of ER stress associated with neuronal cell death, white matter damage, and long-term functional impairment after TBI.	[Liu, Shan; Jin, Rong; Zhong, Wei; Li, Guohong] Penn State Univ, Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Liu, Shan; Jin, Rong; Zhong, Wei; Li, Guohong] Penn State Univ, Hershey Med Ctr, Neurosci Inst, Hershey, PA 17033 USA; [Xiao, Adam Y.] Louisiana State Univ, Dept Mol & Cellular Physiol, Hlth Sci Ctr, Shreveport, LA 71103 USA; [Chen, Rui; Li, Guohong] Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr, Shreveport, LA 71103 USA; [Li, Jarvis] Hershey High Sch, Hershey, PA 17033 USA; [Feng, Xiaozhou] Penn State Univ, Dept Pharmacol, Hershey Med Ctr, Hershey, PA 17033 USA		Li, GH (corresponding author), Penn State Univ, Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA.; Li, GH (corresponding author), Penn State Univ, Hershey Med Ctr, Neurosci Inst, Hershey, PA 17033 USA.; Li, GH (corresponding author), Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr, Shreveport, LA 71103 USA.	guohongli@pennstatehealth.psu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS089991, R01NS088719] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS089991, R01 NS088719] Funding Source: Medline		Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Bartsch T, 2010, SCIENCE, V328, P1412, DOI 10.1126/science.1188160; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Chen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092133; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choi JH, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0078-6; Choi SH, 2005, J NEUROSCI, V25, P4082, DOI 10.1523/JNEUROSCI.4306-04.2005; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Costa C, 2011, IUBMB LIFE, V63, P707, DOI 10.1002/iub.516; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; D'Andrea I, 2015, EMBO MOL MED, V7, P904, DOI 10.15252/emmm.201404697; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Gorse KM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00778; Grayson B, 2015, BEHAV BRAIN RES, V285, P176, DOI 10.1016/j.bbr.2014.10.025; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Han LJ, 2015, STROKE, V46, P2628, DOI 10.1161/STROKEAHA.115.010091; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Huang L, 2015, J NEUROSCI, V35, P10390, DOI 10.1523/JNEUROSCI.0546-15.2015; Jalin AMAA, 2019, EXP NEUROL, V314, P20, DOI 10.1016/j.expneurol.2019.01.002; Jin R, 2019, HYPERTENSION, V73, P206, DOI 10.1161/HYPERTENSIONAHA.118.12001; Jin R, 2011, STROKE, V42, P2033, DOI 10.1161/STROKEAHA.110.601369; Jin R, 2010, BIOCHEM BIOPH RES CO, V399, P458, DOI 10.1016/j.bbrc.2010.07.116; Jover-Mengual T, 2010, BRAIN RES, V1321, P1, DOI 10.1016/j.brainres.2010.01.046; Kadar T, 1998, J NEURAL TRANSM, V105, P987, DOI 10.1007/s007020050107; Kempuraj D, 2018, J NEUROIMMUNE PHARM, V13, P100, DOI 10.1007/s11481-017-9766-1; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lee DY, 2018, EUR J CELL BIOL, V97, P339, DOI 10.1016/j.ejcb.2018.04.003; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Li HT, 2019, INT J BIOL SCI, V15, P277, DOI 10.7150/ijbs.30348; Li SH, 2013, ANN NEUROL, V74, P768, DOI 10.1002/ana.24005; Liang F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08196-3; Narita M, 2004, NEUROSCIENCE, V124, P515, DOI 10.1016/j.neuroscience.2003.11.023; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Passos GF, 2010, BRAIN BEHAV IMMUN, V24, P493, DOI 10.1016/j.bbi.2009.12.003; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruckle T, 2006, NAT REV DRUG DISCOV, V5, P903, DOI 10.1038/nrd2145; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun DD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00193; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Yin Y, 2017, AGEING RES REV, V34, P3, DOI 10.1016/j.arr.2016.08.008; Zhou MF, 2019, CNS NEUROSCI THER, V25, P562, DOI 10.1111/cns.13089	59	2	2	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	OCT	2019	16	4			SI		1320	1334		10.1007/s13311-019-00748-x			15	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	KJ4RT	WOS:000512046900028	31187475	Bronze, Green Published			2022-02-06	
J	Lorente, L; Martin, MM; Gonzalez-Rivero, AE; Perez-Cejas, A; Argueso, M; Ramos, L; Sole-Violin, J; Caceres, JJ; Jimenez, A; Garcia-Marin, V				Lorente, Leonardo; Martin, Maria M.; Gonzalez-Rivero, Agustin E.; Perez-Cejas, Antonia; Argueso, Monica; Ramos, Luis; Sole-Violin, Jordi; Caceres, Juan J.; Jimenez, Alejandro; Garcia-Marin, Victor			High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients	BRAIN SCIENCES			English	Article						cytokeratin; brain trauma; patients; mortality; injury	CORTICAL SPREADING DEPRESSION; CELL-DEATH; APOPTOSIS; ACTIVATION; EXPRESSION; INCREASES; SEVERITY; PATHWAY; DAMAGE; BCL-2	Objective: Apoptosis increases in traumatic brain injury (TBI). Caspase-cleaved cytokeratin (CCCK)-18 in blood during apoptosis could appear. At the time of admission due to TBI, higher blood CCCK-18 levels were found in non-surviving than in surviving patients. Therefore, the objective of our study was to analyze whether serum CCCK-18 levels determined during the first week after TBI could predict early mortality (at 30 days). Methods: Severe TBI patients were included (considering severe when Glasgow Coma Scale < 9) in this observational and multicentre study. Serum CCCK-18 levels were determined at day 1 of TBI, and at days 4 and 8 after TBI. Results: Serum CCCK-18 levels at day 1 of TBI, and in the days 4 and 8 after TBI were higher (p < 0.001) in non-surviving than in surviving patients (34 and 90 patients, respectively) and could predict early mortality (p < 0.001 in the area under the curve). Conclusions: The new findings from our study were that serum CCCK-18 levels at any moment of the first week of TBI were higher in non-surviving patients and were able to predict early mortality.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora de Candelaria, Intens Care Unit, Crta Rosario S-N, Santa Cruz De Tenerife 38010, Spain; [Gonzalez-Rivero, Agustin E.; Perez-Cejas, Antonia] Hosp Univ Canarias, Lab Dept, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Avda Blasco Ibanez 17-19, Valencia 46004, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta, La Palma, Spain; [Sole-Violin, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, CIBERES, Las Palmas Gran Canaria 35010, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Plaza Dr Pasteur S-N, Las Palmas Gran Canaria 35016, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Garcia-Marin, Victor] Hosp Univ Canarias, Dept Neurosurg, San Cristobal la Laguna 38320, Santa Cruz De T, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna 38320, Santa Cruz De T, Spain.	lorentemartin@msn.com; mar.martinvelasco@gmail.com; agonriv@hotmail.com; aperezcejas@gmail.com; moni_begasa@hotmail.com; lramosgomez@gmail.com; jsolvio@gobiernodecanarias.org; juanjose.caceresagra@gobiernodecanarias.org; ajimenersosa@gmail.com; vicgarmar666@gmail.com		Lorente, Leonardo/0000-0003-4902-4065; Jimenez-Sosa, Alejandro/0000-0001-8732-2616	Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife, Spain) [OA18/011]	This study was supported by a grant (OA18/011) from Fundacion DISA a la Investigacion Medica 2017 (Santa Cruz de Tenerife, Spain). Funding did not influence in the study design, the collection, analysis, and interpretation of data, the manuscript writing, and the decision to submit it for publication.	Abrahamson EE, 2006, EXP NEUROL, V197, P437, DOI 10.1016/j.expneurol.2005.10.011; Ari F, 2014, CELL PROLIFERAT, V47, P457, DOI 10.1111/cpr.12123; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Cavallucci V, 2011, CURR PHARM DESIGN, V17, P215, DOI 10.2174/138161211795049705; Chen R, 2013, EXP THER MED, V6, P1463, DOI 10.3892/etm.2013.1342; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Gu SJ, 2016, CLIN CHIM ACTA, V452, P124, DOI 10.1016/j.cca.2015.11.011; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Jahan-Abad AJ, 2018, MOL NEUROBIOL, V55, P4225, DOI 10.1007/s12035-017-0642-z; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Lorente L, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0424-1; Lorente L, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1038-z; Lorente L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091524; Lorente L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121739; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109618; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Luciani P, 2005, J CLIN ENDOCR METAB, V90, P6156, DOI 10.1210/jc.2005-0633; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; TEASDALE G, 1974, LANCET, V2, P81; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wang K, 2014, CHINESE MED J-PEKING, V127, P1964, DOI 10.3760/cma.j.issn.0366-6999.20120638; Wesche-Soldato DE, 2007, CURR DRUG TARGETS, V8, P493, DOI 10.2174/138945007780362764; Xue ZL, 2017, BIOCHEM BIOPH RES CO, V486, P589, DOI 10.1016/j.bbrc.2017.03.097; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yuan ZG, 2015, J NEUROL SCI, V359, P298, DOI 10.1016/j.jns.2015.11.020	38	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	OCT	2019	9	10							269	10.3390/brainsci9100269			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JI5NX	WOS:000493515400023	31658711	Green Published, gold			2022-02-06	
J	Lu, WC; Wu, T; Cui, P; Zhang, JF; Sheng, XD; Ding, ZB				Lu, Wenchao; Wu, Tao; Cui, Ping; Zhang, Junfeng; Sheng, Xudong; Ding, Zhibin			Timing of Tracheotomy in Patients With Severe Traumatic Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Complications; prognosis; severe traumatic brain injury; tracheotomy	EARLY TRACHEOSTOMY; INTUBATION; GUIDELINES; MANAGEMENT; PNEUMONIA; IMPACT	Background: Tracheotomy has played an important role in the treatment of patients with severe traumatic brain injury (TBI), the appropriate tracheotomy time will affect the prognosis of patients. However, the timing of tracheostomy after severe TBI remains controversial. To find the optimal time for tracheostomy, the authors compared the effects of early tracheostomy (ET) versus late tracheostomy (LT) on TBI-related outcomes and prognosis. Methods: The clinical data of 98 patients with severe TBI treated by tracheotomy at NICU, First Affiliated Hospital of Xi'an Medical University, January 2017 to January 2018, were analyzed retrospectively. According to the time of the tracheotomy during the treatment, the patients were divided into ET group (after admission <3 days) and LT group (>3 days after admission). The NICU stay, hospital stay, long duration of antibiotic use, pneumonia rates, mortality rates, improvement of nerve function, complications of tracheotomy, and treatment cost were compared between the 2 groups. Results: The NICU stay, hospitalization stay, and antibiotic use time of patients in the ET group were shorter than those in the LT group (P<0.05). The pneumonia rates and the cost of hospitalization in the ET group were lower than those in the LT group (P<0.05). The complications of the tracheostomy, mortality, and neurologic function improvements were not statistically significant in the 2 groups (P>0.05). Conclusion: For severe TBI, ET can reduce the NICU stay, hospitalization stay, length of antibiotic use, and reduce the incidence rates of pneumonia and the cost of hospitalization compared with LT, but there is no significant improvement in the mortality rates and neurologic function of patients during hospitalization.	[Lu, Wenchao; Wu, Tao; Cui, Ping; Zhang, Junfeng; Sheng, Xudong; Ding, Zhibin] Xian Med Univ, Affiliated Hosp 1, Dept Neurosurg, 48 Fenghao West Rd, Xian 710077, Shaanxi, Peoples R China		Lu, WC (corresponding author), Xian Med Univ, Affiliated Hosp 1, Dept Neurosurg, 48 Fenghao West Rd, Xian 710077, Shaanxi, Peoples R China.	luwenchao1985@163.com					Arabi Y, 2004, CRIT CARE, V8, pR347, DOI 10.1186/cc2924; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cheung NH, 2014, RESP CARE, V59, P895, DOI 10.4187/respcare.02971; da Cruz VM, 2002, EUR RESPIR J, V20, P112, DOI 10.1183/09031936.02.01342001; Durbin CG, 2010, RESP CARE, V55, P1056; Epstein Scott K, 2005, Respir Care, V50, P542; Gessler F, 2015, CRIT CARE MED, V43, P2429, DOI 10.1097/CCM.0000000000001195; Holevar M, 2009, J TRAUMA, V67, P870, DOI 10.1097/TA.0b013e3181b5a960; Hosokawa K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1138-8; Hyde GA, 2015, INJURY, V46, P110, DOI 10.1016/j.injury.2014.08.049; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kurtz P, 2011, NEUROCRIT CARE, V15, P477, DOI 10.1007/s12028-011-9539-2; McWhorter Andrew J, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P473, DOI 10.1097/00020840-200312000-00012; Qureshi AI, 2000, CRIT CARE MED, V28, P1383, DOI 10.1097/00003246-200005000-00020; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Siddiqui Usman Tariq, 2015, Surg Neurol Int, V6, P65, DOI 10.4103/2152-7806.155757; Tae Hyung K, 2009, J KOR NEUROTRAUMATOL, V5, P89; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154	21	2	2	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	OCT	2019	30	7					2168	2170		10.1097/SCS.0000000000005721			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JS5VN	WOS:000500374200105	31274818				2022-02-06	
J	McLaughlin, C; Darcy, D; Park, C; Lane, CJ; Mack, WJ; Bliss, DW; Bhalla, A; Upperman, JS; Nathens, AB; Burd, RS; Jensen, AR				McLaughlin, Cory; Darcy, David; Park, Caron; Lane, Christianne J.; Mack, Wendy J.; Bliss, David W.; Bhalla, Anoopindar; Upperman, Jeffrey S.; Nathens, Avery B.; Burd, Randall S.; Jensen, Aaron R.			Timing of tracheostomy placement among children with severe traumatic brain injury: A propensity-matched analysis	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	5th Annual Meeting of the Pediatric-Trauma-Society (PTS)	NOV 08-10, 2018	Houston, TX	Pediat Trauma Soc		Pediatric; timing; tracheostomy; traumatic brain injury	COMPLICATIONS; OUTCOMES; PART	BACKGROUND: Early tracheostomy has been associated with shorter hospital stay and fewer complications in adult trauma patients. Guidelines for tracheostomy have not been established for children with severe traumatic brain injury (TBI). The purpose of this study was to (1) define nationwide trends in time to extubation and time to tracheostomy and (2) determine if early tracheostomy is associated with decreased length of stay and fewer complications in children with severe TBI. METHODS: Records of children (<15 years) with severe TBI (head Abbreviated Injury Severity [AIS] score >= 3) who were mechanically ventilated (>48 hours) were obtained from the National Trauma Data Bank (2007-2015). Outcomes after early (<= 14 days) and late (>= 15 days) tracheostomy placement were compared using 1:1 propensity score matching to control for potential confounding by indication. Propensity scores were calculated based on age, race, pulse, blood pressure, Glasgow Coma Scale motor score, injury mechanism, associated injury Abbreviated Injury Severity scores, TBI subtype, craniotomy, and intracranial pressure monitor placement. RESULTS: Among 6,101 children with severe TBI, 5,740 (94%) were extubated or died without tracheostomy, 95% of the time within 18 days. Tracheostomy was performed in 361 children (6%) at a median [interquartile range] of 15 [10, 22] days. Using propensity score matching, we compared 121 matched pairs with early or late tracheostomy. Early tracheostomy was associated with fewer ventilator days (14 [9, 19] vs. 25 [19, 35]), intensive care unit days (19 [14, 25] vs. 31 [24, 43]), and hospital days (26 [19, 41] vs. 39 [31, 54], all p < 0.05). Pneumonia (24% vs. 41%), venous thromboembolism (3% vs. 13%), and decubitus ulcer (4% vs. 13%) occurred less frequently with early tracheostomy (p < 0.05). CONCLUSIONS: Early tracheostomy is associated with shorter hospital stay and fewer complications among children with severe TBI. Extubation without tracheostomy is rare beyond 18 days after injury. (Copyright (C) 2019 Wolters Kluwer Health, Inc. All rights reserved.)	[McLaughlin, Cory; Darcy, David; Bliss, David W.; Upperman, Jeffrey S.] Childrens Hosp Los Angeles, Div Pediat Surg, Los Angeles, CA 90027 USA; [Bliss, David W.; Upperman, Jeffrey S.] Univ Southern Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90007 USA; [Park, Caron; Lane, Christianne J.; Mack, Wendy J.] SC CTSI, Los Angeles, CA USA; [Park, Caron; Lane, Christianne J.; Mack, Wendy J.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA; [Bhalla, Anoopindar] Childrens Hosp Los Angeles, Div Crit Care Med, Los Angeles, CA 90027 USA; [Bhalla, Anoopindar] Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90007 USA; [Nathens, Avery B.] Amer Coll Surg, Chicago, IL USA; [Nathens, Avery B.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Burd, Randall S.] Childrens Natl Med Ctr, Div Burn & Trauma Surg, Washington, DC 20010 USA; [Jensen, Aaron R.] UCSF Benioff Childrens Hosp Oakland, Div Pediat Gen Surg, 744 52nd St,OPC 4th Floor, Oakland, CA 94609 USA		Jensen, AR (corresponding author), UCSF Benioff Childrens Hosp Oakland, Div Pediat Gen Surg, 744 52nd St,OPC 4th Floor, Oakland, CA 94609 USA.	ajensen@mail.cho.org			National Center for Advancing Translational Science of the US National Institutes of Health [KL2TR001854, UL1TR001855, UL1TR000130]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001855, KL2TR001854] Funding Source: NIH RePORTER	C.M., D.D., D.W.B., A.B., J.U., A.B.N., R.S.B., and A.R.J. designed the study. C.P., C.J.L., and W.J.M. collected and analyzed the data. C.P., C.J.L., W.J.M., C.M., D.D., A.B., and A.R.J. interpreted the data. C.M., D.D., and A.R.J. wrote the manuscript. C.P., C.J.L., W.J.M., A.B., J.U., A.B.N., and R.S.B. critically revised the manuscript. This work was supported by grants KL2TR001854, UL1TR001855, and UL1TR000130 from the National Center for Advancing Translational Science of the US National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; American College of Surgeons Committee on Trauma, 2019, NATL TRAUMA DATA STA; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Biasucci DG, 2017, MINERVA ANESTESIOL, V83, P105, DOI 10.23736/S0375-9393.16.11382-3; Borse NN, 2009, J SAFETY RES, V40, P71, DOI 10.1016/j.jsr.2009.01.002; Coca-Perraillon M., LOCAL GLOBAL OPTIMAL; de Caen AR, 2015, CIRCULATION, V132, pS526, DOI 10.1161/CIR.0000000000000266; Funamura JL, 2017, LARYNGOSCOPE, V127, P1701, DOI 10.1002/lary.26361; Halum SL, 2012, LARYNGOSCOPE, V122, P38, DOI 10.1002/lary.22364; Holloway Adrian J, 2015, Pediatr Crit Care Med, V16, pe52, DOI 10.1097/PCC.0000000000000336; Holscher CM, 2014, J PEDIATR SURG, V49, P590, DOI 10.1016/j.jpedsurg.2013.09.002; Hosokawa K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1138-8; Kardooni S, 2008, J TRAUMA, V64, P273, DOI 10.1097/TA.0b013e31816335ae; Lee JH, 2016, ACTA ANAESTH SCAND, V60, P1281, DOI 10.1111/aas.12760; McPherson ML, 2017, PEDIATR PULM, V52, P946, DOI 10.1002/ppul.23657; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; Watters K, 2016, LARYNGOSCOPE, V126, P2611, DOI 10.1002/lary.25972; Yang D., UNIFIED APPROACH MEA; Zagli G, 2010, J TRAUMA, V68, P367, DOI 10.1097/TA.0b013e3181a601b3	19	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2019	87	4					818	826		10.1097/TA.0000000000002237			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	KB9MX	WOS:000506812600011	30882764	Green Accepted			2022-02-06	
J	Morgan, MA; Logan, MW; Cullen, FT				Morgan, Mark Alden; Logan, Matthew W.; Cullen, Francis T.			The Battlefield Behind Bars: How Mental Disorder and Suicidal Behavior Impacts the Prison Experience for Veterans	AMERICAN JOURNAL OF CRIMINAL JUSTICE			English	Article						Veterans; Prison adjustment; Prison treatment; Mental disorders; Suicide	TRAUMATIC BRAIN-INJURY; MILITARY VETERANS; RISK-FACTORS; US MILITARY; HEALTH-CARE; JUSTICE; PREVALENCE; AFGHANISTAN; IRAQ; INCARCERATION	Military veteran status has been associated with a variety of criminal justice outcomes as well as higher rates of mental illness and suicide when compared to the general population. Although research has generally focused on why veterans become involved with the justice system, less is known about their experiences while incarcerated. In particular, studies of veterans in the community context indicate that they are unwilling to seek out mental health treatment due to potential stigmas, suggesting that this reluctance may extend into the prison environment. Using a sample of 14,278 veteran and nonveteran inmates, we find that veterans do not necessarily fare worse in prison and are actually more likely to obtain treatment. However, this effect is largely mediated by the greater history of mental disorders and suicidal behaviors among veterans. Our findings lend credence to recent efforts designed to screen and manage justice-involved veterans as a distinct, at-risk group.	[Morgan, Mark Alden] Miami Univ, Dept Justice & Community Studies, 1601 Univ Blvd,103F Phelps Hall, Hamilton, OH 45011 USA; [Logan, Matthew W.] Calif State Univ San Bernardino, Dept Criminal Justice, 5500 Univ Pkwy, San Bernardino, CA 92407 USA; [Cullen, Francis T.] Univ Cincinnati, Sch Criminal Justice, 660-O Teacher Dyer Hall, Cincinnati, OH 45221 USA		Morgan, MA (corresponding author), Miami Univ, Dept Justice & Community Studies, 1601 Univ Blvd,103F Phelps Hall, Hamilton, OH 45011 USA.	morga128@miamioh.edu; matthew.logan@csusb.edu; cullenft@ucmail.uc.edu					Accordino MP, 2001, J REHABIL, V67, P16; Adams K, 2008, CRIM JUSTICE BEHAV, V35, P913, DOI 10.1177/0093854808318624; Albertson K., 2017, PRISON SERV J, V234, P23; Andrews DA, 2010, PSYCHOL PUBLIC POL L, V16, P39, DOI 10.1037/a0018362; Armor D. J., 2004, ALL VOLUNTEER FORCE, P90; ATHENS L, 2003, VIOLENT ACTS VIOLENT; Blodgett JC, 2015, EPIDEMIOL REV, V37, P163, DOI 10.1093/epirev/mxu003; Blonigen D.M., 2016, CRIMINAL JUSTICE POL, V27, P812, DOI [DOI 10.1177/0887403414562602, 10.1177/0887403414562602]; Blonigen Daniel M, 2017, Crim Justice Policy Rev, V28, P790, DOI 10.1177/0887403416628601; Blue-Howells JH, 2013, PSYCHOL SERV, V10, P48, DOI 10.1037/a0029652; Bonett DG, 2005, J EDUC BEHAV STAT, V30, P213, DOI 10.3102/10769986030002213; Bronson J., 2015, VETERANS PRISON JAIL; Cesaroni C, 2010, YOUTH JUSTICE, V10, P107, DOI 10.1177/1473225410369290; Christy A, 2012, CRIM JUSTICE BEHAV, V39, P461, DOI 10.1177/0093854811433539; Clemmer D., 1958, PRISON COMMUNITY; Connor Tray, 2017, NBC NEWS; CULLEN FT, 2005, J OFFENDER REHABIL, V40, P53; Culp R, 2013, JUSTICE Q, V30, P651, DOI 10.1080/07418825.2011.615755; DeLisi M, 2011, INT J OFFENDER THER, V55, P1186, DOI 10.1177/0306624X11383956; Diamond PM, 2001, ADM POLICY MENT HLTH, V29, P21, DOI 10.1023/A:1013164814732; Edelman B., 2016, VETERANS TREATMENT C; Finlay Andrea K, 2016, Crim Justice Policy Rev, V27, DOI 10.1177/0887403414562601; Finlay AK, 2017, ADM POLICY MENT HLTH, V44, P177, DOI 10.1007/s10488-015-0708-z; Finlay AK, 2015, MED CARE, V53, pS105, DOI 10.1097/MLR.0000000000000271; Fontana A, 2005, J NERV MENT DIS, V193, P203, DOI 10.1097/01.nmd.0000154835.92962.e5; Fox John, 2008, APPL REGRESSION ANAL; Friedman MJ, 2004, NEW ENGL J MED, V351, P75, DOI 10.1056/NEJMe048129; GOETTING A, 1986, J QUANTITATIVE CRIMI, V0002; Greenberg GA, 2009, PSYCHIAT QUART, V80, P41, DOI 10.1007/s11126-009-9092-8; Hajjar RM, 2014, ARMED FORCES SOC, V40, P118, DOI 10.1177/0095327X12465261; Hartley R. D., 2016, CRIMINAL JUSTICE POL, P1; Hawkins Judge Michael Daly, 2009, OHIO STATE J CRIMINA, V7, P563; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hill M., 2018, ASS PRESS; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; IRWIN J, 1962, SOC PROBL, V10, P142, DOI 10.1525/sp.1962.10.2.03a00040; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Logan Matthew William, 2016, CRIMINAL JUSTICE POL, V28, P814; Lunasco TK, 2010, MIL MED, V175, P509, DOI 10.7205/MILMED-D-09-00182; MAGUIRE KE, 1988, J QUANTITATIVE CRIMI, V4, P3; May D.C., 2017, CRIMINAL JUSTICE POL, V28, P770; McCormick-Goodhart Mark A, 2012, PENN STATE LAW REV, V125, P895; McCuish E. C., 2017, CRIME DELINQUENCY, P1; Mumola CJ., 2007, VETERANS STATE FEDER; Myers TA, 2011, COMMUN METHODS MEAS, V5, P297, DOI 10.1080/19312458.2011.624490; National Institute of Corrections, 2018, PRIS JAILS DORMS VET; Peyton J, 2004, PRISONER INTAKE SYST; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Pinals DA, 2010, J AM ACAD PSYCHIATRY, V38, P163; Prins SJ, 2014, PSYCHIAT SERV, V65, P862, DOI 10.1176/appi.ps.201300166; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Rogers W, 1993, STATA TECHNICAL B, V2; Sappington AA, 1996, INT J OFFENDER THER, V40, P54, DOI 10.1177/0306624X96401007; Sayers SL, 2009, J CLIN PSYCHIAT, V70, P163, DOI 10.4088/JCP.07m03863; Schaffer BJ, 2016, J EVID-INFORM SOC WO, V13, P293, DOI 10.1080/23761407.2015.1006945; Seamone ER, 2011, MIL LAW REV, V208, P1; Sreenivasan S, 2013, J AM ACAD PSYCHIATRY, V41, P263; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Sun IY, 2007, INT J OFFENDER THER, V51, P599, DOI 10.1177/0306624X07299225; Sykes G., 1958, SOC CAPTIVES STUDY M; Timko Christine, 2016, Justice Res Policy, V17, P123; Timko C, 2014, J OFFENDER REHABIL, V53, P620, DOI 10.1080/10509674.2014.956964; Tsai J, 2013, PSYCHIAT SERV, V64, P36, DOI [10.1176/appi.ps.201200188, 10.1176/appi.ps.001882012]; U. S. Department of Veterans Affairs, 2014, CLAIMS VA BEN CHAR D; U. S. Department of Veterans Affairs, 2017, 10448 IB US DEP VET; Van Dyke K, 2017, AM J CRIM JUSTICE, V42, P426, DOI 10.1007/s12103-016-9373-3; Van Voorhis P, 2010, CRIM JUSTICE BEHAV, V37, P261, DOI 10.1177/0093854809357442; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Webb RT, 2012, J INTERPERS VIOLENCE, V27, P3405, DOI 10.1177/0886260512445387; White M. D, 2013, PREVALENCE PROBLEM M; White MD, 2012, JUSTICE Q, V29, P258, DOI 10.1080/07418825.2011.560890; Wooldredge JD, 1999, CRIM JUSTICE BEHAV, V26, P235, DOI 10.1177/0093854899026002005	74	2	2	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1066-2316	1936-1351		AM J CRIM JUSTICE	Am. J. Crim. Just.	OCT	2019	44	5					746	769		10.1007/s12103-018-9458-2			24	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	IW4LV	WOS:000484952600004					2022-02-06	
J	Mouchtouris, N; Turpin, J; Chalouhi, N; Al Saiegh, F; Theofanis, T; Das, S; Shah, SO; Jallo, J				Mouchtouris, Nikolaos; Turpin, Justin; Chalouhi, Nohra; Al Saiegh, Fadi; Theofanis, Thana; Das, Somnath; Shah, Syed Omar; Jallo, Jack			Statewide Trends in Intracranial Pressure Monitor Use in 36,915 Patients with Severe Traumatic Brain Injury in a Mature Trauma System over the Past 18 Years	WORLD NEUROSURGERY			English	Article						Intracranial pressure monitoring; Neurocritical care; Trauma; Traumatic brain injury	MANAGEMENT; GUIDELINES; OUTCOMES; IMPACT; CARE	OBJECTIVE: Intracranial pressure (ICP)-guided therapy has been the mainstay of treatment of patients with severe traumatic brain injury (TBI), but recent data have questioned its efficacy. The aim of this study was to demonstrate trends in compliance to TBI guidelines and use of ICP-guided care in a mature trauma system. METHODS: A retrospective analysis was conducted of 36,915 patients with severe TBI collected by the Pennsylvania Trauma Systems Foundation. The registry includes all patients >18 years old with a diagnosis of TBI with a Glasgow Coma Scale score <= 8 who were admitted from January 2000 to December 2017. RESULTS: Of 36,915 patients, 73.6% were men with a median age of 43.0 +/- 21.3 years. An ICP monitor was placed in 16.3% of all patients. The rate of ICP monitoring ranged from 17.8% of patients in 2000-2004 to 16.7% in 2005-2009, 16.4% in 2010-2014, and 12.8% in 2015-2017 (P< 0.001). The most statistically significant decrease was noted from 2014 (16.4%) to 2015 (14.1%, P = 0.042). The percent decrease in ICP monitoring from 2000-2014 to 2015-2017 was equivalent for patients with Glasgow Coma Scale scores of 3-5 ( - 4.0%) and 6-8 ( - 4.5%). CONCLUSIONS: As studies emerged that demonstrated unclear benefit of ICP monitoring in improving care in patients with severe TBI, there was a significant statewide decline in the use of ICP monitoring after 2014 among all TBI subpopulations despite noteworthy limitations in the aforementioned studies and clear recommendations recommendations from the Brain Trauma Foundation guidelines.	[Mouchtouris, Nikolaos; Turpin, Justin; Chalouhi, Nohra; Al Saiegh, Fadi; Theofanis, Thana; Das, Somnath; Shah, Syed Omar; Jallo, Jack] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; [Mouchtouris, Nikolaos; Turpin, Justin; Chalouhi, Nohra; Al Saiegh, Fadi; Theofanis, Thana; Das, Somnath; Shah, Syed Omar; Jallo, Jack] Jefferson Hosp Neurosci, Philadelphia, PA USA		Jallo, J (corresponding author), Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA.	Jack.Jallo@jefferson.edu	; Shah, Syed/E-4083-2013	Mouchtouris, Nikolaos/0000-0001-9495-9391; Shah, Syed/0000-0003-4760-5229; Jallo, Jack/0000-0002-5512-1729			Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Alice P, 2017, INJURY, V48, P1944, DOI 10.1016/j.injury.2017.04.033; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2007.9991; Bullock MR, 1996, J NEUROTRAUM, V13, P643; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2014, TRAUM BRAIN INJ US F; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Khormi YH, 2018, J NEUROTRAUM, V35, P1407, DOI 10.1089/neu.2017.5345; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Sahuquillo J, 2006, Cochrane Database Syst Rev, pCD003983; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Suehiro E, 2017, J NEUROTRAUM, V34, P2230, DOI 10.1089/neu.2016.4948; Suehiro E, 2011, WORLD NEUROSURG, V75, P563, DOI 10.1016/j.wneu.2010.09.013; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255	25	2	2	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2019	130						E166	E171		10.1016/j.wneu.2019.06.025			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JB0MH	WOS:000488248200022	31203067				2022-02-06	
J	Nezu, AM; Nezu, CM; Gerber, HR				Nezu, Arthur M.; Nezu, Christine M.; Gerber, Holly R.			(Emotion-centered) problem-solving therapy: An update	AUSTRALIAN PSYCHOLOGIST			English	Article						cognitive and behavioural therapies; emotions; problem-solving therapy; psychotherapy; social problem solving; transdiagnostic	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; COLLABORATIVE CARE; OLDER-ADULTS; DEPRESSION; EFFICACY; CANCER; DISORDERS; OUTCOMES; PROGRAM	Problem-solving therapy (PST) is a psychosocial intervention, typically considered to be a member of the cognitive and behaviour therapies family, and is based on a biopsychosocial, diathesis-stress model of psychopathology. The overarching goal of this approach is to promote the successful adoption of adaptive problem-solving attitudes and the effective implementation of certain behaviours as a means of coping with life stressors in order to attenuate the negative effects of such events on physical and mental well-being. Over the past several decades, in addition to accumulating strong support for its efficacy as a clinical intervention, similar to many other forms of psychotherapy, PST has undergone various evolutionary changes. Developed primarily as a more cognitive-based approach, due to the large body of literature in the field of affective neuroscience that underscores the importance of the impact of affect on problem solving, PST has evolved into emotion-centered problem-solving therapy (EC-PST). This article provides for a brief excursion into the historical roots of PST and why it has evolved into EC-PST, as well as providing support for its characterisation as a transdiagnostic approach. In addition, several meta-analyses that underscore its efficacy are described, as well as the most recent clinical guidelines that comprise EC-PST.	[Nezu, Arthur M.; Nezu, Christine M.; Gerber, Holly R.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA		Nezu, AM (corresponding author), Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA.	artnezu@comcast.net					Alexopoulos GS, 2016, AM J GERIAT PSYCHIAT, V24, P50, DOI 10.1016/j.jagp.2015.02.007; Arean PA, 2005, MED CARE, V43, P381; Bandura A., 1969, PRINCIPLES BEHAV MOD; Bell AC, 2009, CLIN PSYCHOL REV, V29, P348, DOI 10.1016/j.cpr.2009.02.003; Bell KR, 2017, J NEUROTRAUM, V34, P313, DOI 10.1089/neu.2016.4444; Berry JW, 2012, REHABIL PSYCHOL, V57, P98, DOI 10.1037/a0028229; Cape J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-38; Choi NG, 2014, DEPRESS ANXIETY, V31, P653, DOI 10.1002/da.22242; Cuijpers P, 2007, EUR PSYCHIAT, V22, P9, DOI 10.1016/j.eurpsy.2006.11.001; Cuijpers P, 2018, EUR PSYCHIAT, V48, P27, DOI 10.1016/j.eurpsy.2017.11.006; D'Zurilla T.J., 1999, PROBLEM SOLVING THER, V2nd edn; D'Zurilla TJ., 1982, ADV COGNITIVE BEHAV, P201, DOI [10.1016/B978-0-12-010601-1.50010-3, DOI 10.1016/B978-0-12-010601-1.50010-3]; D'Zurilla TJ, 2002, MANUAL SOCIAL PROBLE; D'Zurilla TJ., 2013, PROBLEM SOLVING THER; Damasio A., 1999, FEELING WHAT HAPPENS; Dreer LE, 2016, CURR EYE RES, V41, P50, DOI 10.3109/02713683.2014.1002045; Dwight-Johnson M, 2005, PSYCHOSOMATICS, V46, P224, DOI 10.1176/appi.psy.46.3.224; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Ell K, 2008, J CLIN ONCOL, V26, P4488, DOI 10.1200/JCO.2008.16.6371; Erdley SD, 2014, CLIN NEPHROL, V82, P26, DOI 10.5414/CN108196; Gellis ZD, 2014, J AM GERIATR SOC, V62, P889, DOI 10.1111/jgs.12776; GLADWIN T, 1967, PSYCHIATR, V30, P30, DOI 10.1080/00332747.1967.11023490; Greenwood JD, 1999, J HIST BEHAV SCI, V35, P1, DOI 10.1002/(SICI)1520-6696(199924)35:1<1::AID-JHBS1>3.0.CO;2-4; Gustavson KA, 2016, AM J GERIAT PSYCHIAT, V24, P11, DOI 10.1016/j.jagp.2015.07.010; Hadidi NN, 2015, REHABIL NURS, V40, P327, DOI 10.1002/rnj.148; Harpole LH, 2005, GEN HOSP PSYCHIAT, V27, P4, DOI 10.1016/j.genhosppsych.2004.09.004; Hatcher S, 2011, BRIT J PSYCHIAT, V199, P310, DOI 10.1192/bjp.bp.110.090126; Hirai K, 2012, JPN J CLIN ONCOL, V42, P1168, DOI 10.1093/jjco/hys158; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; Kendall PC, 1979, COGNITIVE BEHAV INTE; Kiosses Dimitris N, 2014, Curr Treat Options Psychiatry, V1, P15; Kirkham JG, 2016, INT J GERIATR PSYCH, V31, P526, DOI 10.1002/gps.4358; Korb A., 2015, UPWARD SPIRAL USING; Lai VT, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00243; Lakerveld J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-47; Langdon PE, 2013, J APPL RES INTELLECT, V26, P167, DOI 10.1111/jar.12004; Linde K, 2015, ANN FAM MED, V13, P56, DOI 10.1370/afm.1719; MAHONEY MJ, 1977, AM PSYCHOL, V32, P5, DOI 10.1037/0003-066X.32.1.5; Malouff JM, 2007, CLIN PSYCHOL REV, V27, P46, DOI 10.1016/j.cpr.2005.12.005; Nezu A. M., 2019, EMOTION CTR PROBLEM; Nezu A.M., 2017, MILITARY BEHAV HLTH, V5, P417; Nezu A.M., 2006, PROMOTING TREATMENT, P135; Nezu AM, 2003, J CONSULT CLIN PSYCH, V71, P1036, DOI 10.1037/0022-006X.71.6.1036; NEZU AM, 1986, J CONSULT CLIN PSYCH, V54, P196, DOI 10.1037/0022-006X.54.2.196; NEZU AM, 1989, J CONSULT CLIN PSYCH, V57, P408, DOI 10.1037/0022-006X.57.3.408; Nieuwsma JA, 2012, INT J PSYCHIAT MED, V43, P129, DOI 10.2190/PM.43.2.c; Okon-Singer H, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00058; Pech M, 2013, SLEEP, V36, P739, DOI 10.5665/sleep.2640; Reynolds CF, 2014, PSYCHIAT SERV, V65, P765, DOI 10.1176/appi.ps.201300216; Rovner BW, 2013, OPHTHALMOLOGY, V120, P1649, DOI 10.1016/j.ophtha.2013.01.022; Sandoval LR, 2017, BEHAV THER, V48, P413, DOI 10.1016/j.beth.2016.04.001; Simon SS, 2015, INT J GERIATR PSYCH, V30, P223, DOI 10.1002/gps.4239; Tenhula WN, 2014, PROF PSYCHOL-RES PR, V45, P416, DOI 10.1037/a0037150; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Vuletic S, 2016, J HEAD TRAUMA REHAB, V31, P147, DOI 10.1097/HTR.0000000000000221; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Waldman MarkRobert., 2009, GOD CHANGES YOUR BRA; Zhang AA, 2018, J AM BOARD FAM MED, V31, P139, DOI 10.3122/jabfm.2018.01.170270	58	2	2	3	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	OCT	2019	54	5					361	371		10.1111/ap.12418			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	IW9DZ	WOS:000485294900001					2022-02-06	
J	O'Neil, J; Egan, M; Marshall, S; Bilodeau, M; Pelletier, L; Sveistrup, H				O'Neil, Jennifer; Egan, Mary; Marshall, Shawn; Bilodeau, Martin; Pelletier, Luc; Sveistrup, Heidi			Remotely Supervised Home-Based Intensive Exercise Intervention to Improve Balance, Functional Mobility, and Physical Activity in Survivors of Moderate or Severe Traumatic Brain Injury: Protocol for a Mixed Methods Study	JMIR RESEARCH PROTOCOLS			English	Article						telerehabilitation; physical activity; traumatic brain injury; home-based exercises; accessibility	RANDOMIZED CONTROLLED-TRIAL; SINGLE-SUBJECT RESEARCH; POSTURAL CONTROL; TELEREHABILITATION; SCALE; REHABILITATION; PEOPLE; STROKE; SATISFACTION; INDIVIDUALS	Background: Traumatic brain injury (TBI) may impact an individual physically, cognitively, socially, and emotionally. Poor balance, reduced mobility, and low daily physical activity often will require ongoing physical rehabilitation intervention. However, face-to-face specialized physiotherapy is not always accessible for individuals living in rural settings. Objective: We will answer four questions: (1) What is the feasibility of a remotely supervised, home-based, intensive exercise intervention with survivors of moderate and severe TBI? (2) Does the frequency of remote supervision have an impact on the feasibility of completing a home based intensive exercise program? (3) Does the frequency of remote supervision impact balance, functional mobility, and physical activity? (4) What is the lived experience of remote supervision for both survivors and caregivers? Methods: Four participants will complete two intensive, 4-week (five days per week) home-based exercise interventions remotely supervised via synchronous videoconference. Each exercise intervention will have a goal of 160 to 300 repetitions or 60 minutes of tailored exercises to promote neuroplasticity and be defined as an intensive home-based exercise intervention. An alternating single-subject design will allow for the comparison between two frequencies of remote supervision, once weekly and five times weekly. Daily repeated outcome measures, pre- and postintervention outcome measures, and 1-month follow-up outcome measures will be collected to explore the effect on feasibility and physical variables. Daily outcome measures include step count and Five Times Sit-to-Stand test. Pre-post measures include assessment of quiet stance and the Community Balance and Mobility Scale. A semistructured interview will be completed at the end of each intervention segment to document the lived experience of both survivors and their study partners. Finally, five questionnaires will be used to understand the overall experience: the Mayo-Portland Adaptability Inventory-4 Participation Index, Satisfaction With Life Scale, Fall Efficacy Scale-International, Interpersonal Behavior Questionnaire, and System Usability Scale. Data will be analyzed following traditional single-subject methods of analysis. Results: Ethics approval was received from both the Bruyere Research Institute and University of Ottawa review boards in March 2019. Recruitment is underway. Conclusions: The proposed intervention is complex in nature due to the involvement of multiple technology sources and the inclusion of a complex dyad (survivors and caregivers) in a community setting. This type of research is timely given that alternative methods of physical intervention delivery are needed to facilitate gains in balance, mobility, physical activity among TBI survivors with limited access to clinical care, and the quality of the patients' experience.	[O'Neil, Jennifer; Egan, Mary; Bilodeau, Martin; Sveistrup, Heidi] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada; [O'Neil, Jennifer; Egan, Mary; Marshall, Shawn; Bilodeau, Martin; Sveistrup, Heidi] Bruyere Res Inst, Ottawa, ON, Canada; [Marshall, Shawn] Univ Ottawa, Fac Med, Phys Med & Rehabil, Ottawa, ON, Canada; [Pelletier, Luc] Univ Ottawa, Fac Social Sci, Sch Psychol, Ottawa, ON, Canada		O'Neil, J (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	joneil@uottawa.ca	Bilodeau, Martin/L-8588-2014	Bilodeau, Martin/0000-0002-8464-8837; Marshall, Shawn/0000-0002-0893-6159; Egan, Mary/0000-0003-0149-958X	University of Ottawa; Bruyere Research Institute; Canadian Institute for Military and Veteran Health Research; True Patriot Love	Financial support was received from an Admission Scholarship at University of Ottawa for 2016-2020, a Graduate Studentship Program at the Bruyere Research Institute and a project research Grant from the Canadian Institute for Military and Veteran Health Research and True Patriot Love.	Backman CL, 1997, ARCH PHYS MED REHAB, V78, P1145, DOI 10.1016/S0003-9993(97)90142-8; Bath B, 2015, PHYSIOTHER CAN, V67, P221, DOI 10.3138/ptc.2014-53; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Brooke J., 1996, USABILITY EVALUATION, P189, DOI DOI 10.1002/HBM.20701; Brossart DF, 2006, BEHAV MODIF, V30, P531, DOI 10.1177/0145445503261167; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Canning CG, 2003, CLIN REHABIL, V17, P355, DOI 10.1191/0269215503cr620oa; Castleberry A, 2018, CURR PHARM TEACH LEA, V10, P807, DOI 10.1016/j.cptl.2018.03.019; Charrette AL, 2016, BRAIN INJURY, V30, P1213, DOI 10.1080/02699052.2016.1187766; Cherney LR, 2011, PERSPECT NEUROPHYSIO, V21, P83, DOI DOI 10.1044/NNSLD21.3.83; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Delbaere K, 2010, AGE AGEING, V39, P210, DOI 10.1093/ageing/afp225; Devine JM, 2016, ARCH PHYS MED REHAB, V97, P1392, DOI 10.1016/j.apmr.2016.04.015; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Fritz NE, 2013, J NEUROL PHYS THER, V37, P37, DOI 10.1097/NPT.0b013e318282a20d; Gage N. A., 2012, J SPEC EDUC, V48, P3, DOI DOI 10.1177/0022466912443894]; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Hawkins J, 2019, J MED INTERNET RES, V21, DOI 10.2196/12374; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Huijgen BCH, 2008, J TELEMED TELECARE, V14, P249, DOI 10.1258/jtt.2008.080104; Hwang R, 2015, J CARDIOPULM REHABIL, V35, P380, DOI 10.1097/HCR.0000000000000121; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Ivankova NV, 2006, FIELD METHOD, V18, P3, DOI 10.1177/1525822X05282260; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kimberley TJ, 2010, J REHABIL RES DEV, V47, P851, DOI 10.1682/JRRD.2010.02.0019; Klassen TD, 2016, PHYS THER, V96, P355, DOI 10.2522/ptj.20140611; Kratochwill T. R., 2010, WHAT WORKS CLEARINGH; Lacroix A, 2017, SPORTS MED, V47, P2341, DOI 10.1007/s40279-017-0747-6; Lin KH, 2014, SENSORS-BASEL, V14, P12451, DOI 10.3390/s140712451; Lorenz LS, 2018, DISABIL HEALTH J, V11, P70, DOI 10.1016/j.dhjo.2017.08.005; Mack N., 2005, QUALITATIVE RES METH; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; McKechnie D, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000146; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mong YQ, 2010, ARCH PHYS MED REHAB, V91, P407, DOI 10.1016/j.apmr.2009.10.030; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; O'Connor SM, 2016, J BIOMECH, V49, P4142, DOI 10.1016/j.jbiomech.2016.10.020; Olive ML., 2005, ED PSYCHOL, V25, P313, DOI [10.1080/0144341042000301238, DOI 10.1080/0144341042000301238]; Gutierrez RO, 2013, NEUROREHABILITATION, V33, P545, DOI 10.3233/NRE-130995; OTTENBACHER KJ, 1986, AM J OCCUP THER, V40, P464, DOI 10.5014/ajot.40.7.464; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Portney LG, 2015, FDN CLIN RES APPL PR; Rocchi M, 2018, SPORT EXERC PERFORM, V7, P141, DOI 10.1037/spy0000116; Rocchi M, 2017, PERS INDIV DIFFER, V104, P423, DOI 10.1016/j.paid.2016.08.034; Schulz-Heik RJ, 2017, BRAIN INJURY, V31, P1287, DOI 10.1080/02699052.2017.1307449; Schulz-Heik RJ, 2016, BRAIN INJURY, V30, P271, DOI 10.3109/02699052.2015.1113567; Tate RL, 2016, CAN J OCCUP THER, V83, P184, DOI 10.1177/0008417416648124; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Tiwari D, 2018, PHYSIOTHER THEOR PR, V34, P137, DOI 10.1080/09593985.2017.1370750; Ustinova KI, 2015, PHYSIOTHER THEOR PR, V31, P1, DOI 10.3109/09593985.2014.945674; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196; Zhan S, 2001, DISABIL REHABIL, V23, P1, DOI 10.1080/09638280150211202	58	2	2	4	9	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	OCT	2019	8	10							e14867	10.2196/14867			12	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	JJ2OQ	WOS:000494002200014	31599733	Green Published, gold			2022-02-06	
J	Oyemolade, TA; Malomo, TA; Adeleye, AO				Oyemolade, Toyin A.; Malomo, Toluyemi A.; Adeleye, Amos O.			Indiscriminate Use of Antibiotics in Neurotrauma Patients Referred for Expert Neurosurgical Care in a Developing Country	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						neurotrauma; antibiotic stewardship; pre-neurosurgical care; developing countries	HEAD-INJURY	Background In Nigeria, pre-neurosurgical care of most neurotrauma patients usually involves administration of many empirical agents including antibiotics with no apparent indications. This practice is fraught with two particular dangers: increase in health care costs and development of drug resistance. This study aimed to interrogate antibiotic stewardship in the pre-neurosurgical care of neurotrauma patients referred to our practice. Materials and Methods This 7-month prospective descriptive study was performed in one University Teaching Hospital of a developing country. Clinical data on all admitted neurotrauma patients with information on the pre-neurosurgical treatment received were captured and analyzed. Results There were 113 patients, 87(77.0%) males; 103(91.2%) had head injury, and 10(8.8%) spinal cord injury. Associated systemic injuries occurred in 47(41.6%): 40 involved skeletal and soft tissue systems, and 12(10.6%) presented with aspiration pneumonitis. These patients were referrals from public health facilities including primary health facilities (PHF), secondary (SHF), and tertiary (THF), as well as private clinics (PC). Antibiotics were given to 74 (65.5%) patients, with a probabilistic indication in only 17.6% (13/74) of these. The proportional distribution of this antibiotic administration according to the referral base was not statistically significant (chi (2) =6.87, p = 0.3): 70% (14/20) from PHF, 56% (14/25) from SHF, 71% (23/32) from THF, and 63% (23/36) from PC. The antimicrobial agent administered was specified in 40 cases: Ceftriaxone was the commonest antibiotic agent implicated. Conclusion There is apparent unnecessary exposure of patients to antibiotics in the pre-neurosurgical care of neurotrauma in this study. There is, therefore, need for education on antibiotic stewardship to the group of health workers involved.	[Oyemolade, Toyin A.; Malomo, Toluyemi A.; Adeleye, Amos O.] Univ Coll Hosp, Dept Neurol Surg, Ibadan, Nigeria; [Adeleye, Amos O.] Univ Ibadan, Dept Surg, Div Neurol Surg, Coll Med, Ibadan, Nigeria; [Adeleye, Amos O.] UCH, Ibadan, Nigeria		Adeleye, AO (corresponding author), Univ Coll Hosp, Dept Neurol Surg, Ibadan, Nigeria.	femdoy@yahoo.com					Adeleye A O, 2017, Ann Ib Postgrad Med, V15, P34; Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; Adeleye AO, 2011, INDIAN J NEUROTRAUM, V8, P1; Blaser M J, 2014, HDB CLIN NEUROLOGY; Chazan B, 2007, ISR MED ASSOC J, V9, P16; DUNN LT, 1994, ANN ROY COLL SURG, V76, P147; Fry DE, 2016, SURG INFECT, V17, P623, DOI 10.1089/sur.2016.29007.df; Goossens H., 2008, Eurosurveillance, V13, P19036; Katsios CM, 2012, CRIT CARE, V16, DOI 10.1186/cc11854; Kiang KM, 2005, EMERG INFECT DIS, V11, P904, DOI 10.3201/eid1106.05144; Sartelli M, 2017, SURG INFECT, V18, P846, DOI 10.1089/sur.2017.219; Sartelli M, 2016, SURG INFECT, V17, P625, DOI 10.1089/sur.2016.187; Sawyer RG, 2015, NEW ENGL J MED, V372, P1996, DOI 10.1056/NEJMoa1411162; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Xin JN, 2016, ACS SUSTAIN CHEM ENG, V4, P2754, DOI 10.1021/acssuschemeng.6b00256	15	2	2	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	OCT	2019	10	4					653	656		10.1055/s-0039-3399591			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	JV4II	WOS:000502328400016	31831986	Green Published, gold			2022-02-06	
J	Unnerback, M; Ottesen, JT; Reinstrup, P				Unnerback, Marten; Ottesen, Johnny T.; Reinstrup, Peter			Increased Intracranial Pressure Attenuates the Pulsating Component of Cerebral Venous Outflow	NEUROCRITICAL CARE			English	Article						Cerebral blood flow measurement; Cerebral hemodynamics; PC-MRI; Jugular veins; Intracranial pressure	TRAUMATIC BRAIN-INJURY; PHASE-CONTRAST MRI; CEREBROSPINAL-FLUID; BLOOD-FLOW; PERFUSION-PRESSURE; MAGNETIC-RESONANCE; ARTERIAL; PULSE; ICP; HEMODYNAMICS	Background The underlying physiology of the intracranial pressure (ICP) curve morphology is still poorly understood. If this physiology is explained it could be possible to extract clinically relevant information from the ICP curve. The venous outflow from the cranial cavity is pulsatile, and in theory the pulsatile component of venous outflow from the cranial cavity should be attenuated with increasing ICP. In this study, we explored the relationship between ICP and the pulsatility of the venous outflow from the intracranial cavity. Methods Thirty-seven neuro-intensive care patients that had been examined with phase-contrast magnetic resonance imaging regarding cerebral blood flow (CBF) through the internal carotid and vertebral arteries and venous flow in the internal jugular veins were retrospectively included. The pulsatility of the jugular flow was determined by calculating the venous pulsatile index. The results were correlated to clinical data registered in the patient data monitoring system, including ICP and cerebral perfusion pressure (CPP). Results CBF was 996 +/- 298 ml/min, and the flow in the internal jugular veins equaled 67 +/- 17% of the CBF, with a range of 22-97%. The venous pulsatile index correlated negatively to ICP (R = - 0.47 p = 0.003). The lowest flow in the internal jugular veins over the cardiac cycle (F-min) was not correlated to ICP. Temperature, end-tidal CO2, MAP, and CPP were not correlated to venous pulsatility. Conclusion An increase in ICP correlates to a lower pulsatility of the venous outflow from the cranial cavity. A lower pulsatility could be due to increased pressure requirements to compress intracranial veins with increasing ICP.	[Unnerback, Marten] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Intens Care & Perioperat Med, Malmo, Sweden; [Ottesen, Johnny T.] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark; [Reinstrup, Peter] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Dept Neurosurg, Lund, Sweden; [Unnerback, Marten] IPV SUS Malmo, Inga Marie Nilssons Gata 47, S-20502 Malmo, Sweden		Unnerback, M (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Intens Care & Perioperat Med, Malmo, Sweden.; Unnerback, M (corresponding author), IPV SUS Malmo, Inga Marie Nilssons Gata 47, S-20502 Malmo, Sweden.	Marten.Unnerback@med.lu.se	Unnerback, Marten/AAX-4210-2021		Department of Intensive and Perioperative Care, Skane University Hospital; Swedish National Training and Research Fund, Region Skane [48451]	The study received financial support from the Department of Intensive and Perioperative Care, Skane University Hospital and the Swedish National Training and Research Fund, Region Skane, Grant No 48451.	Alperin N, 2005, J MAGN RESON IMAGING, V22, P591, DOI 10.1002/jmri.20427; Alperin N, 1996, MAGNET RESON MED, V35, P741, DOI 10.1002/mrm.1910350516; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Baledent O, 2001, INVEST RADIOL, V36, P368, DOI 10.1097/00004424-200107000-00003; Baledent O, 2018, ACTA NEUROCHIR, V160, P225, DOI 10.1007/s00701-017-3436-1; BERING EA, 1955, ARCH NEURO PSYCHIATR, V73, P165, DOI 10.1001/archneurpsyc.1955.02330080043012; BRYANT DJ, 1984, J COMPUT ASSIST TOMO, V8, P588, DOI 10.1097/00004728-198408000-00002; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; Daouk J, 2017, ACTA RADIOL, V58, P977, DOI 10.1177/0284185116676655; Doepp F, 2004, NEURORADIOLOGY, V46, P565, DOI 10.1007/s00234-004-1213-3; DUNBAR HS, 1966, ARCH NEUROL-CHICAGO, V14, P624, DOI 10.1001/archneur.1966.00470120056009; ElSankari S, 2013, J CEREBR BLOOD F MET, V33, P1314, DOI 10.1038/jcbfm.2013.95; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; GREITZ D, 1992, NEURORADIOLOGY, V34, P370, DOI 10.1007/BF00596493; HAMIT H F, 1965, J Trauma, V5, P174, DOI 10.1097/00005373-196503000-00005; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Lagana MM, 2017, BIOMED SIGNAL PROCES, V36, P84, DOI 10.1016/j.bspc.2017.03.019; MARKS MP, 1992, RADIOLOGY, V182, P467, DOI 10.1148/radiology.182.2.1732966; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Schoser BGH, 1999, J NEUROSURG, V91, P744, DOI 10.3171/jns.1999.91.5.0744; Schulz-Stubner S, 2006, EUR J ANAESTH, V23, P177, DOI 10.1017/S0265021505232118; Slater AJ, 1997, AM J PHYSIOL-HEART C, V273, pH380, DOI 10.1152/ajpheart.1997.273.1.H380; Spilt A, 2002, J MAGN RESON IMAGING, V16, P1, DOI 10.1002/jmri.10133; Stoquart-ElSankari S, 2009, J CEREBR BLOOD F MET, V29, P1208, DOI [10.1038/jcbfm.2009.29, 10.1038/sj.jcbfm.jcbfm200929]; Unnerback M, 2018, ACTA NEUROCHIR, V160, P219, DOI 10.1007/s00701-017-3435-2; Unnerback M, 2019, J CLIN MONIT COMPUT, V33, P77, DOI 10.1007/s10877-018-0129-0; WHITE DN, 1979, J NEUROL SCI, V42, P11, DOI 10.1016/0022-510X(79)90150-3; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Zarrinkoob L, 2015, J CEREBR BLOOD F MET, V35, P648, DOI 10.1038/jcbfm.2014.241	31	2	2	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2019	31	2					273	279		10.1007/s12028-019-00733-4			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JA0OX	WOS:000487511700008	31240621	hybrid, Green Published			2022-02-06	
J	Reif, S; Adams, RS; Ritter, GA; Larson, MJ				Reif, Sharon; Adams, Rachel Sayko; Ritter, Grant A.; Larson, Mary Jo			Exploration of the association of selected pain diagnoses with risky alcohol use among active duty soldiers	SUBSTANCE ABUSE			English	Article						Military personnel; pain; alcohol drinking; alcohol-related disorders	POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE USE; AUDIT-C; PRIMARY-CARE; SEPTEMBER 11; COMBAT; CONSUMPTION; SERVICE; DEPLOYMENT; FREQUENCY	Background: Pain and its consequences remain of concern, particularly in high-risk occupations such as the military. Alcohol is a legal and accessible means of self-medication, and risky alcohol use is associated with potentially serious consequences. This exploratory analysis aimed to better understand the association of selected pain diagnoses with risky alcohol use among soldiers returning from deployment. Methods: Analysis of data from active duty soldiers returning from Afghanistan or Iraq deployments in fiscal years 2008?2011 who completed Department of Defense health questionnaires after deployment (n?=?267,100). Each questionnaire included self-reported alcohol consumption and items yielding AUDIT-C screening scores. Military Health System data were used to identify diagnoses of pain-related conditions. Results: About 70% of soldiers had none of the selected pain diagnoses either pre- or post-deployment. 10% had incident pain diagnoses (only post-deployment), 7% had persistent pain diagnoses (both pre- and post-deployment), and 13% had remitted pain diagnoses (only pre-deployment). On the AUDIT-C, 39% screened positive for at-risk drinking and 6% were likely to have severe alcohol problems. Half of the respondents reported any binge drinking; 20% at least monthly binge drinking. Logistic regression analyses found reduced odds of risky alcohol use post-deployment in association with incident and persistent pain diagnoses, compared to no pain diagnoses pre- or post-deployment. Conclusions: Pain diagnoses, binge drinking, and risky alcohol use were prevalent among this sample of Army soldiers. An inverse relationship was found between pain diagnosis (incident, persistent) and risky alcohol use post-deployment. Attention should continue to be paid to risky alcohol use in this population, yet these exploratory findings do not suggest that soldiers with the pain diagnoses used in this study are at greater risk. Combat exposure, traumatic brain injury, and psychological health were more important predictors, and should continue to warrant enhanced alcohol screening.	[Reif, Sharon; Adams, Rachel Sayko; Ritter, Grant A.; Larson, Mary Jo] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St, Waltham, MA 02453 USA		Reif, S (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St, Waltham, MA 02453 USA.	reif@brandeis.edu	Adams, Rachel/AAH-4653-2020		National Center for Complementary and Integrative Health [NCCIH] [R01 AT008404]; National Institute on Drug Abuse [NIDA]United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA030150]	This study was funded by the National Center for Complementary and Integrative Health [NCCIH; R01 AT008404], with support to develop the study cohort from the National Institute on Drug Abuse [NIDA; R01 DA030150]. The funding agencies had no role in study design, data collection, analysis or interpretation of data, writing or review of the manuscript, or decision to submit the manuscript for publication.	Adams RS, 2017, J NEUROTRAUM, V34, P1457, DOI 10.1089/neu.2016.4693; Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bradley Katharine A, 2007, Subst Abus, V28, P133, DOI 10.1300/J465v28n04_05; Bray R, 2009, DEP DEFENSE SURVEY H; Bray R. M., 2008, MIL MED, V175, P390, DOI DOI 10.7205/MILMED-D09-00132; Breslow RA, 2008, ALCOHOL CLIN EXP RES, V32, P513, DOI 10.1111/j.1530-0277.2007.00595.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Calhoun PS, 2010, PSYCHIAT RES, V178, P330, DOI 10.1016/j.psychres.2009.11.009; Crawford EF, 2013, DRUG ALCOHOL DEPEN, V132, P101, DOI 10.1016/j.drugalcdep.2013.01.012; Davis AK, 2018, ADDICT BEHAV, V77, P166, DOI 10.1016/j.addbeh.2017.10.007; Department of Defense, 2018, DOD INSTR 1332 45 RE; Gauntlett-Gilbert J, 2013, BRIT J PAIN, V7, P79, DOI 10.1177/2049463713482082; Goebel JR, 2011, J PAIN SYMPTOM MANAG, V41, P848, DOI 10.1016/j.jpainsymman.2010.07.009; Guo HR, 1999, AM J PUBLIC HEALTH, V89, P1029, DOI 10.2105/AJPH.89.7.1029; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Institute of Medicine, 2013, SUBST US DIS US ARM; Jakubczyk A, 2016, DRUG ALCOHOL DEPEN, V158, P167, DOI 10.1016/j.drugalcdep.2015.11.020; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Larson MJ, 2012, J SOC WORK PRACT ADD, V12, P6, DOI 10.1080/1533256X.2012.647586; Larson MJ, 2007, ADDICTION, V102, P752, DOI 10.1111/j.1360-0443.2007.01759.x; Larson MJ, 2016, MIL MED, V181, P334, DOI 10.7205/MILMED-D-15-00110; Larson MJ, 2014, AM J PUBLIC HEALTH, V104, P1402, DOI 10.2105/AJPH.2014.301901; Larson MJ, 2013, SUBST USE MISUSE, V48, P863, DOI 10.3109/10826084.2013.794840; Moskal D, 2018, EXP CLIN PSYCHOPHARM, V26, P65, DOI 10.1037/pha0000170; Office of The Army Surgeon General, 2010, PAIN MAN TASK FORC P; Prins A, 2004, PRIMARY CARE PSYCHIA, V9, P151, DOI 10.1185/135525703125002360; Reif S, 2018, MIL MED, V183, pE330, DOI 10.1093/milmed/usx200; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Spera C, 2011, J STUD ALCOHOL DRUGS, V72, P5, DOI 10.15288/jsad.2011.72.5; Stahre M, 2006, ADDICTION, V101, P1711, DOI 10.1111/j.1360-0443.2006.01615.x; Witkiewitz K, 2018, ALCOHOL CLIN EXP RES, V42, P478, DOI 10.1111/acer.13594; Witkiewitz K, 2015, ADDICTION, V110, P1262, DOI 10.1111/add.12964; Zale EL, 2015, CLIN PSYCHOL REV, V37, P57, DOI 10.1016/j.cpr.2015.02.005	36	2	2	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0889-7077	1547-0164		SUBST ABUS	Subst. Abus.	OCT 1	2020	41	4					456	462		10.1080/08897077.2019.1671944		SEP 2019	7	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse	PD4KV	WOS:000494213600001	31638881	Green Accepted			2022-02-06	
J	Neal, J; Strothkamp, S; Bedingar, E; Cordaro, P; Wagner, B; Vagnini, V; Jiang, Y				Neal, Jennifer; Strothkamp, Stephanie; Bedingar, Esias; Cordaro, Patrick; Wagner, Benjamin; Vagnini, Victoria; Jiang, Yang			Discriminating Fake From True Brain Injury Using Latency of Left Frontal Neural Responses During Old/New Memory Recognition	FRONTIERS IN NEUROSCIENCE			English	Article						malinger; event-related potentials; EEG; traumatic brain injury; P3; late positive component; fractional peak latency		Traumatic brain injury (TBI) is a major public health concern that affects 69 million individuals each year worldwide. Neuropsychologists report that up to 40% of individuals undergoing evaluations for TBI may be malingering neurocognitive deficits for a compensatory reward. The memory recognition test of malingering detection is effective but can be coached behaviorally. There is great need to develop a novel neural based method for discriminating fake from true brain injury. Here we test the hypothesis that decision making of faking memory deficits prolongs frontal neural responses. We applied an advanced method measuring decision latency in milliseconds for discriminating true TBI from malingerers who fake brain injury. To test this hypothesis, latencies of memory-related brain potentials were compared among true patients with moderate or severe TBI, and healthy age-matched individuals who were assigned either to be honest or faking memory deficit. Scalp signals of electroencephalography (EEG) were recorded with a 32-channel cap during an Old/New memory recognition task in three age- and education-matched groups: honest (n = 12), malingering (n = 15), and brain injured (n = 14) individuals. Bilateral fractional latencies of late positive ERP at frontal sites were compared among the three groups under both studied (Old) and non-studied (New) memory recognition conditions. Results show a significant difference between the fractional latencies of the late positive component during recognition of studied items in malingerers (averaged latencies = 396 ms) and the true brain injured subjects (mean = 312 ms) in the frontal sites. Only malingers showed asymmetrical frontal activity compared to the two other groups. These new findings support the hypothesis that that additional frontal processing of malingering individuals is measurably different from those of actual patients with brain injury. In contrast to our previous reported method using difference waves of amplitudes at frontal to posterior midline sites during new items recognition (Vagnini et al., 2008), there was no significant latency difference among groups during recognition of New items. The current method using delayed left frontal neural responses during studied items reached sensitivity of 80% and specificity of 79% in detecting malingers from true brain injury.	[Neal, Jennifer; Strothkamp, Stephanie; Bedingar, Esias; Cordaro, Patrick; Wagner, Benjamin; Vagnini, Victoria; Jiang, Yang] Univ Kentucky, Coll Med, Dept Behav Sci, Lexington, KY 40536 USA; [Bedingar, Esias] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Vagnini, Victoria] Louisville VA Med Ctr, Louisville, KY USA		Jiang, Y (corresponding author), Univ Kentucky, Coll Med, Dept Behav Sci, Lexington, KY 40536 USA.	yjiang@uky.edu			Henry M. Jackson Foundation; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1R56AG060608]	This work was supported in part by the grant funding from the Henry M. Jackson Foundation and the National Institute on Aging to YJ (1R56AG060608).	Bachiller A, 2015, SCHIZOPHR RES, V169, P318, DOI 10.1016/j.schres.2015.09.028; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Finnigan S, 2002, NEUROPSYCHOLOGIA, V40, P2288, DOI 10.1016/S0028-3932(02)00113-6; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Gerberding JLBS, 2003, REP C MILD TRAUM BRA; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Heaver B, 2011, MEMORY, V19, P398, DOI 10.1080/09658211.2011.575788; Hoover S, 2014, INT J PSYCHOPHYSIOL, V91, P139, DOI 10.1016/j.ijpsycho.2013.12.009; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Levada OV, 2016, NEUROPHYSIOLOGY+, V48, P414, DOI 10.1007/s11062-017-9618-x; Li J, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-016-0229-3; Liu ZL, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.593; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; McBride JW, 2011, ELECTR CONTACT; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nandrajog Puneet, 2017, Asian J Neurosurg, V12, P447, DOI 10.4103/1793-5482.180921; Patel Salil H, 2005, Int J Med Sci, V2, P147; PETRIDES M, 1995, J NEUROSCI, V15, P359; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ramchurn A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00557; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; Sehatpour P, 2008, P NATL ACAD SCI USA, V105, P4399, DOI 10.1073/pnas.0708418105; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vagnini VL, 2008, J CLIN EXP NEUROPSYC, V30, P766, DOI 10.1080/13803390701754746; Vallabhajosula B., 2015, MURDER COURTROOM COG; Weiss Kenneth J, 2017, J Am Acad Psychiatry Law, V45, P339	31	2	2	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	SEP 25	2019	13								988	10.3389/fnins.2019.00988			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA1ZI	WOS:000487616400001	31611760	gold, Green Published			2022-02-06	
J	Boccia, M; Bonavita, A; Diana, S; Di Vita, A; Ciurli, MP; Guariglia, C				Boccia, Maddalena; Bonavita, Alessia; Diana, Sofia; Di Vita, Antonella; Ciurli, Maria Paola; Guariglia, Cecilia			Topographical Disorientation: Clinical and Theoretical Significance of Long-Lasting Improvements Following Imagery-Based Training	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						acquired topographical disorientation; brain damage; spatial navigation; topographical memory; episodic memory	FMRI ACTIVITY REVEAL; SPATIAL NAVIGATION; MENTAL-IMAGERY; BRAIN-REGIONS; MEMORY; DIRECTION; REHABILITATION; MAP; NEUROPSYCHOLOGY; PERFORMANCE	Neuropsychological studies on acquired topographical disorientation have provided useful insights into the contribution of different brain regions to human navigation. However, little is known about the possibility to restore navigational skills after brain damage. Here we describe the case of No Longer Lost (NLL), a 49-year-old man who complained of severe topographical disorientation following traumatic brain injury. Extensive neuropsychological evaluation at baseline revealed selective episodic memory deficits and topographical disorientation. NLL underwent 8-week imagery-based treatment (IBT) inspired by current cognitive models of human spatial navigation. After IBT, NLL improved topographical skills and episodic memory. From a clinical point of view, the present study describes a model-based intervention for topographical disorientation. From a theoretical point of view, it provides new insights into the cognitive models of human spatial navigation and straightforward evidence about common phylogenetic roots of brain mechanisms devoted to spatial navigation and memory.	[Boccia, Maddalena; Diana, Sofia; Di Vita, Antonella; Guariglia, Cecilia] IRCCS Fdn Santa Lucia, Cognit & Motor Rehabil & Neuroimaging Unit, Rome, Italy; [Bonavita, Alessia; Diana, Sofia; Guariglia, Cecilia] Sapienza Univ Rome, Dept Psychol, Rome, Italy; [Diana, Sofia; Di Vita, Antonella] Sapienza Univ Rome, Dept Human Neurosci, Rome, Italy; [Ciurli, Maria Paola] IRCCS Fdn Santa Lucia, Neuropsychol Unit, Rome, Italy		Boccia, M (corresponding author), IRCCS Fdn Santa Lucia, Cognit & Motor Rehabil & Neuroimaging Unit, Rome, Italy.	m.boccia@hsantalucia.it	DI VITA, ANTONELLA/I-8584-2018; Boccia, Maddalena/I-4575-2018	DI VITA, ANTONELLA/0000-0003-2345-4809; Boccia, Maddalena/0000-0002-2044-8326; Bonavita, Alessia/0000-0001-7793-263X	Italian Ministry of HealthMinistry of Health, Italy	This work was partially supported by funding from the Italian Ministry of Health to the IRCCS Fondazione Santa Lucia (Ricerca Corrente).	Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; Bauer ME, 2008, T&F SER REMOTE SENS, P3; Bellmund JLS, 2018, SCIENCE, V362, DOI 10.1126/science.aat6766; Bianchini F, 2010, NEUROPSYCHOLOGIA, V48, P1563, DOI 10.1016/j.neuropsychologia.2010.01.025; Bianchini F, 2014, J NEUROPSYCHOL, V8, P107, DOI 10.1111/jnp.12007; Boccia M, 2019, HUM BRAIN MAPP, V40, P2449, DOI 10.1002/hbm.24535; Boccia M, 2017, BRAIN STRUCT FUNCT, V222, P1945, DOI 10.1007/s00429-016-1318-6; Boccia M, 2017, NEUROIMAGE, V144, P174, DOI 10.1016/j.neuroimage.2016.08.034; Boccia M, 2016, BRAIN STRUCT FUNCT, V221, P2005, DOI 10.1007/s00429-015-1021-z; Boccia M, 2015, HUM BRAIN MAPP, V36, P945, DOI 10.1002/hbm.22678; Boccia M, 2014, NEUROPSYCHOL REV, V24, P236, DOI 10.1007/s11065-014-9247-8; Bouwmeester L, 2015, NEUROPSYCHOL REHABIL, V25, P1, DOI 10.1080/09602011.2014.923318; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Chiaravalloti ND, 2005, MULT SCLER, V11, P58, DOI 10.1191/1352458505ms1118oa; Conson M, 2018, J CLIN EXP NEUROPSYC, V40, P940, DOI 10.1080/13803395.2018.1451493; Corsi P. M., 1972, THESIS MCGILL U MONT; Crawford JR, 2011, CORTEX, V47, P1166, DOI 10.1016/j.cortex.2011.02.017; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Davis SJC, 1999, NEUROPSYCHOL REHABIL, V9, P1, DOI 10.1080/713755586; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ekstrom AD, 2017, J NEUROPHYSIOL, V118, P3328, DOI 10.1152/jn.00531.2017; Holmes G, 1919, ARCH NEURO PSYCHIATR, V1, P385, DOI 10.1001/archneurpsyc.1919.02180040002001; Iaria G, 2007, EUR J NEUROSCI, V25, P890, DOI 10.1111/j.1460-9568.2007.05371.x; Iaria G, 2010, EXP BRAIN RES, V206, P189, DOI 10.1007/s00221-010-2256-9; Incoccia C, 2009, NEUROPSYCHOL REHABIL, V19, P291, DOI 10.1080/09602010802188344; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; LEVINE DN, 1985, NEUROLOGY, V35, P1010, DOI 10.1212/WNL.35.7.1010; Money J., 1965, STANDARDIZED ROAD MA; Montello D. R., 1993, Spatial Information Theory. A Theoretical Basis for GIS. European Conference, COSIT '93 Proceedings, P312; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Palermo L, 2016, J CLIN EXP NEUROPSYC, V38, P752, DOI 10.1080/13803395.2016.1161735; Palermo L, 2014, J CLIN EXP NEUROPSYC, V36, P464, DOI 10.1080/13803395.2014.904843; Piccardi L, 2013, NEUROL SCI, V34, P971, DOI 10.1007/s10072-012-1175-x; Piccardi L, 2008, NEUROSCI LETT, V432, P127, DOI 10.1016/j.neulet.2007.12.044; Piras F, 2011, EUR J PHYS REHAB MED, V47, P27; Rivest J, 2018, NEUROPSYCHOL REHABIL, V28, P797, DOI 10.1080/09602011.2016.1160833; Siegel A. W., 1975, DEV SPATIAL REPRESEN; Stark M, 1996, COGN NEUROPSYCHOL, V13, P481, DOI 10.1080/026432996381908; Sulpizio V, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00167; Sulpizio V, 2017, BEHAV BRAIN RES, V319, P16, DOI 10.1016/j.bbr.2016.10.052; Sulpizio V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00716; Takahashi N, 1997, NEUROLOGY, V49, P464, DOI 10.1212/WNL.49.2.464; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; Thurstone LL, 1937, PSYCHOMETRIKA, V2, P249, DOI 10.1007/BF02287896; Vass LK, 2013, J NEUROSCI, V33, P6133, DOI 10.1523/JNEUROSCI.3873-12.2013; Wang RF, 2002, TRENDS COGN SCI, V6, P376, DOI 10.1016/S1364-6613(02)01961-7; Wolbers T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00571; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001	50	2	2	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	SEP 20	2019	13								322	10.3389/fnhum.2019.00322			8	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	IZ7UY	WOS:000487305500001	31616267	Green Published, gold			2022-02-06	
J	Pang, YT; Li, HL; Zhao, L; Zhang, CX				Pang, Yatao; Li, Hongling; Zhao, Long; Zhang, Chunxia			An Established Early Rehabilitation Therapy Demonstrating Higher Efficacy and Safety for Care of Intensive Care Unit Patients	MEDICAL SCIENCE MONITOR			English	Article						Consciousness; Intensive Care Units; Rehabilitation; Treatment Outcome	DIRECT-CURRENT STIMULATION; CRITICALLY-ILL PATIENTS; HYPERBARIC-OXYGEN; ACQUIRED WEAKNESS; MANAGEMENT; COMPLICATIONS; MOBILIZATION; INFLAMMATION; MORTALITY; DIAGNOSIS	Background: Although survival rates of critically ill patients in Intensive Care Units (ICUs) have improved in recent years, many risk factors cause a few serious complications. This study aimed to evaluate efficacy and safety of comprehensive early rehabilitation therapy for ICU patients. Material/Methods: This study recruited ICU patients who were diagnosed as having cerebral hemorrhage or traumatic brain injury. ICU patients were randomly divided into an early rehabilitation therapy group (Observation group, n=21) and a Control group (n=21). Patients in the Control group underwent persistent monitoring of respiratory functions and blood oxygen saturation, as well as electrocardiographic monitoring. ICU patients in the Observation group underwent individualized treatments based on conventional treatments. APACHE II scores, MRC scores, and consciousness improvement rates of ICU patients were evaluated. Incidences of adverse events and complications were also assessed. Results: Early rehabilitation therapy significantly decreased APACHE II scores and significantly increased MRC scores compared to the Control group (p<0.05). Early rehabilitation therapy significantly improved consciousness of ICU patients compared to the Control group (p<0.05). Early rehabilitation therapy significantly reduced the incidence of complications compared to the Control group (p<0.05). Early rehabilitation therapy significantly shortened ICU or total hospital stay and mechanical ventilation time compared to the Control group (p<0.05). Conclusions: Early rehabilitation therapy decreased APACHE II scores, enhanced MRC scores, and improved consciousness of ICU patients. Moreover, early rehabilitation therapy also reduced the incidence of complications and shortened ICU or total hospital stay and mechanical ventilation time of ICU patients. Therefore, early rehabilitation therapy was shown to be effective and safe for ICU patients.	[Pang, Yatao; Li, Hongling; Zhao, Long; Zhang, Chunxia] Hebei Med Univ, Hosp 2, Dept Rehabil 2, Shijiazhuang, Hebei, Peoples R China		Li, HL (corresponding author), Hebei Med Univ, Hosp 2, Dept Rehabil 2, Shijiazhuang, Hebei, Peoples R China.	hzliangl@hainan.net					Adler Joseph, 2012, Cardiopulm Phys Ther J, V23, P5; Chawla J, 2010, NEUROL CLIN, V28, P961, DOI 10.1016/j.ncl.2010.03.027; Chen ZJ, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00026; Cousin CA, 2017, INT C REHAB ROBOT, P38, DOI 10.1109/ICORR.2017.8009218; Davis J, 2013, J GERIATR PHYS THER, V36, P162, DOI 10.1519/JPT.0b013e31828836e7; Elcadi GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095582; Elwatidy S, 2006, SAUDI MED J, V27, P1547; Fan E, 2014, AM J RESP CRIT CARE, V190, P1437, DOI 10.1164/rccm.201411-2011ST; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Guo LT, 2018, MED SCI MONITOR, V24, P5000, DOI 10.12659/MSM.911308; Gyllensten AL, 2017, DISABIL REHABIL-ASSI, V12, P780, DOI 10.1080/17483107.2016.1263881; Halpern NA, 2015, CRIT CARE MED, V43, P2452, DOI 10.1097/CCM.0000000000001227; Harish MM, 2017, INDIAN J CRIT CARE M, V21, P112, DOI 10.4103/ijccm.IJCCM_26_17; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hodgson C, 2014, HEART LUNG, V43, P19, DOI 10.1016/j.hrtlng.2013.11.003; Hu SL, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.762; Jang SH, 2015, INT J STROKE, V10, P162, DOI 10.1111/ijs.12608; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; Kondo Y, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013828; Lee H, 2015, ANAESTH INTENS CARE, V43, P175, DOI 10.1177/0310057X1504300206; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu B, 2017, NEUROL RES, V39, P23, DOI 10.1080/01616412.2016.1251710; Ma X, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00044; Marais Chantal, 2016, Curationis, V39, P1, DOI 10.4102/curationis.v39i1.1590; Morotti A, 2016, EMERG MED CLIN N AM, V34, P883, DOI 10.1016/j.emc.2016.06.010; Nydahl P, 2017, ANN AM THORAC SOC, V14, P766, DOI 10.1513/AnnalsATS.201611-843SR; Parry SM, 2018, INTENS CARE MED, V44, P470, DOI 10.1007/s00134-017-4908-8; Pires-Neto RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074182; Reichert P, 2018, MED SCI MONITOR, V24, P782, DOI 10.12659/MSM.907260; Rizzo V, 2014, BRAIN STIMUL, V7, P113, DOI 10.1016/j.brs.2013.10.002; Schefold JC, 2010, J CACHEXIA SARCOPENI, V1, P147, DOI 10.1007/s13539-010-0010-6; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Siempos II, 2015, LANCET RESP MED, V3, P150, DOI 10.1016/S2213-2600(15)00007-7; Sosnowski K, 2015, AUST CRIT CARE, V28, P216, DOI 10.1016/j.aucc.2015.05.002; Stephens RS, 2015, CRIT CARE MED, V43, P1995, DOI 10.1097/CCM.0000000000001171; Tal S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00508; TEASDALE G, 1983, LANCET, V2, P678; Turon M, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.12.10; Wu LJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8542576; Yang N, 2017, J CRIT CARE, V42, P101, DOI 10.1016/j.jcrc.2017.07.013; Yu M, 2015, J PHYS THER SCI, V27, P3271, DOI 10.1589/jpts.27.3271; Zheng X, 2011, NEUROIMAGE, V58, P26, DOI 10.1016/j.neuroimage.2011.06.018; Zimmerman R, 2017, ANESTH ANALG, V124, P1547, DOI 10.1213/ANE.0000000000002008	43	2	2	0	7	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	SEP 20	2019	25						7052	7058		10.12659/MSM.916210			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	JA0AT	WOS:000487471600001	31537777	Green Published			2022-02-06	
J	Lyengar, R; Winkels, JL; Smith, CM; Meka, AP; Porath, JD; Meurer, WJ				Lyengar, Rahul; Winkels, Jessica L.; Smith, Chelsea Morrow; Meka, Arjun P.; Porath, Jonathan D.; Meurer, William J.			The Effect of Financial Incentives on Patient Decisions to Undergo Low-value Head Computed Tomography Scans	ACADEMIC EMERGENCY MEDICINE			English	Article							RISK; PAY	Background Excessive diagnostic testing and defensive medicine contribute to billions of dollars in avoidable costs in the United States annually. Our objective was to determine the influence of financial incentives, accompanied with information regarding test risk and benefit, on patient preference for diagnostic testing. Methods We conducted a cross-sectional survey of patients at the University of Michigan emergency department (ED). Each participant was presented with a hypothetical scenario involving an ED visit following minor traumatic brain injury. Participants were given information regarding potential benefit (detecting brain hemorrhage) and risk (developing cancer) of head computed tomography scan, as well as an incentive of $0 or $100 to forego testing. We used 0.1 and 1% for test benefit and risk, and values for risk, benefit, and financial incentive varied across participants. Our primary outcome was patient preference to undergo testing. We also collected demographic and numeracy information. We then used logistic regression to estimate odds ratios (ORs), which were adjusted for multiple potential confounders. Our sample size was designed to find at least 300 events (preference for testing) to allow for inclusion of up to 30 covariates in fully adjusted models. We had 85% to 90% power to detect a 10% absolute difference in testing rate across groups, assuming a 95% significance level. Results We surveyed 913 patients. Increasing test benefit from 0.1% to 1% significantly increased test acceptance (adjusted OR [AOR] = 1.6, 95% confidence interval [CI] = 1.2 to 2.1) and increasing test risk from 0.1% to 1% significantly decreased test acceptance (AOR = 0.70, 95% CI = 0.52 to 0.93). Finally, a $100 incentive to forego low-value testing significantly reduced test acceptance (AOR = 0.6; 95% CI = 0.4 to 0.8). Conclusions Providing financial incentives to forego testing significantly decreased patient preference for testing, even when accounting for test benefit and risk. This work is preliminary and hypothetical and requires confirmation in larger patient cohorts facing these actual decisions.	[Lyengar, Rahul; Winkels, Jessica L.; Smith, Chelsea Morrow; Meka, Arjun P.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [Porath, Jonathan D.] Univ Michigan Hlth Syst, Dept Emergency Med, Ann Arbor, MI USA; [Meurer, William J.] Univ Michigan Hlth Syst, Dept Neurol, Ann Arbor, MI 48109 USA		Meurer, WJ (corresponding author), Univ Michigan Hlth Syst, Dept Neurol, Ann Arbor, MI 48109 USA.	wmeurer@med.umich.edu	Meurer, William/A-7547-2010	Meurer, William/0000-0002-1158-5302; Iyengar, Rahul/0000-0002-1178-1717	NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T35HL007690] Funding Source: Medline		Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brust-Renck Priscila G, 2013, Rev Hum Factors Ergon, V8, P235; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; Kressin NR, 2013, JAMA-J AM MED ASSOC, V309, P39, DOI 10.1001/jama.2012.153826; Meka AP, 2017, ACAD EMERG MED, V24, P686, DOI 10.1111/acem.13148; Mello MM, 2010, HEALTH AFFAIR, V29, P1569, DOI 10.1377/hlthaff.2009.0807; Moriates C, 2013, JAMA-J AM MED ASSOC, V310, P577, DOI 10.1001/jama.2013.7516; Polaris Julian J Z, 2014, BMC Res Notes, V7, P922, DOI 10.1186/1756-0500-7-922; Porath JD, 2018, ACAD EMERG MED, V25, P627, DOI 10.1111/acem.13404; Schapira MM, 2006, J HEALTH COMMUN, V11, P569, DOI 10.1080/10810730600829916; Sharp AL, 2017, ACAD EMERG MED, V24, P22, DOI 10.1111/acem.13061; Wu J, 2012, ANN FAM MED, V10, P261, DOI 10.1370/afm.1334	14	2	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	OCT	2019	26	10					1118	1124		10.1111/acem.13823		SEP 2019	7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JD5WZ	WOS:000487087700001	31535430	Green Published, Bronze			2022-02-06	
J	Erler, KS; Kew, CL; Juengst, SB				Erler, Kimberly S.; Kew, Chung Lin; Juengst, Shannon B.			Participation differences by age and depression 5 years after moderate-to-severe traumatic brain injury	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article						Traumatic brain injury; participation; depression; ageing; neurorehabilitation; lifespan	LIFE SATISFACTION; HEALTH; TRAJECTORIES; VALIDITY; OUTCOMES; IMPACT	Participation restrictions, including restrictions in employment, recreational activities, and social interactions, and depression are common after traumatic brain injury (TBI) and can profoundly affect individuals. Participation and depression demonstrate complex relationships with each other and over time as individuals age. This study (1) identified differences in participation between different age groups; (2) determined if participation differed between those with and without clinically significant depressive symptoms within each age group; and (3) determined the effect of the interaction between age groups and the presence or absence of clinically significant depressive symptoms on participation in community-dwelling adults with a moderate-to-severe TBI. Results indicate that, among community-dwelling adults 5 years post-TBI, there are significant differences in participation between age groups across the lifespan, with younger adults generally having higher levels of participation. Individuals with clinically significant depressive symptoms participate less than individuals without it within the same age group, except for adults over 65 years-old. For the productivity domain, age interacted with depressive symptoms, such that the presence of clinically significant depressive symptoms was associated with a larger difference in productivity in early-to-middle adulthood. Based on these findings, depression should be considered when providing interventions for participation and vice versa.	[Erler, Kimberly S.] MGH Inst Hlth Profess, Dept Occupat Therapy, 36 First Ave, Boston, MA 02129 USA; [Kew, Chung Lin; Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA		Erler, KS (corresponding author), MGH Inst Hlth Profess, Dept Occupat Therapy, 36 First Ave, Boston, MA 02129 USA.	kerler@mgh.harvard.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X; Kew, Novelle/0000-0003-1720-4459	National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR) a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS); NIDILRR grant [90DPTB0013-01-00]	The TBI Model Systems National Database is a multicenter study of the TBI Model Systems Centers Program, and is supported by the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR) a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). However, these contents do not necessarily reflect the opinions or views of the TBI Model Systems Centers, NIDILRR, ACL or HHS. Work on this manuscript was funded in part by NIDILRR grant 90DPTB0013-01-00 (Juengst).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Baird BM, 2010, SOC INDIC RES, V99, P183, DOI 10.1007/s11205-010-9584-9; Biswas RK, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0211-y; Blanchflower DG, 2008, SOC SCI MED, V66, P1733, DOI 10.1016/j.socscimed.2008.01.030; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Corp IBM., 2017, IBM SPSS STAT WINDOW; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Dijkers M, 2009, ARCH PHYS MED REHAB, V90, pe39, DOI DOI 10.1016/j.apmr.2009.08.123; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Erler KS, 2018, OTJR-OCCUP PART HEAL, V38, P143, DOI 10.1177/1539449218757739; Erler KS, 2018, J HEAD TRAUMA REHAB, V33, P257, DOI 10.1097/HTR.0000000000000383; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Juengst S. B., 2017, PHYS MED REHABILITAT; Juengst SB, 2017, PSYCHOL RES BEHAV MA, V10, P175, DOI 10.2147/PRBM.S113264; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Juengst SB, 2014, AM J PHYS MED REHAB, V93, P1086, DOI 10.1097/PHM.0000000000000163; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; National Institute of Neurological Disorders and Stroke, 2018, NINDS COMM DAT EL HA; Perrin PB, 2017, AM J PHYS MED REHAB, V96, P374, DOI 10.1097/PHM.0000000000000644; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; World Health Organization, 2007, INT CLASS FUNCT DIS; Yoon JY, 2014, RES GERONTOL NURS, V7, P152, DOI 10.3928/19404921-20140310-01; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172	41	2	2	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	JAN 2	2020	32	1			SI		12	21		10.1080/09540261.2019.1656175		SEP 2019	10	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	KB4LE	WOS:000486920600001	31533497				2022-02-06	
J	Ledger, C; Karameh, WK; Munoz, DG; Fischer, CE; Schweizer, TA				Ledger, Conor; Karameh, Wael K.; Munoz, David G.; Fischer, Corinne E.; Schweizer, Tom A.			Gender role in sleep disturbances among older adults with traumatic brain injury	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article						Traumatic brain injury (TBI); gender; older adult; sleep disturbance	POST-CONCUSSION SYMPTOMS; DISORDERS; INSOMNIA	Older adults are particularly vulnerable to poor long-term outcomes, and the rate of TBI in this group is increasing. Studies have shown females experience worse outcomes from TBI than males, however this research has been limited. The aim of this study is to examine gender effects on the frequency of sleep disturbances in older adults post-TBI. An analysis was conducted on data obtained from the National Alzheimer's Coordinating Center (NACC) Uniform Data Set. A total of 405 patients greater than 60 years of age were examined. Sleep disturbances were measured using the Nighttime Behavioural Disturbances domain of the Neuropsychiatric Inventory-Questionnaire (NPI-Q). A significant difference (p = 0.025) in reported sleep disturbance was identified in the female TBI population relative to the female non-TBI population. In the male non-TBI group, 14.8% (n = 12) experienced nighttime disturbances while 19.8% (n = 17) of those with TBI experienced nighttime disturbances. This difference was not significant (p = 0.305). These results suggest there is a greater impact from traumatic brain injury on sleep disturbances in older females than males. Further research examining gender differences in older adults related to neuropsychiatric outcomes of TBI should be considered given the implications for treatment.	[Ledger, Conor; Karameh, Wael K.; Munoz, David G.; Fischer, Corinne E.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Res, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Karameh, Wael K.; Fischer, Corinne E.] Univ Toronto, Fac Med, Dept Psychiat, Div Geriatr Psychiat, Toronto, ON, Canada; [Karameh, Wael K.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Munoz, David G.; Schweizer, Tom A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Munoz, David G.] St Michaels Hosp, Div Pathol, Toronto, ON, Canada; [Fischer, Corinne E.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada		Fischer, CE (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Res, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	fischerc@smh.ca	Munoz, David G./AAQ-8003-2020	Munoz, David G./0000-0003-0957-6244	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P50 AG005134, P50 AG016574, P50 AG005138, P30 AG008051, P30 AG013854, P30 AG008017, P30 AG010161];  [P50 AG047366];  [P30 AG010129];  [P50 AG016573];  [P50 AG005131];  [P50 AG023501];  [P30 AG035982];  [P30 AG028383];  [P30 AG053760];  [P30 AG010124];  [P50 AG005133];  [P50 AG005142];  [P30 AG012300];  [P30 AG049638];  [P50 AG005136];  [P50 AG033514];  [P50 AG005681];  [P50 AG047270]	NACC data are contributed by the NIA-funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50 AG005134 (PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Thomas Wisniewski, MD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129 (PI Charles DeCarli, MD), P50 AG016573 (PI Frank LaFerla, PhD), P50 AG005131 (PI James Brewer, MD, PhD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30 AG028383 (PI Linda Van Eldik, PhD), P30 AG053760 (PI Henry Paulson, MD, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P30 AG049638 (PI Suzanne Craft, PhD), P50 AG005136 (PI Thomas Grabowski, MD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50 AG005681 (PI John Morris, MD), P50 AG047270 (PI Stephen Strittmatter, MD, PhD).	Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kalmbach DA, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy147; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; Krishnamoorthy V, 2015, J TRAUMA NURS, V22, P204, DOI 10.1097/JTN.0000000000000135; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Musa Gada, 2017, Dement. neuropsychol., V11, P129, DOI 10.1590/1980-57642016dn11-020005; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rao V, 2015, PSYCHIAT TIMES, V32; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Yi A, 2013, NEUROREHABILITATION, V32, P267, DOI 10.3233/NRE-130843; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	26	2	2	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	JAN 2	2020	32	1			SI		39	45		10.1080/09540261.2019.1657384		SEP 2019	7	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	KB4LE	WOS:000487226000001	31544552	Green Accepted			2022-02-06	
J	Jarras, H; Bourque, M; Poirier, AA; Morissette, M; Coulombe, K; Di Paolo, T; Soulet, D				Jarras, Hend; Bourque, Melanie; Poirier, Andree-Anne; Morissette, Marc; Coulombe, Katherine; Di Paolo, Therese; Soulet, Denis			Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease	JOURNAL OF NEUROENDOCRINOLOGY			English	Article						gut; MPTP; neuroprotection; Parkinson's disease; progesterone	INTESTINAL INFLAMMATORY RESPONSE; MUCOSA STRUCTURE ALTERATIONS; TRAUMATIC BRAIN-INJURY; SEX STEROIDS; MYENTERIC PLEXUS; DOPAMINERGIC-NEURONS; ENTERIC MICROBIOTA; GENDER-DIFFERENCES; RAT MODEL; RECEPTORS	Gastrointestinal symptoms appear in Parkinson's disease patients many years before motor symptoms, suggesting the implication of dopaminergic neurones of the gut myenteric plexus. Inflammation is also known to be increased in PD. We previously reported neuroprotection with progesterone in the brain of mice lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and hypothesised that it also has neuroprotective and immunomodulatory activities in the gut. To test this hypothesis, we investigated progesterone administered to adult male C57BL/6 mice for 10 days and treated with MPTP on day 5. In an additional experiment, progesterone was administered for 5 days following MPTP treatment. Ilea were collected on day 10 of treatment and microdissected to isolate the myenteric plexus. Dopaminergic neurones were reduced by approximately 60% and pro-inflammatory macrophages were increased by approximately 50% in MPTP mice compared to intact controls. These changes were completely prevented by progesterone administered before and after MPTP treatment and were normalised by 8 mg kg(-1) progesterone administered after MPTP. In the brain of MPTP mice, brain-derived neurotrophic peptide (BDNF) and glial fibrillary acidic protein (GFAP) were associated with progesterone neuroprotection. In the myenteric plexus, increased BDNF levels compared to controls were measured in MPTP mice treated with 8 mg kg(-1) progesterone started post MPTP, whereas GFAP levels remained unchanged. In conclusion, the results obtained in the present study show neuroprotective and anti-inflammatory effects of progesterone in the myenteric plexus of MPTP mice that are similar to our previous findings in the brain. Progesterone is non-feminising and could be used for both men and women in the pre-symptomatic stages of the disease.	[Jarras, Hend; Bourque, Melanie; Poirier, Andree-Anne; Morissette, Marc; Coulombe, Katherine; Di Paolo, Therese; Soulet, Denis] CHU Quebec, Ctr Rech, Axe Neurosci, Pavillon CHUL, Quebec City, PQ, Canada; [Jarras, Hend; Poirier, Andree-Anne; Di Paolo, Therese; Soulet, Denis] Laval Univ, Fac Pharm, Quebec City, PQ, Canada		Di Paolo, T; Soulet, D (corresponding author), Univ Laval, Ctr Rech, Axe Neurosci, CHU Quebec, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	therese.dipaolo@crchul.ulaval.ca; denis.soulet@crchul.ulaval.ca			Canadian Foundation for InnovationCanada Foundation for Innovation [CFI-25631]; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-275325]	Canadian Foundation for Innovation, Grant/Award Number: CFI-25631; Canadian Institute of Health Research, Grant/Award Number: MOP-275325	Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; Aksoy AN, 2014, INDIAN J PHARMACOL, V46, P622, DOI 10.4103/0253-7613.144922; Al Sweidi S, 2012, J NEUROENDOCRINOL, V24, P48, DOI 10.1111/j.1365-2826.2011.02193.x; Bassotti G, 2012, NEUROGASTROENT MOTIL, V24, pE155, DOI 10.1111/j.1365-2982.2011.01850.x; Bourque M, 2019, NEUROPHARMACOLOGY, V147, P37, DOI 10.1016/j.neuropharm.2018.04.005; Bourque M, 2016, NEUROENDOCRINOLOGY, V103, P300, DOI 10.1159/000438789; Bourque M, 2012, FRONT NEUROENDOCRIN, V33, P169, DOI 10.1016/j.yfrne.2012.02.003; Bourque Melanie, 2011, Front Endocrinol (Lausanne), V2, P35, DOI 10.3389/fendo.2011.00035; Bourque M, 2009, FRONT NEUROENDOCRIN, V30, P142, DOI 10.1016/j.yfrne.2009.04.014; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Breen DP, 2019, MOVEMENT DISORD, V34, P307, DOI 10.1002/mds.27556; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Casas S, 2013, NEUROL RES, V35, P719, DOI 10.1179/1743132812Y.0000000142; Casas S, 2011, PHARMACOL BIOCHEM BE, V99, P614, DOI 10.1016/j.pbb.2011.06.012; Chao OY, 2011, NEUROSCIENCE, V196, P228, DOI 10.1016/j.neuroscience.2011.08.043; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Cheng L, 2008, AM J PHYSIOL-GASTR L, V295, pG493, DOI 10.1152/ajpgi.90214.2008; Cong P, 2007, GASTROENTEROLOGY, V133, P445, DOI 10.1053/j.gastro.2007.05.021; Cote M, 2015, BRAIN BEHAV IMMUN, V46, P154, DOI 10.1016/j.bbi.2015.01.009; Cote M, 2011, BRAIN BEHAV IMMUN, V25, P1143, DOI 10.1016/j.bbi.2011.02.017; Cote M, 2015, NEUROBIOL DIS, V82, P99, DOI 10.1016/j.nbd.2015.05.017; Cyr M, 2002, J PSYCHIATR NEUROSCI, V27, P12; Cyr M, 2000, CURR PHARM DESIGN, V6, P1287, DOI 10.2174/1381612003399725; Devos D, 2013, NEUROBIOL DIS, V50, P42, DOI 10.1016/j.nbd.2012.09.007; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dressing GE, 2011, STEROIDS, V76, P11, DOI 10.1016/j.steroids.2010.09.006; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; Garg D, 2017, TRENDS ENDOCRIN MET, V28, P656, DOI 10.1016/j.tem.2017.05.006; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gillies GE, 2014, FRONT NEUROENDOCRIN, V35, P370, DOI 10.1016/j.yfrne.2014.02.002; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grandbois M, 2000, NEUROREPORT, V11, P343, DOI 10.1097/00001756-200002070-00024; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hardy DB, 2008, MOL ENDOCRINOL, V22, P1812, DOI 10.1210/me.2007-0443; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6; Holst MC, 1995, J NEUROSCI METH, V62, P121, DOI 10.1016/0165-0270(95)00064-X; Kowalski K, 2019, J NEUROGASTROENTEROL, V25, P48, DOI 10.5056/jnm18087; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Li ZS, 2004, J NEUROSCI, V24, P1330, DOI 10.1523/JNEUROSCI.3982-03.2004; Litim N, 2017, NEUROPHARMACOLOGY, V117, P209, DOI 10.1016/j.neuropharm.2017.02.007; Litim N, 2016, NEUROSCI BIOBEHAV R, V67, P79, DOI 10.1016/j.neubiorev.2015.09.024; Del Rey NLG, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00113; Lu J, 2015, J ENDOCRINOL, V224, P183, DOI 10.1530/JOE-14-0470; Mani S, 2008, ENDOCRINOLOGY, V149, P2750, DOI 10.1210/en.2008-0097; Mani SK, 2012, FRONT ENDOCRINOL, V3, P7, DOI [10.3389/fendo.2012.00007, DOI 10.3389/FENDO.2012.00007]; Mayer EA, 2014, BIOESSAYS, V36, P933, DOI 10.1002/bies.201400075; Miller IN, 2010, MOVEMENT DISORD, V25, P2695, DOI 10.1002/mds.23388; Miller L, 1998, J IMMUNOL, V160, P5098; More SV, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/952375; Morissette M, 2008, MOL CELL ENDOCRINOL, V290, P60, DOI 10.1016/j.mce.2008.04.008; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Natale G, 2008, NEUROGASTROENT MOTIL, V20, P741, DOI 10.1111/j.1365-2982.2008.01162.x; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Peltier MR, 2008, AM J REPROD IMMUNOL, V60, P346, DOI 10.1111/j.1600-0897.2008.00633.x; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Phillips RJ, 2008, NEUROSCIENCE, V153, P733, DOI 10.1016/j.neuroscience.2008.02.074; Pisetsky DS, 2011, CLIN VACCINE IMMUNOL, V18, P1420, DOI 10.1128/CVI.05110-11; Poewe W, 2006, J NEUROL, V253, P2, DOI 10.1007/s00415-006-7002-7; Poirier AA, 2016, NEUROBIOL AGING, V48, P61, DOI 10.1016/j.neurobiolaging.2016.08.004; Preciado-Martinez E, 2018, IMMUNOL INVEST, V47, P181, DOI 10.1080/08820139.2017.1413112; Reichmann H, 2010, NEURODEGENER DIS, V7, P284, DOI 10.1159/000314478; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Savica R, 2009, NEUROLOGY, V73, P1752, DOI 10.1212/WNL.0b013e3181c34af5; Savica R, 2013, JAMA NEUROL, V70, P859, DOI 10.1001/jamaneurol.2013.114; Sawada M, 2006, J NEURAL TRANSM-SUPP, P373; Schust DJ, 1996, HUM REPROD, V11, P980; Shulman LM, 2007, GENDER MED, V4, P8, DOI 10.1016/S1550-8579(07)80003-9; Siderowf A, 2003, ANN INTERN MED, V138, P651, DOI 10.7326/0003-4819-138-8-200304150-00013; Singh M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00159; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; You SJ, 2010, J MOL HISTOL, V41, P101, DOI 10.1007/s10735-010-9265-7; Zeuner KL, 2019, CLIN PHARMACOL THER, V105, P1106, DOI 10.1002/cpt.1374; Zhao XD, 2011, J SURG RES, V171, pE47, DOI 10.1016/j.jss.2011.07.018; Zhu Y, 2008, COMP BIOCHEM PHYS C, V148, P381, DOI 10.1016/j.cbpc.2008.05.019	78	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	JAN	2020	32	1							e12782	10.1111/jne.12782		SEP 2019	11	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	KG4ND	WOS:000490319500001	31430407				2022-02-06	
J	Han, C; Xia, XP; Jiao, S; Li, G; Ran, QS; Yao, ST				Han, Chong; Xia, Xiangping; Jiao, Song; Li, Gang; Ran, Qishan; Yao, Shengtao			Tripartite motif containing protein 37 involves in thrombin stimulated BV-2 microglial cell apoptosis and interleukin 1 beta release	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Intracerebral hemorrhage; TRIM37; PPAR gamma; Ubiquitination	PROLIFERATOR-ACTIVATED-RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; TRAUMATIC BRAIN-INJURY; PPAR-GAMMA; INTRACEREBRAL HEMORRHAGE; TRIM37; GENE; DEGRADATION; MECHANISMS; FAMILY	Intracerebral hemorrhage (ICH) is the most common of stroke with high mortality and severe morbidity. Peroxisome proliferator-activated receptor gamma (PPAR gamma) plays a neuronprotective role in ICH. In the current study, TRIM37 mRNA expression in peripheral blood mononuclear cells (PBMCs) was found to be increased in ICH patients compared to that in healthy controls (n = 15). TRIM37 bound to PPAR gamma and enhanced its ubiquitination in mouse microglial BV-2 cell line. According to previous studies, thrombin is produced in the brain instantaneously after ICH and triggers the activation of microglia. Here, thrombin induced TRIM37 expression, cell apoptosis and interleukin-1 beta (IL-1 beta) release in BV-2 cells, while TRIM37 knockdown partially reversed the effects of thrombin on BV-2 cells. TRIM37 overexpression showed similar effects as thrombin on BV-2 cells, and PPAR gamma agonist rosiglitazone abolished the effects of TRIM37. In summary, TRIM37 involved in apoptosis and IL-1 beta release in BV-2 microglia by regulating PPAR gamma ubiquitination. The present data established a potential biological role of TRIM37 in ICH-induced brain damage and may provide insight into the development of therapy strategies for ICH. (C) 2019 Published by Elsevier Inc.	[Han, Chong; Xia, Xiangping; Jiao, Song; Li, Gang; Ran, Qishan; Yao, Shengtao] Zunyi Med Univ, Affiliated Hosp 1, Dept Cerebrovasc Dis, 149 Dalian Rd, Huichuan Dist 563000, Zunyi, Peoples R China		Yao, ST (corresponding author), Zunyi Med Univ, Affiliated Hosp 1, Dept Cerebrovasc Dis, 149 Dalian Rd, Huichuan Dist 563000, Zunyi, Peoples R China.	yst@zmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81660211]; Doctoral Start-up Foundation of Affiliated Hospital of Zunyi Medical University [201505, 201609]	This research was funded by National Natural Science Foundation of China (81660211). Doctoral Start-up Foundation of Affiliated Hospital of Zunyi Medical University (201505, 201609).	Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Avela K, 2000, NAT GENET, V25, P298, DOI 10.1038/77053; Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955; Chen DH, 2018, ONCOTARGETS THER, V11, P8803, DOI 10.2147/OTT.S178446; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Cordonnier C, 2018, LANCET, V392, P1257, DOI 10.1016/S0140-6736(18)31878-6; Dong SM, 2018, ONCOTARGETS THER, V11, P7935, DOI 10.2147/OTT.S183303; Floyd ZE, 2002, J BIOL CHEM, V277, P4062, DOI 10.1074/jbc.M108473200; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hu CE, 2017, MOL MED REP, V15, P1057, DOI 10.3892/mmr.2017.6125; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Jiang JX, 2016, TUMOR BIOL, V37, P2629, DOI 10.1007/s13277-015-4078-7; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; Li Y, 2018, J PATHOL, V246, P366, DOI 10.1002/path.5144; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Liu J, 2015, DRUG AGING, V32, P57, DOI 10.1007/s40266-014-0228-7; Moller T., 2002, THROMBIN INDUCED ACT, V75, P1539; Moore DF, 2005, CIRCULATION, V111, P212, DOI 10.1161/01.CIR.0000152105.79665.C6; Ohnishi M, 2007, EXP NEUROL, V206, P43, DOI 10.1016/j.expneurol.2007.03.030; Pisanu A, 2014, NEUROBIOL DIS, V71, P280, DOI 10.1016/j.nbd.2014.08.011; Sang M, 2017, DNA CELL BIOL, V36, P647, DOI 10.1089/dna.2017.3650; Steiner T, 2010, STROKE, V41, P402, DOI 10.1161/STROKEAHA.109.552919; Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wang W, 2017, J CELL BIOL, V216, P2843, DOI 10.1083/jcb.201611170; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zhao P, 2017, ONCOL RES, V25, P115, DOI 10.3727/096504016X14732772150181; Zhao X., 2009, HEMATOMA RESOLUTION, P40; Zhao XR, 2015, CNS NEUROSCI THER, V21, P357, DOI 10.1111/cns.12350; Zhao XR, 2007, ANN NEUROL, V61, P352, DOI 10.1002/ana.21097	35	2	2	1	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	SEP 3	2019	516	4					1252	1257		10.1016/j.bbrc.2019.06.158			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	IN9TM	WOS:000479021300031	31301768				2022-02-06	
J	Anwer, M; Bolkvadze, T; Puhakka, N; Ndode-Ekane, XE; Pitkanen, A				Anwer, Mehwish; Bolkvadze, Tamuna; Puhakka, Noora; Ndode-Ekane, Xavier Ekolle; Pitkanen, Asla			Genotype and Injury Effect on the Expression of a Novel Hypothalamic Protein Sushi Repeat-Containing Protein X-Linked 2 (SRPX2)	NEUROSCIENCE			English	Article						hypothalamus; sushi repeat-containing protein X-Linked 2; traumatic brain injury; urokinase-type plasminogen activator receptor	TRAUMATIC BRAIN-INJURY; PLASMINOGEN-ACTIVATOR RECEPTOR; CONTROLLED CORTICAL IMPACT; UROKINASE RECEPTOR; POSTTRAUMATIC EPILEPSY; NEURONAL MIGRATION; EPILEPTOGENESIS; DISORDERS; MOUSE; LANGUAGE	Sushi repeat-containing protein X-linked 2 (SRPX2) is a novel hypothalamic protein and a ligand of the urokinase-type plasminogen activator receptor (uPAR), which is essential for proteolysis of extracellular matrix and tissue remodeling after an insult to the brain. However, little is known about regulation of SRPX2. Our objective was to investigate if SRPX2 expression is altered by (i) the deficiency of uPAR or uPA (urokinase-type plasminogen activator), and (ii) traumatic brain injury (TBI). SRPX2 expression was assessed in wild type (Wt), Plaur(-/-) (uPAR-deficient), and Plaur(-/-) (uPA-deficient) mice, with and without controlled cortical impact injury (CCI). The number of SRPX2+ neurons in hypothalamus was comparable to that in Wt littermates in Plaur(-/-) (2985 +/- 138 vs. 2890 +/- 92, p > 0.05) and Plau(-/-) mice (2180 +/- 232 vs. 2027 +/- 77, p > 0.05). The number of hypothalamic SRPX2+ neurons in the Wt-CCI group was comparable to that in controls (3645 +/- 288 vs. 3385 +/- 192, p > 0.05). Hypothalamic, hippocampal and thalamic Srpx2 gene expression was unaltered after TBI. However, at 4 days post-TBI Srpx2 gene expression was upregulated in the perilesional cortex of Plau(-/-) CCI mice up to 123% of that in the sham group (p < 0.05). Unsupervised hierarchical clustering using SRPX2 expression did not identify genotype or injury-specific clusters. Our data demonstrate that SRPX2 expression in the hypothalamus is resistant to genetic deficiencies in the urokinasesystem or to the hypothalamus-affecting TBI. The contribution of elevated Srpx2 gene expression in perilesional cortex to post-TBI recovery process, however, requires further exploration. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Anwer, Mehwish; Bolkvadze, Tamuna; Puhakka, Noora; Ndode-Ekane, Xavier Ekolle; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632	Academy of FinlandAcademy of FinlandEuropean Commission; European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant [642881]	This work was supported by the Academy of Finland (A.P.), European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement No. 642881 (ECMED; A.P., M.\A.). We thank Mr. Jarmo Hartikainen and Mrs. Merja Lukkari for their excellent technical assistance.	Anwer M, 2018, J COMP NEUROL, V526, P1806, DOI 10.1002/cne.24449; Archinti M, 2011, CNS NEUROL DISORD-DR, V10, P271, DOI 10.2174/187152711794480393; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Beschorner R, 2000, NEUROPATH APPL NEURO, V26, P522, DOI 10.1046/j.0305-1846.2000.287.x; Bolkvadze T, 2016, EPILEPSY BEHAV, V60, P187, DOI 10.1016/j.yebeh.2016.04.038; Bolkvadze T, 2015, EPILEPSY BEHAV, V51, P19, DOI 10.1016/j.yebeh.2015.06.037; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bruneau N, 2011, CURR PHARM DESIGN, V17, P1914, DOI 10.2174/138161211796718198; Capatina C, 2015, J CLIN MED, V4, P1448, DOI 10.3390/jcm4071448; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Eagleson KL, 2005, J COMP NEUROL, V489, P449, DOI 10.1002/cne.20647; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hunt RF, 2012, EPILEPSY RES, V99, P167, DOI 10.1016/j.eplepsyres.2011.10.011; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Iyer AM, 2010, NEUROSCIENCE, V167, P929, DOI 10.1016/j.neuroscience.2010.02.047; Lahtinen L, 2009, NEUROSCIENCE, V163, P316, DOI 10.1016/j.neuroscience.2009.06.019; Lahtinen L, 2006, EUR J NEUROSCI, V24, P1935, DOI 10.1111/j.1460-9568.2006.05062.x; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Lin XB, 2017, BIOMED PHARMACOTHER, V93, P398, DOI 10.1016/j.biopha.2017.06.075; Liu B, 2010, J NEUROSCI RES, V88, P2747, DOI 10.1002/jnr.22419; Liu KL, 2017, DRUG DISCOV THER, V11, P212, DOI 10.5582/ddt.2017.01017; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masos T, 1997, MOL BRAIN RES, V47, P157, DOI 10.1016/S0169-328X(97)00040-5; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Osterstock G, 2014, ENDOCRINOLOGY, V155, P1887, DOI 10.1210/en.2013-1336; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Pitkanen A, 2014, PROG BRAIN RES, V214, P229, DOI 10.1016/B978-0-444-63486-3.00011-6; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Preissner KT, 2000, CURR OPIN CELL BIOL, V12, P621, DOI 10.1016/S0955-0674(00)00141-1; Quirico-Santos T, 2013, BRAIN RES, V1538, P172, DOI 10.1016/j.brainres.2013.09.044; Rantala J, 2015, EPILEPSY BEHAV, V42, P117, DOI 10.1016/j.yebeh.2014.11.001; Reinthaler EM, 2014, EPILEPSIA, V55, pE89, DOI 10.1111/epi.12712; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Royer-Zemmour B, 2008, HUM MOL GENET, V17, P3617, DOI 10.1093/hmg/ddn256; Salmi M, 2013, BRAIN, V136, P2457, DOI 10.1093/brain/awt161; Semina E, 2016, EUR J CELL BIOL, V95, P295, DOI 10.1016/j.ejcb.2016.05.003; Sia GM, 2013, SCIENCE, V342, P987, DOI 10.1126/science.1245079; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Soleman S, 2013, NEUROSCIENCE, V253, P194, DOI 10.1016/j.neuroscience.2013.08.050; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Statler KD, 2008, EPILEPSY RES, V80, P163, DOI 10.1016/j.eplepsyres.2008.04.001; SUMI Y, 1992, DEVELOPMENT, V116, P625; Szmydynger-Chodobska J, 2011, J CEREBR BLOOD F MET, V31, P47, DOI 10.1038/jcbfm.2010.188; Tang HT, 2016, CELL MOL NEUROBIOL, V36, P1067, DOI 10.1007/s10571-015-0300-9; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yamada T, 2014, J SURG ONCOL, V109, P836, DOI 10.1002/jso.23602; Zhou YX, 2017, J MAGN RESON IMAGING, V45, P1105, DOI 10.1002/jmri.25413	58	2	2	2	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 1	2019	415						184	200		10.1016/j.neuroscience.2019.07.040			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IZ6TQ	WOS:000487217100017	31362033				2022-02-06	
J	Aydin, K; Ergan, B; Tokur, ME; Caliskan, T; Gursoy, G; Savran, Y; Yaka, E; Comert, B; Koca, U; Gokmen, N				Aydin, Kutlay; Ergan, Begum; Tokur, Murat Emre; Caliskan, Taner; Gursoy, Gozde; Savran, Yusuf; Yaka, Erdem; Comert, Bilgin; Koca, Ugur; Gokmen, Necati			Current Status of Organ Donation in a University Hospital in Izmir: Identifying Obstacles and Possible Future Solutions	TURKISH JOURNAL OF INTENSIVE CARE-TURK YOGUN BAKIM DERGISI			English	Article						Organ donation; brain death; refusal	BRAIN-DEATH; ATTITUDES; KNOWLEDGE; DONORS	Objective: Although many new interventions including changes in diagnostic policies are performed to increase the rates of diagnosis of brain death (BD) and organ donation in recent years in Turkey, data about the longitudinal effects are limited. The aim of this study was to understand the current status of organ donation in Izmir and to find out whether new regulations have any effect on the diagnosis of BD and organ donation rates. Materials and Methods: All patients diagnosed with BD between January 2001 and December 2016 in a tertiary university hospital were included, and patient data and organ donation status were collected from medical records. Results: There were 303 patients diagnosed with BD during the study period. The most common reason in the pediatric group (n=42) was traumatic brain injury (42.9%) and 12 of these patients (28.6%) became organ donors. In the adult patient group (n=261), the most common reason was intracranial hemorrhage (39.8%) and 97 patients (37.2%) became organ donors. The rate of BD diagnosis increased over the years (from 0.59% to 0.67% after legal regulation), but there was no increase in organ donation rate (39.5 vs 26.5%). The most common cause of ineligibility for donation was refusal by patient's relatives in both pediatric and adult patients (83.3% and 86.6% respectively). Conclusion: This study shows that although the diagnosis of BD has increased over the years, organ donation rates are still low in Izmir. New strategies aiming to increase awareness and change the perception of organ donation should be planned as soon as possible.	[Aydin, Kutlay; Ergan, Begum; Tokur, Murat Emre; Caliskan, Taner; Savran, Yusuf; Comert, Bilgin; Koca, Ugur; Gokmen, Necati] Dokuz Eylul Univ, Fac Med, Intens Care Unit, Izmir, Turkey; [Yaka, Erdem] Dokuz Eylul Univ, Fac Med, Dept Neurol, Izmir, Turkey; [Gursoy, Gozde] Dokuz Eylul Univ, Fac Med, Dept Anesthesiol & Reanimat, Izmir, Turkey		Aydin, K (corresponding author), Dokuz Eylul Univ, Fac Med, Intens Care Unit, Izmir, Turkey.	kutlayaydin@hotmail.com	Gokmen, Necati/B-1775-2008; Savran, Yusuf/AAI-1796-2019; Miniksar, Okkes Hakan/AAT-5813-2021; Ergan, Begum/U-8276-2017	Gokmen, Necati/0000-0002-3225-7666; Miniksar, Okkes Hakan/0000-0001-5645-7729; Ergan, Begum/0000-0003-2920-9214; Yaka, Erdem/0000-0002-6644-4240; tokur, murat emre/0000-0002-3957-4971; SAVRAN, YUSUF/0000-0002-0130-4730; Gursoy, Gozde/0000-0002-9649-533X; Aydin, Kutlay/0000-0003-2469-2833			[Anonymous], 2014, TURKISH J NEUROLOGY, V20, P101; Aykas A, TRANSPLANT P, V47, P1070; Can F, 2017, TRANSPL P, V49, P1969, DOI 10.1016/j.transproceed.2017.09.032; Cheung CY, 2016, HONG KONG MED J, V22, P570, DOI 10.12809/hkrnj164930; de la Rosa G, 2012, AM J TRANSPLANT, V12, P2507, DOI 10.1111/j.1600-6143.2012.04138.x; Delmonico FL, 2011, LANCET, V378, P1414, DOI 10.1016/S0140-6736(11)61486-4; Erdogan O, 2002, TRANSPLANT P, V34, P2007, DOI 10.1016/S0041-1345(02)02831-2; Escudero D, 2015, ANAESTHESIA, V70, P1130, DOI 10.1111/anae.13065; European Commission, 2014, JOURN WORKSH ORG DON; Frutos MA, 2005, TRANSPLANT P, V37, P3646, DOI 10.1016/j.transproceed.2005.08.057; Ghoshal S, 2015, CURR OPIN CRIT CARE, V21, P107, DOI 10.1097/MCC.0000000000000180; Kahveci B, 2017, TRANSPL P, V49, P1988, DOI 10.1016/j.transproceed.2017.09.034; Keten HS, 2014, ANN TRANSPL, V19, P598, DOI 10.12659/AOT.891370; Kosieradzki M, 2014, J TRANSPLANT, V2014, DOI 10.1155/2014/296912; Mahdavi-Mazdeh M, 2013, INT J TRANSPLANT MED, V4, P72; Matesanz R, 2011, TRANSPL INT, V24, P333, DOI 10.1111/j.1432-2277.2010.01204.x; Pandey A, 2017, NEUROSCIENCE J, P7; Rudge C, 2012, BRIT J ANAESTH, V108, pI48, DOI 10.1093/bja/aer399; Seren AKH, 2017, TRANSPL P, V49, P392, DOI 10.1016/j.transproceed.2017.01.010; Turkish Ministry of Health Department of Organ, TISS TRANSPL DIAL; Varelas PN, 2011, NEUROCRIT CARE, V15, P547, DOI 10.1007/s12028-011-9561-4; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wahlster S, 2015, NEUROLOGY, V84, P1870, DOI 10.1212/WNL.0000000000001540	23	2	2	0	0	GALENOS YAYINCILIK	FINDIKZADE	ERKAN MOR, MOLLA GURANI CAD 21-1, FINDIKZADE, ISTANBUL 34093, TURKEY	2602-2974			TURK J INTENS CARE	Turk. J. Intens. Care	SEP	2019	17	3					154	160		10.4274/tybd.galenos.2018.54366			7	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	IS5FJ	WOS:000482177600005		gold			2022-02-06	
J	Boulton, AJ; Tyner, CE; Choi, SW; Sander, AM; Heinemann, AW; Bushnik, T; Chiaravalloti, N; Sherer, M; Kisala, PA; Tulsky, DS				Boulton, Aaron J.; Tyner, Callie E.; Choi, Seung W.; Sander, Angelle M.; Heinemann, Allen W.; Bushnik, Tamara; Chiaravalloti, Nancy; Sherer, Mark; Kisala, Pamela A.; Tulsky, David S.			Linking the GAD-7 and PHQ-9 to the TBI-QOL Anxiety and Depression Item Banks	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; brain injuries; depression; patient-reported outcome measures; psychometrics; quality of life; traumatic	TRAUMATIC BRAIN-INJURY; RESPONSE THEORY; TESTS; POLYTRAUMA; DISORDER; PACKAGE	Objective: To link scores on commonly used measures of anxiety (7-item Generalized Anxiety Disorder Scale; GAD-7) and depression (9-item Patient Health Questionnaire; PHQ-9) to the Traumatic Brain Injury Quality of Life (TBI-QOL) measurement system. Setting: 5 Traumatic Brain Injury Model Systems. Participants: A total of 385 individuals with traumatic brain injury (TBI) (31% complicated mild; 14% moderate; and 54% severe). Design: Observational cohort. Main Measures: GAD-7, PHQ-9, TBI-QOL Anxiety v1.0 and TBI-QOL Depression v1.0. Results: Item response theory-based linking methods were used to create crosswalk tables that convert scores on the GAD-7 to the TBI-QOL Anxiety metric and scores on the PHQ-9 to the TBI-QOL Depression metric. Comparisons between actual and crosswalked scores suggest that the linkages were successful and are appropriate for group-level analysis. Linking functions closely mirror crosswalks between the GAD-7/PHQ-9 and the Patient-Reported Outcomes Measurement Information System (PROMIS), suggesting that general population linkages are similar to those from a TBI sample. Conclusion: Researchers and clinicians can use the crosswalk tables to transform scores on the GAD-7 and the PHQ-9 to the TBI-QOL metric for group-level analyses.	[Boulton, Aaron J.; Tyner, Callie E.; Kisala, Pamela A.; Tulsky, David S.] Univ Delaware, Coll Hlth Sci, Ctr Hlth Assessment Res & Translat, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, 100 Discovery Blvd, Newark, DE 19713 USA; [Choi, Seung W.] Univ Texas Austin, Educ Psychol Dept, Austin, TX 78712 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.; Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Heinemann, Allen W.] Shirley Ryan AbilityLab, Chicago, IL USA; [Bushnik, Tamara] NYU Langone Hlth, Rusk Rehabil, New York, NY USA; [Chiaravalloti, Nancy] Kessler Fdn, E Hanover, NJ USA; [Chiaravalloti, Nancy] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA		Tulsky, DS (corresponding author), Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, 100 Discovery Blvd, Newark, DE 19713 USA.	dtulsky@udel.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Tulsky, David/0000-0002-4335-4509; Tyner, Callie/0000-0003-2945-392X; Chiaravalloti, Nancy/0000-0003-2943-7567; Bushnik, Tamara/0000-0003-3328-257X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, H133A70038, H133A120100]	This study was supported by grant numbers H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, and H133A70038 from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). Additional support for the preparation of this manuscript was provided by NIDILRR grant # H133A120100.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Ashman TA, OPTIMIZING PRO UNPUB; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Choi SW, 2014, PSYCHOL ASSESSMENT, V26, P513, DOI 10.1037/a0035768; Choi SW., 2012, PROSETTA STONE ANAL, VVol. 1; Cook Karon F, 2007, J Appl Meas, V8, P175; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Dorans NJ, 2007, STAT SOC BEHAV SC, P179, DOI 10.1007/978-0-387-49771-6_10; Dorans NJ, 2004, APPL PSYCH MEAS, V28, P227, DOI 10.1177/0146621604265031; Dorans NJ, 2000, J EDUC MEAS, V37, P281, DOI 10.1111/j.1745-3984.2000.tb01088.x; Embretson S.E., 2013, ITEM RESPONSE THEORY; Faul M, 2010, TRAUMATIC BRAIN INJU; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hughes, 2018, WILEY HDB PSYCHOMETR, P639, DOI DOI 10.1002/9781118489772.CH21; Kolen M., 2014, TEST EQUATING SCALIN, V3rd Edn; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; LANGE R, 2012, ARCH CLIN NEUROPSYCH, V27, P619; Lange RT, 2016, J HEAD TRAUMA REHAB, V31, P62, DOI 10.1097/HTR.0000000000000149; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Little T. D., 2013, LONGITUDINAL STRUCTU; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McDonald R, 1999, TEST THEORY UNIFIED; Newsome MR, 2018, BRAIN INJURY, V32, P1236, DOI 10.1080/02699052.2018.1494853; Prevention C. F. D. C. a., 2019, TRAUM BRAIN INJ CONC; Reise SP, 2013, EDUC PSYCHOL MEAS, V73, P5, DOI 10.1177/0013164412449831; Revicki D.A., 2015, HDB ITEM RESPONSE TH; SAMEJIMA F, 1969, PSYCHOMETRIKA, V34, P1; Sander AM, OPTIMIZING PRO UNPUB; Schalet BD, 2014, J ANXIETY DISORD, V28, P88, DOI 10.1016/j.janxdis.2013.11.006; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; TEASDALE G, 1974, LANCET, V2, P81; THISSEN D, 1995, APPL PSYCH MEAS, V19, P39, DOI 10.1177/014662169501900105; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Weeks JP, 2010, J STAT SOFTW, V35, P1; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	45	2	3	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		353	363		10.1097/HTR.0000000000000529			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100015	31498233				2022-02-06	
J	Carlozzi, NE; Tyner, CE; Kisala, PA; Boulton, AJ; Sherer, M; Chiaravalloti, N; Tulsky, DS				Carlozzi, Noelle E.; Tyner, Callie E.; Kisala, Pamela A.; Boulton, Aaron J.; Sherer, Mark; Chiaravalloti, Nancy; Tulsky, David S.			Measuring Self-Reported Cognitive Function Following TBI: Development of the TBI-QOL Executive Function and Cognition-General Concerns Item Banks	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; cognition; health-related quality of life; patient-reported outcome measures; psychometrics	TRAUMATIC BRAIN-INJURY; MEMORY QUESTIONNAIRE; RESPONSE THEORY; HEAD-INJURY; CONCUSSION SYMPTOMS; EVERYDAY MEMORY; NORMATIVE DATA; HEALTH-STATUS; RELIABILITY; PERFORMANCE	Objective: To develop and calibrate new patient-reported outcome measures of cognitive concerns for individuals with traumatic brain injury (TBI). Setting: Five TBI model systems rehabilitation centers in the United States. Participants: Adults with medically confirmed history of TBI. Design: Cross-sectional survey in interview format. Main Measures: Traumatic Brain Injury-Quality of Life (TBI-QOL) Executive Function and TBI-QOL Cognition-General Concerns item banks. Results: A total of 569 adults with complicated-mild, moderate, or severe TBI completed preliminary item pools, which included 65 Executive Function items and 56 Cognition-General Concerns items. Confirmatory factor analysis supported the retention of 37 Executive Function and 39 Cognition-General Concerns items. Samejima's graded response model was used to estimate item parameters for associated computer adaptive test administrations, and informed the selection of corresponding static short forms. Data from an independent sample of 77 adults with complicated-mild, moderate, or severe TBI supported the test-retest reliability of these newly developed measures. Conclusion: The TBI-QOL Executive Function and Cognition-General Concerns item banks provide researchers and clinicians with reliable tools for assessing patient-reported post-TBI cognitive difficulties as part of the comprehensive TBI-QOL measurement system.	[Carlozzi, Noelle E.] Univ Michigan, Med Sch, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Tyner, Callie E.; Kisala, Pamela A.; Boulton, Aaron J.; Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, 100 Discovery Blvd, Newark, DE 19713 USA; [Sherer, Mark] Mem Hermann, Inst Rehabil Res, Houston, TX USA; [Chiaravalloti, Nancy] Rutgers New Jersey Med Sch, Newark, NJ USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, 100 Discovery Blvd, Newark, DE 19713 USA		Tulsky, DS (corresponding author), Univ Delaware, Ctr Hlth Assessment Res & Translat, 100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Phys Therapy, 100 Discovery Blvd, Newark, DE 19713 USA.; Tulsky, DS (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, 100 Discovery Blvd, Newark, DE 19713 USA.	dtulsky@udel.edu		Tyner, Callie/0000-0003-2945-392X; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, H133A70038, H133A120100]	This study was supported by grant numbers H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, and H133A70038 from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR). Additional support for the preparation of this article was provided by NIDILRR grant # H133A120100.	ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bjorner J, 2007, IRTFIT MACRO ITEM FI; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Brown M.W., 1993, SOCIOL METHOD RES, P136; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Chau LT, 2007, NEUROPSYCHOL REHABIL, V17, P707, DOI 10.1080/09602010600923926; Cheng Y, 2012, EDUC PSYCHOL MEAS, V72, P52, DOI 10.1177/0013164411407315; Choi SW, 2011, J STAT SOFTW, V39, P1; Choi SW, 2009, APPL PSYCH MEAS, V33, P644, DOI 10.1177/0146621608329892; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; COHEN J, 1988, NEW YORK TIMES BK R, P26; Cohen ML, 2019, J HEAD TRAUMA REHAB, V34, P326, DOI 10.1097/HTR.0000000000000528; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Crawford JR, 2006, BRIT J CLIN PSYCHOL, V45, P83, DOI 10.1348/014466505X28748; DeVellis R.F., 2017, SCALE DEV THEORY APP; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Embretson S.E., 2013, ITEM RESPONSE THEORY; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Gass CS, 1997, J CLIN EXP NEUROPSYC, V19, P290, DOI 10.1080/01688639708403858; Gershon R, 2010, QUAL LIFE RES, V19, P677, DOI 10.1007/s11136-010-9634-4; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P249, DOI 10.1076/chin.8.4.249.13513; Goldstein G., 1995, INT J REHABILITATION, V1, DOI [10.1007/BF02214959, DOI 10.1007/BF02214959]; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hughes, 2018, WILEY HDB PSYCHOMETR, P639, DOI DOI 10.1002/9781118489772.CH21; Kim SH, 2007, J EDUC MEAS, V44, P93, DOI 10.1111/j.1745-3984.2007.00029.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kisala Pamela A, 2010, J Appl Meas, V11, P315; Kolen M., 2014, TEST EQUATING SCALIN, V3rd Edn; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; MCKINLAY W, 1999, REHABILITATION ADULT, P74; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; MESSICK S, 1995, AM PSYCHOL, V50, P741, DOI 10.1037/0003-066X.50.9.741; MESSICK S, 1980, AM PSYCHOL, V35, P1012, DOI 10.1037/0003-066X.35.11.1012; MetaMetrics, 1995, LEXILE FRAMEWORK REA; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Muthen B. O., 1998, MPLUS USERS GUIDE, V7th; National Institute of Neurological Disorders and Stroke, 2010, US MAN QUAL LIF NEUR; Niemeier JP, 2013, REHABIL PSYCHOL, V58, P51, DOI 10.1037/a0031612; Orlando M, 2003, APPL PSYCH MEAS, V27, P289, DOI 10.1177/0146621603027004004; PROMIS, 2012, PROMIS INSTR DEV PSY; Rast P, 2009, ASSESSMENT, V16, P145, DOI 10.1177/1073191108324440; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; SAMEJIMA F, 1969, PSYCHOMETRIKA, V34, P1; Samejima F, 1996, HDB MODERN ITEM RESP, P85; Santos ME, 1998, BRAIN INJURY, V12, P759, DOI 10.1080/026990598122151; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Steiger J., 1980, ANN M PSYCH SOC IOW, V758; STOCKING ML, 1983, APPL PSYCH MEAS, V7, P201, DOI 10.1177/014662168300700208; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Teresi Jeanne A, 2009, Psychol Sci Q, V51, P148; THISSEN D, 2003, MULTILOG VERSION 7 C; Thissen D., 1993, DIFFERENTIAL ITEM FU, P67; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; TUN PA, 1995, AGING COGNITION, V2, P39, DOI 10.1080/13825589508256588; Tyner CE, 2018, ARCH PHYS MED REHABI; Urbina S, 1997, PSYCHOL TESTING; Vallat-Azouvi C, 2012, NEUROPSYCHOL REHABIL, V22, P634, DOI 10.1080/09602011.2012.681110; Volz-Sidiropoulou E., 2007, Z NEUROPSYCHOL, V18, P299, DOI DOI 10.1024/1016-264X.18.4.299; World Health Organization W, INT HLTH C 1946 NEW; Youn JC, 2009, DEMENT GERIATR COGN, V27, P310, DOI 10.1159/000205512; Zumbo B., 1999, HDB THEORY METHODS D	73	2	2	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		308	325		10.1097/HTR.0000000000000520			18	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100012	31498230				2022-02-06	
J	Cavanagh, JF; Wilson, JK; Rieger, RE; Gill, D; Broadway, JM; Remer, JHS; Fratzke, V; Mayer, AR; Quinn, DK				Cavanagh, James F.; Wilson, J. Kevin; Rieger, Rebecca E.; Gill, Darbi; Broadway, James M.; Remer, Jacqueline Hope Story; Fratzke, Violet; Mayer, Andrew R.; Quinn, Davin K.			ERPs predict symptomatic distress and recovery in sub-acute mild traumatic brain injury	NEUROPSYCHOLOGIA			English	Article						TBI; Executive; Post-concussive; P3a; P3b; EEG	EVENT-RELATED POTENTIALS; SPORT-RELATED CONCUSSION; COGNITIVE CONTROL; ELECTRICAL-ACTIVITY; QUANTITATIVE EEG; NEGATIVE AFFECT; HEAD-INJURY; P300; IDENTIFICATION; ATTENTION	Mild traumatic brain injury (mTBI) can affect high-level executive functioning long after somatic symptoms resolve. We tested if simple EEG responses within an oddball paradigm could capture variance relevant to this clinical problem. The P3a and P3b components reflect bottom-up and top-down processes driving engagement with exogenous stimuli. Since these features are related to primitive decision abilities, abnormal amplitudes following mTBI may account for problems in the ability to exert executive control. Sub-acute (<2 weeks) mTBI participants (N = 38) and healthy controls (N = 24) were assessed at an initial session as well as a two-month follow-up (sessions 1 and 2). We contrasted the initial assessment to a comparison group of participants with chronic symptomatology following brain injury (N = 23). There were no group differences in P3a or P3b amplitudes. Yet in the sub-acute mTBI group, higher symptomatology on the Frontal Systems Behavior scale (FrSBe), a questionnaire validated as measuring symptomatic distress related to frontal lobe injury, correlated with lower P3a in session 1. This relationship was replicated in session 2. These findings were distinct from chronic TBI participants, who instead expressed a relationship between increased FrSBe symptoms and a lower P3b component. In the sub-acute group, P3b amplitudes in the first session correlated with the degree of symptom change between sessions 1 and 2, above and beyond demographic predictors. Controls did not show any relationship between FrSBe symptoms and P3a or P3b. These findings identify symptom-specific alterations in neural systems that vary along the time course of post-concussive symptomatology.	[Cavanagh, James F.; Wilson, J. Kevin; Rieger, Rebecca E.; Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Logan Hall 1,MSC03 2220, Albuquerque, NM 87131 USA; [Gill, Darbi; Broadway, James M.; Remer, Jacqueline Hope Story; Fratzke, Violet; Mayer, Andrew R.] Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, 1101 Yale Blvd,MSC 084740, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA; [Quinn, Davin K.] Univ New Mexico, Dept Psychiat & Behav Sci, Hlth Sci Ctr, 2600 Marble Ave NE, Albuquerque, NM 87106 USA		Cavanagh, JF (corresponding author), Univ New Mexico, Dept Psychol, Logan Hall 1,MSC03 2220, Albuquerque, NM 87131 USA.	jcavanagh@unm.edu			Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM109089]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089] Funding Source: NIH RePORTER	This research is supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM109089.	Anderson NE, 2015, PSYCHOPHYSIOLOGY, V52, P1194, DOI 10.1111/psyp.12441; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Ayaz SI, 2015, AM J EMERG MED, V33, P493, DOI 10.1016/j.ajem.2014.11.015; Bailey NW, 2015, BIOL PSYCHOL, V106, P1, DOI 10.1016/j.biopsycho.2015.01.011; Barcelo F, 2002, NEUROREPORT, V13, P1887, DOI 10.1097/00001756-200210280-00011; Barcelo F, 2006, J COGNITIVE NEUROSCI, V18, P1734, DOI 10.1162/jocn.2006.18.10.1734; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Brush CJ, 2018, INT J PSYCHOPHYSIOL, V132, P124, DOI 10.1016/j.ijpsycho.2017.10.006; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Candrian G, 2018, ANN PHYS REHABIL MED, V61, P18, DOI 10.1016/j.rehab.2017.07.246; Cavanagh JF, 2015, J PHYSIOL-PARIS, V109, P3, DOI 10.1016/j.jphysparis.2014.04.003; Cavanagh JF, 2012, PSYCHOPHYSIOLOGY, V49, P220, DOI 10.1111/j.1469-8986.2011.01293.x; Cavanagh JF, 2019, ELECTROPHYSIOLOGY TH, P1, DOI [10.1111/psyp.13314, DOI 10.1111/PSYP.13314]; Cecchi Marco, 2015, Alzheimers Dement (Amst), V1, P387, DOI 10.1016/j.dadm.2015.08.004; Chang L.J., 2016, LARGE SCALE METAANAL, DOI [10.1523/JNEUROSCI.4402-15.2016, DOI 10.1523/JNEUROSCI.4402-15.2016]; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Damborska A., 2017, ACTIV NERV SUPER, V59, P87, DOI [10.1007/s41470-017-0011-2, DOI 10.1007/S41470-017-0011-2]; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doi R, 2007, AM J PHYS MED REHAB, V86, P641, DOI 10.1097/PHM.0b013e318115aca9; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gaetz M, 2000, BRAIN INJURY, V14, P815; Gillan CM, 2016, NEURON, V91, P19, DOI 10.1016/j.neuron.2016.06.002; Gilmore CS, 2018, BEHAV BRAIN RES, V340, P174, DOI 10.1016/j.bbr.2016.12.002; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; Hanley DF, 2013, J NEUROTRAUM, V30, P2051, DOI 10.1089/neu.2013.3062; Iacono WG, 2003, INT J PSYCHOPHYSIOL, V48, P147, DOI 10.1016/S0167-8760(03)00052-7; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kopp B, 2006, J COGNITIVE NEUROSCI, V18, P949, DOI 10.1162/jocn.2006.18.6.949; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Lang, 1999, INT AFFECTIVE DIGITI; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P61, DOI 10.1016/j.ijpsycho.2011.02.001; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Mayer AR, 2018, BIOL PSYCHIAT-COGN N, V3, P294, DOI 10.1016/j.bpsc.2017.09.012; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Prichep LS, 2015, J NEUROTRAUM, V32, P17, DOI 10.1089/neu.2014.3365; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Quinn DK, 2018, AM J PSYCHIAT, V175, P103, DOI 10.1176/appi.ajp.2017.17020235; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Rohling M.L., 2012, MISERABLE MINORITY F, P4046, DOI [10.1080/13854046.2011.647085, DOI 10.1080/13854046.2011.647085]; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rushby J.A., 2006, AN ORIENTING RE X EX, P539, DOI [10.1007/s00221-006-0590-8, DOI 10.1007/S00221-006-0590-8]; Seer C, 2016, NEUROSCI BIOBEHAV R, V71, P691, DOI 10.1016/j.neubiorev.2016.08.003; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shah SA, 2017, NEUROIMAGE-CLIN, V14, P233, DOI 10.1016/j.nicl.2017.01.010; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Solis-Vivanco R, 2015, CLIN NEUROPHYSIOL, V126, P2142, DOI 10.1016/j.clinph.2014.12.024; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Thatcher R.W., 2001, TRAUMATIC BRAIN INJU, P77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Twomey DM, 2015, EUR J NEUROSCI, V42, P1636, DOI 10.1111/ejn.12936; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Waller DA, 2021, INT J PSYCHOPHYSIOL, V163, P11, DOI 10.1016/j.ijpsycho.2019.01.004; Wessel JR, 2018, TRENDS COGN SCI, V22, P741, DOI 10.1016/j.tics.2018.06.005; Wienke AS, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00218; Wilson MJ, 2014, DEV NEUROPSYCHOL, V39, P113, DOI 10.1080/87565641.2013.870177; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3	92	2	2	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	SEP	2019	132								107125	10.1016/j.neuropsychologia.2019.107125			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	JJ1IK	WOS:000493914100002	31228481	Green Accepted			2022-02-06	
J	Chen, J; Oddson, B; Gilbert, HC				Chen, Jian; Oddson, Bruce; Gilbert, Heather C.			Differential Effect of Recurrent Concussions on Symptom Clusters in Sport Concussion Assessment Tool	JOURNAL OF SPORT REHABILITATION			English	Article						graded symptoms; accumulative; head injury; sport injury; cumulative effects; basal ganglia	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; RECOVERY; CIRCUITS; PLAYERS; VALUES; ZURICH; LIGHT	Context: Symptom checklist in Sport Concussion Assessment Tool has been widely used in preseason assessment and in concussion diagnosis, but the impact of prior concussions on the graded symptoms after a new concussion has not been evaluated. Objective: This study was undertaken to examine reported symptoms associated with recurrent concussions using data of a comprehensive survey among athletes. Design: Retrospective survey and cross-sectional study. Setting: College athletes. Participants: Student athletes who sustained one or more concussions. Main Outcome Measures: Concussion history and graded symptoms of the most recent concussion at time of the survey were surveyed. The impact of prior concussions was examined over symptoms and aggregated symptoms. Results: Multiple concussions were associated with greater reporting of individual symptoms related to emotion and physical symptoms of sensitivity to light and noise: more emotional (z = 2.3, P =.02); sadness (z = 2.4, P =.02); nervousness (z = 2.4, P =.02); irritability (z = 3.6, P =.01); sensitivity to light (z = 2.6, P =.01); and sensitivity to noise (z = 2.4, P =.04). The composite scores of emotional symptom and sensitivity symptom clusters were significantly higher: t = 2.68 (P <.01) and t = 3.35 (P <.01), respectively. Conclusions: The significant rises in emotional and sensitivity symptoms may be an important additive effect of concussive injury. Closer attention should be given to these symptom clusters when evaluating concussion injury and recovery.	[Chen, Jian; Oddson, Bruce; Gilbert, Heather C.] Laurentian Univ, Sch Human Kinet, Sudbury, ON, Canada		Chen, J (corresponding author), Laurentian Univ, Sch Human Kinet, Sudbury, ON, Canada.	jchen@laurentian.ca		Oddson, Bruce/0000-0002-3272-5562			ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	29	2	2	2	8	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	SEP	2019	28	7					735	739		10.1123/jsr.2018-0166			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	IW7SN	WOS:000485194400012	30222472				2022-02-06	
J	Chen, KF; Dai, FH; Li, GX; Dong, JR; Wang, YH				Chen, Kefei; Dai, Feihu; Li, Guangxu; Dong, Jirong; Wang, Yuhai			Using computerized tomography perfusion to measure cerebral hemodynamics following treatment of traumatic brain injury in rabbits	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						computed tomography perfusion; traumatic brain injury; cerebral hemodynamics; compression; decompression	INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; CT; TERM; TBI	The present study aimed to investigate the use of computerized tomography (CT) perfusion for evaluating cerebral hemodynamics following traumatic brain injury (TBI) in rabbits. The animals were randomly assigned into four groups (n=10 animals/group): i) Control, ii) TBI, iii) TBI + common decompression and iv) TBI + controlled decompression groups. A TBI model was established in rabbits using epidural balloon inflation. In the groups receiving intervention, animals were provided common decompression or controlled decompression treatments. Conventional CT and CT perfusion scanning were performed, with cerebral hemodynamic indices, including regional cerebral blood flow (rCBF), regional cerebral blood volume (rCBV) and mean transit time (MTT) being measured. Blood-brain barrier (BBB) permeability was evaluated using Evans blue staining. Compared with those in the control group, rCBF and rCBV values of the bilateral temporal lobes and basal ganglion in the TBI, TBI + common decompression and TBI + controlled decompression groups were significantly lower, whereas the MTT values were markedly prolonged and Evans blue dye content was greatly increased (P<0.01). Controlled decompression was demonstrated to be more potent than common decompression for preventing TBI-induced decline in rCBF and rCBV values in the bilateral temporal lobes and basal ganglion, as well as reversing TBI-induced extension of MTT in the bilateral temporal lobes (P<0.01 vs. TBI group). However, neither common nor controlled decompression could reduce TBI-induced increase in BBB permeability. In conclusion, these findings indicate that CT perfusion may be used to monitor cerebral hemodynamics following TBI in rabbits. Controlled decompression was deduced to be more potent than common decompression for preventing abnormalities in cerebral hemodynamics after TBI.	[Chen, Kefei; Dai, Feihu; Li, Guangxu; Dong, Jirong; Wang, Yuhai] Anhui Med Univ, Hosp Peoples Liberat Army 101, Craniocerebral Injury Cure Ctr Peoples Liberat Ar, Dept Neurosurg,Wuxi Clin Coll, 101 Xingyuan North Rd, Wuxi 214044, Jiangsu, Peoples R China		Wang, YH (corresponding author), Anhui Med Univ, Hosp Peoples Liberat Army 101, Craniocerebral Injury Cure Ctr Peoples Liberat Ar, Dept Neurosurg,Wuxi Clin Coll, 101 Xingyuan North Rd, Wuxi 214044, Jiangsu, Peoples R China.	wangyuhai_pla@163.com			Science Foundation of Wuxi Municipal Commission of Health and Family Planning in China [MS201527]	The present study was supported by The Science Foundation of Wuxi Municipal Commission of Health and Family Planning in China (grant no. MS201527 to KFC).	Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bendinelli C, 2013, INJURY, V44, P1208, DOI 10.1016/j.injury.2013.03.039; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bragin DE, 2014, CRIT CARE MED, V42, P2582, DOI 10.1097/CCM.0000000000000655; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Charry JD, 2016, J NEUROSCI RURAL PRA, V7, P7, DOI 10.4103/0976-3147.172151; [陈卫良 Chen Weiliang], 2015, [中华创伤杂志, Chinese Journal of Trauma], V31, P753; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Donnelly J, 2017, J CEREBR BLOOD F MET, V37, P694, DOI 10.1177/0271678X16639060; Douglas DB, 2018, NEUROIMAG CLIN N AM, V28, P55, DOI 10.1016/j.nic.2017.09.002; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Gungormus M, 2002, J ORAL MAXIL SURG, V60, P541, DOI 10.1053/joms.2002.31852; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; [李臻琰 Li Zhenyan], 2002, [湖南医科大学学报, Bulletin of Hunan Medical University], V27, P441; Lim D, 2014, AM J EMERG MED, V32, P1051, DOI 10.1016/j.ajem.2014.06.020; Moretti R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00040; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Pan JW, 2013, J COMPUT ASSIST TOMO, V37, P645, DOI 10.1097/RCT.0b013e31829866fc; POWERS WJ, 1984, ANN NEUROL, V16, P546, DOI 10.1002/ana.410160504; Quintard H, 2015, ANAESTH CRIT CARE PA, V34, P79, DOI 10.1016/j.accpm.2014.09.002; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00114; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thierfelder KM, 2013, NEURORADIOLOGY, V55, P827, DOI 10.1007/s00234-013-1179-0; Toth P, 2016, AM J PHYSIOL-HEART C, V311, pH1118, DOI 10.1152/ajpheart.00267.2016; Wang YH, 2014, TURK NEUROSURG, V24, P214, DOI 10.5137/1019-5149.JTN.8135-13.1	31	2	2	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	SEP	2019	18	3					2104	2110		10.3892/etm.2019.7785			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	IZ8MG	WOS:000487358600075	31410165	gold, Green Published, Green Submitted			2022-02-06	
J	Cho, T; Kashiwagi, Y; Okabe, S				Cho, Takusei; Kashiwagi, Yutaro; Okabe, Shigeo			Temporal Sequences of Synapse Disintegration Triggered by Afferent Axon Transection, Time-Lapse Imaging Study of Presynaptic and Postsynaptic Molecules	ENEURO			English	Article						dendritic spine; hippocampus; live imaging; NMDA receptor; synaptic plasticity; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; DENDRITIC SPINES; RAT MODEL; PLASTICITY; DENSITY; EXPRESSION; RECOVERY; DAMAGE	Traumatic brain injury (TBI) is one of the major causes of death and disability. Multiple animal models have been developed to explore therapeutic targets for TBI. However, heterogeneity of pathophysiology obstructs discovery of therapeutic targets. To facilitate understanding of TBI pathophysiology, each element of neuronal and glial responses should be studied separately. We focused on synapse remodeling which plays an important role in recovery from TBI and developed a new method, afferent elimination, for analyzing synapse remodeling after selective damage to presynaptic axons by mechanical transection in culture of mouse hippocampal neurons. Afferent elimination can induce various events related to synapse remodeling and we could determine their temporal orders and find relationships between them. Specifically, loss of presynaptic sites preceded loss of postsynaptic sites and spines. Some of the postsynaptic sites initially located inside spines showed translocation toward dendritic shafts. These translocation events started after the loss of contacting presynaptic sites. Also, these events could be blocked or delayed by NMDA receptor inhibition. Taken together, these findings suggest that postsynaptic changes occur in afferent elimination are NMDA dependent and imply that these NMD-Adependent events underlie synaptic remodeling of TBI.	[Cho, Takusei; Kashiwagi, Yutaro; Okabe, Shigeo] Univ Tokyo, Grad Sch Med, Dept Cellular Neurobiol, Tokyo 1130033, Japan		Okabe, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cellular Neurobiol, Tokyo 1130033, Japan.	okabe@m.u-tokyo.ac.jp	Kashiwagi, Yutaro/A-7419-2018	Kashiwagi, Yutaro/0000-0002-8034-3729; Okabe, Shigeo/0000-0003-1216-8890	JSPSMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [17H01387, 18H04727]; Core Research for Evolutional Science and Technology from the Japan Science and Technology AgencyCore Research for Evolutional Science and Technology (CREST) [JPMJCR14W2]; Japan Agency for Medical Research and DevelopmentJapan Agency for Medical Research and Development (AMED) [17gm5010003]; UTokyo Center for Integrative Science of Human Behavior (CiSHuB)	This study was supported by JSPS Grants-in-Aid for Scientific Research (17H01387 and 18H04727 to S.O.), Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency (JPMJCR14W2 to S.O.), the Project for Elucidating and Controlling Mechanisms of Aging and Longevity from the Japan Agency for Medical Research and Development (17gm5010003 to S.O.) and the UTokyo Center for Integrative Science of Human Behavior (CiSHuB).	Adeleye A, 2010, EUR J PHARMACOL, V629, P25, DOI 10.1016/j.ejphar.2009.11.066; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bandaru SP, 2015, J NEUROPHYSIOL, V113, P1598, DOI 10.1152/jn.00566.2014; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gerdts J, 2016, NEURON, V89, P449, DOI 10.1016/j.neuron.2015.12.023; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nagendran T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00652-y; Nahmani M, 2014, NEUROSCIENCE, V283, P4, DOI 10.1016/j.neuroscience.2014.04.029; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Ozcan Ahmet S, 2017, Front Synaptic Neurosci, V9, P12, DOI 10.3389/fnsyn.2017.00012; Park K, 2013, FUTUR NEUROL, V8, P555, DOI 10.2217/FNL.13.35; Perez EJ, 2017, J CLIN INVEST, V127, P3114, DOI 10.1172/JCI92300; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rao VLR, 2001, BRAIN RES, V911, P96; Schoch KM, 2012, NEUROTHERAPEUTICS, V9, P323, DOI 10.1007/s13311-012-0107-z; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tchantchou F, 2017, EXP NEUROL, V289, P9, DOI 10.1016/j.expneurol.2016.12.001; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	36	2	2	0	0	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA		2373-2822		ENEURO	eNeuro	SEP-OCT	2019	6	5							0459-18.2019	10.1523/ENEURO.0459-18.2019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JJ6QC	WOS:000494278900025	31515235	Green Published, gold			2022-02-06	
J	Crasta, JE; Sibel, J; Slomine, BS; Mahone, EM; Mostofsky, SH; Suskauer, SJ				Crasta, Jewel E.; Sibel, Jamie; Slomine, Beth S.; Mahone, E. Mark; Mostofsky, Stewart H.; Suskauer, Stacy J.			Subtle Motor Signs in Children With Chronic Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Traumatic Brain Injury; Pediatric; Subtle Motor Signs; PANESS	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEUROLOGICAL EXAMINATION; MIRROR MOVEMENTS; ADOLESCENTS; ACTIVATION; RECOVERY	Objective The aim of the study was to characterize subtle motor signs in children with moderate-severe traumatic brain injury in the chronic phase of injury. Design Fourteen children with moderate (n = 6) or severe (n = 8) traumatic brain injury, ages 11-18 yrs, who had sustained their injury at least 1-yr before study participation (range 1-14 yrs since injury), and 14 matched typically developing controls were examined using the Physical and Neurological Examination of Subtle Signs (PANESS). To examine the neural correlates of subtle motor signs, measures of total cerebral volume and motor/premotor volume were derived from magnetic resonance imaging. Results Children with traumatic brain injury had significantly poorer PANESS performance than controls on the total timed subscore, proximal overflow, and the PANESS total score. Participants with severe traumatic brain injury had greater proximal overflow than those with moderate injury, after controlling for age at injury. Across all participants, greater proximal overflow correlated with reduced total cerebral volume, whereas within the traumatic brain injury group, reduced motor/premotor volume correlated with lower PANESS total score. Conclusions The study highlights the importance of examining subtle motor signs including overflow during clinical evaluation of chronic pediatric traumatic brain injury and establishes the clinical utility of the PANESS as a measure sensitive to chronic subtle motor signs in this population. To Claim CME Credits Complete the self-assessment activity and evaluation online at CME Objectives Upon completion of this article, the reader should be able to: (1) Define subtle motor signs including motor overflow; (2) Identify subtle motor signs such as motor overflow during clinical evaluation of children with brain injury; and (3) Explain the relevance of examining subtle motor signs in chronic pediatric brain injury during clinical evaluations. Level Advanced. Accreditation The Association of Academic Physiatrists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Association of Academic Physiatrists designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)(TM). Physicians should only claim credit commensurate with the extent of their participation in the activity.	[Crasta, Jewel E.; Sibel, Jamie; Slomine, Beth S.; Mahone, E. Mark; Mostofsky, Stewart H.; Suskauer, Stacy J.] Kennedy Krieger Inst, 716 N Broadway, Baltimore, MD 21205 USA; [Crasta, Jewel E.; Slomine, Beth S.; Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Mostofsky, Stewart H.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Slomine, Beth S.; Mahone, E. Mark] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 716 N Broadway, Baltimore, MD 21205 USA.		Crasta, Jewel/AAV-4936-2021; Crasta, Jewel/S-9932-2019	Crasta, Jewel/0000-0002-5397-6336; 	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23HD06161, UL1TR001079-04, K12 HD001097, R01HD090266]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD090266] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001079] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health (S.S.: K23HD06161, UL1TR001079-04, K12 HD001097, and R01HD090266). Rehabilitation Research Experience for Medical Students (RREMS) program and Craig H. Neilson Foundation (J.S.).	Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; CERNACEK J, 1961, ARCH NEUROL-CHICAGO, V4, P165, DOI 10.1001/archneur.1961.00450080047005; Chapman S.B., 2006, BRAIN INJ PROF, V3, P10; Cole WR, 2008, NEUROLOGY, V71, P1514, DOI 10.1212/01.wnl.0000334275.57734.5f; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Gaddis A, 2015, PSYCHIAT RES-NEUROIM, V233, P488, DOI 10.1016/j.pscychresns.2015.08.001; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; Hoy KE, 2004, BRAIN RES REV, V46, P315, DOI 10.1016/j.brainresrev.2004.07.013; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Larson JCG, 2007, DEV NEUROPSYCHOL, V32, P543; Leinsinger GL, 1997, RADIOLOGY, V203, P545, DOI 10.1148/radiology.203.2.9114119; Max JE, 2016, CHILDHOOD HEAD INJUR, P159; Mostofsky SH, 2006, BIOL PSYCHIAT, V59, P48, DOI 10.1016/j.biopsych.2005.06.011; Mostofsky SH, 2007, BRAIN, V130, P2117, DOI 10.1093/brain/awm129; Ranta ME, 2014, HUM BRAIN MAPP, V35, P2009, DOI 10.1002/hbm.22309; Reich W, 2000, J AM ACAD CHILD PSY, V39, P59, DOI 10.1097/00004583-200001000-00017; Shafer SQ, 1983, DEV NEUROPSYCHIATRY, P133; Stephens J, 2017, J MOTOR BEHAV, V49, P20, DOI 10.1080/00222895.2016.1204267; Stephens JA, 2018, AM J PHYS MED REHAB, V97, P456, DOI 10.1097/PHM.0000000000000906; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; TODOR JI, 1986, DEV MED CHILD NEUROL, V28, P205; Uttner I, 2005, EUR J NEUROL, V12, P964, DOI 10.1111/j.1468-1331.2005.01098.x; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	28	2	2	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	SEP	2019	98	9					737	744		10.1097/PHM.0000000000001110			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	IR6BW	WOS:000481525600007	30550451	Green Accepted			2022-02-06	
J	Forrest, G; Reppel, A; Kodsi, M; Smith, J				Forrest, George; Reppel, Alycia; Kodsi, Mina; Smith, Joshua			Inpatient rehabilitation facilities The 3-hour rule	MEDICINE			English	Article						inpatient rehabilitation facilities; outcomes; three -hour rule	TRAUMATIC BRAIN-INJURY; FUNCTIONAL STATUS; STROKE PATIENTS; THERAPY INTENSITY; OUTCOMES; SERVICES; PATIENT; LENGTH; STAY	The aim of this study was to determine whether patients whose treatment is consistent with the 3-hour rule have better outcomes than patients whose treatment is not consistent with the 3-hour rule. T his is a retrospective review of the records of 581 patients. The authors compared the outcomes of 397 patients whose therapy was consistent with the 3-hour rule to the outcomes of 184 patients whose therapy was not consistent with the rule for at least one 7-day period during the stay on an inpatient rehabilitation facility. Patients whose care was consistent with the rule did not have more improvement in function or shorter length of stay than patients whose care was not consistent with the 3-hour rule. There is not good evidence to support the 3-hour rule as a determinant of the care that a patient at an IRF needs to achieve a good outcome.	[Forrest, George] Albany Med Coll, Dept Phys Med & Rehabil, Albany, NY 12208 USA; [Forrest, George] St Peters Hlth Partners, Dept Internal Med, Albany, NY USA; [Reppel, Alycia] St Marys Hlth Syst, Lewiston, ME USA; [Kodsi, Mina; Smith, Joshua] Univ Rochester, Med Coll, Dept Phys Med & Rehabil, Rochester, NY USA		Forrest, G (corresponding author), Albany Med Ctr Hosp, Albany Med Coll, Albany, NY 12208 USA.	georgemcv78@gmail.com					Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1306, DOI 10.1016/j.apmr.2009.04.003; DiSotto-Monastero M, 2012, ARCH PHYS MED REHAB, V93, P2165, DOI 10.1016/j.apmr.2012.07.003; Dumas Helene M, 2004, Pediatr Phys Ther, V16, P157, DOI 10.1097/01.PEP.0000136004.69289.01; Everink IHJ, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0187-4; Foley N, 2012, TOP STROKE REHABIL, V19, P96, DOI 10.1310/tsr1902-96; Forrest G, 2018, J COMMUNITY SUPPORT, V16, pE138, DOI 10.12788/jcso.0409; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Hughes Kelly, 1993, Physiotherapy Canada, V45, P245; JOHNSTON MV, 1986, ARCH PHYS MED REHAB, V67, P581; Jung HY, 2018, AM J MANAG CARE, V24, pE249; Keith RA, 1997, ARCH PHYS MED REHAB, V78, P1298, DOI 10.1016/S0003-9993(97)90300-2; Keren O, 2004, ISR MED ASSOC J, V6, P736; Kirk-Sanchez NJ, 2001, PHYS THER, V81, P888, DOI 10.1093/ptj/81.3.888; Nelson A, 2007, REHABIL NURS, V32, P179, DOI 10.1002/j.2048-7940.2007.tb00173.x; Peiris CL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-198; Qu Haiyan, 2010, Qual Manag Health Care, V19, P47, DOI 10.1097/QMH.0b013e3181ccbc2a; RAPOPORT J, 1989, PHYS THER, V69, P32, DOI 10.1093/ptj/69.1.32; Reinstein L, 2014, PM&R, V6, P973, DOI 10.1016/j.pmrj.2014.08.950; Roach KE, 1998, PHYS THER, V78, P19, DOI 10.1093/ptj/78.1.19; Ruff RM, 1999, AM J PHYS MED REHAB, V78, P143, DOI 10.1097/00002060-199903000-00011; Shih SL, 2016, J AM MED DIR ASSOC, V17, P921, DOI 10.1016/j.jamda.2016.06.003; Slade A, 2002, J REHABIL MED, V34, P260, DOI 10.1080/165019702760390347; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; Wade DT, 2000, BMJ-BRIT MED J, V320, P1385, DOI 10.1136/bmj.320.7246.1385; Wang H, 2013, PM&R, V5, P122, DOI 10.1016/j.pmrj.2012.08.013	27	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	SEP	2019	98	37							e17096	10.1097/MD.0000000000017096			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JB7ZM	WOS:000488784400026	31517835	gold, Green Published			2022-02-06	
J	Gleason, JD; Oishi, MMK; Wen, JT; Julius, A; Pappu, S; Yonas, H				Gleason, Joseph D.; Oishi, Meeko M. K.; Wen, John T.; Julius, Agung; Pappu, Suguna; Yonas, Howard			Assessing circadian rhythms and entrainment via intracranial temperature after severe head trauma	BIOMEDICAL SIGNAL PROCESSING AND CONTROL			English	Article						Nonlinear estimation; Circadian rhythms; Traumatic brain injury	BRAIN-INJURY; SLEEP DISTURBANCE; LIGHT; MODEL; DISORDERS	We seek a methodological approach to assess circadian processes in subjects who have recently experienced traumatic brain injury, using regularly gathered intracranial temperature data. The health effects of circadian regulation are profound, yet assessments of circadian processes are often infeasible in the neurotrauma intensive care unit (ICU). We assess circadian periodicity through the energy density spectrum, applying model-based and model-free methods: an extended Kalman filter (using the Kronauer model) in conjunction with a fast Fourier transform (FFT), and the Lomb-Scargle periodogram, respectively. We compute the change in relative energy in a narrow band of the spectrum, corresponding to a period of 23-25 h, over the first 48 and last 48 h of each subject's stay in the ICU. The change in relative energy in the spectrum increases in subjects with Good outcomes, and decreases in subjects with Poor outcomes, with statistical significance. For those subjects with Good outcome, we show evidence of regulation in circadian phase using an adaptive notch filter. (C) 2019 Elsevier Ltd. All rights reserved.	[Gleason, Joseph D.; Oishi, Meeko M. K.] Univ New Mexico, Elect & Comp Engn, Albuquerque, NM 87131 USA; [Pappu, Suguna] Loyola Univ Med Ctr, Maywood, IL 60153 USA; [Pappu, Suguna] Loyola Univ, Stritch Sch Med, 2160 S 1st Ave, Maywood, IL 60153 USA; [Wen, John T.; Julius, Agung] Rensselaer Polytech Inst, Elect Comp & Syst Engn, Troy, NY USA; [Yonas, Howard] Univ New Mexico, Neurosurg, Albuquerque, NM 87131 USA		Oishi, MMK (corresponding author), Univ New Mexico, Elect & Comp Engn, Albuquerque, NM 87131 USA.	gleasonj@unm.edu; oishi@unm.edu		Oishi, Meeko/0000-0003-3722-8837	National Science Foundation (NSF) Smart Lighting Engineering Research CenterNational Science Foundation (NSF) [EEC-0812056]; NSFNational Science Foundation (NSF) [CMMI-1254990]	This material is based upon work supported by the National Science Foundation (NSF) Smart Lighting Engineering Research Center (EEC-0812056) and by the NSF under Grant No. CMMI-1254990 (CAREER Award, Oishi). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Allik B, 2014, P AMER CONTR CONF, P4151, DOI 10.1109/ACC.2014.6859251; [Anonymous], 2014, SEVERE TRAUMATIC BRA; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bagheri N, 2005, P AMER CONTR CONF, P3235, DOI 10.1109/ACC.2005.1470470; Bekinschtein TA, 2009, BRAIN INJURY, V23, P915, DOI 10.1080/02699050903283197; Blume C., 2017, NEUROLOGY; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Chien-Shu Hsieh, 2012, 2012 7th IEEE Conference on Industrial Electronics and Applications (ICIEA 2012). Proceedings, P1533, DOI 10.1109/ICIEA.2012.6360967; Childs C, 2008, BRIT J NEUROSURG, V22, P486, DOI 10.1080/02688690802245541; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Fonken LK, 2013, J BIOL RHYTHM, V28, P262, DOI 10.1177/0748730413493862; Forger DB, 1999, J BIOL RHYTHM, V14, P532, DOI 10.1177/074873099129000867; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Grima N. A., 2016, NEUROREHABIL NEURAL; Gunawan R, 2005, IEEE DECIS CONTR P, P3687; Hsieh CS, 2000, IEEE T AUTOMAT CONTR, V45, P2374, DOI 10.1109/9.895577; Hu XS, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-82; Kar S, 2012, IEEE T AUTOMAT CONTR, V57, P405, DOI 10.1109/TAC.2011.2161834; Kronauer RE, 1999, J BIOL RHYTHM, V14, P500, DOI 10.1177/074873099129001073; Kropyvnytskyy I, 1999, BIOL RHYTHM RES, V30, P82, DOI 10.1076/brhm.30.1.82.3067; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Matsumoto M, 2013, ARCH GERONTOL GERIAT, V57, P428, DOI 10.1016/j.archger.2013.05.009; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Mott C, 2011, IEEE T BIO-MED ENG, V58, P1325, DOI 10.1109/TBME.2011.2107321; Paul T, 2007, CHRONOBIOL INT, V24, P45, DOI 10.1080/07420520601142569; Pearson RK, 2002, IEEE T CONTR SYST T, V10, P55, DOI 10.1109/87.974338; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sinopoli B, 2004, IEEE T AUTOMAT CONTR, V49, P1453, DOI 10.1109/TAC.2004.834121; St Hilaire MA, 2007, J PINEAL RES, V43, P294, DOI 10.1111/j.1600-079X.2007.00477.x; Steele DL, 2005, CHRONOBIOL INT, V22, P89, DOI 10.1081/CBI-200042428; Stengel R. F., 2000, OPTIMAL CONTROL ESTI, P386; Svenkeson D, 2014, IEEE T BIO-MED ENG, V61, P2413, DOI 10.1109/TBME.2014.2317942; Taylor SR, 2010, J BIOL RHYTHM, V25, P138, DOI 10.1177/0748730409360949; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Wang YQ, 2014, IEEE T AUTOMAT CONTR, V59, P211, DOI 10.1109/TAC.2013.2270072; Zhang GX, 2012, IEEE T SYST MAN CY B, V42, P2, DOI 10.1109/TSMCB.2011.2165336; Zhang JX, 2013, P AMER CONTR CONF, P2295; Zhu LR, 2012, NEUROL CLIN, V30, P1167, DOI 10.1016/j.ncl.2012.08.011	43	2	2	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1746-8094	1746-8108		BIOMED SIGNAL PROCES	Biomed. Signal Process. Control	SEP	2019	54								101610	10.1016/j.bspc.2019.101610			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JA8ZQ	WOS:000488140200023					2022-02-06	
J	Guo, M; Zhang, H; Lv, QW; Huang, HB; Shen, LJ				Guo, Mi; Zhang, Han; Lv, Qing-Wei; Huang, Hang-Bin; Shen, Liang-Jun			Higher plasma C-type lectin-like receptor 2 concentrations for prediction of higher risk of 30-day mortality in isolated severe blunt traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; C-type lectin-like receptor 2; Prognosis	LARGE-ANIMAL-MODEL; PLATELET DYSFUNCTION; DC-SIGN; COAGULOPATHY; ACTIVATION; CLEC-2; TRANSFUSION; COAGULATION	Background Platelet activation is implicated in secondary brain injury following traumatic brain injury (TBI). C-type lectin-like receptor 2 (CLEC-2) is extensively expressed on platelets and participates in platelet activation. We investigate dthe prognostic significance of plasma CLEC-2 in TBI patients. Methods: One hundred and six patients with isolated severe blunt TBI and 106 healthy controls were prospectively investigated. Plasma CLEC-2 concentrations were detected and Glasgow coma scale (GCS) scores were recorded. The relationship between plasma CLEC-2 concentrations and 30-day mortality in addition to overall survival was determined using multivariate models. Results: Patients exhibited a substantially higher concentration of plasma CLEC-2 than healthy controls. Among patients, plasma CLEC-2 concentrations were remarkably increased in the GCS scores- and Rotterdam computerized tomography classification- dependent manner. As compared with survivors within posttraumatic 30 days, plasma CLEC-2 concentrations were remarkably raised in non-survivors. Rising plasma CLEC-2 concentration was independently associated with an enhanced risk of 30-day mortality and short overall survival time. Plasma CLEC-2 concentrations had a significantly high area under receiver operating characteristic curve for predicting 30-day mortality. Conclusions: Incremental plasma CLEC-2 concentrations are intimately related to increasing trauma severity, in close association with increased 30-day death, indicating the prognostic role of plasma CLEC-2 in TBI.	[Guo, Mi; Zhang, Han; Lv, Qing-Wei; Huang, Hang-Bin; Shen, Liang-Jun] Zhejiang Univ, Affiliated Hosp 1, Shengzhou Peoples Hosp, Dept Neurosurg,Shengzhou Branch Hop, 666 Dangui Rd, Shengzhou 312400, Zhejiang, Peoples R China		Guo, M (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Shengzhou Peoples Hosp, Dept Neurosurg,Shengzhou Branch Hop, 666 Dangui Rd, Shengzhou 312400, Zhejiang, Peoples R China.	szguomi123@163.com					Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Dekker SE, 2014, J SURG RES, V190, P312, DOI 10.1016/j.jss.2014.02.049; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Guillotte AR, 2018, BRAIN INJURY, V32, P1849, DOI 10.1080/02699052.2018.1536805; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Inoue O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139357; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Liu J, 2016, CHIN J TRAUMATOL, V19, P172, DOI 10.1016/j.cjtee.2016.01.011; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Mahadewa TGB, 2018, OPEN ACCESS EMERG M, V10, P135, DOI 10.2147/OAEM.S179090; Martin G, 2018, NEUROCRIT CARE, V28, P330, DOI 10.1007/s12028-017-0485-5; Martin GE, 2019, J TRAUMA ACUTE CARE, V86, P592, DOI 10.1097/TA.0000000000002171; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; Nayak Raghavendra, 2018, Asian J Neurosurg, V13, P685, DOI 10.4103/ajns.AJNS_232_16; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Rayes J, 2019, J CLIN INVEST, V129, P12, DOI 10.1172/JCI122955; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Shirai T, 2017, J THROMB HAEMOST, V15, P513, DOI 10.1111/jth.13604; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Skorko A, 2019, RESUSCITATION, V136, P105, DOI 10.1016/j.resuscitation.2019.01.025; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Verni CC, 2019, J TRAUMA ACUTE CARE, V86, P250, DOI 10.1097/TA.0000000000002140; Watson AA, 2005, ACTA CRYSTALLOGR F, V61, P1094, DOI 10.1107/S1744309105037991; Watson AA, 2007, J BIOL CHEM, V282, P3165, DOI 10.1074/jbc.M610383200; Wu X, 2019, EUR J NEUROL, V26, P1334, DOI 10.1111/ene.13984; Zhang X, 2019, STROKE, V50, P45, DOI 10.1161/STROKEAHA.118.022563	37	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	SEP	2019	496						1	6		10.1016/j.cca.2019.06.014			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	IQ3RX	WOS:000480669900001	31202718				2022-02-06	
J	Haas, R; Zayat, M; Sevrin, A				Haas, Rochelle; Zayat, Maya; Sevrin, Amanda			Current Concepts in the Evaluation of the Pediatric Patient with Concussion	CURRENT REVIEWS IN MUSCULOSKELETAL MEDICINE			English	Article						Concussion evaluation; Concussion; Mild traumatic brain injury; Post-concussion symptoms; Sideline concussion testing	TRAUMATIC BRAIN-INJURY; SPORTS; EPIDEMIOLOGY; IMPACT; RISK	Purpose of the Review A concussion is a mild traumatic brain injury (mTBI) that results in a change in how a person feels or functions after a force transmitted to the head. Nearly 10% of all sports-related injuries are mild traumatic brain injuries. Concussion/mTBIs have accounted for more than 3 million emergency department visits between 2005 and 2009 and present as an important public health concern. Recent Findings Physical, cognitive, and psychological functioning are known to be affected by concussion/mTBI, and various tools are readily available to guide clinicians through the initial evaluation. Evaluation of patients with concussion/mTBI should include symptom report and balance, vestibular-ocular, and neurocognitive testing. Awareness of past medical history and pre-injury history of social, behavioral, and emotional functioning is essential to better understand the injury and to predict the expected course of recovery. No tool available can be used alone to diagnose concussion/mTBI or evaluate for recovery.	[Haas, Rochelle] Nemours, AI duPont Hosp Children, Div Rehabil Med, 1600 Rockland Rd, Wilmington, DE 19803 USA; [Zayat, Maya] Nemours, Div Behav Hlth, AI duPont Hosp Children, Wilmington, DE USA; [Sevrin, Amanda] Cooper Univ Hosp, Dept Med, Camden, NJ USA		Haas, R (corresponding author), Nemours, AI duPont Hosp Children, Div Rehabil Med, 1600 Rockland Rd, Wilmington, DE 19803 USA.	rhaas@nemours.org					[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 2017, BRIT J SPORT MED, V51, P862, DOI [10.1136/bjsports-2016-097270.223, DOI 10.1136/BJSPORTS-2016-097270.223]; Connery AK, 2016, CLIN NEUROPSYCHOL, V30, P579, DOI 10.1080/13854046.2016.1177596; Gioia G, 2013, POST CONCUSSION SYMP; Gioia G, 2006, ACUTE CONCUSSION EVA; Green P, 2004, MANUAL FOR THE MEDIC; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Haas R, 2018, AM MED SOC SPORTS ME; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lumba-Brown A, 2018, JAMA PEDIAT; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maerlender A, 2018, CONCUSSION COMPETENC; Master CL, 2018, ANN INTERN MED, V169, pITC1, DOI 10.7326/AITC201807030; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Naidu D, 2018, J NEUROTRAUM, V35, P2283, DOI 10.1089/neu.2017.5490; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Sady MD, 2019, J HEAD TRAUMA REHAB, V34, pE35, DOI 10.1097/HTR.0000000000000424; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	27	2	2	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1935-973X	1935-9748		CURR REV MUSCULOSKE	Curr. Rev. Musculoskelet. Med.	SEP	2019	12	3					340	345		10.1007/s12178-019-09561-7			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	IO0FF	WOS:000479054100011	31342314	Green Published, Bronze			2022-02-06	
J	Hlusicka, J; Loster, T; Lischkova, L; Vaneckova, M; Diblik, P; Urban, P; Navratil, T; Kacer, P; Kacerova, T; Zakharov, S				Hlusicka, Jiri; Loster, Tomas; Lischkova, Lucie; Vaneckova, Manuela; Diblik, Pavel; Urban, Pavel; Navratil, Tomas; Kacer, Petr; Kacerova, Tereza; Zakharov, Sergey			Reactive carbonyl compounds, carbonyl stress, and neuroinflammation in methyl alcohol intoxication	MONATSHEFTE FUR CHEMIE			English	Article						Methanol; Poisoning; Carbonyl stress; Markers; Neuroinflammation	ACUTE OPTIC NEUROPATHY; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; METHANOL INTOXICATION; TRAUMATIC INJURY; DAMAGE; BRAIN; OUTBREAK; EPIDEMIOLOGY; DYSFUNCTION	Methyl alcohol intoxications are characterized by high lethality and high prevalence of serious visual and brain damage in survivors. The mechanisms of toxic brain damage are complex and the role of carbonyl stress has not been studied yet. We measured the acute and follow-up concentrations of reactive carbonyl compounds in patients with acute methyl alcohol intoxication. Blood samples were collected from 28 subjects hospitalized with confirmed methyl alcohol intoxication and from 36 subjects who survived poisoning 2 years after discharge. Serum concentrations of C6-12 reactive aldehydes were measured by liquid chromatography-electrospray ionization-tandem mass spectrometry. The acute concentrations of all measured reactive aldehydes were higher than the follow-up concentrations: 36.4 +/- 4.8 vs. 21.6 +/- 5.2 ng cm(-3) for C-6; 38.9 +/- 5 vs. 17.0 +/- 2.0 ng cm(-3) for C-7; 18.8 +/- 3.9 vs. 4 +/- 0 cm(-3) for C-8; 36.5 +/- 3.9 vs. 19.0 +/- 3.0 ng cm(-3) for C-9; 6.1 +/- 0.4 vs. 4.0 +/- 0.5 ng cm(-3) for C-10; 13.6 +/- 3.0 vs. 3.7 +/- 0.6 ng cm(-3) for C-11; and 7.8 +/- 0.4 vs. 4.7 +/- 0.4 ng cm(-3) for C-12 (all p < 0.001). The patients who survived the intoxication had higher concentration of reactive carbonyl compounds than those who died: 38.6 +/- 5.9 vs. 28.3 +/- 1.7 ng cm(-3) for C-6 (p = 0.002); 20.7 +/- 4.7 vs. 11.8 +/- 1.2 ng cm(-3) for C-8 (p = 0.001); 37.7 +/- 4.8 vs. 31.8 +/- 3.8 ng cm(-3) for C-9 (p = 0.042); and 7.9 +/- 0.6 vs. 7.3 +/- 0.5 ng cm(-3) for C-12 (p = 0.022). A significant association was present between severity of metabolic acidosis, anion gap, and the acute concentration of measured biomarkers: r = - 0.39; p = 0.046 for C-6; r = - 0.42; p = 0.035 for C-7; r = - 0.48; p = 0.012 for C-8; r = - 0.39; p = 0.046 for C-9; and r = - 0.47; p = 0.015 for C-11. The acute concentration of C-6-C-12 reactive aldehydes positively correlated with the acute serum concentration of leukotrienes (all p < 0.05). Acute elevation of serum concentration of reactive carbonyl compounds suggests that carbonyl stress is involved in the mechanisms of leukotriene-mediated neuroinflammatory response to methyl alcohol-induced toxic brain damage. [GRAPHICS] .	[Hlusicka, Jiri; Lischkova, Lucie; Zakharov, Sergey] Gen Univ Hosp, Toxicol Informat Ctr, Bojisti 1, Prague 12000, Czech Republic; [Hlusicka, Jiri; Lischkova, Lucie; Urban, Pavel; Zakharov, Sergey] Charles Univ Prague, Fac Med 1, Dept Occupat Med, Prague, Czech Republic; [Loster, Tomas] Univ Econ, Fac Informat & Stat, Dept Stat & Probabil, Prague, Czech Republic; [Vaneckova, Manuela] Charles Univ Prague, Fac Med 1, Dept Radiol, Prague, Czech Republic; [Vaneckova, Manuela; Diblik, Pavel; Navratil, Tomas] Gen Univ Hosp, Prague, Czech Republic; [Diblik, Pavel] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic; [Urban, Pavel] Natl Inst Publ Hlth, Ctr Ind Hyg & Occupat Med, Prague, Czech Republic; [Navratil, Tomas] Czech Acad Sci, J Heyrovsky Inst Phys Chem, Prague, Czech Republic; [Navratil, Tomas] Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic; [Kacer, Petr] Czech Univ Life Sci, Prague, Czech Republic; [Kacerova, Tereza] UCL, Dept Chem, London, England		Hlusicka, J (corresponding author), Gen Univ Hosp, Toxicol Informat Ctr, Bojisti 1, Prague 12000, Czech Republic.; Hlusicka, J (corresponding author), Charles Univ Prague, Fac Med 1, Dept Occupat Med, Prague, Czech Republic.	jiri.hlusicka@vfn.cz	Zakharov, Sergey/O-2896-2019; Navratil, Tomas/F-4000-2012; Loster, Tomas/N-2754-2017; Kacerova, Tereza/AAV-7242-2021; Kacer, Petr/AAW-2355-2021; Hlusicka, Jiri/AAA-7425-2020	Zakharov, Sergey/0000-0001-9864-8304; Navratil, Tomas/0000-0003-4633-2601; Loster, Tomas/0000-0002-6894-3545; Kacerova, Tereza/0000-0002-9477-0182; Vaneckova, Manuela/0000-0002-8784-7997; Kacer, Petr/0000-0002-5905-3516	Ministry of Health of the Czech Republic (AZV) [16-27075A, 44/18/D]; First Faculty of Medicine, Charles University in Prague [PROGRES Q25, PROGRES Q29]	This work was supported by the Ministry of Health of the Czech Republic (AZV) under Grant 16-27075A; and under Grant 44/18/D; and by the First Faculty of Medicine, Charles University in Prague under Grant PROGRES Q25; and under Grant PROGRES Q29.	Barceloux DG, 2002, J TOXICOL-CLIN TOXIC, V40, P415; Bell KF, 2011, P NATL ACAD SCI USA, V108, pE1, DOI 10.1073/pnas.1015229108; Bezdicek O, 2017, ALCOHOL, V59, P27, DOI 10.1016/j.alcohol.2016.12.003; Bezdicek O, 2014, CESK SLOV NEUROL N, V77, P320; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Dhillon HS, 1996, J NEUROTRAUM, V13, P781, DOI 10.1089/neu.1996.13.781; Dorokhov YL, 2015, PHYSIOL REV, V95, P603, DOI 10.1152/physrev.00034.2014; Drangsholt E, 2018, BASIC CLIN PHARMACOL, V123, P749, DOI 10.1111/bcpt.13074; EELLS JT, 1983, J PHARMACOL EXP THER, V227, P349; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Halliwel B., 2007, FREE RADICALS BIOL M; HALLIWELL B, 1989, ACTA NEUROL SCAND, V80, P23, DOI 10.1111/j.1600-0404.1989.tb01779.x; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hlusicka J, 2019, MONATSH CHEM, V150, P477, DOI 10.1007/s00706-019-2370-8; Hlusicka J, 2018, CLIN TOXICOL, V56, P893, DOI 10.1080/15563650.2018.1455980; Hovda KE, 2005, J INTERN MED, V258, P181, DOI 10.1111/j.1365-2796.2005.01521.x; Hubacek JA, 2018, CLIN GENET, V94, P445, DOI 10.1111/cge.13411; Hubacek JA, 2015, BASIC CLIN PHARMACOL, V117, P3, DOI 10.1111/bcpt.12409; Hubacek JA, 2015, BASIC CLIN PHARMACOL, V116, P168, DOI 10.1111/bcpt.12310; JACOBSEN D, 1986, MED TOXICOL ADV DRUG, V1, P309, DOI 10.1007/BF03259846; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MCMARTIN KE, 1975, BIOCHEM MED METAB B, V13, P319, DOI 10.1016/0006-2944(75)90171-4; NIOSH, 2008, EM RESP SAF HLTH DAT; Nurieva O, 2018, CLIN TOXICOL; Nurieva O, 2018, AM J OPHTHALMOL, V191, P100, DOI 10.1016/j.ajo.2018.04.015; Nurieva O, 2016, MONATSH CHEM, V147, P239, DOI 10.1007/s00706-015-1580-y; Paasma R, 2007, CLIN TOXICOL, V45, P152, DOI 10.1080/15563650600956329; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Peng XF, 2011, FOOD FUNCT, V2, P289, DOI 10.1039/c1fo10034c; Peterova K, 2018, BASIC CLIN PHARMACOL, V122, P176, DOI 10.1111/bcpt.12853; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Podda M, 1996, J LIPID RES, V37, P893; Riahi Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE879, DOI 10.1152/ajpendo.00508.2010; RICEEVANS C, 1989, FREE RADICAL RES COM, V7, P45, DOI 10.3109/10715768909088161; Rulisek J, 2017, J CRIT CARE, V39, P190, DOI 10.1016/j.jcrc.2017.03.001; Sagai M, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-29; Schneider C, 2001, J BIOL CHEM, V276, P20831, DOI 10.1074/jbc.M101821200; Semchyshyn HM, 2014, SCI WORLD J, DOI 10.1155/2014/417842; Semchyshyn HM, 2011, INTERPLAY OXIDATIVE; Tessier FJ, 2010, PATHOL BIOL, V58, P214, DOI 10.1016/j.patbio.2009.09.014; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Urban P, 2016, INT J OCCUP MED ENV, V29, P471, DOI 10.13075/ijomeh.1896.00452; Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vaneckova M, 2014, CESK SLOV NEUROL N, V77, P235; Vaneckova M, 2015, NEUROENDOCRINOL LETT, V36, P737; Xu S, 2012, J POWER SOURCES, V209, P228, DOI 10.1016/j.jpowsour.2012.02.076; Zakharov S, 2018, TOXICOL LETT, V298, P60, DOI 10.1016/j.toxlet.2018.05.001; Zakharov S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0300-7; Zakharov S, 2017, CLIN TOXICOL, V55, P123, DOI 10.1080/15563650.2016.1250901; Zakharov S, 2017, MONATSH CHEM, V148, P409, DOI 10.1007/s00706-016-1846-z; Zakharov S, 2017, CLIN TOXICOL, V55, P249, DOI 10.1080/15563650.2017.1284332; Zakharov S, 2016, BASIC CLIN PHARMACOL, V119, P228, DOI 10.1111/bcpt.12559; Zakharov S, 2016, ANN EMERG MED, V68, P52, DOI 10.1016/j.annemergmed.2016.01.010; Zakharov S, 2016, MONATSH CHEM, V147, P251, DOI 10.1007/s00706-015-1581-x; Zakharov S, 2015, BIOMED PAP, V159, P666, DOI 10.5507/bp.2015.008; Zakharov S, 2015, CLIN TOXICOL, V53, P884, DOI 10.3109/15563650.2015.1086488; Zakharov S, 2015, CLIN TOXICOL, V53, P797, DOI 10.3109/15563650.2015.1059946; Zakharov S, 2015, MONATSH CHEM, V146, P787, DOI 10.1007/s00706-014-1374-7; Zakharov S, 2015, BASIC CLIN PHARMACOL, V116, P445, DOI 10.1111/bcpt.12338; Zakharov S, 2014, BIOMED PAP, V158, P641, DOI 10.5507/bp.2014.056; Zakharov S, 2014, CLIN TOXICOL, V52, P1013, DOI 10.3109/15563650.2014.974106; Zakharov S, 2014, J APPL BIOMED, V12, P309, DOI 10.1016/j.jab.2014.04.001; Zakharov S, 2014, KIDNEY INT, V86, P199, DOI 10.1038/ki.2014.60; Zirnniak P, 2011, FREE RADICAL BIO MED, V51, P1087, DOI 10.1016/j.freeradbiomed.2011.05.039	67	2	2	0	14	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0026-9247	1434-4475		MONATSH CHEM	Mon. Chem.	SEP	2019	150	9			SI		1723	1730		10.1007/s00706-019-02429-z			8	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	IT5MN	WOS:000482907600024					2022-02-06	
J	Holthe, OO; Hellstrom, T; Andelic, N; Server, A; Sigurdardottir, S				Holthe, Oyvor Oistensen; Hellstrom, Torgeir; Andelic, Nada; Server, Andres; Sigurdardottir, Solrun			Improvement and Prediction of Memory and Executive Functions in Patients Admitted to a Neurosurgery Service With Complicated and Uncomplicated Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; neuropsychology; postconcussion; posttraumatic stress; recovery	POSTTRAUMATIC-STRESS-DISORDER; NEUROPSYCHOLOGICAL OUTCOMES; HEAD-INJURY; COGNITIVE RESERVE; OLDER-ADULTS; 1ST YEAR; RECOVERY; CONCUSSION; ABNORMALITIES; PERFORMANCE	Objectives: To compare neuropsychological performances between patients with and without intracranial abnormalities after mild traumatic brain injury (mTBI) and assess the relationship between demographics, injury severity, and self-reported symptom characteristics with improvements in memory and executive functions (8 weeks to 1 year postinjury). Setting: Inpatient/outpatient followed up at the Department of Physical Medicine and Rehabilitation, Oslo, Norway. Participants: Patients were divided into groups of complicated (n = 73) or uncomplicated mTBIs (n = 77) based on intracranial findings on computed tomographic or magnetic resonance imaging brain scans. Design: Prospective, longitudinal cohort study. Main Measures: Neuropsychological assessments of memory and executive functions, self-reports of postconcussion, depression, posttraumatic stress symptoms, and general functioning at 8 weeks and 1 year postinjury. Results: Longitudinal data showed that patients with complicated and uncomplicated mTBIs had similar cognitive performance and improvements. Hierarchical linear modeling revealed that individuals with early posttraumatic stress disorder and/or depressive symptoms performed worse on measures of Memory functions, and those with younger age (<40 years) and lower education (<12 years) performed worse on measures of Executive functions. Conclusion: Findings are suggestive of a good cognitive outcome following complicated and uncomplicated mTBIs. Early assessments of posttraumatic stress disorder and depression seem useful in identifying those most vulnerable having poorer cognitive outcomes, providing further interventions that may affect emotional and cognitive recovery.	[Holthe, Oyvor Oistensen; Hellstrom, Torgeir; Andelic, Nada] Oslo Univ Hosp, Div Clin Neurosci, Dept Phys Med & Rehabil, Oslo, Norway; [Server, Andres] Oslo Univ Hosp, Sect Neuroradiol, Dept Radiol & Nucl Med, Oslo, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc CHARM, Oslo, Norway; [Hellstrom, Torgeir] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, Bjornemyrveien 11, N-1450 Nesoddtangen, Nesodden, Norway		Sigurdardottir, S (corresponding author), Sunnaas Rehabil Hosp, Dept Res, Bjornemyrveien 11, N-1450 Nesoddtangen, Nesodden, Norway.	solrun.sigurdardottir@sunnaas.no	Hellstrom, Torgeir/AAW-4301-2021; Hellstrom, Torgeir/AAY-6043-2021	Hellstrom, Torgeir/0000-0003-0831-3274; Andelic, Nada/0000-0002-3719-4406			Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brewin CR, 2011, ANNU REV CLIN PSYCHO, V7, P203, DOI 10.1146/annurev-clinpsy-032210-104544; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Hart T, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000210; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hellstrom T, 2017, BRAIN INJURY, V31, P674, DOI 10.1080/02699052.2017.1283537; Hellstrom T, 2016, BRAIN INJURY, V30, P1683, DOI 10.1080/02699052.2016.1199905; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Iverson GL, 2000, BRAIN INJURY, V14, P1057; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinsella GJ, 2014, J INT NEUROPSYCH SOC, V20, P663, DOI 10.1017/S1355617714000447; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Leary JB, 2018, J HEAD TRAUMA REHAB, V33, pE28, DOI 10.1097/HTR.0000000000000329; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Lopez KC, 2017, J NEUROTRAUM, V34, P16, DOI 10.1089/neu.2015.4323; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meyers JE., 1995, REY COMPLEX FIGURE T; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Stegner BL, 1996, EVAL PROGRAM PLANN, V19, P193, DOI 10.1016/0149-7189(96)00011-0; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Tayim FM, 2016, J CLIN EXP NEUROPSYC, V38, P1005, DOI 10.1080/13803395.2016.1182968; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Veeramuthu V, 2017, WORLD NEUROSURG, V97, P416, DOI 10.1016/j.wneu.2016.10.041; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	53	2	2	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		E45	E56		10.1097/HTR.0000000000000463			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100006	30829814	Green Accepted			2022-02-06	
J	Huang, GH; Cao, XY; Li, YY; Zhou, CC; Li, L; Wang, K; Li, H; Yu, P; Jin, Y; Gao, L				Huang, Guo-Hui; Cao, Xiang-Yuan; Li, Yuan-Yuan; Zhou, Cheng-Cheng; Li, Lei; Wang, Ke; Li, Hong; Yu, Peng; Jin, Yi; Gao, Liang			Gene expression profile of the hippocampus of rats subjected to traumatic brain injury	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						differentially expressed genes; hippocampus; neuronal survival-related pathways; P2rx3; traumatic brain injury	NEURAL STEM-CELLS; P2X(3) RECEPTORS; MECHANISMS; OUTGROWTH; REPAIR; PPARS	Traumatic brain injury (TBI) is a serious public health problem as well as a leading cause of severe posttraumatic disability. Numerous studies indicate that the differentially expressed genes (DEGs) of neural signaling pathways are strongly correlated with brain injury. To further analyze the roles of the DGEs in the central nervous system, here we systematically investigated TBI on the hippocampus and its injury mechanism at the whole genome level. On the basis of Gene Ontology and Kyoto Encyclopedia of Genes and Genomes Analyses, we revealed that the DEGs were involved in many signaling pathways related to the nervous system, especially neuronal survival-related pathways. Finally, we verified the microarray results and detected the gene expression of neuronal survival-related genes in the hippocampus by using real-time quantitative polymerase chain reaction. With Western blot and axon growth assay, the expression of P2rx3 was upregulated in rats subjected to TBI, and overexpression of P2rx3 promoted neurite growth of NG108 cells. Our results suggested that the DEGs (especially P2rx3) and several signaling pathways might play a pivotal role in TBI. We also provided several targeted genes related to TBI for future investigation.	[Huang, Guo-Hui; Cao, Xiang-Yuan; Zhou, Cheng-Cheng; Li, Lei; Wang, Ke; Li, Hong; Yu, Peng; Jin, Yi; Gao, Liang] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Neurosurg, Shanghai 200072, Peoples R China; [Li, Yuan-Yuan] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Endocrinol, Baoshan Branch, Shanghai, Peoples R China		Gao, L (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Neurosurg, Shanghai 200072, Peoples R China.	lianggaoh@126.com		Huang, Guo-Hui/0000-0002-1904-5407	Shanghai Municipal Commission of Health and Family Planning [03.02.16.001]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801215]; Shanghai Tenth Hospital's improvement plan for NSFC [SYGZRPY2017015]; Climbing Talent Program of Shanghai Tenth People's Hospital [2018SYPDRC034]	Shanghai Municipal Commission of Health and Family Planning, Grant/Award Numbers: 03.02.16.001, NO. 03.02.16.001; National Natural Science Foundation of China, Grant/Award Number: 81801215; Shanghai Tenth Hospital's improvement plan for NSFC, Grant/Award Number: SYGZRPY2017015; Climbing Talent Program of Shanghai Tenth People's Hospital, Grant/Award Number: 2018SYPDRC034	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Alberi L, 2013, AGEING RES REV, V12, P801, DOI 10.1016/j.arr.2013.03.004; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Brederson JD, 2008, CURR OPIN INVEST DR, V9, P716; Burnstock G, 2015, CURR MED CHEM, V22, P819, DOI 10.2174/0929867321666140706130415; Burnstock G, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00661; Burnstock G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-69; CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Cimini A, 2008, STEM CELL REV, V4, P293, DOI 10.1007/s12015-008-9024-2; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Galvez-Contreras AY, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00258; Giniatullin R, 2008, MOL NEUROBIOL, V37, P83, DOI 10.1007/s12035-008-8020-5; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Hanamsagar R, 2012, TRENDS IMMUNOL, V33, P333, DOI 10.1016/j.it.2012.03.001; Heine C, 2006, NEUROSCIENCE, V138, P303, DOI 10.1016/j.neuroscience.2005.11.056; Heine C, 2016, NEUROPHARMACOLOGY, V104, P255, DOI 10.1016/j.neuropharm.2015.10.022; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Kubo E, 2005, DIABETOLOGIA, V48, P790, DOI 10.1007/s00125-005-1687-5; Li X, 2017, EVID-BASED COMPL ALT, V2017; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057621; Lindner R, 2013, NEUROTHERAPEUTICS, V10, P771, DOI 10.1007/s13311-013-0203-8; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Pedata F, 2016, NEUROPHARMACOLOGY, V104, P105, DOI 10.1016/j.neuropharm.2015.11.007; Ran QS, 2015, NEURAL REGEN RES, V10, P1258, DOI 10.4103/1673-5374.162758; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Schoch KM, 2012, NEUROTHERAPEUTICS, V9, P323, DOI 10.1007/s13311-012-0107-z; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Wang J, 2016, CURR STEM CELL RES T, V11, P188, DOI 10.2174/1574888X10666150416113630; Wilson KHS, 2003, DIABETES, V52, P2151, DOI 10.2337/diabetes.52.8.2151; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Zhao YL, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/1570917	39	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	SEP	2019	120	9					15776	15789		10.1002/jcb.28848			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IK7WN	WOS:000476804200149	31074048				2022-02-06	
J	Ingram, BM; Kay, MC; Vander Vegt, CB; Register-Mihalik, JK				Ingram, Brittany M.; Kay, Melissa C.; Vander Vegt, Christina B.; Register-Mihalik, Johna K.			The Effect of Body Checking Policy Changes on Concussion Incidence in Canadian Male Youth Ice Hockey Players: A Critically Appraised Topic	JOURNAL OF SPORT REHABILITATION			English	Article						education; disclosure; rates; rule changes	INJURY; RISK	Clinical Scenario: Current studies have identified body checking as the most common cause of sports-related concussion in ice hockey across all divisions and levels. As a result, many hockey organizations, particularly in youth sports, have implemented rules making body checking to the head, face, and/or neck illegal. Such a rule, in Canada, makes age 13 the first age in which individuals can engage in body checking. Despite these changes, effectiveness of their implementation on the incidence of concussion in Canadian male youth ice hockey players remains unclear. Clinical Question: What is the effect of body checking policy changes on concussion incidence in male youth ice hockey players? Summary of Key Findings: Of the 3 included studies, 2 studies reported a decrease in the incidence of concussion once a body checking policy change was implemented. The third study showed an increase; however, it is important to note that this may be due, in part, to increased awareness leading to better reporting of injuries. Clinical Bottom Line: Current evidence supports a relationship between body checking policy implementation and decreased concussion incidence; however, more research is needed to understand the long-term implications of policy change and the effects in other leagues. In addition, further data are needed to differentiate between increased concussion incidence resulting from concussion education efforts that may improve disclosure and increased concussion incidence as a direct result of policy changes. Strength of Recommendation: Grade B evidence exists that policy changes regarding body checking decrease concussion incidence in male youth ice hockey players.	[Ingram, Brittany M.; Kay, Melissa C.; Vander Vegt, Christina B.; Register-Mihalik, Johna K.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA		Kay, MC (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA.	mkay@email.unc.edu					Agel J, 2007, J ATHL TRAINING, V42, P241; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Emery CA, 2014, JAMA-J AM MED ASSOC, V303, P2265; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Hockey Canada, ANN REP 2016 2017, P15; Hockey Canada, 2016, REF CAS BOOK RUL COM; Krolikowski MP, 2017, AM J SPORT MED, V45, P468, DOI 10.1177/0363546516669701; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699	10	2	2	0	10	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	SEP	2019	28	7					774	777		10.1123/jsr.2018-0102			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	IW7SN	WOS:000485194400019	30300048	Bronze			2022-02-06	
J	Juan, YH; Livneh, H; Huang, HJ; Lu, MC; Yeh, CC; Tsai, TY				Juan, Ying-Hsu; Livneh, Hanoch; Huang, Hui-Jun; Lu, Ming-Chi; Yeh, Chia-Chou; Tsai, Tzung-Yi			Decreased Risk of Dementia Among Patients With Traumatic Brain Injury Receiving Acupuncture Treatment: A Population-Based Retrospective Cohort Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acupuncture; cohort studies; dementia; risk; traumatic brain injury	DEPRESSION; DIAGNOSIS; TAIWAN	Objective: We conducted a longitudinal cohort study comparing the effect of acupuncture on the risk of dementia in Taiwanese individuals with traumatic brain injury (TBI). Design and Participants: A national health insurance database was used to identify 15 440 newly diagnosed TBI patients 20 to 70 years old between 1998 and 2007. Of the identified patients, 6308 received acupuncture following the onset of TBI (acupuncture users) and 9132 patients did not receive acupuncture (nonacupuncture users). Measures: All enrollees were followed until the end of 2012 to record incident cases of dementia. A Cox proportional hazards regression model was used to compute adjusted hazard ratios for the relationship of acupuncture use with dementia. Results: During the follow-up period, 249 acupuncture users and 810 nonacupuncture users developed dementia, corresponding to incidence rates of 6.11 and 9.64 per 1000 person-years, respectively. Use of acupuncture was significantly associated with a lower risk of dementia. Those who received more than 5 sessions of acupuncture benefited most from it. Conclusions: Adding acupuncture to the clinical management of patients with TBI may benefit these patients by decreasing their risk of developing dementia.	[Juan, Ying-Hsu; Yeh, Chia-Chou] Dalin Tzuchi Hosp, Buddhist Tzuchi Med Fdn, Dept Chinese Med, Chiayi, Taiwan; [Huang, Hui-Jun] Dalin Tzuchi Hosp, Buddhist Tzuchi Med Fdn, Dept Nursing, Chiayi, Taiwan; [Lu, Ming-Chi] Dalin Tzuchi Hosp, Buddhist Tzuchi Med Fdn, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Tsai, Tzung-Yi] Dalin Tzuchi Hosp, Buddhist Tzuchi Med Fdn, Dept Res, 2 Minsheng Rd, Chiayi 62247, Taiwan; [Juan, Ying-Hsu] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan; [Yeh, Chia-Chou] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Livneh, Hanoch] Portland State Univ, Rehabil Counseling Program, Portland, OR 97207 USA; [Lu, Ming-Chi] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Yeh, Chia-Chou] Tzu Chi Univ, Sch Postbaccalaureate Chinese Med, 701 Jhongyang Rd,Sect 3, Hualien 97004, Taiwan; [Tsai, Tzung-Yi] Natl Cheng Kung Univ, Dept Environm & Occupat Hlth, Coll Med, Tainan, Taiwan; [Tsai, Tzung-Yi] Tzu Chi Univ Sci & Technol, Dept Nursing, Hualien, Taiwan		Tsai, TY (corresponding author), Dalin Tzuchi Hosp, Buddhist Tzuchi Med Fdn, Dept Res, 2 Minsheng Rd, Chiayi 62247, Taiwan.; Yeh, CC (corresponding author), Tzu Chi Univ, Sch Postbaccalaureate Chinese Med, 701 Jhongyang Rd,Sect 3, Hualien 97004, Taiwan.	dm732024@tzuchi.com.tw; YEHCC0530@gmail.com			Dalin Tzuchi Hospital [DTCRD103 (2)-E-05]	This study is based on data from the National Health Insurance Research Database, provided by the Bureau of National Health Insurance (Department of Health) and managed by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the Bureau ofNational Health Insurance, Department of Health, or the National Health Research Institutes. This research was supported by Dalin Tzuchi Hospital (grant no. DTCRD103 (2)-E-05).	Alali AS, 2015, VALUE HEALTH, V18, P721, DOI 10.1016/j.jval.2015.04.012; Alzheimer's Disease International, 2013, POLICY BRIEF HEADS G; [Anonymous], 2015, C TRAUM BRAIN INJ US; Bagyinszky E, 2014, BIOCHIP J, V8, P155, DOI 10.1007/s13206-014-8301-1; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Helmer C, 2001, AM J EPIDEMIOL, V154, P642, DOI 10.1093/aje/154.7.642; Lee Y, 2018, J PHYSIOL SCI, V68, P455, DOI 10.1007/s12576-017-0547-7; Li XH, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8460145; Lin YH, 2011, MED ACUPUNCT, V23, P101, DOI 10.1089/acu.2011.0792; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lu MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep20647; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Pandya CD, 2013, ASIAN J PSYCHIATR, V6, P22, DOI 10.1016/j.ajp.2012.08.010; Pi T, 2016, MOL MED REP, V13, P1257, DOI 10.3892/mmr.2015.4652; Scherrer JF, 2009, GEN HOSP PSYCHIAT, V31, P353, DOI 10.1016/j.genhosppsych.2009.04.001; Shih CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032540; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Shivers KY, 2015, CYTOKINE, V72, P121, DOI 10.1016/j.cyto.2015.01.007; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; Wang L, 2017, J MOL NEUROSCI, V61, P379, DOI 10.1007/s12031-016-0872-y; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Weng SW, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010539; Wu CH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8030676; Wu MY, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1239-7; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397	27	2	2	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		E17	E23		10.1097/HTR.0000000000000464			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100003	30829815				2022-02-06	
J	Kreitzer, N; Rath, K; Kurowski, BG; Bakas, T; Hart, K; Lindsell, CJ; Adeoye, O				Kreitzer, Natalie; Rath, Kelly; Kurowski, Brad G.; Bakas, Tamilyn; Hart, Kim; Lindsell, Christopher J.; Adeoye, Opeolu			Rehabilitation Practices in Patients With Moderate and Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury recovery; critical care practice; rehabilitation; traumatic brain injury	INTENSIVE-CARE-UNIT; RESPIRATORY-FAILURE; MOBILITY PROTOCOL; STATES; THERAPY	Objective: To characterize the indications, timing, barriers, and perceived value of rehabilitation currently provided for individuals with moderate or severe traumatic brain injury (TBI) admitted to the intensive care unit (ICU) based on the perspectives of providers who work in the ICU setting. Participants: Members (n = 66) of the Neurocritical Care Society and the American Congress of Rehabilitation Medicine. Design: An anonymous electronic survey of the timing of rehabilitation for patients with TBI in the ICU. Main Measures: Questions asked about type and timing of rehabilitation in the ICU, extent of family involvement, participation of physiatrists in patient care, and barriers to early rehabilitation. Results: Sixty-six respondents who reported caring for patients with TBI in the ICU completed the survey; 98% recommended rehabilitative care while patients were in the ICU. Common reasons to wait for the initiation of physical therapy and occupational therapy were normalization of intracranial pressure (86% and 89%) and hemodynamic stability (66% and 69%). Conclusions: The majority of providers caring for patients with TBI in the ICU support rehabilitation efforts, typically after a patient is extubated, intracranial pressure has normalized, and the patient is hemodynamically stable. Our findings describe current practice; future studies can be designed to determine optimal timing, intensity, and patient selection for early rehabilitation.	[Kreitzer, Natalie; Hart, Kim; Adeoye, Opeolu] Univ Cincinnati, Dept Emergency Med, 231 Albert Sabin Way,POB 670769, Cincinnati, OH 45267 USA; [Kreitzer, Natalie; Rath, Kelly; Adeoye, Opeolu] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH 45221 USA; [Kurowski, Brad G.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Adeoye, Opeolu] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45221 USA; [Rath, Kelly; Bakas, Tamilyn] Univ Cincinnati, Coll Nursing, Cincinnati, OH 45221 USA; [Lindsell, Christopher J.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Adeoye, Opeolu] Sense Diagnost Inc, Norwood, OH USA		Kreitzer, N (corresponding author), Univ Cincinnati, Dept Emergency Med, 231 Albert Sabin Way,POB 670769, Cincinnati, OH 45267 USA.	kreitzne@ucmail.uc.edu	Bakas, Tamilyn/ABC-5664-2020	Rath, Kelly/0000-0003-0592-4096	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS047996] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS047996] Funding Source: Medline		Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; Dinglas VD, 2013, AM J OCCUP THER, V67, P355, DOI 10.5014/ajot.2013.007807; Floyd S, 2016, DIMENS CRIT CARE NUR, V35, P277, DOI 10.1097/DCC.0000000000000197; Guest G., 2011, APPL THEMATIC ANAL; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hildreth AN, 2010, AM SURGEON, V76, P818; Hopkins RO, 2007, CRIT CARE CLIN, V23, P81, DOI 10.1016/j.ccc.2006.11.004; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; Needham DM, 2010, ARCH PHYS MED REHAB, V91, P536, DOI 10.1016/j.apmr.2010.01.002; Roth C, 2013, NEUROCRIT CARE, V18, P33, DOI 10.1007/s12028-012-9799-5; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Thomsen GE, 2008, CRIT CARE MED, V36, P1119, DOI 10.1097/CCM.0b013e318168f986; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Warren AM, 2016, REHABIL PSYCHOL, V61, P179, DOI 10.1037/rep0000080; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	17	2	2	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		E66	E72		10.1097/HTR.0000000000000477			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100008	30829824	Green Accepted			2022-02-06	
J	Longo, L; Rossi, R; Niolu, C; Siracusano, A; Di Lorenzo, G				Longo, L.; Rossi, R.; Niolu, C.; Siracusano, A.; Di Lorenzo, G.			A complex phenotype of suicidal behavior: a case of post brain injury dissociative disorder	JOURNAL OF PSYCHOPATHOLOGY			English	Article						Suicide risk; Dissociation; Dissociative Identity Disorder; Traumatic Brain Injury; Psychogenic Non Epileptic Seizures; Epileptic Seizures; Post Traumatic Stress Disorder; Bipolar Disorder	POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; RISK	We describe a case of a 54-year-old Caucasian woman with a complex phenotype for suicidal behavior after traumatic brain injury. At the admission patient had Bipolar Disorder, Post Traumatic Stress Disorder; Dissociative Identity Disorder, Conversion Disorder (with Psychogenic Non Epileptic Seizures) and a drug treatment fora post-traumatic epilepsy. During a follow up period of 30 months, despite the symptomatological improvements due to psychopharmachological treatments (including also lithium) and psychoeducation treatment, the patient showed yet high risk of suicide and high levels of dissociation.	[Longo, L.; Rossi, R.; Niolu, C.; Siracusano, A.; Di Lorenzo, G.] Univ Roma Tor Vergata, Dept Syst Med, Via Montpellier 1, I-00133 Rome, Italy; [Longo, L.; Niolu, C.; Siracusano, A.; Di Lorenzo, G.] Fdn Policlin Tor Vergata, Psychiat & Clin Psychol Unit, Rome, Italy		Di Lorenzo, G (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Via Montpellier 1, I-00133 Rome, Italy.	di.lorenzo@med.uniroma2.it	Di Lorenzo, Giorgio/B-1308-2013	Di Lorenzo, Giorgio/0000-0002-0576-4064; Longo, Lucia/0000-0003-4805-6241			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Berthier ML, 2001, J NEUROPSYCH CLIN N, V13, P101, DOI 10.1176/appi.neuropsych.13.1.101; Brand Bethany, 2001, J Trauma Dissociation, V2, P133, DOI 10.1300/J229v02n04_07; Calati R, 2017, PSYCHIAT RES, V251, P103, DOI 10.1016/j.psychres.2017.01.035; Christensen J, 2007, LANCET NEUROL, V6, P693, DOI 10.1016/S1474-4422(07)70175-8; D'Alessio L, 2006, SEIZURE-EUR J EPILEP, V15, P333, DOI 10.1016/j.seizure.2006.04.003; Dell PF, 2011, DISSOCIATION AND THE DISSOCIATIVE DISORDERS: DSM-V AND BEYOND, P383; DORAHY MJ, 2007, TRAUMATIC DISSOCIATI, P55; Drange OK, 2018, INT J BIPOLAR DISORD, V6, DOI 10.1186/s40345-018-0128-6; Fenster RJ, 2018, NAT REV NEUROSCI, V19, P535, DOI 10.1038/s41583-018-0039-7; Gonzalez A, 2017, REV NEUROSCIENCE, V28, P431, DOI 10.1515/revneuro-2016-0070; Guillen A, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00303; Luciano M, 2016, RIV PSICHIATR, V51, P116, DOI 10.1708/2304.24798; Lyssenko L, 2018, AM J PSYCHIAT, V175, P37, DOI 10.1176/appi.ajp.2017.17010025; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Pagani M, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00475; Pagani Marco, 2015, Front Psychol, V6, P1614, DOI 10.3389/fpsyg.2015.01614; Pagani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045753; Pagani M, 2012, RIV PSICHIATR, V47, P16, DOI 10.1708/1071.11734; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pompili M, 2013, J NERV MENT DIS, V201, P802, DOI 10.1097/NMD.0b013e3182a21458; Popkirov S, 2018, SEIZURE-EUR J EPILEP, V58, P127, DOI 10.1016/j.seizure.2018.04.009; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; Rossetti MC, 2017, REV BRAS PSIQUIATR, V39, P216, DOI 10.1590/1516-4446-2016-2045; Rossi R, 2019, J PSYCHOPATHOL, V25, P162; Santarnecchit E, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00129; Shalev A, 2017, NEW ENGL J MED, V376, P2459, DOI 10.1056/NEJMra1612499; Sreenivasa V, 2019, AUSTRALAS PSYCHIAT; Stratta P, 2016, PSYCHIAT RES, V244, P165, DOI 10.1016/j.psychres.2016.07.019; Tondo L, 2016, ACTA PSYCHIAT SCAND, V133, P174, DOI 10.1111/acps.12517; Van der Hart O., 2006, HAUTED SELF STRUCTUR; Van Praag DLG, 2019, J NEUROTRAUM, V36, P3220, DOI 10.1089/neu.2018.5759; Webster KD, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00275; Yehuda R, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.57; Zaidner E, 2010, J ECT, V26, P238, DOI 10.1097/YCT.0b013e3181c3046c	36	2	2	0	4	PACINI EDITORE	PISA	VIA DELLA GHERARDESCA-ZONA INDUSTRIALE OSPEDALETTO, 56121 PISA, ITALY	1592-1107	2499-6904		J PSYCHOPATHOL	J. Psychopathol.	SEP	2019	25	3			SI		172	177					6	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	IX8QZ	WOS:000485953900008					2022-02-06	
J	McCarty, AK; Zhang, L; Hansen, S; Jackson, WJ; Bentil, SA				McCarty, Annastacia K.; Zhang, Ling; Hansen, Sarah; Jackson, William J.; Bentil, Sarah A.			Influence of saline solution absorption and compressive rate on the material properties of brain tissue	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Traumatic brain injury; TBI; Viscoelastic; Fractional Zener; Brain	MECHANICAL-PROPERTIES; POSTMORTEM TIME; BEHAVIOR; INJURY; SHEAR; EQUATIONS; MODELS; MATTER; WHITE; GRAY	Traumatic brain injuries (TBI) affect millions of people each year and can result in long-term difficulties in thinking or focusing. Due to the number of people affected by these injuries, significant research has been dedicated to determining the mechanical properties of the brain using postmortem tissue from animals harvested within 24 h. The postmortem brain tissue is often stored in a solution until a rheological experiment is ready to begin. However, the effect of storage duration on the mechanical behavior of brain tissue is not understood. In this paper, postmortem porcine brains were placed in normal saline solution (0.9% NaCl) and refrigerated between 30 min and 6.5 h to allow the brain to absorb the solution. Afterwards, samples from both soaked and freshly extracted brains were subjected to unconfined compression tests at compressive rates of 5, 50, and 500 mm/min. The fractional Zener viscoelastic model was applied to obtain the brain's mechanical properties. While the results did not show a significant relationship between absorption and the long-term stiffness (E-infinity), both the relaxation time (tau(0)) and fractional order (alpha) were statistically influenced by both the length of time in the solution and compressive rate. Further, the instantaneous stiffness (E-0) was statistically influenced by the length of time in solution, though not the compressive rate.	[McCarty, Annastacia K.; Zhang, Ling; Hansen, Sarah; Jackson, William J.; Bentil, Sarah A.] Iowa State Univ Sci & Technol, Dept Mech Engn, 2529 Union Dr, Ames, IA 50011 USA		Bentil, SA (corresponding author), Iowa State Univ Sci & Technol, Dept Mech Engn, 2529 Union Dr, Ames, IA 50011 USA.	sbentil@iastate.edu		Bentil, Sarah/0000-0003-3983-0987	Roy J. Carver Charitable Trust [18-5021]; Iowa State University	This research was financially supported by the Roy J. Carver Charitable Trust under Grant #18-5021 and is acknowledged gratefully. The research is also financially supported by Iowa State University through start-up funds to SA. Bentil, for which the authors are grateful.	Ayyildiz M, 2014, BIORHEOLOGY, V51, P47, DOI 10.3233/BIR-14007; BAGLEY RL, 1983, AIAA J, V21, P741, DOI 10.2514/3.8142; Bentil S. A., 2018, BIOMEDICAL PHYS ENG, V4, P759; Bentil S.A, 2013, THESIS; Bentil SA, 2014, J MECH BEHAV BIOMED, V30, P83, DOI 10.1016/j.jmbbm.2013.10.020; BLAIR GWS, 1947, J COLL SCI IMP U TOK, V2, P21; Boudjema F, 2017, J PHYS CONF SER, V790, DOI 10.1088/1742-6596/790/1/012002; Boudjema F, 2015, J PHYS CONF SER, V602, DOI 10.1088/1742-6596/602/1/012029; Budday S, 2017, J MECH BEHAV BIOMED, V74, P463, DOI 10.1016/j.jmbbm.2017.07.014; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Centers for Disease Control and Prevention, 2017, DAT STAT TRAUM BRAIN; Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Davis GB, 2006, MED ENG PHYS, V28, P455, DOI 10.1016/j.medengphy.2005.07.023; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Finan JD, 2017, ACTA BIOMATER, V55, P333, DOI 10.1016/j.actbio.2017.03.037; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Garo A, 2007, BIORHEOLOGY, V44, P51; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Guthkelch A N, 1979, Acta Neurochir Suppl (Wien), V28, P120; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kohandel M, 2005, PHYS MED BIOL, V50, P2799, DOI 10.1088/0031-9155/50/12/005; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nicolle S, 2010, J MECH BEHAV BIOMED, V3, P630, DOI 10.1016/j.jmbbm.2010.07.010; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2012, ASME 2012 INT MECH E; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2012, J MECH BEHAV BIOMED, V14, P113, DOI 10.1016/j.jmbbm.2012.04.005; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Schiessel H, 1995, J PHYS A-MATH GEN, V28, P6567, DOI 10.1088/0305-4470/28/23/012; Takhounts E.G, 1999, INJ BIOM RES P 27 IN, P141; The Mathworks Inc, 2016, MATLAB; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Tirella A, 2014, J BIOMED MATER RES A, V102, P3352, DOI 10.1002/jbm.a.34914; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Zhang W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19687-2; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005	49	2	2	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	SEP	2019	97						355	364		10.1016/j.jmbbm.2019.05.028			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	IU5OH	WOS:000483636600039	31154155	Green Accepted			2022-02-06	
J	Ortega-Perez, S; Sanchez-Rubio, L; De las Salas, R; Borja-Gonzalez, J				Ortega-Perez, Stefany; Sanchez-Rubio, Lorena; De las Salas, Roxana; Borja-Gonzalez, Juana			An International Perspective of Transition of Neurological Disease The Latin American and the Caribbean Region	NURSING CLINICS OF NORTH AMERICA			English	Article						Latin America; Neurologic disorders; Health transition; Neuroscience nursing; Nursing care	TRAUMATIC BRAIN-INJURY; BURDEN; STROKE	There are roughly 600 million people in the Latin America and the Caribbean region, of whom approximately 36% are living at or below the poverty line. According to this, neurologic injury disorders disproportionately affect this population, which faces not only most risk factors, but also has less developed health systems to deal with illness recovery. Further, most of the risk factors can be attributed to classic preventable cardiovascular risk factors, although there are important differences in demographics, socioeconomic status, and injury mechanisms that may influence the patient's outcome.	[Ortega-Perez, Stefany; De las Salas, Roxana; Borja-Gonzalez, Juana] Univ Norte, Dept Nursing, Km 5 Via Puerto Colombia, Area Metropolitana Barra, Barranquilla, Colombia; [Sanchez-Rubio, Lorena] Univ Tolima, Dept Nursing, Calle 42 1b-1, Ibague, Colombia		Ortega-Perez, S (corresponding author), Univ Norte, Km 5 Via Puerto Colombia, Area Metropolitana Barra, Barranquilla, Colombia.	srortega@uninorte.edu.co	ORTEGA-PEREZ, STEFANY/I-9311-2019	ORTEGA-PEREZ, STEFANY/0000-0003-3058-5161; Sanchez Rubio, Lorena/0000-0001-8728-7283			Heras C, 2016, GAC SANIT, V30, P167, DOI 10.1016/j.gaceta.2016.03.001; [Anonymous], 2015, LANCET NEUROL, V14, P1143, DOI 10.1016/S1474-4422(15)00307-5; Avezum A, 2015, GLOB HEART, V10, P323, DOI 10.1016/j.gheart.2014.01.006; BONILLASOTO LA, 2018, P R HEALTH SCI J, V37, pS; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Cardona-Gomez GP, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00304; Cassiani SHDB, 2017, REV LAT-AM ENFERM, V25, DOI 10.1590/1518-8345.2232.2913; Celix JM, 2013, THESIS; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Custodio N, 2017, FRONT AGING NEUROSCI, V9, P1; de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Friedman D, 2015, NEW ENGL J MED, V373, P1048, DOI 10.1056/NEJMra1407304; Hendrickson P, 2018, WORLD NEUROSURG, V110, pE952, DOI 10.1016/j.wneu.2017.11.142; Hernández-Ruiz Eder A., 2017, Acta Neurol Colomb., V33, P3, DOI 10.22379/24224022122; Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kalkonde YV, 2018, STROKE, V49, P3092, DOI 10.1161/STROKEAHA.118.017384; Kochen Silvia, 2016, Vertex, VXXVII, P457; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Lima M, 2018, REV GAUCHA ENFERM, V39, P1; Manes F, 2016, LANCET NEUROL, V15, P29, DOI 10.1016/S1474-4422(15)00360-9; Marín M Daniel S, 2018, Rev. Univ. Ind. Santander. Salud, V50, P79, DOI 10.18273/revsal.v50n1-2018008; Mejia-Mantilla JH, 2017, ACTA COLOMB CUID INT, V17, P241, DOI DOI 10.1016/j.acci.2017.10.003; Negrotto L, 2018, MULT SCLER RELAT DIS, V22, P97, DOI 10.1016/j.msard.2018.03.014; Nielsen K, 2012, PREHOSP EMERG CARE, V16, P381, DOI 10.3109/10903127.2012.664245; Ortega-Perez S, 2018, J NEUROSCI NURS, V50, P220, DOI 10.1097/JNN.0000000000000384; PAHO WHO, 2008, 60 SESS REG COMM 200; Pan American Health Organization, AMPL ROL ENF ENF AT; Pedroso I, 2012, MEDICC REV, V14, P11, DOI 10.37757/MR2012V14.N1.4; Prescrire Redaction, 2018, REV PRESCRIRE, V38, P135; Punchak M, 2018, WORLD NEUROSURG, V112, pE240, DOI 10.1016/j.wneu.2018.01.029; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Rivera Diego, 2013, Psicol. caribe, V30, P1; Sila C, 2016, NEW ENGL J MED, V374, P2389, DOI 10.1056/NEJMe1605228; Wilson A, 2017, ONLINE J ISSUES NURS, V22, P1; Witt K, 2017, NERVENARZT, V88, P383, DOI 10.1007/s00115-017-0298-y; World Health Organization, 2009, GLOB STAND IN ED PRO; Zug KE, 2016, REV LAT-AM ENFERM, V24, DOI [10.1590/1518-8345.1615.2807, 10.1590/15188345.1615.2807]	41	2	2	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0029-6465	1558-1357		NURS CLIN N AM	Nurs. Clin. North Am.	SEP	2019	54	3					449	+		10.1016/j.cnur.2019.04.012			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	IU3CF	WOS:000483455600014	31331630				2022-02-06	
J	Picinich, C; Madden, LK; Brendle, K				Picinich, Christine; Madden, Lori Kennedy; Brendle, Kellie			Activation to Arrival Transition and Handoff from Emergency Medical Services to Emergency Departments	NURSING CLINICS OF NORTH AMERICA			English	Article						Patient transfer; Emergency medical services (EMS); Emergency departments (ED); Traumatic brain injury (TBI); Spinal cord injury (SCI); Stroke; EMS patient handoff	HEALTH-CARE PROFESSIONALS; UNITED-STATES; STROKE; GUIDELINES; MANAGEMENT; CHILDREN; DISEASE; PATIENT; EMS; RESUSCITATION	The burden of neurologic disease in the United States continues to increase due to a growing older population, increased life expectancy, and improved mortality after cancer and cardiac disease. Emergency medical services (EMS) providers are responding to more patients with stroke, traumatic neurologic injury, neuromuscular weakness, seizure, and spontaneous cardiac arrest. Efficient prehospital care and triage to facilities with specialized services improve outcomes. Effective handoff from EMS to an emergency department ensures continuity of care and patient safety. Although advancements in prehospital cardiopulmonary resuscitation have increased rates of return to spontaneous circulation, a large proportion of patients sustain neurologic injury.	[Picinich, Christine] UC Davis Hlth, Dept Neurol Surg, 4860 Y St,Suite 3740, Sacramento, CA 95817 USA; [Madden, Lori Kennedy] UC Davis Hlth, Ctr Nursing Sci, 2315 Stockton Blvd, Sacramento, CA 95817 USA; [Brendle, Kellie] UC Davis Hlth, Heart & Vasc Serv, 2315 Stockton Blvd, Sacramento, CA 95817 USA		Picinich, C (corresponding author), UC Davis Hlth, Dept Neurol Surg, 4860 Y St,Suite 3740, Sacramento, CA 95817 USA.	cpicinich@ucdavis.edu	Madden, Lori K/K-3749-2012	Madden, Lori K/0000-0001-9179-4202			Abboud ME, 2016, PREHOSP EMERG CARE, V20, P729, DOI 10.1080/10903127.2016.1182602; Ahn H, 2011, J NEUROTRAUM, V28, P1341, DOI 10.1089/neu.2009.1168; American College of Emergency Physicians, 2014, Prehosp Emerg Care, V18, P305, DOI 10.3109/10903127.2014.883001; [Anonymous], 2019, NATL SPINAL CORD INJ; [Anonymous], 2018, LEAD CAUS NONF INJ R; Aroor S, 2017, STROKE, V48, P479, DOI 10.1161/STROKEAHA.116.015169; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Billington M, 2016, J CLIN MED, V5, DOI 10.3390/jcm5090074; Bost N, 2012, INT EMERG NURS, V20, P133, DOI 10.1016/j.ienj.2011.10.002; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Carson PJ, 2012, EMERG INFECT DIS, V18, P684, DOI 10.3201/eid1804.111313; Cheung DS, 2010, ANN EMERG MED, V55, P171, DOI 10.1016/j.annemergmed.2009.07.016; Cui WJ, 2015, MMWR-MORBID MORTAL W, V64, P1209, DOI 10.15585/mmwr.mm6443a2; DiBiasio EL, 2018, J NEUROINTERV SURG; Drenck N, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-018-0580-4; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Elmer J, 2017, NEUROCRIT CARE, V27, pS134, DOI 10.1007/s12028-017-0457-9; Fassbender K, 2013, LANCET NEUROL, V12, P585, DOI 10.1016/S1474-4422(13)70100-5; Fineberg HV, 2013, JAMA-J AM MED ASSOC, V310, P585, DOI 10.1001/jama.2013.13809; Flower O, 2015, NEUROCRIT CARE, V23, pS23, DOI 10.1007/s12028-015-0160-7; Girotra S, 2015, HEART, V101, P1943, DOI 10.1136/heartjnl-2015-307450; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Goldberg SA, 2017, PREHOSP EMERG CARE, V21, P14, DOI 10.1080/10903127.2016.1194930; Gooch CL, 2017, ANN NEUROL, V81, P479, DOI 10.1002/ana.24897; Hankey GJ, 2017, LANCET, V389, P641, DOI 10.1016/S0140-6736(16)30962-X; Hutchinson David, 2008, Pract Neurol, V8, P229, DOI 10.1136/pn.2008.152611; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Koenig MA, 2014, CRIT CARE CLIN, V30, P765, DOI 10.1016/j.ccc.2014.06.007; Madl Christian, 2004, Curr Opin Crit Care, V10, P213, DOI 10.1097/01.ccx.0000127542.32890.fa; Medoro I, 2017, PREHOSP EMERG CARE, V21, P476, DOI 10.1080/10903127.2017.1294222; Meisel ZF, 2015, ANN EMERG MED, V65, P310, DOI 10.1016/j.annemergmed.2014.07.003; Nayak R, 2017, WORLD J CLIN CASES, V5, P270, DOI 10.12998/wjcc.v5.i7.270; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Prabhakaran S, 2015, JAMA-J AM MED ASSOC, V313, P1451, DOI 10.1001/jama.2015.3058; Reay G, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0651-z; ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706; Rui P, 2015, NATL HOSP AMBULATORY; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Schwamm LH, 2017, CIRCULATION, V135, pE24, DOI 10.1161/CIR.0000000000000475; Silverman EC, 2017, WEST J EMERG MED, V18, P419, DOI 10.5811/westjem.2016.12.32066; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; The National Association of State EMS Officials (NASEMSO), 2017, NAT MOD EMS CLIN GUI; Theodore N, 2013, NEUROSURGERY, V72, P35, DOI 10.1227/NEU.0b013e318276edc5; Yew KS, 2015, AM FAM PHYSICIAN, V91, P528; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525; Zack MM, 2017, MMWR-MORBID MORTAL W, V66, P821, DOI 10.15585/mmwr.mm6631a1; Zhang S, 2018, AGING DIS, V9, P426, DOI 10.14336/AD.2017.0601	48	2	2	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0029-6465	1558-1357		NURS CLIN N AM	Nurs. Clin. North Am.	SEP	2019	54	3					313	+		10.1016/j.cnur.2019.04.001			12	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	IU3CF	WOS:000483455600003	31331619				2022-02-06	
J	Ricketts, EJ; Wu, MS; Leman, TY; Piacentini, J				Ricketts, Emily J.; Wu, Monica S.; Leman, Talia Y.; Piacentini, John			A Review of Tics Presenting Subsequent to Traumatic Brain Injury	CURRENT DEVELOPMENTAL DISORDERS REPORTS			English	Article						Tics; Traumatic brain injury; Concussion; neuroimaging		Purpose of ReviewThis review summarizes case reports of patients with tics emerging subsequent to traumatic brain injury (TBI), with respect to demographics, post-TBI symptoms, tic onset latency and topography, clinical history, neuroimaging results, and treatment outcome.Recent FindingsPatients were 22 adults and 3 youth. Trauma onset appeared to fall mostly in adulthood. Two-thirds of patients were male and head trauma was related to motor vehicle accidents in most cases. Loss of consciousness was reported in just below half (48.0%) of cases. Associated physical and cognitive symptoms (e.g., impaired memory, reduced sensory perception, poor balance, muscle weakness, attention problems, aggression/impulsivity, obsessions and compulsions, depression, and anxiety) were commonly reported. The latency between head trauma and tic onset varied, but generally ranged from 1-day post-trauma to approximately 1-year post-trauma. Sole presentation of motor tics was common, with rostral to caudal development of motor tics in other cases. Simple and/or complex vocal tics were present in several cases, often emerging after motor tics. Post-trauma obsessive-compulsive symptoms were noted in five cases (20.0%). A personal or family history of tics was reported in four cases. Damage to the basal ganglia, ventricular system, and temporal region was observed across ten patients (40.0%). Pharmacological intervention varied, with tic symptoms deemed to have significantly or somewhat improved in 12 cases (48.0%). A comparison of post-TBI symptoms in youth with head trauma history relative to those with peripheral injury suggests tic symptoms are not a common post-TBI symptom in youth.SummaryUltimately, there has been limited study on the link between traumatic brain injury and tic expression, and methodological issues preclude the ability to draw definitive conclusions regarding this relationship. Nevertheless, findings do suggest there may be heterogeneity in brain dysfunction associated with tic expression. Future case reports should utilize more systematic and thorough assessment of TBI and tics using validated measures, evaluate medication effects using single-case designs, and perform more longitudinal follow-up of cases with repeated neuroimaging.	[Ricketts, Emily J.; Wu, Monica S.; Leman, Talia Y.; Piacentini, John] Univ Calif Los Angeles, Div Child & Adolescent Psychiat, 760 Westwood Plaza,Rm 67-467, Los Angeles, CA 90024 USA		Ricketts, EJ (corresponding author), Univ Calif Los Angeles, Div Child & Adolescent Psychiat, 760 Westwood Plaza,Rm 67-467, Los Angeles, CA 90024 USA.	ERicketts@mednet.ucla.edu			National Institute of Mental Health (NIMH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH113884, T32MH073517]	The research reported in this publication was supported in part by the National Institute of Mental Health (NIMH) K23MH113884 grant funding to Dr. Ricketts and T32MH073517.	ADELOYE A, 1991, J NATL MED ASSOC, V83, P1018; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Black Kevin J, 2016, F1000Res, V5, P696, DOI 10.12688/f1000research.8428.1; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Caligiore D, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005395; Chouinard S, 2000, J NEUROL NEUROSUR PS, V68, P738, DOI 10.1136/jnnp.68.6.738; Cohen SC, 2013, NEUROSCI BIOBEHAV R, V37, P997, DOI 10.1016/j.neubiorev.2012.11.013; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dale RC, 2017, CURR OPIN PEDIATR, V29, P665, DOI 10.1097/MOP.0000000000000546; Eddy CM, 2016, J PSYCHIATR RES, V81, P102, DOI 10.1016/j.jpsychires.2016.07.002; Eddy CM, 2014, J OBSESS-COMPULS REL, V3, P363, DOI 10.1016/j.jocrd.2014.04.003; ERIKSSON B, 1969, BRIT J PSYCHIAT, V115, P351, DOI 10.1192/bjp.115.520.351; Factor SA, 1997, MOVEMENT DISORD, V12, P1052, DOI 10.1002/mds.870120634; Fahn S, 1982, Adv Neurol, V35, P341; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Ganos C, 2015, NEUROL CLIN, V33, P115, DOI 10.1016/j.ncl.2014.09.008; GAUL JJ, 1994, MOVEMENT DISORD, V9, P121; Gul V., 2015, PRENSA MED ARGENT, V101, P1, DOI [10.4172/lpma.1000150, DOI 10.4172/LPMA.1000150]; Hannawi Y, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1236-2; HYDE TM, 1995, NEUROLOGY, V45, P1176, DOI 10.1212/WNL.45.6.1176; KLEMPEL K, 1974, S AFR MED J, V48, P1379; KOLLER WC, 1989, MOVEMENT DISORD, V4, P20, DOI 10.1002/mds.870040106; Krauss JK, 2002, NEUROSURGERY, V50, P927, DOI 10.1097/00006123-200205000-00003; Krauss JK, 1997, MOVEMENT DISORD, V12, P776, DOI 10.1002/mds.870120527; Krauss Joachim K, 2015, Handb Clin Neurol, V128, P475, DOI 10.1016/B978-0-444-63521-1.00030-3; Kumar Ashutosh, 2016, Curr Dev Disord Rep, V3, P217; Kumar R, 1997, NEUROL CLIN, V15, P309, DOI 10.1016/S0733-8619(05)70315-7; Leckman JF, 2014, J OBSESS-COMPULS REL, V3, P372, DOI 10.1016/j.jocrd.2014.03.004; Majumdar A, 2002, PEDIATR NEUROL, V27, P314, DOI 10.1016/S0887-8994(02)00446-0; MAKI Y, 1980, CHILD BRAIN, V7, P113; Mejia Nicte I, 2005, Rev. Bras. Psiquiatr., V27, P11, DOI 10.1590/S1516-44462005000100006; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; Muller-Vahl KR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-47; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Nespoli E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196515; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Poulopoulos Markos, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-201676; Ranjan N, 2011, BRAIN INJURY, V25, P629, DOI 10.3109/02699052.2011.572944; Richer Petra, 2015, Mol Neuropsychiatry, V1, P156; Robakis D, 2017, TREMOR OTHER HYPERK, V7, DOI 10.7916/D8SQ95ND; Robertson MM, 2014, NAT REV NEUROL, V10, P6, DOI 10.1038/nrneurol.2013.248; Scahill L, 2014, J OBSESS-COMPULS REL, V3, P394, DOI 10.1016/j.jocrd.2014.06.002; Siemers E, 1990, Mov Disord, V5, P183; SINGER C, 1989, MOVEMENT DISORD, V4, P342, DOI 10.1002/mds.870040409; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tijssen MAJ, 1999, J NEUROL NEUROSUR PS, V67, P782, DOI 10.1136/jnnp.67.6.782; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Whitaker AH, 1997, ARCH GEN PSYCHIAT, V54, P847; Worbe Y, 2015, BRAIN, V138, P472, DOI 10.1093/brain/awu311; Worbe Y, 2010, BRAIN, V133, P3649, DOI 10.1093/brain/awq293	55	2	2	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2196-2987		CURR DEV DISORD REP	Curr. Dev. Disord. Rep.	SEP	2019	6	3					145	158		10.1007/s40474-019-00167-9			14	Psychology, Developmental; Neurosciences; Rehabilitation	Emerging Sources Citation Index (ESCI)	Psychology; Neurosciences & Neurology; Rehabilitation	VK4OQ	WOS:000702471200007	31984203	Green Accepted, Bronze			2022-02-06	
J	Rosene, JM; Merritt, C; Wirth, NR; Nguyen, D				Rosene, John M.; Merritt, Christian; Wirth, Nick R.; Nguyen, Daniel			Incidence and Force Application of Head Impacts in Men's Lacrosse: A Pilot Study	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						head impact sensor; subconcussive; sport-related concussion	TRAUMATIC BRAIN-INJURY; BIOMECHANICS; CONCUSSION; EXPOSURE; HOCKEY	Subconcussive head impacts in sport may have a greater impact on neurological degradation versus concussive hits given the repetitive nature of these head impacts. The purpose of this investigation was to quantify the frequency, magnitude, and location of head impacts in an NCAA Division III men's lacrosse team. There was no significant difference (p <= .05) in peak linear acceleration, peak rotational acceleration, and peak rotational velocity between games and practices. There was no significant difference (p <= .05) for PLA among player position and location of head impact. The quantity and intensity of subconcussive head impacts between practices and games were similar. These multiple subconcussive head impacts have the potential to lead to future neurological impairments.	[Rosene, John M.; Merritt, Christian; Wirth, Nick R.; Nguyen, Daniel] Univ New England, Dept Exercise & Sport Performance, Biddeford, ME 04005 USA		Rosene, JM (corresponding author), Univ New England, Dept Exercise & Sport Performance, Biddeford, ME 04005 USA.	jrosene@une.edu		Nguyen, Daniel/0000-0002-9268-0300			Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bonfield CM, 2015, PHYSICIAN SPORTSMED, V43, P236, DOI 10.1080/00913847.2015.1039922; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Karton C, 2016, MEASUREMENT ACCURACY; Kerr Zachary Y, 2017, Inj Epidemiol, V4, P6, DOI 10.1186/s40621-017-0104-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Miyashita T, 2016, ATHLETIC TRAINING SP, V8, P202, DOI DOI 10.3928/19425864-20160503-01; O'Day KM, 2017, CLIN BIOMECH, V43, P23, DOI 10.1016/j.clinbiomech.2017.01.013; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zuckerman SL, 2015, AM J SPORTS MED, V20, P1	21	2	2	0	3	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	SEP	2019	24	5					213	216		10.1123/ijatt.2018-0052			4	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	IX4MB	WOS:000485659200007					2022-02-06	
J	Saadipour, K; Tiberi, A; Lomardo, S; Grajales, E; Montroull, L; Manucat-Tan, NB; LaFrancois, J; Cammer, M; Mathews, PM; Scharfman, HE; Liao, FF; Friedman, WJ; Zhou, XF; Tesco, G; Chao, MV				Saadipour, Khalil; Tiberi, Alexia; Lomardo, Sylvia; Grajales, Elena; Montroull, Laura; Manucat-Tan, Noralyn B.; LaFrancois, John; Cammer, Michael; Mathews, Paul M.; Scharfman, Helen E.; Liao, Francesca-Fang; Friedman, Wilma J.; Zhou, Xin-Fu; Tesco, Giueseppina; Chao, Moses, V			Regulation of BACE1 expression after injury is linked to the p75 neurotrophin receptor	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						BACE1; p75 neurotrophin receptor; JNK; Traumatic brain injury	AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; BETA-SECRETASE BACE1; ALZHEIMERS-DISEASE; MESSENGER-RNA; NERVE; NEURONS; ACTIVATION	BACE1 is a transmembrane aspartic protease that cleaves various substrates and it is required for normal brain function. BACE1 expression is high during early development, but it is reduced in adulthood. Under conditions of stress and injury, BACE1 levels are increased; however, the underlying mechanisms that drive BACE1 elevation are not well understood. One mechanism associated with brain injury is the activation of injurious p75 neurotrophin receptor (p75), which can trigger pathological signals. Here we report that within 72 h after controlled cortical impact (CCI) or laser injury, BACE1 and p75 are increased and tightly co-expressed in cortical neurons of mouse brain. Additionally, BACE1 is not up-regulated in p75 null mice in response to focal cortical injury, while p75 over-expression results in BACE1 augmentation in HEK-293 and SY5Y cell lines. A luciferase assay conducted in SY5Y cell line revealed that BACE1 expression is regulated at the transcriptional level in response to p75 transfection. Interestingly, this effect does not appear to be dependent upon p75 ligands including mature and pro-neurotrophins. In addition, BACE1 activity on amyloid precursor protein (APP) is enhanced in SY5Y-APP cells transfected with a p75 construct. Lastly, we found that the activation of c-jun n-terminal kinase (JNK) by p75 contributes to BACE1 up-regulation. This study explores how two injury-induced molecules are intimately connected and suggests a potential link between p75 signaling and the expression of BACE1 after brain injury.	[Saadipour, Khalil; Tiberi, Alexia; Grajales, Elena; Chao, Moses, V] NYU, Langone Med Ctr, Skirball Inst Biomol Med, Dept Cell Biol, New York, NY 10016 USA; [Saadipour, Khalil; Tiberi, Alexia; Grajales, Elena; Chao, Moses, V] NYU, Langone Med Ctr, Skirball Inst Biomol Med, Dept Physiol & Neurosci, New York, NY 10016 USA; [Saadipour, Khalil; Tiberi, Alexia; Grajales, Elena; Chao, Moses, V] NYU, Langone Med Ctr, Skirball Inst Biomol Med, Dept Psychiat, New York, NY 10016 USA; [Tiberi, Alexia] Scuola Normale Super Pisa, Bio SNS Lab, Piazza Cavalieri 7, I-56126 Pisa, Italy; [Lomardo, Sylvia; Tesco, Giueseppina] Tufts Univ, Alzheimers Dis Res Lab, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA; [Montroull, Laura; Friedman, Wilma J.] Rutgers State Univ, Rutgers Life Sci Ctr, Dept Biol Sci, Newark, NJ 07102 USA; [Manucat-Tan, Noralyn B.; Zhou, Xin-Fu] Univ South Australia, Sch Pharm & Med Sci, Sansom Inst, Adelaide, SA 5000, Australia; [LaFrancois, John; Mathews, Paul M.; Scharfman, Helen E.] Ctr Dementia Res, Nathan Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Cammer, Michael] NYU, Langone Med Ctr, DART Microscopy Lab, New York, NY 10016 USA; [Liao, Francesca-Fang] Univ Tennessee, Dept Pharmacol, Hlth Sci Ctr, Memphis, TN 38163 USA		Saadipour, K; Chao, MV (corresponding author), NYU, Langone Med Ctr, Skirball Inst Biomol Med, Dept Cell Biol, New York, NY 10016 USA.; Saadipour, K; Chao, MV (corresponding author), NYU, Langone Med Ctr, Skirball Inst Biomol Med, Dept Physiol & Neurosci, New York, NY 10016 USA.; Saadipour, K; Chao, MV (corresponding author), NYU, Langone Med Ctr, Skirball Inst Biomol Med, Dept Psychiat, New York, NY 10016 USA.	khalil.saadipour@nyulangone.org; moses.chao@nyulangone.org	Zhou, Xin-Fu/F-4119-2013	Zhou, Xin-Fu/0000-0002-8687-0175; Chao, Moses/0000-0002-6969-3744; Mathews, Paul/0000-0003-1742-7687; Cammer, Michael/0000-0003-4930-1739; Tiberi, Alexia/0000-0002-0093-444X; Lombardo, Sylvia/0000-0002-5207-6723; Manucat-Tan, Noralyn/0000-0002-9618-753X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2R56AG025970-11A1]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH109305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG055328] Funding Source: NIH RePORTER	We thank Dr. Francis S. Lee. (Weill Cornell. School of Medicine, New York, NY) and Dr. Elizabeth Eckman (Biomedical Research Institute of New Jersey, NJ, USA) for kindly providing the p75-/- mice and SY5Y-APP695 cell line, respectively. We also thank Dr. Barbara Hempstead (Weill Cornell School of Medicine, New York, NY) for providing recombinant proNGF. This work was supported by research grant from National Institutes of Health, 2R56AG025970-11A1.	Alder J, 2016, BRAIN INJURY, V30, P48, DOI 10.3109/02699052.2015.1088963; Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI 10.1089/neu.2008-0765; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bentley CA, 2000, J NEUROSCI, V20, P7706; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Choi JHK, 2009, J NEUROCHEM, V110, P1818, DOI 10.1111/j.1471-4159.2009.06277.x; Choi S, 2009, ASN NEURO, V1, DOI 10.1042/AN20090009; Cole SL, 2007, CURR GENOMICS, V8, P509, DOI 10.2174/138920207783769512; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Strooper B, 2000, J CELL SCI, V113, P1857; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Dmitrieva VG, 2016, MOL BIOL+, V50, P684, DOI [10.1134/S0026893316030067, 10.7868/S002689841603006X]; Dowling P, 1999, NEUROLOGY, V53, P1676, DOI 10.1212/WNL.53.8.1676; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; Forsyth PA, 2014, J BIOL CHEM, V289, P8067, DOI 10.1074/jbc.M113.513762; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gersbacher MT, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-61; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guglielmotto M, 2011, J ALZHEIMERS DIS, V27, P871, DOI 10.3233/JAD-2011-110884; Hamanoue M, 1999, MOL CELL NEUROSCI, V14, P28, DOI 10.1006/mcne.1999.0770; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Hartlage-Rubsamen M, 2003, GLIA, V41, P169, DOI 10.1002/glia.10178; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Hempstead B L, 2014, Handb Exp Pharmacol, V220, P17, DOI 10.1007/978-3-642-45106-5_2; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Hinkle DA, 1997, J NEUROTRAUM, V14, P729, DOI 10.1089/neu.1997.14.729; Hitt B, 2012, J BIOL CHEM, V287, P38408, DOI 10.1074/jbc.M112.415505; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2013, CELL REP, V4, P40, DOI 10.1016/j.celrep.2013.06.005; HUBER LJ, 1995, DEV BIOL, V167, P227, DOI 10.1006/dbio.1995.1019; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Irmady K, 2014, J NEUROSCI, V34, P3419, DOI 10.1523/JNEUROSCI.1982-13.2014; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; KOH SY, 1989, J NEUROSCI, V9, P2999; Kohn J, 1999, J NEUROSCI, V19, P5393; Kokaia Z, 1998, NEUROSCIENCE, V84, P1113, DOI 10.1016/S0306-4522(97)00579-4; KOLIATSOS VE, 1991, BRAIN RES, V549, P297, DOI 10.1016/0006-8993(91)90471-7; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lange-Dohna C, 2003, J NEUROSCI RES, V73, P73, DOI 10.1002/jnr.10639; Lee FS, 2001, CURR OPIN NEUROBIOL, V11, P281, DOI 10.1016/S0959-4388(00)00209-9; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Lin Z, 2015, ELIFE, V4, DOI 10.7554/eLife.11692; Lipponen A., 2016, SCI REP, V6; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; MARTINEZMURILLO R, 1993, NEUROSCIENCE, V52, P587, DOI 10.1016/0306-4522(93)90408-8; Meeker RB, 2015, NEURAL REGEN RES, V10, P721, DOI 10.4103/1673-5374.156967; Nelson AR, 2014, J ALZHEIMERS DIS, V38, P867, DOI 10.3233/JAD-130608; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Oh JD, 2000, BRAIN RES, V853, P174, DOI 10.1016/S0006-8993(99)02054-5; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Pacheco-Quinto J, 2013, J BIOL CHEM, V288, P5606, DOI 10.1074/jbc.M112.422964; Petratos S, 2003, J NEUROPATH EXP NEUR, V62, P398, DOI 10.1093/jnen/62.4.398; Qian L, 2019, MOL NEUROBIOL, V56, P4639, DOI 10.1007/s12035-018-1404-2; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Rajapaksha TW, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-88; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Rossner S, 2001, J NEUROSCI RES, V64, P437; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Ruffels J, 2004, EUR J PHARMACOL, V483, P163, DOI 10.1016/j.ejphar.2003.10.032; Saadipour K, 2018, J NEUROCHEM, V144, P302, DOI 10.1111/jnc.14206; Saadipour K, 2017, J BIOL CHEM, V292, P16594, DOI 10.1074/jbc.M117.788729; SAIKA T, 1991, MOL BRAIN RES, V9, P157, DOI 10.1016/0169-328X(91)90142-K; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Singh KK, 2005, NEURON, V45, P837, DOI 10.1016/j.neuron.2005.01.049; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094; Tong Y, 2005, J NEURAL TRANSM, V112, P455, DOI 10.1007/s00702-004-0255-3; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; VonDran MW, 2014, ASN NEURO, V6, DOI 10.1177/1759091414552185; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang RS, 2015, J BIOL CHEM, V290, P22532, DOI 10.1074/jbc.M115.662908; Wang RS, 2013, CELL METAB, V17, P685, DOI 10.1016/j.cmet.2013.03.016; Wen Y, 2004, BRAIN RES, V1009, P1, DOI 10.1016/j.brainres.2003.09.086; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Zheng N, 2015, J ALZHEIMERS DIS, V45, P659, DOI 10.3233/JAD-142517; Zhou LJ, 2012, J BIOL CHEM, V287, P33719, DOI 10.1074/jbc.A112.377465; Zhou XF, 1996, J NEUROSCI, V16, P2901	104	2	2	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	SEP	2019	99								103395	10.1016/j.mcn.2019.103395			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA3ZV	WOS:000487769000006	31422108	Green Accepted			2022-02-06	
J	Saloner, R; Paolillo, EW; Umlauf, A; Moore, DJ; Heaton, RK; Grant, I; Cherner, M				Saloner, Rowan; Paolillo, Emily W.; Umlauf, Anya; Moore, David J.; Heaton, Robert K.; Grant, Igor; Cherner, Mariana		TMARC Grp	Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Substance-related disorders; methamphetamine; ethanol; neuropsychology; neuroprotection; cognitive dysfunction	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL IMPAIRMENT; COGNITIVE FUNCTION; DEFICIT SCORES; OLDER-ADULTS; COCAINE; ETHANOL; HYPERTHERMIA; INDIVIDUALS; DEPENDENCE	Objectives: Methamphetamine (MA) dependence contributes to neurotoxicity and neurocognitive deficits. Although combined alcohol and MA misuse is common, how alcohol consumption relates to neurocognitive performance among MA users remains unclear. We hypothesized that alcohol and MA use would synergistically diminish neurocognitive functioning, such that greater reported alcohol consumption would exert larger negative effects on neurocognition among MA-dependent individuals compared to MA-nonusing persons. Methods: Eighty-seven MA-dependent (MA+) and 114 MA-nonusing (MA-) adults underwent neuropsychological and substance use assessments. Linear and logistic regressions examined the interaction between MA status and lifetime average drinks per drinking day on demographically corrected global neurocognitive T scores and impairment rates, controlling for recent alcohol use, lifetime cannabis use, WRAT reading performance, and lifetime depression. Results: MA+ displayed moderately higher rates of impairment and lower T scores compared to MA-. Lifetime alcohol use significantly interacted with MA status to predict global impairment (ORR = 0.70, p = .003) such that greater lifetime alcohol use increased likelihood of impairment in MA-, but decreased likelihood of impairment in MA+. Greater lifetime alcohol use predicted poorer global T scores among MA- (b = -0.44, p = .030) but not MA+ (b = 0.08, p = .586). Conclusions: Contrary to expectations, greater lifetime alcohol use related to reduced risk of neurocognitive impairment among MA users. Findings are supported by prior research identifying neurobiological mechanisms by which alcohol may attenuate stimulant-driven vasoconstriction and brain thermotoxicity. Replication and examination of neurophysiologic mechanisms underlying alcohol use in the context of MA dependence are warranted to elucidate whether alcohol confers a degree of neuroprotection.	[Saloner, Rowan; Paolillo, Emily W.] San Diego State Univ Univ Calif, San Diego Joint Doctoral Program Clin Psychol, 6363 Alvarado Court,Suite 102, San Diego, CA 92120 USA; [Saloner, Rowan; Paolillo, Emily W.; Umlauf, Anya; Moore, David J.; Heaton, Robert K.; Grant, Igor; Cherner, Mariana; TMARC Grp] Univ Calif San Diego, Dept Psychiat, HIV Neurobehav Res Program, 220 Dickinson St,Suite B, San Diego, CA 92103 USA		Cherner, M (corresponding author), Univ Calif San Diego, Psychiat, HIV Neurobehav Res Program, 220 Dickinson St,Suite B,MC8231, San Diego, CA 92103 USA.	mcherner@ucsd.edu	cherner, mariana/N-4810-2015	cherner, mariana/0000-0002-5479-7401; Saloner, Rowan/0000-0002-1351-6183	NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [P50DA026306, P01DA012065]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA013525]; University of California, San Diego (UCSD); Sanford-Burnham Medical Discovery Institute (SBMDI); University of California, Irvine (UCI)University of California System; National Institute on Drug Abuse (NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [P50DA026306]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA013525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K24DA040550, P50DA026306] Funding Source: NIH RePORTER	Data for this study were collected as part of a NIDA-funded research program that includes the Translational Methamphetamine AIDS Research Center (TMARC), supported by award P50DA026306 and the program projects on NeuroAIDS Effects of Methamphetamine and NeuroAIDS Effects of Methamphetamine & HCV, and supported by award P01DA012065. Stipend support to RS is funded by NIAAA award T32AA013525. The authors declare no conflicts of interest. The Translational Methamphetamine AIDS Research Center (TMARC) is supported by Center award P50DA026306 from the National Institute on Drug Abuse (NIDA) and is affiliated with the University of California, San Diego (UCSD), the Sanford-Burnham Medical Discovery Institute (SBMDI), and the University of California, Irvine (UCI). The TMARC comprises: Administrative Coordinating Core (ACC) - Executive Unit: Director - Igor Grant, M.D.; Co-Directors - Ronald J. Ellis, M.D., Ph.D., Scott L. Letendre, M.D., and Cristian L. Achim, M.D., Ph.D.; Center Manager - Mariana Cherner, Ph.D.; Associate Center Managers - Erin E. Morgan, Ph.D. and Jared Young, Ph.D.; Data Management and Information Systems (DMIS) Unit: Anthony C. Gamst, Ph.D. (Unit Chief) and Clint Cushman, B.A. (Unit Manager); ACC - Statistics Unit: Florin Vaida, Ph.D. (Unit Chief), Ian S. Abramson, Ph.D., Reena Deutsch, Ph.D., and Anya Umlauf, M.S.; ACC - Participant Unit: J. Hampton Atkinson, M.D. (Unit Chief), Jennifer Marquie-Beck, and M.P.H. (Unit Manager); Behavioral Assessment and Medical (BAM) Core - Neuromedical and Laboratory Unit (NLU): Scott L. Letendre, M.D. (Core Co-Director/NLU Chief) and Ronald J. Ellis, M.D., Ph.D.; BAM Core - Neuropsychiatric Unit (NPU): Robert K. Heaton, Ph.D. (Core Co-Director/NPU Chief), J. Hampton Atkinson, M.D., Thomas D. Marcotte, Ph.D., Erin E. Morgan, Ph.D., and Matthew Dawson (NPU Manager); Neuroimaging (NI) Core: Gregory G. Brown, Ph.D. (Core Director), Thomas T. Liu, Ph.D., Miriam Scadeng, Ph.D., Christine Fennema-Notestine, Ph.D., Sarah L. Archibald, M.A., John R. Hesselink, M.D., Mary Jane Meloy, Ph.D., and Craig E.L. Stark, Ph.D.; Neuroscience and Animal Models (NAM) Core: Cristian L. Achim, M.D., Ph.D. (Core Director), Marcus Kaul, Ph.D., and Virawudh Soontornniyomkij, M.D.; Pilot and Developmental (PAD) Core: Mariana Cherner, Ph.D. (Core Director), Stuart A. Lipton, M.D., Ph.D.; Project 1: Arpi Minassian, Ph.D. (Project Director), William Perry, Ph.D., Mark A. Geyer, Ph.D., and Jared W. Young, Ph.D.; Project 2: Amanda B. Grethe, Ph.D. (Project Director), Susan F. Tapert, Ph.D., and Assawin Gongvatana, Ph.D.; Project 3: Erin E. Morgan, Ph.D. (Project Director) and Igor Grant, M.D.; Project 4: Svetlana Semenova, Ph.D. (Project Director).; Project 5: Marcus Kaul, Ph.D. (Project Director). The views expressed in this article are those of the authors and do not reflect the official policy or position of the United States Government.	Abdul Muneer P M, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P48; Abi-Saab D, 2005, AM J ADDICTION, V14, P166, DOI 10.1080/10550490590924854; Althobaiti Y.S., 2016, J ADDICT RES THER, V7, P281, DOI DOI 10.4172/2155-6105.1000281; Bau PFD, 2005, ALCOHOL, V37, P53, DOI 10.1016/j.alcohol.2005.10.034; Bechara A, 2004, NEUROPSYCHOLOGY, V18, P152, DOI 10.1037/0894-4105.18.1.152; Bernardin F, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00078; Blackstone K, 2012, CLIN NEUROPSYCHOL, V26, P894, DOI 10.1080/13854046.2012.694479; Bolla KI, 1999, J NEUROPSYCH CLIN N, V11, P361, DOI 10.1176/jnp.11.3.361; Bolla KI, 2000, NEUROLOGY, V54, P2285, DOI 10.1212/WNL.54.12.2285; Britton A, 2004, AM J EPIDEMIOL, V160, P240, DOI 10.1093/aje/kwh206; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brown PL, 2003, J NEUROSCI, V23, P3924; Brust JCM, 2010, INT J ENV RES PUB HE, V7, P1540, DOI 10.3390/ijerph7041540; Bujarski S, 2014, DRUG ALCOHOL DEPEN, V142, P127, DOI 10.1016/j.drugalcdep.2014.06.004; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; CAETANO R, 1995, ADDICTION, V90, P351, DOI 10.1111/j.1360-0443.1995.tb03783.x; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Chang L, 2002, PSYCHIAT RES-NEUROIM, V114, P65, DOI 10.1016/S0925-4927(02)00004-5; Cherner M, 2010, DRUG ALCOHOL DEPEN, V106, P154, DOI 10.1016/j.drugalcdep.2009.08.010; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P902, DOI 10.1097/01.ALC.0000164544.45746.A7; Dean AC, 2013, NEUROPSYCHOPHARMACOL, V38, P259, DOI 10.1038/npp.2012.179; Elias PK, 1999, AM J EPIDEMIOL, V150, P580; Farre M, 1997, J PHARMACOL EXP THER, V283, P164; Furr CDM, 2000, DRUG ALCOHOL DEPEN, V59, P89, DOI 10.1016/S0376-8716(99)00078-2; Goldstein RZ, 2004, NEUROPSYCHOLOGIA, V42, P1447, DOI 10.1016/j.neuropsychologia.2004.04.002; Gonzalez R, 2004, DRUG ALCOHOL DEPEN, V76, P181, DOI 10.1016/j.drugalcdep.2004.04.014; Gonzalez R, 2007, J CLIN EXP NEUROPSYC, V29, P155, DOI 10.1080/13803390600582446; GORELICK P B, 1987, Stroke, V18, P268; Gottschalk PC, 2002, DRUG ALCOHOL DEPEN, V68, P95, DOI 10.1016/S0376-8716(02)00109-6; GRANT I, 1987, J CONSULT CLIN PSYCH, V55, P310, DOI 10.1037/0022-006X.55.3.310; Gross AL, 2011, J GERONTOL B-PSYCHOL, V66, P39, DOI 10.1093/geronb/gbq062; Halkitis PN, 2005, J URBAN HEALTH, V82, pI18, DOI 10.1093/jurban/jti020; Hart CL, 2012, NEUROPSYCHOPHARMACOL, V37, P586, DOI 10.1038/npp.2011.276; Heaton R. K., 2004, REVISED COMPREHENSIV; Ho EL, 2009, NEUROCRIT CARE, V10, P295, DOI 10.1007/s12028-008-9177-5; Horowitz JM, 1999, ADDICT BIOL, V4, P127, DOI 10.1080/13556219971632; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Johanson CE, 2006, PSYCHOPHARMACOLOGY, V185, P327, DOI 10.1007/s00213-006-0330-6; Kalapatapu RK, 2017, J ADDICT DIS, V36, P38, DOI 10.1080/10550887.2016.1245029; Kalechstein AD, 2003, J NEUROPSYCH CLIN N, V15, P215, DOI 10.1176/appi.neuropsych.15.2.215; Kirkpatrick MG, 2012, PSYCHOPHARMACOLOGY, V219, P109, DOI 10.1007/s00213-011-2383-4; Kiyatkin EA, 2009, INT REV NEUROBIOL, V88, P65, DOI 10.1016/S0074-7742(09)88004-5; Lawton-Craddock A, 2003, ALCOHOL CLIN EXP RES, V27, P457, DOI 10.1097/01.ALC.0000056620.98842.E6; LEE JA, 1990, ELECTROEN CLIN NEURO, V77, P362, DOI 10.1016/0168-5597(90)90058-L; Liang M, 2012, J ANAL TOXICOL, V36, P30, DOI 10.1093/jat/bkr007; Mahoney JJ, 2017, NEUROPSYCHOLOGY, V31, P311, DOI 10.1037/neu0000344; Manly J., 2003, CLIN INTERPRETATION, P181, DOI DOI 10.1016/B978-012703570-3/50010-9; McCann UD, 2008, SYNAPSE, V62, P91, DOI 10.1002/syn.20471; MENDELSON J, 1995, CLIN PHARMACOL THER, V57, P559, DOI 10.1016/0009-9236(95)90041-1; Muneer PMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019258; National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; Neafsey EJ, 2011, NEUROPSYCH DIS TREAT, V7, P465, DOI 10.2147/NDT.S23159; Norman MA, 2011, J CLIN EXP NEUROPSYC, V33, P793, DOI 10.1080/13803395.2011.559157; Oscar-Berman M, 2003, ALCOHOL RES HEALTH, V27, P125; Oscar-Berman Marlene, 2014, Handb Clin Neurol, V125, P183, DOI 10.1016/B978-0-444-62619-6.00012-4; Park D., 2014, J ADDICTION RES THER, V5, DOI [10.4172/2155-6105.1000e123, DOI 10.4172/2155-6105.1000E123]; PEREZREYES M, 1992, ALCOHOL CLIN EXP RES, V16, P75, DOI 10.1111/j.1530-0277.1992.tb00640.x; Piano MR, 2017, ALCOHOL RES-CURR REV, V38, P219; Potvin S, 2014, J ADDICT MED, V8, P368, DOI 10.1097/ADM.0000000000000066; Renaud SC, 1996, CLIN CHIM ACTA, V246, P77, DOI 10.1016/0009-8981(96)06228-6; Rippeth JD, 2004, J INT NEUROPSYCH SOC, V10, P1, DOI 10.1017/S1355617704101021; Robinson JE, 1999, J INT NEUROPSYCH SOC, V5, P10, DOI 10.1017/S1355617799511028; Rodgers B, 2005, ADDICTION, V100, P1280, DOI 10.1111/j.1360-0443.2005.01158.x; Rosselli M., 2016, J DRUG ABUSE, V2, P1, DOI DOI 10.21767/2471-853X.100017; Roussotte FF, 2011, NEUROIMAGE, V54, P3067, DOI 10.1016/j.neuroimage.2010.10.072; Sajja RK, 2016, J CEREBR BLOOD F MET, V36, P539, DOI 10.1177/0271678X15616978; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Sowell ER, 2010, J NEUROSCI, V30, P3876, DOI 10.1523/JNEUROSCI.4967-09.2010; Spitzer R, 1995, STRUCTURED CLIN INTE; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Sullivan EV, 2010, ALCOHOL RES HEALTH, V33, P127; Syapin PJ, 2005, ALCOHOL CLIN EXP RES, V29, P1080, DOI 10.1097/01.ALC.0000167961.39176.E6; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Topiwala A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2353; Turowski P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00156; Vaghef L., 2014, J ALCOHOL DRUG DEPEN, V2, DOI [10.4172/2329-6488.1000159, DOI 10.4172/2329-6488.1000159]; Walter EJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1376-4; Wang LW, 2017, INT J DRUG POLICY, V49, P32, DOI 10.1016/j.drugpo.2017.07.009; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; WILSON L, 1966, CAN MED ASSOC J, V94, P478; Woicik PA, 2009, NEUROPSYCHOPHARMACOL, V34, P1112, DOI 10.1038/npp.2008.60; Wood S, 2014, PHARMACOL REV, V66, P193, DOI 10.1124/pr.112.007054; YAMAMURA T, 1992, PHARMACOL BIOCHEM BE, V42, P389, DOI 10.1016/0091-3057(92)90131-X; YEN DJ, 1994, EUR NEUROL, V34, P16, DOI 10.1159/000117002; Yu SB, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/103969	85	2	2	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2019	25	8					787	799	PII S1355617719000493	10.1017/S1355617719000493			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	IV9ZE	WOS:000484621400002	31179969	Green Accepted, Green Submitted			2022-02-06	
J	Thomas, PAW; Moffatt, CE; Rudd, D; Marshman, LAG				Thomas, Piers A. W.; Moffatt, Claire E.; Rudd, Donna; Marshman, Laurence A. G.			S-100 beta in chronic subdural haematoma: Prospective cohort study	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Chronic; Subdural haematoma; S-100 beta; Traumatic brain injury	RISK-FACTORS; S100B; SERUM	Chronic subdural haematoma (CSDH) is invariably classified as 'neurotrauma'. However, whilst a history of trauma/fall is frequent, it is usually distant, mild or even absent. Serum S-100 beta > 1.38 mu g/L is associated with a 100% specificity for mortality/poor outcome acutely after moderate-severe neurotrauma. Serum S-100 beta > 0.10 mu g/L is used to screen mild neurotrauma cases for emergent neuro-imaging. Serum S-100 in controls is 0.057 mu g/L. S-100 beta in serum or CSDH fluid (CSDHf) has not been studied. No normal 'subdural fluid' exists to compare CSDHf. We measured serum and CSDHf S-100 beta at surgical drainage in a novel prospective single-centre cohort. Of n = 86/86 (100%, M65, age 73 +/- 13 yrs), n = 66 (76%) reported mild trauma/fall 31 +/- 23 days previously. N = 54 (63%) presented with good clinical Markwalder Grade (MG: 0-1). Paired serum and CSDHf S-100 beta samples were obtained in n = 45. CSDHf S-100 beta (n = 80) was elevated (0.9 +/- 0.6 mu g/L), was significantly higher than serum S-100 beta (n = 51) (0.33 +/- 0.05 mu g/L, P = 0.002), and was significantly correlated with midline-shift (r = 0.43, P = 0.005) and CSDH volume (r = 0.225, P = 0.046). CSDHf S-100 beta was not significantly associated with any demographic factor, co-morbidity or outcome measure. Conclusions: Despite expectations, S-100 beta was elevated in serum CSDH, but was significantly higher in CSDHf. Indeed, CSDHf S-100 beta approached serum levels associated with a poor prognosis after acute-neurotrauma. However, CSDHf S-100 beta did not represent a biomarker for trauma nor functional outcome. Whilst the non-traumatic source for on-going S-100 beta release could not be determined, prolonged compression of an atrophic brain, subsequent CSF leakage, or 'subdural-space' meningeal disruption/proliferation, represent theoretical possibilities. Elevated S-100 beta may therefore not be specific for mild-moderate-severe acute neurotrauma. Alternative non-traumatic intra-cranial mechanisms evidently also exist. Crown Copyright (C) 2019 Published by Elsevier Ltd. All rights reserved.	[Thomas, Piers A. W.; Marshman, Laurence A. G.] Townsville Hosp, Dept Neurosurg, Townsville, Qld 4810, Australia; [Thomas, Piers A. W.; Marshman, Laurence A. G.] James Cook Univ, Sch Med & Dent, Townsville, Qld 4810, Australia; [Moffatt, Claire E.] James Cook Univ, Dept Psychol, Townsville, Qld 4810, Australia; [Rudd, Donna] James Cook Univ, Dept Physiol, Townsville, Qld 4810, Australia		Marshman, LAG (corresponding author), Townsville Hosp, Dept Neurosurg, Townsville, Qld 4810, Australia.	l.a.g.marshman@btinternet.com	Rudd, Donna/AAA-8595-2022		Townsville Hospital Research fund	This research received a specific internal grant from the Townsville Hospital Research fund.	Allouchery G, 2018, CLIN CHEM LAB MED, V56, P1897, DOI 10.1515/cclm-2018-0471; Altman D.G., 1982, STAT PRACTICE; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Chari A, 2016, J NEUROTRAUM, V33, P1212, DOI 10.1089/neu.2015.3983; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; Chen JCT, 2000, NEUROSURG CLIN N AM, V11, P399, DOI 10.1016/S1042-3680(18)30101-3; Gao Q, 2015, J NEUROL SCI, V354, P27, DOI 10.1016/j.jns.2015.04.031; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; Kristof RA, 2008, J NEUROSURG, V108, P275, DOI 10.3171/JNS/2008/108/2/0275; Lyubimova NV, 2011, B EXP BIOL MED+, V150, P732, DOI 10.1007/s10517-011-1236-9; Manickam A, 2017, J CLIN NEUROSCI, V40, P39, DOI 10.1016/j.jocn.2016.12.043; Manickam A, 2016, J CLIN NEUROSCI, V34, P100, DOI 10.1016/j.jocn.2016.05.026; Marshman LAG, 2013, ACTRN12613000175774; Marshman LAG, 2015, CLIN NEUROL NEUROSUR, V131, P1, DOI 10.1016/j.clineuro.2015.01.009; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Putnam T, 1927, ARCH SURG-CHICAGO, V11, P329; Ramachandran R, 2007, SURG NEUROL, V67, P367, DOI 10.1016/j.surneu.2006.07.022; Santarius T, 2004, BRIT J NEUROSURG, V18, P328, DOI 10.1080/02688690400004845; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; Squier W, 2009, FORENSIC SCI INT, V187, P6, DOI 10.1016/j.forsciint.2009.02.005; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Trotter W, 1914, BRIT J SURG, V2, P271, DOI 10.1002/bjs.1800020608; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Virchow R., 1857, VERH PHYS MED GES WU, V7, P134	24	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2019	67						145	150		10.1016/j.jocn.2019.05.058			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IU2MD	WOS:000483413600026	31202636				2022-02-06	
J	Vadlamani, A; Perry, JA; McCunn, M; Stein, DM; Albrecht, JS				Vadlamani, Aparna; Perry, Justin A.; McCunn, Maureen; Stein, Deborah M.; Albrecht, Jennifer S.			Racial Differences in Discharge Location After a Traumatic Brain Injury Among Older Adults	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Race; Rehabilitation; Traumatic brain injuries	OUTCOMES; REHABILITATION; DISPARITIES; INSURANCE; RACE; DISABILITY; IMPACT; CARE	Objective: To determine if there were racial differences in discharge location among older adults treated for traumatic brain injury (TBI) at a level 1 trauma center. Design: Retrospective cohort study. Setting: R Adams Cowley Shock Trauma Center. Participants: Black and white adults aged >= 65 years treated for TBI between 1998 and 2012 and discharged to home without services or inpatient rehabilitation (N = 2902). Main Outcome Measures: We assessed the association between race and discharge location via logistic regression. Covariates included age, sex, Abbreviated Injury Scale-Head score, insurance type, Glasgow Coma Scale score, and comorbidities. Results: There were 2487 (86%) whites and 415 blacks (14%) in the sample. A total of 1513 (52%) were discharged to inpatient rehabilitation and 1389 (48%) were discharged home without services. In adjusted logistic regression, blacks were more likely to be discharged to inpatient rehabilitation than to home without services compared to whites (odds ratio 1.34, 95% confidence interval, 1.06-1.70). Conclusions: In this group of Medicare-eligible older adults, blacks were more likely to be discharged to inpatient rehabilitation compared to whites. (C) 2019 by the American Congress of Rehabilitation Medicine	[Vadlamani, Aparna; Albrecht, Jennifer S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 360,10 South Pine St, Baltimore, MD 21201 USA; [Perry, Justin A.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Care Management, Baltimore, MD 21201 USA; [McCunn, Maureen] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Anesthesiol,Div Trauma Anesthesiol & Surg Cr, Baltimore, MD 21201 USA; [Stein, Deborah M.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Surg,Div Surg Crit Care, Baltimore, MD 21201 USA		Vadlamani, A (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, MSTF 360,10 South Pine St, Baltimore, MD 21201 USA.	avadlamani@som.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AG000262]; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K0IHS024560]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000262] Funding Source: NIH RePORTER	Supported by the National Institutes of Health grant no. T32AG000262. A.V. is supported by the National Institutes of Health (grant no. T32AG000262) (Magaziner. PI). J.S.A. was supported by the Agency for Healthcare Research and Quality (grant no. K0IHS024560).	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; [Anonymous], 1971, JAMA, V215, P277; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnett J, HLTH INSURANCE COVER; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dharmarajan K, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2616; Eichner J, 2005, HEALTH AFFAIR, V24, P365, DOI 10.1377/hlthaff.24.2.365; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Frieden TR, TRAUMATIC BRAIN INJU; Fuller-Thomson E, 2009, J AGING HEALTH, V21, P677, DOI 10.1177/0898264309338296; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Greenwood RJ, 2004, BRIT J NEUROSURG, V18, P462, DOI 10.1080/02688690400012327; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Kelley-Moore JA, 2004, J GERONTOL B-PSYCHOL, V59, pS34, DOI 10.1093/geronb/59.1.S34; Maryland Institute for Emergency Medical Services Systems, ANN REP 2015 2016; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nicholas JA, 2011, MT SINAI J MED, V78, P498, DOI 10.1002/msj.20275; Nuru-Jeter AM, 2011, PUBLIC HEALTH REP, V126, P834, DOI 10.1177/003335491112600609; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Rosenthal M., 1996, J HEAD TRAUMA REHAB, V11, P69; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Schumacher R, 2016, BRAIN INJURY, V30, P1186, DOI 10.1080/02699052.2016.1183821; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Yap SGM, 2008, J HEAD TRAUMA REHAB, V23, P158, DOI 10.1097/01.HTR.0000319932.15085.fe	30	2	2	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2019	100	9					1622	1628		10.1016/j.apmr.2019.03.008			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	IY7GS	WOS:000486563600006	30954440	Green Accepted			2022-02-06	
J	Wei, QX; Li, YD; Yu, J; Chen, J; Chen, DY; Wang, JB				Wei, Qiuxu; Li, Yadong; Yu, Jie; Chen, Jian; Chen, Deyong; Wang, Junbo			Optimization of LC sensor enabling wireless passive intracranial pressure monitoring	MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND PROCESSING SYSTEMS			English	Article							TRAUMATIC BRAIN-INJURY; IN-VITRO	With the increasingly widespread researches of wireless passive sensing technology based on LC sensors in the field of intracranial pressure (ICP) monitoring and other biomedical applications, the importance of sensor optimization has become increasingly prominent. This paper presents an optimization method of LC sensor enabling wireless passive ICP monitoring. The LC sensor is a resonant tank formed by a pressure-sensitive capacitor and a fixed inductor. The parameters of the capacitor and the inductor are optimized based on four optimization criteria: maximizing sensitivity, setting anodic bonding voltage less than pull-in voltage, maximizing quality factor and setting an upper limit of resonant frequency. Among them, the pull-in voltage is a critical value when pull-in effect occurs during anodic bonding, a key step in the process of capacitor fabrication. To analytically calculate the pull-in voltage, a pull-in effect model is built, and its effectiveness is verified by simulation and experiment. Based on the above-mentioned optimization criteria, the LC sensor is optimized, fabricated and characterized. The experimental results show that the optimized sensor achieves competitive sensitivity, quality factor and resonant frequency compared with the previous reports, and illustrate the effectiveness of the optimization method enabling ICP monitoring.	[Wei, Qiuxu; Li, Yadong; Yu, Jie; Chen, Jian; Chen, Deyong; Wang, Junbo] Chinese Acad Sci, Inst Elect, Beijing, Peoples R China; [Wei, Qiuxu; Li, Yadong; Yu, Jie; Chen, Jian; Chen, Deyong; Wang, Junbo] Univ Chinese Acad Sci, Beijing, Peoples R China		Wang, JB (corresponding author), Chinese Acad Sci, Inst Elect, Beijing, Peoples R China.; Wang, JB (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	jbwang@mail.ie.ac.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61825107, 61431019, 61671430]	This work was supported by the National Natural Science Foundation of China under Grant nos 61825107, 61431019 and 61671430.	[Anonymous], 2017, OPT MOD US GUID VERS; Bao KK, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/8/085104; Behfar MH, 2016, IEEE ENG MED BIO, P1950, DOI 10.1109/EMBC.2016.7591105; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen PJ, 2008, J MICROELECTROMECH S, V17, P1342, DOI 10.1109/JMEMS.2008.2004945; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Hsu TR, 2002, MEMS MICROSYSTEMS DE, P2002; Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Khan MWA, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON ELECTROMAGNETICS IN ADVANCED APPLICATIONS (ICEAA), P383, DOI 10.1109/ICEAA.2015.7297141; Khan MWA, 2016, IEEE MICROW WIREL CO, V26, P549, DOI 10.1109/LMWC.2016.2574836; Li ZK, 2015, AIP ADV, V5, DOI 10.1063/1.4939217; Meng X, 2013, IEEE T MICROW THEORY, V61, P316, DOI 10.1109/TMTT.2012.2224361; Moradi E, 2014, 2014 IEEE RFID TECHNOLOGY AND APPLICATIONS CONFERENCE (RFID-TA), P145, DOI 10.1109/RFID-TA.2014.6934217; Nakamura T, 2006, Patent, Patent No. [EP1665977, 1665977]; Nopper R, 2010, IEEE T INSTRUM MEAS, V59, P2450, DOI 10.1109/TIM.2009.2032966; Shi Q, 2014, BIOMED MICRODEVICES, V16, P859, DOI 10.1007/s10544-014-9890-0; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Vera J, 2018, J MICROMECH MICROENG, V28, DOI 10.1088/1361-6439/aa9a4e; Wei QX, 2018, IEEE T ELECTRON DEV, V65, P2592, DOI 10.1109/TED.2018.2825247; Xiong JJ, 2015, SENSORS-BASEL, V15, P21844, DOI 10.3390/s150921844; Xue N, 2012, J MICROELECTROMECH S, V21, P1338, DOI 10.1109/JMEMS.2012.2206072; Yang WH, 1998, J MATER PROCESS TECH, V84, P122, DOI 10.1016/S0924-0136(98)00079-X	23	2	2	3	25	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0946-7076	1432-1858		MICROSYST TECHNOL	Microsyst. Technol.	SEP	2019	25	9					3437	3446		10.1007/s00542-019-04336-z			10	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics; Materials Science; Physics	IN6HH	WOS:000478778400018					2022-02-06	
J	Xu, L; Zhang, Y; Zhang, RJ; Zhang, HQ; Song, PW; Ma, T; Li, Y; Wang, X; Hou, X; Li, Q; Xu, JG; Gao, XP; Shen, CL				Xu, Long; Zhang, Yong; Zhang, Renjie; Zhang, Huaqing; Song, Peiwen; Ma, Tai; Li, Yue; Wang, Xian; Hou, Xin; Li, Qun; Xu, Jiegou; Gao, Xiaoping; Shen, Cailiang			Elevated plasma BDNF levels are correlated with NK cell activation in patients with traumatic spinal cord injury	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Spinal cord injury; BDNF; NK cells; Activation	NATURAL-KILLER-CELLS; GROWTH-FACTOR-BETA; NEUROTROPHIC FACTOR; MECHANISMS; EXPRESSION; SYSTEM; IMMUNITY; BIOLOGY	Background: The precise role of innate immune responses in the early stage of traumatic spinal cord injury (SCI), especially those mediated by natural killer (NK) cells, is poorly understood. Methods: The frequency and phenotype of NK cells from traumatic SCI patients and healthy controls were assessed by flow cytometry. ELISA assay was used to detect the production of a series of cytokines, neurotrophins, and neurohormones in plasma samples. In vitro cell culture was performed to observe brain-derived neurotrophic factor (BDNF)-induced NK cell activation. Results: A significant increase in the NR cell frequency and the presence of NK cells with the activated phenotype was observed, as reflected by the enhanced expression of CD69, HLA-DR, NKG2D, and NKp30 on the NK cells, in traumatic SCI patients within 24 h of injury, compared to case for the healthy controls. Meanwhile, a higher level of BDNF, a member of the neurotrophin family, was observed in the plasma samples of the SCI patients; the elevated level of BDNF was strongly and positively correlated with the percentage of NK cells during the early stage of traumatic SCI. Furthermore, the expression of CD69 and NKp30 on the NK cells increased following stimulation with BDNF for 24 h in vitro, which is consistent with the in vivo observation in SCI patients. Conclusion: Collectively, our findings demonstrate the activation of NK cells within 24 h after traumatic SCI, and reveal a novel role of BDNF in regulating NK cell activation.	[Xu, Long; Ma, Tai; Li, Yue; Wang, Xian; Hou, Xin; Li, Qun; Xu, Jiegou] Anhui Med Univ, Sch Basic Med Sci, Hefei, Anhui, Peoples R China; [Zhang, Yong; Zhang, Renjie; Zhang, Huaqing; Song, Peiwen; Shen, Cailiang] Anhui Med Univ, Affiliated Hosp 1, Dept Orthoped & Spine Surg, 218 Ji Xi Rd, Hefei 230022, Anhui, Peoples R China; [Gao, Xiaoping] Anhui Med Univ, Affiliated Hosp 1, Dept Rehabil Med, 218 Ji Xi Rd, Hefei 230022, Anhui, Peoples R China; [Xu, Long] Anhui Med Univ, Sch Basic Med Sci, Dept Immunol, 81 Mei Shan Rd, Hefei 230032, Anhui, Peoples R China		Xu, L (corresponding author), Anhui Med Univ, Sch Basic Med Sci, Hefei, Anhui, Peoples R China.; Shen, CL (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Orthoped & Spine Surg, 218 Ji Xi Rd, Hefei 230022, Anhui, Peoples R China.; Gao, XP (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Rehabil Med, 218 Ji Xi Rd, Hefei 230022, Anhui, Peoples R China.	xulong@ahmu.edu.cn; gxp678@163.com; shencailiang1616@163.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401281, 81571540]; Anhui Medical University [xj201401, 2013500023]	This work was supported by the Natural Science Foundation of China [81401281, 81571540], grants for scientific research of BSKY from the Anhui Medical University [xj201401], and grants for the 4th excellently scientific research of QNBJRC from Anhui Medical University [2013500023].	Ahmed A, 2018, MOL CELL BIOCHEM, V441, P181, DOI 10.1007/s11010-017-3184-9; Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bronzetti E, 2006, INT J MOL MED, V18, P49; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Campagnolo DI, 2008, SPINAL CORD, V46, P477, DOI 10.1038/sc.2008.4; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; David S, 2012, INT REV NEUROBIOL, V106, P127, DOI 10.1016/B978-0-12-407178-0.00006-5; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; EHRHARD PB, 1993, P NATL ACAD SCI USA, V90, P10984, DOI 10.1073/pnas.90.23.10984; Fu BQ, 2014, IMMUNOLOGY, V141, P483, DOI 10.1111/imm.12224; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Garofalo S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7623; Gold SM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-32; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Held KS, 2010, EXP NEUROL, V226, P242, DOI 10.1016/j.expneurol.2010.08.036; Iversen PO, 2000, BLOOD, V96, P2081; Jones TB, 2014, EXP NEUROL, V258, P78, DOI 10.1016/j.expneurol.2014.03.003; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kliesch WF, 1996, PARAPLEGIA, V34, P82, DOI 10.1038/sc.1996.14; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; McAleer JP, 2011, J LEUKOCYTE BIOL, V90, P263, DOI 10.1189/jlb.0211099; Minnone G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051028; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; ROBERTSON MJ, 1990, BLOOD, V76, P2421; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Takahashi K, 2004, BRAIN, V127, P1917, DOI 10.1093/brain/awh219; TANG GH, 2013, P NATL ACAD SCI USA, V114, DOI DOI 10.1063/1.4829913; Ueta M, 2008, SPINAL CORD, V46, P26, DOI 10.1038/sj.sc.3102054; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Yoshimura A, 2011, CURR TOP MICROBIOL, V350, P127, DOI 10.1007/82_2010_87; Yoshimura S, 2010, MULT SCLER J, V16, P1178, DOI 10.1177/1352458510375706; Zong SH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/786947	40	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	SEP	2019	74								105722	10.1016/j.intimp.2019.105722			8	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	IY0OQ	WOS:000486093000052	31255880				2022-02-06	
J	Eggleston, B; Dismuke-Greer, CE; Pogoda, TK; Denning, JH; Eapen, BC; Carlson, KF; Bhatnagar, S; Nakase-Richardson, R; Troyanskaya, M; Nolen, T; Walker, WC				Eggleston, B.; Dismuke-Greer, C. E.; Pogoda, T. K.; Denning, J. H.; Eapen, B. C.; Carlson, K. F.; Bhatnagar, S.; Nakase-Richardson, R.; Troyanskaya, M.; Nolen, T.; Walker, W. C.			A prediction model of military combat and training exposures on VA service-connected disability: a CENC study	BRAIN INJURY			English	Article						Prediction; disability; potential concussive event; military; veteran; concussion and traumatic brain injury	REGRESSION TREES; BRAIN-INJURY; VETERANS; HEALTH; BLAST; VALIDITY; PERFORMANCE; SYMPTOMS; MEMBERS; SCALE	Background: Research has shown that number of and blast-related Traumatic Brain Injuries (TBI) are associated with higher levels of service-connected disability (SCD) among US veterans. This study builds and tests a prediction model of SCD based on combat and training exposures experienced during active military service. Methods: Based on 492 US service member and veteran data collected at four Department of Veterans Affairs (VA) sites, traditional and Machine Learning algorithms were used to identify a best set of predictors and model type for predicting %SCD >= 50, the cut-point that allows for veteran access to 0% co-pay for VA health-care services. Results: The final model of predicting %SCD >= 50 in veterans revealed that the best blast/injury exposure-related predictors while deployed or non-deployed were: 1) number of controlled detonations experienced, 2) total number of blast exposures (including controlled and uncontrolled), and 3) the total number of uncontrolled blast and impact exposures. Conclusions and Relevance: We found that the highest blast/injury exposure predictor of %SCD >= 50 was number of controlled detonations, followed by total blasts, controlled or uncontrolled, and occurring in deployment or non-deployment settings. Further research confirming repetitive controlled blast exposure as a mechanism of chronic brain insult should be considered.	[Eggleston, B.; Nolen, T.] RTI Int, Res Triangle Pk, NC USA; [Dismuke-Greer, C. E.] VA Palo Alto Healthcare Syst, HERC, Palo Alto, CA USA; [Dismuke-Greer, C. E.] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Pogoda, T. K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Pogoda, T. K.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Denning, J. H.] Ralph H Johnson VA Med Ctr, Mental Hlth Care Line, Charleston, SC USA; [Denning, J. H.] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Eapen, B. C.] VA Greater Los Angeles Healthcare Syst, Dept Phys Med & Rehabil, Los Angeles, CA USA; [Carlson, K. F.] VA Portland Hlth Care Syst R&D 66, HSR&D Ctr Improve Vet Involvement Care CIVIC, Portland, OR USA; [Carlson, K. F.] Oregon Hlth & Sci Univ, OHSU PSU Sch Publ Hlth, Portland, OR 97201 USA; [Bhatnagar, S.] Dept Vet Affairs, Acting Assistant Deputy Undersecretary Hlth Qual, Washington, DC USA; [Nakase-Richardson, R.] James A Haley Vet Hosp, MHBS, Tampa, FL USA; [Nakase-Richardson, R.] Univ S Florida, Div Pulm & Sleep Med, Morsani Coll Med, Tampa, FL USA; [Nakase-Richardson, R.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Troyanskaya, M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Troyanskaya, M.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Walker, W. C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Walker, W. C.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA		Dismuke-Greer, CE (corresponding author), VA Palo Alto Hlth Care Syst VAPAHCS, HERC, 795 Willow Rd 152 MPD, Menlo Pk, CA 94025 USA.	Clara.dismuke@va.gov		Eggleston, Barry/0000-0003-0472-9707; Nolen, Tracy/0000-0003-2512-343X	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]	This work was supported by grant funding from: Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095 and Department of Veterans Affairs CENC Award I01 CX001135	Berk RA, 2006, SOCIOL METHOD RES, V34, P263, DOI 10.1177/0049124105283119; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Buchner F, 2017, HEALTH ECON, V26, P74, DOI 10.1002/hec.3277; Congressional Budget Office, 2014, VET DIS COMP TRENDS; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Dismuke-Greer CE, 2018, BRAIN INJURY, V32, P1178, DOI 10.1080/02699052.2018.1482428; Fried DA, 2015, MIL MED, V180, P1034, DOI 10.7205/MILMED-D-14-00435; Geron A, 2019, HANDS ON MACHINE LEA; Godsey B, 2017, THINK DATA SCI TACKL; Grubaugh AL, 2009, MIL MED, V174, P1241, DOI 10.7205/MILMED-D-09-00070; Hastie T, 2009, ELEMENTS STAT LEARNI, V2nd, DOI 10.1007/978-0-387-84858-7; Kamimori GH, 2017, SHOCK WAVES, V27, P837, DOI 10.1007/s00193-017-0738-4; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuhn M., 2013, APPL PREDICTIVE MODE, V26; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Maciejewski ML, 2012, HEALTH ECON, V21, P902, DOI 10.1002/hec.1759; Maynard C, 2017, MED CARE, V55, P965, DOI 10.1097/MLR.0000000000000806; McCulloch CE, 2001, GEN LINEAR MIXED MOD; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Silva A, 2016, MIL MED, V181, P469, DOI 10.7205/MILMED-D-15-00094; Spoont MR, 2007, MIL MED, V172, P572, DOI 10.7205/MILMED.172.6.572; Steyerberg E., 2010, CLIN PREDICTION MODE; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tsao JW, 2017, NEUROLOGY, V89, P2010, DOI 10.1212/WNL.0000000000004616; US Department of Veterans Affairs, ANN BEN REP FISC YEA; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Zumel N, 2014, PRACTICAL DATA SCI	34	2	2	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2019	33	13-14					1602	1614		10.1080/02699052.2019.1655793		AUG 2019	13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KG3JC	WOS:000485090100001	31476880				2022-02-06	
J	Cogan, AM; Haines, CE; Devore, MD				Cogan, Alison M.; Haines, Christine E.; Devore, Maria D.			Intersections of US Military Culture, Hegemonic Masculinity, and Health Care Among Injured Male Service Members	MEN AND MASCULINITIES			English	Article						mild traumatic brain injury; military personnel; culture; masculinity	TRAUMATIC BRAIN-INJURY; HELP-SEEKING; STIGMA; BOURDIEU; MEN	In this paper, we explore how socially constructed hegemonic masculinity permeates military culture, and how this cultural context intersects with the seeking and receiving of health care by active duty US military service members with chronic mild traumatic brain injury (mTBI) (n = 18). Data were collected through individual interviews and focus groups. Using Bourdieu's theory of practice as an analytical framework, we identified four themes: maintenance of social capital, remaining in the field, reframing health care use to bolster social capital, and risk of health care use as not being rewarded. Each emerged from statements about why participants had avoided seeking health care for physical and psychological needs during their military service. We consider our findings in the context of maintaining status within an institutional steeped in hegemonic masculinity and describe implications for reframing caring for the body and dealing with problems as masculine acts.	[Cogan, Alison M.] Washington DC Vet Affairs Med Ctr, Dept Phys Med & Rehabil, Washington, DC USA; [Haines, Christine E.] Michael E DeBakey VA Med Ctr, Conroe, TX USA; [Devore, Maria D.] US Dept Vet Affairs, ORO, Vet Hlth Adm, Washington, DC USA		Cogan, AM (corresponding author), Washington DC VA Med Ctr, Dept Phys Med & Rehabil, 50 Irving St NW, Washington, DC 20422 USA.	alison.cogan@va.gov	Cogan, Alison/AAS-3101-2021		University of Southern California (USC)	This work was completed in partial fulfilment of the first author's requirements for a PhD in occupational science from the University of Southern California (USC). At the time this work was completed, the second and third authors were affiliated with Naval Hospital Camp Pendleton (NHCP). We are grateful to the leadership at NHCP for their support of this work. We extend our gratitude to Dr. Florence Clark of USC for her role in facilitating this research. In addition, we wish to thank CAPT Karla Lepore and Dr. Margaret Ryan for their feedback on earlier drafts of this manuscript.	Abraham T, 2017, AM J MENS HEALTH, V11, P1358, DOI 10.1177/1557988315596037; Agee J, 2009, INT J QUAL STUD EDUC, V22, P431, DOI 10.1080/09518390902736512; Agostino K., 1998, J INTERDISCIPLINARY, V3, P58; Barrett F., 1996, GENDER WORK ORG, V3, P129, DOI DOI 10.1111/J.1468-0432.1996.TB00054.X; Bourdieu P., 1977, OUTLINE THEORY PRACT; Bradshaw C, 2017, GLOB QUALIT NURS RES, V4, DOI 10.1177/2333393617742282; Britt TW, 2015, PSYCHIATR REHABIL J, V38, P142, DOI 10.1037/prj0000120; Chaudoir SR, 2013, BASIC APPL SOC PSYCH, V35, P75, DOI 10.1080/01973533.2012.746612; Cogan AM, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.027599; Cogan AM, 2019, OTJR-OCCUP PART HEAL, V39, P232, DOI 10.1177/1539449218813849; Coles T, 2009, MEN MASC, V12, P30, DOI 10.1177/1097184X07309502; Connell R.W., 1995, MASCULINITIES; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Courtenay W, 2000, PSYCHOL MEN MASC, V1, P4, DOI [DOI 10.1037/1524-9220.1.1.4, 10.1037/1524-9220.1.1.4]; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; DOD (Department of Defense) Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Hale HC, 2012, GENDER WORK ORGAN, V19, P699, DOI 10.1111/j.1468-0432.2010.00542.x; Hancock K, 2012, AM PSYCHOL, V67, P10, DOI 10.1037/a0024659; Heath PJ, 2017, PSYCHOL MEN MASCULIN, V18, P193, DOI 10.1037/men0000111; Hinojosa R., 2010, J MENS STUD, V18, P179, DOI [10.3149/jms.1802.179, DOI 10.3149/JMS.1802.179]; Hom MA, 2017, CLIN PSYCHOL REV, V53, P59, DOI 10.1016/j.cpr.2017.01.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Langston V, 2007, MIL MED, V172, P931, DOI 10.7205/MILMED.172.9.931; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; Merriam SB., 2016, QUALITATIVE RES GUID, V4; Morin MA, 2017, PSYCHOL MEN MASCULIN, V18, P251, DOI 10.1037/men0000124; Quartana PJ, 2014, AM J PUBLIC HEALTH, V104, P1671, DOI 10.2105/AJPH.2014.301971; Robinson M, 2014, SOC THEOR HEALTH, V12, P339, DOI 10.1057/sth.2014.8; Schrock D, 2009, ANNU REV SOCIOL, V35, P277, DOI 10.1146/annurev-soc-070308-115933; Sharp ML, 2015, EPIDEMIOL REV, V37, P144, DOI 10.1093/epirev/mxu012; Shields DM, 2017, PSYCHOL MEN MASCULIN, V18, P215, DOI 10.1037/men0000114; Vandello JA, 2013, PSYCHOL MEN MASCULIN, V14, P101, DOI 10.1037/a0029826; WILLIAMS SJ, 1995, SOCIOL HEALTH ILL, V17, P577, DOI 10.1111/1467-9566.ep10932093	35	2	2	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1097-184X	1552-6828		MEN MASC	Men Masc.	AUG	2021	24	3					468	482	1097184X19872793	10.1177/1097184X19872793		AUG 2019	15	Sociology	Social Science Citation Index (SSCI)	Sociology	TE4FL	WOS:000483317600001					2022-02-06	
J	Ferraro, FR; Cuccolo, K; Wise, RA				Ferraro, F. Richard; Cuccolo, Kelly; Wise, Richard A.			Should you let your child play football? What about soccer or hockey?	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						College students; concussion; sports	CHRONIC TRAUMATIC ENCEPHALOPATHY; YOUTH SPORTS; CONCUSSION; CONSEQUENCES; ASSOCIATION; STATES; RISK	College students (n = 120) answered 18 yes-no questions that varied the child's gender (male, female), grade (grade school, high school, college), and sport (football, soccer, hockey). The format of the 18 yes or no questions was "If you had a child in (grade school, high school, college) would you let (him, her) play (football, soccer, hockey)"? Similar to a previous study, a large percentage (78.8%) of the respondents answered yes to the questions about football, indicating that they would permit their children to play football despite the risk of concussion (96% yes for male children, 67% yes for female children). Although the number of respondents who would allow their male child to play soccer (98% for male children, 99% for female children) or hockey (92% for male children, 89% for female children) was similar to the percentage of respondents that would allow their male child to play football, significantly more respondents would allow their female child to play soccer or hockey than football. This result is potentially problematic because soccer and hockey have high rates of concussion, especially for females, which suggests that the respondents may have been unaware of this fact.	[Ferraro, F. Richard; Cuccolo, Kelly; Wise, Richard A.] Univ North Dakota, Dept Psychol, Grand Forks, ND 58202 USA		Ferraro, FR (corresponding author), Univ North Dakota, Grand Forks, ND 58202 USA.	f.ferraro@und.edu					Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P779, DOI 10.2519/jospt.2019.8760; Bompadre V, 2014, J ATHL TRAINING, V49, P486, DOI 10.4085/1062-6050-49.3.30; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Chrisman SPD, 2019, J PEDIATR-US, V207, P176, DOI 10.1016/j.jpeds.2018.11.003; Chrisman SPD, 2019, CLIN J SPORT MED, V29, P3, DOI 10.1097/JSM.0000000000000497; Delaney J Scott, 2005, Clin J Sport Med, V15, P216, DOI 10.1097/01.jsm.0000168077.74497.a4; Edwards JC, 2014, J LAW MED ETHICS, V42, P128, DOI 10.1111/jlme.12126; Fedor A, 2016, APPL NEUROPSYCH-CHIL, V5, P107, DOI 10.1080/21622965.2014.999770; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Perry J. R., 2019, DIFFERENCE CONCUSSIO; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Sayre H. D., 2019, ATHLETIC TRAINING SP, V11, P143; Sosin DM, 1996, BRAIN INJURY, V10, P47; Waltzman D, 2019, J SAFETY RES, V68, P157, DOI 10.1016/j.jsr.2018.11.005; Weber M, 2012, ARCH CLIN NEUROPSYCH, V27, P355, DOI 10.1093/arclin/acs029; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	23	2	2	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	APR 3	2021	10	2					165	170		10.1080/21622965.2019.1654385		AUG 2019	6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	RH2HM	WOS:000484723600001	31476888				2022-02-06	
J	Kornblith, E; Posecion, L; Abrams, G; Chen, AJW; Burciaga, J; D'Esposito, M; Novakovic-Agopian, T				Kornblith, Erica; Posecion, Lainie; Abrams, Gary; Chen, Anthony J. -W.; Burciaga, Joaquin; D'Esposito, Mark; Novakovic-Agopian, Tatjana			Long-Term Effect of Cognitive Rehabilitation Regardless of Prerehabilitation Cognitive Status for Veterans with TBI	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Cognitive rehabilitation; traumatic brain injury; Veterans	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; PREDICTORS; SATISFACTION; AFGHANISTAN; INTEGRATION; CONFLICTS; VALIDITY; SEQUELAE; PROGRAM	Persisting difficulties in executive functioning (EF) are common after traumatic brain injury (TBI). Cognitive rehabilitation can be effective, but the impact of pretreatment neurocognitive functioning on long term effects of rehabilitation is unknown. Because this information can impact treatment planning, we examined the relationship between prerehabilitation neurocognitive status and long-term effects of EF training. Archival data were drawn from a trial of Goal-Oriented Attentional Self-Regulation group-format EF training for Veterans with TBI [mild-severe; 11 years postinjury; 96% male, 32% nonwhite, 14.21 years education (SD 1.72), 41.13 years old (SD 11.39)]. Using prerehabilitation neurocognitive performance, participants were clustered into cognitive difficulty (CD) and cognitively normal (CN) groups. Six-plus months after EF rehabilitation training, participants completed a structured telephone interview and/or in-person cognitive/functional/emotional assessment using standardized measures of cognitive, daily, and emotional functioning frequently employed in TBI research. At 6+ months post-EF training compared to prerehabilitation, CD and CN improved in multiple cognitive (Overall Attention/EF: F(1,18) = 26.17, partial eta(2) = .59; Total Memory: F(1,18) = 6.82, partial eta(2) = .28) and functional domains (Goal Processing Scale [GPS] total score: F(1,15) = 6.71, partial eta(2) = .31). CD improved more than CN on Learning and Memory functional domain [F(1,15) = 6.10, partial eta(2) = .29]. Results of our small archival analysis raise the possibility that Veterans with chronic TBI may demonstrate long-term effects of EF training.	[Kornblith, Erica; Posecion, Lainie; Abrams, Gary; Novakovic-Agopian, Tatjana] San Francisco VA Med Ctr, 4150 Clement St,116c, San Francisco, CA 94121 USA; [Abrams, Gary; Chen, Anthony J. -W.; Novakovic-Agopian, Tatjana] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Chen, Anthony J. -W.] Vet Affairs Northern Calif Hlth Care Syst, Rehabil, Martinez, CA USA; [Chen, Anthony J. -W.; Burciaga, Joaquin] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Burciaga, Joaquin; D'Esposito, Mark] Childrens Hlth Council, Palo Alto, CA USA; [D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA		Kornblith, E (corresponding author), San Francisco VA Med Ctr, 4150 Clement St,116c, San Francisco, CA 94121 USA.; Novakovic-Agopian, T (corresponding author), Univ Calif San Francisco, SFVA Med Ctr, 4150 Clement St,Mail Code 127, San Francisco, CA 94121 USA.	Erica.kornblith@va.gov; tatjana.novakovic-agopian@va.gov			Department of Veterans Affairs Rehabilitation Research & Development Service Merit Review Awards [VANCHCS Project]US Department of Veterans Affairs [B7467I, VA 1IO1RX001111-01A1]; VA Office of Academic Affiliation Interprofessional TBI/Polytrauma Rehabilitation Research Fellowship	This material is based upon work supported by the Department of Veterans Affairs Rehabilitation Research & Development Service Merit Review Awards [VANCHCS Project # B7467I and VA 1IO1RX001111-01A1] and VA Office of Academic Affiliation Interprofessional TBI/Polytrauma Rehabilitation Research Fellowship.	Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bosco FM, 2018, ARCH CLIN NEUROPSYCH, V33, P875, DOI 10.1093/arclin/acy041; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Heaton RK, 2004, COMPREHENSIVE NORMS; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; IMBCorp, 2016, IBM SPSS STAT WIND V; Ivins BJ, 2006, NEUROEPIDEMIOLOGY, V27, P154, DOI 10.1159/000096127; Keane T.M., 1991, PCL M DSM 4; Kornblith E, 2020, APPL NEUROPSYCH-ADUL, V27, P108, DOI 10.1080/23279095.2018.1490738; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; McNair DM, 1992, MANUAL PROFILE MOOD; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Novakovic-Agopian T., 2016, WORLD C NEUR PHIL PA; Novakovic-Agopian T, 2018, J NEUROTRAUM, V35, P2784, DOI 10.1089/neu.2017.5529; Novakovic-Agopian T, 2019, BRAIN INJURY, V33, P1513, DOI 10.1080/02699052.2019.1645357; Novakovic-Agopian T, 2014, J HEAD TRAUMA REHAB, V29, P136, DOI 10.1097/HTR.0b013e3182691b15; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Reiber GE, 2010, J REHABIL RES DEV, V47, P275, DOI 10.1682/JRRD.2010.01.0009; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00048; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; Turner GR, 2020, AGING MENT HEALTH, V24, P464, DOI 10.1080/13607863.2018.1534080; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vasterling J, 2007, PTSD NEUROCOGNITION, V18, P1; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	50	2	2	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JUL 4	2021	28	4					436	448		10.1080/23279095.2019.1652174		AUG 2019	13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	SB4JK	WOS:000484083200001	31456428				2022-02-06	
J	Li, L; Chopp, M; Ding, GL; Davoodi-Bojd, E; Li, QJ; Mahmood, A; Xiong, Y; Jiang, Q				Li, Lian; Chopp, Michael; Ding, Guangliang; Davoodi-Bojd, Esmaeil; Li, Qingjiang; Mahmood, Asim; Xiong, Ye; Jiang, Quan			Diffuse white matter response in trauma-injured brain to bone marrow stromal cell treatment detected by diffusional kurtosis imaging	BRAIN RESEARCH			English	Article						Traumatic brain injury; Bone marrow stromal cells; Structural change; DKI; MRI	CONTROLLED CORTICAL IMPACT; MESENCHYMAL STEM-CELL; SPINAL-CORD; MICROSTRUCTURAL ALTERATIONS; VASCULAR-PERMEABILITY; FUNCTIONAL RECOVERY; AXONAL INJURY; RAT MODEL; STROKE; DEMYELINATION	Diffuse white matter (WM) response to traumatic brain injury (TBI) and transplantation of human bone marrow stromal cells (hMSCs) after the injury were non-invasively and dynamically investigated. Male Wistar rats (300-350 g) subjected to TBI were intravenously injected with 1 ml of saline (n = 10) or with hMSCs in suspension (similar to 3 x 10(6) hMSCs, n = 10) 1-week post-TBI. MRI measurements of T2-weighted imaging and diffusional kurtosis imaging (DKI) were acquired on all animals at multiple time points up to 3-months post-injury. Functional outcome was assessed using the Morris water maze test. DKI-derived metrics of fractional anisotropy (FA), axonal water fraction (AWF) and radial kurtosis (RK) longitudinally reveal an evolving pattern of structural alteration post-TBI occurring in the brain region remote from primary impact site. The progressive structural change is characterized by gradual disruption of WM integrity at an early stage (weeks post-TBI), followed by spontaneous recovery at a later stage (months post-TBI). Transplantation of hMSCs post-TBI promotes this structural plasticity as indicated by significantly increased FA and AWF in conjunction with substantially elevated RK at the later stage. Our long-term imaging data demonstrate that hMSC therapy leads to modified temporal profiles of these metrics, inducing an earlier presence of enhanced structural remodeling, which may contribute to improved functional recovery.	[Li, Lian; Chopp, Michael; Ding, Guangliang; Davoodi-Bojd, Esmaeil; Li, Qingjiang; Jiang, Quan] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA; [Mahmood, Asim; Xiong, Ye] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI 48208 USA; [Li, Lian; Chopp, Michael; Ding, Guangliang; Davoodi-Bojd, Esmaeil; Li, Qingjiang; Mahmood, Asim; Xiong, Ye; Jiang, Quan] Henry Ford Hosp, Dept Neurol, B126 Educ & Res Bldg,2799 West Grand Blvd, Detroit, MI 48202 USA		Jiang, Q (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA.; Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, B126 Educ & Res Bldg,2799 West Grand Blvd, Detroit, MI 48202 USA.	lli2@hfhs.org; MCHOPP1@hfhs.org; gding1@hfhs.org; EDAVOOD1@hfhs.org; QLI1@hfhs.org; AMAHMOO2@hfhs.org; YXIONG1@hths.org; QJIANG1@hfhs.org		Li, Lian/0000-0003-0097-1184; Xiong, Ye/0000-0001-9770-6031; Ding, Guangliang/0000-0003-1286-5901	National Institutes of Health, United StatesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS064134]	We thank Dr. Changsheng Qu for animal experiment assistance. This work was supported by National Institutes of Health, United States, RO1 NS064134.	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Akiyama Y, 2002, GLIA, V39, P229, DOI 10.1002/glia.10102; Al Jumah MA, 2012, INT J MOL SCI, V13, P9298, DOI 10.3390/ijms13079298; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Benitez A, 2014, NEUROIMAGE-CLIN, V4, P64, DOI 10.1016/j.nicl.2013.11.001; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Buyukturkoglu K, 2018, J NEUROIMAGING, V28, P320, DOI 10.1111/jon.12497; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Darkazalli A, 2016, RESTOR NEUROL NEUROS, V34, P433, DOI 10.3233/RNN-150628; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; Ding XS, 2013, J CEREBR BLOOD F MET, V33, P1015, DOI 10.1038/jcbfm.2013.50; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; Etherton MR, 2017, NEUROLOGY, V88, P1701, DOI 10.1212/WNL.0000000000003890; Falangola MF, 2014, NMR BIOMED, V27, P948, DOI 10.1002/nbm.3140; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Garbuzova-Davis S, 2016, J NEUROPATH EXP NEUR, V75, P673, DOI 10.1093/jnen/nlw040; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Gong NJ, 2013, MAGN RESON IMAGING, V31, P688, DOI 10.1016/j.mri.2012.10.027; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Grassi DC, 2018, ARQ NEURO-PSIQUIAT, V76, P189, DOI [10.1590/0004-282X20180007, 10.1590/0004-282x20180007]; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Li L, 2017, BRAIN RES, V1675, P61, DOI 10.1016/j.brainres.2017.09.007; Li L, 2017, J NEUROTRAUM, V34, P182, DOI 10.1089/neu.2015.4315; Li L, 2012, J CEREBR BLOOD F MET, V32, P2023, DOI 10.1038/jcbfm.2012.106; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Liu CB, 2016, STEM CELL TRANSL MED, V5, P1004, DOI 10.5966/sctm.2015-0298; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2011, J NEUROTRAUM, V28, P1199, DOI 10.1089/neu.2010.1694; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Morita T, 2016, NEUROSCIENCE, V335, P221, DOI 10.1016/j.neuroscience.2016.08.037; Nie XJ, 2015, MAGN RESON IMAGING, V33, P437, DOI 10.1016/j.mri.2014.12.008; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Pati S, 2016, CURR STEM CELL RES T, V11, P149, DOI 10.2174/1574888X10666151019120050; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Rolfe A, 2015, BRAIN NEUROTRAUMA MO, V2015; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Sharma A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0794-0; Shu J, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/5083797; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Spampinato MV, 2017, AM J NEURORADIOL, V38, P1494, DOI 10.3174/ajnr.A5225; Spampinato MV, 2017, AM J NEURORADIOL, V38, P1328, DOI 10.3174/ajnr.A5180; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Ukai R, 2007, J NEUROTRAUM, V24, P508, DOI 10.1089/neu.2006.0161; Veraart J, 2011, MAGN RESON MED, V65, P138, DOI 10.1002/mrm.22603; Vernooij MW, 2009, ARCH GEN PSYCHIAT, V66, P545, DOI 10.1001/archgenpsychiatry.2009.5; Weber RA, 2015, STROKE, V46, P545, DOI 10.1161/STROKEAHA.114.006782; Weishaupt N, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00081; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xin HQ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00377; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; Xiong Y., 2018, CHIN J TRAUMATOL; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, DISCOV MED, V10, P434; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhu JJ, 2015, NEUROIMAGE-CLIN, V7, P170, DOI 10.1016/j.nicl.2014.12.008; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	84	2	2	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 15	2019	1717						127	135		10.1016/j.brainres.2019.04.020			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC2OG	WOS:000470799000014	31009610	Green Accepted			2022-02-06	
J	Oh, H; Shin, S; Kim, S; Seo, W				Oh, HyunSoo; Shin, SeonYoung; Kim, SooHyun; Seo, WhaSook			Construct validity and reliability of the Full Outline of UnResponsiveness (FOUR) score in spontaneous subarachnoid haemorrhage caused by aneurysm rupture	JOURNAL OF CLINICAL NURSING			English	Article						consciousness; reliability and validity; ruptured aneurysm; subarachnoid haemorrhage	GLASGOW COMA SCALE; TRAUMATIC BRAIN-INJURY; INTERRATER RELIABILITY; NEUROSURGICAL PATIENTS; CEREBRAL INFARCTION; GRADING SYSTEM; STROKE SCALE; VALIDATION; RISK; CONSCIOUSNESS	Aims and objectives This study aimed at examining the construct validity and reliability of the Full Outline of UnResponsiveness score in patients with spontaneous subarachnoid haemorrhage caused by aneurysm rupture. Background The Full Outline of UnResponsiveness score is known to be a valid and reliable consciousness assessment tool and provides comprehensive information not given by the Glasgow Coma Scale. However, the validity and reliability of this tool have not been tested in patients with spontaneous subarachnoid haemorrhage. Design A nonexperimental, descriptive, correlational study design was adopted. Methods The STROBE statement was used for reporting this study. The study participants were 72 patients with spontaneous subarachnoid haemorrhage caused by aneurysm rupture, admitted to an intensive care unit in a university hospital between August 2016-July 2017. Data on demographic characteristics, Hunt-Hess clinical stage scores, Fisher CT stage scores, disease-related characteristics, Full Outline of UnResponsiveness scores and 1-month Glasgow Outcome Scale scores were subjected to analysis. Results Full Outline of UnResponsiveness scores were found to have significant correlations with scores on Hunt-Hess clinical or Fisher CT stage tool and adequately predict 1-month recovery. This tool also exhibited excellent inter-rater agreement and internal consistency. Conclusions The Full Outline of UnResponsiveness score is valid and reliable for consciousness evaluation in spontaneous subarachnoid haemorrhage. It has been believed that use of this tool may help prevent negative consequences arising from impaired consciousness and improve the outcomes of patients with spontaneous aneurysmatic subarachnoid haemorrhage. Relevance to clinical practice The Full Outline of UnResponsiveness score is a consciousness assessment tool that provides more neurological detail because it includes consideration of brainstem reflexes, visual tracking, breathing patterns and respiratory drive, and can be applied in cases of spontaneous subarachnoid haemorrhage and other types of brain injury, especially in patients with severe consciousness impairment.	[Oh, HyunSoo; Kim, SooHyun; Seo, WhaSook] Inha Univ, Dept Nursing, Incheon, South Korea; [Shin, SeonYoung] Inha Univ Hosp, Incheon, South Korea		Seo, W (corresponding author), Inha Univ, Dept Nursing, Coll Med, YongHyun Dong 253, Incheon 402751, South Korea.	wschang@inha.ac.kr; wschang@inha.ac.kr			INHA UNIVERSITY Research Grant	This work was supported by INHA UNIVERSITY Research Grant.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chen BX, 2013, ACTA NEUROCHIR, V155, P2133, DOI 10.1007/s00701-013-1854-2; Cohen J, 2009, J NEUROSCI NURS, V41, P261, DOI 10.1097/JNN.0b013e3181b2c766; Dewey HM, 1999, CEREBROVASC DIS, V9, P323, DOI 10.1159/000016006; Eken C, 2009, EUR J EMERG MED, V16, P29, DOI 10.1097/MEJ.0b013e32830346ab; Elmer J, 2016, ANN NEUROL, V80, P175, DOI 10.1002/ana.24697; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gorji Mohammad Ali Heidari, 2015, Int J Appl Basic Med Res, V5, P92, DOI 10.4103/2229-516X.157152; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Iacono LA, 2014, J NEUROSCI NURS, V46, P125, DOI 10.1097/JNN.0000000000000035; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; Jang SH, 2015, AM J NEURORADIOL, V36, P667, DOI 10.3174/ajnr.A4203; JENNETT B, 1975, LANCET, V1, P480; Johnston KC, 2003, STROKE, V34, P200, DOI 10.1161/01.STR.0000047102.61863.E3; Josephson SA, 2006, CEREBROVASC DIS, V22, P389, DOI 10.1159/000094857; Juvela S, 2005, J NEUROSURG, V102, P998, DOI 10.3171/jns.2005.102.6.0998; Kasprowicz M, 2016, BRIT J NEUROSURG, V30, P211, DOI 10.3109/02688697.2016.1161173; Kerner A, 2007, NEUROL RES, V29, P647, DOI 10.1179/016164107X248983; Khanal K, 2016, INDIAN J CRIT CARE M, V20, P473, DOI 10.4103/0972-5229.188199; Kim H., 2009, THESIS; Kocak Y, 2012, ANAESTH INTENS CARE, V40, P131, DOI 10.1177/0310057X1204000115; Laureys S, 2005, LANCET NEUROL, V4, P789, DOI 10.1016/S1474-4422(05)70230-1; Lindsay K. W., 2013, NEUROLOGY NEUROSURGE; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Lu HY, 2015, J MED SYST, V39, DOI 10.1007/s10916-014-0187-x; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; Mouri S, 2015, NEUROCRIT CARE, V22, P251, DOI 10.1007/s12028-014-0078-5; Ogilvy CS, 1998, NEUROSURGERY, V42, P959, DOI 10.1097/00006123-199805000-00001; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Oshiro EM, 1997, NEUROSURGERY, V41, P140, DOI 10.1097/00006123-199707000-00029; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Schmid-Elsaesser R, 2006, NEUROSURGERY, V58, P1054, DOI 10.1227/01.NEU.0000215868.40441.D9; Scott P, 2002, SEMIN RESP CRIT CARE, V23, P69, DOI 10.1055/s-2002-20590; Sepahvand E, 2016, TURK NEUROSURG, V26, P720, DOI 10.5137/1019-5149.JTN.13536-14.0; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; SPIRO RL, 1990, J MARKETING RES, V27, P61, DOI 10.2307/3172551; Starke RM, 2009, J CLIN NEUROSCI, V16, P894, DOI 10.1016/j.jocn.2008.10.010; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Suwatcharangkoon S, 2016, JAMA NEUROL, V73, P28, DOI 10.1001/jamaneurol.2015.3188; Tadrisi SD, 2012, IRAN J CRIT CARE NUR, V5, P95; TEASDALE G, 1974, LANCET, V2, P81; Temiz NC, 2018, TURK NEUROSURG, V28, P364, DOI 10.5137/1019-5149.JTN.19510-16.0; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Woertgen C, 2003, ZBL NEUROCHIR, V64, P104	49	2	3	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1067	1365-2702		J CLIN NURS	J. Clin. Nurs.	NOV	2019	28	21-22					3776	3785		10.1111/jocn.14877		AUG 2019	10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	JD9FG	WOS:000481190400001	30939215	Green Submitted			2022-02-06	
J	Reddy, SP; Walsh, MS; Paulino-Ramirez, R; Florenzan, J; Fernandez, J; Nwariaku, FE; Abdelnaby, A				Reddy, Sumanth P.; Walsh, Maura S.; Paulino-Ramirez, Robert; Florenzan, Jomar; Fernandez, Jaime; Nwariaku, Fiemu E.; Abdelnaby, Abier			Neurologic injuries following road traffic accidents in the Dominican Republic: Examining causes and potential solutions	TRAFFIC INJURY PREVENTION			English	Article						Dominican Republic; traumatic brain injuries; road traffic accidents; road traffic injuries	TRAUMATIC BRAIN-INJURY; COST-EFFECTIVENESS; HEAD-INJURY; HEALTH; IMPACT; CARE	Objective: Road traffic accidents (RTAs) are the number one cause of traumatic brain injuries (TBIs) worldwide. This study examines RTA-related TBIs in the Dominican Republic, a country in the Caribbean with the highest RTA fatality rate in the Western Hemisphere. Methods: We interviewed 117 adult patients or medical guardians of patients admitted to Hospital Traumatologico Dr. Ney Arias Lora in Santo Domingo following an RTA. Information regarding the type of accident, patient demographics, and injuries sustained was collected for each patient. Results: Most study participants were males (79.5%), and the most common method of transportation was motorized 2-wheeled vehicle (MTW; 74.4%). Of the 69 patients who suffered a TBI, 66.7% were classified as moderate-severe TBIs and 30.3% were classified as mild TBIs. The most common types of intracranial hemorrhage were subdural hemorrhage (12%) and subarachnoid hemorrhage (9.4%). Helmet use among admitted MTW riders was reported at 22.4%, and none of the 9 MTW riders who died in the hospital were wearing a helmet. Only 58.1% of patients lived in an area that offered 911 emergency response services at the time of the study. At 66.2%, the majority of people living within the 911 service area utilized emergency response services following an RTA. Multiple logistic regression determined that the utilization of 911 emergency response services was associated with a decrease in the likelihood of presenting with a moderate/severe TBI by a factor of 0.78 (adjusted odds ratio [OR]; P < .008; 95% confidence interval [CI], 0.65, 0.93). Nonuse of a helmet was associated with a 1.22 times increased risk of presenting with a moderate/severe TBI (adjusted OR; P < .04; 95% CI, 1.01, 1.61). Age and gender were not statistically significant in this model. Conclusions: The results of this study support 2 important avenues for reducing the burden of RTA-associated neurologic disease in the Dominican Republic. As with many other middle-income countries, MTWs represent an economical and efficient mode of transportation. Therefore, increasing helmet use may be the most effective way to reduce RTA-associated TBIs. In addition, continuing the expansion of postcrash emergency response services may mitigate the severity of RTA-associated neurologic disease.	[Reddy, Sumanth P.; Walsh, Maura S.] Univ Texas Southwestern, Sch Med, Off Global Hlth, Dallas, TX USA; [Paulino-Ramirez, Robert] Univ Iberoamer UNIBE, Inst Med Trop & Salud Global, Santo Domingo, Dominican Rep; [Florenzan, Jomar; Fernandez, Jaime] Univ Iberoamer UNIBE, Sch Med, Santo Domingo, Dominican Rep; [Fernandez, Jaime] Hosp Traumatol Dr Ney Arias Lora, Dept Surg, Santo Domingo, Dominican Rep; [Nwariaku, Fiemu E.; Abdelnaby, Abier] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA		Reddy, SP (corresponding author), Univ Texas Southwestern, Sch Med, 5323 Harry Hines Blvd,MC 9001, Dallas, TX 75390 USA.	sumanth.reddy@utsouthwestern.edu		Reddy, Sumanth/0000-0002-6275-6001	UT Southwestern Medical Center; Universidad Iberoamericana (UNIBE)	Funding for this study was provided by UT Southwestern Medical Center and Universidad Iberoamericana (UNIBE).	Arellano N, 2010, INJURY PREV, V16, P272, DOI 10.1136/ip.2009.025627; Bishai D, 2008, INJURY PREV, V14, P223, DOI 10.1136/ip.2008.018341; Borges G, 2017, ALCOHOL CLIN EXP RES, V41, P1731, DOI 10.1111/acer.13467; CHISHOLM D, 2012, BMJ BRIT MED J, V0344, DOI DOI 10.1136/BMJ.E612; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Ditsuwan V, 2013, VALUE HEALTH, V16, P23, DOI 10.1016/j.jval.2012.08.2209; Espitia-Hardeman V, 2008, SALUD PUBLICA MEXICO, V50, pS69, DOI 10.1590/S0036-36342008000700011; Garner A, 2001, INJURY, V32, P455, DOI 10.1016/S0020-1383(01)00013-4; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jagnoor J, 2014, AUST FAM PHYSICIAN, V43, P758; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Olson Z, 2016, INJURY PREV, V22, P233, DOI 10.1136/injuryprev-2015-041650; Puello A, 2013, REV PANAM SALUD PUBL, V34, P41; Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5	17	2	2	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	OCT 3	2019	20	7					690	695		10.1080/15389588.2019.1643016		AUG 2019	6	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	JB3SV	WOS:000479935700001	31381379				2022-02-06	
J	Afshari, J; Haghpanahi, M; Kalantarinejad, R; Tafarroj, MM				Afshari, J.; Haghpanahi, M.; Kalantarinejad, R.; Tafarroj, M. M.			Proposing a Radial Basis Function and CSDM Indices to Predict the Traumatic Brain Injury Risk	IRBM			English	Article						Traumatic brain injury; Computational modeling; Finite element method; Injury criteria; Artificial neural network	HEAD; CONCUSSION; FOOTBALL; DIRECTION; POSITION; IMPACTS	Background: Many head injury indices and finite element (FE) head models have been proposed to predict traumatic brain injury (TBI). Although FE head models are suitable methods with high accuracy, they are computationally intensive. Head motion-based brain injury criteria are usually fast tools with lower accuracy. So, the objective of this study is to propose new criteria along with an artificial neural network model to predict TBI risks, which can be fast and accurate. Methods: For this purpose, 250 FE head simulations have been carried out at 5 magnitudes and 50 rotational impact directions using the SIMon model. The effects of directions and magnitudes of rotational impacts were assessed for cumulative strain damage measure (CSDM) values. Next, statistical analysis and neural network were applied to predict CSDM values. Results: The results of the present research showed that the direction of rotation in the sagittal and frontal planes had a considerable effect on the CSDM values. Furthermore, new brain injury indices and a radial basis function neural network have been proposed to predict CSDM values which having high correlation coefficients with SIMon responses. Conclusions: The results of this research demonstrated that rotational impact directions should be used to develop new head injury criteria being able to predict CSDM values. However, findings of present research proved that head motion-based brain injury criteria and RBF network can be used to predict FE head model responses with high speed and accuracy. (C) 2019 AGBM. Published by Elsevier Masson SAS. All rights reserved.	[Afshari, J.; Haghpanahi, M.] Iran Univ Sci & Technol, Sch Mech Engn, Tehran 1684613114, Iran; [Kalantarinejad, R.] Shezan Res & Innovat Ctr, 25 Innovat 2 St, Tehran, Iran; [Tafarroj, M. M.] Ferdowsi Univ Mashhad, Dept Mech Engn, Mashhad, Razavi Khorasan, Iran		Afshari, J (corresponding author), Iran Univ Sci & Technol, Sch Mech Engn, Tehran 1684613114, Iran.	j_afshari_m@yahoo.com; mhaghpanahi@iust.ac.ir; rezakalantarinezhad@gmail.com; tafarroj@mail.um.ac.ir					Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Afshari J, 2017, J BRAZ SOC MECH SCI, P1; Afshari J., 2017, IEEE T POWER ELECTR, V23, P1; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Breedlove KM, 2016, J BIOMECH, V49, P2838, DOI 10.1016/j.jbiomech.2016.06.030; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Fanta O, 2013, ACTA BIOENG BIOMECH, V15, P105, DOI 10.5277/abb130113; Faul M, 2010, TRAUMATIC BRAIN INJU; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Garali I, 2016, IRBM, V37, P23, DOI 10.1016/j.irbm.2015.10.002; Gennarelli T.A., 1987, SAE TECH PAP; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gurney K, 1997, ARI INTRO NEURAL NET; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Mccuen E, 2015, J BIOMECH, P1; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Milne G, 2014, INT J CRASHWORTHINES, V19, P323, DOI 10.1080/13588265.2013.859470; Minaee S., 2017, SIGN PROC MED BIOL S, P1; Minaee S, 2018, ARXIV180202925; Minaee S., 2018, ARXIV180610419; Moiduddin K, 2017, IRBM, V38, P78, DOI 10.1016/j.irbm.2017.01.003; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Takhounts E. G., 2011, P 22 ENH SAF VEH C; Takhounts EG, 2008, STAPP CAR C, V52, P1; Trosseille X., 1992, DEV FEM HUMAN HEAD A; Vergara VM, 2018, NEUROIMAGE-CLIN, V19, P30, DOI 10.1016/j.nicl.2018.03.017; Ward CC., 1977, INTRACRANIAL PRESSUR; Zanoosi AAP, 2015, ACTA ASTRONAUT, V115, P58, DOI 10.1016/j.actaastro.2015.04.016	40	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1959-0318	1876-0988		IRBM	IRBM	AUG	2019	40	4					244	252		10.1016/j.irbm.2019.06.003			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	IR6QA	WOS:000481562600006					2022-02-06	
J	Augustovicova, D; Lystad, RP; Arriaza, R				Augustovicova, Dusana; Lystad, Reidar P.; Arriaza, Rafael			Time-Loss Injuries in Karate: A Prospective Cohort Study of 4 Consecutive World Karate Championships	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						athletic injuries; karate; combat sport; incidence; risk factors	SPORTS INJURY; COMPETITION; EPIDEMIOLOGY; SURVEILLANCE; CONCUSSIONS; PROFILE; RATES; RISK	Background: Prospective studies on injuries in martial arts competitions are scarce, especially those involving time-loss injuries. The upsurge of karate athletes competing in top-level karate competitions warrants elucidation of the time-loss injury risk. Purpose: To determine the time-loss injury proportion and incidence rate, describe the injury pattern among elite senior karate athletes, and compare the risk of time-loss injuries in male versus female athletes and in individual (ie, weight categories) versus team competitions (free-weight category). Study Design: Descriptive epidemiology study. Methods: Data were collected at 4 consecutive World Karate Championships (2010, 2012, 2014, and 2016). Injury incidence rates were calculated per 1000 athlete-exposures (IIRAE) and per 1000 minutes of exposure (IIRME), with 95% CIs. Subgroups were compared by calculating their rate ratios with 95% CIs. Results: A total of 506 injuries were recorded, of which 51 were time-loss injuries (10%). The overall time-loss injury rate was significantly lower for female versus male athletes and slightly lower for team versus individual competitions. Overall, 1.4% of all athletes sustained a time-loss injury, and the IIRAE and IIRME were 5.13 (95% CI, 3.82-6.74) and 1.98 (95% CI, 1.47-2.60), respectively. The most common type of time-loss injury was fracture (41%), followed by dislocation (20%) and concussion (12%). Conclusion: The time-loss injury incidence rate for top-level karate competitions found in this prospective study was relatively low. Comprehensive knowledge about the incidence of time-loss injuries during karate competitions represents an essential basis to develop effective strategies for injury prevention. Thus, the introduction of a uniform injury surveillance system in martial arts is of utmost importance.	[Augustovicova, Dusana; Lystad, Reidar P.; Arriaza, Rafael] Univ A Coruna, Phys Educ & Sports Sch, La Coruna, Spain; [Augustovicova, Dusana] Comenius Univ, Fac Phys Educ & Sports, Nabrelie Armedneho Gen Ludvika Svobodu 9, Bratislava 81469, Slovakia; [Lystad, Reidar P.] Macquarie Univ, Australian Inst Hlth Innovat, Sydney, NSW, Australia; [Arriaza, Rafael] Inst Med Arriaza & Asociados, La Coruna, Spain		Augustovicova, D (corresponding author), Comenius Univ, Fac Phys Educ & Sports, Nabrelie Armedneho Gen Ludvika Svobodu 9, Bratislava 81469, Slovakia.	augustovicova.dusana@gmail.com	Lystad, Reidar P./D-1611-2013	Lystad, Reidar P./0000-0003-0506-0902; Arriaza, Rafael/0000-0003-1743-3809; Cierna, Dusana/0000-0003-0206-6815	Medical Commission of the WKF	The authors thank the Medical Commission of the WKF for its support and cooperation.	Alesi Marianha, 2014, Muscles Ligaments Tendons J, V4, P114; Arriaza R, 2005, KNEE SURG SPORT TR A, V13, P603, DOI 10.1007/s00167-004-0593-6; Arriaza R, 2017, BRIT J SPORT MED, V51, P226, DOI 10.1136/bjsports-2016-096574; Arriaza R, 2009, KNEE SURG SPORT TR A, V17, P1437, DOI 10.1007/s00167-009-0856-3; Bahrami F, 2016, J AUTISM DEV DISORD, V46, P978, DOI 10.1007/s10803-015-2643-y; Beis K, 2007, J SPORT SCI MED, V6, P45; Boostani MH, 2012, J AM SCI, V8, P637; Cierna D, 2018, BRIT J SPORT MED, V52, P730, DOI 10.1136/bjsports-2017-097756; Ekegren CL, 2015, SCAND J MED SCI SPOR, V25, P315, DOI 10.1111/sms.12216; Finch CF, 2014, BRIT J SPORT MED, V48, P552, DOI 10.1136/bjsports-2012-091219; Fuller C, 2004, SPORTS MED, V34, P349, DOI 10.2165/00007256-200434060-00001; Graham P, 2005, STAT MED, V24, P1135, DOI [10.1002/sim.1993, 10.1002/sim.1992]; Halabchi F, 2007, J SPORT SCI MED, V6, P52; International Olympic Committee, IOC APPR 5 NEW SPORT; Junge A, 2008, BRIT J SPORT MED, V42, P413, DOI 10.1136/bjsm.2008.046631; Lystad RP, 2014, J INT ASS TAEKWONDO, V1, P1; Macan J, 2006, BRIT J SPORT MED, V40, P326, DOI 10.1136/bjsm.2005.022459; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Pieter W, 2010, SCI SPORT, V25, P32, DOI 10.1016/j.scispo.2009.07.001; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; World Karate Federation, 2017 REV REC BREAK Y; Ziaee Vahid, 2015, Asian J Sports Med, V6, pe26832, DOI 10.5812/asjsm.26832	23	2	2	2	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	AUG	2019	7	8							2325967119865866	10.1177/2325967119865866			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	IS8FB	WOS:000482383900001	31489331	Green Published, gold, Green Submitted			2022-02-06	
J	Beaulieu, K				Beaulieu, Karen			Lived experiences of return to paid work following a brain injury	BRITISH JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Brain injury; return to work; occupational therapy	MODERATE; MILD; PHENOMENOLOGY; PEOPLE	Introduction Due to resulting psychosocial, cognitive, psychological, communication and/or physical difficulties following a brain injury, it is often difficult to return to paid work. Being in paid work is generally good for individuals' health; however, currently only one third of the brain injury population manage to achieve this return. Method A descriptive phenomenological approach was used to collect and analyse data from 10 male and six female individuals who had sustained either a moderate or severe traumatic or acquired brain injury. Unstructured interviews explored their experiences of return to paid work. Data analysis resulted in synthesised descriptions of their return to paid work lived experiences following a brain injury. Findings: Sixty-one meaning units were established from the data, and six themes emerged: coping with ongoing difficulties; expectation and timing of return to work; workplace colleague reactions; things that help; change and return to work options; and feelings of success. Conclusion Findings can be used to develop a more consistent approach to return to paid work, and will inform future occupational therapy practice and return to paid work rehabilitation. Occupational therapists need to support these individuals to cope with the ongoing difficulties facing them, especially in relation to fatigue, memory and transportation difficulties.	[Beaulieu, Karen] Univ Plymouth, Fac Hlth & Human Sci, Derriford Rd, Plymouth PL6 8BH, Devon, England		Beaulieu, K (corresponding author), Univ Plymouth, Fac Hlth & Human Sci, Derriford Rd, Plymouth PL6 8BH, Devon, England.	Karen.beaulieu@plymouth.ac.uk	Beaulieu, Karen/AAA-5264-2021	Beaulieu, Karen/0000-0002-0789-3281	Irwin Mitchell Research Award in 2011; Irwin Mitchell Solicitors; UK Occupational Therapy Research Foundation, Royal College of Occupational Therapists	The author disclosed receipt of the Irwin Mitchell Research Award in 2011, to part-support PhD study, from Irwin Mitchell Solicitors and the UK Occupational Therapy Research Foundation, Royal College of Occupational Therapists.	Artman LK, 2013, J VOCAT REHABIL, V39, P13, DOI 10.3233/JVR-130638; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bjorkdahl A, 2010, BRAIN INJURY, V24, P1061, DOI 10.3109/02699052.2010.494588; Bonneterre V., 2013, Annals of Physical and Rehabilitation Medicine, V56, P652, DOI 10.1016/j.rehab.2013.10.001; Donker-Cools BHPM, 2018, DISABIL REHABIL, V40, P185, DOI 10.1080/09638288.2016.1250118; Friedland D, 2014, CLIN PSYCHOL FORUM, V259, P16; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Giorgi A, 2000, SCAND J CARING SCI, V14, P3, DOI 10.1111/j.1471-6712.2000.tb00554.x; Giorgi A, 2000, SCAND J CARING SCI, V14, P11, DOI 10.1111/j.1471-6712.2000.tb00555.x; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Husserl Edmund, 2001, SHORTER LOGICAL INVE; Ownsworth T, 2010, WORK, V36, P381, DOI 10.3233/WOR-2010-1041; Phillips J, 2010, BRIT J OCCUP THER, V73, P422, DOI 10.4276/030802210X12839367526138; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rubenson Camilla, 2007, Scand J Occup Ther, V14, P205, DOI 10.1080/11038120601110934; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Schonbrun SL, 2007, J REHABIL, V73, P26; Shigaki CL, 2009, DISABIL REHABIL, V31, P484, DOI 10.1080/09638280802240449; Soeker MS, 2011, J OCCUP SCI, V18, P81, DOI 10.1080/14427591.2011.554155; Soeker MS, 2012, WORK, V42, P589, DOI 10.3233/WOR-2012-1414; Stergiou-Kita M, 2016, BRIT J OCCUP THER, V79, P309, DOI 10.1177/0308022616631759; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002	26	2	2	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0308-0226	1477-6006		BRIT J OCCUP THER	Br. J. Occup. Ther.	NOV	2019	82	11					658	665	0308022619860980	10.1177/0308022619860980		AUG 2019	8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	JI7NY	WOS:000479789700001		Green Submitted			2022-02-06	
J	Brickell, TA; Reid, MW; French, LM; Lippa, SM; Sullivan, JK; Wright, MM; Driscoll, AE; Gartner, RL; Varbedian, NV; Lange, RT				Brickell, Tracey A.; Reid, Matthew W.; French, Louis M.; Lippa, Sara M.; Sullivan, Jamie K.; Wright, Megan M.; Driscoll, Angela E.; Gartner, Rachel L.; Varbedian, Nicole V.; Lange, Rael T.			Factor Analysis of the Caregiver Appraisal Scale in Military TBI	REHABILITATION PSYCHOLOGY			English	Article						Caregiving Appraisal Scale; caregiver; service member and veteran; military; traumatic brain injury	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SERVICE MEMBERS; VETERANS; HEALTH; POSTCONCUSSION; POLYTRAUMA; BURDEN	Purpose/Objective: To (a) examine the factor structure of the original 47-item Caregiver Appraisal Scale (CAS) in caregivers of service members/veterans (SMVs) following traumatic brain injury (TBI) and (b) assess whether the CAS yields a similar factor structure in this population compared to caregivers of civilian adults following TBI. Research Method/Design: Participants were 287 caregivers (female = 96.2%; spouse = 87.8%; mean age = 38.6 years) of SMVs who sustained a mild, moderate, severe, or penetrating TBI, recruited from Walter Reed National Military Medical Center and via caregiver community outreach. Caregivers completed the CAS, Caregiver Questionnaire, and Mayo-Portland Adaptability Inventory-4 upon enrollment in the study. Results: Principal component analysis (PCA) revealed four factors that explained 43.2% of the variance in CAS scores: Perceived Burden, Caregiving Relationship Satisfaction, Caregiving Ideology, and Caregiving Mastery. Thirty-seven of the 47 CAS items loaded significantly onto only one of the four factors (>=.40). A secondary PCA was performed on these 37 items, resulting in a four-factor solution very similar to that of the 47-item solution, which explained 46.8% of the variance in the 37-item measure. All but one item loaded significantly on a factor corresponding to a conceptually similar construct. Conclusions/Implications: Military and civilian caregivers have overlapping and differing concerns. The findings support a 37-item four-factor model of caregiving stress appraisal that has the potential for use as an outcome measure for developing caregiver interventions. It may be as useful to administer a reduced 37-item measure of the CAS to caregivers as the original 47-item measure, but further development is required.	[Brickell, Tracey A.; French, Louis M.; Lippa, Sara M.; Sullivan, Jamie K.; Wright, Megan M.; Driscoll, Angela E.; Gartner, Rachel L.; Varbedian, Nicole V.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,4954 North Palmer Rd, Bethesda, MD 20889 USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Reid, Matthew W.] San Antonio Mil Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Brickell, TA (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bldg 51,Room 1502B,4954 North Palmer Rd, Bethesda, MD 20889 USA.	tbrickell@dvbic.org	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604; Gartner, Rachel/0000-0001-8327-9737	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs Funding Source: Medline		Brickell TA, 2019, REHABIL PSYCHOL, V64, P72, DOI 10.1037/rep0000249; Brickell TA, 2018, J HEAD TRAUMA REHAB, V33, P133, DOI 10.1097/HTR.0000000000000384; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Costello AB, 2005, PRACT ASSES RES EVAL, V10, P9; Field A., 2017, DISCOVERING STAT USI, V5th; Folkman S., 1984, STRESS; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hutcheson G, 1999, MULTIVARIATE SOCIAL, DOI [10.4135/9780857028075, DOI 10.4135/9780857028075]; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; National Alliance for Caregiving, 2010, CAR VET SERV HOM; Pituch K.A., 2016, APPL MULTIVARIATE ST, V6th; Ramchand R., 2017, HIDDEN HEROES AMERIC, DOI [10.7249/rr499, DOI 10.7249/RR499]; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Schaaf KPW, 2013, REHABIL PSYCHOL, V58, P106, DOI 10.1037/a0031693; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01	24	2	2	3	8	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2019	64	3					366	376		10.1037/rep0000270			11	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	IE7MX	WOS:000472559200013	30896246				2022-02-06	
J	Chan, V; Toccalino, D; Colantonio, A				Chan, Vincy; Toccalino, Danielle; Colantonio, Angela			Systematic review protocol for facilitators and barriers to integrating health services for traumatic brain injury and mental health or addictions	BMJ OPEN			English	Article							PSYCHIATRIC-DISORDERS; INCOME COUNTRIES; MIDDLE-INCOME; SUBSTANCE USE; ADOLESCENTS; PREVALENCE; CHILDREN	Introduction In the most populous province of Canada, one in five adults and one in six students report a lifetime history of traumatic brain injury (TBI). These individuals were also more likely to report elevated psychological distress and use illicit substances compared with those without TBI. The need for integrated health services has been recognised globally, yet efforts to develop more comprehensive and effective care for TBI and mental health and/or addictions (MHA) continue to be challenged by the siloing of the two systems. This protocol is for a systematic review that describes the current types of integrated care for TBI and MHA and identifies the barriers and facilitators to integrating healthcare for these populations. Methods and analysis This review will systematically search MEDLINE, EMBASE, PsycINFO, CINAHL, Cochrane Central Register of Controlled Trials, Sociological Abstracts, and Dissertations & Theses Global. References of eligible articles will also be searched for additional relevant studies. The search strategy will include the use of text words and subject headings relevant to the concepts 'TBI,' 'substance abuse, gambling, or mental health,' 'integrated healthcare,' 'barriers and facilitators,' and 'healthcare access.' Two reviewers will independently screen all articles based on predetermined inclusion and exclusion criteria and perform quality assessment on eligible studies. A narrative synthesis will be conducted using the data abstracted by the two reviewers. Ethics and dissemination Findings from the systematic review will be published in peer-reviewed journals, presented at scientific meetings, and summarised for key stakeholders in the field of TBI and/or MHA. This protocol will form a systematic review that holds the potential to impact policy and planning in the development of integrated person-centred care for TBI and MHA and addresses a recognised gap in TBI care.	[Chan, Vincy; Colantonio, Angela] Univ Hlth Network, KITE Toronto Rehab, Toronto, ON, Canada; [Toccalino, Danielle; Colantonio, Angela] Univ Toronto, Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada		Chan, V (corresponding author), Univ Hlth Network, KITE Toronto Rehab, Toronto, ON, Canada.	vincy.chan@uhn.ca	Chan, Vincy/AAA-7813-2020	Colantonio, Angela/0000-0003-2094-4765; Chan, Vincy/0000-0002-6884-044X	2017/18 Health System Research Fund Program Awards, 'Integrating Brain Injury, Mental Health, and Addictions', Ministry [267]	This study was conducted as part of the 2017/18 Health System Research Fund Program Awards, 'Integrating Brain Injury, Mental Health, and Addictions', Ministry Grant No. 267.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Albicini M, 2020, J MENT HEALTH, V29, P439, DOI 10.1080/09638237.2017.1385733; [Anonymous], 2014, MAPPING CONNECTIONS; Atun R, 2010, HEALTH POLICY PLANN, V25, P1, DOI 10.1093/heapol/czp053; Balogh KN, 2016, CANCER IMMUNOL RES, V4, DOI 10.1158/2326-6074.CRICIMTEATIAACR15-A152; Briggs CJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub2; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cancer Care Ontario, 2018, ONT CANC STAT 2018, P172; Challacombe L, 2018, EPIDEMIOLOGY HIV CAN; Chan V, 2019, BRAIN INJURY, V33, P213; Chuah FLH, 2017, HEALTH POLICY PLANN, V32, P27, DOI 10.1093/heapol/czw169; Gibson R, 2015, BRAIN INJURY, V29, P306, DOI 10.3109/02699052.2014.896471; Gilmour H, 2018, MULTIPLE SCLEROSIS P, P3; Haldane V, 2018, AIDS CARE, V30, P103, DOI 10.1080/09540121.2017.1344350; Haldane V, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21585; Heyeres M, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00223; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kantor V, 2017, CLIN PSYCHOL REV, V52, P52, DOI 10.1016/j.cpr.2016.12.001; Legido-Quigley H, 2013, TROP MED INT HEALTH, V18, P199, DOI 10.1111/tmi.12029; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Munce SEP, 2014, BRAIN INJURY, V28, P1042, DOI 10.3109/02699052.2014.890744; National Heart Lung and Blood Institute, BACKGR DEV US STUD Q; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Popay J., 2006, ESRC METHODS PROGRAM, DOI DOI 10.13140/2.1.1018.4643; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; Secretariat WHO, 2016, FRAM INT PEOPL CTR H; Sigfrid L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181156; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Suter E., 2007, HLTH SYSTEMS INTEGRA; Wakida EK, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0561-0; Watt N, 2017, HEALTH POLICY PLANN, V32, P13, DOI 10.1093/heapol/czw149; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	40	2	2	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	AUG	2019	9	7							e027534	10.1136/bmjopen-2018-027534			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IW8US	WOS:000485269700149	31340961	Green Published, gold			2022-02-06	
J	Dickson, TJ; Waddington, G; Terwiel, FA; Elkington, L				Dickson, Tracey J.; Waddington, Gordon; Terwiel, F. Anne; Elkington, Lisa			The King-Devick test is not sensitive to self-reported history of concussion but is affected by English language skill	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article; Proceedings Paper	22nd International Congress on Snow Sports Trauma and Safety / Biennial Meeting of the International-Society-for-Skiing-Safety (ISSS)	APR 17-22, 2017	Univ Innsbruck, Innsbruck, AUSTRIA	Int Soc Skiing Safety	Univ Innsbruck	Visual proprioception; Concussion; Skiing; Snowboarding; Helmets	SCREENING TOOL; RUGBY LEAGUE; DIAGNOSIS; INJURY; SKIERS; UNION	Objectives: Head injuries, including concussion, are a concern in many sports. Current validated concussion assessment protocols such are problematic with suggestions that an oculomotor examination, such as the King-Devick (K-D) test, could be included. This research explores the role of the K-D test in snowsport concussion research. Design: Experienced snowsport participants were recruited through a western Canadian resort (n = 75). Methods: Participants completed a questionnaire that included their history of prior serious head impacts and were assessed via the computer-based K-D test in English. Results: Of the 75 participants, 23 (69%) reported at least one previous serious head impact. English was the not primary language for seven participants. Independent sample t-tests revealed: significant differences in the K-D average saccade scores for those who had broken their helmets, with or without a serious head injury (-(x) over bar =171.23, SD= 12.9) and those who had not broken a helmet (-(x) over bar= 186.61, SD= 20.18; t (70) = - 2.53, p =.014, twotailed) and significant differences in the K-D time for those whose native language is English (-(x) over bar= 47.9, SD = 6.3) and those where English was not their first language (-(x) over bar= 53.3, SD = 7.4; t(73)=.48, p = .04), but no significant difference for their saccade velocities: English (-(x) over bar = 183.64, SD = 20.0) versus those where English is a second or third language (-(x) over bar = 188.44, SD = 20.1; t(70) = -.56, p = .576). Conclusions: For subjects whose first language is not English, such as in many snowsport resorts, the K-D test may need to be conducted in a person's native language to provide a valid assessment based upon the time to complete the task. (C) 2018 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Dickson, Tracey J.; Waddington, Gordon; Elkington, Lisa] Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia; [Terwiel, F. Anne] Thompson Rivers Univ, Fac Adventure Culinary Arts & Tourism, Kamloops, BC, Canada		Dickson, TJ (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia.	Tracey.Dickson@canberra.edu.au		Terwiel, Anne/0000-0003-4621-201X; Dickson, Tracey/0000-0002-9889-1512; Waddington, Gordon/0000-0002-4306-9193			[Anonymous], 2011, SNOW SPORT HELM ACT; Australian Ski Areas Association, 2011, ALP RESP COD; Bianchi G., 2017, SNOW SPORTS TRAUMA S, P29; Canada West Ski Areas Association, 2016, POL ALP RESP COD; Canadian Ski Council, 2014, HELM US DAT ALL CAN; CBC News, 2012, CBC NEWS; Costa-Scorse B, 2015, SKIING TRAUMA SAFETY; Dempsey K, 2016, NEUROLOGY S, V86, P113; Dhawan PSA, 2014, NEUROL CLIN PRACT, V82, pS11; Dickson TJ, 2017, SCAND J MED SCI SPOR, V27, P236, DOI 10.1111/sms.12642; Dickson TJ, 2007, TOUR REV, V62, P7, DOI 10.1108/16605370780000315; Echemendia RJ, 2017, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097506SCAT5, DOI 10.1136/BJSPORTS-2017-097506SCAT5]; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Fuller GW., 2018, BR J SPORTS MED; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; MCLAUGHLIN B, 1983, LANG LEARN, V33, P135, DOI 10.1111/j.1467-1770.1983.tb00532.x; Molloy JH, 2017, J SCI MED SPORT, V20, P708, DOI 10.1016/j.jsams.2017.02.002; Naidu D, 2018, J NEUROTRAUM, V35, P2283, DOI 10.1089/neu.2017.5490; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Ruedl G, 2012, SCAND J MED SCI SPOR, V22, P448, DOI 10.1111/j.1600-0838.2011.01429.x; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Siesmaa EJ, 2018, WILD ENVIRON MED, V29, P194, DOI 10.1016/j.wem.2018.01.011; Waddington G, 2017, SNOW SPORTS TRAUMA S; Worksafe BC, 2013, INF SHEET; Xu-Wilson M, 2009, EXP BRAIN RES, V196, P475, DOI 10.1007/s00221-009-1879-1	30	2	2	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	AUG	2019	22			1			S34	S38		10.1016/j.jsams.2018.08.013			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Sport Sciences	JI6OQ	WOS:000493587000008	30193857				2022-02-06	
J	Gubari, MIM; Norouzy, A; Hosseini, M; Mohialdeen, FA; Hosseinzadeh-Attar, MJ				Gubari, Mohammed I. M.; Norouzy, Abdolreza; Hosseini, Mostafa; Mohialdeen, Fadhil A.; Hosseinzadeh-Attar, Mohammad Javad			The Relationship between Serum Concentrations of Pro- and Anti-Inflammatory Cytokines and Nutritional Status in Patients with Traumatic Head Injury in the Intensive Care Unit	MEDICINA-LITHUANIA			English	Article						pro- and anti-inflammatory cytokines; traumatic head injury (THI); lean body mass; fat body mass; APACHE II and SOFA scores	ADDUCTOR POLLICIS MUSCLE; BRAIN-INJURY; CEREBROSPINAL-FLUID; HEMORRHAGIC-SHOCK; TNF-ALPHA; INTERLEUKIN-6; PLASMA; THICKNESS; SCORE; IL-6	Background and objective: The aim of the present study was to examine the relationship between serum levels of pro-inflammatory cytokines (IL-6, IL-1 beta, and TNF-alpha) and anti-inflammatory cytokines (IL-10) measured once at the baseline with changes in nutritional status of patients with traumatic head injury (THI) assessed at three consecutive times (24 h after admission, day 6 and day 13) during hospital stay in the intensive care unit (ICU). Materials and Methods: Sixty-four patients with THI were recruited for the current study (over 10 months). The nutritional status of the patients was determined within 24 h after admission and on days 6 and 13, using actual body weight, body composition analysis, and anthropometric measurements. The APACHE II score and SOFA score were also assessed within 24 h of admission and on days 6 and 13 of patients staying in the ICU. Circulatory serum levels of cytokines (IL-6, IL-1 beta, TNF-alpha, and IL-10) were assessed once within 24 h of admission. Results: The current study found a significant reduction in BMI, FBM, LBM, MAUAC, and APM, of THI patients with high serum levels the cytokines, over the course of time from the baseline to day 7 and to day 13 in patients staying in the ICU (p < 0.001). It was also found that patients with low levels of some studied cytokines had significant improvement in their nutritional status and clinical outcomes in term of MAUAC, APM, APACHE II score and SOFA score (p < 0.001 to p < 0.01). Conclusion: THI patients who had high serum levels of studied cytokines were more prone to develop a reduction of nutritional status in terms of BMI, FBM, LBM MAUAC and APM over the course of time from patient admission until day 13 of ICU admission.	[Gubari, Mohammed I. M.; Norouzy, Abdolreza; Hosseinzadeh-Attar, Mohammad Javad] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, Tehran 1416643931, Iran; [Hosseini, Mostafa] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran 1417613151, Iran; [Mohialdeen, Fadhil A.] Sulaimani Polytech Univ, Tech Coll Hlth, Community Hlth Dept, Sulaimani 46001, Iraq; [Hosseinzadeh-Attar, Mohammad Javad] Univ Adelaide, Ctr Res Excellence Translating Nutr Sci Good Hlth, Adelaide, SA 5005, Australia		Hosseinzadeh-Attar, MJ (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, Tehran 1416643931, Iran.	mhosseinzadeh@tums.ac.ir	Norouzy, Abdolreza/AAX-1160-2020; Hosseinzadeh-Attar, Mohammad Javad/E-9358-2018	Hosseinzadeh-Attar, Mohammad Javad/0000-0002-5787-4089; Norouzy, Abdolreza/0000-0001-6740-5502; Gubari, Mohammed Ibrahim Mohialdeen/0000-0002-2873-3981; Ahmed, Fadhil/0000-0001-6232-1473			Aadal L, 2015, J NEUROSCI NURS, V47, P85, DOI 10.1097/JNN.0000000000000121; Allard JP, 2016, CLIN NUTR, V35, P144, DOI 10.1016/j.clnu.2015.01.009; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Antunes Alessandra Armstrong, 2010, Asian J Neurosurg, V5, P68; Barton R G, 1994, Nutr Clin Pract, V9, P127; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Biffl WL, 1996, ANN SURG, V224, P647, DOI 10.1097/00000658-199611000-00009; Caporossi FS, 2012, NUTR HOSP, V27, P490, DOI [10.3305/nh.2012.27.2.5514, 10.1590/S0212-16112012000200021]; Costello L., 2015, INTENSIV CARE MED EX, V3, pA984, DOI [10.1186/2197-425X-3-S1-A984, DOI 10.1186/2197-425X-3-S1-A984]; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dickerson RN, 2012, J TRAUMA ACUTE CARE, V73, P549, DOI 10.1097/TA.0b013e318256de1b; Dirriopoulou I, 2008, CYTOKINE, V41, P263, DOI 10.1016/j.cyto.2007.11.019; Eagan TML, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-48; Foley N., 2008, ARCH PHYS MED REHAB, V89, pe29, DOI [10.1016/j.apmr.2008.08.107, DOI 10.1016/J.APMR.2008.08.107]; FRANKENFIELD DC, 1994, CRIT CARE MED, V22, P1796; Frink M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-49; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Genton L, 2011, INT J VITAM NUTR RES, V81, P143, DOI 10.1024/0300-9831/a000058; Ghorabi S, 2016, NUTR CLIN PRACT, V31, P523, DOI 10.1177/0884533615621547; Gupta R, 2004, INDIAN J MED RES, V119, P273; Hasenboehler Erik, 2006, World J Emerg Surg, V1, P29, DOI 10.1186/1749-7922-1-29; Hejazi N, 2016, IRAN J MED SCI, V41, P171; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Heyland DK, 2011, CRIT CARE, V15, DOI 10.1186/cc10546; Huang YC, 2000, CLIN NUTR, V19, P101, DOI 10.1054/clnu.1999.0077; Fuentes MTI, 2010, ENFERM INTENSIV, V21, P113, DOI 10.1016/j.enfi.2009.11.002; Jeschke MG, 2004, ANN SURG, V239, P553, DOI 10.1097/01.sla.0000118569.10289.ad; Kalanda O.P., 2014, THESIS; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kim Hyunjung, 2011, Intensive Crit Care Nurs, V27, P194, DOI 10.1016/j.iccn.2011.05.002; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Knoblach SM, 2000, NEUROSCI LETT, V289, P5, DOI 10.1016/S0304-3940(00)01263-5; Kubrak C, 2007, INT J NURS STUD, V44, P1036, DOI 10.1016/j.ijnurstu.2006.07.015; Langhans C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092048; Lew CCH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010010; Lim SH, 2005, YONSEI MED J, V46, P21, DOI 10.3349/ymj.2005.46.1.21; Lo TYM, 2010, J NEUROTRAUM, V27, P2139, DOI 10.1089/neu.2010.1387; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Ludwigs U, 2000, SCAND CARDIOVASC J, V34, P371; Maier B, 2005, J NEUROTRAUM, V22, P822, DOI 10.1089/neu.2005.22.822; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; Mashaal D, 2016, THESIS; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Moinard C, 2013, J NEUROTRAUM, V30, P975, DOI 10.1089/neu.2012.2707; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Nematy M, 2012, MEDITERR J NUTR META, V5, P163, DOI 10.1007/s12349-011-0071-x; Okeny PK, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0048-z; Pereira TG, 2018, CLIN NUTR ESPEN, V24, P165, DOI 10.1016/j.clnesp.2017.10.013; Plank LD, 2003, P NUTR SOC, V62, P545, DOI 10.1079/PNS2003259; Rodrigues KF, 2017, ARCH ENDOCRIN METAB, V61, P438, DOI 10.1590/2359-3997000000254; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; de Melo CYSV, 2014, ABCD-ARQ BRAS CIR DI, V27, P13, DOI 10.1590/s0102-67202014000100004; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Sungurtekin H, 2008, NUTR CLIN PRACT, V23, P635, DOI 10.1177/0884533608326137; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Webb A, 2016, OXFORD TXB CRITICAL; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yamada Y, 1996, BURNS, V22, P587, DOI 10.1016/S0305-4179(96)00052-6	63	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1010-660X	1648-9144		MEDICINA-LITHUANIA	Med. Lith.	AUG	2019	55	8							486	10.3390/medicina55080486			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IZ0GQ	WOS:000486769900085	31443251	Green Published, gold, Green Submitted			2022-02-06	
J	Gunasekaran, P; Hodge, C; Rose, K; Fraser, CL				Gunasekaran, Premkumar; Hodge, Christopher; Rose, Kathryn; Fraser, Clare L.			Persistent visual disturbances after concussion	AUSTRALIAN JOURNAL OF GENERAL PRACTICE			English	Article							SPORT-RELATED CONCUSSION; EYE-MOVEMENTS; CONVERGENCE; IMPAIRMENT; POINT	Background Ocular dysfunction, including eye movement defects, has been documented in up to 69% of patients with concussion. However, standard sports-related concussion assessment protocols do not typically include any clinical examination of the ocular system. Objective The aim of this article is to inform general practitioners (GPs) about ocular defects associated with concussion, identify test procedures and highlight the important role of GPs within the concussion paradigm. Discussion Ocular dysfunction that commonly occurs with concussion includes abnormalities of accommodation, convergence, saccades and smooth pursuits. This may cause blurred vision, double vision, ocular pain and difficulty with close work. Symptoms can severely affect daily work, school or play activities. Patients complaining of extended ocular symptoms following concussion should be referred to an ophthalmologist for a complete ocular assessment.	[Gunasekaran, Premkumar; Hodge, Christopher; Rose, Kathryn] Univ Technol Sydney, Grad Sch Hlth, Discipline Orthopt, Sydney, NSW, Australia; [Hodge, Christopher] Univ Sydney, Save Sight Inst, Discipline Ophthalmol, Sydney Med Sch, Sydney, NSW, Australia; [Fraser, Clare L.] Univ Sydney, Save Sight Inst, Discipline Ophthalmol, Sydney Med Sch,Neuroophthalmol, Sydney, NSW, Australia		Fraser, CL (corresponding author), Univ Sydney, Save Sight Inst, Discipline Ophthalmol, Sydney Med Sch,Neuroophthalmol, Sydney, NSW, Australia.	clare.fraser@sydney.edu.au	Hodge, Christopher/AAD-2598-2019	Hodge, Christopher/0000-0002-0516-6486; Rose, Kathryn/0000-0003-2851-4145; Fraser, Clare/0000-0002-0379-7743; Gunasekaran, Premkumar/0000-0002-8872-2600			Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Arnoldi Kyle, 2007, Am Orthopt J, V57, P123, DOI 10.3368/aoj.57.1.123; Bin Zahid A, APPL NEUROPSYCHOL AD, V25, P110; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Cohen D, 2015, NEUROLOGY APR S14, V84; DAUM KM, 1983, DOC OPHTHALMOL, V55, P177, DOI 10.1007/BF00140808; Debacker J, 2018, HAND CLINIC, V158, P145, DOI 10.1016/B978-0-444-63954-7.00015-X; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Gunasekaran P, 2020, PHYSICIAN SPORTSMED, V48, P1, DOI 10.1080/00913847.2019.1624656; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Helps Y, 2018, INJURY RES STAT SERI, V45; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Hughes, 2019, CONCUSSION SPORT AUS; Jacobs SM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0389-5; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Raghuram A, 2019, AM J OPHTHALMOL, V206, P235, DOI 10.1016/j.ajo.2019.04.008; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Rowe F, 2012, CLIN ORTHOPTICS; Simpson-Jones ME, 2019, DISABIL REHABIL, V41, P2206, DOI 10.1080/09638288.2018.1460407; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Urosevich TG, 2018, MIL MED, V183, pE564, DOI 10.1093/milmed/usy102; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955	37	2	2	2	5	ROYAL AUSTRALIAN COLLEGE GENERAL PRACTITIONERS	SOUTH MELBOURNE	1 PALMERSTON CRESCENT, SOUTH MELBOURNE, VICTORIA 3205, AUSTRALIA	2208-794X	2208-7958		AUST J GEN PRACT	Aust. J. Gen. Pract.	AUG	2019	48	8					531	536		10.31128/AJGP-03-19-4876			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IM3VU	WOS:000477924100007	31370123	Bronze			2022-02-06	
J	Oris, C; Chabanne, R; Durif, J; Kahouadji, S; Brailova, M; Sapin, V; Bouvier, D				Oris, Charlotte; Chabanne, Russel; Durif, Julie; Kahouadji, Samy; Brailova, Marina; Sapin, Vincent; Bouvier, Damien			Measurement of S100B protein: evaluation of a new prototype on a bioMerieux Vidas (R) 3 analyzer	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article							MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; SERUM; MANAGEMENT; STORAGE; FAMILY; BLOOD; MILD	Background: The addition of S100B protein to guidelines for the management of mild traumatic brain injury (mTBI) decreases the amount of unnecessary computed tomography (CT) scans with a significant decrease in radiation exposure and an increase in cost savings. Both DiaSorin and Roche Diagnostics have developed automated assays for S100B determination. Recently, bioMerieux developed a prototype immunoassay for serum S100B determination. For the first time, we present the evaluation of the S100B measurement using a bioMerieux Vidas (R) 3 analyzer. Methods: We evaluated the matrix effects of serum and plasma, and their stability after storage at 2-8 degrees C, -20 degrees C and -80 degrees C. The new measurement prototype (bioMerieux) was compared with an established one (Roche Diagnostics), and a precision study was also conducted. Lastly, clinical diagnostics performance of the bioMerieux and Roche Diagnostics methods were compared for 80 patients referred to the Emergency Department for mTBI. Results: Stability after storage at 2-8 degrees C, -20 degrees C, and -80 degrees C and validation of the serum matrix were demonstrated. The bioMerieux analyzer was compared to the Roche Diagnostics system, and the analytical precision was found to be efficient. Clinical diagnosis performance evaluation confirmed the predictive negative value of S100B in the management of mTBI. Conclusions: The study's data are useful for interpreting serum S100B results on a bioMerieux Vidas (R) 3 analyzer.	[Oris, Charlotte; Durif, Julie; Kahouadji, Samy; Brailova, Marina; Sapin, Vincent; Bouvier, Damien] CHU Clermont Ferrand, Biochem & Mol Biol Dept, Clermont Ferrand, France; [Sapin, Vincent; Bouvier, Damien] Clermont Auvergne Univ, INSERM, CNRS, GReD, Clermont Ferrand, France; [Chabanne, Russel] CHU Clermont Ferrand, Dept Perioperat Med, Clermont Ferrand, France		Bouvier, D (corresponding author), CHU Clermont Ferrand, Biochem & Mol Biol Dept, Clermont Ferrand, France.; Bouvier, D (corresponding author), Clermont Auvergne Univ, INSERM, CNRS, GReD, Clermont Ferrand, France.	dbouvier@chu-clermontferrand.fr		Bouvier, Damien/0000-0002-2707-4320; Oris, Charlotte/0000-0002-7360-4142	bioMerieux company	This work was supported by the bioMerieux company.	Allouchery G, 2018, CLIN CHEM LAB MED, V56, P1897, DOI 10.1515/cclm-2018-0471; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bouvier D, 2016, CLIN CHEM LAB MED, V54, P833, DOI 10.1515/cclm-2015-0771; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Delefortrie Q, 2018, CLIN BIOCHEM, V52, P123, DOI 10.1016/j.clinbiochem.2017.11.004; Djukanovic D, 2001, BRIT J DERMATOL, V145, P1030, DOI 10.1046/j.1365-2133.2001.04545.x; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Feriel J, 2015, CLIN CHEM LAB MED, V53, pE169, DOI 10.1515/cclm-2014-1090; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mazer CD, 2007, CAN J ANESTH, V54, P44607; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Padoan A, 2018, CLIN CHIM ACTA, V483, P271, DOI 10.1016/j.cca.2018.05.018; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Raabe A, 2003, CLIN CHEM LAB MED, V41, P700, DOI 10.1515/CCLM.2003.106; Smit LHM, 2005, INT J BIOL MARKER, V20, P34, DOI 10.1177/172460080502000106; Steiner J, 2011, BRAIN BEHAV IMMUN, V25, P1233, DOI 10.1016/j.bbi.2011.03.015; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tort ABL, 2003, CLIN BIOCHEM, V36, P629, DOI 10.1016/S0009-9120(03)00107-3; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Wang S, 2012, CLIN CHEM LAB MED, V50, P525, DOI [10.1515/CCLM.2011.794, 10.1515/cclm.2011.794]; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	26	2	2	0	7	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	AUG	2019	57	8					1177	1184		10.1515/cclm-2018-1217			8	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	IH2UC	WOS:000474349000020	30763262	Green Submitted			2022-02-06	
J	Ross, R				Ross, Ryan			Between Shell Shock and PTSD? 'Accident Neurosis' and Its Sequelae in Post-War Britain	SOCIAL HISTORY OF MEDICINE			English	Article						accident neurosis; post-concussional syndrome; shell shock; PTSD; trauma	HEAD-INJURY; COMPENSATION NEUROSIS; PSYCHIATRIC SEQUELAE; TRAUMA; CONCUSSION; SYMPTOMS	This article focuses on the concept of 'accident neurosis', popularised by neurologist Henry Miller in studies published in 1961. It aims to realise two goals. First, it introduces Miller's concept of accident neurosis to the broader history of trauma-to a field, that is, more preoccupied with military traumata and clear-cut psychiatric aetiologies. Secondly, I use Miller's studies, and the considerable legacy they created, to reflect on how historians of trauma construct historical narratives, asking whether there is sufficient appreciation of the ways in which events seem to leak into or retroactively animate one another.	[Ross, Ryan] ArtsTwo, Sch Hist, Mile End Rd, London E1 4NS, England		Ross, R (corresponding author), ArtsTwo, Sch Hist, Mile End Rd, London E1 4NS, England.	ryan.ross@qmul.ac.uk		Ross, Ryan/0000-0002-0637-0622	Wellcome TrustWellcome TrustEuropean Commission [101990/Z/13/Z]	This research was supported by the Wellcome Trust [101990/Z/13/Z].	[Anonymous], 1967, BMJ-BRIT MED J, V3, P61; Miller H G, 1976, Br Med J, V2, P591; [Anonymous], 1961, Br Med J, V1, P1018; [Anonymous], 1967, BRIT MED J, V3, P62; [Anonymous], 1976, TIMES, P14; [Anonymous], 1961, BRIT MED J, V1, P1459; [Anonymous], 1961, BRIT MED J; [Anonymous], 1961, TIMES, P11; ASTON JN, 1961, BRIT MED J, V1, P1604, DOI 10.1136/bmj.1.5239.1604-b; Bethell Martin F., 1961, TIMES, P15; Burnham J., 2009, ACCIDENT PRONE HIST; COHEN RI, 1987, MED SCI LAW, V27, P177, DOI 10.1177/002580248702700305; Collins Alan F, 2006, Hist Psychol, V9, P89, DOI 10.1037/1093-4510.9.2.89; Cooter R, 1997, Clio Med, V41, P1; Cooter R., 1998, WAR MED MODERNITY, P125; COZZENS SE, 1985, SOC STUD SCI, V15, P127, DOI 10.1177/030631285015001005; De Landa Manuel, 2000, 1000 YEARS NONLINEAR; DeLanda Manuel, 2011, SPECULATIVE TURN CON, P381; Delaporte Sophie, 2016, TRAUMATIC MEMORIES 2, P23; EDDY JA, 1961, BRIT MED J, V1, P1175, DOI 10.1136/bmj.1.5233.1175; FENTON GW, 1994, J ROY SOC MED, V87, P499; Figlio Karl, 1982, PROBLEM MED KNOWLEDG, P174; Figlio Karl, 1986, SOCIAL HIST OCCUPATI, P180; Gruneberg R., 1970, INJURY, V1, P210; Harrington R, 2003, SOC HIST MED, V16, P209, DOI 10.1093/shm/16.2.209; Hayward R, 2014, TRANSFORMATION OF THE PSYCHE IN BRITISH PRIMARY CARE, 1870-1970, P1; HOWARD SHF, 1961, LANCET, V1, P1224; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; JAYSON MIV, 1992, BRIT MED J, V305, P7, DOI 10.1136/bmj.305.6844.7; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Jones E, 2007, J ANXIETY DISORD, V21, P164, DOI 10.1016/j.janxdis.2006.09.009; Jones Edgar, 2005, SHELL SHOCK PTSD MIL; KAY DWK, 1971, LANCET, V2, P1052; KELLY M, 1961, BRIT MED J, V2, P110, DOI 10.1136/bmj.2.5244.110; KELLY R, 1981, J ROY SOC MED, V74, P630; KELLY R, 1981, J ROY SOC MED, V74, P242; KELLY R, 1981, J ROY SOC MED, V74, P275, DOI 10.1177/014107688107400407; Kelly R., 1972, PAHLAVI MED J, V3, P530; Kelly R., 1975, FORENSIC SCI, V6, P24; Lawton Frederick, 1978, MED LEGAL J, V47, P9; Leese Peter, 2002, SHELL SHOCK TRAUMATI; Lenoir Timothy, 1998, INSCRIBING SCI SCI T; Leys Ruth, 2000, TRAUMA GENEALOGY, P6; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LISHMAN WA, 1966, P ROY SOC MED, V59, P261, DOI 10.1177/003591576605900328; Lock Stephen, 1977, REMEMBERING HENRY; Loughran Tracey, 2017, SHELL SHOCK MED CULT, P10; Loughran Tracey, 2012, J HIST MED ALL SCI, V67, P108; Mayou R, 1996, BRIT J PSYCHIAT, V168, P399, DOI 10.1192/bjp.168.4.399; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MEALY K, 1986, BRIT MED J, V292, P656, DOI 10.1136/bmj.292.6521.656; Mendelson Danuta, 1998, INTERFACES MED LAW H; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MERSKEY H, 1984, CAN MED ASSOC J, V130, P1119; Micale Mark, 2017, PSYCHOL TRAUMA LEGAC, P291; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLER H, 1961, LANCET, V1, P1349; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; MILLER H, 1965, LANCET, V1, P225; Miller Henry, 1964, TS OPHTHALMOLOGICAL, V84, P630; Miller Henry, 1967, CURRENT MED DRUGS, V7, P6; Miller Henry, 1968, HEADACHES CRANIAL NE, V5, P179; Miller Henry, 1972, BROCKS INJURIES BRAI, P643; NAISH JM, 1979, LANCET, V2, P139; Neustatter Lindesay W., 1962, MED LEGAL J, V30, P164; Norris Donald C., 1962, MED LEGAL J, V30, P65; Ramsay J, 1939, BRIT MED J, V2, P385, DOI 10.1136/bmj.2.4102.385; REED JL, 1978, BRIT J HOSP MED, V19, P314; Reynard W. A., 1961, LANCET, V278, P52; Ross T. A., 1936, ENQUIRY PROGNOSIS NE, P87; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUSSELL WR, 1966, P ROY SOC MED, V59, P266; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; RYAN JA, 1961, BRIT MED J, V1, P1251, DOI 10.1136/bmj.1.5234.1251; Salzberg M, 2004, AUST NZ J PSYCHIAT, V38, P2, DOI 10.1111/j.1440-1614.2004.01302.x; STEADMAN JH, 1970, P ROY SOC MED, V63, P23, DOI 10.1177/003591577006300109; TARSH MJ, 1985, BRIT J PSYCHIAT, V146, P18, DOI 10.1192/bjp.146.1.18; TAYLOR AR, 1966, LANCET, V2, P178; TAYLOR AR, 1967, BRIT MED J, V3, P67, DOI 10.1136/bmj.3.5557.67; Teff Harvey, 2009, CAUSING PSYCHIAT EMO, P146; TRETHOWAN WH, 1970, P ROY SOC MED, V63, P32, DOI 10.1177/003591577006300111; Trimble M.R., 1981, POSTTRAUMATIC NEUROS; Walton Lord, 1993, SPICE LIFE NORTHUMBR, P277; WEIGHILL VE, 1983, J PSYCHOSOM RES, V27, P97, DOI 10.1016/0022-3999(83)90085-5; West W. H., 1961, TIMES, P13; WHITE AC, 1987, BRIT J PSYCHIAT, V150, P692, DOI 10.1192/bjp.150.5.692; Wilson R. N., 1961, LANCET, V278, P155; Woodyard J. E., 1980, OCCUPATIONAL MED, V30; WOODYARD JE, 1982, ANN ROY COLL SURG, V64, P191; WOODYARD JE, 1980, OCCUPATIONAL MED, V30, P57; Young A., 1997, HARMONY ILLUSIONS IN; Young Allan, 2015, CULTURE PTSD TRAUMA, P147; Young Allan, 2014, STRESS SHOCK ADAPTAT, P3; 1961, LANCET, V1, P1099	96	2	2	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0951-631X	1477-4666		SOC HIST MED	Soc. Hist. Med.	AUG	2019	32	3					565	585		10.1093/shm/hkx118			21	History; History & Philosophy Of Science	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	History; History & Philosophy of Science	JI2OE	WOS:000493302800007	31384101	Green Published, Green Submitted, hybrid			2022-02-06	
J	Schwulst, SJ; Islam, MR				Schwulst, Steven J.; Islam, Mecca R.			Murine Model of Controlled Cortical Impact for the Induction of Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 150; Traumatic brain injury; craniectomy; dura mater; controlled cortical impact; intraparenchymal hemorrhage; subarachnoid hemorrhage; subdural Hemorrhage; stereotaxic	SHORT-TERM; EPIDEMIOLOGY; MILD	The Centers for Disease Control and Injury Prevention estimate that almost 2 million people sustain a traumatic brain injury (TBI) every year in the United States. In fact, TBI is a contributing factor to over a third of all injury-related mortality. Nonetheless, the cellular and molecular mechanisms underlying the pathophysiology of TBI are poorly understood. Thus, preclinical models of TBI capable of replicating the injury mechanisms pertinent to TBI in human patients are a critical research need. The controlled cortical impact (CCI) model of TBI utilizes a mechanical device to directly impact the exposed cortex. While no model can full recapitulate the disparate injury patterns and heterogeneous nature of TBI in human patients, CCI is capable of inducing a wide range of clinically applicable TBI. Furthermore, CCI is easily standardized allowing investigators to compare results across experiments as well as across investigative groups. The following protocol is a detailed description of applying a severe CCI with a commercially available impacting device in a murine model of TBI.	[Schwulst, Steven J.; Islam, Mecca R.] Northwestern Univ, Dept Surg, Evanston, IL 60208 USA		Schwulst, SJ (corresponding author), Northwestern Univ, Dept Surg, Evanston, IL 60208 USA.	s-schwulst@northwestern.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM117341]; American College of Surgeons C. James Carrico Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM117341] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant GM117341 and The American College of Surgeons C. James Carrico Research Fellowship to S.J.S.`	Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faul M, 2010, TRAUMATIC BRAIN INJU; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Kramer S P, 1896, Ann Surg, V23, P163, DOI 10.1097/00000658-189601000-00031; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Ma X, 2019, MOL NEUROBIOLOGY; Makinde HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202722; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0	25	2	3	0	0	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	AUG	2019		150							e60027	10.3791/60027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IY7QI	WOS:000486589800110	31475969	Green Accepted			2022-02-06	
J	Takagi, M; Hearps, SJC; Babl, FE; Anderson, N; Bressan, S; Clarke, C; Davis, GA; Doyle, M; Dunne, K; Lanyon, C; Rausa, V; Thompson, E; Anderson, V				Takagi, Michael; Hearps, Stephen J. C.; Babl, Franz E.; Anderson, Nicholas; Bressan, Silvia; Clarke, Cathriona; Davis, Gavin A.; Doyle, Melissa; Dunne, Kevin; Lanyon, Chloe; Rausa, Vanessa; Thompson, Emma; Anderson, Vicki			Does a computerized neuropsychological test predict prolonged recovery in concussed children presenting to the ED?	CHILD NEUROPSYCHOLOGY			English	Article						Concussion; CNT; CogSport; concussion recovery; pediatrics	SPORT-RELATED CONCUSSION; TEST-RETEST RELIABILITY; TRAUMATIC BRAIN-INJURY; HEAD-TO-HEAD; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; EMERGENCY-DEPARTMENT; ONLINE VERSION; BASE-LINE; IMPACT	Computerized neuropsychological tests (CNTs) are widely used internationally in concussion management. Their prognostic value for predicting recovery post-concussion is poorly understood, particularly in pediatric populations. The aim of the present study was to examine whether cognitive functioning (measured by CogSport) has prognostic value for predicting rapid versus slow recovery. This is a prospective longitudinal observational cohort study conducted at a state-wide tertiary pediatric hospital. Data were collected at 1-4, 14, and 90 days post-injury. Eligible children were aged >= 5 and <18 years presenting to the Emergency Department having sustained a concussion within 48 h. Concussion was defined according to the Zurich/Berlin Consensus Statement on Concussion in Sport. Dependent variables were reaction times and error rates on the CogSport Brief Battery. In total, 220 cases were analyzed; 98 in a rapid recovery group (asymptomatic at 14 days post-injury, mean age 11.5 [3.2], 73.5% male) and 122 in a slow recovery group (symptomatic at 14 days post-injury, mean age 12.0 [3.1], 69.7% male). Longitudinal GEE analyses modeled the trajectories of both mean log(10)-transformed reaction time and error rates between groups over time (1-4, 14 and 90 days). Both group main and interaction (time by group) terms for all models were non-significant (p > .05). Cognitive functioning, measured by CogSport and assessed within 1-4 days of concussion, does not predict prolonged recovery in a pediatric sample. Further, there were no significant group differences at any time point. Considering the widespread use and promotion of CNTs, it is important that clinicians understand the significant limitations of the CogSport battery.	[Takagi, Michael; Hearps, Stephen J. C.; Babl, Franz E.; Anderson, Nicholas; Bressan, Silvia; Clarke, Cathriona; Davis, Gavin A.; Doyle, Melissa; Dunne, Kevin; Lanyon, Chloe; Rausa, Vanessa; Thompson, Emma; Anderson, Vicki] Murdoch Childrens Res Inst, Clin Sci, Brain & Mind Grp, Melbourne, Vic, Australia; [Takagi, Michael; Babl, Franz E.; Doyle, Melissa; Dunne, Kevin; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia		Babl, FE (corresponding author), Murdoch Childrens Res Inst, Emergency Med Res, Level 4 West,50 Flemington Rd, Parkville, Vic 3012, Australia.	franz.babl@rch.org.au	Hearps, Stephen/L-6853-2016	Hearps, Stephen/0000-0003-2984-1172; Visser, Melissa/0000-0002-5313-3347; Takagi, Michael/0000-0003-2903-7598	Royal Children's Hospital Research Foundation; Victorian Government Operational Infrastructure Scheme; Australian National Health and Medical Research Council (NHMRC) Development grantNational Health and Medical Research Council of Australia; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia; Melbourne Campus Clinician Scientist Fellowship; NHMRC Senior Practitioner FellowshipNational Health and Medical Research Council of Australia	This study was funded by the Royal Children's Hospital Research Foundation and the Victorian Government Operational Infrastructure Scheme. Hearps was funded by an Australian National Health and Medical Research Council (NHMRC) Development grant; Babl was funded by the Royal Children's Hospital Research Foundation, an NHMRC Practitioner Fellowship, and a Melbourne Campus Clinician Scientist Fellowship; and Anderson by an NHMRC Senior Practitioner Fellowship. The funding organizations did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Bangirana P, 2015, CHILD ADOL PSYCH MEN, V9, DOI 10.1186/s13034-015-0063-6; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Fratti S, 2017, CLIN NEUROPSYCHOL, V31, P569, DOI 10.1080/13854046.2016.1256435; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Hearps SJC, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2003; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckay CD, 2014, ARCH CLIN NEUROPSYCH, V29, P141, DOI 10.1093/arclin/act116; Nelson LD, 2017, J INT NEUROPSYCH SOC, V23, P293, DOI 10.1017/S1355617717000157; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Sicard V, 2019, CLIN J SPORT MED, V29, P62, DOI 10.1097/JSM.0000000000000492; StataCorp, 2017, STATA STAT SOFTWARE; Williams J, 2016, APPL NEUROPSYCH-CHIL, V5, P35, DOI 10.1080/21622965.2014.939271; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	39	2	2	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JAN 2	2020	26	1					54	68		10.1080/09297049.2019.1639653		AUG 2019	15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OM4UA	WOS:000479954800001	31364925				2022-02-06	
J	Vegliante, G; Tolomeo, D; Drieu, A; Rubio, M; Micotti, E; Moro, F; Vivien, D; Forloni, G; Ali, C; Zanier, ER				Vegliante, Gloria; Tolomeo, Daniele; Drieu, Antoine; Rubio, Marina; Micotti, Edoardo; Moro, Federico; Vivien, Denis; Forloni, Gianluigi; Ali, Carine; Zanier, Elisa R.			Longitudinal Molecular Magnetic Resonance Imaging of Endothelial Activation after Severe Traumatic Brain Injury	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; neuroimaging; neuroinflammation; endothelial activation	MOUSE MODEL; REVEALS; MRI; INFLAMMATION; DISEASE; IMPACT	Traumatic brain injury (TBI) is a major cause of death and disability. Despite progress in neurosurgery and critical care, patients still lack a form of neuroprotective treatment that can counteract or attenuate injury progression. Inflammation after TBI is a key modulator of injury progression and neurodegeneration, but its spatiotemporal dissemination is only partially known. In vivo approaches to study post-traumatic inflammation longitudinally are pivotal for monitoring injury progression/recovery and the effectiveness of therapeutic approaches. Here, we provide a minimally invasive, highly sensitive in vivo molecular magnetic resonance imaging (MRI) characterization of endothelial activation associated to neuroinflammatory response after severe TBI in mice, using microparticles of iron oxide targeting P-selectin (MPIOs-alpha-P-selectin). Strong endothelial activation was detected from 24 h in perilesional regions, including the cortex and hippocampus, and peaked in intensity and diffusion at two days, then partially decreased but persisted up to seven days and was back to baseline 15 days after injury. There was a close correspondence between MPIOs-alpha-P-selectin signal voids and the P-selectin stained area, confirming maximal endothelial activation at two days. Molecular MRI markers of inflammation may thus represent a useful tool to evaluate in vivo endothelial activation in TBI and monitoring the responses to therapeutic agents targeting vascular activation and permeability.	[Vegliante, Gloria; Tolomeo, Daniele; Micotti, Edoardo; Moro, Federico; Forloni, Gianluigi; Zanier, Elisa R.] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, I-20156 Milan, Italy; [Drieu, Antoine; Rubio, Marina; Vivien, Denis; Ali, Carine] Normandie Univ, INSERM, INSERM UMR S U1237,Physiopathol & Imaging Neurol, UNICAEN,Inst Blood & Brain Caen Normandie,GIP Cyc, F-14000 Caen, France; [Vivien, Denis] Caen Normandie Univ Hosp, Dept Clin Res, F-14000 Caen, France		Zanier, ER (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, I-20156 Milan, Italy.	elisa.zanier@marionegri.it	Vegliante, Gloria/ABF-9054-2021; moro, federico/K-5644-2016; Moro, Federico/AAG-1731-2021; Micotti, Edoardo/J-9359-2018; Forloni, Gianluigi/AAB-2115-2020; Zanier, Elisa/AAA-8095-2020	Vegliante, Gloria/0000-0002-7563-0889; moro, federico/0000-0002-2682-5583; Moro, Federico/0000-0002-2682-5583; Micotti, Edoardo/0000-0002-5995-2992; Forloni, Gianluigi/0000-0001-5374-3914; Zanier, Elisa/0000-0002-3011-8718; VIVIEN, DENIS/0000-0002-7636-2185; Drieu, Antoine/0000-0001-6237-4719; Tolomeo, Daniele/0000-0002-5219-6397; Ali, Carine/0000-0001-8007-7910	Ministero della Salute (Italy)Ministry of Health, Italy	The study was partially supported by the Ministero della Salute (Italy) within the framework of ERA-NET NEURON.	Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chakraborty S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0625-x; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Fournier AP, 2017, P NATL ACAD SCI USA, V114, P6116, DOI 10.1073/pnas.1619424114; Gauberti M, 2018, THERANOSTICS, V8, P1195, DOI 10.7150/thno.22662; Gauberti M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00389; Gauberti M, 2013, STROKE, V44, P1988, DOI 10.1161/STROKEAHA.111.000544; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lee Bruce, 2005, NeuroRx, V2, P372; Lutton EM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00582; Martin GE, 2018, SHOCK, V50, P551, DOI 10.1097/SHK.0000000000001056; McAteer MA, 2007, NAT MED, V13, P1253, DOI 10.1038/nm1631; Meeker RB, 2012, CELL ADHES MIGR, V6, P390, DOI 10.4161/cam.21054; Merten M, 2000, CIRCULATION, V102, P1931, DOI 10.1161/01.CIR.102.16.1931; Monai H, 2019, P NATL ACAD SCI USA, V116, P11010, DOI 10.1073/pnas.1817347116; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Puntambekar SS, 2018, BRAIN BEHAV IMMUN, V71, P9, DOI 10.1016/j.bbi.2018.03.033; Quenault A, 2017, BRAIN, V140, P146, DOI 10.1093/brain/aww260; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rossi B, 2011, J LEUKOCYTE BIOL, V89, P539, DOI 10.1189/jlb.0710432; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serres S, 2012, P NATL ACAD SCI USA, V109, P6674, DOI 10.1073/pnas.1117412109; Serres S, 2011, FASEB J, V25, P4415, DOI 10.1096/fj.11-183772; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Wang MH, 2012, J NEUROSCI, V32, P17948, DOI 10.1523/JNEUROSCI.1860-12.2012; Yarjanli Z, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0369-9; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	36	2	2	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	AUG	2019	8	8							1134	10.3390/jcm8081134			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IU7AV	WOS:000483737700011	31366109	gold, Green Published, Green Submitted			2022-02-06	
J	Woo, PYM; Ng, BCF; Xiao, JX; Wong, D; Seto, A; Lam, S; Yim, C; Lo, HY; Po, YC; Wong, LYW; Lee, MWY; Yam, KY; Pu, JKS; Chan, KY; Poon, WS				Woo, Peter Y. M.; Ng, Ben C. F.; Xiao, Jacob X.; Wong, Daniel; Seto, Andrew; Lam, Sandy; Yim, Carmen; Lo, Hong-Yip; Po, Yin-Chung; Wong, Larry Y. W.; Lee, Michael W. Y.; Yam, Kwong-Yui; Pu, Jenny K. S.; Chan, Kwong-Yau; Poon, Wai-Sang			The importance of aspirin, catheterization accuracy, and catheter design in external ventricular drainage-related hemorrhage: a multicenter study of 1002 procedures	ACTA NEUROCHIRURGICA			English	Article						External ventricular drainage; Ventricular catheter; Hemorrhage; Tract hematoma	RISK-FACTORS; INTRACEREBRAL HEMORRHAGE; PLACEMENT; COMPLICATIONS; INSERTION; GUIDE; RATES	BackgroundExternal ventricular drainage (EVD) is the commonest neurosurgical procedure performed in daily neurosurgical practice, but relatively few studies have investigated the incidence and risk factors of its related hemorrhagic complications.MethodsThis was a multicenter retrospective review of consecutive EVD procedures. Patients 18years or older who underwent EVD and had aroutine postoperative computed tomography (CT) scan performed within 24hours were included. EVD-related hemorrhage was defined as new intracranial hemorrhage immediately adjacent or within the ventricular catheter trajectory. The volume of hemorrhage and the position of the catheter tip were assessed. A review of patient-, disease-, and surgery-related factors including the ventricular catheter design utilized was conducted. The Bonferroni correction was applied to the alpha level of significance (0.05) for multivariable analysis.ResultsNine hundred sixty-two patients underwent 1002 EVD performed by neurosurgeons in the operating theater. Sixteen percent (154) of patients were on aspirin before the procedure. Thirty-four percent (333) of patients had intracerebral hemorrhage, 25% (251) had aneurysmal subarachnoid hemorrhage and 16% (158) had traumatic brain injury. The mean duration from EVD to the first postoperative CT scan was 204h. EVD-related hematomas were detected after 81 procedures with a per-catheter risk of 8.1%. Mean hematoma volume was 1.2 +/- 3.3ml. Most were less than 1ml (grade I, 79%, 64), 1 to 15ml (grade II) in 20% (16) and a single clot larger than 15ml (grade III, 1%) were detected. Clinically significant hemorrhage that resulted in catheter occlusion occurred in 1.7% (17) of procedures. Most catheters (62%, 625) were optimally placed, i.e., its tip being within the ipsilateral frontal horn or third ventricle. Three non-antibiotic-impregnatedventricular catheter designs were used with 55% (550) being the 2.2-mm Integra (TM) catheter, 14% (137) being the 2.8-mm Medtronic (TM) catheter, and 31% (315) being the 3.1-mm Codman (TM) catheter. Independent significant predictors for EVD-related hemorrhage were the preoperative prescription of aspirin (adjusted OR 1.94; 95% CI 1.10-3.44), catheter malposition (aOR 1.99; 95% CI 1.22-3.23), and use of the 2.8-mm Medtronic (TM) catheter (aOR 4.22; 95% CI 2.39-7.41).Conclusions The per-catheter risk of hemorrhage was 8.1%, but the incidence of symptomatic hemorrhage was low. The only patient risk factor was aspirin intake. This is the first study to evaluate and establish an association between catheter malposition and catheter design with EVD-related hemorrhage.	[Woo, Peter Y. M.; Xiao, Jacob X.; Wong, Daniel; Seto, Andrew; Lam, Sandy; Yim, Carmen; Lo, Hong-Yip; Chan, Kwong-Yau] Kwong Wah Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Ng, Ben C. F.; Wong, Larry Y. W.] Queen Elizabeth Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Po, Yin-Chung] Princess Margaret Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Lee, Michael W. Y.] Pamela Youde Nethersole Eastern Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Yam, Kwong-Yui] Tuen Mun Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Pu, Jenny K. S.] Queen Mary Hosp, Div Neurosurg, Dept Surg, Hong Kong, Peoples R China; [Poon, Wai-Sang] Prince Wales Hosp, Div Neurosurg, Dept Surg, Hong Kong, Peoples R China		Woo, PYM (corresponding author), Kwong Wah Hosp, Dept Neurosurg, Hong Kong, Peoples R China.	wym307@ha.org.hk	Poon, Wai Sang/F-1558-2011	Wong, Daniel W.Y./0000-0002-8316-8575; Woo, Peter Yat Ming/0000-0002-7345-7904			Bauer DF, 2011, NEUROSURGERY, V69, P255, DOI 10.1227/NEU.0b013e31821a45ba; Bauer DF, 2011, J TRAUMA, V70, P1112, DOI 10.1097/TA.0b013e3181e7c2ae; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; 허준, 2011, Journal of Cerebrovascular and Endovascular Neurosurgery, V13, P256; Foreman PM, 2015, CLIN NEUROL NEUROSUR, V128, P94, DOI 10.1016/j.clineuro.2014.09.026; Galarza M, 2015, CHILD NERV SYST, V31, P37, DOI 10.1007/s00381-014-2477-5; GHAJAR JBG, 1985, J NEUROSURG, V63, P985, DOI 10.3171/jns.1985.63.6.0985; Hudson JS, 2019, NEUROSURGERY, V84, P479, DOI 10.1093/neuros/nyy127; Huyette DR, 2008, J NEUROSURG, V108, P88, DOI 10.3171/JNS/2008/108/01/0088; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Ko JK, 2014, NEUROL MED-CHIR, V54, P545, DOI 10.2176/nmc.oa.2013-0178; Kung DK, 2011, J NEUROSURG, V114, P1021, DOI 10.3171/2010.9.JNS10445; Lin J, 2003, J NEUROSURG, V99, P426, DOI 10.3171/jns.2003.99.2.0426; Majmundar N, 2019, WORLD NEUROSURG, V122, pE961, DOI 10.1016/j.wneu.2018.10.181; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; Miller C, 2017, J NEUROSURG, V126, P289, DOI 10.3171/2015.12.JNS152341; Nesvick CL, 2015, NEUROSURGERY, V77, P321, DOI 10.1227/NEU.0000000000000849; O'Leary ST, 2000, J NEUROSURG, V92, P801, DOI 10.3171/jns.2000.92.5.0801; O'Neill BR, 2008, SURG NEUROL, V70, P268, DOI 10.1016/j.surneu.2007.05.007; Park J, 2016, J NEUROSURG, V124, P1429, DOI 10.3171/2015.5.JNS15226; Patil V, 2013, ACTA NEUROCHIR, V155, P1773, DOI 10.1007/s00701-013-1769-y; Phillips SB, 2014, WORLD NEUROSURG, V82, P739, DOI 10.1016/j.wneu.2013.08.030; Rosenbaum BP, 2014, J CLIN NEUROSCI, V21, P623, DOI 10.1016/j.jocn.2013.09.001; Rowe AS, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1030-7; Saladino A, 2009, NEUROCRIT CARE, V10, P248, DOI 10.1007/s12028-008-9154-z; Srinivasan VM, 2014, J NEUROSURG, V120, P228, DOI 10.3171/2013.6.JNS121577; Sussman ES, 2014, J NEUROSURG, V120, P931, DOI 10.3171/2013.12.JNS131685; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Thomale UW, 2010, CHILD NERV SYST, V26, P781, DOI 10.1007/s00381-009-1055-8; Toma AK, 2009, NEUROSURGERY, V65, P1197, DOI 10.1227/01.NEU.0000356973.39913.0B; Webb AJS, 2015, STROKE, V46, P2470, DOI 10.1161/STROKEAHA.114.007343; Weisenberg SH, 2016, J NEUROSURG, V125, P1504, DOI 10.3171/2015.12.JNS151181; Wiesmann M, 2001, J CLIN NEUROSCI, V8, P126, DOI 10.1054/jocn.2000.0749; Woo PYM, 2017, J CLIN NEUROSCI, V45, P67, DOI 10.1016/j.jocn.2017.05.042; Yuen J, 2018, ANN ROY COLL SURG, V100, P221, DOI 10.1308/rcsann.2017.0221; Zhu X, 2017, J NEUROSURG SCI, V61, P53	37	2	3	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	AUG	2019	161	8					1623	1632		10.1007/s00701-019-03978-2			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IJ1WE	WOS:000475688800018	31222516				2022-02-06	
J	Zasler, ND; Bender, SD				Zasler, Nathan D.; Bender, Scoft D.			Validity Assessment in Traumatic Brain Injury Impairment and Disability Evaluations	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Validity; Response bias; Malingering; Physical examination; Cognition; Behavior; Forensic	RESPONSE BIAS; HEAD-INJURY; SYMPTOMS; PERFORMANCE; COMPENSATION; DISORDERS	This article provides an overview of validity assessment in persons with traumatic brain injury including evaluation caveats. Specific discussion is provided on post-concussive disorders, malingering, examination techniques to assess for validity, response bias, effort and non-organic/ functional presentations. Examinee and examiner biases issues will also be explored. Discussion is also provided regarding judicial trends in limiting examiner scope of testing and/or testimony, and risk of liability when providing expert witness opinions on validity of examinee presentations. The hope is to encourage physiatrists to become more aware and skilled in validity assessment given its importance in differential diagnosis of impairment following traumatic brain injury.	[Zasler, Nathan D.] Tree Life Serv Inc, Concuss Care Ctr Virginia Ltd, 3721 Westerre Pkwy,Suite B, Richmond, VA 23233 USA; [Zasler, Nathan D.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Zasler, Nathan D.] Int Brain Injury Assoc, Alexandria, VA USA; [Bender, Scoft D.] Univ Virginia, Inst Law Psychiat & Publ Policy, Dept Psychiat & Neurobehav Sci, 1230 Cedars Court,Suite 108, Charlottesville, VA 22903 USA		Zasler, ND (corresponding author), Tree Life Serv Inc, Concuss Care Ctr Virginia Ltd, 3721 Westerre Pkwy,Suite B, Richmond, VA 23233 USA.	nzasler@cccv-ltd.com					American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Aronoff Gerald M, 2007, Pain Pract, V7, P178, DOI 10.1111/j.1533-2500.2007.00126.x; Aronoff GM, 2002, CURR PAIN HEADACHE R, V7, P105; Bass C, 2014, LANCET, V383, P1422, DOI 10.1016/S0140-6736(13)62186-8; Bender SD, 2013, PSYCHOL INJ LAW, V6, P113, DOI 10.1007/s12207-013-9156-9; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Carone D.A., 2013, MILD TRAUMATIC BRAIN; Creager RT, 2002, J VIRGINIA TRIAL LAW, P24; Daum C, 2014, J NEUROL NEUROSUR PS, V85, P180, DOI 10.1136/jnnp-2012-304607; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Drob SL, 2009, J AM ACAD PSYCHIATRY, V37, P98; Feinstein Anthony, 2018, Continuum (Minneap Minn), V24, P861, DOI 10.1212/CON.0000000000000601; Fink JW, 2017, APA HDB FORENSIC NEU, P41; Granacher Jr R.P., 2015, TRAUMATIC BRAIN INJU; Greer S, 2005, J FAM PRACTICE, V54, P719; Greve KW, 2013, CLIN NEUROPSYCHOL, V27, P108, DOI 10.1080/13854046.2012.739646; Gunstad J, 2011, J INT NEUROPSYCH SOC, V7, P323; Hall RCW, 2012, J AM ACAD PSYCHIATRY, V40, P390; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hirsch AR, 2018, NEUROLOGICAL MALINGE; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2008, NEUROPSYCHOLOGY COUR, P243; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Kaufmann PM, 2013, BEHAV SCI LAW, V31, P739, DOI 10.1002/bsl.2085; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P2; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; Lockhart J., 2015, ARCH FOREN PSYCH, V1, P78; Lockhart Joseph, 2015, Neurol Clin Pract, V5, P17, DOI 10.1212/CPJ.0000000000000092; Martelli MF, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1415; McDermott BE, 2007, PSYCHIAT CLIN N AM, V30, P645, DOI 10.1016/j.psc.2007.07.007; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Merten T, 2013, PSYCHOL INJ LAW, V6, P122, DOI 10.1007/s12207-013-9155-x; Niesten IJM, 2015, INT J LAW PSYCHIAT, V41, P34, DOI 10.1016/j.ijlp.2015.03.005; Pierchowski LD, 2015, INT J LAW PSYCHIAT, V42, P75; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rogers R., 2013, HDB PSYCHOL FORENSIC, V11, P517; Rogers R, 2011, J PSYCHOPATHOL BEHAV, V33, P355, DOI 10.1007/s10862-011-9222-0; Ruchinskas R, 2002, PHYS MED REHABILITAT, P113; Sbordone RJ, 2000, ARCH CLIN NEUROPSYCH, V15, P465; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silverberg ND, 2016, J HEAD TRAUMA REHAB, V31, P388, DOI 10.1097/HTR.0000000000000198; Vanderploeg RD, 2014, PSYCHOL INJ LAW, V7, P245, DOI 10.1007/s12207-014-9201-3; Weiss Kenneth J, 2017, J Am Acad Psychiatry Law, V45, P339; Whiteside DM, 2015, CLIN NEUROPSYCHOL, V29, P788, DOI 10.1080/13854046.2015.1093660; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021; Zasler ND, 2017, PHYS MED REH CLIN N, V28, P379, DOI 10.1016/j.pmr.2016.12.012; Zasler ND, 2015, NEUROREHABILITATION, V36, P401, DOI 10.3233/NRE-151229; Zasler ND, 2002, APPENDIX FUNCTIONAL, V16, P167	52	2	2	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	AUG	2019	30	3					621	+		10.1016/j.pmr.2019.03.009			17	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	IM0NU	WOS:000477686300014	31227137				2022-02-06	
J	Constantinidou, F				Constantinidou, Fofi			Effects of Systematic Categorization Training on Cognitive Performance in Healthy Older Adults and in Adults with Traumatic Brain Injury	BEHAVIOURAL NEUROLOGY			English	Article							CATEGORY; REHABILITATION; KNOWLEDGE; OBJECTS; TRIAL; STATE; LESS	This study investigated the effects of hierarchical cognitive training using the categorization program (CP), designed initially for adults with cognitive deficits associated with traumatic brain injury (TBI). Fifty-eight participants were included: a group of fifteen young adults with TBI (ages 18-48), another group of fifteen noninjured young adults (ages 18-50), and two groups of adults over 60 randomly assigned into the experimental group (n=14) or the control group (n=14). Following neuropsychological testing, the two young adult groups and the experimental older adult group received the CP training for 10-12 weeks. The CP training consisted of 8 levels targeting concept formation, object categorization, and decision-making abilities. Two CP tests (administered before and after the training) and three probe tasks (administered at specified intervals during the training) assessed skills relating to categorization. All treated groups showed significant improvement in their categorization performance, although younger participants (with or without TBI) demonstrated greater gains. Gains on the categorization measures were maintained by a subgroup of older adults up to four months posttraining. Implications of these findings in terms of adult cognitive learning and directions for future research on adult cognitive rehabilitation and cognitive stimulation programs are discussed.	[Constantinidou, Fofi] Univ Cyprus, Dept Psychol, Nicosia, Cyprus; [Constantinidou, Fofi] Univ Cyprus, Ctr Appl Neurosci, Nicosia, Cyprus		Constantinidou, F (corresponding author), Univ Cyprus, Dept Psychol, Nicosia, Cyprus.; Constantinidou, F (corresponding author), Univ Cyprus, Ctr Appl Neurosci, Nicosia, Cyprus.	fofic@ucy.ac.cy		Messinis, Lambros/0000-0002-3216-9025; Constantinidou, Fofi/0000-0002-7928-8363	Bakersfield, CA; (NeuroRestorative), Carbondale, IL; Committee on Faculty Research at Miami University; University of Cyprus	Special thanks are due to the study volunteers, to the clinical site collaborators at the Center for Neuro Skills (CNS), Bakersfield, CA; Center for Neuro Skills, Dallas, Texas; and Center for Comprehensive Services (CCS, NeuroRestorative), Carbondale, IL, and to the members of the NeuroCognitive Disorders Laboratory at Miami University for their contributions, especially Abigail Migut, Lacy Robinson, and Jessica Schneider. This research was supported in part by a grant from the Committee on Faculty Research at Miami University, Oxford, Ohio, where Constantinidou was Professor of Speech Pathology and Audiology. The statistical analyses, preparation, writing, and editing of this manuscript was supported by the author's current employer, the University of Cyprus, Nicosia, Cyprus.	Ackerman PL, 2010, PSYCHOL AGING, V25, P753, DOI 10.1037/a0019277; ADAMOVICH BB, 1985, COGNITIVE REHABILITA; Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; American Psychiatric Association, 1994, DSM 4 DIAGN STAT MAN, V4th; Ashby F Gregory, 2004, Behav Cogn Neurosci Rev, V3, P101, DOI 10.1177/1534582304270782; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Ashby FG, 2000, CURR DIR PSYCHOL SCI, V9, P10, DOI 10.1111/1467-8721.00049; Ashby FG, 2003, NEUROPSYCHOLOGY, V17, P115, DOI 10.1037/0894-4105.17.1.115; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benton A., 1978, MULTILINGUAL APHASIA; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Brickman AM, 2011, NEUROBIOL AGING, V32, P1588, DOI 10.1016/j.neurobiolaging.2009.10.013; Cahn DA, 1998, ARCH CLIN NEUROPSYCH, V13, P575, DOI 10.1016/S0887-6177(98)00024-9; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Constantinidou F, 2004, BRAIN LANG, V89, P216, DOI 10.1016/S0093-934X(03)00399-7; Constantinidou F, 2002, BRAIN LANG, V82, P296, DOI 10.1016/S0093-934X(02)00018-4; Constantinidou F., 2008, J INT NEUROPSYCH SOC, V14, P76; Constantinidou F., 2006, THIS IS COPYRIGHT PR; Constantinidou F., 2017, TRAUMATICBRAIN INJUR, V4th, P513; Constantinidou F., 2004, TRAUMATIC BRAIN INJU, P337; Constantinidou F., 2008, PSYCHOLOGIA, V15, P342, DOI [10.12681/psy_hps.23842, DOI 10.12681/PSY_HPS.23842]; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; Constantinidou F, 2014, J INT NEUROPSYCH SOC, V20, P822, DOI 10.1017/S1355617714000678; Constantinidou F, 2010, TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION, P549, DOI 10.1201/9781439849828-c18; Cree GS, 2003, J EXP PSYCHOL GEN, V132, P163, DOI 10.1037/0096-3445.132.2.163; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; De Filippis N. A., 1998, BOOKLET CATEGORY TES; DeCaro MS, 2008, COGNITION, V107, P284, DOI 10.1016/j.cognition.2007.07.001; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dutton F., 1999, ISHIHARA TEST COLOR; Duvvuri R., 1995, ED WORD FREQUENCY GU; Erickson MA, 2008, MEM COGNITION, V36, P749, DOI 10.3758/MC.36.4.749; Folstein M.F., 2001, MINIMENTAL STATE EXA; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENTILINI M, 1989, MILD HEAD INJURY, P163; Giogkaraki E, 2013, J CLIN EXP NEUROPSYC, V35, P1024, DOI 10.1080/13803395.2013.847906; Goodglass H., 2000, BOSTON DIAGNOSTIC AP; Grant D.A., 1981, WISCONSIN CARD SORTI; Hagen C., 1972, REHABILITATION HEAD; Humphreys GW, 1999, PSYCHOL RES-PSYCH FO, V62, P118, DOI 10.1007/s004260050046; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P453, DOI 10.1017/S0140525X01004150; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Karbach J, 2014, PSYCHOL SCI, V25, P2027, DOI 10.1177/0956797614548725; Kaszniak A. W., 1986, HDB CLIN MEMORY ASSE, P168, DOI 10.1037/10057-014; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Konstantinou N, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01163; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; Levin H. S., 1979, GALVESTON ORIENTATIO; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Li SC, 2008, PSYCHOL AGING, V23, P731, DOI 10.1037/a0014343; Luria AR, 1963, RESTORATION FUNCTION; Maddox WT, 2008, COGNITION, V108, P578, DOI 10.1016/j.cognition.2008.03.010; Maddox WT, 2004, BEHAV PROCESS, V66, P309, DOI 10.1016/j.beproc.2004.03.011; Maddox WT, 2001, J INT NEUROPSYCH SOC, V7, P710, DOI 10.1017/S1355617701766076; Myers, 1995, REY COMPLEX FIGURE T; Nosofsky R. M., 1992, MULTIDIMENSIONAL MOD, P363; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pettemeridou E., 2018, ARCH PHYS MED REHAB, V99, DOI [10.1016/j.apmr.2018.07.136, DOI 10.1016/J.APMR.2018.07.136]; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Smith, 1973, SYMBOL DIGIT MODALIT; Task Force on Promotion and Dissemination of Psychological Procedures, 1995, CLIN PSYCHOL, V48, P13; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1999, WECHSLER MEMORY SCAL; Woodcock R. W., 2001, WOODCOCK JOHNSON TES, V3rd	70	2	2	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.	JUL 29	2019	2019								9785319	10.1155/2019/9785319			17	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IY5OD	WOS:000486440600001	31534559	Green Submitted, gold, Green Published			2022-02-06	
J	Albrecht, JS; Al Kibria, GM; Greene, CR; Dischinger, P; Ryb, GE				Albrecht, Jennifer S.; Al Kibria, Gulam Muhammed; Greene, Christina R.; Dischinger, Patricia; Ryb, Gabriel E.			Post-Discharge Mortality of Older Adults with Traumatic Brain Injury or Other Trauma	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						traumatic brain injury; older adults; traumatic injury; mortality	LONG-TERM SURVIVAL; RISK; REHABILITATION; DEMENTIA; AGE	OBJECTIVES Prior studies of mortality following traumatic brain injury (TBI) have not focused specifically on older adults compared with a non-TBI trauma cohort or included specific causes of death. The objectives of this study were, among adults aged 65 years and older, to (1) generate standardized mortality ratios (SMRs) by cause of death for TBI and a non-TBI trauma cohort compared with a general population, and (2) assess risk of mortality associated with TBI compared with a non-TBI trauma cohort. DESIGN Retrospective cohort study of adults aged 65 years and older who were treated at an urban trauma center from 1997 to 2008. MEASUREMENTS Data from the trauma registry were linked to the National Death Index through 2008 to obtain date and cause of death. We identified individuals with TBI and non-TBI trauma and calculated age- and sex-adjusted SMRs by comparing with the state general population. We next compared time to mortality between individuals with TBI (n = 852) and non-TBI trauma (n = 1050), adjusting for potential confounders. RESULTS Compared with the age- and sex-adjusted state general population, older adults with TBI (SMR = 8.1; 95% confidence interval [CI] = 7.4-9.0) and non-TBI trauma (SMR = 6.7; 95% CI = 6.1-7.4) were at a greatly increased risk of mortality. Highest SMRs in both cohorts were observed for accidents. In adjusted Cox regression models, TBI was not associated with increased risk of all-cause mortality (hazard ratio = 1.03; 95% CI = .87-1.23) compared with non-TBI trauma. CONCLUSION This study provides evidence that, over a 4-year follow-up of older adults, any moderate to severe injury is associated with increased mortality risk. Specifically, older injured adults are at high risk of death from accidental and therefore preventable causes, suggesting that intervention could reduce mortality.	[Albrecht, Jennifer S.; Al Kibria, Gulam Muhammed; Greene, Christina R.; Dischinger, Patricia; Ryb, Gabriel E.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 South Pine St, Baltimore, MD 21201 USA; [Ryb, Gabriel E.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Ryb, Gabriel E.] Univ Maryland, Prince Georges Hosp, Med Ctr, Trauma Serv, Cheverly, MD USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 South Pine St, Baltimore, MD 21201 USA.	jalbrecht@som.umaryland.edu	Kibria, Gulam Muhammed Al/E-3061-2017	Kibria, Gulam Muhammed Al/0000-0002-7037-6658; Albrecht, Jennifer/0000-0003-4838-2274	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [1K01HS024560]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER	Jennifer Albrecht was supported by Agency for Healthcare Research and Quality grant 1K01HS024560. The authors have declared no conflicts of interest for this article.	Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Albrecht JS, 2015, J HEAD TRAUMA REHAB, V30, pE62, DOI 10.1097/HTR.0000000000000035; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Centers for Disease Control and Prevention, UND CAUS DEATH 1999; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Deb S, 1999, AM J PSYCHIAT, V156, P374; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Maryland Institute for Emergency Medical Services Systems, 2017, 2016 2017 ANN REP; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Rating the severity of tissue damage. I, 1971, JAMA-J AM MED ASSOC, V215, P277; Rothman K.J., 2008, Modern epidemiology, V3rd; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Strong BL, 2017, ANN SURG, V265, P847, DOI 10.1097/SLA.0000000000001823; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	29	2	2	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	NOV	2019	67	11					2382	2386		10.1111/jgs.16098		JUL 2019	5	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	JN2UF	WOS:000479574600001	31343731	Green Accepted			2022-02-06	
J	Gami, A; Singman, EL				Gami, Abhishek; Singman, Eric L.			Underlying Ehlers-Danlos syndrome discovered during neuro-ophthalmic evaluation of concussion patients: a case series	BMC OPHTHALMOLOGY			English	Article						Concussion; Ehlers-Danlos syndrome; Rehabilitation; Convergence insufficiency; Traumatic brain injury	MANIFESTATIONS	BackgroundThe Ehlers-Danlos syndromes are a heterogenous group of diseases that cause connective tissue defects. At present, there are no published reports focusing upon the neuro-ophthalmic symptoms that might occur in EDS patients after mild traumatic brain injury. The demographics and clinical course of seven patients with subclinical EDS and mild traumatic brain injury are presented.Case presentationThis series describes patients with Ehlers Danlos Syndrome whose diagnosis was discovered in a neuro-ophthalmic clinic for brain injury. Patient demographics and neuro-ophthalmological symptoms are presented.ConclusionsPatients with subclinical EDS and brain injury may experience a slower, less complete recovery course. Heightened awareness of undiagnosed or underlying Ehlers Danlos Syndrome is important for patients and providers.	[Gami, Abhishek] Johns Hopkins Sch Med, Baltimore, MD USA; [Singman, Eric L.] Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21287 USA		Singman, EL (corresponding author), Johns Hopkins Univ Hosp, Wilmer Eye Inst, Baltimore, MD 21287 USA.	esingma1@jhmi.edu					Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Castori M, 2015, AM J MED GENET C, V169, P84, DOI 10.1002/ajmg.c.31426; Hamonet C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0428-9; Henderson FC, 2017, AM J MED GENET C, V175, P195, DOI 10.1002/ajmg.c.31549; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Singman E, 2019, NEUROSENSORY DISORDERS IN MILD TRAUMATIC BRAIN INJURY, P223, DOI 10.1016/B978-0-12-812344-7.00015-7; Stanitski DF, 2000, CLIN ORTHOP RELAT R, P213; Wallman D, 2014, J NEUROL SCI, V340, P99, DOI 10.1016/j.jns.2014.03.002; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wood TA, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00053	11	2	2	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2415			BMC OPHTHALMOL	BMC Ophthalmol.	JUL 25	2019	19								159	10.1186/s12886-019-1174-2			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	IL9MD	WOS:000477607900001	31345188	Green Published, gold			2022-02-06	
J	Simpson, B; Shepard, S; Kitagawa, R				Simpson, Brett; Shepard, Scott; Kitagawa, Ryan			Golf cart associated traumatic brain injury	BRAIN INJURY			English	Article						Golf cart; sports injury; traumatic brain injury		Object: Although contact sport-related head injuries are frequently reported, golf cart accidents may have significant consequences including severe traumatic brain injury (TBI) or head injury. As no standardized regulations exist, this mechanism may be underreported. Methods: A retrospective review of TBI or cranial trauma after a golf cart accident at a level I trauma center over 5 years were performed. Data regarding age, sex, race, initial Glasgow Coma Scale score, alcohol status, type and location of the injury, and outcomes were analyzed and reported in terms of Modified Rankin Scale (MRS). Results: A total of 23 patients with TBI or cranial trauma following golf cart accident were identified. The mean age was 36 years old with the most common injury being skull fracture followed by acute subdural hematoma. Most patients had good outcomes, MRS 0-3, at discharge, but like most forms of TBI, surgical interventions, intracranial pressure monitoring, post-traumatic seizures, hydrocephalus, and death did occur. Conclusions: Head injuries sustained by golf cart accidents are not insignificant and may be underreported. More awareness of these injuries and safety guidelines are needed.	[Simpson, Brett; Kitagawa, Ryan] Univ Texas Hlth Sci Ctr Houston, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA; [Shepard, Scott] Lewis Katz Scholl Med, Dept Neurosurg, Philidelphia, PA USA		Simpson, B (corresponding author), Univ Texas Hlth Sci Ctr Houston, Med Sch, Vivian L Smith Dept Neurosurg, 6400 Fannin 2800, Houston, TX 77030 USA.	Brett.M.Simpson@uth.tmc.edu	liu, ting/AAA-1112-2022	Simpson, Brett/0000-0003-0156-8178			Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Kelly EG, 1996, ORTHOPEDICS, V19, P519; McGwin G, 2008, J TRAUMA, V64, P1562, DOI 10.1097/TA.0b013e3181238d39; Miller BL, 2011, OTOLARYNG HEAD NECK, V144, P883, DOI 10.1177/0194599810396790; Passaro KT, 1996, PREY, V2, P124, DOI DOI 10.1136/IP.2.2.124; Rahimi SY, 2005, J NEUROSURG, V102, P163, DOI 10.3171/jns.2005.102.2.0163; Seluga KJ, 2006, ACCIDENT ANAL PREV, V38, P1151, DOI 10.1016/j.aap.2006.04.023; SMITH RA, 1991, BRIT MED J, V302, P1505, DOI 10.1136/bmj.302.6791.1505; Tung M. Y. Y., 2000, SMJ Singapore Medical Journal, V41, P504; Watson DS, 2008, AM J PREV MED, V35, P55, DOI 10.1016/j.amepre.2008.03.029	10	2	2	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2019	33	11					1476	1478		10.1080/02699052.2019.1642516		JUL 2019	3	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IP7SR	WOS:000478501400001	31335210				2022-02-06	
J	Tsushima, WT; Yamamoto, MH; Ahn, HJ; Siu, AM; Choi, SY; Murata, NM				Tsushima, William T.; Yamamoto, Marcus H.; Ahn, Hyeong Jun; Siu, Andrea M.; Choi, So Yung; Murata, Nathan M.			Invalid Baseline Testing with ImPACT: Does Sandbagging Occur with High School Athletes?	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Invalid baseline; ImPACT; sandbagging	IMMEDIATE POST-CONCUSSION; TEST-RETEST RELIABILITY; TEST-PERFORMANCE; ONLINE VERSION; BRAIN INJURY; SPORTS; UTILITY; PREVALENCE; VALIDITY; SPECIFICITY	The aim of this large-scale research was to determine the frequency of valid, invalid, and sandbagging results in ImPACT baseline testing of high school athletes. This retrospective study identified valid, invalid (identified by five embedded Invalidity Indicators), and sandbagging (identified by three "red flags") results in the ImPACT baseline test scores of 6,346 high school athletes. In addition, the ImPACT postconcussion scores of 266 athletes who sustained a concussion during the school year were evaluated to compare the baseline-to-postconcussion changes of valid versus a combined group of invalid and sandbagging scorers. There were 3,299 (51.99%) athletes who had valid baseline scores, 269 (4.24%) had invalid scores, and 3,009 (47.42%) had sandbagging scores. (There were 231 who obtained both invalidity and sandbagging scores.) The overall difference in baseline-to-postconcussion changes between the valid scorers and the combined group of invalid and sandbagging scorers was statistically significant. The high rate of athletes who had invalid and sandbagging scores raised concern that the underperformance of baseline testing occurs more commonly than is probably realized by those who utilize computerized neuropsychological testing with high school athletes. Accordingly, efforts are needed to improve test administration procedures so that maximal attention and effort can be maintained among the test takers. In the meantime, increased caution is called for in employing the baseline-to-postconcussion paradigm when return-to-play decisions are made.	[Tsushima, William T.] Straub Med Ctr, Psychiat & Psychol Dept, 888 South King St, Honolulu, HI 96813 USA; [Yamamoto, Marcus H.] Creighton Univ, Dept Biol, Omaha, NE 68178 USA; [Ahn, Hyeong Jun] Univ Hawaii, John A Burns Sch Med, Off Biostat & Quantitat Hlth Sci, Honolulu, HI 96822 USA; [Siu, Andrea M.] Hawaii Pacific Hlth, Res Inst, Honolulu, HI USA; [Choi, So Yung] Univ Hawaii, John A Burns Sch Med, Dept Complementary & Integrat Med, Honolulu, HI 96822 USA; [Murata, Nathan M.] Univ Hawaii Manoa, Coll Educ, Honolulu, HI 96822 USA		Tsushima, WT (corresponding author), Straub Med Ctr, Psychiat & Psychol Dept, 888 South King St, Honolulu, HI 96813 USA.	wtsushima@straub.net			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54MD007584, U54MD00760131, 2U54GM104944-06]	Hyeong Jun Ahn and So Yung Choi were partially supported by grants [U54MD007584, U54MD00760131, and 2U54GM104944-06] from the National Institute of Health.	Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Barth JT, 1989, MILD HEAD INJURY, P257; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Boone K. B., 2007, ASSESSMENT FEIGNED C; Cohen J, 1998, STAT POWER ANAL BEHA; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Higgins KL, 2018, ARCH CLIN NEUROPSYCH, V33, P437, DOI 10.1093/arclin/acx071; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; ImPACT Applications Inc, 2016, ADM INT MAN; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Kuhn AW, 2014, J ATHL TRAINING, V49, P800, DOI 10.4085/1062-6050-49.3.66; Larrabee G. J., 2005, FORENSIC NEUROPSYCHO, P116; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Lovell M, 2007, IMPACT 2007 6 0 CLIN; Manderino LM, 2018, ARCH CLIN NEUROPSYCH, V33, P596, DOI 10.1093/arclin/acx102; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Ott SD, 2018, ARCH CLIN NEUROPSYCH, V33, P319, DOI 10.1093/arclin/acx132; R Core Team, 2017, R LANG ENV STAT COMP; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Randolph C, 2005, J ATHL TRAINING, V40, P139; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Schatz P, 2017, SPORT EXERC PERFORM, V6, P243, DOI 10.1037/spy0000100; Schatz P, 2014, J ATHL TRAINING, V49, P659, DOI 10.4085/1062-6050-49.3.37; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Siedlik JA, 2016, J SPORT MED PHYS FIT, V56, P1086; Szabo AJ, 2013, J ATHL TRAINING, V48, P851, DOI 10.4085/1062-6050-48.6.20; Tsushima WT, 2016, ARCH CLIN NEUROPSYCH, V31, P105, DOI 10.1093/arclin/acv066; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001	49	2	2	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JUL 3	2021	10	3					209	218		10.1080/21622965.2019.1642202		JUL 2019	10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	TW4CZ	WOS:000482149100001	31407597				2022-02-06	
J	Teng, S; Palmieri, A; Maita, I; Zheng, C; Das, G; Park, J; Zhou, RP; Alder, J; Thakker-Varia, S				Teng, Shavonne; Palmieri, Alicia; Maita, Isabella; Zheng, Cynthia; Das, Gitanjali; Park, Juyeon; Zhou, Renping; Alder, Janet; Thakker-Varia, Smita			Inhibition of EphA/Ephrin-A signaling using genetic and pharmacologic approaches improves recovery following traumatic brain injury in mice	BRAIN INJURY			English	Article						EphA6; lateral fluid percussion; caspase-3; rotarod	SPINAL-CORD-INJURY; EPH RECEPTORS; UP-REGULATION; SODIUM ORTHOVANADATE; AXONAL REGENERATION; EXPRESSION; PHOSPHATASE; ACTIVATION; MECHANISMS; APOPTOSIS	Primary Objective: Eph/Ephrin signaling is inhibitory for developing axons and blocking Eph pathways enhances regeneration after spinal cord injury. It was hypothesized that inhibition of Eph signaling promotes cellular and behavioral recovery after traumatic brain injury (TBI). Research design: Lateral fluid percussion (LFP) injury was performed on wildtype (WT) and EphA6 knockout (KO) mice. EphA6-Fc, Ephrin-A5-Fc fusion proteins, and sodium orthovanadate were used to alter the signaling pathway. Immunohistochemistry and tissue explants revealed cellular changes. Rotarod tests demonstrated vestibulomotor function. Outcomes: The EphA6 receptor expression is upregulated following LFP. Uninjured EphA6 KO mice exhibit greater neurite density and clustered Ephrin-A5-Fc causes growth cone collapse in vitro. After LFP, EphA6 KO mice demonstrate longer neurites and decreased neuronal cell death and astrocytosis compared to WT mice. Blocking EphA signaling by soluble EphA6-Fc fusion protein reduces cell death and improves motor function following LFP whereas clustered Ephrin-A5-Fc exacerbates cell death and neurodegeneration. Sodium orthovanadate rescues growth cone collapse in vitro as well as cell death and neurodegeneration in vivo. Conclusions: Eph/Ephrin signaling plays an inhibitory role following TBI. Targeting the Eph signaling pathway with Fc fusion proteins and pharmacological agents can be a novel strategy to counter the damaging effects of TBI.	[Teng, Shavonne; Palmieri, Alicia; Maita, Isabella; Zheng, Cynthia; Park, Juyeon; Alder, Janet; Thakker-Varia, Smita] Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane West,Res Bldg 357A, Piscataway, NJ 08854 USA; [Das, Gitanjali; Zhou, Renping] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Chem Biol, Piscataway, NJ USA		Thakker-Varia, S (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane West,Res Bldg 357A, Piscataway, NJ 08854 USA.	varia@rutgers.edu			New Jersey Commission on Brain Injury Research [CBIR13IRG003]	This research was supported by a grant from the New Jersey Commission on Brain Injury Research CBIR13IRG003.	Alder J, 2016, BRAIN INJURY, V30, P48, DOI 10.3109/02699052.2015.1088963; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Cramer Karina S, 2016, F1000Res, V5, DOI 10.12688/f1000research.7417.1; Cruz-Orengo L, 2007, NEUROSCI LETT, V418, P49, DOI 10.1016/j.neulet.2007.03.015; Cruz-Orengo L, 2006, EXP NEUROL, V202, P421, DOI 10.1016/j.expneurol.2006.07.005; Das G, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0115-5; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Dobrzanski P, 2004, CANCER RES, V64, P910, DOI 10.1158/0008-5472.CAN-3430-2; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feng YZ, 2008, BRAIN RES BULL, V76, P102, DOI 10.1016/j.brainresbull.2008.01.012; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Giorgio C, 2018, BIOCHEM PHARMACOL, V147, P21, DOI 10.1016/j.bcp.2017.11.002; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Hanell A, 2012, J NEUROTRAUM, V29, P2660, DOI 10.1089/neu.2012.2376; Hasegawa Y, 2012, J NEUROSCI RES, V90, P691, DOI 10.1002/jnr.22801; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Hsieh CY, 2007, J COMP NEUROL, V504, P508, DOI 10.1002/cne.21465; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Irizarry-Ramirez M, 2005, J NEUROTRAUM, V22, P929, DOI 10.1089/neu.2005.22.929; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001; Kandouz M, 2018, APOPTOSIS, V23, P265, DOI 10.1007/s10495-018-1458-7; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Lackmann M, 1998, J BIOL CHEM, V273, P20228, DOI 10.1074/jbc.273.32.20228; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Lee H, 2015, MOL CELLS, V38, P349, DOI 10.14348/molcells.2015.2279; Lifshitz Jonathan, 2009, P369, DOI 10.1007/978-1-60327-185-1_32; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Liu J, 2016, APOPTOSIS, V21, P546, DOI 10.1007/s10495-016-1231-8; Mansour M, 2016, J CELL SCI, V129, P277, DOI 10.1242/jcs.174490; Megiorni F, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0530-z; Moreno-Flores MT, 1999, NEUROSCIENCE, V91, P193, DOI 10.1016/S0306-4522(98)00568-5; Morinville A, 1998, TRENDS PHARMACOL SCI, V19, P452, DOI 10.1016/S0165-6147(98)01257-7; Nikolakopoulou AM, 2016, ASN NEURO, V8, DOI 10.1177/1759091416630220; Ouyang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171976; Pegg CL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06685-z; Perez EJ, 2016, NEUROBIOL DIS, V94, P73, DOI 10.1016/j.nbd.2016.06.007; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Savelieva KV, 2008, NEUROSCI LETT, V438, P205, DOI 10.1016/j.neulet.2008.04.013; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Spanevello MD, 2013, J NEUROTRAUM, V30, P1023, DOI 10.1089/neu.2012.2729; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HB, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0338; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Verma A, 2015, J STROKE CEREBROVASC, V24, P2434, DOI 10.1016/j.jstrokecerebrovasdis.2015.02.019; Wang XH, 2018, BIOCHEM BIOPH RES CO, V504, P805, DOI 10.1016/j.bbrc.2018.08.055; Willson CA, 2002, CELL TRANSPLANT, V11, P229; Wimmer-Kleikamp SH, 2008, BLOOD, V112, P721, DOI 10.1182/blood-2007-11-121681; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Xia Y, 2013, EPILEPSY RES, V105, P20, DOI 10.1016/j.eplepsyres.2013.01.001; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yen TL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041100; Yue Xin, 2013, Methods Mol Biol, V1018, P221, DOI 10.1007/978-1-62703-444-9_21; Yun ME, 2003, J COMP NEUROL, V456, P203, DOI 10.1002/cne.10498; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	71	2	2	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG 24	2019	33	10					1385	1401		10.1080/02699052.2019.1641622		JUL 2019	17	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM5YC	WOS:000477545900001	31319723				2022-02-06	
J	Rigon, A; Klooster, NB; Crooks, S; Duff, MC				Rigon, Arianna; Klooster, Nathaniel B.; Crooks, Samantha; Duff, Melissa C.			Procedural Memory Following Moderate-Severe Traumatic Brain Injury: Group Performance and Individual Differences on the Rotary Pursuit Task	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						traumatic brain injury; individual differences; assessment; rotary pursuit; memory; procedural	PARKINSONS-DISEASE; LEARNING-TASKS; HEAD-INJURY; SYSTEMS; SKILL; IMPAIRMENT; IMPLICIT; MOTOR; CONNECTIVITY; HUNTINGTONS	The impact of traumatic brain injury (TBI) on procedural memory has received significantly less attention than declarative memory. Although to date studies on procedural memory have yielded mixed findings, many rehabilitation protocols (e.g., errorless learning) rely on the procedural memory system, and assume that it is relatively intact. The aim of the current study was to determine whether individuals with TBI are impaired on a task of procedural memory as a group, and to examine the presence of individual differences in performance. We administered to a sample of 36 individuals with moderate-severe TBI and 40 healthy comparisons (HCs) the rotary pursuit task, and then examined their rate of learning, as well as their retention of learning. Our analyses revealed that while individuals with TBI spent a significantly shorter amount of time on target as a group, they did not retain significantly less procedural learning, and as a group their rate of learning was not different from HCs. However, there were high individual differences in both groups, indicating that some individuals might not be able to take advantage of treatment methods designed to leverage intact procedural memory system. Future work is needed to better assess and characterize procedural memory in individuals with TBI across a larger battery of tasks in experimental and clinical setting as memory and learning status may predict rehabilitation success.	[Rigon, Arianna; Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA; [Klooster, Nathaniel B.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Crooks, Samantha] Kennedy Krieger Inst, Baltimore, MD USA		Rigon, A (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA.; Klooster, NB (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	arianna.rigon@vanderbilt.edu; klooster@pennmedicine.upenn.edu			GPSG Grant from The University of Iowa; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD071844] Funding Source: NIH RePORTER	This study was funded by a GPSG Grant from The University of Iowa.	AMMONS RB, 1955, PSYCHOL BULL, V52, P69, DOI 10.1037/h0040849; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Cohen, 2001, CONDITIONING CONSCIO; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; CORKIN S, 1968, NEUROPSYCHOLOGIA, V6, P255, DOI 10.1016/0028-3932(68)90024-9; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Finn AS, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12450; Gabrieli JDE, 1997, NEUROPSYCHOLOGY, V11, P272, DOI 10.1037/0894-4105.11.2.272; Haaland KY, 1997, NEUROPSYCHOLOGY, V11, P180, DOI 10.1037/0894-4105.11.2.180; Hannula DE, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00080; HARRINGTON DL, 1990, J CLIN EXP NEUROPSYC, V12, P323, DOI 10.1080/01688639008400978; HEINDEL WC, 1989, J NEUROSCI, V9, P582; Kraus MF, 2010, COGN BEHAV NEUROL, V23, P210, DOI 10.1097/WNN.0b013e3181cefe2e; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Murray Laura L., 2001, Seminars in Speech and Language, V22, P127; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Reber PJ, 1996, BEHAV NEUROSCI, V110, P861, DOI 10.1037/0735-7044.110.5.861; Rigon A, 2017, NEUROIMAGE-CLIN, V13, P370, DOI 10.1016/j.nicl.2016.12.010; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Schiller Jeannine S, 2012, Vital Health Stat 10, P1; Skidmore Elizabeth R, 2015, Curr Phys Med Rehabil Rep, V3, P99; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; TULVING E, 1987, HUM NEUROBIOL, V6, P67; Tulving E, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p327A; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 2001, J CLIN EXP NEUROPSYC, V23, P207, DOI 10.1076/jcen.23.2.207.1209; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; Vakil E, 2014, J CLIN EXP NEUROPSYC, V36, P447, DOI 10.1080/13803395.2014.901299; Ward H, 2002, J CLIN EXP NEUROPSYC, V24, P458, DOI 10.1076/jcen.24.4.458.1032; Watt S, 1999, NEUROPSYCHOLOGY, V13, P338, DOI 10.1037/0894-4105.13.3.338; Wright MJ, 2014, J CLIN EXP NEUROPSYC, V36, P268, DOI 10.1080/13803395.2014.884543; Ylvisaker M., 1998, COLLABORATIVE BRAIN	35	2	2	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JUL 19	2019	13								251	10.3389/fnhum.2019.00251			8	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	IL1AT	WOS:000477032000001	31379544	Green Published, gold			2022-02-06	
J	Balaban, N; Biran, M; Sacher, Y				Balaban, Noga; Biran, Michal; Sacher, Yaron			Theory of Mind and referring expressions after Traumatic Brain Injury	APHASIOLOGY			English	Article						Traumatic Brain Injury; Theory of Mind; language; referring; aTOMia; Hebrew	NARRATIVE DISCOURSE; DEFICITS; PERSPECTIVE; BELIEFS; NEUROPSYCHOLOGY; COMPREHENSION; AGRAMMATISM; IMPAIRMENTS; PRAGMATICS; COHERENCE	Background: This study focused on the linguistic consequences of damage to Theory of Mind (TOM) in patients after Traumatic Brain Injury (TBI). It was designed to extend a previous study that tested the consequences of TOM impairment (aTOMia) on referring abilities in right-hemisphere damaged patients. Aims: To explore whether aTOMia in patients with TBI affects their use and comprehension of various referring expressions (definite and indefinite noun phrases, proper names and pronouns). Methods and Procedures: We identified individuals with TOM impairment (aTOMia) in a group of 15 TBI patients using a battery of six types of TOM task. We then tested two groups of TBI patients: participants with aTOMia and participants without aTOMia, compared to a control group of non brain-damaged participants. Four TOM-related language tasks assessed their ability to vary the use of referring expressions according to the knowledge of the discourse partners. Outcomes and Results: Five of the participants showed TOM impairment (aTOMia), whereas ten showed intact-TOM ability. The two groups did not differ according to most neuropsychological measures, or on grammatical performance. On the TOM-related language tasks the participants with aTOMia performed consistently worse than the participants with TBI and intact-TOM, and the control group. Conclusions: Individuals after TBI do not form a homogenous group regarding their TOM abilities. Some patients show TOM-related language impairment, and should be considered for language evaluation and treatment focusing on aspects of language that depend on TOM ability.	[Balaban, Noga; Biran, Michal] Tel Aviv Univ, Sch Educ, Language & Brain Lab, Tel Aviv, Israel; [Biran, Michal] Univ Haifa, Dept Commun Sci & Disorders, Haifa, Israel; [Sacher, Yaron] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Sacher, Yaron] Loewenstein Hosp Rehabil Ctr, Dept Traumat Brain Injury Rehabil, Raanana, Israel		Balaban, N (corresponding author), Tel Aviv Univ, Language & Brain Lab, IL-69978 Tel Aviv, Israel.	Nogab@tauex.tau.ac.il					Apperly Ian, 2010, MINDREADERS COGNITIV; Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; Ariel, 1990, ACCESSING NOUN PHRAS; Balaban N, 2016, APHASIOLOGY, V30, P1424, DOI 10.1080/02687038.2015.1137274; Balaban N, 2016, APHASIOLOGY, V30, P1399, DOI 10.1080/02687038.2015.1137275; Balaban N, 2016, LINGUA, V169, P1, DOI 10.1016/j.lingua.2015.09.004; Barker M., 2005, OTHER MINDS HUMANS B, P223; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biran M, 2005, LANG COGNITIVE PROC, V20, P589, DOI 10.1080/01690960400005813; Biran M., 2007, MA KASHUR WORD ASS T; Biran M., 2004, SHEMESH NAMING 100 O; Blake ML, 2007, AM J SPEECH-LANG PAT, V16, P331, DOI 10.1044/1058-0360(2007/037); Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Champagne-Lavau Maud, 2009, Cogn Neuropsychiatry, V14, P217, DOI 10.1080/13546800903004114; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Chomsky Noam., 1981, LECT GOVT BINDING; CLARK HH, 1986, COGNITION, V22, P1, DOI 10.1016/0010-0277(86)90010-7; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Crawford JR, 1998, J CLIN EXP NEUROPSYC, V20, P755, DOI 10.1076/jcen.20.5.755.1132; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; De Cat C, 2013, J PRAGMATICS, V56, P58, DOI 10.1016/j.pragma.2012.08.002; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Friedmann N, 2005, APHASIOLOGY, V19, P1037, DOI 10.1080/02687030544000236; Friedmann N, 2001, J PSYCHOLINGUIST RES, V30, P71, DOI 10.1023/A:1005256224207; Friedmann N., 1998, BAFLA FRIEDMANNS BAT; Galati A, 2010, J MEM LANG, V62, P35, DOI 10.1016/j.jml.2009.09.002; Granger CV, 1993, GUIDE UNIFORM DATA S; GROSZ BJ, 1995, COMPUT LINGUIST, V21, P203; Gundel JK, 2013, J PRAGMATICS, V56, P43, DOI 10.1016/j.pragma.2013.04.003; GUNDEL JK, 1993, LANGUAGE, V69, P274, DOI 10.2307/416535; Gvion A, 2012, APHASIOLOGY, V26, P579, DOI 10.1080/02687038.2011.643759; Hanna JE, 2003, J MEM LANG, V49, P43, DOI 10.1016/S0749-596X(03)00022-6; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Hickmann M., 1995, 1 LANG, V15, P277; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; ITZKOVICH M, 1990, LOEWENSTEIN OCCUPATI; Keysar B, 2003, COGNITION, V89, P25, DOI 10.1016/S0010-0277(03)00064-7; Kilov AM, 2009, APHASIOLOGY, V23, P584, DOI 10.1080/02687030701855382; Knutsen D, 2012, J MEM LANG, V67, P326, DOI 10.1016/j.jml.2012.06.001; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Le K, 2011, APHASIOLOGY, V25, P748, DOI 10.1080/02687038.2010.539696; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; McDonald S, 2000, BRAIN LANG, V75, P82, DOI 10.1006/brln.2000.2342; McDonald S., 1999, BRAIN DAM B; McDonald S, 2016, APHASIOLOGY, V30, P801, DOI 10.1080/02687038.2015.1070948; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mira Ariel, 2001, TEXT REPRESENTATION, P29, DOI DOI 10.1075/HCP.8.04ARI; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Nadig AS, 2002, PSYCHOL SCI, V13, P329, DOI 10.1111/1467-9280.00460; Perkins MR, 2005, CLIN LINGUIST PHONET, V19, P367, DOI 10.1080/02699200400027155; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Ruigendijk E, 2010, LINGUA, V120, P1991, DOI 10.1016/j.lingua.2010.02.009; Samson D, 2010, J EXP PSYCHOL HUMAN, V36, P1255, DOI 10.1037/a0018729; Schaeffer J, 2005, NAT LANG LINGUIST TH, V23, P53, DOI 10.1007/s11049-004-5540-1; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Sperber D., 1995, RELEVANCE COMMUNICAT; SULLIVAN K, 1994, DEV PSYCHOL, V30, P395, DOI 10.1037/0012-1649.30.3.395; TEASDALE G, 1974, LANCET, V2, P81; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Ziv M, 2004, COGNITIVE DEV, V19, P457, DOI 10.1016/j.cogdev.2004.09.002	74	2	2	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	NOV 2	2019	33	11					1319	1347		10.1080/02687038.2019.1637812		JUL 2019	29	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	IZ8MQ	WOS:000478366100001					2022-02-06	
J	Shour, AR; Holmes, B; Ameh, EA; Olaomi, OO; Anguzu, R; Cassidy, LD				Shour, Abdul Rahman; Holmes, Benjamin; Ameh, Emmanuel Adoyi; Olaomi, Oluwole Olayemi; Anguzu, Ronald; Cassidy, Laura Dawn			Motor vehicle accident is a risk factor for traumatic head injury among children in Abuja: analysis of the first trauma registry in Nigeria	PAN AFRICAN MEDICAL JOURNAL			English	Article						Pediatric trauma; mechanism of injury; motor vehicle accident; head injuries; lower and middle-income countries; Nigeria trauma registry	BRAIN-INJURY; DEVELOPING-COUNTRIES; GLOBAL BURDEN; EPIDEMIOLOGY; MORTALITY; DEATHS; UGANDA; CARE	Introduction: pediatric traumatic injury is a major public health concern that is poorly documented in lower and middle-income countries. This study analyzed data on pediatric injuries from a unique hospital trauma registry in Abuja, Nigeria. Methods: data were analyzed on 220 traumatically injured patients aged 21 years/less to describe injury characteristics and to determine the association between mechanism of injury and pediatric head injuries in Abuja, Nigeria, between 2014 and 2015. Bivariate analysis using Pearson's chi-square and adjusted logistic regression were conducted to characterize the population and identify risk factors for head injury. P-values<0.05 were considered statistically significant. All statistical analyses were performed using STATA v.15.1. Results: the majority of patients were male (60.9%) with a mean age (SD) of 12.5 +/- 6.9 years. Head injuries were most common (49.6%), followed by chest (14.1%), abdomen (12.3%) and back (7.7%). The mechanism of injury was statistically significantly associated with head injury (p=0.027) with 63% of children in a motor vehicle accident sustaining a head injury. After adjusting for covariates, the odds of head injury were 3.8 times higher for children injured in a motor vehicle accidents (MVA) compared to those with falls (95%CI 1.40-10.40). Conclusion: this analysis reveals that motor vehicle accident is a risk factor for traumatic head injury among children in Nigeria. Therefore, efforts should be made to address motor vehicle accidents involving children. These data will help to inform age-related prevention and treatment strategies. The results of this study highlight the importance of collecting pediatric trauma data in developing countries.	[Shour, Abdul Rahman; Holmes, Benjamin; Anguzu, Ronald; Cassidy, Laura Dawn] Med Coll Wisconsin, Inst Hlth & Equ, Milwaukee, WI 53226 USA; [Ameh, Emmanuel Adoyi; Olaomi, Oluwole Olayemi] Natl Hosp Abuja, Abuja, Federal Capital, Nigeria		Cassidy, LD (corresponding author), Med Coll Wisconsin, Inst Hlth & Equ, Milwaukee, WI 53226 USA.			Shour, Abdul/0000-0001-6884-9535			Abantanga FA, 1998, PEDIATR SURG INT, V13, P515, DOI 10.1007/s003830050387; Abdelgadir J, 2018, J CLIN NEUROSCI, V47, P79, DOI 10.1016/j.jocn.2017.10.004; Abdur-Rahman LO, 2012, SEMIN PEDIATR SURG, V21, P111, DOI 10.1053/j.sempedsurg.2012.01.003; ADELOYE A, 1986, CHILD NERV SYST, V2, P309, DOI 10.1007/BF00271945; Ademuyiwa Adesoji O, 2012, J Emerg Trauma Shock, V5, P55, DOI 10.4103/0974-2700.93114; Adesunkanmi ARK, 2000, INJURY, V31, P225, DOI 10.1016/S0020-1383(99)00236-3; Alonge O, 2016, PEDIATR CLIN N AM, V63, P167, DOI 10.1016/j.pcl.2015.08.009; Alonge O, 2014, ARCH DIS CHILD, V99, P62, DOI 10.1136/archdischild-2013-304177; Bangash MYH, 2007, TRAUMA ENG ANAL MED; Bishai D, 2003, HEALTH POLICY PLANN, V18, P232, DOI 10.1093/heapol/czg028; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1; Boughton O, 2015, SICOT-J, V1, DOI 10.1051/sicotj/2015007; Cassidy Laura D, 2016, J Registry Manag, V43, P23; Cassidy LD, 2009, J TRAUMA, V67, pS172, DOI 10.1097/TA.0b013e3181af0aeb; Danjuma S, 2016, ARCH MED SURG, V1, P1; Ekenze S O, 2009, Niger J Med, V18, P79; Esin Issa Abdul Razaq, 2013, Afr J Paediatr Surg, V10, P367, DOI 10.4103/0189-6725.125450; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Hazen A, 2006, J NATL MED ASSOC, V98, P73; Hsia RY, 2010, INT J EMERG MED, V3, P165, DOI 10.1007/s12245-010-0200-1; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nnadi MON, 2014, J PEDIATR NEUROSCI, V9, P237, DOI 10.4103/1817-1745.147577; O'Reilly G, 2012, INJURY PREV, V18, P40; O'Reilly GM, 2013, INJURY, V44, P713, DOI 10.1016/j.injury.2013.02.003; Obajimi M, 2002, NIGER J SURG RES, V4, P84; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; Osifo OD, 2012, INJURY, V43, P1861, DOI 10.1016/j.injury.2011.07.016; Osifo OD, 2012, PREHOSP DISASTER MED, V27, P136, DOI 10.1017/S1049023X12000465; Ostlin P, 2005, B WORLD HEALTH ORGAN, V83, P948; Peden M., 2004, WORLD REPORT ROAD TR; Punchak M, 2018, WORLD NEUROSURG, V114, pE396, DOI 10.1016/j.wneu.2018.02.191; Schultz CR, 2007, J TRAUMA, V63, P1143, DOI 10.1097/TA.0b013e31815688e3; Shokunbi T, 1994, West Afr J Med, V13, P38; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; StataCorp, 2017, STAT STAT SOFTW REL, V10; Thanni LOA, 2011, PREHOSP DISASTER MED, V26, P293, DOI 10.1017/S1049023X11006546; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; United Nations Department of Economic and Social Affairs, 2015, WORLD POP PROJ REACH; Wesson HKH, 2014, HEALTH POLICY PLANN, V29, P795, DOI 10.1093/heapol/czt064; Wong S, 2011, INT J GYNECOL OBSTET, V114, P190, DOI 10.1016/j.ijgo.2011.06.001; World Health Organization, 2015, INJ PREV; World Health Organization (WHO), 2014, GLOB HLTH EST 2014 S	48	2	2	1	1	AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET	KAMPALA	PO BOX 12874, KAMPALA, 00000, UGANDA	1937-8688			PAN AFR MED J	Pan Afr. Med. J.	JUL 16	2019	33								215	10.11604/pamj.2019.33.215.19289			9	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	JA0VI	WOS:000487531200008	31692769	Green Published, gold, Green Submitted			2022-02-06	
J	Kjeldgard, L; Ohlin, M; Elrud, R; Stigson, H; Alexanderson, K; Friberg, E				Kjeldgard, Linnea; Ohlin, Maria; Elrud, Rasmus; Stigson, Helena; Alexanderson, Kristina; Friberg, Emilie			Bicycle crashes and sickness absence - a population-based Swedish register study of all individuals of working ages	BMC PUBLIC HEALTH			English	Article						Sick-leave; Disability pension; Bicycle crash; Traffic injury; Population-based; Cross-sectional	CYCLING OUTWEIGH; HEALTH-BENEFITS; BODY REGION; ALL-CAUSE; ACCIDENTS; INJURY; LEAVE; RISK; CONSEQUENCES; DISABILITY	BackgroundIn recent years, bicycle injuries have increased, yet little is known about the impact of such injures on sickness absence (SA) and disability pension (DP). The aim was to explore SA and DP among individuals of working ages injured in a bicycle crash.MethodA nationwide register-based study, including all individuals aged 16-64years and living in Sweden, who in 2010 had in- or specialized out-patient healthcare (including emergency units) after a bicycle crash. Information on age, sex, sociodemographics, SA, DP, crash type, injury type, and injured body region was used. We analyzed individuals with no SA or DP, with ongoing SA or full-time DP already at the time of the crash, and with new SA >14days in connection to the crash. Crude and adjusted odds ratios (OR) with 95% confidence intervals for new SA were estimated by logistic regression.ResultsIn total, 7643 individuals had healthcare due to a new bicycle crash (of which 85% were single-bicycle crashes). Among all, 10% were already on SA or full-time DP at the time of the crash, while 18% had a new SA spell. The most common types of injuries were external injuries (38%) and fractures (37%). The body region most frequently injured was the upper extremities (43%). Women had higher OR (1.40; 1.23-1.58) for new SA than men, as did older individuals compared with younger (OR 2.50; 2.02-3.09, for ages: 55-64 vs. 25-34). The injury types with the highest ORs for new SA, compared with the reference group external injuries was fractures (8.04; 6.62-9.77) and internal injuries (7.34; 3.67-14.66). Individuals with traumatic brain injury and injuries to the vertebral column and spinal cord had higher ORs for SA compared with other head, face, and neck injuries (2.72; 1.19-6.22 and 3.53; 2.24-5.55, respectively).ConclusionsIn this explorative nationwide study of new bicycle crashes among individuals of working ages, 18% had a new SA spell in connection to the crash while 10% were already on SA or DP. The ORs for new SA were higher among women, older individuals, and among individuals with a fracture.	[Kjeldgard, Linnea; Elrud, Rasmus; Stigson, Helena; Alexanderson, Kristina; Friberg, Emilie] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, SE-17177 Stockholm, Sweden; [Ohlin, Maria] Univ Gothenburg, Dept Food & Nutr & Sport Sci, Gothenburg, Sweden; [Ohlin, Maria] Chalmers Univ Technol, Dept Mech & Maritime Sci, Gothenburg, Sweden; [Ohlin, Maria] VTI, Swedish Natl Rd & Transport Res Inst, POB 8072, S-40278 Gothenburg, SE, Sweden; [Stigson, Helena] Chalmers Univ Technol, Dept Appl Mech, Vehicle Safety Div, Gothenburg, Sweden; [Stigson, Helena] Folksam Res, Stockholm, Sweden		Kjeldgard, L (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, SE-17177 Stockholm, Sweden.	linnea.kjeldgard@ki.se; kristina.alexanderson@ki.se	Stigson, Helena/AAZ-6786-2020	Stigson, Helena/0000-0002-2409-1379; Friberg, Emilie/0000-0001-7874-4243; Rizzi, Maria/0000-0003-1155-3519; Kjeldgard, Linnea/0000-0002-4575-7483	Skyltfonden; Swedish Research Council for Health, Working Life and WelfareSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte); Folksam Insurance Group Research Foundation; Swedish Transport Administration	The study was funded by Skyltfonden, the Swedish Research Council for Health, Working Life and Welfare, the Folksam Insurance Group Research Foundation, and the Swedish Transport Administration. The funding bodies had no influence over study design, analyses, interpretation of data or the writing of the manuscript.	Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P49, DOI 10.1080/14034950410021853; Allebeck P, 2004, SCAND J PUBLIC HEALT, V32, P36, DOI 10.1080/14034950410021835; Amoros E, 2006, ACCIDENT ANAL PREV, V38, P627, DOI 10.1016/j.aap.2005.11.006; [Anonymous], 2014, SAF CYCL COMM STRAT; [Anonymous], 2017, AN ROAD SAF TRENDS 2, V098; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Berecki-Gisolf J, 2013, ACCIDENT ANAL PREV, V51, P129, DOI 10.1016/j.aap.2012.11.010; BJORNSTIG U, 1984, ACTA CHIR SCAND, V150, P353; de Hartog JJ, 2011, CIENC SAUDE COLETIVA, V16, P4731, DOI 10.1590/S1413-81232011001300022; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Elrud R, 2017, IRCOBI C 2017 ANTW B; HANSSON PG, 1976, SCAND J SOC MED, V4, P103; Holm AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001135; Jansson C, 2012, PAIN, V153, P998, DOI 10.1016/j.pain.2012.01.028; Juhra C, 2012, INJURY, V43, P2026, DOI 10.1016/j.injury.2011.10.016; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; Nilsson P, 2017, ACCIDENT ANAL PREV, V100, P30, DOI 10.1016/j.aap.2016.12.020; Ohlin M, 2018, J TRANSP HEALTH, V9, P275, DOI 10.1016/j.jth.2018.01.011; OLKKONEN S, 1993, SCAND J SOC MED, V21, P98, DOI 10.1177/140349489302100207; Peden M., 2004, WORLD REPORT ROAD TR; Rizzi M, 2013, IRCOBI C 2013 GOTH S; Rojas-Rueda D, 2013, PREV MED, V57, P573, DOI 10.1016/j.ypmed.2013.07.021; Social insurance in figures 2016, 2016, SOC INS FIG 2016; Stutts JC, 1999, ACCIDENT ANAL PREV, V31, P505, DOI 10.1016/S0001-4575(99)00007-X; Wang M, 2014, OCCUP ENVIRON MED, V71, P12, DOI 10.1136/oemed-2013-101462; World Health Organization, 1993, INT STAT CLASS DIS R	28	2	2	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2458			BMC PUBLIC HEALTH	BMC Public Health	JUL 15	2019	19								943	10.1186/s12889-019-7284-1			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	IJ2OK	WOS:000475744600008	31307453	gold, Green Published			2022-02-06	
J	Srivastava, PK; Han, SS; Tu, CC; Jing, LL				Srivastava, Prateek K.; Han, Shanshan; Tu, Chang-Ching; Jing, Lili			Phototoxicity Generated by Silicon Quantum Dot Nanoparticles on Zebrafish Embryos	ACS APPLIED BIO MATERIALS			English	Article						phototoxicity; singlet oxygen; silicon quantum dot; zebrafish embryo; photodynamic therapy	SINGLET OXYGEN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; NANOCRYSTALS; TOXICITY	We demonstrate phototoxicity generated by silicon quantum dot nanoparticles (SiQDNPs) using zebrafish as an animal model. Having long exciton lifetime, the SiQDNPs can function as photosensitizers which absorb incident optical light and transfer the energy to oxygen molecules in close proximity, generating cytotoxic singlet oxygens. First, the zebrafish embryos were soaked in the SiQDNP suspension in E3 medium, while being illuminated under blue light or kept in the dark for 6 h. Through neutral red staining immediately afterward, the illuminated embryos showed more prominent injuries at their head, yolk sac and tail parts than those in the dark. Furthermore, prolonged observation after the treatment revealed that the illuminated embryos had mortality rates significantly higher than those without illumination, clearly showing the phototoxicity effect generated by the SiQDNPs. However, adverse effect due to the immersion of whole embryos in the SiQDNP suspension was also observed. To alleviate this issue, minute amounts of the SiQDNPs were microinjected to the embryos, followed by blue light illumination. By acridine orange staining subsequently, cell apoptosis localized near the microinjection site was revealed, whereas no apoptosis was found for those also microinjected with the SiQDNPs but without illumination. The phototoxicity effect demonstrated on zebrafish embryos in this work manifests the potential of using the SiQDNPs as a photosensitizer for photodynamic therapy.	[Srivastava, Prateek K.; Jing, Lili] Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Minist Educ, Shanghai 200240, Peoples R China; [Srivastava, Prateek K.; Jing, Lili] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; [Han, Shanshan; Tu, Chang-Ching] Shanghai Jiao Tong Univ, Univ Michigan Shanghai Jiao Tong Univ Joint Inst, Shanghai 200240, Peoples R China		Jing, LL (corresponding author), Shanghai Jiao Tong Univ, Engn Res Ctr Cell & Therapeut Antibody, Minist Educ, Shanghai 200240, Peoples R China.; Jing, LL (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China.; Tu, CC (corresponding author), Shanghai Jiao Tong Univ, Univ Michigan Shanghai Jiao Tong Univ Joint Inst, Shanghai 200240, Peoples R China.	changching.tu@situ.edu.cn; lilijing@sjtu.edu.cn			Shanghai Pujiang Talent Program [18PJ1404900, 16PJ1405500]	This research was financially supported by the Shanghai Pujiang Talent Program (18PJ1404900 and 16PJ1405500). We thank Prof. Chang-Ching Tu and Shanshan Han for proposing the original idea, synthesizing and analyzing the SiQDNPs and finalizing the manuscript. Prof. Lili Jing and Prateek K. Srivastava for conducting all the zebrafish experiments and composing the first manuscript draft.	Abrahamse H, 2016, BIOCHEM J, V473, P347, DOI 10.1042/BJ20150942; Bakalova R, 2004, NAT BIOTECHNOL, V22, P1360, DOI 10.1038/nbt1104-1360; Cheng Y, 2011, J AM CHEM SOC, V133, P2583, DOI 10.1021/ja108846h; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Day RA, 2017, CHEM COMMUN, V53, P13043, DOI 10.1039/c7cc07038a; Deng J, 2009, AQUAT TOXICOL, V93, P29, DOI 10.1016/j.aquatox.2009.03.001; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Dohnalova K, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3141481; Dohnalova K, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.3; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Embry MR, 2010, AQUAT TOXICOL, V97, P79, DOI 10.1016/j.aquatox.2009.12.008; Erogbogbo F, 2011, ACS NANO, V5, P413, DOI 10.1021/nn1018945; Gibot L, 2014, BIOMACROMOLECULES, V15, P1443, DOI 10.1021/bm5000407; Godefroo S, 2008, NAT NANOTECHNOL, V3, P174, DOI 10.1038/nnano.2008.7; Haque E, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8070561; Kalka K, 2000, J AM ACAD DERMATOL, V42, P389, DOI 10.1016/S0190-9622(00)90209-3; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knobel M, 2012, ENVIRON SCI TECHNOL, V46, P9690, DOI 10.1021/es301729q; Kovalev D, 2005, ADV MATER, V17, P2531, DOI 10.1002/adma.200500328; Kusova K, 2010, ACS NANO, V4, P4495, DOI 10.1021/nn1005182; Lapkin AA, 2008, CHEM ENG J, V136, P331, DOI 10.1016/j.cej.2007.04.013; Li Z, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-356; Portoles MJL, 2010, LANGMUIR, V26, P10953, DOI 10.1021/la100980x; Lucky SS, 2015, CHEM REV, V115, P1990, DOI 10.1021/cr5004198; MOAN J, 1990, J PHOTOCH PHOTOBIO B, V6, P343, DOI 10.1016/1011-1344(90)85104-5; Mroz P, 2011, NANOMED-NANOTECHNOL, V7, P965, DOI 10.1016/j.nano.2011.04.007; Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]; Peng GT, 2018, ENVIRON SCI-NANO, V5, P1200, DOI 10.1039/c8en00190a; PROOT JP, 1992, APPL PHYS LETT, V61, P1948, DOI 10.1063/1.108372; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI 10.1038/NMETH.1248; Sadasivam M, 2013, EUR J NANOMED, V5, P115, DOI 10.1515/ejnm-2013-0010; Samia ACS, 2003, J AM CHEM SOC, V125, P15736, DOI 10.1021/ja0386905; Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121; Tu CC, 2017, ACS PHOTONICS, V4, P1306, DOI 10.1021/acsphotonics.7b00188; Tu CC, 2016, ACS APPL MATER INTER, V8, P13714, DOI 10.1021/acsami.6b02318; Xiao L, 2011, ACS NANO, V5, P3651, DOI 10.1021/nn1035262; Yang GB, 2015, NANO RES, V8, P751, DOI 10.1007/s12274-014-0558-0; Yong KT, 2013, CHEM SOC REV, V42, P1236, DOI 10.1039/c2cs35392j; Zhang J, 2018, ACTA PHARM SIN B, V8, P137, DOI 10.1016/j.apsb.2017.09.003	41	2	2	1	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2576-6422			ACS APPL BIO MATER	ACS Appl. Bio Mater.	JUL 15	2019	2	7					2872	2878		10.1021/acsabm.9b00264			7	Nanoscience & Nanotechnology; Materials Science, Biomaterials	Emerging Sources Citation Index (ESCI)	Science & Technology - Other Topics; Materials Science	VJ6PW	WOS:000616369500018	35030821				2022-02-06	
J	Cecchi, NJ; Oros, TJ; Monroe, DC; Fote, GM; Moscoso, WX; Hicks, JW; Reinkensmeyer, DJ				Cecchi, Nicholas J.; Oros, Theophil J.; Monroe, Derek C.; Fote, Gianna M.; Moscoso, Wyatt X.; Hicks, James W.; Reinkensmeyer, David J.			The Effectiveness of Protective Headgear in Attenuating Ball-to-Forehead Impacts in Water Polo	FRONTIERS IN SPORTS AND ACTIVE LIVING			English	Article						sports; concussion; head injury; head kinematics; biomechanics; head acceleration; helmet		Recent reports have demonstrated that there is a serious risk of head impact and injury in water polo. The use of protective headgear in contact sports is a commonly accepted strategy for reducing the risk of head injury, but there are few available protective headgears for use in water polo. Many of those that are available are banned by the sport's governing bodies due to a lack of published data supporting the effectiveness of those headgears in reducing head impact kinematics. To address this gap in knowledge, we launched a water polo ball at the forehead of an anthropomorphic testing device fitted with either a standard water polo headgear or one of two protective headgears. We selected a range of launch speeds representative of those observed across various athlete ages. Mixed-model ANOVAs revealed that, relative to standard headgear, protective headgears reduced peak linear acceleration (by 10.8-21.6%; p < 0.001), and peak rotational acceleration (by 24.5-48.5%; p < 0.001) induced by the simulated ball-to-forehead impacts. We discuss the possibility of using protective headgears in water polo to attenuate head impact kinematics.	[Cecchi, Nicholas J.; Oros, Theophil J.; Moscoso, Wyatt X.; Reinkensmeyer, David J.] Univ Calif Irvine, Dept Mech & Aerosp Engn, Irvine, CA USA; [Cecchi, Nicholas J.; Hicks, James W.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Monroe, Derek C.] Univ Calif Irvine, Dept Neurol, Irvine, CA USA; [Fote, Gianna M.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA USA		Hicks, JW (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	jhicks@uci.edu			Center for Exercise Medicine and Sport Sciences at the University of California, IrvineUniversity of California System	The authors received funding from the Center for Exercise Medicine and Sport Sciences at the University of California, Irvine for study expenses. The Center for Exercise Medicine and Sport Sciences did not have any role in study design.	Abraldes J.A, 2012, OPEN SPORTS SCI J, V5, P141, DOI [10.2174/1875399X01205010141, DOI 10.2174/1875399X01205010141]; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Cecchi NJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216369; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Johnson G., 2014, PADDED CAPS PROHIBIT; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McIntosh AS, 2015, BRIT J SPORT MED, V49, P1108, DOI 10.1136/bjsports-2015-095094; Mountjoy M, 2010, BRIT J SPORT MED, V44, P522, DOI 10.1136/bjsm.2010.071720; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Nur Sarah, 2015, Sports Biomech, V14, P459, DOI 10.1080/14763141.2015.1084035; O'Sullivan DM, 2016, EUR J SPORT SCI, V16, P1219, DOI 10.1080/17461391.2016.1161073; O'Sullivan DM, 2013, BRIT J SPORT MED, V47, P447, DOI 10.1136/bjsports-2012-091416; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Uljevic O, 2013, J SPORT SCI MED, V12, P646; Wallace C, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000433; WHITING WC, 1985, AM J SPORT MED, V13, P95, DOI 10.1177/036354658501300203; Wirsching A, 2019, J NEUROTRAUM, V36, P548, DOI 10.1089/neu.2018.5836	26	2	2	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2624-9367		FRONT SPORTS ACT LIV	Front. Sports Act. Living	JUL 10	2019	1								2	10.3389/fspor.2019.00002			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VK1IE	WOS:000660297900001	33344926	Green Published, gold			2022-02-06	
J	Mateu, NC				Mateu, Nuri Cayuelas			Traumatic brain injury in Denmark 2008-2012	SCANDINAVIAN JOURNAL OF PUBLIC HEALTH			English	Article						Traumatic brain injury; epidemiology; external causes; day of the week; violence	HEAD-INJURY; EPIDEMIOLOGY; MILD; RISK	Aims: To examine the epidemiology of traumatic brain injury (TBI) in Denmark, including the relative frequency, distribution of injuries and the external causes across the days of the week, sex and age. Methods: I carried out a nationwide register-based study of the full population aged 16-65 years with a diagnosis of TBI between 2008 and 2012, a total of 27,030 hospital contacts. I calculated the average annual relative frequency and the sex risk ratio for four TBI diagnoses across age. I report the distribution of five external causes and the odds ratio of acquiring a TBI during the weekend. Results: The relative frequency of TBI peaked among 16- to 35-year-olds for all diagnosis except for haemorrhages, which increase with age. During weekends, the relative frequency of concussions increases for men, whereas the relative frequency of severe TBI increases for young men and decreases for older men. The relative frequency of TBI is stable throughout the week for women aged 16-35 years, but decreases for women aged 36-65 years. For 16- to 35-year-olds, the main external causes of TBI are falls and road traffic accidents. During the weekend, the risk of violence-, sport- and fall-related TBI increases for 16- to 35-year-olds, whereas the risk of TBI related to road traffic accidents decreases for women and older men. The risk of sports-related TBI increases during weekends for older men. Conclusions: Injury patterns and external causes across TBI diagnoses differ substantially across sex, age and the day of week, indicating differences in the behavioural patterns that result in a TBI.	[Mateu, Nuri Cayuelas] Aalborg Univ, Dept Sociol & Social Work, Frederikskaj 10B, DK-2450 Copenhagen SV, Denmark		Mateu, NC (corresponding author), Aalborg Univ, Dept Sociol & Social Work, Frederikskaj 10B, DK-2450 Copenhagen SV, Denmark.	ncm@socsci.aau.dk		Mateu, Nuri Cayuelas/0000-0001-9125-947X	Danish Ministry for Children, Gender Equality, Integration and Social Affairs; Aalborg University	This project is part of a grant from the Danish Ministry for Children, Gender Equality, Integration and Social Affairs and Aalborg University.	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Danish Health Agency (Sundhedsstyrelsen), 2011, FORL REH VOKSN MED E; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; Engberg A, 1995, Acta Neurol Scand Suppl, V164, P1; Engberg Aase Worsaae, 2007, Ugeskr Laeger, V169, P199; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; International Labour Organization, 2005, INTR REP DEC WORK SA; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Juel K, 2008, SCAND J PUBLIC HEALT, V36, P11, DOI 10.1177/1403494808097590; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; Roberts DJ, 2014, CAN J SURG, V57, pE62, DOI 10.1503/cjs.030812; Rubin D.B., 1987, MULTIPLE IMPUTATION; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale TW, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002321; Weber EU, 2010, WIRES COGN SCI, V1, P79, DOI 10.1002/wcs.5; Weber EU, 2005, RISK ANAL, V25, P597, DOI 10.1111/j.1539-6924.2005.00627.x	25	2	2	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1403-4948	1651-1905		SCAND J PUBLIC HEALT	Scand. J. Public Health	MAY	2020	48	3			SI		331	337	1403494819852826	10.1177/1403494819852826		JUL 2019	7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	LM6GD	WOS:000476682400001	31291817				2022-02-06	
J	Della-Pace, ID; de Souza, TL; Graunck, ACB; Rambo, LM; Ribeiro, LR; Cipolatto, RP; Severo, L; Papalia, WL; Santos, ARS; Facundo, VA; Oliveria, MS; Furian, AF; Fighera, MR; Royes, LFF				Della-Pace, Iuri Domingues; de Souza, Thayse Lopes; Beck Graunck, Ana Claudia; Rambo, Leonardo Magno; Ribeiro, Leandro Rodrigo; Cipolatto, Rafael Parcianello; Severo, Leandro; Papalia, Willian Link; Soares Santos, Adair Roberto; Facundo, Valdir A.; Oliveria, Mauro Schneider; Furian, Ana Flavia; Fighera, Michele Rechia; Freire Royes, Luiz Fernando			Modulation of Na+ /K+ - ATPase activity by triterpene 3 beta, 6 beta, 16 beta-trihidroxilup-20 (29)-ene (TTHL) limits the long-term secondary degeneration after traumatic brain injury in mice	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						FPI; Na+, K+ -ATPase, TTHL; NMDA receptors, spatial memory, plant	NA+,K+-ATPASE; EXERCISE; NEURONS	Traumatic brain injury (TBI) is a public health problem characterized by a combination of immediate mechanical dysfunction of the brain tissue, and secondary damage. Based on the hypothesis that selected targets, such as Na+ K+ -ATPase are involved in the secondary damage after TBI and modulation of this enzyme activity by triterpene 3 beta, 6 beta, 16 beta-trihidroxilup-20 (29)-ene (TTHL) supports the ethnomedical applications of this plant, we decided to investigate whether previous TTHL treatment interrupts the progression of pathophysiology induced by TBI. Statistical analyses revealed that percussion fluid injury (FPI) increased Na+,K+ -ATPase activity in all isoform (alpha(1) and alpha(2)) 15 min after neuronal injury. The FPI protocol inhibited Na+,K+ -ATPase activity total and alpha(1) isoform, increased [H-3]MK-801 binding but did not alter Dichloro-dihydro-fluorescein diacetate (DCFH-DA) oxidation, carbonylated proteins and free-SH groups 60 min after injury. The increase of immunoreactivity of protein PKC and state of phosphorylation of at Ser(16) of Na+,K+-ATPase 60 min after FPI suggest the involvement of PKC on Na+,K+ -ATPase activity oscillations characterized by inhibition of total and alpha(1) isoform. Our experimental data also revealed that natural product rich in compounds such as triterpenes (TTHL; 30 mg/kg) attenuates [H-3]MK-801 binding increase, phosphorylation of the PKC and the Na+,K+ -ATPase alpha 1 subunit (Ser(16)) induced by FPI. The previous TTHL treatment had not effect on motor disability but protected against spatial memory deficit, BDNF, TrKB expression decrease, protein carbonylation and hippocampal cell death 7 days after FPI. These data suggest that TTHL-induced reduction on initial damage limits the long-term secondary degeneration and supports neural repair or behavioral compensation after neuronal injury.	[Della-Pace, Iuri Domingues; de Souza, Thayse Lopes; Beck Graunck, Ana Claudia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Programa Posgrad Farmacol, Ctr Ciencias Saude, BR-97105900 Santa Maria, RS, Brazil; [Rambo, Leonardo Magno; Ribeiro, Leandro Rodrigo] Univ Fed Santa Maria, Programa Posgrad Ciencias Biol Bioquim Toxicol, BR-97105900 Santa Maria, RS, Brazil; [Cipolatto, Rafael Parcianello; Severo, Leandro; Papalia, Willian Link; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Dept Metodos & Tecn Desportivas, Ctr Educ Fis & Desportos, BR-97105900 Santa Maria, RS, Brazil; [Oliveria, Mauro Schneider; Furian, Ana Flavia] Univ Fed Santa Maria, Dept Quim, Ctr Ciencias Nat & Exatas, Lab Neurotoxicidade, BR-97105900 Santa Maria, RS, Brazil; [Fighera, Michele Rechia] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Clin Med & Pediat, BR-97105900 Santa Maria, RS, Brazil; [Soares Santos, Adair Roberto] Univ Fed Santa Catarina, Dept Ciencias Fisiol, Lab Neurobiol Dor & Inflamacao, Ctr Ciencias Biol, Florianopolis, SC, Brazil; [Facundo, Valdir A.] Univ Fed Rondonia, Dept Quim, BR-78900500 Porto Velho, RO, Brazil		Royes, LFF (corresponding author), Univ Fed Santa Maria, Dept Metodos & Tecn Desportivas, Ctr Educ Fis & Desportos, BR-97105900 Santa Maria, RS, Brazil.	nandoroyes@yahoo.com.br	Fighera, Michele R/J-9576-2014; Santos, Adair/C-5565-2013	Santos, Adair/0000-0002-6435-4698; Rambo, Leonardo/0000-0002-4769-3663; Parcianello Cipolat, Rafael/0000-0002-0013-1153; Fighera, Michele/0000-0002-3111-7530; Ribeiro, Leandro/0000-0002-8442-4075; de Souza, Thaize Lopes/0000-0002-9204-9447	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [CNPq: 11/2082-4, CNPq 307382/2017-6]; FAPERGS fellowship	This work was supported by the CNPq (grants: CNPq: 11/2082-4). Michele Rechia Fighera and Luiz Fernando Freire Royes are recipients of CNPq fellowships (grants: CNPq 307382/2017-6). L.R.H Silva is a recipient of a FAPERGS fellowship. All authors confirm that there is no competing financial conflict of interest.	Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Ansari KI, 2009, DALTON T, P8525, DOI 10.1039/b905276c; Aperia A, 2012, J AM SOC NEPHROL, V23, P1283, DOI 10.1681/ASN.2012010102; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Cheng HS, 1999, BBA-BIOMEMBRANES, V1418, P31, DOI 10.1016/S0005-2736(99)00011-5; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Marcaida G, 1996, J NEUROCHEM, V66, P99; Peng L, 1997, J NEUROSCI, V17, P3488; Poulsen H, 2010, FEBS LETT, V584, P2589, DOI 10.1016/j.febslet.2010.04.035; Rambo LM, 2012, BRAIN RES BULL, V88, P553, DOI 10.1016/j.brainresbull.2012.06.007; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; 2013, NEUROPHARMACOLOGY, V67, P455, DOI DOI 10.1016/J.NEUROPHARM.2012.10.022; 2016, J NEUROTRAUM, V33, P1317, DOI DOI 10.1089/NEU.2015.4068	18	2	2	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	JUL 5	2019	854						387	397		10.1016/j.ejphar.2019.02.040			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HY7HQ	WOS:000468305200044	30807746				2022-02-06	
J	Oddo, A; O'Conor, E; Shore, S; Piraino, M; Gibney, K; Tsao, J; Stanfill, AG				Oddo, Anthony; O'Conor, Ellen; Shore, Sarah; Piraino, Mary; Gibney, Kyla; Tsao, Jack; Stanfill, Ansley Grimes			Making Headway for Discussions About Concussions: Experiences of Former High School and Collegiate Student-Athletes	FRONTIERS IN NEUROLOGY			English	Article						concussion; traumatic brain injury; athlete; sports; adolescent	EDUCATION; SYMPTOMS; KNOWLEDGE; PLAYERS	In order to better understand how to identify and treat student-athletes who experience concussions, better insight into reporting behavior of athletes is needed. This study aims to identify information influencing athletes' attitudes toward reporting their concussions and the perceived trajectory of their recovery both athletically and academically. Twenty-five former high school and collegiate athletes who experienced concussions in a wide variety of sports, organizational levels, and time periods gave insight through structured, qualitative interviews. A number of factors regarding education about concussions, proper diagnosis of concussions, and motivational pressures within high school and collegiate athletics were assessed. Eight major themes were identified regarding the participants' experiences with sport-related concussion: optimism bias, invisibility of the injury, diagnostic barriers, desire to play, external support and pressures, uncertainty of long-term prognosis, generational factors, and protection of future athletes. The findings support that underreporting of concussions among those players interviewed is related to misperceived risk, lack of education, and a struggle between internal and external pressures to play through injury. However, those who did seek medical and academic support, often did receive the necessary aid.	[Oddo, Anthony] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [O'Conor, Ellen; Shore, Sarah; Gibney, Kyla; Tsao, Jack] Univ Tennessee, Ctr Hlth Sci, Coll Med, Dept Neurol, Memphis, TN 38163 USA; [Piraino, Mary; Stanfill, Ansley Grimes] Univ Tennessee, Ctr Hlth Sci, Coll Nursing, Dept Acute & Tertiary Care, Memphis, TN 38163 USA		Stanfill, AG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Nursing, Dept Acute & Tertiary Care, Memphis, TN 38163 USA.	astanfi4@uthsc.edu		Gibney, Kyla/0000-0003-4319-9200	University of Tennessee Health Science Center College of Nursing Dean's Research Fellowship Award	This work was supported by the University of Tennessee Health Science Center College of Nursing Dean's Research Fellowship Award (PI: AS).	Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Beverly EA, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0818-2; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Caron JG, 2018, J SPORT SCI, V36, P48, DOI 10.1080/02640414.2017.1280180; Carroll-Alfano M, 2017, J ATHL TRAINING, V52, P689, DOI 10.4085/1062-6050-52.3.08; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Devitt BM, 2016, CLIN SPORT MED, V35, P195, DOI 10.1016/j.csm.2015.10.004; Greenwald RM, 2012, CLIN J SPORT MED, V22, P83, DOI 10.1097/JSM.0b013e31824cc5d3; Howland J, 2018, J SCH NURS, V34, P344, DOI 10.1177/1059840517702697; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Knoll LJ, 2015, PSYCHOL SCI, V26, P583, DOI 10.1177/0956797615569578; Kuhn AW, 2017, NEUROSURGERY, V64, P211, DOI 10.1093/neuros/nyx294; Leitch H, 2015, J NATL MED ASSOC, V107, P60, DOI 10.1016/S0027-9684(15)30053-5; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McDonald T, 2016, J TRAUMA NURS, V23, P241, DOI 10.1097/JTN.0000000000000227; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Pringle Jan, 2018, Pilot Feasibility Stud, V4, P69, DOI 10.1186/s40814-018-0259-7; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Sarmiento K, 2019, J SAFETY RES, V68, P223, DOI 10.1016/j.jsr.2018.10.010; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1	27	2	2	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 5	2019	10								698	10.3389/fneur.2019.00698			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IH1XA	WOS:000474286500001	31333560	Green Published, gold			2022-02-06	
J	Clasby, B; Bennet, M; Hughes, N; Hodges, E; Meadham, H; Hinder, D; Williams, H; Mewse, A				Clasby, Betony; Bennet, Matthew; Hughes, Nathan; Hodges, Emma; Meadham, Hannah; Hinder, Darren; Williams, Huw; Mewse, Avril			The consequences of traumatic brain injury from the classroom to the courtroom: understanding pathways through structural equation modelling	DISABILITY AND REHABILITATION			English	Article						Brain injuries; post-concussion syndrome; educational status; schools; crime; criminals	CONCUSSION SYMPTOMS QUESTIONNAIRE; HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; CHILDHOOD TRAUMA; MENTAL-HEALTH; CHILDREN; PREVALENCE; PREDICTORS; TBI; PERFORMANCE	Purpose: Paediatric traumatic brain injury (TBI) can have resultant ongoing significant impairments which can impact life outcomes. The primary aim of this research was to explore whether TBI contributes to the relationship between poor educational outcomes and offending trajectories. Materials and methods: Through analysis of a dataset consisting of self-reported health, educational, and offending histories of 70 incarcerated young males, structural equation modelling was used to explore the mediation of educational outcomes and patterns in offending behaviour by chronic symptoms following TBI. Results: Symptoms related to TBI significantly mediated the relationship between decreased educational attainment and more frequent convictions. It did not mediate any relationships involving age at first conviction. Conclusions: Traumatic brain injury appears to have more influence over frequency of offending patterns than age at first conviction. However, TBI remains a pervasive factor in both higher rates of offending and poorer educational attainment. In order to tackle this effect on adverse social outcomes, greater attention to the impact of TBI is required in education and criminal justice systems.	[Clasby, Betony; Hughes, Nathan] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Clasby, Betony; Hughes, Nathan] Univ Sheffield, Dept Sociol Studies, Sheffield, S Yorkshire, England; [Bennet, Matthew] Univ Birmingham, Dept Social Policy Sociol & Criminol, Birmingham, W Midlands, England; [Hodges, Emma; Meadham, Hannah; Hinder, Darren; Williams, Huw; Mewse, Avril] Univ Exeter, Dept Psychol, Exeter, Devon, England; [Meadham, Hannah] Hywel Dda Univ Hlth Board, Carmarthen Community Team Learning Disabil, Carmarthen, Dyfed, Wales		Clasby, B (corresponding author), Dept Sociol Studies, Northumberland Rd, Sheffield S10 2TU, S Yorkshire, England.	beclasby1@sheffield.ac.uk	Clasby, Betony/ABC-4657-2020; Hughes, Nathan/O-8600-2014	Clasby, Betony/0000-0001-7104-4308; Hughes, Nathan/0000-0002-5859-808X; Bennett, Matthew/0000-0002-9523-6053	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_PC_MR/R019991/1] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_PC_MR/R019991/1] Funding Source: Medline		Anderson V., 2002, PRINCIPLES FRONTAL L; [Anonymous], 2018, PERM FIX PER EXCL EN; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bollen K.A., 2013, HDB CAUSAL ANAL SOCI, P301; Bowman-Perrott L, 2013, J EMOT BEHAV DISORD, V21, P83, DOI 10.1177/1063426611407501; Broomhall L., 2005, PSYCHIAT PSYCHOL LAW, V12, P367, DOI DOI 10.1375/PPLT.12.2.367; Bryan K, 2007, INT J LANG COMM DIS, V42, P505, DOI 10.1080/13682820601053977; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Creese B, 2016, LOND REV EDUC, V14, P13, DOI 10.18546/LRE.14.3.02; Dennis M., 1989, CLIN NEUROPSYCHOLOGY; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Farrington D P, 1989, Violence Vict, V4, P79; Farrington D.P., 2006, CRIMINAL CAREERS AGE, V2nd; Faul MXL., 2010, TRAUMATIC BRAIN INJU, P2002; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Field A., 2017, DISCOVERING STAT USI, V5th; Fielding S, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-57; Glang A, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P602; Glass D, 2018, INVESTIGATION VICTOR; Gunter TD, 2013, J AM ACAD PSYCHIATRY, V41, P245; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hjalmarsson R, 2015, ECON J, V125, P1290, DOI 10.1111/ecoj.12204; Hooper D., 2008, EJBRM, V6, P53, DOI [10.21427/D7CF7R, DOI 10.21427/D7CF7R]; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hoyle R. H., 1995, STRUCTURAL EQUATION, P159; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Kawachi I, 1999, SOC SCI MED, V48, P719, DOI 10.1016/S0277-9536(98)00400-6; Kenny DT, 2007, CONT ISSUES CRIME JU, V107, P1; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Knight V, 2014, BR J COMMUN JUST, V12, P49; Konrad KN, 2000, BRAIN INJURY, V14, P859; Krezmien MP, 2006, J EMOT BEHAV DISORD, V14, P217, DOI 10.1177/10634266060140040501; Lan W., 2003, J ED STUDENTS PLACED, V8, P309, DOI DOI 10.1207/S15327671ESPR0803_2; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lee VE, 2003, AM EDUC RES J, V40, P353, DOI 10.3102/00028312040002353; Lei PW., 2007, EDUC MEAS-ISSUES PRA, V26, P33, DOI [10.1111/j.1745-3992.2007.00099.x, DOI 10.1111/J.1745-3992.2007.00099.X]; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Losen D.J., 2015, ARE WE CLOSING SCH D; Machin S, 2012, GER ECON REV, V13, P366, DOI 10.1111/j.1468-0475.2012.00576.x; Machin S, 2011, ECON J, V121, P463, DOI 10.1111/j.1468-0297.2011.02430.x; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; McKinlay A, 2016, J INT NEUROPSYCH SOC, V22, P717, DOI 10.1017/S1355617716000497; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McVie S., 2005, BRIT SOC CRIMINOLOGY, V7, P1; Ministry of Finance P, 2018, FACTSH SCHORS VERW 2, P7; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Mounce L, 2011, OUTCOME MILD T UNPUB; Nachtigall C., 2003, METHODS PSYCHOL RES, V8, P1; Neild RC, 2007, EDUC LEADERSHIP, V65, P28; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Porche MV, 2011, CHILD DEV, V82, P982, DOI 10.1111/j.1467-8624.2010.01534.x; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Schroeder RD, 2010, J ADOLESCENT RES, V25, P64, DOI 10.1177/0743558409354215; Shah R, 2006, J OPER MANAG, V24, P148, DOI 10.1016/j.jom.2005.05.001; Spady DW, 2004, PEDIATRICS, V113, P522, DOI 10.1542/peds.113.3.522; Stoddard SA, 2011, PEDIATRICS, V127, P1074, DOI 10.1542/peds.2010-2453; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Voormolen DC, 2019, BRAIN INJURY, V33, P1078, DOI 10.1080/02699052.2019.1607557; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Welch K., 2017, ENCY JUVENILE DELINQ, P1, DOI [10.1002/9781118524275.ejdj0102, DOI 10.1002/9781118524275.EJDJ0102]; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	83	2	2	3	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	AUG 13	2020	42	17			SI		2412	2421		10.1080/09638288.2019.1635214		JUL 2019	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NE7PD	WOS:000474400000001	31282232	Green Published, Green Accepted			2022-02-06	
J	Mayo, CD; Scarapicchia, V; Robinson, LK; Gawryluk, JR				Mayo, Chantel D.; Scarapicchia, Vanessa; Robinson, Lara K.; Gawryluk, Jodie R.			Neuropsychological assessment of traumatic brain injury: Current ethical challenges and recommendations for future practice	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Ethics; neuropsychology; traumatic brain injury	DECISION-MAKING CAPACITY; INFORMED-CONSENT; CLINICAL NEUROPSYCHOLOGY; 3RD-PARTY OBSERVATION; ISSUES; COMPETENCE; CONTROVERSIES; ASSOCIATION; TECHNOLOGY; DISCLOSURE	Numerous ethical challenges may arise over the course of neuropsychological assessment. This paper highlights the ethical considerations associated with neuropsychological assessment of individuals with traumatic brain injury. Issues regarding professional competency, providing and obtaining informed consent, neuropsychological test selection and administration, effectively communicating assessment results, and working as part of a multidisciplinary team are discussed with practical recommendations. Ultimately, a comprehensive understanding of these issues as well as an integration of resources to guide clinical practice will contribute to ethical decision-making and strong professional practice.	[Mayo, Chantel D.; Scarapicchia, Vanessa; Robinson, Lara K.; Gawryluk, Jodie R.] Univ Victoria, Dept Psychol, POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada		Gawryluk, JR (corresponding author), Univ Victoria, Dept Psychol, POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada.	gawryluk@uvic.ca		Gawryluk, Jodie/0000-0003-4924-7517			Adams KM, 2000, PSYCHOL ASSESSMENT, V12, P281, DOI 10.1037/1040-3590.12.3.281; American Psychological Association [APA], 2010, ETH PRINC PSYCH COD; Attix DK, 2007, CLIN NEUROPSYCHOL, V21, P232, DOI 10.1080/13854040601042928; Banja JD, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1374; Barnett JE, 2007, PROF PSYCHOL-RES PR, V38, P510, DOI 10.1037/0735-7028.38.5.510; Bennett T. L., 2008, NEUROPSYCHOLOGY HDB, P533; BINDER LM, 1995, ARCH CLIN NEUROPSYCH, V10, P27, DOI 10.1016/0887-6177(93)E0004-U; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Brickman AM, 2006, APPL NEUROPSYCHOL, V13, P91, DOI 10.1207/s15324826an1302_4; Bush S, 2002, CLIN NEUROPSYCHOL, V16, P536, DOI 10.1076/clin.16.4.536.13911; Bush S. S., 2008, NEUROPSYCHOLOGY HDB, P515; Bush SS, 2008, J HEAD TRAUMA REHAB, V23, P181, DOI 10.1097/01.HTR.0000319936.07462.7c; Bush SS, 2008, CLIN NEUROPSYCHOL, V22, P321, DOI 10.1080/13854040601139187; Bush SS, 2006, APPL NEUROPSYCHOL, V13, P63, DOI 10.1207/s15324826an1302_1; Bush SS, 2015, NEUROREHABILITATION, V36, P383, DOI 10.3233/NRE-151227; Bush SS, 2010, CLIN NEUROPSYCHOL, V24, P7, DOI 10.1080/13854040903313589; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; BUSH SS, 2007, ETHICAL DECISION MAK; Cairncross M, 2016, CAMB Q HEALTHC ETHIC, V25, P691, DOI 10.1017/S0963180116000414; Canadian Psychological Association, 2002, CAN COD ETH PSYCH; Casas R, 2012, CLIN NEUROPSYCHOL, V26, P88, DOI 10.1080/13854046.2011.640641; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Demakis GJ, 2013, PSYCHOL INJ LAW, V6, P41, DOI 10.1007/s12207-013-9147-x; Fields LM, 2015, PSYCHIAT CLIN NEUROS, V69, P462, DOI 10.1111/pcn.12289; Fujii D., 2017, CONDUCTING CULTURALL, P13; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Howe LLS, 2010, CLIN NEUROPSYCHOL, V24, P518, DOI 10.1080/13854041003775347; Hudgins C, 2013, FAM SYST HEALTH, V31, P9, DOI 10.1037/a0031974; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Johnson-Greene D, 1997, CLIN NEUROPSYCHOL, V11, P454, DOI 10.1080/13854049708400478; Johnson-Greene D, 2005, ARCH CLIN NEUROPSYCH, V20, P335, DOI 10.1016/j.acn.2004.08.003; Johnson-Greene D., 2008, TXB CLIN NEUROPSYCHO, P945; Johnson-Greene D, 2010, J HEAD TRAUMA REHAB, V25, P145, DOI 10.1097/HTR.0b013e3181d8287d; Kaufmann PM, 2009, CLIN NEUROPSYCHOL, V23, P1130, DOI 10.1080/13854040903107809; Kazarian S. S., 2011, LAW STANDARDS PRACTI, P317; Lewandowski A, 2016, APPL NEUROPSYCH-ADUL, V23, P391, DOI 10.1080/23279095.2016.1176366; Liu ZL, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.593; Lux WE, 2007, NEUROTHERAPEUTICS, V4, P525, DOI 10.1016/j.nurt.2007.04.002; Manly JJ, 2008, NEUROPSYCHOL REV, V18, P179, DOI 10.1007/s11065-008-9068-8; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; Martin TA, 2008, NEUROREHABILITATION, V23, P447; Moberg PJ, 2006, APPL NEUROPSYCHOL, V13, P101, DOI 10.1207/s15324826an1302_5; Moberg PJ, 2012, CIVIL CAPACITIES CLI, P264; Morris T, 2010, HANDBOOK OF MEDICAL NEUROPSYCHOLOGY: APPLICATIONS OF COGNITIVE NEUROSCIENCE, P17, DOI 10.1007/978-1-4419-1364-7_2; Nagy T. F., 2000, ETHICS PLAIN ENGLISH; National Academy of Neuropsychology, 2003, TEST SEC UPD; Owen GS, 2017, NEUROPSYCHOL REHABIL, V27, P133, DOI 10.1080/09602011.2015.1053948; Palmer BW, 2016, ARCH CLIN NEUROPSYCH, V31, P530, DOI 10.1093/arclin/acw051; Palmer RM, 2012, IMPLANTS IN CLINICAL DENTISTRY, 2ND EDITION, P69; Prigatano GP, 2009, CURR OPIN NEUROL, V22, P606, DOI 10.1097/WCO.0b013e328332a1e7; Rapp D. L., 2008, NEUROPSYCHOLOGY HDB, P471; Rey-Casserly C., 2013, HDB PSYCHOL ASSESSME, P192; Rey-Casserly C, 2012, PROF PSYCHOL-RES PR, V43, P422, DOI 10.1037/a0028721; Rosenthal M, 1996, NEUROREHABILITATION, V6, P113, DOI 10.3233/NRE-1996-6203; Sherer M, 2014, HDB NEUROPSYCHOLOGY, P49; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson LL, 2002, STUD NEUROPSYCHOL DE, P51; Triebel KL, 2012, NEUROLOGY, V78, P1472, DOI 10.1212/WNL.0b013e3182553c38; Triebel KL, 2016, J HEAD TRAUMA REHAB, V31, pE49, DOI 10.1097/HTR.0000000000000163; Tussey CM, 2015, PSYCHOL INJ LAW, V8, P281, DOI 10.1007/s12207-015-9240-4; Wajman José Roberto, 2015, Dement. neuropsychol., V9, P203, DOI [10.1590/1980-57642015dn93000002, 10.1590/1980-57642015DN93000002]; White MH, 2016, AUST PSYCHOL, V51, P352, DOI 10.1111/ap.12206; Wilde E, 2002, STUD NEUROPSYCHOL DE, P195; Wong TM, 2006, APPL NEUROPSYCHOL, V13, P68, DOI 10.1207/s15324826an1302_2; Zgaljardic D. J., 2014, HDB CLIN PSYCHOL MED, P691	65	2	2	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	JUL 4	2019	26	4					383	391		10.1080/23279095.2017.1416472			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	IL0AC	WOS:000476957400009	29313718				2022-02-06	
J	Rigon, A; Voss, MW; Turkstra, LS; Mutlu, B; Duff, MC				Rigon, Arianna; Voss, Michelle W.; Turkstra, Lyn S.; Mutlu, Bilge; Duff, Melissa C.			White matter correlates of different aspects of facial affect recognition impairment following traumatic brain injury	SOCIAL NEUROSCIENCE			English	Article						TBI; emotion recognition; emotion labeling; facial affect recognition; emotion matching; fractional anisotropy	SOCIAL-COMMUNICATION IMPAIRMENT; EMOTION RECOGNITION; STRUCTURAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; ANATOMIC DISSECTION; UNCINATE FASCICULUS; DIFFUSION; MICROSTRUCTURE; EXPRESSION; NETWORK	Although facial affect recognition deficits are well documented in individuals with moderate-to-severe traumatic brain injury (TBI), little research has examined the neural mechanisms underlying these impairments. Here, we use diffusion tensor imaging (DTI), specifically the scalars fractional anisotropy (FA), mean diffusivity (MD), and radial diffusivity (RD), to examine relationships between regional white-matter integrity and two facial affect sub-skills: perceptual affect recognition abilities (measured by an affect matching task) and verbal categorization of facial affect (measured by an affect labeling task). Our results showed that, within the TBI group, higher levels of white-matter integrity in tracts involved in affect recognition (inferior fronto-occipital, inferior longitudinal, and uncinate fasciculi) were associated with better performance on both tasks. Verbal categorization skills were specifically and positively correlated with integrity of the left uncinate fasciculus. Moreover, we observed a striking lateralization effect, with perceptual abilities having an almost exclusive relationship with integrity of right hemisphere tracts, while verbal abilities were associated with both left and right hemisphere integrity. The findings advance our understanding of the neurobiological mechanisms that underlie subcomponents of facial affect recognition and lead to different patterns of facial affect recognition impairment in adults with TBI.	[Rigon, Arianna] Univ Iowa, Interdisciplinary Neurosci Program, Iowa City, IA USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA; [Turkstra, Lyn S.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Mutlu, Bilge] Univ Wisconsin Madison, Dept Comp Sci, Madison, WI USA; [Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA		Rigon, A (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA.	arianna.rigon@vanderbilt.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NICHD/NCMRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD071089]; American Psychological Foundation Benton-Meier Fellowship; University of Iowa Magnetic Resonance Research Facility; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER	The current work was supported by the by NICHD/NCMRR grant R01 HD071089, by an American Psychological Foundation Benton-Meier Fellowship, and by a pilot grant issued by the University of Iowa Magnetic Resonance Research Facility.	ADAMS J, 2017, LANCET, V2, P1420; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Back SA, 2011, ANN NEUROL, V70, P465, DOI 10.1002/ana.22484; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Catani M, 2003, ANN NEUROL, V53, P242, DOI 10.1002/ana.10445; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Germine LT, 2011, PSYCHOL MED, V41, P937, DOI 10.1017/S0033291710001571; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; KERR SL, 1993, J ABNORM PSYCHOL, V102, P312, DOI 10.1037/0021-843X.102.2.312; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; McLaughlin NCR, 2007, INT J DEV NEUROSCI, V25, P215, DOI 10.1016/j.ijdevneu.2007.03.008; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Neumann D, 2016, BRAIN IMAGING BEHAV, V10, P569, DOI 10.1007/s11682-015-9415-3; Palermo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068126; PETTERSEN L, 2003, PERCEPT MOTOR SKIL 2, V73, P1139; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Power JD, 2014, NEURON, V84, P681, DOI 10.1016/j.neuron.2014.09.007; Racine AM, 2014, NEUROIMAGE-CLIN, V4, P604, DOI 10.1016/j.nicl.2014.02.001; Rigon A, 2017, NEUROIMAGE-CLIN, V13, P370, DOI 10.1016/j.nicl.2016.12.010; Rigon A, 2018, NEUROPSYCHOLOGY, V32, P476, DOI 10.1037/neu0000368; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Ryan NP, 2017, SOC COGN AFFECT NEUR, V12, P1414, DOI 10.1093/scan/nsx066; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Staios M, 2013, FRONT HUM NEUROSCI, V7, DOI [10.3389/fnhum.2013.00178, 10.3389/fnhum.2013.00464]; Tamamiya Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057325; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	69	2	2	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-0919	1747-0927		SOC NEUROSCI-UK	Soc. Neurosci.	JUL 4	2019	14	4					434	448		10.1080/17470919.2018.1489302			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HZ4NJ	WOS:000468824700006	29902960	Green Accepted			2022-02-06	
J	Bandelow, NC; Hartmann, A; Hornung, J				Bandelow, Nils C.; Hartmann, Anja; Hornung, Johanna			Winter is Coming - But Not Yet. German Health Policy Under the Third Merkel Chancellorship	GERMAN POLITICS			English	Article							PUNCTUATED EQUILIBRIUM; TOBACCO CONTROL	Health policy in Germany for a long time was considered to be hardly reformable. During the last 25 years, reforms became more frequent, yet substantial major policy change is still rare. When taking a closer look, German health policy follows phases of stability alternating with punctuations of this equilibrium when fundamental structural reforms occur. This contribution analyses the German health policy of the 18th legislative period against the backdrop of this newly emerging pattern of health policy making by applying Punctuated Equilibrium Theory (PET). Marginal reforms without profound reorganisation of the health system were only possible in this period because of the particularly favourable financial situation of sickness funds. Consequently, the conflicting parties and interest groups were able to postpone fundamental solutions to upcoming problems to a later point in time. After explaining the marginal reforms under the third Grand Coalition, it becomes clear that the dominant equilibrium is not going to last: Winter is coming and will bring about concussions in German health policy soon.	[Bandelow, Nils C.] Tech Univ Carolo Wilhelmina Braunschweig, Polit Sci, Braunschweig, Germany; [Hartmann, Anja] Univ Appl Sci & Arts Dortmund, Sociol Demog Change, Dortmund, Germany; [Hornung, Johanna] Tech Univ Carolo Wilhelmina Braunschweig, Chair Comparat Polit & Publ Policy, Braunschweig, Germany		Bandelow, NC (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Polit Sci, Braunschweig, Germany.		Hornung, Johanna/AAC-4038-2020	Hornung, Johanna/0000-0001-6542-3985; Bandelow, Nils C./0000-0002-6745-3253	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [BA 1912/3-1]; Agence Nationale de la RechercheFrench National Research Agency (ANR)European Commission [ANR-17-FRAL-0008-01]	This work was supported by Deutsche Forschungsgemeinschaft [grant number BA 1912/3-1] and the Agence Nationale de la Recherche (grant number ANR-17-FRAL-0008-01).	Altenstetter C, 2005, J HEALTH POLIT POLIC, V30, P121, DOI 10.1215/03616878-30-1-2-121; Bandelow NC, 2019, J COMP POLICY ANAL, V21, P167, DOI 10.1080/13876988.2017.1393920; Bandelow NC, 2014, GER POLIT, V23, P371, DOI 10.1080/09644008.2014.953067; Baumgartner F.R., 2009, CHICAGO STUDIES AM P; Baumgartner FR, 2009, AM J POLIT SCI, V53, P603, DOI 10.1111/j.1540-5907.2009.00389.x; Baumgartner Frank R., 2017, THEORIES POLICY PROC, V4th ed., P55; Berger Elke, 2018, GESUNDHEITS SOZIALPO, V73, P1611; Breunig C, 2006, J EUR PUBLIC POLICY, V13, P1069, DOI 10.1080/13501760600924167; Breunig C, 2011, COMP POLIT STUD, V44, P1060, DOI 10.1177/0010414011405169; Brunn M., 2018, G S GESUNDHEITS SOZI G S GESUNDHEITS SOZI, P7; Busse R, 2017, LANCET, V390, P882, DOI 10.1016/S0140-6736(17)31280-1; Czada Roland., 2005, GOVERNANCE CONT GERM, P165; Deruelle Thibaud, 2016, Eur Policy Anal, V2, P43, DOI 10.18278/epa.2.2.4; Dohler M., 1991, POLICY NETWORKS EMPI, P235; Ewert Benjamin., 2015, EUROPEAN POLICY ANAL, V1, P149, DOI [10.18278/epa.1.1.10, DOI 10.18278/epa.1.1.10]; Fagan EJ, 2017, J EUR PUBLIC POLICY, V24, P809, DOI 10.1080/13501763.2017.1296483; Gruning T, 2008, GER POLIT, V17, P140, DOI 10.1080/09644000802075708; Hassenteufel P, 2010, J HEALTH POLIT POLIC, V35, P517, DOI 10.1215/03616878-2010-015; Herweg N, 2018, THEORIES POLICY PROC, P17, DOI [10.4324/9780429494284-2, DOI 10.4324/9780429494284-2]; Katzenstein P., 1987, POLICY POLITICS W GE; Knieps F, 2017, GESUNDHEITSPOLITIK A; Kohlen H, 2016, ETHIK MED, V28, P1, DOI 10.1007/s00481-015-0378-0; Osterloh F., 2014, DT ARZTEBLATT, V111, pC560; Poguntke T., 2007, PRESIDENTIALIZATION; Ruof J, 2014, EUR J HEALTH ECON, V15, P577, DOI 10.1007/s10198-013-0495-y; Schaich-Walch Gudrun, 2016, IMPULSE; Statistisches Bundesamt, 2017, STAT JB DEUTSCHL INT; Studlar DT, 2014, INT REV ADM SCI, V80, P513, DOI 10.1177/0020852313517997; Walgrave S, 2008, GOVERNANCE, V21, P365, DOI 10.1111/j.1468-0491.2008.00404.x; Wilsford D, 1994, J PUBLIC POLICY, V14, P251, DOI DOI 10.1017/S0143814X00007285; Worsham J, 2012, POLICY STUD J, V40, P169, DOI 10.1111/j.1541-0072.2011.00439.x	31	2	2	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0964-4008	1743-8993		GER POLIT	Ger. Polit.	JUL 3	2019	28	3			SI		444	461		10.1080/09644008.2018.1512592			18	Political Science	Social Science Citation Index (SSCI)	Government & Law	IE7FH	WOS:000472539300009		Bronze			2022-02-06	
J	Bueso-Izquierdo, N; Verdejo-Roman, J; Martinez-Barbero, JP; Perez-Rosillo, MA; Perez-Garcia, M; Hidalgo-Ruzzante, N; Hart, SD				Bueso-Izquierdo, Natalia; Verdejo-Roman, Juan; Pablo Martinez-Barbero, Jose; Angel Perez-Rosillo, Miguel; Perez-Garcia, Miguel; Hidalgo-Ruzzante, Natalia; Hart, Stephen D.			Prevalence and Nature of Structural Brain Abnormalities in Batterers: A Magnetic Resonance Imaging Study	INTERNATIONAL JOURNAL OF FORENSIC MENTAL HEALTH			English	Article						Intimate partner violence; structural brain abnormalities; magnetic resonance imaging	INCIDENTAL FINDINGS; DOMESTIC VIOLENCE; CLINICAL MANAGEMENT; PINEAL CYSTS; MRI; NEUROSCIENCE; NEUROPSYCHOLOGY; PERPETRATORS; POPULATION; OFFENDERS	Introduction: Past research has found differences in the brain activation of batterers vs. other offenders in response to depictions of violence, but it is not known whether these functional differences are associated with structural brain abnormalities (SBAs). Objective: Investigate the prevalence and nature of SBAs in batterers using neuroimaging methods. Method: Two neuroradiologists independently diagnosed SBAs based on Magnetic Resonance Imaging scans for the 21 batterers and 20 other offenders. All participants had been screened to ensure that they had no obvious brain damage secondary to neurological injury or insult, including traumatic brain injury. Results: One participant had both a major and minor SBA; 13 had one or more minor SBAs. Most were judged to be not clinically relevant. Conclusion: SBAs are not strongly or specifically associated with IPV, and it is unlikely they are responsible for the differences in brain functioning between batterers and other offenders observed in past research.	[Bueso-Izquierdo, Natalia; Perez-Garcia, Miguel] Univ Granada, Dept Personal Assessment & Psychol Treatment, Granada, Spain; [Bueso-Izquierdo, Natalia; Verdejo-Roman, Juan; Perez-Garcia, Miguel; Hidalgo-Ruzzante, Natalia] Univ Granada, CIMCYC UGR, Brain Mind & Behav Res Ctr, Campus Cartuja S-N, E-18071 Granada, Spain; [Verdejo-Roman, Juan] Univ Granada, Dept Expt Psychol, Granada, Spain; [Pablo Martinez-Barbero, Jose] HealthTime Grp, EDiNRNeuroimaging Dept, Jaen, Spain; [Angel Perez-Rosillo, Miguel] Hosp Comarcal Ubeda, Radiol Dept, Ubeda, Spain; [Hidalgo-Ruzzante, Natalia] Univ Granada, Dept Dev & Educ Psychol, Granada, Spain; [Hart, Stephen D.] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Hart, Stephen D.] Univ Bergen, Bergen, Norway		Verdejo-Roman, J (corresponding author), Univ Granada, CIMCYC UGR, Brain Mind & Behav Res Ctr, Campus Cartuja S-N, E-18071 Granada, Spain.	juanverdejo@ugr.es	Hidalgo-Ruzzante, Natalia/F-1108-2016; Hart, Stephen D./D-3908-2013; Roman, Juan Verdejo/B-5188-2017; Perez-Garcia, Miguel/F-9630-2010	Hidalgo-Ruzzante, Natalia/0000-0002-9952-9478; Hart, Stephen D./0000-0002-1027-6081; Roman, Juan Verdejo/0000-0001-5112-8918; Bueso Izquierdo, Natalia/0000-0002-2469-8867; Perez-Garcia, Miguel/0000-0003-4775-7556; Martinez-Barbero, Jose Pablo/0000-0003-4217-0633			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Becerra-Garcia JA, 2015, MED SCI LAW, V55, P35, DOI 10.1177/0025802414525148; Berhouma M, 2015, NEUROCHIRURGIE, V61, P201, DOI 10.1016/j.neuchi.2013.08.010; Bos D, 2016, RADIOLOGY, V281, P507, DOI 10.1148/radiol.2016160218; Bueso-Izquierdo N, 2016, SOC COGN AFFECT NEUR, V11, P852, DOI 10.1093/scan/nsw020; Bueso-Izquierdo N, 2015, AGGRESS VIOLENT BEH, V25, P243, DOI 10.1016/j.avb.2015.09.009; Chester DS, 2018, CURR OPIN PSYCHOL, V19, P55, DOI 10.1016/j.copsyc.2017.04.009; Choudhury S, 2009, BIOSOCIETIES, V4, P61, DOI 10.1017/S1745855209006437; Cohen RA, 2003, J INT NEUROPSYCH SOC, V9, P760, DOI 10.1017/S1355617703950090; Corvo K, 2013, AGGRESS VIOLENT BEH, V18, P175, DOI 10.1016/j.avb.2012.11.017; Eastman N, 2006, NAT REV NEUROSCI, V7, P311, DOI 10.1038/nrn1887; Evans RW, 2017, HEADACHE, V57, P780, DOI 10.1111/head.13057; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Filippi M, 2016, LANCET NEUROL, V15, P292, DOI 10.1016/S1474-4422(15)00393-2; First M.B., 1999, GUIA USUARIO ENTREVI; Gazzaniga MS, 2008, NEURON, V60, P412, DOI 10.1016/j.neuron.2008.10.022; George DT, 2006, MED HYPOTHESES, V67, P345, DOI 10.1016/j.mehy.2006.01.049; Gondolf E., 2007, COURT REV, V43, P178; Gondolf EW, 2011, AGGRESS VIOLENT BEH, V16, P347, DOI 10.1016/j.avb.2011.04.011; Goodenough OR, 2010, ANNU REV LAW SOC SCI, V6, P61, DOI 10.1146/annurev.lawsocsci.093008.131523; Harper L, 2015, J NEUROL NEUROSUR PS, V86, P1225, DOI 10.1136/jnnp-2014-310090; Hart S.D., 2016, WILEY HDB THEORIES A, P643, DOI https://doi.org/10.1002/9781118574003.wattso030; Hart SD, 2011, WILEY SER FOREN CLIN, P83; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kaufman N. L., 1997, K BIT TEST BREVE INT; Knabb JJ, 2009, BEHAV SCI LAW, V27, P219, DOI 10.1002/bsl.854; Lee TMC, 2008, MOL PSYCHIATR, V13, P655, DOI 10.1038/mp.2008.46; Lee TMC, 2009, J CLIN PSYCHIAT, V70, P36, DOI 10.4088/JCP.08m04143; Majovsky M, 2016, ACTA NEUROCHIR, V158, P663, DOI 10.1007/s00701-016-2726-3; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Osborn AG, 2015, DIAGNOSTIC IMAGING B; OSBORN RE, 1991, AM J NEURORADIOL, V12, P521; Pinto LA, 2010, AGGRESS VIOLENT BEH, V15, P387, DOI 10.1016/j.avb.2010.07.001; Romero-Martinez A, 2013, REV NEUROLOGIA, V57, P515, DOI 10.33588/rn.5711.2013141; Seifert CL, 2008, HEADACHE, V48, P448, DOI 10.1111/j.1526-4610.2007.00965.x; Sempere AP, 2005, CEPHALALGIA, V25, P30, DOI 10.1111/j.1468-2982.2004.00798.x; Slotter E.B., 2011, HUMAN AGGRESSION VIO, P35, DOI [10.1037/ 12346-002., DOI 10.1037/12346-002, 10.1037/12346-002]; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Topper R, 1999, J NEUROL NEUROSUR PS, V67, P234, DOI 10.1136/jnnp.67.2.234; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Vincent N, 2013, NEUROSCIENCE LEGAL R; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wikstrom POH, 2009, INT J CONFL VIOLENCE, V3, P75; World Health Organization, 2002, WORLD REPORT VIOLENC	44	2	2	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1499-9013	1932-9903		INT J FORENSIC MENT	Int. J. Forensic Ment. Health	JUL 3	2019	18	3			SI		220	227		10.1080/14999013.2018.1476422			8	Criminology & Penology; Psychiatry	Social Science Citation Index (SSCI)	Criminology & Penology; Psychiatry	JD0UV	WOS:000489692900005					2022-02-06	
J	Chen, NYC; Batchelor, J				Chen, Nicole Yun Ching; Batchelor, Jennifer			Length of post-traumatic amnesia and its prediction of neuropsychological outcome following severe to extremely severe traumatic brain injury in a litigating sample	BRAIN INJURY			English	Article						Post-traumatic amnesia; traumatic brain injury; litigation; cognition; neuropsychology	SEVERE HEAD-INJURY; PERCEIVED INJUSTICE; COGNITIVE SEQUELAE; MODERATE; EXPERIENCE; RECOVERY; DURATION; SCALE; NEUROPATHOLOGY; MULTICENTER	Primary Objective: The aim of the current study was to examine the relationship between duration of post-traumatic amnesia (PTA) and neuropsychological outcome at one or more years following severe to extremely severe traumatic brain injury (TBI) in a litigating sample.Research Design: Retrospective study design, using data collected from 2010 to 2017.Methods and Procedures: Data from 41 cases obtained from a private medicolegal neuropsychological database was examined. The database comprised information pertaining to TBI etiology, TBI severity parameters, demographic variables, neuropsychological test results and scores on psychological questionnaires. PTA duration was examined as a continuous variable. All cases that demonstrated non-credible effort were excluded.Main Outcomes and Results: Continuous PTA duration was not found to be a significant predictor of cognitive impairment across domains of verbal intellect, non-verbal intellect, working memory, information processing speed, immediate memory, delayed memory, and executive functioning.Conclusions: The predictive relationship between duration of PTA and cognitive impairment that has been reported in non-litigating populations did not exist in a litigating TBI sample. Findings illustrate the importance of investigating the relationships between injury variables and cognitive outcome in a population undergoing litigation, to provide better understanding of outcome in this subgroup of patients with TBI.	[Chen, Nicole Yun Ching; Batchelor, Jennifer] Macquarie Univ, Dept Psychol, Balaclava Rd,Macquarie Pk NSW, Sydney, NSW 2109, Australia		Chen, NYC (corresponding author), Macquarie Univ, Dept Psychol, Balaclava Rd,Macquarie Pk NSW, Sydney, NSW 2109, Australia.	nicole.chen@students.mq.edu.au		Chen, Nicole/0000-0003-3718-1127; Batchelor, Jennifer/0000-0003-4438-4993			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bayen E, 2018, DISABIL REHABIL, V40, P2040, DOI 10.1080/09638288.2017.1325522; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bennett T L, 1997, Appl Neuropsychol, V4, P1, DOI 10.1207/s15324826an0401_1; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; Corrigan JD, 1998, REHABIL PERSONS TRAU, P51, DOI [10.1001/jama.282.10.974, DOI 10.1001/JAMA.282.10.974]; DeFilippis NA, 1997, MANUAL BOOKLET CATEG; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; Friedland D, 2016, J NEUROL NEUROSUR PS, V87, P1068, DOI 10.1136/jnnp-2015-312193; Gouse H, 2013, ARCH CLIN NEUROPSYCH, V28, P38, DOI 10.1093/arclin/acs100; Greenwood R, 1997, LANCET, V349, P1041, DOI 10.1016/S0140-6736(05)62288-X; HASLAM C, 1995, NEUROPSYCHOLOGY, V9, P599, DOI 10.1037/0894-4105.9.4.599; Hess Dean R, 2004, Respir Care, V49, P1171; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kongs S. K., 2000, WCST 64 WISCONSIN CA; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; Matsuzawa YK, 2014, PSYCHOL INJ LAW, V7, P388, DOI 10.1007/s12207-014-9204-0; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller DT, 2001, ANNU REV PSYCHOL, V52, P527, DOI 10.1146/annurev.psych.52.1.527; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moss A, 2003, BRAIN INJURY, V17, P377, DOI 10.1080/0269905031000070125; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ruff R M, 1986, Arch Clin Neuropsychol, V1, P87, DOI 10.1016/0887-6177(86)90009-0; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strasburger LH, 1999, J AM ACAD PSYCHIATRY, V27, P203; Sullivan MJL, 2008, J OCCUP REHABIL, V18, P249, DOI 10.1007/s10926-008-9140-5; Sullivan MJL, 2011, SPINE, V36, pS244, DOI 10.1097/BRS.0b013e3182387fed; Symonds CP, 1943, LANCET, V1, P7; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Webb JW, 2012, CLIN NEUROPSYCHOL, V26, P1377, DOI 10.1080/13854046.2012.728248; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P239, DOI 10.1016/j.acn.2005.12.004	58	2	2	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2019	33	8					1087	1096		10.1080/02699052.2019.1610797			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM6FW	WOS:000478089800016	31046471				2022-02-06	
J	Koehl, LM; Walls, BD; Brothers, SL; Morris, SN; Glueck, AC; Schmitt, FA; Berry, DTR; Han, DY				Koehl, Lisa M.; Walls, Brittany D.; Brothers, Stacey L.; Morris, Sarah N.; Glueck, Amanda C.; Schmitt, Frederick A.; Berry, David T. R.; Han, Dong Y.			Convergent and discriminant validity of the Immediate Postconcussion Assessment and Cognitive Testing Battery (ImPACT) in young athletes	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						ImPACT; sports-related concussion; test validity		Sports concussions are recognized as significant injuries among young athletes. Research demonstrates that return-to-play prior to becoming asymptomatic has significant repercussions including sustained cognitive deficits. Many programs have begun to use computerized testing rather than traditional neuropsychological tests to (a) determine baseline performance, (b) track symptoms, and (c) measure symptoms following concussion. Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) is one such tool. The current study examined ImPACT's convergent and discriminant validity by comparing scores from sports-related concussion athletes (SRC) to those from nonconcussed controls (CTL). SRC included 29 athletes, ages 12-16, referred for neuropsychological assessment following sports-related concussions. CTL included 25 healthy athletes, ages 12-16, who were concussion-free in the past year. Overall, results showed general support for ImPACT, when used to screen cognition. In fact, all ImPACT domains successfully differentiated between SRC and CTL athletes. Evidence supporting appropriate convergent validity was best for the Visual Memory domain. Further, ImPACT domains demonstrated variable discriminant validity. Overall examination of validity demonstrated that ImPACT has some weaknesses but may have utility in detecting postconcussion cognitive impairment.	[Koehl, Lisa M.; Schmitt, Frederick A.; Han, Dong Y.] Univ Kentucky, Dept Neurol, 740 S Limestone,Suite J400, Lexington, KY 40536 USA; [Walls, Brittany D.; Brothers, Stacey L.; Berry, David T. R.] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Morris, Sarah N.] Univ Kentucky, Dept Epidemiol & Biostat, Lexington, KY USA; [Glueck, Amanda C.; Han, Dong Y.] Univ Kentucky, Sports Med Res Inst, Lexington, KY USA; [Schmitt, Frederick A.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Koehl, LM (corresponding author), Univ Kentucky, Dept Neurol, 740 S Limestone,Suite J400, Lexington, KY 40536 USA.	lhma222@uky.edu			American College of Sports Medicine Foundation Doctoral Student Research Grant	Funding provided by the American College of Sports Medicine Foundation Doctoral Student Research Grant.	Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Allen DN, 2009, CHILD NEUROPSYCHOL, V15, P543, DOI 10.1080/09297040902748234; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Beery K. E., 2010, BEERY BUKTENICA DEVE, V6th; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Centers for Disease Control (CDC), 2007, NATL CTR INJURY PREV; Cohen M., 1997, CHILDREN S MEMORY SC; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Delis DC., 2001, DELIS KAPLAN EXECUTI; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harrison JE, 2000, BRIT J CLIN PSYCHOL, V39, P181, DOI 10.1348/014466500163202; ImPACT Applications Inc, 2013, OVERVIEW FEATURES IM; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Jones GN, 2012, APPL NEUROPSYCH-ADUL, V19, P257, DOI 10.1080/09084282.2011.643966; Kibby M, 2008, CHILD NEUROPSYCHOL, V14, P525, DOI 10.1080/09297040701821752; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M.R., 2005, IMPACT IMMEDIATE POS; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Stavinoha PL, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P135, DOI 10.1007/978-0-387-89545-1_11; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; U.S. Food and Drug Administration, 2016, PRESS ANNOUNCEMENTSF; Wechsler D., 1997, WECHSLER MEMORY SCAL; WILLIAMS J, 1993, PERCEPT MOTOR SKILL, V76, P803, DOI 10.2466/pms.1993.76.3.803	39	2	2	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JUL 3	2019	8	3					253	263		10.1080/21622965.2018.1436440			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	VJ5KA	WOS:000607416600007	29465268				2022-02-06	
J	Soberay, KA; Hanson, JE; Dwyer, M; Plant, EA; Gutierrez, PM				Soberay, Kelly A.; Hanson, Jetta E.; Dwyer, Megan; Plant, E. Ashby; Gutierrez, Peter M.			The Relationship between Suicidal Responses and Traumatic Brain Injury and Severe Insomnia in Active Duty, Veteran, and Civilian Populations	ARCHIVES OF SUICIDE RESEARCH			English	Article						insomnia; military; suicide; traumatic brain injury; veteran	COGNITIVE-BEHAVIORAL THERAPY; POSTTRAUMATIC-STRESS-DISORDER; SLEEP DISTURBANCE; US ARMY; HEALTH; EPIDEMIOLOGY; PREVALENCE; DEPRESSION; IMPACT; RISK	This study examined how a positive traumatic brain injury (TBI) screening and insomnia severity relate to suicidal outcomes across active duty, veteran, and civilian samples. Data were used from 3,993 participants from 19 studies. We conducted a series of analyses by group to identify which significantly differed on the variables of interest. TBI and insomnia each had independent relationships with outcomes over and above the impact of the other factor. Veterans presented as clinically worse across the outcomes. However, the relationship between insomnia and suicidal responses was stronger for active duty military compared to veterans. Continued research on TBIs and insomnia severity across groups will improve quality of care for those at risk of suicide.	[Soberay, Kelly A.; Hanson, Jetta E.; Dwyer, Megan; Plant, E. Ashby; Gutierrez, Peter M.] Mil Suicide Res Consortium, 90 Madison St Suite 202, Denver, CO 80206 USA; [Soberay, Kelly A.; Hanson, Jetta E.; Dwyer, Megan; Gutierrez, Peter M.] Rocky Mt Mental Illness Res Educ & Clin Ctr MIREC, Dept Vet Affairs, Denver, CO USA; [Plant, E. Ashby] Florida State Univ, Tallahassee, FL 32306 USA; [Gutierrez, Peter M.] Univ Colorado, Sch Med, Denver, CO USA		Soberay, KA (corresponding author), Mil Suicide Res Consortium, 90 Madison St Suite 202, Denver, CO 80206 USA.	Kelly.Soberay@va.gov			Military Suicide Research Consortium; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-10-2-0178]	This research was supported in part by a grant from the Military Suicide Research Consortium, an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-10-2-0178.	Alexander CL, 2014, MIL MED, V179, P1062, DOI 10.7205/MILMED-D-13-00574; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P12; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bernert Rebecca A, 2007, Neuropsychiatr Dis Treat, V3, P735; Bernert RA, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0554-4; Bossarte R.M., 2013, SUICIDE DATA REPORT; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Brancu Mira, 2011, N C Med J, V72, P54; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Bryan CJ, 2011, SUICIDE LIFE-THREAT, V41, P126, DOI 10.1111/j.1943-278X.2011.00023.x; Burnam MA, 2008, INVISIBLE WOUNDS WAR, P245; Callahan COLDJ, 2010, J AM OSTEOPATH ASSOC, V110, P520; Callender L, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0828-z; Catrett CD, 2009, J GENET PSYCHOL, V170, P287, DOI 10.1080/00221320903218331; Centers for Disease Control and Prevention, 2016, LEAD CAUS DEATH REP; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; FRIEDMAN JMH, 1989, PSYCHIAT ANN, V19, P382, DOI 10.3928/0048-5713-19890701-11; Gehrman P., 2013, NHRC1203; Goodwin RD, 2008, SLEEP, V31, P1097; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2012, JAMA-J AM MED ASSOC, V308, P671, DOI 10.1001/jama.2012.9955; Holmqvist M, 2014, SLEEP MED, V15, P187, DOI 10.1016/j.sleep.2013.10.013; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; KAPLAN ML, 1994, J CLIN PSYCHOL, V50, P294, DOI 10.1002/1097-4679(199403)50:2<294::AID-JCLP2270500224>3.0.CO;2-R; KENDALL PC, 1989, COGNITIVE THER RES, V13, P109, DOI 10.1007/BF01173268; Koffel EA, 2015, SLEEP MED REV, V19, P6, DOI 10.1016/j.smrv.2014.05.001; Kuhn E, 2016, J CLIN SLEEP MED, V12, P597, DOI 10.5664/jcsm.5700; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Luxton DD, 2012, AM J PUBLIC HEALTH, V102, pS195, DOI 10.2105/AJPH.2011.300608; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; MacGregor KL, 2012, J GEN INTERN MED, V27, P339, DOI 10.1007/s11606-011-1884-5; McCall WV, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0389-9; McCall WV, 2010, SLEEP MED, V11, P822, DOI 10.1016/j.sleep.2010.04.004; McCarthy JF, 2009, AM J EPIDEMIOL, V169, P1033, DOI 10.1093/aje/kwp010; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Olson-Madden J. H., 2012, REHABIL RES PRACT, V2012; Olson-Madden JH, 2014, ARCH PHYS MED REHAB, V95, P925, DOI 10.1016/j.apmr.2014.01.008; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Pigeon Wilfred R, 2012, J Clin Psychiatry, V73, pe1160, DOI 10.4088/JCP.11r07586; Pigeon WR, 2012, AM J PUBLIC HEALTH, V102, pS93, DOI 10.2105/AJPH.2011.300470; Ramchand Rajeev, 2011, Rand Health Q, V1, P2; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Ringer FB, 2018, PSYCHOL ASSESSMENT, V30, P767, DOI 10.1037/pas0000519; Risling Marten, 2010, Front Neurol, V1, P1, DOI 10.3389/fneur.2010.00001; ROBINS E, 1959, AM J PSYCHIAT, V115, P724, DOI 10.1176/ajp.115.8.724; Rosekind MR, 2010, AM J MANAG CARE, V16, P617; Schneider AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00059; Smith MT, 2002, AM J PSYCHIAT, V159, P5, DOI 10.1176/appi.ajp.159.1.5; Talbot LS, 2014, SLEEP, V37, P327, DOI 10.5665/sleep.3408; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Ursano RJ, 2015, JAMA PSYCHIAT, V72, P917, DOI 10.1001/jamapsychiatry.2015.0987; US Department of Veterans Affairs, 2016, VA COND NAT LARG AN; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Walter Reed Army Institute of Research, 2007, APP B SLEEP MAN; Weiner J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-374; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280; 2014, 21 REN, V21, P21	70	2	2	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1381-1118	1543-6136		ARCH SUICIDE RES	Arch. Suicide Res.	JUL 3	2019	23	3					391	410		10.1080/13811118.2018.1479322			20	Psychiatry; Psychology; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychiatry; Psychology	IF0JD	WOS:000472762200003	29792569				2022-02-06	
J	Bennett, TD; Marsh, R; Maertens, JA; Rutebemberwa, A; Morris, MA; Hankinson, TC; Matlock, DD				Bennett, Tellen D.; Marsh, Rebekah; Maertens, Julie A.; Rutebemberwa, Alle; Morris, Megan A.; Hankinson, Todd C.; Matlock, Daniel D.			Decision-Making About Intracranial Pressure Monitor Placement in Children With Traumatic Brain Injury*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						clinical decision-making; intracranial hypertension; intracranial pressure; pediatrics; qualitative research; traumatic brain injury	CARE; OUTCOMES	Objectives: Little is known about how clinicians make the complex decision regarding whether to place an intracranial pressure monitor in children with traumatic brain injury. The objective of this study was to identify the decisional needs of multidisciplinary clinician stakeholders. Design: Semi-structured qualitative interviews with clinicians who regularly care for children with traumatic brain injury. Setting: One U.S. level I pediatric trauma center. Subjects: Twenty-eight clinicians including 17 ICU nurses, advanced practice providers, and physicians and 11 pediatric surgeons and neurosurgeons interviewed between August 2017 and February 2018. Interventions: None. Measurements and Main Results: Participants had a mean age of 43 years (range, 30-66 yr), mean experience of 10 years (range, 0-30 yr), were 46% female (13/28), and 96% white (27/28). A novel conceptual model emerged that related the difficulty of the decision about intracranial pressure monitor placement (y-axis) with the estimated outcome of the patient (x-axis). This model had a bimodal shape, with the most difficult decisions occurring for patients who 1) had a good opportunity for recovery but whose neurologic examination had not yet normalized or 2) had a low but uncertain likelihood of neurologically functional recovery. Emergent themes included gaps in medical knowledge and information available for decision-making, differences in perspective between clinical specialties, and ethical implications of decision-making about intracranial pressure monitoring. Experienced clinicians described less difficulty with decision-making overall. Conclusions: Children with severe traumatic brain injury near perceived transition points along a spectrum of potential for recovery present challenges for decision-making about intracranial pressure monitor placement. Clinician experience and specialty discipline further influence decision-making. These findings will contribute to the design of a multidisciplinary clinical decision support tool for intracranial pressure monitor placement in children with traumatic brain injury.	[Bennett, Tellen D.] Univ Colorado, Sect Pediat Crit Care, Dept Pediat, Sch Med, Aurora, CO 80045 USA; [Bennett, Tellen D.; Marsh, Rebekah; Maertens, Julie A.; Morris, Megan A.; Hankinson, Todd C.; Matlock, Daniel D.] Univ Colorado, Sch Med, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO 80045 USA; [Rutebemberwa, Alle] Childrens Hosp Colorado, Res Inst, Aurora, CO USA; [Hankinson, Todd C.] Univ Colorado, Sch Med, Dept Neurosurg, Div Pediat Neurosurg, Aurora, CO USA; [Matlock, Daniel D.] Univ Colorado, Sch Med, Dept Med, Div Gen Internal Med, Aurora, CO USA		Bennett, TD (corresponding author), Univ Colorado, Sect Pediat Crit Care, Dept Pediat, Sch Med, Aurora, CO 80045 USA.; Bennett, TD (corresponding author), Univ Colorado, Sch Med, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO 80045 USA.	tell.bennett@ucdenver.edu		Matlock, Dan/0000-0001-9597-9642; Bennett, Tellen/0000-0003-1483-4236			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS28; Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Crabtree B. F., 1999, DOING QUALITATIVE RE; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Faul M, 2010, TRAUMATIC BRAIN INJU; Frieden TR, 2014, TRAUMATIC BRAIN INJU; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jacobsen M, 2006, POPULATION NEEDS ASS; Jensen RL, 1997, SURG NEUROL, V47, P16, DOI 10.1016/S0090-3019(96)00276-5; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Koriyama H, 2014, PEDIATR CRIT CARE ME, V15, pE66, DOI 10.1097/PCC.0000000000000021; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; O'Connor A., OTTAWA DECISION SUPP; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716; October TW, 2014, PEDIATR CRIT CARE ME, V15, P291, DOI 10.1097/PCC.0000000000000076; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Smith MA, 2018, J PALLIAT MED, V21, P1290, DOI 10.1089/jpm.2017.0528; Stacey D, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub4, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub2]; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Watson AC, 2016, AM J CRIT CARE, V25, P489, DOI 10.4037/ajcc2016817; Wennberg JE, 2007, HEALTH AFFAIR, V26, P1564, DOI 10.1377/hlthaff.26.6.1564	30	2	3	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2019	20	7					645	651		10.1097/PCC.0000000000001934			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Pediatrics	IK7KG	WOS:000476767300017	30985605				2022-02-06	
J	Chen, SF; Su, YC; Wang, LY; Hsu, CY; Shen, YC				Chen, Shih-Fen; Su, Yuan-Chih; Wang, Ling-Yi; Hsu, Chung-Y; Shen, Yu-Chih			Tourette's syndrome is associated with an increased risk of traumatic brain injury: A nationwide population-based cohort study	PARKINSONISM & RELATED DISORDERS			English	Article						Tourette's syndrome; Traumatic brain injury; Antipsychotic; Cohort	IMPULSE-CONTROL DISORDERS; CHILDREN; BEHAVIOR; PHENOMENOLOGY; ADOLESCENTS	Introduction: Violent motor tics or severe self-harm behaviors have been reported in patients with Tourette's syndrome (TS) and leading to traumatic brain injury (TBI). The study aimed to determine the risk of TBI in TS patients, the effects associated with concurrent psychiatric disorders (attention-deficit/hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), or depressive disorder), and the effects of medication treatment (antipsychotics, antidepressants, or clonidine) on the risk of TBI. Methods: Using the National Health Insurance Research Database of Taiwan, 2261 TS patients and 20349 non-TS controls matched by gender and age were enrolled between 2000 and 2012, and followed until the end of 2013. Participants who developed TBI during the follow-up period were identified. Cox regression analysis was performed to examine the risk of TBI between TS patients and non-TS controls. Results: TS patients were associated with an increased risk of TBI compared to non-TS controls (hazard ratio (HR): 1.59, 95% confidence interval (95% CI): 1.37-1.85). Also, this study revealed TS patients with ADHD, OCD, or depressive disorder predicted a higher TBI incidence rate than those who did not, but the estimate was not statistically significant. Moreover, this study found that TS patients with frequent use of antipsychotics were associated with a lower risk of TBI than infrequent users (HR: 0.76, 95% CI: 0.57-0.99). Conclusions: This study highlights the need to pay more attention to the risk of TBI in TS patients, and the importance of adequate antipsychotic medication may reduce the risk of TBI.	[Chen, Shih-Fen] Tzu Chi Gen Hosp, Ctr Med Genet, Hualien, Taiwan; [Su, Yuan-Chih] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Su, Yuan-Chih] China Med Univ, Coll Med, Taichung, Taiwan; [Wang, Ling-Yi] Tzu Chi Gen Hosp, Epidemiol & Biostat Consulting Ctr, Dept Med Res, Hualien, Taiwan; [Wang, Ling-Yi] Tzu Chi Gen Hosp, Dept Pharm, Hualien, Taiwan; [Hsu, Chung-Y] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Shen, Yu-Chih] Tzu Chi Gen Hosp, Dept Psychiat, 707,Sec 3,Chung Yang Rd, Hualien 970, Taiwan; [Shen, Yu-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan		Shen, YC (corresponding author), Tzu Chi Gen Hosp, Dept Psychiat, 707,Sec 3,Chung Yang Rd, Hualien 970, Taiwan.	shengmp@gmail.com			Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW107-TDU-B-212-123004]; China Medical University Hospital, Taiwan [DMR-107-192]; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10701010021]; NRPB Stroke Clinical Trial Consortium, Taiwan [MOST 106-2321-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW107-TDU-B-212-123004), China Medical University Hospital, Taiwan (DMR-107-192), Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10701010021), NRPB Stroke Clinical Trial Consortium, Taiwan (MOST 106-2321-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Budman CL, 2003, J PSYCHOSOM RES, V55, P59, DOI 10.1016/S0022-3999(02)00584-6; Cheung MYC, 2007, MOVEMENT DISORD, V22, P1743, DOI 10.1002/mds.21599; Du JC, 2010, PEDIATR NEONATOL, V51, P255, DOI 10.1016/S1875-9572(10)60050-2; Fasano A, 2018, PARKINSONISM RELAT D, V49, P114, DOI 10.1016/j.parkreldis.2018.01.011; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Frank MC, 2011, J NEUROL SCI, V310, P276, DOI 10.1016/j.jns.2011.06.032; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ipser J, 2007, PSYCHOPHARMACOLOGY, V191, P127, DOI 10.1007/s00213-006-0537-6; Leckman JF, 1998, PEDIATRICS, V102, P14, DOI 10.1542/peds.102.1.14; Lehman LL, 2011, NEUROLOGY, V77, P1706, DOI 10.1212/WNL.0b013e318238253c; Liou YJ, 2018, J ADOLESCENT HEALTH, V63, P233, DOI 10.1016/j.jadohealth.2018.02.012; Lu YY, 2017, EUR CHILD ADOLES PSY, V26, P531, DOI 10.1007/s00787-016-0916-4; Mathews CA, 2004, J NEUROL NEUROSUR PS, V75, P1149, DOI 10.1136/jnnp.2003.020693; Murphy TK, 2013, J AM ACAD CHILD PSY, V52, P1341, DOI 10.1016/j.jaac.2013.09.015; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Robertson MM, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2016.97; Robertson MM, 2015, LANCET PSYCHIAT, V2, P68, DOI 10.1016/S2215-0366(14)00132-1; ROBERTSON MM, 1989, PSYCHOL MED, V19, P611, DOI 10.1017/S0033291700024211; Roessner V, 2011, EUR CHILD ADOLES PSY, V20, P173, DOI 10.1007/s00787-011-0163-7; Scahill L., 2009, Morbidity and Mortality Weekly Report, V58, P581; Storch EA, 2015, DEPRESS ANXIETY, V32, P744, DOI 10.1002/da.22357; Wang HS, 2003, BRAIN DEV-JPN, V25, pS29, DOI 10.1016/S0387-7604(03)90005-2; Wright A, 2012, J NEUROPSYCH CLIN N, V24, P16, DOI 10.1176/appi.neuropsych.10010013	23	2	2	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1353-8020	1873-5126		PARKINSONISM RELAT D	Parkinsonism Relat. Disord.	JUL	2019	63						88	93		10.1016/j.parkreldis.2019.02.033			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IS6FK	WOS:000482247500014	30833232				2022-02-06	
J	Diaz, B; Elkbuli, A; Wobig, R; McKenney, K; Jaguan, D; Boneva, D; Hai, S; McKenney, M				Diaz, Brandon; Elkbuli, Adel; Wobig, Rachel; McKenney, Kelly; Jaguan, Daniella; Boneva, Dessy; Hai, Shaikh; McKenney, Mark			Subarachnoid versus Nonsubarachnoid Traumatic Brain Injuries: The Impact of Decision-Making on Patient Safety	JOURNAL OF EMERGENCIES TRAUMA AND SHOCK			English	Article						Intracranial hemorrhage; mortality outcomes; outcome and comparison; subarachnoid hemorrhage	MANAGEMENT; GUIDELINES	Introduction: Traumatic intracranial hemorrhages (ICHs) are high priority injuries. Traumatic brain bleeds can be categorized as traumatic subarachnoid hemorrhage (SAH) versus non-SAH-ICH. Non-SAH-ICH includes subdural, epidural, and intraventricular hematomas and brain contusions. We hypothesize that awake patients with SAH will have lower mortality and needless interventions than awake patients with non-SAH-ICHs. Study Design and Methods: A review of data collected from our Level I trauma center was conducted. Awake was defined as an initial Glasgow coma score (GCS) 13-15. Patients were divided into two cohorts: awake SAH and awake non-SAH-ICH. Chi-square and t-test analyses were used with statistical significance defined as P < 0.05. Results: A total of 12,482 trauma patients were admitted during the study period, of which 225 had a SAH and GCS of 13-15 while 826 had a non-SAH-ICH with a GCS of 13-15. There was no significant difference in demographics between the two groups. Predicted survival between the two groups was similar (97.3 vs. 95.7%, P > 0.05). Mortality rates were, however, significantly lower in SAH patients compared to the non-SAH-ICH (4/225 [1.78%] vs. 22/826 [2.66%], P < 0.05). The need for neurosurgical intervention was significantly different comparing the SAH group versus non-SAH-ICH (2/225 [0.89%] vs. 100/826 [12.1%], P < 0.05). Conclusion: Despite similar predicted mortality rates, awake patients with a SAH are associated with a significantly lower risk of death and need for neurosurgical intervention when compared to other types of awake patients with a traumatic brain bleed.	[Diaz, Brandon; Elkbuli, Adel; Wobig, Rachel; McKenney, Kelly; Jaguan, Daniella; Boneva, Dessy; Hai, Shaikh; McKenney, Mark] Kendall Reg Med Ctr, Dept Surg, Miami, FL USA; [Boneva, Dessy; McKenney, Mark] Univ S Florida, Tampa, FL USA		Elkbuli, A (corresponding author), 11750 Bird Rd, Miami, FL 33175 USA.	adel.elkbuli@hcahealthcare.com	Elkbuli, Adel/AAK-7374-2021				Alsulaim HA, 2017, AM J SURG, V214, P207, DOI 10.1016/j.amjsurg.2016.07.012; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Gabbe BJ, 2004, ACAD EMERG MED, V11, P181, DOI 10.1197/j.aem.2003.08.019; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Overton TL, 2014, AM J SURG, V208, P806, DOI 10.1016/j.amjsurg.2014.02.012; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Seddighi AS, 2013, BRAIN INJURY, V27, P1666, DOI 10.3109/02699052.2013.830333; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003	9	2	2	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0974-2700	0974-519X		J EMERG TRAUMA SHOCK	J. Emerg. Trauma Shock	JUL-SEP	2019	12	3					173	175		10.4103/JETS.JETS_123_18			3	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	IV4JF	WOS:000484238700003	31543638	Green Published, gold			2022-02-06	
J	Furtado, LMF; Val, JAC; Ferreira, RI; Mariano, IGGD				Ferreira Furtado, Leopoldo Mandic; Costa Val Filho, Jose Aloysio; Ferreira, Raquel Ida; Giarola de Freitas Mariano, Italo Guilherme			Intracranial arachnoid cyst rupture after mild TBI in children: have we underestimated this risk?	BMJ CASE REPORTS			English	Article						neurosurgery; neurological injury; coma and raised intracranial pressure; neuroimaging		The association between intracranial arachnoid cyst rupture and mild brain trauma is infrequently reported. The purpose of this case report is to describe the case of a child with a left temporal arachnoid cyst who suffered rupture with haemorrhage after mild trauma during a football match. The child presented with chronic headache of mild intensity that progressed to a more intense headache after a traumatic event. He underwent surgical intervention after diagnosis of chronic haemorrhage in an arachnoid cyst in the ipsilateral subdural space. The risk of intracranial arachnoid cyst rupture should be considered during the evaluation of oligosymptomatic patients because it is a potentially catastrophic event.	[Ferreira Furtado, Leopoldo Mandic] Biocor Inst, Pediat Neurosurg, Nova Lima, Brazil; [Ferreira Furtado, Leopoldo Mandic] Fundacao Hosp Estado Minas Gerais, Neurotraumatol, Belo Horizonte, MG, Brazil; [Costa Val Filho, Jose Aloysio] Vila Serra Hosp, Pediat Neurosurg, Nova Lima, Brazil; [Ferreira, Raquel Ida; Giarola de Freitas Mariano, Italo Guilherme] Fac Med Barbacena, Barbacena, Brazil		Furtado, LMF (corresponding author), Biocor Inst, Pediat Neurosurg, Nova Lima, Brazil.; Furtado, LMF (corresponding author), Fundacao Hosp Estado Minas Gerais, Neurotraumatol, Belo Horizonte, MG, Brazil.	lmandicster@gmail.com					Aydogmus E, 2019, TURK NEUROSURG, V29, P940, DOI 10.5137/1019-5149.JTN.20885-17.2; Cress M, 2013, NEUROSURGERY, V72, P716, DOI 10.1227/NEU.0b013e318285b3a4; EUSTACE S, 1992, J COMPUT ASSIST TOMO, V16, P995, DOI 10.1097/00004728-199211000-00034; GALASSI E, 1980, SURG NEUROL, V14, P211; Iaconetta G, 2006, NEUROL SCI, V26, P451, DOI 10.1007/s10072-006-0532-z; Lee JY, 2012, CHILD NERV SYST, V28, P1203, DOI 10.1007/s00381-012-1722-z; Pascoe HM, 2015, J CLIN NEUROSCI, V22, P897, DOI 10.1016/j.jocn.2014.12.006	7	2	2	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND		1757-790X		BMJ CASE REP	BMJ Case Rep.	JUL	2019	12	4							e228790	10.1136/bcr-2018-228790			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	VK1LR	WOS:000661382700132	31040140	hybrid, Green Published			2022-02-06	
J	Garavito, DMN; Reyna, VF; DeTello, JE				Garavito, David M. N.; Reyna, Valerie F.; DeTello, Joseph E.			A concussion by any other name: Differences in willingness to risk brain injury by label and level of participation in high-school and college sports	APPLIED COGNITIVE PSYCHOLOGY			English	Article						concussions; decision making; risk familiarity; risk taking; sports psychology	CHRONIC TRAUMATIC ENCEPHALOPATHY; ASSOCIATION POSITION STATEMENT; DECISION-MAKING; PERCEPTION; FUZZY; EPIDEMIOLOGY; DEPRESSION; MANAGEMENT; TOLERANCE; KNOWLEDGE	One factor in reducing the likelihood of sports-related brain injuries is the recognition of risks. However, using colloquial terms may deemphasize the severity of these risks. We hypothesized that using colloquial language to describe sports-related brain injuries will lead to greater willingness to take on the risk. We conducted two experiments, varying the label describing an injury (getting your bell rung, concussion, or brain injury) and assessing willingness of current athletes, former athletes, and nonathletes to accept this risk as part of sports participation. High-school and college athletes were willing to expose themselves to a high probability of risk, compared with nonathletes, when described colloquially. However, risk thresholds were low and indistinguishable across groups when using the term "brain injury." Findings remained significant when controlling for knowledge, age, and sensation seeking. These differences indicate that the term "getting your bell rung" should not be used to describe a brain injury.	[Garavito, David M. N.; Reyna, Valerie F.; DeTello, Joseph E.] Cornell Univ, Dept Human Dev, Ithaca, NY 14850 USA		Garavito, DMN (corresponding author), Cornell Univ, Dept Human Dev, Ithaca, NY 14850 USA.	dmg345@cornell.edu		Garavito, David/0000-0003-4903-9486	Cornell University - Engaged Cornell; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR014368-01]	Cornell University - Engaged Cornell, Grant/Award Numbers: Engaged Risky Decision Making, Sports, Memory, and Decision Making: A Fuzzy-Trace; National Institute of Nursing Research, Grant/Award Number: R01NR014368-01	Albicini M., 2018, J CONCUSSION, V2, P1, DOI [10.1177/2059700218784826, DOI 10.1177/2059700218784826]; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; BENTHIN A, 1993, J ADOLESCENCE, V16, P153, DOI 10.1006/jado.1993.1014; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown SL, 2007, BRIT J PSYCHOL, V98, P575, DOI 10.1348/000712606X169020; Brown SL, 2013, J EXP PSYCHOL-APPL, V19, P120, DOI 10.1037/a0033284; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Centers for Disease Control and Prevention, 2016, HEADS HLTH CAR PROV; Cook B, 2018, FORBES          0203; Defoe IN, 2015, PSYCHOL BULL, V141, P48, DOI 10.1037/a0038088; Figner B, 2011, CURR DIR PSYCHOL SCI, V20, P211, DOI 10.1177/0963721411415790; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Kelly JP, 1997, NEUROLOGY, V48, P581; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miyashita TL, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114554549; Pines JM, 2010, AM J EMERG MED, V28, P771, DOI 10.1016/j.ajem.2009.03.019; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Reyna VF, 2006, J EXP PSYCHOL-APPL, V12, P179, DOI 10.1037/1076-898X.12.3.179; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Reyna VF, 2011, J EXP PSYCHOL LEARN, V37, P1125, DOI 10.1037/a0023943; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Snedden TR, 2013, J SPEC PEDIATR NURS, V18, P211, DOI 10.1111/jspn.12038; Stevenson M, 2018, DEMENTIA-LONDON, V17, P359, DOI 10.1177/1471301216647542; Swets J A, 2000, Psychol Sci Public Interest, V1, P1, DOI 10.1111/1529-1006.001; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Wetherill RR, 2007, J ADOLESCENT HEALTH, V41, P294, DOI 10.1016/j.jadohealth.2007.04.019; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; Young A, 2008, KIDNEY INT, V73, P1159, DOI 10.1038/ki.2008.65; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	44	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0888-4080	1099-0720		APPL COGNITIVE PSYCH	Appl. Cogn. Psychol.	JUL	2019	33	4					646	654		10.1002/acp.3481			9	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	II7XE	WOS:000475404200018					2022-02-06	
J	Hoffman, SN; Herbert, MS; Crocker, LD; DeFord, NE; Keller, AV; Jurick, SM; Sanderson-Cimino, M; Jak, AJ				Hoffman, Samantha N.; Herbert, Matthew S.; Crocker, Laura D.; DeFord, Nicole E.; Keller, Amber V.; Jurick, Sarah M.; Sanderson-Cimino, Mark; Jak, Amy J.			The Role of Pain Catastrophizing in Cognitive Functioning Among Veterans With a History of Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						combat; Iraq war; mild traumatic brain injury; neuropsychological functioning; pain catastrophizing; posttraumatic stress disorder	POSTTRAUMATIC-STRESS-DISORDER; OEF/OIF VETERANS; BLAST EXPOSURE; MENTAL-HEALTH; ASSOCIATION; PERFORMANCE; VALIDITY	Objective: To determine the role of pain catastrophizing (PC) in neuropsychological functioning in veterans with a history of mild traumatic brain injury (TBI). Participants: Thirty-nine Iraq and Afghanistan combat veterans evaluated in the post-acute phase following mild TBI. Methods: Participants underwent psychiatric and TBI clinical interviews, neuropsychological tests, and self-report assessments of PC, pain intensity, depression, and posttraumatic stress disorder symptoms. Cognitive functioning composite scores of executive functioning, processing speed, and learning and memory were created. Composites were entered as dependent variables into separate linear regressions to examine relations with PC. Results: Greater PC was associated with worse executive functioning and processing speed even when controlling for confounding variables. Conclusions: One's interpretation of pain, in addition to pain intensity, has implications for cognitive functioning. Future research is encouraged to determine whether adaptive pain coping mechanisms improve cognitive functioning or, alternatively, whether cognitive rehabilitation strategies reduce PC.	[Hoffman, Samantha N.; Herbert, Matthew S.; Crocker, Laura D.; DeFord, Nicole E.; Keller, Amber V.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, 3350 LaJolla Village Dr 151B, San Diego, CA 92161 USA; [Herbert, Matthew S.; Jak, Amy J.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, 3350 LaJolla Village Dr 151B, San Diego, CA 92161 USA; [Jurick, Sarah M.; Sanderson-Cimino, Mark] San Diego State Univ Univ Calif San Diego Joint D, San Diego, CA USA; [Herbert, Matthew S.; Jak, Amy J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Jurick, Sarah M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA		Jak, AJ (corresponding author), VA San Diego Healthcare Syst, Psychol Serv, 3350 LaJolla Village Dr 151B, San Diego, CA 92161 USA.; Jak, AJ (corresponding author), VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, 3350 LaJolla Village Dr 151B, San Diego, CA 92161 USA.	Amy.Jak@va.gov		Hoffman, Samantha/0000-0002-2792-8576; Keller, Amber/0000-0002-2972-784X; Sanderson-Cimino, Mark/0000-0002-5872-3186	US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); US Department of Veterans Affairs (Chronic Effects of Neurotrauma Consortium)US Department of Veterans Affairs [W81XWH-13-2-0095, I01 RX002076]; VA Rehabilitation RD Service [IK2 RX002459]	This work was supported by the US Army Medical Research and Material Command and the US Department of Veterans Affairs (Chronic Effects of Neurotrauma Consortium) under Award No. W81XWH-13-2-0095 and I01 RX002076. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702 is the awarding and administering acquisition office. Laura Crocker received salary support during this work from Career Development Award Number IK2 RX002459 from the VA Rehabilitation R&D Service.	Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Carty J, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.5652; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Chaput G, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/2825856; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Edwards RR, 2006, ARTHRIT RHEUM-ARTHR, V55, P325, DOI 10.1002/art.21865; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Legarreta M, 2016, PROF PSYCHOL-RES PR, V47, P418, DOI 10.1037/pro0000104; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Sheehan DV, 2016, J CLIN PSYCHIAT, V59, P22; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Wechsler D., 2008, WECHSLER ADULT INTEL	27	2	2	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2019	34	4					E61	E66		10.1097/HTR.0000000000000453			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IQ4XH	WOS:000480754400007	30499934				2022-02-06	
J	Kundu, S; Ghodadra, A; Fakhran, S; Alhilali, LM; Rohde, GK				Kundu, S.; Ghodadra, A.; Fakhran, S.; Alhilali, L. M.; Rohde, G. K.			Assessing Postconcussive Reaction Time Using Transport-Based Morphometry of Diffusion Tensor Images	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; PRINCIPAL COMPONENT ANALYSIS; WHITE-MATTER INJURY; PERFORMANCE; CONCUSSION; INTEGRITY; MODERATE; IMPACT; SPEED	BACKGROUND AND PURPOSE: Cognitive deficits are among the most commonly reported post-concussive symptoms, yet the underlying microstructural injury is poorly understood. Our aim was to discover white matter injury underlying reaction time in mild traumatic brain injury DTI by applying transport-based morphometry. MATERIALS AND METHODS: In this retrospective study, we performed DTI on 64 postconcussive patients (10-28 years of age; 69% male, 31% female) between January 2006 and March 2013. We measured the reaction time percentile by using Immediate Post-Concussion Assessment and Cognitive Testing. Using the 3D transport-based morphometry technique we developed, we mined fractional anisotropy maps to extract the common microstructural injury associated with reaction time percentile in an automated manner. Permutation testing established statistical significance of the extracted injuries. We visualized the physical substrate responsible for reaction time through inverse transport-based morphometry transformation. RESULTS: The direction in the transport space most correlated with reaction time was significant after correcting for covariates of age, sex, and time from injury (Pearson r = 0.44, P < .01). Inverting the computed direction using transport-based morphometry illustrates physical shifts in fractional anisotropy in the corpus callosum (increase) and within the optic radiations, corticospinal tracts, and anterior thalamic radiations (decrease) with declining reaction time. The observed shifts are consistent with biologic pathways underlying the visual-spatial interpretation and response-selection aspects of reaction time. CONCLUSIONS: Transport-based morphometry discovers complex white matter injury underlying postconcussive reaction time in an automated manner. The potential influences of edema and axonal loss are visualized in the visual-spatial interpretation and response-selection pathways. Transport-based morphometry can bridge the gap between brain microstructure and function in diseases in which the structural basis is unknown.	[Rohde, G. K.] Univ Virginia, Dept Biomed Engn Elect & Comp Engn, Charlottesville, VA USA; [Kundu, S.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Kundu, S.] Univ Pittsburgh, Med Ctr, Med Scientist Training Program, Pittsburgh, PA USA; [Ghodadra, A.] Banner Hlth & Hosp Syst, Dept Radiol, Mesa, AZ USA; [Fakhran, S.] Barrow Neurol Inst, Dept Neuroradiol, Phoenix, AZ 85013 USA; [Alhilali, L. M.] Univ Pittsburgh, Med Ctr, Dept Internal Med, Pittsburgh, PA USA		Kundu, S (corresponding author), Univ Pittsburgh, Med Scientist Training Program, 526 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.; Kundu, S (corresponding author), Carnegie Mellon Univ, 526 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	shk71@pitt.edu		Alhilali, Lea/0000-0002-9059-2454	National Science FoundationNational Science Foundation (NSF) [CCF 1421502]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM130825, GM090033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM130825, R01GM090033] Funding Source: NIH RePORTER	This work was supported, in part, by the National Science Foundation award CCF 1421502 and National Institutes of Health awards GM130825 and GM090033.	Aboitiz F, 1992, Biol Res, V25, P51; [Anonymous], 2009, VA DOD CLIN PRACT GU; [Anonymous], FMRIB SOFTW LIB VERS; Anstey KJ, 2007, NEUROPSYCHOLOGIA, V45, P1911, DOI 10.1016/j.neuropsychologia.2006.11.020; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Basu S, 2014, P NATL ACAD SCI USA, V111, P3448, DOI 10.1073/pnas.1319779111; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Booth T, 2013, NEUROPSYCHOLOGY, V27, P595, DOI 10.1037/a0033354; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Eckert MA, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.010.2010; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Erlanger D, 2001, J ATHL TRAINING, V36, P280; FDT, FMRIBS DIFF TOOLB; Ghodadra A, 2016, AM J NEURORADIOL, V37, P274, DOI 10.3174/ajnr.A4505; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Jbabdi S, 2011, BRAIN CONNECT, V1, P169, DOI 10.1089/brain.2011.0033; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kolouri S, 2016, PATTERN RECOGN, V51, P453, DOI 10.1016/j.patcog.2015.09.019; Kundu S, 2018, NEUROIMAGE, V167, P256, DOI 10.1016/j.neuroimage.2017.11.006; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Righart R, 2013, NEUROIMAGE-CLIN, V2, P854, DOI 10.1016/j.nicl.2013.06.006; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Wang W, 2013, INT J COMPUT VISION, V101, P254, DOI 10.1007/s11263-012-0566-z; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; Womack KB, 2017, J NEUROTRAUM, V34, P1539, DOI 10.1089/neu.2016.4670; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004	46	2	2	0	1	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	JUL	2019	40	7					1117	1123		10.3174/ajnr.A6087			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	II6BK	WOS:000475277900011	31196860	Green Published, hybrid			2022-02-06	
J	Lin, HY; Lin, KC; Tsai, CC; Wan, DH				Lin, Hsin-Yao; Lin, Kai-Chun; Tsai, Cheng-Chia; Wan, Dehui			Simultaneous or staged operation? Timing of cranioplasty and ventriculoperitoneal shunt after decompressive craniectomy	FORMOSAN JOURNAL OF SURGERY			English	Article						Cranioplasty; decompressive craniectomy; ventriculoperitoneal shunt	COMPLICATIONS; PLACEMENT; SERIES; RISK	Aims: Cranioplasty and ventriculoperitoneal shunt (VPS) are common procedures for patients who undergo decompressive craniectomy. The ideal time for these two procedures remains controversial. Settings and Design: This is a retrospective, single institute, chart review comparing the complications associated with simultaneous and staged cranioplasty and VPS. Materials and Methods: From January 2012 to December 2017, 56 patients who underwent both cranioplasty and VPS surgery at our hospital were separated into simultaneous or staged operation groups. We compared the demographic data and complications, including infections, subdural or epidural hemorrhage, and revision surgery between the groups. Statistical Analysis Used: Independent Student's t-test was used for analysis of continuous variables, and Fisher's exact test was used for categorical data. MedCalc (version: 18.11) was used to perform all analysis. Results: Nineteen patients underwent simultaneous cranioplasty and VPS, whereas 37 underwent staged operation. Etiologies for craniectomy included traumatic brain injury, infarction, spontaneous subarachnoid hemorrhage, and spontaneous intracerebral hemorrhage. There were no significant differences in the baseline characteristics between the groups. The overall complication rate was 14.3%. Three (15.8%) patients experienced complications in the simultaneous group: One (5.3%) with skin infection and two (10.5%) with overdrainage. Five (13.5%) patients experienced complications in the staged group: three (10.8%) with skin infections, one with central nervous system (CNS) infections, and one with both skin and CNS infections. Overall complications, wound infections, CNS infections, overdrainage, and revision surgery showed no significant differences between the groups. Conclusions: Simultaneous cranioplasty and VPS showed complication rates similar to those of staged operation.	[Lin, Hsin-Yao; Lin, Kai-Chun; Tsai, Cheng-Chia] Maykay Mem Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan; [Lin, Hsin-Yao] Natl Tsing Hua Univ, Inst Nano Engn & Microsyst, Hsinchu, Taiwan; [Lin, Hsin-Yao; Wan, Dehui] Natl Tsing Hua Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Tsai, Cheng-Chia] Mackay Med Coll, Dept Med, Hsinchu, Taiwan; [Wan, Dehui] Natl Tsing Hua Univ, Frontier Res Ctr Fundamental & Appl Sci Matters, Hsinchu, Taiwan		Tsai, CC (corresponding author), Maykay Mem Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan.; Tsai, CC (corresponding author), Mackay Med Coll, Dept Med, Hsinchu, Taiwan.; Wan, DH (corresponding author), 101,Sect 2 Kuang Fu Rd, Hsinchu, Taiwan.	angle@mmh.org.tw; dhwan@mx.nthu.edu.tw					Agarwalla PK, 2014, NEUROSURGERY, V74, pS151, DOI 10.1227/NEU.0000000000000226; Bohman LE, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0392-x; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; de Oliveira JG, 2007, NEUROSURGERY, V61, P924, DOI 10.1227/01.neu.0000303188.72425.24; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; El Ahmadieh TY, 2013, NEUROSURG CLIN N AM, V24, P375, DOI 10.1016/j.nec.2013.03.003; Fattahian Reza, 2018, Med Arch, V72, P214, DOI 10.5455/medarh.2018.72.214-219; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Fodstad H, 1979, Acta Neurochir Suppl (Wien), V28, P514; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Heo J, 2014, J NEUROSURG, V121, P313, DOI 10.3171/2014.2.JNS131480; Jussen D, 2015, MINERVA ANESTESIOL, V81, P398; Meyer RM, 2017, WORLD NEUROSURG, V107, P830, DOI 10.1016/j.wneu.2017.08.034; Panwar N, 2019, WORLD NEUROSURG, V122, pE96, DOI 10.1016/j.wneu.2018.09.108; Schuss P, 2015, WORLD NEUROSURG, V84, P1051, DOI 10.1016/j.wneu.2015.05.066; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yang XF, 2017, BRAIN INJURY, V31, P1651, DOI 10.1080/02699052.2017.1332781; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99; Zhou Qing, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P254	21	2	2	1	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1682-606X	2213-5413		FORMOS J SURG	Formos. J. Surg.	JUL-AUG	2019	52	4					122	126		10.4103/fjs.fjs_18_19			5	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	IV4HW	WOS:000484235200002		gold			2022-02-06	
J	Liu, T; Lu, YQ; Yu, JN; Kuang, WC; Wang, XY; Jiang, Y; Qiu, XJ; Wen, X; Zeng, Y; Zhang, GT; Liu, Y				Liu, Tong; Lu, Yanqing; Yu, Jiani; Kuang, Weichuan; Wang, Xiaoyin; Jiang, Ye; Qiu, Xiaojia; Wen, Xi; Zeng, Yao; Zhang, Guitao; Liu, Yue			Effect of auricular electroacupuncture combined with body acupuncture in improving the consciousness of patients after traumatic brain injury Study protocol for a randomized controlled trial	MEDICINE			English	Article						auricular acupoint; body acupuncture; consciousness; electro-acupuncture; GCS; mismatch negativity; traumatic brain injury	VEGETATIVE STATE; NEUROPATHOLOGY; EPIDEMIOLOGY; METAANALYSIS; SEVERITY; ACUPOINT	Background: Traumatic brain injury (TBI) has become a major cause of morbidity and mortality both in China and abroad. Disorders of consciousness following severe TBI is a common refractory complication, resulting in difficult rehabilitation and poor life quality. However, effective therapeutic approaches remain limited. Although acupuncture has been widely applied in the treatment of neurological disorders in China, its efficacy and safety for consciousness recovery remain to be elucidated. Methods: Here, we conduct a study design and protocol of a randomized, blinded, controlled study to evaluate the efficacy and safety of electroacupuncture at auricular acupoints "heart" and "brainstem" combined with body acupuncture in the consciousness recovery of patients with TBI. A total of 80 patients with initial Glasgow coma scale score between 3 and 8 points will be recruited in the trial and randomized into intervention (combined application of auricular electroacupuncture and body acupuncture) group or control (conventional treatment) group. Patients in the intervention group will receive electroacupuncture at bilateral auricular acupoints "heart" and "brainstem" (4 points in total) combined with body acupuncture in addition to conventional treatment while patients in the control group will receive conventional treatment alone for 8 weeks. The primary outcomes are changes of Glasgow coma scale score and mismatch negativity of event-related brain potentials at baseline after 4 weeks after the final treatment and 4 weeks after the final treatment. The secondary outcome measures will be changes of Barthel and FuglMeyer scores at baseline after 4 weeks after the final treatment and 4 weeks after the final treatment. The safety will also be assessed by monitoring the incidence of adverse events and changes in vital signs during the study. Discussion: Results from this trial will significantly support the application of auricular acupuncture and body acupuncture in the consciousness recovery of patients with severe TBI. If found to be effective and safe, auricular acupuncture combined with body acupuncture will be a valuable complementary option for comatose patients with TBI.	[Liu, Tong; Kuang, Weichuan; Wang, Xiaoyin; Jiang, Ye; Qiu, Xiaojia; Wen, Xi; Zeng, Yao; Zhang, Guitao; Liu, Yue] GuangDong Second Hosp Tradit Chi Ese Med, Dept Acupuncture & Rehabil, Guangzhou, Guangdong, Peoples R China; [Lu, Yanqing] Guangzhou Univ Chinese Med, Dept Acupuncture & Rehabil, Guangzhou, Guangdong, Peoples R China; [Yu, Jiani] Guangdong Prov Hosp Tradit Chinese Med, Dept Rehabil Med, Guangzhou, Guangdong, Peoples R China		Liu, Y (corresponding author), GuangDong Second Hosp Tradit Chi Ese Med, Dept Acupuncture & Rehabil, Guangzhou, Guangdong, Peoples R China.; Yu, JN (corresponding author), Guangdong Prov Hosp Tradit Chinese Med, Dept Rehabil Med, Guangzhou, Guangdong, Peoples R China.	502799533@qq.com; liuyue2288@163.com			National Science Foundation for Young Scientists of China [81704179]	This report is financially supported by the National Science Foundation for Young Scientists of China, No. 81704179.	Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; [Anonymous], 2018, FRONT MED; Auricular acupoint Diagnosis and Treatment Professional Committee of China Acupuncture Society, 2008, AUR AC NAM POS; Austin CA, 2013, BRAIN INJURY, V27, P1056, DOI 10.3109/02699052.2013.794964; Baker TE, 2016, AM J ADDICTION, V25, P592, DOI 10.1111/ajad.12453; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Gao L, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/465760; Garner BK, 2018, MED ACUPUNCT, V30, P262, DOI 10.1089/acu.2018.1294; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; James KE, 1996, STAT MED, V15, P1421; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Joseph B, 2015, CURR OPIN CRIT CARE, V21, P506, DOI 10.1097/MCC.0000000000000247; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; Kwon CY, 2018, EVID-BASED COMPL ALT, V2018, P1; Lan Ying, 2015, BMC Complement Altern Med, V15, P103, DOI 10.1186/s12906-015-0606-7; Li YM, 2015, BRAIN INJURY, V29, P981, DOI 10.3109/02699052.2014.989405; Lim S, 2010, EVID-BASED COMPL ALT, V7, P167, DOI 10.1093/ecam/nep006; Liu J, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2687-3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Matsumoto-Miyazaki J, 2016, J ALTERN COMPLEM MED, V22, P887, DOI 10.1089/acm.2014.0356; Matsumoto-Miyazaki J, 2016, J ALTERN COMPLEM MED, V22, P895, DOI 10.1089/acm.2016.0180; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; Murakami M, 2017, PAIN MED, V18, P551, DOI 10.1093/pm/pnw215; Murakami M, 2016, PAIN MED, V18, P215; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Patrick PD, 2009, BRAIN INJURY, V23, P528, DOI 10.1080/02699050902926325; Peng L, 2017, HEARING RES, V359, P1; Romoli M, 2014, NEUROL SCI, V35, pS189, DOI 10.1007/s10072-014-1768-7; Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18; Shan QH, 1996, ZHONGGUO ZHEN JIU, V9, P9; Shi XM, 2009, SHI XUEMIN PRACTICAL; Song HJ, 2018, FRONT MED-PRC, V12, P334, DOI 10.1007/s11684-017-0539-2; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Usichenko T, 2017, BRAIN STIMUL, V10, P1042, DOI 10.1016/j.brs.2017.07.013; Wang Y, 2016, NEURAL REGEN RES, V11, P957, DOI 10.4103/1673-5374.184495; Watzlawick R, 2016, JAMA NEUROL, V73, P149, DOI 10.1001/jamaneurol.2015.3627; White A, 2016, MED ACUPUNCTURE W SC; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xu Kai-Sheng, 2014, Zhongguo Zhen Jiu, V34, P529; Yang LH, 2015, J ALTERN COMPLEM MED, V58, P30; Yang LH, 2014, J ALTERN COMPLEM MED, V20, P590, DOI 10.1089/acm.2013.0324; Yang ZX, 2017, NEURAL REGEN RES, V12, P1308, DOI 10.4103/1673-5374.213551; Yu HL, 2016, NEURAL REGEN RES, V11, P1141, DOI 10.4103/1673-5374.187053; Zhao Lei, 2015, Zhongguo Zhen Jiu, V35, P609	45	2	3	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JUL	2019	98	30							e16587	10.1097/MD.0000000000016587			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IQ4UV	WOS:000480747400073	31348298	Green Published, gold			2022-02-06	
J	Masse, IO; Moquin, L; Provost, C; Guay, S; Gratton, A; De Beaumont, L				Masse, Ian O.; Moquin, Luc; Provost, Chloe; Guay, Samuel; Gratton, Alain; De Beaumont, Louis			A Novel and Translational Rat Model of Concussion Combining Force and Rotation with In Vivo Cerebral Microdialysis	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 149; mild traumatic brain injury; concussion; head acceleration; in vivo; cerebral microdialysis; rat	TRAUMATIC BRAIN-INJURY; AMINO-ACIDS; INTERVAL; TIME	Persistent cognitive and motor symptoms are known consequences of concussions/mild traumatic brain injury (mTBIs) that can be partly attributable to altered neurotransmission. Indeed, cerebral microdialysis studies in rodents have demonstrated an excessive extracellular glutamate release in the hippocampus within the first 10 min following trauma. Microdialysis offers the clear advantage of in vivo neurotransmitter continuous sampling while not having to sacrifice the animal. In addition to the aforementioned technique, a closed head injury model that exerts rapid acceleration and deceleration of the head and torso is needed, as such a factor is not available in many other animal models. The Wayne State weight-drop model mimics this essential component of human craniocerebral trauma, allowing the induction of an impact on the head of an unrestrained rodent with a falling weight. Our novel and translational rat model combines cerebral microdialysis with the Wayne State weight-drop model to study, in lightly anesthetized and unrestrained adult rats, the acute changes in extracellular neurotransmitter levels following concussion. In this protocol, the microdialysis probe was inserted inside the hippocampus as region of interest, and was left inserted in the brain at impact. There is a high density of terminals and receptors in the hippocampus, making it a relevant region to document altered neurotransmission following concussion. When applied to adult Sprague-Dawley rats, our combined model induced increases in hippocampal extracellular glutamate concentrations within the first 10 min, consistent with the previously reported post-concussion symptomology. This combined weight-drop model provides a reliable tool for researchers to study early therapeutic responses to concussions in addition to repetitive brain injury, since this protocol induces a closed-head mild trauma.	[Masse, Ian O.; Provost, Chloe; Guay, Samuel; De Beaumont, Louis] Hop Sacre Coeur Montreal, Res Ctr, Montreal, PQ, Canada; [Moquin, Luc; Gratton, Alain] Douglas Inst, Res Ctr, Montreal, PQ, Canada		Masse, IO (corresponding author), Hop Sacre Coeur Montreal, Res Ctr, Montreal, PQ, Canada.	ian.masse.im@gmail.com		Guay, Samuel/0000-0001-6990-839X	Caroline Durand Foundation Chair in acute traumatology of the Universite de Montreal	We are grateful to Louis Chiocchio for animal care and maintenance, Morgane Regniez for assistance with the intracardiac perfusion procedure, and David Castonguay for assistance with the cryostat. This work was supported by the Caroline Durand Foundation Chair in acute traumatology of the Universite de Montreal awarded to LDB.	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; McCrory P, 2017, BRIT J SPORT MED, V51, P837, DOI 10.1136/bjsports-2017-097878; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Sumbria RK, 2011, NEUROCHEM RES, V36, P109, DOI 10.1007/s11064-010-0276-2; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404	34	2	2	1	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JUL	2019		149							e59585	10.3791/59585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IN6QT	WOS:000478806500022	31355795	Bronze			2022-02-06	
J	Mitchell, KM; Cinelli, ME				Mitchell, Katelyn M.; Cinelli, Michael E.			Balance control in youth hockey players with and without a history of concussions during a lower limb reaching task	CLINICAL BIOMECHANICS			English	Article						Balance control; Concussion; Visuomotor task; Youth athletes; Go/No-Go task	GAIT; DEFICITS; POSTURE	Background: Sport-related concussion (SRC) is a functional injury that affects several clinical domains, including balance and cognition. The purpose of this study was, 1) to determine whether a lower limb visuomotor task could identify balance control differences between youth athletes with and without previous SRC; and 2) if balance is affected by training over time. Methods: Youth hockey players (n = 34) who reported previous SRC (CONCUSSED; n = 12; mean age = 14.4 yrs., SD = 1.6, mean time from injury = 1.9 yrs., median = 1.7 yrs. [0.6-4.6]) and no history of SRC (CONTROL; n = 22; mean age = 14.7, SD = 1.5) were tested twice over 70 days. Participants stood in single support on a Nintendo Wii Balance board sampled at 100 Hz and performed Go/No-Go tasks with each foot. Five FitLight Trainee (TM) (Aurora, ON) lights were arranged on the floor at 60 degrees, 30 degrees, and 0 degrees and illuminated in random GREEN (Go) or RED (No-Go). Balance was assessed using root mean square displacement and velocity of CoP in anterior-posterior and medial-lateral directions. Findings: CONCUSSED had significantly lower velocity of CoP in the anterior-posterior (F-(1,F- 32) = 13.81, p <.001) and medial-lateral (F-(1,F- 32) = 13.80, p <.001) directions than CONTROL, with no learning effects over time (anterior-posterior: F-(1,F- 32) = 0.30, p =.137: F-(1,F- 32) = 0.91, p =.346; medial-lateral: F-(1,F- 32) = 0.91, p =.346). These findings suggest that CONCUSSED consistently performed the task more conservatively. Interpretation: A lower limb Go/No-Go task may objectively identify differences between youth athletes with and without previous SRC. These visuomotor and balance control deficits may persist beyond clinical recovery.	[Mitchell, Katelyn M.; Cinelli, Michael E.] Wilfrid Laurier Univ, Dept Kinesiol, Waterloo, ON, Canada		Mitchell, KM (corresponding author), Dept Kinesiol & Phys Educ, 75 Univ Ave W, Waterloo, ON N2L 3C5, Canada.	mitc0010@mylaurier.ca	Cinelli, Michael/ABE-7625-2020	Cinelli, Michael/0000-0002-5802-2590; Mitchell, Katelyn/0000-0002-7889-9568	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [05288-2014]	The results of the study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. The authors would like to thank Simon Jones from Toronto Rehab, for developing the software for the Wii Balance board. The authors would also like to thank the Natural Sciences and Engineering Research Council of Canada (05288-2014) for support.	Allum J H J, 2012, Front Neurol, V3, P83, DOI 10.3389/fneur.2012.00083; [Anonymous], 1995, GAIT POSTURE; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Buckley TA, 2017, ARCH PHYS MED REHAB, V98, P1962, DOI 10.1016/j.apmr.2017.05.002; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Clark RA, 2018, GAIT POSTURE, V61, P40, DOI 10.1016/j.gaitpost.2017.12.022; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Haghpanah SA, 2017, J BIOMECH, V53, P154, DOI 10.1016/j.jbiomech.2017.01.020; Highstein SM, 2012, ANAT REC, V295, P2000, DOI 10.1002/ar.22582; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2018, BRAIN INJURY, P1; Howes David, 2018, SENSES SENSATIONS CR, P1; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Masani K, 2003, J NEUROPHYSIOL, V90, P3774, DOI 10.1152/jn.00730.2002; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Molinari M, 2002, NEUROSCIENCE, V111, P863, DOI 10.1016/S0306-4522(02)00024-6; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006	28	2	2	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	JUL	2019	67						142	147		10.1016/j.clinbiomech.2019.05.006			6	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	IU2NG	WOS:000483416500022	31103964				2022-02-06	
J	Mummareddy, N; Legarreta, AD; Yengo-Kahn, AM; Bow, HC; Solomon, GS; Naftel, RP; Zuckerman, SL				Mummareddy, Nishit; Legarreta, Andrew D.; Yengo-Kahn, Aaron M.; Bow, Hansen C.; Solomon, Gary S.; Naftel, Robert P.; Zuckerman, Scott L.			Sport-Related Structural Brain Injury in High School Soccer Epidural Hemorrhage After a "Header"	WORLD NEUROSURGERY			English	Article						Epidural hematoma; Soccer; Sport-related structural brain injury	ACUTE SUBDURAL-HEMATOMA; ARACHNOID CYST; 2ND IMPACT; PLAYER; CONCUSSION	BACKGROUND: Sports-related structural brain injury (SRSBI) is a rare, but potentially catastrophic, injury. Limited data exist outlining its epidemiology, pathophysiology, and outcomes. We have presented a case of an epidural hematoma (EDH) that occurred during a high school soccer game. CASE DESCRIPTION: A 16-year-old boy had experienced a head-to-ball collision and head-to-head collision with another player. He denied loss of consciousness, endorsed retrograde amnesia, and complained of a minor headache. On the sidelines, he subsequently passed brief orientation and physical exertion tests. However, on returning to play, he experienced blurry vision, along with headache and nausea/vomiting. At the local hospital, he was found to have a 2.6-cm right frontal EDH. After transfer to our institution, increasing somnolence was noted, prompting emergent evacuation of the EDH. His postoperative course was unremarkable, and he was discharged on postoperative day 2. At the 2-week and 3-month follow-up visits, he did not express any complaints or residual deficits and was cleared for full sporting activity. CONCLUSIONS: The present case highlights one of the few SRSBIs that have, occurred in soccer. Because of their rarity and severity, a concerted effort should be made to report these cases of SRSBIs regarding the mechanism, postcollision symptoms, and long-term outcomes.	[Mummareddy, Nishit; Legarreta, Andrew D.; Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Yengo-Kahn, Aaron M.; Bow, Hansen C.; Solomon, Gary S.; Naftel, Robert P.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37235 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA.; Zuckerman, SL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN 37235 USA.	scott.zuckerman@vumc.org	Yengo-Kahn, Aaron/AAV-7647-2020	Yengo-Kahn, Aaron/0000-0002-5989-3064			Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Bruzzone E, 2000, AM J SPORT MED, V28, P901, DOI 10.1177/03635465000280062201; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; DATTI R, 1995, BRIT J SPORT MED, V29, P95, DOI 10.1136/bjsm.29.2.95; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Demetriades AK, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.005710; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Ganz JC, 2013, J NEUROSURG, V118, P739, DOI 10.3171/2012.12.JNS121264; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Keller TM, 1998, BRIT J SPORT MED, V32, P338, DOI 10.1136/bjsm.32.4.338; Kerr ZY, 2018, J SCI MED SPORT, V21, P447, DOI 10.1016/j.jsams.2017.08.025; Kushi H, 2009, J TRAUMA, V66, P298, DOI 10.1097/TA.0b013e3181715dba; Logan SM, 2001, J ATHL TRAINING, V36, P433; Lutfi R, 2009, PEDIATR EMERG CARE, V25, P582, DOI 10.1097/PEC.0b013e3181b4f5f7; Matsuda W, 2008, J TRAUMA, V65, P461, DOI 10.1097/01.ta.0000202465.13784.2a; Mueller FO, 2001, J ATHL TRAINING, V36, P312; Nemecek AN, 2005, PEDIATR NEUROSURG, V41, P170, DOI 10.1159/000085880; Register-Mihalik JK, 2015, CLIN J SPORT MED, V25, P502, DOI 10.1097/JSM.0000000000000161; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Stovitz SD, 2017, CURR SPORT MED REP, V16, P50, DOI 10.1249/JSR.0000000000000326; Stump S., 2015, TODAY; Tsuzuki N, 2003, NEUROSURGERY, V53, P242, DOI 10.1227/01.NEU.0000072303.16102.E1; US Youth Soccer,, 2016, US YOUTH SOCC ANN RE; Wang A, 2011, J NEUROSURG-PEDIATR, V7, P111, DOI 10.3171/2010.10.PEDS10283; Yengo-Kahn AM, 2017, WORLD NEUROSURG, V106, DOI 10.1016/J.WNEU.2017.07.072; Zeng T, 2011, CHIN J TRAUMATOL, V14, P174, DOI 10.3760/cma.j.issn.1008-1275.2011.03.010; Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, pE9	31	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2019	127						20	23		10.1016/j.wneu.2019.03.198			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IF5NH	WOS:000473128300164	30928598				2022-02-06	
J	Ouyang, Z; Xu, GQ; Jiang, YG				Ouyang, Zhu; Xu, Ganqiong; Jiang, Yugang			L-Cysteine augments microtubule-associated protein 2 levels and enhances antioxidant activity in rats following traumatic brain injury	3 BIOTECH			English	Article						L-Cysteine; Traumatic brain injury; Reduced glutathione; Lipid peroxidation; Rats	DIETARY L-CYSTEINE; LIPID-PEROXIDATION; GLUTATHIONE LEVELS; LIVER; OXIDATION; GLUCOSE; BLOOD; MAP2	L-Cysteine is a well-known sulfur-containing non-essential amino acid that can be oxidized to cysteine, which possesses a variety of pharmacological actions, including antioxidant and anti-inflammatory activities. Traumatic brain injury (TBI) is defined as a closed head injury that leads to temporary alterations in neural function and further leads to pathophysiological processes. In the present study, rats were categorized into sham, control, 100 mg/kg L-cysteine, and 200 mg/kg L-cysteine groups and then the levels of lipid peroxidation, reduced glutathione (GSH), catalase, superoxide dismutase (SOD), reactive oxygen species (ROS), and mRNA and protein expression of microtubule-associated protein 2 (MAP2) were determined. Following supplementation with L-cysteine, there were reductions in lipid peroxidation and ROS levels, whereas catalase, SOD, and GSH levels increased. Additionally, the mRNA expression of MAP2 in the control rats was drastically reduced by 67% compared to the sham rats. However, supplementation with 100 mg/kg of L-cysteine and 200 mg/kg of L-cysteine significantly increased MAP2 mRNA expression by 84.8% and 169.7%, respectively. Similarly, MAP2 protein expression was drastically reduced by 61% in control rats compared to sham rats, but supplementation with 100 mg/kg of L-cysteine and 200 mg/kg of L-cysteine significantly increased MAP2 protein expression by 41% and 94.9%, respectively. Taken together, these data suggest that supplementation with L-cysteine significantly reduced lipid peroxidation and ROS levels, but increased antioxidant levels and the mRNA and protein expression of MAP2 in rats following TBI.	[Ouyang, Zhu; Jiang, Yugang] Cent S Univ, Dept Neurosurg, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Xu, Ganqiong] Cent S Univ, Dept Ultrasound Diag, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China		Jiang, YG (corresponding author), Cent S Univ, Dept Neurosurg, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.	jiangyugang123@csu.edu.cn			National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801721]	This study was supported by National Natural Sciences Foundation of China (Grant No. 81801721).	Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Balic M, 2011, APPL IMMUNOHISTO M M, V19, P33, DOI 10.1097/PAI.0b013e3181ebf4e8; Baydas G, 2002, NEUROSCI LETT, V323, P195, DOI 10.1016/S0304-3940(02)00144-1; Bobyn PJ, 2002, NUTR NEUROSCI, V5, P407, DOI 10.1080/1028415021000055952; Buddle M, 2003, BRAIN RES, V978, P38, DOI 10.1016/S0006-8993(03)02758-6; Carbone DL, 2005, CHEM RES TOXICOL, V18, P1324, DOI 10.1021/tx050078z; d'Hemecourt P, 2011, CLIN SPORT MED, V30, P63, DOI 10.1016/j.csm.2010.08.008; Dilger RN, 2007, J NUTR, V137, P331, DOI 10.1093/jn/137.2.331; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Elias RJ, 2005, J AGR FOOD CHEM, V53, P10248, DOI 10.1021/jf0521698; Fechter LD, 2008, INHAL TOXICOL, V20, P885, DOI [10.1080/08958370801975329, 10.1080/08958370801975329 ]; Fontaine-Lenoir V, 2006, P NATL ACAD SCI USA, V103, P4711, DOI 10.1073/pnas.0600113103; Hasegawa S, 2012, CLIN EXP IMMUNOL, V167, P269, DOI 10.1111/j.1365-2249.2011.04519.x; Higashikata T, 2004, ATHEROSCLEROSIS, V177, P353, DOI 10.1016/j.atherosclerosis.2004.07.013; Hoffer BJ, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0377-1; Jain SK, 2016, MOL NUTR FOOD RES, V60, P1090, DOI 10.1002/mnfr.201500667; Jordao AA, 2004, FOOD CHEM TOXICOL, V42, P459, DOI 10.1016/j.fct.2003.10.008; Karanth J, 2005, INT J VITAM NUTR RES, V75, P333, DOI 10.1024/0300-9831.75.5.333; Kim HJ, 2017, PEERJ, V5, DOI 10.7717/peerj.2818; Landino LM, 2004, J BIOL CHEM, V279, P35101, DOI 10.1074/jbc.M405471200; Lee S, 2013, BIOSCI BIOTECH BIOCH, V77, P1430, DOI 10.1271/bbb.130083; Li JJ, 2016, PAIN, V157, P1711, DOI 10.1097/j.pain.0000000000000575; Miura Y, 2014, BIOSCI BIOTECH BIOCH, V78, P1452, DOI 10.1080/09168451.2014.918496; MIYAZAWA T, 1993, ACTA NEUROPATHOL, V85, P526; Roesslein M, 2013, INT J MOL SCI, V14, P24320, DOI 10.3390/ijms141224320; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Saleh A. A. S., 2015, Journal of Basic and Applied Zoology, V72, P73, DOI 10.1016/j.jobaz.2015.05.001; Saravanan N, 1995, PHARMACOL RES, V32, P165, DOI 10.1016/S1043-6618(05)80010-6; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Ye S, 2010, J SURG RES, V158, P138, DOI 10.1016/j.jss.2009.01.002	31	2	2	3	20	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	2190-572X	2190-5738		3 BIOTECH	3 Biotech	JUL	2019	9	7							280	10.1007/s13205-019-1805-6			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	IH5WI	WOS:000474563800001	31245244	Green Published			2022-02-06	
J	Sharma, A; Phillips, CJC				Sharma, Arvind; Phillips, Clive J. C.			Avoidance Distance in Sheltered Cows and Its Association with Other Welfare Parameters	ANIMALS			English	Article						human-animal relationship; cow shelters; avoidance distance; welfare; assessment	HUMAN-ANIMAL RELATIONSHIP; TIED DAIRY-COWS; SCORING SYSTEM; RISK-FACTORS; MILK-YIELD; PHYSIOLOGICAL-RESPONSES; APPROACH BEHAVIOR; LEG INJURIES; SAMPLE-SIZE; HEART-RATE	Simple Summary Avoidance distance is an indicator of the welfare of farmed animals, which is routinely included in contemporary animal welfare assessments. Determination of this parameter for cows in traditional Indian shelters is important because the shelters owe their existence due to the concept of non-violence and compassion to animals, which is held by the Hindu majority population in India. These cows have outlived their economic value due to old age, reproductive problems, and/or subsequent abandonment by their owners. Their slaughter is prohibited by law in most Indian states. The avoidance distance test measures the closest distance that a person can approach a cow, which is a measure of whether stockpersons handling the cows in shelters have had a humane and positive relationship with these cows. Association of the avoidance distance was observed with the cows' health, in particular their dirtiness and extent of musculoskeletal, digestive, and respiratory problems. This study provides information to justify monitoring this critical-but often neglected-aspect of cow shelter management for a sustainable improvement in sheltered cow welfare. The human-animal relationship is an important welfare parameter in animal welfare assessment in cows, and the avoidance distance of cows to a stranger at the feed bunk is measured to assess this relationship. The assessment of the human-animal relationship in cow shelters in India, where old, unproductive, and abandoned cows are sheltered, is important to explore the welfare of cows in these shelters. The cows observed were of indigenous Indian breeds and breeds which were crosses between indigenous breeds and pure bred exotic cows. The human-animal contact in this context is of particular interest for welfare assessment as traditional Indian farming and sheltering systems involves regular close human-animal contact. In a cross-sectional study across 6 states, 54 cow shelters were visited and 30 cows in each shelter were randomly selected (1620 in total) for the assessment of avoidance distance and other cow-based (27 parameters) and resource-based (15 parameters) welfare parameters. Avoidance distance was assessed 1 h after morning feeding. Cows standing at the feeding manger were approached from the front at a rate of one step/s, starting 2 m away from the manger. The distance between the assessor's hand and the cow's head was estimated at the moment the cow moved away and turned its head, using a four-point scale (0, touched; 1, 0-50 cm; 2, 51-100 cm; and 3, >100 cm). The majority, 52%, of the cows allowed touch by the assessor and another 32% allowed approach within 50 cm, demonstrating tolerance, or even solicitation of close human-animal relationships by the cows. Avoidance distance increased with the proportion of cows with dirty hind limbs, tarsal joint swellings, and hair loss, and the extent of rumen fill. There was also evidence of reduced avoidance distances in cows with high levels of body condition score (BCS), dirty flanks, tarsal joint ulceration, carpal joint injuries, diarrhoea, hampered respiration, lesions on the body due to traumatic injuries, and body coat condition, probably as a result of moving difficulties. The avoidance distance was thus related to the health and welfare of the cows, providing a vital insight into the factors affecting human-animal contact in the shelters.	[Sharma, Arvind; Phillips, Clive J. C.] Univ Queensland, Sch Vet Sci, Ctr Anim Welf & Eth, Gatton Campus, Gatton 4343, Australia		Sharma, A (corresponding author), Univ Queensland, Sch Vet Sci, Ctr Anim Welf & Eth, Gatton Campus, Gatton 4343, Australia.	arvind.sharma@uqconnect.edu.au			School of Veterinary Science, The University of Queensland, Australia; Humane Society International (HSI), Australia [14444]; Fondation Brigitte Bardot, France; Universities Fund for AnimalWelfare (UFAW) UFAW, UK [13-16/17]	This study is a part of the PhD research project of the first author which was funded by the School of Veterinary Science, The University of Queensland, Australia, Humane Society International (HSI) payment no. 14444 dated 21/09/2016, Australia, Universities Fund for AnimalWelfare (UFAW) UFAW grant no. 13-16/17, UK, and the Fondation Brigitte Bardot, France.	Abe N, 1999, HOARDS DAIRYMAN, V144, P439; AITCHISON EM, 1986, BRIT J NUTR, V56, P463, DOI 10.1079/BJN19860126; Arnold NA, 2007, APPL ANIM BEHAV SCI, V106, P13, DOI 10.1016/j.applanim.2006.07.004; Avery D., 2000, J ANIM SCI, V78, P1467, DOI [10.2527/2000.7861467x, DOI 10.2527/2000.7861467X]; Beggs DS, 2019, J DAIRY SCI, V102, P3406, DOI 10.3168/jds.2018-14850; Boissy A, 1995, APPL ANIM BEHAV SCI, V46, P17, DOI 10.1016/0168-1591(95)00633-8; Botreau R, 2007, ANIM WELFARE, V16, P225; Botreau R, 2009, ANIM WELFARE, V18, P363; Brenninkmeyer C, 2013, PREV VET MED, V109, P236, DOI 10.1016/j.prevetmed.2012.10.014; Breuer K, 2003, APPL ANIM BEHAV SCI, V84, P3, DOI 10.1016/S0168-1591(03)00146-1; Breuer K, 2000, APPL ANIM BEHAV SCI, V66, P273, DOI 10.1016/S0168-1591(99)00097-0; BROOM DM, 1986, APPL ANIM BEHAV SCI, V15, P186, DOI 10.1016/0168-1591(86)90074-2; Brouek J., 2014, SLOVAK J ANIM SCI, V47, P111; Bruckert M, 2018, ANTHROPOZOOLOGICA, V53, P207, DOI 10.5252/anthropozoologica2018v53a18; Burfeind O, 2010, J DAIRY SCI, V93, P3635, DOI 10.3168/jds.2009-3044; Cafe LM, 2011, J ANIM SCI, V89, P1452, DOI 10.2527/jas.2010-3304; Chaplin SJ, 2000, APPL ANIM BEHAV SCI, V66, P263, DOI 10.1016/S0168-1591(99)00100-8; Coignard M, 2013, PREV VET MED, V112, P296, DOI 10.1016/j.prevetmed.2013.07.018; Constable P.D., 2017, VET MED TXB DIS CATT, P2065; Cook N.B., 2002, P 35 ANN CONV AM BOV, P97; de Passille AM, 2005, APPL ANIM BEHAV SCI, V92, P193, DOI 10.1016/j.applanim.2005.05.006; de Vries M, 2013, ANIM WELFARE, V22, P85, DOI 10.7120/09627286.22.1.085; des Roches AD, 2016, J DAIRY SCI, V99, P5573, DOI 10.3168/jds.2015-10633; Destrez A, 2018, LIVEST SCI, V212, P7, DOI 10.1016/j.livsci.2018.03.011; Dohoo I, 2009, VET EPIDEMIOLOGIC RE, V2nd; Ebinghaus A, 2017, APPL ANIM BEHAV SCI, V196, P22, DOI 10.1016/j.applanim.2017.07.006; Ebinghaus A, 2016, APPL ANIM BEHAV SCI, V185, P30, DOI 10.1016/j.applanim.2016.09.010; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Evans DL, 2017, INT SER OPER RES MAN, V247, P165, DOI 10.1007/978-3-319-43317-2_13; Flower FC, 2006, J DAIRY SCI, V89, P139, DOI 10.3168/jds.S0022-0302(06)72077-X; Fournel S, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7050037; Galindo Francisco, 2002, Journal of Applied Animal Welfare Science, V5, P193, DOI 10.1207/S15327604JAWS0503_03; GRANDIN T, 1987, VET CLIN N AM-FOOD A, V3, P323, DOI 10.1016/S0749-0720(15)31155-5; Hanna D, 2006, ANIM SCI, V82, P791, DOI 10.1017/ASC2006092; Haskell MJ, 2006, J DAIRY SCI, V89, P4259, DOI 10.3168/jds.S0022-0302(06)72472-9; Hemsworth PH, 2011, HUMAN-LIVESTOCK INTERACTIONS, 2ND EDITION: THE STOCKPERSON AND THE PRODUCTIVITY AND WELFARE OF INTENSIVELY FARMED ANIMALS, P1, DOI 10.1079/9781845936730.0000; Hemsworth PH, 2002, J ANIM SCI, V80, P68; HEMSWORTH PH, 1993, ANIM WELFARE, V2, P33; Herlin AH, 1997, SWED J AGR RES, V27, P189; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Hutson GD, 2000, APPL ANIM BEHAV SCI, V66, P187, DOI 10.1016/S0168-1591(99)00084-2; Huxley J., 2006, UK Vet: Livestock, V11, P51, DOI 10.1111/j.2044-3870.2006.tb00048.x; Huxley J, 2006, LIVESTOCK, V11, P18, DOI DOI 10.1111/j.2044-3870.2006.tb00021.x; Huzzey JM, 2007, J DAIRY SCI, V90, P3220, DOI 10.3168/jds.2006-807; Ivemeyer S, 2011, J DAIRY SCI, V94, P5890, DOI 10.3168/jds.2010-4048; Jurkovich V, 2017, ACTA VET HUNG, V65, P301, DOI 10.1556/004.2017.029; Kennedy U, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8050064; Kester E, 2014, VET J, V202, P222, DOI 10.1016/j.tvjl.2014.07.004; Kielland C, 2010, J DAIRY SCI, V93, P3979, DOI 10.3168/jds.2009-2909; King DA, 2006, MEAT SCI, V74, P546, DOI 10.1016/j.meatsci.2006.05.004; Kloosterman P., 1997, LAMENESS CATTLE, P123; Lean IJ, 2001, AUST VET J, V79, P262, DOI 10.1111/j.1751-0813.2001.tb11978.x; Leeb CH, 2004, BRISTOL WELFARE ASSU; LEFCOURT AM, 1989, J DAIRY SCI, V72, P3040, DOI 10.3168/jds.S0022-0302(89)79457-1; Lensink BJ, 2001, ANIM SCI, V72, P105, DOI 10.1017/S1357729800055600; LLAMASLAMAS G, 1991, J DAIRY SCI, V74, P526, DOI 10.3168/jds.S0022-0302(91)78200-3; Lurzel S, 2018, ANIMAL, V12, P340, DOI 10.1017/S1751731117001495; Mulleder C, 2003, ANIM WELFARE, V12, P579; Munksgaard L, 1997, J DAIRY SCI, V80, P1106, DOI 10.3168/jds.S0022-0302(97)76036-3; Munksgaard L, 2001, APPL ANIM BEHAV SCI, V73, P15, DOI 10.1016/S0168-1591(01)00119-8; Oetzel GR, 2004, VET CLIN N AM-FOOD A, V20, P651, DOI 10.1016/j.cvfa.2004.06.006; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Otten ND, 2016, ANIM WELFARE, V25, P207, DOI 10.7120/09627286.25.2.207; Phillips C. J. C., 2009, Principles of cattle production, P95, DOI 10.1079/9781845933975.0095; Phillips C. J. C., 2010, PRINCIPLES CATTLE PR; Phillips CJC, 2000, J DAIRY SCI, V83, P1767, DOI 10.3168/jds.S0022-0302(00)75047-8; Phillips CJC, 2001, J DAIRY SCI, V84, P623, DOI 10.3168/jds.S0022-0302(01)74517-1; Popescu S, 2010, SLOV VET RES, V47, P77; Potterton SL, 2011, J DAIRY SCI, V94, P2952, DOI 10.3168/jds.2010-4084; PURCELL D, 1988, APPL ANIM BEHAV SCI, V21, P307, DOI 10.1016/0168-1591(88)90065-2; Regula G, 2004, PREV VET MED, V66, P247, DOI 10.1016/j.prevetmed.2004.09.004; Roussel AJ, 2014, VET CLIN N AM-FOOD A, V30, P429, DOI 10.1016/j.cvfa.2014.04.005; Rushen J, 1999, APPL ANIM BEHAV SCI, V65, P285, DOI 10.1016/S0168-1591(99)00089-1; Rushen J, 1998, APPL ANIM BEHAV SCI, V55, P259, DOI 10.1016/S0168-1591(97)00053-1; Rushen J, 1999, J DAIRY SCI, V82, P720, DOI 10.3168/jds.S0022-0302(99)75289-6; Rushen J., 2008, WELFARE CATTLE, P305; Sarkar R, 2016, POLIT RELIG IDEOL, V17, P329, DOI 10.1080/21567689.2016.1259108; Schmied C, 2008, J DAIRY SCI, V91, P596, DOI 10.3168/jds.2007-0360; SEABROOK MF, 1984, VET REC, V115, P84, DOI 10.1136/vr.115.4.84; Sharma A, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9040172; Sharma A, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9040120; Sprecher DJ, 1997, THERIOGENOLOGY, V47, P1179, DOI 10.1016/S0093-691X(97)00098-8; Sserunjogi B, 2016, INDIAN J DAIRY SCI, V69, P571; Thomsen PT, 2006, PREV VET MED, V75, P133, DOI 10.1016/j.prevetmed.2006.02.004; van der Tol PPJ, 2005, J DAIRY SCI, V88, P615, DOI 10.3168/jds.S0022-0302(05)72725-9; VANDENHEEDE M, 1993, APPL ANIM BEHAV SCI, V37, P39, DOI 10.1016/0168-1591(93)90069-2; Vecera M, 2016, ANN ANIM SCI, V16, P1153, DOI 10.1515/aoas-2016-0021; von Keyserlingk MAG, 2012, J DAIRY SCI, V95, P7399, DOI 10.3168/jds.2012-5807; Waiblinger S, 2007, ANIM WELFARE, V16, P143; Waiblinger S, 2003, ANIM WELFARE, V12, P585; Waiblinger S, 2003, APPL ANIM BEHAV SCI, V84, P23, DOI 10.1016/S0168-1591(03)00148-5; Waiblinger S, 2006, APPL ANIM BEHAV SCI, V101, P185, DOI 10.1016/j.applanim.2006.02.001; Wechsler B, 2000, APPL ANIM BEHAV SCI, V69, P189, DOI 10.1016/S0168-1591(00)00134-9; Whay HR, 2003, VET REC, V153, P197, DOI 10.1136/vr.153.7.197; Winckler C, 2007, ANIM WELFARE, V16, P197; Winckler C, 2003, ANIM WELFARE, V12, P619; Windschnurer I, 2008, APPL ANIM BEHAV SCI, V114, P37, DOI 10.1016/j.applanim.2008.01.017; Windschnurer I, 2009, APPL ANIM BEHAV SCI, V117, P117, DOI 10.1016/j.applanim.2008.12.013; WOO AKM, 2010, BRIT J PAIN, V4, P8, DOI DOI 10.1177/204946371000400103; Zaaijer D, 2003, IRISH VET J, V56, P145; Zurbrigg K, 2005, J DAIRY SCI, V88, P3201, DOI 10.3168/jds.S0022-0302(05)73003-4	101	2	2	2	9	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-2615			ANIMALS-BASEL	Animals	JUL	2019	9	7							396	10.3390/ani9070396			20	Agriculture, Dairy & Animal Science; Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture; Veterinary Sciences; Zoology	IN3YH	WOS:000478611800041	31261826	Green Published, gold, Green Submitted			2022-02-06	
J	Sribnick, EA; Lunney, M; Wright, DW; Allen, JW; Hudgins, PA; Shi, JX; Wheeler, K; Leonard, JR; Dhall, SS; Xiangh, H				Sribnick, Eric A.; Lunney, Michael; Wright, David W.; Allen, Jason W.; Hudgins, Patricia A.; Shi, Junxin; Wheeler, Krista; Leonard, Jeffrey R.; Dhall, Sanjay S.; Xiangh, Henry			The Surgical Intervention for Traumatic Injury Scale: A Clinical Tool for Traumatic Brain Injury	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article								Introduction: There is no widely used method for communicating the possible need for surgical intervention in patients with traumatic brain injury (TBI). This study describes a scoring system designed to communicate the potential need for surgical decompression in TBI patients. The scoring system, named the Surgical Intervention for Traumatic Injury (SITI), was designed to be objective and easy to use. Methods: The SITI scale uses radiographic and clinical findings, including the Glasgow Coma Scale Score, pupil examination, and findings noted on computed tomography. To examine the scale, we used the patient database for the Progesterone for the Treatment of Traumatic Brain Injury III (ProTECT III) trial, and retrospectively applied the SITI scale to these patients. Results: Of the 871 patients reviewed, 164 (18.8%) underwent craniotomy or craniectomy, and 707 (81.2%) were treated nonoperatively. The mean SITI score was 5.1 for patients who underwent surgery and 2.5 for patients treated nonoperatively (P<0.001). The area under the receiver operating characteristic curve was 0.887. Conclusion: The SITI scale was designed to be a simple, objective, clinical decision tool regarding the potential need for surgical decompression after TBI. Application of the SITI scale to the ProTECT III database demonstrated that a score of 3 or more was well associated with a perceived need for surgical decompression. These results further demonstrate the potential utility of the SITI scale in clinical practice.	[Sribnick, Eric A.; Leonard, Jeffrey R.] Nationwide Childrens Hosp, Div Neurosurg, 700 Childrens Dr, Columbus, OH 43205 USA; [Sribnick, Eric A.; Leonard, Jeffrey R.] Ohio State Univ, Dept Neurosurg, Columbus, OH 43210 USA; [Shi, Junxin; Wheeler, Krista; Xiangh, Henry] Nationwide Childrens Hosp, Ctr Pediat Trauma Res, Columbus, OH USA; [Lunney, Michael; Wright, David W.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Allen, Jason W.; Hudgins, Patricia A.] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA; [Dhall, Sanjay S.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA		Sribnick, EA (corresponding author), Nationwide Childrens Hosp, Div Neurosurg, 700 Childrens Dr, Columbus, OH 43205 USA.	eric.sribnick@nationwidechildrens.org	Sribnick, Eric/AAH-6693-2020				Bullock M Ross, 2006, Neurosurgery, V58, pS56; Bullock M Ross, 2006, Neurosurgery, V58, pS47; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Bullock MR, 2006, NEUROSURGERY, V58, pS1; Centers for Disease Control and Prevention, 2015, INJ US EP REH; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HEROS RC, 1982, STROKE, V13, P106, DOI 10.1161/01.STR.13.1.106; Joosse P, 2012, J TRAUMA ACUTE CARE, V72, P487, DOI 10.1097/TA.0b013e318226ed59; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Sribnick Eric A, 2015, Surg Neurol Int, V6, P1, DOI 10.4103/2152-7806.148541; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; TSAI FY, 1980, J COMPUT ASSIST TOMO, V4, P291, DOI 10.1097/00004728-198006000-00002; Vaccaro AR, 2007, SPINE, V32, P2365, DOI 10.1097/BRS.0b013e3181557b92; Vassar MJ, 1999, J TRAUMA, V47, P324, DOI 10.1097/00005373-199908000-00017; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	20	2	2	1	1	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	JUL	2019	20	4					578	584		10.5811/westjem.2019.4.41802			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JM8DM	WOS:000496438800007	31316696	gold, Green Published			2022-02-06	
J	Taskapilioglu, MO; Ozmarasali, AI; Ocakoglu, G				Taskapilioglu, M. Ozgur; Ozmarasali, Ali Imran; Ocakoglu, Gokhan			Retrospective analysis of decompressive craniectomy performed in pediatric patients with subdural hematoma	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Acute subdural hematoma; decompressive craniectomy; head injury	TRAUMATIC BRAIN-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; CRANIOTOMY; MORTALITY; CHILDREN; SIZE	BACKGROUND: The impact of decompressive craniectomy (DC) on the overall outcome of pediatric acute subdural hematoma patients has not been fully determined to date. In this paper, we aimed to investigate the role of decompressive craniectomy performed to treat traumatic subdural hematoma in patients from the pediatric age group. METHODS: We described our experience with DC in pediatric acute subdural hematoma patients and analyzed the outcomes. RESULTS: Eleven (7 unilateral and 4 bilateral) DCs were performed. The patients' ages ranged from 8 months to 15 years. The mean GCS score at admission was 7.8. All patients underwent DC with duraplasty within 2 hours of injury. All the patients were admitted to the intensive care unit for 10 days postoperatively. The mean hospital stay was 22 days and the mean follow-up period was 3.7 years. CONCLUSION: Early DC for pediatric subdural hematoma patients, independent of their initial GCS, was recommended. Larger studies are needed to define the indications, surgical techniques, and timing of DC in the pediatric population.	[Taskapilioglu, M. Ozgur; Ozmarasali, Ali Imran] Uludag Univ, Dept Neurosurg, Fac Med, Bursa, Turkey; [Ocakoglu, Gokhan] Uludag Univ, Dept Biostat, Fac Med, Bursa, Turkey		Taskapilioglu, MO (corresponding author), Uludag Univ, Tip Fak, Beyin & Sinir Cerrahisi Anabilim Dali, Bursa, Turkey.	ozgurt@uludag.edu.tr	Taskapilioglu, M Ozgur/AAW-5254-2020; Taskapilioglu, Ozgur/ABB-8161-2020; ocakoglu, gokhan/AAH-5180-2021	Taskapilioglu, M Ozgur/0000-0001-5472-9065; 			Adelson PD, 2003, PEDIATR CRIT CARE ME, V4, P56; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Morina Arsim, 2011, Surg Neurol Int, V2, P72, DOI 10.4103/2152-7806.81735; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Perez SE, 2011, J TRAUMA, V71, P133; Phan K, 2017, WORLD NEUROSURG, V101, P677, DOI 10.1016/j.wneu.2017.03.024; Qiu W, 2009, CRITICAL CARE, V13, P185; Rocque BG, 2018, J NEUROSURG-PEDIATR, V22, P225, DOI 10.3171/2018.3.PEDS17234; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Sedney CL, 2014, J NEUROSCI RURAL PRA, V5, P212, DOI 10.4103/0976-3147.133555; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Tanrikulu L, 2015, CLIN NEUROL NEUROSUR, V135, P15, DOI 10.1016/j.clineuro.2015.04.019; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Walker PA, 2009, J TRAUMA, V67, pS120, DOI 10.1097/TA.0b013e3181ad323a; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	28	2	2	0	0	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JUL	2019	25	4					383	388		10.5505/tjtes.2018.02403			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IH8XS	WOS:000474791100011	31297771	Bronze			2022-02-06	
J	Wayment, HA; Huffman, AH; Lane, TS; Lininger, MR				Wayment, Heidi A.; Huffman, Ann H.; Lane, Taylor S.; Lininger, Monica R.			Relationship of athletic and academic identity to concussion reporting intentions	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Athletic self-identity; Academic identity; Concussion-reporting intentions	ICE HOCKEY; EPIDEMIOLOGY; KNOWLEDGE; SYMPTOMS; BEHAVIOR; MOTIVATIONS; ATTITUDES; SPORTS; FUTURE	Background: Understanding concussed athletes' motivations for reporting concussion symptoms is important for health care professionals who are charged with the care, management, and prevention of future injury. Objectives: To examine if athletic and academic identity predict concussion symptom reporting intentions above and beyond traditional socio-cognitive predictors. Design: Cross-sectional study using self-report measures during the 2016 collegiate football season. Method: In a sample of National Collegiate Athletic Association (NCAA) Division I American football athletes (N = 205) we examined the relationship of athletic and academic identity with three indices of symptom reporting behavior: reporting during a game, reporting 24 h after a game, and reporting on behalf of a teammate. We used descriptive statistical analyses, correlations, and linear regression to examine hypotheses. Results: Controlling for traditional predictors, athletic identity was associated with a lower likelihood to report symptoms during a game (beta = -0.22, t = -3.28, p < .001) or within 24 h (beta = -0.28, t = -4.12, p < .001). Academic identity was positively associated with reporting intentions during a game (beta = 0.12, t = 1.68, p < .05), 24 h later (beta = 0.13, t = 1.85, p < .05), and on behalf of a teammate (beta = 0.22, t = -3.36, p < .001). Conclusions: Athletic and academic identities offer additional insight into athletes' motivation for concussion symptom reporting intentions, above and beyond traditional socio-cognitive predictors. Discussion focuses on the benefit of incorporating these important self-identities into educational health interventions to improve their impact.	[Wayment, Heidi A.; Huffman, Ann H.] No Arizona Univ, Psychol Sci, 1100 S Beaver St, Flagstaff, AZ 86011 USA; [Huffman, Ann H.] No Arizona Univ, WA Franke Coll Business, 101 E McConnell, Flagstaff, AZ 86011 USA; [Lininger, Monica R.] No Arizona Univ, Phys Therapy & Athlet Training, 208 E Pine Knoll Dr, Flagstaff, AZ USA; [Lane, Taylor S.] No Arizona Univ, Interdisciplinary Hlth PhD Program, 1100 S Beaver St, Flagstaff, AZ 86011 USA		Wayment, HA (corresponding author), No Arizona Univ, Psychol Sci, 1100 S Beaver St, Flagstaff, AZ 86011 USA.	heidi.wayment@nau.edu; ann.huffman@nau.edu; taylor.lane@nau.edu; monica.lininger@nau.edu		Lane, Taylor Scarlett/0000-0001-9387-5700	National Collegiate Athletic Association; U.S. Department of DefenseUnited States Department of Defense	This research was supported by the National Collegiate Athletic Association and the U.S. Department of Defense (http://www.ncaa.org/sport-science-institute/topics/mind-matters-challenge) on a programmatic research project investigating NCAA football programs' efforts to increase concussion-reporting behavior. The sponsors of this research had no input in any aspect of study design, data collection, analysis and interpretation, writing of the report, or submitting for publication. We gratefully acknowledge our MindMatters team for their assistance related to this study (Co-PI Debbie Craig, PhD, LAT, ATC, and graduate assistant Patrick Doyle).	Albarracin D, 2000, J PERS SOC PSYCHOL, V79, P5, DOI 10.1037//0022-3514.79.1.5; Armstrong D., 2016, COLL REQUIRE ATHLETE; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; BREWER BW, 1993, INT J SPORT PSYCHOL, V24, P237; Canadian Government, 2017, CONC SPORT; CDC, 2017, HEADS UP        0622; Cieslak T. J., 2005, DESCRIBING MEASURING; Comstock R., 2014, AM COLL SPORTS MED O; Craig DI, 2020, RES SPORTS MED, V28, P181, DOI 10.1080/15438627.2019.1586706; Davies SC, 2015, J CLIN SPORT PSYCHOL, V9, P101, DOI 10.1123/jcsp.2014-0037; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Greenaway KH, 2016, EUR J SOC PSYCHOL, V46, P294, DOI 10.1002/ejsp.2169; Guay JL, 2016, AM PSYCHOL, V71, P875, DOI 10.1037/a0040430; Hilliard RC, 2017, J SPORT REHABIL, V26, P208, DOI 10.1123/jsr.2015-0134; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Jetten J, 2017, EUR J SOC PSYCHOL, V47, P789, DOI 10.1002/ejsp.2333; Kerr ZY, 2018, J ATHL TRAINING, V53, P738, DOI 10.4085/1062-6050-144-17; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lininger M, 2017, ATHLETIC TRAIN SPORT, V9, P71, DOI DOI 10.3928/19425864-20161116-01; Lininger MR, 2019, J ATHL TRAINING, V54, P21, DOI 10.4085/1062-6050-47-18; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Montano D.E., 2015, HLTH BEHAV THEORY RE, V5th, P95; NCAA, 2013, DO NCAA STUD ATHL VI, P1; O'Rourke DJ, 2017, SPORT EXERC PERFORM, V6, P262, DOI 10.1037/spy0000097; Oyserman D., 2015, PATHWAYS SUCCESS IDE; Patricios JS, 2018, BRIT J SPORT MED, V52, P635, DOI 10.1136/bjsports-2018-099079; Petrie TA, 2014, SPORT EXERC PERFORM, V3, P13, DOI 10.1037/a0032698; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rise J, 2010, J APPL SOC PSYCHOL, V40, P1085, DOI 10.1111/j.1559-1816.2010.00611.x; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Savage JL, 2018, J ATHL TRAINING, V53, P983, DOI 10.4085/1062-6050-394-17; Stryker S, 2000, SOC PSYCHOL QUART, V63, P284, DOI 10.2307/2695840; Taylor C. A., 2017, SURVEILLANCE SUMMARI, V2002, P1, DOI [10.15585/mmwr.ss6609a1, DOI 10.15585/MMWR.SS6609A1]; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wayment H. A, 2018, STUDY REGISTERED DAT; Wayment HA, 2019, AM J PREV MED, V56, P323, DOI 10.1016/j.amepre.2018.10.007; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Yardley K., 1987, SELF IDENTITY PSYCHO, P89; Yukhymenko-Lescroart MA, 2018, PSYCHOL SPORT EXERC, V34, P10, DOI 10.1016/j.psychsport.2017.09.006; Yukhymenko-Lescroart MA, 2014, SPORT EXERC PERFORM, V3, P89, DOI 10.1037/spy0000009; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	52	2	2	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	JUL	2019	42						186	192		10.1016/j.msksp.2019.04.003			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	IC2BJ	WOS:000470764100025	31014920	Bronze			2022-02-06	
J	Linden, MA; O'Rourke, C; Lohan, M				Linden, Mark A.; O'Rourke, Conall; Lohan, Maria			Traumatic brain injury and social competence among young male offenders	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; young offenders; behavioural regulation; aggression; hopelessness	SUBSTANCE USE; MULTIDIMENSIONAL SCALE; MENTAL-DISORDERS; PRISONERS; PREVALENCE; MISCONCEPTIONS; RELIABILITY; AGGRESSION; VALIDITY; MILD	Purpose: To investigate the prevalence of traumatic brain injury (TBI) among young incarcerated males and determine the extent of deficits in behavioural regulation, aggression, hopelessness, and perceived social support, compared to a control group of non-incarcerated males. Methods: Sixty-two young offenders and 58 university-based, gender-matched controls agreed to take part. We collected information on criminal history, risk taking behaviour, drug and alcohol abuse, and mental illness. In addition, we employed measures of brain injury, hopelessness, behavioural regulation, aggression, and perceived social support. Results: Just over 87% (n = 54) of offenders exhibited some level of TBI with over 31% (n = 17) reporting six or more injuries. Offenders with TBI exhibited poorer behavioural control (p < 0.001; M = 66.01 vs. M = 51.33; 95% CI -19.08 to -11.76), higher levels of aggression (p < 0.001; M = 101.19 vs. M = 69.39; 95% CI -38.31 to -27.17), and higher levels of hopelessness (p < 0.001; M = 5.65 vs. M = 2.55) when compared to controls with TBI. Severity of TBI correlated positively with behavioural regulation, aggression, and hopelessness. Conclusions: Greater recognition of the presence and consequences of TBI within the custodial estate is necessary if the needs of young offenders are to be adequately met. Young offenders with TBI experience heightened vulnerability and need rehabilitative input to support their time in prison and on their return to society.	[Linden, Mark A.; O'Rourke, Conall; Lohan, Maria] Queens Univ Belfast, Sch Nursing & Midwifery, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland		Linden, MA (corresponding author), Queens Univ Belfast, Sch Nursing & Midwifery, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	m.linden@qub.ac.uk		Lohan, Maria/0000-0003-3525-1283; Linden, Mark/0000-0002-3832-4102			Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Andrews DA, 2010, PSYCHOLOGY OF CRIMINAL CONDUCT, 5TH EDITION, P1; [Anonymous], 2017, SAF CUST STAT B MIN; [Anonymous], 2016, REP UN INSP HYD WOOD; Australian Bureau of Statistics, 2011, AUSTR NZ STAND OFF C; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bohm B, 2002, DEV MED CHILD NEUROL, V44, P508; Bradley K., 2009, BRADLEY REPORT LORD; Brooks G, 2012, YOUTH JUSTICE, V12, P184, DOI 10.1177/1473225412459836; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Butler T, 2006, AUST NZ J PSYCHIAT, V40, P272, DOI 10.1111/j.1440-1614.2006.01785.x; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; CHANG EC, 1994, COGNITIVE THER RES, V18, P143, DOI 10.1007/BF02357221; Chapman RCG, 2010, BRAIN INJURY, V24, P797, DOI 10.3109/02699051003709607; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Fazel S, 2017, ADDICTION, V112, P1725, DOI 10.1111/add.13877; Fazel S, 2008, J AM ACAD CHILD PSY, V47, P1010, DOI [10.1097/CHI.ObO13e31817eecf3, 10.1097/CHI.0b013e31817eeef3]; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Grunau RE, 2009, PAIN, V143, P138, DOI 10.1016/j.pain.2009.02.014; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hopkins, 2013, MINISTRY JUSTICE ANA; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; IBM, 2013, SPSS STAT WIND VERS; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; McCarthy J, 2016, J INTELL DISABIL RES, V60, P201, DOI 10.1111/jir.12237; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2016, CONCUSSION, V1, P1; Mounce L., 2012, NOBODY MADE CONNECTI; O'Rourke C, 2018, DISABIL REHABIL, V40, P1119, DOI 10.1080/09638288.2017.1288274; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; Osman A, 2014, J PERS ASSESS, V96, P103, DOI 10.1080/00223891.2013.838170; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Ray B, 2017, CRIM JUSTICE BEHAV, V44, P472, DOI 10.1177/0093854816686631; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Singleton N, 2003, INT REV PSYCHIATR, V15, P150, DOI 10.1080/0954026021000046092; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Squeglia LM, 2009, CLIN EEG NEUROSCI, V40, P31, DOI 10.1177/155005940904000110; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; Williams WH, 2015, J HEAD TRAUMA REHAB, V30, P69, DOI 10.1097/HTR.0000000000000134; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yuhasz JE, 2013, J CORRECT HEALTH CAR, V19, P135, DOI 10.1177/1078345812474644; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	62	2	2	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	AUG 13	2020	42	17			SI		2422	2429		10.1080/09638288.2019.1629699		JUN 2019	8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NE7PD	WOS:000475139000001	31230475	Green Published			2022-02-06	
J	Moon, JM; Chun, BJ; Cho, YS; Mun, JG				Moon, Jeong Mi; Chun, Byeong Jo; Cho, Yong Soo; Mun, Jong Goo			Does alcohol play the role of confounder or neuroprotective agent in acute carbon monoxide poisoning?	CLINICAL TOXICOLOGY			English	Article						Carbon monoxide; ethanol; poisoning; blood alcohol content	TRAUMATIC BRAIN-INJURY; PLASMA LACTATE; INTOXICATION; ETHANOL; SEQUELAE; RISK; MORTALITY; MARKERS	Objectives: This study investigated whether alcohol influences the predictive value of initial blood lactate concentration and Glasgow Coma Scale (GCS) score at presentation for the severity of acute carbon monoxide (CO) poisoning and neurologic outcome in patients with acute CO poisoning. Additionally, whether alcohol has a neuroprotective effect after acute CO poisoning was evaluated. Methods: This retrospective study included 158 patients who presented with acute CO poisoning between January 2017 and July 2018 and had an available blood alcohol content (BAC) at presentation. The baseline characteristics, clinical course during hospitalization and neurologic status at 30 days after acute CO poisoning were collected and compared according to BAC. To account for possible confounding or neuroprotective effects of alcohol, BAC was introduced as a continuous variable and a stratified categorical variable in the analysis. Results: The mean and maximum BAC at presentation were 56.8 mg/dl and 408 mg/dl, respectively, in 158 patients presented at a mean of 1.0 hour after acute CO poisoning. Lactate, adjusted for previously suggested predictors, was not associated with acute CO poisoning severity; however, after additional adjustment with BAC variables, lactate was associated with CO poisoning severity. Initial GCS score was associated with CO poisoning severity during hospitalization and neurologic outcome at 30 days after acute CO poisoning, regardless of BAC adjustment. BAC variables were negatively associated with CO poisoning severity but not neurologic outcome at 30 days. Discussion and conclusion: The severity of CO poisoning should never be predicted based on serum lactate alone without adjusting for BAC. However, the initial GCS score can be used as a predictor of CO poisoning severity and the neurologic outcome at 30 days after acute CO poisoning, regardless of alcohol consumption history. Alcohol does not have a neuroprotective effect on acute CO poisoning. Further study is needed to validate these results.	[Moon, Jeong Mi; Chun, Byeong Jo; Cho, Yong Soo; Mun, Jong Goo] Chonnam Natl Univ, Sch Med, Dept Emergency Dept, Gwangju, South Korea		Chun, BJ (corresponding author), Chonnam Natl Univ, Sch Med, Dept Emergency Med, Hak Dong 8, Gwangju 501747, South Korea.	emdrmjm@gmail.com			Chonnam National University [2017-2926]	This study was financially supported by Chonnam National University [Grant number: 2017-2926]	Aronowski J, 2003, STROKE, V34, P1246, DOI 10.1161/01.STR.0000068170.80517.B3; Benaissa ML, 2003, INTENS CARE MED, V29, P1372, DOI 10.1007/s00134-003-1866-0; Berry C, 2011, AM SURGEON, V77, P1416; Cervellin G, 2014, CLIN BIOCHEM, V47, P298, DOI 10.1016/j.clinbiochem.2014.09.016; Cha YS, 2014, EMERG MED J, V31, P210, DOI 10.1136/emermed-2012-202152; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Ding QP, 2017, ALCOHOL CLIN EXP RES, V41, P1532, DOI 10.1111/acer.13436; Dunham CM, 2000, J EMERG MED, V18, P165, DOI 10.1016/S0736-4679(99)00188-2; FULOP M, 1986, AM J MED, V80, P191, DOI 10.1016/0002-9343(86)90008-2; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Grieb G, 2011, BURNS, V37, P610, DOI [10.1016/j.burns.2010.03.007, 10.1016/j.burns.2011.01.002]; Hampson NB, 2015, UNDERSEA HYPERBAR M, V42, P159; Hampson NB, 2013, J EMERG MED, V44, P625, DOI 10.1016/j.jemermed.2012.08.033; Herbert HK, 2011, AM SURGEON, V77, P1576; Inoue S, 2008, AM J EMERG MED, V26, P966; Iqbal S, 2012, PUBLIC HEALTH REP, V127, P486, DOI 10.1177/003335491212700504; Janik M, 2017, J FORENSIC LEG MED, V48, P23, DOI 10.1016/j.jflm.2017.04.002; Jones AW, 2010, FORENSIC SCI INT, V200, P1, DOI 10.1016/j.forsciint.2010.02.021; Jung JY, 2013, KOREAN J ANESTHESIOL, V64, P246, DOI 10.4097/kjae.2013.64.3.246; Jung JW, 2019, AM J EMERG MED, V37, P823, DOI 10.1016/j.ajem.2018.07.046; Kim HH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009569; Kim H, 2018, CLIN EXP EMERG MED, V5, P185, DOI 10.15441/ceem.17.217; Kitamoto T, 2016, ACUTE MED SURG, V3, P315, DOI 10.1002/ams2.197; Kruse O, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-74; LAMMINPAA A, 1993, ACTA PAEDIATR, V82, P783, DOI 10.1111/j.1651-2227.1993.tb12558.x; Langorgen J, 2016, SCAND CARDIOVASC J, V50, P201, DOI 10.1080/14017431.2016.1191664; Liao WC, 2019, J FORMOS MED ASSOC, V118, P821, DOI 10.1016/j.jfma.2018.09.005; Lisbona CF, 2018, J FORENSIC SCI, V63, P1776, DOI 10.1111/1556-4029.13790; MINION GE, 1989, J TOXICOL-CLIN TOXIC, V27, P375, DOI 10.3109/15563658909000358; Moon JM, 2018, CLIN TOXICOL, V56, P751, DOI 10.1080/15563650.2017.1415347; Moon JM, 2011, HUM EXP TOXICOL, V30, P836, DOI 10.1177/0960327110384527; Mostofsky E, 2016, CIRCULATION, V133, P979, DOI 10.1161/CIRCULATIONAHA.115.019743; Mukhopadhyay S, 2018, AM J EMERG MED, V36, P1837, DOI 10.1016/j.ajem.2018.02.011; Mutluoglu M, 2016, UNDERSEA HYPERBAR M, V43, P49; Ng PCY, 2018, INTERN EMERG MED, V13, P223, DOI 10.1007/s11739-018-1798-x; Pepe G, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-16; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Scheenen ME, 2016, J NEUROTRAUM, V33, P339, DOI 10.1089/neu.2015.3926; Sircar K, 2015, AM J EMERG MED, V33, P1140, DOI 10.1016/j.ajem.2015.05.002; Tam TWM, 2006, FORENSIC SCI INT, V156, P95, DOI 10.1016/j.forsciint.2004.12.020; Wang F, 2012, STROKE, V43, P205, DOI 10.1161/STROKEAHA.111.629576; Zhao YJ, 1998, ALCOHOL CLIN EXP RES, V22, P717, DOI 10.1097/00000374-199805000-00025	44	2	2	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1556-3650	1556-9519		CLIN TOXICOL	Clin. Toxicol.	MAR 3	2020	58	3					161	170		10.1080/15563650.2019.1625915		JUN 2019	10	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	KF1UD	WOS:000478214100001	31198068				2022-02-06	
J	Molstrom, S; Nielsen, TH; Nordstrom, CH; Hassager, C; Moller, JE; Kjaergaard, J; Moller, S; Schmidt, H; Toft, P				Molstrom, Simon; Nielsen, Troels Halfeld; Nordstrom, Carl H.; Hassager, Christian; Moller, Jacob Eifer; Kjaergaard, Jesper; Moller, Soren; Schmidt, Henrik; Toft, Palle			Design paper of the "Blood pressure targets in post-resuscitation care and bedside monitoring of cerebral energy state: a randomized clinical trial"	TRIALS			English	Article						Out-of-hospital cardiac arrest; Neuroprotection; Blood pressure; Microdialysis; Cerebral metabolism	HOSPITAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; TEMPERATURE MANAGEMENT; THERAPEUTIC HYPOTHERMIA; CONSOLIDATED STANDARDS; MICRODIALYSIS; RESUSCITATION; AUTOREGULATION; 36-DEGREES-C; 33-DEGREES-C	BackgroundNeurological injuries remain the leading cause of death in comatose patients resuscitated from out-of-hospital cardiac arrest (OHCA). Adequate blood pressure is of paramount importance to optimize cerebral perfusion and to minimize secondary brain injury. Markers measuring global cerebral ischemia caused by cardiac arrest and consecutive resuscitation and reflecting the metabolic variations after successful resuscitation are needed to assist a more individualized post-resuscitation care. Currently, no technique is available for bedside evaluation of global cerebral energy state, and until now blood pressure targets have been based on limited clinical evidence. Recent experimental and clinical studies indicate that it might be possible to evaluate cerebral oxidative metabolism from measuring the lactate-to-pyruvate (LP) ratio of the draining venous blood. In this study, jugular bulb microdialysis and immediate bedside biochemical analysis are introduced as new diagnostic tools to evaluate the effect of higher mean arterial blood pressure on global cerebral metabolism and the degree of cellular damage after OHCA.Methods/designThis is a single-center, randomized, double-blinded, superiority trial. Sixty unconscious patients with sustained return of spontaneous circulation after OHCA will be randomly assigned in a one-to-one fashion to low (63mm Hg) or high (77mm Hg) mean arterial blood pressure target. The primary end-point will be a difference in mean LP ratio within 48h between blood pressure groups. Secondary end-points are (1) association between LP ratio and all-cause intensive care unit (ICU) mortality and (2) association between LP ratio and survival to hospital discharge with poor neurological function.DiscussionMarkers measuring cerebral ischemia caused by cardiac arrest and consecutive resuscitation and reflecting the metabolic changes after successful resuscitation are urgently needed to enable a more personalized post-resuscitation care and prognostication. Jugular bulb microdialysis may provide a reliable global estimate of cerebral metabolic state and can be implemented as an entirely new and less invasive diagnostic tool for ICU patients after OHCA and has implications for early prognosis and treatment.Trial registrationClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT03095742). Registered March 30, 2017.	[Molstrom, Simon; Schmidt, Henrik; Toft, Palle] Odense Univ Hosp, Dept Anesthesiol & Intens Care, JB Winslows Vej 4, DK-5000 Odense C, Denmark; [Nielsen, Troels Halfeld; Nordstrom, Carl H.] Odense Univ Hosp, Dept Neurosurg, JB Winslows Vej 4, DK-5000 Odense, Denmark; [Moller, Jacob Eifer] Odense Univ Hosp, Dept Cardiol, JB Winslows Vej 4, DK-5000 Odense, Denmark; [Moller, Soren] Univ Southern Denmark, Odense Univ Hosp, OPEN Odense Patient Data Explorat Network, JB Winslows Vej 9, DK-5000 Odense, Denmark; [Moller, Soren] Dept Clin Res, JB Winslows Vej 9, DK-5000 Odense, Denmark; [Hassager, Christian; Kjaergaard, Jesper] Copenhagen Univ Hosp, Heart Ctr, Blegdamsvej 9, DK-2100 Copenhagen, Denmark		Molstrom, S (corresponding author), Odense Univ Hosp, Dept Anesthesiol & Intens Care, JB Winslows Vej 4, DK-5000 Odense C, Denmark.	simon.molstrom@rsyd.dk	Moller, Soren/X-8738-2019	Moller, Soren/0000-0003-0858-4269; Toft, Palle/0000-0002-3188-449X; Kjaergaard, Jesper/0000-0001-5244-0399; Molstrom, Simon/0000-0002-2778-8075; Hassager, Christian/0000-0002-1199-0981	University of Southern Denmark; Region of Southern Denmark; Department of Anesthesiology and Intensive Care, Odense; A.P. Moller Foundation for the Advancement of Medical Science [17-L-0030]	Until now, the study has been supported by non-profit organizations, including the University of Southern Denmark, Region of Southern Denmark, and Department of Anesthesiology and Intensive Care, Odense. The study received a grant from the A.P. Moller Foundation for the Advancement of Medical Science of 50.000 DKK (grant number 17-L-0030). Any additional funding will be included along with the publication of trial results.	Arawwawala D, 2007, CRIT CARE, V11, DOI 10.1186/cc6139; BANKIER AA, 1995, AM J ROENTGENOL, V164, P437, DOI 10.2214/ajr.164.2.7839985; Bennett JA, 2005, NURS RES, V54, P128; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bro-Jeppesen J, 2015, CRIT CARE MED, V43, P318, DOI 10.1097/CCM.0000000000000691; Bro-Jeppesen J, 2009, RESUSCITATION, V80, P171, DOI 10.1016/j.resuscitation.2008.09.009; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Grand J, 2018, CRIT CARE MED, V46, P1626, DOI 10.1097/CCM.0000000000003289; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Herlitz J, 2003, RESUSCITATION, V58, P309, DOI 10.1016/S0300-9572(03)00155-2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchinson P, 2014, NEUROCRIT CARE, V21, P148, DOI 10.1007/s12028-014-0035-3; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jakkula P, 2018, INTENS CARE MED, V44, P2091, DOI 10.1007/s00134-018-5446-8; Kirkegaard H, 2017, JAMA-J AM MED ASSOC, V318, P341, DOI 10.1001/jama.2017.8978; Koenig MA, 2014, CRIT CARE CLIN, V30, P765, DOI 10.1016/j.ccc.2014.06.007; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lorette G, 2013, ANN DERMATOL VENER, V140, P431, DOI 10.1016/j.annder.2013.04.091; Mak M, 2016, RESUSCITATION, V100, P6, DOI 10.1016/j.resuscitation.2015.12.005; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Matthews EA, 2017, RESUSCITATION, V114, P79, DOI 10.1016/j.resuscitation.2017.03.005; Molstrom S, 2017, J CARDIOTHOR VASC AN, V31, P1166, DOI 10.1053/j.jvca.2016.11.001; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P793, DOI 10.1111/aas.12092; Nishizawa H, 1996, ACTA ANAESTH SCAND, V40, P1149, DOI 10.1111/j.1399-6576.1996.tb05579.x; Nolan JP, 2015, INTENS CARE MED, V41, P2039, DOI 10.1007/s00134-015-4051-3; Nordstrom CH, 2017, ACTA NEUROCHIR, V159, P2275, DOI 10.1007/s00701-017-3339-1; Nordstrom Carl-Henrik, 2013, Crit Care Med, V41, pe4, DOI 10.1097/CCM.0b013e31826be835; Paraforou Theoniki, 2011, BMC Res Notes, V4, P540, DOI 10.1186/1756-0500-4-540; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; SIESJO BK, 1978, J NEURAL TRANSM, P17; Sinha N, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0770-x; Soholm H, 2013, RESUSCITATION, V84, P162, DOI 10.1016/j.resuscitation.2012.06.029; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sundgreen C, 2001, STROKE, V32, P128, DOI 10.1161/01.STR.32.1.128; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC	38	2	2	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	JUN 10	2019	20								344	10.1186/s13063-019-3397-1			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	ID0BJ	WOS:000471348400003	31182135	Green Published, gold			2022-02-06	
J	Kontojannis, V; Hostettler, I; Brogan, RJ; Raza, M; Harper-Payne, A; Kareem, H; Boutelle, M; Wilson, M				Kontojannis, Vassilios; Hostettler, Isabel; Brogan, Robert James; Raza, Muhammad; Harper-Payne, Abby; Kareem, Haider; Boutelle, Martyn; Wilson, Mark			Detection of intracranial hematomas in the emergency department using near infrared spectroscopy	BRAIN INJURY			English	Article						Brain injury; intracranial haematoma; near infrared spectroscopy	BRAIN-INJURY	Hypothesis: Traumatic brain injury (TBI) is one of the most important causes of morbidity and mortality in our society. The development of near infrared technology for the detection of intracranial hematomas may assist earlier diagnosis of TBI. This in turn may enable earlier targeted treatments minimizing the harm and subsequent social and economic effects of TBI. Methods: A handheld, noninvasive Near Infrared Spectroscopy device, Infrascanner 2000, (Infrascan Inc., Philadelphia, PA, USA) was used in a major trauma center to screen for traumatic intracranial hematomas. The Infrascanner was used successfully in 205 patients on their arrival in the emergency department prior to CT head. Results: In the whole cohort, sensitivity was 75%, specificity was 50.43%, with negative predictive value 72.84%, and positive predictive value 53.23%. In 45 patients, where the volume of blood was >3.5mL, the sensitivity was 89.36%, specificity 48.73% with negative predictive value 93.9% and positive predictive value 34.15%. Conclusions: The Infrascanner has a relatively high specificity and negative predictive value; therefore, it could in association with the Neurological examination, help in the triage of the trauma patient with potential brain injury. Further investigation is necessary to determine the use of Infrascanner 2000 as a diagnostic method in TBI.	[Kontojannis, Vassilios] Imperial Coll London, Ctr Neurosci, Neurosurg, London, England; [Hostettler, Isabel; Raza, Muhammad; Kareem, Haider; Wilson, Mark] Imperial Coll Healthcare NHS Trust, Neurosurg, London, England; [Brogan, Robert James] Imperial Coll Healthcare NHS Trust, Imperial Neurotrauma Ctr, Major Trauma Ctr, Marys Hosp, London, England; [Harper-Payne, Abby] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Major Trauma Ctr, London, England; [Boutelle, Martyn] Imperial Coll, Bioengn, London, England		Kontojannis, V (corresponding author), Imperial Coll London, Ctr Neurosci, London W12 0NN, England.	v.kontojannis13@ic.ac.uk		Wilson, Mark/0000-0002-2346-4911			Brogan RJ, 2017, BRAIN INJURY, V31, P581, DOI 10.1080/02699052.2017.1287956; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Koizumi H, 1999, J BIOMED OPT, V4, P403, DOI 10.1117/1.429959; Orihuela-Espina F, 2010, PHYS MED BIOL, V55, P3701, DOI 10.1088/0031-9155/55/13/009; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Robertson C S, 1997, J Biomed Opt, V2, P31, DOI 10.1117/12.261680; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wilson MH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-24	10	2	2	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN 7	2019	33	7					875	883		10.1080/02699052.2019.1610796			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	OM5BT	WOS:000586040800007	31284787				2022-02-06	
J	Cho, KH; Huang, SM; Choi, CH; Chen, MJ; Chiang, HH; Buschbeck, RP; Farrher, E; Shah, NJ; Garipov, R; Chang, CP; Chang, H; Kuo, LW				Cho, Kuan-Hung; Huang, Sheng-Min; Choi, Chang-Hoon; Chen, Ming-Jye; Chiang, Hsuan-Han; Buschbeck, Richard P.; Farrher, Ezequiel; Shah, N. Jon; Garipov, Ruslan; Chang, Ching-Ping; Chang, Hsu; Kuo, Li-Wei			Development, integration and use of an ultra-high-strength gradient system on a human-size 3 T magnet for small animal MRI	PLOS ONE			English	Article							RAT-BRAIN; DIFFUSION TENSOR; SUSCEPTIBILITY	This study aims to integrate an ultra-high-strength gradient coil system on a clinical 3 T magnet and demonstrate its preclinical imaging capabilities. Dedicated phantoms were used to qualitatively and quantitatively assess the performance of the gradient system. Advanced MR imaging sequences, including diffusion tensor imaging (DTI) and quantitative susceptibility mapping (QSM), were implemented and executed on an ex vivo specimen as well as in vivo rats. The DTI and QSM results on the phantom agreed well with those in the literature. Furthermore, studies on ex vivo specimens have demonstrated the applicability of DTI and QSM on our system to probe microstructural changes in a mild traumatic brain injury rat model. The feasibility of in vivo rat DTI was also demonstrated. We showed that the inserted ultra-high-strength gradient coil was successfully integrated on a clinically used magnet. After careful tuning and calibration, we verified the accuracy and quantitative preclinical imaging capability of the integrated system in phantom and in vivo rat brain experiments. This study can be essential to establish dedicated animal MRI platform on clinical MRI scanners and facilitate translational studies at clinical settings.	[Cho, Kuan-Hung; Huang, Sheng-Min; Chen, Ming-Jye; Chiang, Hsuan-Han; Chang, Hsu; Kuo, Li-Wei] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Miaoli, Taiwan; [Huang, Sheng-Min] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Choi, Chang-Hoon; Buschbeck, Richard P.; Farrher, Ezequiel; Shah, N. Jon] Forschungszentrum Julich, INM 4, Julich, Germany; [Shah, N. Jon] Forschungszentrum Julich, INM 11, Julich, Germany; [Shah, N. Jon] JARA BRAIN Translat Med, Aachen, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Garipov, Ruslan] MR Solut Ltd, Guildford, Surrey, England; [Chang, Ching-Ping] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Kuo, Li-Wei] Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan		Kuo, LW (corresponding author), Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Miaoli, Taiwan.; Kuo, LW (corresponding author), Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan.	lwkuo@nhri.org.tw	Choi, Chang-Hoon/S-9688-2019; Huang, Sheng-Min/ABE-8722-2021; Buschbeck, Richard P./G-5968-2017; Shah, N. Jon/H-5849-2013	Choi, Chang-Hoon/0000-0003-3569-0905; Huang, Sheng-Min/0000-0003-2930-8562; Chang, Ching-Ping/0000-0003-0890-9414; Buschbeck, Richard P./0000-0001-8201-3937; Cho, Kuan-Hung/0000-0001-9267-8342; Shah, N. Jon/0000-0002-8151-6169	Taiwan Ministry of Science and Technology [106-2221-E-400-002, 107-2911-I-400-502, 107-2321-B-400-005, 107-2221-E-400-001]; National Health Research InstitutesNational Health Research Institutes, Japan [BN-107-PP-06, BN-107-SP-05]; Chi Mei Medical Center (Taiwan) grant [CMFHT 10504]; Taiwan Central Government S T grant [107-1901-01-19-02]; DAADDeutscher Akademischer Austausch Dienst (DAAD)European Commission [57334221]	This work was supported in part by the Taiwan Ministry of Science and Technology (106-2221-E-400-002, 107-2911-I-400-502, 107-2321-B-400-005, and 107-2221-E-400-001), the National Health Research Institutes (BN-107-PP-06 and BN-107-SP-05), Chi Mei Medical Center (Taiwan) grant (CMFHT 10504), and the Taiwan Central Government S & T grant (107-1901-01-19-02). C.-H.C. thanks DAAD (57334221) for travels. Ruslan Garipov is an employee of MR Solutions Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida GS, 2017, BRIT J CANCER, V117, P791, DOI 10.1038/bjc.2017.251; Aradi M, 2011, J NEURORADIOLOGY, V38, P90, DOI 10.1016/j.neurad.2009.11.003; Barral JK, 2010, MAGN RESON MED, V64, P1057, DOI 10.1002/mrm.22497; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Brihuega-Moreno O, 2004, MAGN RESON MED, V51, P1048, DOI 10.1002/mrm.20044; Chen F, 2007, METHODS, V43, P12, DOI 10.1016/j.ymeth.2007.03.007; Chen MJ, 2018, JOINT ANN M ISMRM ES, P1755; Cho KH, 2009, J MAGN RESON IMAGING, V29, P1386, DOI 10.1002/jmri.21776; Chou W, 2018, MOL NEUROBIOL, V55, P8602, DOI 10.1007/s12035-018-1011-2; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Deh K, 2019, MAGN RESON MED, V81, P1229, DOI 10.1002/mrm.27410; Dyrby TB, 2011, HUM BRAIN MAPP, V32, P544, DOI 10.1002/hbm.21043; Gallichan D, 2010, HUM BRAIN MAPP, V31, P193, DOI 10.1002/hbm.20856; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Guzman R, 2000, J NEUROSCI METH, V97, P77, DOI 10.1016/S0165-0270(00)00172-2; Herrmann KH, 2012, MAGN RESON MATER PHY, V25, P233, DOI 10.1007/s10334-011-0284-5; Jones DK, 2018, NEUROIMAGE, V182, P8, DOI 10.1016/j.neuroimage.2018.05.047; Lee Y, 2019, MAGN RESON MED, V81, P454, DOI 10.1002/mrm.27421; Li W, 2016, NMR BIOMED, V29, P896, DOI 10.1002/nbm.3536; Liu J, 2012, NEUROIMAGE, V59, P2560, DOI 10.1016/j.neuroimage.2011.08.082; Mayer D, 2007, NEUROIMAGE, V35, P1077, DOI 10.1016/j.neuroimage.2007.01.006; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Pfefferbaum A, 2004, J MAGN RESON IMAGING, V20, P779, DOI 10.1002/jmri.20181; POON CS, 1992, J MAGN RESON IMAGING, V2, P541, DOI 10.1002/jmri.1880020512; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Vavasour IM, 2019, J NEUROIMAGING, V29, P42, DOI 10.1111/jon.12559; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713	28	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2019	14	6							e0217916	10.1371/journal.pone.0217916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9ZE	WOS:000469915700034	31158259	Green Published, gold, Green Submitted			2022-02-06	
J	Alunpipatthanachai, B; Thirapattaraphan, P; Fried, H; Vavilala, MS; Lele, AV				Alunpipatthanachai, Bhunyawee; Thirapattaraphan, Porntip; Fried, Herbert; Vavilala, Monica S.; Lele, Abhijit, V			External Ventricular Drain Management Practices in Thailand: Results of the EPRACT Study	WORLD NEUROSURGERY			English	Article						External ventricular drain; Insertion; Maintenance; Protocols; Quality improvement; Thailand	INFECTIONS	OBJECTIVE: We explored the external ventricular drain (EVD) practices in Thailand. METHODS: We performed a survey-based study to describe EVD insertion, maintenance, quality improvement (QI) practices, and incidence of EVD infection. RESULTS: The study included 58 of 101 hospitals contacted (57.4% response rate), with >= 600 beds (44.8%) and dedicated neurocritical care units (53%). The reasons for EVD placement included aneurysmal subarachnoid hemorrhage, traumatic brain injury, and ventriculoperitoneal shunt malfunction or infection; 75.9% of the hospitals cared for <= 100 EVDs annually. In Thailand, nonantimicrobial EVD catheters (98.3%) were used most often. Most hospitals (56.9%) did not routinely sample the cerebrospinal fluid. Prophylactic daily antibiotic use was prevalent (62.1%). Most hospitals (77.6%) did not measure the intracranial pressure during intrahospital transport. EVD infection was a commonly (69%) tracked QI measure; however, up to one third of the hospitals did not track any EVD QI measure. Most hospitals (94.8%) had no written EVD insertion and maintenance protocols. Most hospitals (79.3%) reported an EVD infection rate of <= 5% in the previous year. The low EVD infection rate, high cost, and/or the lack of equipment could account for the low usage of antimicrobial catheters and intracranial pressure monitoring. CONCLUSIONS: The results of the present study have identified QI opportunities in EVD management in Thailand. The development of an EVD-related QI process, reliable tracking of EVD infection rates, adaptation of U.S. guidelines to create standardized EVD protocols, and examination of the association between EVD practices and clinical outcomes in low-to middle-income countries are urgently needed.	[Alunpipatthanachai, Bhunyawee; Vavilala, Monica S.; Lele, Abhijit, V] Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9Th Ave, Seattle, WA 98104 USA; [Thirapattaraphan, Porntip] Khon Kaen Univ, Fac Med, Dept Surg, Div Neurosurg, Khon Kaen, Thailand; [Fried, Herbert] Univ Colorado, Dept Neurol Surg, Aurora, CO USA		Lele, AV (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9Th Ave, Seattle, WA 98104 USA.	abhijit2@uw.edu					[Anonymous], 2017, STAT IC COMP PROGR; Chaikittisilpa N, 2017, NEUROCRIT CARE, V26, P196, DOI 10.1007/s12028-016-0308-0; Champey J, 2019, J NEUROSURG, V130, P2034, DOI 10.3171/2018.1.JNS172486; CLARK WC, 1989, NEUROSURGERY, V25, P20; Fried HI, 2016, NEUROCRIT CARE, V24, P61, DOI 10.1007/s12028-015-0224-8; Fuangworawong P, 2016, INT J SURG, V33, P88, DOI 10.1016/j.ijsu.2016.07.068; Hanchaiphiboolkul Suchat, 2011, Journal of the Medical Association of Thailand, V94, P427; Kammoun B, 2018, WORLD NEUROSURG, V119, P428, DOI 10.1016/j.wneu.2018.07.261; Kohli G, 2018, WORLD NEUROSURG, V110, pE135, DOI 10.1016/j.wneu.2017.10.129; Lele AV, 2017, J NEUROSURG ANESTH, V29, P191, DOI 10.1097/ANA.0000000000000407; Lewis A, 2017, NEUROHOSPITALIST, V7, P15, DOI 10.1177/1941874416663281; Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.neu.0000316273.35833.7c, 10.1227/01.NEU.0000017465.78245.6C]; Ortiz R, 2006, CURR NEUROL NEUROSCI, V6, P525, DOI 10.1007/s11910-006-0056-1; Phuenpathom N, 2000, J CLIN NEUROSCI, V7, P223, DOI 10.1054/jocn.1999.0203; Sekula RF, 2008, BRIT J NEUROSURG, V22, P213, DOI 10.1080/02688690701832084; Suwanwela NC, 2014, J STROKE, V16, P1, DOI 10.5853/jos.2014.16.1.1; Veerasarn Kullapat, 2016, Journal of the Medical Association of Thailand, V99, pS62	17	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2019	126						E743	E752		10.1016/j.wneu.2019.02.144			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IA0BU	WOS:000469222400092	30851470				2022-02-06	
J	Bae, IS; Chun, HJ; Yi, HJ; Bak, KH; Choi, KS; Kim, DW				Bae, In-Suk; Chun, Hyoung-Joon; Yi, Hyeong-Joong; Bak, Koang-Hum; Choi, Kyu-Sun; Kim, Dong-Won			Modified Glasgow Coma Scale Using Serum Factors as a Prognostic Model in Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Decompressive craniectomy; Glasgow Coma Scale; Mortality; Outcome; Traumatic brain injury	BASE DEFICIT; PREDICTIVE-VALUE; MORTALITY; LACTATE; HYPERGLYCEMIA; COAGULOPATHY; SCORE; OUTCOMES; IMPACT	BACKGROUND: Traumatic brain injury (TBI) is a major cause of death and disability. This study evaluated a possible relationship between serum factors at admission and the outcome of TBI. We propose a statistically validated scale for patients with TBI that combines serum factors and the Glasgow Coma Scale (GCS). METHODS: Between May 2011 and July 2016, 219 patients underwent decompressive craniectomy for TBI. We assessed laboratory data on admission, and correlations with GSC and Glasgow Outcome Scale were investigated. The modified GCS was developed from a multivariable logistic regression model, which was validated with the backward stepwise method. RESULTS: Of 219 patients with TBI enrolled in our study, 175 were men (79.9%) and 44 were women (20.1%) with a mean age of 49.1 +/- 11.5 years. Initial serum values of hemoglobin, platelets, prothrombin time, and lactate dehydrogenase were associated with in-hospital mortality. The factor score was derived by adding the following points: hemoglobin (>= 13.0 g/dL [0, < 13.0 g/dL = 1), platelets (>= 150 x 10(3)/mm(3) [0, < 150 x 10(3)/mm(3) = 1), prothrombin time (< 13.2 seconds [0, >= 13.2 seconds = 1), and lactate dehydrogenase (< 271 U/L = 0, >= 271 U/L = 1). The modified GCS score (GCS score [range, 6-15] - FS [range, 0-4]) was calculated. CONCLUSIONS: The modified GCS score using serum factors extended the information provided about patient outcomes to be comparable to more complex methods. The modified GCS score may be useful to predict in-hospital mortality in patients with TBI.	[Bae, In-Suk; Chun, Hyoung-Joon; Yi, Hyeong-Joong; Bak, Koang-Hum; Choi, Kyu-Sun] Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea; [Kim, Dong-Won] Hanyang Univ, Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea		Chun, HJ (corresponding author), Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea.	tdy815@hanyang.ac.kr	Yi, Hyeong-Joong/AAR-2685-2020	Bae, In-Suk/0000-0002-0738-9253			Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769; Callaway DW, 2009, J TRAUMA, V66, P1040, DOI 10.1097/TA.0b013e3181895e9e; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Husain FA, 2003, AM J SURG, V185, P485, DOI 10.1016/S0002-9610(03)00044-8; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Namiki J, 2011, CLIN NEUROL NEUROSUR, V113, P393, DOI 10.1016/j.clineuro.2011.01.001; Paladino L, 2008, RESUSCITATION, V77, P363, DOI 10.1016/j.resuscitation.2008.01.022; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RAO CJ, 1978, J NEUROL NEUROSUR PS, V41, P948, DOI 10.1136/jnnp.41.10.948; Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Saika A, 2015, ACTA NEUROCHIR, V157, P1323, DOI 10.1007/s00701-015-2469-6; Salim A, 2009, AM SURGEON, V75, P25; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Schreiber MA, 2005, J TRAUMA, V58, P475, DOI 10.1097/01.TA.0000153938.77777.26; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Ting HW, 2010, J CHIN MED ASSOC, V73, P139, DOI 10.1016/S1726-4901(10)70028-9; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Weiskopf RB, 2002, ANESTHESIOLOGY, V96, P871, DOI 10.1097/00000542-200204000-00014; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	34	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2019	126						E959	E964		10.1016/j.wneu.2019.02.197			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IA0BU	WOS:000469222400120	30876987				2022-02-06	
J	Brooks, BL; MacAllister, WS; Fay-McClymont, TB; Vasserman, M; Sherman, EMS				Brooks, Brian L.; MacAllister, William S.; Fay-McClymont, Taryn B.; Vasserman, Marsha; Sherman, Elisabeth M. S.			Derivation of New Embedded Performance Validity Indicators for the Child and Adolescent Memory Profile (ChAMP) Objects Subtest in Youth with Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Effort; Malingering; Children; Adolescents; Memory	DIGIT SPAN; UTILITY; BIAS	Background: Development of an embedded performance validity test (PVT) is desired for visual memory tests. The goal of this study was to derive an embedded PVT for the Child and Adolescent Memory Profile (ChAMP) Objects visual memory subtest in youth with mild traumatic brain injury (MTBI). Methods: Children and adolescents (N = 91; mean age = 14.9 years, SD = 2.2, range = 8-18) on average 25.2 weeks (SD = 15.4) post-MTBI were administered ChAMP Objects. Two stand-alone PVTs (Test of Memory Malingering and Medical Symptom Validity Test) were administered, which allowed for grouping into valid (zero failed stand-alone PVTs) and invalid (both stand-alone PVTs failed). Cutoff scores for invalid performance on ChAMP Objects and Objects Delayed were established using failure on two PVTs as the criterion. Results: One in five youth (n = 19) failed both PVTs. Invalid performance was not associated with demographics or time since injury, but was significantly correlated with both ChAMP Objects (r = .53, p<.001) and Objects Delayed (r = -.63, p<.001). Area under the curve suggested adequate discrimination by Objects (. 87) and excellent discrimination by Objects Delayed (. 91). A cutoff scaled score of 5 or less on ChAMP Objects provided sensitivity of 58% for detecting invalid performance with 96% sensitivity. A cutoff scaled score of 5 or less on ChAMP Objects Delayed achieved sensitivity of 63% and specificity of 96%. Interpreting the two embedded PVTs simultaneously improved sensitivity to 79% with 93% specificity. Conclusion: This study yields promising new embedded PVTs for the ChAMP Objects subtest with strong sensitivity and specificity for detecting invalid performance in youth with MTBI.	[Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Neuropsychol Serv, Res Inst,Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Neuropsychol Serv, Res Inst,Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Neuropsychol Serv, Res Inst,Dept Psychol, Calgary, AB, Canada; [MacAllister, William S.] Univ Calgary, Alberta Childrens Hosp, Neuropsychol Serv, Calgary, AB, Canada; [MacAllister, William S.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Fay-McClymont, Taryn B.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Neuropsychol Serv,Dept Paediat, Calgary, AB, Canada; [Vasserman, Marsha] Univ Calgary, Alberta Childrens Hosp, Res Inst, Neuropsychol Serv, Calgary, AB, Canada; [Sherman, Elisabeth M. S.] Copeman Healthcare Ctr, Calgary, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca		Fay-McClymont, Taryn/0000-0002-2706-6179	Kinsmen Chair of Pediatric Neurosciences; Alberta Children's Hospital Research Institute (ACHRI) Neurotrauma Fund; Alberta Children's Hospital (ACH) Neurosciences Program; Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary AwardCanadian Institutes of Health Research (CIHR)	The BrainChild database was supported by funding from the Kinsmen Chair of Pediatric Neurosciences, the Alberta Children's Hospital Research Institute (ACHRI) Neurotrauma Fund, and the Alberta Children's Hospital (ACH) Neurosciences Program (Conny Betuzzi). Brian Brooks acknowledges salary funding from the Canadian Institutes for Health Research (CIHR) Embedded Clinician Researcher Salary Award.	Armistead-Jehle P, 2013, ARCH CLIN NEUROPSYCH, V28, P297, DOI 10.1093/arclin/act017; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brooks B. L., 2016, VALIDITY TESTING CHI, P207; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; Brooks BL, 2015, ARCH CLIN NEUROPSYCH, V30, P200, DOI 10.1093/arclin/acv017; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Glassmire DM, 2003, J CLIN EXP NEUROPSYC, V25, P465, DOI 10.1076/jcen.25.4.465.13875; Green P., 2004, MANUAL GREENS MED SY; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry GK, 2007, APPL NEUROPSYCHOL, V14, P267, DOI 10.1080/09084280701719245; IBM Corp, 2016, IBM SPSS STAT WIND V; Kirkwood M. W, 2016, VALIDITY TESTING CHI; Kirkwood M. W, 2012, PEDIAT FORENSIC NEUR, P136; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Krishnan M, 2011, ARCH CLIN NEUROPSYCH, V26, P176, DOI 10.1093/arclin/acr010; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P167, DOI 10.1080/13854040801968443; Loughan AR, 2012, ARCH CLIN NEUROPSYCH, V27, P716, DOI 10.1093/arclin/acs072; MacAllister W. S., 2016, VALIDITY TESTING CHI, P164; Perna R, 2014, APPL NEUROPSYCH-CHIL, V3, P45, DOI 10.1080/21622965.2012.691067; Perna RB, 2013, CHILD NEUROPSYCHOL, V19, P438, DOI 10.1080/09297049.2012.731500; Sherman E.M.S., 2015, CHILD ADOLESCENT MEM; Sherman EMS, 2015, MEMORY VALIDITY PROF; Sussman ZW, 2019, APPL NEUROPSYCH-CHIL, V8, P70, DOI 10.1080/21622965.2017.1382359; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063	31	2	2	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2019	34	4					531	538		10.1093/arclin/acy068			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	IS9UK	WOS:000482493200010	30124740	Bronze			2022-02-06	
J	Davis, JS; Johns, JA; Olvera, DJ; Wolfe, AC; Gragossian, A; Rees, EM; Pillar, EA; Davis, DP				Davis, Jessie S.; Johns, Jared A.; Olvera, David J.; Wolfe, Allen C.; Gragossian, Alin; Rees, Eliana M.; Pillar, Edward A.; Davis, Daniel P.			Vital sign patterns before shock-related cardiopulmonary arrest	RESUSCITATION			English	Article						Shock; End-tidal CO2; Cardiopulmonary arrest; Pre-arrest patterns; Vital sign patterns; Capnography	SYSTOLIC BLOOD-PRESSURE; TRAUMATIC BRAIN-INJURY; INCREASED MORTALITY; CARDIAC-ARREST; 110 MMHG; HYPOTENSION; RESUSCITATION; RETURN; MODEL; HG	Objective: Traditional vital sign thresholds reflect an increased risk of mortality, which may occur hours, days, or weeks following illness/injury, limiting immediate clinical significance to guide rescue therapy to avoid arrest. Our objective is to explore vital sign patterns prior to arrest due to shock. Design: This retrospective observational analysis utilized physiological data from adult helicopter patients suffering provider-witnessed arrest. Pre-arrest values for systolic blood pressure (SBP), mean arterial pressure (MAP), heart rate (HR), shock index, and end-tidal carbon dioxide (EtCO2) were modeled against time using polynomial linear regression. The "terminal inflection point" beyond which arrest was imminent was identified where slope equals 1.0 (shock index) or -1.0 (SBP, MAP, HR, EtCO2) and was then compared to initial values. Setting: Air ambulance services. Patients: 70 helicopter patients over age fourteen suffering cardiac arrest. Results: SBP and MAP demonstrated a gentle decline followed by acceleration beyond the inflection point (SBP 80.7 mmHg, MAP 61.9 mmHg). HR demonstrated an increase followed by a terminal drop, but inflection point values fell within normal range. Shock index increased gradually from a mean of 0.9 to the inflection point of 1.1. Initial EtCO2 values declined gradually from normal (34.4 mmHg) to the inflection point (24.7 mmHg), then dropped precipitously into arrest. All inflection points occurred 2-5 min prior to arrest. Conclusions: Vital sign patterns were defined for SBP, MAP, HR, shock index, and EtCO2 with clear inflection points identified 2-5 min prior to arrest. These patterns may help guide therapy to reverse deterioration and prevent arrest.	[Davis, Jessie S.] Desert Reg Med Ctr, Dept Emergency Med, Palm Springs, CA USA; [Johns, Jared A.; Pillar, Edward A.; Davis, Daniel P.] Arrowhead Reg Med Ctr, Dept Emergency Med, Colton, CA USA; [Olvera, David J.; Wolfe, Allen C.; Davis, Daniel P.] Air Methods Corp, Greenwood Village, CO USA; [Gragossian, Alin] Drexel Univ, Dept Emergency Med, Philadelphia, PA 19104 USA; [Rees, Eliana M.] Univ Calif San Diego, San Diego, CA 92103 USA; [Davis, Daniel P.] Calif Univ Sci & Med, San Bernardino, CA USA; [Johns, Jared A.] 1147 Cornell Ave,Apt D, Redlands, CA 92374 USA; [Olvera, David J.; Wolfe, Allen C.] 5500 South Quebec St,Suite 300, Greenwood Village, CO 80111 USA; [Gragossian, Alin] 245 N 15th St,Rm 2108, Philadelphia, PA 19102 USA; [Rees, Eliana M.] 2015 Gum Branch Rd,Apt 223, Jacksonville, NC 28540 USA; [Pillar, Edward A.] 35605 Abelia St, Murrieta, CA 92562 USA; [Davis, Daniel P.] 2867 Via Rancheros Way, Fallbrook, CA 92028 USA		Davis, JS (corresponding author), 1455 Sunflower Cir S, Palm Springs, CA 92262 USA.	jessiesdavis@gmail.com					Andersen LW, 2016, RESUSCITATION, V98, P112, DOI 10.1016/j.resuscitation.2015.08.016; Bellezzo JM, 2012, RESUSCITATION, V83, P966, DOI 10.1016/j.resuscitation.2012.01.027; Bergum D, 2015, RESUSCITATION, V87, P63, DOI 10.1016/j.resuscitation.2014.11.007; Bruijns SR, 2013, J TRAUMA ACUTE CARE, V74, P1432, DOI 10.1097/TA.0b013e31829246c7; Brunauer A, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0719-2; Bruns B, 2008, J TRAUMA, V65, P1217, DOI 10.1097/TA.0b013e318184ee63; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chandrasekharan P, 2017, PEDIATR RES, V81, P898, DOI 10.1038/pr.2017.26; Conhaim RL, 2008, SHOCK, V29, P410, DOI 10.1097/SHK.0b013e318145a342; Cooper CJ, 2013, PREHOSP DISASTER MED, V28, P87, DOI 10.1017/S1049023X12001768; Darocha T, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0357-1; Davis DP, 2018, JT COMM J QUAL PATIE, V44, P413, DOI 10.1016/j.jcjq.2018.01.003; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; DAVIS JW, 1991, J TRAUMA, V31, P813, DOI 10.1097/00005373-199106000-00012; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Eastridge BJ, 2011, AM J SURG, V202, P404, DOI 10.1016/j.amjsurg.2010.10.012; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; Funk DJ, 2013, CRIT CARE MED, V41, P573, DOI 10.1097/CCM.0b013e31827bfc25; Hartmann SM, 2015, J INTENSIVE CARE MED, V30, P426, DOI 10.1177/0885066614530839; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Hasler RM, 2011, RESUSCITATION, V82, P1202, DOI 10.1016/j.resuscitation.2011.04.021; Hildebrand F, 2015, INJURY, V46, pS93, DOI 10.1016/S0020-1383(15)30025-5; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Hostler D, 2010, RESUSCITATION, V81, P826, DOI 10.1016/j.resuscitation.2010.02.005; Kheng CP, 2012, INT J EMERG MED, V5, DOI 10.1186/1865-1380-5-31; Lee Young Im, 2016, J Clin Med Res, V8, P575, DOI 10.14740/jocmr2597w; Morrison Jonathan J, 2012, J Emerg Trauma Shock, V5, P233, DOI 10.4103/0974-2700.99690; Oh H, 2016, J ADV NURS, V72, P1122, DOI 10.1111/jan.12897; Pellis T, 2005, J TRAUMA, V58, P817, DOI 10.1097/01.TA.0000152674.69802.47; Richard Aurore, 2018, Air Med J, V37, P104, DOI 10.1016/j.amj.2017.11.014; Seymour CW, 2013, ACAD EMERG MED, V20, P597, DOI 10.1111/acem.12142; Weingart S, 2015, CLIN EXP EMERG MED, V2, P131, DOI 10.15441/ceem.15.010	34	2	2	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	JUN	2019	139						337	342		10.1016/j.resuscitation.2019.03.028			6	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	IB2CL	WOS:000470076000045	30926452				2022-02-06	
J	Desai, KB; Mella, D; Pan, E				Desai, Kunal B.; Mella, Divya; Pan, Edward			An Adult Patient With Rare Primary Intracranial Alveolar Rhabdomyosarcoma	ANTICANCER RESEARCH			English	Article						Alveolar rhabdomyosarcoma; intracranial; traumatic brain injury	POSTTRAUMATIC GLIOMA; SURVIVAL; CHILDREN	We report a rare case of primary intracranial alveolar rhabdomyosarcoma (ARMS) in the right temporal lobe of a 51-year-old male. ARMS is one of 3 histological subtypes of rhabdomyosarcoma that most commonly presents in older children and younger adults. To our knowledge, there have been no prior published reports of primary intracranial ARMS in adults. Known cases of intracranial ARMS in adults are due to central nervous system (CNS) metastases from the head and neck and extremities. Diagnostic workup did not reveal any primary source outside the CNS. Given that risk factors for ARMS have not been studied in adults, it is difficult to ascertain what aspects of this patient's clinical history may have contributed to his diagnosis. Interestingly, he had prior history of traumatic brain injury requiring evacuation of a right fronto-temporal intraparenchymal hematoma.	[Desai, Kunal B.] Cleveland Clin, Dept Med, 9500 Euclid Ave, Cleveland, OH 44106 USA; [Mella, Divya; Pan, Edward] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA		Desai, KB (corresponding author), Cleveland Clin, Dept Med, 9500 Euclid Ave, Cleveland, OH 44106 USA.	desaik@ccf.org		Pan, Edward/0000-0002-2676-1639			Abeloff MD, 2008, ABELOFFS CLIN ONCOLO; ANDERSENRANBERG F, 1987, CLIN NEUROPATHOL, V6, P120; Anselmi E, 2006, TUMORI J, V92, P175, DOI 10.1177/030089160609200215; Bisogno G, 2012, CANCER-AM CANCER SOC, V118, P821, DOI 10.1002/cncr.26355; Celli P, 1998, J NEURO-ONCOL, V36, P259, DOI 10.1023/A:1005884202389; Chen SC, 2011, J CHIN MED ASSOC, V74, P140, DOI 10.1016/j.jcma.2011.01.031; De B, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26710; DROPCHO EJ, 1987, J NEURO-ONCOL, V5, P139, DOI 10.1007/BF02571302; Fletcher C, 2013, WHO CLASSIFICATION T, V4th; FOSCHINI MP, 1994, SEMIN DIAGN PATHOL, V11, P58; Grufferman S, 2009, CANCER EPIDEM BIOMAR, V18, P1271, DOI 10.1158/1055-9965.EPI-08-0775; Henry PT, 2000, BRIT J NEUROSURG, V14, P64; KLEINERT R, 1985, ACTA NEUROPATHOL, V67, P341, DOI 10.1007/BF00687824; Luporsi M, 2018, CLIN NUCL MED, V43, pe98, DOI 10.1097/RLU.0000000000001971; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; Meza JL, 2006, J CLIN ONCOL, V24, P3844, DOI 10.1200/JCO.2005.05.3801; Missiaglia E, 2012, J CLIN ONCOL, V30, P1670, DOI 10.1200/JCO.2011.38.5591; Palta Manisha, 2011, Sarcoma, V2011, P312802, DOI 10.1155/2011/312802; Pastore G, 2006, EUR J CANCER, V42, P2136, DOI 10.1016/j.ejca.2006.05.016; Punyko JA, 2005, CANCER-AM CANCER SOC, V103, P1475, DOI 10.1002/cncr.20929; Ruiz-Mesa C, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0342-8; Sarkar Debojyoti, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-006523; Seiz M, 2006, ZBL NEUROCHIR, V67, P219, DOI 10.1055/s-2006-942118; Selfe J, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26386; Sorensen PHB, 2002, J CLIN ONCOL, V20, P2672, DOI 10.1200/JCO.2002.03.137; Stegmaier S, 2011, PEDIATR BLOOD CANCER, V57, P406, DOI 10.1002/pbc.22958; Sultan I, 2009, J CLIN ONCOL, V27, P3391, DOI 10.1200/JCO.2008.19.7483; Wang Zhi-Hui, 2009, Ai Zheng, V28, P1214; Zhou B, 2010, INT J MED SCI, V7, P248	29	2	2	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	JUN	2019	39	6					3067	3070		10.21873/anticanres.13441			4	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	IC0RE	WOS:000470666800029	31177150	Bronze			2022-02-06	
J	Drapeau, J; Gosselin, N; Peretz, I; McKerral, M				Drapeau, Joanie; Gosselin, Nathalie; Peretz, Isabelle; McKerral, Michelle			Electrophysiological Responses to Emotional Facial Expressions Following a Mild Traumatic Brain Injury	BRAIN SCIENCES			English	Article						mild traumatic brain injury; event related potentials; emotions; facial expressions	IMPAIRED RECOGNITION; DEFICITS; ERP; FACES; METAANALYSIS; PERCEPTION; COMPONENT; MARKERS; ADULT	The present study aimed to measure neural information processing underlying emotional recognition from facial expressions in adults having sustained a mild traumatic brain injury (mTBI) as compared to healthy individuals. We thus measured early (N1, N170) and later (N2) event-related potential (ERP) components during presentation of fearful, neutral, and happy facial expressions in 10 adults with mTBI and 11 control participants. Findings indicated significant differences between groups, irrespective of emotional expression, in the early attentional stage (N1), which was altered in mTBI. The two groups showed similar perceptual integration of facial features (N170), with greater amplitude for fearful facial expressions in the right hemisphere. At a higher-level emotional discrimination stage (N2), both groups demonstrated preferential processing for fear as compared to happiness and neutrality. These findings suggest a reduced early selective attentional processing following mTBI, but no impact on the perceptual and higher-level cognitive processes stages. This study contributes to further improving our comprehension of attentional versus emotional recognition following a mild TBI.	[Drapeau, Joanie; McKerral, Michelle] CIUSSS Ctr Sud Ile Montreal, IURDPM, Ctr Interdisciplinary Res Rehabil CRIR, Montreal, PQ H3S 2J4, Canada; [Drapeau, Joanie; Gosselin, Nathalie; Peretz, Isabelle; McKerral, Michelle] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Drapeau, Joanie; Gosselin, Nathalie; Peretz, Isabelle] Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ H3C 3J7, Canada		McKerral, M (corresponding author), CIUSSS Ctr Sud Ile Montreal, IURDPM, Ctr Interdisciplinary Res Rehabil CRIR, Montreal, PQ H3S 2J4, Canada.; McKerral, M (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada.	joanie.drapeau@gmail.com; nathalie.gosselin@umontreal.ca; isabelle.peretz@umontreal.ca; michelle.mckerral@umontreal.ca			National Science and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Centre de readaptation Lucie-Bruneau; Canada Research ChairNatural Resources CanadaCanadian Forest ServiceCanada Research Chairs; Fonds de recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec; Faculte des etudes superieures et postdoctorales de l'Universite de Montreal	This study was supported by the National Science and Engineering Research Council of Canada and the Centre de readaptation Lucie-Bruneau (grants to M.M.), a Canada Research Chair (to I.P.), as well as the Fonds de recherche du Quebec-Sante and the Faculte des etudes superieures et postdoctorales de l'Universite de Montreal (scholarships to J.D.).	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Arlinghaus K, 2011, TXB TRAUMATIC BRAIN, P55; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beck AT, 2013, MANUAL BECK DEPRESSI; Bigler E.D., 2011, TXB TRAUMATIC BRAIN, P73, DOI DOI 10.1177/1753193410381840; Blau Vera C, 2007, Behav Brain Funct, V3, P7; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Carrier-Toutant F, 2018, J INT NEUROPSYCH SOC, V24, P673, DOI 10.1017/S1355617718000231; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; D'Hondt F, 2017, COGN AFFECT BEHAV NE, V17, P124, DOI 10.3758/s13415-016-0467-7; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Drapeau J, 2017, BRAIN INJURY, V31, P221, DOI 10.1080/02699052.2016.1208846; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Elting JW, 2008, BRAIN INJURY, V22, P870, DOI 10.1080/02699050802403581; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Gosselin N, 2011, CORTEX, V47, P1116, DOI 10.1016/j.cortex.2011.05.012; Hajcak G, 2012, OXFORD HDB EVENT REL, V441, P474, DOI DOI 10.1093/OXFORDHB/9780195374148.001.0001; Hinojosa JA, 2015, NEUROSCI BIOBEHAV R, V55, P498, DOI 10.1016/j.neubiorev.2015.06.002; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; LeDoux J., 1996, EMOTIONAL BRAIN MYST; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P35; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Mancuso M, 2015, J NERV MENT DIS, V203, P87, DOI 10.1097/NMD.0000000000000245; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKerral M., 2018, SPORTS CONCUSSIONS C; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Roy S., 2007, J VIS, V7, P944, DOI [10.1167/7.9.944, DOI 10.1167/7.9.944]; Schupp HT, 2014, SOC COGN AFFECT NEUR, V9, P1738, DOI 10.1093/scan/nst171; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Van Dillen LF, 2012, EMOTION, V12, P1340, DOI 10.1037/a0028624; Vandekerckhove M, 2014, NEUROPSYCHOLOGY, V28, P605, DOI 10.1037/neu0000057; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1017/S0048577200981265; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Zhang DD, 2013, BRAIN RES, V1512, P78, DOI 10.1016/j.brainres.2013.03.044; Zuj DV, 2017, BRAIN COGNITION, V118, P19, DOI 10.1016/j.bandc.2017.07.001; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560	59	2	2	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JUN	2019	9	6							142	10.3390/brainsci9060142			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IG4UE	WOS:000473797900019	31216634	gold, Green Submitted, Green Published			2022-02-06	
J	Furlan, JC; Fehlings, MG; Craven, BC				Furlan, Julio C.; Fehlings, Michael G.; Craven, B. Catharine			Economic Impact of Aging on the Initial Spine Care of Patients With Acute Spine Trauma: From Bedside to Teller	NEUROSURGERY			English	Article						Spinal cord injury; Acute spine trauma; Neurotrauma; Elderly; Costs; Health economics	LENGTH-OF-STAY; CORD-INJURY; HEALTH-CARE; UNITED-STATES; COSTS; AGE; EPIDEMIOLOGY; MORTALITY; MORBIDITIES; VETERANS	BACKGROUND Aging of the population has prompted an escalation of service utilization and costs in many jurisdictions including North America. However, relatively little is known on the economic impact of old age on the management of acute spine trauma (AST). OBJECTIVE To examine the potential effects of age on the service utilization and costs of the management of patients with acute spine trauma. METHODS This retrospective cohort study included consecutive patients with AST admitted to an acute spine care unit of a Canadian quaternary university hospital between February, 2002 and September, 2007. The study population was grouped into elderly (65 yr) and younger individuals. All costing data were converted and updated to US dollars in June/2017. RESULTS There were 55 women and 91 men with AST (age range: 16-92 yr, mean age of 49.9 yr) of whom 37 were elderly. The mean total hospital costs for initial admission after AST in the elderly (USD $19 338 $4892) were significantly greater than among younger individuals (USD $13775 +/- $1344). However, elderly people had significantly lower per diem total, fixed, direct, and indirect costs for AST than younger individuals. Both groups were comparable regarding the proportion of services utilized in the acute care hospital. CONCLUSION Given the escalating demand for surgical and nonsurgical spine treatment in the age of aging population, the timely results of this study underline key aspects of the economic impact of the spine care of the elderly. Further investigations are needed to fulfill significant knowledge gaps on the economics of caring for elderly with AST.	[Furlan, Julio C.; Craven, B. Catharine] Univ Toronto, Div Phys Med & Rehabil, Dept Med, Toronto, ON, Canada; [Furlan, Julio C.; Craven, B. Catharine] Univ Hlth Network, Toronto Rehabil Inst, Lyndhurst Ctr, 520 Sutherland Dr,Room 205, Toronto, ON M4G 3V9, Canada; [Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Hlth Network, Div Neurosurg, Toronto Western Hosp, Spinal Program, Toronto, ON, Canada		Furlan, JC (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Lyndhurst Ctr, 520 Sutherland Dr,Room 205, Toronto, ON M4G 3V9, Canada.	jcfurlan@gmail.com	Craven, Beverley/D-5001-2015; Furlan, Julio/Q-8290-2018	Craven, Beverley/0000-0001-8234-6803; Fehlings, Michael/0000-0002-5722-6364; Furlan, Julio/0000-0002-2038-0018			Ahn H, 2015, CAN MED ASSOC J, V187, P873, DOI 10.1503/cmaj.150085; Boccuzzi SJ, 2003, CONTEMP CARDIOL, P63; Burns AS, 2017, J NEUROTRAUM, V34, P2910, DOI 10.1089/neu.2016.4935; Chamberlain JD, 2015, INJURY EPIDEMIOLOGY, V2, P1, DOI DOI 10.1186/S40621-014-0032-1; CHARLES ED, 1978, PARAPLEGIA, V15, P302, DOI 10.1038/sc.1977.46; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen HY, 1997, NEUROEPIDEMIOLOGY, V16, P241, DOI 10.1159/000109693; Chen YY, 2016, ARCH PHYS MED REHAB, V97, P1610, DOI 10.1016/j.apmr.2016.03.017; Cifu DX, 1999, J NEUROTRAUM, V16, P805, DOI 10.1089/neu.1999.16.805; CIHI, 2007, BURD NEUR DIS DIS IN; Como JJ, 2005, J TRAUMA, V59, P912, DOI 10.1097/01.ta.0000187660.03742.a6; Couris CM, 2010, SPINAL CORD, V48, P39, DOI 10.1038/sc.2009.77; DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178; DEVIVO MJ, 1990, ARCH NEUROL-CHICAGO, V47, P687, DOI 10.1001/archneur.1990.00530060101026; DeVivo MJ., 2011, TOP SPINAL CORD INJ, V16, P1, DOI DOI 10.1310/SCI1604-1; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fine MJ, 2000, AM J MED, V109, P378, DOI 10.1016/S0002-9343(00)00500-3; French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581; Furlan JC, 2009, SPINAL CORD, V47, P674, DOI 10.1038/sc.2009.23; Furlan JC, 2012, TRAUMATIC BRAIN SPIN, P216; Furlan JC, 2013, NEUROSURGERY, V40, pS46; Furlan JC, 2017, J SPINAL CORD MED, V40, P649, DOI 10.1080/10790268.2017.1368267; Furlan JC, 2016, NEUROSURGERY, V79, P418, DOI 10.1227/NEU.0000000000001314; Furlan JC, 2013, AGING CLIN EXP RES, V25, P463, DOI 10.1007/s40520-013-0066-1; Furlan JC, 2011, NEUROEPIDEMIOLOGY, V37, P96, DOI 10.1159/000330835; Furlan JC, 2009, J NEUROTRAUM, V26, P1707, DOI [10.1089/neu.2009.0888, 10.1089/neu.2009-0888]; Furlan JC, 2009, J NEUROTRAUM, V26, P1361, DOI [10.1089/neu.2008.0764, 10.1089/neu.2008-0764]; Furlan JC, 2010, NEUROBIOL AGING, V31, P434, DOI 10.1016/j.neurobiolaging.2008.05.003; Furlan JC, 2008, J NEUROTRAUM, V25, P1273, DOI 10.1089/neu.2008.0617; Guyatt GH, 2007, OPEN MED PEER REV IN, V1, P27; Halfhill TR, TOMS INFLATION CALCU; Himmelstein DU, 2014, HEALTH AFFAIR, V33, P1586, DOI 10.1377/hlthaff.2013.1327; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Knutsdottir S, 2012, SPINAL CORD, V50, P123, DOI 10.1038/sc.2011.105; Krassioukov AV, 2003, J NEUROTRAUM, V20, P391, DOI 10.1089/089771503765172345; Lee DS, 2017, EUR SPINE J, V26, P2333, DOI 10.1007/s00586-017-5104-9; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Mahabaleshwarkar R, 2014, SPINAL CORD, V52, P139, DOI 10.1038/sc.2013.144; Majdan M, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0410-0; Munce SEP, 2013, SPINAL CORD, V51, P64, DOI 10.1038/sc.2012.81; NSCIC, 2016, SPIN CORD INJ FACTS; O'Lynnger TM, 2015, NEUROSURGERY, V77, pS136, DOI 10.1227/NEU.0000000000000945; Pickett W, 2003, J TRAUMA, V55, P1070, DOI 10.1097/01.TA.0000034228.18541.D1; Richard-Denis A, 2017, AM J PHYS MED REHAB, V96, P449, DOI 10.1097/PHM.0000000000000659; Roberts RR, 1999, JAMA-J AM MED ASSOC, V281, P644, DOI 10.1001/jama.281.7.644; ROTH EJ, 1992, PARAPLEGIA, V30, P520, DOI 10.1038/sc.1992.109; Seel R T, 2001, J Spinal Cord Med, V24, P241; Stroupe, 2011, TOP SPINAL CORD INJ, V16, P27, DOI DOI 10.1310/SCI1604-27; Stroupe K., 2011, TOP SPINAL CORD INJU, V16, P62, DOI [10.1310/sci1604-62, DOI 10.1310/SCI1604-62, DOI 10.1310/SCI1604]; Ugiliweneza B, 2014, SPINE, V39, P1235, DOI 10.1097/BRS.0000000000000378; US-BLS, 2016, CONS PRIC IND ALL UR; Waldrop R, 2015, NEUROSURGERY, V77, pS46, DOI 10.1227/NEU.0000000000000950; Weil TP, 2016, INT J HEALTH PLAN M, V31, DOI 10.1002/hpm.2374; WHO, 2014, WHO GLOB HLTH EXP DA; Yu W, 2004, AM J MANAG CARE, V10, P909; Yu Wei, 2004, J Med Syst, V28, P271, DOI 10.1023/B:JOMS.0000032844.26308.95	57	2	2	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2019	84	6					1251	1259		10.1093/neuros/nyy180			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IC8QQ	WOS:000471247000036	29790981	Bronze			2022-02-06	
J	Galea, OA; O'Leary, SP; Treleaven, JM				Galea, Olivia A.; O'Leary, Shaun P.; Treleaven, Julia M.			Persistent impairment based symptoms post mild traumatic brain injury: Does a standard symptom scale detect them?	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Concussion; Impairment; Mild traumatic brain injury; Self-report symptom; Tool	ANXIETY STRESS SCALES; HEART-RATE-VARIABILITY; CONCUSSION SYMPTOMS; AUTONOMIC DYSREGULATION; VISUAL DISTURBANCES; CONSTRUCT-VALIDITY; NORMATIVE DATA; SHORT-FORM; DIZZINESS; SLEEP	Aim: To further explore symptoms in patients beyond the expected recovery period post mild Traumatic Brain Injury (mTBI) that are potentially indicative of impairment. Methods: Ninety-four individuals (62 diagnosed with mTBI within the previous 4-24 weeks and 32 healthy controls) participated in the study. Participants in the mTBI group were further grouped as symptomatic (n = 33) or asymptomatic (n = 29) based on their spontaneous report of symptoms at the time of screening. Measures included a demographic questionnaire, 8 impairment specific self-report clinical tools, and a standard post-mTBI self-report symptom scale (Head Injury Scale (HIS)). Results: Compared to the control group, scores for all instruments (including the HIS) were higher in the symptomatic mTBI group (P < 0.05), and higher for the neck disability and hyperarousal measures in the asymptomatic mTBI group (p < 0.035), but not the HIS (p > 0.093). Overall 94% of the symptomatic and 62% of the asymptomatic participants post-mTBI, recorded scores considered to be clinically relevant on at least one impairment screening tool. In contrast, only 28% of the asymptomatic mTBI group recorded a clinically relevant score for the HIS. Conclusion: Symptoms indicative of persisting impairments beyond the expected recovery period were apparent in a substantial proportion of individuals post mTBI. Furthermore, a high percentage of individuals initially reporting as symptom free demonstrated clinically relevant scores on at least one impairment screening tool. Findings also suggest that a standard post-mTBI self-report symptom scale may often not detect the presence of persisting symptoms.	[Galea, Olivia A.; O'Leary, Shaun P.; Treleaven, Julia M.] Univ Queensland, Sch Hlth & Rehabil Sci, Bldg 84a Therapies Annexe, St Lucia, Qld 4072, Australia; [O'Leary, Shaun P.] Royal Brisbane & Womens Hosp, Physiotherapy Dept, Herston, Qld, Australia		Galea, OA (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Bldg 84a Therapies Annexe, St Lucia, Qld 4072, Australia.	olivia.galea@uqconnect.edu.au	Treleaven, Julia/N-1379-2019	Treleaven, Julia/0000-0002-6258-3972; GALEA, Olivia/0000-0001-5013-7580	Research Training Program Scholarship	This study was supported by a Research Training Program Scholarship.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], J HEAD TRAUMA REHABI, V8, P86; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Brandt T, 2017, NAT REV NEUROL, V13, P352, DOI 10.1038/nrneurol.2017.58; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Cohen H, 2000, PSYCHIAT RES, V96, P1, DOI 10.1016/S0165-1781(00)00195-5; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Dennis PA, 2017, PSYCHOSOM MED, V79, P496, DOI 10.1097/PSY.0000000000000438; DSM-IV, 1994, PROP CRIT POSTC DIS; Duclos C, 2017, NEUROLOGY, V88, P268, DOI 10.1212/WNL.0000000000003508; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Elliott JE, 2018, J CLIN SLEEP MED, V14, P1177, DOI 10.5664/jcsm.7220; Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Green KT, 2016, J PSYCHOSOM RES, V82, P31, DOI 10.1016/j.jpsychores.2016.01.003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heart rate variability, EUR HEART J, V17, P354; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Huang TY, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/378726; JACOB RG, 1993, J PSYCHOPATHOL BEHAV, V15, P299, DOI 10.1007/BF00965035; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Laukkanen H, 2017, OPTOMETRY VISION SCI, V94, P43, DOI 10.1097/OPX.0000000000000940; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Liao KH, 2016, PSYCHIAT RES, V243, P349, DOI 10.1016/j.psychres.2016.07.001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCarthy S, 2008, OCCUP MED-OXFORD, V58, P379, DOI 10.1093/occmed/kqn062; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Mollayeva T, 2017, SLEEP MED, V34, P179, DOI 10.1016/j.sleep.2017.02.021; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Piland SG, 2003, J ATHL TRAINING, V38, P104; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Reneker JC, 2018, MUSCULOSKEL SCI PRAC, V34, P8, DOI 10.1016/j.msksp.2017.11.012; Reneker Jennifer C, 2015, Inj Epidemiol, V2, P22; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Strupp M, 2013, CURR OPIN NEUROL, V26, P81, DOI 10.1097/WCO.0b013e32835c5fd4; Sung CW, 2016, CLIN NEUROPHYSIOL, V127, P1629, DOI 10.1016/j.clinph.2015.08.006; Tesio L, 1999, AM J PHYS MED REHAB, V78, P233, DOI 10.1097/00002060-199905000-00009; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Treleaven J, 2014, MANUAL THER, V19, P203, DOI 10.1016/j.math.2014.01.005; Ulmer CS, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy174; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Young IA, 2019, PHYSIOTHER THEOR PR, V35, P1328, DOI 10.1080/09593985.2018.1471763; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zhou DY, 2016, NEUROSCI LETT, V610, P154, DOI 10.1016/j.neulet.2015.10.055	72	2	2	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	JUN	2019	41						15	22		10.1016/j.msksp.2019.02.002			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HU5TT	WOS:000465342800004	30825848	Green Accepted			2022-02-06	
J	Gioia, S; Franceschetto, L; Lancia, M; Bacci, M; Suadoni, F				Gioia, Sara; Franceschetto, Lisa; Lancia, Massimo; Bacci, Mauro; Suadoni, Fabio			A Case of Bilateral Extracranial Internal Carotid Artery Dissection Due to the Helmet Strap After Motorcycle Crash	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						arterial dissection; helmet injury; traumatic dissection; traffic injuries		The authors report a case of a man who developed stroke symptoms a few days after a road accident on his motorcycle. Radiographic examinations revealed the presence of bilateral dissection of the extracranial internal carotid arteries with signs of involvement of the brain parenchyma. The location, timing, and presentation lead to the conclusion that the carotid lesions were secondary to the motorcycle collision; in particular, we suppose that it is due to the pressure exerted by the helmet strap worn. Although helmets have undoubtedly prevented serious injuries, this report highlights that the helmets themselves may cause injuries, especially to cervical soft tissues and vessels.	[Gioia, Sara; Lancia, Massimo; Bacci, Mauro] Univ Perugia, Sect Legal Med, Pzza Lucio Severi 1, I-06123 Perugia, Italy; [Franceschetto, Lisa] Univ Perugia, Sch Med, Perugia, Italy; [Suadoni, Fabio] Hosp Terni, Sect Legal Med, Terni, Italy		Lancia, M (corresponding author), Univ Perugia, Sect Legal Med, Pzza Lucio Severi 1, I-06123 Perugia, Italy.	massimo.lancia@unipg.it	Gioia, Sara/AAN-1048-2020	Gioia, Sara/0000-0002-2078-416X; Lancia, Massimo/0000-0003-2307-470X			Abbas AK, 2012, ACCIDENT ANAL PREV, V49, P249, DOI 10.1016/j.aap.2011.09.033; COOTER RD, 1988, LANCET, V1, P84; Cruciata Giuseppe, 2017, Radiol Case Rep, V12, P371, DOI 10.1016/j.radcr.2017.01.016; de Bray JM, 2005, ARCH NEUROL-CHICAGO, V62, P1168, DOI 10.1001/archneur.62.7.1168; Derrick AJ, 2009, J PUBLIC HEALTH POL, V30, P226, DOI 10.1057/jphp.2009.11; Doi A, 2004, NEUROL SURG TOKYO, V32, P1279; Gioia S, 2013, AM J FOREN MED PATH, V34, P325, DOI 10.1097/PAF.0000000000000060; Haneline MT, 2007, J CHIROPR MED, V6, P110, DOI 10.1016/j.jcme.2007.04.007; Khor D, 2017, INJURY, V48, P1093, DOI 10.1016/j.injury.2017.02.006; Kumar V, 2005, ROBBINS COTRAN PATHO; Kuo Liang-Chi, 2008, Am J Emerg Med, V26, DOI 10.1016/j.ajem.2007.04.015; La Torre G, 2007, EUR J PUBLIC HEALTH, V17, P607, DOI 10.1093/eurpub/ckm028; Lee WW, 2000, J EMERG MED, V19, P35, DOI 10.1016/S0736-4679(00)00190-6; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Lopez-Sanchez M, 2009, MED INTENSIVA, V33, P353, DOI 10.1016/j.medin.2008.12.001; Mourad JJ, 1997, NEW ENGL J MED, V336, P516, DOI 10.1056/NEJM199702133360717; Opeskin K, 1997, AM J FOREN MED PATH, V18, P251, DOI 10.1097/00000433-199709000-00005; Ostby ET, 2018, ANN OTO RHINOL LARYN, V127, P282, DOI 10.1177/0003489418755405; Paramasivam S, 2012, J NEUROINTERV SURG, V4, DOI 10.1136/neurintsurg-2011-010103; Thanvi B, 2005, POSTGRAD MED J, V81, P383, DOI 10.1136/pgmj.2003.016774; Zoja R, 2011, FORENSIC SCI INT, V207, pE48, DOI 10.1016/j.forsciint.2010.12.010	21	2	2	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	JUN	2019	40	2					153	155		10.1097/PAF.0000000000000458			3	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	HY9UR	WOS:000468487300013	30624242	Green Published			2022-02-06	
J	Greenan, K; Taylor, SL; Fulkerson, D; Shahlaie, K; Gerndt, C; Krueger, EM; Zwienenberg, M				Greenan, Krista; Taylor, Sandra L.; Fulkerson, Daniel; Shahlaie, Kiarash; Gerndt, Clayton; Krueger, Evan M.; Zwienenberg, Marike			Selection of children with ultra-severe traumatic brain injury for neurosurgical intervention	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatric; severe TBI; outcome prediction; trauma	COMA SCALE SCORE; SEVERE HEAD-INJURY; PROGNOSTIC-FACTORS; MORTALITY; OUTCOMES; MODELS; PREDICTORS; VALIDATION	OBJECTIVE A recent retrospective study of severe traumatic brain injury (TBI) in pediatric patients showed similar outcomes in those with a Glasgow Coma Scale (GCS) score of 3 and those with a score of 4 and reported a favorable longterm outcome in 11.9% of patients. Using decision tree analysis, authors of that study provided criteria to identify patients with a potentially favorable outcome. The authors of the present study sought to validate the previously described decision tree and further inform understanding of the outcomes of children with a GCS score 3 or 4 by using data from multiple institutions and machine learning methods to identify important predictors of outcome. METHODS Clinical, radiographic, and outcome data on pediatric TBI patients (age < 18 years) were prospectively collected as part of an institutional TBI registry. Patients with a GCS score of 3 or 4 were selected, and the previously published prediction model was evaluated using this data set. Next, a combined data set that included data from two institutions was used to create a new, more statistically robust model using binomial recursive partitioning to create a decision tree. RESULTS Forty-five patients from the institutional TBI registry were included in the present study, as were 67 patients from the previously published data set, for a total of 112 patients in the combined analysis. The previously published prediction model for survival was externally validated and performed only modestly (AUC 0.68, 95% CI 0.47, 0.89). In the combined data set, pupillary response and age were the only predictors retained in the decision tree. Ninety-six percent of patients with bilaterally nonreactive pupils had a poor outcome. If the pupillary response was normal in at least one eye, the outcome subsequently depended on age: 72% of children between 5 months and 6 years old had a favorable outcome, whereas 100% of children younger than 5 months old and 77% of those older than 6 years had poor outcomes. The overall accuracy of the combined prediction model was 90.2% with a sensitivity of 68.4% and specificity of 93.6%. CONCLUSIONS A previously published survival model for severe TBI in children with a low GCS score was externally validated. With a larger data set, however, a simplified and more robust model was developed, and the variables most predictive of outcome were age and pupillary response.	[Greenan, Krista; Shahlaie, Kiarash; Gerndt, Clayton; Zwienenberg, Marike] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Taylor, Sandra L.] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Div Biostat, Sacramento, CA 95817 USA; [Greenan, Krista; Krueger, Evan M.] Univ Colorado, Dept Pediat Neurosurg, Aurora, CO USA; [Fulkerson, Daniel] Indiana Univ, Dept Neurol Surg, Goodman Campbell Brain & Spine Riley Hosp Childre, Indiana, PA USA		Zwienenberg, M (corresponding author), Univ Calif Davis, Sacramento, CA 95817 USA.	mzwien@ucdavis.edu		gerndt, clayton/0000-0001-9226-1790	UC Davis Department of Neurological Surgery; UC Davis Clinical and Translational Science Center; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 TR001860]	This work was supported by a financial grant from the UC Davis Department of Neurological Surgery and the UC Davis Clinical and Translational Science Center supported by the National Institutes of Health through grant no. UL1 TR001860.	Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Centers for Disease Control and Prevention [CDC], 2016, 10 LEAD CAUS DEATH A; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Fulkerson DH, 2015, J NEUROSURG-PEDIATR, V16, P410, DOI 10.3171/2015.3.PEDS14679; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Haider AH, 2011, J PEDIATR SURG, V46, P1557, DOI 10.1016/j.jpedsurg.2011.04.055; Han JLXG, 2017, WORLD NEUROSURG, V108, P885, DOI 10.1016/j.wneu.2017.08.147; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Kesmarky K, 2017, J NEUROTRAUM, V34, P2235, DOI 10.1089/neu.2016.4606; Kirkham FJ, 2008, DEV MED CHILD NEUROL, V50, P267, DOI 10.1111/j.1469-8749.2008.02042.x; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Rizoli S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0098-x; SIMPSON D, 1982, LANCET, V2, P450; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tatman A, 1997, ARCH DIS CHILD, V77, P519, DOI 10.1136/adc.77.6.519; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Young AMH, 2016, J NEUROSURG-PEDIATR, V18, P558, DOI 10.3171/2016.5.PEDS15427	30	2	2	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2019	23	6					670	679		10.3171/2019.1.PEDS18293			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	IB0EH	WOS:000469930400002	30952132				2022-02-06	
J	Gunia-Krzyzak, A; Bareyre, FM; Marona, H; Waszkielewicz, AM				Gunia-Krzyzak, Agnieszka; Bareyre, Florence M.; Marona, Henryk; Waszkielewicz, Anna M.			Four N-(E)-cinnamoyl (cinnamamide) derivatives of aminoalkanols with promising anticonvulsant and analgesic activity	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Anticonvulsant; Cinnamamide; Epilepsy; Neuropathic pain; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MODEL; PAIN; STRATEGIES; MICE	Epilepsy and neuropathic pain are frequent neurological disorders with pathomechanism based on abnormal neuronal discharges. Secondary tissue impairment observed after traumatic brain injury is also connected with neuronal dysfunction. Those three neurological disorders are ineffectively treated with currently available pharmacotherapy options so great effort is made in searching for new effective drugs. Four N-(E)-cinnamoyl (cinnamamide) derivatives of aminoalkanols: S-(2E)-N-(1-hydroxypropan-2-yl)-3-(2-methylphenyl)prop-2-enamide (1), R,S-(2E)-3-(4-chlorophenyl)-N-(1-hydroxybutan-2-yl)prop-2-enamide (2), R,S-(2E)-3-(4-chlorophenyl)-N-(2-hydroxypropyl)prop-2-enamide (3), (2E)-3-(4-chlorophenyl)-N-(4-hydroxycyclohexyl)prop-2-enamide (4) were evaluated in vivo and in vitro for anticonvulsant, neuroprotective and/or analgesic activity. In intravenous metrazol seizure threshold test compounds 1-3 did not show pro-convulsive effect but proved anticonvulsant potential. In corneal kindled mice model the tested compounds showed beneficial anticonvulsant properties with ED50 of 36.8 mg/kg for 1, 25.7 mg/kg for 2, and 51.1 mg/kg for 3. Compound 2 tested in vitro in spontaneously bursting rat hippocampal slice model significantly reduced burst rate. Compounds 1 and 2 did not decrease lesion volume in acute model of traumatic brain injury. In formalin test of hyperalgesia in mice, compound 1 was active in the acute phase of the test, while compound 4 caused reduction of the time of licking of the affected paw by approx. 88% during the acute phase and 100% during the inflammatory phase. In rat sciatic ligation model of neuropathic pain, compound 1 significantly increased the paw withdrawal threshold starting from one hour after oral administration and the activity continued up to six hours. Reported here four N-( E)-cinnamoyl derivatives of aminoalkanols possess promising activity as anticonvulsant and/or analgesic agents.	[Gunia-Krzyzak, Agnieszka; Marona, Henryk; Waszkielewicz, Anna M.] Jagiellonian Univ, Fac Pharm, Dept Bioorgan Chem, Chair Organ Chem,Med Coll, Med 9, PL-30688 Krakow, Poland; [Bareyre, Florence M.] Ludwig Maximilians Univ Munchen, Hosp & Biomed Ctr BMC, Inst Clin Neuroimmunol, Grosshademer 9, D-82152 Planegg Martinsried, Germany; [Bareyre, Florence M.] Munich Cluster Syst Neurol SyNergy, Munich, Germany		Gunia-Krzyzak, A (corresponding author), Jagiellonian Univ, Fac Pharm, Dept Bioorgan Chem, Chair Organ Chem,Med Coll, Med 9, PL-30688 Krakow, Poland.	agnieszka.gunia@uj.edu.pl		Marona, Henryk/0000-0002-3815-4174; Waszkielewicz, Anna/0000-0002-2871-9418; Gunia-Krzyzak, Agnieszka/0000-0003-4162-4760	Jagiellonian University Medical College [K/DSC/004292, K/ZDS/007882, K/ZDS/007884]; Foundation for Polish Science (Skills Programme); Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [SFB 870]; Munich Center for Neurosciences (MCN); Wings for Life foundation; Munich Center for Systems Neurology (DFG, SyNergy)German Research Foundation (DFG) [EXC 1010]	The work was supported by Jagiellonian University Medical College (Grants K/DSC/004292, K/ZDS/007882, K/ZDS/007884) and Foundation for Polish Science (within Skills Programme). FMB is supported by grants from the Deutsche Forschungsgemeinschaft (DFG, SFB 870), by the Munich Center for Neurosciences (MCN), the Wings for Life foundation and by the Munich Center for Systems Neurology (DFG, SyNergy; EXC 1010).	Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Brodie MJ, 2001, EPILEPSIA, V42, P27, DOI 10.1046/j.1528-1157.2001.042suppl.3027.x; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; Gunia-Krzyak A, 2017, BIOORGAN MED CHEM, V25, P471, DOI 10.1016/j.bmc.2016.11.014; Gunia-Krzyzak A, 2017, CHEM BIOL DRUG DES, V90, P244, DOI 10.1111/cbdd.12943; Gunia-Krzyzak A, 2015, CHEMMEDCHEM, V10, P1302, DOI 10.1002/cmdc.201500153; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Holmes GL, 2007, NEUROLOGY, V69, pS28, DOI 10.1212/01.wnl.0000302369.24230.c6; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mandhane SN, 2007, SEIZURE-EUR J EPILEP, V16, P636, DOI 10.1016/j.seizure.2007.05.005; Matagne A, 1998, EPILEPSY RES, V31, P59, DOI 10.1016/S0920-1211(98)00016-3; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Rowley NM, 2010, EPILEPSY RES, V92, P163, DOI 10.1016/j.eplepsyres.2010.09.002; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Sridharan R, 2002, CURR SCI INDIA, V82, P664; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Waszkielewicz AM, 2011, CURR MED CHEM, V18, P4344; Wordliczek J., 2011, POL PRZ NEUROL, V7, P39; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; 1972, ELECTROENCEPHALOGR C, V32, P281	25	2	2	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	JUN 1	2019	29	11					1298	1303		10.1016/j.bmcl.2019.04.006			6	Chemistry, Medicinal; Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Chemistry	HU8NP	WOS:000465546100007	30975624				2022-02-06	
J	Jiang, JP; Niu, XG; Dai, C; Ma, K; Xu, HY; Cheng, SX; Zhang, ZW; Duan, F; Zhu, X; Wang, YT; Chen, XY; Zhang, S				Jiang, Ji-Peng; Niu, Xue-Gang; Dai, Chen; Ma, Ke; Xu, Hui-You; Cheng, Shi-Xiang; Zhang, Zhi-Wen; Duan, Feng; Zhu, Xu; Wang, Yu-Ting; Chen, Xu-Yi; Zhang, Sai			Neurological functional evaluation based on accurate motions in big animals with traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; evaluation method; neurological deficiency; traumatic brain injury; motion capture; electromyogram; ground reaction force; neural regeneration	GLUTEUS MEDIUS MUSCLE; SURFACE ELECTROMYOGRAPHY; VASTUS LATERALIS; HEMIPLEGIC PATIENT; PROGNOSTIC VALUE; BICEPS FEMORIS; DOGS; KINEMATICS; MODEL; GAIT	An accurate and effective neurological evaluation is indispensable in the treatment and rehabilitation of traumatic brain injury. However, most of the existing evaluation methods in basic research and clinical practice are not objective or intuitive for assessing the neurological function of big animals, and are also difficult to use to qualify the extent of damage and recovery. In the present study, we established a big animal model of traumatic brain injury by impacting the cortical motor region of beagles. At 2 weeks after successful modeling, we detected neurological deficiencies in the animal model using a series of techniques, including three-dimensional motion capture, electromyogram and ground reaction force. These novel technologies may play an increasingly important role in the field of traumatic brain injury diagnosis and rehabilitation in the future. The experimental protocol was approved by the Animal Care and Use Committee of Logistics University of People's Armed Police Force (approval No. 2017-0006.2).	[Jiang, Ji-Peng; Dai, Chen; Ma, Ke; Xu, Hui-You; Cheng, Shi-Xiang; Chen, Xu-Yi; Zhang, Sai] Med Ctr Peoples Armed Policed Force, Ctr Neurol & Neurosurg, Lab Neurotrauma Repair Tianjin, Tianjin, Peoples R China; [Niu, Xue-Gang] Tianjin Fourth Cent Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Zhang, Zhi-Wen; Duan, Feng] Nankai Univ, Dept Automat, Coll Comp & Control Engn, Tianjin, Peoples R China; [Zhu, Xu; Wang, Yu-Ting] Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China		Chen, XY; Zhang, S (corresponding author), Med Ctr Peoples Armed Policed Force, Ctr Neurol & Neurosurg, Lab Neurotrauma Repair Tianjin, Tianjin, Peoples R China.	chenxuyi1979@l26.com; Zhangsai718@yahoo.com; chenxuyi1979@126.com; Zhangsai718@yahoo.com		Jiang, Jipeng/0000-0002-8954-7277	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11672332, 11102235, 31200809]; National Key Research and Development Plan of China [2016YFC1101500]; Science and Technology Program of Tianjin, China [17YFZCSY00620, 16ZXHLSY00120]	This work was supported by the National Natural Science Foundation of China, No. 11672332, 11102235 and 31200809 (all to XYC); the National Key Research and Development Plan of China, No. 2016YFC1101500 (to SZ); and the Science and Technology Program of Tianjin, China, No. 17YFZCSY00620 and 16ZXHLSY00120 (both to XYC).; This work was supported by the the National Natural Science Foundation of China, No. 11672332, 11102235 and 31200809 (all to XYC); the National Key Research and Development Plan of China, No. 2016YFC1101500 (to SZ); and the Science and Technology Program of Tianjin, China, No. 17YFZCSY00620 and 16ZXHLSY00120 (both to XYC). The funding sources had no role in study design, conception, analysis or interpretation of data, writing and deciding to submit this paper for publication.	Alizadeh M, 2016, RES VET SCI, V109, P94, DOI 10.1016/j.rvsc.2016.09.009; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Beltran E, 2014, J VET INTERN MED, V28, P1256, DOI 10.1111/jvim.12368; Bockstahler B, 2012, VET SURG, V41, P54, DOI 10.1111/j.1532-950X.2011.00932.x; Bockstahler BB, 2009, VET SURG, V38, P754, DOI 10.1111/j.1532-950X.2009.00561.x; Bosco G, 2001, PHYSIOL REV, V81, P539, DOI 10.1152/physrev.2001.81.2.539; Breitfuss K, 2015, VET SURG, V44, P588, DOI 10.1111/j.1532-950X.2014.12302.x; Brochard S, 2010, CURR OPIN NEUROL, V23, P683, DOI 10.1097/WCO.0b013e32833f61ce; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Chow JW, 2012, ARCH PHYS MED REHAB, V93, P2287, DOI 10.1016/j.apmr.2012.03.020; Courtine G, 2005, J NEUROPHYSIOL, V93, P3127, DOI 10.1152/jn.01073.2004; Cullen KL, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0985-8; Druen S, 2010, BERL MUNCH TIERARZTL, V123, P339, DOI 10.2376/0005-9366-123-339; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P73; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Ivanenko YP, 2008, J NEUROPHYSIOL, V99, P1890, DOI 10.1152/jn.01308.2007; Jiang JP, 2018, J NEUROSCI METH, V307, P95, DOI 10.1016/j.jneumeth.2018.06.025; Kappos EA, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.723; Kinder HA, 2019, NEURAL REGEN RES, V14, P413, DOI 10.4103/1673-5374.245334; Kluitenberg B, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-235; Licka TF, 2004, AM J VET RES, V65, P155, DOI 10.2460/ajvr.2004.65.155; Marras WS, 2001, J ELECTROMYOGR KINES, V11, P1, DOI 10.1016/S1050-6411(00)00039-0; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Mumford N, 2010, BRAIN INJURY, V24, P780, DOI 10.3109/02699051003652807; Neckel ND, 2018, J NEUROTRAUMA; Ouyang W, 2018, J NEUROSCI RES, V96, P1412, DOI 10.1002/jnr.24261; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; PURDY PD, 1989, STROKE, V20, P1361, DOI 10.1161/01.STR.20.10.1361; Robert C, 1999, CELLS TISSUES ORGANS, V165, P113, DOI 10.1159/000016681; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Tan CL, 2019, PITUITARY, V22, P332, DOI 10.1007/s11102-018-0925-z; VandeMeent H, 1996, J NEUROTRAUM, V13, P741; Wenger N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008325; Zibara K, 2019, NEUROPHARMACOLOGY, V145, P177, DOI 10.1016/j.neuropharm.2018.09.032	40	2	2	1	37	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JUN	2019	14	6					991	996		10.4103/1673-5374.250578			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HL2GM	WOS:000458522600016	30762010	gold, Green Published			2022-02-06	
J	Khan, KA; Choudhary, M; Sinha, VD; Gora, N; Bairwa, M				Khan, Khursheed Alam; Choudhary, Madhur; Sinha, Virendra D.; Gora, Nandkishore; Bairwa, Mohan			Predictors of Outcome After Traumatic Brain Injuries: Experience of a Tertiary Health Care Institution in Northwest India	WORLD NEUROSURGERY			English	Article						Glasgow coma score; Injury severity score; Prehospital care; Rotterdam score; Traumatic brain injury	PROGNOSTIC MODELS; SEVERITY SCORE; HEAD-INJURIES; EPIDEMIOLOGY; IMPACT; COMA; CLASSIFICATION; DESIGN	BACKGROUND AND OBJECTIVE: Traumatic brain injury (TBI) is a major health issue in developing nations such as India along with underreporting of TBI data because of a lack of major studies targeting the population with TBI. Various lacunae from field to tertiary centers are responsible for this significant burden of TBIs. We studied the epidemiologic profile of 1150 patients with TBI including the predictors of the outcome of TBIs in a tertiary health care institution in North India to identify the modifiable factors that could be used to improve the outcome and reduce the TBI burden. METHODS: Patients presenting with TBI to a level I trauma center were identified and enrolled in the study. Data regarding patient information from accident to discharge or death were collected as per designed format and analyzed to determine outcome predictors. RESULTS: Mean age was 36 +/- 15.8 years and 84.6% of patients were male; road traffic accident was the mode of injury in 64.26% of cases. Lack of adequate prehospital care was seen in our study. Glasgow Coma Scale score on admission, Injury Severity Score, and Rotterdam CT score were found to be the 3 statistically significant predictors of outcome in patients with TBI. CONCLUSIONS: Knowledge about the causes, pattern, and distribution of patients with TBI from this study is helpful in policy making, research, health management, and rehabilitation at the national level in ours and in other nations.	[Khan, Khursheed Alam; Choudhary, Madhur; Sinha, Virendra D.; Gora, Nandkishore] Sawai Maan Singh Med Coll, Dept Neurosurg, Jaipur, Rajasthan, India; [Bairwa, Mohan] Indian Inst Hlth Management Res, Dept Publ Hlth & Epidemiol, Jaipur, Rajasthan, India		Khan, KA (corresponding author), Sawai Maan Singh Med Coll, Dept Neurosurg, Jaipur, Rajasthan, India.	kkneuro15@gmail.com	Bairwa, Mohan/G-9463-2015; Khan, Ikhlas/AAA-1490-2020	Bairwa, Mohan/0000-0001-7763-2530; 			Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bajracharya A, 2010, J NEUROSCI RURAL PRA, V1, P2, DOI 10.4103/0976-3147.63092; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Gururaj G, 2005, USITC PUBL, V61; Hoyt DB, 2004, J TRAUMA, V57, P410, DOI 10.1097/00005373-200408000-00038; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kamal VK, 2016, J NEUROSCI RURAL PRA, V7, P515, DOI 10.4103/0976-3147.188637; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Liesemer K, 2014, PEDIATR CRIT CARE ME, V15, P554, DOI 10.1097/PCC.0000000000000150; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murthy TVSP, 2005, INDIAN J NEUROTRAUM, V2, P99; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Tay SY, 2004, J TRAUMA, V56, P162, DOI 10.1097/01.TA.0000058311.67607.07; TEASDALE G, 1974, LANCET, V2, P81	28	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2019	126						E699	E705		10.1016/j.wneu.2019.02.126			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IA0BU	WOS:000469222400086	30844525				2022-02-06	
J	Kinch, K; Fullerton, JL; Stewart, W				Kinch, Kevin; Fullerton, J. L.; Stewart, W.			One hundred years (and counting) of blast-associated traumatic brain injury	JOURNAL OF THE ROYAL ARMY MEDICAL CORPS			English	Article							HIGH EXPLOSIVES; DISEASE	Blast-associated traumatic brain injury (TBI) has become one of the signature issues of modern warfare and is increasingly a concern in the civilian population due to a rise in terrorist attacks. Despite being a recognised feature of combat since the introduction of high explosives in conventional warfare over a century ago, only recently has there been interest in understanding the biology and pathology of blast TBI and the potential long-term consequences. Progress made has been slow and there remain remarkably few robust human neuropathology studies in this field. This article provides a broad overview of the history of blast TBI and reviews the pathology described in the limited scientific studies found in the literature.	[Kinch, Kevin; Stewart, W.] Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland; [Fullerton, J. L.; Stewart, W.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland		Kinch, K (corresponding author), Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow G51 4TF, Lanark, Scotland.	kevin.kinch@nhs.net		Stewart, William/0000-0003-2199-2582	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, R01NS094003] Funding Source: NIH RePORTER	This study was funded by the National Institutes of Health.	COHEN H, 1946, ARCH PATHOL, V42, P12; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mott F W, 1917, Br Med J, V2, P612; Mott FW, 1916, LANCET, V1, P441; Mott FW, 1916, LANCET, V1, P331; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Shephard B, 1999, HIST PSYCHIATR, V10, P491, DOI 10.1177/0957154X9901004005; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Turner WA, 1915, BRIT MED J, V1915, P833; US Army Medical Research and Materiel Command, ANN REP C DIR MED RE; Wittenbrook JM, 1941, J NERV MENT DIS, V94, P170, DOI 10.1097/00005053-194194020-00004	18	2	3	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0035-8665	2052-0468		J ROY ARMY MED CORPS	J. R. Army Med. Corps	JUN	2019	165	3					180	182		10.1136/jramc-2017-000867			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IC6OU	WOS:000471092200012	29326126	Green Accepted			2022-02-06	
J	Laird, V; Elliott, TR; Brossart, DF; Luo, W; Hicks, JA; Warren, AM; Foreman, M				Laird, Vanessa; Elliott, Timothy R.; Brossart, Daniel F.; Luo, Wen; Hicks, Joshua A.; Warren, Ann Marie; Foreman, Michael			Trajectories of Affective Balance 1 Year After Traumatic Injury: Associations with Resilience, Social Support, and Mild Traumatic Brain Injury	JOURNAL OF HAPPINESS STUDIES			English	Article						Affective balance; Well-being; Traumatic injury; Mild traumatic brain injury; Resilience; Social support; Multilevel modeling	CONNOR-DAVIDSON RESILIENCE; POSTTRAUMATIC-STRESS-DISORDER; SPINAL-CORD-INJURY; SCALE CD-RISC; LIFE SATISFACTION; FUNCTIONAL OUTCOMES; SEVERITY SCORE; MENTAL-HEALTH; ADAPTATION; HAPPINESS	We examined trajectories of affective balance (AB) among 488 individuals admitted to a metropolitan Level 1 trauma center for serious physical injury. AB was measured prior to hospital discharge, and at three, six, and 12 months post-discharge. Multilevel modeling (MLM) was used to investigate whether initial demographic variables, injury severity, the occurrence of a mild traumatic brain injury (TBI), self-reported resilience and social support predicted AB trajectories. Participants' change in resilience and social support over the 12-month period were also tested as predictors. The results revealed a large amount of between-individual variation in the first year post-injury. Initial resilience, resilience change, initial social support, and social support change predicted AB 1 year later. Changes in resilience and social support predicted the linear growth in AB over time. Demographic and injury-related variables did not significantly predict AB, nor did the diagnosis of a mild TBI. Participants' self-perceived resilience and social support scores changed substantially, for better or worse, over the 12-month period. AB was strongly associated with these changes, even when controlling for initial resilience and social support: Increases in either resilience or social support were significantly associated with increases in AB over time. The final model accounted for 33.2% of the between-individual variance in final scores and 46.9% of the variance in linear growth. These results provide additional evidence of the beneficial effects of existing levels of resilience and social support following traumatic injury, and these characteristics are better predictors of AB than injury severity, basic demographic data, and the presence of a mild head injury. Furthermore, changes that may occur in social support and self-perceived resilience are associated with significant changes in AB, and these factors should be considered in post-discharge plans to facilitate subsequent adjustment.	[Laird, Vanessa; Elliott, Timothy R.; Brossart, Daniel F.; Luo, Wen; Hicks, Joshua A.; Warren, Ann Marie; Foreman, Michael] Texas A&M Univ, College Stn, TX 77843 USA		Laird, V (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	vanessaclaird@gmail.com	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714; Warren, Ann Marie/0000-0002-3753-5573			Aaland MO, 2012, J TRAUMA ACUTE CARE, V73, P1507, DOI 10.1097/TA.0b013e31826fc928; American College of Surgeons, 2014, RES OPT CAR INJ PAT; Anusic I, 2014, SOC INDIC RES, V119, P1265, DOI 10.1007/s11205-013-0541-2; Armenta C.N., 2015, INT ENCY SOCIAL BEHA, V23, P648; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bezner JR, 2001, ARCH PHYS MED REHAB, V82, P787, DOI 10.1053/apmr.2001.23269; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Bonanno GA, 2005, CURR DIR PSYCHOL SCI, V14, P135, DOI 10.1111/j.0963-7214.2005.00347.x; Braden CA, 2012, BRAIN INJURY, V26, P1315, DOI 10.3109/02699052.2012.706351; Bryant RA, 2015, BRIT J PSYCHIAT, V206, P417, DOI 10.1192/bjp.bp.114.145516; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burns RA, 2010, PERS INDIV DIFFER, V48, P527, DOI 10.1016/j.paid.2009.11.026; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Centers for Disease Control National Center for Injury Prevention and Control, 2010, TRAUM BRAIN INJ CONC; Centers for Disease Control National Center for Injury Prevention and Control, 2013, INJ PREV CONTR DAT S; Clarke G N, 2000, Ment Health Serv Res, V2, P155, DOI 10.1023/A:1010141826867; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cutrona C, 1986, PSYCHOL AGING, V1, P47, DOI 10.1037/0882-7974.1.1.47; CUTRONA CE, 1984, J ABNORM PSYCHOL, V93, P378, DOI 10.1037/0021-843X.93.4.378; CUTRONA CE, 1986, J PERS SOC PSYCHOL, V51, P201, DOI 10.1037/0022-3514.51.1.201; Cutrona EC., 1987, ADV PERSONAL RELATIO, V1, P37, DOI DOI 10.1037/0882-7974.1.1.47; Denissen JJA, 2008, J PERS, V76, P67, DOI 10.1111/j.1467-6494.2007.00480.x; Diener E, 2006, AM PSYCHOL, V61, P305, DOI 10.1037/0003-066X.61.4.305; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Diener E, 2017, CAN PSYCHOL, V58, P87, DOI 10.1037/cap0000063; Diener E, 2012, AM PSYCHOL, V67, P590, DOI 10.1037/a0029541; Dunn D, 2017, OXFORD HDB POSITIVE; Elliott TR, 2017, J CLIN PSYCHOL, V73, P1160, DOI 10.1002/jclp.22414; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; ELLIOTT TR, 2002, HDB POSITIVE PSYCHOL, P00687; Farkas D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120883; Fleishman JA, 2007, MED CARE, V45, P602, DOI 10.1097/MLR.0b013e31803bb4b0; Fredrickson BL, 2013, ADV EXP SOC PSYCHOL, V47, P1, DOI 10.1016/B978-0-12-407236-7.00001-2; Gramzow RH, 2004, EUR J PERSONALITY, V18, P367, DOI 10.1002/per.513; Halcomb Elizabeth, 2005, Aust Crit Care, V18, P17, DOI 10.1016/S1036-7314(05)80020-7; Hartley MT, 2012, J COLL COUNS, V15, P37, DOI 10.1002/j.2161-1882.2012.00004.x; Hernandez CL, 2014, REHABIL PSYCHOL, V59, P183, DOI 10.1037/a0035887; Hox J.J., 2010, QUANTITATIVE METHODO, V2; Kazis LE, 2006, J AMBUL CARE MANAG, V29, P310, DOI 10.1097/00004479-200610000-00007; Kelly CM, 2017, PSYCHIATRY, V80, P279, DOI 10.1080/00332747.2016.1271162; Kok B. E., 2014, INTERVENTIONS POLICI, VVI, P277; Kok BE, 2013, PSYCHOL SCI, V24, P1123, DOI 10.1177/0956797612470827; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lucas RE, 1996, J PERS SOC PSYCHOL, V71, P616, DOI 10.1037/0022-3514.71.3.616; Lucas RE, 2007, CURR DIR PSYCHOL SCI, V16, P75, DOI 10.1111/j.1467-8721.2007.00479.x; Luhmann M, 2012, J PERS SOC PSYCHOL, V102, P592, DOI 10.1037/a0025948; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Martz E, 2005, ARCH PHYS MED REHAB, V86, P1182, DOI 10.1016/j.apmr.2004.11.036; McCord CE, 2016, J HAPPINESS STUD, V17, P553, DOI 10.1007/s10902-014-9610-8; Ong AD, 2009, J PERS, V77, P1777, DOI 10.1111/j.1467-6494.2009.00600.x; Ormel J., 2017, PERSONALITY DEV LIFE, P117, DOI [DOI 10.1016/B978-0-12-804674-6.00009-0, 10.1016/B978-0-12-804674-6.00009-0]; Oswald AJ, 2008, J PUBLIC ECON, V92, P1061; Pretz CR, 2016, ARCH PHYS MED REHAB, V97, P1706, DOI 10.1016/j.apmr.2016.04.022; Quene H, 2004, SPEECH COMMUN, V43, P103, DOI 10.1016/j.specom 2004.02.004; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V1; Rohling M. L., 2017, HDB FORENSIC NEUROPS, P147, DOI [10.1037/0000032-007, DOI 10.1037/0000032-007]; Schwarz N., 1999, WELL BEING FDN HEDON, P302; SEMMLOW JL, 1976, HEALTH SERV RES, V11, P45; Silverman AM, 2015, ARCH PHYS MED REHAB, V96, P1262, DOI 10.1016/j.apmr.2015.02.023; Stone A. A., 2013, SUBJECTIVE WELLBEING; van Leeuwen CMC, 2012, DISABIL REHABIL, V34, P76, DOI 10.3109/09638288.2011.587089; Vandiver V, 1995, QUAL LIFE RES, V4, P498; Wallace D, 2002, MULT APPL BK SER, P103; Walsh MV, 2016, ARCH PHYS MED REHAB, V97, P781, DOI 10.1016/j.apmr.2016.01.016; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Ware J.E., 2002, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weiss R. S., 1974, DOING OTHERS, P17; Willett JB, 1998, DEV PSYCHOPATHOL, V10, P395, DOI 10.1017/S0954579498001667; Williamson MLC, 2016, J HEAD TRAUMA REHABI; Wiseman T, 2013, INJURY, V44, P1383, DOI 10.1016/j.injury.2012.02.015; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	75	2	2	2	9	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1389-4978	1573-7780		J HAPPINESS STUD	J. Happiness Stud.	JUN	2019	20	5					1419	1437		10.1007/s10902-018-0004-1			19	Psychology, Multidisciplinary; Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Psychology; Social Sciences - Other Topics	HZ1GN	WOS:000468595000006		Green Published			2022-02-06	
J	Lichtenstein, JD; Merz, ZC				Lichtenstein, Jonathan D.; Merz, Zachary C.			Post-Exertion Neuropsychological Testing in the Management of Sport-Related Concussion	PSYCHOLOGICAL INJURY & LAW			English	Article						Sport-related concussion; Concussion; Return to play; Neuropsychological testing; Post-exertion neurocognitive testing; Concussion management	HIGH-SCHOOL; SYMPTOMS; RELIABILITY; RECOVERY; PLAY	The objective of this study was to determine the effect of physical exertion on computerized neuropsychological test performance in high school athletes as part of concussion return-to-play protocols. ImPACT data and consultation records were retrospectively reviewed among athletes undergoing their physical stepwise progression for return-to-play following sport-related concussion. Two hundred forty athletes met inclusion criteria and participated in the study. 36.7% of concussed athletes who were symptom-free and had reached an advanced stage of their return-to-play protocol demonstrated cognitive decline following a moderate level of physical exertion. Cognitive changes occurred on all four cognitive ImPACT composites after physical exertion. There was no difference with respect to post-concussive symptoms among within RCI (W-RCI) and below RCI (B-RCI) groups. Return-to-play protocols should include post-exertion neuropsychological testing, as relying on athlete symptom report will miss a significant portion of athletes who are continuing to recover from sport-related concussion, putting them at additional risk for repeat or catastrophic injury.	[Lichtenstein, Jonathan D.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Psychiat, Pediat, Lebanon, NH 03756 USA; [Lichtenstein, Jonathan D.] Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dartmouth Inst, Lebanon, NH 03756 USA; [Merz, Zachary C.] Univ N Carolina, Dept Phys Med & Rehabil, Chapel Hill, NC 27515 USA		Lichtenstein, JD (corresponding author), Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dept Psychiat, Pediat, Lebanon, NH 03756 USA.; Lichtenstein, JD (corresponding author), Dartmouth Hitchcock Med Ctr, Geisel Sch Med Dartmouth, Dartmouth Inst, Lebanon, NH 03756 USA.	Jonathan.D.Lichtenstein@dartmouth.edu					Abeare C., 2018, J HEAD TRAUMA REHABI; Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Centers for Disease Control and Prevention, 2016, TBI DAT STAT EM DEP; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Fernandes J, 2017, NEUROSCI BIOBEHAV R, V80, P443, DOI 10.1016/j.neubiorev.2017.06.012; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Greco T, 2019, EXP NEUROL, V317, P206, DOI 10.1016/j.expneurol.2019.01.012; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; ImPACT Applications Inc., 2018, IMPACT ADM INT MAN; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Johnson EW, 2011, CLIN SPORT MED, V30, P73, DOI 10.1016/j.csm.2010.08.007; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Lichtenstein JD, 2018, APPL NEUROPSYCH-CHIL, V7, P334, DOI 10.1080/21622965.2017.1340158; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Luke S, 2018, HS FOOTBALL PLAYER D; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maerlender A, 2018, CONCUSSION COMPETENC; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGrath N, 2013, BRAIN INJURY, V27, P103, DOI 10.3109/02699052.2012.729282; McKnight PE, 2010, MANN WHITNEY U TEST; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Wallace J, 2018, J SPORT HEALTH SCI, V7, P204, DOI 10.1016/j.jshs.2016.11.002	39	2	2	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2019	12	2					146	154		10.1007/s12207-019-09350-0			9	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	IF6ZK	WOS:000473231100004					2022-02-06	
J	Oeur, RA; Gilchrist, MD; Hoshizaki, TB				Oeur, R. Anna; Gilchrist, Michael D.; Hoshizaki, Thomas Blaine			Interaction of external head impact parameters on region and volume of strain for collisions in sport	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Brain trauma; strain; head impact; collision; concussion; sport	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; DYNAMIC-RESPONSE; INTRACRANIAL-PRESSURE; PROFESSIONAL FOOTBALL; CONCUSSION; RECONSTRUCTION; BIOMECHANICS; MECHANICS; ENCEPHALOPATHY	Collisions with the head are the primary cause of concussion in contact sports. Head impacts can be further characterized by velocity, striking mass, compliance, and location (direction). The purpose of this study was to describe the interaction effects of these parameters on peak strain in four brain regions and the volume of strain for collision impacts. A pendulum test set-up was used to deliver impacts to an adult Hybrid III headform according to four levels of mass (3, 9, 15, and 21 kg), four velocities (1.5, 3.0, 4.5, and 6.0 m/s), two impact locations (through the centre of gravity and a non-centre of gravity), and three levels of compliance simulating unprotected, helmeted, and well-padded conditions in sport. Headform accelerations were input into a brain finite element model to obtain peak strain in the frontal, temporal, parietal, and occipital lobes and the volume of the brain experiencing 0.10, 0.15, 0.20, and 0.25 strains. Centre-of-gravity impacts created the highest strains (peak and volume) under low compliance and non-centre-of-gravity impacts produced greater strain responses under medium and high compliance conditions. The temporal lobe was the region that consistently displayed the highest peak strains, which may be due to the proximity of the impact locations to this region. Interactions between mass and velocity displayed effects where the 9-kg mass had higher peak and volumes of strain than the 15-kg mass at velocities of 3.0 and 4.5 m/s. This study demonstrates the important role of interacting impact parameters on increasing strain responses that are relevant to the spectrum of diffuse brain injuries, including concussion.	[Oeur, R. Anna; Hoshizaki, Thomas Blaine] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Oeur, R. Anna] Emory Univ, Sch Med, Whitehead Biomed Res Bldg,615 Michael St Suite 65, Atlanta, GA 30322 USA; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Oeur, RA (corresponding author), Emory Univ, Sch Med, Whitehead Biomed Res Bldg,615 Michael St Suite 65, Atlanta, GA 30322 USA.	anna.oeur@emory.edu			Natural Sciences and Engineering Research Council of Canada (NSERC) post-graduate research scholarship	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) post-graduate research scholarship.	ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BANDAK FA, 1995, J NEUROTRAUM, V12, P635, DOI 10.1089/neu.1995.12.635; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Chatelin S., 2013, J BIORHEOL, V27, P26; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Fife GP, 2013, BRIT J SPORT MED, V47, P1161, DOI 10.1136/bjsports-2012-090979; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gennarelli T., 2003, ANN P ASS ADV AUTOMO, V47, P624; Gennarelli T, 2015, P INT RES COUNC BIOM, pIX; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA., 1987, 872197 SAE; Gimbel GM, 2008, EUR J SPORT SCI, V8, P341, DOI 10.1080/17461390802438763; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; GURDJIAN E S, 1964, J Trauma, V4, P309; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1958, J NEUROSURG, V15, P125, DOI 10.3171/jns.1958.15.2.0125; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HODGSON VR, 1983, 27 STAPP CAR CRASH C; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Kang J, 2005, 2005011704 SAE; Karton CM, 2014, AM SOC TEST MATER, V1552, P23, DOI 10.1520/STP155220120175; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; KRUSKAL W, 1989, AM STAT, V43, P2, DOI 10.2307/2685157; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marieb E., 2007, HUMAN ANATOMY PHYSL; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Newman JA., 1998, KINEMATICS HEAD INJU; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Oeur RA, INT J CRASHWORTHINES, DOI [10.1080/13588265.2018.1441617, DOI 10.1080/13588265.2018.1441617.]; Oeur RA, 2017, FRONT TRAUM BRAIN IN; Oeur RA, 2016, EFFECT IMPACT COMPLI; OMMAYA A K, 1968, Journal of Biomechanics, V1, P127, DOI 10.1016/0021-9290(68)90015-8; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patrick L., 1963, 7 STAPP CAR CRASH C, P470; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Spyrou E, 2000, SPORTS ENG, V3, P25; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Thibault L.E., 1990, P INT C BIOM IMP LYO, P191; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Walsh ES, 2012, ASTM INT F08 S MECH; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Zhang L, 2011, IRCOBI IMP BIOM, V74, P315; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	77	2	2	4	12	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	JUN	2019	233	2					258	267		10.1177/1754337118819337			10	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	IA9LX	WOS:000469879800009					2022-02-06	
J	Pitskhelauri, D; Konovalov, A; Kudieva, E; Bykanov, A; Pronin, I; Eliseeva, N; Melnikova-Pitskhelauri, T; Melikyan, A; Sanikidze, A				Pitskhelauri, David; Konovalov, Alexander; Kudieva, Elina; Bykanov, Andrey; Pronin, Igor; Eliseeva, Natalya; Melnikova-Pitskhelauri, Tatiana; Melikyan, Armen; Sanikidze, Alexander			Burr Hole Microsurgery for Intracranial Tumors and Mesial Temporal Lobe Epilepsy: Results of 200 Consecutive Operations	WORLD NEUROSURGERY			English	Article						Burr hole; Epilepsy; Hippocampal sclerosis; Mari device; Microsurgery; Tumor	SUPRAORBITAL KEYHOLE APPROACH; SELECTIVE AMYGDALOHIPPOCAMPECTOMY; SURGERY; CRANIOTOMY; RESECTION; LESIONS; REMOVAL	OBJECTIVE: Recently, in modern neurosurgery, a tendency toward low-traumatic surgical approaches has become clear. To provide a minimal degree of injury to the brain tissue, we have offered microsurgical approaches through a burr hole. METHODS: From February 2016 to November 2017, 200 microsurgical interventions through a single burr hole with a diameter of 14 mm were performed. The age of the patients varied from 16 to 79 years. The female/male ratio was 1.6:1. In 176 cases, the procedure was performed on an intracranial mass lesion in various locations. In the remaining 24 cases, selective amygdalohippocampectomy was performed in patients with hippocampal sclerosis. RESULTS: Various surgical approaches were used, including transcortical in 81 (40.5%), retrosigmoid in 38 (19%), subtemporal in 32 (16%), infratentorial supracerebellar in 25 (12.5%), interhemispheric in 17 (8.5%), telovelar in 5 (2.5%), and eyebrow in 2. The extent of lesion removal was evaluated in 167 patients for whom maximal tumor resection had been planned before surgery. Gross total and near total removal was achieved in 145 patients (87%), subtotal in 15 patients (9%), and partial in 7 patients (4%). The operative time ranged from 35 to 300 minutes (median, 80). The interval to extubation postoperatively varied from 5 minutes to 5 days (median, 70 minutes). Of the 200 patients, 195 (97.5%) were mobilized during the first 3 postoperative days. CONCLUSIONS: Burr hole microsurgery provides the ability to perform successful surgery on patients with the most diverse intracranial pathological features through a smaller opening than that used for keyhole surgery.	[Pitskhelauri, David; Konovalov, Alexander; Kudieva, Elina; Bykanov, Andrey; Melikyan, Armen; Sanikidze, Alexander] Burdenko Neurosurg Ctr, Dept Neurooncol, Moscow, Russia; [Pronin, Igor; Melnikova-Pitskhelauri, Tatiana] Burdenko Neurosurg Ctr, Dept Neuroradiol, Moscow, Russia; [Eliseeva, Natalya] Burdenko Neurosurg Ctr, Dept Neuroophthalmol, Moscow, Russia		Pitskhelauri, D (corresponding author), Burdenko Neurosurg Ctr, Dept Neurooncol, Moscow, Russia.	davidpneuro@gmail.com	Pitzkhelauri, David/AAO-6736-2020; Konovalov, Alexander/ABG-6541-2021; Bykanov, Andrey/R-1370-2017; Pronin, Igor/AAO-6511-2020				Almenawer SA, 2013, NEUROSURG REV, V36, P321, DOI 10.1007/s10143-012-0442-x; Vanegas MAA, 2017, EPILEPSIA, V58, P10, DOI 10.1111/epi.13684; Baker CM, 2017, WORLD NEUROSURG, V106, P359, DOI [10.1016/j.wneu.2017.06.118, 10.1016/J.WNEU.2017.06.118]; Barbara S, 2017, EPILEPSY BEHAV, V76, P39, DOI 10.1016/j.yebeh.2017.08.037; Bonney PA, 2015, J CLIN NEUROSCI, V22, P1105, DOI 10.1016/j.jocn.2014.12.029; BROCK M, 1978, NEUROCHIRURGIA, V21, P185; Burks JD, 2018, NEUROSURGERY, V82, P388, DOI 10.1093/neuros/nyx213; Burks JD, 2016, CUREUS, V8, DOI 10.7759/cureus.588; Cai Q, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005823; Charalampaki P, 2008, NEUROSURGERY, V62, P1049, DOI [10.1227/01.NEU.0000176638.86772.2D, 10.1227/01.neu.0000333770.58693.ed]; Chen I, 2013, IEEE T BIO-MED ENG, V60, P3494, DOI 10.1109/TBME.2013.2272658; Conner AK, 2018, J NEUROSURG, V128, P1388, DOI 10.3171/2016.12.JNS162168; Delev D, 2016, ACTA NEUROCHIR, V158, P1757, DOI 10.1007/s00701-016-2860-y; Duckworth EA, 2008, NEUROSURGERY S1, V63; Duckworth EA, 2008, NEUROSURGERY S1, V63; Duckworth EAM, 2008, NEUROSURGERY, V63, P156; Eivazi S, 2015, ACTA NEUROCHIR, V157, P1147, DOI 10.1007/s00701-015-2433-5; Fatemi N, 2009, NEUROSURGERY, V64, P269, DOI 10.1227/01.NEU.0000327857.22221.53; Figueiredo EG, 2007, NEUROSURGERY, V61, P256, DOI 10.1227/01.neu.0000303978.11752.45; Fischer G, 2011, NEUROSURGERY, V68, DOI 10.1227/NEU.0b013e31820934ca; Hernesniemi J, 2005, ACT NEUR S, V94, P17; Hoshide R, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2017.11.FOCUS17607; Kalani MYS, 2016, WORLD NEUROSURG, V94, P442, DOI 10.1016/j.wneu.2016.07.024; Kotwica Z, 2017, TRANSL NEUROSCI, V8, P207, DOI 10.1515/tnsci-2017-0028; Li P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28654; Li Z, 2010, EUR SURG RES, V44, P56, DOI 10.1159/000264636; Little AS, 2009, J NEUROSURG, V111, P1263, DOI 10.3171/2008.10.17673; Makarenko S, 2017, J NEUROSURG, V126, P1191, DOI 10.3171/2016.3.JNS152307; Manji H, 2000, J NEUROL NEUROSUR PS, V68, P80, DOI 10.1136/jnnp.68.1.80; Mathon B, 2016, ACTA NEUROCHIR, V158, P785, DOI 10.1007/s00701-016-2717-4; Mori K, 2019, J NEUROSURG, V130, P1359, DOI 10.3171/2017.10.JNS171973; Mostafa BE, 2008, SKULL BASE-INTERD AP, V18, P371, DOI 10.1055/s-0028-1087220; Nathal Edgar, 2005, Neurosurgery, V56, P178; Paladino J, 2005, MINIM INVAS NEUROSUR, V48, P251, DOI 10.1055/s-2005-915599; Peng YP, 2016, WORLD NEUROSURG, V92, P120, DOI 10.1016/j.wneu.2016.04.121; Perneczky A, 2008, KEYHOLE APPROACHES N; Pitskhelauri D I, 2017, Zh Vopr Neirokhir Im N N Burdenko, V81, P89, DOI 10.17116/neiro201781689-98; Pitskhelauri DI, 2014, J NEUROSURG, V121, P161, DOI 10.3171/2014.3.JNS12578; Ray A, 2002, BRIT J NEUROSURG, V16, P456, DOI 10.1080/0268869021000030258; Reisch R, 2003, SURG NEUROL, V59, P223, DOI 10.1016/S0090-3019(02)01037-6; Reisch R, 2009, MINIM INVAS NEUROSUR, V52, P163, DOI 10.1055/s-0029-1238285; Reisch R, 2013, WORLD NEUROSURG, V79, DOI 10.1016/j.wneu.2012.02.024; Renovanz M, 2015, CHILD NERV SYST, V31, P665, DOI 10.1007/s00381-015-2620-y; Roberts William C, 2009, Proc (Bayl Univ Med Cent), V22, P178; Shahinian HK, 2011, MINIM INVAS NEUROSUR, V54, P61, DOI 10.1055/s-0031-1275335; Singh H, 2017, J NEUROSURG, V126, P940, DOI 10.3171/2016.3.JNS1634; Sughrue ME, 2016, TURK NEUROSURG, V26, P475, DOI 10.5137/1019-5149.JTN.14534-15.0; WILSON DH, 1971, J NEUROSURG, V34, P102, DOI 10.3171/jns.1971.34.1.0102; Yang PF, 2016, NEUROSURG REV, V39, P99, DOI 10.1007/s10143-015-0657-8	49	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2019	126						E1257	E1267		10.1016/j.wneu.2019.02.239			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IA0BU	WOS:000469222400159	30902775				2022-02-06	
J	Retzer, A; Turner, GM; Slade, A; Kyte, D; McMullan, C; Jones, L; Belli, A; Calvert, M				Retzer, Ameeta; Turner, Grace M.; Slade, Anita; Kyte, Derek; McMullan, Christel; Jones, Laura; Belli, Antonio; Calvert, Melanie			Electronic patient reported outcomes to support care of patients with traumatic brain injury: PRiORiTy study qualitative protocol	BMJ OPEN			English	Article							OF-LIFE; RECOMMENDATIONS; TBI; PERSPECTIVES; CAREGIVERS; EXPERIENCE; MODERATE	Introduction Traumatic brain injury (TBI) represents a major health and socioeconomic problem internationally. The expansive nature of injuries results in a heterogeneous population. The degree and type of long-term impacts following TBI and improvement following injury are highly variable. The use of electronic Patient Reported Outcomes Measures (ePROMs) could help identify residual impacts of TBI and support patient management and care. The Patient Reported Outcomes Research in Trauma study is a qualitative study exploring the long-term symptoms and impacts that are experienced by those with TBI and the potential utility of an ePROM platform to collect real-time information on patient symptoms and quality of life to inform treatment and identify support needs. Methods and analysis Semi-structured telephone and face-to-face interviews will be conducted with approximately 30-40 individuals recruited from five groups: (1) people with TBI; (2) carers and relatives of individuals with TBI; (3) TBI healthcare professionals; (4) researchers and (5) third sector staff members and volunteers working with those with TBI. Data will be analysed using directed thematic analysis employing an iterative coding frame that will be modified as analysis progresses. Intercoder triangulation will be employed to enhance credibility. Ethics and dissemination This study was approved by the West Midlands-Black Country Research Ethics Committee (Ref: 18/WM/0033). Findings will be disseminated via conference presentations, peer-reviewed journals, social media (@CPROR_UoB; http://www.birmingham.ac.uk/cpror) and the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre.	[Retzer, Ameeta; Turner, Grace M.; Slade, Anita; Kyte, Derek; McMullan, Christel; Jones, Laura; Calvert, Melanie] Univ Birmingham, Inst Appl Hlth Res, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England; [Retzer, Ameeta; Turner, Grace M.; Slade, Anita; McMullan, Christel; Belli, Antonio; Calvert, Melanie] Queen Elizabeth Hosp Birmingham, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Slade, Anita; Kyte, Derek; Calvert, Melanie] Univ Hosp Birmingham NHS Fdn Trust, NIHR Birmingham Biomed Res Ctr, Birmingham, W Midlands, England; [Slade, Anita; Kyte, Derek; Calvert, Melanie] Univ Birmingham, Birmingham, W Midlands, England		Turner, GM (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England.; Turner, GM (corresponding author), Queen Elizabeth Hosp Birmingham, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England.	g.turner.1@bham.ac.uk	Turner, Grace/H-3929-2019; Calvert, Melanie/F-7055-2011; Belli, Antonio/I-3799-2015; McMullan, Christel/F-4948-2017; Jones, Laura/AAY-6159-2020; Slade, Anita/M-3246-2017	Turner, Grace/0000-0002-9783-9413; Calvert, Melanie/0000-0002-1856-837X; Belli, Antonio/0000-0002-3211-9933; McMullan, Christel/0000-0002-0878-1513; Jones, Laura/0000-0002-4018-3855; Slade, Anita/0000-0003-2827-7741; kyte, Derek/0000-0002-7679-6741	National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust; NIHR Surgical Reconstruction and Microbiology Research Centre at the University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; Macmillan Cancer Support [5592105, ERN-17-0085]; NIHR PDF programme [PDF-2016-09-009]; NIHR Birmingham Biomedical Research Centre; NIHR Surgical Reconstruction and Microbiology Research Centre; NIHR PDR programme [PDF-2017-10-047]; NIHR SRMRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	This research was funded by the National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC). MC, DK and AS are partly funded by the NIHR Birmingham Biomedical Research Centre and the NIHR Surgical Reconstruction and Microbiology Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. AR is employed on another project funded by Macmillan Cancer Support (grant: 5592105). DK is funded by the NIHR PDF programme (PDF-2016-09-009); Macmillan Cancer Support (grant: 5592105); NIHR Birmingham Biomedical Research Centre and the NIHR Surgical Reconstruction and Microbiology Research Centre. GMT is funded by the NIHR PDR programme (PDF-2017-10-047) and the NIHR SRMRC. AS is working on another project funded my Macmillan Cancer Support (grant ERN-17-0085). MC has received personal fees from Ferring and chairs the ISOQOL Best Practice for PROs in Trials Taskforce.	Ash JS, 2015, STUD HEALTH TECHNOL, V208, P55, DOI 10.3233/978-1-61499-488-6-55; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Basch E, 2016, J CLIN ONCOL, V34, P557, DOI 10.1200/JCO.2015.63.0830; Basch E, 2009, JNCI-J NATL CANCER I, V101, P1624, DOI 10.1093/jnci/djp386; Black N, 2013, BMJ-BRIT MED J, V346, pf167, DOI [DOI 10.1136/BMJ.F167, 10.1136/bmj.f167]; Calvert M, 2015, J ROY SOC MED, V108, P299, DOI 10.1177/0141076815579896; Calvert MJ, 2003, J CLIN PHARM THER, V28, P513, DOI 10.1046/j.0269-4727.2003.00521.x; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Chen J, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-211; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Fadyl JK, 2017, NEUROPSYCHOL REHABIL, P1; Fereday J., 2006, INT J QUAL METHODS, V5, P80, DOI [10.1177/160940690600500107, DOI 10.1177/160940690600500107]; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gould KR, 2017, NEUROPSYCHOL REHABIL, V30, P533; Graff HJ, 2018, DISABIL REHABIL, V40, P926, DOI 10.1080/09638288.2017.1280542; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Iaccarino MA, 2018, J ATTEN DISORD; ICF Research Branch, DEV ICF COR SETS TRA; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; King PR, 2018, REHABIL PSYCHOL, V63, P121, DOI 10.1037/rep0000165; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCulloch KL, 2016, J NEUROL PHYS THER, V40, P269, DOI 10.1097/NPT.0000000000000145; *MED DIS SOC, 1988, MAN TRAUM BRAIN INJ; Meulenbroek P, 2016, J VOCAT REHABIL, V44, P15, DOI 10.3233/JVR-150777; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Muehlhausen W, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0362-x; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Recinos PF, 2017, ADV THER, V34, P452, DOI 10.1007/s12325-016-0463-x; Rivera SC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002370; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; The National Institute for Health and Care Excellence, 2014, QS74 NAT I HLTH CAR; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	39	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2019	9	1							e024617	10.1136/bmjopen-2018-024617			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IC6XU	WOS:000471116800190	30782736	Green Published, gold			2022-02-06	
J	Ruel-Laliberte, J; Bonaventure, PL; Fergusson, D; Lacroix, J; Zarychanski, R; Lauzier, F; Tinmouth, A; Hebert, PC; Green, R; Griesdale, D; Fowler, R; Kramer, A; McIntyre, LA; Zygun, D; Walsh, T; Stanworth, S; Capellier, G; Pili-floury, S; Samain, E; Clayton, L; Marshall, J; Pagliarello, G; Sabri, E; Neveu, X; Leger, C; Turgeon, AF				Ruel-Laliberte, Jessica; Bonaventure, Paule Lessard; Fergusson, Dean; Lacroix, Jacques; Zarychanski, Ryan; Lauzier, Francois; Tinmouth, Alan; Hebert, Paul C.; Green, Robert; Griesdale, Donald; Fowler, Robert; Kramer, Andreas; McIntyre, Lauralyn A.; Zygun, David; Walsh, Tim; Stanworth, Simon; Capellier, Gilles; Pili-floury, Sebastien; Samain, Emmanuel; Clayton, Lucy; Marshall, John; Pagliarello, Giuseppe; Sabri, Elham; Neveu, Xavier; Leger, Caroline; Turgeon, Alexis F.		Canadian Critical Care Trials Grp	Effect of age of transfused red blood cells on neurologic outcome following traumatic brain injury (ABLE-tbi Study): a nested study of the Age of Blood Evaluation (ABLE) trial	CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							STORED-BLOOD; STORAGE; OXYGENATION; MORTALITY	BackgroundAnemia is common in critically ill patients with traumatic brain injury, and often requires red blood cell transfusion. Studies suggest that prolonged storage causes lesions of the red blood cells, including a decreased ability to carry oxygen. Considering the susceptibility of the brain to hypoxemia, victims of traumatic brain injury may thus be more vulnerable to exposure to older red blood cells.MethodsOur study aimed to ascertain whether the administration of fresh red blood cells (seven days or less) results in a better neurologic outcome compared with standard red blood cells in critically ill patients with traumatic brain injury requiring transfusion. The Age of Blood Evaluation in traumatic brain injury (ABLE-tbi) study was a nested study within the ABLE study (ISRCTN44878718). Our primary outcome was the extended Glasgow Outcome Scale (GOSe) at six months.ResultsIn the ABLE study, 217 subjects suffered a traumatic brain injury: 110 in the fresh group, and 107 in the standard group. In the fresh group, 68 (73.1%) of the patients had an unfavourable neurologic outcome (GOSe 4) compared with 60 (64.5%) in the standard group (P = 0.21). Using a sliding dichotomy approach, we observed no overall effect of fresh red blood cells on neurologic outcome (odds ratio [OR], 1.34; 95% confidence interval [CI], 0.72 to 2.50; P = 0.35) but observed differences across prognostic bands with a decreased odds of unfavourable outcome in patients with the best prognosis at baseline (OR, 0.33; 95% CI, 0.11 to 0.96; P = 0.04) but an increased odds in those with intermediate and worst baseline prognosis (OR, 5.88; 95% CI,1.66 to 20.81; P = 0.006; and OR, 1.67; 95% CI, 0.53 to 5.30; P = 0.38, respectively).ConclusionOverall, transfusion of fresh red blood cells was not associated with a better neurologic outcome at six months in critically ill patients with traumatic brain injury. Nevertheless, we cannot exclude a differential effect according to the patient baseline prognosis.Trial registrationABLE study (ISRCTN44878718); registered 22 August, 2008.	[Ruel-Laliberte, Jessica; Bonaventure, Paule Lessard; Lauzier, Francois; Neveu, Xavier; Leger, Caroline; Turgeon, Alexis F.] Univ Laval, Res Ctr, CHU Quebec,Trauma Emergency Crit Care Med, Populat Hlth & Optimal Hlth Practices Res Unit, Quebec City, PQ, Canada; [Fergusson, Dean; Tinmouth, Alan; Sabri, Elham] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Lacroix, Jacques; Clayton, Lucy] Univ Montreal, CHU Ste Justine, CHU Ste Justine Res Ctr, Montreal, PQ, Canada; [Zarychanski, Ryan] Univ Manitoba, Fac Med, Dept Internal Med, Sect Crit Care Med, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Fac Med, Dept Internal Med, Sect Haematol, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Fac Med, Dept Internal Med, Sect Med Oncol, Winnipeg, MB, Canada; [Lauzier, Francois; Turgeon, Alexis F.] Univ Laval, Fac Med, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada; [Lauzier, Francois] Univ Laval, Fac Med, Dept Med, Quebec City, PQ, Canada; [Hebert, Paul C.; Marshall, John] Univ Montreal, Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ, Canada; [Green, Robert] Dalhousie Univ, Dept Emergency Med, Div Crit Care Med, Halifax, NS, Canada; [Griesdale, Donald] Univ British Columbia, Dept Anesthesiol, Div Crit Care Med, Vancouver, BC, Canada; [Fowler, Robert] Univ Toronto, Sunnybrook Hlth Serv Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Kramer, Andreas] Univ Calgary, Foothills Hlth Sci Ctr, Dept Crit Care Med, Calgary, AB, Canada; [McIntyre, Lauralyn A.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [McIntyre, Lauralyn A.; Pagliarello, Giuseppe] Ottawa Hosp, Dept Crit Care Med, Ottawa, ON, Canada; [Zygun, David] Univ Alberta, Dept Crit Care Med, Edmonton, AB, Canada; [Walsh, Tim] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Stanworth, Simon] Univ Oxford, Dept Hematol, Oxford, England; [Capellier, Gilles; Pili-floury, Sebastien; Samain, Emmanuel] Univ Besancon, Dept Anesthesiol & Crit Care Med, Besancon, France; [Turgeon, Alexis F.] Univ Laval, CHU Quebec, Ctr Rech,Hop Enfant Jesus,Trauma Emergency Crit C, Populat Hlth & Optimal Hlth Practices Res Unit, 1401,18e Rue,Room Z-204, Quebec City, PQ, Canada		Turgeon, AF (corresponding author), Univ Laval, Res Ctr, CHU Quebec,Trauma Emergency Crit Care Med, Populat Hlth & Optimal Hlth Practices Res Unit, Quebec City, PQ, Canada.; Turgeon, AF (corresponding author), Univ Laval, Fac Med, Dept Anesthesiol & Crit Care Med, Div Crit Care Med, Quebec City, PQ, Canada.; Turgeon, AF (corresponding author), Univ Laval, CHU Quebec, Ctr Rech,Hop Enfant Jesus,Trauma Emergency Crit C, Populat Hlth & Optimal Hlth Practices Res Unit, 1401,18e Rue,Room Z-204, Quebec City, PQ, Canada.	alexis.turgeon@fmed.ulaval.ca	McIntyre, Lauralyn/AAR-7710-2021; Zarychanski, Ryan/AAB-6369-2022; Lauzier, Francois/B-9237-2015	McIntyre, Lauralyn/0000-0001-7421-1407; Lauzier, Francois/0000-0002-6530-5513	Fonds de Recherche du Quebec - Sante (FRQS)Fonds de la Recherche en Sante du Quebec; Traumatology Research Consortium of the FRQS; New Investigator Award from the Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	Dr. Turgeon is the chairholder of the Canada Research Chair in Critical Neurology and Trauma. Drs. Lauzier and Moore are recipients of a research career award from the Fonds de Recherche du Quebec - Sante (FRQS). Dr. Hebert holds the Hema-Quebec - Bayer Endowed Chair in Transfusion Medicine from Universite de Montreal. Drs. Turgeon, Lauzier, and Moore are supported by the Traumatology Research Consortium of the FRQS. Dr. Zarychanski and Turgeon were recipients of a New Investigator Award from the Canadian Institutes of Health Research (CIHR) when this work was conducted.	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Aubron C, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-2; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Boutin A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014472; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Clarke G, 2017, GUIDE PRATIQUE TRANS; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; D'Alessandro A, 2010, BLOOD TRANSFUS-ITALY, V8, P82, DOI 10.2450/2009.0122-09; Fergusson DA, 2012, JAMA-J AM MED ASSOC, V308, P1443, DOI 10.1001/2012.jama.11953; Heddle NM, 2016, NEW ENGL J MED, V375, P1937, DOI 10.1056/NEJMoa1609014; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lacroix J, 2015, NEW ENGL J MED, V372, P1410, DOI 10.1056/NEJMoa1500704; Lacroix J, 2011, TRANSFUS MED REV, V25, P197, DOI 10.1016/j.tmrv.2011.03.001; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Stapley R, 2012, BIOCHEM J, V446, P499, DOI 10.1042/BJ20120675; Steiner ME, 2015, NEW ENGL J MED, V372, P1419, DOI 10.1056/NEJMoa1414219; Tinmouth A, 2006, TRANSFUSION, V46, P2014, DOI 10.1111/j.1537-2995.2006.01026.x; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x; Yamal JM, 2015, J TRAUMA ACUTE CARE, V79, P843, DOI 10.1097/TA.0000000000000834	23	2	2	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0832-610X	1496-8975		CAN J ANESTH	Can. J. Anesth.	JUN	2019	66	6					696	705		10.1007/s12630-019-01326-7			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	HX5ID	WOS:000467433500009	30809776	Bronze			2022-02-06	
J	Strickland, J; Bevill, G				Strickland, John; Bevill, Grant			Experimental Evaluation of Softball Protective Headgear for Defensive Play	JOURNAL OF APPLIED BIOMECHANICS			English	Article						Hybrid III; concussion; mild traumatic brain injury; fielder's mask; impact attenuation	TRAUMATIC BRAIN-INJURY; IMPACT; BASEBALL; ACCELERATIONS; FOOTBALL; HELMETS; ABILITY	The majority of head injuries sustained during softball play are due to defensive fielders being struck by a ball. The main objective of this study was to test the impact attenuation and facial protection capabilities of fielder's masks from softball impacts. Testing with an instrumented Hybrid III headform was conducted at 2 speeds and 4 impact locations for several protective conditions: 6 fielder's masks, 1 catcher's mask, and unprotected (no mask). The results showed that most fielder's masks reduced head accelerations, but not to the standard of catcher's masks. On average, they reduced peak linear and angular acceleration from 40 mph impacts by 36% to 49% and 14% to 45%, respectively, whereas for 60 mph impacts, they were reduced by 25% to 42% and 13% to 46%, respectively. Plastic-type fielder's masks were observed to allow facial contact when struck at the nose region at high speed. A few fielder's masks performed appreciably different at certain impact locations suggesting influence from specific design features such as foam padding and frame properties. Overall, the results suggest that head/facial injuries may be mitigated through the broader use of masks, while further optimization of impact attenuation for fielder's masks is pursued.	[Strickland, John; Bevill, Grant] Univ North Florida, Dept Engn, Jacksonville, FL 32224 USA		Bevill, G (corresponding author), Univ North Florida, Dept Engn, Jacksonville, FL 32224 USA.	grant.bevill@unf.edu					Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Clark JM, 2016, AM J SPORT MED, V44, P1047, DOI 10.1177/0363546515623272; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Gadd C. W., 1966, P 10 STAPP CAR CRASH; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Jelsema T, 2015, J EXERCISE SPORTS OR, V2, P1; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McIntosh AS, 2003, BRIT J SPORT MED, V37, P325, DOI 10.1136/bjsm.37.4.325; National Aeronautics and Space Administration, STD3000 NASA; National Fastpitch Coaches Association, 2011, TOP RECRUIT NFCA CAM, V6, P12; National Operating Committee on Standards for Athletic Equipment, 2017, ND02411M17 NAT OP CO; National Operating Committee on Standards for Athletic Equipment, 2015, ND02912M15A NAT OP C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2016, COMPUT METHOD BIOMEC, V19, P366, DOI 10.1080/10255842.2015.1029921; Robinson MB, 2011, PROCEDIA ENGINEER, V13, P415, DOI 10.1016/j.proeng.2011.05.107; Rodowicz KA, 2015, ANN BIOMED ENG, V43, P949, DOI 10.1007/s10439-014-1154-x; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Schmitt K.-U., 2007, TRAUMA BIOMECHANICS; Schwizer P, 2016, PROCEDIA ENGINEER, V147, P228, DOI 10.1016/j.proeng.2016.06.218; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Spaniol FJ, 2009, STRENGTH COND J, V31, P26, DOI 10.1519/SSC.0b013e31819d3af8; Strickland JS, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119825660; Versace J, 1971, SAE TECHNICAL PAPER; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	26	2	2	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	JUN	2019	35	3					202	208		10.1123/jab.2018-0262			7	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	IA1US	WOS:000469348600005	30860426				2022-02-06	
J	Todd, RA; Soklaridis, S; Treen, AK; Bhalerao, SU; Cusimano, MD				Todd, Ryan A.; Soklaridis, Sophie; Treen, Alice K.; Bhalerao, Shree U.; Cusimano, Michael D.			Understanding the resistance to creating safer ice hockey: essential points for injury prevention	INJURY PREVENTION			English	Article							TRAUMATIC BRAIN-INJURY; BODY-CHECKING; RISK-FACTORS; CONCUSSION; CHILDREN; DEPRESSION; VIOLENCE; ANXIETY; EPIDEMIOLOGY; BODYCHECKING	Introduction Despite the known negative health outcomes of concussions in minor level boys' hockey, there has been significant resistance to creating a safer game with less body checking. Methods To better understand cultural barriers that prevent making the sport safer for youth and adolescents, semistructured interviews, with 20 ice hockey stakeholders, were conducted and analysed using thematic analysis. Results Through this analysis, two primary concepts arose from respondents. The first concept is that body checking, despite the harm it can cause, should be done in a respectful sportsmanlike fashion. The second concept is the contradiction that the game of ice hockey is both dynamic and unchangeable. Discussion Using structural functionalist theory, we propose an argument that the unfortunate perpetuation of violence and body checking in youth ice hockey serves to maintain the social order of the game and its culture. Any strategies aimed at modifying and promoting healthy behaviour in the game should take these concepts into account.	[Todd, Ryan A.] Univ Calgary, Dept Psychiat, Calgary, AB T2N 2T9, Canada; [Soklaridis, Sophie] Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON, Canada; [Treen, Alice K.; Cusimano, Michael D.] St Michaels Hosp, Dept Injury Prevent Res, Toronto, ON, Canada; [Bhalerao, Shree U.] St Michaels Hosp, Dept Psychiat, Toronto, ON, Canada; [Cusimano, Michael D.] St Michaels Hosp, Dept Surg, Toronto, ON, Canada		Todd, RA (corresponding author), Univ Calgary, Dept Psychiat, Calgary, AB T2N 2T9, Canada.	ratodd@hotmail.ca	Soklaridis, Sophie/ABG-2223-2020	Soklaridis, Sophie/0000-0001-5119-8473	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; Physician Services Incorporated Foundation	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research (#TIR-103946), the Ontario Neurotrauma Foundation, as well as the Physician Services Incorporated Foundation. The opinions contained herein are solely those of the authors and not necessarily of the funding organisations.	Adams S, 2015, SOCIOL SPORT J, V32, P248, DOI 10.1123/ssj.2014-0092; Allain KA, 2008, SOCIOL SPORT J, V25, P462, DOI 10.1123/ssj.25.4.462; [Anonymous], 2013, HOCK CAN VOT BAN BOD; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Branch J., 2015, NY TIMES; Braun V, 2006, QUAL RES PSYCHOL; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; COAKLEY J, 2002, HDB SPORTS STUDIES; CRAIB I, 1984, MODERN SOCIAL THEORY; Crotty M., 1998, FDN SOCIAL RES MEANI; Cusimano MD, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.015, 10.1371/journal.pone.0156683]; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Cusimano Michael D, 2011, Open Med, V5, pe57; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hockey Canada, 2011, HOCK CAN NEW HEAD CO; Hockey Canada, 2004, NO RED LIN 2004 05; Hockey Canada, CHECK RES GUID TEACH; Izraelski Jason, 2014, J Can Chiropr Assoc, V58, P346; JONES JCH, 1993, AM J ECON SOCIOL, V52, P63, DOI 10.1111/j.1536-7150.1993.tb02742.x; Jones JCH, 1996, AM J ECON SOCIOL, V55, P231, DOI 10.1111/j.1536-7150.1996.tb03203.x; Keays G, 2013, CHRON DIS INJ CAN, V33, P55; Kingsbury N., 2009, STRUCTURAL FUNCTIONA; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kyriacou O, 2009, J HEALTH PSYCHOL, V14, P843, DOI 10.1177/1359105309340977; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lepage C, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0196-6; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Parsons T., 1966, EVOLUTIONARY COMP PE; Pauelsen M, 2017, CLIN J SPORT MED, V27, P283, DOI 10.1097/JSM.0000000000000347; Perry R., 2013, COACHS CORNER COMMEN; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Roberts WO, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.11.1102; Robidoux M, 2002, J AM FOLKLORE, V115, P209, DOI 10.1353/jaf.2002.0021; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SIM FH, 1987, AM J SPORT MED, V15, P30, DOI 10.1177/036354658701500105; SMITH MD, 1979, CAN J SOCIOL, V4, P105, DOI 10.2307/3339824; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Turan JM, 2008, AIDS CARE, V20, P938, DOI 10.1080/09540120701767224; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Mars D., 2011, COMPLETE GUIDE SPORT; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166	67	2	2	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	JUN	2019	25	3					211	216		10.1136/injuryprev-2016-042272			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	IC6OO	WOS:000471091600013	29180519				2022-02-06	
J	Tripathy, S; Ahmad, SR				Tripathy, Swagata; Ahmad, Suma Rabab			Raised Intracranial Pressure Syndrome: A Stepwise Approach	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Complications; Cerebrospinal fluid; Hypertonic saline; Intracranial pressure; Management; Steroids	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY INFARCTION; DECOMPRESSIVE CRANIECTOMY; SEDATION; HEMICRANIECTOMY; MULTICENTER; TRIAL; RESUSCITATION; HYPERTENSION; ANESTHESIA	Raised intracranial pressure (rICP) syndrome is seen in various pathologies. Appropriate and systematic management is important for favourable patient outcome. This review describes the stepwise approach to control the raised ICP in a tiered manner, with increasing aggressiveness. The role of ICP measurement in the assessment of cerebral autoregulation and individualised management is discussed. Although a large amount of research has been undertaken for the management of raised ICP, there still remain unanswered questions. This review tries to put together the best evidence in a succinct manner.	[Tripathy, Swagata; Ahmad, Suma Rabab] All India Inst Med Sci, Dept Anesthesia & Intens Care, Bhubaneswar, Odisha, India		Tripathy, S (corresponding author), All India Inst Med Sci, Dept Anesthesia & Intens Care, Bhubaneswar, Odisha, India.	tripathyswagata@gmail.com					Alexander P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-014390; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Aryan HE, 2006, BRAIN INJURY, V20, P791, DOI 10.1080/02699050600789447; Chang LC, 2013, CNS NEUROSCI THER, V19, P390, DOI 10.1111/cns.12077; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Frank JI, 2014, STROKE, V45, P781, DOI 10.1161/STROKEAHA.113.003200; Godoy DA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00250; Gu J., 2018, NEUROSURG REV; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hays AN, 2011, NEUROCRIT CARE, V14, P222, DOI 10.1007/s12028-010-9477-4; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; Joseph M, 2005, INDIAN J CRIT CARE M, V9, P35, DOI 10.4103/0972-5229.16268; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; MAYBERG TS, 1995, ANESTH ANALG, V81, P84, DOI 10.1097/00000539-199507000-00017; Monro A., 1783, OBSERVATIONS STRUCTU; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nair SS, 2017, INT SURG J, V4, P656; O'Reilly C, GUIDELINES MANAGEMEN; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Purrucker JC, 2015, BRIT J ANAESTH, V114, P934, DOI 10.1093/bja/aev070; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Rivera-Lara L, 2017, ANESTHESIOLOGY, V126, P1187, DOI 10.1097/ALN.0000000000001625; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Robin M, 2017, J NEUROANAESTHESIOL, V4, P167; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Shrestha G, 2017, BANGLADESH CRIT CARE, V5, P53; Singhi SC, 2009, INDIAN J PEDIATR, V76, P519, DOI 10.1007/s12098-009-0137-7; Skoglund K, 2012, CRIT CARE MED, V40, P216, DOI 10.1097/CCM.0b013e31822d7dbd; SMITH J, 2006, TXB SURG, P44; Stevens RD, 2015, NEUROCRIT CARE, V23, pS76, DOI 10.1007/s12028-015-0168-z; Tripathy S, 2015, INDIAN J ANAESTH, V59, P9, DOI 10.4103/0019-5049.149442; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Villa F, 2012, CRIT CARE MED, V40, P2797, DOI 10.1097/CCM.0b013e31825b8bc6; Weed LH, 1919, AM J PHYSIOL, V48, P512, DOI 10.1152/ajplegacy.1919.48.4.512; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478	41	2	2	0	0	JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD	NEW DEHLI	4838-24, ANSARI RD, DARYAGANJ, NEW DEHLI, 110 002, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	JUN	2019	23			2			S129	S135		10.5005/jp-journals-10071-23190			7	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JM9IN	WOS:000496519900007	31485121	gold, Green Published, Green Submitted			2022-02-06	
J	White, P; Townsend, C; Lakhani, A; Cullen, J; Bishara, J; White, A				White, Paul; Townsend, Clare; Lakhani, Ali; Cullen, Jennifer; Bishara, Jason; White, Alan			The Prevalence of Cognitive Impairment among People Attending a Homeless Service in Far North Queensland with a Majority Aboriginal and/or Torres Strait Islander People	AUSTRALIAN PSYCHOLOGIST			English	Article						Aboriginal and; or Torres Strait islander; activities of daily living; cognitive impairment; homelessness	TRAUMATIC BRAIN-INJURY; DISABILITY; ADULTS; HEALTH; EXPERIENCES; MAORI	ObjectiveTo establish the point prevalence of cognitive impairment among a representative group of homeless people in Cairns. The sample included a large number of Aboriginal and/or Torres Strait Islander people. MethodThis research was conducted among an opportunistic sample of participants residing in a homeless shelter. An interview administered cross-sectional survey was conducted with 60 participants over 12weeks. The Kimberly Indigenous Cognitive Assessment (KICA-Cog) and a clinical diagnosis by a psychiatrist (using DSM-V criteria) were used to establish cognitive impairment. The 36-item version of the World Health Organisation Disability Assessment Survey 2.0 (WHODAS 2.0) was employed to ascertain limitations in daily living activities. ResultsSeventy-five percent of participants were Aboriginal and/or Torres Strait Islander people. Thirty-five percent of the sample had a cognitive impairment based on the KICA-cog while over 70% of the sample had a cognitive impairment based on clinical criteria. Being screened for dementia or global cognitive impairment according to the KICA-Cog was significantly correlated with having greater difficulty across the following WHODAS domains: understanding or communicating, self-care, and life activities. ConclusionsMany people who are homeless have a cognitive impairment and this impairment impacts their ability to participate in society. A shift in practice is necessary to support homeless populations with a high proportion of Aboriginal and/or Torres Strait Islander people. It is important that culturally appropriate methodsfocusing on cognitive healthare employed to support Aboriginal and/or Torres Strait Islander people who are homeless.	[White, Paul; White, Alan] Griffith Univ, Hopkins Ctr, SDSAOT, Nathan, Qld, Australia; [Townsend, Clare; Lakhani, Ali; Cullen, Jennifer; Bishara, Jason] Griffith Univ, Hopkins Ctr, Synapse, Nathan, Qld, Australia; [Lakhani, Ali] Griffith Univ, Hopkins Ctr, Menzies Hlth Inst Queensland, Nathan, Qld, Australia		White, P (corresponding author), SDSAOT, 55 Russell St, South Brisbane, Qld 4101, Australia.	paul.white@communities.qld.gov.au		Lakhani, Ali/0000-0003-3209-7831			[Anonymous], 1993, ORGANIZATION, V2, pvi; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Ardilly P, 2001, SURVEY METHODOL, V27, P109; Australia Buerea of Statistics, 2015, CAIRNS REG STAT; Avery S., 2016, LOW I INT IND HLTH W; Biddle N., 2013, CAEPR INDIGENOUS POP; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; Cairns Regional Council, 2017, EC PROF; Caspi A, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0005; Caton C. L., 2007, UND HOM 2007 NAT S H; Cullen J, 2014, AUST NZ J PSYCHIAT, V48, P15; Dudley M, 2013, ARCH CLIN NEUROPSYCH, V28, P551; Dudley M, 2014, NEW ZEAL J PSYCHOL, V43, P14; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Federici S, 2017, DISABIL REHABIL, V39, P2347, DOI 10.1080/09638288.2016.1223177; Fforde C, 2013, MEDIA INT AUST, P162, DOI 10.1177/1329878X1314900117; Galindo-Garre F, 2015, INT J METH PSYCH RES, V24, P1, DOI 10.1002/mpr.1462; Glasson EJ, 2005, J INTELL DISABIL RES, V49, P626, DOI 10.1111/j.1365-2788.2005.00722.x; Guilera G, 2015, J AFFECT DISORDERS, V174, P353, DOI 10.1016/j.jad.2014.12.028; Herrman H, 2004, AUST NZ J PSYCHIAT, V38, P965, DOI 10.1111/j.1440-1614.2004.01488.x; Hunter E., 1993, ABORIGINAL HLTH HIST; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Kalton G, 2009, SURV METHODOL, V35, P125; Konecky B, 2014, AM J PSYCHIAT, V171, P818, DOI 10.1176/appi.ajp.2014.14050587; Lakhani A, 2017, BRAIN INJURY, V31, P1718, DOI 10.1080/02699052.2017.1374468; LoGiudice D, 2006, INT PSYCHOGERIATR, V18, P269, DOI 10.1017/S1041610205002681; LoGiudice D, 2011, AUSTRALAS J AGEING, V30, P215, DOI 10.1111/j.1741-6612.2010.00486.x; National Alliance to End Homelessness, 2016, SOLUTIONS; Nelson J, 2014, AUST PSYCHOL, V49, P22, DOI 10.1111/ap.12041; O'Brien G, 2014, AUST NZ J PSYCHIAT, V48, P102; Productivity Commission, 2011, 54 PROD COMM; Purdie N., 2010, WORKING TOGETHER ABO, V1st ed.; Queensland Council of Social Service, 2011, QCOSS REG HOM PROF F; Queensland Council of Social Services, 2016, EN LOC COMM HOM CAIR; Raising the Roof, 2016, LONG TERM SOL HOM; Roy A, 2015, FIRST PEOPLES CHILD, V10, P62; Smith K, 2009, AUST PSYCHOL, V44, P54, DOI 10.1080/00050060802563463; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; Somerville R., 2017, NEWPARADIGM, V14, P1; Spence S, 2004, J ROY SOC MED, V97, P375, DOI 10.1258/jrsm.97.8.375; Stergiopoulos V, 2015, ACTA PSYCHIAT SCAND, V131, P256, DOI 10.1111/acps.12391; Thurston W. E., 2013, International Journal of Multiple Research Approaches, V7, P250, DOI 10.5172/mra.2013.7.2.250; Tourangeau R., 2014, HARD TO SURVEY POPUL; Townsend C, 2018, AUST HEALTH REV, V42, P227, DOI 10.1071/AH16229; Ulu B, 2001, TURK PSIKIYATR DERG, V12, P121; van der Plas AGM, 2012, INT J SOC PSYCHIATR, V58, P629, DOI 10.1177/0020764011419056; Vicary DA, 2005, AUST PSYCHOL, V40, P8, DOI 10.1080/00050060512331317210; WHO, 2017, WHO DIS ASS SCHED 2; Ypinazar VA, 2007, AUST NZ J PSYCHIAT, V41, P467, DOI 10.1080/00048670701332953	49	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	JUN	2019	54	3					193	201		10.1111/ap.12359			9	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	HY7YJ	WOS:000468353600006		Green Submitted			2022-02-06	
J	Williams, G; Hassett, L; Clark, R; Bryant, A; Olver, J; Morris, ME; Ada, L				Williams, Gavin; Hassett, Leanne; Clark, Ross; Bryant, Adam; Olver, John; Morris, Meg E.; Ada, Louise			Improving Walking Ability in People With Neurologic Conditions: A Theoretical Framework for Biomechanics-Driven Exercise Prescription	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Exercise; Gait; Neurology; Paresis; Physical and rehabilitation medicine; Rehabilitation	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; POWER-GENERATION; CEREBRAL-PALSY; MUSCLE-TENDON; STRENGTH; REHABILITATION; RESISTANCE; CHILDREN; GAIT	The purpose of this paper is to discuss how knowledge of the biomechanics of walking can be used to inform the prescription of resistance exercises for people with mobility limitations. Muscle weakness is a key physical impairment that limits walking in commonly occurring neurologic conditions such as cerebral palsy, traumatic brain injury, and stroke. Few randomized trials to date have shown conclusively that strength training improves walking in people living with these conditions. This appears to be because (1) the most important muscle groups for forward propulsion when walking have not been targeted for strengthening, and (2) strength training protocols have focused on slow and heavy resistance exercises, which do not improve the fast muscle contractions required for walking. We propose a theoretical framework to improve exercise prescription by integrating the biomechanics of walking with the principles of strength training outlined by the American College of Sports Medicine to prescribe exercises that are specific to improving the task of walking. The high angular velocities that occur in the lower limb joints during walking indicate that resistance exercises targeting power generation would be most appropriate. Therefore, we propose the prescription of plyometric and ballistic resistance exercise, applied using the American College of Sports Medicine guidelines for task specificity, once people with neurologic conditions are ambulating, to improve walking outcomes. This new theoretical framework for resistance training ensures that exercise prescription matches how the muscles work during walking. (C) 2019 by the American Congress of Rehabilitation Medicine	[Williams, Gavin] Epworth Healthcare, Physiotherapy Dept, Melbourne, Vic, Australia; [Williams, Gavin; Bryant, Adam] Univ Melbourne, Fac Med Dent & Hlth Sci, Sch Physiotherapy, Melbourne, Vic, Australia; [Hassett, Leanne; Ada, Louise] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Hassett, Leanne] Univ Sydney, Sydney Med Sch, George Inst Global Hlth, Sydney, NSW, Australia; [Clark, Ross] Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld, Australia; [Olver, John] Epworth Healthcare, Rehabil Med, Melbourne, Vic, Australia; [Morris, Meg E.] La Trobe Univ, Healthscope, Melbourne, Vic, Australia; [Morris, Meg E.] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	; Clark, Ross/R-5664-2018	Olver, John/0000-0001-7069-1191; Morris, Meg/0000-0002-0114-4175; Clark, Ross/0000-0002-7291-8553			Ada L, 2006, AUST J PHYSIOTHER, V52, P241, DOI 10.1016/S0004-9514(06)70003-4; Allen NE, 2010, MOVEMENT DISORD, V25, P1217, DOI 10.1002/mds.23082; Alterman DM, 2013, J VASC SURG, V57, P741, DOI 10.1016/j.jvs.2012.09.006; Ang KK, 2013, IEEE ENG MED BIO, P6603, DOI 10.1109/EMBC.2013.6611069; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; BOHANNON RW, 1988, INT J REHABIL RES, V11, P181, DOI 10.1097/00004356-198806000-00012; DELECLUSE C, 1995, MED SCI SPORT EXER, V27, P1203; DeVita P, 2007, J EXP BIOL, V210, P3361, DOI 10.1242/jeb.003970; Dorsch S, 2018, J PHYSIOTHER, V64, P84, DOI 10.1016/j.jphys.2018.02.012; Franz JR, 2015, GAIT POSTURE, V41, P192, DOI 10.1016/j.gaitpost.2014.10.001; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229, DOI 10.1098/rspb.2000.1361; Hakkinen K, 1985, SCAND J SPORTS SCI, V7, P65; Hendrey G, 2018, ARCH PHYS MED REHAB, V99, P2430, DOI 10.1016/j.apmr.2018.04.032; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hunnicutt JL, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/7316250; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Johnson BA, 2014, PEDIATR PHYS THER, V26, P169, DOI 10.1097/PEP.0000000000000012; Johnson BA, 2012, PEDIATR PHYS THER, V24, P199, DOI 10.1097/PEP.0b013e31824d30ee; Kjolhede T, 2012, MULT SCLER J, V18, P1215, DOI 10.1177/1352458512437418; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; Kudo S, 2015, J PHYS THER SCI, V27, P3763, DOI 10.1589/jpts.27.3763; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.3.CO;2-D; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Mehrholz J, 2006, CLIN REHABIL, V20, P406, DOI 10.1191/0269215506cr954oa; Mentiplay BF, 2018, GAIT POSTURE, V65, P190, DOI 10.1016/j.gaitpost.2018.06.162; Moreau NG, 2016, PHYS THER REHABIL J, V96, P1938, DOI 10.2522/ptj.20150401; Morgan P, 2015, J REHABIL RES DEV, V52, P77, DOI 10.1682/JRRD.2014.04.0109; Morris SL, 2004, CLIN REHABIL, V18, P27, DOI 10.1191/0269215504cr699oa; Nadeau S, 1999, AM J PHYS MED REHAB, V78, P123, DOI 10.1097/00002060-199903000-00007; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Newton RU., 1994, STRENGTH COND J, V16, P20; Peden M., 2004, WORLD REPORT ROAD TR; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Roberts TJ, 2002, COMP BIOCHEM PHYS A, V133, P1087, DOI 10.1016/S1095-6433(02)00244-1; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Ryschon TW, 1997, J APPL PHYSIOL, V83, P867, DOI 10.1152/jappl.1997.83.3.867; Sawicki GS, 2009, EXERC SPORT SCI REV, V37, P130, DOI 10.1097/JES.0b013e31819c2df6; Schache AG, 2014, J ORTHOP SPORT PHYS, V44, P813, DOI 10.2519/jospt.2014.5433; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; Sugisaki N, 2005, INT J SPORT HLTH SCI, V3, P100; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Tonmukayakul U, 2018, RES DEV DISABIL, V80, P93, DOI 10.1016/j.ridd.2018.06.012; van der Krogt MM, 2012, GAIT POSTURE, V36, P113, DOI 10.1016/j.gaitpost.2012.01.017; van Vulpen LF, 2017, NEUROREHAB NEURAL RE, V31, P827, DOI 10.1177/1545968317723750; Whittle M. W., 2012, WHITTLES GAIT ANAL; WICKIEWICZ TL, 1983, CLIN ORTHOP RELAT R, P275, DOI 10.1097/00003086-198310000-00042; Wiley ME, 1998, DEV MED CHILD NEUROL, V40, P100, DOI 10.1111/j.1469-8749.1998.tb15369.x; Williams G, 2016, GAIT POSTURE, V43, P265, DOI 10.1016/j.gaitpost.2015.10.009; Williams G, 2014, AM J PHYS MED REHAB, V93, P828, DOI 10.1097/PHM.0000000000000139; Williams G, 2014, AM J PHYS MED REHAB, V93, P511, DOI 10.1097/PHM.0000000000000058; Williams GP, 2013, J HEAD TRAUMA REHAB, V28, P371, DOI 10.1097/HTR.0b013e31824a1d40; Williams GP, 2010, J HEAD TRAUMA REHAB, V25, P164, DOI 10.1097/HTR.0b013e3181dc120b; Wilson G, 1997, COACH SPORT SCI J, V2, P3; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147; WINTER DA, 1983, J MOTOR BEHAV, V15, P302	55	2	2	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2019	100	6					1184	1190		10.1016/j.apmr.2019.01.003			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	ID7BL	WOS:000471836600018	30690011				2022-02-06	
J	Wolf, TJ; Doherty, M; Boone, A; Rios, J; Polatajko, H; Baum, C; McEwen, S				Wolf, Timothy J.; Doherty, Meghan; Boone, Anna; Rios, Jorge; Polatajko, Helene; Baum, Carolyn; McEwen, Sara			Cognitive oriented strategy training augmented rehabilitation (COSTAR) for ischemic stroke: a pilot exploratory randomized controlled study	DISABILITY AND REHABILITATION			English	Article						Stroke; stroke rehabilitation; occupational therapy; cognition; neurological rehabilitation; activities of daily living	TRAUMATIC BRAIN-INJURY; CONTROLLED-TRIAL; RISK-FACTORS; PARTICIPATION; PERFORMANCE; INTERVENTION; VALIDATION; THERAPY; PROGRAM; DISEASE	Purpose: To investigate the effect of adding cognitive strategy training to task-specific training (TST), called Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR), compared with TST on activity and participation for chronic stroke survivors in an outpatient occupational therapy setting Materials and methods: We conducted an exploratory, single-blind, randomized controlled trial. Participants were randomized to TST or COSTAR protocol. Our primary outcomes measured activity and participation after stroke: the Stroke Impact Scale (SIS), Canadian Occupational Performance Measure (COPM), and Performance Quality Rating Scale (PQRS). Results: Forty-four participants were randomized. The COSTAR group had an attrition rate of 50% and an average of 9.8 of 12 sessions were completed; the TST group had an attrition rate of 25% and an average of 10.7 sessions were completed. Generally both groups improved on the majority of primary and secondary outcomes. There is little evidence to support a beneficial effect of COSTAR over TST for improvement of primary measures of activity performance or secondary measures. Conclusion: Negligible findings may be attributed to an inadvertent treatment group equivalency. Further, the research design did not allow for adequate measurement of the effect of each intervention on participants' ability to generalize learned skills.	[Wolf, Timothy J.; Boone, Anna] Univ Missouri, Dept Occupat Therapy, 810 Clark Hall, Columbia, MO 65211 USA; [Doherty, Meghan] St Louis Univ, Dept Occupat Sci & Occupat Therapy, St Louis, MO 63103 USA; [Rios, Jorge; McEwen, Sara] Sunnybrook Res Inst, St Johns Rehab Program, Toronto, ON, Canada; [Polatajko, Helene; McEwen, Sara] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Baum, Carolyn] Washington Univ, Sch Med, Program Occupat Therapy, St Louis, MO USA		Wolf, TJ (corresponding author), Univ Missouri, Dept Occupat Therapy, 810 Clark Hall, Columbia, MO 65211 USA.	wolftj@health.missouri.edu			National Center for Medical Rehabilitation Research (NCMRR) in the National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) [R03HD069626]	This study was funded by the National Center for Medical Rehabilitation Research (NCMRR) in the National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) under award number R03HD069626. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bandura A., 1994, SELF EFFICACY, P71; Baron IS, 2004, CHILD NEUROPSYCHOL, V10, P147, DOI 10.1080/09297040490911140; BAUM C, 1993, AM J OCCUP THER, V47, P431, DOI 10.5014/ajot.47.5.431; Baum C, 2009, S STROK REH FOC SYMP; Baum C.M., 2008, ACTIVITY CARD SORT, V2nd; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bosch J., 2014, ISRN STROKE, V2014, pe504910, DOI [DOI 10.1155/2014/504910, 10.1155/2014/504910]; Cohen J, 1988, STAT POWER ANAL BEHA; Combs SA, 2010, DISABIL REHABIL, V32, P669, DOI 10.3109/09638280903242716; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; French B, 2008, HEALTH TECHNOL ASSES, V12, P1; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Geusgens CAV, 2007, J CLIN EXP NEUROPSYC, V29, P831, DOI 10.1080/13803390601125971; Glass TA, 1998, GERONTOLOGIST, V38, P101, DOI 10.1093/geront/38.1.101; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hahn Bridget, 2014, Am J Occup Ther, V68, pe241, DOI 10.5014/ajot.2014.008565; Hartman-Maeir A, 2007, DISABIL REHABIL, V29, P559, DOI 10.1080/09638280600924996; Henshaw E, 2011, AM J OCCUP THER, V65, P55, DOI 10.5014/ajot.2011.09010; Hubbard IJ, 2009, OCCUP THER INT, V16, P175, DOI 10.1002/oti.275; Lee D, 2018, DISABIL REHABIL, V40, P110, DOI 10.1080/09638288.2016.1242172; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mandich, 2004, ENABLING OCCUPATION; Martini R, 2015, DISABIL REHABIL, V37, P231, DOI 10.3109/09638288.2014.913702; McEwen S, 2015, NEUROREHAB NEURAL RE, V29, P526, DOI 10.1177/1545968314558602; MEICHENBAUM DH, 1971, J ABNORM PSYCHOL, V77, P115, DOI 10.1037/h0030773; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray H.A., 1938, EXPLOR PERS; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Polatajko HJ, 2012, AM J OCCUP THER, V66, P104, DOI 10.5014/ajot.2012.001784; Polatajko Helene J., 2001, Physical and Occupational Therapy in Pediatrics, V20, P107, DOI 10.1300/J006v20n02_07; Polatajko HJ, 2010, ARCH PHYS MED REHAB, V90, pe31; Pollock N, 1998, CANADIAN OCCUPATIONA; Pollock N., 2005, CANADIAN OCCUPATIONA; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Winstein CJ, 2016, JAMA-J AM MED ASSOC, V315, P571, DOI 10.1001/jama.2016.0276; Winstein CJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-5; Winstein CJ, 2008, STROKE RECOVERY REHA, P267; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Wolf TJ, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.017293; Wolf TJ, 2009, AM J OCCUP THER, V63, P621, DOI 10.5014/ajot.63.5.621; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; Woollacott, 2007, MOTOR CONTROL TRANSL	45	2	2	2	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JAN 16	2021	43	2					201	210		10.1080/09638288.2019.1620877		MAY 2019	10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	PO7OV	WOS:000470580300001	31155969	Green Accepted			2022-02-06	
J	Yamal, JM; Hannay, HJ; Gopinath, S; Aisiku, IP; Benoit, JS; Robertson, CS				Yamal, Jose-Miguel; Hannay, H. Julia; Gopinath, Shankar; Aisiku, Imoigele P.; Benoit, Julia S.; Robertson, Claudia S.			Glasgow Outcome Scale Measures and Impact on Analysis and Results of a Randomized Clinical Trial of Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						closed head injury; EPO; GOS; hemoglobin transfusion trigger; sliding dichotomy; traumatic brain injury	SEVERE HEAD-INJURY; COGNITIVE SEQUELAE; FOLLOW-UP; 1ST YEAR; MODERATE; RESUSCITATION; AGREEMENT; MISCLASSIFICATION; RECOMMENDATIONS; COEFFICIENT	The original unstructured Glasgow Outcome Scale (uGOS) and the newer structured interviews GOS and the Extended GOS (GOS-E) have been used widely as outcomes in severe traumatic brain injury (TBI) trials. We compared outcome categories (ranging from dead [D] to good recovery [GR]) for each measure in a randomized trial of transfusion threshold and the implications of measure choice and analysis methods for the results of the trial. We planned to explore patient symptomology possibly driving any discrepancies between the patient's uGOS and GOS scores. Category correspondence between uGOS and GOS scores occurred in 160 (88.4%) of the 181 analyzed cases. The GOS-E and GOS instruments incorporated more behavioral/cognitive/social and other components, leading to a worse outcome in some cases than for the uGOS. Choice of outcome measure and analysis led to incongruous conclusions. Dichotomizing uGOS into favorable outcome (GR and moderate disability [MD] categories) versus unfavorable (severe disability [SD], vegetative state [VS], and D categories), we observed a significant effect of transfusion threshold (odds ratio [OR] = 0.51, p = 0.03; adjusted OR = 0.40, p = 0.02). For the same dichotomization of GOS and GOS-E, the effect was not statistically significant but the ORs were similar (ORs between 0.57 and 0.68, p > 0.15 for all). An effect was not detected using ordinal logistic regression or sliding dichotomy method for all three measures. Differences in categorizations of subjects between moderate and severe disability among the scales impacted conclusions of the trial. In future studies, particular attention should be given to implementing GOS measures and describing the methodology for how outcomes were ascertained.	[Yamal, Jose-Miguel] Univ Texas Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Coordinating Ctr Clin Trials, 1200 Pressler,RAS E809, Houston, TX 77030 USA; [Hannay, H. Julia] Univ Houston, Dept Psychol, POB 2278, Houston, TX 36831 USA; [Hannay, H. Julia; Benoit, Julia S.] Univ Houston, Texas Inst Measurement Evaluat & Stat, POB 2278, Houston, TX 36831 USA; [Benoit, Julia S.] Univ Houston, Dept Basic Vis Sci, Houston, TX USA; [Gopinath, Shankar; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Aisiku, Imoigele P.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA		Yamal, JM (corresponding author), Univ Texas Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Coordinating Ctr Clin Trials, 1200 Pressler,RAS E809, Houston, TX 77030 USA.; Hannay, HJ (corresponding author), Univ Houston, Dept Psychol, POB 2278, Houston, TX 36831 USA.; Hannay, HJ (corresponding author), Univ Houston, Texas Inst Measurement Evaluat & Stat, POB 2278, Houston, TX 36831 USA.	Jose-Miguel.Yamal@uth.tmc.edu; Julia.Hannay@times.uh.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS38660]	This study was supported by the National Institute of Neurological Disorders and Stroke (grant #P01-NS38660).	Alali AS, 2015, J NEUROTRAUM, V32, P581, DOI 10.1089/neu.2014.3495; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; Bulger EM, 2012, J TRAUMA ACUTE CARE, V72, P567, DOI 10.1097/TA.0b013e31824baddf; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Henden PL, 2014, J NEUROSURG ANESTH, V26, P50, DOI 10.1097/ANA.0b013e3182a47b62; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Lu J, 2012, J NEUROTRAUM, V29, P719, DOI 10.1089/neu.2010.1746; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Matsushima K, 2012, J CRIT CARE, V27, P125, DOI 10.1016/j.jcrc.2011.08.012; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Moen KG, 2014, J NEUROTRAUM, V31, P56, DOI 10.1089/neu.2013.3000; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Silberstein Morry, 2002, Neurosurg Focus, V13, pecp2, DOI 10.3171/foc.2002.13.1.6; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Thelin EP, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00159; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Wang HE, 2014, EMERG MED J, V31, P186, DOI 10.1136/emermed-2012-202101; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2007, INT CLASS FUNCT DIS; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Zelnick LR, 2014, J NEUROTRAUM, V31, P1029, DOI 10.1089/neu.2013.3122; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698	52	2	4	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2019	36	17					2484	2492		10.1089/neu.2018.5939		MAY 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IW9BT	WOS:000470627300001	30973053	Green Published			2022-02-06	
J	Post, A; Dawson, L; Hoshizaki, TB; Gilchrist, MD; Cusimano, MD				Post, Andrew; Dawson, Lauren; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Cusimano, Michael D.			The influence of impact source on variables associated with strain for impacts in ice hockey	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Ice hockey; biomechanics; concussion; impact	TRAUMATIC BRAIN-INJURY; ACCIDENT RECONSTRUCTION; INTRACRANIAL-PRESSURE; VIDEO ANALYSIS; AXONAL DAMAGE; HEAD; ACCELERATION; CONCUSSION; TISSUE; MODEL	Concussion can occur from a variety of events (falls to ice, collisions etc) in ice hockey, and as a result it is important to identify how these different impact sources affect the relationship between impact kinematics and strain that has been found to be associated to this injury. The purpose of this research was to examine the relationship between kinematic variables and strain in the brain for impact sources that led to concussion in ice hockey. Video of professional ice hockey games was analyzed for impacts that resulted in reported clinically diagnosed concussions. The impacts were reconstructed using physical models/ATDs to determine the impact kinematics and then simulated using finite element modelling to determine maximum principal strain and cumulative strain damage measure. A stepwise linear regression was conducted between linear acceleration, change in linear velocity, rotational acceleration, rotational velocity, and strain response in the brain. The results for the entire dataset was that rotational acceleration had the highest r(2) value for MPS (r(2) = 0.581) and change in rotational velocity for cumulative strain damage measure (r(2) = 450). When the impact source (shoulder, elbow, boards, or ice impacts) was isolated the rotational velocity and acceleration r(2) value increased, indicating that when evaluating the relationships between kinematics and strain based metrics the characteristics of the impact is an important factor. These results suggest that rotational measures should be included in future standard methods and helmet innovation and design in ice hockey as they have the highest association with strain in the brain tissues.	[Post, Andrew; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Post, Andrew; Dawson, Lauren; Hoshizaki, T. Blaine] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Toronto, St Michaels Hosp, Toronto, ON, Canada.; Post, A (corresponding author), Univ Ottawa, Human Kinet, Ottawa, ON, Canada.	apost@uottawa.ca	Cusimano, Michael/X-4059-2019	Post, Andrew/0000-0002-5960-5552; Cusimano, Michael/0000-0002-9989-0650	Canadian Standards Association operating as CSA Group; Canadian Institutes of Health Research Postdoctoral FellowshipCanadian Institutes of Health Research (CIHR)	This work was funded by Canadian Standards Association operating as CSA Group. Support was also provided by the Canadian Institutes of Health Research Postdoctoral Fellowship.	Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 1994, STAPP CAR CRASH C SO, V38, P145; Canadian Standards Association (CSA), 2015, Z262115 CSA; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Clark JM, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040605; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBL D; Foreman S, 2010, ICE HOCKEY SUMMIT AC; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Gabler LF, 2018, ANN BIOMED ENG; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1972, P 16 STAPP CAR CRASH; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; GRAY JAB, 1954, J PHYSIOL-LONDON, V124, P84, DOI 10.1113/jphysiol.1954.sp005087; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; HAFTEK J, 1970, Journal of Bone and Joint Surgery British Volume, V52, P354; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Ho J, 2008, THESIS; Holbourn A. H. S., 1943, LANCET, V3, P147; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hoshizaki TB, 2016, DEV THRESHOLD CURVE; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Karton CK, 2018, P CAN SOC BIOM HAL C; Kendall M., 2016, THESIS; King A., 2003, P IRCOBI C LISB PORT; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Miller R.T., 1998, STAPP CAR CRASH J, P155; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Morrison III B., 2003, 20032200066 SAE; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; Newman J A, 2000, Stapp Car Crash J, V44, P215; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2017, INT J CRASHWORTHINES; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2017, SPORTS ENG, V20, P111, DOI 10.1007/s12283-016-0219-5; Post A, 2017, J NEUROSURG-PEDIATR, V19, P502, DOI 10.3171/2016.10.PEDS16449; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Rousseau P., 2014, THESIS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Ruan J, 1994, THESIS; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Saatman KE, 1993, THESIS; SAE International, 1995, J2111 SAE; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; Van Lierde C, 2005, THESIS; Walsh ES, 2018, SPORT ENG; Willinger R., 1992, P INT IRCOBI C BIOM, P179; Willinger R, 1995, P IRCOBI C BIOM IMP; Yang JK, 2011, COMPUTATIONAL BIOMECHANICS FOR MEDICINE: SOFT TISSUES AND THE MUSCULOSKELETAL SYSTEM, P5, DOI 10.1007/978-1-4419-9619-0_2; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	78	2	2	3	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	MAY 19	2019	22	7					713	726		10.1080/10255842.2019.1588255			14	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	HZ8JT	WOS:000469101900004	30880464				2022-02-06	
J	Ferraro, S; Nigri, A; Nava, S; Rosazza, C; Sattin, D; Sebastiano, DR; Porcu, L; Bruzzone, MG; Marotta, G; Benti, R; Redolfi, A; Matilde, L; D'Incerti, L; Andronache, A; Fazio, P; Caldiroli, D; Ciaraffa, F; Covelli, V; Giovannetti, A; Minati, L; Molteni, F; Pagani, M; Panzica, F; Parati, EA; Reggiori, B; Rosazza, C; Varotto, G; Gomez, JV; Visani, E				Ferraro, Stefania; Nigri, Anna; Nava, Simone; Rosazza, Cristina; Sattin, Davide; Sebastiano, Davide Rossi; Porcu, Luca; Bruzzone, Maria Grazia; Marotta, Giorgio; Benti, Riccardo; Redolfi, Alberto; Matilde, Leonardi; D'Incerti, Ludovico; Andronache, A.; Fazio, P.; Caldiroli, D.; Ciaraffa, F.; Covelli, V; Giovannetti, A.; Minati, L.; Molteni, F.; Pagani, M.; Panzica, F.; Parati, E. A.; Reggiori, B.; Rosazza, C.; Varotto, G.; Gomez, J. Vela; Visani, E.		Fdn IRCCS Ist Neurologico Carlo Be	Interhemispherical Anatomical Disconnection in Disorders of Consciousness Patients	JOURNAL OF NEUROTRAUMA			English	Article						brain metabolism; corpus callosum; diffusion tensor imaging; disorders of consciousness; etiology	TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; VEGETATIVE STATE; DIFFUSION-TENSOR; CORPUS-CALLOSUM; INTRACEREBRAL HEMORRHAGE; CONNECTIVITY; RECOVERY; AGE; NEUROPATHOLOGY	In patients with disorder of consciousness (DOC), the corpus callosum (CC) and subcortical white matter (SWM) integrity were shown to discriminate between diagnostic categories. The aims of the study were: (1) to clarify the link between the integrity of CC and of SWM and the clinical status in DOC patients, disentangling the role played by the different brain injuries (traumatic or hemorrhagic brain injury); (2) to investigate the relationship between the CC integrity and the brain metabolism. We assessed the diagnostic accuracy of the CC and SWM integrity, using diffusion tensor imaging (DTI) and structural magnetic resonance imaging (sMRI), in a sample of DOC individuals, well balanced for diagnosis and etiology. The CC DTI-derived measures were correlated with the brain metabolism, computed with fluorodeoxyglucose positron emission tomography. Our results showed that the CC macrostructural DTI-derived measures discriminate between diagnosis and correlate with the clinical status of DOC patients irrespective of the etiology. Moreover, the CC DTI-derived measures strongly correlate with the metabolism of the right hemisphere. No significant diagnostic accuracy emerged for the CC sMRI evaluation and the SWM measures. Our results indicate that: (1) the degree of the interhemispherical anatomical disconnection is a marker of the level of consciousness independent from the type of brain injury; (2) CC alterations might be the consequence of the reduced brain metabolism. Remarkably, our results suggest that the functional interplay between the two hemispheres is linked tightly to the level of consciousness.	[Ferraro, Stefania; Nigri, Anna; Nava, Simone; Bruzzone, Maria Grazia; Redolfi, Alberto; D'Incerti, Ludovico] Fdn IRCCS Ist Neurol Carlo Besta, Neuroradiol Dept, Via Celoria 11, Milan, Italy; [Rosazza, Cristina] Fdn IRCCS Ist Neurol Carlo Besta, Sci Dept, Milan, Italy; [Sattin, Davide; Matilde, Leonardi] Fdn IRCCS Ist Neurol Carlo Besta, Neurol Publ Hlth Disabil Unit, Milan, Italy; [Sebastiano, Davide Rossi] Fdn IRCCS Ist Neurol Carlo Besta, Neurophysiol Dept, Milan, Italy; [Porcu, Luca] IRCCS Ist Ric Farmacol Mario Negri, Oncol Dept, Lab Methodol Clin Res, Milan, Italy; [Marotta, Giorgio; Benti, Riccardo] Fdn IRCCS Ca Granda Osped Maggiore, Dept Nucl Med, Milan, Italy		Nigri, A (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Neuroradiol Dept, Via Celoria 11, Milan, Italy.	anna.nigri@istituto-besta.it	Panzica, Ferruccio/K-6711-2016; Ferraro, Stefania/AAN-1066-2021; Bruzzone, Maria/AAM-4478-2021; Porcu, Luca/AAD-8322-2019; Nigri, Anna/AAM-9827-2021; Sattin, Davide/AAX-4083-2020; Caldiroli, Dario/AAS-8405-2021; Parati, Eugenio Agostino/AAN-5893-2021; Visani, Elisa/J-2331-2016; Rossi Sebastiano, Davide/G-8541-2016; Sattin, Davide/K-5963-2016	Panzica, Ferruccio/0000-0002-0105-943X; Ferraro, Stefania/0000-0002-5939-0459; Bruzzone, Maria/0000-0002-2786-1471; Nigri, Anna/0000-0002-1197-5458; Sattin, Davide/0000-0001-7736-4337; Caldiroli, Dario/0000-0002-1106-3213; Parati, Eugenio Agostino/0000-0001-5020-6523; Visani, Elisa/0000-0002-1399-2630; Rossi Sebastiano, Davide/0000-0003-3698-8615; Sattin, Davide/0000-0001-7736-4337; Porcu, Luca/0000-0002-0911-9775; Rosazza, Cristina/0000-0002-7799-415X; Marotta, Giorgio/0000-0002-5945-8628			Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Andoh J, 2015, J NEUROSCI, V35, P14602, DOI 10.1523/JNEUROSCI.2333-15.2015; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gotts SJ, 2013, P NATL ACAD SCI USA, V110, pE3435, DOI 10.1073/pnas.1302581110; Hua Y, 2006, J NEUROSURG, V104, P305, DOI 10.3171/jns.2006.104.2.305; Iturria-Medina Y, 2011, CEREB CORTEX, V21, P56, DOI 10.1093/cercor/bhq058; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kuczynski B, 2010, ALZHEIMERS DEMENT, V6, P54, DOI 10.1016/j.jalz.2009.04.1228; Lant ND, 2016, NEUROIMAGE-CLIN, V10, P27, DOI 10.1016/j.nicl.2015.11.004; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Lebel C, 2010, NEUROIMAGE, V52, P20, DOI 10.1016/j.neuroimage.2010.03.072; Liu Y, 2011, AM J NEURORADIOL, V32, P2011, DOI 10.3174/ajnr.A2690; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Nigri A, 2016, EUR J NEUROL, V23, P605, DOI 10.1111/ene.12907; Nigri A, 2017, BRAIN IMAGING BEHAV, V11, P1526, DOI 10.1007/s11682-016-9613-7; Pierpaoli C., 2010, P INT SOC MAGNETIC R, P1597; Qing WG, 2009, J NEUROSURG, V110, P462, DOI 10.3171/2008.4.JNS17512; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Rosazza C, 2016, ANN NEUROL, V79, P841, DOI 10.1002/ana.24634; Schiff ND, 2012, ANN NEUROL, V72, P305, DOI 10.1002/ana.23671; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stender J, 2016, CURR BIOL, V26, P1494, DOI 10.1016/j.cub.2016.04.024; Stender J, 2015, J CEREBR BLOOD F MET, V35, P58, DOI 10.1038/jcbfm.2014.169; Tamraz JC, 2004, ATLAS REGIONAL ANATO; van der Eerden AW, 2014, RADIOLOGY, V270, P506, DOI 10.1148/radiol.13122720; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; YAMAGUCHI T, 1990, BRAIN, V113, P937, DOI 10.1093/brain/113.4.937; YAMAUCHI H, 1995, J NEUROL NEUROSUR PS, V59, P420, DOI 10.1136/jnnp.59.4.420; Yao S, 2015, J NEUROL SCI, V356, P168, DOI 10.1016/j.jns.2015.06.044; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167	41	2	2	4	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1535	1543		10.1089/neu.2018.5820			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900005	30520674				2022-02-06	
J	Liu, QF; Li, XM; Zhao, YS; Cao, K; Liu, Y; Xiao, R; Wang, CY; Li, YX; Huang, WL; Wang, X				Liu, Qiaofeng; Li, Xuemei; Zhao, Yanshuang; Cao, Kang; Liu, Yang; Xiao, Rui; Wang, Chenyi; Li, Yanxia; Huang, Wenli; Wang, Xin			Dopamine D1 receptor agonist treatment alleviates morphine-exposure-induced learning and memory impairments	BRAIN RESEARCH			English	Article						Dopamine D1 receptor; Morphine exposure; PAG; PKA; TLR4; Learning and memory	MORRIS WATER MAZE; TRAUMATIC BRAIN-INJURY; TOLL-LIKE RECEPTORS; LONG-TERM-MEMORY; ACQUISITION; TLR4; CAMP; ACTIVATION; EXPRESSION; DEFICITS	We investigated the mechanisms by which the dopamine D1 receptor alleviates morphine-exposure-induced cognitive impairments. Rats were intraperitoneally injected with morphine in a dose-escalating manner over 10 days, and 15 min before the morphine injection on days 1, 3, 5, 7, and 9, the rats were administered the D1 receptor agonist SKF81297 or the D1 receptor antagonist SCH38933 into the midbrain periaqueductal gray (PAG). The Morris water maze was used to examine learning- and memory-related behavioral changes. Midbrain PAG toll-like receptor 4 (TLR4) and protein kinase A (PKA) protein expression was examined using western blot analysis, and cellular expression and localization of TLR4 and PICA were investigated using immunohistochemistry. Chronic morphine exposure impaired spatial learning and memory ability, and resulted in longer latency to the platform, decreased number of platform crossings, and shortened time in the effective area and the target quadrant. Chronic morphine exposure also increased TLR4 and PKA expression in the PAG. However, D1 receptor agonist treatment improved learning and memory ability; in morphine-treated rats, administration of the D1 receptor agonist SKF81297 could shorten the latency to the platform, increase the number of platform crossings, and increase the time spent in the effective area and the target quadrant. In addition, TLR4 expression decreased and PKA expression significantly increased in the PAG in these animals. In summary, administration of the dopamine D1 receptor agonist SKF81297 into the PAG alleviated morphine-exposure-induced cognitive impairments.	[Liu, Qiaofeng; Li, Xuemei; Zhao, Yanshuang; Liu, Yang; Xiao, Rui; Li, Yanxia] Chengdu Med Coll, Dept Pathol & Pathophysiol, Chengdu, Sichuan, Peoples R China; [Cao, Kang; Wang, Chenyi; Wang, Xin] Chengdu Med Coll, Dept Pathogen Biol, Chengdu 610500, Sichuan, Peoples R China; [Huang, Wenli] Sichuan Acad Agr Sci, Inst Biotechnol & Nucl Technol, Chengdu 610061, Sichuan, Peoples R China		Wang, X (corresponding author), Chengdu Med Coll, Dept Pathogen Biol, Chengdu 610500, Sichuan, Peoples R China.; Huang, WL (corresponding author), Sichuan Acad Agr Sci, Chengdu 610061, Sichuan, Peoples R China.	wenlih11@126.com; 407434194@qq.com	Cao, Kang/AAV-1997-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301145]; Sichuan Provincial Health Department [130304]; Sichuan Provincial Education Department [13ZB0090, 13ZA0208]; Development and Regeneration Key Laboratory of Sichuan Province, Chengdu, China [SYS13-005]; Chengdu Medical College Higher Education and Teaching Reform [JG201813]	This study was supported by the National Natural Science Foundation of China (81301145), the Sichuan Provincial Health Department (130304), the Sichuan Provincial Education Department (13ZB0090, 13ZA0208), the Development and Regeneration Key Laboratory of Sichuan Province, Chengdu, China (SYS13-005), and the Chengdu Medical College Higher Education and Teaching Reform (JG201813).	Abadi AHA, 2017, CAN J PHYSIOL PHARM, V95, P163, DOI 10.1139/cjpp-2016-0168; Bachtell R, 2015, CNS NEUROL DISORD-DR, V14, P692, DOI 10.2174/1871527314666150529132503; Bollen E, 2014, NEUROPSYCHOPHARMACOL, V39, P2497, DOI 10.1038/npp.2014.106; Bowman CC, 2003, GLIA, V43, P281, DOI 10.1002/glia.10256; Brolin E, 2018, PHARMACOL BIOCHEM BE, V167, P1, DOI 10.1016/j.pbb.2018.01.007; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Caldwell MA, 1997, BRAIN RES, V771, P305, DOI 10.1016/S0006-8993(97)00817-2; Chen JX, 2017, BEHAV BRAIN RES, V335, P151, DOI 10.1016/j.bbr.2017.08.022; Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x; Cho RW, 2015, NEURON, V88, P749, DOI 10.1016/j.neuron.2015.10.011; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Fang F, 1999, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V21, P262; Friswell J, 2008, PSYCHOPHARMACOLOGY, V198, P243, DOI 10.1007/s00213-008-1123-x; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Hong S., 2006, J FORENSIC MED, V22; Hu Y. J, 2006, CHIN J NEUROIMMUNOL, V13, P369; Jaber M, 1996, NEUROPHARMACOLOGY, V35, P1503, DOI 10.1016/S0028-3908(96)00100-1; Jin Q. H., 2015, CHIN J PATHOPHYSIOL, V10, P1860; Kabel AM, 2018, PHYSIOL BEHAV, V188, P108, DOI 10.1016/j.physbeh.2018.01.028; Khajevand-Khazaei MR, 2018, EUR J PHARMACOL, V826, P114, DOI 10.1016/j.ejphar.2018.03.001; Li L., 2016, CHIN J TRAUMATOL, V32; Liu QF, 2016, ARCH ITAL BIOL, V154, P133, DOI 10.12871/00039829201644; Liu QF, 2018, NEUROL RES, V40, P1080, DOI 10.1080/01616412.2018.1519946; Lu G, 2010, J NEUROSCI, V30, P5058, DOI 10.1523/JNEUROSCI.0148-10.2010; Luo Y, 2017, ONCOTARGET, V8, P35558, DOI 10.18632/oncotarget.16009; Nway NC, 2017, NEUROTOXICOLOGY, V63, P155, DOI 10.1016/j.neuro.2017.10.001; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Garcia-Pardo MP, 2016, EUR J PHARMACOL, V781, P10, DOI 10.1016/j.ejphar.2016.03.065; Potter OV, 2019, BRAIN BEHAV IMMUN, V76, P37, DOI 10.1016/j.bbi.2018.10.010; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Qu J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0997-0; Sante AB, 2000, BEHAV PHARMACOL, V11, P583, DOI 10.1097/00008877-200011000-00005; Schwarz JM, 2013, J NEUROSCI, V33, P961, DOI 10.1523/JNEUROSCI.2516-12.2013; SPAIN JW, 1991, PSYCHOPHARMACOLOGY, V105, P101, DOI 10.1007/BF02316870; Tang R, 2018, INT J BIOCHEM CELL B, V99, P64, DOI 10.1016/j.biocel.2018.03.017; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang S, 2018, J MOL NEUROSCI, V64, P363, DOI 10.1007/s12031-018-1032-3; Xue L, 2016, INT IMMUNOPHARMACOL, V36, P187, DOI 10.1016/j.intimp.2016.04.030; Yan ZQ, 2006, ARTERIOSCL THROM VAS, V26, P2582, DOI 10.1161/01.ATV.0000250933.92917.dd; Zhang LF, 2014, TOXICOLOGY, V323, P95, DOI 10.1016/j.tox.2014.06.011; Zheng XG, 2002, ACTA PHARMACOL SIN, V23, P477; Zhong Y, 2018, BRAIN RES, V1691, P64, DOI 10.1016/j.brainres.2018.04.022	44	2	2	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 15	2019	1711						120	129		10.1016/j.brainres.2019.01.020			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HS7ZP	WOS:000464088100016	30660614				2022-02-06	
J	Lee, E; Jayasinghe, N; Swenson, C; Dams-O'Connor, K				Lee, Elsa; Jayasinghe, Nimali; Swenson, Carly; Dams-O'Connor, Kristen			Dispositional optimism and cognitive functioning following traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; cognitive functioning; optimism	QUALITY-OF-LIFE; SOCIAL SUPPORT; OLDER-ADULTS; HEALTH; IMPAIRMENT; SEVERITY; RECOVERY; MILD; PREDICTOR; INTERVENTION	Objective: The association of dispositional optimism with health-related factors has been well established in several clinical populations, but little is known about the role of optimism in recovery after traumatic brain injury (TBI). Given the high prevalence of cognitive complaints after TBI, the present study examined the association between optimism and cognitive functioning after TBI. Methods: 171 individuals with complicated mild, moderate or severe TBI completed a series of questionnaires via structured interview and self-report, including a self-report assessment of dispositional optimism, the revised Life Orientation Test (LOT-R), and an objective assessment of cognition, the Brief Test of Adult Cognition by Telephone (BTACT). Multiple hierarchical regression analysis was conducted to examine the relationships between optimism and cognitive functioning. Results: Dispositional optimism was significantly and positively associated with post-TBI cognitive functioning after controlling for the effects of age, race, injury severity, health status, and positive and negative affect. Conclusion: Dispositional optimism may promote higher levels of cognitive functioning in people who sustained a TBI. Research is warranted to examine whether interventions that promote optimism in clinical and social encounters can enhance cognitive recovery in individuals with TBI.	[Lee, Elsa; Swenson, Carly; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Lee, Elsa; Jayasinghe, Nimali] NYU, Dept Appl Psychol, New York, NY USA; [Jayasinghe, Nimali] Weill Cornell Med, New York, NY USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		Lee, E (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA.	elsa.lee@mountsinai.org			NIH Centers for Disease Control and Prevention [1R49Ce001171]	This work was supported by the NIH Centers for Disease Control and Prevention [1R49Ce001171].	Abbott J, 2001, DISABIL REHABIL, V23, P315; Allison PJ, 2000, QUAL LIFE RES, V9, P951, DOI 10.1023/A:1008931906253; Arbuckle TY, 1986, PSYCHOL AGING, V1, P55, DOI 10.1037/0882-7974.1.1.55; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; Bond MR, 1975, CIBA FDN S 34 OUTC S; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; CARVER CS, 1993, J PERS SOC PSYCHOL, V65, P375, DOI 10.1037/0022-3514.65.2.375; Charles ST, 2016, PSYCHOL AGING, V31, P661, DOI 10.1037/pag0000118; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Durston S, 2006, NEUROPSYCHOLOGIA, V44, P2149, DOI 10.1016/j.neuropsychologia.2005.10.010; Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498; Farwell L, 1998, J PERS, V66, P65, DOI 10.1111/1467-6494.00003; Fournier M, 2002, BRIT J HEALTH PSYCH, V7, P409, DOI 10.1348/135910702320645390; FRIEDMAN LC, 1992, J BEHAV MED, V15, P127, DOI 10.1007/BF00848321; Friedman LC, 2006, PSYCHO-ONCOLOGY, V15, P595, DOI 10.1002/pon.992; Fritsch T, 2007, GERONTOLOGIST, V47, P307, DOI 10.1093/geront/47.3.307; Ganguli M, 2013, NEUROLOGY, V80, P2112, DOI 10.1212/WNL.0b013e318295d776; Gawronski KAB, 2016, PSYCHOSOM MED, V78, P819, DOI 10.1097/PSY.0000000000000345; Gordon NS, 2016, COGENT PSYCHOL, V3, DOI 10.1080/23311908.2016.1195068; Herzog AR, 1997, J GERONTOL B-PSYCHOL, V52, P37, DOI 10.1093/geronb/52B.Special_Issue.37; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Huffman JC, 2011, HEART INT, V6, P47, DOI 10.4081/hi.2011.e14; IBM Corp, 2017, SPSS STAT WIND; Jenaabadi H, 2015, HEALTH-LONDON, V7, P865, DOI [DOI 10.4236/HEALTH.2015.77102, 10.4236/health.2015.77102.]; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Lachman ME, 2014, ASSESSMENT, V21, P404, DOI 10.1177/1073191113508807; Lachman ME, 2008, HDB COGNITIVE AGING; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; Luchetti M, 2016, J GERONTOL B-PSYCHOL, V71, P591, DOI 10.1093/geronb/gbu184; Mann T, 2001, ANN BEHAV MED, V23, P26, DOI 10.1207/S15324796ABM2301_5; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mohammadi N, 2018, GEN HOSP PSYCHIAT, V51, P46, DOI 10.1016/j.genhosppsych.2017.12.004; Mondloch MV, 2001, CAN MED ASSOC J, V165, P174; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rabinowitz AR, 2018, APPL NEUROPSYCH-ADUL, V25, P295, DOI 10.1080/23279095.2018.1458514; Ramanathan DM, 2011, BRAIN INJURY, V25, P328, DOI 10.3109/02699052.2011.554336; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rasmussen HN, 2006, J PERS, V74, P1721, DOI 10.1111/j.1467-6494.2006.00426.x; Rasmussen HN, 2009, ANN BEHAV MED, V37, P239, DOI 10.1007/s12160-009-9111-x; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Schacter DL, 2007, NAT NEUROSCI, V10, P1345, DOI 10.1038/nn1107-1345; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; SCHEIER MF, 1992, COGNITIVE THER RES, V16, P201, DOI 10.1007/BF01173489; SCHWARZER R, 1994, PSYCHOL HEALTH, V9, P161, DOI 10.1080/08870449408407475; Seligman M., 1990, LEARNED OPTIMISM CHA; Shepperd JA, 1996, J RES PERS, V30, P517, DOI 10.1006/jrpe.1996.0038; STANTON AL, 1993, HEALTH PSYCHOL, V12, P16, DOI 10.1037/0278-6133.12.1.16; Steptoe A, 2008, BRIT J PSYCHOL, V99, P211, DOI 10.1111/j.2044-8295.2008.tb00474.x; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Trunzo JJ, 2003, J CONSULT CLIN PSYCH, V71, P805, DOI 10.1037/0022-006X.71.4.805; Tyng CM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01454; Vadikolias K, 2012, BRAIN BEHAV, V2, P620, DOI 10.1002/brb3.88; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Whitbourne SB, 2008, J APPL GERONTOL, V27, P331, DOI 10.1177/0733464807312175; Yaffe K, 2009, NEUROLOGY, V72, P2029, DOI 10.1212/WNL.0b013e3181a92c36; Yang JY, 2013, NEUROSCI LETT, V553, P201, DOI 10.1016/j.neulet.2013.08.032	62	2	2	1	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2019	33	8					985	990		10.1080/02699052.2019.1606448		MAY 2019	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM6FW	WOS:000469685100001	31055941				2022-02-06	
J	O'Neil, ME; Laman-Maharg, B; Schnurr, PP; Carlson, KF; Twamley, EW; Peterson, C; Storzbach, D; Helfand, M; Sayer, NA				O'Neil, Maya E.; Laman-Maharg, Benjamin; Schnurr, Paula P.; Carlson, Kathleen F.; Twamley, Elizabeth W.; Peterson, Carolyn; Storzbach, Daniel; Helfand, Mark; Sayer, Nina A.			Objective cognitive impairment and subjective cognitive problems in veterans initiating psychotherapy for posttraumatic stress disorder: An exploratory study	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Cognitive symptoms; cognitive therapies; evidence based practice; exposure therapies; neuropsychology; PTSD; veterans	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; OEF/OIF VETERANS; VERBAL MEMORY; COMPLAINTS; PERSONNEL; SYMPTOMS; EXPOSURE; THERAPY; PTSD	The prevalence of cognitive impairment in Veterans initiating an evidence-based psychotherapy (EBP) for posttraumatic stress disorder (PTSD) is not yet established and has implications for service delivery. Our objectives were to (1) describe the type, severity, and prevalence of objective cognitive impairment and subjective cognitive problems experienced by Veterans at the time they began an EBP for PTSD and (2) determine whether assessments of objective cognitive impairment and subjective cognitive problems agree. We conducted objective and subjective (self-report) cognitive assessments in a sample of 38 Veterans initiating EBP for PTSD at one Veterans Affairs Medical Center. Thirty Veterans produced valid assessments. Almost half (14/30) of the participants demonstrated objective impairment in one or more cognitive domains, primarily in the areas of learning, memory, and processing speed. Almost all (29/30) participants endorsed moderate or greater cognitive problems on at least one self-report measure. After adjustment for multiple comparisons, there were no significant correlations between objective and subjective assessments. Objective cognitive impairment and subjective cognitive problems are common in Veterans beginning an EBP for PTSD. Longitudinal research on a larger sample is warranted to better understand relationships among subjective cognitive problems, objective cognitive impairment, and PTSD treatment participation and outcomes.	[O'Neil, Maya E.; Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [O'Neil, Maya E.; Helfand, Mark] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [O'Neil, Maya E.; Laman-Maharg, Benjamin; Carlson, Kathleen F.; Peterson, Carolyn; Storzbach, Daniel; Helfand, Mark] VA Portland Hlth Care Syst, Portland, OR USA; [Schnurr, Paula P.] Natl Ctr PTSD, Execut Div, White River Jct, VT USA; [Schnurr, Paula P.] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ Portland State Univ Sch Pu, Portland, OR USA; [Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Twamley, Elizabeth W.] Univ Calif San Diego, San Diego Dept Psychiat, San Diego, CA 92103 USA; [Peterson, Carolyn] Univ Oregon, Dept Counseling Psychol, Eugene, OR 97403 USA; [Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Helfand, Mark] Oregon Hlth & Sci Univ, Dept Gen Internal Med, Portland, OR 97201 USA; [Sayer, Nina A.] Minneapolis VA Healthcare Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Sayer, Nina A.] Univ Minnesota, Dept Med & Psychiat, Minneapolis, MN USA		O'Neil, ME (corresponding author), VA Portland Hlth Care Syst, R&D 66, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	maya.oneil@va.gov			Agency for Healthcare Research QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; Veterans Affairs Health Services Research and Development Center of Innovation grant, Center to Improve Veteran Involvement in Care [CIN 13-404]	This work was supported by an Agency for Healthcare Research & Quality-funded PCOR K12 award to M.E.O. (#K12HS022981) and a Veterans Affairs Health Services Research and Development Center of Innovation grant, Center to Improve Veteran Involvement in Care, Award #CIN 13-404. This material is the result of work supported with resources and the use of facilities at the Veterans Affairs Portland Health Care System, Portland, Oregon. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The corresponding author (M.E. O'Neil) declares she had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Benton A.L., 1983, MULTILINGUAL APLASIA, V2nd; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cusack K, 2016, CLIN PSYCHOL REV, V43, P128, DOI 10.1016/j.cpr.2015.10.003; Delis D.C., 2000, CALIFORNIA VERBAL LE; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Haaland KY, 2016, J INT NEUROPSYCH SOC, V22, P643, DOI 10.1017/S1355617716000424; Harpaz-Rotem I., 2015, FY2015 OVERVIEW PTSD; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Johnson ES, 2013, PHARMACOEPIDEM DR S, V22, P1, DOI 10.1002/pds.3334; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Nijdam MJ, 2015, J CLIN PSYCHIAT, V76, pE1023, DOI 10.4088/JCP.14m09438; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Reitan R, 1985, HALSTEAD REITAN NEUR; Roca V, 2001, AM J PSYCHIAT, V158, P1738, DOI 10.1176/appi.ajp.158.10.1738-a; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Stricker NH, 2017, J CLIN EXP NEUROPSYC, V39, P768, DOI 10.1080/13803395.2016.1264575; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; US Department of Veterans Affairs, 2016, VA MENT HLTH CAR FAC; US Department of Veterans Affairs, 2017, VA DOD CLIN PRACT GU; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wechsler D., 2008, WECHSLER ADULT INTEL; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029	33	2	2	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAY 4	2019	26	3					247	254		10.1080/23279095.2017.1395334			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HX3CH	WOS:000467268500005	29172725				2022-02-06	
J	Debert, CT; Stilling, J; Wang, M; Sajobi, T; Kowalski, K; Benson, BW; Yeates, K; Dukelow, SP				Debert, Chantel Teresa; Stilling, Joan; Wang, Meng; Sajobi, Tolulope; Kowalski, Kristina; Benson, Brian Walter; Yeates, Keith; Dukelow, Sean Peter			The Montreal Cognitive Assessment as a Cognitive Screening Tool in Athletes	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Concussion; Montreal Cognitive Assessment; Cognitive assessment tool; Athletes; Sport-related concussion	4TH INTERNATIONAL-CONFERENCE; TEST-RETEST RELIABILITY; NEUROCOGNITIVE PERFORMANCE; HIGH-SCHOOL; CONSENSUS STATEMENT; ASSESSMENT MOCA; SPORT HELD; CONCUSSION; SCORES; IMPAIRMENT	Background: The Montreal Cognitive Assessment (MoCA) is a cognitive screening tool known to accurately measure mild cognitive impairment (MCI) in many different neurological populations. Objective: We aimed to determine whether a sport-related concussion (SRC) history and other concussion modifiers influence global cognitive function in high-performance athletes. Methods: A cross-sectional study of 326 varsity and national team athletes aged 18-36 years was completed at the University of Calgary Sports Medicine Clinic, Calgary, Alberta, Canada. Logistic regression analysis was used to examine the association between the total MoCA score, MoCA subscales, and number of previous SRC, adjusting for age, sex, sport participation (SP), and concussion modifiers. Results: Athletes with a history of three or more SRC were 5.36 times more likely to score less than 26/30 on the MoCA (the cutoff for MCI) compared to athletes with two or less SRC (p = 0.02). Males were 2.23 times more likely to have MCI than females (p = 0.0004). There was a significant relationship between the number of previous concussions and the MoCA subscales of attention (p = 0.05) and abstraction (p = 0.003). Age, SP, and concussion modifiers (migraine, depression, anxiety, and attention deficit and hyperactivity disorder) did not influence the relationship between MoCA and previous concussion history. Conclusion: In the appropriate clinical context, cognitive screening with the MoCA may benefit clinical care in athletes with multiple previous SRC, but should not replace a full neuropsychological assessment. Thus, further research is needed to compare the MoCA to full neuropsychological assessments in this population. RESUME:L'evaluation cognitive de Montreal comme outil de depistage pour les athletes. Contexte: L'evaluation cognitive de Montreal (MoCA en anglais) constitue un outil de depistage cognitif repute pour mesurer de facon precise des troubles legers de la cognition (TLC) parmi divers segments de la population. Objectif: Nous avons cherche a determiner dans quelle mesure des commotions cerebrales anterieures liees au sport ainsi que des facteurs modificateurs produits par ces memes commotions peuvent avoir un impact sur les fonctions cognitives globales d'athletes de haut niveau. Methodes: Une etude de prevalence incluant 326 athletes universitaires et membres d'equipes nationales ages entre 18 et 36 ans a ete completee a la Clinique de medecine sportive de l'Universite de Calgary (Canada). Pour ce faire, nous avons fait appel a l'analyse de regression logistique pour examiner l'association pouvant exister entre les scores totaux au MoCA, les sous-echelles du MoCA et le nombre de commotions cerebrales liees a la pratique d'un sport, et ce, apres controle de l'age, du sexe, du taux de participation sportive et des facteurs modificateurs lies a ces memes commotions. Resultats: Les athletes victimes de trois commotions cerebrales ou plus en lien avec la pratique d'un sport etaient 5,36 fois plus susceptibles d'obtenir un score de moins de 26/30 au MoCA (la valeur seuil d'un TLC) en comparaison avec des athletes ayant subi deux commotions ou moins (p = 0,02). Les hommes etaient par ailleurs 2,23 fois plus susceptibles que les femmes de souffrir de TLC (p = 0,0004). De plus, on a note une relation notable entre le nombre de commotions cerebrales anterieures et les sous-echelles de l'attention (p = 0,05) et de l'abstraction (p = 0,003) du MoCA. L'age, le taux de participation sportive et les facteurs modificateurs induits par les commotions cerebrales (migraine, depression, anxiete, TDAH) n'ont pas eu d'incidence sur la relation entre les scores au MoCA et des antecedents de commotions cerebrales. Conclusion: Dans un contexte clinique approprie, le depistage cognitif au moyen du MoCA pourrait ameliorer les soins cliniques prodigues aux athletes victimes de nombreuses commotions cerebrales. Il ne devrait toutefois pas remplacer une evaluation neuropsychologique complete si cela est necessaire. De ce point de vue, des recherches plus approfondies sont necessaires afin de comparer le MoCA a une evaluation neuropsychologique complete dans le cas de ce segment de la population.	[Debert, Chantel Teresa; Stilling, Joan; Wang, Meng; Sajobi, Tolulope; Benson, Brian Walter; Dukelow, Sean Peter] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Debert, Chantel Teresa; Kowalski, Kristina; Benson, Brian Walter; Yeates, Keith] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Sajobi, Tolulope] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Sajobi, Tolulope] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Benson, Brian Walter] WinSport Med Clin, Calgary, AB, Canada; [Benson, Brian Walter; Dukelow, Sean Peter] Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Benson, Brian Walter] Canadian Sport Inst Calgary, Calgary, AB, Canada; [Dukelow, Sean Peter] Univ Calgary, Fac Kinesiol, Dept Kinesiol, Calgary, AB, Canada		Debert, CT (corresponding author), Univ Calgary, Div Phys Med & Rehabil, Dept Clin Neurosci, 1403-29 St NW, Calgary, AB T2N 2T9, Canada.	chantel.debert@ahs.ca	Yeates, Keith/AAJ-4223-2020	Debert, Chantel/0000-0002-2704-0438; Yeates, Keith/0000-0001-7680-2892	Own the Podium funding agency	This work was supported by Own the Podium funding agency (Supporting Canadian Athletes to achieve excellence).	Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; [Anonymous], 2010, COMMUN SOIL SCI PLAN, V41, P231, DOI [10.1080/00103620903460757, DOI 10.1007/s12439-010-0218-0]; [Anonymous], 2014, PEERJ, V2, pe447, DOI DOI 10.1177/2325967114550623; [Anonymous], 1999, JAMA-J AM MED ASSOC, V282, P964, DOI DOI 10.1001/jama.282.10.964; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brown CN, 2007, J ATHL TRAINING, V42, P515; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Freitas S, 2011, J CLIN EXP NEUROPSYC, V33, P989, DOI 10.1080/13803395.2011.589374; Frenette LC, 2019, BRAIN INJURY, V33, P189, DOI 10.1080/02699052.2018.1542506; Fujiwara Y, 2013, J GERIATR PSYCH NEUR, V26, P209, DOI 10.1177/0891988713497096; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Jones NS, 2014, CLIN J SPORT MED, V24, P284, DOI 10.1097/JSM.0000000000000031; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lee JY, 2008, J GERIATR PSYCH NEUR, V21, P104, DOI 10.1177/0891988708316855; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Panwar N, 2019, ASIAN J PSYCHIATR, V41, P60, DOI 10.1016/j.ajp.2018.08.007; Rahman TTA, 2009, GERIATR GERONTOL INT, V9, P54, DOI 10.1111/j.1447-0594.2008.00509.x; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Wen Hong-Bo, 2008, Zhonghua Nei Ke Za Zhi, V47, P36; Yengo-Kahn AM, 2015, PHYSICIAN SPORTSMED, V43, P227, DOI 10.1080/00913847.2015.1071638; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	45	2	2	5	21	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2019	46	3					311	318		10.1017/cjn.2019.18			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ID5XJ	WOS:000471750300008	31084666	Bronze			2022-02-06	
J	Dubey, V; Nau, E; Sycip, M				Dubey, Vivek; Nau, Eric; Sycip, Marc			Altered Mental Status in Children After Traumatic Brain Injury	PEDIATRIC ANNALS			English	Article							GUIDELINES; MANAGEMENT; MORTALITY	Pediatric head injuries are common and may present with varying degrees of altered mental status in children. The approach to evaluation, diagnosis, treatment, and prevention of further injury is important in achieving good health outcomes after a head injury. In this article, we review the pathophysiology, classifications, signs and symptoms, and management of traumatic brain injury. We also discuss the importance of preventing a secondary injury during recovery by educating families about head injury sequelae and return-to-play guidelines.	[Dubey, Vivek; Nau, Eric; Sycip, Marc] Childrens Mercy Kansas City, Div Emergency Med, 2401 Gillham Rd, Kansas City, MO 64108 USA		Nau, E (corresponding author), Childrens Mercy Kansas City, Div Emergency Med, 2401 Gillham Rd, Kansas City, MO 64108 USA.	ednau@cmh.edu					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS9; American Heart Association, PED ADV LIF SUPP 12; Boone Myles Dustin, 2015, Surg Neurol Int, V6, P177, DOI 10.4103/2152-7806.170248; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Brown FD, 2000, J ACCID EMERG MED, V17, P268; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Guilliams K, 2016, J CHILD NEUROL, V31, P35, DOI 10.1177/0883073814562626; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hardcastle N, 2014, PEDIATR ANESTH, V24, P703, DOI 10.1111/pan.12415; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levitt CJ, 1994, CHILD ABUSE MED DIAG, P1; Lorton F, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0287-3; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; Nita Dragos A, 2016, Pediatr Neurol Briefs, V30, P18, DOI 10.15844/pedneurbriefs-30-3-1; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Schutzman SA, 2010, FLEISHER LUDWIGS TXB, P247; Shi JX, 2009, BRAIN INJURY, V23, P602, DOI 10.1080/02699050903014907; Tasker RC, 2006, DEV NEUROSCI-BASEL, V28, P302, DOI 10.1159/000094156	27	2	2	2	2	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Ann.	MAY	2019	48	5					E192	E196		10.3928/19382359-20190422-03			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	HX7CW	WOS:000467562600004	31067334				2022-02-06	
J	Friedl, NK; Muensterer, OJ				Friedl, Nina K.; Muensterer, Oliver J.			Special Aspects in Pediatric Surgical Inpatient Care of Refugee Children: A Comparative Cohort Study	CHILDREN-BASEL			English	Article						refugee; children; anemia; burns; trauma; foreign bodies; Methicillin-resistant Staphylococcus aureus; Multidrugresistant gram negative bacteria	HEALTH-CARE; ASYLUM SEEKERS; MINOR REFUGEES; GERMANY; ANEMIA; BURNS; NEEDS	Background: Recently, the number of refugees in Germany has skyrocketed, leading to a marked increase in refugee children admitted to hospitals. This study describes the special characteristics encountered in pediatric surgical inpatient refugees compared to locally residing patients. Methods: Hospital records of minor refugees admitted to our department from 2005 up to and including 2015 were retrospectively reviewed. Demographic data, diagnoses, comorbidities, body mass indexes, hemoglobin values, and lengths of stay were extracted and statistically compared to local patients. Results: A total of 63 refugee children were analyzed and compared to 24,983 locally residing children. There was no difference in median body mass index (16.2 vs. 16.3, respectively, p = 0.26). However, refugee children had significantly lower hemoglobin values (11.95 vs. 12.79 g/dL, p < 0.0001) and were more likely to be colonized with methicillin-resistant Staphylococcus. aureus (8% vs. 0.04%, p < 0.01). Refugees were much more likely to present with burn injuries (16% versus 3% of admissions, p < 0.001), esophageal foreign bodies (4% vs. 0.5%, p < 0.001), as well as trauma, except for closed head injury. Conclusion: The cohort of refugee children in this study was found to be at a particular risk for suffering from burn injuries, trauma, foreign body aspirations, and anemia. Appropriate preventive measures and screening programs should be implemented accordingly.	[Friedl, Nina K.; Muensterer, Oliver J.] Johannes Gutenberg Univ Mainz, Dept Pediat Surg, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany		Muensterer, OJ (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pediat Surg, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany.	nina-friedl@gmx.de; oliver.muensterer@unimedizin-mainz.de		Muensterer, Oliver/0000-0003-2790-4395			[Anonymous], 2016, LANCET, V388, P1130, DOI 10.1016/S0140-6736(16)31642-7; Battersby A, 2018, CHILD CARE HLTH DEV, V44, P161, DOI 10.1111/cch.12485; Beukeboom C, 2018, J IMMIGR MINOR HEALT, V20, P1317, DOI 10.1007/s10903-018-0730-9; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Buchmuller T, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00212; Dempsey MP, 2006, BURNS, V32, P242, DOI 10.1016/j.burns.2005.09.004; Dissanaike S, 2009, INT REV PSYCHIATR, V21, P505, DOI 10.3109/09540260903340865; Guess MA, 2019, J IMMIGR MINOR HEALT, V21, P793, DOI 10.1007/s10903-018-0795-5; Gungor A, 2018, INT HEALTH, V10, P371, DOI 10.1093/inthealth/ihy034; Heudorf U, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.2.30109; Hodes M, 2018, EUR CHILD ADOLES PSY, V27, P389, DOI 10.1007/s00787-017-1094-8; Kerbl R, 2018, J PEDIATR-US, V197, P323, DOI 10.1016/j.jpeds.2018.03.061; Kim SY, 2018, ANNU REV CLIN PSYCHO, V14, P343, DOI [10.1146/annurev-clinpsy-050817084925, 10.1146/annurev-clinpsy-050817-084925]; Kossow A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198103; Leidman E, 2018, JAMA-J AM MED ASSOC, V319, P1505, DOI 10.1001/jama.2018.2405; Lichtl C, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2672-7; Loucas M, 2018, EUR J PEDIATR SURG, V28, P60, DOI 10.1055/s-0037-1604398; Lynch M A, 2001, Med Confl Surviv, V17, P125, DOI 10.1080/13623690108409566; Mellin-Sanchez L, 2018, CLIN CHEM, V64, P1567, DOI 10.1373/clinchem.2017.283283; Mjones S, 2005, EUR J PEDIATR, V164, P535, DOI 10.1007/s00431-005-1696-x; Muller LRF, 2019, CHILD ADOL PSYCH MEN, V13, DOI 10.1186/s13034-019-0268-1; Newman K, 2019, J PAEDIATR CHILD H, V55, P574, DOI 10.1111/jpc.14250; Nicolai T, 2015, NEW ENGL J MED, V373, P1593, DOI 10.1056/NEJMp1512139; Pavlopoulou ID, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0888-7; Plener PL, 2017, EUR CHILD ADOLES PSY, V26, P733, DOI 10.1007/s00787-017-0943-9; Pohl C, 2017, EUR J PEDIATR, V176, P1681, DOI 10.1007/s00431-017-3014-9; Schiergens KA, 2018, NEUROPEDIATRICS, V49, P363, DOI 10.1055/s-0038-1661415; Spallek J, 2016, BUNDESGESUNDHEITSBLA, V59, P636, DOI 10.1007/s00103-016-2339-2; Statistisches Bundesamt, 2018, MIGR 1991 2017; Tenenbaum T, 2016, INFECT CONT HOSP EP, V37, P1310, DOI 10.1017/ice.2016.179; Theodorou P, 2013, BURNS, V39, P49, DOI 10.1016/j.burns.2012.05.003; Zur B, 2016, INTERNIST, V57, P444, DOI 10.1007/s00108-016-0030-1	32	2	2	1	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9067		CHILDREN-BASEL	Children-Basel	MAY	2019	6	5							62	10.3390/children6050062			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	IC4SS	WOS:000470956200001	31052220	Green Submitted, Green Published, gold			2022-02-06	
J	Juengst, SB; Silva, V; Goldin, Y; Cicerone, K; Lengenfelder, J; Chiaravalloti, N; Driver, S; Mellick, D; Dart, G; Kew, CL; Nabasny, A; Bell, KR				Juengst, Shannon B.; Silva, Valeria; Goldin, Yelena; Cicerone, Keith; Lengenfelder, Jean; Chiaravalloti, Nancy; Driver, Simon; Mellick, David; Dart, Georgianna; Kew, Chung Lin; Nabasny, Andrew; Bell, Kathleen R.			Care partner problem solving training (CP-PST) for care partners of adults with traumatic brain injury during inpatient rehabilitation: Study protocol for a multisite, randomized, single-blind clinical feasibility trial	CONTEMPORARY CLINICAL TRIALS			English	Article							FAMILY CAREGIVERS; TELEPHONE INTERVENTION; INFORMAL CAREGIVERS; STROKE SURVIVORS; SOCIAL SUPPORT; HEALTH; NEEDS; LONG; INDIVIDUALS; LIFE	Traumatic brain injury (TBI) often leads to immediate and chronic functional impairments that affect care partners, or those providing physical and/or emotional support to individuals with TBI. The many challenges associated with being a care partner often lead to caregiver burden and can compromise the well-being and quality of life of care partners and individuals with TBI under their care. Equipping care partners with problem-solving skills could facilitate and sustain their transition into this supportive role. Problem-solving training (PST) has demonstrated efficacy for providing such skills to care partners of individuals with TBI after discharge from inpatient rehabilitation. We propose that PST delivered to care partners during inpatient rehabilitation of individuals with TBI will provide care partners with the skills to manage their caregiving roles across the transition from hospital to home. Herein, we describe the methodology of a current randomized controlled trial that examines the feasibility and efficacy of PST plus TBI education compared to TBI education alone to improve care partner burden, emotional distress, and adaptive coping when delivered during the inpatient rehabilitation stay of individuals with moderate-severe TBI.	[Juengst, Shannon B.; Silva, Valeria; Bell, Kathleen R.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Juengst, Shannon B.; Kew, Chung Lin; Nabasny, Andrew] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, Dallas, TX 75390 USA; [Goldin, Yelena; Cicerone, Keith; Dart, Georgianna] Hackensack Meridian Hlth, JFK Johnson Rehabil Inst, Cognit Rehabil Dept, Edison, NJ USA; [Cicerone, Keith] Hackensack Meridian Hlth, JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ USA; [Lengenfelder, Jean] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [Lengenfelder, Jean; Chiaravalloti, Nancy] Rutgers New Jersey Med Sch, Dept Neurol, Newark, NJ USA; [Lengenfelder, Jean; Chiaravalloti, Nancy] Kessler Fdn, E Hanover, NJ USA; [Driver, Simon] Baylor Scott & White Inst Rehabil, Dallas, TX USA; [Mellick, David] Craig Hosp, Englewood, CO USA		Juengst, SB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA.	Shannon.Juengst@UTSouthwestern.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X; Chiaravalloti, Nancy/0000-0003-2943-7567; Bell, Kathleen/0000-0002-0928-2046; driver, simon/0000-0003-2356-432X; Kew, Novelle/0000-0003-1720-4459	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0013, 90DPTB0003, 90DPTB0014]	The contents of this manuscript were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant numbers: 90DPTB0013; 90DPTB0003; 90DPTB0014). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government.	[Anonymous], PA17062; Arnould A, 2015, BRAIN INJURY, V29, P1597, DOI 10.3109/02699052.2015.1075156; Attkisson C. C., 1999, USE PSYCHOL TESTING, P1333; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bell K. R., 2014, CONTEMP CLIN TRIALS, V40C, P54, DOI [10.1016/J.CCT2014.11.001, DOI 10.1016/J.CCT2014.11.001]; Bell KR, 2017, J NEUROTRAUM, V34, P313, DOI 10.1089/neu.2016.4444; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bhalerao U, 2013, BRAIN INJURY, V27, P767, DOI 10.3109/02699052.2013.793396; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ US; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Elliott TR, 2009, BEHAV RES THER, V47, P548, DOI 10.1016/j.brat.2009.03.006; Elliott TR, 2009, J CLIN PSYCHOL, V65, P406, DOI 10.1002/jclp.20527; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Gitlin LN, 2005, J AGING HEALTH, V17, P148, DOI 10.1177/0898264304274184; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Grant JS, 2006, ARCH PHYS MED REHAB, V87, P343, DOI 10.1016/j.apmr.2005.09.019; Grant JS, 2002, STROKE, V33, P2060, DOI 10.1161/01.STR.0000020711.38824.E3; Hart T, 2013, DISABIL REHABIL, V35, P1668, DOI 10.3109/09638288.2012.751131; Hatcher RL, 2006, PSYCHOTHER RES, V16, P12, DOI 10.1080/10503300500352500; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; Hildebrand MW, 2012, AM J PHYS MED REHAB, V91, P715, DOI 10.1097/PHM.0b013e31824ad462; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Joice Sara, 2012, Nurs Stand, V26, P39; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lefebvre H, 2008, CAN J NURS RES, V40, P142; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; McPherson KM, 2000, INT J REHABIL RES, V23, P295, DOI 10.1097/00004356-200023040-00005; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Nezu CM, 2005, WILEY SER FOREN CLIN, P103; Nezu CM., 2007, SOLVING LIFES PROBLE; Niemeier JP, 2019, ARCH PHYS MED REHAB, V100, pS65, DOI 10.1016/j.apmr.2018.07.422; Nonterah CW, 2013, BRAIN INJURY, V27, P1287, DOI 10.3109/02699052.2013.812243; Perepletchikova F, 2005, CLIN PSYCHOL-SCI PR, V12, P365, DOI 10.1093/clipsy/bpi045; Pfeiffer K, 2014, J CONSULT CLIN PSYCH, V82, P628, DOI 10.1037/a0036987; Pinquart M, 2007, J GERONTOL B-PSYCHOL, V62, pP126, DOI 10.1093/geronb/62.2.P126; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Powell JM, 2017, J HEAD TRAUMA REHAB, V32, pE33, DOI 10.1097/HTR.0000000000000219; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Saunders J. B., ADDICTION, V88; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Steffen AM, 2002, J GERONTOL B-PSYCHOL, V57, pP74, DOI 10.1093/geronb/57.1.P74; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Tarlow BJ, 2004, RES AGING, V26, P429, DOI 10.1177/0164027504264493	64	2	2	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	MAY	2019	80						9	15		10.1016/j.cct.2019.03.004			7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	HX6IO	WOS:000467507500002	30885800				2022-02-06	
J	McGinnis, I; Cobb, J; Tierney, R; Russ, A				McGinnis, Ian; Cobb, Justin; Tierney, Ryan; Russ, Anne			Vestibular Rehabilitation for Dizziness and Imbalance Following Concussion: A Critically Appraised Topic	INTERNATIONAL JOURNAL OF ATHLETIC THERAPY & TRAINING			English	Article						evidence-based; mTBI; recovery	TRAUMATIC BRAIN-INJURY	Clinical Question: What is the efficacy of vestibular rehabilitation for treating imbalance and self-reported dizziness in patients experiencing prolonged symptoms of concussion? Clinical Bottom Line: There is consistent, but low-level, evidence supporting that vestibular rehabilitation can have a positive effect on self-reported dizziness (dizziness severity, Dizziness Handicap Inventory [DHI], Activities-Specific Balance Confidence Scale [ABC]) and objective balance (Sensory Organization Test [SOT], Balance Error Scoring System [BESS]) in patients with prolonged symptoms following concussion. Vestibular rehabilitation is not for every concussed patient. Several, though few, patients did not improve or became worse with the implementation of vestibular rehabilitation. Many of the vestibular rehabilitation exercises utilized in these studies are easily accessible to athletic trainers and, with informed decision making and proper oversight, could be implemented in the athletic training room.	[McGinnis, Ian; Cobb, Justin; Tierney, Ryan; Russ, Anne] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA		Russ, A (corresponding author), Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA.	anne.russ@temple.edu					Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Gottshall KR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00106; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Peterson MD, 2010, J HEAD TRAUMA REHAB, V25, P193, DOI 10.1097/HTR.0b013e3181dc82fa; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; 2009, CLIN J SPORT MED, V19, P216, DOI DOI 10.1097/JSM.0B013E31819D6EDB; 2015, BRAIN INJURY, V29, P175, DOI DOI 10.3109/02699052.2014.965206	12	2	2	0	5	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	2157-7277	2157-7285		INT J ATHL THER TRAI	Int. J. Athl. Ther. Train.	MAY	2019	24	3					95	99		10.1123/ijatt.2018-0007			5	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	HW1VQ	WOS:000466471600002		Bronze			2022-02-06	
J	Sanz-Garcia, A; Perez-Romero, M; Pastor, J; Sola, RG; Vega-Zelaya, L; Monasterio, F; Torrecilla, C; Vega, G; Pulido-Rivas, P; Ortega, GJ				Sanz-Garcia, Ancor; Perez-Romero, Miriam; Pastor, Jesus; Sola, Rafael G.; Vega-Zelaya, Lorena; Monasterio, Fernando; Torrecilla, Carmen; Vega, Gema; Pulido-Rivas, Paloma; Ortega, Guillermo J.			Is it possible to extract intracranial pressure information based on the EEG activity?	REVISTA DE NEUROLOGIA			Spanish	Article						Electroencephalography; Granger causality; Intracranial pressure; Subarachnoid hemorrhage; Traumatic brain injury	ANESTHESIA; INDUCTION; MIDAZOLAM; FENTANYL	Introduction. The capability of the electroencephalography (EEG) of recording the bioelectrical activity of the brain has made of it a fundamental tool for the evaluation of the patient's neurological condition. In recent years, moreover, it has also begun to be used in obtaining information for other kind of variables, as the ones related with the cerebral hemodynamics. Aim. To study the potential relationship between the EEG activity and the intracranial pressure (ICP) in patients suffering from traumatic brain injury and subarachnoid hemorrhage, during their stay at the intensive care unit. Patients and methods. Twenty-one adult patients (10 women) were included in the present observational prospective cohort study. They suffered from either traumatic brain injury or subarachnoid hemorrhage, requiring continuous EEG and ICP monitoring. In every patient, Granger causality between spectral functions of the EEG and the ICP was evaluated. Temporal windows of 10 minute were used to evaluate whether a causal relationship between those variables exist or not. In all of the cases, several days of continuous recording and assessment were performed. Results. In most patients and during most of the time, Granger causality turns out to be significant in the direction from the EEG to the ICP, meaning that the EEG dynamics actually leads the ICP dynamics. Conclusions. The present work provides useful information and shed light in discovering a hidden relationship between the ICP and EEG dynamics. The potential use of this relationship could lead to develop a medical device to measure ICP in a non-invasive fashion.	[Pastor, Jesus; Vega-Zelaya, Lorena] Hosp Univ La Princesa, Serv Neurofisiol Cim, Madrid, Spain; [Sola, Rafael G.; Pulido-Rivas, Paloma; Ortega, Guillermo J.] Hosp Univ La Princesa, Serv Neurocirugia, Madrid, Spain; [Monasterio, Fernando; Torrecilla, Carmen; Vega, Gema] Hosp Univ La Princesa, Unidad Cuidados Intens, Madrid, Spain; [Sanz-Garcia, Ancor; Perez-Romero, Miriam; Pastor, Jesus; Sola, Rafael G.; Monasterio, Fernando; Torrecilla, Carmen; Vega, Gema; Pulido-Rivas, Paloma; Ortega, Guillermo J.] Hosp Univ La Princesa, Inst Invest Sanitaria, Madrid, Spain		Ortega, GJ (corresponding author), Hosp Univ La Princesa, Fdn Invest Biomed, Hosp La Princesa, Diego de Leon 62, E-28006 Madrid, Spain.	gjortega.hlpr@salud.madrid.org	Pastor, Jesus/AAH-9238-2020; Sanz-Garcia, Ancor/AAL-8043-2021; Vega-Zelaya, Lorena/AAV-5670-2021	Pastor, Jesus/0000-0001-6870-8409; Sanz-Garcia, Ancor/0000-0002-5024-5108; G. Sola, Rafael/0000-0002-0063-9301; Pulido Rivas, Paloma/0000-0002-5933-9274			ALBRECHT RF, 1977, ANESTHESIOLOGY, V47, P252, DOI 10.1097/00000542-197709000-00004; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Brown CR, ANESTHESIOLOGY; Chen H, 2012, CAN J NEUROL SCI, V39, P483, DOI 10.1017/S0317167100013998; Colton K, 2014, J TRAUMA ACUTE CARE, V77, P47, DOI 10.1097/TA.0000000000000270; Connolly M, 2016, ACTA NEUROCHIR SUPPL, V122, P225, DOI 10.1007/978-3-319-22533-3_45; Connolly M, 2015, NEUROCRIT CARE, V22, P212, DOI 10.1007/s12028-014-0059-8; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hafner CM, 2009, STAT NEERL, V63, P294, DOI 10.1111/j.1467-9574.2009.00424.x; Horcajadas A, 2011, NEUROCIRUGIA, V22, P310, DOI 10.4321/S1130-14732011000400002; Huang ZC, 2002, CLIN NEUROPHYSIOL, V113, P446, DOI 10.1016/S1388-2457(02)00012-3; Katyal N, 2017, CASE REP NEUROL MED, V2017, DOI 10.1155/2017/4742026; Khan James, 2014, J Anaesthesiol Clin Pharmacol, V30, P409, DOI 10.4103/0970-9185.137280; Kirkman M A, 2013, BRIT J ANAESTH, V112, P36; Kristiansson H, 2013, J NEUROSURG ANESTH, V25, P372, DOI 10.1097/ANA.0b013e31829795ce; Kuizenga K, 2001, BRIT J ANAESTH, V86, P354, DOI 10.1093/bja/86.3.354; Lescot T, 2005, ACTA NEUROCHIR, V147, P125, DOI 10.1007/s00701-004-0355-8; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MUNARI C, 1981, ELECTROEN CLIN NEURO, V51, P170, DOI 10.1016/0013-4694(81)90006-7; PAPAZIAN L, 1993, BRIT J ANAESTH, V71, P267, DOI 10.1093/bja/71.2.267; Purdon PL, 2015, ANESTHESIOLOGY, V123, P937, DOI 10.1097/ALN.0000000000000841; Ravi R., 2003, CURR ANAESTH CRIT CA, V14, P229, DOI DOI 10.1016/J.CACC.2003.09.003; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Sanz-Garcia A, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aadeea; Sanz-Garcia A, 2017, REV NEUROLOGIA, V64, P337, DOI 10.33588/rn.6408.2016269; SEBEL PS, 1981, ANESTHESIOLOGY, V55, P203, DOI 10.1097/00000542-198109000-00004; Sharbrough FW, 1973, STROKE, V4, P674, DOI 10.1161/01.STR.4.4.674; SPERRY RJ, 1992, ANESTHESIOLOGY, V77, P416, DOI 10.1097/00000542-199209000-00002; Sueiras M, 1998, REV NEUROLOGIA, V26, P766, DOI 10.33588/rn.26153.98030; Toda HY, 1995, J EC; Vega-Zelaya L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140859; Vergara JM, 1999, REV NEUROLOGIA, V28, P765, DOI 10.33588/rn.2808.98328	33	2	2	2	7	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	MAY 1	2019	68	9					375	383		10.33588/rn.6809.2018179			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HY1YZ	WOS:000467914700003	31017290				2022-02-06	
J	Williams, R; Jupiter, DC; Maassen, NH				Williams, Robert; Jupiter, Daniel C.; Maassen, Nicholas H.			The Incidence and Risk Factors of Scaphoid Fracture Associated With Radial Head and Neck Fracture in Trauma Patients	JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS GLOBAL RESEARCH AND REVIEWS			English	Article							EPIDEMIOLOGY	Background: Scaphoid and radial head fractures are two injuries derived from the common fall on outstretched hand. How these injuries are related has not been fully investigated. The aim of this study was to evaluate risk factors for having concomitant proximal radius and scaphoid fractures. The goal was to identify at-risk patient populations and drive improvement in diagnosis and management of these injuries. Methods: A retrospective review of the National Trauma Data Bank from 2007 through 2012 identified 11,309 patients with proximal radius fracture, and, as a proxy for low-energy injury, an injury severity score of less than 15. These patients were then categorized by presence of concomitant scaphoid injury. Presence of scaphoid fracture was then analyzed based on age, sex, race, trauma type, mechanism, and injury severity score. Results: Three hundred seventy-eight (3%) scaphoid fractures among the 11,309 proximal radius fractures were identified. Both age and sex reached statistical significance as risk factors for concomitant scaphoid and radial head injury. There was an incremental increase in risk for concomitant injury with younger age. Subset analysis demonstrated a 10% incidence of concomitant fractures in men aged 18 to 30 years. Discussion: This study provides a better understanding of how these two fractures are related. There is a markedly higher risk for concomitant injuries in male and young patients, especially those whose mechanism is a fall. Close examination of the wrist should be performed for any proximal radius fracture, and any pain should be a cause for further investigation of scaphoid injury.	[Williams, Robert; Maassen, Nicholas H.] Univ Texas Med Branch, Dept Orthopaed Surg & Rehabil, Galveston, TX 77555 USA; [Jupiter, Daniel C.] Univ Texas Med Branch, Div Biostat, Dept Preventat Med & Community Hlth, Galveston, TX 77555 USA		Maassen, NH (corresponding author), Univ Texas Med Branch, Dept Orthopaed Surg & Rehabil, Galveston, TX 77555 USA.	nickmaass@gmail.com					Buijze GA, 2012, J HAND SURG-AM, V37A, P1095, DOI 10.1016/j.jhsa.2012.03.002; Duckworth AD, 2012, J HAND SURG-AM, V37A, P112, DOI 10.1016/j.jhsa.2011.09.034; Duckworth AD, 2012, J TRAUMA ACUTE CARE, V72, pE41, DOI 10.1097/TA.0b013e31822458e8; Kaas L, 2010, J SHOULDER ELB SURG, V19, P520, DOI 10.1016/j.jse.2009.10.015; Karl JW, 2015, J BONE JOINT SURG AM, V97A, P1860, DOI 10.2106/JBJS.O.00099; Kawamura K, 2008, J HAND SURG-AM, V33A, P988, DOI 10.1016/j.jhsa.2008.04.026; LINDSTROM G, 1992, J HAND SURG-BRIT EUR, V17B, P697, DOI 10.1016/0266-7681(92)90204-F; Merrell GA, 2002, J HAND SURG-AM, V27A, P685, DOI 10.1053/jhsu.2002.34372; Meyer C, 2013, J BONE JOINT SURG AM, V95A, P1518, DOI 10.2106/JBJS.9516icl; MORREY BF, 1979, J BONE JOINT SURG AM, V61, P63, DOI 10.2106/00004623-197961010-00012; Nguyen Q, 2008, ANN ROY COLL SURG, V90, P488, DOI 10.1308/003588408X300948; Rozental Tamara D, 2003, J Am Acad Orthop Surg, V11, P68; Tejwani NC, 2007, J AM ACAD ORTHOP SUR, V15, P380, DOI 10.5435/00124635-200707000-00003; van Riet RP, 2005, CLIN ORTHOP RELAT R, P351, DOI 10.1097/01.blo.0000180606.30981.78; Van Tassel DC, 2010, J HAND SURG-AM, V35A, P1242, DOI 10.1016/j.jhsa.2010.05.017; Wildin CJ, 2001, J HAND SURG-BRIT EUR, V26, P25, DOI 10.1054/jhsb.2000.0495	16	2	2	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2474-7661			JAAOS GLOB RES REV	J. Am. Acad. Orthop. Surg. Glob. Res. Rev.	MAY	2019	3	5							e055	10.5435/JAAOSGlobal-D-19-00055			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	IQ4DJ	WOS:000480701000004	31321373	gold, Green Published, Green Submitted			2022-02-06	
J	Yue, YM; Shang, CZ; Dong, HJ; Meng, K				Yue, Yingming; Shang, Chongzhi; Dong, Huajiang; Meng, Kun			Interleukin-1 in cerebrospinal fluid for evaluating the neurological outcome in traumatic brain injury	BIOSCIENCE REPORTS			English	Article							MESENCHYMAL STEM-CELLS; PROTEOMIC ANALYSIS; UMBILICAL-CORD; BONE-MARROW; DYSFUNCTION; ACTIVATION; EXPRESSION; CYTOKINES	Objective Severe traumatic brain injury (TBI) is associated with unfavorable outcomes secondary to injury from activation of the inflammatory cascade, the release of excitotoxic neurotransmitters, and changes in the reactivity of cerebral vessels, causing ischemia. Inflammation induced by TBI is complex, individual-specific, and associated with morbidity and mortality. The aim of the present study was to discover the differentially expressed cerebrospinal fluid (CSF) proteins and identify which can improve the clinical outcomes in TBI patients. Methods In the present study, we reported 145 patients with TBI and found the change in patients' leukocytes in serum and interleukin-1 (IL-1) in CSF, which strongly correlated with the neurological outcome. In terms of results of leukocytes in blood and IL-1 in CSF, we retained the patient's CSF specimens and conducted a proteomic analysis. Results A total of 119 differentially expressed proteins were detected between samples of TBI and the normal, which were commonly expressed in all samples, indicating the differentially expressed proteins. When the patients' Glasgow outcome score (GOS) improved, IL-1 was down-regulated, and when the patients' GCS score deteriorated, IL-1 was up-regulated accompanied with the progression in TBI. Conclusion The differentially expressed proteins in CSF may be the novel therapeutic targets for TBI treatment. The leukocytes in blood samples and the IL-1 in CSF may be two important indicators for predicting the prognosis of TBI patients.	[Yue, Yingming; Meng, Kun] Capital Med Univ, Beijing Tiantan Hosp, Dept Infect Dis, Beijing 100070, Peoples R China; [Shang, Chongzhi] Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Neurol Hosp, Dept Neurosurg, Tianjin 300161, Peoples R China; [Dong, Huajiang] Logist Univ Chinese Peoples Armed Police Forces, Tianjin 300192, Peoples R China		Meng, K (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Infect Dis, Beijing 100070, Peoples R China.	fergowill@163.com					Akalan N, 2005, CHILD NERV SYST, V21, P194, DOI 10.1007/s00381-004-1033-0; Bartfai T, 2007, ANN NY ACAD SCI, V1113, P173, DOI 10.1196/annals.1391.022; Chen M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0284-x; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Dong HJ, 2017, J CRANIOFAC SURG, V28, P1615, DOI 10.1097/SCS.0000000000003563; Dong HJ, 2017, INT J CLIN EXP MED, V10, P7213; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Fual M., 2010, TRAUMATIC BRAIN INJU; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Hultin-Rosenberg L, 2013, MOL CELL PROTEOMICS, V12, P2021, DOI 10.1074/mcp.M112.021592; Kim JY, 2015, CNS NEUROSCI THER, V21, P309, DOI 10.1111/cns.12360; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lee WS, 2011, BIOL BLOOD MARROW TR, V17, P465, DOI 10.1016/j.bbmt.2010.04.016; Li G, 2018, TURK NEUROSURG, V28, P696, DOI 10.5137/1019-5149.JTN.20829-17.1; Li G, 2009, PROTEOMICS, V9, P20, DOI 10.1002/pmic.200701195; Maccarrone G, 2004, ELECTROPHORESIS, V25, P2402, DOI 10.1002/elps.200305909; Mateos J, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0110-5; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Peffers MJ, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0384-2; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Rasouli J, 2012, NEUROSCI LETT, V519, P4, DOI 10.1016/j.neulet.2012.03.089; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Sarrafzadeh A, 2010, NEUROCRIT CARE, V13, P339, DOI 10.1007/s12028-010-9432-4; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Sickmann A, 2000, ELECTROPHORESIS, V21, P2721, DOI 10.1002/1522-2683(20000701)21:13<2721::AID-ELPS2721>3.0.CO;2-3; Sordillo PP, 2016, BRAIN INJURY, V30, P1043, DOI 10.3109/02699052.2016.1163618; Szmydynger-Chodobska J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079328; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tu WJ, 2017, NEUROLOGY, V88, P1899, DOI 10.1212/WNL.0000000000003937; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Wenner BR, 2004, J PROTEOME RES, V3, P97, DOI 10.1021/pr034070r; Yuan XL, 2005, PROTEOMICS, V5, P541, DOI 10.1002/pmic.200400934; Zhang N, 2018, INT J CLIN EXP MED, V11, P674; Zougman A, 2008, J PROTEOME RES, V7, P386, DOI 10.1021/pr070501k	43	2	2	0	0	PORTLAND PRESS LTD	LONDON	CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND	0144-8463	1573-4935		BIOSCIENCE REP	Biosci. Rep.	APR 30	2019	39		4						BSR20181966	10.1042/BSR20181966			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HW3RC	WOS:000466609400033	30898979	Green Submitted, Green Published, gold			2022-02-06	
J	Choi, H; Choi, NY; Park, HH; Lee, KY; Lee, YJ; Koh, SH				Choi, Hojin; Choi, Na-Young; Park, Hyun-Hee; Lee, Kyu-Yong; Lee, Young Joo; Koh, Seong-Ho			Sublethal Doses of Zinc Protect Neural Stem Cells Against Hypoxia Through Activation of the PI3K Pathway	STEM CELLS AND DEVELOPMENT			English	Article						hypoxia; phosphatidylinositol-3 kinase; zinc; neural stem cells; sublethal dose	TRAUMATIC BRAIN-INJURY; NEURONAL DEATH; SYNTHASE KINASE-3-BETA; GLUCOSE DEPRIVATION; CEREBRAL-CORTEX; OXYGEN; APOPTOSIS; ACCUMULATION; HIPPOCAMPUS; MECHANISMS	Cerebral infarction is one of the major causes of severe morbidity and mortality, and thus, research has focused on developing treatment options for this condition. Zinc (Zn) is an essential element in the central nervous system and has several neuroprotective effects in the brain. In this study, we examined the neuroprotective effects of Zn on neural stem cells (NSCs) exposed to hypoxia. After treatment with several concentrations of Zn, the viability of NSCs under hypoxic conditions was measured by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, Trypan blue staining, and a lactate dehydrogenase assay. To evaluate the effect of Zn on the proliferation of NSCs, bromodeoxyuridine/5-bromo-2 '-deoxyuridine (BrdU) labeling and colony formation assays were performed. Apoptosis was also examined in NSCs exposed to hypoxia with and without Zn treatment. In addition, a western blot analysis was performed to evaluate the effect of Zn on intracellular signaling proteins. NSC viability and proliferation were decreased under hypoxic conditions, but treatment with sublethal doses of Zn restored viability and proliferation. Sublethal doses of Zn reduced apoptosis caused by hypoxia, increased the expression levels of proteins related to the phosphatidylinositol-3 kinase (PI3K) pathway, and decreased the expression levels of proteins associated with neuronal cell death. These findings confirm that in vivo, sublethal doses of Zn protect NSCs against hypoxia through the activation of the PI3K pathway. Thus, Zn could be employed as a therapeutic option to protect NSCs in ischemic stroke.	[Choi, Hojin; Choi, Na-Young; Park, Hyun-Hee; Lee, Kyu-Yong; Lee, Young Joo; Koh, Seong-Ho] Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Koh, Seong-Ho] Hanyang Univ, Grad Sch Biomed Sci & Engn, Dept Translat Med, Seoul, South Korea		Koh, SH (corresponding author), Hanyang Univ, Dept Neurol, Coll Med, 249-1 Guri Hosp, Guri Si 471701, Gyeonggi Do, South Korea.	ksh213@hanyang.ac.kr			Basic Science Research Program of the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [2018R1A2A2A15023219, 2018R1C1B5044530]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C2160, HI18C1254]; Medical Research Center [2017R1A5A2015395]	This research was supported by the Basic Science Research Program of the National Research Foundation of Korea, which is funded by the Ministry of Science, ICT and Future Planning (2018R1A2A2A15023219 and 2018R1C1B5044530), by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI17C2160 and HI18C1254), and by the Medical Research Center (2017R1A5A2015395).	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Bak SW, 2016, MOL NEUROBIOL, V53, P6644, DOI 10.1007/s12035-015-9563-x; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Chen YH, 2014, J CLIN NEUROL, V10, P84, DOI 10.3988/jcn.2014.10.2.84; Choi BY, 2014, J TRACE ELEM MED BIO, V28, P474, DOI 10.1016/j.jtemb.2014.07.007; Choi H, 2013, STEM CELLS DEV, V22, P2112, DOI 10.1089/scd.2012.0604; Choi NY, 2014, BRAIN RES, V1551, P1, DOI 10.1016/j.brainres.2014.01.016; Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55; Chung H, 2008, J ENDOCRINOL, V198, P511, DOI 10.1677/JOE-08-0160; Cuajungco MP, 1998, BRAIN RES, V799, P118, DOI 10.1016/S0006-8993(98)00463-6; Currle D.S., 2007, J VIS EXP, V152; Duprez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046831; Ekici M, 2008, J BIOL CHEM, V283, P9257, DOI 10.1074/jbc.M709388200; Filomeni G, 2003, CANCER RES, V63, P5940; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; HALAS ES, 1983, PHYSIOL BEHAV, V30, P371, DOI 10.1016/0031-9384(83)90140-3; Harris CJ, 2014, J ALZHEIMERS DIS, V41, P179, DOI 10.3233/JAD-131703; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Kido J, 2016, J NEUROL NEUROPHYSIO, V7, P1; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim YH, 1999, NEUROSCIENCE, V89, P175, DOI 10.1016/S0306-4522(98)00313-3; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Koh SH, 2008, BRAIN RES, V1188, P254, DOI 10.1016/j.brainres.2007.10.064; Koh SH, 2015, J CLIN NEUROL, V11, P297, DOI 10.3988/jcn.2015.11.4.297; Koide N, 2012, NAGOYA J MED SCI, V74, P157; Lee S, 2009, AM J PHYSIOL-HEART C, V297, pH569, DOI 10.1152/ajpheart.00293.2009; Lee YJ, 2009, J NEUROCHEM, V111, P90, DOI 10.1111/j.1471-4159.2009.06297.x; Li CG, 2003, J CELL SCI, V116, P2677, DOI 10.1242/jcs.00470; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; Manev H, 1997, EXP NEUROL, V146, P171, DOI 10.1006/exnr.1997.6510; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Maret W, 2011, J BIOL INORG CHEM, V16, P1079, DOI 10.1007/s00775-011-0800-0; Martel G, 2011, BEHAV BRAIN RES, V223, P233, DOI 10.1016/j.bbr.2011.04.020; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Pan LY, 2018, DRUG DES DEV THER, V12, P1941, DOI 10.2147/DDDT.S159428; Pap M, 2002, MOL CELL BIOL, V22, P578, DOI 10.1128/MCB.22.2.578-586.2002; Park ES, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/438079; Saeed SA, 2007, EXP BRAIN RES, V182, P1, DOI 10.1007/s00221-007-1050-9; Sandstead HH, 2000, J NUTR, V130, p496S, DOI 10.1093/jn/130.2.496S; Sobieszczanska M, 2012, ADV CLIN EXP MED, V21, P245; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Truong-Tran AQ, 2001, BIOMETALS, V14, P315, DOI 10.1023/A:1012993017026; Viswanath K, 2011, BIOMETALS, V24, P171, DOI 10.1007/s10534-010-9371-8; Wang X, 2009, STROKE, V40, P1877, DOI 10.1161/STROKEAHA.108.540765; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Yu XW, 2018, EXP THER MED, V16, P2219, DOI 10.3892/etm.2018.6466; Zeng X, 2015, MOL MED REP, V12, P1850, DOI 10.3892/mmr.2015.3603; Zhen HW, 2012, FRONT BIOSCI-LANDMRK, V17, P1294, DOI 10.2741/3987; Zhu L, 2009, BRAIN RES, V1289, P96, DOI 10.1016/j.brainres.2009.07.015; Zivin JA, 1997, DRUGS, V54, P83, DOI 10.2165/00003495-199700543-00012	54	2	2	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	JUN 15	2019	28	12					769	780		10.1089/scd.2018.0138		APR 2019	12	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	ID6NS	WOS:000465488400002	30896367				2022-02-06	
J	Pruitt, P; Naidech, A; Van Ornam, J; Borczuk, P				Pruitt, Peter; Naidech, Andrew; Van Ornam, Jonathan; Borczuk, Pierre			Seizure frequency in patients with isolated subdural hematoma and preserved consciousness	BRAIN INJURY			English	Article						Subdural hematoma; seizures; seizure medications; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; PHENYTOIN; MORTALITY; IMPACT	Background: Seizures are a complication of subdural hematoma (SDH), and there is substantial variability in the use of seizure prophylaxis for patients with SDH. However, the incidence of seizures in patients with SDH without severe neurotrauma is not clear. The objective of this study was to assess the frequency of and factors associated with seizures in patients with isolated SDH (iSDH) without severe neurotrauma. Methods: In this retrospective, observational study, we identified adults with Glasgow Coma Score (GCS) >= 13 and computed tomography (CT)-documented iSDH. The primary outcome was clinical seizure frequency. Seizure medication use was also assessed. Fisher's exact test and logistic regression were used to assess association. Results: Of 643 patients with iSDH, 14 (2.2%) had seizures during hospitalization. Of 630 patients (98%) not receiving seizure medication prior to SDH, 522 (82.9%) received levetiracetam. Of the patients who received a seizure medication, 12 (2.3%) had a seizure, while of the 121 patients who did not receive seizure medications, 2 (1.9%) had a seizure (p = .49). In multivariable regression, the only variable significantly associated with seizure was thickness of subdural hematoma (OR 1.16, p = .005). Conclusion: In patients with iSDH and preserved consciousness, in-hospital seizures were rare regardless of seizure medications use.	[Pruitt, Peter] Northwestern Univ, Dept Emergency Med, Feinberg Sch Med, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA; [Naidech, Andrew] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL USA; [Van Ornam, Jonathan] Harvard Affiliated Emergency Med Residency, Boston, MA USA; [Van Ornam, Jonathan; Borczuk, Pierre] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Van Ornam, Jonathan; Borczuk, Pierre] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA		Pruitt, P (corresponding author), Northwestern Univ, Dept Emergency Med, Feinberg Sch Med, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA.	peter.pruitt@northwestern.edu			Society for Academic Emergency Medicine Foundation (SAEMF); National Research Service Award from the Agency for Healthcare Research and Quality (AHRQ) [T-32 HS 000078]; Society for Academic Emergency Medicine; Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [T-32 HS 000078]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS110779] Funding Source: NIH RePORTER	Dr. Pruitt is supported by a Research Training Grant from the Society for Academic Emergency Medicine Foundation (SAEMF) and a National Research Service Award from the Agency for Healthcare Research and Quality (AHRQ) T-32 HS 000078 (PI: Jane L. Holl, MD, MPH). SAEMF and AHRQ were not involved in the design or execution of this research; Society for Academic Emergency Medicine [Research Training Grant]; Agency for Healthcare Research and Quality [T-32 HS 000078].	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Naidech AM, 2005, STROKE, V36, P583, DOI 10.1161/01.STR.0000141936.36596.1e; Naidech AM, 2018, CRIT CARE MED; Naidech AM, 2009, STROKE, V40, P3810, DOI 10.1161/STROKEAHA.109.559948; Oddo M, 2009, CRIT CARE MED, V37, P6, DOI [10.1097/CCM.0b013e3181a96267, DOI 10.1097/CCM.0B013E3181A96267]; Rabinstein AA, 2010, J NEUROSURG, V112, P455, DOI 10.3171/2009.7.JNS09392; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; Won SY, 2017, SEIZURE-EUR J EPILEP, V45, P28, DOI 10.1016/j.seizure.2016.11.017	17	2	2	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 3	2019	33	8					1059	1063		10.1080/02699052.2019.1606446		APR 2019	5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IM6FW	WOS:000471389900001	31007086				2022-02-06	
J	Zanin, AC; Kamrath, JK; Ruston, SW; Posteher, KA; Corman, SR				Zanin, Alaina C.; Kamrath, Jessica K.; Ruston, Scott W.; Posteher, Karlee A.; Corman, Steven R.			Labeling Avoidance in Healthcare Decision-Making: How Stakeholders Make Sense of Concussion Events through Sport Narratives	HEALTH COMMUNICATION			English	Article							MASCULINITY; UNCERTAINTY; EDUCATION; IDENTITY; PATIENT; SELF	This study documents how cultural sport narratives influence athletic team member sensemaking during concussion events. Analysis of macro-level sport culture narratives and interviews (N = 93) with collegiate athletes and athletic trainers from eleven large universities within the United States revealed that participants utilized five cultural sport narratives when making sense of a concussion event (i.e., Play-through-pain, Commodification, Big leagues, Masculine-Warrior, and Need-for-safety). These narratives functioned in two specific ways as athletic team members made sense of concussion events (i.e., as extracted cues and identity defenses). The study presents the concept of labeling avoidance (e.g., avoiding a formal concussion diagnosis) to describe how athletes retrospectively rationalized their non-disclosure of a severe head impact. Theoretical and practical implications of the study findings are discussed.	[Zanin, Alaina C.; Ruston, Scott W.; Posteher, Karlee A.; Corman, Steven R.] Arizona State Univ, The Hugh Downs Sch Human Commun, Tempe, AZ 85287 USA; [Kamrath, Jessica K.] Calif State Univ Fullerton, Dept Human Commun Studies, Fullerton, CA 92634 USA; [Posteher, Karlee A.] Calif State Univ Monterey Bay, Coll Business, Seaside, CA USA		Zanin, AC (corresponding author), Arizona State Univ, Stauffer Hall,Room 434A, Tempe, AZ 85287 USA.	alaina.zanin@asu.edu					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Babrow AS, 1998, HEALTH COMMUN, V10, P1, DOI 10.1207/s15327027hc1001_1; Billings A.C., 2015, COMMUNICATION SPORT, V2nd; Brashers DE, 2001, J COMMUN, V51, P477, DOI 10.1111/j.1460-2466.2001.tb02892.x; Brown AD, 2008, HUM RELAT, V61, P1035, DOI 10.1177/0018726708094858; Bruner Jerome, 1985, ACTUAL MINDS POSSIBL; Chartoff R., 1976, ROCKY MOTION PICTURE; Clandinin DJ, 2006, RES STUD MUSIC EDUC, V27, P44, DOI 10.1177/1321103X060270010301; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Ellingson LL, 2009, ROUTLEDGE HANDBOOK OF APPLIED COMMUNICATION RESEARCH, P129; Fagan KM, 2017, J SAFETY RES, V60, P79, DOI 10.1016/j.jsr.2016.12.002; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Fried R., 1993, RUDY MOTION PICTURE; Gilmore S., 2004, ELECT J RADICAL ORG, V8, P2; Goldsmith DJ, 2009, UNCERTAINTY INFORM M, P204; Gray F., 2006, INVINCIBLE MOTION PI; Gray J.B., 2009, J COMMUNICATION HEAL, V2, P258, DOI DOI 10.1179/175380609790912670; Halverson JR, 2011, MASTER NARRATIVES OF ISLAMIST EXTREMISM, P1; Himmelstein MS, 2016, PREV MED, V84, P34, DOI 10.1016/j.ypmed.2015.12.008; Kerr Zachary Y, 2018, Inj Epidemiol, V5, P28, DOI 10.1186/s40621-018-0158-7; Kirk M., 2013, LEAGUE DENIAL DOCUME; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lind EA, 2002, RES ORGAN BEHAV, V24, P181, DOI 10.1016/S0191-3085(02)24006-X; Lindlof TR, 2017, QUALITATIVE COMMUNIC; Magala SJ, 1997, ORGAN STUD, V18, P317, DOI 10.1177/017084069701800206; MCCASKEY MB, 1982, EXECUTIVE CHALLENGE; Miller AL, 2007, ANAL HUS YB, V94, P103; Miller AC, 2010, J POP CULT, V43, P1222, DOI 10.1111/j.1540-5931.2010.00797.x; Patterson W., 2008, DOING NARRATIVE RES, P1, DOI DOI 10.4135/9780857024992.D3; Petraglia J, 2007, J HEALTH COMMUN, V12, P493, DOI 10.1080/10810730701441371; Phipps G., 2010, J SPORT LIT, V28, P75; Polkinghorne, 1988, NARRATIVE KNOWING HU; Polkinghorne D.E., 1995, INT J QUAL STUD EDUC, V8, P5, DOI DOI 10.1080/0951839950080103; Pompeii LA, 2016, AM J IND MED, V59, P853, DOI 10.1002/ajim.22629; PONDY LR, 1979, RES ORGAN BEHAV, V1, P3; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Reichertz J., 2014, SAGE HDB QUALITATIVE, P153; Reichertz J., 2007, SAGE HDB GROUNDED TH, P214, DOI DOI 10.4135/9781848607941.N10; Rhodes C, 2005, INT J MANAG REV, V7, P167, DOI 10.1111/j.1468-2370.2005.00112.x; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Ronkainen NJ, 2016, PSYCHOL SPORT EXERC, V27, P128, DOI 10.1016/j.psychsport.2016.08.010; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; Sabo D., 2009, J INTERCOLLEGIATE SP, V2, P145, DOI [10.1123/jis.2.1.145, DOI 10.1123/jis.2.1.145]; Saldana J, 2016, CODING MANUAL QUALIT, V3rd; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Smith L, 2016, SPORTS HEALTH, V8, P607, DOI 10.1177/1941738116670873; Starbuck W. H., 1988, EXECUTIVE EFFECT CON, P35; Strauss B., 2014, NY TIMES; Tracy S.J., 2013, QUALITATIVE RES METH; TRUJILLO N, 1991, CRIT STUD MASS COMM, V8, P290, DOI 10.1080/15295039109366799; Weick K.E., 1995, SENSEMAKING ORG; Weick KE, 2015, MANAGING THE UNEXPECTED: SUSTAINED PERFORMANCE IN A COMPLEX WORLD, 3RD EDITION, P1, DOI 10.1002/9781119175834; Weick KE, 2005, ORGAN SCI, V16, P409, DOI 10.1287/orsc.1050.0133; William C., 2015, 20 BADASS ATHLETES W; Young, 2004, SPORTING BODIES DAMA, P59; Zanin AC, 2018, J APPL COMMUN RES, V46, P267, DOI 10.1080/00909882.2018.1465578; Zoller HM, 2003, J APPL COMMUN RES, V31, P118, DOI 10.1080/0090988032000064588	58	2	2	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1041-0236	1532-7027		HEALTH COMMUN	Health Commun.		2020	35	8					935	945		10.1080/10410236.2019.1598742		APR 2019	11	Communication; Health Policy & Services	Social Science Citation Index (SSCI)	Communication; Health Care Sciences & Services	NA4ML	WOS:000469707400001	31007073				2022-02-06	
J	Errante, A; Saviola, D; Fasano, F; Basagni, B; Alinovi, S; Bosetti, S; Chiari, M; Minardi, R; Pinardi, C; Crisi, G; Fogassi, L; De Tanti, A				Errante, Antonino; Saviola, Donatella; Fasano, Fabrizio; Basagni, Benedetta; Alinovi, Serena; Bosetti, Sara; Chiari, Margherita; Minardi, Rita; Pinardi, Chiara; Crisi, Girolamo; Fogassi, Leonardo; De Tanti, Antonio			Application of an Intensive Rehabilitation Program After Very Late Recovery of Consciousness: A Single-Case Neurorehabilitation and Neuroimaging Study	JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE			English	Article						Disorders of consciousness; vegetative state; rehabilitation; fMRI; functional recovery	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; VEGETATIVE STATE; MEMORY REHABILITATION; ITALIAN POPULATION; NATURAL-HISTORY; DISCONNECTION; IMPROVEMENT; HODOLOGY; OUTCOMES	Late recovery of consciousness in vegetative state is considered as an exceptional outcome and has been reported prevalently in patients who suffered a traumatic brain injury. In these patients. the benefits of prolonging the rehabilitation, aimed at the recovery of autonomy in basic everyday activities. has been demonstrated. Here, we describe the application of an intensive multi-professional rehabilitation program carried out on a young female patient, with exceptionally late recovery of consciousness. specifically. after 7 years of vegetative state due to severe brain hemorrhage. Neuropsychological and functional assessment was conducted before and after the end of the rehabilitation program. In addition, functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI)-based probabilistic tractography were performed. Two follow-up neuropsychological and functional assessments were also conducted 6 and 29 months after the conclusion of the program. Functional results showed an improvement. maintained over time. in walking with assistance. cognitive efficiency. visual acuity and visual field, dysarthria. and execution of activities of daily living. Moreover. functional and structural magnetic resonance imaging (MRI) data documented the existence of preserved neural networks involved in sensory. motor, and linguistic tasks, which in all likelihood support the recovery process. This report suggests the possibility of undertaking an intensive rehabilitation program in patients who remain for long periods in altered states of consciousness. in spite of early negative prognosis.	[Errante, Antonino; Pinardi, Chiara; Fogassi, Leonardo] Univ Parma, Dept Med & Surg, Parma, Italy; [Saviola, Donatella; Basagni, Benedetta; Alinovi, Serena; Bosetti, Sara; Chiari, Margherita; Minardi, Rita; De Tanti, Antonio] S Stefano Inst, Cardinal Ferrari Rehabil Ctr, Via 5 Novembre, I-43012 Fontanellato, Italy; [Fasano, Fabrizio] Cardiff Univ, Brain Res Imaging Ctr, Cardiff, S Glam, Wales; [Crisi, Girolamo] Hosp & Univ Parma, Dept Diagnost, Neuroradiol Unit, Parma, Italy		De Tanti, A (corresponding author), S Stefano Inst, Cardinal Ferrari Rehabil Ctr, Via 5 Novembre, I-43012 Fontanellato, Italy.	antonio.detanti@centrocardinalferrari.it	Basagni, Benedetta/AAJ-5799-2021	Pinardi, Chiara/0000-0002-6043-0251; CHIARI, MARGHERITA/0000-0001-8374-8548			ARTS WFM, 1985, J NEUROL NEUROSUR PS, V48, P1300, DOI 10.1136/jnnp.48.12.1300; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Avanzi S., 1997, Archivio di Psicologia Neurologia e Psichiatria, V58, P85; Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; Brosseau L, 2006, TOP STROKE REHABIL, V13, P1, DOI 10.1310/3TKX-7XEC-2DTG-XQKH; Caffarra P, 2003, NEUROL SCI, V24, P336, DOI 10.1007/s10072-003-0185-0; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; Carlesimo G, 2002, NUOVA RIV NEUROLOGIA, V12, P1; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Chiari MC, 2014, NEUROPSYCOL TRENDS, V15, P35; Costa A, 2014, NEUROL SCI, V35, P365, DOI 10.1007/s10072-013-1520-8; De Tanti A, 2016, BRAIN INJURY, V30, P1029, DOI 10.3109/02699052.2016.1147078; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Dhamapurkar SK, 2016, BRAIN INJURY, V30, P230, DOI 10.3109/02699052.2015.1094132; Dieci, 2002, NUOVA RIV NEUROLOGIA, V12, P111; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Elshout JA, 2018, RESTOR NEUROL NEUROS, V36, P1, DOI 10.3233/RNN-170719; Epelbaum S, 2008, CORTEX, V44, P962, DOI 10.1016/j.cortex.2008.05.003; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Ffytche DH, 2005, PHILOS T R SOC B, V360, P767, DOI 10.1098/rstb.2005.1621; Ffytche DH, 2008, CORTEX, V44, P1067, DOI 10.1016/j.cortex.2008.04.005; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Fox CJ, 2008, CORTEX, V44, P996, DOI 10.1016/j.cortex.2008.04.003; Fussi F, 1999, PROFILO VALUTAZIONE; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Hagen C, 1987, REHABILITATION HEAD, P87; Hammil D, 1994, TEST PERCEZIONE VISI; Henriksson L, 2007, J NEUROL NEUROSUR PS, V78, P74, DOI 10.1136/jnnp.2006.099374; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; Hu MH, 2010, DISABIL REHABIL, V32, P1251, DOI 10.3109/09638280903464448; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STORK; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Laiacona M, 2000, NEUROL SCI, V21, P279, DOI 10.1007/s100720070065; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Leon-Carrion J, 2013, BRAIN INJURY, V27, P1119, DOI 10.3109/02699052.2013.804204; Leonardi M, 2013, BRAIN INJURY, V27, P473, DOI 10.3109/02699052.2012.750758; LEWINSOHN PM, 1977, J CONSULT CLIN PSYCH, V45, P717, DOI 10.1037/0022-006X.45.5.717; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Maeda A, 2000, AM J PHYS MED REHAB, V79, P519, DOI 10.1097/00002060-200011000-00008; Mancuso M, 2015, NEUROL SCI, V36, P1233, DOI 10.1007/s10072-015-2088-2; Matteo BM, 2016, J VISION, V16, DOI 10.1167/16.9.11; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Parish L, 2007, NEUROPSYCHOL REHABIL, V17, P230, DOI 10.1080/09602010600750675; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Registered Nurses' Association of Ontario (RNAO), 2005, NURS BEST PRACT GUID; Robertson SJ, 1987, DYSARTHRIA PROFILE; Ross ED, 2008, CORTEX, V44, P1010, DOI 10.1016/j.cortex.2008.02.002; Sancisi E, 2009, BRAIN INJURY, V23, P163, DOI 10.1080/02699050802660446; Sandhaug M, 2015, BRAIN INJURY, V29, P915, DOI 10.3109/02699052.2015.1022880; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Spinnler H, 1987, ITAL J NEUROL SCI, V8, P1; Stroke Foundation of New Zealand and New Zealand Guidelines Group, 2010, CLIN GUID STROK MAN; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Talib M, 2018, METHODS MOL BIOL, V1715, P327, DOI 10.1007/978-1-4939-7522-8_24; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thiebaut de Schotten M, 2008, CORTEX, V44, P1097, DOI 10.1016/j.cortex.2008.02.003; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Wade D T, 1988, Int Disabil Stud, V10, P64; Wales LR, 2000, AUST J PHYSIOTHER, V46, P143, DOI 10.1016/S0004-9514(14)60324-X; Wechsler D., 1981, WAIS R WECHSLER ADUL; World Health Organization, 2007, INT CLASS FUNCT DIS	69	2	2	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-5735			J CENT NERV SYST DIS	J. Cent. Nerv. Syst. Dis.	APR 18	2019	11								1179573519843492	10.1177/1179573519843492			16	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HX5VL	WOS:000467472400001	31037040	Green Published, gold			2022-02-06	
J	Chia, AA; Power, E; Kenny, B; Elbourn, E; McDonald, S; Tate, R; MacWhinney, B; Turkstra, L; Holland, A; Togher, L				Chia, An An; Power, Emma; Kenny, Belinda; Elbourn, Elise; McDonald, Skye; Tate, Robyn; MacWhinney, Brian; Turkstra, Lyn; Holland, Audrey; Togher, Leanne			Patterns of early conversational recovery for people with traumatic brain injury and their communication partners	BRAIN INJURY			English	Article						Traumatic brain injury; communication; recovery; conversation patterns; communication partner	QUALITY-OF-LIFE; CLOSED-HEAD INJURY; DISCOURSE; DEFICITS; HEALTH; ADULTS; REHABILITATION; INDIVIDUALS; POPULATION; RELATIVES	Primary objective: To investigate whether the degree of participation by people with severe Traumatic Brain Injury (TBI), and the degree of support by their communication partners (CPs) changes in conversation during subacute recovery. Methods and procedures: Seventeen pairs of participants with TBI and their CPs were video-recorded during a 10 min casual conversation at 3 and 6 months post-injury. Communication behaviors were rated using the adapted Measure of Participation in Conversation (MPC) and the adapted Measure of Support in Conversation (MSC) at both time points and compared. Results: Inferential analyses showed that there was no significant change in the degree of participation in conversation by participants with TBI and the degree of conversation support by their CPs from 3 to 6 months post. Comparison of qualitative field notes revealed that specific conversational behaviors changed over time, including better turn-taking and topic maintenance. Conclusion: Documenting early communication recovery is a complex and challenging endeavor. The lack of change in conversational effectiveness during the sub-acute period using global rating scales highlights the need for social communication tools that are sensitive to communication recovery following severe TBI.	[Chia, An An; Power, Emma; Kenny, Belinda; Elbourn, Elise; Togher, Leanne] Univ Sydney, Discipline Speech Pathol, Fac Hlth Sci, Lidcombe, NSW, Australia; [Power, Emma] Univ Technol, UTS Grad Sch Hlth, Discipline Speech Pathol, Sydney, NSW, Australia; [Kenny, Belinda; Elbourn, Elise; McDonald, Skye; Tate, Robyn; Togher, Leanne] NHMRC Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia; [McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Tate, Robyn] Univ Sydney, Fac Med, Sydney, NSW, Australia; [MacWhinney, Brian] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Turkstra, Lyn] Univ Wisconsin, Dept Commun Disorders, Madison, WI 53706 USA; [Holland, Audrey] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ USA		Chia, AA (corresponding author), Univ Sydney, Sydney, NSW, Australia.	chia.an.an@skh.com.sg	Turkstra, Lyn/ABC-5831-2021; Togher, Leanne/AAC-7083-2019; McDonald, Skye/G-4118-2014; Power, Emma/A-9263-2015	McDonald, Skye/0000-0003-0723-6094; Turkstra, Lyn/0000-0002-6948-6921; Togher, Leanne/0000-0002-4518-6748; Power, Emma/0000-0002-2638-0406	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [632681]	This work was supported by the National Health and Medical Research Council [#632681].	Australian Institute of Health and Welfare (AIHW), 2007, BULLETIN, V55; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Boles L, 1998, APHASIOLOGY, V12, P547, DOI 10.1080/02687039808249557; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Curyto KJ, 2008, RES GERONTOL NURS, V1, P52, DOI 10.3928/19404921-20080101-02; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Enderby P, 2006, THERAPY OUTCOME MEAS; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Eriksson K, 2014, J INTERACT RES COM D, V5, P245, DOI 10.1558/jircd.v5i2.245; Feldman M, 2012, J CONTIN EDUC HEALTH, V32, P279, DOI 10.1002/chp.21156; Fleming J., 1995, BRIT J OCCUPATIONAL, V58, P55, DOI [https://doi.org/10.1177/030802269505800204, DOI 10.1177/030802269505800204]; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Guo YE, 2008, BRAIN INJURY, V22, P83, DOI 10.1080/02699050701824150; Halliday M., 2004, INTRO FUNCTIONAL GRA; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; IBM Corp, 2016, IBM SPSS STAT WINDOW; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Klonoff PS, 2008, B MENNINGER CLIN, V72, P109, DOI 10.1521/bumc.2008.72.2.109; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 2003, BRAIN IMPAIR, V4, P36, DOI [10.1375/brim.4.1.36.27032, DOI 10.1375/BRIM.4.1.36.27032, DOI 10.1375/brim.4.1.36.27032]; McKellin WH, 2007, J PRAGMATICS, V39, P2159, DOI 10.1016/j.pragma.2006.11.012; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Ponsford J, 2012, UNDERSTANDING MANAGI; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Saldert C, 2012, J INTERACT RES COM D, V3, P141, DOI 10.1558/jircd.v3i2.141; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Stubbs E, 2014, THESIS; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 2006, BRAIN IMPAIR, V7, P190, DOI DOI 10.1375/brim.7.3.190; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Vogler J, 2014, BRAIN INJURY, V28, P1381, DOI 10.3109/02699052.2014.919536; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Yap BW, 2011, J STAT COMPUT SIM, V81, P2141, DOI 10.1080/00949655.2010.520163; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P303; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; Youse KM, 2009, NEUROREHABILITATION, V24, P355, DOI 10.3233/NRE-2009-0490	75	2	2	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2019	33	5					690	698		10.1080/02699052.2019.1571632			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HR1NT	WOS:000462901200017	30798627				2022-02-06	
J	Ye, LM; Zhang, DB; Shao, MH; Zhao, PH; Yin, B; Zhuang, JF; Wang, FF; Yan, ZH; Bai, GH				Ye, Limei; Zhang, Danbin; Shao, Meihua; Zhao, Pinghui; Yin, Bo; Zhuang, Jinfei; Wang, Feifei; Yan, Zhihan; Bai, Guanghui			Lower Posttraumatic alpha-Synuclein Level Associated With Altered Default Mode Network Connectivity Following Acute Mild Traumatic Brain Injury	FRONTIERS IN NEURAL CIRCUITS			English	Article						mild traumatic brain injury; alpha-synuclein; rs-fMRI; default mode network; functional connectivity	HEAD-INJURY; FUNCTIONAL CONNECTIVITY; CINGULATE CORTEX; SYMPTOMS; RISK; EPIDEMIOLOGY; MECHANISMS; DISEASE; MEMORY; REST	This study aimed to investigate the changes of alpha-synuclein in serum and its relationship with default mode network (DMN) connectivity after acute mild traumatic brain injury (mild TBI). Fifty-two patients with mild TBI at the acute phase and 47 matched healthy controls were enrolled in the study. All participants received resting-state functional magnetic resonance imaging (fMRI) and neuropsychological assessments. Relations between the levels of alpha-synuclein in serum and clinical assessments were obtained using multivariate linear regression. Results showed that the patients with lower alpha-synuclein presented more complaints on post-concussion symptoms and depression. Moreover, patients with high levels of alpha-synuclein exhibited significantly decreased functional connectivity in the left precuneus and increased functional connectivity in both the left anterior cingulate cortex and ventro-medial prefrontal cortex (MPFC) compared with patients with low levels of alpha-synuclein. These findings supported that alpha-synuclein may modulate the functional connectivity within the DMN and suggest the feasibility of using alpha-synuclein as an objective biomarker for diagnosis and prognosis of mild TBI.	[Ye, Limei; Zhang, Danbin; Zhao, Pinghui; Yan, Zhihan; Bai, Guanghui] Wenzhou Med Univ, Dept Radiol, Affiliated Hosp 2, Wenzhou, Peoples R China; [Ye, Limei; Zhang, Danbin; Zhao, Pinghui; Yin, Bo; Zhuang, Jinfei; Yan, Zhihan; Bai, Guanghui] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Ye, Limei] Zhejiang Univ, Dept Radiol, Jinhua Municipal Cent Hosp, Jinhua, Peoples R China; [Ye, Limei] Zhejiang Univ, Jinhua Hosp, Jinhua, Peoples R China; [Shao, Meihua] Tongde Hosp Zhejiang Prov, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [Yin, Bo] Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 2, Wenzhou, Peoples R China; [Zhuang, Jinfei] Wenzhou Med Univ, Dept Rehabil, Affiliated Hosp 2, Wenzhou, Peoples R China; [Wang, Feifei] Zhengzhou Univ, Dept MRI, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China		Yan, ZH; Bai, GH (corresponding author), Wenzhou Med Univ, Dept Radiol, Affiliated Hosp 2, Wenzhou, Peoples R China.; Yan, ZH; Bai, GH (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China.	zhihanyanwz@163.com; bghu79@126.com		Shao, Meihua/0000-0003-1203-9730	Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [LY19H180003, LY16H180009, LY15H090016]	This research was supported by the Natural Science Foundation of Zhejiang Province (nos. LY19H180003, LY16H180009 and LY15H090016).	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Duan XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032532; Espirito-Santo H, 2017, APPL NEUROPSYCH-ADUL, V24, P275, DOI 10.1080/23279095.2017.1290636; Fingelkurts AA, 2011, BRAIN COGNITION, V75, P79, DOI 10.1016/j.bandc.2010.11.015; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Institute of Medicine, 2009, GULF WAR HLTH, V7; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Kenborg L, 2015, NEUROLOGY, V84, P1098, DOI 10.1212/WNL.0000000000001362; Kennis M, 2015, HUM BRAIN MAPP, V36, P99, DOI 10.1002/hbm.22615; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Lin CH, 2017, J NEUROL NEUROSUR PS, V88, P818, DOI 10.1136/jnnp-2016-314857; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Reiland SA, 2017, ENCY PERSONALITY IND, P1, DOI 10.1007/978-3-319-28099-8_6-1; Rocca MA, 2010, NEUROLOGY, V74, P1252, DOI 10.1212/WNL.0b013e3181d9ed91; Sadeghniiat-Haghighi K, 2014, QUAL LIFE RES, V23, P533, DOI 10.1007/s11136-013-0489-3; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Thompson WH, 2016, NEUROIMAGE-CLIN, V12, P1004, DOI 10.1016/j.nicl.2016.05.005; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vekrellis K, 2011, LANCET NEUROL, V10, P1015, DOI 10.1016/S1474-4422(11)70213-7; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Weathers FW, 1991, PTSD CHECKLIST CIVIL; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; 2015, EPILEPSIA, V56, P991, DOI DOI 10.1111/EPI.13100; 2014, AM J PATHOL, V184, P966, DOI DOI 10.1016/J.AJPATH.2013.12.007; 2013, NEUROSCI LETT, V532, P44, DOI DOI 10.1016/J.NEULET.2012.11.004; 1998, NEUROSCI LETT, V251, P205, DOI DOI 10.1016/S0304-3940(98)00504-7; 2018, NEUROMOL MED, V20, P83, DOI DOI 10.1007/S12017-017-8475-5	57	2	2	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5110			FRONT NEURAL CIRCUIT	Front. Neural Circuits	APR 16	2019	13								26	10.3389/fncir.2019.00026			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HW9DG	WOS:000466990200001	31040769	Green Published, gold			2022-02-06	
J	Lai, FHY; Dawson, D; Yan, EWH; Ho, ECW; Tsui, JWM; Fan, SHU; Lee, ATK				Lai, Frank Ho-yin; Dawson, Deirdre; Yan, Elaine Wai-hung; Ho, Eric Chun-wui; Tsui, Jess Wan-man; Fan, Silvia Hiu-ue; Lee, Alice Tsz-kiu			The validity, reliability and clinical utility of a performance-based executive function assessment in people with mild to moderate dementia	AGING & MENTAL HEALTH			English	Article						Executive function; performance-based; people with mild to moderate dementia	MULTIPLE ERRANDS TEST; ECOLOGICAL VALIDITY; ALZHEIMERS-DISEASE; INSTRUMENTAL ACTIVITIES; DISABILITY ASSESSMENT; SIMPLIFIED VERSION; VALIDATION; ADULTS; TRAIL; MET	Objective: Performance-based evaluation of executive function by using real-world daily living activities is an important area of study. This approach has been used extensively in evaluating patients after stroke or traumatic brain injury and patients with schizophrenia. Most important is the fact that until now, there has been no validated performance-based evaluation of executive function in people with dementia. Methods: To address that knowledge gap, this study recruited 80 patients diagnosed with dementia and 80 demographically matched healthy controls. The participants were administered tests for evaluating their performance-based executive function (Chinese Multiple Errands Test), their instrumental activities of daily living (Lawton Instrumental Activities of Daily Living Scale, Chinese Version), and their functional disability (Chinese Version of the Disability Assessment for Dementia), along with a cognitive screening test (Montreal Cognitive Assessment, Hong Kong Version) and a neuropsychological test of executive function (Trail-making Test). Results: The Chinese Multiple Errands Test demonstrated excellent inter-rater reliability, test-retest reliability and high internal consistency. Results revealed that the healthy controls out-performed the dementia patients in the performance-based executive function and cognitive screening, but not in the instrumental activities of daily living tests. Additionally, the performance efficiency scores of the older adults with dementia on the Chinese Multiple Errands Test correlated significantly with their performance results on the neuropsychological test of executive function and on the tests of functional disability and cognitive function. Conclusion: Our results indicated that the Chinese Multiple Errands Test is a reliable and valid instrument for assessing executive function in Chinese older people with dementia.	[Lai, Frank Ho-yin] Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Hong Kong, Peoples R China; [Dawson, Deirdre] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Rehabil Sci Inst, Rotman Res Inst,Baycrest Hlth Sci, Toronto, ON, Canada; [Yan, Elaine Wai-hung] Kowloon Hosp, Occupat Therapy Dept, Kowloon, Hong Kong, Peoples R China; [Ho, Eric Chun-wui] Pamela Youde Nethersole Eastern Hosp, Occupat Therapy Dept, Chai Wan, Hong Kong, Peoples R China; [Tsui, Jess Wan-man; Fan, Silvia Hiu-ue] Tai Po Hosp, Occupat Therapy Dept, Tai Po, Hong Kong, Peoples R China; [Lee, Alice Tsz-kiu] TWGHs Jockey Club Rehabil Complex, Occupat Therapy Dept, Aberdeen, Hong Kong, Peoples R China		Lai, FHY (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Hong Kong, Peoples R China.	frank.hy.lai@polyu.edu.hk	Lai, Frank Ho-yin/AAD-8723-2021; Dawson, Deirdre/I-8882-2014	Lai, Frank Ho-yin/0000-0003-0365-7000; Dawson, Deirdre/0000-0001-7517-6121			Afshin A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003058; Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Bulzacka E, 2016, PSYCHIAT RES, V240, P390, DOI 10.1016/j.psychres.2016.04.056; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burns S., 2018, NEUROPSYCHOL REHABIL, P1; Castiel M, 2012, NEUROPSYCHOL REHABIL, V22, P734, DOI 10.1080/09602011.2012.686884; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Cuberos-Urbano G, 2013, J CLIN EXP NEUROPSYC, V35, P329, DOI 10.1080/13803395.2013.776011; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Farias ST, 2003, ARCH CLIN NEUROPSYCH, V18, P655, DOI 10.1016/S0887-6177(02)00159-2; Fellows RP, 2017, CLIN NEUROPSYCHOL, V31, P154, DOI 10.1080/13854046.2016.1238510; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Gelinas I, 1999, AM J OCCUP THER, V53, P471, DOI 10.5014/ajot.53.5.471; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Llinas-Regla J, 2017, ASSESSMENT, V24, P183, DOI 10.1177/1073191115602552; Martyr A, 2012, DEMENT GERIATR COGN, V33, P189, DOI 10.1159/000338233; Mok CCM, 2005, DEMENT GERIATR COGN, V20, P112, DOI 10.1159/000086612; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Nalder EJ, 2017, NEUROPSYCHOL REHABIL, V27, P685, DOI 10.1080/09602011.2015.1067628; Poulin V, 2013, AUST OCCUP THER J, V60, P3, DOI 10.1111/1440-1630.12024; Puente AN, 2016, CLIN NEUROPSYCHOL, V30, P95, DOI 10.1080/13854046.2015.1133847; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Raspelli S, 2010, STUD HEALTH TECHNOL, V154, P115, DOI 10.3233/978-1-60750-561-7-115; Razani J, 2007, APPL NEUROPSYCHOL, V14, P208, DOI 10.1080/09084280701509125; Royall DR, 2007, J NEUROPSYCH CLIN N, V19, P249, DOI 10.1176/appi.neuropsych.19.3.249; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Steverson T, 2017, J APPL RES INTELLECT, V30, P255, DOI 10.1111/jar.12236; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Tong AYC, 2002, OTJR-OCCUP PART HEAL, V22, P132, DOI 10.1177/153944920202200402; Wong ACY, 2009, ADV POLYM TECH, V28, P1, DOI 10.1002/adv.20142; World Health Organization, 1992, ICD10 WHO, V67, P227	34	2	2	1	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1360-7863	1364-6915		AGING MENT HEALTH	Aging Ment. Health	SEP 1	2020	24	9					1496	1504		10.1080/13607863.2019.1599818		APR 2019	9	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	NH8SX	WOS:000466045100001	30990085				2022-02-06	
J	Mrazik, M; Naidu, D; Borza, C; Kobitowich, T; Shergill, S				Mrazik, Martin; Naidu, Dhiren; Borza, Carley; Kobitowich, Tara; Shergill, Simran			King Devick computerized neurocognitive test scores in professional football players with learning and attentional disabilities	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Concussion; Football; King-Devick test; Learning disability; Attention deficit hyperactivity disorder	HIGH-SCHOOL; TEST-PERFORMANCE; REFERENCE VALUES; SCREENING TOOL; CONCUSSION; ADHD; PREVALENCE	Objective: This study examined outcomes from the King Devick (K-D) in athletes with Learning Disabilities (LD) and attention disorders (ADHD). Methods: A total of 574 professional football players from the Canadian Football League (CFL) completed baseline evaluations with computerized neurocognitive testing (CNT) prior to the 2016 competitive season. Player age, education, history of concussion, LD, and ADHD were analyzed for K-D and Immediate Post Concussion Assessment and Cognitive Testing (ImPACT) performance. A series of analyses of co-variance (ANCOVA's) were used to compare participants with a history of LD and ADHD with history of concussion as a co-variate. Results: Approximately 5% of participants reported a diagnosed history of LD and 13% with ADHD. Performance on the K-D test was not significantly correlated with age, education, or history of concussion but was significantly correlated with history of LD and ADHD. Participants with LD performed approximately 6.9 s slower on the K-D test (t[563] = 4.70, p. = 0.0003) and participants with ADHD were approximately 2s slower (t [572] = 2.04, p. = 0.04). Conclusions: Results indicated that players with a history of diagnosed LD and ADHD performed slower on the KD test in comparison to athletes with no history of diagnoses. The results of this study underscore the importance of recognizing individualized outcomes when using the K-D.	[Mrazik, Martin; Borza, Carley; Kobitowich, Tara] Univ Alberta, Dept Educ Psychol, 6-135 Educ North,11210-87 Ave, Edmonton, AB T6G 2G6, Canada; [Naidu, Dhiren; Shergill, Simran] Univ Alberta, Fac Dent & Med, Edmonton, AB, Canada		Mrazik, M (corresponding author), Univ Alberta, Dept Educ Psychol, 6-135 Educ North,11210-87 Ave, Edmonton, AB T6G 2G6, Canada.	mrazik@ualberta.ca; dnaidu@ualberta.ca; borza@ualberta.ca; kobitowi@ualberta.ca; sshergil@ualberta.ca		Mrazik, Martin/0000-0002-4653-4636			Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; Cohen J., 2013, STAT POWER ANAL BEHA; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Dodick D, 2017, J CHILD NEUROL, V32, P104, DOI 10.1177/0883073816668704; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; Kulp MT, 1997, OPTOMETRY VISION SCI, V74, P37, DOI 10.1097/00006324-199701000-00018; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; MacDonald JP, 2016, MED SCI SPORT EXER, V48, P627, DOI 10.1249/01.mss.0000486882.92607.c1; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P377, DOI 10.1080/13803395.2017.1353590; Molloy JH, 2017, J SCI MED SPORT, V20, P708, DOI 10.1016/j.jsams.2017.02.002; Naidu D, 2018, J NEUROTRAUM, V35, P2283, DOI 10.1089/neu.2017.5490; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Quaid P, 2013, GRAEF ARCH CLIN EXP, V251, P169, DOI 10.1007/s00417-012-2135-0; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Smolyansky  V., 2016, OPTOM VIS PERFORM, V4, P147; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Weise KK, 2017, OPTOMETRY VISION SCI, V94, P89, DOI 10.1097/OPX.0000000000000938; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	29	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	APR 15	2019	399						140	143		10.1016/j.jns.2019.02.020			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU3CK	WOS:000465148900023	30807981				2022-02-06	
J	Bor-Seng-Shu, E; de-Lima-Oliveira, M; Nogueira, RC; Almeida, KJ; Paschoal, EHA; Paschoal, FM				Bor-Seng-Shu, Edson; de-Lima-Oliveira, Marcelo; Nogueira, Ricardo Carvalho; Almeida, Kelson James; Albuquerque Paschoal, Eric Homero; Paschoal, Fernando Mendes, Jr.			Decompressive Craniectomy for Traumatic Brain Injury: Postoperative TCD Cerebral Hemodynamic Evaluation	FRONTIERS IN NEUROLOGY			English	Article						decompressive craniectomy; traumatic brain injury; transcranial Doppler ultrasonography; intracranial pressure (ICP); cerebral hemodynamics	BLOOD-FLOW; TRANSCRANIAL DOPPLER; PRESSURE-GRADIENTS; INTRACRANIAL-PRESSURE; HEAD-INJURY; AUTOREGULATION; MICRODIALYSIS; VASOSPASM; OXYGENATION; METABOLISM	Background: There are no studies describing the cerebral hemodynamic patterns that can occur in traumatic brain injury (TBI) patients following decompressive craniectomy (DC). Such data have potentially clinical importance for guiding the treatment. The objective of this study was to investigate the postoperative cerebral hemodynamic patterns, using transcranial Doppler (TCD) ultrasonography, in patients who underwent DC. The relationship between the cerebral circulatory patterns and the patients' outcome was also analyzed. Methods: Nineteen TBI patients with uncontrolled brain swelling were prospectively studied. Cerebral blood circulation was evaluated by TCD ultrasonography. Patients and their cerebral hemispheres were categorized based on TCD-hemodynamic patterns. The data were correlated with neurological status, midline shift on CT scan, and Glasgow outcome scale scores at 6 months after injury. Results: Different cerebral hemodynamic patterns were observed. One patient (5.3%) presented with cerebral oligoemia, 4 patients (21%) with cerebral hyperemia, and 3 patients (15.8%) with cerebral vasospasm. One patient (5.3%) had hyperemia in one cerebral hemisphere and vasospasm in the other hemisphere. Ten patients (52.6%) had nonspecific circulatory pattern. Abnormal TCD-circulatory patterns were found in 9 patients (47.4%). There was no association between TCD-cerebral hemodynamic findings and outcome. Conclusion: There is a wide heterogeneity of postoperative cerebral hemodynamic findings among TBI patients who underwent DC, including hemodynamic heterogeneity between their cerebral hemispheres. DC was proved to be effective for the treatment of cerebral oligoemia. Our data support the concept of heterogeneous nature of the pathophysiology of the TBI and suggest that DC as the sole treatment modality is insufficient.	[Bor-Seng-Shu, Edson; de-Lima-Oliveira, Marcelo; Nogueira, Ricardo Carvalho; Paschoal, Fernando Mendes, Jr.] Univ Sao Paulo, Med Sch, Lab Neurosonol & Cerebral Hemodynam, Div Neurol Surg,Hosp Clin, Sao Paulo, Brazil; [Almeida, Kelson James] Univ Fed Piaui, Med Sch, Dept Neurol, Teresina, Brazil; [Albuquerque Paschoal, Eric Homero; Paschoal, Fernando Mendes, Jr.] Fed Univ Para, Med Sch, Dept Neurol, Sao Paulo, Brazil		Bor-Seng-Shu, E (corresponding author), Univ Sao Paulo, Med Sch, Lab Neurosonol & Cerebral Hemodynam, Div Neurol Surg,Hosp Clin, Sao Paulo, Brazil.	edsonshu@hotmail.com	de Carvalho Nogueira, Ricardo/V-3482-2019; BOR-SENG-SHU, EDSON/AAC-9762-2019	de Carvalho Nogueira, Ricardo/0000-0003-3309-3760; BOR-SENG-SHU, EDSON/0000-0002-6713-8974			Amorim RL, 2012, J NEURORADIOLOGY, V39, P346, DOI 10.1016/j.neurad.2012.02.006; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Bor-Seng-Shu E, 2007, J NEUROSURG, V106, P728, DOI 10.3171/jns.2007.106.4.728; Bor-Seng-Shu E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/750809; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bor-Seng-Shu E, 2012, ARQ NEURO-PSIQUIAT, V70, P357, DOI 10.1590/S0004-282X2012000500010; Bor-Seng-Shu E, 2010, J NEUROSURG, V112, P1351, DOI 10.3171/2009.10.JNS091426; Caldas JR, 2017, AM J PHYSIOL-REG I, V312, pR108, DOI 10.1152/ajpregu.00361.2016; Chang JJ, 2016, AM J NEURORADIOL, V37, P408, DOI 10.3174/ajnr.A4548; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; De-Lima-Oliveira M, 2018, WORLD NEUROSURG, V113, P110, DOI 10.1016/j.wneu.2018.01.194; de-Lima-Oliveira M, 2018, ACTA NEUROCHIR, V160, P919, DOI 10.1007/s00701-018-3484-1; Gupta D, 2017, BRAIN INJURY, V31, P1660, DOI 10.1080/02699052.2017.1370553; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kumar A, 2005, J NEUROL NEUROSUR PS, V76, P1570, DOI 10.1136/jnnp.2004.059493; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lubillo ST, 2018, J NEUROSURG, V128, P1538, DOI 10.3171/2017.1.JNS161840; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Mazzucco S, 2017, INT J STROKE, V12, P580, DOI 10.1177/1747493017706189; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Oliveira MD, 2014, J NEUROTRAUM, V31, P1750, DOI 10.1089/neu.2014.3386; Oliveira MD, 2014, NEUROCRIT CARE, V21, P152, DOI 10.1007/s12028-013-9884-4; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Sharma VK, 2016, FRONT NEUROL NEUROSC, V40, P124, DOI 10.1159/000448309; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Vedantam A, 2018, J NEUROSURG, V129, P241, DOI 10.3171/2017.4.JNS163036; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x; Wolfla CE, 1997, J NEUROSURG, V86, P505, DOI 10.3171/jns.1997.86.3.0505; Wolfla CE, 1996, J NEUROSURG, V84, P642, DOI 10.3171/jns.1996.84.4.0642	34	2	2	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 12	2019	10								354	10.3389/fneur.2019.00354			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HT3AN	WOS:000464436000001	31031689	Green Published, gold			2022-02-06	
J	Foks, KA; Dijkland, SA; Lingsma, HF; Polinder, S; van den Brand, CL; Jellema, K; Jacobs, B; van der Naalt, J; Sir, O; Jie, KE; Schoonman, GG; Hunink, MGM; Steyerberg, EW; Dippel, DWJ; Gaakeer, MI; Schutte, CE; Visee, HF; den Boogert, H; Reijners, E; Braaksma, M; de Jong, E; Patka, P				Foks, Kelly A.; Dijkland, Simone A.; Lingsma, Hester F.; Polinder, Suzanne; van den Brand, Crispijn L.; Jellema, Korne; Jacobs, Bram; van der Naalt, Joukje; Sir, Ozcan; Jie, Kim E.; Schoonman, Guus G.; Hunink, Myriam G. M.; Steyerberg, Ewout W.; Dippel, Diederik W. J.; Gaakeer, Menno, I; Schutte, Charlotte E.; Visee, Huib F.; den Boogert, Hugo; Reijners, Eef; Braaksma, Meriam; de Jong, Eline; Patka, Peter			Risk of Intracranial Complications in Minor Head Injury: The Role of Loss of Consciousness and Post-Traumatic Amnesia in a Multi-Center Observational Study	JOURNAL OF NEUROTRAUMA			English	Article						clinical guidelines; loss of consciousness; mild traumatic brain injury; minor head injury; post-traumatic amnesia	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; ADULTS; PROPOSAL; CHILDREN; COHORT	Various guidelines for minor head injury focus on patients with a Glasgow Coma Scale (GCS) score of 13-15 and loss of consciousness (LOC) or post-traumatic amnesia (PTA), while clinical management for patients without LOC or PTA is often unclear. We aimed to investigate the effect of presence and absence of LOC or PTA on intracranial complications in minor head injury. A prospective multi-center cohort study of all patients with blunt head injury and GCS score of 15 was conducted at six Dutch centers between 2015 and 2017. Five centers used the national guideline and one center used a local guideline-both based on the CT in Head Injury Patients (CHIP) prediction model-to identify patients in need of a computed tomography (CT) scan. We studied the presence of traumatic findings and neurosurgical interventions in patients with and without LOC or PTA. In addition, we assessed the association of LOC and PTA with traumatic findings with logistic regression analysis and the additional predictive value of LOC and PTA compared with other risk factors in the CHIP model. Of 3914 patients, 2249 (58%) experienced neither LOC nor PTA and in 305 (8%) LOC and PTA was unknown. Traumatic findings were present in 153 of 1360 patients (11%) with LOC or PTA and in 67 of 2249 patients (3%) without LOC and PTA. Five patients without LOC and PTA had potential neurosurgical lesions and one patient underwent a neurosurgical intervention. LOC and PTA were strongly associated with traumatic findings on CT, with adjusted odds ratios of 2.9 (95% confidence interval [CI] 2.2-3.8) and 3.5 (95% CI 2.7-4.6), respectively. To conclude, patients who had minor head injury with neither LOC nor PTA are at risk of intracranial complications. Clinical guidelines should include clinical management for patients without LOC and PTA, and they should include LOC and PTA as separate risk factors rather than as diagnostic selection criteria.	[Foks, Kelly A.; Dijkland, Simone A.; Lingsma, Hester F.; Polinder, Suzanne; Steyerberg, Ewout W.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Foks, Kelly A.; Dippel, Diederik W. J.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands; [van den Brand, Crispijn L.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Emergency Med, Rotterdam, Netherlands; [Hunink, Myriam G. M.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands; [Hunink, Myriam G. M.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Epidemiol, Rotterdam, Netherlands; [van den Brand, Crispijn L.] Haaglanden Med Ctr, Dept Emergency Med, The Hague, Netherlands; [Jellema, Korne] Haaglanden Med Ctr, Dept Neurol, The Hague, Netherlands; [Jacobs, Bram; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Sir, Ozcan] Radboud Univ Nijmegen, Med Ctr, Dept Emergency Med, Nijmegen, Netherlands; [Jie, Kim E.] Jeroen Bosch Hosp, Dept Emergency Med, Shertogenbosch, Netherlands; [Schoonman, Guus G.] Elisabeth Tweesteden Hosp, Dept Neurol, Tilburg, Netherlands; [Hunink, Myriam G. M.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands		Foks, KA (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	k.foks@erasmusmc.nl	Dippel, Diederik/AAJ-2192-2020	Dippel, Diederik/0000-0002-9234-3515; van der Naalt, Joukje/0000-0001-9873-2418			Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; Foks K.A., 2017, J NEUROTRAUMA; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2018, LANCET NEUROL, V17, P737, DOI 10.1016/S1474-4422(18)30275-8; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mower WR, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002313; National Clinical Guideline Centre. National Institute for Health and Clinical Excellence: Guidance, 2014, HEAD INJ TRIAG ASS I; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sharif-Alhoseini Mahdi, 2011, J Emerg Trauma Shock, V4, P472, DOI 10.4103/0974-2700.86631; Sheehan A, 2012, EMERG MED J, V29, P899, DOI 10.1136/emermed-2011-200155; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Strand IH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-62; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Van den Brand C.L., 2017, EUR J EMERG MED, V25, P355	28	2	2	3	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2019	36	16					2377	2384		10.1089/neu.2018.6354		APR 2019	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IN3NH	WOS:000464546000001	30860435	Green Submitted			2022-02-06	
J	Zelencich, L; Kazantzis, N; Wong, DN; McKenzie, D; Downing, M; Ponsford, J				Zelencich, Leah; Kazantzis, Nikolaos; Wong, Dana; McKenzie, Dean; Downing, Marina; Ponsford, Jennie			Predictors of working alliance in cognitive behaviour therapy adapted for traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; cognitive behaviour therapy; working alliance; anxiety; depression	ANXIETY STRESS SCALES; HOSPITAL ANXIETY; SELF-AWARENESS; PSYCHOMETRIC PROPERTIES; DEPRESSION SCALE; REHABILITATION; SYMPTOMS; IMPACT; CLIENT; PSYCHOTHERAPY	Cognitive Behaviour Therapy (CBT) has the strongest preliminary support for treatment of depression and anxiety following traumatic brain injury (TBI). TBI associated cognitive impairments may pose an obstacle to development of a strong working alliance, on which therapeutic gains depend. The current study examined the association of demographic (i.e., gender, age at study entry, years of education and premorbid IQ) and injury-related (i.e., years since injury, post-trauma amnesia duration, memory and executive functioning test performance) variables with alliance in CBT adapted for TBI (CBT-ABI). The audio-recordings of 177 CBT-ABI sessions from 31 participants were assessed with an observer version of the Working Alliance Inventory at nine time-points. Multi-level mixed model regressions showed that participants and therapists maintained a relatively strong alliance across all sessions. Pre-intervention symptom severity was considered as a confounder variable and was found to have no statistically significant influence on the models. None of the demographic variables were significantly associated with alliance scores. More years since injury was associated with a stronger alliance. These findings demonstrate that TBI associated cognitive impairments do not necessarily pose an obstacle to development and maintenance of a strong working alliance, which is more likely to develop with more time post-brain injury.	[Zelencich, Leah; Kazantzis, Nikolaos] Monash Univ, Sch Psychol Sci, Cognit Behav Therapy Res Unit, Clayton, Vic, Australia; [Wong, Dana] La Trobe Univ, Sch Psychol & Publ Hlth, Bundoora, Vic, Australia; [McKenzie, Dean; Downing, Marina; Ponsford, Jennie] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [McKenzie, Dean] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia		Ponsford, J (corresponding author), Sch Psychol Sci, 18 Innovat Walk, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020; Wong, Dana/AAD-3410-2020; Ponsford, Jennie/H-8341-2014; Kazantzis, Nikolaos/F-9520-2013	Downing, Marina/0000-0002-3126-6632; Wong, Dana/0000-0001-9619-1929; Ponsford, Jennie/0000-0003-0430-125X; Kazantzis, Nikolaos/0000-0001-9559-4160	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [606432]	The parent RCT was supported by the National Health and Medical Research Council [grant number 606432].	Alway Y, 2016, PSYCHOL MED, V46, P1331, DOI 10.1017/S0033291715002986; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Beck AT., 1979, COGNITIVE THERAPY DE; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bordin ES, 1979, RES PRACTICE, V16, P252, DOI DOI 10.1037/H0085885; Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Burgess P.W., 1997, HAYLING BRIXTON TEST; Connors GJ, 2000, J STUD ALCOHOL, V61, P139, DOI 10.15288/jsa.2000.61.139; Coughlan A. K., 2007, BIRT MEMORY INFORM P; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Everitt N., 2017, CLIN PSYCHOL GLOBAL, P383; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; FINN RH, 1970, EDUC PSYCHOL MEAS, V30, P71, DOI 10.1177/001316447003000106; Fleiss J. L., 2013, STAT METHODS RATES P; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fluckiger C, 2018, PSYCHOTHERAPY, V55, P316, DOI 10.1037/pst0000172; Gaston L., 1994, CALIFORNIA PSYCHOTHE, P85; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; Harrell FE, 2015, SPRINGER SER STAT, P311, DOI 10.1007/978-3-319-19425-7_13; Hartmann A, 2015, PSYCHOTHER RES, V25, P408, DOI 10.1080/10503307.2014.927601; Hatcher RL, 2006, PSYCHOTHER RES, V16, P12, DOI 10.1080/10503300500352500; Hilsenroth MJ, 2004, J PERS ASSESS, V83, P332, DOI 10.1207/s15327752jpa8303_14; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Kazantzis N., 2017, THERAPEUTIC RELATION; Kazantzis N., 2018, WORKING ALLIAN UNPUB; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Klonoff P. S., 2010, PSYCHOTHERAPY BRAIN; Knerr M, 2011, J MARITAL FAM THER, V37, P182, DOI 10.1111/j.1752-0606.2009.00176.x; Lorenzo-Luaces L, 2014, J CONSULT CLIN PSYCH, V82, P368, DOI 10.1037/a0035994; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lysaker PH, 2011, J NERV MENT DIS, V199, P191, DOI 10.1097/NMD.0b013e31820c73eb; Markin RD, 2014, PSYCHOTHERAPY, V51, P413, DOI 10.1037/a0036069; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Munder T, 2010, CLIN PSYCHOL PSYCHOT, V17, P231, DOI 10.1002/cpp.658; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Norton PJ, 2016, J CONSULT CLIN PSYCH, V84, P146, DOI 10.1037/ccp0000062; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Ownsworth T, 2006, REHABIL PSYCHOL, V51, P50, DOI 10.1037/0090-5550.51.1.50; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Piper WE, 2005, INT J GROUP PSYCHOTH, V55, P527, DOI 10.1521/ijgp.2005.55.4.527; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; Rosti-Otajarvi E, 2014, J NEUROL SCI, V338, P156, DOI 10.1016/j.jns.2013.12.039; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Snijders TAB., 2012, MULTILEVEL ANAL INTR; Soo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005239.pub2; StataCorp  L. P, 2017, STAT STAT SOFTW VERS; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Streiner D.L., 2015, HLTH MEASUREMENT SCA, V5th ed.; Tabachnick B.G., 2013, USING MULTIVARIATE S; Tinsley H.E., 2000, HDB APPL MULTIVARIAT, P95, DOI DOI 10.1016/B978-012691360-6/50005-7; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Tracey T.J., 1989, J CONSULT CLIN PSYCH, V1, P207, DOI [10.1037/1040-3590.1.3.207, DOI 10.1037/1040-3590.1.3.207, 10.1037/1040-3590.1.3.207.]; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Webb CA, 2011, J CONSULT CLIN PSYCH, V79, P279, DOI 10.1037/a0023252; WHITEHURST GJ, 1984, AM PSYCHOL, V39, P22, DOI 10.1037/0003-066X.39.1.22; Wong D., COGNITIVE BEHAV THER; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zilcha-Mano S, 2017, AM PSYCHOL, V72, P311, DOI 10.1037/a0040435	80	2	2	1	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	OCT 20	2020	30	9					1682	1700		10.1080/09602011.2019.1600554		APR 2019	19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	NH7ZH	WOS:000465926900001	30990370				2022-02-06	
J	Mowafy, SMS; Abdelgalel, EF				Mowafy, Sherif M. S.; Abdelgalel, Essam F.			Diaphragmatic rapid shallow breathing index for predicting weaning outcome from mechanical ventilation: Comparison with traditional rapid shallow breathing index	EGYPTIAN JOURNAL OF ANAESTHESIA			English	Article						Weaning; Rapid shallow breathing index; Diaphragmatic rapid shallow breathing index; Diaphragmatic ultrasound	EXTUBATION FAILURE; TRIAL; PATIENT; WORK	Background: Rapid shallow breathing index (RSBI) is a well-known weaning index. However; its diagnostic performance is less than satisfactory. Recently, diaphragmatic rapid shallow breathing index (DRSBI) is proposed as a promising tool in weaning outcome prediction. The aim of this study was to evaluate if DRSBI is more accurate than RSBI for weaning outcome prediction.Patients and methods: This prospective, randomized clinical trial was carried out on 106 mechanically ventilated patients for more than 48h and ready to wean at their first spontaneous breathing trial (SBT). After one minute of SBT, RSBI and DRSBI were calculated. According to the decision to continue SBT patients were divided into: Group I (53 patients) the decision depends on the RSBI. Group II (53 patients) the decision based on DRSBI. 30min later, patients were reevaluated for tolerance of SBT then RSBI and DRSBI were calculated. Outcome of the weaning attempt was recorded and ROC analysis was done to evaluate the diagnostic accuracy.Results: 106 patients were enrolled. Trauma was the commonest diagnosis on ICU admission and traumatic brain injury was the main indication for initiation of mechanical ventilation in the two groups. 33 patients (31.1%) failed to wean (19 patients in group I and 14 patients in group II). RSBI at 1min and 30min as well as DRSBI at 1min and 30min were highly statistical significant higher in weaning failure patients. RSBI and DRSBI at 30min were highly statistical significant increased compared to at 1min. DRSBI at 30min was the parameter with the best diagnostic accuracy for predicting weaning success with a cutoff value <1.6 breaths/min/mm.Conclusion: DRSBI has a better diagnostic accuracy than the traditional RSBI in predicting weaning outcome specially when monitored at 30min from the start of SBT.Trial registration: this clinical trial was registered with ClinicalTrials.gov (NCT03561792)	[Mowafy, Sherif M. S.; Abdelgalel, Essam F.] Zagazig Univ, Dept Anesthesia & Surg Intens Care, Fac Med, Zagazig, Egypt		Mowafy, SMS (corresponding author), Zagazig Univ, Dept Anesthesia & Surg Intens Care, Fac Med, Zagazig, Egypt.	sherifmowafy2012@gmail.com	Abdelgalel, Essam/ABB-5960-2020; Mowafy, Sherif M S/AAW-3873-2020	Mowafy, Sherif M S/0000-0002-0357-7986			Abbas A, 2018, INT J CHRONIC OBSTR, V13, P1655, DOI 10.2147/COPD.S161691; Barrera R, 1999, J CRIT CARE, V14, P172, DOI 10.1016/S0883-9441(99)90031-X; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Boussuges A, 2009, CHEST, V135, P391, DOI 10.1378/chest.08-1541; Boutou AK, 2011, HEART LUNG, V40, P105, DOI 10.1016/j.hrtlng.2010.02.002; Burns SM, 2010, AM J CRIT CARE, V19, P431, DOI 10.4037/ajcc2010273; Chatila W, 1996, AM J MED, V101, P61, DOI 10.1016/S0002-9343(96)00064-2; Conti G, 2004, INTENS CARE MED, V30, P830, DOI 10.1007/s00134-004-2230-8; Reis Helena Franca Correia dos, 2013, Rev. bras. ter. intensiva, V25, P212, DOI 10.5935/0103-507X.20130037; Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186; EPSTEIN SK, 1995, AM J RESP CRIT CARE, V152, P545, DOI 10.1164/ajrccm.152.2.7633705; Johannigman JA, 1997, SURGERY, V122, P737, DOI 10.1016/S0039-6060(97)90081-7; Karthika M, 2016, ANN THORAC MED, V11, P167, DOI 10.4103/1817-1737.176876; Kim WY, 2011, CRIT CARE MED, V39, P2627, DOI 10.1097/CCM.0b013e3182266408; Krieger BP, 1997, CHEST, V112, P1029, DOI 10.1378/chest.112.4.1029; Kulkarni AP, 2008, INDIAN J CRIT CARE M, V12, P1, DOI 10.4103/0972-5229.40942; LEE KH, 1994, CHEST, V105, P540, DOI 10.1378/chest.105.2.540; Li C, 2018, MEDICINE, V97, DOI DOI 10.1097/MD.0000000000010968; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; Matamis D, 2013, INTENS CARE MED, V39, P801, DOI 10.1007/s00134-013-2823-1; McConville JF, 2012, NEW ENGL J MED, V367, P2233, DOI 10.1056/NEJMra1203367; Meade M, 2001, CHEST, V120, p400S, DOI 10.1378/chest.120.6_suppl.400S; Penuelas O, 2011, AM J RESP CRIT CARE, V184, P430, DOI 10.1164/rccm.201011-1887OC; Pirompanich P, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0277-9; Segal LN, 2010, INTENS CARE MED, V36, P487, DOI 10.1007/s00134-009-1735-6; Spadaro S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1479-y; Thille AW, 2011, CRIT CARE MED, V39, P2612, DOI 10.1097/CCM.0b013e3182282a5a; Vallverdu I, 1998, AM J RESP CRIT CARE, V158, P1855, DOI 10.1164/ajrccm.158.6.9712135; YAN S, 1993, J APPL PHYSIOL, V75, P1364, DOI 10.1152/jappl.1993.75.3.1364; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101; Zambon M, 2017, INTENS CARE MED, V43, P29, DOI 10.1007/s00134-016-4524-z; Zhou PM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015043; 2018, KOREAN J INTERN MED, V33, P331, DOI DOI 10.3904/KJIM.2016.152; 2006, J FORMOS MED ASS, V105, P390	34	2	2	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND		1110-1849		EGYPT J ANAESTH	Egypt. J. Anaesth.	APR 8	2019	35	1					7	13		10.1016/j.egja.2018.10.003			7	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	HW6KA	WOS:000466797500001		gold			2022-02-06	
J	Umemoto, Y; Patel, A; Huynh, T; Chitravanshi, VC				Umemoto, Yasunori; Patel, Anshu; Trong Huynh; Chitravanshi, Vineet C.			Wogonin attenuates the deleterious effects of traumatic brain injury in anesthetized Wistar rats	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Baroreflex; BP; Fluid percussion injury; HR; Splanchnic activity; Wogonin	NUCLEUS-TRACTUS-SOLITARIUS; BLOOD-PRESSURE; GLUTAMATE RELEASE; MODEL; MICROINJECTIONS; HYPOTENSION; IMPAIRMENT; RECEPTORS; BAICALIN; INCREASE	Wogonin, a flavonoid (5,7-dihydroxy-8-methoxyflavone) with reported neuroprotective properties, is widely used in treating inflammatory diseases. The main goal of this study was to explore the role of wogonin in preventing deleterious cardiovascular effects of traumatic brain injury (TBI). Experiments were carried out in adult male urethane-anesthetized, artificially ventilated, Wistar rats, weighing 300-350 gm. TBI was produced by fluid percussion injury (FPI). A significant decrease in blood pressure (BP), heart rate (HR) and greater splanchnic nerve activity (GSNA), which lasted for up to 4 h, was observed after the application of moderate FPI. Intravenous (i.v.) and intracerebroventricular (i.c.v.) administration of wogonin before and after the moderate FPI significantly attenuated the decreases in BP, HR, and GSNA elicited by FPI. Administration of wogonin also prevented the attenuation of baroreflex-induced bradycardia elicited by FPI. Based on these results, it was concluded that administration of wogonin attenuates the deleterious effects of moderate FPI.	[Patel, Anshu; Trong Huynh; Chitravanshi, Vineet C.] Rutgers New Jersey Med Sch, Dept Neurol Surg, 185 South Orange Ave, Newark, NJ 07103 USA; [Umemoto, Yasunori] Wakayama Med Univ, Dept Rehabil Med, Wakayama, Japan		Chitravanshi, VC (corresponding author), Rutgers New Jersey Med Sch, Dept Neurol Surg, MSB H-586,185 South Orange Ave, Newark, NJ 07103 USA.	chitrava@njms.rutgers.edu		Chitravanshi, Vineet/0000-0001-5610-4739	New Jersey Commission on Brain Injury Research Grant [CBIR15IRG014]	This work was supported by New Jersey Commission on Brain Injury Research Grant # CBIR15IRG014.	ANDERSON ID, 1990, J TRAUMA, V30, P974, DOI 10.1097/00005373-199008000-00005; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chitravanshi VC, 1996, BRAIN RES, V715, P104, DOI 10.1016/0006-8993(95)01565-5; Chitravanshi VC, 2011, AM J PHYSIOL-HEART C, V300, pH223, DOI 10.1152/ajpheart.00391.2010; Chitravanshi VC, 2009, AM J PHYSIOL-REG I, V296, pR1402, DOI 10.1152/ajpregu.90978.2008; Cho J, 2004, BIOL PHARM BULL, V27, P1561, DOI 10.1248/bpb.27.1561; Cooper TM, 2015, BRAIN BEHAV IMMUN, V49, P94, DOI 10.1016/j.bbi.2014.12.017; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Du Yue, 2002, Yaoxue Xuebao, V37, P362; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Fong SYK, 2014, J PHARMACEUT BIOMED, V97, P9, DOI 10.1016/j.jpba.2014.03.033; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hammer PE, 2005, AM J PHYSIOL-REG I, V288, pR1637, DOI 10.1152/ajpregu.00050.2004; Hanrahan JR, 2011, BRIT J PHARMACOL, V163, P234, DOI 10.1111/j.1476-5381.2011.01228.x; Hui KM, 2002, BIOCHEM PHARMACOL, V64, P1415, DOI 10.1016/S0006-2952(02)01347-3; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Jaiswal MK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-64; Kawabe T, 2008, NEUROSCIENCE, V153, P605, DOI 10.1016/j.neuroscience.2008.02.076; Kawabe T, 2006, BRAIN RES, V1102, P117, DOI 10.1016/j.brainres.2006.05.002; Kawabe T, 2014, AM J PHYSIOL-HEART C, V306, pH438, DOI 10.1152/ajpheart.00628.2013; Kawabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045180; Kumar G Phani, 2012, Pharmacogn Rev, V6, P81, DOI 10.4103/0973-7847.99898; Lee H, 2003, FASEB J, V17, P1943, DOI 10.1096/fj.03-0057fje; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Mascarucci P, 1998, NEUROSCIENCE, V86, P1285, DOI 10.1016/S0306-4522(98)00105-5; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMahon CG, 2008, CRIT CARE MED, V36, P216, DOI 10.1097/01.CCM.0000295425.41831.85; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; Piao HZ, 2004, ARCH PHARM RES, V27, P930, DOI 10.1007/BF02975846; Qu JT, 2015, BIOL PHARM BULL, V38, P1873, DOI 10.1248/bpb.b15-00444; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; SAPRU HN, 1982, BRAIN RES BULL, V8, P267, DOI 10.1016/0361-9230(82)90058-2; Sapru HN, 2002, CLIN EXP PHARMACOL P, V29, P491, DOI 10.1046/j.1440-1681.2002.03661.x; Tai MC, 2005, CNS DRUG REV, V11, P141; TALMAN WT, 1980, SCIENCE, V209, P813, DOI 10.1126/science.6105709; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tsai TH, 1996, PLANTA MED, V62, P263, DOI 10.1055/s-2006-957874; Umemoto Y., 2017, CARDIOVASCULAR CHANG; Velmahos GC, 1999, WORLD J SURG, V23, P54, DOI 10.1007/s002689900564; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; WILLETTE RN, 1983, J PHARMACOL EXP THER, V226, P893; WILLETTE RN, 1983, NEUROPHARMACOLOGY, V22, P1071, DOI 10.1016/0028-3908(83)90027-8; Zhang LJ, 2006, J ETHNOPHARMACOL, V103, P120, DOI 10.1016/j.jep.2005.07.013	54	2	2	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	APR 5	2019	848						121	130		10.1016/j.ejphar.2019.01.035			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HM4ZF	WOS:000459483200015	30689996				2022-02-06	
J	Albert, V; Subramanian, A; Pati, HP; Agrawal, D; Bhoi, SK				Albert, Venencia; Subramanian, Arulselvi; Pati, Hara Prasad; Agrawal, Deepak; Bhoi, Sanjeev Kumar			Efficacy of Thromboelastography (TEG) in Predicting Acute Trauma-Induced Coagulopathy (ATIC) in Isolated Severe Traumatic Brain Injury (iSTBI)	INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION			English	Article; Proceedings Paper	Laboratory Medicine Congress and Exhibition (LMCE) / 57th Annual Meeting of the Korean-Society-for-Laboratory-Medicine (KSLM)	OCT 26-28, 2016	Korean Soc Lab Med, Seoul, SOUTH KOREA		Korean Soc Lab Med	Thromboelastography; Point-of-care systems; Blood coagulation tests; TraumaticBrain injuries	CONVENTIONAL COAGULATION TESTS; RAPID THROMBELASTOGRAPHY; FIBRINOGEN	To evaluate the efficacy of point-of-care thromboelastography (TEG) to predict acute trauma-induced coagulopathy (ATIC) in isolated severe TBI (iSTBI). We conducted an observational diagnostic cohort. Patients for whom TEG was performed before blood transfusion were stratified by conventional coagulation tests (CCTs) on admission and classified as ATIC (prothrombin time >= 16.70s; international normalized ratio >= 1.27; activated partial thromboplastin time >= 28.80s) (n=24) or no ATIC (n=34). Univariate analysis to compare groups, receiver operating characteristic analysis to establish cut-off and diagnostic validation was done. Fifty-eight patients were included [32(25-45) years; 97% male; GCS 6.3 +/- 1.5]. 41% developed ATIC. Compared to no-ATIC, ATIC group had significantly prolonged kappa-time (4.6 vs. 2.5min; p=0.01) and shortened alpha-angle (40.2 degrees vs. 56.3 degrees; p=0.03). A cut-off for kappa-time >= 3.7 (AUC 0.68 95% CI 0.54-0.82, specificity 70%, sensitivity 63%) and alpha angle <= 48.0 (AUC 0.66, 95% CI 0.51-0.81, specificity 67%, sensitivity 67%) was established. The diagnostic accuracy of this cut-off for identifying ATIC, was 55.6% with sensitivity (81.8%) and specificity (14.3%). TEG may be a clinically sensitive test for identifying the underlying coagulopathy following TBI. However confirmation with CCTs is recommended.	[Albert, Venencia; Subramanian, Arulselvi] AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Lab Med, New Delhi, India; [Pati, Hara Prasad] AIIMS, Dept Hematol, New Delhi, India; [Agrawal, Deepak] AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Neurosurg, New Delhi, India; [Bhoi, Sanjeev Kumar] AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Emergency Med, New Delhi, India		Subramanian, A (corresponding author), AIIMS, Jai Prakash Narayan Apex Trauma Ctr, Dept Lab Med, New Delhi, India.	albertvenencia@gmail.com; arulselvi.jpnatc@gmail.com; harappati@yahoo.co.in; drdeepak@gmail.com; sanjeevbhoi@gmail.com	/AAG-3032-2021; Subramanian, arulselvi/AAG-1670-2020	/0000-0002-5499-0746; Subramanian, arulselvi/0000-0001-7797-6683; ALBERT, VENENCIA/0000-0001-9736-8319			Agren A, 2013, SCAND J CLIN LAB INV, V73, P214, DOI 10.3109/00365513.2013.765960; Badr A, 2004, CRIT CARE S1, V8, pP104, DOI [10.1186/cc2571, DOI 10.1186/CC2571]; Bluth MH, 2011, CRIT CARE, V15, DOI 10.1186/cc10569; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Cotton BA, 2011, J TRAUMA, V71, P407, DOI 10.1097/TA.0b013e31821e1bf0; Dobson GP, 2015, J TRAUMA ACUTE CARE, V79, P301, DOI 10.1097/TA.0000000000000729; Doran CM, 2010, J TRAUMA, V69, pS40, DOI 10.1097/TA.0b013e3181e4257b; Fries D, 2010, BRIT J ANAESTH, V105, P116, DOI 10.1093/bja/aeq161; Gonzalez E, 2010, SEMIN THROMB HEMOST, V36, P723, DOI 10.1055/s-0030-1265289; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Howley Isaac W, 2018, Trauma Surg Acute Care Open, V3, pe000140, DOI 10.1136/tsaco-2017-000140; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Jeger V, 2012, SCI WORLD J, DOI 10.1100/2012/821794; Kashuk JL, 2009, J SURG RES, V156, P133, DOI 10.1016/j.jss.2009.03.046; Kornblith LZ, 2014, J TRAUMA ACUTE CARE, V76, P255, DOI 10.1097/TA.0000000000000108; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Lance MD, 2015, THROMB J, V13, DOI 10.1186/1477-9560-13-1; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; Schreiber MA, 2005, CURR OPIN CRIT CARE, V11, P590, DOI 10.1097/01.ccx.0000186374.49320.ab; Sharma P, 2010, AM J CLIN PATHOL, V134, P97, DOI 10.1309/AJCPPZ4J6CAFYDVM; Sixta SL, 2005, J NEUROL NEUROPHYSIO, V6, P316; Sorensen B, 2012, BRIT J SURG, V99, P40, DOI 10.1002/bjs.7770; Subramanian Arulselvi, 2014, ISRN Hematol, V2014, P849626, DOI 10.1155/2014/849626; Subramanian A, 2014, INDIAN J PATHOL MICR, V57, P43, DOI 10.4103/0377-4929.130896; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	31	2	2	0	2	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0971-4502	0974-0449		INDIAN J HEMATOL BLO	Indian J. Hematol. Blood Transfus.	APR	2019	35	2					325	331		10.1007/s12288-018-1003-4			7	Hematology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Hematology	IH8PL	WOS:000474767900019	30988571	Green Published			2022-02-06	
J	Besagar, S; Radabaugh, HL; Bleimeister, IH; Meyer, EA; Niesman, PJ; Cheng, JP; Bondi, CO; Kline, AE				Besagar, Sonya; Radabaugh, Hannah L.; Bleimeister, Isabel H.; Meyer, Elizabeth A.; Niesman, Peter J.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.			Aripiprazole and environmental enrichment independently improve functional outcome after cortical impact injury in adult male rats, but their combination does not yield additional benefits	EXPERIMENTAL NEUROLOGY			English	Article						Antipsychotic drugs; Behavioral outcome; Controlled cortical impact; Functional recovery; Learning and memory; Morris water maze; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; HISTOLOGICAL BENEFITS; INCREASES DOPAMINE; RODENT MODELS; RECOVERY; HALOPERIDOL; RISPERIDONE; AGITATION; BEHAVIOR; AGONIST	Typical antipsychotic drugs (APDs) with D2(a)ntagonistic properties impede functional outcome after experimental traumatic brain injury (TBI) and reduce the effectiveness of environmental enrichment (EE). Here we test the hypothesis that aripiprazole (ARIP), an atypical APD with partial D(2)and 5-HT(1A)receptor agonist activities will improve recovery after TBI and when combined with EE will further enhance the benefits. Anesthetized adult male rats received either a controlled cortical impact of moderate severity or sham injury and then were randomly assigned to EE or standard (STD) housing and once daily intraperitoneal injections of ARIP (0.1 mg/kg) or vehicle (VEH; 1.0 mL/kg) beginning 24 h after injury for 19 days. Motor (beam-walking time and beam-walk score) and cognitive (acquisition of spatial learning and memory) outcomes were assessed on post-operative days 1-5 and 14-19, respectively. Cortical lesion volume was quantified on day 21. There were no statistical differences among the sham groups, regardless of housing or treatment, so the data were pooled. The SHAM group performed better than all TBI groups on motor and spatial learning (p < 0.05) but did not differ from either EE group on memory retention. Regarding TBI, both EE groups improved motor and cognitive outcomes vs. the VEH-treated STD group (p < 0.05) but did not differ from one another (p > 0.05). The ARIP-treated STD group performed better than the VEH-treated STD group on beam-walk score and spatial learning (p < 0.05), but not beam-walking time or memory retention (p > 0.05). Cortical lesion volume was smaller in all treated groups compared to the TBI + STD + VEH group (p < 0.05). The data replicate previous work and extend the findings by demonstrating that 1) ARIP promotes recovery after TBI, but combining treatments does not yield additional benefits, which is contrary to the hypothesis, and 2) unlike APDs that exhibit D-2 receptor antagonism, ARIP does not impede rehabilitation (i.e., EE).	[Besagar, Sonya; Radabaugh, Hannah L.; Bleimeister, Isabel H.; Meyer, Elizabeth A.; Niesman, Peter J.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Besagar, Sonya; Radabaugh, Hannah L.; Bleimeister, Isabel H.; Meyer, Elizabeth A.; Niesman, Peter J.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15213 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15213 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15213 USA; [Besagar, Sonya] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10032 USA; [Radabaugh, Hannah L.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Niesman, Peter J.] Yale Univ, Dept Neurosci, New Haven, CT 06510 USA		Kline, AE (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res,John G Rangos Res Ctr, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu		Niesman, Peter/0000-0002-6156-2205; Bleimeister, Isabel/0000-0003-1565-0017	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, HD069620-S1, NS060005, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; UMPC Rehabilitation Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS099674, R21NS099683, R03NS094950, R01NS084967] Funding Source: NIH RePORTER	This work was supported, in part, by NIH grants HD069620, HD069620-S1, NS060005, NS084967 (AEK), NS094950, NS099683 (COB), the University of Pittsburgh Physicians/UPMC Academic Foundation, and the UMPC Rehabilitation Institute (COB).	Ahmed T, 2017, CURR NEUROPHARMACOL, V15, P480, DOI 10.2174/1570159X14666160325121145; Archer DP, 2018, BRIT J ANAESTH, V121, P1272, DOI 10.1016/j.bja.2018.07.024; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Burris KD, 2002, J PHARMACOL EXP THER, V302, P381, DOI 10.1124/jpet.102.033175; Chen YH, 2017, CELL TRANSPLANT, V26, P1156, DOI 10.1177/0963689717714105; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Drago A, 2008, INT J NEUROPSYCHOPH, V11, P701, DOI 10.1017/S1461145707008218; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Free KE, 2017, EXP NEUROL, V296, P62, DOI 10.1016/j.expneurol.2017.07.004; Goldstein LB, 2002, NEUROREHAB NEURAL RE, V16, P321, DOI 10.1177/154596830201600402; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Kline A. E, 2002, NEUROSCI LETT, V280, P163; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Lajud N, 2019, J NEUROTRAUM, V36, P756, DOI 10.1089/neu.2018.5866; Leary JB, 2017, J NEUROTRAUM, V34, P444, DOI 10.1089/neu.2016.4438; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Li Z, 2004, EUR J PHARMACOL, V493, P75, DOI 10.1016/j.ejphar.2004.04.028; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Matsuda Y, 2014, PSYCHIAT CLIN NEUROS, V68, P425, DOI 10.1111/pcn.12147; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Newman-Tancredi A, 2011, NEUROPSYCHIATRY-LOND, V1, P149, DOI 10.2217/NPY.11.12; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; O'Neil DA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00579; Okigbo AA, 2019, NEUROSCI LETT, V694, P69, DOI 10.1016/j.neulet.2018.11.030; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Phelps TI, 2017, NEUROREHAB NEURAL RE, V31, P25, DOI 10.1177/1545968316650281; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Radabaugh HL, 2017, EXP NEUROL, V294, P12, DOI 10.1016/j.expneurol.2017.04.013; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Schatzberg AF, 2009, AMERICAN PSYCHIATRIC PUBLISHING TEXTBOOK OF PSYCHOPHARMACOLOGY, 4TH EDITION, P1; Semple BD, 2016, METHODS MOL BIOL, V1462, P325, DOI 10.1007/978-1-4939-3816-2_18; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Tanahashi S, 2012, NEUROPHARMACOLOGY, V62, P765, DOI 10.1016/j.neuropharm.2011.08.031; Umene-Nakano W, 2013, GEN HOSP PSYCHIAT, V35, DOI 10.1016/j.genhosppsych.2012.05.002; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; Wood M, 2007, EXPERT OPIN INV DRUG, V16, P771, DOI 10.1517/13543784.16.6.771; Zocchi A, 2005, NEUROSCI LETT, V387, P157, DOI 10.1016/j.neulet.2005.06.035	58	2	2	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2019	314						67	73		10.1016/j.expneurol.2019.01.010			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN1MX	WOS:000459952400007	30659800	Green Accepted			2022-02-06	
J	Elbin, RJ; Fazio-Sumrok, V; Anderson, MN; D'Amico, NR; Said, A; Grossel, A; Schatz, P; Lipinski, D; Womble, M				Elbin, R. J.; Fazio-Sumrok, Vanessa; Anderson, Melissa N.; D'Amico, Nathan R.; Said, Azkya; Grossel, Adam; Schatz, Philip; Lipinski, Damon; Womble, Melissa			Evaluating the suitability of the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) computerized neurocognitive battery for short-term, serial assessment of neurocognitive functioning	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Test-retest reliability; Neurocognitive testing; Statistical methods; Practice effects/reliable change	TEST-RETEST RELIABILITY; DEHYDRATION; CHEMOTHERAPY	Background: Computerized Neurocognitive Testing (CNT) is frequently used for serial assessment of athletes following concussion. The Immediate Post-Concussion Assessment for Cognitive Testing (ImPACT) is a commonly used CNT with well-documented test-retest reliability in healthy samples for intervals ranging from one month to two years. However, previous research has not explored use of ImPACT for other serial testing methodologies such as immediately before and after an experimental trial/intervention where administration on the same day may be necessary. Purpose: To examine the suitability of ImPACT for short-term, serial assessment of neurocognitive functioning. Study design: Prospective, repeated measures research design. Methods: Forty-two healthy, college-aged individuals completed ImPACT twice, with a one-hour break between assessments. Reliability was assessed using Pearson correlation coefficients, intraclass correlation coefficients (ICCs), reliable change indices (RCIs) and regression-based methods (RBM). Results: No significant increases in mean ImPACT composite or symptom scores were observed between assessments. ICCs ranged from 0.34 to 0.74 (single)/0.51 to 0.85 (average). Across two test administrations, 92-100% and 93-98% of participants' change scores fell within cutoffs when utilizing the RCI and RBM, respectively. Conclusion: The ICCs for ImPACT composite and factor scores across the one-hour administration were consistent with previous studies. Only a small percentage of scores fell outside of RCI and RBM cutoffs. These statistical metrics suggest that ImPACT has sufficient reliability when repeating administration within one-hour. (C) 2018 Elsevier Ltd. All rights reserved.	[Elbin, R. J.; D'Amico, Nathan R.; Said, Azkya] Univ Arkansas, Off Sport Concuss Res, Dept Hlth Human Performance & Recreat, 155 Stadium Dr, Fayetteville, AR 72701 USA; [Fazio-Sumrok, Vanessa] Univ Pittsburgh, UPMC Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA; [Anderson, Melissa N.] Univ Georgia, Concuss Res Lab, Dept Kinesiol, Athens, GA 30602 USA; [Grossel, Adam; Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Lipinski, Damon] Univ Arkansas Med Sci, Schmeiding Dev Ctr, Lowell, AR USA; [Womble, Melissa] Inova Med Grp Orthopaed & Sports Med, Inova Sports Med Concuss Program, Fairfax, VA USA		Elbin, RJ (corresponding author), Univ Arkansas, Off Sport Concuss Res, Dept Hlth Human Performance & Recreat, 155 Stadium Dr, Fayetteville, AR 72701 USA.	rjelbin@uark.edu					Barr WB, 2002, CNS SPECTRUMS, V7, P4; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Crawford JR, 2006, NEUROPSYCHOLOGY, V20, P259, DOI 10.1037/0894-4105.20.3.259; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; FLEISHMAN J, 1987, EDUC PSYCHOL MEAS, V47, P925, DOI 10.1177/0013164487474008; Ganio MS, 2011, BRIT J NUTR, V106, P1535, DOI 10.1017/S0007114511002005; Irwin C, 2018, J SPORT SCI, V36, P247, DOI 10.1080/02640414.2017.1298828; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2001, LUPUS, V10, P266, DOI 10.1191/096120301680416959; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kerkhof GA, 2010, PROG BRAIN RES, V185, P37, DOI 10.1016/B978-0-444-53702-7.00003-8; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Lovell MR., 2013, IMPACT TECHNICAL MAN; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2017, BR J SPORTS MED; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Olson K, 2016, SUPPORT CARE CANCER, V24, P3223, DOI 10.1007/s00520-016-3215-1; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Stachenfeld NS, 2018, PHYSIOL BEHAV, V185, P103, DOI 10.1016/j.physbeh.2017.12.028; Vardy J, 2007, J CLIN ONCOL, V25, P2455, DOI 10.1200/JCO.2006.08.1604; Vardy J, 2006, SUPPORT CARE CANCER, V14, P1111, DOI 10.1007/s00520-006-0037-6; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wilk CM, 2002, AM J PSYCHIAT, V159, P838, DOI 10.1176/appi.ajp.159.5.838	26	2	2	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	APR	2019	62						138	141		10.1016/j.jocn.2018.11.041			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HR4NR	WOS:000463123700024	30472342				2022-02-06	
J	Fuentes, MM; Moore, M; Qiu, Q; Quistberg, A; Frank, M; Vavilala, MS				Fuentes, Molly M.; Moore, Megan; Qiu, Qian; Quistberg, Alex; Frank, Matthew; Vavilala, Monica S.			Differences in Injury Characteristics and Outcomes for American Indian/Alaska Native People Hospitalized with Traumatic Injuries: an Analysis of the National Trauma Data Bank	JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES			English	Article						American Indian; Alaska Native; Trauma; Rehabilitation; Health care disparity; Hospitalization	BRAIN-INJURY; ALASKA NATIVES; UNITED-STATES; FUNCTIONAL OUTCOMES; ETHNIC DISPARITIES; INDIANS; MORTALITY; CHILDREN; REHABILITATION; CARE	ObjectiveThis study compares characteristics of American Indian/Alaska Natives (AI/AN) and non-Hispanic Whites (NHW) hospitalized for traumatic injury and examines the effect of race on hospital disposition.MethodsUsing 2007-2014 National Trauma Data Bank data, we described differences in demographic and injury characteristics between AI/AN (n=39,656) and NHWs (n=3,309,484) hospitalized with traumatic injuries. Multivariable regressions, adjusted for demographic and injury characteristics, compared in-hospital mortality and the risk of discharge to different dispositions (inpatient rehabilitation/long-term care facility, skilled nursing facility, home with home health services) rather than home between AI/AN and NHW patients.ResultsCompared to NHWs, a higher proportion of AI/ANs were age 19-44 (49% versus 27%)years and hospitalized with assault-related injuries (25% versus 5%). AI/ANs had lower odds of dying than NHWs during hospitalization (adjusted odds ratio (aOR) 0.72, 95% CI 0.63-0.84). However, AI/ANs also had lower odds than NHWs to discharge to locations with additional health services even after controlling for injury severity (inpatient rehabilitation/long-term care facilities aOR 0.79, 95% CI 0.67-0.93; skilled nursing facility aOR 0.70, 95% CI 0.49-0.98; home with home health services aOR 0.62, 95% CI 0.49-0.79).ConclusionsInjury patterns and acute hospitalization outcomes were significantly different for AI/ANs compared to NHWs. Injury prevention strategies targeting AI/ANs should reflect these differential injury patterns. Outcomes such as disability and access to rehabilitation services should be included when considering the burden of injury among AI/AN communities.	[Fuentes, Molly M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Fuentes, Molly M.; Moore, Megan; Qiu, Qian; Vavilala, Monica S.] Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Fuentes, Molly M.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98101 USA; [Moore, Megan] Univ Washington, Sch Social Work, Seattle, WA 98195 USA; [Quistberg, Alex] Drexel Univ, Dept Environm & Occupat Hlth, Philadelphia, PA 19104 USA; [Quistberg, Alex] Drexel Univ, Urban Hlth Collaborat, Philadelphia, PA 19104 USA; [Frank, Matthew] Albuquerque Area Southwest Tribal Epidemiol Ctr, Albuquerque, NM USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA		Fuentes, MM (corresponding author), Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA.; Fuentes, MM (corresponding author), Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA.; Fuentes, MM (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98101 USA.	molly.fuentes@seattlechildrens.org			Pediatric Injury Research Training Program [T32-HD057822]; Rehabilitation Medicine Scientist Training Program [K12-HD001097]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421]; Northwest Center for Public Health Practice (NWCPHP) at the University of Washington; Behavioral Health Workforce Education and Training for Professionals [HRSA-14-077]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, T32HD057822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000421] Funding Source: NIH RePORTER	Dr. Fuentes' time on this project was supported by the Pediatric Injury Research Training Program (T32-HD057822) and the Rehabilitation Medicine Scientist Training Program (K12-HD001097). Dr. Moore's time on this project was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (KL2TR000421). Mr. Frank's time on this project was supported by the Northwest Center for Public Health Practice (NWCPHP) at the University of Washington and Behavioral Health Workforce Education and Training for Professionals (HRSA-14-077).	[Anonymous], 2014, NAT TRAUM DAT BANK 2; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Berns RM, 2017, J PRIM PREV, V38, P195, DOI 10.1007/s10935-016-0459-y; Bowser TR, 2012, IHS PRIMARY CARE PRO, V37, P164; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P303; Cook AD, 2015, INJ EPIDEMIOL, V2, P1; Cwik MF, 2016, AM J PUBLIC HEALTH, V106, P2183, DOI 10.2105/AJPH.2016.303453; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Espey DK, 2014, AM J PUBLIC HEALTH, V104, pS303, DOI 10.2105/AJPH.2013.301798; Frieden TR, 2015, CTR DIS CONTROL PREV; Fuentes MM, 2017, ARCH PHYS MED REHAB, V98, P1763, DOI 10.1016/j.apmr.2016.12.013; Fuentes MM, 2016, J PEDIATR REHAB MED, V9, P133, DOI 10.3233/PRM-160376; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Haider AH, 2014, J TRAUMA ACUTE CARE, V76, P1061, DOI 10.1097/TA.0000000000000182; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Haozous EA, 2014, J ENVIRON PUBLIC HEA, V2014, DOI 10.1155/2014/321604; Hoopes MJ, 2015, INJURY PREV, V21, P335, DOI 10.1136/injuryprev-2014-041419; Jim MA, 2014, AM J PUBLIC HEALTH, V104, pS295, DOI 10.2105/AJPH.2014.301933; Johnson SI, 1999, WESTERN J MED, V171, P10; Lapidus JA, 2013, AM J PUBLIC HEALTH, V103, P355, DOI 10.2105/AJPH.2012.300834; Linton KF, 2014, BRAIN INJURY, V28, P1076, DOI 10.3109/02699052.2014.901558; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Murphy T, 2014, AM J PUBLIC HEALTH, V104, pS470, DOI 10.2105/AJPH.2013.301854; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Smith N, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-316; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; West Bethany A, 2014, MMWR Suppl, V63, P28; Wong CA, 2014, AM J PUBLIC HEALTH, V104, pS320, DOI 10.2105/AJPH.2013.301598	30	2	2	0	4	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2197-3792	2196-8837		J RACIAL ETHN HEALTH	J. Racial Ethn. Health Disparities	APR	2019	6	2					335	344		10.1007/s40615-018-0529-3			10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	HP8JL	WOS:000461935600012	30276637	Green Accepted			2022-02-06	
J	Hanafi, MG; Verki, MM; Parei, SN				Hanafi, Mohammad Ghasem; Verki, Mohammadreza Maleki; Parei, Sima Norouzi			Ultrasonic Assessment of Optic Nerve Sheath to Detect Increased Intracranial Pressure	JOURNAL OF MEDICAL ULTRASOUND			English	Article						Intracranial pressure; optic nerve sheath; traumatic brain injury; ultrasound	SONOGRAPHIC MEASUREMENT; DIAMETER; ULTRASONOGRAPHY; DIAGNOSIS	Purpose: Increased intracranial pressure (ICP) is one of the prevalent symptoms of trauma, especially traumatic headache, which requires quick action for the diagnosis and treatment. The optic nerve sheath diameter (ONSD) is a newly proposed technique for the detection of an increase in ICP. The aim of this study was to assess the efficacy of this new diagnostic method in patients with increased ICP induced by trauma. Methods: This prospective study was conducted between December 2016 and February 2017. The patients with traumatic headache and who had been diagnosed with increased ICP using clinical signs and computed tomography scan were compared to the voluntary healthy group. In each patient, measurements were performed employing ultrasound three times on each eye in an axial region, and the mean of these sizes was obtained as the ONSD. Results: A total of 112 participants were examined. The mean ONSD measurement of the patients and the voluntary healthy group was 6.01 +/- 0.76 and 3.41 +/- 0.56 mm in the right eye, 6.11 +/- 0.75 and 3.39 +/- 0.54 mm in the left eye, and 6.06 +/- 0.75 and 4.02 +/- 1.07 mm in both sides, respectively. The ONSD in the right and left sides had high and significant correlation in the patients (r = 0.929, P < 0.000) and voluntary healthy (r = 0.630, P < 0.000) group. The mean ONSD of one of the patients was 6.24 +/- 0.56 mm, and in another patient with no clinical sign of increased ICP, the mean ONSD was 4.61 +/- 0.09 mm. Conclusions: Ultrasound performed on the diaphragm of the optic nerve with acceptable sensitivity can detect patients with an increase in ICP and can be efficacious in expediting the action needed to reduce ICP. Due to the sensitivity and specificity of the ultrasound and high accuracy of the diameter of optic nerve sheath in detecting increase in ICP, as well as considering the fact that ultrasound is a noninvasive and available technique; it can be performed at the patient's bedside.	[Hanafi, Mohammad Ghasem; Parei, Sima Norouzi] Ahvaz Jundishapur Univ Med Sci, Dept Radiol, Ahvaz, Iran; [Verki, Mohammadreza Maleki] Ahvaz Jundishapur Univ Med Sci, Dept Emergency Med, Ahvaz, Iran		Verki, MM (corresponding author), Ahvaz Jundishapur Univ Med Sci, Dept Emergency Med, Ahvaz, Iran.	drmalaki676@yahoo.com			office of research and technology development of Ahvaz Jundishapur University of Medical Sciences [U-95104]	This study was financially supported by the office of research and technology development of Ahvaz Jundishapur University of Medical Sciences under the research code U-95104.	Aduayi OS, 2015, J NEUROSCI RURAL PRA, V6, P563, DOI 10.4103/0976-3147.165347; Amini A, 2013, AM J EMERG MED, V31, P236, DOI 10.1016/j.ajem.2012.06.025; Bajoghli M, 2010, INT J PREVENTIVE MED, V1, P220; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1373/clinchem.2015.246280, 10.1136/bmj.h5527, 10.1148/radiol.2015151516]; Czosnyka M, 1800, J Neurosurg, V88, P802; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Frumin E, 2014, WEST J EMERG MED, V15, P217, DOI 10.5811/westjem.2013.9.16191; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Girisgin AS, 2007, EMERG MED J, V24, P251, DOI 10.1136/emj.2006.040931; Goel RS, 2008, INJURY, V39, P519, DOI 10.1016/j.injury.2007.09.029; Goeres P, 2016, J CRIT CARE, V31, P168, DOI 10.1016/j.jcrc.2015.10.009; Guthoff R, 1991, ULTRASOUND OPHTHALMO; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; HASSLER W, 1988, J NEUROSURG, V68, P745; Hylkema C, 2016, CRIT CARE NURS CLIN, V28, P95, DOI 10.1016/j.cnc.2015.10.005; Jeon JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183170; Karakitsos D, 2006, TRANSPL P, V38, P3700, DOI 10.1016/j.transproceed.2006.10.185; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Komut E, 2016, AM J EMERG MED, V34, P963, DOI 10.1016/j.ajem.2016.02.012; Lee Lorri A, 2002, Int Anesthesiol Clin, V40, P31; Liu DC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0964-5; Messerer M, 2013, NEUROCHIRURGIE, V59, P55, DOI 10.1016/j.neuchi.2013.02.001; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; OSSOINIG KC, 1993, DOC OPHTH P, V55, P3; RASSAM SMB, 1995, EXP PHYSIOL, V80, P53, DOI 10.1113/expphysiol.1995.sp003834; Robba C, 2017, J NEUROSURG ANESTH, V29, P243, DOI 10.1097/ANA.0000000000000295; SARKISIAN AE, 1991, J TRAUMA, V31, P247, DOI 10.1097/00005373-199131020-00016; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Soldatos T, 2009, EMERG MED J, V26, P630, DOI 10.1136/emj.2008.058453; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Williams Peter, 2017, Case Rep Crit Care, V2017, P3978934, DOI 10.1155/2017/3978934	32	2	2	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra, INDIA	0929-6441	2212-1552		J MED ULTRASOUND	J. Med. Ultrasound	APR-JUN	2019	27	2					69	74		10.4103/JMU.JMU_54_18			6	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	IG3FP	WOS:000473688700003	31316215	Green Published, gold			2022-02-06	
J	Pham, H; Russell, T; Seiwert, A; Kasper, G; Lurie, F				Hao Pham; Russell, Todd; Seiwert, Andrew; Kasper, Gregory; Lurie, Fedor			Timing of Hospital-acquired Venous Thromboembolism and Its Relationship with Venous Thromboembolism Prevention Measures in Immobile Patients	ANNALS OF VASCULAR SURGERY			English	Article; Proceedings Paper	41st Annual Meeting of the Midwestern-Vascular-Surgery-Society	SEP 07-09, 2017	Chicago, IL	Midwestern Vasc Surg Soc			HEALTH-CARE PROFESSIONALS; THROMBOSIS; GUIDELINE; PROPHYLAXIS	Background: The aim of this study is to describe the timing of venous thromboembolism (VTE) diagnosis in patients with cerebral or spinal trauma and stroke and describe the relationships between VTE prophylaxis and timing of VTE diagnosis at a community hospital. Methods: Retrospective cohort observational study over a span of 10 years from 2006 to 2016 was conducted. Results: Lower extremity ultrasound surveillance identified 138 patients who developed VTE during their hospital stay (mean age 62 years, 61.6% males). Mechanical prophylaxis was used in 79.7% and pharmacologic prophylaxis in 78.3% of patients. The average time of admission to administration of mechanical prophylaxis was 1.92 and 7.7 days for pharmacologic prophylaxis. In patients who received pharmacologic prophylaxis within 2 days, 51.5% of all VTE events occurred during the first week, 73.5% by the second week, and 91.2% by the third week of the hospital stay. In patients who started pharmacologic prophylaxis after 2 days in the hospital, 85% of all VTE events occurred within the first week and 90% within 10 days of the hospital stay (P < 0.001). The timing of initiation of mechanical prophylaxis did not influence the timing of VTE events. Conclusions: In immobilized patients with stroke, traumatic brain injury, or spinal cord injury, VTE screening should be performed at different schedules based on the timing of initiation of pharmacologic prophylaxis. In patients who did not start prophylaxis during the first 2 days of admission to the hospital, the majority of the VTE events occurred during the first 10 days.	[Hao Pham; Russell, Todd; Seiwert, Andrew; Kasper, Gregory; Lurie, Fedor] Univ Michigan, ProMed Toledo Hosp, Jobst Vasc Inst, 2109 Hughes Dr,Suite 400, Toledo, OH 43606 USA; [Hao Pham; Russell, Todd; Seiwert, Andrew; Kasper, Gregory; Lurie, Fedor] Univ Michigan, ProMed Toledo Hosp, Div Vasc Surg, 2109 Hughes Dr,Suite 400, Toledo, OH 43606 USA		Lurie, F (corresponding author), Univ Michigan, ProMed Toledo Hosp, Jobst Vasc Inst, 2109 Hughes Dr,Suite 400, Toledo, OH 43606 USA.; Lurie, F (corresponding author), Univ Michigan, ProMed Toledo Hosp, Div Vasc Surg, 2109 Hughes Dr,Suite 400, Toledo, OH 43606 USA.	fedor.lurie@promedica.org		Lurie, Fedor/0000-0003-0644-0560	Conrad and Caroline Jobst Foundation	This work was funded by Conrad and Caroline Jobst Foundation.	Abdel-Aziz H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0814-z; Anderson Jr FA, 2005, BLOOD, V106, P910, DOI 10.1182/blood.V106.11.910.910; Arnold PM, 2017, GLOB SPINE J, V7, p138S, DOI 10.1177/2192568217703665; Azarbal A, 2011, J VASC SURG, V54, P743, DOI 10.1016/j.jvs.2011.02.058; Buller HR, 2005, J THROMB HAEMOST, V3, P1554, DOI 10.1111/j.1538-7836.2005.01414.x; Caprini JA, 2005, DM-DIS MON, V51, P70, DOI 10.1016/j.disamonth.2005.02.003; Grosse SD, 2016, THROMB RES, V137, P3, DOI 10.1016/j.thromres.2015.11.033; Haut ER, 2011, J TRAUMA, V70, P27, DOI 10.1097/TA.0b013e3182077d55; Heit JA, 2017, BLOOD, V130, P109, DOI 10.1182/blood-2016-12-758995; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; McClendon J, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.03.068; Nyquist P, 2016, NEUROCRIT CARE, V24, P47, DOI 10.1007/s12028-015-0221-y	13	2	2	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0890-5096	1615-5947		ANN VASC SURG	Ann. Vasc. Surg.	APR	2019	56						24	28		10.1016/j.avsg.2018.09.014			5	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery; Cardiovascular System & Cardiology	HS4XZ	WOS:000463875300004	30500652				2022-02-06	
J	Hutchinson, S; Ellison, P; Levy, A; Marchant, D				Hutchinson, Sarah; Ellison, Paul; Levy, Andrew; Marchant, David			Knowledge and attitudes towards concussion in UK-based male ice hockey players: A need for attitude change?	INTERNATIONAL JOURNAL OF SPORTS SCIENCE & COACHING			English	Article						Head injury; traumatic brain injury	SCHOOL; DISCLOSURE; CONSENSUS	Objective Concussion is a common injury in ice hockey, and previous research suggests some misconceptions and unsafe attitudes amongst players. The purpose of this study was to assess sport concussion knowledge, attitudes and the effect of sport concussion history in UK-based male ice hockey players across three levels of competition: professional, semi-professional and amateur. Methods Sixty-one participants across a number of UK ice hockey teams completed the Rosenbaum Concussion Knowledge and Attitudes Survey and reviewed a series of statements to assess knowledge (concussion knowledge index), attitudes (concussion attitude index) and misconceptions of concussion. Results Level of competition and concussion history had no significant effect on concussion knowledge index or concussion attitude index. A positive significant relationship exists between playing experience and concussion knowledge index and concussion attitude index. Statements identified common misconceptions and areas of accurate knowledge regarding concussion symptoms suggesting that male ice hockey players have a higher level knowledge compared to a sample of the UK general public. Playing experience was associated with increased knowledge and increasingly safe attitudes towards concussion. Conclusion Despite knowledge relating to loss of consciousness and correct management of symptoms being generally accurate, there are worryingly unsafe attitudes regarding aspects of concussion. Such attitudes may well pose significant threats to players' safety and long-term health.	[Hutchinson, Sarah; Levy, Andrew] Edge Hill Univ, Dept Psychol, Ormskirk, England; [Ellison, Paul; Marchant, David] Edge Hill Univ, Dept Sport & PA, Ormskirk, England		Ellison, P (corresponding author), Edge Hill Univ, St Helens Rd, Ormskirk L39 4QP, England.	paul.ellison@edgehill.ac.uk	Ellison, Paul H/F-3078-2011	Marchant, David/0000-0002-2601-6794; Levy, Andrew/0000-0002-6709-4190; Ellison, Paul/0000-0003-0011-1192			Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Chapman EB, 2018, CLIN J SPORT MED, V28, P117, DOI 10.1097/JSM.0000000000000421; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Hanninen T, 2018, J SCI MED SPORT, V21, P794, DOI 10.1016/j.jsams.2017.12.001; Jorgensen M, 2018, INT J SPORTS SCI COA, V13, P1134, DOI 10.1177/1747954118778771; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130507; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tucker AM, 2014, CURR REV MUSCULOSKE, V7, P366, DOI 10.1007/s12178-014-9243-x; Tuominen M, 2017, BRIT J SPORT MED, V51, P244, DOI 10.1136/bjsports-2016-097119; Weber M, 2012, ARCH CLIN NEUROPSYCH, V27, P355, DOI 10.1093/arclin/acs029; Williams JM, 2016, J SPORT HEALTH SCI, V5, P197, DOI 10.1016/j.jshs.2015.01.009	22	2	2	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-9541	2048-397X		INT J SPORTS SCI COA	Int. J. Sports Sci. Sci. Coach.	APR	2019	14	2					153	161		10.1177/1747954119826515			9	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	HR5ZF	WOS:000463226200004		Green Submitted			2022-02-06	
J	Jones, C; Pike, A; Bremault-Phillips, S				Jones, Chelsea; Pike, Ashley; Bremault-Phillips, Suzette			Brain Bootcamp: Pre-post comparison findings of an integrated behavioural health intervention for military members with reduced executive cognitive functioning	JOURNAL OF MILITARY VETERAN AND FAMILY HEALTH			English	Article						brain injury; Canadian Armed Forces; cognition; cognitive dysfunction; cognitive rehabilitation therapy; occupational therapy; concussion; executive cognitive function; mental health; mild traumatic brain injury; military; occupational therapy; rehabilitation; traumatic brain injury	OCCUPATIONAL-THERAPY; SERVICE MEMBERS; INJURY; REHABILITATION; SYMPTOMS; AFGHANISTAN; PERSONNEL; SOLDIERS; IRAQ	Introduction: Canadian Armed Forces (CAF) Service members (SMs) experience higher rates of mild traumatic brain injuries (mTBIs) and psychosocial risk factors such as mental health diagnoses, sleep disturbances, alcohol consumption, and post-concussion symptoms than Canadian civilians. Associated challenges with executive cognitive functioning (ECF) can significantly impede their performance, engagement, and deployability. To address challenges with ECF, an occupational therapist providing rehabilitation services to CAF SMs created and delivered Brain Bootcamp - an integrated behavioural health intervention for CAF SMs who sustained an mTBI or more serious traumatic brain injury (TBI) and had reduced ECF. Although anecdotal post-intervention feedback is favourable, Brain Bootcamp's impact on ECF in individuals with mTBI or TBI, mental health diagnoses, or both has yet to be determined. This study aimed to determine whether Brain Bootcamp improves cognitive performance, reduces mTBI- and TBI-related symptoms, and increases external aid utilization among CAF SMs with reduced ECF. Methods: We conducted a quasi-experimental study of clinical outcomes collected from 55 participants who participated in Brain Bootcamp. Measures used to determine changes in client ECF before and after the intervention included the Montreal Cognitive Assessment, Rivermead Post-Concussion Symptom Questionnaire, and External Aids Utilization Survey. Results: Statistically significant changes pre- and post-intervention were observed, including improved cognitive performance, reduced self-reported mTBI or TBI symptoms, and increased external aid utilization. Discussion: Brain Bootcamp may have a positive effect on ECF. Such improvements can enable CAF SMs to be operationally ready for military service and have greater overall well-being. Brain Bootcamp appears to be a promising ECF-enhancing intervention.	[Jones, Chelsea] Canadian Forces Base Edmonton, Field Ambulance Phys Rehabil Dept, Edmonton, AB, Canada; [Jones, Chelsea; Pike, Ashley; Bremault-Phillips, Suzette] Univ Alberta, Fac Rehabil Med, Heroes Mind Advocacy & Res Consortium HiMARC, Edmonton, AB, Canada; [Jones, Chelsea; Pike, Ashley; Bremault-Phillips, Suzette] Univ Alberta, Fac Rehabil Med, Dept Occupat Therapy, 8205 114 St 3-48 Corbett Hall, Edmonton, AB, Canada		Jones, C (corresponding author), Univ Alberta, Fac Rehabil Med, Dept Occupat Therapy, 8205 114 St 3-48 Corbett Hall, Edmonton, AB, Canada.	cweiman@ualberta.ca	Bremault-Phillips, Suzette/H-8258-2015	Bremault-Phillips, Suzette/0000-0003-4167-1815			Anderson V., 2007, EXECUTIVE FUNCTIONS; [Anonymous], 2006, DAOD50230 U SERV; Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Brown Cary A, 2013, Sleep Disord, V2013, P160374, DOI 10.1155/2013/160374; Brown HV, 2013, PHYS THER, V93, P1244, DOI 10.2522/ptj.20120162; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cook TD., 1979, QUASIEXPERIMENTATION; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Department of National Defense, 2016, HLTH LIF INF SURV CA; Garber B., 2008, CANADIAN FORCES HLTH; Garber BG, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010780; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Haskins E.C., 2012, COGNITIVE REHABILITA; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Jones C, 2016, OCCUP THER NOW, V19, P15; Julayanont P., 2016, COGNITIVE SCREENING, P111; Kabatova O, 2016, CLIN SOC WORK HEALTH, V7, P62; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morrison MT, 2013, AM J OCCUP THER, V67, P460, DOI 10.5014/ajot.2013.007880; Ontario Neurological Foundation, 2013, GUID MILD TRAUM BRAI, V2nd; Powell T., 2013, BRAIN INJURY WORKBOO; Radmonski MR., 2015, MILD MTBI REHAB TOOL, P473; Radmonski MR., 2015, MILD MTBI REHAB TOOL, P175; Radomski MV, 2009, AM J OCCUP THER, V63, P646, DOI 10.5014/ajot.63.5.646; Ray MR., 2015, STUDY COGNITIVE REHA; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Stenfors CUD, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01536; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thompson J., PERSISTENT SYMPTOMS; Toglia JP, 2012, CAN J OCCUP THER, V79, P225, DOI 10.2182/cjot.2012.79.4.4; Toglia JP., 2013, COGNITION OCCUPATION, V3rd, P161	37	2	2	0	0	UNIV TORONTO PRESS INC	TORONTO	JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8, CANADA		2368-7924		J MIL VETERAN FAM HL	J. Mil. Veteran Fam. Hlth.	APR 1	2019	5	1					131	140		10.3138/jmvfh.2018-0005			10	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	XL2ZI	WOS:000728016900015					2022-02-06	
J	Kao, YCJ; Lui, YW; Lu, CF; Chen, HL; Hsieh, BY; Chen, CY				Kao, Y-C J.; Lui, Y. W.; Lu, C-F; Chen, H-L; Hsieh, B-Y; Chen, C-Y			Behavioral and Structural Effects of Single and Repeat Closed-Head Injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DIFFUSION TENSOR; ANIMAL-MODELS; MILD; RAT; MRI; NEUROINFLAMMATION; ABNORMALITIES; VALIDATION; ATROPHY	BACKGROUND AND PURPOSE: The effects of multiple head impacts, even without detectable primary injury, on subsequent behavioral impairment and structural abnormality is yet well explored. Our aim was to uncover the dynamic changes and long-term effects of single and repetitive head injury without focal contusion on tissue microstructure and macrostructure. MATERIALS AND METHODS: We introduced a repetitive closed-head injury rodent model (n = 70) without parenchymal lesions. We performed a longitudinal MR imaging study during a 50-day study period (T-2-weighted imaging, susceptibility-weighted imaging, and diffusion tensor imaging) as well as sequential behavioral assessment. Immunohistochemical staining for astrogliosis was examined in a subgroup of animals. Paired and independent t tests were used to evaluate the outcome change after injury and the cumulative effects of impact load, respectively. RESULTS: There was no gross morphologic evidence for head injury such as skull fracture, contusion, or hemorrhage on micro-CT and MR imaging. A significant decrease of white matter fractional anisotropy from day 21 on and an increase of gray matter fractional anisotropy from day 35 on were observed. Smaller mean cortical volume in the double-injury group was shown at day 50 compared with sham and single injury (P < .05). Behavioral deficits (P < .05) in neurologic outcome, balance, and locomotor activity were also aggravated after double injury. Histologic analysis showed astrogliosis 24 hours after injury, which persisted throughout the study period. CONCLUSIONS: There are measurable and dynamic changes in microstructure, cortical volume, behavior, and histopathology after both single and double injury, with more severe effects seen after double injury. This work bridges cross-sectional evidence from human subject and pathologic studies using animal models with a multi-time point, longitudinal research paradigm.	[Kao, Y-C J.; Chen, C-Y] Taipei Med Univ, Neurosci Res Ctr, Taipei, Taiwan; [Kao, Y-C J.; Chen, C-Y] Taipei Med Univ, Translat Imaging Res Ctr, Taipei, Taiwan; [Kao, Y-C J.; Chen, C-Y] Taipei Med Univ, Dept Radiol, Sch Med, Coll Med, 250 Wuxing St, Taipei 110, Taiwan; [Lui, Y. W.] NYU, Dept Radiol, Sch Med, NYU Langone Hlth, 560 1St Ave, New York, NY 10016 USA; [Lu, C-F] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Chen, H-L] Taipei Med Univ Hosp, Dept Med Res, Taipei, Taiwan; [Chen, C-Y] Taipei Med Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Kao, Y-C J.; Chen, C-Y] Taipei Med Univ Hosp, Radiogen Res Ctr, Taipei, Taiwan; [Hsieh, B-Y] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan		Chen, CY (corresponding author), Taipei Med Univ, Dept Radiol, Sch Med, Coll Med, 250 Wuxing St, Taipei 110, Taiwan.	sandy0932@gmail.com	Kao, Yu-Chieh Jill/AAW-7050-2020	Kao, Yu-Chieh Jill/0000-0001-7416-759X; Chen, Cheng-Yu/0000-0003-0428-4373; Hsieh, Bao-Yu/0000-0002-9379-4211; Lu, Chia-Feng/0000-0003-1344-9950	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST105-2628-B-038-002-MY2, MOST104-2923-B-038-003-MY3, MOST106-2314-B-010-058-MY2, MOST105-2221-E-038-007-MY3, MOST107-2314-B-038-005]; Taipei Medical University [TMU103-AE1-B27]; Taipei Medical University Hospital [105TMUH-SP-01, GH107SP02]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB017183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090349, R01NS039135] Funding Source: NIH RePORTER	This work was supported by the Ministry of Science and Technology, Taiwan (MOST105-2628-B-038-002-MY2, MOST104-2923-B-038-003-MY3, MOST106-2314-B-010-058-MY2, MOST105-2221-E-038-007-MY3 and MOST107-2314-B-038-005), Taipei Medical University (TMU103-AE1-B27), and Taipei Medical University Hospital (105TMUH-SP-01, GH107SP02).	Acabchuk Rebecca, 2016, Concussion, V1, DOI 10.2217/cnc-2015-0001; Borja MJ, 2018, NEUROIMAG CLIN N AM, V28, P117, DOI 10.1016/j.nic.2017.09.009; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Leon AMC, 2018, J NEUROTRAUM, V35, P2365, DOI 10.1089/neu.2018.5691; Chong CD, 2018, HEADACHE, V58, P827, DOI 10.1111/head.13269; Chung S, 2018, J NEUROTRAUM, V35, P1015, DOI 10.1089/neu.2017.5320; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Green EW, 2015, P NATL ACAD SCI USA, V112, P8702, DOI 10.1073/pnas.1506093112; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Kao YCJ, 2017, STROKE, V48, P754, DOI 10.1161/STROKEAHA.116.015878; Kao YCJ, 2014, NEUROBIOL DIS, V71, P131, DOI 10.1016/j.nbd.2014.07.005; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Kuo DP, 2017, KOREAN J RADIOL, V18, P269, DOI 10.3348/kjr.2017.18.2.269; Lai HY, 2015, MAGN RESON MED, V73, P1246, DOI 10.1002/mrm.25239; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Mountney A, 2017, J NEUROTRAUM, V34, P2768, DOI 10.1089/neu.2016.4679; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Robinson S, 2016, J NEUROSURG-PEDIATR, V17, P739, DOI 10.3171/2015.10.PEDS15554; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salo RA, 2017, NEUROIMAGE, V152, P221, DOI 10.1016/j.neuroimage.2017.03.003; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Sizonenko SPV, 2007, CEREB CORTEX, V17, P2609, DOI 10.1093/cercor/bhl168; Sosin DM, 1996, BRAIN INJURY, V10, P47; Tambalo S, 2015, J NEUROSCI, V35, P10088, DOI 10.1523/JNEUROSCI.0540-15.2015; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Wang ML, 2018, AM J NEURORADIOL, V39, P1650, DOI 10.3174/ajnr.A5737; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yarnell Angela M, 1800, Curr Protoc Neurosci, V75, DOI 10.1002/cpns.10; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569	40	2	2	1	4	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2019	40	4					601	608		10.3174/ajnr.A6014			8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	HY6ZO	WOS:000468280300004	30923084	Green Published, Green Accepted, hybrid			2022-02-06	
J	Keatley, E; Hanks, R; Sander, AM; Kratz, AL; Tulsky, DS; Ianni, P; Miner, J; Carlozzi, NE				Keatley, Eva; Hanks, Robin; Sander, Angelle M.; Kratz, Anna L.; Tulsky, David S.; Ianni, Phillip; Miner, Jennifer; Carlozzi, Noelle E.			Group Differences Among Caregivers of Civilians and Service Members or Veterans With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Burnout; Caregivers; Military; psychological; Rehabilitation; Traumatic brain injury; Veterans	QUALITY-OF-LIFE; BURDEN; HEALTH; INDIVIDUALS; RELATIVES; PARTNERS; SYMPTOMS; DISTRESS; SEQUELAE; FAMILY	Objective: To examine group differences among caregivers of service members or veterans (SMVs) and civilians with traumatic brain injury (TBI). Design: An observational research study examining the group differences between caregivers of SMVs and civilians with TBI. The data presented was collected as part of a larger study that calibrated and validated the Traumatic Brain Injury-Care Quality of Life (TBI-CareQOL) item banks. Setting: Participants in this multicenter study completed an online survey via a study-specific website. Surveys were completed at the study site, at home, or via phone interview. Civilian caregivers were recruited from 4 rehabilitation hospitals and caregivers of SMVs were recruited through community outreach and collaboration with the Hearts of Valor. Participants: Participants (N=473) consisted of 344 caregivers of civilians with TBI and 129 caregivers of SMVs with TBI. Interventions: Not applicable. Main Outcome Measures: Zarit Burden Interview Scale, TBI-CareQOL, and Mayo Portland Adaptability Inventory, 4th revision (MPAI-4). Results: Of the independent variables included in the logistic regression model that classified military-affiliated vs civilian caregivers, 5 were statistically significant: age, spousal status, time since injury, MPAI-4 Adjustment, and TBI-CareQOL Feeling Trapped. Conclusions: The results indicate that caregivers of SMVs were more likely to report worse emotional and social adjustment among the individuals with TBI and caregivers of SMVs were more likely to report greater levels of feeling trapped by their caregiving duties. (C) 2018 by the American Congress of Rehabilitation Medicine	[Keatley, Eva] Univ Windsor, Dept Psychol, Windsor, ON, Canada; [Keatley, Eva; Hanks, Robin] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin] Wayne State Univ, Sch Med, Detroit, MI USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Kratz, Anna L.; Ianni, Phillip; Miner, Jennifer; Carlozzi, Noelle E.] Univ Michigan, Med Sch, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA		Keatley, E (corresponding author), Rehabil Inst Michigan, 261 Mack Blvd,Suite 555, Detroit, MI 48201 USA.	ekeatley@dmc.org		Tulsky, David/0000-0002-4335-4509	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NR013658]; National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433, UL1TR002240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by the National Institutes of Health (grant no. R01 NR013658), the National Institute of Nursing Research, and the National Center for Advancing Translational Sciences (grant no. UL1TR000433).	Bagalman E, TRAUMATIC BRAIN INJU; Calhoun PS, 2002, J TRAUMA STRESS, V15, P205, DOI 10.1023/A:1015251210928; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS43, DOI 10.1016/j.apmr.2018.06.025; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS13, DOI 10.1016/j.apmr.2018.05.033; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS31, DOI 10.1016/j.apmr.2018.05.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS22, DOI 10.1016/j.apmr.2018.05.027; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Fischer H., 2014, GUIDE US MILITARY CA; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MacDonell GV, 2014, AUST PSYCHOL, V49, P305, DOI 10.1111/ap.12069; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Phelan SM, 2013, PSYCHO-ONCOLOGY, V22, P65, DOI 10.1002/pon.2048; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Ramchand Rajeev, 2014, Rand Health Q, V4, P14; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	32	2	2	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S52	S57		10.1016/j.apmr.2018.11.009			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900006	30537488	Green Accepted			2022-02-06	
J	Matias, I; Elias, DH; Garcia, CAB; Silva, GH; Mejia, J; Cabral, FR; Miranda, ACC; da Silva, SG; Lopes, LD; Coimbra, NC; Machado, HR				Matias, Ivair, Jr.; Elias, Daoud Hibrahim; Bernardino Garcia, Camila Araujo; Silva, Guilherme Henrique; Mejia, Jorge; Cabral, Francisco Romero; Camargo Miranda, Ana Claudia; da Silva, Sergio Gomes; Lopes, Luiza da Silva; Coimbra, Norberto Cysne; Machado, Helio Rubens			A new model of experimental hemispherotomy in young adult Rattus norvegicus: a neural tract tracing and SPECT in vivo study	JOURNAL OF NEUROSURGERY			English	Article						hemispherotomy; biotinylated dextran amine neurotracer; cerebral cortex; corpus callosum; small-animal SPECT; epilepsy	BISTRIATA SPIDER VENOM; TRAUMATIC BRAIN-INJURY; NEONATAL HEMIDECORTICATION; ROTAROD TEST; HEMISPHERECTOMY; PLASTICITY; SEIZURES; CORTEX; REORGANIZATION; STIMULATION	OBJECTIVE The objective of this study was to describe a new experimental model of hemispherotomy performed on laboratory animals. METHODS Twenty-six male young adult Wistar rats were distributed into two groups (surgery and control). The nonfluo-rescent anterograde neurotracer biotinylated dextran amine (BDA; 10,000 MW) was microinjected into the motor cortex area (M1) according to The Rat Brain in Stereotaxic Coordinates atlas to identify pathways and fibers disconnected after the experimental hemispherectomy. SPECT tomographic images of Tc-99m hexamethylpropyleneamine oxime were obtained to verify perfusion in functioning areas of the disconnected and intact brain. A reproducible and validated surgical procedure is described in detail, including exact measurements and anatomical relationships. An additional 30 rodents (n = 10 rats per group) were divided into naive, sham, and hemispherotomy groups and underwent the rotarod test. RESULTS Cortico-cortical neural pathways were identified crossing the midline and contacting neuronal perikarya in the contralateral brain hemisphere in controls, but not in animals undergoing hemispherotomy. There was an absence of perfusion in the left side of the brain of the animals undergoing hemispherotomy. Motor performance was significantly affected by brain injuries, increasing the number of attempts to maintain balance on the moving cylinder in the rotarod test at 10 and 30 days after the hemispherotomy, with a tendency to minimize the motor performance deficit over time. CONCLUSIONS The present findings show that the technique reproduced neural disconnection with minimal resection of brain parenchyma in young adult rats, thereby duplicating the hemispherotomy procedures in human patients.	[Matias, Ivair, Jr.; Bernardino Garcia, Camila Araujo; Silva, Guilherme Henrique; Lopes, Luiza da Silva; Machado, Helio Rubens] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg & Anat, Lab Pediat Neurosurg & Dev Neuropathol, Sao Paulo, Brazil; [Matias, Ivair, Jr.; Elias, Daoud Hibrahim; Coimbra, Norberto Cysne] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Lab Neuroanat & Neuropsychobiol, Sao Paulo, Brazil; [Mejia, Jorge; Cabral, Francisco Romero; Camargo Miranda, Ana Claudia; da Silva, Sergio Gomes] Univ Sao Paulo, Ribeirao Preto Med Sch, Neuroelectrophysiol Multiuser Ctr, Sao Paulo, Brazil; [Coimbra, Norberto Cysne; Machado, Helio Rubens] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg & Anat, Neurobiol Pain & Emot Lab, Sao Paulo, Brazil; [da Silva, Sergio Gomes] Univ Mogi das Cruzes, NPT, Sao Paulo, Brazil		Coimbra, NC (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Sao Paulo, Brazil.	nccoimbr@fmrp.usp.br	Mejia, Jorge/ABC-4213-2021; Lopes, Luiza S/H-2253-2012; da Silva, Sergio Gomes/F-1847-2013	Mejia, Jorge/0000-0002-1182-4668; Lopes, Luiza S/0000-0001-6229-4196; da Silva, Sergio Gomes/0000-0002-9650-809X; Machado, Helio/0000-0002-1069-7804; Cabral, Francisco Romero/0000-0003-2582-6960	CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [483763/2010-1, 474853/2013-6, 301905/2010-0, 301341/2015-0, 501858/2005-9, 372654/2006-1, 372810/2008-0, 372877/2010-9]; FAEPA [1291/97, 355/2000, 68/2001, 15/2003, 423/2017]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/01174-1, 2012/03798-0, 2017/11855-8, 02/01497-1]; CAPES (Scientiae Doctor Fellowship)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	This study was supported by CNPq (grant nos. 483763/2010-1 and 474853/2013-6), FAEPA (grant nos. 1291/97, 355/2000, 68/2001, 15/2003, and 423/2017), and FAPESP (grant nos. 2007/01174-1, 2012/03798-0, and 2017/11855-8). I. Matias Jr. was supported by CAPES (Scientiae Doctor Fellowship). N.C. Coimbra is a researcher (Level 1A) from CNPq (grant nos. 301905/2010-0 and 301341/2015-0). D. H. Elias-Filho was the recipient of technician scholarships from FAPESP (TT-2, grant no. 02/01497-1) and CNPq (grant nos. 501858/2005-9, 372654/2006-1, 372810/2008-0, and 372877/2010-9).	Akakin A, 2014, J ANAT SOC INDIA, V63, P117, DOI 10.1016/j.jasi.2014.11.011; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Brus-Ramer M, 2009, J NEUROSCI, V29, P6196, DOI 10.1523/JNEUROSCI.5852-08.2009; Bulteau C, 2017, EPILEPSY BEHAV, V69, P86, DOI 10.1016/j.yebeh.2017.01.004; Carvalho MC, 2013, NEUROBIOL LEARN MEM, V102, P20, DOI 10.1016/j.nlm.2013.03.004; Castellan-Baldan L, 2006, J CHEM NEUROANAT, V32, P1, DOI 10.1016/j.jchemneu.2006.05.002; Coimbra NC, 2001, BRAIN RES, V903, P216, DOI 10.1016/S0006-8993(01)02366-6; Cunha AOS, 2005, COMP BIOCHEM PHYS C, V141, P50, DOI 10.1016/j.cca.2005.05.004; de Bode S, 2005, J CHILD NEUROL, V20, P64, DOI 10.1177/08830738050200011101; de Faria O, 2018, DEV NEUROBIOL, V78, P93, DOI 10.1002/dneu.22539; de Freitas RL, 2016, NEUROSCIENCE, V336, P133, DOI 10.1016/j.neuroscience.2016.08.040; De Ribaupierre S, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/9/E14; Delalande O, 2008, NEUROCHIRURGIE, V54, P353, DOI 10.1016/j.neuchi.2008.02.024; Delalande O., 1992, Epilepsia, V33, P99; Delalande O, 2007, NEUROSURGERY, V60, P19, DOI 10.1227/01.NEU.0000249246.48299.12; DUNHAM NW, 1957, J AM PHARM ASSOC, V46, P208, DOI 10.1002/jps.3030460322; Fachim HA, 2011, EPILEPSY BEHAV, V22, P158, DOI 10.1016/j.yebeh.2011.05.008; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gelfuso EA, 2013, NEUROSCI LETT, V543, P12, DOI 10.1016/j.neulet.2013.02.074; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hashizume K, 1998, EPILEPSY RES, V32, P389, DOI 10.1016/S0920-1211(98)00065-5; HICKS S P, 1970, Experimental Neurology, V29, P416, DOI 10.1016/0014-4886(70)90069-5; HICKS SP, 1975, AM J ANAT, V143, P1, DOI 10.1002/aja.1001430102; LEITE JP, 1990, NEUROSCI BIOBEHAV R, V14, P511, DOI 10.1016/S0149-7634(05)80076-4; Lenz M, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/2652560; Lopez-Alonso V, 2015, BRAIN STIMUL, V8, P1209, DOI 10.1016/j.brs.2015.07.042; Machado AGG, 2003, EPILEPSIA, V44, P500, DOI 10.1046/j.1528-1157.2003.37602.x; Marino R, 2001, STEREOT FUNCT NEUROS, V76, P83; Mejia J, 2016, EINSTEIN-SAO PAULO, V14, P408, DOI 10.1590/S1679-45082016AO3696; Merricks EM, 2015, BRAIN, V138, P2891, DOI 10.1093/brain/awv208; Morino M, 2002, J NEUROSURG, V97, P423, DOI 10.3171/jns.2002.97.2.0423; Ono T, 2002, EPILEPSY RES, V51, P117, DOI 10.1016/S0920-1211(02)00105-5; Otte WM, 2015, J CEREBR BLOOD F MET, V35, P1358, DOI 10.1038/jcbfm.2015.101; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Ramantani G, 2013, EPILEPSIA, V54, P1046, DOI 10.1111/epi.12140; RASMUSSEN T, 1983, CAN J NEUROL SCI, V10, P71, DOI 10.1017/S0317167100044668; Ribeiro SJ, 2005, J CHEM NEUROANAT, V30, P184, DOI 10.1016/j.jchemneu.2005.07.004; Santos JM, 2008, NEUROBIOL LEARN MEM, V90, P560, DOI 10.1016/j.nlm.2008.06.007; Save-Pedebos J, 2016, EPILEPSY BEHAV, V55, P139, DOI 10.1016/j.yebeh.2015.12.013; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Song M, 2017, MOL PSYCHIATR, V22, P1370, DOI 10.1038/mp.2017.144; Takahashi M, 2009, EUR J NEUROSCI, V30, P1878, DOI 10.1111/j.1460-9568.2009.06989.x; Tanaka T, 2001, STEREOT FUNCT NEUROS, V77, P239, DOI 10.1159/000064621; Umeda T, 2014, NEUROSCI RES, V78, P30, DOI 10.1016/j.neures.2013.08.011; Umeda T, 2011, EUR J NEUROSCI, V34, P1453, DOI 10.1111/j.1460-9568.2011.07866.x; VEENMAN CL, 1992, J NEUROSCI METH, V41, P239, DOI 10.1016/0165-0270(92)90089-V; VILLEMURE JG, 1995, NEUROSURGERY, V37, P975, DOI 10.1227/00006123-199511000-00018; Wanakhachornkrai O, 2014, NEUROSCI RES, V79, P94, DOI 10.1016/j.neures.2013.11.003; Willemse RB, 2016, NEUROIMAGE-CLIN, V10, P46, DOI 10.1016/j.nicl.2015.11.002; WINSTON KR, 1992, J NEUROSURG, V77, P889, DOI 10.3171/jns.1992.77.6.0889; Xerri C, 2004, ARCH ITAL BIOL, V142, P217; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yoon YS, 2012, ANN REHABIL MED-ARM, V36, P596, DOI 10.5535/arm.2012.36.5.596; Yoshikawa A, 2011, DEV NEUROSCI-BASEL, V33, P539, DOI 10.1159/000335526	55	2	2	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2019	130	4					1210	1223		10.3171/2017.12.JNS171150			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HR1CV	WOS:000462866700017	29882701	Bronze			2022-02-06	
J	Michelson, E; Huff, JS; Garrett, J; Naunheim, R				Michelson, Edward; Huff, J. Stephen; Garrett, John; Naunheim, Rosanne			Triage of Mild Head-Injured Intoxicated Patients Could Be Aided by Use of an Electroencephalogram-Based Biomarker	JOURNAL OF NEUROSCIENCE NURSING			English	Article						brain electrical activity; brain function index; drug and alcohol intoxication; EEG; quantitative electrophysiological measures; structural brain injury; structural injury classifier; traumatic brain injury; TBI	TRAUMATIC BRAIN-INJURY; ELECTRICAL-ACTIVITY BIOMARKER; ALCOHOL-USE; MORTALITY; SEVERITY; IMPACT; EEG	Objective: Drug and alcohol (DA)-related emergency department (ED) visits represent an increasing fraction the head-injured population seen in the ED. Such patients present a challenge to the evaluation of head injury and determination of need for computed tomographic (CT) scan and further clinical path. This effort examined whether an electroencephalogram (EEG)-based biomarker could aid in reducing unnecessary CT scans in the intoxicated ED population. Method: This is a retrospective secondary study of an independent prospective US Food and Drug Administration validation trial that demonstrated the efficacy of (1) an automatic Structural Injury Classifier for the likelihood of injury visible on a CT (CT+) and (2) an EEG-based Brain Function Index to assess functional impairment in minimally impaired, head-injured adults presenting within 3 days of injury. Impact on the biomarker performance in patients who presented with or without DA was studied. Results: Structural Injury Classifier sensitivity was not significantly impacted by the presence of DA. Although specificity decreased, it remained several times higher than obtained using standard CT decision rules. Furthermore, the potential to reduce the number of unnecessary scans by approximately 30% was demonstrated when the Structural Injury Classifier was integrated into CT clinical triage. The Brain Function Index was demonstrated to be independent of the presence of DA. Conclusion: This EEG-based assessment technology used to identify the likelihood of structural or functional brain injury in mildly head-injured patients represents an objective way to aid in triage patients with DA on presentation, with the potential to decrease overscanning while not sacrificing sensitivity to injuries visible on CT.	[Michelson, Edward] Texas Tech Univ, Hlth Sci Ctr, Dept Emergency Med, Paul L Foster Sch Med, El Paso, TX 79905 USA; [Huff, J. Stephen] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Garrett, John] Baylor Univ, Med Ctr, Dallas, TX USA; [Naunheim, Rosanne] Washington Univ, Barnes Jewish Med Ctr, St Louis, MO USA		Michelson, E (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Emergency Med, Paul L Foster Sch Med, El Paso, TX 79905 USA.	Edward.Michelson@ttuhsc.edu			US ArmyUnited States Department of Defense [W81XWH-14-C-1405]	The parent study from which this study cohort was derived was funded in part by a research contract from the US Army, contract #W81XWH-14-C-1405.	Ceballos NA, 2009, CLIN EEG NEUROSCI, V40, P122, DOI 10.1177/155005940904000210; Cheever C, 2018, J NEUROSCI NURS, V50, P83, DOI 10.1097/JNN.0000000000000345; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Hanley D, 2017, ACAD EMERG MED, V24, P617, DOI 10.1111/acem.13175; Huff JS, 2017, AM J EMERG MED, V35, P1777, DOI 10.1016/j.ajem.2017.05.027; Johnson PT, 2015, J AM COLL RADIOL, V12, P1185, DOI 10.1016/j.jacr.2015.02.021; Kamarajan C, 2015, ALCOHOL RES-CURR REV, V37, P53; Korcha RA, 2013, J ADDICT NURS, V24, P158, DOI 10.1097/JAN.0b013e3182a04b47; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mullins PM, 2017, ALCOHOL ALCOHOLISM, V52, P119, DOI 10.1093/alcalc/agw074; Mumtaz W, 2018, COGN NEURODYNAMICS, V12, P141, DOI 10.1007/s11571-017-9465-x; Naunheim R, 2018, AM J EMERG MED, V36, P142, DOI 10.1016/j.ajem.2017.07.007; Olson-Madden JH, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/174579; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Rangaswamy M, 2014, HDB CLIN NEUROLOGY, V125; Richardson JTE, 2011, STAT MED, V30, P890, DOI 10.1002/sim.4116; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Scheenen ME, 2016, J NEUROTRAUM, V33, P339, DOI 10.1089/neu.2015.3926; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Taylor TR, 2009, BRIT J NEUROSURG, V23, P622, DOI 10.3109/02688690903215666; Wallach J, 2007, INTERPRETATION DIAGN	23	2	2	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2019	51	2					62	66		10.1097/JNN.0000000000000420			5	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	HO1JP	WOS:000460661800002	30649089				2022-02-06	
J	Rigon, A; Voss, MW; Turkstra, LS; Mutlu, B; Duff, MC				Rigon, Arianna; Voss, Michelle W.; Turkstra, Lyn S.; Mutlu, Bilge; Duff, Melissa C.			Functional neural correlates of facial affect recognition impairment following TBI	BRAIN IMAGING AND BEHAVIOR			English	Article						TBI; Emotion recognition; Facial affect; fMRI; Perceptual; Labeling	TRAUMATIC BRAIN-INJURY; FUSIFORM FACE AREA; EMOTION RECOGNITION; WORKING-MEMORY; ARTIFACT REMOVAL; ICA-AROMA; PERCEPTION; FMRI; DEFICITS; ROBUST	Facial affect recognition deficits following traumatic brain injury (TBI) have been well documented, as has their relationship with impairment in several other cognitive domains. However, little is known about the neurobiological mechanisms underlying affect recognition deficits, in particular mechanisms underlying different aspects of facial affect recognition (e.g., perceptual and interpretive processes). In the current study, 33 adults with moderate-to-severe TBI and 24 demographically matched healthy comparison (HC) participants completed an fMRI facial affect recognition study. While in the scanner, participants were asked to match the affect of a target face to either (a) one of two faces differing in affect (perceptual condition) or (b) one of two written affect labels (interpretative condition). In both groups we found activations in regions typically involved in affect recognition. Our results revealed that in the perceptual condition individuals with TBI tended to activate the left dorsolateral prefrontal cortex less than HCs, and within the HC group individuals with higher perceptual affect recognition scores showed higher levels of activation in the same brain region. Individuals with TBI who were specifically impaired at interpretative affect recognition showed less activation than HCs in the right fusiform gyrus. Moreover, in the labeling condition individuals with TBI tended to de-activate medial prefrontal regions less than HCs. A region of interest analysis revealed that individuals with TBI showed significantly less activation than HCs in the FFA for all the contrasts of interest. Our results suggest involvement of several brain regions in facial affect recognition impairment post TBI, and provide neurobiological support for the notion that distinct aspects of facial affect recognition can be differentially impaired following TBI.	[Rigon, Arianna; Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA; [Turkstra, Lyn S.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Mutlu, Bilge] Univ Wisconsin, Dept Comp Sci, 1210 W Dayton St, Madison, WI 53706 USA		Rigon, A (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37235 USA.	arianna.rigon@vanderbilt.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NICHD/NCMRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD071089]; American Psychological Foundation Benton-Meier Fellowship; University of Iowa Magnetic Resonance Research Facility; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER	The study was funded by NICHD/NCMRR grant R01 HD071089, by an American Psychological Foundation Benton-Meier Fellowship, and by a pilot grant issued by the University of Iowa Magnetic Resonance Research Facility.	Andersson J., 2007, SD; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Aupperle RL, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00042; Barbey AK, 2015, CURR OPIN BEHAV SCI, V4, P92, DOI 10.1016/j.cobeha.2015.04.002; Berman MG, 2010, NEUROIMAGE, V50, P56, DOI 10.1016/j.neuroimage.2009.12.024; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Brodeur MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010773; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dotsch R, 2008, PSYCHOL SCI, V19, P978, DOI 10.1111/j.1467-9280.2008.02186.x; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Ferrucci R, 2012, COGNITION EMOTION, V26, P786, DOI 10.1080/02699931.2011.619520; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Frith C, 1997, PHILOS T R SOC B, V352, P1221, DOI 10.1098/rstb.1997.0104; Gee DG, 2012, SCHIZOPHR RES, V134, P1, DOI 10.1016/j.schres.2011.10.005; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Gordon BA, 2015, NEUROBIOL AGING, V36, P1771, DOI 10.1016/j.neurobiolaging.2015.01.019; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kumfor F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067457; Lundqvist D, 2015, COGNITION EMOTION, V29, P621, DOI 10.1080/02699931.2014.927352; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McDonald S, 2011, INT J PSYCHOPHYSIOL, V82, P124, DOI 10.1016/j.ijpsycho.2011.01.014; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Neumann D, 2016, BRAIN IMAGING BEHAV, V10, P569, DOI 10.1007/s11682-015-9415-3; Neumann D, 2014, BRAIN IMAGING BEHAV, V8, P460, DOI 10.1007/s11682-013-9285-5; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Nieuwhof F, 2017, BRAIN, V140, P1384, DOI 10.1093/brain/awx042; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Palermo R, 2018, J EXP PSYCHOL HUMAN, V44, P503, DOI 10.1037/xhp0000463; Palermo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068126; Parada M, 2016, J SEX MED, V13, P1508, DOI 10.1016/j.jsxm.2016.08.008; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pruim RHR, 2015, NEUROIMAGE, V112, P278, DOI 10.1016/j.neuroimage.2015.02.063; Pruim RHR, 2015, NEUROIMAGE, V112, P267, DOI 10.1016/j.neuroimage.2015.02.064; Rigon A, 2017, NEUROIMAGE-CLIN, V13, P370, DOI 10.1016/j.nicl.2016.12.010; Rigon A., 2018, NEUROPSYCHOLOGY; Rigon A, 2018, J CLIN EXP NEUROPSYC, V40, P805, DOI 10.1080/13803395.2018.1437120; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Samu D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14743; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sood MR, 2016, HUM BRAIN MAPP, V37, P2784, DOI 10.1002/hbm.23208; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Wang JX, 2014, SCIENCE, V345, P1054, DOI 10.1126/science.1252900; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Worsley K.J., 2001, FUNCTIONAL MRI INTRO; Yang YJD, 2017, BEHAV RES THER, V93, P55, DOI 10.1016/j.brat.2017.03.014; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	69	2	2	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	APR	2019	13	2			SI		526	540		10.1007/s11682-018-9889-x			15	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HV7TJ	WOS:000466183200022	29737489	Green Accepted			2022-02-06	
J	Rodriguez, UA; Zeng, YP; Parsley, MA; Hawkins, BE; Prough, DS; DeWitt, DS				Rodriguez, Uylissa A.; Zeng, Yaping; Parsley, Margaret A.; Hawkins, Bridget E.; Prough, Donald S.; DeWitt, Douglas S.			Effects of Blast-induced Neurotrauma on Pressurized Rodent Middle Cerebral Arteries	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 146; TBI; blast-induced traumatic brain injury (bTBI); blast-induced neurotrauma; primary blast injury; cerebral vascular reactivity; middle cerebral arteries (MCA); myogenic response	TRAUMATIC BRAIN-INJURY; FLUID-PERCUSSION INJURY; CORTICAL IMPACT INJURY; CLOSED-HEAD-INJURY; BLOOD-FLOW; MYOGENIC RESPONSE; AUTOREGULATION; RAT; MODEL; MICROCIRCULATION	Though there have been studies on the histopathological and behavioral effects of blast exposure, fewer have been dedicated to blast's cerebral vascular effects. Impact (i.e., non-blast) traumatic brain injury (TBI) is known to decrease pressure autoregulation in the cerebral vasculature in both humans and experimental animals. The hypothesis that blast-induced traumatic brain injury (bTBI), like impact TBI, results in impaired cerebral vascular reactivity was tested by measuring myogenic dilatory responses to reduced intravascular pressure in rodent middle cerebral arterial (MCA) segments from rats subjected to mild bTBI using an Advanced Blast Simulator (ABS) shock tube. Adult, male Sprague-Dawley rats were anesthetized, intubated, ventilated and prepared for Sham bTBI (identical manipulation and anesthesia except for blast injury) or mild bTBI. Rats were randomly assigned to receive Sham bTBI or mild bTBI followed by sacrifice 30 or 60 min post-injury. Immediately after bTBI, righting reflex (RR) suppression times were assessed, euthanasia at the time points post-injury was completed, the brain was harvested and the individual MCA segments were collected, mounted and pressurized. As the intraluminal pressure perfused through the arterial segments was reduced in 20 mmHg increments from 100 to 20 mmHg, MCA diameters were measured and recorded. With decreasing intraluminal pressure, MCA diameters steadily increased significantly above baseline in the Sham bTBI groups while MCA dilator responses were significantly reduced (p < 0.05) in both bTBI groups as evidenced by the impaired, smaller MCA diameters recorded for the bTBI groups. In addition, RR suppression in the bTBI groups was significantly (p < 0.05) higher than in the Sham bTBI groups. MCA's collected from the Sham bTBI groups exhibited typical vasodilatory properties to decreases in intraluminal pressure while MCA's collected following bTBI exhibited significantly impaired myogenic vasodilatory responses to reduced pressure that persisted for at least 60 min after bTBI.	[Rodriguez, Uylissa A.; Zeng, Yaping; Parsley, Margaret A.; Hawkins, Bridget E.; Prough, Donald S.; DeWitt, Douglas S.] Univ Texas Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, Galveston, TX 77555 USA; [Rodriguez, Uylissa A.; Zeng, Yaping; Parsley, Margaret A.; Hawkins, Bridget E.; Prough, Donald S.; DeWitt, Douglas S.] Univ Texas Med Branch, Moody Project Translat Traumat Brain Injury Res, Galveston, TX 77555 USA		Rodriguez, UA (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, Galveston, TX 77555 USA.; Rodriguez, UA (corresponding author), Univ Texas Med Branch, Moody Project Translat Traumat Brain Injury Res, Galveston, TX 77555 USA.	uarodrig@utmb.edu	; Hawkins, Bridget/H-4933-2015	DeWitt, Douglas/0000-0001-9810-8156; Hawkins, Bridget/0000-0002-1887-3657	Moody Project for Translational Traumatic Brain Injury Research [W81XWH-08-2-0132]; U.S. Army Medical Research and Material Command -Department of DefenseU.S. Army Medical Research & Materiel Command (USAMRMC)United States Department of Defense	Studies were completed as part of a team supported by The Moody Project for Translational Traumatic Brain Injury Research and award W81XWH-08-2-0132 from the U.S. Army Medical Research and Material Command -Department of Defense.	Ahn DS, 2007, J VASC RES, V44, P182, DOI 10.1159/000100374; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Allen SP, 1997, HYPERTENSION, V30, P203, DOI 10.1161/01.HYP.30.2.203; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Atkinson C. L., 1985, J APPL PHYSIOL, V119, P858; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; Cipolla MJ, 2004, AM J PHYSIOL-HEART C, V286, pH2127, DOI 10.1152/ajpheart.01154.2003; De Mey J.G., 1985, PROG APPL MICROCIRC, V8, P181; Degnan AJ, 2012, AM J NEURORADIOL, V33, P1427, DOI 10.3174/ajnr.A2697; DeWitt D. S, 2012, ANIMAL MODELS ACUTE, VII; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; FRIEDLANDER FG, 1946, PROC R SOC LON SER-A, V186, P322, DOI 10.1098/rspa.1946.0046; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Golding EM, 1998, J NEUROTRAUM, V15, P635, DOI 10.1089/neu.1998.15.635; Golding EM, 1998, BRAIN RES, V785, P293, DOI 10.1016/S0006-8993(97)01419-4; GOLDING EM, 1999, AM J PHYSL 2, V277, pH145; HALPERN W, 1991, BLOOD VESSELS, V28, P245; JOHNSON PC, 1975, FED PROC, V34, P2020; JOHNSON PC, 1977, MICROVASC RES, V13, P1, DOI 10.1016/0026-2862(77)90112-1; JOHNSON PC, 1989, J HYPERTENS, V7, pS33; KONTOS HA, 1981, ANNU REV PHYSIOL, V43, P397, DOI 10.1146/annurev.ph.43.030181.002145; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu Q, 2013, INT J CARDIOVAS IMAG, V29, P1491, DOI 10.1007/s10554-013-0237-3; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; MCHEDLISHVILI G, 1980, STROKE, V11, P240, DOI 10.1161/01.STR.11.3.240; Morris RK, 2012, EUR J OBSTET GYN R B, V165, P141, DOI 10.1016/j.ejogrb.2012.07.027; Newell D W, 1990, Neurosurg Clin N Am, V1, P319; NILSSON H, 1985, ACTA PHYSIOL SCAND, V125, P429, DOI 10.1111/j.1748-1716.1985.tb07739.x; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Roy C S, 1890, J Physiol, V11, P85; Schenone MH, 2011, CLIN PERINATOL, V38, P83, DOI 10.1016/j.clp.2010.12.003; Soehle M, 2004, ANESTH ANALG, V98, P1133, DOI 10.1213/01.ANE.0000111101.41190.99; SPEDEN RN, 1985, EXPERIENTIA, V41, P1026, DOI 10.1007/BF01952126; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; WEI EP, 1980, AM J PHYSIOL, V238, pH697, DOI 10.1152/ajpheart.1980.238.5.H697; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Yu GX, 2014, J NEUROTRAUM, V31, P739, DOI 10.1089/neu.2013.3187; 1990, CEREBROVASCULAR BRAI, V2, P161	50	2	2	1	1	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	APR	2019		146							e58792	10.3791/58792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HW2GG	WOS:000466500600016	30985764	Bronze			2022-02-06	
J	Tomar, GS; Singh, GP; Bithal, P; Upadhyay, AD; Chaturvedi, A				Tomar, Gaurav Singh; Singh, Gyaninder Pal; Bithal, Parmod; Upadhyay, Ashish Datt; Chaturvedi, Arvind			Comparison of Effects of Manual and Mechanical Airway Clearance Techniques on Intracranial Pressure in Patients With Severe Traumatic Brain Injury on a Ventilator: Randomized, Crossover Trial	PHYSICAL THERAPY			English	Article							END-EXPIRATORY PRESSURE; CHEST PHYSIOTHERAPY; VIBRATION; PERCUSSION; INCREASES	Background Physical therapist intervention can play a significant role in the prevention of mechanical and infectious complications in patients with traumatic brain injury (TBI) who are mechanically ventilated. Objective The objective of this study was to observe and compare the effects of manual and mechanical airway clearance techniques on intracranial pressure (ICP) and hemodynamics in patients with severe TBI. Design The design was a prospective, randomized, crossover trial. Setting The setting was a neurointensive care unit at a level 1 trauma center. Patients Forty-six adult patients aged 18 to 75 years, of either sex, with severe TBI, receiving mechanical ventilatory support with continuous ICP monitoring, and undergoing regular airway clearance techniques participated in this study. Intervention Two techniques were performed by a single trained physical therapist. Treatment A was a manual chest percussion technique and treatment B used a mechanical chest wall vibrator. Each treatment was applied for 10 minutes alternately, separated by an interval of 4 hours. Measurements ICP was measured from the start of intervention to 10 minutes postintervention. Secondary measurements included cerebral perfusion pressure, heart rate, mean arterial pressure (each from the start of the intervention until 10 minutes postintervention at 1-minute intervals), and arterial blood gas parameters (from just before the start of the intervention and 10 minutes postintervention). Results The increases in mean (95% CI) intracranial pressure of 2.4 (1.4-3.4) and 1.0 (0.2-1.8) mmHg, during and after the intervention with treatment A, respectively, were statistically significantly higher than for treatment B, irrespective of sequence. In contrast, a mean heart rate rise of 6.4 (3.3-9.5) beats/min and mean arterial pressure rise of 5.3 (2.0-8.6) mmHg were significantly higher only during the intervention phase of treatment A compared with treatment B. Peak mean values of ICP, heart rate, and arterial pressure were also significantly higher during treatment A. However, mean values of cerebral perfusion pressure or its degree of change were statistically comparable in both treatment groups. Limitations Patients with high baseline ICP values (>20 mmHg) were excluded, and, because of the crossover design, the effect of individual technique on final (long-term) neurological or respiratory outcomes could not be studied. Conclusion Manual chest percussion technique in patients with severe TBI was associated with statistically significant transient increases in ICP and hemodynamics, compared with the mechanical method. However, such transient increases in ICP by either technique were not clinically relevant in patients with moderate-to-severe TBI without intracranial hypertension on a mechanical ventilator.	[Tomar, Gaurav Singh; Singh, Gyaninder Pal; Bithal, Parmod; Chaturvedi, Arvind] All India Inst Med Sci, Neurosci Ctr, Dept Neuroanaesthesiol & Crit Care, Delhi 110029, India; [Upadhyay, Ashish Datt] All India Inst Med Sci, Dept Biostat, Delhi 110029, India		Tomar, GS (corresponding author), All India Inst Med Sci, Neurosci Ctr, Dept Neuroanaesthesiol & Crit Care, Delhi 110029, India.	spunkygst@gmail.com	Tomar, Gaurav Singh/G-9567-2015; SINGH, GYANINDER/T-7976-2017	Tomar, Gaurav Singh/0000-0003-1333-6614; SINGH, GYANINDER/0000-0002-6702-6892			BRIERLEY S, 2003, RESP CARE, V48; Castro AAM, 2013, RESP MED, V107, P68, DOI 10.1016/j.rmed.2012.09.016; Chen YC, 2009, J CHIN MED ASSOC, V72, P316, DOI 10.1016/S1726-4901(09)70378-8; Clini E, 2005, RESP MED, V99, P1096, DOI 10.1016/j.rmed.2005.02.024; Cohen D, 1996, CRIT CARE MED, V24, P612, DOI 10.1097/00003246-199604000-00011; de Cerqueira-Neto ML, 2010, ARQ NEURO-PSIQUIAT, V68, P567, DOI 10.1590/S0004-282X2010000400017; Della Torre V, 2017, J THORAC DIS, V9, P5368, DOI 10.21037/jtd.2017.11.03; FESSLER HE, 1991, AM REV RESPIR DIS, V143, P19, DOI 10.1164/ajrccm/143.1.19; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; HAMMON WE, 1993, CHEST, V103, P1409, DOI 10.1378/chest.103.5.1409; Hill Kylie, 2010, Chron Respir Dis, V7, P9, DOI 10.1177/1479972309348659; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Lee K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/207247; McCarren B, 2006, AUST J PHYSIOTHER, V52, P267, DOI 10.1016/S0004-9514(06)70006-X; McCool FD, 2006, CHEST, V129, p250S, DOI 10.1378/chest.129.1_suppl.250S; Morrison L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006842.pub4; Nemer SN, 2005, FISIOTER BRAS, V6, P437; Ntoumenopoulos G, 2002, INTENS CARE MED, V28, P850, DOI 10.1007/s00134-002-1342-2; Olson DM, 2009, AM J CRIT CARE, V18, P330, DOI 10.4037/ajcc2009523; Rosner B., 2010, FUNDAMENTALS BIOSTAT, P673; Shin S, 2004, CLIN HEMORHEOL MICRO, V30, P353; Thiesen RA, 2005, ARQ NEURO-PSIQUIAT, V63, P110, DOI 10.1590/S0004-282X2005000100020; Toledo Cassia, 2008, Rev. bras. ter. intensiva, V20, P339, DOI 10.1590/S0103-507X2008000400004; WEISSMAN C, 1994, CRIT CARE MED, V22, P1809; WHITE PF, 1982, ANESTHESIOLOGY, V57, P242, DOI 10.1097/00000542-198209000-00019; Zeng Hui, 2017, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V29, P403, DOI 10.3760/cma.j.issn.2095-4352.2017.05.004	26	2	3	1	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	APR	2019	99	4					388	395		10.1093/ptj/pzy141			8	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	HU0GL	WOS:000464949300003	30690546				2022-02-06	
J	Waldron-Perrine, B; Gabel, NM; Seagly, K; Kraal, AZ; Pangilinan, P; Spencer, RJ; Bieliauskas, L				Waldron-Perrine, Brigid; Gabel, Nicolette M.; Seagly, Katharine; Kraal, A. Zarina; Pangilinan, Percival; Spencer, Robert J.; Bieliauskas, Linas			Montreal Cognitive Assessment as a screening tool	NEUROLOGY-CLINICAL PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; DIGIT SPAN; PERFORMANCE; VALIDITY; MOCA; CLASSIFICATION; MILITARY; UTILITY; SCORES; RATES	Background We evaluated Montreal Cognitive Assessment (MoCA) performance in a veteran traumatic brain injury (TBI) population, considering performance validity test (PVT) and symptom validity test (SVT) data, and explored associations of MoCA performance with neuropsychological test performance and self-reported distress. Methods Of 198 consecutively referred veterans to a Veterans Administration TBI/Polytrauma Clinic, 117 were included in the final sample. The MoCA was administered as part of the evaluation. Commonly used measures of neuropsychological functioning and performance and symptom validity were also administered to aid in diagnosis. Results Successively worse MoCA performances were associated with a greater number of PVT failures (ps < 0.05). Failure of both the SVT and at least 1 PVT yielded the lowest MoCA scores. Self-reported distress (both posttraumatic stress disorder symptoms and neurobehavioral cognitive symptoms) was also related to MoCA performance. Conclusions Performance on the MoCA is influenced by task engagement and symptom validity. Causal inferences about neurologic and neuro-cognitive impairment, particularly in the context of mild TBI, wherein the natural course of recovery is well known, should therefore be made cautiously when such inferences are based heavily on MoCA scores. Neuropsychologists are well versed in the assessment of performance and symptom validity and thus may be well suited to explore the influences of abnormal performances on cognitive screening.	[Waldron-Perrine, Brigid] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI 48202 USA; [Gabel, Nicolette M.; Seagly, Katharine; Pangilinan, Percival] Univ Michigan, Dept Phys Med & Rehabil, Michigan Med, Ann Arbor, MI 48109 USA; [Kraal, A. Zarina] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Pangilinan, Percival] VA Hlth Syst, Ann Arbor, MI USA; VA Ann Arbor Healthcare, Mental Hlth Serv 116B RJS, Ann Arbor, MI USA; [Spencer, Robert J.; Bieliauskas, Linas] Michigan Med, Neuropsychol Sect Psychiat, Ann Arbor, MI USA		Waldron-Perrine, B (corresponding author), Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI 48202 USA.	brigid.waldron@gmail.com					Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Biundo R, 2016, J NEURAL TRANSM, V123, P431, DOI 10.1007/s00702-016-1517-6; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Cleeland CS, 1991, BRIEF PAIN INVENTORY; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; Dunn L. M., 2007, PPVT 4 PEABODY PICTU; Frances A, 1994, DIAGN STAT MAN MENT; Freitas S, 2012, J INT NEUROPSYCH SOC, V18, P1031, DOI 10.1017/S135561771200077X; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lam B, 2013, J AM GERIATR SOC, V61, P2181, DOI 10.1111/jgs.12541; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; MAIN CJ, 1992, SPINE, V17, P42, DOI 10.1097/00007632-199201000-00007; MAIN CJ, 1983, J PSYCHOSOM RES, V27, P503, DOI 10.1016/0022-3999(83)90040-5; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Paul R, 2011, ARCH CLIN NEUROPSYCH, V26, P454, DOI 10.1093/arclin/acr017; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Reitan R, 1985, HALSTEAD REITAN NEUR; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Smith T, 2007, CAN J PSYCHIAT, V52, P329, DOI 10.1177/070674370705200508; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sugarman MA, 2014, COGN BEHAV NEUROL, V27, P148, DOI 10.1097/WNN.0000000000000035; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Waldron-Perrine B, 2012, INT J GERIATR PSYCH, V27, P1189, DOI 10.1002/gps.3768; Weathers F, 1994, PCL M DSM 4; Wechsler D., 2014, WECHSLER ADULT INTEL, Vfourth; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	40	2	2	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0402	2163-0933		NEUROL-CLIN PRACT	Neurol.-Clin. Pract.	APR	2019	9	2					101	108		10.1212/CPJ.0000000000000604			8	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	IF5HQ	WOS:000473112300006	31041123	Green Published			2022-02-06	
J	Walker, A; Kim, J; Wyatt, J; Terlouw, A; Balachandran, K; Wolchok, J				Walker, Addison; Kim, Johntaehwan; Wyatt, Joseph; Terlouw, Abby; Balachandran, Kartik; Wolchok, Jeffrey			Repeated In Vitro Impact Conditioning of Astrocytes Decreases the Expression and Accumulation of Extracellular Matrix	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Mechanobiology; Nervous system; Glial cells; Central nervous system	TRAUMATIC BRAIN-INJURY; REACTIVE ASTROCYTES; ANIMAL-MODEL; TISSUE; HEAD; STRAIN; PLASTICITY; INCREASES; CULTURES; EXPOSURE	Pathological changes to the physical and chemical properties of brain extracellular matrix (ECM) occur following injury. It is generally assumed that astrocytes play an important role in these changes. What remain unclear are the triggers that lead to changes in the regulation of ECM by astrocytes following injury. We hypothesize that mechanical stimulation triggers genotypic and phenotypic changes to astrocytes that could ultimately reshape the ECM composition of the central nervous system following injury. To explore astrocyte mechanobiology, an in vitro drop test bioreactor was employed to condition primary rat astrocytes using short duration (10ms), high deceleration (150G) and strain (20%) impact stimuli. Experiments were designed to explore the effect of single and repeated impact (single vs. double) on mechano-sensitive behavior including cell viability; ECM gene (collagens I and IV, fibronectin, neurocan, versican) and reactivity gene [glial fibrillary acidic protein (GFAP), S100B, vimentin] expression; matrix regulatory cytokine secretion [matrix metalloproteinase 2 (MMP-2), tissue inhibitor of metalloproteinases 1 (TIMP1), transforming growth factor beta 1 (TGF1)]; and matrix accumulation [collagen and glycosaminoglycan (GAG)]. Experiments revealed that both ECM and reactive gliosis gene expression was significantly decreased in response to impact conditioning. The decreases for several genes, including collagen, versican, and GFAP were sensitive to impact number, suggesting mechano-sensitivity to repeated impact conditioning. The measured decreases in ECM gene expression were supported by longer-term in vitro experiments that demonstrated significant decreases in chondroitin sulfate proteoglycan (CSPG) and collagen accumulation within impact conditioned 3-D scaffolds accompanied by a 25% decrease in elastic modulus. Overall, the general trend across all samples was towards altered ECM and reactive gliosis gene expression in response to impact. These results suggest that the regulation of ECM production by astrocytes is sensitive to mechanical stimuli, and that repeated impact conditioning may increase this sensitivity.	[Walker, Addison; Kim, Johntaehwan; Wyatt, Joseph; Terlouw, Abby; Balachandran, Kartik; Wolchok, Jeffrey] Univ Arkansas, Dept Biomed Engn, 125 Engn Hall, Fayetteville, AR 72701 USA		Wolchok, J (corresponding author), Univ Arkansas, Dept Biomed Engn, 125 Engn Hall, Fayetteville, AR 72701 USA.	jwolchok@uark.edu			National Science FoundationNational Science Foundation (NSF) [CMMI-1404716]; Arkansas Biosciences Institute	This work was supported by the National Science Foundation (Grant #CMMI-1404716) as well as the Arkansas Biosciences Institute.	Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Balestrini JL, 2010, BIOMECH MODEL MECHAN, V9, P329, DOI 10.1007/s10237-009-0179-9; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bayly PV, 2004, J BIOMECH ENG-T ASME, V126, P523, DOI 10.1115/1.1785811; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Gould RA, 2012, ACTA BIOMATER, V8, P1710, DOI 10.1016/j.actbio.2012.01.006; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Heller Z, 2014, CELL MOL BIOENG, V7, P521, DOI 10.1007/s12195-014-0347-6; Hurd SA, 2015, BIOMATERIALS, V49, P9, DOI 10.1016/j.biomaterials.2015.01.027; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kettenmann H, 2011, FORTSCHR NEUROL PSYC, V79, P588, DOI 10.1055/s-0031-1281704; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Laksari K, 2014, J MECH BEHAV BIOMED, V32, P132, DOI 10.1016/j.jmbbm.2013.12.021; Lasher RA, 2010, BIOTECHNOL PROGR, V26, P857, DOI 10.1002/btpr.380; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Mallard C, 2014, PEDIATR RES, V75, P234, DOI 10.1038/pr.2013.188; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Ralay R. H., 2011, J NEUROTRAUM, V28, P1757, DOI DOI 10.1089/NEU.2011.1799; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soza G, 2005, INT J MED ROBOT COMP, V1, P87, DOI 10.1002/rcs.32; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Sullivan KE, 2014, STEM CELL RES THER, V5, P15, DOI [10.1186/scrt404, DOI 10.1186/SCRT404]; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P99, DOI 10.1007/978-3-7091-1434-6_17; Toy Dana, 2013, Exp Neurobiol, V22, P68, DOI 10.5607/en.2013.22.2.68; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Veliz P, 2018, J ADOLESC HLTH; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Wiese S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00120; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Winter CC, 2016, ACTA BIOMATER, V38, P44, DOI 10.1016/j.actbio.2016.04.021; Wolchok JC, 2012, BIOTECHNOL PROG; Wolchok JC, 2013, ANN BIOMED ENG, V41, P2358, DOI 10.1007/s10439-013-0845-z; Wolchok JC, 2009, BIOMATERIALS, V30, P327, DOI 10.1016/j.biomaterials.2008.08.035; Yates NJ, 2017, EXP BRAIN RES, V235, P2133, DOI 10.1007/s00221-017-4958-8; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	66	2	2	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	APR	2019	47	4					967	979		10.1007/s10439-019-02219-y			13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	HO6FZ	WOS:000461026400005	30706307				2022-02-06	
J	Wu, XH; Zang, D; Wu, X; Sun, YR; Yu, J; Hu, J				Wu, Xuehai; Zang, Di; Wu, Xing; Sun, Yirui; Yu, Jian; Hu, Jin			Diagnosis and Management for Secondary Low- or Negative-Pressure Hydrocephalus and a New Hydrocephalus Classification Based on Ventricular Pressure	WORLD NEUROSURGERY			English	Article						Classification; Diagnosis; Low pressure hydrocephalus; Management; Negative pressure hydrocephalus; Ventricular pressure		BACKGROUND: Low-pressure hydrocephalus (LPH) and negative-pressure hydrocephalus (NegPH), secondary to traumatic brain injury, cerebral hemorrhage, tumor resection, and central nervous system (CNS) infection in adults, are seldom reported. They have not been recognized enough pathophysiologically in previous clinical practice. They used to have poor prognosis, and routine shunt surgery has unsatisfactory outcomes. The current classifications of hydrocephalus do not provide proper guidance for clinical practice, especially for LPH and NegPH. METHODS: Thirty-nine cases of LPH and NegPH were included from January 2013 to March 2018. Clinical features and image characteristics were reviewed. The prognosis of these patients were evaluated by Glasgow Outcome Scale-Extended (GOS-E) within 3 months after external ventricular drainage or ventriculoperitoneal (VP) shunt accepted. Management strategies were discussed in detail. RESULTS: Ventricular pressure was lower than 70 mm H2O in all 39 patients, and the lowest value was -10 cm H2O. About an average of 3.5 operations were completed for every patient. Eighteen cases had CNS infection. Eight patients died. Besides 2 patients lost to follow-up, all patients had a poor prognosis with an average GOS-E score of 2.7. For the 29 surviving patients, the time interval from onset to last VP shunt achieved was 31-3880 days, with an average of 376 days. CONCLUSIONS: Both LPH and NegPH used to have poor prognosis. However, a good prognosis can be achieved by proper management with a further understanding of the pathophysiology. A new classification for hydrocephalus was proposed according to ventricular pressure, which is necessary and reasonable.	[Wu, Xuehai; Zang, Di; Wu, Xing; Sun, Yirui; Yu, Jian; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China		Wu, XH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.	wuxuehai2013@163.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571025]; International Cooperation Project from Shanghai Science Foundation [18410711300]	This work was supported by the Natural Science Foundation of China (81571025) and International Cooperation Project from Shanghai Science Foundation (18410711300).	Akins PT, 2011, NEUROCRIT CARE, V15, P461, DOI 10.1007/s12028-011-9543-6; Clarke MJ, 2006, J NEUROSURG, V105, P475, DOI 10.3171/jns.2006.105.3.475; Cohen AR, 2011, J NEUROSURG, V115, P1029, DOI 10.3171/2011.5.JNS11703; Filippidis AS, 2011, J NEUROSURG, V115, P1031, DOI 10.3171/2011.6.JNS101504; Hunn BHM, 2014, CLIN NEUROL NEUROSUR, V116, P67, DOI 10.1016/j.clineuro.2013.10.019; Kalani MYS, 2013, J CLIN NEUROSCI, V20, P462, DOI 10.1016/j.jocn.2012.04.027; Lesniak MS, 2002, BRIT J NEUROSURG, V16, P555; Levine DN, 2008, J NEUROL SCI, V269, P1, DOI 10.1016/j.jns.2007.12.022; Lin B-J, 2016, NEUROSURG QUART, V26, P256; Miller J D, 1975, Clin Neurosurg, V22, P76; Owler BK, 2001, BRIT J NEUROSURG, V15, P353; Pandey S, 2017, WORLD NEUROSURG, V99, DOI 10.1016/j.wneu.2016.12.049; PANG DL, 1994, NEUROSURGERY, V35, P643, DOI 10.1227/00006123-199410000-00010; Rekate HL, 2008, J NEUROSURG-PEDIATR, V2, P1, DOI 10.3171/PED/2008/2/7/001; Smalley ZS, 2017, NEUROSURGERY, V80, P439, DOI 10.1093/neuros/nyw046; Strand A, 2018, WORLD NEUROSURG, V109, pE131, DOI 10.1016/j.wneu.2017.09.120; Suarez-Rivera O, 1998, SURG NEUROL, V49, P563, DOI 10.1016/S0090-3019(97)00342-X; VASSILYADI M, 1995, J NEUROSURG, V83, P486, DOI 10.3171/jns.1995.83.3.0486	18	2	3	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2019	124						E510	E516		10.1016/j.wneu.2018.12.123			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HR4BE	WOS:000463087800066	30611954				2022-02-06	
J	Griemert, EV; Hedrich, J; Hirnet, T; Thal, SC				Griemert, Eva-Verena; Hedrich, Jana; Hirnet, Tobias; Thal, Serge C.			Deficiency of Plasminogen Activator Inhibitor Type 2 Limits Brain Edema Formation after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier; brain edema; inflammation; plasminogen activator inhibitor-1 (PAI-1); plasminogen activator inhibitor-2 (PAI-2); traumatic brain injury	EXPRESSION; BLOOD; PAI-2; GENE; CONSEQUENCES; CONTUSION; RECOVERY; BARRIER; SYSTEM; LIGHT	Plasminogen activator inhibitor-2 (PAI-2/SerpinB2) inhibits extracellular urokinase plasminogen activator (uPA). Under physiological conditions, PAI-2 is expressed at low levels but is rapidly induced by inflammatory triggers. It is a negative regulator of fibrinolysis and serves to stabilize clots. In the present study, PAI-2 expression is upregulated 25-fold in pericontusional brain tissue at 6 h after traumatic brain injury (TBI), with a maximum increase of 87-fold at 12 h. To investigate a potentially detrimental influence of PAI-2 on secondary post-traumatic processes, male PAI-2-deficient (PAI-2-KO) and wild-type mice (WT) were subjected to TBI by controlled cortical impact injury. Brain lesion volume and cerebral inflammation were not different. Total brain volume was significantly smaller in PAI-2-KO, indicating reduced brain swelling. The brain water content at 24 h post-insult was significantly smaller in PAI-2-KO mice. Markers of vasogenic brain edema showed no difference in blood-brain barrier integrity and expression of blood-brain barrier proteins (claudin-5, zonula occludens-1). In contrast to plasminogen activator inhibitor-1 (PAI-1), PAI-2 plays a limited role for brain lesion formation and does not influence blood-brain barrier integrity. PAI-2 contributes to brain edema formation and could therefore be a promising new target to treat post-traumatic brain edema.	[Griemert, Eva-Verena; Hirnet, Tobias; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany; [Hedrich, Jana] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol, Mainz, Germany; [Hedrich, Jana] Max Planck Inst Polymer Res, Mainz, Germany		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	serge@thal.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729	Microscopy Core Facility of the Institute of Molecular Biology (IMB), Mainz; Focus Program Translational Neurosciences (FTN) of the Johannes Gutenberg-University Mainz; "Stufe 1 grant" of the University Medical Center of the Johannes Gutenberg-University Mainz	The authors thank Frida Kornes and Dana Pieter for their excellent technical and organizational assistance, and Dr. Robert Dickinson (Imperial College London, UK) for critically reading the manuscript. The support by the Microscopy Core Facility of the Institute of Molecular Biology (IMB), Mainz, is gratefully acknowledged.; This work was supported by a grant from the Focus Program Translational Neurosciences (FTN) of the Johannes Gutenberg-University Mainz to SCT and by a "Stufe 1 grant" of the University Medical Center of the Johannes Gutenberg-University Mainz to JH. No additional external funding sources were used for this study.	AKIYAMA H, 1993, NEUROSCI LETT, V164, P233, DOI 10.1016/0304-3940(93)90899-V; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Boncela J, 2011, J BIOL CHEM, V286, P43164, DOI 10.1074/jbc.M111.245647; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; Diaz A, 2017, J NEUROSCI, V37, P10310, DOI 10.1523/JNEUROSCI.1630-17.2017; DICKINSON JL, 1995, J BIOL CHEM, V270, P27894, DOI 10.1074/jbc.270.46.27894; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dietzmann K, 2000, PATHOL RES PRACT, V196, P15, DOI 10.1016/S0344-0338(00)80017-5; Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GENTON C, 1987, J CELL BIOL, V104, P705, DOI 10.1083/jcb.104.3.705; Griemert E.V., 2018, TRANSL STROKE RES; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; HUBER A, 1993, INT J LEGAL MED, V106, P152, DOI 10.1007/BF01225238; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Katayama Y, 1998, ACT NEUR S, V71, P289; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; KRUITHOF EKO, 1995, BLOOD, V86, P4007, DOI 10.1182/blood.V86.11.4007.bloodjournal86114007; Lemarchant S, 2012, NEUROPHARMACOLOGY, V62, P749, DOI 10.1016/j.neuropharm.2011.10.020; Levin EG, 1997, J CELL SCI, V110, P139; Lijnen HR, 2007, J THROMB HAEMOST, V5, P2259, DOI 10.1111/j.1538-7836.2007.02735.x; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luh C., 2018, TRANSL STROKE RES; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Maeda T, 1997, ACT NEUR S, V70, P102; Medcalf RL, 2017, J THROMB HAEMOST, V15, P2089, DOI 10.1111/jth.13849; Medcalf RL, 2011, METHOD ENZYMOL, V499, P105, DOI 10.1016/B978-0-12-386471-0.00006-7; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Sebastiani A, 2017, J NEUROSCI METH, V276, P73, DOI 10.1016/j.jneumeth.2016.11.012; Sharon R, 2002, MOL BRAIN RES, V104, P170, DOI 10.1016/S0169-328X(02)00354-6; Siefert SA, 2014, J THROMB HAEMOST, V12, P1706, DOI 10.1111/jth.12657; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; ZLOKOVIC BV, 1995, NEUROSURGERY, V37, P955, DOI 10.1227/00006123-199511000-00015	44	2	2	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2019	36	14					2272	2278		10.1089/neu.2018.6126		MAR 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IH1NO	WOS:000462602400001	30755137				2022-02-06	
J	Szczygielski, J; Hubertus, V; Kruchten, E; Muller, A; Albrecht, LF; Mautes, AE; Schwerdtfeger, K; Oertel, J				Szczygielski, Jacek; Hubertus, Vanessa; Kruchten, Eduard; Mueller, Andreas; Albrecht, Lisa Franziska; Mautes, Angelika E.; Schwerdtfeger, Karsten; Oertel, Joachim			Brain Edema Formation and Functional Outcome After Surgical Decompression in Murine Closed Head Injury Are Modulated by Acetazolamide Administration	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; acetazolamide; decompressive craniectomy; brain edema; mouse; closed head injury	CEREBROVASCULAR RESERVE CAPACITY; CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; CEREBROSPINAL-FLUID; CHOROID-PLEXUS; TIME-COURSE; AQUAPORIN-4; CRANIECTOMY; MICE	Acetazolamide (ACZ), carbonic anhydrase inhibitor, has been successfully applied in several neurosurgical conditions for diagnostic or therapeutic purposes. Furthermore, neuroprotective and anti-edematous properties of ACZ have been postulated. However, its use in traumatic brain injury (TBI) is limited, since ACZ-caused vasodilatation according to the Monro-Kellie doctrine may lead to increased intracranial blood volume / raise of intracranial pressure. We hypothesized that these negative effects of ACZ will be reduced or prevented, if the drug is administered after already performed decompression. To test this hypothesis, we used a mouse model of closed head injury (CHI) and decompressive craniectomy (DC). Mice were assigned into following experimental groups: sham, DC, CHI, CHI+ACZ, CHI+DC, and CHI+DC+ACZ (n = 8 each group). 1d and 3d post injury, the neurological function was assessed according to Neurological Severity Score (NSS) and Beam Balance Score (BBS). At the same time points, brain edema was quantified by MRI investigations. Functional impairment and edema volume were compared between groups and over time. Among the animals without skull decompression, the group additionally treated with acetazolamide demonstrated the most severe functional impairment. This pattern was reversed among the mice with decompressive craniectomy: CHI+DC treated but not CHI+DC+ACZ treated animals showed a significant neurological deficit. Accordingly, radiological assessment revealed most severe edema formation in the CHI+DC group while in CHI+DC+ACZ animals, volume of brain edema did not differ from DC-only animals. In our CHI model, the response to acetazolamide treatment varies between animals with decompressive craniectomy and those without surgical treatment. Opening the cranial vault potentially creates an opportunity for acetazolamide to exert its beneficial effects while vasodilatation-related risks are attenuated. Therefore, we recommend further exploration of this potentially beneficial drug in translational research projects.	[Szczygielski, Jacek; Hubertus, Vanessa; Kruchten, Eduard; Albrecht, Lisa Franziska; Mautes, Angelika E.; Schwerdtfeger, Karsten; Oertel, Joachim] Saarland Univ, Med Ctr, Dept Neurosurg, Homburg, Germany; [Szczygielski, Jacek; Hubertus, Vanessa; Kruchten, Eduard; Mueller, Andreas; Albrecht, Lisa Franziska; Mautes, Angelika E.; Schwerdtfeger, Karsten; Oertel, Joachim] Saarland Univ, Fac Med, Homburg, Germany; [Szczygielski, Jacek] Saarland Univ, Inst Neuropathol, Med Ctr, Homburg, Germany; [Szczygielski, Jacek] Univ Rzeszow, Fac Med, Rzeszow, Poland; [Hubertus, Vanessa] Charite, Dept Neurosurg, Berlin, Germany; [Kruchten, Eduard] Karlsruhe Municipal Hosp, Inst Intervent & Diagnost Radiol, Karlsruhe, Germany; [Mueller, Andreas] Saarland Univ, Dept Radiol, Med Ctr, Homburg, Germany		Szczygielski, J (corresponding author), Saarland Univ, Med Ctr, Dept Neurosurg, Homburg, Germany.; Szczygielski, J (corresponding author), Saarland Univ, Fac Med, Homburg, Germany.; Szczygielski, J (corresponding author), Saarland Univ, Inst Neuropathol, Med Ctr, Homburg, Germany.; Szczygielski, J (corresponding author), Univ Rzeszow, Fac Med, Rzeszow, Poland.	jacek.szczygielski@uks.eu	Szczygielski, Jacek/AAV-4791-2021; Oertel, Joachim/AAO-5012-2021	Szczygielski, Jacek/0000-0002-3157-2824; Hubertus, Vanessa/0000-0002-2653-5818; Muller, Andreas/0000-0003-0924-3490	voluntary association Freunde des UKS (Friends of Saarland University Medical Center)	This work has been supported by financial award of voluntary association Freunde des UKS (Friends of Saarland University Medical Center) for JS.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Abbasi S, 2014, COMPUT METH PROG BIO, V113, P697, DOI 10.1016/j.cmpb.2013.11.008; Abrishamkar Saeid, 2013, Acta Med Iran, V51, P467; Acker G, 2018, J NUCL MED, V59, P294, DOI 10.2967/jnumed.117.195818; Akdemir G, 2014, NEUROSCI LETT, V574, P70, DOI 10.1016/j.neulet.2014.03.073; Arngrim N, 2014, PAIN, V155, P1649, DOI 10.1016/j.pain.2014.05.019; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Barkai G, 2004, PSYCHIAT RES-NEUROIM, V132, P279, DOI 10.1016/j.pscychresns.2004.09.004; Bloch O, 2005, J NEUROCHEM, V95, P254, DOI 10.1111/j.1471-4159.2005.03362.x; BORN JD, 1981, NEUROCHIRURGIE, V27, P71; Cabella B, 2017, NEUROCRIT CARE, V27, P103, DOI 10.1007/s12028-016-0319-x; Carrion E, 2001, ARCH DIS CHILD, V84, P68, DOI 10.1136/adc.84.1.68; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cherian Iype, 2016, Surg Neurol Int, V7, pS711; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CZERNICKI Z, 1994, ACTA NEUROCHIR, P329; CZUCZWAR SJ, 1986, EPILEPSIA, V27, P204, DOI 10.1111/j.1528-1157.1986.tb03529.x; DAHL A, 1995, STROKE, V26, P2302, DOI 10.1161/01.STR.26.12.2302; Duan L, 2017, MED SCI MONITOR, V23, P5818, DOI 10.12659/MSM.903855; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FOSSATI P, 1963, Lille Med, V8, P501; Gao M, 2010, J ASIAN NAT PROD RES, V12, P407, DOI 10.1080/10286020.2010.485129; Giammattei L, 2018, WORLD NEUROSURG, V109, P460, DOI 10.1016/j.wneu.2017.10.085; HARBAUGH RD, 1979, NEUROSURGERY, V5, P656, DOI 10.1227/00006123-197912000-00002; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Hartkamp NS, 2012, STROKE, V43, P553, DOI 10.1161/STROKEAHA.111.637314; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; HOLL K, 1990, NEUROCHIRURGIA, V33, P29; HOLLOWAY LS, 1972, AM J PHYSIOL, V223, P503; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Huang YH, 2013, J NEUROSURG, V118, P1329, DOI 10.3171/2013.1.JNS121775; Huber VJ, 2007, BIOORG MED CHEM LETT, V17, P1270, DOI 10.1016/j.bmcl.2006.12.010; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Intiso D, 2011, BRAIN INJURY, V25, P379, DOI 10.3109/02699052.2011.558046; JOHANSON CE, 1992, AM J PHYSIOL, V262, pR909, DOI 10.1152/ajpregu.1992.262.5.R909; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Kassamali R, 2011, CARDIOL REV, V19, P276, DOI 10.1097/CRD.0b013e31822b4939; Katada R, 2014, FASEB J, V28, P705, DOI 10.1096/fj.13-231274; Katada R, 2012, AM J PATHOL, V180, P17, DOI 10.1016/j.ajpath.2011.09.011; Kershenovich A, 2017, J NEUROL SURG PART A, V78, P33, DOI 10.1055/s-0036-1584815; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; KNUCKEY NW, 1991, J NEUROSURG, V74, P965, DOI 10.3171/jns.1991.74.6.0965; Liu GT, 1998, DRUGS TODAY, V34, P563, DOI 10.1358/dot.1998.34.6.485254; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Marciano D, 2007, J NEUROTRAUM, V24, P1378, DOI 10.1089/neu.2007.0318; Marmarou A, 1980, Adv Neurol, V28, P345; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; MILLSON C, 1981, ACTA NEUROCHIR, V56, P167, DOI 10.1007/BF01407228; Nabiuni M, 2013, J MED FOOD, V16, P504, DOI 10.1089/jmf.2012.0208; Okazawa H, 2001, J CEREBR BLOOD F MET, V21, P1472, DOI 10.1097/00004647-200112000-00012; OKUDAIRA Y, 1995, STROKE, V26, P1234, DOI 10.1161/01.STR.26.7.1234; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Portelli M, 2017, ACTA NEUROCHIR, V159, P491, DOI 10.1007/s00701-016-3050-7; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Shima K, 2003, ACT NEUR S, V86, P17; Sripathirathan K, 2009, J NEUROTRAUM, V26, P261, DOI 10.1089/neu.2008.0682; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sturdivant NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33330; Szczygielski J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00799; Szczygielski J, 2017, J NEUROTRAUM, V34, P1623, DOI 10.1089/neu.2016.4615; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Szczygielski J, 2010, ACTA NEUROCHIR SUPPL, V106, P225, DOI 10.1007/978-3-211-98811-4_42; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tradtrantip Lukmanee, 2017, Adv Exp Med Biol, V969, P239, DOI 10.1007/978-94-024-1057-0_16; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Uldall M, 2017, NEUROSCI LETT, V645, P33, DOI 10.1016/j.neulet.2017.02.032; Vagal AS, 2009, AM J NEURORADIOL, V30, P876, DOI 10.3174/ajnr.A1538; Wall M, 2014, JAMA-J AM MED ASSOC, V311, P1641, DOI 10.1001/jama.2014.3312; Watanabe K, 1976, No Shinkei Geka, V4, P351; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Xiang Y, 2004, ACTA PHARMACOL SIN, V25, P812; Yamada SM, 2013, CLIN NUCL MED, V38, P671, DOI 10.1097/RLU.0b013e31829959a9; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675; Yao XM, 2015, NEUROSCI LETT, V584, P368, DOI 10.1016/j.neulet.2014.10.040; Zahedi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079327; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	86	2	2	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 26	2019	10								273	10.3389/fneur.2019.00273			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ6TB	WOS:000462549800001	30972006	Green Published, gold			2022-02-06	
J	Molteni, E; Slomine, BS; Castelli, E; Zasler, N; Schnakers, C; Estraneo, A				Molteni, Erika; Slomine, Beth S.; Castelli, Enrico; Zasler, Nathan; Schnakers, Caroline; Estraneo, Anna			International survey on diagnostic and prognostic procedures in pediatric disorders of consciousness	BRAIN INJURY			English	Article						Disorders of consciousness; pediatric population; severe brain injury; diagnosis; prognosis; medical practice survey; questionnaire	DISABILITY RATING-SCALE; TRAUMATIC BRAIN-INJURY; GLASGOW OUTCOME SCALE; MISSING DATA; MULTIPLE IMPUTATION; PROLONGED DISORDERS; YOUNG-PATIENTS; RECOVERY; COMA; STATE	Aims: 1. to investigate diagnostic and prognostic procedures routinely used by international professionals to assess children with disorders of consciousness (DoC); 2. to explore use and availability of internal and national guidelines for pediatric DoC; 3. to identify international differences in diagnostic/prognostic protocols. Methods: The International Brain Injury Association DoC Special Interest Group emailed a survey link to 43,469 professionals. The survey included questions on diagnostic/prognostic procedures and guidelines for children with DoC. Results: Data on 82 respondents [(50% physicians) primarily from Europe (43.9%)and North America (37.8%)] were analyzed. Common diagnostic tools included the Glasgow Coma Scale for clinical assessment (94%), the Coma Recovery Scale-Revised for outcome measurement (57%), and cerebral MRI (94%). Clinical features used most frequently to inform prognosis varied with patient age. Few respondents used national (28%) admission protocols for children with DoC, and most were unaware of published national guidelines for diagnostic (72%) and prognostic (85%) procedures. Compared to North American respondents, more European respondents were physicians and used neurophysiological data for prognosis. Conclusions: This international survey provides useful information about diagnostic and prognostic procedures currently used for children with DoC and highlights the need for guidelines to promote best practices for diagnosis/prognosis in pediatric DoC.	[Molteni, Erika] IRCCS E Medea, Sci Inst, Acquired Brain Injury Unit, Lecce, Italy; [Molteni, Erika] Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England; [Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Neurophysiol, Kennedy Krieger Inst, Baltimore, MD USA; [Castelli, Enrico] Bambino Gesu Pediat Hosp, Neurosci & Neurorehabil Dept, Paediat Neurorehabil Units, Rome, Italy; [Zasler, Nathan] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Tree Life Serv Inc, Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Schnakers, Caroline] Casa Colina Hosp & Ctr Healthcare, Res Inst, Pomona, CA USA; [Estraneo, Anna] IRCCS, Maugeri Clin Sci Inst, DOC Res Lab, Telese Terme, Italy; [Estraneo, Anna] IRCCS, Maugeri Clin Sci Inst, Neurorehabil Unit DOC Patients, Telese Terme, Italy		Slomine, BS (corresponding author), Kennedy Krieger Inst, Dept Neuropsychol, 707 North Broadway, Baltimore, MD 21205 USA.	Slomine@kennedykrieger.org	Molteni, Erika/P-4564-2016; Laureys, Steven/A-3349-2011; estraneo, anna/K-5409-2016	Molteni, Erika/0000-0001-7773-8140; estraneo, anna/0000-0001-6646-5626			Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Andre-Obadia N, 2018, NEUROPHYSIOL CLIN, V48, P143, DOI 10.1016/j.neucli.2018.05.038; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Avantaggiato P, 2015, J HEAD TRAUMA REHAB, V30, P334, DOI 10.1097/HTR.0000000000000122; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Beretta E., 2017, DEV NEUROREHABIL, V19, P1; Candelieri A, 2011, J NEUROTRAUM, V28, P2013, DOI 10.1089/neu.2011.1885; Davis KC, 2016, J HEAD TRAUMA REHAB, V31, pE39, DOI 10.1097/HTR.0000000000000159; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Dennis EL, 2017, CHILD NERV SYST, V33, P1683, DOI 10.1007/s00381-017-3522-y; Dolce G, 2010, BRAIN INJURY, V24, P1628, DOI 10.3109/02699052.2010.523055; Eilander HJ, 2016, BRAIN INJURY, V30, P1302, DOI 10.3109/02699052.2016.1170881; Eilander HJ, 2013, J PEDIATR REHAB MED, V6, P73, DOI 10.3233/PRM-130241; Estraneo A, 2018, ARCH PHYS MED REHAB, V99, P2523, DOI 10.1016/j.apmr.2018.04.024; Estraneo A, 2016, CLIN NEUROPHYSIOL, V127, P2379, DOI 10.1016/j.clinph.2016.03.021; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Fichman M, 2003, ORGAN RES METHODS, V6, P282, DOI 10.1177/1094428103255532; Flannery J, 1998, Rehabil Nurs, V23, P88; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hua CA, 2015, J NUCL MED, V56, P575, DOI 10.2967/jnumed.114.146993; Laureys S., 2018, COMA DISORDERS CONSC, P17, DOI 10.1007/978-3-319-55964-3; Laureys S, 2017, COMA DISORDERS CONSC, DOI [10.1007/978-3-319-55964-3, DOI 10.1007/978-3-319-55964-3]; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Margetis K, 2014, NEUROMODULATION, V17, P699, DOI 10.1111/ner.12147; Martens G, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120162; Molteni E, 2017, DEV MED CHILD NEUROL, V59, P199, DOI 10.1111/dmcn.13332; Molteni E, 2016, J CLIN SLEEP MED, V12, P1131, DOI 10.5664/jcsm.6052; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Newman DA, 2003, ORGAN RES METHODS, V6, P328, DOI 10.1177/1094428103254673; Pascarella A, 2016, J NEUROL, V263, P2048, DOI 10.1007/s00415-016-8232-y; Pham K, 2014, J HEAD TRAUMA REHAB, V29, pE44, DOI 10.1097/HTR.0000000000000022; Ragazzoni A, 2017, CLIN NEUROPHYSIOL, V128, P1629, DOI 10.1016/j.clinph.2017.06.037; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Saunders JA, 2006, SOC WORK RES, V30, P19, DOI 10.1093/swr/30.1.19; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2006, ANN NEUROL, V60, P744, DOI 10.1002/ana.20919; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Shan ZYY, 2014, HUM BRAIN MAPP, V35, P2297, DOI 10.1002/hbm.22328; Slomine BS, 2016, REHABIL PSYCHOL, V61, P328, DOI 10.1037/rep0000096; Slovis JC, 2018, PEDIATR CRIT CARE ME, V19, P353, DOI 10.1097/PCC.0000000000001490; TEASDALE G, 1974, LANCET, V2, P81; Villa F, 2015, J CHILD NEUROL, V30, P1125, DOI 10.1177/0883073814553798	52	2	3	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					517	528		10.1080/02699052.2019.1565899			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100013	30663416	Green Submitted			2022-02-06	
J	Tiernan, S; Byrne, G				Tiernan, Stephen; Byrne, Gary			The effect of impact location on brain strain	BRAIN INJURY			English	Article						Concussion; maximum principal strain; corpus callosum	PROFESSIONAL FOOTBALL; HEAD IMPACTS; INJURY; CONCUSSION; RUGBY	Objective: To determine the effect of impact direction on strains within the brain. Research design: Laboratory drop tests of hybrid III head-form and finite element simulation of impacts. Methods and Procedures: A head-form instrumented with accelerometers and gyroscopes was dropped from 10 different heights in four orientations: front, rear, left and right-hand side. Twelve impacts with constant impact energy were chosen to simulate, to determine the effect of the impact location. A finite element head model was used to simulate these impacts, using 6 degrees of freedom. Following this, a further set of simulations were performed, where the same acceleration profiles were applied to different head locations. Main outcome and Results: The angular accelerations recorded were up to 30% higher in lateral and rear impacts when compared to frontal impacts. High strains in the midbrain (41%) were recorded from severe frontal impacts where as high strains in the corpus callosum (44%) resulted from lateral impacts with the same energy. Conclusion: Impact direction is very significant in determining the subsequent strains developed in the brain. Lateral impacts result in the highest strains in the corpus callosum and frontal impacts result in high strains in the mid-brain.	[Tiernan, Stephen; Byrne, Gary] Technol Univ Dublin, Dept Mech Engn, Dublin, Ireland		Tiernan, S (corresponding author), Inst Technol, Dept Mech Engn, Dublin 24, Tallaght, Ireland.	stephen.tiernan@ittdublin.ie		Tiernan, Stephen/0000-0002-0658-7557	Institute of Technology, Tallaght [PPRA1507]	This work was supported by the Institute of Technology, Tallaght [PPRA1507].	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Baumgartner D, 2005, SOLID MECH APPL, V124, P195; Dokko Y, 2003, ENHANC SAF VEH, V322; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Flashman LA, 2015, ANN BIOMED ENG, V40, P127; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Kendall M., 2012, INT RES COUNC BIOM I, P430, DOI DOI 10.1016/J.JECP.2012.07.001; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2000, THESIS; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Meaney DF, 1995, J COMPUT ASSIST TOMO, V12, P4; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Prasad P, 2008, STAPP CAR C, V52, P187; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Ward CC., 1977, INTRACRANIAL PRESSUR; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang L, 2001, STAPP CAR CRASH J; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	34	2	2	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					427	434		10.1080/02699052.2019.1566834			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100005	30663407	Green Submitted			2022-02-06	
J	Briet, C; Braun, K; Lefranc, M; Toussaint, P; Boudailliez, B; Bony, H				Briet, Claire; Braun, Karine; Lefranc, Michel; Toussaint, Patrick; Boudailliez, Bernard; Bony, Helene			Should We Assess Pituitary Function in Children After a Mild Traumatic Brain Injury? A Prospective Study	FRONTIERS IN ENDOCRINOLOGY			English	Article						traumatic brain injury; pituitary function; pediatric; hypopituitarism; growth hormone deficiency	GROWTH-HORMONE DEFICIENCY; COMA SCALE SCORE; HYPOTHALAMOHYPOPHYSEAL DYSFUNCTION; SERUM CONCENTRATIONS; PEDIATRIC SURVIVORS; REFERENCE VALUES; ADOLESCENTS; DIAGNOSIS; HYPOPITUITARISM; INSULIN	Objective: The aim of this study was to evaluate the frequency of hypopituitarism following TBI in a cohort of children who had been hospitalized for mild TBI and to identify the predictive factors for this deficiency. Design: A prospective study was conducted on children between 2 and 16 years of age who had been hospitalized for mild TBI according to the Glasgow Coma Scale between September 2009 and June 2013. Clinical parameters, basal pituitary hormone assessment at 0, 6, and 12 months, as well as a dynamic testing (insulin tolerance test) 12 months after TBI were performed. Results: The study included 109 children, the median age was 8.5 years. Patients were examined 6 months (n = 99) and 12 months (n = 96) after TBI. Somatotropic deficiency (defined by a GH peak <20 mUI/l in two tests, an IGF-1 <-1SDS and a delta height <0SDS) were confirmed in 2 cases. One case of gonadotrophic deficiency occurred 1 year after TBI among 13 pubertal children. No cases of precocious puberty, 5 cases of low prolactin level, no cases of corticotropic insufficiency (cortisol peak <500 nmol/l) and no cases diabetes insipidus were recorded. Conclusion: Pituitary insufficiency was present 1year after mild TBI in about 7% of children. Based on our results, we suggest testing children after mild TBI in case of clinical abnormalities. i.e., for GH axis, IGF-1, which should be assessed in children with a delta height <0 SDS, 6 to 12 months after TBI, and a dynamic GH testing (preferentially by an ITT) should be performed in case of IGF-1 <-1SDS, with a GH threshold at 20 mUI/L. However, if a systematic pituitary assessment is not required for mild TBI, physicians should monitor children 1 year after mild TBI with particular attention to growth and weight gain.	[Briet, Claire; Braun, Karine; Boudailliez, Bernard; Bony, Helene] Univ Med Ctr, Dept Pediat, Amiens, France; [Briet, Claire] Angers Univ, Univ Med Ctr Angers, Inst MITOVASC, Dept Endocrinol Diabetol & Nutr,INSERM U1083, Angers, France; [Lefranc, Michel; Toussaint, Patrick] Univ Med Ctr, Dept Neurosurg, Amiens, France; [Lefranc, Michel; Toussaint, Patrick; Boudailliez, Bernard] Univ Picardie Jules Verne, Dept Med, Amiens, France		Briet, C (corresponding author), Univ Med Ctr, Dept Pediat, Amiens, France.; Briet, C (corresponding author), Angers Univ, Univ Med Ctr Angers, Inst MITOVASC, Dept Endocrinol Diabetol & Nutr,INSERM U1083, Angers, France.	claire.briet@chu-angers.fr	claire, briet/AAQ-6715-2020		IpsenIpsen; Defi-TC grant from the French Endocrine Society	This study received financial support from Ipsen and a Defi-TC grant from the French Endocrine Society.	Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Auble BA, 2014, J NEUROTRAUM, V31, P321, DOI 10.1089/neu.2013.2916; Bellone S, 2013, PITUITARY, V16, P499, DOI 10.1007/s11102-012-0446-0; Borgialli DA, 2016, ACAD EMERG MED, V23, P878, DOI 10.1111/acem.13014; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Casano-Sancho P, 2017, ARCH DIS CHILD, V102, P572, DOI 10.1136/archdischild-2016-311609; Casano-Sancho P, 2013, CLIN ENDOCRINOL, V79, P853, DOI 10.1111/cen.12237; Chanson P, 2016, J CLIN ENDOCR METAB, V101, P3450, DOI 10.1210/jc.2016-1257; Cohen P, 2008, J CLIN ENDOCR METAB, V93, P4210, DOI 10.1210/jc.2008-0509; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Dickstein G, 2003, J Endocrinol Invest, V26, P25; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Fenske W, 2012, J CLIN ENDOCR METAB, V97, P3426, DOI 10.1210/jc.2012-1981; Ghigo E, 1996, J CLIN ENDOCR METAB, V81, P3323, DOI 10.1210/jc.81.9.3323; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Gonzalbez J, 2000, CLIN ENDOCRINOL, V53, P199; Grimberg A, 2016, HORM RES PAEDIAT, V86, P361, DOI 10.1159/000452150; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Israel E, 2000, J CLIN ENDOCR METAB, V85, P3990; Jourdan C, 2012, DEV MED CHILD NEUROL, V54, P624, DOI 10.1111/j.1469-8749.2012.04291.x; Juul A, 2002, HORM RES, V58, P233, DOI 10.1159/000066265; Kaulfers AMD, 2010, J PEDIATR-US, V157, P894, DOI 10.1016/j.jpeds.2010.07.004; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Khairullah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108838; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Krahulik D, 2017, BIOMED PAP, V161, P80, DOI 10.5507/bp.2016.047; Kreitschmann-Andermahr I, 2008, GROWTH HORM IGF RES, V18, P472, DOI 10.1016/j.ghir.2008.08.007; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193278; Lamberts SWJ, 1998, LANCET, V352, P127; Lem AJ, 2012, J CLIN ENDOCR METAB, V97, P3170, DOI 10.1210/jc.2012-1759; Maghnie M, 2005, EUR J ENDOCRINOL, V152, P735, DOI 10.1530/eje.1.01911; MARIN G, 1994, J CLIN ENDOCR METAB, V79, P537, DOI 10.1210/jc.79.2.537; Martinez AS, 2000, J CLIN ENDOCR METAB, V85, P4168, DOI 10.1210/jc.85.11.4168; Mauras N, 2000, PEDIATR RES, V48, P614, DOI 10.1203/00006450-200011000-00010; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Moon RJ, 2010, J NEUROTRAUM, V27, P1827, DOI 10.1089/neu.2010.1408; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Norwood KW, 2010, CLIN PEDIATR, V49, P1044, DOI 10.1177/0009922810376234; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; Peacock WF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00641; Personnier C, 2014, J CLIN ENDOCR METAB, V99, P2052, DOI 10.1210/jc.2013-4129; Petersenn S, 2010, DTSCH ARZTEBL INT, V107, P437, DOI 10.3238/arztebl.2010.0437; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Rakholia MV, 2019, J NEUROTRAUM, V36, P1156, DOI 10.1089/neu.2018.5782; Reifschneider K, 2015, J CLIN MED, V4, P1536, DOI 10.3390/jcm4081536; Resende EAMR, 2007, J CLIN ENDOCR METAB, V92, P1424, DOI 10.1210/jc.2006-1569; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; Salomon-Estebanez MA, 2014, J ENDOCRINOL INVEST, V37, P143, DOI 10.1007/s40618-013-0020-2; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; TEASDALE G, 1974, LANCET, V2, P81; Ulutabanca H, 2014, CHILD NERV SYST, V30, P1021, DOI 10.1007/s00381-013-2334-y; Wagner IV, 2014, EUR J ENDOCRINOL, V171, P389, DOI 10.1530/EJE-14-0165; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILLIAMS T, 1984, NEW ENGL J MED, V311, P1403, DOI 10.1056/NEJM198411293112203	58	2	2	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2392			FRONT ENDOCRINOL	Front. Endocrinol.	MAR 19	2019	10								149	10.3389/fendo.2019.00149			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	HP4QV	WOS:000461661900001	30941101	gold, Green Published			2022-02-06	
J	Sanz, LRD; Lejeune, N; Blandiaux, S; Bonin, E; Thibaut, A; Stender, J; Farber, NM; Zafonte, RD; Schiff, ND; Laureys, S; Gosseries, O				Sanz, Leandro R. D.; Lejeune, Nicolas; Blandiaux, Severine; Bonin, Estelle; Thibaut, Aurore; Stender, Johan; Farber, Neal M.; Zafonte, Ross D.; Schiff, Nicholas D.; Laureys, Steven; Gosseries, Olivia			Treating Disorders of Consciousness With Apomorphine: Protocol for a Double-Blind Randomized Controlled Trial Using Multimodal Assessments	FRONTIERS IN NEUROLOGY			English	Article						disorders of consciousness; unresponsive wakefulness syndrome; minimally conscious state; apomorphine; dopamine; mesocircuit; clinical trial; protocol	TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; SUBCUTANEOUS APOMORPHINE; THALAMIC-STIMULATION; SCALE; RECOVERY; CONNECTIVITY; RESTORATION; DYSFUNCTION; AMANTADINE	Background: There are few available therapeutic options to promote recovery among patients with chronic disorders of consciousness (DOC). Among pharmacological treatments, apomorphine, a dopamine agonist, has exhibited promising behavioral effects and safety of use in small-sample pilot studies. The true efficacy of the drug and its neural mechanism are still unclear. Apomorphine may act through a modulation of the anterior forebrain mesocircuit, but neuroimaging and neurophysiological investigations to test this hypothesis are scarce. This clinical trial aims to (1) assess the treatment effect of subcutaneous apomorphine infusions in patients with DOC, (2) better identify the phenotype of responders to treatment, (3) evaluate tolerance and side effects in this population, and (4) examine the neural networks underlying its modulating action on consciousness. Methods/Design: This study is a prospective double-blind randomized parallel placebo-controlled trial. Forty-eight patients diagnosed with DOC will be randomized to receive a 30-day regimen of either apomorphine hydrochloride or placebo subcutaneous infusions. Patients will be monitored at baseline 30 days before initiation of therapy, during treatment and for 30 days after treatment washout, using standardized behavioral scales (Coma Recovery Scale-Revised, Nociception Coma Scale-Revised), neurophysiological measures (electroencephalography, body temperature, actigraphy) and brain imaging (magnetic resonance imaging, positron emission tomography). Behavioral follow-up will be performed up to 2 years using structured phone interviews. Analyses will look for changes in behavioral status, circadian rhythmicity, brain metabolism, and functional connectivity at the individual level (comparing before and after treatment) and at the group level (comparing apomorphine and placebo arms, and comparing responder and non-responder groups). Discussion: This study investigates the use of apomorphine for the recovery of consciousness in the first randomized placebo-controlled double-blind trial using multimodal assessments. The results will contribute to define the role of dopamine agonists for the treatment of these challenging conditions and identify the neural correlates to their action. Results will bring objective evidence to further assess the modulation of the anterior forebrain mesocircuit by pharmacological agents, which may open new therapeutic perspectives.	[Sanz, Leandro R. D.; Lejeune, Nicolas; Blandiaux, Severine; Bonin, Estelle; Thibaut, Aurore; Laureys, Steven; Gosseries, Olivia] Univ Liege, GIGA Consciousness, Liege, Belgium; [Sanz, Leandro R. D.; Lejeune, Nicolas; Blandiaux, Severine; Bonin, Estelle; Thibaut, Aurore; Laureys, Steven; Gosseries, Olivia] Univ Hosp Liege, Coma Sci Grp, Liege, Belgium; [Lejeune, Nicolas] Grp Hosp St Luc, CHN William Lennox, Ottignies, Belgium; [Lejeune, Nicolas] UCLouvain, Inst Neurosci, Brussels, Belgium; [Thibaut, Aurore; Zafonte, Ross D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Thibaut, Aurore; Zafonte, Ross D.] Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp, 75 Francis St, Boston, MA 02115 USA; [Stender, Johan] Univ Copenhagen, Dept Neurosci, Copenhagen, Denmark; [Farber, Neal M.] NeuroHealing Pharmaceut Inc, Newton, MA USA; [Schiff, Nicholas D.] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY USA		Gosseries, O (corresponding author), Univ Hosp Liege, Coma Sci Grp, Liege, Belgium.	ogosseries@uliege.be	Sanz, Leandro R. D./AAL-6984-2021; Laureys, Steven/AAN-2097-2021; Gosseries, Olivia/AAB-6469-2020; Thibaut, Aurore/U-8101-2019; Laureys, Steven/A-3349-2011	Sanz, Leandro R. D./0000-0001-5054-2471; Laureys, Steven/0000-0002-3096-3807; Gosseries, Olivia/0000-0001-9011-7496; Lejeune, Nicolas/0000-0001-6059-606X; BONIN, Estelle/0000-0002-5120-2767	European Union's Horizon 2020 Framework Programme for Research and Innovation [785907]; Luminous project [EU-H2020-fetopenga686764]; Center-TBI project [FP7-HEALTH-602150]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [778234]	We thank the University and University Hospital of Liege, the Belgian National Funds for Scientific Research (F. R.S-.FNRS), NeuroHealing Pharmaceuticals Inc., the European Union's Horizon 2020 Framework Programme for Research and Innovation under the Specific Grant Agreement No. 785907 (Human Brain Project SGA2), the Luminous project (EU-H2020-fetopenga686764), the Center-TBI project (FP7-HEALTH-602150), the Public Utility Foundation Universite Europeenne du Travail, the Fondazione Europea di Ricerca Biomedica, the Bial Foundation, the Mind Science Foundation, the European Commission, the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 778234, the European Space Agency (ESA) and the Belgian Federal Science Policy Office (BELSPO). LS and NL are research fellows, AT is postdoctoral researcher and SL is research director at F.R.S-.FNRS. We thank Eurogenerics and Britannia Pharmaceuticals Ltd. for providing clinical trial materials. We thank in advance all the patients and their families who will be included in this study, the staff of the departments of neurology, radiology, and nuclear medicine at the University Hospital of Liege and the staff of the William Lennox Neurological Hospital for their precious collaboration.	ANDEN NE, 1967, J PHARM PHARMACOL, V19, P627, DOI 10.1111/j.2042-7158.1967.tb09604.x; Annen J, 2016, HUM BRAIN MAPP, V37, P3707, DOI 10.1002/hbm.23269; Annen J, 2018, ANN NEUROL, V83, P842, DOI 10.1002/ana.25214; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bekinschtein TA, 2009, P NATL ACAD SCI USA, V106, P1672, DOI 10.1073/pnas.0809667106; Bhidayasiri R, 2016, PARKINSONISM RELAT D, V33, pS42, DOI 10.1016/j.parkreldis.2016.11.017; Blume C, 2017, NEUROLOGY, V88, P1933, DOI 10.1212/WNL.0000000000003942; Boyle A, 2015, CNS DRUGS, V29, P83, DOI 10.1007/s40263-014-0221-z; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Chennu S, 2017, BRAIN, V140, P2120, DOI 10.1093/brain/awx163; Chudy D, 2018, J NEUROSURG, V128, P1189; Ciurleo R, 2013, DRUGS, V73, P1849, DOI 10.1007/s40265-013-0138-8; Cruse D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-18; Deleu D, 2004, DRUG AGING, V21, P687, DOI 10.2165/00002512-200421110-00001; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; Doggrell SA, 2014, EXPERT OPIN DRUG SAF, V13, P131, DOI 10.1517/14740338.2014.851193; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Engemann DA, 2018, BRAIN, V141, P3179, DOI 10.1093/brain/awy251; Estraneo A, 2017, J NEUROL SCI, V375, P464, DOI 10.1016/j.jns.2017.02.036; Fischer DB, 2016, NEUROLOGY, V87, P2427, DOI 10.1212/WNL.0000000000003404; Food and Drug Administration, 2010, FDA APPR LAB TEXT ND; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Fridman EA, 2010, BRAIN INJURY, V24, P636, DOI 10.3109/02699051003610433; Fridman EA, 2009, BRAIN INJURY, V23, P172, DOI 10.1080/02699050802649662; Gancher S, 1995, J NEURAL TRANSM-SUPP, P137; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries O, 2014, CURR PHARM DESIGN, V20, P4167; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kirsch M, 2017, ANESTH ANALG, V124, P588, DOI 10.1213/ANE.0000000000001721; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Magrassi L, 2016, J NEUROSURG, V125, P972, DOI 10.3171/2015.7.JNS15700; Martens G, 2018, BRAIN STIMUL, V11, P982, DOI 10.1016/j.brs.2018.04.021; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V15, P414, DOI 10.1080/09602010443000588; Matsumoto M, 2013, ARCH GERONTOL GERIAT, V57, P428, DOI 10.1016/j.archger.2013.05.009; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Ribaric S, 2012, MOLECULES, V17, P5289, DOI 10.3390/molecules17055289; Sattin D, 2015, INT J REHABIL RES, V38, P350, DOI 10.1097/MRR.0000000000000135; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2017, CURR OPIN NEUROL, V30, P573, DOI 10.1097/WCO.0000000000000495; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Stender J, 2016, CURR BIOL, V26, P1494, DOI 10.1016/j.cub.2016.04.024; Stender J, 2015, J CEREBR BLOOD F MET, V35, P58, DOI 10.1038/jcbfm.2014.169; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Thibaut A, 2017, BRAIN INJURY, V31, P466, DOI 10.1080/02699052.2016.1274776; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Thonnard M., 2014, FUNCTIONAL NEUROLOGY, V28, P259; Ugoya SO, 2010, CLIN NEUROPHARMACOL, V33, P279, DOI 10.1097/WNF.0b013e3182011070; van Erp WS, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2014.10.014; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Whyte J, 2008, AM J PHYS MED REHAB, V87, P85, DOI 10.1097/PHM.0b013e3181619609; Whyte J, 2014, AM J PHYS MED REHAB, V93, P101, DOI 10.1097/PHM.0000000000000069; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Zafonte RD, 2000, J HEAD TRAUMA REHAB, V15, P1179, DOI 10.1097/00001199-200010000-00014; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014	71	2	2	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 19	2019	10								248	10.3389/fneur.2019.00248			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HP5IG	WOS:000461710200002	30941094	Green Published, gold			2022-02-06	
J	Royce, TJ; Dwyer, K; Yu-Moe, CW; DeRoo, C; Jacobson, JO; Tishler, RB				Royce, Trevor J.; Dwyer, Kathy; Yu-Moe, C. Winnie; DeRoo, Courtney; Jacobson, Joseph O.; Tishler, Roy B.			Medical Malpractice Analysis in Radiation Oncology: A Decade of Results From a National Comparative Benchmarking System	INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS			English	Article							UNITED-STATES; CLAIMS; THERAPY; PATIENT	Purpose: Medical errors in radiation oncology (RO) practice have received significant national attention over the last decade. Medical errors can lead to malpractice cases. Better characterizing these events can educate providers with the goal of improving patient care. Methods and Materials: The Controlled Risk Insurance Company Strategies' Comparative Benchmarking System (CBS) represents approximately 30% of all closed US malpractice cases and includes the experience of more than 30 academic hospitals. Registered nurses trained as clinical taxonomy specialists code each case, and individual case-level details are available. Practicing radiation oncologists extracted all closed RO cases from years 2005 to 2014 and subgrouped them by patient allegation category, clinical injury severity, care setting and academic affiliation, disease site and natural history, treatment modality, and contributing factor. Within categories, chi(2) tests were used to test for the variables' association with an indemnity payment. Results: RO was the primary service in 102 closed cases (0.2% of all cases in the CBS), accounting for $13,323,578 in indemnity payments (0.1% of all payments in the CBS). The median indemnity payment was $100,000. Head-and-neck and central nervous system tumors accounted for 23.9% and 10.9% of all RO cases, respectively, and 41.3% and 31.4% of all indemnity payments, respectively. Benign diseases and brachytherapy were involved in 12.0% and 15.2% of cases, respectively. Cases involving benign disease (P = .009), treatment of the wrong site (P = .001), or treatment using the wrong dose (P < .001) were all associated with indemnity payments. The top 5 most expensive cases accounted for nearly 80% of all indemnity payments, and all involved head-and-neck, central nervous system, benign, or brachytherapy cases. Conclusions: We found that although closed malpractice cases involving RO are rare events, certain populations may be overrepresented in closed claims. These data can help inform providers and systems with the goal of ultimately improving patient safety. (C) 2018 Elsevier Inc. All rights reserved.	[Royce, Trevor J.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Royce, Trevor J.; Tishler, Roy B.] Harvard Med Sch, Harvard Radiat Oncol Program, Boston, MA USA; [Royce, Trevor J.] Univ North Carolina Chapel Hill, Dept Radiat Oncol, Chapel Hill, NC USA; [Dwyer, Kathy; Yu-Moe, C. Winnie; DeRoo, Courtney] Harvard Med Inst, CRICO Risk Management Fdn, Boston, MA USA; [Jacobson, Joseph O.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA		Royce, TJ (corresponding author), Univ North Carolina Hosp, Dept Radiat Oncol, CB 7512, Chapel Hill, NC 27514 USA.	trevor.royce@mail.harvard.edu					American College of Radiology, PRACT PAR TECHN STAN; Arnone A, 2017, SAN DIEG CA ASTRO AN; ASTRO, RO ILS ED Q DAT REP; ASTRO Workforce Subcommittee, 2017, ASTRO 2017 RAD ONC W; Berwick DM, 2003, MED CARE, V41, pI30; Bogdanich Walt, NY TIMES; Chera BS, 2015, JAMA ONCOL, V1, P958, DOI 10.1001/jamaoncol.2015.0891; CRICO, 2018, CRICO STRAT COMP BEN; Halperin EC, 2009, AM J CLIN ONCOL-CANC, V32, P432, DOI 10.1097/COC.0b013e318187dd82; Harvey HB, 2016, J AM COLL RADIOL, V13, P124, DOI 10.1016/j.jacr.2015.07.013; Huq MS, 2016, MED PHYS, V43, P4209, DOI 10.1118/1.4947547; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lutz ST, 2014, J CLIN ONCOL, V32, P2913, DOI 10.1200/JCO.2014.55.1143; Marks L, 2015, ENG PATIENT SAFETY R; Marks LB, 2015, PRACT RADIAT ONCOL, V5, P277, DOI 10.1016/j.prro.2015.07.004; Marshall D, 2017, INT J RADIAT ONCOL, V98, P21, DOI 10.1016/j.ijrobp.2017.01.022; Marshall DC, 2015, INT J RADIAT ONCOL, V93, P241, DOI 10.1016/j.ijrobp.2015.05.040; Pan HY, 2017, J AM COLL RADIOL, V14, P1027, DOI 10.1016/j.jacr.2017.02.040; Rule WG, 2016, CLIN RAD ONCOLOGY; Sowka, 1980, MALPRACTICE CLAIMS F; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Zaorsky NG, 2016, FUTURE ONCOL, V12, P2643, DOI 10.2217/fon-2016-0131	22	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0360-3016	1879-355X		INT J RADIAT ONCOL	Int. J. Radiat. Oncol. Biol. Phys.	MAR 15	2019	103	4					801	808		10.1016/j.ijrobp.2018.11.009			8	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Radiology, Nuclear Medicine & Medical Imaging	HM0RB	WOS:000459153600010	30439486				2022-02-06	
J	Kong, APH; Lau, DKY; Cheng, CYY				Kong, Anthony Pak-Hin; Lau, Dustin Kai-Yan; Cheng, Chloe Yuen-Yi			Analysing coherence of oral discourse among Cantonese speakers in Mainland China with traumatic brain injury and cerebrovascular accident	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						aphasia; traumatic brain injury (TBI); discourse coherence	NARRATIVE LANGUAGE; MULTILEVEL APPROACH; VERBAL IMPAIRMENT; HONG-KONG; APHASIA; INDIVIDUALS; SEVERITY; VALIDATION; ABILITIES; PATTERNS	Purpose: Coherence can reflect subtle language deficits in individuals with traumatic brain injury (TBI) and cerebrovascular accident (CVA). This study aimed at investigating whether global and local coherence in Cantonese-speaking adults with CVA and TBI differ from non-brain-injured (NBI) speakers. Factors contributing to the coherence ratings and impacts of elicitation tasks on coherence were examined. Method: Two clinical groups with fluent aphasia (7 CVA and 11 TBI) and 18 controls matched in age and education, who were Cantonese speakers living in China participated. Language samples of single and sequential picture description and storytelling were elicited, and subsequently analysed on global and local coherence, content sequence, and informativeness. Result: TBI speakers had impaired global and local coherence, while CVA speakers had poor global coherence. Sequence of main events produced by the three groups correlated significantly with global coherence. Attention and visuospatial skills were also significantly related to global coherence in both clinical groups. Finally, impaired language integrity was associated with problems of local coherence. Conclusion: The results were consistent with previous studies. Linguistic deficits of coherence in discourse in the two clinical groups and possible impacts of elicitation tasks on the cognitive demands and coherence ratings were discussed.	[Kong, Anthony Pak-Hin] Univ Cent Florida, Sch Commun Sci & Disorders, HPA 2 106,PO 118 58 Box 162215, Orlando, FL 32816 USA; [Lau, Dustin Kai-Yan; Cheng, Chloe Yuen-Yi] Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Hong Kong, Peoples R China		Kong, APH (corresponding author), Univ Cent Florida, Sch Commun Sci & Disorders, HPA 2 106,PO 118 58 Box 162215, Orlando, FL 32816 USA.	antkong@ucf.edu	Kong, Anthony Pak Hin/AAE-9449-2021	Kong, Anthony Pak Hin/0000-0002-6211-0358; Lau, Dustin Kai-Yan/0000-0002-7088-7511	2016 Departmental General Research Funds - Research Office of The Polytechnic University of Hong Kong [4-ZZFP]	This study was supported by The 2016 Departmental General Research Funds sponsored by the Research Office of The Polytechnic University of Hong Kong (project code 4-ZZFP) to Dustin Kai-Yan Lau (PI) and Anthony Pak-Hin Kong (Co-I).	Andreetta S, 2015, APHASIOLOGY, V29, P705, DOI 10.1080/02687038.2014.979394; Andreetta S, 2012, NEUROPSYCHOLOGIA, V50, P1787, DOI 10.1016/j.neuropsychologia.2012.04.003; Barker MS, 2017, BRAIN LANG, V168, P23, DOI 10.1016/j.bandl.2017.01.004; Bliss L. S., 2008, IMAGINATION COGNITIO, V28, P137, DOI DOI 10.2190/IC.28.2.c; Booth S, 1999, APHASIOLOGY, V13, P283, DOI 10.1080/026870399402109; Capilouto GJ, 2006, APHASIOLOGY, V20, P205, DOI 10.1080/02687030500473122; Carlomagno S., 2008, 46 ANN M AC APH TURK; Chow W., 2016, FRONTIERS PSYCHOL C, DOI [10.3389/conf.fpsyg.2016.68.00018, DOI 10.3389/CONF.FPSYG.2016.68.00018]; CHRISTIANSEN JA, 1995, BRAIN LANG, V51, P291, DOI 10.1006/brln.1995.1062; Coelho C, 2003, APHASIOLOGY, V17, P173, DOI 10.1080/729255216; Frankel T, 2007, APHASIOLOGY, V21, P814, DOI 10.1080/02687030701192448; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Graham D, 2007, APHASIA THERAPY FILE, V2, P59; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Hilger A, 2014, APHASIOLOGY, V28, P840, DOI 10.1080/02687038.2014.895974; Hinchliffe F. J, 2001, TRAUMATIC BRAIN INJU, P223; Holland A., 1977, RATIONALE ADULT APHA, P167; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Huber W., 1990, DISCOURSE ABILITY BR, P154; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; Kong, 2016, ANAL NEUROGENIC DISO; Kong A.P.H., 2016, MAIN CONCEPT ANAL MC; Kong APH, 2010, PROCD SOC BEHV, V6, P57, DOI 10.1016/j.sbspro.2010.08.029; Kong APH, 2019, APHASIOLOGY, V33, P216, DOI 10.1080/02687038.2018.1463085; Kong APH, 2018, AM J SPEECH-LANG PAT, V27, P1491, DOI 10.1044/2018_AJSLP-18-0015; Kong APH, 2018, INT J SPEECH-LANG PA, V20, P406, DOI 10.1080/17549507.2017.1293158; Kong APH, 2019, BEHAV RES METHODS, V51, P1131, DOI 10.3758/s13428-018-1043-6; Kong APH, 2016, LOGOP PHONIATR VOCO, V41, P129, DOI 10.3109/14015439.2015.1041551; Kong APH, 2015, J COMMUN DISORD, V56, P88, DOI 10.1016/j.jcomdis.2015.06.007; Kong APH, 2011, J SPEECH LANG HEAR R, V54, P148, DOI 10.1044/1092-4388(2010/09-0240); Kong APH, 2009, J COMMUN DISORD, V42, P442, DOI 10.1016/j.jcomdis.2009.06.002; Kong APH, 2009, CLIN LINGUIST PHONET, V23, P255, DOI 10.1080/02699200802673234; Law SP, 2015, APHASIOLOGY, V29, P81, DOI 10.1080/02687038.2014.951598; Le K., 2011, ASHA LEADER, V16, P18, DOI [10.1044/leader.FTR4.16022011.18, DOI 10.1044/LEADER.FTR4.16022011.18, DOI 10.1044/leader.FTR4.16022011.18]; Lee T, 2013, PROCD SOC BEHV, V94, P71, DOI 10.1016/j.sbspro.2013.09.032; Li JL, 2015, LANCET, V386, P49, DOI 10.1016/S0140-6736(15)00630-3; Linden MA, 2005, BRAIN INJURY, V19, P1011, DOI 10.1080/02699050500110314; Lindsey A, 2019, AM J SPEECH-LANG PAT, V28, P330, DOI 10.1044/2018_AJSLP-17-0151; *LING SOC HONG KON, 1994, LSHK CANT ROM SCHEM; Liu BY, 2015, CHIN J TRAUMATOL, V18, P135, DOI 10.1016/j.cjtee.2015.04.002; LUZZATTI C, 1989, APHASIOLOGY, V3, P643, DOI 10.1080/02687038908249030; Marini A, 2011, APHASIOLOGY, V25, P1372, DOI 10.1080/02687038.2011.584690; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2012, J COGNITIVE NEUROSCI, V24, P2211, DOI 10.1162/jocn_a_00283; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; McCabe A., 2003, PATTERNS NARRATIVE D, P171; Miao Y., 2016, 2016 CHIN INT C EL D, P1, DOI [DOI 10.1093/acrefore/9780190228613.013.162, DOI 10.1109/CICED.2016.7576095]; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; Neuling I, 1999, DIFFERENCES COMMUNIC; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Olness GS, 2011, APHASIOLOGY, V25, P713, DOI 10.1080/02687038.2010.537346; Olness GS, 2006, APHASIOLOGY, V20, P175, DOI 10.1080/02687030500472710; Rogalski Y, 2010, J COMMUN DISORD, V43, P212, DOI 10.1016/j.jcomdis.2010.02.001; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Scott C.M., 1988, LATER LANGUAGE DEV A, P27; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; ULATOWSKA H, 1990, SPR S NEUR, P180; Ulatowska HK, 2013, TOP STROKE REHABIL, V20, P36, DOI 10.1310/tsr2001-36; Van Dijk TeunA., 1980, MACROSTRUCTURES INTE; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; Weinrich M, 2002, NEUROREHAB NEURAL RE, V16, P249, DOI 10.1177/154596802401105199; Wright HH, 2012, APHASIOLOGY, V26, P656, DOI 10.1080/02687038.2012.676855; YIU EML, 1992, J NEUROLINGUIST, V7, P379, DOI 10.1016/0911-6044(92)90025-R; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745; Yu JH, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/274326	66	2	2	2	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	JAN 2	2020	22	1					37	47		10.1080/17549507.2019.1581256		MAR 2019	11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	LE0OE	WOS:000463565200001	30897971				2022-02-06	
J	Algin, A; Gulacti, U; Erdogan, MO; Tayfur, I; Yusufoglu, K; Lok, U				Algin, Abdullah; Gulacti, Umut; Erdogan, Mehmet Ozgur; Tayfur, Ismail; Yusufoglu, Kaan; Lok, Ugur			Escalator-related injuries in one of the deepest subway stations in Europe	ANNALS OF SAUDI MEDICINE			English	Article							UNITED-STATES; TRAUMA; SEVERITY; OBESITY; FALLS; RISK	BACKGROUND: Escalator-related injuries (ERI) have emerged as a new injury type due to the frequent use of escalators in Metro stations. OBJECTIVES: Investigate ERI in the stations on the Marmaray metro line. DESIGN: Retrospective, observational study. SETTING: Patients admitted to the emergency department of a training and research hospital. PATIENTS AND METHODS: All patients with ERI were included in the study. We analyzed demographic characteristics, injury type and anatomical location of injury, Glasgow coma score, and body mass index (BMI). Patients were grouped by BMI: underweight (BMI<18.5 kg/m(2)), normal weight (BMI=18.5-24.9 kg/m(2)), overweight (BMI=25-29.9 kg/m(2)) and obese (BMI >= 30kg/m(2)). MAIN OUTCOME MEASURES: Injury characteristics and BMI values of patients with ERI. SAMPLE SIZE: 82 patients. RESULTS: The mean age was 45.1 (15.5) years (range:14-77 years). Forty-two were women (52.5%). The mean BMI was 26.7 (2.2) kg/m(2)(range: 22.1-33.3 kg/m(2))]. Most of the patients who were injured due to escalators were older than 50 years (n=39, 47.6%) and 77.5% (n=62) of all patients were overweight. There was a significant relationship between increased BMI and serious ERI (P=.010, OR: 1.85, 95% C.I: 1.13-2.65). The most frequent mechanism of injuries was a fall (97.6%). The majority of injuries were the head (42%) and extremity injuries (33%). The major type of ERI was soft tissue injuries (41.3%), followed by lacerations (20.7%), closed head injuries (18.5%), fractures (15.2%) and serious injuries (4.4%). Serious injuries were more prevalent in patients aged older than 50 years (P<.05), and in overweight and obese individuals (P<.001) CONCLUSION: Novel protective measures against ERI should be developed for crowded subway stations. LIMITATIONS: The small sample size and retrospective nature.	[Algin, Abdullah; Gulacti, Umut; Lok, Ugur] Adiyaman Univ, Training & Res Hosp, Med Fac, Dept Emergency Med, TR-02000 Adiyaman, Turkey; [Erdogan, Mehmet Ozgur] Bahcesehir Univ, Fac Hlth Sci, Dept Emergency Med, Istanbul, Turkey; [Tayfur, Ismail; Yusufoglu, Kaan] Haydarpasa Numune Training & Res Hosp, Fac Hlth Sci, Emergency Dept, Istanbul, Turkey		Gulacti, U (corresponding author), Adiyaman Univ, Training & Res Hosp, Med Fac, Dept Emergency Med, TR-02000 Adiyaman, Turkey.	umutgu-lacti@gmail.com	Erdogan, Mehmet Ozgur/N-5852-2017; Algin, Abdullah/AAB-5013-2020	Erdogan, Mehmet Ozgur/0000-0001-7325-6646; Gulacti, Umut/0000-0003-2151-7212; TAYFUR, Ismail/0000-0002-4852-7915			Aktas Nurettin, 2018, Bull Emerg Trauma, V6, P64, DOI 10.29252/beat-060110; Chia CF, 2006, ACCIDENT ANAL PREV, V38, P662, DOI 10.1016/j.aap.2005.12.010; Dhanasekaran R., 2016, GRD J ENG, V12; Diaz JJ, 2009, J TRAUMA, V66, P226, DOI 10.1097/TA.0b013e31815eb776; Durgun HM, 2016, ULUS TRAVMA ACIL CER, V22, P457, DOI 10.5505/tjtes.2016.93385; Howland J, 2012, J SAFETY RES, V43, P133, DOI 10.1016/j.jsr.2012.02.001; Lim KBL, 2010, J PEDIATR ORTHOPED, V30, P414, DOI 10.1097/BPO.0b013e3181df1546; Lykke S, 2005, TUNN UNDERGR SP TECH, V20, P600, DOI 10.1016/j.tust.2005.08.004; Maheshwari R, 2009, J ORTHOP TRAUMA, V23, P634, DOI 10.1097/BOT.0b013e3181a7f06c; McGeehan J, 2006, PEDIATRICS, V118, pE279, DOI 10.1542/peds.2005-1822; O'Neil J, 2008, ACCIDENT ANAL PREV, V40, P527, DOI 10.1016/j.aap.2007.08.008; Platt SL, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.2.e2; Ryb GE, 2008, J TRAUMA, V64, P406, DOI 10.1097/TA.0b013e31802beff9; Schminke LH, 2013, WEST J EMERG MED, V14, P141, DOI 10.5811/westjem.2012.12.13346; Woolley SM, 1997, J GERONTOL A-BIOL, V52, pM80, DOI 10.1093/gerona/52A.2.M80; Xiang H, 2005, AM J PREV MED, V29, P41, DOI 10.1016/j.amepre.2005.03.013; Xing YY, 2019, ACCIDENT ANAL PREV, V122, P332, DOI 10.1016/j.aap.2017.10.007	17	2	2	1	2	K FAISAL SPEC HOSP RES CENTRE	RIYADH	PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA	0256-4947	1319-9226		ANN SAUDI MED	Ann. Saudi Med.	MAR-APR	2019	39	2					112	117		10.5144/0256-4947.2019.112			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HR7KZ	WOS:000463334200008	30955019	Green Published, gold			2022-02-06	
J	Astafiev, SV; Wen, J; Brody, DL; Cross, AH; Anokhin, AP; Zinn, KL; Corbetta, M; Yablonskiy, DA				Astafiev, Serguei V.; Wen, Jie; Brody, David L.; Cross, Anne H.; Anokhin, Andrey P.; Zinn, Kristina L.; Corbetta, Maurizio; Yablonskiy, Dmitriy A.			A Novel Gradient Echo Plural Contrast Imaging Method Detects Brain Tissue Abnormalities in Patients With TBI Without Evident Anatomical Changes on Clinical MRI: A Pilot Study	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences System Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			Traumatic Brain Injury; gray matter; MRI	MAGNETIC-SUSCEPTIBILITY; INJURY; T2-ASTERISK; CONCUSSION; DISORDER; CORTEX; MODEL	Research objectives It is widely accepted that mild traumatic brain injury (mTBI) causes injury to the white matter, but the extent of gray matter (GM) damage in mTBI is less clear. Methods We tested 26 civilian healthy controls and 14 civilian adult subacute-chronic mTBI patients using quantitative features of MRI-based Gradient Echo Plural Contrast Imaging (GEPCI) technique. GEPCI data were reconstructed using previously developed algorithms allowing the separation of R2t*, a cellular-specific part of gradient echo MRI relaxation rate constant, from global R2* affected by BOLD effect and background gradients. Results Single-subject voxel-wise analysis (comparing each mTBI patient to the sample of 26 control subjects) revealed GM abnormalities that were not visible on standard MRI images (T1w and T2w). Analysis of spatial overlap for voxels with low R2t* revealed tissue abnormalities in multiple GM regions, especially in the frontal and temporal regions, that are frequently damaged after mTBI. The left posterior insula was the region with abnormalities found in the highest proportion (50%) of mTBI patients. Conclusions Our data suggest that GEPCI quantitative R2t* metric has potential to detect abnormalities in GM cellular integrity in individual TBI patients, including abnormalities that are not detectable by a standard clinical MRI.	[Astafiev, Serguei V.; Wen, Jie; Yablonskiy, Dmitriy A.] Washington Univ, Dept Radiol, 660 S Euclid Ave,Campus Box 8225, St Louis, MO 63110 USA; [Astafiev, Serguei V.; Anokhin, Andrey P.] Washington Univ, Dept Psychiat, 660 S Euclid Ave,Campus Box 8134, St Louis, MO 63110 USA; [Cross, Anne H.; Zinn, Kristina L.; Corbetta, Maurizio] Washington Univ, Dept Neurol, 660 S Euclid Ave,Campus Box 8111, St Louis, MO 63110 USA; [Brody, David L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Corbetta, Maurizio] Univ Padua, Dept Neurosci, Palazzina Neurosci,Via Giustiniani 2, I-35128 Padua, Italy; [Corbetta, Maurizio] Univ Padua, PNC, Palazzina Neurosci,Via Giustiniani 2, I-35128 Padua, Italy		Astafiev, SV (corresponding author), Washington Univ, Dept Radiol, 660 S Euclid Ave,Campus Box 8225, St Louis, MO 63110 USA.		Corbetta, Maurizio/AAZ-5219-2020; Yablonskiy, Dmitriy/N-7252-2017	CORBETTA, MAURIZIO/0000-0001-8295-3304; Astafiev, Serguei/0000-0003-3736-7095; Anokhin, Andrey/0000-0001-8158-6346; Yablonskiy, Dmitriy/0000-0003-2898-8797	James S. McDonnell Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS095741, R01HD083614, R21DA038834, R01AG054513]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG 4463A18]; Mallinckrodt Institute of Radiology (MIR) Facilities Pilot Study Fund [MIR 14-021]; Office of the Secretary of Defense for Health Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD083614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG054513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA038834] Funding Source: NIH RePORTER	This work was supported by James S. McDonnell Foundation (grant for the Attention Dynamics Consortium in Traumatic Brain Injury), National Institutes of Health (award numbers: R01NS095741, R01HD083614, R21DA038834, R01AG054513) and National Multiple Sclerosis Society (grant RG 4463A18). Scanning services were partially supported by the Mallinckrodt Institute of Radiology (MIR) Facilities Pilot Study Fund (award MIR 14-021). This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Chang DJ, 2002, EPILEPSIA, V43, P68, DOI 10.1046/j.1528-1157.2002.21601.x; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; Corbetta M, 2015, NEURON, V85, P927, DOI 10.1016/j.neuron.2015.02.027; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; de Pasquale F, 2018, NEUROIMAGE, V180, P370, DOI 10.1016/j.neuroimage.2017.09.063; Dickson JD, 2011, J MAGN RESON, V212, P17, DOI 10.1016/j.jmr.2011.06.003; Faul M, 2010, TRAUMATIC BRAIN INJU; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gennarelli TA, 2014, PROG NEUROL SURG, V28, P243, DOI 10.1159/000358788; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; He X, 2008, MAGN RESON MED, V60, P882, DOI 10.1002/mrm.21719; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kriegel J, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024059; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Luo J, 2014, MULT SCLER J, V20, P349, DOI 10.1177/1352458513495935; Luo J, 2012, NEUROIMAGE, V60, P1073, DOI 10.1016/j.neuroimage.2012.01.108; Mamah D, 2015, SCHIZOPHR RES, V169, P36, DOI 10.1016/j.schres.2015.10.004; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Patel KR, 2015, MULT SCLER J EXP TRA, V1, p2055217315606465, DOI 10.1177/2F2055217315606465; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Quirk JD, 2009, J MAGN RESON, V198, P49, DOI 10.1016/j.jmr.2009.01.001; Rowland DJ, 2005, NUCL MED BIOL, V32, P567, DOI 10.1016/j.nucmedbio.2005.05.002; Sati P, 2010, NEUROIMAGE, V51, P1089, DOI 10.1016/j.neuroimage.2010.03.045; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; Ulrich X, 2016, MAGN RESON MED, V75, P606, DOI 10.1002/mrm.25610; Wang XQ, 2013, MAGN RESON MED, V69, P1034, DOI 10.1002/mrm.24338; Wen J, 2018, P NATL ACAD SCI USA, V115, pE9727, DOI 10.1073/pnas.1808121115; Wen J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187915; Wen J, 2015, NEUROIMAGE-CLIN, V9, P164, DOI 10.1016/j.nicl.2015.08.003; Wen J, 2015, MAGN RESON MED, V73, P195, DOI 10.1002/mrm.25114; Widerstrom-Noga E, 2016, J NEUROTRAUM, V33, P1380, DOI 10.1089/neu.2015.4098; Wolf EJ, 2016, BIOL PSYCHIAT, V80, P363, DOI 10.1016/j.biopsych.2015.11.023; Yablonskiy DA, 1998, MAGNET RESON MED, V39, P417, DOI 10.1002/mrm.1910390312; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Yablonskiy DA, 2013, MAGN RESON MED, V70, P1283, DOI 10.1002/mrm.24585; Yablonskiy DA, 2012, P NATL ACAD SCI USA, V109, P14212, DOI 10.1073/pnas.1206037109; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhao Y, 2017, NEUROIMAGE, V148, P296, DOI 10.1016/j.neuroimage.2016.12.026; Zhao Y, 2016, NEUROIMAGE, V133, P417, DOI 10.1016/j.neuroimage.2016.03.022	54	2	2	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			218	227		10.1093/milmed/usy394			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100033	30901451	Green Published, Bronze			2022-02-06	
J	Ataizi, S; Ozkoc, M; Kanbak, G; Karimkhani, H; Donmez, DB; Ustunisik, N; Ozturk, B				Ataizi, Serdar; Ozkoc, Mete; Kanbak, Gungor; Karimkhani, Hadi; Donmez, Dilek Burukoglu; Ustunisik, Novber; Ozturk, Buket			A possible protective role of betain and omega-3 supplementation in traumatic brain injury	ANNALI ITALIANI DI CHIRURGIA			English	Article						Betain; Caspase-3; Cytochrome C and Neuron-specific enolase; Omega-3; Traumatic brain injury	NEURON-SPECIFIC-ENOLASE; EICOSAPENTAENOIC ACID; CEREBRAL VASOSPASM; CASPASE INHIBITORS; OXIDATIVE STRESS; PROTEIN; OMEGA-3-FATTY-ACIDS; PATHOPHYSIOLOGY; INFLAMMATION; APOPTOSIS	INTRODUCTION: Due to irreversible damage following head trauma, many overlapping pathophysiological events occur including excitotoxicity, acidotoxicity, ionic imbalance, edema, oxidative stress inflammation and apoptosis. MATERIAL AND METHODS: In this this study, after the rats were separated in to groups theserats were fed throughout fourteen days with betaine, omega-3 or betaine+omega-3 combination in physiological limits prior to the trauma. After a closed head trauma, the damaged brain tissues were collected for biochemically and histologically analyses. This examination involved analyses of levels of caspase-3 and cytochrome C and neuron-specific enolase (NSE) levels in brain tissue. RESULTS: These analyses showed that traumatic brain injury (TBI) caused an increase in the levels of caspase-3, cytochrome C and neuron-specific enolase (NED) in the brain tissues examined. DISCUSSION: In this study, apoptotic and/or necrotic cell death via mitochondrial cytochrome C caspase pathway in traumatized cells and neuron-specific enolase (NED) increase indicative of neuronal damage confirmed the research hypothesis. CONCLUSION: Level of the biomarkers induced by brain injury in the groups fed with betaine, omega-3 and betaine+omega-3 combination before the traumatic damage approximated to that of control group values, suggesting that these products may have a neuroprotective role.	[Ataizi, Serdar] Yunusemre State Hosp, Dept Neurosurg, Eskisehir, Turkey; [Ozkoc, Mete; Kanbak, Gungor; Ustunisik, Novber] Osmangazi Univ, Grad Sch Hlth Sci, Med Biochem, Eskisehir, Turkey; [Karimkhani, Hadi] Medipol Univ, Grad Sch Hlth Sci, Med Biochem, Istanbul, Turkey; [Donmez, Dilek Burukoglu] Osmangazi Univ, Grad Sch Hlth Sci, Med Histol & Embryol, Eskisehir, Turkey; [Ozturk, Buket] Osmangazi Univ, Fac Arts & Sci, Dept Biol, Eskisehir, Turkey		Ataizi, S (corresponding author), Yunusemre State Hosp, Dept Neurosurg, Eskisehir, Turkey.	sataizi@gmail.com	karimkhani, Hadi/D-6792-2018	karimkhani, Hadi/0000-0002-4966-1745			Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Campbell F, 2013, EUR J PREV CARDIOL, V20, P107, DOI 10.1177/2047487312437056; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; Dyall SC, 2008, NEUROMOL MED, V10, P219, DOI 10.1007/s12017-008-8036-z; El-Ansary AK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-142; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Ganesan B, 2009, CELL STRESS CHAPERON, V14, P661, DOI 10.1007/s12192-009-0111-3; Haar CV, 2016, BRAIN RES, V1640, P114, DOI 10.1016/j.brainres.2015.12.030; Horio M, 2001, NEPHROL DIAL TRANSPL, V16, P483, DOI 10.1093/ndt/16.3.483; Kacira T, 2007, NEUROSURGERY, V60, P674, DOI 10.1227/01.NEU.0000255394.77538.BB; Kim SK, 1998, FOOD CHEM TOXICOL, V36, P655, DOI 10.1016/S0278-6915(98)00024-6; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin DSD, 2002, J BIOL CHEM, V277, P34239, DOI 10.1074/jbc.M205289200; Meguro T, 2001, STROKE, V32, P561, DOI 10.1161/01.STR.32.2.561; Mishina M, 2013, ACTA NEUROL SCAND, V127, P181, DOI 10.1111/j.1600-0404.2012.01695.x; Munoz-Cespedes JM, 2001, REV NEUROLOGIA, V32, P351, DOI 10.33588/rn.3204.2000456; Naeimi ZS, 2006, BRAIN INJURY, V20, P463, DOI 10.1080/02699050600664418; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ol KK, 2016, CHILD NERV SYST, V32, P467, DOI 10.1007/s00381-015-2990-1; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Sinclair AJ, 2007, ASIA PAC J CLIN NUTR, V16, P391; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Stelmasiak Z, 2000, Med Sci Monit, V6, P426; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tomioka M, 2002, MOL BRAIN RES, V108, P18, DOI 10.1016/S0169-328X(02)00486-2; Wu BTF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043448; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649; Yang SJ, 2017, NEUROTOX RES, V32, P107, DOI 10.1007/s12640-017-9717-x; Yin J, 2016, INT J BIOCHEM CELL B, V75, P11, DOI 10.1016/j.biocel.2016.03.008; Yoneda H, 2008, ACTA NEUROL SCAND, V118, P54, DOI 10.1111/j.1600-0404.2007.00983.x; Yoneda H, 2014, WORLD NEUROSURG, V81, P309, DOI 10.1016/j.wneu.2012.09.020; Zhang F, 1996, FEBS LETT, V391, P293, DOI 10.1016/0014-5793(96)00754-5; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13; Zubkov AY, 2002, LIFE SCI, V70, P3007, DOI 10.1016/S0024-3205(02)01550-3	45	2	2	0	6	EDIZIONI LUIGI POZZI	ROME	VIA PANAMA 68, 00198 ROME, ITALY	0003-469X	2239-253X		ANN ITAL CHIR	Ann. Ital. Chir.	MAR-APR	2019	90	2					174	181	PII S0003469X19029300				8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	IC7FU	WOS:000471139700013	31182701				2022-02-06	
J	Bartley, CN; Atwell, K; Cairns, B; Charles, A				Bartley, Colleen N.; Atwell, Kenisha; Cairns, Bruce; Charles, Anthony			Racial and Ethnic Disparities in Discharge to Rehabilitation Following Burn Injury	JOURNAL OF BURN CARE & RESEARCH			English	Article							INSURANCE STATUS DISPARITIES; TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; POSTHOSPITALIZATION CARE; FUNCTIONAL OUTCOMES; HEALTH	Racial and ethnic disparities in access to inpatient rehabilitation have been previously described for various injury groups; however, no studies have evaluated whether such disparities exist among burn patients. Their aim was to determine if racial disparities in discharge destination (inpatient rehabilitation, skilled nursing facility, home with home health, or home) following burn injury existed in this single-institution study. A retrospective analysis of all adult burn patients admitted to UNC Jaycee Burn Center from 2002 to 2012 was conducted. Patient characteristics included age, gender, burn mechanism, insurance status, percentage total body surface area (%TBSA) burned, presence of inhalation injury, and hospital length of stay. Patients were categorized into one of three mutually exclusive racial or ethnic groups: White, Hispanic, or Black. Propensity score weighting followed by ordered logistic regression was performed in the analytical sample and in a subgroup analysis of patients with severe burns (TBSA > 20%). For analysis, 4198 patients were included: 2661 White, 340 Hispanic, and 1197 Black. Propensity weighting resulted in covariate balance among racial groups. Black patients (OR: 1.58, 95% CI: 1.23-2.03; P < .001) were more likely than Whites to be discharged to a higher level of rehabilitation, whereas Hispanics were less likely (OR: 0.78, 95% CI: 0.38-1.58; P = .448). In their subgroup analysis, Black (OR: 1.88, 95% CI: 1.07-3.28; P = .026) and Hispanic (OR: 1.53, 95% CI: 0.31-7.51; P = .603) patients were more likely to discharge to a higher level of rehabilitation than White patients. Racial and ethnic disparities in discharge destination to a higher level of rehabilitative services among burn-injured patients exist particularly for Hispanic patients but not for Black or White burn patient groups. Further studies are needed to elucidate the potential sources of these disparities specifically for Hispanic patients.	[Bartley, Colleen N.; Atwell, Kenisha; Cairns, Bruce; Charles, Anthony] Univ N Carolina, North Carolina Jaycee Burn Ctr, Dept Surg, Chapel Hill, NC 27515 USA		Charles, A (corresponding author), UNC Sch Med, 4008 Burnett Womack Bldg,CB 7228, Chapel Hill, NC 27599 USA.	anthchar@med.unc.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32GM008450-23]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008450] Funding Source: NIH RePORTER	This work was supported by the National Institute of Health under award number 5T32GM008450-23.	American Burn Association, 2016, FACT SHEET; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; Fauerbach JA, 2001, J BURN CARE REHABIL, V22, P26, DOI 10.1097/00004630-200101000-00007; Goverman J, 2017, J BURN CARE RES, V38, pE328, DOI 10.1097/BCR.0000000000000380; Greene NH, 2015, J BURN CARE RES, V36, P613, DOI 10.1097/BCR.0000000000000200; Kane WG, 2014, J HEAD TRAUMA REHAB, V29, pE10, DOI 10.1097/HTR.0000000000000028; Klein MB, 2014, ANN SURG, V259, P833, DOI 10.1097/SLA.0000000000000438; Klein MB, 2011, J BURN CARE RES, V32, P66, DOI 10.1097/BCR.0b013e318203336a; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Nelson A, 2002, J NATL MED ASSOC, V94, P666; Sacks GD, 2011, J TRAUMA, V71, P1011, DOI 10.1097/TA.0b013e3182092c27; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Skolarus LE, 2017, STROKE, V48, P3329, DOI 10.1161/STROKEAHA.117.017290; Sliwa JA, 2005, ARCH PHYS MED REHAB, V86, P1920, DOI 10.1016/j.apmr.2005.04.024; Spires MC, 2005, J BURN CARE REHABIL, V26, P532, DOI 10.1097/01.bcr.0000185397.39029.0a	20	2	2	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1559-047X	1559-0488		J BURN CARE RES	J. Burn Care Res.	MAR-APR	2019	40	2					143	147		10.1093/jbcr/irz001			5	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	JD9RE	WOS:000490325100001	30698732	Green Published, Green Submitted			2022-02-06	
J	Begonia, M; Rooks, T; Pintar, FA; Yoganandan, N				Begonia, Mark; Rooks, Tyler; Pintar, Frank A.; Yoganandan, Narayan			Development of a Methodology for Simulating Complex Head Impacts With the Advanced Combat Helmet	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences System Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			Advanced Combat Helmet; NOCSAE; Hybrid III; EuroSID-2; CSDM	TRAUMATIC BRAIN-INJURY; ANGULAR ACCELERATIONS; BALLISTIC IMPACT; HYBRID III; MILITARY; BLAST; DEVICE; MODEL; SIMON; RISK	Blunt impact assessment of the Advanced Combat Helmet (ACH) is currently based on the linear head response. The current study presents a methodology for testing the ACH under complex loading that generates linear and rotational head motion. Experiments were performed on a guided, free-fall drop tower using an instrumented National Operating Committee for Standards on Athletic Equipment (NOCSAE) head attached to a Hybrid III (HIII) or EuroSID-2 (ES-2) dummy neck and carriage. Rear and lateral impacts occurred at 3.0 m/s with peak linear accelerations (PLA) and peak rotational accelerations (PRA) measured at the NOCSAE head center-of-gravity. Experimental data served as inputs for the Simulated Injury Monitor (SIMon) computational model to estimate brain strain. Rear ACH impacts had 22% and 7% higher PLA and PRA when using the HIII neck versus the ES-2 neck. Lateral ACH impacts had 33% and 35% lower PLA and PRA when using HIII neck versus the ES-2 neck. Computational results showed that total estimated brain strain increased by 25% and 76% under rear and lateral ACH impacts when using the ES-2 neck. This methodology was developed to simulate complex ACH impacts involving the rotational head motion associated with diffuse brain injuries, including concussion, in military environments.	[Begonia, Mark; Pintar, Frank A.; Yoganandan, Narayan] Med Coll Wisconsin, Dept Neurosurg, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA; [Begonia, Mark; Pintar, Frank A.; Yoganandan, Narayan] Zablocki VA Med Ctr, Neurosci Res Labs, 5000 West Natl Ave, Milwaukee, WI 53295 USA; [Rooks, Tyler] US Army Aeromed Res Lab, Injury Biomech Div, 6901 Farrel Rd, Ft Rucker, AL 36362 USA		Begonia, M (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.; Begonia, M (corresponding author), Zablocki VA Med Ctr, Neurosci Res Labs, 5000 West Natl Ave, Milwaukee, WI 53295 USA.				U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-16-1-0010]; Office of the Secretary of Defense for Health Affairs	This work was supported by the U.S. Army Medical Research and Materiel Command under Contract Number W81XWH-16-1-0010. This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	Bartsch A, 2012, ACCIDENT ANAL PREV, V48, P285, DOI 10.1016/j.aap.2012.01.032; Begonia M., 2017, BIOMED SCI INSTRUM, V53, P165; Bilisik AK, 2009, TEXT RES J, V79, P1331, DOI 10.1177/0040517509104275; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Committee on Review of Test Protocols Used by the DoD to Test Combat Helmets and Board on Army Science and Technology, 2014, REV DEP DEF TEST PRO; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; Department of the Army, 2007, COPD0504 DEP ARM PRO; Department of Transportation, 2006, 218 DEP TRANSP; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fang MR, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00044; Gordon C, 2012, 2012 ANTHROPOMETRIC; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Hopping J., 2010, P PERS ARM SYST S QU, P1; Humm John, 2012, Biomed Sci Instrum, V48, P187; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Knapik JJ, 2011, AVIAT SPACE ENVIR MD, V82, P797, DOI 10.3357/ASEM.3061.2011; Knowles BM, 2017, ANN BIOMED ENG, V45, P2146, DOI 10.1007/s10439-017-1848-y; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Li XG, 2016, INT J IMPACT ENG, V91, P56, DOI 10.1016/j.ijimpeng.2015.12.010; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Ng LJ, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00269; Rooks T, 2018, MIL MED, V183, P294, DOI 10.1093/milmed/usx208; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Society of Automotive Engineers, 1995, 1995J211 SAE; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tham CY, 2008, INT J IMPACT ENG, V35, P304, DOI 10.1016/j.ijimpeng.2007.03.008; Vasquez KB, 2011, P ASME INT MECH ENG, P1; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Yoganandan N, 2006, J BIOMECH, V39, P1347, DOI 10.1016/j.jbiomech.2005.03.016; Yoganandan N, 2015, J BIOMECH, V48, P3534, DOI 10.1016/j.jbiomech.2015.06.008; Yoganandan N, 2009, TRAFFIC INJ PREV, V10, P51, DOI 10.1080/15389580802524876; Yoganandan N, 2009, J TRAUMA, V66, P309, DOI 10.1097/TA.0b013e3181692104; Zhao W, 2018, J NEUROTRAUM, V35, P1	42	2	2	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			237	244		10.1093/milmed/usy282			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100035	30901450	hybrid			2022-02-06	
J	Gupta, A; Sikka, K; Irugu, DVK; Verma, H; Bhalla, AS; Thakar, A				Gupta, A.; Sikka, K.; Irugu, D. V. K.; Verma, H.; Bhalla, A. S.; Thakar, A.			Temporal bone meningoencephaloceles and cerebrospinal fluid leaks: experience in a tertiary care hospital	JOURNAL OF LARYNGOLOGY AND OTOLOGY			English	Article; Proceedings Paper	Indian-Society-of-Otology Conference	NOV 20, 2017	Raipur, INDIA	Indian Soc Otol		Temporal Bone; Encephalocele; Cerebrospinal Fluid Otorrhea; Cerebrospinal Fluid Rhinorrhea; Meningitis; Cranial Fossa, Middle; Otitis Media; Cholesteatoma, Middle Ear; Mastoid; Ear, Middle	CHRONIC OTITIS-MEDIA; BRAIN HERNIATION; MIDDLE-EAR; CSF OTORRHEA; MANAGEMENT; DIAGNOSIS; ENCEPHALOCELE; DEFECTS; TEGMEN	Objective. To recount experience with cerebrospinal fluid otorrhoea and temporal bone meningoencephalocele repair in a tertiary care hospital. Method. A retrospective review was conducted of 16 cerebrospinal fluid otorrhoea and meningoencephalic herniation patients managed surgically from 1991 to 2016. Results. Aetiology was: congenital (n = 3), post-traumatic (n = 2), spontaneous (n = 1) or post-mastoidectomy (n = 10). Surgical repair was undertaken by combined middle cranial fossa and transmastoid approach in 3 patients, transmastoid approach in 2, oval window plugging in 1, and subtotal petrosectomy with middle-ear obliteration in 10. All patients had successful long-term outcomes, except one, who experienced recurrence after primary stage oval window plugging, but has been recurrence-free after second-stage subtotal petrosectomy with middle-ear obliteration. Conclusion. Dural injury or exposure in mastoidectomy may lead to cerebrospinal fluid otorrhoea or meningoencephalic herniation years later. Congenital, spontaneous and traumatic temporal bone defects may present similarly. Middle cranial fossa dural repair, transmastoid multilayer closure and subtotal petrosectomy with middle-ear obliteration were successful procedures. Subtotal petrosectomy with middle-ear obliteration offers advantages over middle cranial fossa dural repair alone; soft tissue closure is more robust and is preferred in situations where hearing preservation is not a priority.	[Gupta, A.; Sikka, K.; Irugu, D. V. K.; Verma, H.; Thakar, A.] All India Inst Med Sci, Dept Otolaryngol & Head Neck Surg, New Delhi 110029, India; [Bhalla, A. S.] All India Inst Med Sci, Dept Radiodiag, New Delhi, India		Thakar, A (corresponding author), All India Inst Med Sci, Dept Otolaryngol & Head Neck Surg, New Delhi 110029, India.	drathakar@gmail.com	VERMA, HITESH/N-7053-2019	Irugu, David/0000-0002-1732-6504; Verma, Hitesh/0000-0001-7905-3073			ADKINS WY, 1983, LARYNGOSCOPE, V93, P1038; Ahren C., 1965, ACTA OTO-LARYNGOL, V60, P407; ARISTEGUI M, 1995, LARYNGOSCOPE, V105, P513, DOI 10.1288/00005537-199505000-00013; Brown NE, 2004, LARYNGOSCOPE, V114, P800, DOI 10.1097/00005537-200405000-00002; da Cruz MJ, 1998, AM J OTOL, V19, P288; FEENSTRA L, 1985, AM J OTOL, V6, P311; FERGUSON BJ, 1986, LARYNGOSCOPE, V96, P635; Gacek RR, 1999, AM J OTOL, V20, P770; GLASSCOCK ME, 1979, LARYNGOSCOPE, V89, P1743; Gubbels SP, 2007, OTOL NEUROTOL, V28, P1131, DOI 10.1097/MAO.0b013e318157f7b6; IURATO S, 1989, LARYNGOSCOPE, V99, P950; Jackson CG, 1997, AM J OTOL, V18, P198; KAMERER DB, 1982, LARYNGOSCOPE, V92, P878; KAPUR TR, 1986, J LARYNGOL OTOL, V100, P1129, DOI 10.1017/S0022215100100702; Kutz JW, 2008, LARYNGOSCOPE, V118, P2195, DOI 10.1097/MLG.0b013e318182f833; Kveton JF, 2000, LARYNGOSCOPE, V110, P1655, DOI 10.1097/00005537-200010000-00016; Lundy LB, 1996, AM J OTOL, V17, P461; Manolidis S, 2002, AM J OTOLARYNG, V23, P203, DOI 10.1053/ajot.2002.123456; Mayeno JK, 2004, OTOLARYNG HEAD NECK, V130, P486, DOI 10.1016/j.otohns.2003.09.022; Merchant SN, 2000, AM J OTOL, V21, P234, DOI 10.1016/S0196-0709(00)80015-0; MONTGOMERY WW, 1969, ARCH OTOLARYNGOL, V89, P319; Mosnier I, 2000, CLIN OTOLARYNGOL, V25, P385, DOI 10.1046/j.1365-2273.2000.00383.x; Nahas Z, 2008, ARCH OTOLARYNGOL, V134, P509, DOI 10.1001/archotol.134.5.509; NEELY JG, 1985, LARYNGOSCOPE, V95, P1299; Pelosi S, 2010, SKULL BASE-INTERD AP, V20, P253, DOI 10.1055/s-0030-1249249; Rao AK, 2005, OTOL NEUROTOL, V26, P1171, DOI 10.1097/01.mao.0000179526.17285.cc; Sanna M, 2009, LARYNGOSCOPE, V119, P1579, DOI 10.1002/lary.20510; Savva A, 2003, LARYNGOSCOPE, V113, P50, DOI 10.1097/00005537-200301000-00010; Shetty PG, 1997, AM J NEURORADIOL, V18, P478; Stone JA, 1999, AM J NEURORADIOL, V20, P706; WETMORE SJ, 1987, AM J OTOL, V8, P96; Wootten CT, 2005, LARYNGOSCOPE, V115, P1256, DOI 10.1097/01.MLG.0000165455.20118.E3	32	2	2	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0022-2151	1748-5460		J LARYNGOL OTOL	J. Laryngol. Otol.	MAR	2019	133	3					192	200		10.1017/S0022215119000203			9	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Otorhinolaryngology	KI2FR	WOS:000511163500006	30777139				2022-02-06	
J	Helmich, I; von Gotz, D; Emsermann, C; Fu, XJ; Lausberg, H; Griese, A; Lauterbach, I				Helmich, Ingo; von Goetz, Daniel; Emsermann, Carina; Fu Xuanjin; Lausberg, Hedda; Griese, Anne; Lauterbach, Ilka			Not just contact sports: significant numbers of sports-related concussions in cycling	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						Brain concussion; Bicycling; Athletic injuries	PREVENTING HEAD-INJURY; BICYCLE HELMETS; PERFORMANCE	BACKGROUND. Although sports-related concussions (SRCs)/mild traumatic brain injuries in contact sports have recently received much attention, investigation of SRCs in cycling - a sport yielding some of the highest percentages of SRC - remains strikingly limited. In particular, rates of incidence, cycling-specific causes, and potential long-term effects of SRC have not been examined in this sport. Here, a retrospective online survey was used to investigate the incidence and potential long-term effects of SRCs among cyclists. METHODS. A cycling-specific questionnaire was developed and administered to 2792 cyclists via an online survey. First, participants were asked about their acute symptomatology, and secondly, cycling-specific items and concussion history were addressed. RESULTS. Of the 999 cyclists whom completed the questionnaire, 23.8% had experienced a concussion. Incidence of concussion was significantly higher in cyclists who were club members, who cycled more than 200 kilometers per week, and who wore a helmet. Cyclists with a history of concussion complained significantly more often about headaches, pressure in the head, sensitivity to light, confusion, and irritability. CONCLUSIONS. Concussions in cycling are a serious injury with a high incidence relative to other sports. Although wearing a helmet reduces the risk of severe brain injury, interesting, the present results show a relation between helmet use, participation in cycling clubs, and increased concussion incidence. These data are in line with the growing number of findings showing that athletes with a history of concussion report more symptoms.	[Helmich, Ingo; von Goetz, Daniel; Emsermann, Carina; Fu Xuanjin; Lausberg, Hedda; Griese, Anne; Lauterbach, Ilka] German Sport Univ Cologne GSU, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Sportpk Mungersdorf 6, D-50933 Cologne, Germany		Helmich, I (corresponding author), German Sport Univ Cologne GSU, Inst Hlth Promot & Clin Movement Sci, Dept Neurol Psychosomat Med & Psychiat, Sportpk Mungersdorf 6, D-50933 Cologne, Germany.	i.helmich@dshs-koeln.de					[Anonymous], 2002, Am Psychol, V57, P1060; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Beasley TM, 1995, J EXP EDUC, V64, P79, DOI 10.1080/00220973.1995.9943797; Burt CW, 2001, ANN EMERG MED, V37, P301, DOI 10.1067/mem.2001.111707; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Emond SD, 1999, ANN EMERG MED, V33, P56, DOI 10.1016/S0196-0644(99)70417-8; Fridman L, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-30; Gansslen A, 2015, LEICHTES SCHADEL HIR; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Greve MW, 2012, CLIN J SPORT MED, V22, P81, DOI 10.1097/JSM.0b013e318243bf32; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Kloss FR, 2006, TRAUMA, V8, P77, DOI 10.1177/1460408606072681; Last J, 2015, DTSCH Z SPORTMED, V66, P5; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrea HJ, 2013, SPORTS HEALTH, V5, P160, DOI 10.1177/1941738112462203; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Schmidt A., 2013, HDB RADSPORT; Strohm PC, 2005, UNFALLCHIRURG, V108, P1022, DOI 10.1007/s00113-005-0975-3; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; Thompson DC, 2000, COCHRANE DB SYST REV, V2; van Gelder MMHJ, 2010, AM J EPIDEMIOL, V172, P1292, DOI 10.1093/aje/kwq291; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5	26	2	2	0	4	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707	1827-1928		J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	MAR	2019	59	3					496	501		10.23736/S0022-4707.18.08329-9			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	HR3ED	WOS:000463018600022	29619800				2022-02-06	
J	Hirsch, MA; Kropf, ME; Hammond, FM; Schur, L; Karlawish, JH; Ball, AM				Hirsch, Mark A.; Kropf, Martha E.; Hammond, Flora M.; Schur, Lisa; Karlawish, Jason H.; Ball, Andrew M.			Voting Characteristics of Individuals With Traumatic Brain Injury	WORLD MEDICAL & HEALTH POLICY			English	Article						traumatic brain injury; political participation; voting	LIFE-CYCLE; PARTICIPATION; VOTE; PRISONERS; PREVALENCE; ELECTION; RIGHTS; AGE; ASSOCIATION; INTEGRATION	Voting is the foundation of democracy. Limited data exist about voting characteristics of individuals with neurologic impairment including those living with a traumatic brain injury (TBI). To statistically examine voting characteristics using a convenience sample of registered voters with TBI during elections held in Mecklenburg County, North Carolina-2007, 2008. Data were collected on 51 participants with TBI during May 2007, 2008 general, and 2008 Presidential Election. (i) There was a significant difference between the Competence Assessment Tool for Voting (CAT-V) total score of participants with TBI who voted and the CAT-V total score of participants with TBI who did not vote and the CAT-V total score predicted voting; (ii) the age of the participants with TBI was predictive of voting; and (iii) being married was inversely related to voting. We find that there is variation in voting even among this small sample interviewed for the present study, and that the variation is predictable. Those with the highest CAT-Vs are most likely to vote. In addition, we find that traditional predictors of voting simply are not predictors among this TBI group, and even one, whether the person is married, has a negative effect on voting.	[Hirsch, Mark A.] Atrium Hlth, Carolinas Med Ctr, Dept Phys Med & Rehabil, Monroe, NC 28112 USA; [Kropf, Martha E.] Univ North Carolina Charlotte, Polit Sci & Publ Adm, Charlotte, NC USA; [Kropf, Martha E.] Univ North Carolina Charlotte, Publ Policy Program, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Hammond, Flora M.] Traumat Brain Injury Model Syst, Washington, DC USA; [Schur, Lisa] Rutgers State Univ, Dept Lab Studies & Employment Relat, New Brunswick, NJ USA; [Karlawish, Jason H.] Univ Penn, Med Med Eth & Hlth Policy & Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ball, Andrew M.] Atrium Hlth, Charlotte, NC USA; [Ball, Andrew M.] NxtGen Inst, Qual & Performance, Atlanta, GA USA		Hirsch, MA (corresponding author), Atrium Hlth, Carolinas Med Ctr, Dept Phys Med & Rehabil, Monroe, NC 28112 USA.	mark.hirsch@atriumhealth.org	Schur, Lisa/AAH-1855-2020; Hirsch, Mark A./D-2798-2016	Schur, Lisa/0000-0002-3752-0777; Hirsch, Mark A./0000-0002-8997-7971; Ball, Andrew/0000-0002-0888-5363	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD055202-01, HD05520202-S1]; Carolinas HealthCare Foundation, Charlotte, North Carolina	This study was partially supported by National Institutes of Health grant HD055202-01, HD05520202-S1 and by a grant from Carolinas HealthCare Foundation, Charlotte, North Carolina.	Agran M, 2016, INTELLECT DEV DISAB, V54, P285, DOI 10.1352/1934-9556-54.4.285; Alvarez Michael R., 2008, 1267R CALTECH, DOI [10.2139/ssrn.1084598, DOI 10.2139/SSRN.1084598]; Ansolabehere S, 2013, POLITICS GOV, V1, P132, DOI 10.17645/pag.v1i2.97; Ansolabehere S, 2012, Q J POLIT SCI, V7, P333, DOI 10.1561/100.00011112; Appelbaum PS, 2000, PSYCHIATR SERV, V51, P849, DOI 10.1176/appi.ps.51.7.849; Appelbaum PS, 2005, AM J PSYCHIAT, V162, P2094, DOI 10.1176/appi.ajp.162.11.2094; Arah OA, 2008, J EPIDEMIOL COMMUN H, V62, P759, DOI 10.1136/jech.2007.071100; Ashok V, 2016, ELECT LAW J, V15, P115, DOI 10.1089/elj.2015.0310; Beckman L, 2014, SOC POLICY SOC, V13, P221, DOI 10.1017/S1474746413000407; Belio C., 2014, Annals of Physical and Rehabilitation Medicine, V57, P114, DOI 10.1016/j.rehab.2013.11.005; Blakely TA, 2001, AM J PUBLIC HEALTH, V91, P99; BRADY HE, 1995, AM POLIT SCI REV, V89, P271, DOI 10.2307/2082425; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Coughlin Jennifer M., 2017, J AM MED ASS NEUROLO, V71, P67; CURTIS JE, 1976, CAN J POLIT SCI, V9, P293, DOI 10.1017/S0008423900043730; Davis C., 2010, BRAIN INJURY, V24, P208; De Cauwer H, 2005, GERIATRICS-US, V60, P13; Denny KJ, 2007, EUR J PUBLIC HEALTH, V17, P400, DOI 10.1093/eurpub/ckm002; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Doron A, 2014, ISR J PSYCHIATR REL, V51, P169; Farmer S, 2010, LOS ANGELES TIMES; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Hammel J, 2006, TOP STROKE REHABIL, V13, P43, DOI 10.1310/5X2G-V1Y1-TBK7-Q27E; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Hayes C., 2017, US TODAY; Hirsch Mark A., 2010, 2010 MIDW POL SCI AS; Hurme S. B., 2007, MCGEORGE LAW REV, V38, P931; Irastorza Luis Javier, 2011, INT J ALZHEIMERS DIS, V5; JENNINGS MK, 1979, AM J POLIT SCI, V23, P755, DOI 10.2307/2110805; Karlawish Jason, 2008, LDI Issue Brief, V13, P1; Karlawish JHT, 2008, J AGING SOC POLICY, V20, P65, DOI 10.1300/J031v20n01_04; Karlawish JHT, 2002, NEUROLOGY, V58, P1100, DOI 10.1212/WNL.58.7.1100; Keeley H, 2008, J INTELL DISABIL RES, V52, P175, DOI 10.1111/j.1365-2788.2007.00991.x; Kisser J, 2017, BRAIN INJURY, V31, P620, DOI 10.1080/02699052.2017.1283057; Knack Stephen., 1992, RATION SOC, V4, P133, DOI DOI 10.1177/1043463192004002002; Lampel Katherine., 2011, DOD TEST VOTING TECH; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lawn S, 2014, J PSYCHIATR MENT HLT, V21, P289, DOI 10.1111/jpm.12109; Leighley Jan E., 2014, WHO VOTES NOW DEMOGR; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Link JN, 2012, ELECT LAW J, V11, P52, DOI 10.1089/elj.2011.0121; Martin Michel., 2012, NATL PUBLIC RADIO; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Melamed Y, 2007, J NERV MENT DIS, V195, P705, DOI 10.1097/NMD.0b013e318123fc10; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Mulligan CB, 2003, PUBLIC CHOICE, V116, P31, DOI 10.1023/A:1024244329828; Neale Todd., 2009, ABC NEWS; Ott BR, 2003, NEUROLOGY, V60, P1546, DOI 10.1212/01.WNL.0000061481.46191.75; Penna S, 2010, J HEAD TRAUMA REHAB, V25, P52, DOI 10.1097/HTR.0b013e3181c29952; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Raad R, 2009, PSYCHIAT SERV, V60, P624, DOI 10.1176/appi.ps.60.5.624; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; Rees G, 2016, BJPSYCH BULL, V40, P169, DOI 10.1192/pb.bp.115.050781; Sabella SA, 2018, BRAIN INJURY, V32, P926, DOI 10.1080/02699052.2018.1469168; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Schriner K, 1997, PUBLIUS J FEDERALISM, V27, P75, DOI 10.1093/oxfordjournals.pubjof.a029929; Schriner K, 2001, POLICY STUD J, V29, P663, DOI 10.1111/j.1541-0072.2001.tb02119.x; Schriner Kay, 2000, BERKELEY J EMPLOYMEN, V21, P437, DOI DOI 10.15779/Z38PK93; Schriner Kay, 2000, ENCY CRIMINOLOGY DEV; Schur L, 2003, POLIT PSYCHOL, V24, P119, DOI 10.1111/0162-895X.00319; Schur L., 2012, SOCIAL SCI Q, V94, P811; SCHUR L, 1998, J DISABIL POLICY STU, V9, P3, DOI DOI 10.1177/104420739800900202; Schur LA, 2000, SOC SCI QUART, V81, P571; Schur L, 2015, ELECT LAW J, V14, P60, DOI 10.1089/elj.2014.0269; Schur Lisa., 2013, DISABILITY VOTER TUR; Schur Lisa, 2009, FACTSHEET DISABILITY; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; SQUIRE P, 1987, AM POLIT SCI REV, V81, P45, DOI 10.2307/1960778; STOKER L, 1995, AM POLIT SCI REV, V89, P421, DOI 10.2307/2082435; Storrs C, 2009, SCI AM; STRATE JM, 1989, AM POLIT SCI REV, V83, P443, DOI 10.2307/1962399; Sund R, 2017, J EPIDEMIOL COMMUN H, V71, P475, DOI 10.1136/jech-2016-208314; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teixeira R, 2001, INT J HEALTH SERV, V31, P881, DOI 10.2190/2XRK-9QDR-GR9B-MNPF; Tiraboschi Pietro, 2011, Int J Alzheimers Dis, V2011, P983895, DOI 10.4061/2011/983895; Vanderploeg Rodney D., 2010, TRAUMATIC BRAIN INJU; Verba S., 1995, VOICE EQUALITY CIVIC; Wolfinger NH, 2008, SOC FORCES, V86, P1513, DOI 10.1353/sof.0.0031; Yates Tiffany., 2016, 1 AMENDMENT LAW REV, V15, P121; Young I. M., 2002, INCLUSION DEMOCRACY	87	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1948-4682			WORLD MED HEALTH POL	World Med. Health Policy	MAR	2019	11	1					24	42		10.1002/wmh3.296			19	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	HP6VL	WOS:000461825000003		Green Submitted			2022-02-06	
J	Morris, DH; Spencer, RJ; Winters, JJ; Walton, MA; Friday, S; Chermack, ST				Morris, David H.; Spencer, Robert J.; Winters, Jamie J.; Walton, Maureen A.; Friday, Steve; Chermack, Stephen T.			Association of Persistent Postconcussion Symptoms With Violence Perpetration Among Substance-Using Veterans	PSYCHOLOGY OF VIOLENCE			English	Article						intimate partner violence; nonpartner violence; traumatic brain injury; postconcussion symptoms; substance use	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; INTIMATE PARTNER VIOLENCE; AGGRESSIVE-BEHAVIOR; CHRONIC PAIN; EMOTION REGULATION; ABUSE; PREVALENCE; AFGHANISTAN; MILITARY	Objective: Traumatic brain injury (TBI) and persistent postconcussion symptoms (PPCS) are associated with increased substance use among veterans. Each factor is independently associated with the perpetration of violence; however, little is known about the associations TEl and PPCS have with violence among substance users. This study examined the distinct associations probable TB! and PPCS have with partner aggression (PA) and nonpartner aggression (NPA) in substance-using veterans. Method: Present sample included 810 veterans (6.7% women; M-age = 48.2, SD = 13.3) who completed self-report measures assessing sociodemographic characteristics, past month binge drinking and cocaine use. probable TBI, PPCS, probable posttraumatic stress disorder (PTSD), and chronic pain. Aggression measures included psychological, physical, and injury-related PA and NPA. Results: Bivariate analyses revealed age, probable PTSD, and PPCS were associated with most forms of PA and NPA, whereas race, cocaine use, pain, and TBI severity were mostly associated with NPA. Multivariate negative binomial regression analyses adjusting for other identified risk factors (e.g., age, probable PTSD, and chronic pain) revealed PPCS, but not TBI, was associated with most forms of PA and NPA. Conclusions: Findings highlight the importance of PPCS as a risk factor for PA and NPA in substance-using veterans and have important implications concerning the screening of violence risk.	[Morris, David H.; Spencer, Robert J.; Winters, Jamie J.; Friday, Steve; Chermack, Stephen T.] Vet Affairs Ann Arbor Healthcare Syst, 116C,2215 Fuller Rd, Ann Arbor, MI 48105 USA; [Morris, David H.; Winters, Jamie J.; Chermack, Stephen T.] Univ Michigan, Dept Psychiat, Addict Res Ctr, Ann Arbor, MI 48109 USA; [Walton, Maureen A.] Univ Michigan, Dept Psychiat, Addict Res Ctr, Injury Ctr, Ann Arbor, MI 48109 USA		Morris, DH (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, 116C,2215 Fuller Rd, Ann Arbor, MI 48105 USA.	morrisdh@med.umich.edu		Morris, David/0000-0003-3717-8366	Department of Veterans Affairs Office of Research and Development Grant [IIR 099-333]; Mental Health Service at Veterans Affairs Ann Arbor Healthcare System; University of Michigan Department of Psychiatry	This research was supported by a Department of Veterans Affairs Office of Research and Development Grant IIR 099-333 (Clinicaltrials. gov number NCT01337973) awarded to Stephen T. Chermack. In addition, writing of this article was supported by the Mental Health Service at Veterans Affairs Ann Arbor Healthcare System and the University of Michigan Department of Psychiatry.	Aboulafia-Brakha T, 2016, J HEAD TRAUMA REHAB, V31, pE21, DOI 10.1097/HTR.0000000000000171; Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Anderson RE, 2017, J STUD ALCOHOL DRUGS, V78, P597, DOI 10.15288/jsad.2017.78.597; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bailie JM, 2015, J HEAD TRAUMA REHAB, V30, P12, DOI 10.1097/HTR.0000000000000024; Basile KC, 2011, J INTERPERS VIOLENCE, V26, P230, DOI 10.1177/0886260510362896; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Buchholz KR, 2017, ADDICT BEHAV, V64, P194, DOI 10.1016/j.addbeh.2016.08.039; Buckley TC, 2000, CLIN PSYCHOL REV, V20, P1041, DOI 10.1016/S0272-7358(99)00030-6; Bueso-Izquierdo N, 2016, J FORENSIC PSYCHOL P, V16, P321, DOI 10.1080/15228932.2016.1219216; Burns B., 1996, SUBSTANCE ABUSE OUTC; Byrne C, 2016, NEUROREHABILITATION, V39, P205, DOI 10.3233/NRE-161352; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chemtob CM, 1997, J TRAUMA STRESS, V10, P17, DOI 10.1002/jts.2490100104; Chermack ST, 2000, DRUG ALCOHOL DEPEN, V58, P43, DOI 10.1016/S0376-8716(99)00067-8; Chermack ST, 2008, DRUG ALCOHOL DEPEN, V98, P35, DOI 10.1016/j.drugalcdep.2008.04.010; Chermack ST, 2014, ADDICT BEHAV, V39, P265, DOI 10.1016/j.addbeh.2013.10.004; Clements K, 2010, AGGRESS VIOLENT BEH, V15, P357, DOI 10.1016/j.avb.2010.06.004; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Elbogen EB, 2014, BRIT J PSYCHIAT, V204, P368, DOI 10.1192/bjp.bp.113.134627; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Elbogen EB, 2010, CLIN PSYCHOL REV, V30, P595, DOI 10.1016/j.cpr.2010.03.009; Epstein-Ngo QM, 2014, J SUBST ABUSE TREAT, V47, P282, DOI 10.1016/j.jsat.2014.05.005; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Fishbain DA, 2000, PAIN MED, V1, P140, DOI 10.1046/j.1526-4637.2000.00013.x; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Forbes GB, 2005, SEX ROLES, V52, P165, DOI 10.1007/s11199-005-1292-6; Giancola PR, 2000, EXP CLIN PSYCHOPHARM, V8, P576, DOI 10.1037//1064-1297.8.4.576; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holley SR, 2017, J INTERPERS VIOLENCE, V32, P1692, DOI 10.1177/0886260515592619; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Johnson MP, 2011, AGGRESS VIOLENT BEH, V16, P289, DOI 10.1016/j.avb.2011.04.006; Kamphuis J, 2012, SLEEP MED, V13, P327, DOI 10.1016/j.sleep.2011.12.006; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Luaute J, 2016, ANN PHYS REHABIL MED, V59, P58, DOI 10.1016/j.rehab.2015.11.001; Macdonald S, 2003, DRUG ALCOHOL DEPEN, V72, P99, DOI 10.1016/S0376-8716(03)00202-3; MacManus D, 2015, EPIDEMIOL REV, V37, P196, DOI 10.1093/epirev/mxu006; MCCANN IL, 1988, COUNS PSYCHOL, V16, P531, DOI 10.1177/0011000088164002; MILLER L, 1994, J OFFENDER REHABILIT, V21, P91, DOI DOI 10.1300/J076; Moore TM, 2008, CLIN PSYCHOL REV, V28, P247, DOI 10.1016/j.cpr.2007.05.003; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Paschall MJ, 2002, AGGRESS VIOLENT BEH, V7, P215, DOI 10.1016/S1359-1789(00)00044-6; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Roth PL, 1999, ORGAN RES METHODS, V2, P211, DOI 10.1177/109442819923001; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Simpson LE, 2005, PSYCHOL ASSESSMENT, V17, P423, DOI 10.1037/1040-3590.17.4.423; Smith GR, 2006, PSYCHIAT SERV, V57, P1452, DOI 10.1176/appi.ps.57.10.1452; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Sullivan CP, 2014, LAW HUMAN BEHAV, V38, P1, DOI 10.1037/lhb0000035; Sullivan TP, 2012, PSYCHOL VIOLENCE, V2, P154, DOI 10.1037/a0027106; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Taft CT, 2008, J ABNORM PSYCHOL, V117, P637, DOI 10.1037/0021-843X.117.3.637; Taft CT, 2007, J ABNORM PSYCHOL, V116, P498, DOI 10.1037/0021-843X.116.3.498; Taft CT, 2011, J CONSULT CLIN PSYCH, V79, P22, DOI 10.1037/a0022196; Taft CT, 2005, J CONSULT CLIN PSYCH, V73, P151, DOI 10.1037/0022-006X.73.1.151; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Walker R, 2007, J HEAD TRAUMA REHAB, V22, P360, DOI 10.1097/01.HTR.0000300231.90619.50; Walling SM, 2012, J MARITAL FAM THER, V38, P471, DOI 10.1111/j.1752-0606.2011.00226.x; Weather F, 1994, PTSD CHECKLIST CIVIL; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005	84	2	2	0	4	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	2152-0828	2152-081X		PSYCHOL VIOLENCE	Psychol. Violence	MAR	2019	9	2					167	176		10.1037/vio0000175			10	Psychology, Clinical; Criminology & Penology; Family Studies	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies	HL3JF	WOS:000458609600003		Bronze			2022-02-06	
J	Neumann, D; Zupan, B				Neumann, Dawn; Zupan, Barbra			Empathic Responses to Affective Film Clips Following Brain Injury and the Association With Emotion Recognition Accuracy	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injury; Emotion; Empathy; Rehabilitation	FACIAL AFFECT RECOGNITION; INDIVIDUAL-DIFFERENCES; NONVERBAL-COMMUNICATION; SOCIAL COGNITION; IMPAIRMENTS; EXPRESSION; DEFICITS; SYSTEM	Objective: To compare empathic responses to affective film clips in participants with traumatic brain injury (TBI) and controls, and examine associations with affect recognition. Design: Cross sectional study using a quasi-experimental design. Setting: Multi-site study conducted at a postacute rehabilitation facility in the United States and a university in Canada. Participants: Adults (N=120) with moderate to severe TBI (n=60) and those without TBI (n=60), frequency matched for age and sex. Average time postinjury was 14 years (range: .5-37). Main Outcome Measures: Participants were shown affective film clips and asked to report how the main character in the clip felt and how they personally felt in response to the clip. Empathic responses were operationalized as participants feeling the same emotion they identified the character to be feeling. Results: Participants with TBI had lower emotion recognition scores (P=.007) and fewer empathic responses than controls (67% vs 79%; P<.001). Participants with TBI accurately identified and empathically responded to characters' emotions less frequently (65%) than controls (78%). Participants with TBI had poorer recognition scores and fewer empathic responses to sad and fearful clips compared to controls. Affect recognition was associated with empathic responses in both groups (P<.001). When participants with TBI accurately recognized characters' emotions, they had an empathic response 71% of the time, which was more than double their empathic responses for incorrectly identified emotions. Conclusions: Participants with TBI were less likely to recognize and respond empathically to others' expressions of sadness and fear, which has implications for interpersonal interactions and relationships. This is the first study in the TBI population to demonstrate a direct association between an affect stimulus and an empathic response. (C) 2018 by the American Congress of Rehabilitation Medicine	[Neumann, Dawn] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Zupan, Barbra] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Dept Exercise & Hlth Sci, Rockhampton, Qld, Australia		Neumann, D (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	dmneuman@iupui.edu			Cannon Research Center at Carolinas Rehabilitation in Charlotte. North Carolina; Humanity Research Institute at Brock University	Supported by Cannon Research Center at Carolinas Rehabilitation in Charlotte. North Carolina, and the Humanity Research Institute at Brock University.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Besel LDS, 2010, PERS INDIV DIFFER, V49, P107, DOI 10.1016/j.paid.2010.03.013; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Carr MB, 2005, ADOLESCENCE, V40, P601; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Feshbach N. D., 1982, DEV PROSOCIAL BEHAV, P315, DOI DOI 10.1016/B978-0-12-234980-5.50017-1; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Iacoboni M, 2007, ANN NEUROL, V62, P213, DOI 10.1002/ana.21198; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Neumann D, 2014, BRAIN IMAGING BEHAV, V8, P460, DOI 10.1007/s11682-013-9285-5; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Neumann DR, 2011, J HEAD TRAUMA REHAB, V26, P375, DOI 10.1097/HTR.0b013e3181f8d52d; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Seidel EM, 2013, PSYCHIAT RES, V210, P1168, DOI 10.1016/j.psychres.2013.08.027; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Woods S, 2009, CHILD ABUSE NEGLECT, V33, P307, DOI 10.1016/j.chiabu.2008.11.002; YIRMIYA N, 1992, CHILD DEV, V63, P150, DOI 10.2307/1130909; Zupan B, 2017, J SOC PSYCHOL, V157, P194, DOI 10.1080/00224545.2016.1208138; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6	34	2	2	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2019	100	3					458	463		10.1016/j.apmr.2018.07.431			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HN5BU	WOS:000460198500008	30142314	Green Submitted			2022-02-06	
J	Ohbe, H; Koakutsu, T; Kushimoto, S				Ohbe, Hiroyuki; Koakutsu, Tomoaki; Kushimoto, Shigeki			Analysis of risk factors for hyponatremia in patients with acute spinal cord injury: a retrospective single-institution study in Japan	SPINAL CORD			English	Article							TRAUMATIC BRAIN-INJURY; CLINICAL-PRACTICE GUIDELINE; DIAGNOSIS; CONSEQUENCES	Study design: Retrospective single-institution observational study. Objective: Spinal cord injury (SCI) is associated with a high prevalence of hyponatremia, which can cause various clinical symptoms and increase mortality. We aimed to analyze the risk factors for hyponatremia in patients with acute SCI. Setting: Trauma Center, Tohoku University Hospital, Japan Methods: We reviewed the medical records of patients with SCI admitted between January 2008 and November 2016. Least angle regression analyses was performed to assess the association between hyponatremia and other parameters. Results: Of the 213 enrolled patients, 85 (40%) had hyponatremia (serum Na < 135 mmol/L) whilst 19 (9%) had severe hyponatremia (serum Na < 130 mmol/L). Least angle regression analyses revealed that hyponatremia was significantly associated with higher American Spinal Injury Association impairment scale, nosocomial pneumonia, deep vein thrombosis, bradycardia, and surgery for SCI before developing hyponatremia. Severe hyponatremia was significantly associated with traumatic brain injury with an abbreviated injury scale score >= 3, higher American Spinal Injury Association impairment scale, bradycardia, vasopressors, and nosocomial pneumonia. Conclusion: Various factors including traumatic brain injury with an abbreviated injury scale score >= 3 and higher American Spinal Injury Association impairment scale may be associated with hyponatremia in patients with acute SCI. These factors can help clinicians identify and monitor SCI patients with a higher hyponatremia risk, and potentially help patients to avoid severe complications.	[Ohbe, Hiroyuki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Koakutsu, Tomoaki; Kushimoto, Shigeki] Tohoku Univ Hosp, Dept Emergency & Crit Care Med, Emergency Ctr, Sendai, Miyagi, Japan; [Kushimoto, Shigeki] Tohoku Univ, Div Emergency & Crit Care Med, Grad Sch Med, Sendai, Miyagi, Japan		Ohbe, H (corresponding author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan.	hohbey@gmail.com	Ohbe, Hiroyuki/ABB-6008-2021	Ohbe, Hiroyuki/0000-0001-8544-2569			Adrian M., 2006, LARS STATA MODULE PE; BIYANI A, 1993, INJURY, V24, P671, DOI 10.1016/0020-1383(93)90318-Z; Bourassa-Moreau E, 2013, J TRAUMA ACUTE CARE, V74, P849, DOI 10.1097/TA.0b013e31827e1381; EFRON B, 2003, LEAST ANGLE REGRESSI; Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0; Furlan JC, 2003, J NEUROTRAUM, V20, P1351, DOI 10.1089/089771503322686148; Kirshblum S, 2014, PHYS MED REH CLIN N, V25, P505, DOI 10.1016/j.pmr.2014.04.001; Kriz J, 2015, SPINAL CORD, V53, P291, DOI 10.1038/sc.2014.240; Kushner DS, 2014, PHYS MED REH CLIN N, V25, P681, DOI 10.1016/j.pmr.2014.04.005; Moore K, 2003, CLIN MED, V3, P28, DOI 10.7861/clinmedicine.3-1-28; Nakao Y, 2012, SPINAL CORD, V50, P285, DOI 10.1038/sc.2011.142; Patel GP, 2007, CLIN THER, V29, P211, DOI 10.1016/j.clinthera.2007.02.004; PERUZZI WT, 1994, CRIT CARE MED, V22, P252, DOI 10.1097/00003246-199402000-00016; PETRUCELLI E, 1981, ACCIDENT ANAL PREV, V13, P29, DOI 10.1016/0001-4575(81)90040-3; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rajagopal R, 2017, WORLD NEUROSURG, V108, P529, DOI 10.1016/j.wneu.2017.09.013; Spasovski G, 2014, NEPHROL DIAL TRANSPL, V29, P1, DOI 10.1093/ndt/gfu040; Spasovski G, 2014, INTENS CARE MED, V40, P320, DOI 10.1007/s00134-014-3210-2; Teasell RW, 2000, ARCH PHYS MED REHAB, V81, P506, DOI 10.1053/mr.2000.3848; The Ministry of Health, 2018, CURR STAT PROBL EM M; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Upadhyay A, 2009, SEMIN NEPHROL, V29, P227, DOI 10.1016/j.semnephrol.2009.03.004; Yumoto T, 2015, ACTA MED OKAYAMA, V69, P213	23	2	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	MAR	2019	57	3					240	246		10.1038/s41393-018-0208-6			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	HN3XZ	WOS:000460119800009	30327495	Bronze			2022-02-06	
J	Oremakinde, AA; Malomo, AO; Dairo, MD; Shokunbi, TM; Adeolu, AA; Adeleye, AO				Oremakinde, Adetunji A.; Malomo, Adefolarin O.; Dairo, Magbagbeola D.; Shokunbi, Temitayo M.; Adeolu, Augustine A.; Adeleye, Amos O.			Assessment of predictors of one-month outcome in head injury in a Nigerian tertiary hospital	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Predictors; Head injury; Outcomes; Assessment	TRAUMATIC BRAIN-INJURY; PROGNOSTIC VALUE; MORTALITY RISK; ADMISSION; CLASSIFICATION; DETERMINANTS; VARIABLES; TREE	Background: Current prognostic models for head injury were developed using data mostly from high income countries. A more useful model may be obtained from predictors designed from data obtained from low and middle income countries where trauma is said to be a neglected endemic condition. Methods: This prospective study, after ethical and institutional clearance, examined 19 clinical and Computerized Tomographic (CT) scan parameters of all head injured patients who ma the study's inclusion criteria. The significance of these parameters in predicting outcomes at 15 and 30 days post-injury using the Glasgow Outcome Scale (GOS) and mortality/survival was statistically determined using Univariate and Multivariate analysis. Results: One hundred and fifty patients were prospectively recruited. The age range was 0.33 to 82 years. After univariate analysis, the clinical parameters that were significantly predictive of outcomes were pupillary response (p < 0.0001, 95% CI = 0.0653-0.3589), Glasgow Coma Score (p < 0.0001, 95% CI = 15.3340-199.6713) and Age (p = 0.008, 95% CI = 0.0446-0.6142). Among the CT scan parameters, presence of multifocal contusions (p = 0.000), intracerebral haematoma (ICH) (p = 0.01), intraventricular haematoma (IVH) (p = 0.000), effacement of ventricles (p = 0.004) and cisterns (p = 0.000), midline shift (p = 0.012), and crowding of foramen magnum (p = 0.026) were found to be significantly associated with poor outcome. Multivariate analysis showed that GCS (p = 0.006, OR = 12.8171, 95% CI = 2.1013-78.1779), multifocal contusion (p = 0.01, OR = 0.1908, 95% CI = 0.0537-0.6773) and pupillary response (p = 0.046, OR = 0.2256, 95%CI = 0.0445-1.1453) were retained as independent predictors associated with overall outcome. Conclusions: This study suggests that GCS, pupillary response and multifocal contusions may independently predict outcome using GOS in head injury. A prediction model designed on these predictors needs to be considered and evaluated for this environment.	[Oremakinde, Adetunji A.; Malomo, Adefolarin O.; Shokunbi, Temitayo M.; Adeolu, Augustine A.; Adeleye, Amos O.] Univ Coll Hosp, Dept Neurol Surg, Ibadan, Nigeria; [Malomo, Adefolarin O.; Shokunbi, Temitayo M.; Adeolu, Augustine A.; Adeleye, Amos O.] Univ Ibadan, Coll Med, Dept Neurol Surg, Ibadan, Nigeria; [Dairo, Magbagbeola D.] Univ Ibadan, Coll Med, Dept Epidemiol, Ibadan, Nigeria		Malomo, AO (corresponding author), Univ Coll Hosp, Dept Neurol Surg, Ibadan, Nigeria.	adetunji.oremakinde@mail.utoronto.ca	Dairo, Magbagbeola David/AAZ-1195-2021	Dairo, Magbagbeola David/0000-0003-4891-0698; Shokunbi, Temitayo/0000-0002-7819-6862	University of Edinburgh; Royal College of Surgeons of Edinburgh	This work was carried out as a research project which contributed towards a Masters in Surgical Sciences degree awarded by the University of Edinburgh and the Royal College of Surgeons of Edinburgh.	Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; Adeolu AA, 2010, J CLIN NEUROSCI, V17, P325, DOI 10.1016/j.jocn.2009.07.088; Adeolu A. A., 2005, INTERNET J EPIDEMIOL, V2, P2; ALEXANDER E, 1992, SURG NEUROL, V38, P478, DOI 10.1016/0090-3019(92)90124-6; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; BARLOW P, 1986, NEUROSURGERY, V19, P989, DOI 10.1227/00006123-198612000-00014; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cassidy LD, 2003, J PEDIATR SURG, V38, P482, DOI 10.1053/jpsu.2003.50084; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; Cope D., 1993, J HEAD TRAUMA REHAB, V8, P1; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Gregson B. A., 2003, EUR MULT NEUR 8 C GR; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; JENNETT B, 1976, LANCET, V1, P1031; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; LEE KL, 1986, AM J MED, V80, P553, DOI 10.1016/0002-9343(86)90807-7; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; Ogungbo B, 2004, J AM COLL SURGEONS, V198, P852, DOI 10.1016/j.jamcollsurg.2004.02.003; OVERGAARD J, 1973, LANCET, V2, P631; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Pillai SV, 2003, NEUROL INDIA, V51, P345; Poon WS, 2005, ACT NEUR S, V93, P207; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Schaan M, 2002, J TRAUMA, V52, P667, DOI 10.1097/00005373-200204000-00009; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034	41	2	2	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2214-7519			INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	MAR	2019	15						89	97		10.1016/j.inat.2018.10.005			9	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HD5IW	WOS:000452563400018		gold			2022-02-06	
J	Papalia, R; Torre, G; Zampogna, B; Vorini, F; Grasso, A; Denaro, V				Papalia, R.; Torre, G.; Zampogna, B.; Vorini, F.; Grasso, A.; Denaro, V			SPORT ACTIVITY AS RISK FACTOR FOR EARLY KNEE OSTEOARTHRITIS	JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS			English	Article						knee; osteoarthritis; sport; injury; sport medicine; athletes	PROFESSIONAL FOOTBALL; ARTICULAR-CARTILAGE; INJURIES; HIP; PROGRESSION; PREVALENCE; ASSOCIATION; EXERCISE; DENSITY; PLAYERS	There is wide discussion about the association between sport activity and musculoskeletal disorders, as sports-related joint loading increases the risk of osteoarthritis (OA). The present article reviews the current available literature on the connections between participation in several sports and athletic activities and prevalence of knee OA, especially focusing on early knee OA. The study was based on an electronic search through web databases including Medline, Cochrane and Google Scholar. Articles were retrieved and evaluated, and case series, retrospective studies, case-control studies, prospective cohort studies and randomized controlled trials were considered for inclusion. The main data were extracted and summarized in tables and text. Athletic individuals do show an increased prevalence of knee OA, especially for professional athletes when compared to general population or non-professional athletes. Furthermore, several features related to sport activity were associated to increased risk of early knee OA, such as knee ligamentous injury, concussion, high-impact sports and different team roles. Methodology and results of the included studies are barely comparable, thus preventing the authors to carry out an accurate and systematic comparison of the results of the included studies. Only low level evidence studies are available, and better designed studies, with radiological and functional evaluation of the knee based on internationally validated measures, should be planned. Also, follow-up of patients during and after their life-period of sport involvement should be considered.	[Papalia, R.; Torre, G.; Zampogna, B.; Vorini, F.; Denaro, V] Campus Biomed Univ Rome, Dept Orthopaed & Trauma Surg, Via Alvaro del Portillo 200, I-00128 Rome, Italy; [Grasso, A.] Villa Valeria Clin, Rome, Italy		Torre, G (corresponding author), Campus Biomed Univ Rome, Dept Orthopaed & Trauma Surg, Via Alvaro del Portillo 200, I-00128 Rome, Italy.	g.torre@unicampus.it	Zampogna, Biagio/AAL-9403-2020	Zampogna, Biagio/0000-0002-9318-4114; Papalia, Rocco/0000-0002-6069-4871			Alentorn-Geli E, 2017, J ORTHOP SPORT PHYS, V47, P373, DOI 10.2519/jospt.2017.7137; Angioi M, 2014, CLIN J SPORT MED, V24, P435, DOI 10.1097/JSM.0000000000000035; Arliani GG, 2014, CLINICS, V69, P589, DOI 10.6061/clinics/2014(09)03; Arokoski JPA, 2000, SCAND J MED SCI SPOR, V10, P186, DOI 10.1034/j.1600-0838.2000.010004186.x; Bowersock CD, 2017, J SPORT SCI, V35, P2005, DOI 10.1080/02640414.2016.1249904; Carta Mauro Giovanni, 2008, Clin Pract Epidemiol Ment Health, V4, P1, DOI 10.1186/1745-0179-4-1; Clements KM, 2001, OSTEOARTHR CARTILAGE, V9, P499, DOI 10.1053/joca.2000.0417; Cramp F, 2010, SUPPORT CARE CANCER, V18, P1367, DOI 10.1007/s00520-010-0904-z; Deacon A, 1997, MED J AUSTRALIA, V166, P187, DOI 10.5694/j.1326-5377.1997.tb140072.x; Drawer S, 2001, BRIT J SPORT MED, V35, P402, DOI 10.1136/bjsm.35.6.402; Driban JB, 2014, ARTHRIT CARE RES, V66, P1673, DOI 10.1002/acr.22359; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Golightly YM, 2009, J PHYS ACT HEALTH, V6, P638, DOI 10.1123/jpah.6.5.638; Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008; Haggerty M, 2014, GAIT POSTURE, V39, P1017, DOI 10.1016/j.gaitpost.2013.12.027; Iosifidis MI, 2015, KNEE SURG SPORT TR A, V23, P2528, DOI 10.1007/s00167-014-3047-9; Kettunen JA, 2001, AM J SPORT MED, V29, P2, DOI 10.1177/03635465010290010801; Krajnc Z, 2010, WIEN KLIN WOCHENSCHR, V122, P40, DOI 10.1007/s00508-010-1341-1; KUJALA UM, 1995, ARTHRITIS RHEUM, V38, P539, DOI 10.1002/art.1780380413; LANE NE, 1986, JAMA-J AM MED ASSOC, V255, P1147; Lane NE, 1998, J RHEUMATOL, V25, P334; LANE NE, 1993, J RHEUMATOL, V20, P461; Larsen E, 1999, SCAND J MED SCI SPOR, V9, P285; Lavie CJ, 2011, PROG CARDIOVASC DIS, V53, P464, DOI 10.1016/j.pcad.2011.03.007; Lojovich JM, 2010, J HEAD TRAUMA REHAB, V25, P184, DOI 10.1097/HTR.0b013e3181dc78cd; Lynall RC, 2017, J ATHL TRAINING, V52, P518, DOI 10.4085/1062-6050-52.2.03; Maffulli N, 2011, BRIT MED BULL, V97, P47, DOI 10.1093/bmb/ldq026; McDermott M, 1983, Br J Sports Med, V17, P84; MORETZ JA, 1984, AM J SPORT MED, V12, P298, DOI 10.1177/036354658401200410; Petrillo S, 2018, BRIT MED BULL, V125, P121, DOI 10.1093/bmb/ldy001; Plotnikoff R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2529-0; Rajabi R, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-12; Ryd L, 2015, CARTILAGE, V6, P156, DOI 10.1177/1947603515586048; Spector TD, 1996, ARTHRITIS RHEUM, V39, P988, DOI 10.1002/art.1780390616; Teng HL, 2015, CLIN BIOMECH, V30, P383, DOI 10.1016/j.clinbiomech.2015.02.008; Turner AP, 2000, BRIT J SPORT MED, V34, P332, DOI 10.1136/bjsm.34.5.332; Tveit M, 2012, AM J SPORT MED, V40, P527, DOI 10.1177/0363546511429278; Vannini F, 2016, KNEE SURG SPORT TR A, V24, P1786, DOI 10.1007/s00167-016-4090-5; Verniba D, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-016-0072-x; Vignon E, 2006, JOINT BONE SPINE, V73, P442, DOI 10.1016/j.jbspin.2006.03.001; Wong M, 2003, BONE, V33, P1, DOI 10.1016/S8756-3282(03)00083-8	41	2	2	0	2	BIOLIFE SAS	SILVA MARINA (TE)	VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY	0393-974X	1724-6083		J BIOL REG HOMEOS AG	J. Biol. Regul. Homeost. Agents	MAR-APR	2019	33	2		1			29	37					9	Endocrinology & Metabolism; Immunology; Medicine, Research & Experimental; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Research & Experimental Medicine; Physiology	UL5ML	WOS:000692695000005	31169000				2022-02-06	
J	Perry, SB; Billek-Sawhney, B; Woollard, J; Little, S; Szalinski, A				Perry, Susan B.; Billek-Sawhney, Barbara; Woollard, Jason; Little, Susan; Szalinski, Amy			Balance and Mobility Improvements During Inpatient Rehabilitation Are Similar in Young-Old, Mid-Old, and Old-Old Adults With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						balance; geriatric; mobility; outcomes; rehabilitation; traumatic brain injury	DWELLING ELDERLY-PEOPLE; PERFORMANCE-MEASURES; OUTCOME MEASURES; WALKING; FALLS; SCALE; AGE; PROBABILITY; ASSOCIATION; COMORBIDITY	Objective: To compare balance, mobility, and functional outcomes across 3 age groups of older adults with traumatic brain injury; to describe differences between those discharged to private residences versus institutional care. Setting: Acute inpatient rehabilitation facility. Participants: One hundred adults, mean age of 78.6 +/- 7.9 years (range = 65-95 years), with an admitting diagnosis of traumatic brain injury. Design: Retrospective case series. Main Measures: Functional Independence Measure (FIM) for Cognition and Mobility; Berg Balance Scale; Timed Up and Go; and gait speed, at admission to and discharge from an inpatient rehabilitation facility. Results: Statistically significant improvements (P < .01) were made on the Timed Up and Go, Berg Balance Scale, and gait speed for young-old, mid-old, and old-old adults, with no differences among the 3 age groups. Substantial balance and mobility deficits remained. The FIM cognition (P = .013), FIM Walk (P = .009), and FIM Transfer (P = .013) scores were significantly better in individuals discharged home or home with family versus those discharged to an institution. Conclusion: Preliminary outcome data for specific balance and mobility measures are reported in 3 subgroups of older adults following traumatic brain injury, each of which made significant and similar improvements. Some FIM item scores discriminated between those discharged to a private residence versus a higher level of care.	[Perry, Susan B.; Woollard, Jason] Chatham Univ, Phys Therapy Program, Woodland Rd, Pittsburgh, PA 15232 USA; [Billek-Sawhney, Barbara] Slippery Rock Univ, Grad Sch Phys Therapy, Slippery Rock, PA 16057 USA; [Szalinski, Amy] ReMed, Pittsburgh, PA USA		Perry, SB (corresponding author), Chatham Univ, Phys Therapy Program, Woodland Rd, Pittsburgh, PA 15232 USA.	perry@chatham.edu					Brooks D, 2006, ARCH PHYS MED REHAB, V87, P105, DOI 10.1016/j.apmr.2005.08.109; Centers for Medicare & Medicaid Services, 2013 HLTH HLTH CAR M; Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Chui KK, 2010, J GERIATR PHYS THER, V33, P173, DOI 10.1097/JPT.0b013e3181ff262c; Concussion C TBIa, 2016, PERC DISTR TBI REL E; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Federal Interagency Forum on Aging Related Statistics, 2012, OLD AM 2012 KEY IND; Feld JA, 2001, NEUROREHAB NEURAL RE, V15, P239, DOI 10.1177/154596830101500312; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gervasoni E, 2017, ARCH PHYS MED REHAB, V98, P337, DOI 10.1016/j.apmr.2016.09.128; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; McCulloch KL, 2016, J NEUROL PHYS THER, V40, P269, DOI 10.1097/NPT.0000000000000145; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; Muir SW, 2008, PHYS THER, V88, P449, DOI 10.2522/ptj.20070251; Newson P, 2007, NURS RESIDENTIAL CAR, V9, P218; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; O'Brien SR, 2016, PHYS THER REHABIL J, V96, P1381, DOI 10.2522/ptj.20150364; Peel NM, 2013, J GERONTOL A-BIOL, V68, P39, DOI 10.1093/gerona/gls174; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Rydwik E, 2011, PHYS OCCUP THER GERI, V29, P102, DOI 10.3109/02703181.2011.564725; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Stevenson TJ, 2001, AUST J PHYSIOTHER, V47, P29, DOI 10.1016/S0004-9514(14)60296-8; Stineman MG, 1997, ARCH PHYS MED REHAB, V78, P636, DOI 10.1016/S0003-9993(97)90430-5; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Tilson JK, 2010, PHYS THER, V90, P196, DOI 10.2522/ptj.20090079; Tyson S, 2009, CLIN REHABIL, V23, P1018, DOI 10.1177/0269215509339004; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa; Wright AA, 2011, J ORTHOP SPORT PHYS, V41, P319, DOI 10.2519/jospt.2011.3515	40	2	2	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		E66	E73		10.1097/HTR.0000000000000415			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400008	30045220				2022-02-06	
J	Polat, O; Uckun, OM; Tuncer, C; Belen, AD				Polat, Omer; Uckun, Ozhan Merzuk; Tuncer, Cengiz; Belen, Ahmet Deniz			Is IL-8 level an indicator of clinical and radiological status of traumatic brain injury?	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Glasgow Coma Scale; interleukin; traumatic brain injury	INTERLEUKIN-8; MARKERS	BACKGROUND: Since understanding the fact that traumatic brain injury includes an inflammatory process, the number of studies of cytokines has increased. The objective of this study was to analyze and discuss the association of interleukin (IL)-8 level with the clinical and radiological status of patients with head trauma. METHODS: Patients who were admitted to our hospital due to head trauma were included in the study. Findings of clinical and laboratory examinations were analyzed. Data regarding patient age, gender, available clinical findings, Glasgow Coma Scale (GCS) score, trauma cause, brain tomography findings, and biochemical laboratory test results were recorded. The patients were divided into 3 groups according to their GCS score: Group I: GCS >= 13, Group II: GCS = 9-12, and Group III: GCS = 3-8. RESULTS: A total of 23 (76.7%) patients were male and 7 (23.3%) were female. Overall, 17 (56.7%) patients were admitted due to a fall, 8 (26.7%) due to a traffic accident, and 5 (16.7%) due to assault. Each group comprised 10 patients. As the GCS score increased, the IL-8 level decreased. The mean IL-8 level was 1.2 pg/mL in Group I, 6.6 pg/mL in Group II, and 4.7 pg/mL in Group III; however, there was no statistically significant difference between the groups (p=0.147). Moreover, the IL-8 level was significantly greater in patients who demonstrated an abnormal tomography finding (p=0.023). CONCLUSION: IL-8 may be a beneficial indicator for monitoring the clinical and radiological status of traumatic brain injury. Nonetheless, studies of larger cohorts in which IL-8 levels are measured at all stages of brain injury and follow-up of long-term prognosis are warranted.	[Polat, Omer; Tuncer, Cengiz] Duzce Univ, Fac Med, Dept Neurosurg, Duzce, Turkey; [Uckun, Ozhan Merzuk; Belen, Ahmet Deniz] Univ Hlth Sci, Ankara Numune Training & Res Hosp, Dept Neurosurg, Ankara, Turkey		Polat, O (corresponding author), Duzce Univ, Fac Med, Dept Neurosurg, Duzce, Turkey.	polatnrs@gmail.com					Acar E, 2016, EUR J TRAUMA EMERG S, V42, P611, DOI 10.1007/s00068-015-0579-8; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Gopcevic A, 2007, TOHOKU J EXP MED, V211, P387, DOI 10.1620/tjem.211.387; Gungor H, 2010, FU SAG BIL TIP DERG, V24, P179; Jha MK, 2015, EXPERT OPIN THER PAT, V25, P241, DOI 10.1517/13543776.2014.972937; KASAHARA T, 1991, IMMUNOLOGY, V74, P60; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mukaida N, 2000, INT J HEMATOL, V72, P391; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Wiendl H, 2013, NAT REV NEUROL, V9, P125, DOI 10.1038/nrneurol.2013.2; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357	16	2	3	1	2	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAR	2019	25	2					193	197		10.14744/tjtes.2019.59845			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HP2DT	WOS:000461479100018	30892675	Bronze, Green Published			2022-02-06	
J	Renaud, M; Fath, L; Cheptou, M; Dillenseger, L; Riehm, S; Venkatasamy, A; Debry, C; Djennaoui, I				Renaud, M.; Fath, L.; Cheptou, M.; Dillenseger, L.; Riehm, S.; Venkatasamy, A.; Debry, C.; Djennaoui, I			Iatrogenic meningoencephalocele after traumatic perforation of the cribriform plate during nasal intubation of a preterm infant	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						Nasotracheal intubation; Iatrogenic meningoencephalocele; Brain injury; Preterm infant; Endoscopic endonasal surgery	ENDOSCOPIC ENDONASAL; LAMINA-CRIBROSA; CSF LEAK; ENCEPHALOCELE; RECONSTRUCTION; TRANSNASAL; MANAGEMENT	Traumatic iatrogenic meningoencephaloceles infants are rare and there is no consensus on management in the literature. This article presents a case of a meningoencephalocele diagnosed 15 months after a traumatic perforation of the cribriform plate due to a difficult intubation of a preterm infant that was treated by an endoscopic endonasal surgery. A close collaboration between pediatricians and ENT surgeons appears essential for early diagnosis and management. Endoscopic endonasal approach for meningoencephalocele management has several advantages and is a safe procedure when performed by an experienced surgeon.	[Renaud, M.; Fath, L.; Debry, C.; Djennaoui, I] Univ Hosp Strasbourg, Dept Otolaryngol Head & Neck Surg, 1 Ave Moliere, F-67200 Strasbourg, France; [Cheptou, M.] Robert Debre Hosp, AP HP, Dept Pediat, Paris, France; [Dillenseger, L.] Univ Hosp Strasbourg, Dept Pediat, Strasbourg, France; [Riehm, S.; Venkatasamy, A.] Univ Hosp Strasbourg, Dept Radiol 1, Strasbourg, France		Renaud, M (corresponding author), Univ Hosp Strasbourg, Dept Otolaryngol Head & Neck Surg, 1 Ave Moliere, F-67200 Strasbourg, France.	marion.renaud@chru-strasbourg.fr					BANNISTER CM, 1993, ARCH DIS CHILD-FETAL, V69, P81, DOI 10.1136/adc.69.1_Spec_No.81; Braun JJ, 2016, ARCH PEDIATRIE, V23, P192, DOI 10.1016/j.arcped.2015.11.010; CAMERON D, 1993, ARCH DIS CHILD-FETAL, V69, P79, DOI 10.1136/adc.69.1_Spec_No.79; Celik O, 2016, J CRANIOFAC SURG, V27, P1028, DOI 10.1097/SCS.0000000000002601; Charrier J. B., 2007, EMC OTO RHINO LARYNG, V2, P1, DOI [10.1016/S0246-0351(07)41889-X, DOI 10.1016/S0246-0351(07)41889-X]; de Vries MJ, 2014, PEDIATRICS, V133, pE762, DOI 10.1542/peds.2012-3802; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Gonzalez-Garcia L, 2016, CHILD NERV SYST, V32, P369, DOI 10.1007/s00381-015-2828-x; Komotar RJ, 2013, J NEUROL SURG PART A, V74, P239, DOI 10.1055/s-0032-1325636; Krmpotic-Nemanic J, 1998, ANN ANAT, V180, P555, DOI 10.1016/S0940-9602(98)80065-4; Ogiwara H, 2013, J NEUROSURG-PEDIATR, V11, P505, DOI 10.3171/2013.2.PEDS12231; Rastatter JC, 2015, OTOLARYNG CLIN N AM, V48, P79, DOI 10.1016/j.otc.2014.09.007; Spence K, 2000, COCHRANE DB SYST REV, V1999; Steven RA, 2011, J LARYNGOL OTOL, V125, P1075, DOI 10.1017/S0022215111001800; Sweet DG, 2017, NEONATOLOGY, V111, P107, DOI 10.1159/000448985; Tan SH, 2015, CHILD NERV SYST, V31, P1165, DOI 10.1007/s00381-015-2667-9; Upasani AV, 2014, PEDIATR NEONATOL, V55, P404, DOI 10.1016/j.pedneo.2012.12.015; VANDENANKER JN, 1992, PEDIATR RADIOL, V22, P545, DOI 10.1007/BF02013011; Verma RK, 2017, INT J PEDIATR OTORHI, V100, P211, DOI 10.1016/j.ijporl.2017.07.001; Zeinalizadeh M, 2017, J NEUROSURG-PEDIATR, V19, P312, DOI 10.3171/2016.10.PEDS16270	20	2	2	1	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	MAR	2019	118						120	123		10.1016/j.ijporl.2018.12.016			4	Otorhinolaryngology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Pediatrics	HP1FN	WOS:000461410900023	30611097				2022-02-06	
J	Russell, KW; Katz, MG; Short, SS; Scaife, ER; Fenton, SJ				Russell, Katie W.; Katz, Micah G.; Short, Scott S.; Scaife, Eric R.; Fenton, Stephen J.			Longboard injuries treated at a level 1 pediatric trauma center	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatric trauma; Longboard; Skateboard; Traumatic brain injury; Skull fracture	HEAD-INJURIES; SKATEBOARD	Introduction: Recreation on longboards is gaining in popularity. The purpose of this study is to detail the injury patterns, treatment and management of children with longboarding injuries seen at a level 1 pediatric trauma center. Methods: A retrospective review using our trauma registry from 2006 to 2016 of pediatric patients who sustained injuries while riding a longboard. Results: Of 12,920 injured children, 64 (05%) were treated for injuries that occurred while riding a longboard. Median age was 14.5 years (IQR 13.6, 15.4) and 84% were male. Fifty-one (80%) suffered a traumatic brain injury (TBI) including 32 intracranial hemorrhages (ICH), 17 concussions, and 31 skull fractures. Seven (11%) were wearing helmets. Three patients required neurosurgical intervention. Extremity fractures were the most common reason for surgery. Ninety-six percent of patients were admitted to the hospital with a median length of stay of 1 day (IQR 1, 3). All children survived to discharge. Compared with skateboard injuries during the same period, TBI, ICH, concussion, and skull fractures were all greater. Conclusions: TBI ranging from concussion to ICH requiring craniotomy is common in children injured while riding a longboard, and greater than rates after skateboarding injuries. Extremity fracture was the most common reason for operative intervention. (C) 2018 Published by Elsevier Inc.	[Russell, Katie W.; Short, Scott S.; Scaife, Eric R.; Fenton, Stephen J.] Univ Utah, Sch Med, Div Pediat Surg, Salt Lake City, UT 84113 USA; [Katz, Micah G.] Univ Utah, Dept Surg, Sch Med, Salt Lake City, UT 84113 USA		Russell, KW (corresponding author), Univ Utah, Primary Childrens Hosp, Div Pediat Surg, 100 Mario Capecchi Dr, Salt Lake City, UT 84113 USA.	katie.russell@hsc.utah.edu	Katz, Micah/L-3841-2019	Katz, Micah/0000-0001-8315-0909			[Anonymous], 2017, FASTEST SKATEBOARDER; [Anonymous], 2017, WIKIPEDIA, P1; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Fabian LA, 2014, EMERG MED INT, V2014, DOI 10.1155/2014/924381; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Keays G, 2014, INJURY, V45, P1215, DOI 10.1016/j.injury.2014.03.010; Lustenberger T, 2010, J TRAUMA, V69, P924, DOI 10.1097/TA.0b013e3181b9a05a; Majercik S, 2015, NEUROSURGERY, V77, P927, DOI 10.1227/NEU.0000000000000957; McKenzie Lara B, 2016, Inj Epidemiol, V3, P10; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; SCHUMAN SH, 1967, CLIN PEDIATR, V6, P252, DOI 10.1177/000992286700600421; Tominaga GT, 2015, BRAIN INJURY, V29, P1044, DOI 10.3109/02699052.2014.989404	13	2	2	2	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	MAR	2019	54	3					569	571		10.1016/j.jpedsurg.2018.10.098			3	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	HL5PY	WOS:000458782300035	30593338				2022-02-06	
J	Sacco, TL; Davis, JG				Sacco, Tara L.; Davis, Jenna Gonillo			Management of Intracranial Pressure Part II: Nonpharmacologic Interventions	DIMENSIONS OF CRITICAL CARE NURSING			English	Article						Intracranial pressure; Neurologic injury; Nonpharmacologic interventions	TRAUMATIC BRAIN-INJURY; THERAPEUTIC TEMPERATURE MODULATION; DECOMPRESSIVE CRANIECTOMY; ACID-BASE; FEVER; NORMOTHERMIA; PERFUSION; NURSES; SALINE; FLUID	Pharmacologic and nonpharmacologic interventions are available to treat patients who experience serious elevations in intracranial pressure (ICP). In some cases, patients may experience ICP that is refractory to treatment. Significant negative effects on cerebral blood flow, tissue oxygenation, and cerebral metabolism occur as a result of intracranial hypertension, leading to secondary brain injury. In part 2 of this series, nonpharmacologic interventions for ICP and ICP refractory to treatment are discussed. Interventions include neurologic monitoring (bedside assessment and multimodal monitoring), ventilatory support, fluid and electrolyte maintenance, targeted temperature management, and surgical intervention. Technology is always evolving, and the focus of multimodal monitoring here includes devices to monitor ICP, brain tissue oxygen tension, and cerebral blood flow and cerebral microdialysis monitors. Nursing care of these patients includes perspicacious assessment and integration of data, monitoring ventilatory and hemodynamic functioning, and appropriate patient positioning. Nurses must collaborate with the interprofessional care team to ensure favorable patient outcomes while utilizing an evidence-based guideline for the management of ICP.	[Sacco, Tara L.] St John Fisher Coll, Wegmans Sch Nursing, 3690 East Ave, Rochester, NY 14618 USA; [Sacco, Tara L.] Univ Rochester, Med Ctr, Adult Crit Care Nursing, Rochester, NY 14642 USA; [Davis, Jenna Gonillo] Univ Rochester, Med Ctr, Neuromed Intens Care Unit, New York, NY USA		Sacco, TL (corresponding author), St John Fisher Coll, Wegmans Sch Nursing, 3690 East Ave, Rochester, NY 14618 USA.	tsacco@sjfc.edu					Abraham P, 2017, ACTA NEUROCHIR, V159, P2279, DOI 10.1007/s00701-017-3363-1; Audibert G, 2012, ANN FR ANESTH, V31, P109; Bader MK, 2005, AACN ADV CRIT CARE, V16, P526, DOI 10.1097/00044067-200510000-00009; Badjatia N, 2013, NEUROSURG CLIN N AM, V24, P457, DOI 10.1016/j.nec.2013.02.001; Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Blissitt PA, 2012, AACN ADV CRIT CARE, V23, P186, DOI 10.1097/NCI.0b013e31824db4f3; Bohman LE, 2014, CURR OPIN CRIT CARE, V20, P182, DOI 10.1097/MCC.0000000000000070; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Brain Trauma Foundation, 2016, GUID MAN SEV TRAUM B; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Censullo JL, 2003, J NEUROSCI NURS, V35, P225; Centers for Disease Control and Prevention, 2017, SEV TBI; Cerda-Esteve M, 2008, EUR J INTERN MED, V19, P249, DOI 10.1016/j.ejim.2007.06.019; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Cook CJ, 2017, J NEUROSCI NURS, V49, P5, DOI 10.1097/JNN.0000000000000215; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Dutton Richard P, 2003, Curr Opin Crit Care, V9, P503, DOI 10.1097/00075198-200312000-00007; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hafizah M, 2017, J NEUROSURG SCI, V61, P263, DOI 10.23736/S0390-5616.16.03221-5; Hassan MH, 2017, MALAYS J MED SCI, V24, P83, DOI 10.21315/mjms2017.24.5.9; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Inoue Kelly, 2010, AORN J, V91, P511, DOI 10.1016/j.aorn.2009.12.025; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; Jauch-Chara K, 2014, NEUROSCIENCE, V283, P202, DOI 10.1016/j.neuroscience.2014.04.059; Josephson Linda, 2004, Dimens Crit Care Nurs, V23, P194, DOI 10.1097/00003465-200409000-00002; Kirk A, 2016, THER HYPOTHERMIA TEM, V6, P135, DOI 10.1089/ther.2016.0001; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Ledwith MB, 2010, J NEUROSCI NURS, V42, P280, DOI 10.1097/JNN.0b013e3181ecafd4; Lipp LL, 2014, CRIT CARE NURS CLIN, V26, P389, DOI 10.1016/j.ccell.2014.04.008; Littlejohns L, 2005, AACN ADV CRIT CARE, V16, P501, DOI 10.1097/00044067-200510000-00007; Livesay SL, 2016, CRIT CARE NURS CLIN, V28, P1, DOI 10.1016/j.cnc.2015.10.002; Lord AS, 2014, NEUROCRIT CARE, V21, P200, DOI 10.1007/s12028-013-9948-5; Madden LK, 2017, NEUROCRIT CARE, V27, P468, DOI 10.1007/s12028-017-0469-5; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; Mahdavi Z, 2015, CRIT CARE NURS CLIN, V27, P213, DOI 10.1016/j.cnc.2015.02.002; Marcoux KK, 2005, AACN ADV CRIT CARE, V16, P212, DOI 10.1097/00044067-200504000-00012; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Oddo M, 2012, CURR OPIN CRIT CARE, V18, P111, DOI 10.1097/MCC.0b013e32835132a5; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Peacock SH, 2018, AACN ADV CRIT CARE, V29, P183, DOI 10.4037/aacnacc2018632; Perman SM, 2014, CHEST, V145, P386, DOI 10.1378/chest.12-3025; Presciutti M, 2012, CRIT CARE NURSE, V32, P33, DOI 10.4037/ccn2012189; Price Ann M, 2003, Nurs Crit Care, V8, P126, DOI 10.1046/j.1478-5153.2003.00019.x; Rinkel GJ, 2004, COCHRANE DB SYST REV, V2004, P1; Robinson JD, 2016, CRIT CARE NURS CLIN, V28, P67, DOI 10.1016/j.cnc.2015.09.004; Rockett H, 2015, J NEUROSCI NURS, V47, P66, DOI 10.1097/JNN.0000000000000118; Sacco TL, 2018, DIMENS CRIT CARE NUR, V37, P120, DOI 10.1097/DCC.0000000000000293; Saiki Robin L, 2009, Crit Care Nurs Clin North Am, V21, P549, DOI 10.1016/j.ccell.2009.07.009; Stone JJ, 2014, NEUROL RES, V36, P164, DOI 10.1179/1743132813Y.0000000285; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	55	2	2	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0730-4625	1538-8646		DIMENS CRIT CARE NUR	Dimens. Crit. Care Nurs.	MAR-APR	2019	38	2					61	69		10.1097/DCC.0000000000000341			9	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	HM6ZN	WOS:000459627100002	30702474				2022-02-06	
J	Szatala, A; Young, B				Szatala, Amanda; Young, Bethany			Implementation of a Data Acquisition and Integration Device in the Neurologic Intensive Care Unit	AACN ADVANCED CRITICAL CARE			English	Article						device implementation; multimodality monitoring; data integration; data acquisition; device integration	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; MULTIDISCIPLINARY CONSENSUS CONFERENCE; NEUROCRITICAL CARE; METABOLISM; STATEMENT; DISPLAYS; OXYGEN	The neurologic intensive care unit has evolved into a data-rich, complex arena. Various neurologic monitors, collectively referred to as multimodality monitoring, provide clinicians with a plethora of realtime information about a comatose patient's condition. The time and cognitive burden required to synthesize the available data and reach meaningful clinical conclusions can be overwhelming.The Moberg Component Neuromonitoring System (Moberg Research, Inc) is a data acquisition and integration device that collects data from multiple monitors, displaying them on a single screen in a way that highlights physiological trends throughout a patient's clinical course. Implementation of the Moberg Component Neuromonitoring System in the neurologic intensive care unit can improve understanding of a patient's neurophysiology, enhance clinical decision-making, and improve quality of care. Use of a staged process of implementation including exploration, installation, initial implementation, and full implementation can bring technology to the bedside in a sustainable fashion.	[Szatala, Amanda] Penn Presbyterian Med Ctr, Neurointens & Progress Care Unit, 51 N 39th St, Philadelphia, PA 19104 USA; [Young, Bethany] Hosp Univ Penn, Neurointens Care Unit, 3400 Spruce St, Philadelphia, PA 19104 USA		Szatala, A (corresponding author), Penn Presbyterian Med Ctr, Neurointens & Progress Care Unit, 51 N 39th St, Philadelphia, PA 19104 USA.	amanda.szatala@pennmedicine.upenn.edu					Al-Mufti F, 2019, J INTENSIVE CARE MED, V34, P449, DOI 10.1177/0885066618788022; Al-Mufti F, 2018, J NEUROL SCI, V390, P184, DOI 10.1016/j.jns.2018.03.032; Alonso DL, 1998, BEHAV INFORM TECHNOL, V17, P249, DOI 10.1080/014492998119328; Altmiller G, 2011, CLIN NURSE SPEC, V25, P28, DOI 10.1097/NUR.0b013e318201f830; Balas E., 1991, THESIS; Bithal PK, 2017, J NEUROANAESTH CRIT, V3, P1; Cecil S, 2011, CRIT CARE NURSE, V31, P25, DOI 10.4037/ccn2010226; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Committee on Quality of Health Care in America Institute of Medicine, 2001, CROSSING QUALITY CHA; De Turck F, 2007, COMPUT BIOL MED, V37, P97, DOI 10.1016/j.compbiomed.2005.10.004; Effken JA, 2008, INT J MED INFORM, V77, P765, DOI 10.1016/j.ijmedinf.2008.05.004; Elson RB, 1997, J AM MED INFORM ASSN, P233; Fixsen D.L., 2007, BEHAV ANAL TODAY, V8, P96, DOI [10.1037/h0100104, DOI 10.1037/H0100104]; Fixsen D, 2013, EXCEPT CHILDREN, V79, P213, DOI 10.1177/001440291307900206; Greenhalgh T, 2011, J ROY SOC MED, V104, P501, DOI 10.1258/jrsm.2011.110285; Healey CG, 2012, IEEE T VIS COMPUT GR, V18, P1170, DOI 10.1109/TVCG.2011.127; Heck C, 2016, CRIT CARE NURS CLIN, V28, P77, DOI 10.1016/j.cnc.2015.10.001; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Koch SH, 2010, P HUM FACTORS ERGON; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Lewis B, 2015, CLIN NURSE SPEC, V29, pE1, DOI 10.1097/NUR.0000000000000102; Moberg Research Inc., CNS MON; Moberg Research Inc, CNS READ; National Implementation Research Network FPG Child Development Institute University of North Carolina Chapel Hill, LEARN IMPL; Nogueira AB, 2014, NEUROSURGERY, V75, P678, DOI 10.1227/NEU.0000000000000512; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Olson DM, 2017, AM J CRIT CARE, V26, P136, DOI 10.4037/ajcc2017410; Olson DM, 2015, NEUROCRIT CARE, V22, P337, DOI 10.1007/s12028-015-0132-y; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Perl HI, 2011, ADDICT BEHAV, V36, P590, DOI 10.1016/j.addbeh.2011.01.027; Roh D, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0659-0; Schmidt JM, 2014, NEUROCRIT CARE, V21, P229, DOI 10.1007/s12028-014-0037-1; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Sinha S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17449; Zhang JJ, 2005, J BIOMED INFORM, V38, P1, DOI 10.1016/j.jbi.2004.12.002	39	2	2	0	0	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	SPR	2019	30	1					40	47		10.4037/aacnacc2019188			8	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	HN7RF	WOS:000460388600006	30842072				2022-02-06	
J	Zhang, M; Guo, MN; Guo, XP; Gao, L; Zhou, JY; Bai, X; Cui, SN; Pang, C; Gao, LL; Xing, B; Wang, Y				Zhang, Meng; Guo, Moning; Guo, Xiaopeng; Gao, Lu; Zhou, Jingya; Bai, Xue; Cui, Shengnan; Pang, Cheng; Gao, Lingling; Xing, Bing; Wang, Yi			Unintentional injuries: A profile of hospitalization and risk factors for in-hospital mortality in Beijing, China	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Hospitalization; In-hospital mortality; Risk factors; Epidemiological study; Low- and middle-income countries; International classification of diseases-based injury severity score; Barthel Index; Charlson comorbidity index; Injury mechanisms; Unintentional injuries	FOREIGN-BODY ASPIRATION; TRAUMATIC BRAIN-INJURY; GLOBAL BURDEN; EPIDEMIOLOGY; PREVALENCE; EXPERIENCE; PATTERNS; CHILDREN; DISEASES; FALLS	Introduction: Unintentional injuries (Uls) impose a significant burden on low- and middle-income countries (LMICs). However, available UI epidemiological data are limited for LMICs, including China. This article aimed to provide an overview of the UI hospitalization profile, identify risk factors for in-hospital mortality and provide diagnosis-specific survival risk ratios (SRRs) for reference by LMICs using hospital discharge abstract data (DAD) from Beijing, China. Patients and methods: A cross-sectional study was conducted for patients sustaining UIs requiring admission. Information was retrieved from 138 hospitals in Beijing to describe the demographics, injury nature, mechanisms, severity and hospital outcomes. Multivariate logistic regression was performed to identify and evaluate risk factors for in-hospital mortality for UIs. Results: Falls (57.1%), transport accidents (19.9%) and exposure to inanimate mechanical forces (16.4%) were the leading causes of UI hospitalization. Falls and transport accidents were responsible for 94.2% of the in-hospital deaths caused by UIs. Injury mechanisms differed among sex (chi(2) = 5322.1, P< 0.001) and age (chi(2) = 24,143.3, P < 0.001) groups. Male sex (OR: 1.50, 95% confidence interval (CI): 1.23-1.79), age >= 85 years (OR: 16.39, 95% CI: 7.46-36.00), Barthel Index at admission <= 60 (OR: 25.78, 95% CI: 13.30-49.95), modified Charlson comorbidity index >= 6 (OR: 2.60, 95% CI: 1.91-3.55), International Classification of Diseases-based injury severity score (ICISS) < 0.85 (OR: 15.17, 95% CI: 12.57-18.30), sustaining injuries to the head/neck (OR: 23.20, 95% CI: 7.31-73.64), injuries caused by foreign body entering through natural orifice (OR: 34.00, 95%CI: 6.37-181.54) and injuries resulting from transport accidents (OR: 1.71, 95% CI: 1.41-2.07) were important risk factors for in-hospital mortality for UIs. Conclusions: Hospital DAD are an objective and cost-effective data source that allows for a hospital-based perspective of UI epidemiology. Sex, age, functional status at admission, comorbidities, injury nature, severity and mechanism are significantly associated with the in-hospital mortality of UIs in China. This study generates a reference dataset of diagnosis-specific SRRs from a large trauma population in China, which may be more applicable in injury severity estimation using ICISS in LMICs. (C) 2019 The Authors. Published by Elsevier Ltd.	[Zhang, Meng; Zhou, Jingya; Bai, Xue; Cui, Shengnan; Pang, Cheng; Wang, Yi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Med Records, Beijing, Peoples R China; [Zhang, Meng; Guo, Xiaopeng; Gao, Lu; Zhou, Jingya; Bai, Xue; Cui, Shengnan; Pang, Cheng; Xing, Bing; Wang, Yi] Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Meng; Zhou, Jingya; Bai, Xue; Cui, Shengnan; Pang, Cheng; Wang, Yi] Collaborating Ctr WHO Family Int Classificat, Beijing, Peoples R China; [Zhang, Meng; Zhou, Jingya; Bai, Xue; Cui, Shengnan; Pang, Cheng; Wang, Yi] Natl Ctr Qual Control Med Records, Beijing, Peoples R China; [Guo, Moning] Beijing Municipal Commiss Hlth & Family Planning, Informat Ctr, Beijing, Peoples R China; [Guo, Xiaopeng; Gao, Lu; Xing, Bing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing, Peoples R China; [Gao, Lingling] Peking Univ, Clin Res Inst, Beijing, Peoples R China		Xing, B; Wang, Y (corresponding author), 1 Shuaifuyuan, Beijing 100730, Peoples R China.	xingbingemail@aliyun.com; wypumch@163.com	Gao, Lu/AAH-2415-2021	Gao, Lu/0000-0003-1632-5101; Guo, Xiaopeng/0000-0002-4183-5560; Zhang, Meng/0000-0003-1112-9822			Albirmawy OA, 2011, AURIS NASUS LARYNX, V38, P88, DOI 10.1016/j.anl.2010.05.010; Alexandrescu R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-226; Bhamkar R, 2016, INDIAN J PEDIATR, V83, P1114, DOI 10.1007/s12098-016-2159-2; Botchey IM, 2017, SURGERY, V162, pS54, DOI 10.1016/j.surg.2017.02.016; Bouamra O, 2015, EMERG MED J, V32, P933, DOI 10.1136/emermed-2015-205176; Boufersaoui A, 2013, INT J PEDIATR OTORHI, V77, P1683, DOI 10.1016/j.ijporl.2013.07.026; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Cheng XG, 2007, J CLIN DENSITOM, V10, P276, DOI 10.1016/j.jocd.2007.05.004; China's Central Party Committee and the State Council, 2019, HLTH CHIN 2030 PLANN; Clark DE, 2004, J TRAUMA, V57, P130, DOI 10.1097/01.TA.0000114240.58834.84; Deng X, 2010, CHIN J DIS CONTR PRE, V17, P837; Duan LL, 2015, INJURY, V46, P572, DOI 10.1016/j.injury.2014.12.013; Er Y L, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P1330, DOI 10.3760/cma.j.issn.0254-6450.2017.10.007; Fines P, 2013, CHRON DIS INJ CAN, V33, P204; Gagne M, 2016, J TRAUMA ACUTE CARE, V80, P419, DOI 10.1097/TA.0000000000000944; Gedeborg R, 2014, J TRAUMA ACUTE CARE, V76, P358, DOI 10.1097/TA.0b013e3182a9cd31; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Grossman DC, 2018, JAMA-J AM MED ASSOC, V319, P1696, DOI 10.1001/jama.2018.3097; Gullon A, 2018, EUR J INTERN MED, V47, P69, DOI 10.1016/j.ejim.2017.09.020; Isogai T, 2017, J CARDIOL, V69, P287, DOI 10.1016/j.jjcc.2016.05.008; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI 10.1016/S0140-6736(16)31460-X; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; KILGO PD, 2003, J TRAUMA, V55, P606; Li YM, 2017, J CLIN NEUROSCI, V44, P107, DOI 10.1016/j.jocn.2017.05.026; Ma DR, 2015, TRAFFIC INJ PREV, V16, P835, DOI 10.1080/15389588.2015.1030501; MAHONEY F I, 1965, Md State Med J, V14, P61; New York State Department of Health Bureau of Occupational Health and Injury Prevention., 2012, INC UN INJ DEATHS HO; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Ovalle VW, 2016, J TRAUMA ACUTE CARE, V81, pS14, DOI 10.1097/TA.0000000000001179; Pi HY, 2015, Int J Nurs Sci, V2, P237, DOI 10.1016/j.ijnss.2015.07.002; Ricart PA, 2017, INJURY, V48, P2529, DOI 10.1016/j.injury.2017.08.060; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Scallan E, 2004, J PUBLIC HEALTH-UK, V26, P6, DOI 10.1093/pubmed/fdh107; Suarez-Garcia I, 2009, INJURY PREV, V15, P275, DOI 10.1136/ip.2008.018747; Tohira H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-63; United Nations, 2020, SUSTAINABLE DEV GOAL; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wang J, 2016, CAPITAL J PUBLIC HLT, V4, P148; Wang JX, 2012, ANN REPORT DEV AUTO, P2013; Waqas M, 2018, PEDIATR NEUROSURG, V53, P7, DOI 10.1159/000479561; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2016, GLOB HLTH EST 2015 D; WHO, 2019, INT STAT CLASS DIS R; World Health Organization, 2019, FALLS KEY FACTS; Yadollahi M, 2017, CHIN J TRAUMATOL, V20, P27, DOI 10.1016/j.cjtee.2015.10.006; Yu PL, 2009, BIOMED ENVIRON SCI, V22, P179, DOI 10.1016/S0895-3988(09)60043-X; Zhou B Y, 2018, Zhonghua Liu Xing Bing Xue Za Zhi, V39, P308, DOI 10.3760/cma.j.issn.0254-6450.2018.03.011	47	2	3	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAR	2019	50	3					663	670		10.1016/j.injury.2019.01.029			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	HU0OG	WOS:000464969600007	30709541	hybrid			2022-02-06	
J	Saxena, T; Lyon, JG; Pai, SB; Pare, D; Amero, J; Karumbaiah, L; Carroll, SL; Gaupp, E; Bellamkonda, RV				Saxena, Tarun; Lyon, Johnathan G.; Pai, S. Balakrishna; Pare, Daniel; Amero, Jessica; Karumbaiah, Lohitash; Carroll, Sheridan L.; Gaupp, Eric; Bellamkonda, Ravi V.			Engineering Controlled Peritumoral Inflammation to Constrain Brain Tumor Growth	ADVANCED HEALTHCARE MATERIALS			English	Article						glial scars; glioblastoma; inflammation; reactive gliosis; stromal reprogramming	CHONDROITIN SULFATE PROTEOGLYCANS; IN-VIVO; GLIOBLASTOMA-MULTIFORME; SECONDARY INJURY; DOWN-REGULATION; COLLOIDAL GOLD; GLIOMA-CELLS; GLIAL SCAR; MICROGLIA; NANOPARTICLE	Brain tumors remain a great clinical challenge, in part due to their capacity to invade into eloquent, inoperable regions of the brain. In contrast, inflammation in the central nervous system (CNS) due to injuries activates microglia and astrocytes culminating in an astroglial scar that typically walls-off the injury site. Here, the hypothesis is tested that targeting peritumoral cells surrounding tumors to activate them via an inflammatory stimulus that recapitulates the sequelae of a traumatic CNS injury, could generate an environment that would wall-off and contain invasive tumors in the brain. Gold nanoparticles coated with inflammatory polypeptides to target stromal cells in close vicinity to glioblastoma (GBM) tumors, in order to activate these cells and stimulate stromal CNS inflammation, are engineered. It is reported that this approach significantly contains tumors in rodent models of GBM relative to control treatments (reduction in tumor volume by over 300% in comparison to controls), by the activation of the innate and adaptive immune response, and by triggering pathways related to cell clustering. Overall, this report outlines an approach to contain invasive tumors that can complement adjuvant interventions for invasive GBM such as radiation and chemotherapy.	[Saxena, Tarun; Lyon, Johnathan G.; Carroll, Sheridan L.; Bellamkonda, Ravi V.] Duke Univ, Dept Biomed Engn, Pratt Sch Engn, 101 Sci Dr, Durham, NC 27705 USA; [Pai, S. Balakrishna; Pare, Daniel; Amero, Jessica; Gaupp, Eric] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, UA Whitaker Bldg,313 Ferst Dr, Atlanta, GA 30332 USA; [Pai, S. Balakrishna; Pare, Daniel; Amero, Jessica; Gaupp, Eric] Emory Sch Med, UA Whitaker Bldg,313 Ferst Dr, Atlanta, GA 30332 USA; [Karumbaiah, Lohitash] Univ Georgia, Regenerat Biosci Ctr, 425 River Rd,ADS Complex, Athens, GA 30602 USA		Bellamkonda, RV (corresponding author), Duke Univ, Dept Biomed Engn, Pratt Sch Engn, 101 Sci Dr, Durham, NC 27705 USA.	ravi@duke.edu		Swan, Sheridan/0000-0002-0668-2386; Karumbaiah, Lohitash/0000-0001-7969-417X	Ian's Friends Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD012266-01A1]	D.P. and J.A. contributed equally to this work. R.V.B. and T.S. conceived the idea. T.S. supervised the study, conducted experiments, and analyzed the data. J.G.L. analyzed and illustrated proteomics data. S.B.P. conceived the Zpep extraction and purification strategy. D.P. and J.A. analyzed the MRI data and assisted with nanoparticle fabrication and in vitro experiments. L.K. assisted with aggrecan spot assays. S.L.C. performed the PCR experiments and analysis. E.G. assisted with surgeries and MRI. T.S., J.G.L., and R.V.B. wrote the manuscript. All authors read and edited the manuscript. The authors thank the Ian's Friends Foundation for generously supporting this research. Helpful discussions with, and inputs from, Dr. Syed Enam, Dr. Nalini Mehta, Dr. Daniel Brat, and Dr. Peter Fecci are greatly appreciated. Assistance with immunofluorescence by Ms. Ketki Patil and Mr. William Burke is greatly appreciated. The authors thank Laura Dubois, Dr. Arthur Moseley, and Dr. J. Will Thompson at the Duke Proteomics and Metabolomics Shared Resource for their help with proteomics. This work was performed using a Q-Exactive Plus tandem mass spectrometer acquired via the S10 grant NIH S10OD012266-01A1.	Alvarado AG, 2017, CELL STEM CELL, V20, P450, DOI 10.1016/j.stem.2016.12.001; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Beauchesne Patrick, 2011, Cancers (Basel), V3, P461, DOI 10.3390/cancers3010461; Belting M, 2014, THROMB RES, V133, pS95, DOI 10.1016/S0049-3848(14)50016-3; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Capelle L, 2013, J NEUROSURG, V118, P1157, DOI 10.3171/2013.1.JNS121; Chicoine MR, 2007, NEUROSURGERY, V60, P372, DOI 10.1227/01.NEU.0000249280.61761.2E; Choi H, 2015, J PROTEOMICS, V129, P121, DOI 10.1016/j.jprot.2015.07.036; Chow RD, 2017, NAT NEUROSCI, V20, P1329, DOI 10.1038/nn.4620; CLARK WH, 1991, BRIT J CANCER, V64, P631, DOI 10.1038/bjc.1991.375; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; FESTING MFW, 1978, NATURE, V274, P365, DOI 10.1038/274365a0; Fitch MT, 1999, J NEUROSCI, V19, P8182; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; GERZER R, 1988, THROMB RES, V52, P11, DOI 10.1016/0049-3848(88)90036-9; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Gu L, 2016, NAT REV CANCER, V16, P56, DOI 10.1038/nrc.2015.3; Hamilton JD, 2014, J CLIN ONCOL, V32, pE80, DOI 10.1200/JCO.2013.48.7546; Hwang SY, 2009, BBA-MOL CELL RES, V1793, P1656, DOI 10.1016/j.bbamcr.2009.08.011; Iliadis G, 2009, STRAHLENTHER ONKOL, V185, P743, DOI 10.1007/s00066-009-2015-7; Jain A, 2014, NAT MATER, V13, P309, DOI [10.1038/nmat3878, 10.1038/NMAT3878]; Karumbaiah L, 2014, CURR MED CHEM, V21, P4257, DOI 10.2174/0929867321666140815124447; Karumbaiah L, 2011, GLIA, V59, P981, DOI 10.1002/glia.21170; Kees T, 2012, NEURO-ONCOLOGY, V14, P64, DOI 10.1093/neuonc/nor182; LALAND P, 1963, NATURE, V199, P465, DOI 10.1038/199465a0; Li W, 2013, CNS NEUROL DISORD-DR, V12, P750, DOI 10.2174/18715273113126660171; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; LIOTTA LA, 1984, AM J PATHOL, V117, P339; Liu TT, 2016, AM J NEURORADIOL, V37, P621, DOI 10.3174/ajnr.A4631; Lun M, 2011, J NEURO-ONCOL, V105, P261, DOI 10.1007/s11060-011-0575-8; Lyon JG, 2017, ADV DRUG DELIVER REV, V114, P19, DOI 10.1016/j.addr.2017.06.006; Mathieu D, 2007, CAN J NEUROL SCI, V34, P296, DOI 10.1017/S0317167100006715; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mehta N, 2017, MOL THER-ONCOLYTICS, V4, P1, DOI 10.1016/j.omto.2016.12.003; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Mistry AM, 2017, J NEURO-ONCOL, V132, P341, DOI 10.1007/s11060-017-2374-3; Mora R, 2009, GLIA, V57, P561, DOI 10.1002/glia.20785; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Munson JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003016; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Paciotti GF, 2004, DRUG DELIV, V11, P169, DOI 10.1080/10717540490433895; Perrault SD, 2009, J AM CHEM SOC, V131, P17042, DOI 10.1021/ja907069u; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Phulwani NK, 2008, J IMMUNOL, V181, P3841, DOI 10.4049/jimmunol.181.6.3841; Powell AC, 2010, METHODS MOL BIOL, V624, P375, DOI 10.1007/978-1-60761-609-2_25; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Roller BT, 2015, DRUG DELIV TRANSL RE, V5, P116, DOI 10.1007/s13346-013-0139-x; Sarkar S, 2013, ANN NEUROSCI, V20, P154, DOI 10.5214/ans.0972.7531.200407; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Saxena T, 2015, ACS NANO, V9, P1492, DOI 10.1021/nn505980z; Silver DJ, 2014, CURR OPIN NEUROBIOL, V27, P171, DOI 10.1016/j.conb.2014.03.016; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thobhani S, 2010, J IMMUNOL METHODS, V356, P60, DOI 10.1016/j.jim.2010.02.007; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Varga I, 2012, PATHOL ONCOL RES, V18, P413, DOI 10.1007/s12253-011-9461-0; Viapiano MS, 2005, CANCER RES, V65, P6726, DOI 10.1158/0008-5472.CAN-05-0585; Wade A, 2013, FEBS J, V280, P2399, DOI 10.1111/febs.12109; Waldmannova E, 2016, INT IMMUNOPHARMACOL, V39, P295, DOI 10.1016/j.intimp.2016.08.004; Weller M, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.17; Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14; Yeh YC, 2012, NANOSCALE, V4, P1871, DOI 10.1039/c1nr11188d; Zagzag D, 2005, LAB INVEST, V85, P328, DOI 10.1038/labinvest.3700233	74	2	3	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2192-2640	2192-2659		ADV HEALTHC MATER	Adv. Healthc. Mater.	FEB 21	2019	8	4			SI				1801076	10.1002/adhm.201801076			14	Engineering, Biomedical; Nanoscience & Nanotechnology; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics; Materials Science	HO1UR	WOS:000460697200001	30537355	Green Accepted			2022-02-06	
J	Rydon-Grange, M; Coetzer, R				Rydon-Grange, Michelle; Coetzer, Rudi			Association between cognitive impairments and obsessive-compulsive spectrum presentations following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; obsessive-compulsive symptoms; obsessive-compulsive personality disorder; personality change; cognitive impairment	II PSYCHIATRIC-DISORDERS; MEMORY IMPAIRMENT; HEAD-INJURY; AXIS-I; NEUROPSYCHOLOGICAL PERFORMANCE; ANXIETY DISORDERS; NONVERBAL MEMORY; VISUAL MEMORY; PSYCHOPATHOLOGY; INDIVIDUALS	This study examined the association between self-reported obsessive-compulsive spectrum symptomatology and cognitive performance in a sample of patients with traumatic brain injury (TBI). Twenty-four adults with a moderate-severe TBI accessing a community brain injury rehabilitation service were recruited. Age ranged between 19 and 69 years. Participants completed a battery of neuropsychological tasks assessing memory, executive functioning, and speed of information processing. Self-report questionnaires assessing obsessive-compulsive (OC) symptoms and obsessive-compulsive personality disorder (OCPD) traits were also completed. Correlational analyses revealed that deficits in cognitive flexibility were associated with greater self-reported OC symptomatology and severity. Greater OC symptom severity was significantly related to poorer performance on a visual memory task. Verbal memory and speed of information processing impairments were unrelated to OC symptoms. Performance on tasks of memory, executive functioning, and speed of information processing were not associated with OCPD traits. Overall, results indicate that greater OC symptomatology and severity were associated with specific neuropsychological functions (i.e., cognitive flexibility, visual memory). OCPD personality traits were unrelated to cognitive performance. Further research is needed to examine the potential causal relationship and longer-term interactions between cognitive sequelae and obsessive-compulsive spectrum presentations post-TBI.	[Rydon-Grange, Michelle] Bangor Univ, North Wales Clin Psychol Programme, Bangor, Gwynedd, Wales; [Coetzer, Rudi] Betsi Cadwaladr Univ Hlth Board NHS Wales, North Wales Brain Injury Serv, Colwyn Bay, Wales; [Coetzer, Rudi] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales		Coetzer, R (corresponding author), Betsi Cadwaladr Univ Hlth Board, Colwyn Bay Hosp, North Wales Brain Injury Serv, Hesketh Rd, Colwyn Bay LL29 8AY, Wales.	rudi.coetzer@wales.nhs.uk					Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Abramovitch A, 2013, CLIN PSYCHOL REV, V33, P1163, DOI 10.1016/j.cpr.2013.09.004; Aldea MA, 2009, J ANXIETY DISORD, V23, P124, DOI 10.1016/j.janxdis.2008.05.001; American Psychiatric Association DSM, 2013, DIAGNOSTIC STAT MANU; American Psychiatric Association DSM-IV, 1994, DIAGN STAT MAN MENT; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arco L, 2008, NEUROPSYCHOL REHABIL, V18, P109, DOI 10.1080/09602010701656706; Batistuzzo MC, 2015, NEUROPSYCHOPHARMACOL, V40, P1837, DOI 10.1038/npp.2015.33; Berthier ML, 1996, NEUROLOGY, V47, P353, DOI 10.1212/WNL.47.2.353; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Calabrese WR, 2012, PSYCHOL ASSESSMENT, V24, P751, DOI 10.1037/a0026915; Childers MK, 1998, BRAIN INJURY, V12, P613; CHRISTENSEN KJ, 1992, BIOL PSYCHIAT, V31, P4, DOI 10.1016/0006-3223(92)90003-I; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Clark L. A., 1993, PSYCHOL ASSESSMENT, V5, P81, DOI DOI 10.1037/1040-3590.5.1.81; Clark LA, 1996, PSYCHOL ASSESSMENT, V8, P294, DOI 10.1037/1040-3590.8.3.294; Clark LA, 1993, SCHEDULE ADAPTIVE NO; Coetzer B. R., 2003, J COGNITIVE REHABILI, V21, P4; Coetzer B. R., 2011, J NEUROPSYCHIATRY CL, V22, P12; Coetzer BR, 2004, INT J PSYCHIAT MED, V34, P363, DOI 10.2190/XENN-NNWT-7N2K-R26A; Coetzer R, 2001, PSYCHIAT CLIN NEUROS, V55, P83, DOI 10.1046/j.1440-1819.2001.00792.x; Deckersbach T, 2000, PSYCHOTHER PSYCHOSOM, V69, P101, DOI 10.1159/000012373; Diaz AP, 2014, CNS NEUROSCI THER, V20, P479, DOI 10.1111/cns.12256; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DIRSON S, 1995, PSYCHOTHER PSYCHOSOM, V63, P22, DOI 10.1159/000288933; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Gould KR, 2014, J CLIN EXP NEUROPSYC, V36, P1, DOI 10.1080/13803395.2013.863832; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Grados MA, 2003, INT REV PSYCHIATR, V15, P350, DOI 10.1080/09540260310001606737; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Greisberg S, 2003, CLIN PSYCHOL REV, V23, P95, DOI 10.1016/S0272-7358(02)00232-5; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hendler T, 1999, EUR NEUROPSYCHOPHARM, V9, P371; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hofer H, 2013, NEUROCASE, V19, P390, DOI 10.1080/13554794.2012.690423; Kant R, 1996, BRAIN INJURY, V10, P55; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Koponen S, 2011, BRAIN INJURY, V25, P1029, DOI 10.3109/02699052.2011.607783; Kuelz AK, 2004, BIOL PSYCHOL, V65, P185, DOI 10.1016/j.biopsycho.2003.07.007; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Muller J, 2005, J ANXIETY DISORD, V19, P1, DOI 10.1016/j.janxdis.2003.12.001; Norup A, 2015, ARCH PHYS MED REHAB, V96, P56, DOI 10.1016/j.apmr.2014.08.009; Ogai M, 2005, ACTA PSYCHIAT SCAND, V111, P74, DOI 10.1111/j.1600-0447.2004.00395.x; Olley A, 2007, J AFFECT DISORDERS, V104, P15, DOI 10.1016/j.jad.2007.02.023; Osterreith P., 1993, CLIN NEUROPSYCHOL, V7, P9; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Radomsky AS, 1999, BEHAV RES THER, V37, P605, DOI 10.1016/S0005-7967(98)00151-X; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reynolds SK, 2001, J PERS, V69, P199, DOI 10.1111/1467-6494.00142; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rydon-Grange M, 2015, CNS SPECTRUMS, V20, P463, DOI 10.1017/S109285291500053X; Saipanish R, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0643-2; Savage CR, 2000, NEUROPSYCHOLOGY, V14, P141, DOI 10.1037/0894-4105.14.1.141; Savage CR, 1999, BIOL PSYCHIAT, V45, P905, DOI 10.1016/S0006-3223(98)00278-9; Schmidt M., 1996, REY AUDITORY VERBAL; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shin MS, 2004, NEUROPSYCHOLOGY, V18, P665, DOI 10.1037/0894-4105.18.4.665; Shin NY, 2014, PSYCHOL MED, V44, P1121, DOI 10.1017/S0033291713001803; Stengler-Wenzke K, 2002, AM J PSYCHIAT, V159, P872, DOI 10.1176/appi.ajp.159.5.872; Storch EA, 2007, J CLIN PSYCHOL, V63, P851, DOI 10.1002/jclp.20382; Tallis F, 1999, BEHAV RES THER, V37, P161, DOI 10.1016/S0005-7967(98)00075-8; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058	81	2	2	1	16	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2019	29	2					214	231		10.1080/09602011.2016.1272469			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HE7RF	WOS:000453636700003	28043199				2022-02-06	
J	Ali, MM; Al Zoubi, L; Eissa, M; Splieth, CH				Ali, M. Mustafa; Al Zoubi, L.; Eissa, M.; Splieth, Ch H.			Changes in the epidemiology and aetiology of dental traumatic injuries in permanent teeth in children before and after German unification	EUROPEAN ARCHIVES OF PAEDIATRIC DENTISTRY			English	Article						Dental trauma; Aetiology; Epidemiology; Permanent dentition	PREVALENCE; CARIES	Aim To evaluate the longitudinal occurrence of traumatic dental injuries in permanent teeth comparing recent data from 2014 to 2016 in Greifswald after German unification with a historic sample from socialist times (1974-1989). Materials and methods In this retrospective study, traumatic dental injury parameters as type, date, location, and cause of injury as well as tooth affected were extracted from the trauma records of patients from 1974 to 1989 and 2014-2016. Results The descriptive analysis of 444 teeth in 245 patients revealed that the recent and historic samples had a very similar pattern of dental trauma (201/243 teeth in 117/128 patients, respectively): Maxillary permanent central incisors were affected in 70.7% and 68.3%, respectively. Enamel-dentine fractures were the most prevalent fracture injury in both recent and historic samples (64% and 43.1%, respectively) followed by enamel fractures (20.7% and 36.9%, respectively). Subluxations were the most common luxation traumatic dental injury (44.7%) followed by lateral luxation (39.8%) as reported in the historic sample while in the recent sample subluxation constituted 42.9% of luxation injuries followed by concussion (36.2%). Conclusion This study detected a very stable pattern of dental traumatic injuries over 40 years, even after the change from a socialistic society to a market economy.	[Ali, M. Mustafa; Al Zoubi, L.; Eissa, M.; Splieth, Ch H.] Ernst Moritz Arndt Univ Greifswald, Dept Prevent & Pediat Dent, Walther Rathenau Str 42, Greifswald, Germany		Ali, MM (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Prevent & Pediat Dent, Walther Rathenau Str 42, Greifswald, Germany.	mhmoudali@yahoo.com		Mustafa Ali, Mahmoud/0000-0001-5309-4977			Andersson L, 2013, J ENDODONT, V39, pS2, DOI 10.1016/j.joen.2012.11.021; Bucher K, 2013, DENT TRAUMATOL, V29, P127, DOI 10.1111/j.1600-9657.2012.01149.x; Glendor U, 2001, COMMUNITY DENT ORAL, V29, P150, DOI 10.1034/j.1600-0528.2001.290210.x; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Hurst J W, 1991, Health Care Financ Rev, V12, P73; Krauss MJ, 2007, INFECT CONT HOSP EP, V28, P544, DOI 10.1086/513725; Lam R, 2016, AUST DENT J, V61, P4, DOI 10.1111/adj.12395; Lexomboon D, 2016, DENT TRAUMATOL, V32, P58, DOI 10.1111/edt.12218; Mahmoodi B, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0124-5; Rahimi-Nedjat RK, 2014, DENT TRAUMATOL, V30, P435, DOI 10.1111/edt.12118; Sari ME, 2014, NIGER J CLIN PRACT, V17, P644, DOI 10.4103/1119-3077.141438; Schatz JP, 2013, DENT TRAUMATOL, V29, P110, DOI 10.1111/j.1600-9657.2012.01150.x; Schuch HS, 2013, DENT TRAUMATOL, V29, P297, DOI 10.1111/edt.12003; Soares TRC, 2017, DENT TRAUMATOL, V33, P4, DOI 10.1111/edt.12295; Splieth C, 1996, EUR J ORAL SCI, V104, P444, DOI 10.1111/j.1600-0722.1996.tb00111.x; Tello G, 2016, DENT TRAUMATOL, V32, P274, DOI 10.1111/edt.12255	16	2	2	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1818-6300	1996-9805		EUR ARCH PAEDIATR DE	Eur. Arch. Paediatr. Dent.	FEB	2019	20	1					41	46		10.1007/s40368-018-0383-3			6	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	HM3UA	WOS:000459398600007	30374855				2022-02-06	
J	Berry, JAD; Miulli, DE; Lam, B; Elia, C; Minasian, J; Podkovik, S; Wacker, MRS				Berry, James A. D.; Miulli, Dan E.; Lam, Benjamin; Elia, Christopher; Minasian, Julia; Podkovik, Stacey; Wacker, Margaret R. S.			The neurosurgical wound and factors that can affect cosmetic, functional, and neurological outcomes	INTERNATIONAL WOUND JOURNAL			English	Article						drug-induced liver injury; fatty liver; hepatology	TRAUMATIC BRAIN-INJURY; FREE-RADICALS; RHEUMATOID-ARTHRITIS; NUTRITION; IMPACT; TISSUE; HYPERMETABOLISM; COMPLICATIONS; CHEMOTHERAPY; RADIOTHERAPY	Surgically accessing pathological lesions located within the central nervous system (CNS) frequently requires creating an incision in cosmetic regions of the head and neck. The biggest factors of surgical success typically tend to focus on the middle portion of the surgery, but a vast majority of surgical complications tend to happen towards the end of a case, during closure of the surgical site incisions. One of the most difficult complications for a surgeon to deal with is having to take a patient back to the operating room for wound breakdowns and, even worse, wound or CNS infections, which can negate all the positive outcomes from the surgery itself. In this paper, we discuss the underlying anatomy, pharmacological considerations, surgical techniques and nutritional needs necessary to help facilitate appropriate wound healing. A successful surgery begins with preoperative planning regarding the placement of the surgical incision, being cognizant of cosmetics, and the effects of possible adjuvant radiation therapy on healing incisions. We need to assess patient's medications and past medical history to make sure we can optimise conditions for proper wound reepithelialisation, such as minimizing the amount of steroids and certain antibiotics. Contrary to harmful medications, it is imperative to optimise nutritional intake with adequate supplementation and vitamin intake. The goals of this paper are to reinforce the mechanisms by which surgical wounds can fail, leading to postoperative complications, and to provide surgeons with the reminder and techniques that can help foster a more successful surgical outcome.	[Berry, James A. D.; Elia, Christopher; Podkovik, Stacey] Riverside Univ Hlth Syst, Dept Surg, Div Neurosurg, Moreno Valley, CA 92555 USA; [Miulli, Dan E.; Wacker, Margaret R. S.] Arrowhead Reg Med Ctr, Dept Surg, Div Neurosurg, Colton, CA USA; [Lam, Benjamin] Philadelphia Coll Osteopath Med, Dept Plast & Reconstruct Surg, Philadelphia, PA USA; [Minasian, Julia] Western Univ, Coll Osteopath Med, Dept Neurosurg, Pomona, CA USA		Podkovik, S (corresponding author), Riverside Univ Hlth Syst, Dept Surg, Div Neurosurg, Moreno Valley, CA 92555 USA.	s.podkovik@ruhealth.org		Podkovik, Stacey/0000-0002-4735-1276			Aghajanian P, 2015, J BONE MINER RES, V30, P1945, DOI 10.1002/jbmr.2709; Agur A. M. R., 2009, GRANTS ATLAS ANATOMY; Alteri R., SCARS AND WOUNDS; Anstead G M, 1998, Adv Wound Care, V11, P277; Barry S, 2010, VET COMP ORTHOPAED, V23, P385, DOI 10.3415/VCOT-10-01-0017; Beitz JM, 2017, OSTOMY WOUND MANAG, V63, P18; Brookes M, 1971, BLOOD SUPPLY BONE SC; Buehring B, 2013, J ALLERGY CLIN IMMUN, V132, P1019, DOI 10.1016/j.jaci.2013.08.040; Busti AJ, 2005, PHARMACOTHERAPY, V25, P1566, DOI 10.1592/phco.2005.25.11.1566; Campbell WF, 1908, TXB SURG ANATOMY; Carrillo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089412; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Curtis L, 2014, J NEUROSURG SCI, V58, P151; Cutolo M, 2016, EXPERT REV CLIN IMMU, V12, P417, DOI 10.1586/1744666X.2016.1133295; Deaver JB, 1912, SURG ANATOMY TREATIS; Decker MR, 2012, SURGERY, V152, P382, DOI 10.1016/j.surg.2012.05.001; Dryden Steven V, 2013, Atlas Oral Maxillofac Surg Clin North Am, V21, P37, DOI 10.1016/j.cxom.2012.12.008; Dubrow R, 2013, NEURO-ONCOLOGY, V15, P1750, DOI 10.1093/neuonc/not122; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Grocott P, 2013, CURR OPIN SUPPORT PA, V7, P101, DOI 10.1097/SPC.0b013e32835c0482; Gu Qingyang, 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P71; HADLEY MN, 1989, NUTRITION, V5, P143; HADLEY MN, 1986, NEUROSURGERY, V19, P367, DOI 10.1097/00006123-198609000-00006; Haubner F, 2017, RADIAT ONCOL, V7, P162; Huemer HP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/349176; Hunt ND, 2012, AGE, V34, P1453, DOI 10.1007/s11357-011-9321-6; Iyer SS, 2012, J IMMUNOL, V188, P77, DOI 10.4049/jimmunol.1004027; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; Joaquim AF, 2014, AUTOIMMUN REV, V13, P1195, DOI 10.1016/j.autrev.2014.08.014; Karibe J, 2017, BMJ CASE REP, V2017, P1; Keith J, 2013, SURG NEUROL INT, V4, pS192; Khoo NKH, 2012, FREE RADICAL BIO MED, V52, P2312, DOI 10.1016/j.freeradbiomed.2012.04.011; Kocher M, 2011, J CLIN ONCOL, V29, P134, DOI 10.1200/JCO.2010.30.1655; KOLB BA, 1992, OBSTET GYNECOL, V79, P988; Kourbeti IS, 2015, J NEUROSURG, V122, P1113, DOI 10.3171/2014.8.JNS132557; Ladha H, 2015, J NEURO-ONCOL, V124, P501, DOI 10.1007/s11060-015-1868-0; Lagman M, INVESTIGATING CAUSES; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Li CYC, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002269; Liu D, 2014, CELL PHYSIOL BIOCHEM, V33, P1654, DOI 10.1159/000362948; Liu SA, 2011, HEAD NECK-J SCI SPEC, V33, P954, DOI 10.1002/hed.21560; Liuni FM, 2015, AGING CLIN EXP RES, V27, pS37, DOI 10.1007/s40520-015-0422-4; Magnuson B, 1994, Nutr Clin Pract, V9, P146, DOI 10.1177/0115426594009004146; Maier EA, 2013, VACCINE, V32, P48, DOI 10.1016/j.vaccine.2013.10.072; Meier FMP, 2013, IMMUNOTHERAPY-UK, V5, P955, DOI 10.2217/imt.13.94; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Minami Noriaki, 2014, Surg Neurol Int, V5, P69, DOI 10.4103/2152-7806.132562; Mirastschijski U, 2013, BIOL TRACE ELEM RES, V153, P76, DOI 10.1007/s12011-013-9658-z; Mithal A, 2013, OSTEOPOROSIS INT, V24, P1555, DOI 10.1007/s00198-012-2236-y; Monti P, 2013, DIABETES, V62, P2500, DOI 10.2337/db12-1726; Mtaweh H, 2014, PEDIATR CRIT CARE ME, V15, P242, DOI 10.1097/PCC.0000000000000041; Murapa P, 2012, PHYTOTHER RES, V26, P106, DOI 10.1002/ptr.3510; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Nizam N, 2014, J PERIODONTOL, V85, P636, DOI 10.1902/jop.2013.130184; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Shevel E, 2017, SAMJ S AFR MED J, V107, P691, DOI [10.7196/SAMJ.2017.v107i8.12417, 10.7196/samj.2017.v107i8.12417]; Snall J, 2013, BRIT J ORAL MAX SURG, V51, P808, DOI 10.1016/j.bjoms.2013.08.015; Tauro LF, 2012, J NEUROSCI RURAL PRA, V3, P95, DOI 10.4103/0976-3147.91976; Theilla M, 2013, WORLD REV NUTR DIET, V105, P179, DOI 10.1159/000341297; Trabucchi E, 2002, INT J TISSUE REACT, V24, P65; Xuan YH, 2014, PLOS ONE, V9, P9, DOI DOI 10.1371/J0URNAL.P0NE.0108182; YOUNG B, 1987, J NEUROSURG, V67, P76, DOI 10.3171/jns.1987.67.1.0076	63	2	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-4801	1742-481X		INT WOUND J	Int. Wound J.	FEB	2019	16	1					71	78		10.1111/iwj.12993			8	Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dermatology; Surgery	HH2FU	WOS:000455535100010	30251324	Green Published, Bronze			2022-02-06	
J	Chen, TJ; Ji, MX; Tao, ZQ; Fu, QY; Xiong, K; Cheng, B				Chen, Tie-Jiang; Ji, Ming-Xia; Tao, Zhi-Qiang; Fu, Qing-Yang; Xiong, Kai; Cheng, Bin			The relationship between serum fibrinogen-like protein 2 concentrations and 30-day mortality of patients with traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Fibrinogen-like protein 2; Mortality; Severity	DISEASE PROGRESSION; CONTRIBUTES	Background: Fibrinogen-like protein 2 (FGL2) is an inflammatory procoagulant protein. We discerned the impact of serum FGL2 on trauma severity and 30-day mortality in patients with traumatic brain injury (TBI). Methods: A total of 114 severe TBI patients were subjected to assessment of trauma severity using the Glasgow coma scale (GCS). Measurement of the serum concentrations of FGL2 was done. 114 matched control subjects for their age and sex were included for comparison of serum concentration of FGL2. Results: The concentration of FGL2 was dramatically increased in the patients as compared with the control subjects. FGL2 concentration was inversely correlated with GCS score among the patients. The non-survivors within 30 days exhibited substantially higher FGL2 concentrations than the alive. FGL2 concentrations discriminated the patients at risk of 30-day death with significantly high area under receiver operating characteristic curve. Serum FGL2 emerged as an independent predictor for mortality and overall survival at 30 days after head trauma. Conclusions: Serum FGL2 is a promising biomarker for assessing the severity and prognosis in severe TBI.	[Chen, Tie-Jiang; Ji, Ming-Xia; Tao, Zhi-Qiang; Fu, Qing-Yang; Xiong, Kai; Cheng, Bin] Yiwu Cent Hosp, Dept Emergency Surg, 699 Jiangdong Rd, Yiwu 322000, Zhejiang, Peoples R China		Chen, TJ (corresponding author), Yiwu Cent Hosp, Dept Emergency Surg, 699 Jiangdong Rd, Yiwu 322000, Zhejiang, Peoples R China.	hzhzzhoufeng@163.com					Becker A, 2018, CHIN J TRAUMATOL, V21, P152, DOI 10.1016/j.cjtee.2018.01.004; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Cheng J, 2016, INTERNAL MED, V55, P2343, DOI 10.2169/internalmedicine.55.6149; Condron M, 2018, J TRAUMA ACUTE CARE, V85, P888, DOI 10.1097/TA.0000000000002040; Du Q, 2018, CLIN CHIM ACTA, V487, P145, DOI 10.1016/j.cca.2018.09.035; Hancock WW, 2004, P NATL ACAD SCI USA, V101, P3005, DOI 10.1073/pnas.0308369101; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Mahadewa TGB, 2018, OPEN ACCESS EMERG M, V10, P135, DOI 10.2147/OAEM.S179090; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Melnyk MC, 2011, SCAND J RHEUMATOL, V40, P269, DOI 10.3109/03009742.2010.536163; Nayak Raghavendra, 2018, Asian J Neurosurg, V13, P685, DOI 10.4103/ajns.AJNS_232_16; Nik Amir, 2018, Bull Emerg Trauma, V6, P141, DOI 10.29252/beat-060208; Ogunlade J, 2018, CUREUS, V10, DOI 10.7759/cureus.3042; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Shalev I, 2009, HEPATOLOGY, V49, P387, DOI 10.1002/hep.22684; Su K, 2008, WORLD J GASTROENTERO, V14, P5980, DOI 10.3748/wjg.14.5980; Tang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13149-x; Ye XH, 2014, EXP THER MED, V7, P85, DOI 10.3892/etm.2013.1354; Yuan BQ, 2017, MOL NEUROBIOL, V54, P6187, DOI 10.1007/s12035-016-0141-7; Yuan BQ, 2016, IMMUNOL LETT, V179, P114, DOI 10.1016/j.imlet.2016.10.001; Zhang P, 2015, MICROVASC RES, V99, P36, DOI 10.1016/j.mvr.2015.02.003; Zhu CL, 2005, WORLD J GASTROENTERO, V11, P6936, DOI 10.3748/wjg.v11.i44.6936	25	2	2	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	FEB	2019	489						53	57		10.1016/j.cca.2018.11.033			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	HK1KQ	WOS:000457664200009	30503273				2022-02-06	
J	Chen, XW; Tang, C; Zhou, HW; Li, ZL				Chen, Xiaowei; Tang, CheukYing; Zhou, Hongwei; Li, Zhenlan			Effect of amantadine on vegetative state after traumatic brain injury: a functional magnetic resonance imaging study	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						Vegetative state; traumatic brain injury; fMRI; amantadine; rehabilitation; brain function	DISORDERS; COGNITION; RECOVERY; SCALE	Objective We assessed the use of functional magnetic resonance imaging (fMRI) to observe residual brain function and responsiveness to amantadine in a patient in a vegetative state (VS) following traumatic brain injury. Method We observed cerebral cortex activation in a 52-year-old man in a VS, and in a healthy individual using fMRI during passive listening and motor-imagery tasks. The patient received oral amantadine for 3 months. fMRI was repeated after treatment. Results Activation around the left insular regions occurred during stimulation by a familiar voice, and activity in the left temporal and bi-occipital cortices occurred during stimulation by a familiar/unfamiliar voice. Activity in the bilateral frontal and parietal cortices occurred during the motor-imagination task. Brain cortex activation was reduced in the VS patient compared with the healthy volunteer. However, the patient responded to certain auditory stimuli and motor imagery, suggesting that he retained some intact auditory and motor cortical functions. fMRI scans after 3 months of treatment showed increased activation of brain areas corresponding to task instructions. Conclusion fMRI could be used to observe the effects of amantadine on brain function, and to aid the diagnosis and prognostic prediction in VS patients in terms of recovery and rehabilitation planning.	[Chen, Xiaowei; Li, Zhenlan] Jilin Univ, Hosp 1, Dept Phys Med & Rehabil, XinMin St 71, Changchun 130021, Jilin, Peoples R China; [Tang, CheukYing] Mt Sinai Sch Med, Dept Radiol, New York, NY USA; [Zhou, Hongwei] Jilin Univ, Hosp 1, Dept Radiol, Changchun, Jilin, Peoples R China		Li, ZL (corresponding author), Jilin Univ, Hosp 1, Dept Phys Med & Rehabil, XinMin St 71, Changchun 130021, Jilin, Peoples R China.	lizhenlankfjlu@sina.com			Department of Physical Medicine and Rehabilitation, The First Hospital of Jilin University	The authors would like to acknowledge the support of the Department of Physical Medicine and Rehabilitation, The First Hospital of Jilin University.	Bekinschtein TA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00005; Avezaat C J, 1977, Ned Tijdschr Geneeskd, V121, P2117; Bender A, 2015, DTSCH ARZTEBL INT, V112, P235, DOI 10.3238/arztebl.2015.0235; Cecil RLF, 2012, GOLDMANS CECIL MED; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Dilling Daniel, 2007, Virtual Mentor, V9, P359, DOI 10.1001/virtualmentor.2007.9.5.cprl1-0705; Flannery J, 1993, West J Nurs Res, V15, P465, DOI 10.1177/019394599301500406; Flannery J., 1993, WESTERN J NURS RES, V15, P477; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Ghalaenovi H, 2018, BRAIN INJURY, V32, P1050, DOI 10.1080/02699052.2018.1476733; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gibson RM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00950; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moreno DR, 2010, NEUROLOGY, V75, P1871, DOI 10.1212/WNL.0b013e3181feb259; Naci L, 2014, P NATL ACAD SCI USA, V111, P14277, DOI 10.1073/pnas.1407007111; Owen AM, 2014, NAT REV NEUROL, V10, P370, DOI 10.1038/nrneurol.2014.102; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sharon H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074711; Vogel D, 2013, ARCH PHYS MED REHAB, V94, P1891, DOI 10.1016/j.apmr.2012.11.053	26	2	2	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	FEB	2019	47	2					1015	1024		10.1177/0300060518814127			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	HL6KG	WOS:000458842200055	30514146	Green Published, gold			2022-02-06	
J	Ciszek, R; Ndode-Ekane, XE; Gomez, CS; Casillas-Espinosa, PM; Ali, I; Smith, G; Puhakka, N; Lapinlampi, N; Andrade, P; Kamnaksh, A; Immonen, R; Paananen, T; Hudson, MR; Brady, RD; Shultz, SR; O'Brien, TJ; Staba, RJ; Tohka, J; Pitkanen, A				Ciszek, Robert; Ndode-Ekane, Xavier Ekolle; Gomez, Cesar Santana; Casillas-Espinosa, Pablo M.; Ali, Idrish; Smith, Gregory; Puhakka, Noora; Lapinlampi, Niina; Andrade, Pedro; Kamnaksh, Alaa; Immonen, Riikka; Paananen, Tomi; Hudson, Matthew R.; Brady, Rhys D.; Shultz, Sandy R.; O'Brien, Terence J.; Staba, Richard J.; Tohka, Jussi; Pitkanen, Asla			Informatics tools to assess the success of procedural harmonization in preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis	EPILEPSY RESEARCH			English	Article						Classification; Common data element; Dimensionality reduction; Intraclass correlation; k-nearest neighbor; Lateral fluid-percussion; Machine learning; Traumatic brain injury	COMMON DATA ELEMENTS; PREVENTION	The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) is a National Institutes for Neurological Diseases and Stoke funded Centers-Without-Walls international multidisciplinary study aimed at preventing epileptogenesis. The preclinical biomarker discovery in EpiBios4Rx applies a multicenter study design to allow the number of animals that are required for adequate statistical power for the analysis to be studied in an efficient manner. Further, the use of multiple centers mimics the clinical trial situation, and therefore potentially the chance of successful clinical translation of the outcomes of the study. Its successful implementation requires harmonization of procedures and data analyses between the three contributing centers in Finland, Australia, and USA. The objective of the present analysis was to develop metrics for analysis of the success of harmonization of procedures to guide further data analyses and plan the future multicenter preclinical studies. The interim analysis of data is based on the analysis of data from 212 rats with lateral fluid-percussion injury or sham-operation included in the biomarker discovery by April 30, 2018. The details of protocols, including production of injury, post-injury follow-up, blood sampling, electroencephalogram recording, and magnetic resonance imaging have been presented in the accompanying manuscripts in this Supplement. Implementation of protocols in EpiBios4Rx project participant centers was visualized in 2D using t-distributed stochastic neighborhood embedding (t-SNE). The protocols applied to each rat were presented as feature vectors of procedure related variables (e.g., impact pressure, anesthesia time). The total number of protocol features linked to each rat was 112. The missing data was accounted in visualization by utilizing imputation and adding the number of missing values as a third dimension to 2D t-SNE plot, resulting in a 3D overview of protocol data. Intraclass correlation coefficient (ICC) using Euclidean distances and area under receiver operating characteristic curve (AUC) of k-nearest neighbor classifier (KNN) were utilized to quantify the degree of clustering by center. Both subsets of data with incomplete protocol vectors omitted and missing protocol data imputed were assessed. Our data show that a visible clustering by center was observed in all t-SNE plots, except for day 7 neuroscores. Both ICC and AUC indicated clustering by center in all protocol variable subsets, excluding unimputed day 7 neuroscores (ICC 0.04 and AUC 0.6). ICC for imputed set of all protocol related variables was 0.1 and KNN AUC 0.92. In conclusion, both ICC and AUC indicated differences in protocol between EpiBios4Rx participating centers, which needs to be taken into account in data analysis. Importantly, the majority of observed differences are recoverable as they relate to insufficient updates in record keeping. While AUC score of KNN is a more sensitive measure for protocol harmonization than ICC for data that displays complex splintered clustering, ICC and AUC provide complementary measures to assess the degree of procedural harmonization. This experience should be helpful for other groups planning such multicenter post-traumatic epileptogenesis studies in the future.	[Ciszek, Robert; Ndode-Ekane, Xavier Ekolle; Puhakka, Noora; Lapinlampi, Niina; Andrade, Pedro; Immonen, Riikka; Paananen, Tomi; Tohka, Jussi; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627 Neulaniementie 2, FI-70211 Kuopio, Finland; [Gomez, Cesar Santana; Smith, Gregory; O'Brien, Terence J.; Staba, Richard J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Casillas-Espinosa, Pablo M.; Ali, Idrish; Hudson, Matthew R.; Brady, Rhys D.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia; [Casillas-Espinosa, Pablo M.; Ali, Idrish; Hudson, Matthew R.; Brady, Rhys D.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3052, Australia; [Kamnaksh, Alaa] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD USA; [O'Brien, Terence J.] Alfred Hosp, Dept Neurol, Commercial Rd, Melbourne, Vic 3004, Australia; [O'Brien, Terence J.] Royal Melbourne Hosp, Dept Neurol, Grattan St, Parkville, Vic 3050, Australia		Ciszek, R (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627 Neulaniementie 2, FI-70211 Kuopio, Finland.	ciszek@uef.fi	Andrade, Pedro/N-8410-2018; Ali, Idrish/P-4989-2018; O'Brien, Terence/AAU-5525-2021; Hudson, Matthew/AAH-9168-2020; Tohka, Jussi/D-2385-2013; Staba, Richard/AAN-3149-2021; Santana-Gomez, Cesar/AAY-1014-2021; O'Brien, Terence/L-8102-2013	Andrade, Pedro/0000-0001-9118-8341; Ali, Idrish/0000-0002-0971-4654; Tohka, Jussi/0000-0002-1048-5860; Santana-Gomez, Cesar/0000-0001-9163-5615; Lapinlampi, Niina/0000-0003-3210-6312; Hudson, Matthew/0000-0001-5016-735X; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632; O'Brien, Terence/0000-0002-7198-8621	National Institute of Neurological Disorders and Stroke (NINDS) Centers without Walls [U54 NS100064]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS100064] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) Centers without Walls [grant number U54 NS100064].	Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Casillas-Espinosa P. M., 2019, EPILEPSY RES; Duda R. O., 2016, PATTERN CLASSIFICATI, V2nd; Ekolle Ndode-Ekane X, 2019, EPILEPSY RES; Fisher R.A., 1950, STAT METHODS RES WOR; Flach P.A., 2011, COHERENT INTERPRETAT; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Harte-Hargrove LC, 2017, EPILEPSIA, V58, P78, DOI 10.1111/epi.13906; Immonen R., 2019, EPILEPSY RES; Kahan BC, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-20; Kamnaksh A., 2018, EPILEPSY RES; Kochanek P. M., 2011, J TRAUMA, V71, pS24; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lapinlampi N, 2017, EPILEPSY RES, V129, P87, DOI 10.1016/j.eplepsyres.2016.11.010; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; PitIMnen A., 2017, MODELS SEIZURES EPIL, P661; Pitkanen A., 2018, NEUROBIOL DIS; Santana Gomez C., 2019, EPILEPSY RES; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Ukoumunne OC, 2003, STAT MED, V22, P3805, DOI 10.1002/sim.1643; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wu S, 2012, CONTEMP CLIN TRIALS, V33, P869, DOI 10.1016/j.cct.2012.05.004; Yang Z., 2018, J NEUROTRAUMA, V36	29	2	2	2	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	FEB	2019	150						17	26		10.1016/j.eplepsyres.2018.12.010			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HP1CY	WOS:000461404200003	30605864	Green Accepted			2022-02-06	
J	Glass, SM; Napoli, A; Thompson, ED; Obeid, I; Tucker, CA				Glass, Stephen M.; Napoli, Alessandro; Thompson, Elizabeth D.; Obeid, Iyad; Tucker, Carole A.			Validity of an Automated Balance Error Scoring System	JOURNAL OF APPLIED BIOMECHANICS			English	Article						kinematics; clinical biomechanics; motion analysis; motor behavior; sports medicine	POSTURAL STABILITY; CONCUSSION; INJURY; RELIABILITY; PLATE	The balance error scoring system (BESS) is a human-scored, field-based balance test used in cases of suspected concussion. Recently developed instrumented alternatives to human scoring carry substantial advantages over traditional testing, but thus far report relatively abstract outcomes that may not be useful to clinicians or coaches. In contrast, the automated assessment of postural stability (AAPS) is a computerized system that tabulates error events in accordance with the original description of the BESS. This study compared AAPS and human-based BESS scores. A total of 25 healthy adults performed the modified BESS. Tests were scored twice each by 3 human raters and the computerized system. Interrater (between human) and intermethod (AAPS vs human) agreement (interclass correlation coefficient(2,1)) were calculated alongside Bland-Altman limits of agreement. Interrater analyses were significant (P < .01) and demonstrated good to excellent agreement. Intermethod agreement analyses were significant (P < .01), with agreement ranging from poor to excellent. Computerized scores were equivalent across rating occasions. Limits of agreement ranges for AAPS versus the human average exceeded the average limits of agreement ranges between human raters. Coaches and clinicians may consider a system such as AAPS to automate balance testing while maintaining the familiarity of human-based scoring, although scores should not yet be considered interchangeable with those of a human rater.	[Glass, Stephen M.] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Napoli, Alessandro; Obeid, Iyad; Tucker, Carole A.] Temple Univ, Coll Engn, Dept Elect & Comp Engn, Philadelphia, PA 19122 USA; [Thompson, Elizabeth D.; Tucker, Carole A.] Temple Univ, Coll Publ Hlth, Dept Phys Therapy, Philadelphia, PA 19122 USA; [Glass, Stephen M.] Ohio State Univ, Dept Otolaryngol, Columbus, OH 43210 USA		Glass, SM (corresponding author), Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA.; Glass, SM (corresponding author), Ohio State Univ, Dept Otolaryngol, Columbus, OH 43210 USA.	stephen.glass@osumc.edu		Glass, Stephen/0000-0001-6263-527X			Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; Amick R. Z., 2015, ATHL TRAIN SPORT HLT, V7, P89, DOI DOI 10.3928/19425864-20150422-04; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fleiss J., 1999, DESIGN ANAL CLIN EXP; Goble DJ, 2016, INT J SPORTS PHYS TH, V11, P149; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Napoli A, 2017, ANN BIOMED ENG, V45, P2784, DOI 10.1007/s10439-017-1911-8; NASHNER LM, 1982, J NEUROSCI, V2, P536; Peterka RJ, 1989, J VESTIBUL RES-EQUIL, V1, P73; Revelle W., 2015, PROCEDURES PERSONALI; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Teyhen D, 2014, CURR SPORT MED REP, V13, P52, DOI 10.1249/JSR.0000000000000023; Teyhen DS, 2016, MIL MED, V181, P1324, DOI 10.7205/MILMED-D-15-00297; Teyhen Deydre S, 2012, J Strength Cond Res, V26 Suppl 2, pS61, DOI 10.1519/JSC.0b013e31825d80e6	25	2	2	0	1	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	FEB	2019	35	1					32	36		10.1123/jab.2018-0056			5	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	HK1OQ	WOS:000457675600006	30080433				2022-02-06	
J	Khalayleh, H; Lin, G; Kadar Sfarad, H; Mostafa, M; Abu Abed, N; Imam, A; Zbar, AP; Mavor, E				Khalayleh, H.; Lin, G.; Kadar Sfarad, H.; Mostafa, M.; Abu Abed, N.; Imam, A.; Zbar, A. P.; Mavor, E.			Traumatic Minor Intracranial Hemorrhage: Management by Non-neurosurgeon Consultants in a Regional Trauma Center is Safe and Effective	WORLD JOURNAL OF SURGERY			English	Article							HEAD COMPUTED-TOMOGRAPHY; GLASGOW COMA SCALE; WORKFORCE-A BLUEPRINT; BRAIN-INJURY; MILD; CARE; UTILITY; CRANIOTOMY; SURGERY; ABSENCE	BackgroundThere is debate concerning the need for specialist neurosurgical transfer of patients presenting to Level II trauma centers with a minimal head injury (Glasgow Coma Scale 13) and a small non-progressive intracranial bleeding (ICB).MethodsA retrospective chart analysis was performed assessing the outcomes of adult patients presenting with a minor traumatic ICB on initial CT scan (minimal subarachnoid hemorrhage; small-width subdural hematoma without shift; punctate cerebral contusion). Patients with extradural hematomas and those patients on antiplatelet or anticoagulant therapy were excluded from the protocol.ResultsOverall 291 cases were assessed (mean age 69.9years) with 75% of cases presenting after a fall. There was deterioration of neurological status in 11 patients (3.8%) with 8 hospital transfers and 5 with an abnormal neurological examination (NE). Two patients with an abnormal INR and a worsening head CT were transferred without neurosurgical intervention. Of the 8 transferred cases there were 2 deaths (both >90years of age with multiple comorbidities) with one craniotomy performed for a subdural hematoma (with full recovery). Three patients meeting transfer criteria were not transferred with one death (patient >90years of age with severe dementia). The remaining 2 patients were discharged with normal neurological outcomes.ConclusionsPatients with a minimal traumatic brain injury and a non-progressive minor ICB may be safely managed in a Level II trauma center by an acute care consultant with neurosurgical consultation but without the need for neurosurgical transfer.Level of evidenceRetrospective analysis: Level IV.	[Khalayleh, H.; Lin, G.; Kadar Sfarad, H.; Mostafa, M.; Abu Abed, N.; Imam, A.; Zbar, A. P.; Mavor, E.] Hebrew Univ Jerusalem, Sch Med, Dept Gen Surg, Kaplan Med Ctr, IL-76100 Rehovot, Israel		Khalayleh, H (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Gen Surg, Kaplan Med Ctr, IL-76100 Rehovot, Israel.	kraceve30@hotmail.com		Imam, Ashraf/0000-0003-0172-3844			Ashkenazi I, 2007, EMERG MED J, V24, P550, DOI 10.1136/emj.2006.044461; Barker DE, 2006, AM SURGEON, V72, P1166; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Catalano AR, 2012, NEUROCRIT CARE, V17, P324, DOI 10.1007/s12028-012-9679-z; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Harbrecht BG, 2010, J TRAUMA, V68, P1367, DOI 10.1097/TA.0b013e3181d990da; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Huynh T, 2006, AM SURGEON, V72, P1162; Jagoda AS, 2010, PSYCHIAT CLIN N AM, V33, P797, DOI 10.1016/j.psc.2010.09.004; Joseph B, 2015, JAMA SURG, V150, P866, DOI 10.1001/jamasurg.2015.1134; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, AM SURGEON, V80, P43; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kim BJ, 2014, ACTA NEUROCHIR, V156, P1605, DOI 10.1007/s00701-014-2151-4; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nayak NV, 2013, J TRAUMA ACUTE CARE, V75, P273, DOI 10.1097/TA.0b013e3182905eb4; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Reljic T, 2014, J NEUROTRAUM, V31, P78, DOI 10.1089/neu.2013.2873; RHODES M, 1993, J TRAUMA, V35, P384, DOI 10.1097/00005373-199309000-00009; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salim A, 2013, J TRAUMA ACUTE CARE, V74, P973; Scantling D, 2017, EUR J TRAUMA EMERG S, V43, P741, DOI 10.1007/s00068-017-0793-7; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Thorson CM, 2013, J TRAUMA ACUTE CARE, V74, P967, DOI 10.1097/TA.0b013e3182877fed; Valadka AB, 2001, NEUROSURGERY, V48, P17, DOI 10.1097/00006123-200101000-00004; Valadka AB, 2010, J TRAUMA, V68, P1372; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	35	2	2	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	FEB	2019	43	2					497	503		10.1007/s00268-018-4821-5			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HH2NO	WOS:000455555600023	30361746				2022-02-06	
J	MacDonald, SL; Robinson, LR				MacDonald, Shannon L.; Robinson, Lawrence R.			The Incidence of Physiatry-Relevant Complications in Trauma Patients Admitted to an Urban Canadian Trauma Center	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Physical and Rehabilitation Medicine; Referral and Consultation; Rehabilitation; Wounds and Injuries	SPINAL-CORD-INJURY; CARE; PNEUMONIA; DELIRIUM	The objective of this study was to describe the incidence of complications in trauma patients that could be prevented, diagnosed, or managed by a consulting acute care physiatrist. Demographic and complication data were extracted by chart review of adult trauma patients admitted to a Canadian academic trauma center. Subjects were included if they had a diagnosis of traumatic brain injury, spinal cord injury, or multiple injuries resulting in an Injury Severity Score greater than 15. Means and standard deviations were calculated for continuous variables and frequencies for categorical data. Secondary analyses involved using Spearman's rho and chi(2) analysis to examine relationships between the development of complications and various patient factors. A total of 286 individuals were included. The overall incidence of a physical medicine & rehabilitation-relevant complication was 32.9%. The complications with the highest incidence were pneumonia (15.5%), delirium (14.1%), and urinary tract infection (13.4%). Secondary analyses demonstrated associations between the development of complications with older age, the presence of comorbidities, having both a traumatic brain injury and spinal cord injury, and length of stay. This study demonstrated that trauma patients may experience multiple complications that are of relevance to the consulting physiatrist.	[MacDonald, Shannon L.; Robinson, Lawrence R.] Univ Toronto, Div Phys Med & Rehabil, Dept Med, Toronto, ON, Canada; [Robinson, Lawrence R.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada		Robinson, LR (corresponding author), St Johns Rehab, 285 Cummer Ave,Room S125, Toronto, ON M2M 2G1, Canada.		MacDonald, Shannon/AAG-5960-2020	MacDonald, Shannon/0000-0001-5022-4449; Robinson, Lawrence/0000-0002-9590-8745	Sunnybrook Academic Health Science Centre Alternative Funding Plan Innovation Fund	The project was funded by the Sunnybrook Academic Health Science Centre Alternative Funding Plan Innovation Fund.	Angles EM, 2008, AM J SURG, V196, P864, DOI 10.1016/j.amjsurg.2008.07.037; [Anonymous], 2013, NAT TRAUM REG REP 20; Banerjee A, 2011, CURR OPIN ANESTHESIO, V24, P195, DOI 10.1097/ACO.0b013e3283445382; Clark DE, 2013, PHYS THER, V93, P186, DOI 10.2522/ptj.20110417; Clavet H, 2008, CAN MED ASSOC J, V178, P691, DOI 10.1503/cmaj.071056; Duceppe MA, 2019, J INTENSIVE CARE MED, V34, P330, DOI 10.1177/0885066617698646; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Glance LG, 2012, ARCH SURG-CHICAGO, V147, P732, DOI 10.1001/archsurg.2012.1138; Hashmi ZG, 2014, J TRAUMA ACUTE CARE, V76, P1184, DOI 10.1097/TA.0000000000000215; Hemmila MR, 2008, SURGERY, V144, P307, DOI 10.1016/j.surg.2008.05.003; Hyllienmark P, 2013, ACTA ANAESTH SCAND, V57, P848, DOI 10.1111/aas.12111; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Krassioukov AV, 2003, J NEUROTRAUM, V20, P707, DOI 10.1089/089771503767869944; Lichte P, 2015, INT ORTHOP, V39, P947, DOI 10.1007/s00264-015-2698-6; Melchiorre PJ, 1998, ARCH PHYS MED REHAB, V79, P62, DOI 10.1016/S0003-9993(98)90210-6; Mondello S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/473419; OSullivan KL, 1997, J TRAUMA, V42, P276, DOI 10.1097/00005373-199702000-00016; White BAB, 2017, J NEUROTRAUM, V34, P2892, DOI 10.1089/neu.2016.4934	19	2	2	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	2019	98	2					165	168		10.1097/PHM.0000000000001021			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	HH8NY	WOS:000455990100016	30124492				2022-02-06	
J	Majmundar, N; Sarris, C; Shastri, D; Doran, J; Gandhi, C; Assina, R				Majmundar, Neil; Sarris, Christina; Shastri, Darshan; Doran, Joseph; Gandhi, Chirag; Assina, Rachid			Hemorrhagic Complications of External Ventriculostomy in the Aspirin and P2Y12 Response Assay Era	WORLD NEUROSURGERY			English	Article						Catheter-induced hemorrhage (CIH); External ventricular drain (EVD); External ventriculostomy; Platelet inhibition assay; VerifyNow assay	PLATELET TRANSFUSION; ANTIPLATELET AGENTS; INTRACEREBRAL HEMORRHAGE; ANTICOAGULANT-THERAPY; DRAIN PLACEMENT; BLOOD-PRESSURE; RATES; INHIBITION; REACTIVITY; INSERTION	OBJECTIVE: Hemorrhagic complications reported from external ventricular drain (EVD) placement range from 10% to 44%. There remains limited literature investigating the incidence, risk factors, and mechanisms to prevent its occurrence, especially in the setting of antiplatelet agent use. We investigated EVD-related hemorrhagic complications after the implementation of VerifyNow platelet inhibition assays at our institution. METHODS: Medical records from 445 patients requiring EVD placement during a 2-year period during which our institution used the assays were reviewed. In total 345 patients were included, and 208 of them underwent assay testing. Indications for EVD included complications of cerebrovascular disease (n = 215), traumatic brain injury (n = 74), primary hydrocephalus (n = 23), and tumor (n = 33). Hemorrhage was defined as any new area of hyperdensity adjacent to or immediately along the catheter trajectory on computed tomography. RESULTS: There was no significant decrease in catheter-induced hemorrhage (CIH) between patients who underwent the VerifyNow assay and those who did not. Platelet transfusion did not significantly decrease the risk of CIH. CIH occurred in 17.7% of patients, significantly decreased when compared with our previously published incidence of 33% before platelet inhibition assay use (P < 0.05). Patients with cerebrovascular disease complications exhibited a significant decrease in CIH, 20% versus 39%, before assay use (P < 0.01). CONCLUSIONS: The incidence of hemorrhage is lower in our new cohort when compared with that of our previously published cohort. Despite the overall decreased rate of hemorrhage, there was no significant difference in hemorrhage rates between patients who did or did not undergo the assay. Platelet transfusion did not decrease the incidence of hemorrhage in patients with inhibited platelet function.	[Majmundar, Neil; Doran, Joseph; Assina, Rachid] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA; [Sarris, Christina] St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ USA; [Shastri, Darshan] Univ N Carolina, Dept Neurosurg, Chapel Hill, NC 27515 USA; [Gandhi, Chirag] NY Med Coll, Westchester Med Ctr, Dept Neurosurg, Valhalla, NY USA		Assina, R (corresponding author), Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA.	assinara@njms.rutgers.edu		Majmundar, Neil/0000-0001-5910-6094; Doran, Joseph/0000-0001-6341-6714; Shastri, Darshan/0000-0001-7062-2786			Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Bauer DF, 2011, J TRAUMA, V70, P1112, DOI 10.1097/TA.0b013e3181e7c2ae; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Butcher K, 2003, J CLIN NEUROSCI, V10, P158, DOI 10.1016/S0967-5868(02)00324-7; Choi PA, 2017, NEUROSURGERY, V80, P98, DOI 10.1227/NEU.0000000000001401; Dey M, 2012, CURR NEUROL NEUROSCI, V12, P24, DOI 10.1007/s11910-011-0231-x; Gardner PA, 2009, J NEUROSURG, V110, P1021, DOI 10.3171/2008.9.JNS17661; GRATZ I, 1992, J THORAC CARDIOV SUR, V104, P1417; Husted SE, 2006, EUR HEART J, V27, P913, DOI 10.1093/eurheartj/ehi714; Ko JK, 2014, NEUROL MED-CHIR, V54, P545, DOI 10.2176/nmc.oa.2013-0178; Kung DK, 2011, J NEUROSURG, V114, P1021, DOI 10.3171/2010.9.JNS10445; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; Maruishi M, 2001, NEUROL MED-CHIR, V41, P300, DOI 10.2176/nmc.41.300; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Moon HH, 2009, J KOREAN NEUROSURG S, V46, P215, DOI 10.3340/jkns.2009.46.3.215; Muller A, 2018, NEUROCRIT CARE, V29, P23, DOI 10.1007/s12028-017-0492-6; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Pakala R, 2011, CARDIOVASC REVASCULA, V12, P312, DOI 10.1016/j.carrev.2010.09.005; Park YG, 2011, J KOREAN NEUROSURG S, V50, P317, DOI 10.3340/jkns.2011.50.4.317; Parry PV, 2017, NEUROSURGERY, V80, P92, DOI 10.1227/NEU.0000000000001406; Patal R, 2012, HAREFUAH, V151, P61; Patal R, 2012, HAREFUAH, V151, P62; Powner DJ, 2005, NEUROSURGERY, V57, P823, DOI 10.1227/01.NEU.0000179915.74429.b2; Ranucci M, 2007, J CARDIOTHOR VASC AN, V21, P851, DOI 10.1053/j.jvca.2007.05.009; Rasool AHG, 2004, J HUM HYPERTENS, V18, P187, DOI 10.1038/sj.jhh.1001647; Rehman T, 2012, CLIN NEUROL NEUROSUR, V114, P651, DOI 10.1016/j.clineuro.2011.12.040; Rowe AS, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1030-7; Sussman ES, 2014, J NEUROSURG, V120, P931, DOI 10.3171/2013.12.JNS131685; Taylor G, 2013, J TRAUMA ACUTE CARE, V74, P1367, DOI 10.1097/TA.0b013e31828cca61; Wiesmann M, 2001, J CLIN NEUROSCI, V8, P126, DOI 10.1054/jocn.2000.0749; Yuen J, 2018, ANN ROY COLL SURG, V100, P221, DOI 10.1308/rcsann.2017.0221; Zhu X, 2017, J NEUROSURG SCI, V61, P53	33	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2019	122						E961	E968		10.1016/j.wneu.2018.10.181			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HJ6UM	WOS:000457328100116	30439521				2022-02-06	
J	Makino, Y; Arai, N; Hoshioka, Y; Yoshida, M; Kojima, M; Horikoshi, T; Mukai, H; Iwase, H				Makino, Yohsuke; Arai, Nobutaka; Hoshioka, Yumi; Yoshida, Maiko; Kojima, Masatoshi; Horikoshi, Takuro; Mukai, Hiroki; Iwase, Hirotaro			Traumatic axonal injury revealed by postmortem magnetic resonance imaging: A case report	LEGAL MEDICINE			English	Article						Diffuse axonal injury; Autopsy; Magnetic resonance imaging; Forensic pathology; Neuropathology	AMYLOID PRECURSOR PROTEIN; NONMISSILE HEAD-INJURY; QUANTITATIVE-ANALYSIS; WHITE-MATTER; BRAIN-DAMAGE; DIAGNOSIS; AUTOPSY; MRI	In forensic investigations, it is important to detect traumatic axonal injuries (TAIs) to reveal head trauma that might otherwise remain occult. These lesions are subtle and frequently ambiguous on macroscopic evaluations. We present a case of TAI revealed by pre-autopsy postmortem magnetic resonance imaging (PMMR). A man in his sixties was rendered unconscious in a motor vehicle accident. CT scans revealed traumatic mild subarachnoid hemorrhage. Two weeks after the accident he regained consciousness, but displayed an altered mental state. Seven weeks after the accident, he suddenly died in hospital. Postmortem computed tomography (PMCT) and PMMR were followed by a forensic autopsy. PMMR showed low-intensity lesions in parasagittal white matter, deep white matter, and corpus callosum on three-dimensional gradient-echo Tl-weighted imaging (3D-GRE T1WI). In some of these lesions, T2*-weighted imaging also showed low-intensity foci suggesting hemorrhagic axonal injury. The lesions were difficult to find on PMCT and macroscopic evaluation, but were visible on antemortem MRI and confirmed as TAIs on histopathology. From this case, it can be said that PMMR can detect subtle TAIs missed by PMCT and macroscopic evaluation. Hence, pre-autopsy PMMR scanning could be useful for identifying TAIs during forensic investigations.	[Makino, Yohsuke; Iwase, Hirotaro] Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Makino, Yohsuke; Hoshioka, Yumi; Yoshida, Maiko; Kojima, Masatoshi; Iwase, Hirotaro] Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan; [Arai, Nobutaka] Tokyo Metropolitan Inst Med Sci, Lab Neuropathol, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Horikoshi, Takuro; Mukai, Hiroki] Chiba Univ Hosp, Dept Radiol, Chuo Ku, 1-8-1 Inohana, Chiba 2608677, Japan		Makino, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	ymakino-tky@umin.ac.jp		Horikoshi, Takuro/0000-0003-1433-2914	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP16H06242, JP26870102]	This work was supported by JSPS KAKENHI Grant Number JP16H06242, and JP26870102. The authors would like to thank Makoto Nakajima, Hisako Saitoh, Katsura Otsuka, Kazuhiro Kobayashi, Sayaka Nagaskawa, Ayaka Sakuma, Shiori Kasahara, Miyuki Miura Keisuke Okaba, and Namio Ishii for their technical support. We thank Libby Cone, MD, MA, from Edanz Group Japan (www.edanzediting.com/ac) for editing a draft of this manuscript.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1989, SCOT MED J, V34, P399, DOI 10.1177/003693308903400106; Adolphi NL, 2016, J FORENSIC RADIOL IM, V4, P27, DOI 10.1016/j.jofri.2015.12.007; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Birkl C, 2014, MAGN RESON MED, V71, P1575, DOI 10.1002/mrm.24799; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Cicuendez M, 2017, NEUROCIRUGIA, V28, P266, DOI [10.1016/j.neucir.2017.06.001, 10.1016/j.neucie.2017.06.007]; Davceva N, 2012, Soud Lek, V57, P2; Davceva N, 2015, AM J FOREN MED PATH, V36, P127, DOI 10.1097/PAF.0000000000000168; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Geddes J. F., 2000, NEUROPATHOL APPL NEU, V23, P339; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Graham D I, 1983, Acta Neurochir Suppl (Wien), V32, P65; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Kobayashi T, 2010, JPN J RADIOL, V28, P8, DOI 10.1007/s11604-009-0373-9; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Mata-Mbemba D, 2018, J NEUROSURG, V129, P1317, DOI 10.3171/2017.6.JNS17466; MAXWELL WL, 1994, J NEUROCYTOL, V23, P379, DOI 10.1007/BF01666527; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Tashiro K, 2015, MAGN RESON MED SCI, V14, P51, DOI 10.2463/mrms.2013-0126; Thali MJ, 2003, J FORENSIC SCI, V48, P386; TOMEI G, 1990, ACTA NEUROPATHOL, V80, P506, DOI 10.1007/BF00294611; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013; Zech WD, 2015, EUR RADIOL, V25, P2381, DOI 10.1007/s00330-015-3588-4; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501	37	2	2	1	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	FEB	2019	36						9	16		10.1016/j.legalmed.2018.09.019			8	Medicine, Legal; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Biomedical Social Sciences	HK3MO	WOS:000457820800002	30312836				2022-02-06	
J	Mino, M; Fujimura, M; Yoshida, M; Sonobe, S; Tominaga, T				Mino, Masaki; Fujimura, Miki; Yoshida, Masahiro; Sonobe, Shinya; Tominaga, Teiji			Application of neuro-endoscopic target aspiration of the necrotic core for cerebral contusion with delayed progression: technical note	ACTA NEUROCHIRURGICA			English	Article						Cerebral contusion; Endoscopic; Intracranial pressure; Edema		BackgroundThe optimal management strategy for cerebral contusion remains controversial, especially when standard craniotomy could not be used. We performed neuro-endoscopic target lesionectomy for the delayed progression of cerebral contusion in order to aspirate the necrotic core, which is the primal source of contusional edema.MethodsThe present study included 10 consecutive patients (2 women and 8 men, with a mean age of 67years old) with traumatic brain injury presenting with delayed deterioration of cerebral contusion where standard craniotomy could not be used. Neuro-endoscopic aspiration of the necrotic core was prospectively performed for all patients. We assessed the computed tomography findings after surgery to evaluate the efficacy of this procedure.ResultsEndoscopic surgery was performed promptly after neurological deterioration, with a mean interval between trauma and surgery of 7days, ranging from 2 to 16days. During the operation, the centers of contusions comprised serous liquid components in all 10 patients and were easily aspirated by endoscopy. Contusional edemas were markedly decreased in all within 3days after surgery.ConclusionsProgression of contusional edema can be caused by the accumulation of water into the necrotic core due to the rapid increase in osmolality. In light of the highly liquefied demarcated characteristics of the necrotic core, neuro-endoscopic aspiration could be an optional treatment strategy for cerebral contusion with delayed progression in a minimally invasive manner.	[Mino, Masaki; Yoshida, Masahiro; Sonobe, Shinya] Osaki Citizen Hosp, Dept Neurosurg, Osaki, Japan; [Fujimura, Miki] Kohnan Hosp, Dept Neurosurg, Taihaku Ku, 4-20-1 Nagamachiminami, Sendai, Miyagi 9828523, Japan; [Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi, Japan		Fujimura, M (corresponding author), Kohnan Hosp, Dept Neurosurg, Taihaku Ku, 4-20-1 Nagamachiminami, Sendai, Miyagi 9828523, Japan.	fujimur417@kohnan-sendai.or.jp					Katayama Y, 1998, ACT NEUR S, V71, P289; KATAYAMA Y, 1992, NEURORADIOLOGY, V34, P381, DOI 10.1007/BF00596494; Kawamata T, 2006, ACTA NEUROCHIR SUPPL, V96, P3; Kawamata T, 2007, PROG BRAIN RES, V161, P235, DOI 10.1016/S0079-6123(06)61016-9; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; Marion DW, 2006, NEUROSURGERY, V58, P655; Shima Katsuji, 2010, Asian J Neurosurg, V5, P15	8	2	3	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2019	161	2					225	230		10.1007/s00701-018-3753-z			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HL1RG	WOS:000458477400004	30515614				2022-02-06	
J	Murray, NG; Reed-Jones, RJ; Szekely, BJ; Powell, DW				Murray, Nicholas G.; Reed-Jones, Rebecca J.; Szekely, Brian J.; Powell, Douglas W.			Clinical Assessments of Balance in Adults with Concussion: An Update	SEMINARS IN SPEECH AND LANGUAGE			English	Article						balance assessment; postural control; dual task; gait; oculomotor	TRAUMATIC BRAIN-INJURY; ANTICIPATORY POSTURAL ADJUSTMENTS; ERROR SCORING SYSTEM; HIGH-SCHOOL FOOTBALL; GAIT INITIATION; HEAD IMPACTS; DUAL-TASK; TRACKING SYSTEM; SMOOTH-PURSUIT; SINGLE-TASK	Postural instability is a cardinal indicator of concussion. Assessments of the postural control system range from clinical to laboratory tests that assess the balance of the individual. In a previous article regarding clinical assessment of balance in adults with concussion, we reviewed the importance of balance as a component in concussion evaluations. The purpose of this review article is to update the information previously published in 2014. Since 2014, research has provided evidence for the incorporation of dynamic methods for evaluating balance postconcussion with particular emphasis on sensory system integration and dual tasking. Therefore, this review will examine the current state of knowledge on how concussion injuries affect postural control, advancements in evaluating balance postconcussion, such as novel eye-tracking techniques, and current recommendations for best practices for balance assessment.	[Murray, Nicholas G.; Szekely, Brian J.] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA; [Reed-Jones, Rebecca J.] Univ Prince Edward Isl, Dept Appl Human Sci, Fac Sci, Charlottetown, PE, Canada; [Powell, Douglas W.] Univ Memphis, Sch Hlth Studies, Memphis, TN 38152 USA		Murray, NG (corresponding author), Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA.	nicholasmurray@unr.edu					[Anonymous], 1995, GAIT POSTURE; Baloh RW, 1998, ARCH NEUROL-CHICAGO, V55, P649, DOI 10.1001/archneur.55.5.649; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Buckley TA, 2017, ARCH PHYS MED REHAB, V98, P1962, DOI 10.1016/j.apmr.2017.05.002; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Chang WH, 2010, GAIT POSTURE, V32, P487, DOI 10.1016/j.gaitpost.2010.07.007; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; Dierijck JK, 2018, INT J PSYCHOPHYSIOL, V132, P74, DOI 10.1016/j.ijpsycho.2018.03.005; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halliday SE, 1998, GAIT POSTURE, V8, P8, DOI 10.1016/S0966-6362(98)00020-4; Hanninen T, 2018, J SCI MED SPORT, V21, P794, DOI 10.1016/j.jsams.2017.12.001; Hass CJ, 2008, CLIN BIOMECH, V23, P743, DOI 10.1016/j.clinbiomech.2008.02.012; Hass CJ, 2012, GAIT POSTURE, V35, P669, DOI 10.1016/j.gaitpost.2011.12.022; Hass CJ, 2005, ARCH PHYS MED REHAB, V86, P2172, DOI 10.1016/j.apmr.2005.05.013; Hearn MC, 2018, CLIN J SPORT MED, V28, P177, DOI 10.1097/JSM.0000000000000435; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; HENRY FM, 1960, RES QUART, V31, P448, DOI 10.1080/10671188.1960.10762052; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Horak FB, 1997, GAIT POSTURE, V6, P76, DOI 10.1016/S0966-6362(97)00018-0; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; Levy SS, 2018, J GERIATR PHYS THER, V41, P102, DOI 10.1519/JPT.0000000000000111; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Murray NG, 2018, MEASUREMENT, V126, P96, DOI 10.1016/j.measurement.2018.05.039; Murray NG, 2018, INT J PSYCHOPHYSIOL, V132, P81, DOI 10.1016/j.ijpsycho.2017.09.018; O'Connor SM, 2016, J BIOMECH, V49, P4142, DOI 10.1016/j.jbiomech.2016.10.020; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Powell DW, 2015, HUM MOVEMENT SCI, V44, P73, DOI 10.1016/j.humov.2015.08.013; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Reed-Jones RJ, 2014, SEMIN SPEECH LANG, V35, P186, DOI 10.1055/s-0034-1384680; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Schmidt JD, 2018, J ATHL TRAINING, V53, P109, DOI 10.4085/1062-6050-326-16; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Sosnoff JJ, 2008, MED SCI SPORT EXER, V40, pS69, DOI 10.1249/01.mss.0000321749.54286.56; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Williams DSB, 2016, J SPORT HEALTH SCI, V5, P70, DOI 10.1016/j.jshs.2016.01.010; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	64	2	2	2	7	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	FEB	2019	40	1					48	56		10.1055/s-0038-1676451			9	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HG5OT	WOS:000455027900006	30616294				2022-02-06	
J	Rugg, A				Rugg, Adam			Working Out Their Future: The NFL's Play 60 Campaign and the Production of Adolescent Fans and Players	JOURNAL OF SPORT & SOCIAL ISSUES			English	Article						NFL; concussions; football; youth sports; physical education	CHILDHOOD OBESITY; MOVE	This article critically examines the National Football League's (NFL) extensive "Play 60" campaign that operates in more than 73,000 schools in the United States. The year-round program-marketed as a campaign to end childhood obesity-now holds significance influence over school curriculums and operations, public constructions of health and diet, and governmental recommendations and policies on health and exercise. This article argues that the emergence of the Play 60 campaign as a major influence in these areas reflects the increasing privatization of physical education and wellness in U.S. schools. Furthermore, the program serves the commercial and political interests of the league by instilling familiarity with the labor and verbiage of football in program participants and advocating for the role of athletes (and the leagues they are a part of) in influencing youth ideas regarding nutrition and health. Most importantly, the program situates football as a safe and healthy practice for children amid increasing societal awareness and concern over the substantial health risks associated with playing youth football.	[Rugg, Adam] Fairfield Univ, Commun, Fairfield, CT 06430 USA		Rugg, A (corresponding author), Fairfield Univ, Dept Commun, 1073 North Benson Rd, Fairfield, CT 06824 USA.	arugg@fairfield.edu					[Anonymous], 2016, CHILDS PLAY SPORT KI; [Anonymous], 2010, PR NEWSWIRE; [Anonymous], 2016, ASS PRESS; [Anonymous], 2008, PR NEWSWIRE; Ayo N, 2012, CRIT PUBLIC HEALTH, V22, P99, DOI 10.1080/09581596.2010.520692; Baker A., 2012, NY TIMES; Ball S.J., 2012, GLOBAL ED INC NEW PO; Barry CL, 2011, PEDIATRICS, V128, P132, DOI 10.1542/peds.2010-3924; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; Centers for Disease Control and Prevention, 2014, PHYS ED PROF 2012 PH; Fainaru S., 2014, ESPN; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Farley TA, 2014, AM J PUBLIC HEALTH, V104, P1579, DOI 10.2105/AJPH.2014.302015; Feudtner C, 2018, JAMA PEDIATR, V172, P492, DOI 10.1001/jamapediatrics.2017.5242; GENYOUth, 2015, GENYOUTH KICKS FUEL; GENYOUth Foundation, 2011, GENYOUTH LAUNCH NFL; Harty S., 1979, HUCKSTERS CLASSROOM; Howard M., 2016, REUTERS; Jacob Feldman FanDuel, 2018, SPORTS ILLUSTRATED; Jette S, 2016, SPORT EDUC SOC, V21, P1109, DOI 10.1080/13573322.2014.993961; Keilman J., 2017, CHICAGO TRIBUNE; King S., 2006, PINK RIBBONS INC BRE; King S, 2010, HEALTH COMMUN, V25, P286, DOI 10.1080/10410231003698960; Laurendeau J, 2015, SOCIOL SPORT J, V32, P332, DOI 10.1123/ssj.2014-0160; Macdonald D, 2011, QUEST, V63, P36, DOI 10.1080/00336297.2011.10483661; Messner MA, 2014, SOCIOL SPORT J, V31, P102, DOI 10.1123/ssj.2013-0111; Miller P., 2008, GOVERNING PRESENT AD; Murphy B., 2018, NEWS OBSERVER   0119; National Academy of Medicine, 2013, SCH SHOULD PROV OPP; National Football League, 2007, NFL LAUNCH NFL PLAY; National Football League, 2014, NFL US FOOTB FUEL PL; National Football League, 2009, PRES OB JOINS NFL PL; National Football League Communications, 2014, NFL THANKSG WEEK GAM; National Football League Communications, 2017, GAM NFL SOC RESP REP; Newswire PR, 2007, PR NEWSWIRE; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nuckols B., 2017, ASS PRESS; Oates T. P., 2017, FOOTB MANL UN FEM AC; Office of the First Lady, 2013, REM 1 LAD LAUNCH LET; Pfohl SY, 2012, CHILD OBES, V8, P5, DOI 10.1089/chi.2011.0800.pfoh; POWELL D, 2013, SPORT ED SOC, V20, P463, DOI DOI 10.1080/13573322.2013.777661; Powell D, 2014, CRIT PUBLIC HEALTH, V24, P226, DOI 10.1080/09581596.2013.846465; PR Newswire, 2006, PR NEWSWIRE; Rugg A, 2019, COMMUN SPORT, V7, P46, DOI 10.1177/2167479517745299; Rugg A, 2016, POP COMMUN, V14, P21, DOI 10.1080/15405702.2015.1084625; Schwarz A., 2016, NY TIMES; Shape America, 2018, NFL FLAG SCH CURR CO; Silver M., 2011, GQ              0201; United We Serve, 2009, PRES OB UN WE SERV N; US Department of Education, CAROL M WHIT PHYS ED; Wilking C., 2015, OUT BOUNDS NFLS INTE	51	2	2	2	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-7235	1552-7638		J SPORT SOC ISSUES	J. Sport Soc. Issues	FEB	2019	43	1					69	88		10.1177/0193723518823332			20	Hospitality, Leisure, Sport & Tourism; Sociology	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sociology	HI4DC	WOS:000456400300004		Bronze			2022-02-06	
J	Samuel, S; Patel, N; McGuire, MF; Salazar, M; Nguyen, T				Samuel, Sophie; Patel, Niral; McGuire, Mary F.; Salazar, Miguel; Thuy Nguyen			Analysis of venous thromboembolism in neurosurgical patients undergoing standard versus routine ultrasonography	JOURNAL OF THROMBOSIS AND THROMBOLYSIS			English	Article						Ultrasonography; Neurosurgery; Venous thromboembolism; Pulmonary embolism; Deep vein thrombosis	DEEP-VEIN THROMBOSIS; TRAUMATIC BRAIN-INJURY; SCREENING PROTOCOL; RISK; PROPHYLAXIS; PREVENTION; HEPARIN; MANAGEMENT; SAFETY	Routine screening of high-risk asymptomatic trauma or surgical patients for venous thromboembolism (VTE) is controversial. Studies suggest against screening while others recognize that some patients at high risk may benefit. The purpose of this pilot study is to evaluate the benefit of routine screening using doppler ultrasonography for the early detection of deep venous thrombosis (DVT) in post-operative neurosurgical patients. This was a quasi-experimental study at a major academic tertiary care medical center. A total of 157 adults underwent cranial or spinal surgical interventions from March through August 2017 and received either standard screening (n=104) versus routine ultrasonography screening (n=53). There was no significant difference in incidence of DVT between the two groups: 11 (11%) in the standard screening group versus 5 (9%) in the routine screening group, p=0.823. Upper and lower extremity ultrasonography was performed in 43 (41%) of the standard screening group versus 53 (100%) in the routine screening group, p<0.001. DVT was identified in nearly one of every 6 ultrasonography screenings in the standard screening group versus 27 ultrasonography screenings required to identify one DVT in the routine screening group. There were the same number of screenings for upper extremity ultrasonography, but they did not yield or detect DVT; instead only superficial, untreatable, DVTs were reported. Total cost to diagnose one DVT, including screening and labor, averaged $13,664 in the standard group versus $56,525 in the routine group. Routine screening in neurosurgical patients who received VTE prophylaxis was not associated with lower incidence of VTE and mortality attributed to PE. Thus, routine screening may not be cost effective to prevent complications from DVT incidence.	[Samuel, Sophie; Thuy Nguyen] Mem Hermann Texas Med Ctr, Neurosci Intens Care Unit, Dept Pharm, 6411 Fannin St, Houston, TX 77054 USA; [Patel, Niral] Mem Reg Hosp, Dept Crit Care Med, Hollywood, FL USA; [McGuire, Mary F.] Univ Texas Houston, Dept Neurosurg & Neurol, Med Sch Houston, Houston, TX USA; [Salazar, Miguel] Baylor Coll Med, Dept Pharm, Houston, TX 77030 USA		Samuel, S (corresponding author), Mem Hermann Texas Med Ctr, Neurosci Intens Care Unit, Dept Pharm, 6411 Fannin St, Houston, TX 77054 USA.	Sophie.samuel@memorialhermann.org					Adams RC, 2008, J TRAUMA, V65, P300, DOI 10.1097/TA.0b013e31817cf744; BLACK PM, 1986, NEUROSURGERY, V18, P440, DOI 10.1227/00006123-198604000-00008; BOEER A, 1991, J NEUROL NEUROSUR PS, V54, P466, DOI 10.1136/jnnp.54.5.466; Brasel KJ, 1997, J TRAUMA, V42, P456, DOI 10.1097/00005373-199703000-00013; BURNS GA, 1993, J TRAUMA, V35, P405, DOI 10.1097/00005373-199309000-00012; Cipolle MD, 2002, J TRAUMA, V52, P453, DOI 10.1097/00005373-200203000-00007; Danish SF, 2005, NEUROSURGERY, V56, P1286, DOI 10.1227/01.NEU.0000159882.11635.EA; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; Engelherger RP, 2012, CIRCULATION, V126, P768, DOI 10.1161/CIRCULATIONAHA.111.051276; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Glotzbecker MP, 2009, SPINE, V34, P291, DOI 10.1097/BRS.0b013e318195601d; Kiphuth IC, 2009, CEREBROVASC DIS, V27, P146, DOI 10.1159/000177923; Kodadek LM, 2016, CURR TRAUMA REP, V2, P29, DOI 10.1007/s40719-016-0038-y; Lee JA, 2012, VASC ENDOVASC SURG, V46, P139, DOI 10.1177/1538574411432145; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; MEYER CS, 1995, ANN VASC SURG, V9, P109, DOI 10.1007/BF02015324; Munoz FJ, 2008, CHEST, V133, P143, DOI 10.1378/chest.07-1432; NAPOLITANO LM, 1995, J TRAUMA, V39, P651, DOI 10.1097/00005373-199510000-00006; Nyquist P, 2016, NEUROCRIT CARE, V24, P47, DOI 10.1007/s12028-015-0221-y; Patel AP, 2013, J NEUROSURG, V118, P505, DOI 10.3171/2012.11.JNS121243; Piotrowski JJ, 1996, AM J SURG, V172, P210, DOI 10.1016/S0002-9610(96)00154-7; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Samuel S, 2017, J THROMB THROMBOLYS, V43, P98, DOI 10.1007/s11239-016-1422-8; Samuel S, 2015, J THROMB THROMBOLYS, V40, P302, DOI 10.1007/s11239-015-1202-x; Spain DA, 1997, J TRAUMA, V42, P463, DOI 10.1097/00005373-199703000-00014; Spyropoulos AC, 2007, J MANAGE CARE PHARM, V13, P475, DOI 10.18553/jmcp.2007.13.6.475; Spyropoulos AC, 2009, J THROMB THROMBOLYS, V28, P458, DOI 10.1007/s11239-009-0351-1; Valle EJ, 2014, J TRAUMA ACUTE CARE, V77, P243, DOI 10.1097/TA.0000000000000307; Velmahos GC, 1998, J AM COLL SURGEONS, V187, P529, DOI 10.1016/S1072-7515(98)00223-3; Winters JP, 2015, J THROMB HAEMOST, V13, P2155, DOI 10.1111/jth.13131	30	2	4	0	4	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5305	1573-742X		J THROMB THROMBOLYS	J. Thromb. Thrombolysis	FEB	2019	47	2					209	215		10.1007/s11239-018-1761-8			7	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Hematology	HM9LN	WOS:000459806100007	30392138				2022-02-06	
J	Tanaka, H; Ehara, A; Nakadate, K; Yoshimoto, K; Shimoda, K; Ueda, S				Tanaka, Hiromi; Ehara, Ayuka; Nakadate, Kazuhiko; Yoshimoto, Kanji; Shimoda, Kazutaka; Ueda, Shuich			Behavioral, hormonal, and neurochemical outcomes of neonatal repeated shaking brain injury in male adult rats	PHYSIOLOGY & BEHAVIOR			English	Article						Shaking brain injury; Anxiety-like behavior; Corticosterone; ACTH; Adrenocorticosteroid receptors; Monoamines	TRAUMATIC INJURY; MATERNAL-CARE; ANIMAL-MODELS; PLUS-MAZE; STRESS; ANXIETY; IRON; RECEPTOR; SYSTEMS; PATHOPHYSIOLOGY	It is well known that an abusive environment in childhood is related to individual anxiety behavior in adulthood. Though an imbalance of adrenocorticosteroid receptors and a dysfunction of monoaminergic neuron systems have been proposed, the underlying mechanisms are not fully understood. To address these problems, we recently developed a new model of shaking brain injury (SBI) in neonatal rats. These model rats showed transient microhemorrhages in the gray matter of the cerebral cortex and hippocampus. Using this model, we assessed the effects of neonatal repeated mild SBI on subsequent behavior and the stress response, and we further examined the possible contribution of adrenocorticosteroid receptors in the hippocampus and central monoaminergic neuron systems mediating such abnormalities. Behavioral screening examination with a novel open-field test showed that the rats with postnatal day (P) 3-7 shaking had significantly reduced locomotor activity and exploration behaviors than those with late (P8-14) shaking periods, indicating a critical period for neonatal SBI. In the elevated plus maze (EPM) and the light/dark transition (L/D) tests, the model rats spent less time in the open arm of the EPM and the light box of the L/D test, indicating anxiety-like behavior as adults. In adults, the novel EPM-induced adrenocorticotrophic hormone (ACTH) and corticosterone (CORT) responses were significantly increased by neonatal SBI. Further experiments showed that the expression of mineralocorticoid receptor (MR), but not glucocorticoid receptor (GR), was significantly downregulated in the hippocampus of this model rat. These results suggest that neonatal SBI-induced downregulation of MRs in the hippocampus attenuates negative feedback of the hypothalamic-pituitary-adrenal (HPA) axis, which results in abnormal secretion of ACTH and CORT. Furthermore, the neurochemical analysis showed that shaken rats had higher dopamine (DA), serotonin (5-HT), 5-hydroxyindolacetic acid (5-HIAA), and noradrenaline (NA) levels in the dorsal part of the medial prefrontal cortex (dmPFC). In the amygdala, higher 5-HIAA and lower NA levels were observed. Both areas are known to be anxiety and stress-related. Taken together, the effects of neonatal SBI on the monoaminergic systems may also be involved in the changes of behavioral and hormonal responses in this model.	[Tanaka, Hiromi; Shimoda, Kazutaka] Dokkyo Med Univ, Sch Med, Dept Psychiat, Mibu, Tochigi 3210293, Japan; [Tanaka, Hiromi; Ehara, Ayuka; Ueda, Shuich] Dokkyo Med Univ, Sch Med, Dept Histol & Neurobiol, Mibu, Tochigi 3210293, Japan; [Nakadate, Kazuhiko] Meiji Pharmaceut Univ, Dept Basic Biol, Educ & Res Ctr Pharm, Tokyo 2048588, Japan; [Yoshimoto, Kanji] Hiroshima Inst Technol, Dept Food Sci & Biotechnol, Fac Life Sci, Saeki Ku, Hiroshima 7315193, Japan		Ueda, S (corresponding author), Dokkyo Med Univ, Sch Med, Dept Histol & Neurobiol, Mibu, Tochigi 3210293, Japan.	shu-ueda@dokkyomed.ac.jp	Ehara, Ayuka/V-8285-2019				Auger CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003606; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Cernak I, 2010, DEV NEUROSCI-BASEL, V32, P442, DOI 10.1159/000320085; Chevignard MP, 2014, PEDIATR RADIOL, V44, P548, DOI 10.1007/s00247-014-3169-8; Daniels WMU, 2004, METAB BRAIN DIS, V19, P3, DOI 10.1023/B:MEBR.0000027412.19664.b3; de Kloet ER, 2018, FRONT NEUROENDOCRIN, V49, P124, DOI 10.1016/j.yfrne.2018.02.003; de Kloet ER, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12379; de Kloet ER, 2013, EUR J PHARMACOL, V719, P53, DOI 10.1016/j.ejphar.2013.04.053; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faraji J, 2014, HORM BEHAV, V65, P66, DOI 10.1016/j.yhbeh.2013.11.007; Figueiredo LS, 2016, MOL NEUROBIOL, V53, P6228, DOI 10.1007/s12035-015-9514-6; FILE SE, 1994, PSYCHOPHARMACOLOGY, V113, P543, DOI 10.1007/BF02245237; Francis DD, 1999, BIOL PSYCHIAT, V46, P1153, DOI 10.1016/S0006-3223(99)00237-1; GRAFE MR, 1994, BRAIN RES, V653, P161, DOI 10.1016/0006-8993(94)90385-9; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Heim C, 1999, BIOL PSYCHIAT, V46, P1509, DOI 10.1016/S0006-3223(99)00224-3; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Huppertz-Kessler CJ, 2012, BRAIN DEV-JPN, V34, P274, DOI 10.1016/j.braindev.2011.07.008; Ishikawa J, 2015, EUR J NEUROSCI, V41, P442, DOI 10.1111/ejn.12825; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kawamata Y, 2018, NEUROSCI LETT, V684, P29, DOI 10.1016/j.neulet.2018.06.059; Kelly P, 2015, ARCH DIS CHILD, V100, P1123, DOI 10.1136/archdischild-2014-306960; Kim J, 2014, J NUTR BIOCHEM, V25, P1101, DOI 10.1016/j.jnutbio.2014.07.003; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maaroufi K, 2009, PHYSIOL BEHAV, V96, P343, DOI 10.1016/j.physbeh.2008.10.019; Masis-Calvo M, 2013, PHYSIOL BEHAV, V118, P212, DOI 10.1016/j.physbeh.2013.05.033; Matsuda W, 2018, CONGENIT ANOM, V58, P16, DOI 10.1111/cga.12228; McAteer K. M., 2016, PLOS ONE, DOI [10.1371/journalpone.0160220, DOI 10.1371/JOURNALPONE.0160220]; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Paxinos G, 2009, RAT BRAIN STEREOTAXI; Raineki C, 2014, DEV PSYCHOBIOL, V56, P1613, DOI 10.1002/dev.21241; Rocha-Ferreira E, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4901014; Rodgers RJ, 1999, PHYSIOL BEHAV, V68, P47, DOI 10.1016/S0031-9384(99)00140-7; Rogalska J, 2010, VITAM HORM, V82, P391, DOI 10.1016/S0083-6729(10)82020-5; Rosenholm M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175258; Russell JA, 2008, ANN NY ACAD SCI, V1148, P428, DOI 10.1196/annals.1410.032; Schwarz LA, 2015, CURR BIOL, V25, pR1051, DOI 10.1016/j.cub.2015.09.039; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Takao Keizo, 2006, J Vis Exp, P104, DOI 10.3791/104; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Teicher MH, 2016, NAT REV NEUROSCI, V17, P652, DOI 10.1038/nrn.2016.111; Teicher MH, 2016, J CHILD PSYCHOL PSYC, V57, P241, DOI 10.1111/jcpp.12507; ter Heegde F, 2015, PSYCHONEUROENDOCRINO, V52, P92, DOI 10.1016/j.psyneuen.2014.10.022; Tohei A, 2010, EXP ANIM TOKYO, V59, P95, DOI 10.1538/expanim.59.95; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Ueda S, 2000, NEUROSCIENCE, V95, P389; van Bodegom M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00087; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang GX, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.030387; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhao M, 2016, NEUROSCIENCE, V330, P90, DOI 10.1016/j.neuroscience.2016.05.025	60	2	2	1	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	FEB 1	2019	199						118	126		10.1016/j.physbeh.2018.11.025			9	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	HI9CW	WOS:000456753900016	30465805				2022-02-06	
J	Vaickus, M; Hsieh, T; Kintsurashvili, E; Kim, J; Kirsch, D; Kasotakis, G; Remick, DG				Vaickus, Max; Hsieh, Terry; Kintsurashvili, Ekaterina; Kim, Jiyoun; Kirsch, Daniel; Kasotakis, George; Remick, Daniel G.			Mild Traumatic Brain Injury in Mice Beneficially Alters Lung NK1R and Structural Protein Expression to Enhance Survival after Pseudomonas aeruginosa Infection	AMERICAN JOURNAL OF PATHOLOGY			English	Article							CHEMOTHERAPY-INDUCED NAUSEA; PLACEBO-CONTROLLED TRIAL; VAGAL NERVE-STIMULATION; INNATE IMMUNE-SYSTEM; HIGH-DOSE CISPLATIN; SUBSTANCE-P; ANTAGONIST APREPITANT; VE-CADHERIN; NEUTROPHIL MIGRATION; RECEPTOR EXPRESSION	Mild traumatic brain injury (mTBI) in a murine model increases survival to a bacterial pulmonary challenge compared with blunt tail trauma (TT). We hypothesize substance P and its receptor, the neurokinin 1 receptor (NK1R; official name TACR1), play a role in the increased survival of mTBI mice. Mice were subjected to mTBI or TT, and 48 hours after trauma, the levels of NK1R mRNA and protein were significantly up-regulated in mTBI lungs. Examination of the lung 48 hours after injury by microarray showed significant differences in the expression of 433 gene sets between groups, most notably genes related to intercellular proteins. Despite down-regulated gene expression of connective proteins, the presence of an intact pulmonary vasculature was supported by normal histology and bronchoalveolar lavage protein levels. To determine whether these mTBI-induced lung changes benefited in vivo responses, two chemotactic stimuli (a CXCL1 chemokine and a live Pseudomonas aeruginosa infection) were administered 48 hours after trauma. For both stimuli, mTBI mice recruited more neutrophils to the lung 4 hours after instillation (CXCL1: mTBI = 6.3 +/- 1.3 versus TT = 3.3 +/- 0.7 neutrophils/mL; Pseudomonas aeruginosa: mTBI = 9.4 +/- 1.4 versus TT = 5.3 +/- 1.1 neutrophils/mL). This study demonstrates that the downstream consequences of mTBI on lung NK1R levels and connective protein expression enhance neutrophil recruitment to a stimulus that may contribute to increased survival.	[Vaickus, Max; Hsieh, Terry; Kintsurashvili, Ekaterina; Kim, Jiyoun; Kirsch, Daniel; Kasotakis, George; Remick, Daniel G.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA		Remick, DG (corresponding author), 670 Albany St,4th Floor, Boston, MA 02118 USA.	remickd@bu.edu		Kasotakis, George/0000-0002-7630-0742; Remick, Daniel/0000-0002-2615-3713	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1GM117519, T32GM86308, R21AA022122, R21AI112887, UL1-TR001430]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM086308] Funding Source: NIH RePORTER	Supported by NIH grants RO1GM117519, T32GM86308, R21AA022122, R21AI112887, and UL1-TR001430.	Agarwala R, 2017, NUCLEIC ACIDS RES, V45, pD12, DOI [10.1093/nar/gks1189, 10.1093/nar/gky1069, 10.1093/nar/gkw1071, 10.1093/nar/gkx1095]; Attia EF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149687; BAIGELMAN W, 1981, NEUROSURGERY, V9, P729, DOI 10.1227/00006123-198112000-00021; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; BEKEMEYER WB, 1989, SOUTH MED J, V82, P380, DOI 10.1097/00007611-198903000-00026; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhargava M, 2012, TRANSL RES, V159, P205, DOI 10.1016/j.trsl.2012.01.007; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Brettschneider J, 2008, TECHNOMETRICS, V50, P241, DOI 10.1198/004017008000000334; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; CARLSON RW, 1979, CHEST, V75, P731, DOI 10.1378/chest.75.6.731; CAROLAN EJ, 1993, J ALLERGY CLIN IMMUN, V92, P589, DOI 10.1016/0091-6749(93)90083-R; Chawla SP, 2003, CANCER-AM CANCER SOC, V97, P2290, DOI 10.1002/cncr.11320; Chen GS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/729831; COLICE GL, 1984, AM REV RESPIR DIS, V130, P941; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dando TM, 2004, DRUGS, V64, P777, DOI 10.2165/00003495-200464070-00013; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; de Wit R, 2003, J CLIN ONCOL, V21, P4105, DOI 10.1200/JCO.2003.10.128; Dejana E, 2013, PROG MOL BIOL TRANSL, V116, P119, DOI 10.1016/B978-0-12-394311-8.00006-6; DEMLING R, 1990, CRIT CARE MED, V18, P768, DOI 10.1097/00003246-199007000-00019; DEROSE V, 1994, J IMMUNOL, V152, P1339; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; GAMSE R, 1979, N-S ARCH PHARMACOL, V306, P37, DOI 10.1007/BF00515591; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giza CC, 2001, J ATHL TRAINING, V36, P228; Golovkine G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003939; Gotsch U, 1997, J CELL SCI, V110, P583; GRONSTAD KO, 1985, SCAND J GASTROENTERO, V20, P163; HAINES KA, 1993, J IMMUNOL, V151, P1491; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; HOLM BA, 1988, CHEM PHYS LIPIDS, V49, P49, DOI 10.1016/0009-3084(88)90063-1; Hsieh T, 2018, AM J PATHOL, V188, P6, DOI 10.1016/j.ajpath.2017.08.028; Hsieh T, 2016, AM J PATHOL, V186, P3236, DOI 10.1016/j.ajpath.2016.08.014; Hudry-Clergeon H, 2005, FASEB J, V19, P512, DOI 10.1096/fj.04-2202com; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iskander KN, 2013, CRIT CARE MED, V41, P159, DOI 10.1097/CCM.0b013e3182676322; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kuo HP, 2000, AM J RESP CRIT CARE, V162, P1891, DOI 10.1164/ajrccm.162.5.9911065; Levy G, 2012, J TRAUMA ACUTE CARE, V73, P338, DOI 10.1097/TA.0b013e31825debd3; Lim MJ, 2001, MICROVASC RES, V62, P366, DOI 10.1006/mvre.2001.2355; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MACKERSIE RC, 1983, J TRAUMA, V23, P968, DOI 10.1097/00005373-198311000-00002; Sarrasague MM, 2011, RESP PHYSIOL NEUROBI, V175, P316, DOI 10.1016/j.resp.2010.12.009; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Maung AA, 2008, J IMMUNOL, V180, P2450, DOI 10.4049/jimmunol.180.4.2450; McCarson KE, 1999, NEUROSCIENCE, V93, P361, DOI 10.1016/S0306-4522(99)00102-5; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x; OTT L, 1989, NUTRITION, V5, P75; Paterson HM, 2003, J IMMUNOL, V171, P1473, DOI 10.4049/jimmunol.171.3.1473; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; PERIANIN A, 1989, BIOCHEM BIOPH RES CO, V161, P520, DOI 10.1016/0006-291X(89)92630-2; Poli-Bigelli S, 2003, CANCER-AM CANCER SOC, V97, P3090, DOI 10.1002/cncr.11433; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; REGOLI D, 1994, PHARMACOL REV, V46, P551; ROCHARVEILLER M, 1986, PHARMACOLOGY, V33, P266, DOI 10.1159/000138225; Schmoll HJ, 2006, ANN ONCOL, V17, P1000, DOI 10.1093/annonc/mdl019; SERRA MC, 1988, J IMMUNOL, V141, P2118; Southard R, 2012, SHOCK, V37, P629, DOI 10.1097/SHK.0b013e31824ee551; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sun J, 2007, AM J PHYSIOL-CELL PH, V293, pC696, DOI 10.1152/ajpcell.00060.2007; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; WALKER DC, 1995, MICROVASC RES, V50, P397, DOI 10.1006/mvre.1995.1067; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang S, 2014, CRIT CARE MED, V42, P2092, DOI 10.1097/CCM.0000000000000486; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	78	2	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	FEB	2019	189	2					295	307		10.1016/j.ajpath.2018.10.019			13	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	HL4SM	WOS:000458713400009	30472211	Bronze, Green Published			2022-02-06	
J	Wauters, L; Marquardt, TP				Wauters, Lisa; Marquardt, Thomas P.			Disorders of Emotional Communication in Traumatic Brain Injury	SEMINARS IN SPEECH AND LANGUAGE			English	Article						Traumatic brain injury; cognitive rehabilitation; emotional processing; affective processing disorders	FACIAL AFFECT RECOGNITION; NONVERBAL-COMMUNICATION; PERCEPTION DEFICITS; EXECUTIVE FUNCTION; DIFFERENT MEDIA; EXPRESSION; ADULTS; IMPAIRMENT; PEOPLE; MEMORY	Traumatic brain injury (TBI) leads to a wide array of behavioral and cognitive deficits. Individuals with TBI often demonstrate difficulties with the recognition and expression of emotion communicated through multiple modalities including facial expression, vocal prosody, and linguistic content. Deficits in emotional communication contribute to a pattern of social pragmatic communication problems, leading to decreased psychosocial function. Growing evidence supports intervention targeting affective processing. This article summarizes the current evidence for evaluation and treatment of affective processing disorders in TBI.	[Wauters, Lisa; Marquardt, Thomas P.] Univ Texas Austin, Dept Commun Sci & Disorders, CMA4-112, Austin, TX 78712 USA		Marquardt, TP (corresponding author), Univ Texas Austin, Dept Commun Sci & Disorders, CMA4-112, Austin, TX 78712 USA.	tmarq@utexas.edu					Aday J, 2017, EMOTIONS AND AFFECT IN HUMAN FACTORS AND HUMAN-COMPUTER INTERACTION, P27, DOI 10.1016/B978-0-12-801851-4.00002-1; Adolphs R, 2002, EMOTION, V2, P23, DOI 10.1037/1528-3542.2.1.23; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Ben-David BM, 2011, BRAIN INJURY, V25, P206, DOI 10.3109/02699052.2010.536197; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Bradley MM, 1996, PSYCHOPHYSIOLOGY, V33, P662, DOI 10.1111/j.1469-8986.1996.tb02362.x; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Cahill L, 1995, CONSCIOUS COGN, V4, P410, DOI 10.1006/ccog.1995.1048; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Constantinidou F, 2013, APHASIA RELATED NEUR, P365; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Czimskey N, 2018, RECALL EMOTIONAL NEU, DOI [10.1080/02687038.2018.1512079, DOI 10.1080/02687038.2018.1512079]; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; Douglas JM, 2017, BRAIN IMPAIR, V18, P321, DOI 10.1017/BrImp.2017.20; Douglas JM, 2014, BRAIN IMPAIR, V15, P190, DOI 10.1017/BrImp.2014.25; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Ekman P., 2006, COMPREHENSIVE AFFECT; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Grattan LM, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P266; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Heilman KM, 1999, FLORIDA AFFECT BATTE; Hoofien D, 2001, BRAIN INJURY, V15, P189; Ibanez A, 2011, SOC NEUROSCI-UK, V6, P464, DOI 10.1080/17470919.2011.620769; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Karow Colleen M., 2003, Seminars in Speech and Language, V24, P69, DOI 10.1055/s-2003-38900; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kensinger EA, 2004, NEUROPSYCHOLOGIA, V42, P791, DOI 10.1016/j.neuropsychologia.2003.11.011; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kucharska-Pietura K, 2003, NEUROPSYCHOLOGIA, V41, P1082, DOI 10.1016/S0028-3932(02)00294-4; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Marquardt TP, 2001, APHASIOLOGY, V15, P1091, DOI 10.1080/02687040143000429; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Nieuwenhuis-Mark RE, 2009, AM J ALZHEIMERS DIS, V24, P155, DOI 10.1177/1533317508330561; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Paul M., 2011, TRAUMATIC BRAIN INJU; Payne J, 1997, ADULT NEUROGENIC LAN, P365; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Rosenstein LD., 1995, ADM SCORING MANUAL B; Sass K, 2013, BEHAV SCI-BASEL, V3, P372, DOI 10.3390/bs3030372; Schirmer A, 2014, EMOTION; Schwartz R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047279; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Turkstra LS, 2017, BRAIN IMPAIR, V18, P49, DOI 10.1017/BrImp.2016.29; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Wiltshire GE, 2014, J SOC INCL, V5, P9, DOI 10.36251/josi.73; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P159; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Zupan B, 2015, BRAIN INJURY, V29, P877, DOI 10.3109/02699052.2015.1011233; Zupan B, 2009, J COMMUN DISORD, V42, P1, DOI 10.1016/j.jcomdis.2008.06.001	73	2	3	0	14	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	FEB	2019	40	1					13	26		10.1055/s-0038-1676364			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HG5OT	WOS:000455027900003	30616291				2022-02-06	
J	Dismuke-Greer, CE; Gebregziabher, M; Byers, AL; Taber, D; Axon, N; Yaffe, K; Egede, LE				Dismuke-Greer, C. E.; Gebregziabher, M.; Byers, A. L.; Taber, D.; Axon, N.; Yaffe, K.; Egede, L. E.			Comorbid TBI-depression costs in veterans: a chronic effect of neurotrauma consortium (CENC) study	BRAIN INJURY			English	Article						Traumatic Brain Injury; Depression; Cost; Veterans; Military	TRAUMATIC BRAIN-INJURY	Background: The U.S. Veterans Health Administration (VHA) provides depression treatment to veterans with Traumatic Brain Injury (TBI). VHA costs of comorbid TBI-depression were estimated by Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) status over 14 years. Methods: VHA-USING veterans with TBI DIAGNOSED IN 2000-2010 were followed through FY2014. TBI severity was determined using the Department of Defense criteria. Depression was identified by the Elixhauser algorithm. Generalized linear and seemingly unrelated regression models were used to estimate the impact of depression on annual per veteran and total VHA inpatient, outpatient, and pharmaceutical costs, by OEF/OIF status. Results: A total of 66.57% of pre-OEF/OIF and 87.46% of OEF/OIF veterans had depression. Depression was estimated to increase annual total ($1,847), outpatient ($1,558), and pharmaceutical ($287) costs for pre-OEF/OIF, and $1,228, $1,685, and $191 for OEF/OIF veterans. However, depression was estimated to lower annual inpatient costs by $648 per OEF/OIF veteran. The annual VHA cost for all veterans with comorbid TBI-depression was estimated at $1,101,329,953. Conclusions: The estimated annual cost for Veterans with comorbid TBI-depression was more than $1 billion. TBI and depression screening/treatment may result in reduced inpatient VHA costs in OEF/OIF veterans exposed to TBI. VHA policymakers should consider screening for TBI and depression in pre-OEF/OIF veterans.	[Dismuke-Greer, C. E.; Gebregziabher, M.; Taber, D.; Axon, N.] Ralph H Johnson VA Med Ctr, Hlth Equ & Rural Outreach Innovat Ctr, Charleston, SC 29401 USA; [Dismuke-Greer, C. E.; Axon, N.] Med Univ South Carolina, Dept Internal Med, Charleston, SC 29425 USA; [Gebregziabher, M.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Byers, A. L.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Byers, A. L.] San Francisco VA Med Ctr, Res Serv, San Francisco, CA USA; [Taber, D.] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA; [Yaffe, K.] Univ Calif San Francisco, Ctr Populat Brain Hlth, San Francisco, CA 94143 USA; [Egede, L. E.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Egede, L. E.] Med Coll Wisconsin, Ctr Adv Populat Sci, Milwaukee, WI 53226 USA		Dismuke-Greer, CE (corresponding author), Ralph H Johnson VA Med Ctr, Hlth Equ & Rural Outreach Innovat Ctr, Charleston, SC 29401 USA.	clara.dismuke@va.gov		Egede, Leonard/0000-0003-1546-1515; Gebregziabher, Mulugeta/0000-0002-4826-481X	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma Consortium [W81XWH-13-2-0095]; Health Equity and Rural Outreach Innovation Center at the Ralph H. Johnson VA Medical Center, Department of Veterans Affairs Award [HX001229]	This material is based upon work supported by the U.S. Army Medical Research and Materiel Command and from the U.S. Department of Veterans Affairs Chronic Effects of Neurotrauma Consortium under Award No. W81XWH-13-2-0095. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the U.S. Government, or the U.S. Department of Veterans Affairs, and no official endorsement should be inferred.; This work was also supported by the Health Equity and Rural Outreach Innovation Center at the Ralph H. Johnson VA Medical Center, Department of Veterans Affairs Award HX001229. The authors report no conflicts of interest. The views, opinions and or/findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy, or decision, unless so designated by other official documentation.	Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; [Anonymous], 2013, FED REG; Centers for Disease Control and Prevention, 2018, TRAUM BRAIN INJ CONC; Defense and Veterans Brain Injury Center (DVBIC), 2018, DOD WORLDW NUMB TBI; DiNapoli EA, 2016, INT J GERIATR PSYCH, V31, P575, DOI 10.1002/gps.4362; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Health Economics Resource Center, 2018, AV COST; IOM, 2009, GULF WAR HLTH, V7; Kehle-Forbes SM, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000227; Military Health System and The Defense Health Agency Traumatic Brain Injury (TBI) DoD Standard Surveillance Case Definition for TBI Adapted for AFHSB Use, 2016, MIL HLTH SYST DEF HL; Pape TLB, 2018, ARCH PHYS MED REHAB, V99, P1370, DOI 10.1016/j.apmr.2017.11.017; Polgreen LA, 2012, APPL HEALTH ECON HEA, V10, P319, DOI 10.2165/11632430-000000000-00000; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843	17	2	2	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2019	33	2					198	204		10.1080/02699052.2018.1542508			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG9RL	WOS:000455346300010	30403538				2022-02-06	
J	Torres, AR; Shaikh, ZI; Chavez, W; Maldonado, JE				Torres, Alcy R.; Shaikh, Zakir, I; Chavez, Wilson; Maldonado, John E.			Brain MRI in Children with Mild Traumatic Brain Injury and Persistent Symptoms in Both Sports- and Non-sports-related Concussion	CUREUS			English	Article						pediatric concussion; postconcussion syndrome; magnetic resonance imaging; mild traumatic brain injury; brain mri		Aim: To evaluate the utility of magnetic resonance imaging (MRI) in children with mild traumatic brain injury (mTBI), persistent post-concussive syndrome (PPCS), and normal neurologic examination. Materials and methods: This was a retrospective review of pediatric patients, who were evaluated in a Pediatric Concussion Clinic between August 2013 and November 2018, with documented persistent post-concussive symptoms, normal neurological examination, and available brain MRI. Results: In our analysis of 86 cases we found seven MRI studies with abnormal findings, but none were clinically significant. Conclusion: We conclude that MRI has a low diagnostic yield in this population, and based on these results we recommend that clinicians should avoid ordering MRI studies in this group. Further research is necessary to validate these results in larger and prospective studies.	[Torres, Alcy R.] Boston Univ, Sch Med, Pediat, Boston, MA 02118 USA; [Shaikh, Zakir, I] Surat Municipal Inst Med Educ & Res, Pediat, Surat, India; [Chavez, Wilson] Boston Med Ctr, Radiol, Boston, MA USA; [Maldonado, John E.] Pontificia Univ Catolica Ecuador, Pediat, Quito, Ecuador		Torres, AR (corresponding author), Boston Univ, Sch Med, Pediat, Boston, MA 02118 USA.	artorres@bu.edu		Torres, Alcy/0000-0001-5798-9161			[Anonymous], 2018, BRAIN MRI COST PROCE; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bauer Derek, 2015, Semin Neurol, V35, pe14, DOI 10.1055/s-0035-1549095; Bonow RH, 2017, J NEUROTRAUM, V34, P2706, DOI 10.1089/neu.2017.4970; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; Pervez M, 2018, NEUROIMAG CLIN N AM, V28, P1, DOI 10.1016/j.nic.2017.09.010; Raschle N, 2012, ANN NY ACAD SCI, V1252, P43, DOI 10.1111/j.1749-6632.2012.06457.x; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rose SC, 2017, BRAIN INJURY, V31, P260, DOI 10.1080/02699052.2016.1235285; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thukral Brij Bhushan, 2015, Indian J Radiol Imaging, V25, P359, DOI 10.4103/0971-3026.169466; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Wendling-Keim DS, 2017, PEDIATR SURG INT, V33, P249, DOI 10.1007/s00383-016-4021-z; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	25	2	2	0	2	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	JAN 22	2019	11	1							e3937	10.7759/cureus.3937			11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HP0QB	WOS:000461369600003	30937235	Green Published, Green Submitted, gold			2022-02-06	
J	Sellappan, P; Cote, J; Kreth, PA; Schepkin, VD; Darkazalli, A; Morris, DR; Alvi, FS; Levenson, CW				Sellappan, Prabu; Cote, Jason; Kreth, Phillip A.; Schepkin, Victor D.; Darkazalli, Ali; Morris, Deborah R.; Alvi, Farrukh S.; Levenson, Cathy W.			Variability and uncertainty in the rodent controlled cortical impact model of traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						TBI; Lesion; Injury; Impact; CCI	STEM-CELL TREATMENT; ZINC SUPPLEMENTATION; RAT MODEL	Background . Controlled cortical impact (CCI) has emerged as one of the most flexible and clinically applicable approaches for the induction of traumatic brain injury (TBI) in rodents and other species. Although this approach has been shown to model cognitive and functional outcomes associated with TBI in humans, recent work has shown that CCI is limited by excessive variability in lesion size despite attempts to control velocity, impact depth, and dwell time. New method: Thus, this work used high-speed imaging to evaluate the delivery of cortical impact and permit the identification of specific parameters associated with technical variability in the CCI model. Results: Variability is introduced by vertical oscillations that result in multiple impacts of varying depths, lateral movements after impact, and changes in velocity, particularly at the prescribed impact depth. Conclusions: Together these data can inform future work to design modifications to commonly used CCI devices that produce TBI with less variability in severity and lesion size.	[Sellappan, Prabu; Kreth, Phillip A.; Alvi, Farrukh S.] FAMU FSU Coll Engn, Mech Engn, Tallahassee, FL USA; [Sellappan, Prabu; Kreth, Phillip A.; Alvi, Farrukh S.] FAMU FSU Coll Engn, Florida Ctr Adv Aeropropuls, Tallahassee, FL USA; [Cote, Jason; Darkazalli, Ali; Levenson, Cathy W.] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; [Schepkin, Victor D.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Cote, Jason; Darkazalli, Ali; Morris, Deborah R.; Levenson, Cathy W.] Florida State Univ, Dept Biomed Sci, Coll Med, 1115 W Call St, Tallahassee, FL 32306 USA; [Sellappan, Prabu; Alvi, Farrukh S.] Florida State Univ, Aeropropuls Mechatron & Energy Bldg, 2003 Levy Ave, Tallahassee, FL 32310 USA; [Kreth, Phillip A.] Univ Tennessee, Inst Space, Dept Mech Aerosp & Biomed Engn, 411 BH Goethert Pkwy,MS-18, Tullahoma, TN 37388 USA; [Schepkin, Victor D.] Natl High Magnet Field Lab, 1800 E Paul Dirac Dr, Tallahassee, FL 32310 USA		Levenson, CW (corresponding author), Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA.; Levenson, CW (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, 1115 W Call St, Tallahassee, FL 32306 USA.	psellappan@fsu.edu; jcote@neuro.fsu.edu; pkreth@utsi.edu; schepkin@magnet.fsu.edu; falvi@fsu.edu; cathy.levenson@med.fsu.edu	Sellappan, Prabu/AAC-3852-2020; Kreth, Phil/ABA-3387-2021; Sellappan, Prabu/ABC-6573-2020; Schepkin, Victor/A-1245-2007	Kreth, Phil/0000-0002-8906-2034; Sellappan, Prabu/0000-0002-5995-9772; Levenson, Cathy W/0000-0003-4463-3136; Schepkin, Victor/0000-0001-5475-2636	NSFNational Science Foundation (NSF) [DMR 11549]	This study was partially performed at the National High Magnetic Field Laboratory (Tallahassee) supported by NSF Grant No. DMR 11549.	Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Chen W, 2017, RESTOR NEUROL NEUROS, V35, P217, DOI 10.3233/RNN-160705; Cope EC, 2016, EXP NEUROL, V279, P96, DOI 10.1016/j.expneurol.2016.02.017; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Darkazalli A, 2017, J NEUROTRAUM, V34, P204, DOI 10.1089/neu.2015.4322; Darkazalli A, 2016, RESTOR NEUROL NEUROS, V34, P433, DOI 10.3233/RNN-150628; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Pareja JCM, 2016, METHODS MOL BIOL, V1462, P345, DOI 10.1007/978-1-4939-3816-2_19; Romine J, 2014, JOVE-J VIS EXP, V5; Schepkin VD, 2012, MAGN RESON MED, V67, P1159, DOI 10.1002/mrm.23077; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	21	2	2	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 15	2019	312						37	42		10.1016/j.jneumeth.2018.10.027			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HI1QU	WOS:000456220900005	30423350				2022-02-06	
J	Lancelot, C; Gilles, C				Lancelot, Celine; Gilles, Cindy			How does visual context influence recognition of facial emotion in people with traumatic brain injury?	BRAIN INJURY			English	Article						Traumatic brain injury; emotion recognition; facial expression; visual context	SOCIAL-BEHAVIOR; HEAD-INJURY; PERCEPTION; COMMUNICATION; EXPRESSIONS; DEFICITS; IMPAIRMENT; ADULTS; COGNITION; CHILDREN	Objective: The current study assessed recognition of facial emotional stimuli following traumatic brain injury (TBI) and examined whether performance may be influenced by emotional visual scenes. Methods: Thirty-five patients with moderate-to-severe TBI and 55 matched controls completed the novel Angers Facial Expression in Context Task (AFECT), designed to examine recognition of facial expressions of basic emotions in both congruent and incongruent emotional visual contexts. Results: In comparison with non-brain damaged adults, patients with TBI performed more poorly and slowly on both contextual conditions (congruent vs. incongruent) of the AFECT. Conclusion: Taken together, these results raise the possibility that adults with TBI may not fully benefit from supportive contextual cues. Also, they stress the importance of using emotional stimuli that better capture affect processing in real-world contexts and open up new avenues to better understand negative social outcomes in patients with TBI.	[Lancelot, Celine; Gilles, Cindy] Univ Angers, Psychol Lab Pays de la Loire, EA 4638, Fac Literature Languages & Human Sci,LUNAM, 11 Blvd Lavoisier, F-49045 Angers 1, France; [Gilles, Cindy] UEROS Fontenailles, Chateau De Fontenailles, Louestault, France		Lancelot, C (corresponding author), Univ Angers, Psychol Lab Pays de la Loire, EA 4638, Fac Literature Languages & Human Sci,LUNAM, 11 Blvd Lavoisier, F-49045 Angers 1, France.	celine.lancelot@univ-angers.fr					Aviezer H., 2008, 1 IMPRESSIONS, P255; Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x; Aviezer H, 2017, CURR OPIN PSYCHOL, V17, P47, DOI 10.1016/j.copsyc.2017.06.006; Aviezer H, 2012, J PERS SOC PSYCHOL, V103, P20, DOI 10.1037/a0027411; Aviezer H, 2011, EMOTION, V11, P1406, DOI 10.1037/a0023578; Aviezer H, 2009, BRAIN, V132, P1633, DOI 10.1093/brain/awp067; Azouvi P, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000169; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Borgaro SR, 2004, BRAIN INJURY, V18, P33, DOI 10.1080/0269905031000110562; Braun C M, 1989, Brain Inj, V3, P5, DOI 10.3109/02699058909008068; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bruner JS., 1954, HDB SOCIAL PSYCHOL, P634; Calbi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07262-0; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Drapeau J, 2017, BRAIN INJURY, V31, P221, DOI 10.1080/02699052.2016.1208846; Goodglass H., 1972, ASSESSMENT APHASIA R; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hassin RR, 2013, EMOT REV, V5, P60, DOI 10.1177/1754073912451331; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kumfor F, 2018, BRAIN, V141, DOI 10.1093/brain/awy002; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Mobbs D, 2006, SOC COGN AFFECT NEUR, V1, P95, DOI 10.1093/scan/nsl014; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Munn NL, 1940, J ABNORM SOC PSYCH, V35, P324, DOI 10.1037/h0063680; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Ngo N, 2015, EMOTION, V15, P292, DOI 10.1037/emo0000062; Noh SR, 2013, EMOTION, V13, P238, DOI 10.1037/a0030234; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Reschke PJ, 2018, EMOTION, V18, P153, DOI 10.1037/emo0000350; Righart R, 2008, COGN AFFECT BEHAV NE, V8, P264, DOI 10.3758/CABN.8.3.264; Rigon A, 2018, NEUROPSYCHOLOGY, V32, P476, DOI 10.1037/neu0000368; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spreen, 1983, BENTONS TEST FACIAL; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Turkstra LS, 2017, BRAIN IMPAIR, V18, P49, DOI 10.1017/BrImp.2016.29; Wieser MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00471; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Zupan B, 2017, BRAIN IMPAIR, V18, P36, DOI 10.1017/BrImp.2016.22; Zupan B, 2016, JOVE-J VIS EXP, DOI 10.3791/53774; Zupan B, 2015, BRAIN INJURY, V29, P877, DOI 10.3109/02699052.2015.1011233; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6	66	2	2	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2019	33	1			SI		4	11		10.1080/02699052.2018.1531308			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG2RW	WOS:000454812400002	30296177				2022-02-06	
J	Arik, M; Ekinci, Y; Gurbuz, K; Batin, S				Arik, Mustafa; Ekinci, Yakup; Gurbuz, Kaan; Batin, Sabri			The effects of focal brain damage on fracture healing: An experimental rat study	EKLEM HASTALIKLARI VE CERRAHISI-JOINT DISEASES AND RELATED SURGERY			English	Article						Bone healing; motor cortex; somatosensory cortex; traumatic brain injury	SOMATOSENSORY CORTEX; CALLUS FORMATION; INJURY	Objectives: This study aims to investigate whether the motor cortex (MC) or the somatosensory cortex (SC) is more active during the course of bone healing after traumatic brain injury (TBI). Materials and methods: Thirty-three male Wistar albino rats (age, 8 to 10 months; weighing, 250 to 300 g) were randomized into three groups as the control group, MC damage group and SC damage group. Two rats from each brain damage group were sacrificed to verify the locations of the cortical injuries. Callus formation, callus/diaphysis ratios, and serum alkaline phosphatase (ALP) levels were measured at one, three and six weeks. Results: The increases in callus masses in the control, MC, and SC groups were statistically significantly different between one and three weeks (p<0.05). Although this increase in the MC and SC groups was significant compared to the control group at the end of one week, no statistically significant difference was found between the MC and SC groups (p>0.05). There was a statistically significant difference in callus/diaphysis ratio between control, MC and SC groups in favor of MC group only at one week (p<0.05). The increase in serum ALP levels at three weeks was statistically significantly different in the MC and SC groups compared to the control group and significantly higher in the MC group compared to the SC group (p<0.05). Conclusion: There is a possible relationship between enhanced fracture healing after TBI and damage in the MC. Motor cortex plays a more active role on fracture healing in TBI.	[Arik, Mustafa] Baskent Univ, Med Fac, Dept Orthoped & Traumatol, Ankara, Turkey; [Arik, Mustafa; Ekinci, Yakup; Gurbuz, Kaan; Batin, Sabri] Kayseri City Hosp, Dept Orthoped & Traumatol, Kayseri, Turkey		Ekinci, Y (corresponding author), Kayseri Sehir Hastanesi, Ortopedi & Travmatol Klin, TR-38070 Kayseri, Turkey.	belduya@gmail.com	Ekinci, Yakup/W-2025-2018	Ekinci, Yakup/0000-0002-3190-0840			Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Buckwalter JA, 2001, ROCKWOOD GREENS FRAC, P245; CALANDRIELLO B, 1964, Bull Hosp Joint Dis, V25, P170; Einhorn TA, 2005, J ORTHOP TRAUMA, V19, pS4, DOI 10.1097/00005131-200511101-00002; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Halici M, 2010, EKLEM HAST CERRAHISI, V21, P172; Hiraba H, 2000, SOMATOSENS MOT RES, V17, P361; Kockara N, 2017, EKLEM HAST CERRAHISI, V28, P19, DOI 10.5606/ehc.2017.50897; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Muljacic A, 2013, COLLEGIUM ANTROPOL, V37, P1275; Nakajima A, 2002, J BONE MINER RES, V17, P2038, DOI 10.1359/jbmr.2002.17.11.2038; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; Paxinos G, 2004, RAT BRAIN STEREOTAXI; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Petrof I, 2015, J NEUROPHYSIOL, V113, P2400, DOI 10.1152/jn.00949.2014; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Togral G, 2015, EKLEM HAST CERRAHISI, V26, P137, DOI 10.5606/ehc.2015.29; Trentz OA, 2005, CRIT CARE MED, V33, P399, DOI 10.1097/01.CCM.0000152221.87477.21; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	22	2	2	0	1	TURKISH JOINT DISEASES FOUNDATION	KAVAKLIDERE	BUGDAY SOKAK 6-27, KAVAKLIDERE, ANKARA 06700, TURKEY	1305-8282	1309-0313		EKLEM HAST CERRAHISI	Eklem Hast. Cerrahisi		2019	30	3					267	274		10.5606/ehc.2019.66041			8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	JL2JT	WOS:000495358300013	31650924	gold			2022-02-06	
J	Becker, RE; Greig, NH				Becker, Robert E.; Greig, Nigel H.			Can We Prevent Dementia and Not Prevent Neurons from Dying?	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; amyloid hypothesis; animal models; clinical trial failures; neuronal death; programmed cell death; traumatic brain injury		Neuronal death is the final step in the progression of preclinical Alzheimer's disease (AD) pathologies into clinically evident AD and its profound dementia. As such, a drug candidate proposed to be effective in AD must successfully prevent neuronal losses. The lack of preclinical demonstrated abilities to prevent neuronal programmed cell death may explain the recent failure of 300-400 AD drug candidates, identify a flaw in the Amyloid Hypothesis, and a risk for subsequent drug candidate interventions against AD. We propose that investigators use either animal models or small early translational clinical trials to test for AD drug candidates' efficacy against clinically critical features of the disease, such as prevention of neuronal death. Such stringent testing would more effectively shelter AD patients from being recruited into clinical trials that are destined to fail in Phase II or III.	[Becker, Robert E.] Aristea Translat Med Corp, 3435 Cedar Dr, Park City, UT 84098 USA; [Becker, Robert E.; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program, Baltimore, MD 21224 USA		Becker, RE (corresponding author), Aristea Translat Med Corp, 3435 Cedar Dr, Park City, UT 84098 USA.	rebecker@AristeaTM.com			National Institute on Aging, NIH, Baltimore, MD, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000311] Funding Source: NIH RePORTER	This work was supported in part by the Intramural Research program, National Institute on Aging, NIH, Baltimore, MD, USA.	ALZHEIMER A, 1995, CLIN ANAT, V8, P429, DOI DOI 10.1002/CA.980080612; Becker RE, 2008, J ALZHEIMERS DIS, V15, P303; Becker RE, 2018, J PATIENT-CENTER RES, V5, P183, DOI 10.17294/2330-0698.1589; Becker RE, 2018, ALZHEIMERS DEMENT, V14, P431, DOI 10.1016/j.jalz.2017.11.007; Becker RE, 2014, LANCET, V384, P2260, DOI 10.1016/S0140-6736(14)61887-0; Becker RE, 2014, NAT REV DRUG DISCOV, V13, P157, DOI 10.1038/nrd3842-c2; Chai GL, 2018, NATURE, V563, P631, DOI 10.1038/d41586-018-07334-9; Chang CF, 2017, BRAIN RES, V1677, P118, DOI 10.1016/j.brainres.2017.09.015; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099818; Hoffer BJ, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0377-1; Li Luming, 2011, Int J Alzheimers Dis, V2011, P171464, DOI 10.4061/2011/171464; Lowe D, 2018, ALZHEIMERS STATEMENT; Mullin Emily, 2017, MIT TECHNOLOGY REV; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Novarino Gaia, 2017, Sci Transl Med, V9, DOI 10.1126/scitranslmed.aam9867; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Wirths Oliver, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/723782	18	2	2	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2019	68	2					489	492		10.3233/JAD-181300			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HR1FP	WOS:000462875000006	30814363				2022-02-06	
J	Bos, N; Engel, MF; van Rijswijk, NJ; Verheijden, JMA; Coster, W; Moed, R; Ketelaar, M				Bos, Nynke; Engel, Madelon F.; van Rijswijk, Nina J.; Verheijden, Johannes M. A.; Coster, Wendy; Moed, Richard; Ketelaar, Marjolijn			Translation and cross-cultural adaptation of the PEDI-CAT: Dutch version	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Pediatric rehabilitation; daily functioning; computer adaptive test; cognitive interviewing; end-user involvement; parents	TRAUMATIC BRAIN INJURY; PEDIATRIC EVALUATION; DISABILITY INVENTORY; CEREBRAL-PALSY; CHILDREN; PERFORMANCE	PURPOSE: The PEDI-CAT measures daily functioning of children and youth, aged 1 to 21 years, with a variety of physical, cognitive and/or behavioral disabilities. In order to use an instrument in another culture or language, translation and cross-cultural validation are important, particularly for end-users. This study describes the process of translation and cross-cultural adaptation of the Dutch version of the PEDI-CAT. METHODS: End-users were involved in all steps. First, the PEDI-CAT items were reviewed to determine whether the items were relevant and acceptable in the Dutch culture. Then, the PEDI-CAT was translated into Dutch using specific guidelines. Finally, the wording of the Dutch items and response options were reviewed and tested with 22 parents of children and adolescents with and without disabilities. RESULTS: All 267 items and response options of the original PEDI-CAT were assessed as relevant and translated into Dutch. A selection of 175 items was tested with Think Aloud interviews which revealed that the translation of 46 items could be improved. CONCLUSION: The role of end-users in the process of translation and cross-cultural adaptation was crucial. This collaborative process resulted in a Dutch version of the PEDI-CAT that has been optimally adapted to the Dutch language and culture.	[Bos, Nynke; Engel, Madelon F.; van Rijswijk, Nina J.; Ketelaar, Marjolijn] Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Ctr Excellence Rehabil Med, Rembrandtkade 10, NL-3583 TM Utrecht, Netherlands; [Bos, Nynke; Engel, Madelon F.; van Rijswijk, Nina J.; Ketelaar, Marjolijn] De Hoogstr Rehabil, Rembrandtkade 10, NL-3583 TM Utrecht, Netherlands; [Bos, Nynke] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Amsterdam, Netherlands; [Bos, Nynke] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Sci Ctr Qual Healthcare, Nijmegen, Netherlands; [van Rijswijk, Nina J.] Hogesch Utrecht, Dept Physiotherapy, Utrecht, Netherlands; [Verheijden, Johannes M. A.] Assoc Persons Phys Disabil, BOSK, Utrecht, Netherlands; [Coster, Wendy] Boston Univ, Sargent Coll Hlth & Rehabil Sci, Dept Occupat Therapy, Boston, MA 02215 USA; [Moed, Richard] CREcare LLC, Boston, MA USA		Ketelaar, M (corresponding author), Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Ctr Excellence Rehabil Med, Rembrandtkade 10, NL-3583 TM Utrecht, Netherlands.; Ketelaar, M (corresponding author), De Hoogstr Rehabil, Rembrandtkade 10, NL-3583 TM Utrecht, Netherlands.	M.Ketelaar@dehoogstraat.nl		Ketelaar, Marjolijn/0000-0002-8324-518X	research foundation De Hoogstraat Rehabilitation, Utrecht, The Netherlands	The authors are grateful to all parents that participated in this study. The Dutch PEDI-CAT study group contributed to this study, and consists of A. Dallmeijer, VU Amsterdam; J. Verheijden, BOSK Utrecht; J. Wassenberg-Severijnen, Utrecht University; J. Custers, University of Applied Sciences Utrecht; H. Gorter, Roessingh Rehabilitation Enschede; G. Verkerk, Academic Medical Center Amsterdam; J. Voorman, Wilhelmina Children's Hospital, UMC Utrecht; M. A. Kuijper and I. van Wijk, De Hoogstraat Rehabilitation, Utrecht. This study was financially supported by the research foundation De Hoogstraat Rehabilitation, Utrecht, The Netherlands.	Bamm EL, 2008, ARCH PHYS MED REHAB, V89, P1618, DOI 10.1016/j.apmr.2007.12.034; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Dumas H, 2010, PHYS OCCUP THER PEDI, V30, P168, DOI 10.3109/01942631003640493; Dumas HM, 2012, DISABIL REHABIL, V34, P393, DOI 10.3109/09638288.2011.607217; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Haley S, 1992, PEDIAT EVALUATION DI; Haley S. M., 2012, PEDIAT EVALUATION DI; Haley SM, 2011, DEV MED CHILD NEUROL, V53, P1100, DOI 10.1111/j.1469-8749.2011.04107.x; Haley SM, 2010, PEDIATR PHYS THER, V22, P69, DOI 10.1097/PEP.0b013e3181cbfbf6; Holsbeeke L, 2009, ARCH PHYS MED REHAB, V90, P849, DOI 10.1016/j.apmr.2008.11.015; King G, 2014, J CHILD NEUROL, V29, P1046, DOI 10.1177/0883073814533009; Kramer JM, 2017, DEV MED CHILD NEUROL, V59, P1083, DOI 10.1111/dmcn.13482; Mancini MC, 2016, BRAZ J PHYS THER, V20, P561, DOI 10.1590/bjpt-rbf.2014.0166; Palisano RJ, 2016, PHYS OCCUP THER PEDI, V36, P229, DOI 10.1080/01942638.2016.1194687; RICHARDS T, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F2614; Vos-Vromans DCW, 2005, DISABIL REHABIL, V27, P1245, DOI 10.1080/09638280500076178; Willis Gordon B, 2013, J Grad Med Educ, V5, P353, DOI 10.4300/JGME-D-13-00154.1; World Health Organization, 2001, INT FUNCT DIS HLTH I; World Health Organization, 2007, INT CLASS FUNCT DIS	23	2	2	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2019	12	1					57	64		10.3233/PRM-180544			8	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	HU0FJ	WOS:000464946500007	30883373				2022-02-06	
S	Chemali, Z; Nehme, R; Fricchione, G		Reus, VI; Lindqvist, D		Chemali, Zeina; Nehme, R.; Fricchione, Gregory			Sensory neurologic disorders: Tinnitus	PSYCHOPHARMACOLOGY OF NEUROLOGIC DISEASE	Handbook of Clinical Neurology		English	Article; Book Chapter							TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; VENTRAL COCHLEAR NUCLEUS; HEARING-LOSS; THALAMOCORTICAL DYSRHYTHMIA; MINDFULNESS MEDITATION; SUBJECTIVE TINNITUS; REUPTAKE INHIBITOR; CONTROLLED-TRIAL; NOISE EXPOSURE	Tinnitus is the sensation of hearing a sound with no external auditory stimulus present. It is a public health issue correlated with multiple comorbidities and precipitating factors such as noise exposure, military service, and traumatic brain injury, migraine, insomnia, small vessel disease, smoking history, stress exposure, anxiety, depression, and socioeconomic status. Clinical experience and a recent literature review point at tinnitus as a neuropsychiatric condition involving both auditory and nonauditory cortical areas of the brain and affecting brain-auditory circuitry. In fact, brain-ear connections have been highlighted in different models. Forward management of this disorder should take this body of research into consideration as tinnitus remains a challenging condition to evaluate and treat with current management protocols still symptomatic at best. With a better understanding of the etiologic factors and comorbidities of tinnitus, additional research trials and new therapeutic approaches could see the light to tackle this public health disability bringing hope to patients and doctors.	[Chemali, Zeina] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Chemali, Zeina; Fricchione, Gregory] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [Nehme, R.] Harvard Med Sch, Cambridge Hlth Alliance, Cambridge, MA USA		Chemali, Z (corresponding author), Harvard Med Sch, 15 Parkman St,WACC 815, Boston, MA 02114 USA.	zelchemali@mgh.harvard.edu					AHMAD S, 1995, AM FAM PHYSICIAN, V51, P1830; Al-Swiahb J, 2016, NOISE HEALTH, V18, P214, DOI 10.4103/1463-1741.189240; ALSTER J, 1993, BIOL PSYCHIAT, V34, P84, DOI 10.1016/0006-3223(93)90260-K; Andersson G, 2000, J SPEECH LANG HEAR R, V43, P1168, DOI 10.1044/jslhr.4305.1168; Arif M, 2017, J LARYNGOL OTOL, V131, P501, DOI 10.1017/S002221511700069X; Ashton H, 2007, NEUROSCI LETT, V426, P23, DOI 10.1016/j.neulet.2007.08.034; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Baigi A, 2011, EAR HEARING, V32, P787, DOI 10.1097/AUD.0b013e31822229bd; BARNEA G, 1990, AUDIOLOGY, V29, P36; Bauer CA, 2006, LARYNGOSCOPE, V116, P675, DOI 10.1097/01.MLG.0000216812.65206.CD; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8; Bennett S, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-7; Bledsoe SC, 2009, J NEUROPHYSIOL, V102, P886, DOI 10.1152/jn.91003.2008; Boddu S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164466; Boniver Raymond, 2002, Int Tinnitus J, V8, P129; Brantberg K, 2010, J NEUROL NEUROSUR PS, V81, P451, DOI 10.1136/jnnp.2009.173732; Bulbul SF, 2009, INT J PEDIATR OTORHI, V73, P1124, DOI 10.1016/j.ijporl.2009.04.018; Burgos I, 2005, SOMNOLOGIE, V9, P133, DOI DOI 10.1111/j.1439-054X.2005.00056.x; Burton H, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-3; de Vasconcelos CAC, 2011, INT J MORPHOL, V29, P272, DOI 10.4067/S0717-95022011000100045; CASSVAN A, 1990, ARCH PHYS MED REHAB, V71, P583; Chang JPC, 2012, J CLIN PSYCHOPHARM, V32, P729, DOI 10.1097/JCP.0b013e31826563da; Clewes J, 2012, CNS DISORD, V14; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; Das SK, 2012, LARYNGOSCOPE, V122, P2533, DOI 10.1002/lary.23555; Davies J, 2014, INT J AUDIOL, V53, P192, DOI 10.3109/14992027.2013.846482; De Marinis M, 2010, J HEADACHE PAIN, V11, P83, DOI 10.1007/s10194-009-0167-6; De Ridder D, 2012, J NEUROSURG SCI, V56, P323; De Ridder D, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00124; De Ridder D, 2013, BRAIN STIMUL, V6, P355, DOI 10.1016/j.brs.2012.07.002; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; DeJulio A, 2017, POSTER SESSION AMERI; Desbordes G, 2015, MINDFULNESS, V6, P356, DOI 10.1007/s12671-013-0269-8; Digre Kathleen B, 2002, Curr Pain Headache Rep, V6, P217, DOI 10.1007/s11916-002-0038-1; DOBIE RA, 1993, AM J OTOL, V14, P18; Durai M, 2016, INT J AUDIOL, V55, P605, DOI 10.1080/14992027.2016.1198966; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 1998, HEARING RES, V117, P149, DOI 10.1016/S0378-5955(98)00008-2; Eggermont JJ, 2017, HEARING RES, V352, P12, DOI 10.1016/j.heares.2016.10.015; Eggermont JJ, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00265; Esposito G, 2016, WORLD NEUROSURG, V96, P556, DOI 10.1016/j.wneu.2016.09.030; Falkenberg Eva-Signe, 2012, Int J Otolaryngol, V2012, P375460, DOI 10.1155/2012/375460; Farri A, 1999, Acta Otorhinolaryngol Ital, V19, P70; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Flores LS, 2016, INT ARCH OTORHINOLAR, V20, P248, DOI 10.1055/s-0035-1562935; Folmer RL, 2003, LARYNGOSCOPE, V113, P821, DOI 10.1097/00005537-200305000-00010; Folmer RL, 2015, JAMA OTOLARYNGOL, V141, P716, DOI 10.1001/jamaoto.2015.1219; Friedland DR, 2007, OTOL NEUROTOL, V28, P1005, DOI 10.1097/MAO.0b013e318159ebf5; Gananca Mauricio Malavasi, 2002, Int Tinnitus J, V8, P50; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Gross BA, 2017, J NEUROINTERV SURG, V9, P381, DOI 10.1136/neurintsurg-2016-012668; Gu JW, 2012, JARO-J ASSOC RES OTO, V13, P819, DOI 10.1007/s10162-012-0344-1; Guest H, 2017, HEARING RES, V344, P265, DOI 10.1016/j.heares.2016.12.002; Haider H, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009171; Hall DA, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1399-9; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; He M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150600; Hebert S, 2004, HEARING RES, V190, P1, DOI 10.1016/S0378-5955(04)00021-8; Hebert S, 2007, NEUROSCI LETT, V411, P138, DOI 10.1016/j.neulet.2006.10.028; Hebert S, 2012, PSYCHOTHER PSYCHOSOM, V81, P324, DOI 10.1159/000335043; Hebert S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037733; Hebert S, 2011, J SLEEP RES, V20, P38, DOI 10.1111/j.1365-2869.2010.00860.x; Hesse G, 2016, HEAD NECK SURG, V15; Hesser H, 2011, CLIN PSYCHOL REV, V31, P545, DOI 10.1016/j.cpr.2010.12.006; Hiller W, 1997, J PSYCHOSOM RES, V43, P613, DOI 10.1016/S0022-3999(97)00188-8; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; Hirschtritt ME, 2017, JAMA-J AM MED ASSOC, V317, P1358, DOI 10.1001/jama.2017.2200; Hoare DJ, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5130503; Hoare DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114553; Hoare DJ, 2011, LARYNGOSCOPE, V121, P1555, DOI 10.1002/lary.21825; Hoekstra CEL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007960.pub2; HOUSE JW, 1978, LARYNGOSCOPE, V88, P406, DOI 10.1288/00005537-197803000-00004; House P R, 1981, Ciba Found Symp, V85, P193; HULSHOF JH, 1985, ORL J OTO-RHINO-LARY, V47, P262, DOI 10.1159/000275781; Jacobson G P, 2001, J Am Acad Audiol, V12, P493; JAKES SC, 1985, AUDIOLOGY, V24, P195; Jalali MM, 2009, MED SCI MONITOR, V15, pPI55; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; Jeon HW, 2016, OTOL NEUROTOL, V37, P1344, DOI 10.1097/MAO.0000000000001179; Kabat-Zinn J, 1994, YOU GO 3 YOU ARE MIN; Kaltenbach JA, 2006, ACTA OTO-LARYNGOL, V126, P20, DOI 10.1080/03655230600895309; Kanold PO, 2001, J NEUROSCI, V21, P7848, DOI 10.1523/JNEUROSCI.21-19-07848.2001; Kim JY, 2012, INT J AUDIOL, V51, P413, DOI 10.3109/14992027.2011.652677; Kim YH, 2012, LARYNGOSCOPE, V122, P2279, DOI 10.1002/lary.23482; Koo M, 2016, LARYNGOSCOPE, V26; Kraaijenga VJC, 2016, JAMA OTOLARYNGOL, V142, P389, DOI 10.1001/jamaoto.2015.3667; Kreuzer PM, 2014, J HEAD TRAUMA REHAB, V29, P432, DOI 10.1097/HTR.0b013e31829d3129; Kreuzer PM, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-235; Kreuzer PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045599; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Lee H, 2003, ARCH NEUROL-CHICAGO, V60, P113, DOI 10.1001/archneur.60.1.113; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; LEWIS JE, 1994, CLIN OTOLARYNGOL, V19, P50, DOI 10.1111/j.1365-2273.1994.tb01147.x; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Lopez-Escamez JA, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00377; Lopez-Gonzalez MA, 2007, AURIS NASUS LARYNX, V34, P23, DOI 10.1016/j.anl.2006.09.021; Ma WLD, 2006, HEARING RES, V212, P9, DOI 10.1016/j.heares.2005.10.003; Mansbach A L, 1983, Acta Otorhinolaryngol Belg, V37, P697; Marciano E, 2003, INT J AUDIOL, V42, P4, DOI 10.3109/14992020309056079; Matthies C, 1997, NEUROSURGERY, V40, P1; Maudoux A, 2012, BRAIN RES, V1485, P10, DOI 10.1016/j.brainres.2012.05.006; Mazurek B, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00047; McCormack A, 2016, HEARING RES, V337, P70, DOI 10.1016/j.heares.2016.05.009; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Melcher JR, 2009, HEARING RES, V257, P63, DOI 10.1016/j.heares.2009.08.005; Menkes DB, 1998, J NEUROL NEUROSUR PS, V65, P803, DOI 10.1136/jnnp.65.5.803; Michiels S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00545; Minen MT, 2014, J NEUROL NEUROSUR PS, V85, P1138, DOI 10.1136/jnnp-2013-307339; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Moller AR, 2011, TEXTBOOK OF TINNITUS, P9, DOI 10.1007/978-1-60761-145-5_2; MOLLER AR, 1984, ANN OTO RHINOL LARYN, V93, P39; Moreno-Fernandez AM, 2017, MOD RHEUMATOL, V1, P1; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Panford-Walsh R, 2008, MOL PHARMACOL, V74, P595, DOI 10.1124/mol.108.046375; Person OC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009832.pub2; Philippot P, 2012, CLIN PSYCHOL PSYCHOT, V19, P411, DOI 10.1002/cpp.756; Piccirillo JF, 2007, ARCH OTOLARYNGOL, V133, P390, DOI 10.1001/archotol.133.4.390; Pinchoff RJ, 1998, AM J OTOL, V19, P785; Plewnia C, 2007, J NEUROL NEUROSUR PS, V78, P152, DOI 10.1136/jnnp.2006.095612; Plewnia C, 2003, ANN NEUROL, V53, P263, DOI 10.1002/ana.10468; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Pondrom MF, 2009, AM J HEALTH-SYST PH, V66, P1606, DOI 10.2146/ajhp090309; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Raghavan P, 2016, NEUROIMAG CLIN N AM, V26, P301, DOI 10.1016/j.nic.2015.12.008; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Robinson SK, 2005, PSYCHOSOM MED, V67, P981, DOI 10.1097/01.psy.0000188479.04891.74; Rogha M, 2011, J RES MED SCI, V16, P1217; Roland LT, 2015, OTOLARYNG HEAD NECK, V152, P919, DOI 10.1177/0194599815571556; Rosing SN, 2016, INT J PEDIATR OTORHI, V89, P112, DOI 10.1016/j.ijporl.2016.07.036; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Sadlier M, 2008, J LARYNGOL OTOL, V122, P31, DOI 10.1017/S0022215107007438; Salvi R, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00621; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Sedley W, 2016, TRENDS NEUROSCI, V39, P799, DOI 10.1016/j.tins.2016.10.004; SETTLE EC, 1991, J CLIN PSYCHIAT, V52, P352; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; She WD, 2009, MED SCI MONITOR, V15, pPI35; Shekhawat GS, 2013, J AM ACAD AUDIOL, V24, P747, DOI 10.3766/jaaa.24.8.11; Shore SE, 2005, TINNITUS THEORY MANA, P125; Shore S, 2007, PROG BRAIN RES, V166, P107, DOI 10.1016/S0079-6123(07)66010-5; Skollerud S, 2003, AUDIOL MED, V1, P132, DOI DOI 10.1080/16513860301715; Slengerik-Hansen J, 2016, OTOL NEUROTOL, V37, P820, DOI 10.1097/MAO.0000000000001090; Soleymani Teo, 2011, Surg Neurol Int, V2, P154, DOI 10.4103/2152-7806.86834; Song JJ., 2012, SCI WORLD J, V2012, P427941, DOI DOI 10.1100/2012/427941; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; STURZENEGGER MH, 1985, HEADACHE, V25, P408; Tegg-Quinn S, 2016, INT J AUDIOL, V55, P533, DOI 10.1080/14992027.2016.1185168; Thompson DM, 2017, EAR HEARING, V38, P149, DOI 10.1097/AUD.0000000000000363; Tyler R S, 1983, Br J Audiol, V17, P191, DOI 10.3109/03005368309107884; Vago DR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00296; van den Berge MJ, 2016, J NEUROSURG, V2, P1; van Zwieten Gusta, 2016, Surg Neurol Int, V7, pS125, DOI 10.4103/2152-7806.176134; Vanneste S, 2012, EXP BRAIN RES, V221, P337, DOI 10.1007/s00221-012-3176-7; Vanneste S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00031; Volcy M, 2005, HEADACHE, V45, P1083, DOI 10.1111/j.1526-4610.2005.05193_2.x; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wall M, 2017, NEUROL CLIN, V35, P45, DOI 10.1016/j.ncl.2016.08.004; Witsell DL, 2007, OTOL NEUROTOL, V28, P11, DOI 10.1097/01.mao.0000235967.53474.93; Yang P, 2015, INT J HYPERTENS, V2015, DOI 10.1155/2015/583493; Zenner HP, 2017, EUR ARCH OTO-RHINO-L, V274, P2079, DOI 10.1007/s00405-016-4401-y; Zhao Y, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2162105; Zheng Y, 2008, ACTA OTO-LARYNGOL, V128, P48, DOI 10.1080/00016480701361939; Zoger S, 2006, J CLIN PSYCHOPHARM, V26, P32, DOI 10.1097/01.jcp.0000195111.86650.19	175	2	3	1	2	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-464013-0; 978-0-444-64012-3	HAND CLINIC			2019	165						365	381		10.1016/B978-0-444-64012-3.00022-8			17	Behavioral Sciences; Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	BP5NM	WOS:000557239100024	31727224				2022-02-06	
J	Church, HR; Seewald, PM; Clark, JMR; Jak, AJ; Twamley, EW				Church, Haley R.; Seewald, P. Michelle; Clark, Jillian M. R.; Jak, Amy J.; Twamley, Elizabeth W.			Predictors of work outcomes following supported employment in veterans with a history of traumatic brain injury	NEUROREHABILITATION			English	Article						Brain injuries; cognition; unemployment; neuropsychological tests; mental disorders; return to work		BACKGROUND: The effects of traumatic brain injury (TBI) on return to work have been the focus of many clinical studies in recent years. Veterans with a history of TBI may be at increased risk of unemployment. OBJECTIVE: We sought to understand predictors of work outcomes for Veterans with a history of TBI who received evidence-based supported employment. METHODS: Fifty unemployed Veterans with a history of mild-to-moderate TBI and current neuropsychological impairment participated in a 12-month supported employment intervention. Demographic data and baseline assessments of neuropsychological impairment, functional capacity, and psychiatric and post-concussive symptom severity were investigated as predictors of work outcomes (job attainment, weeks worked, and wages earned). RESULTS: Bivariate analyses showed that lower disability ratings, more recent work history, more months worked in the past 5 years, lower PTSD symptom severity, worse verbal memory, and better cognitive flexibility were all associated with better work outcomes. In multivariate regression analyses, better cognitive flexibility and worse verbal memory performance predicted better work outcomes. CONCLUSIONS: Further research is needed to determine how treatment of cognitive impairments and psychiatric symptoms is related to return to work in Veterans with a history of TBI.	[Church, Haley R.] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Seewald, P. Michelle; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Clark, Jillian M. R.; Jak, Amy J.; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth VA, San Diego, CA 92161 USA; [Clark, Jillian M. R.; Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA 92161 USA; [Jak, Amy J.; Twamley, Elizabeth W.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA		Twamley, EW (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr,116A, San Diego, CA 92161 USA.	etwamley@ucsd.edu			Department of Defense AwardUnited States Department of Defense [W81XWH-08-2-0193]	The authors declare no conflicts of interest. This research was funded by Department of Defense Award W81XWH-08-2-0193 to Dr. Elizabeth W. Twamley. Writing of this manuscript was supported by the Office of Academic Affiliations, Center of Excellence for Stress and Mental Health, Department of Veterans Affairs.	BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Carlson KF, 2018, ARCH PHYS MED REHAB, V99, pS4, DOI 10.1016/j.apmr.2017.06.027; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; IBM Corp, 2016, IBM SPSS STAT WIND V; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Mausbach BT, 2007, SCHIZOPHRENIA BULL, V33, P1364, DOI 10.1093/schbul/sbm014; Olsen DC, 2018, BRAIN INJURY, V32, P544, DOI 10.1080/02699052.2018.1431845; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Twamley E. W., 2014, J REHABILITATION RES, V51; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001	16	2	2	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2019	44	3					333	339		10.3233/NRE-182631			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IE8IG	WOS:000472616500002	31177239				2022-02-06	
J	Cohen, ML; Tulsky, DS; Boulton, AJ; Kisala, PA; Bertisch, H; Yeates, KO; Zonfrillo, MR; Durbin, DR; Jaffe, KM; Temkin, N; Wang, J; Rivara, FP				Cohen, Matthew L.; Tulsky, David S.; Boulton, Aaron J.; Kisala, Pamela A.; Bertisch, Hilary; Yeates, Keith Owen; Zonfrillo, Mark R.; Durbin, Dennis R.; Jaffe, Kenneth M.; Temkin, Nancy; Wang, Jin; Rivara, Frederick P.			Reliability and Construct Validity of the TBI-QOL Communication Short Form as a Parent-Proxy Report Instrument for Children With Traumatic Brain Injury	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							QUALITY-OF-LIFE; ITEM RESPONSE THEORY; OUTCOMES MEASUREMENT; DISABILITY; BANKS; RECOMMENDATIONS; DYSARTHRIA; DISORDERS; NEUROLOGY; MODELS	Purpose: The purpose of this study was to evaluate the internal consistency and construct validity of the Traumatic Brain Injury Quality of Life Communication Item Bank (TBI-QOL COM) short form as a parent-proxy report measure. The TBI-QOL COM is a patient-reported outcome measure of functional communication originally developed as a self-report measure for adults with traumatic brain injury (TM), but it may also be valid as a parent-proxy report measure for children who have sustained TBI. Method: One hundred twenty-nine parent-proxy raters completed the TBI-QOL COM short form 6 months postinjury as a secondary aim of a multisite study of pediatric TBI outcomes. The respondents' children with TBI were between 8 and 18 years old (M-age= 13.2 years old) at the time of injury, and the proportion of TBI severity mirrored national trends (73% complicated-mild; 27% moderate or severe). Results: The parent-proxy report version of the TBI-QOL COM displayed strong internal consistency (ordinal alpha = .93). It also displayed evidence of known-groups validity by virtue of more severe injuries associated with more abnormal scores. The instrument also showed evidence of convergent and discriminant validity by displaying a pattern of correlations with other constructs according to their conceptual relatedness to functional communication. Conclusions: This preliminary psychometric investigation of the TBI-QOL COM supports the further development of a parent report version of the instrument. Future development of the TBI-QOL COM with this population may include expanding the content of the item bank and developing calibrations specifically for parent-proxy raters.	[Cohen, Matthew L.] Univ Delaware, Dept Commun Sci & Disorders, Newark, DE 19716 USA; [Cohen, Matthew L.; Tulsky, David S.; Boulton, Aaron J.; Kisala, Pamela A.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Cohen, Matthew L.; Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA; [Bertisch, Hilary] NYU, Langone Med Ctr, Rusk Rehabil, New York, NY USA; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Durbin, Dennis R.] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH USA; [Durbin, Dennis R.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Jaffe, Kenneth M.; Wang, Jin; Rivara, Frederick P.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA		Cohen, ML (corresponding author), Univ Delaware, Dept Commun Sci & Disorders, Newark, DE 19716 USA.; Cohen, ML (corresponding author), Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19716 USA.; Cohen, ML (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.	mlcohen@udel.edu	Cohen, Mathew/W-3982-2019; Durbin, Dennis/AAD-7829-2022; Yeates, Keith/AAJ-4223-2020	Tulsky, David/0000-0002-4335-4509; Cohen, Matthew/0000-0001-9609-2461; Yeates, Keith/0000-0001-7680-2892	Centers for Disease Control and Prevention GrantUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002196]	This study was supported by the Centers for Disease Control and Prevention Grant U01CE002196, awarded to Frederick Rivera. The TBI-QOL Communication scale (copyright (C) 2013 David Tulsky and Kessler Foundation) was modified with permission for use in this study. The parent proxy revised scale is copyright (C) 2018. David Tulsky and Kessler Foundation. All rights reserved. All TBI-QOL measures are freely available to the public by contacting tbi-qol@udel.edu, via the Assessment Center platform (http://www.assessmentcenter.net), and via the NIH Toolbox iPad application.	Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baylor C, 2011, AM J SPEECH-LANG PAT, V20, P243, DOI 10.1044/1058-0360(2011/10-0079); Bertisch H, 2017, QUAL LIFE RES, V26, P1887, DOI 10.1007/s11136-017-1524-6; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Cheng K, 2017, J NEUROTRAUM, V34, P1603, DOI 10.1089/neu.2016.4657; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; Dennis M, 2010, J CLIN EXP NEUROPSYC, V32, P417, DOI 10.1080/13803390903164355; Doyle PJ, 2008, APHASIOLOGY, V22, P718, DOI 10.1080/02687030701803093; Eisenberg T, 2015, J EMPIR LEGAL STUD, V12, P161, DOI 10.1111/jels.12068; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fung CH, 2008, QUAL LIFE RES, V17, P1297, DOI 10.1007/s11136-008-9379-5; Gadermann A. M., 2012, PRACTICAL ASSESSMENT, V17, P1, DOI DOI 10.1080/10705519709540077; Gershon R, 2010, QUAL LIFE RES, V19, P677, DOI 10.1007/s11136-010-9634-4; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hays RD, 2000, MED CARE, V38, P28; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; MESSICK S, 1995, AM PSYCHOL, V50, P741, DOI 10.1037/0003-066X.50.9.741; Morgan AT, 2010, CHILD CARE HLTH DEV, V36, P44, DOI 10.1111/j.1365-2214.2009.00961.x; Morgan AT, 2009, EUR J PHYS REHAB MED, V45, P197; National Institute for Neurological Disorders and Stroke, 2018, COMM DAT EL; Perez Lori, 2007, J Neurosci Nurs, V39, P342; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Scott Long J., 1997, REGRESSION MODELS CA, V7; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Swanson JO, 2012, PEDIATR RADIOL, V42, P974, DOI 10.1007/s00247-012-2372-8; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Thomas ML, 2011, ASSESSMENT, V18, P291, DOI 10.1177/1073191110374797; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni J.W., 2017, SCALING SCORING PEDI; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	50	2	2	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	JAN	2019	62	1					84	92		10.1044/2018_JSLHR-L-18-0074			9	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HL1SP	WOS:000458482300006	30950756				2022-02-06	
J	Daugherty, J; Miles, I; Sarmiento, K; Sansone, C; Kroshus, E; Bethea, B				Daugherty, Jill; Miles, Isa; Sarmiento, Kelly; Sansone, Cristina; Kroshus, Emily; Bethea, Brittaney			A Description and Evaluation of the Concussion Education Application HEADS UP Rocket Blades	HEALTH PROMOTION PRACTICE			English	Article						concussion; mobile gaming; health communication	TRAUMATIC BRAIN-INJURY; BEHAVIORAL OUTCOMES; KNOWLEDGE; CHILDREN; ATTITUDES	Background. Concussions are responsible for numerous emergency department visits and hospitalizations among children annually. However, there remains a great deal of confusion about how to prevent and manage concussions in youth. To teach children aged 6 to 8 years about concussion safety, the Centers for Disease Control and Prevention (CDC) created a mobile gaming application called HEADS UP Rocket Blades. This report introduces the game and presents findings on its evaluation. Methods. The aim of the game is to teach children what a concussion is, its commons signs and symptoms, how to prevent one, and what to do if one occurs. An early version of the game went through two rounds of usability testing with children and parents to obtain initial impressions and make improvements. Results. The first round of usability testing focused on the mechanics of the game. Based on feedback from this session, CDC and the developers simplified the messaging and adjusted the game's level of difficulty. The second round focused on the gaming experience. The children indicated that they enjoyed playing, and nearly all were able to relay at least one learning objective. Conclusions. Parents and children rated Rocket Blades as a good learning tool and indicated that they would download it for personal use.	[Daugherty, Jill; Sarmiento, Kelly] Ctr Dis Control & Prevent, Atlanta, GA 30307 USA; [Miles, Isa; Sansone, Cristina; Bethea, Brittaney] Banyan Commun, Atlanta, GA USA; [Kroshus, Emily] Univ Washington, Seattle, WA 98195 USA		Daugherty, J (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, 4770 Buford Highway NE, Atlanta, GA 30307 USA.	jdaugherty@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Andrews R., 2011, INT J SPORTS ETHICS, V1, P31; Centers for Disease Control and Prevention, 2016, FACTS CONC BRAIN INJ; Centers for Disease Control and Prevention, 2017, WHAT IS A CONC; Ching D., 2009, GAME CHANGER INVESTI; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Curaudeau GA, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11186; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoffler TN, 2007, LEARN INSTR, V17, P722, DOI 10.1016/j.learninstruc.2007.09.013; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; Kabali HK, 2015, PEDIATRICS, V136, P1044, DOI 10.1542/peds.2015-2151; Kato PM, 2008, PEDIATRICS, V122, pE305, DOI 10.1542/peds.2007-3134; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Kroshus E, 2017, CHILD CARE HLTH DEV, V43, P758, DOI 10.1111/cch.12433; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lin AC, 2015, SPORTS HEALTH, V7, P124, DOI 10.1177/1941738115571570; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Montano D.E., 2015, HLTH BEHAV THEORY RE, V70, P231; Morrongiello BA, 2008, INJURY PREV, V14, P176, DOI 10.1136/ip.2007.016782; Murphy R., 2002, E DESK REV RECENT EV; Piaget J., 2003, J RES SCI TEACH, V40, pS8; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Sawyer B., 2008, SLID SER GAM SUMM GA; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Tate R., 2009, HOPELABS APPROACH RE; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; The NPD Group, 2013, HALF CHILDR NOW US S; University of Pittsburgh Medical Center, 2016, KNOWL AR AM CONC ASS; Zin Nor Azan Mat, 2009, WSEAS Transactions on Computers, V8, P322	39	2	2	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1524-8399	1552-6372		HEALTH PROMOT PRACT	Health Promot. Pract.	JAN	2019	20	1					22	30		10.1177/1524839918764670			9	Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Public, Environmental & Occupational Health	HE6TY	WOS:000453548800006	29597872	Green Accepted			2022-02-06	
J	Doherty, CP; O'Keeffe, E; Keaney, J; Lawlor, B; Coen, RF; Farrell, M; Campbell, M				Doherty, Colin P.; O'Keeffe, Eoin; Keaney, James; Lawlor, Brian; Coen, Robert F.; Farrell, Michael; Campbell, Matthew			Neuropolypathology as a result of severe traumatic brain injury?	CLINICAL NEUROPATHOLOGY			English	Article						blood-brain barrier (BBB); polypathology; claudin-5	ENVIRONMENTAL RISK-FACTORS; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; PATHOLOGY	A history of brain trauma has long been acknowledged as increasing an individual's risk of developing dementia in later life. The underlying mechanisms that belie this pre-disposition are, however, very poorly understood. Here, we report a clinical-neuropathological correlation of a man who presented at the age of 66 with a progressive complex atypical dementia with early and prominent neurobehavioral symptoms. His neurological condition continued to decline up to his death at the age of 74. During the compilation of his clinical history, it was established that the subject had experienced a single severe traumatic brain injury (TBI) aged 12 years in 1954 resulting in loss of consciousness, hospitalization, and coma for a number of days after which he was deemed to have recovered. Following post-mortem neuropathological analysis, numerous distinct neuropathologies were observed in various brain regions and these included i) widespread Braak stage VI neurofibrillary tangle formation, ii) widespread a-synuclein positive Lewy bodies and Lewy neurites and iii) diffuse amyloid plaques and severe cerebral amyloid angiopathy (CAA). Added to this, a comprehensive analysis of blood-brain barrier (BBB) integrity, known to be disrupted during and after TBI, showed iv) distinct BBB breakdown with extravasated IgG and activated microglia present. This report represents an interesting documented case of neuropolypathology that may be associated with prior history of severe TBI. We propose one testable theory that a history of brain trauma may be a potential trigger for late onset dementia due to damage and unresolved functioning of the cerebral micro-vasculature.	[Doherty, Colin P.] St James Hosp, Hosp 5, Hlth Care Ctr, Dept Neurol, Dublin, Ireland; [O'Keeffe, Eoin; Keaney, James; Campbell, Matthew] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Lawlor, Brian; Coen, Robert F.] St James Hosp, Mercers Inst Res Ageing, Dublin, Ireland; [Farrell, Michael] Beaumont Hosp, Dept Neuropathol, Dublin, Ireland		Campbell, M (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland.	matthew.campbell@tcd.ie		Doherty, Colin/0000-0002-8869-8567	Science Foundation Ireland (SFI)Science Foundation Ireland [12/YI/B2614, 08/IN. I/B2033]; SFIScience Foundation Ireland; Health Research Board of Ireland (HRB); Bright Focus FoundationBrightFocus Foundation; St James' Hospital Research Foundation	This work was supported by grants from Science Foundation Ireland (SFI), (12/YI/B2614; 08/IN. I/B2033), SFI funded centre FutureNeuro, The Health Research Board of Ireland (HRB), the Bright Focus Foundation and St James' Hospital Research Foundation.	Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Graff-Radford J, 2017, JAMA NEUROL, V74, P308, DOI 10.1001/jamaneurol.2016.4926; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Keaney J, 2015, FEBS J, V282, P4067, DOI 10.1111/febs.13412; Marin R, 2017, NEUROBIOL AGING, V49, P52, DOI 10.1016/j.neurobiolaging.2016.08.027; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Yamada M, 2015, J STROKE, V17, P17, DOI 10.5853/jos.2015.17.1.17	20	2	2	0	7	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.	JAN-FEB	2019	38	1					14	22		10.5414/NP301131			9	Clinical Neurology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	HM0EJ	WOS:000459119100004	30336803				2022-02-06	
S	El Khoury, D		Kobeissy, FH		El Khoury, Diala			Study of Myelin Gene Expression in the Central Nervous System Using Real-Time PCR	PSYCHIATRIC DISORDERS: Methods and Protocols	Methods in Molecular Biology		English	Article; Book Chapter						Oligodendrocytes; Myelination genes; PLP; MBP; RT-PCR; Treatment effect	MULTIPLE-SCLEROSIS; OLIGODENDROCYTE DEVELOPMENT; REMYELINATION; MICROGLIA; EXPOSURE; MODELS	Myelin sheaths are crucial for the survival and maintenance of the axons and the rapid propagation of the action potential. The glial cells involved are Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS). One oligodendrocyte may myelinate over 40 axons. In the CNS, myelin is composed of several layers of cytoplasmic membrane from oligodendrocytes stabilized by structural myelin-specific proteins such as proteolipid protein (PLP) and myelin basic protein (MBP). Those genes are expressed during myelination and then silenced. They can be re-expressed after demyelinating episodes, where they contribute to remyelination. Demyelination occurs after injuries of the CNS such as traumatic brain injury or during acute episodes of neurodegeneration observed in demyelinating and neurodegenerative diseases. Remyelination process is achieved by oligodendrocytes newly generated following the recruitment and differentiation of oligodendrocyte precursor cells (OPCs). Failure of remyelination process leads to irreversible axonal loss, functional impairment, and finally decreased cognitive performances. Several techniques have been described to study myelination and remyelination in culture systems. In this chapter, we explain how we can study myelin genes' expression in oligodendrocytes by real-time polymerase chain reaction (RT-PCR) using specific primers for plp and mbp. This technique can be crucial and prompt to determine the effect of specific chemicals (such as pesticides) on the myelination process in oligodendrocytes.	[El Khoury, Diala] Notre Dame Univ, Dept Biol Louaize Lebanon, NDU Nat & Appl Sci, Zouk Mosbeh, Lebanon		El Khoury, D (corresponding author), Notre Dame Univ, Dept Biol Louaize Lebanon, NDU Nat & Appl Sci, Zouk Mosbeh, Lebanon.						Barateiro A, 2014, BBA-MOL CELL RES, V1843, P1917, DOI 10.1016/j.bbamcr.2014.04.018; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; El Waly B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00145; Fan LW, 2015, J NEUROCHEM, V133, P532, DOI 10.1111/jnc.12988; Feutz AC, 2001, GLIA, V34, P241, DOI 10.1002/glia.1058; Frohman EM, 2006, ARCH NEUROL-CHICAGO, V63, P614, DOI 10.1001/archneur.63.4.614; GarciaLadona FJ, 1997, J NEUROSCI RES, V50, P50, DOI 10.1002/(SICI)1097-4547(19971001)50:1<50::AID-JNR6>3.0.CO;2-K; Grenier J, 2006, M S-MED SCI, V22, P16, DOI 10.1051/medsci/200622116; GRINSPAN J, 1993, J NEUROCYTOL, V22, P322, DOI 10.1007/BF01195556; Jagielska A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00093; Jana M, 2018, NEUROCHEM RES, V43, P407, DOI 10.1007/s11064-017-2435-1; Jarjour AA, 2012, GLIA, V60, P1, DOI 10.1002/glia.21231; Linden JR, 2015, MBIO, V6, DOI 10.1128/mBio.02513-14; Meffre D, 2015, P NATL ACAD SCI USA, V112, P7587, DOI 10.1073/pnas.1424951112; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Morell P., 1999, BASIC NEUROCHEMISTRY; Napoli I, 2010, EXP NEUROL, V225, P24, DOI 10.1016/j.expneurol.2009.04.024; Padhi BK, 2015, NEUROTOXICOLOGY, V48, P223, DOI 10.1016/j.neuro.2015.04.006; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Pott F, 2009, BRAIN RES, V1305, P137, DOI 10.1016/j.brainres.2009.09.084; Quarles RH, 1999, BASIC NEUROCHEMISTRY; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shiraki A, 2016, J APPL TOXICOL, V36, P24, DOI 10.1002/jat.3140; Siegel GJ, 1990, BASIC NEUROCHEMISTRY; Tawk M, 2011, J NEUROSCI, V31, P3729, DOI 10.1523/JNEUROSCI.4270-10.2011; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Trousson A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008080; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01	28	2	2	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-9554-7; 978-1-4939-9553-0	METHODS MOL BIOL	Methods Mol. Biol.		2019	2011						659	670		10.1007/978-1-4939-9554-7_38	10.1007/978-1-4939-9554-7		12	Biochemical Research Methods; Biochemistry & Molecular Biology; Psychiatry	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Psychiatry	BS2ER	WOS:000700605200040	31273727				2022-02-06	
J	Ellison, JM; Colvonen, PJ; Haller, M; Norman, SB; Angkaw, AC				Ellison, Jennifer M.; Colvonen, Peter J.; Haller, Moira; Norman, Sonya B.; Angkaw, Abigail C.			Examining the relation between PTSD and insomnia on aggression	MILITARY PSYCHOLOGY			English	Article						PTSD; insomnia; aggression	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCES; PHYSICAL AGGRESSION; REACTIVE AGGRESSION; PROLONGED EXPOSURE; ALCOHOL-PROBLEMS; SOCIAL SUPPORT; POOR SLEEP; VETERANS	Posttraumatic stress disorder (PTSD) symptoms and poor sleep have been identified as potential causals factor in aggression, violence, and impulsive behavior. Given the high cost of aggression to society and public health, identifying modifiable factors related to aggression, such as insomnia, may guide treatment strategies to help decrease aggression. Participants were 143 Veterans seeking treatment for PTSD at a VA outpatient PTSD clinic. Linear and logistic regression analyses were used to examine the relation between PTSD and insomnia on aggression. Results from bivariate analyses indicated that while both PTSD and insomnia severity were associated with higher aggression scores independently, when PTSD and insomnia were examined together, PTSD severity was the only significant predictor of aggression. Interaction effects yielded nonsignificant results suggesting that poor sleep did not moderate the PTSD and aggression relation. Results suggest that addressing PTSD symptoms as a first treatment target may be more important for decreasing risk for aggression than targeting insomnia. More research is needed to understand whether treating PTSD and insomnia reduces aggression in Veterans.	[Ellison, Jennifer M.; Colvonen, Peter J.; Haller, Moira; Norman, Sonya B.; Angkaw, Abigail C.] VA San Diego Healthcare Syst, 8810 Rio San Diego Dr 116A4Z, San Diego, CA 92108 USA; [Colvonen, Peter J.; Haller, Moira; Norman, Sonya B.; Angkaw, Abigail C.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Colvonen, Peter J.; Norman, Sonya B.] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Norman, Sonya B.; Angkaw, Abigail C.] Natl Ctr PTSD, White River Jct, VT USA		Angkaw, AC (corresponding author), VA San Diego Healthcare Syst, 8810 Rio San Diego Dr 116A4Z, San Diego, CA 92108 USA.	abigail.angkaw@va.gov			Veterans Affairs Clinical Science Research and Development Merit Grant [1I01CX000756, 1lK2Rx002120-01]; US Department of Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs	Funding for this work was made possible by a Veterans Affairs Clinical Science Research and Development Merit Grant, 1I01CX000756 (PI: Sonya Norman). This work was supported in part by a Career Development Award Grant #1lK2Rx002120-01 to Peter J. Colvonen from the US Department of Veterans Affairs Rehabilitation Research and Development Service. This publication does not represent the views of the US Department of Veterans Affairs or the United States Government.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Angkaw AC, 2013, MIL MED, V178, P1044, DOI 10.7205/MILMED-D-13-00061; Arnetz JE, 2001, SOC SCI MED, V52, P417, DOI 10.1016/S0277-9536(00)00146-5; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Begic D, 2001, MIL MED, V166, P671, DOI 10.1093/milmed/166.8.671; Belleville G, 2009, J NERV MENT DIS, V197, P126, DOI 10.1097/NMD.0b013e3181961d8e; Bonnet MH, 1997, ELECTROEN CLIN NEURO, V102, P390, DOI 10.1016/S0921-884X(96)96070-1; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Buckley L, 2017, AGGRESS VIOLENT BEH, V37, P26, DOI 10.1016/j.avb.2017.08.004; Cloitre M, 2005, BEHAV THER, V36, P119, DOI 10.1016/S0005-7894(05)80060-7; Colvonen PJ, 2019, PSYCHOL TRAUMA-US, V11, P107, DOI 10.1037/tra0000402; Colvonen PJ, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0916-9; Cote KA, 2013, BIOL PSYCHOL, V92, P249, DOI 10.1016/j.biopsycho.2012.09.011; Crocker LD, 2016, PSYCHOL TRAUMA-US, V8, P520, DOI 10.1037/tra0000151; Denson TF, 2012, CURR DIR PSYCHOL SCI, V21, P20, DOI 10.1177/0963721411429451; DIMSDALE JE, 1986, PSYCHOSOM MED, V48, P430, DOI 10.1097/00006842-198607000-00005; Dougherty DM, 1999, PSYCHIAT RES, V85, P315, DOI 10.1016/S0165-1781(99)00011-6; Dyer KFW., 2017, TRAUMATOLOGY, V23, P294, DOI [10.1037/trm0000114, DOI 10.1037/TRM0000114]; Elbogen EB, 2014, PSYCHOL SERV, V11, P220, DOI 10.1037/a0035088; Finkel EJ, 2018, CURR OPIN PSYCHOL, V19, P125, DOI 10.1016/j.copsyc.2017.03.013; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Girschik J, 2012, J EPIDEMIOL, V22, P462, DOI 10.2188/jea.JE20120012; Golden SH, 2006, PSYCHONEUROENDOCRINO, V31, P325, DOI 10.1016/j.psyneuen.2005.08.008; Haack M, 2005, PAIN, V119, P56, DOI 10.1016/j.pain.2005.09.011; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Harvey AG, 2002, BEHAV RES THER, V40, P267, DOI 10.1016/S0005-7967(01)00012-2; HATCH JP, 1991, HEADACHE, V31, P302, DOI 10.1111/j.1526-4610.1991.hed3105302.x; Hellmuth JC, 2012, J TRAUMA STRESS, V25, P527, DOI 10.1002/jts.21732; INMAN DJ, 1990, J TRAUMA STRESS, V3, P429, DOI DOI 10.1007/BF00974782; Ireland JL, 2006, J ADOLESCENT HEALTH, V38, P649, DOI 10.1016/j.jadohealth.2005.05.027; Jaffee CMS, 2009, CLIN NEUROPSYCHOL, V23, P1291, DOI 10.1080/13854040903307250; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Jakupcak Matthew, 2005, Violence Vict, V20, P589, DOI 10.1891/088667005780927494; Kamphuis J, 2014, PHYSIOL BEHAV, V123, P168, DOI 10.1016/j.physbeh.2013.10.015; Kamphuis J, 2012, SLEEP MED, V13, P327, DOI 10.1016/j.sleep.2011.12.006; Kotler M, 2001, J NERV MENT DIS, V189, P162, DOI 10.1097/00005053-200103000-00004; LaMotte AD, 2017, PSYCHOL TRAUMA-US, V9, P113, DOI 10.1037/tra0000178; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Lee AH, 2018, CURR OPIN PSYCHOL, V19, P65, DOI 10.1016/j.copsyc.2017.04.004; Lind MJ, 2017, J CLIN SLEEP MED, V13, P291, DOI 10.5664/jcsm.6466; Lopez CM, 2017, J PSYCHOPATHOL BEHAV, V39, P755, DOI 10.1007/s10862-017-9618-6; Maher MJ, 2006, CNS DRUGS, V20, P567, DOI 10.2165/00023210-200620070-00003; Margolies SO, 2013, J CLIN PSYCHOL, V69, P1026, DOI 10.1002/jclp.21970; Marsee MA, 2008, J CLIN CHILD ADOLESC, V37, P519, DOI 10.1080/15374410802148152; McFall M, 1999, J TRAUMA STRESS, V12, P501, DOI 10.1023/A:1024771121189; Miller L., 1994, PSYCHOBIOLOGY AGGRES, V21, P91, DOI DOI 10.1300/J076; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Morin cm, 1993, TREATMENT MANUALS PR; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Nissen C, 2011, J SLEEP RES, V20, P129, DOI 10.1111/j.1365-2869.2010.00872.x; O'Donnell C, 2006, J TRAUMA STRESS, V19, P859, DOI 10.1002/jts.20157; Ouimette P, 2011, PSYCHOL SERV, V8, P212, DOI 10.1037/a0024360; Pigeon WR, 2013, J PSYCHOSOM RES, V75, P546, DOI 10.1016/j.jpsychores.2013.09.004; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Ram S, 2010, SLEEP BREATH, V14, P63, DOI 10.1007/s11325-009-0281-3; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Serper MR, 2005, COMPR PSYCHIAT, V46, P121, DOI 10.1016/j.comppsych.2004.07.031; Sorgi P, 1991, J Neuropsychiatry Clin Neurosci, V3, pS52; Stappenbeck CA, 2014, PSYCHOL TRAUMA-US, V6, P65, DOI 10.1037/a0031468; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Taft CT, 2007, J ABNORM PSYCHOL, V116, P498, DOI 10.1037/0021-843X.116.3.498; Talbot LS, 2014, J CLIN SLEEP MED, V10, P795, DOI 10.5664/jcsm.3878; Taylor DJ, 2005, SLEEP, V28, P1457, DOI 10.1093/sleep/28.11.1457; Teten AL, 2010, J INTERPERS VIOLENCE, V25, P1612, DOI 10.1177/0886260509354583; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; Tsai J, 2012, PSYCHIATRY, V75, P135, DOI 10.1521/psyc.2012.75.2.135; Tyrer P, 2008, LANCET, V371, P57, DOI 10.1016/S0140-6736(08)60072-0; Volungis, 2004, J CHILD FAM STUD, V13, DOI [https://doi.org/10.1023/B:JCFS.0000044730.66750.57, DOI 10.1023/B:JCFS.0000044730.66750.57]; Weaver EM, 2004, ARCH OTOLARYNGOL, V130, P453, DOI 10.1001/archotol.130.4.453; Williams JE, 2002, STROKE, V33, P13, DOI 10.1161/hs0102.101625	71	2	2	2	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0899-5605	1532-7876		MIL PSYCHOL	Milit. Psychol.		2019	31	3					241	250		10.1080/08995605.2019.1598220			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	IG3JX	WOS:000473702400008					2022-02-06	
J	Faure, CE; Casnova, M				Faure, Caroline E.; Casnova, Madeline			The Fall of the Gladiators: Wives' Tales of Concussion Reporting and (Possible) Progressive Neurodegenerative Disease in NFL Players	QUALITATIVE REPORT			English	Article						Concussion; Football; NFL; Wives; Progressive Neurodegenerative Disease; Chronic Traumatic Encephalopathy (CTE); Brain Injury; Thematic Analysis	CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN-INJURY; DEPRESSION; SPORT; MASCULINITY; CAREGIVERS; SPECTRUM	This study aims to uncover and describe stories of progressive cognitive, emotional, and behavioral decline in NFL players, as told by those who may know them best: their wives. The goal of the study was to simply explore and understand this new phenomenon with a group of individuals who had not yet been asked to voice their experiences. For this qualitative study, we conducted interviews with 20 wives of current and retired NFL players. Through thematic analysis of the wives' narratives, we identified four themes that help to describe the wives' attitudes and experiences. These were (a) Husbands' Willingness to Conceal Concussions, (b) Husbands Become Unrecognizable, (c) An Emotional Toll on Wives and Families, and (d) Frustrations with the NFL. Our interviews provided vivid, emotionally charged descriptions of both men and women whose lives were irrevocably altered, presumably by a concussion history related to the game of football.	[Faure, Caroline E.] Idaho State Univ, Sport Sci, Pocatello, ID 83209 USA; [Casnova, Madeline] Univ Idaho, Sport Psychol, Moscow, ID 83843 USA		Faure, CE (corresponding author), Idaho State Univ, Sport Sci, Pocatello, ID 83209 USA.; Casnova, M (corresponding author), Univ Idaho, Sport Psychol, Moscow, ID 83843 USA.	faurcaro@isu.edu; madelinepcasanova@gmail.com					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; [Anonymous], 2011, ESPN            1226; Armstrong RA, 2017, NEUROPATH APPL NEURO, V43, P154, DOI 10.1111/nan.12323; Baez B, 2002, QUALITATIVE RESEARCH, V2, P35, DOI DOI 10.1177/1468794102002001638; Belson K., 2017, NY TIMES; Biddle SJH, 2001, J SPORT SCI, V19, P777, DOI 10.1080/026404101317015438; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Butterworth ML, 2014, SPORT SOC, V17, P867, DOI 10.1080/17430437.2013.806033; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Creswell JW., 2014, RES DESIGN QUALITATI, V4; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Crotty M., 1998, FDN SOCIAL RES MEANI; Denzin N.K., 1998, LANDSCAPE QUALITATIV; Duff Diane, 2002, Axone, V24, P14; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Fainaru S., 2013, ESPN; Faure C. E., 2018, APPL RES COACHING AT, V34; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Holdredge R., 2011, MAJOR LEAGUE BASEBAL; JANSEN SC, 1994, SOCIOL SPORT J, V11, P1, DOI 10.1123/ssj.11.1.1; Jenkins S, 2013, WASHINGTON POST; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Leech NL, 2007, POLYGLOSSIA, V43, P265; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Liu WH, 2015, Int J Nurs Sci, V2, P231, DOI 10.1016/j.ijnss.2015.07.001; Maese R, 2018, WASHINGTON POST; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Maroon Joseph C., 2015, PLOS ONE, V10, P1; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mathis M, 1984, J Neurosurg Nurs, V16, P36; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Morse JM., 1994, HDB QUALITATIVE RES, P220, DOI DOI 10.1109/HICSS.2013.531; National Basketball Association (NBA), 2016, PLAYERS UN FUND HLTH; NEUENDORF K.A., 2017, CONTENT ANAL GUIDEBO; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Rodgers K., 2014, NFL CRITICAL CULTURA, P142; Saffary R, 2012, J CLIN SPORT PSYCHOL, V6, P351, DOI 10.1123/jcsp.6.4.351; Saunders B, 2015, QUAL RES, V15, P616, DOI 10.1177/1468794114550439; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stinson S., 2012, FOX BUSINESS NE 0803; Thompson SM, 1997, ADV NURS SCI, V20, P55, DOI 10.1097/00012272-199712000-00007	59	2	2	0	4	NOVA SOUTHEASTERN UNIV	FORT LAUDERDALE-DAVIE	3301 COLLEGE AVE, FORT LAUDERDALE-DAVIE, FL 33314 USA	2160-3715			QUAL REP	Qual. Rep.	JAN	2019	24	1							1				23	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	HM1FZ	WOS:000459196700001					2022-02-06	
J	Freckelton, I				Freckelton, Ian			CONCUSSION, DEFAMATION AND THE RINGSIDE DOCTOR	JOURNAL OF LAW AND MEDICINE			English	Article						ringside doctors; martial arts; concussion; defamation action; damages		Ringside doctors play a vital public health role in protecting fighters from the deleterious effects of concussive and other injuries which are reasonably foreseeable from the contests in which they engage. This column reviews a landmark action for defamation taken by a ringside doctor against a media organisation that published a critique of his performance of his role in a high-profile boxing bout in Sydney, Australia. It reviews the judgment of McCallum J in O'Neill v Fairfax Media Publications Pty Ltd (No 2) [2019] NSWSC 655 (O'Neill) and reflects on the broader significance of the decision for the role played by ringside doctors while boxing and other martial arts contests continue to be permitted by law.	[Freckelton, Ian] Crockett Chambers, Melbourne, Vic, Australia; [Freckelton, Ian] Univ Melbourne, Law & Psychiat, Melbourne, Vic, Australia; [Freckelton, Ian] Monash Univ, Forens Med, Clayton, Vic, Australia		Freckelton, I (corresponding author), Crockett Chambers, Melbourne, Vic, Australia.; Freckelton, I (corresponding author), Univ Melbourne, Law & Psychiat, Melbourne, Vic, Australia.; Freckelton, I (corresponding author), Monash Univ, Forens Med, Clayton, Vic, Australia.	I.Freckelton@vicbar.com.au	Freckelton, Ian/ABF-6358-2020				[Anonymous], 2017, SYDNEY MORNING HERAL; Brain Injury Research Institute, PROT BRAIN; Chesanow N, 2015, WHAT IS PHYS ROLE MO; Dahl Linda D, 2018, TOOTH NAIL MAKING FE; Diedrich J, 2018, RINGSIDE DOCTOR PROM; Freckelton I, 2019, EXPERT EVIDENCE LAW; Kelly M, 2009, CLIN SPORT MED, V28, P515, DOI 10.1016/j.csm.2009.07.003; Neidecker J, 2019, BRIT J SPORT MED, V53, P328, DOI 10.1136/bjsports-2017-098799; Rodriguez RG, 2009, REGULATION BOXING HI; Salomon B, 2018, NEUROLOGY, V91, P1018, DOI 10.1212/WNL.0000000000006581; Sethi N K, 2018, SA J. Sports Med., V30, P1, DOI 10.17159/2078-516x/2018/v30i1a4255; Sethi NK, 2018, NEUROLOGY, V91, P1018; Weinbaum W, 2017, PARENTS EXBOXER PRIC	13	2	2	0	0	THOMSON REUTERS AUSTRALIA LTD	NORTH RYDE	THOMSON REUTERS AUSTRALIA LTD, NORTH RYDE, 00000, AUSTRALIA	1320-159X			J LAW MED	J. Law Med.		2019	27	1					55	65					11	Law	Emerging Sources Citation Index (ESCI)	Government & Law	JC9TC	WOS:000489618400005	31682342				2022-02-06	
S	Galindo, AN; Macron, C; Cominetti, O; Dayon, L		Brun, V; Coute, Y		Galindo, Antonio Nunez; Macron, Charlotte; Cominetti, Ornella; Dayon, Loic			Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery	PROTEOMICS FOR BIOMARKER DISCOVERY: Methods and Protocols	Methods in Molecular Biology		English	Article; Book Chapter						Alzheimer; Automation; Biomarker; Brain; Clinical research; CSF; Depletion; Human; Isobaric tagging; Large scale; Mass spectrometry	DISEASE PATHOLOGY; BLOOD	Over the past decade, liquid chromatography tandem mass spectrometry (LC MS/MS)-based workflows become standard for biomarker discovery in proteomics. These medium- to high-throughput (in terms of protein content) profiling approaches have been applied to clinical research. As a result, human proteomes have been characterized to a greater extent than ever before. However, proteomics in clinical research and biomarker discovery studies has generally been performed with small cohorts of subjects (or pooled samples from larger cohorts). This is problematic, as when aiming to identify novel biomarkers, small studies suffer from inherent and important limitations, as a result of the reduced biological diversity and representativity of human populations. Consequently, larger-scale proteomics will be key to delivering robust biomarker candidates and enabling translation to clinical practice. Cerebrospinal fluid (CSF) is a highly clinically relevant body fluid, and an important source of potential biomarkers for brain-associated damage, such as that induced by traumatic brain injury and stroke, and brain diseases, such as Alzheimer's disease and Parkinson's disease. We have developed a scalable automated proteomic pipeline (ASAP2) for biomarker discovery. This workflow is compatible with larger clinical research studies in terms of sample size, while still allowing several hundred proteins to be measured in CSF by MS. In this chapter, we describe the whole proteomic workflow to analyze human CSF. We further illustrate our protocol with some examples from an analysis of hundreds of human CSF samples, in the specific context of biomarker discovery to characterize central nervous system disorders.	[Galindo, Antonio Nunez] Nestle Inst Hlth Sci, Nestle Res, Prote, Lausanne, Switzerland; [Macron, Charlotte; Cominetti, Ornella; Dayon, Loic] Nestle Inst Hlth Sci, Prote, Lausanne, Switzerland		Galindo, AN (corresponding author), Nestle Inst Hlth Sci, Nestle Res, Prote, Lausanne, Switzerland.		Dayon, Loic/J-2499-2019	Dayon, Loic/0000-0002-8499-270X; Cominetti, Ornella/0000-0001-8564-1963			Agrawal M, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00054; Begcevic I, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-016-9111-3; Cominetti O, 2016, J PROTEOME RES, V15, P389, DOI 10.1021/acs.jproteome.5b00901; Dayon L, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0397-4; Dayon L, 2017, J ALZHEIMERS DIS, V60, P1641, DOI 10.3233/JAD-170426; Dayon L, 2017, METHODS MOL BIOL, V1619, P433, DOI 10.1007/978-1-4939-7057-5_30; Dayon L, 2014, J PROTEOME RES, V13, P3837, DOI 10.1021/pr500635f; Fang QJ, 2009, MOL CELL PROTEOMICS, V8, P451, DOI 10.1074/mcp.M800231-MCP200; Galindo AN, 2015, ANAL CHEM, V87, P10755, DOI 10.1021/acs.analchem.5b02748; Henriksen K, 2014, ALZHEIMERS DEMENT, V10, P115, DOI 10.1016/j.jalz.2013.01.013; Lista S, 2013, PROG NEUROBIOL, V101, P1, DOI 10.1016/j.pneurobio.2012.06.007; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Moreno SO, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201600150; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007	14	2	2	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-9164-8; 978-1-4939-9163-1	METHODS MOL BIOL	Methods Mol. Biol.		2019	1959						89	112		10.1007/978-1-4939-9164-8_6	10.1007/978-1-4939-9164-8		24	Biochemical Research Methods; Biochemistry & Molecular Biology	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology	BS2QB	WOS:000706396700007	30852817				2022-02-06	
J	Gutierrez, ML; Christy, EB; Whitney, SL				Gutierrez, Michelle L.; Christy, Ennifer B.; Whitney, Susan L.			Development of Military Concussion Readiness Inventory for Dizziness and Balance	PATIENT-RELATED OUTCOME MEASURES			English	Article						blast injury; questionnaire; return-to-duty; service member	CONTENT VALIDITY; DELPHI TECHNIQUE; CLASSIFICATION; RELIABILITY; RECOVERY; LESSONS; GAIT	Purpose: The objective of this study was to develop and establish content validity of a new instrument titled the Military Concussion Readiness Inventory for Dizziness and Balance (MCRI-DB). The MCRI-DB was intended to recognize functional impairments and predict readiness for return-to-duty in service members who experienced mild traumatic brain injury (mTBI). Methods: Nineteen male service members were included in a nominal group technique (NGT) process to produce items for the MCRI-DB. Items were categorized according to the International Classification of Functioning, Disability and Health (ICF) and were sent to 13 physical therapy experts through a Delphi survey to determine content validity. The consensus to include an item was defined as an agreement of at least 70% of the participants. Results: The NGT produced 222 items with 108 duplicates removed. The ICF categorization linked 84 of the items to 36 unique ICF Codes, 9 items were not linkable to the ICF due to the complex nature of the activity, and 21 items were removed. After three rounds of the Delphi survey, 68 items were included in this instrument. Conclusion: In this study, we successfully combined the use of service members' experiences with expert opinion to determine content validity of the MCRI-DB. This instrument may be used for assessment of service members who have experienced mTBI to help identify environmental factors, functional activities, and body functions that may reduce the safe and efficient fulfillment of their duties and determine their ability to return-to-duty. Further research is needed to develop the psychometric properties of the instrument fully.	[Gutierrez, Michelle L.] Univ Texas El Paso, Doctor Phys Therapy Program, 1101 N Campbell,Room 308, El Paso, TX 79902 USA; [Christy, Ennifer B.] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL USA; [Whitney, Susan L.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA USA; [Whitney, Susan L.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA		Gutierrez, ML (corresponding author), Univ Texas El Paso, Doctor Phys Therapy Program, 1101 N Campbell,Room 308, El Paso, TX 79902 USA.	mgutierrez28@utep.edu	Gutierrez, Michelle L/J-7100-2014				Alghwiri AA., 2011, DEV VALIDATION VESTI; Alghwiri AA, 2012, ARCH PHYS MED REHAB, V93, P1822, DOI 10.1016/j.apmr.2012.03.017; [Anonymous], 2007, PRACTICAL ASSESSMENT, V12, P1; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Dalkey, 1969, DELPHI METHOD EXPT S; De Villiers MR, 2005, MED TEACH, V27, P639, DOI 10.1080/13611260500069947; Defense and Veterans Brain Injury Center, 2018, BLAST INJURIES; Defense and Veterans Brain Injury Center, 2018, TBI NUMB; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Green LW, 1991, HLTH PROMOTION PLANN; Herdman SJ, 2007, VESTIBULAR REHABILIT; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Maarsingh OR, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-12; McCulloch KL, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932010-00002; Mueller M, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-75; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Perroca MG, 2011, REV LAT-AM ENFERM, V19, P58, DOI 10.1590/S0104-11692011000100009; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Potter M., 2004, NZ J PHYSIOTHERAPY, V32, P126; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Russell Cynthia K, 2003, Evid Based Nurs, V6, P36; Scherer M, 2007, MIL MED, V172, P731, DOI 10.7205/MILMED.172.7.731; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; VANDEVEN AH, 1972, AM J PUBLIC HEALTH N, V62, P337, DOI 10.2105/AJPH.62.3.337; Veterans Affairs/Department of Defense, 2016, VA DOD CLIN PACT GUI; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Whitney SL, 2016, J VESTIBUL RES-EQUIL, V26, P297, DOI 10.3233/VES-160580; World Health Organization, 2007, INT CLASS FUNCT DIS; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	38	2	2	0	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-271X			PATIENT-RELAT OUTCOM	PATIENT-RELAT. OUTCOME MEAS.		2019	10						67	80		10.2147/PROM.S171380			14	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	HN9JJ	WOS:000460515400003	30881164	gold, Green Submitted, Green Published			2022-02-06	
J	Higbee, M; Eliason, J; Weinberg, H; Lifshitz, J; Handmaker, H				Higbee, Mark; Eliason, Jon; Weinberg, Hilary; Lifshitz, Jonathan; Handmaker, Hirsch			Involving Police Departments in Early Awareness of Concussion Symptoms during Domestic Violence Calls	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						DV; intimate partner violence; traumatic brain injury; officers; assessment; strangulation; sexual assault	STRANGULATION; LEGAL	Police officers around the world respond to and investigate calls regarding domestic violence (DV) daily. Police departments operate with standard protocols, particularly when engaging in investigations that involve allegations of strangulation or sexual assault. Operating under advisement of the Maricopa County Attorney's Office, the Mesa Police Department (Mesa, AZ) has established protocols for detecting, recording, and prosecuting DV cases that involve strangulation and sexual assault. Allegations of strangulation (defined as impeded breathing) or sexual assault prompt officers to offer a forensic nursing exam (FNE) combined with strangulation treatment by forensic nurses at the Mesa Family Advocacy Center. Recognizing the potential for head injury to the assault victim in all DV situations, including intimate partner violence (IPV), the police department has added concussion-awareness training, as well as a point-of-incident investigative tool for its officers to record neurological function of the victim. Officers were instructed to use the ConQVerge device to measure and record the Near Point of Convergence (NPC) as a test of neurological impairment in suspected head injuries. In this article, we discuss the challenges and opportunities for assisting victims of DV strangulation and sexual assault (including non-DV sexual assault) with on-site assessment and consent for further medical assessment and treatment. Additionally, rates of domestic assault victims that report a crime, but decline to follow through with forensic medical tests, are reported for the first time. Lessons leamed from the project that inform strategic operations in this space are offered to other agencies prior to the implementation of similar procedures.	[Higbee, Mark] Mesa Police Dept, Mesa, AZ USA; [Eliason, Jon; Weinberg, Hilary] Maricopa Cty Attorneys Off, Phoenix, AZ USA; [Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Lifshitz, Jonathan] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Lifshitz, Jonathan] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ USA; [Lifshitz, Jonathan; Handmaker, Hirsch] CACTIS Fdn, 4400 N Scottsdale Rd 9704, Scottsdale, AZ 85251 USA; [Handmaker, Hirsch] Univ Arizona, Dept Radiol, Coll Med, Phoenix, AZ USA		Handmaker, H (corresponding author), CACTIS Fdn, 4400 N Scottsdale Rd 9704, Scottsdale, AZ 85251 USA.	hhandmaker@gmail.com			Hickey Family Foundation	This work was supported by the Hickey Family Foundation.	Block C., 2000, CHICAGO WOMENS HLTH; Block C. R., 2004, CHICAGO WOMENS HLTH; Cronholm P. F., 2018, AM FAMILY PHYS, V97; Evans JR, 2009, PSYCHOL PUBLIC POL L, V15, P194, DOI 10.1037/a0016837; Glass N, 2008, J EMERG MED, V35, P329, DOI 10.1016/j.jemermed.2007.02.065; Hawley DA, 2001, J EMERG MED, V21, P317, DOI 10.1016/S0736-4679(01)00401-2; McClane GE, 2001, J EMERG MED, V21, P311, DOI 10.1016/S0736-4679(01)00400-0; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Robinson J, 2015, INT J LAW PSYCHIAT, V42-43, P168, DOI 10.1016/j.ijlp.2015.08.022; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Strack GB, 2001, J EMERG MED, V21, P303, DOI 10.1016/S0736-4679(01)00399-7; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610	12	2	2	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma		2019	28	7			SI		826	837		10.1080/10926771.2019.1653412			12	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	IV7RC	WOS:000484463300003		Green Published			2022-02-06	
J	Ho, T; Frisbie, J; Wasfie, T; Boyer, JJ; Knisely, T; Cwalina, N; Barber, K; Shapiro, B				Ho, Tran; Frisbie, Jacob; Wasfie, Tarik; Boyer, Jennifer J.; Knisely, Tara; Cwalina, Natalia; Barber, Kimberly; Shapiro, Brian			A retrospective analysis of factors influencing readmission rates of acute traumatic subdural hematoma in the elderly: A cohort study	INTERNATIONAL JOURNAL OF SURGERY OPEN			English	Article						Subdural hematoma; Readmission; Risk factors	BRAIN-INJURY; MORTALITY; OUTCOMES; REHOSPITALIZATION; COMORBIDITIES; ASSOCIATION; PREVALENCE; DISORDERS; ADULTS; MODEL	Objective: Acute traumatic subdural hematomas (TSDH) readmission rate is high (27.8%) with an increase in morbidity and cost for the elderly. This study identifies risk factors affecting readmission rates for these patients and presents strategies to reduce it. Methods: A retrospective analysis was conducted including patients with TSDH admitted to our Community Hospital and followed subsequently for two years regarding readmission within 6 months of initial discharge. The following factors were compared for patients readmitted versus not readmitted: patient age, sex, number of comorbidities, anticoagulation status, surgical intervention, ICU length of stay, injury severity score, and discharge disposition. Results: A total of 167 patients were included in the study. Overall, 75 patients (44.9%) were readmitted within 6 months. Readmitted patients had an overall higher mean age (74.1 vs. 65.4, p = 0.001). Readmission with recurrent subdural hematoma was diagnosed in 32.2% of readmitted patients vs. 67.8% (p < 0.0005) with readmission for other medical complications. 80.0% of readmitted patients had more than four comorbid conditions (p < 0.0001). Conclusion: This study identifies risk factors that affect readmission rates for patients with TSDH and establishes strategies that may help to decrease readmission. (C) 2019 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd.	[Ho, Tran; Frisbie, Jacob] Genesys Reg Med Ctr, Dept Gen Surg, Grand Blanc, MI USA; [Wasfie, Tarik; Boyer, Jennifer J.; Cwalina, Natalia; Shapiro, Brian] Genesys Reg Med Ctr, Dept Trauma Surg, Grand Blanc, MI USA; [Knisely, Tara; Barber, Kimberly] Genesys Reg Med Ctr, Dept Med Res, Grand Blanc, MI USA		Wasfie, T (corresponding author), One Genesys Pkwy, Grand Blanc, MI 48439 USA.	tarik.wasfie@ascension.com		Wasfie, Tarik/0000-0003-4172-6695			Agha RA, 2017, INT J SURG, V46, P198, DOI 10.1016/j.ijsu.2017.08.586; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Bullock MR, 2006, NEUROSURGERY S, V58, P516; Canner JK, 2016, BRAIN INJURY, V30, P1570, DOI 10.1080/02699052.2016.1199898; Centers for Disease Control and Prevention, 2001, RAT TBI REL HOSP AG; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chan Vincy, 2017, BMC Res Notes, V10, P371, DOI 10.1186/s13104-017-2682-x; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Guido D, 2015, AGING CLIN EXP RES, V27, P849, DOI 10.1007/s40520-015-0360-1; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Manickam A, 2016, J CLIN NEUROSCI, V34, P100, DOI 10.1016/j.jocn.2016.05.026; Morris NA, 2016, NEUROCRIT CARE, V24, P226, DOI 10.1007/s12028-015-0178-x; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Schmidt L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140450; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tran J, 2017, J HEAD TRAUMA REHAB, V32, P264, DOI 10.1097/HTR.0000000000000296; United States Census Bureau, 2010, 65 US; Walcott BP, 2014, J CLIN NEUROSCI, V21, P2107, DOI 10.1016/j.jocn.2014.05.016; Wasfie T, 2017, AM SURGEON, V83, pE231; Zatzick DF, 2017, PSYCHIAT SERV, V68, P596, DOI 10.1176/appi.ps.201600311	24	2	2	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2405-8572			INT J SURG OPEN	Int. J. Surg. Open		2019	20						20	23		10.1016/j.ijso.2019.09.007			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	JL9VT	WOS:000495874100004		gold			2022-02-06	
